PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Brain function associated with reaction time after sport-related concussion	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Reaction time; Cognition; fMRI; Connectivity	DEFAULT-MODE NETWORK; SALIENCE NETWORK; NEUROCOGNITIVE PERFORMANCE; NORMATIVE DATA; BASE-LINE; SPEED; CONNECTIVITY; EFFICIENCY; RELIABILITY; IMPAIRMENTS	Concussion is associated with significant functional disturbances in the first week post-injury. Computerized neurocognitive testing tools have become widely adopted in concussion management, to identify specific domains of impairment and obtain more objective measures of recovery. Reaction time (RT) slowing is a common sequela of concussion, however, the functional brain networks that underlie RT performance remain under-studied in both healthy and concussed athletic cohorts. This study used blood-oxygenation-level-dependent function magnetic resonance imaging (BOLD fMRI) to evaluate resting brain function of 45 university-level athletes with concussion in the first week post-injury, along with a control cohort of 102 athletes without recent concussion. We evaluated the main effects of concussion and RT on functional connectivity, along with concussion x RT interactions, using multivariate analysis techniques. Concussion was associated with reduced connectivity throughout the brain, whereas RT slowing was associated with elevated connectivity in parietal and temporal regions, for both control and concussed groups. For the concussed group, RT slowing was also associated with disrupted connectivity between fronto-insular and default mode networks. For concussed athletes, the brain networks associated with slower post-injury RT also showed similar but non-significant associations with longitudinal changes in RT performance relative to pre-injury baseline. These study findings provide new insights into the effects of concussion on neurocognitive function and suggest the presence of functional brain networks that are specific to concussion-related RT slowing.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada.	nchurchill.research@gmail.com; michael.hutchison@utoronto.ca; sgraham@sri.utoronto.ca; Tom.Schweizer@unityhealth.to			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342-401065, RN294001-367456]; Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada Ltd.	This study was funded by Canadian Institutes of Health Research (CIHR) (grant numbers RN356342-401065, RN294001-367456); the Canadian Institutes of Military and Veterans Health (CIMVHR) (grant number W7714-145967); and Siemens Canada Ltd.	Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Birren J. E., 1980, BEHAV SLOWING AGE CA; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bro R., 1996, J CHEMOMETRICS, V10; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Buckner R. L., 2008, BRAINS DEFAULT NETWO; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Churchill N. W., 2018, NEUROIMAGE CLIN; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Deary IJ, 2005, AGING NEUROPSYCHOL C, V12, P187, DOI 10.1080/13825580590969235; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Genova HM, 2009, J INT NEUROPSYCH SOC, V15, P383, DOI 10.1017/S1355617709090535; Goulden N, 2014, NEUROIMAGE, V99, P180, DOI 10.1016/j.neuroimage.2014.05.052; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Hutchison MG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00046; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Loose R, 2006, BRAIN RES, V1090, P146, DOI 10.1016/j.brainres.2006.03.039; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Menon V, 2000, NEUROIMAGE, V12, P357, DOI 10.1006/nimg.2000.0613; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Moritz AR, 1943, ANN SURG, V117, P562, DOI 10.1097/00000658-194304000-00006; Neubauer AC, 2009, INTELLIGENCE, V37, P223, DOI 10.1016/j.intell.2008.10.008; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Rypma B, 2005, CORTEX, V41, P582, DOI 10.1016/S0010-9452(08)70198-9; Rypma B, 2009, INTELLIGENCE, V37, P207, DOI 10.1016/j.intell.2008.12.004; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Smith AB, 2004, HUM BRAIN MAPP, V21, P247, DOI 10.1002/hbm.20007; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tarlochan F., 2013, INT, V2, P17; te Grotenhuis M, 2017, INT J PUBLIC HEALTH, V62, P163, DOI 10.1007/s00038-016-0901-1; Uddin LQ, 2015, NAT REV NEUROSCI, V16, P55, DOI 10.1038/nrn3857; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	63	5	5	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2021	15	3					1508	1517		10.1007/s11682-020-00349-9		AUG 2020	10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TJ9UM	WOS:000563824000001	32851585				2022-02-06	
J	Mao, M; Xu, Y; Zhang, XY; Yang, L; An, XB; Qu, Y; Chai, YN; Wang, YR; Li, TT; Ai, J				Mao, Meng; Xu, Yi; Zhang, Xin-Yu; Yang, Lin; An, Xiao-bin; Qu, Yang; Chai, Ya-ni; Wang, Yan-Ru; Li, Ting-ting; Ai, Jing			MicroRNA-195 prevents hippocampal microglial/macrophage polarization towards the M1 phenotype induced by chronic brain hypoperfusion through regulating CX3CL1/CX3CR1 signaling	JOURNAL OF NEUROINFLAMMATION			English	Article						Chronic brain hypoperfusion; MicroRNA-195; Microglial; macrophage polarization; Neuronal-microglial cross-talk; Neuroinflammation	MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; FRACTALKINE; TNF; NEUROINFLAMMATION; MACROPHAGES; EXPRESSION; MECHANISM; DYNAMICS; PATHWAY	Background Microglial polarization is a dynamic response to acute brain hypoxia induced by stroke and traumatic brain injury (TBI). However, studies on the polarization of microglia in chronic cerebral circulation insufficiency (CCCI) are limited. Our objective was to investigate the effect of CCCI on microglial polarization after chronic brain hypoperfusion (CBH) and explore the underlying molecular mechanisms. Methods CBH model was established by bilateral common carotid artery occlusion (2-vessel occlusion, 2VO) in rats. Using the stereotaxic injection technique, lenti-pre-miR-195and anti-miR-195oligonucleotide fragments (lenti-pre-AMO-miR-195) were injeted into the CA1 region of the hippocampus to construct animal models with high or low expression ofmiR-195. Immunofluorescence staining and flow cytometry were conducted to examine the status of microglial polarization. In vitro, Transwell co-culture system was taken to investigate the role ofmiR-195on neuronal-microglial communication through CX3CL1-CX3CR1 signaling. Quantitative real-time PCR was used to detect the level ofmiR-195and inflammatory factors. The protein levels of CX3CL1 and CX3CR1 were evaluated by both western blot and immunofluorescence staining. Results CBH induced by 2VO initiated microglial/macrophage activation in the rat hippocampus from 1 week to 8 weeks, as evaluated by increased ratio of (CD68(+)and CD206(+))/Iba-1 immunofluorescence. And the microglial/macrophage polarization was shifted towards the M1 phenotype at 8 weeks following CBH. The expression of CX3CL1 and CX3CR1 was increased in the hippocampus of 2VO rats at 8 weeks. An in vitro study in a Transwell co-culture system demonstrated that transfection of either primary-cultured neonatal rat neurons (NRNs) or microglial BV2 cells with AMO-195-induced M1 polarization of BV2 cells and increased CX3CL1 and CX3CR1 expression and that these effects were reversed bymiR-195mimics. Furthermore, the upregulation ofmiR-195induced by lenti-pre-miR-195injection prevented microglial/macrophage polarization to M1 phenotype triggered by hippocampal injection of lenti-pre-AMO-miR-195and 2VO surgery. Conclusions Our findings conclude that downregulation ofmiR-195in the hippocampus is involved in CBH-induced microglial/macrophage polarization towards M1 phenotype by governing communication between neurons and microglia through the regulation of CX3CL1 and CX3CR1 signaling. This indicates thatmiR-195may provide a new strategy for clinical prevention and treatment of CBH.	[Mao, Meng; Xu, Yi; Zhang, Xin-Yu; Yang, Lin; An, Xiao-bin; Qu, Yang; Chai, Ya-ni; Wang, Yan-Ru; Li, Ting-ting; Ai, Jing] Harbin Med Univ, Coll Pharm, State Prov Key Labs Biomed Pharmaceut China, Dept Pharmacol, Harbin 150086, Heilongjiang, Peoples R China		Ai, J (corresponding author), Harbin Med Univ, Coll Pharm, State Prov Key Labs Biomed Pharmaceut China, Dept Pharmacol, Harbin 150086, Heilongjiang, Peoples R China.	azhrbmu@126.com		Ai, Jing/0000-0001-6496-7059	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870849, 81671052, 81471115]; Key project of the Natural Science Foundation of Heilongjiang province [ZD2018004]; Heilongjiang Touyan Innovation Team Program	This work was supported by the Natural Science Foundation of China (81870849, 81671052, and 81471115 to J. A.), the Key project of the Natural Science Foundation of Heilongjiang province (ZD2018004), and Heilongjiang Touyan Innovation Team Program.	Ai J, 2013, J NEUROSCI, V33, P3989, DOI 10.1523/JNEUROSCI.1997-12.2013; Bras JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188530; Cechetti F, 2012, BRAIN RES BULL, V87, P109, DOI 10.1016/j.brainresbull.2011.10.006; Chen X, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.243; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; DELATORRE JC, 1994, NEUROSCI BIOBEHAV R, V18, P397, DOI 10.1016/0149-7634(94)90052-3; DING AH, 1988, J IMMUNOL, V141, P2407; Ding J, 2013, HEPATOLOGY, V58, P654, DOI 10.1002/hep.26378; Duncombe J, 2017, CLIN SCI, V131, P2451, DOI 10.1042/CS20160727; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grosse GM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-74; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Heneka MT, 2019, NAT REV IMMUNOL, V19, P79, DOI 10.1038/s41577-018-0112-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Kim TS, 2008, NEUROSCI LETT, V436, P196, DOI 10.1016/j.neulet.2008.03.019; Kirik, 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [DOI 10.1007/S11055-016-0231-Z, 10.1007/s11055-016-0231-z]; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lauro C, 2015, ANN NY ACAD SCI, V1351, P141, DOI 10.1111/nyas.12805; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liu CD, 2016, NEUROBIOL AGING, V45, P76, DOI 10.1016/j.neurobiolaging.2016.05.010; Liu YZ, 2017, LIFE SCI, V184, P87, DOI 10.1016/j.lfs.2017.06.012; Liu Y, 2015, J CEREBR BLOOD F MET, V35, P1623, DOI 10.1038/jcbfm.2015.97; Mecca C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010318; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Soriano SG, 2002, J NEUROIMMUNOL, V125, P59, DOI 10.1016/S0165-5728(02)00033-4; Strobel S, 2015, J NEURAL TRANSM, V122, P1069, DOI 10.1007/s00702-015-1369-5; Sun LH, 2015, J NEUROCHEM, V134, P1139, DOI 10.1111/jnc.13212; Sun LL, 2018, J MOL CELL CARDIOL, V120, P12, DOI 10.1016/j.yjmcc.2018.05.009; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Theriault P, 2016, BIO-PROTOCOL, V6; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yan ML, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2668; Yang G, 2019, J NEUROSURG, V131, P1445, DOI 10.3171/2018.5.JNS173061; Yao H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5386; Zhang LH, 2018, REV NEUROSCIENCE, V29, P837, DOI 10.1515/revneuro-2017-0084; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.3.CO;2-M	51	5	5	5	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	AUG 20	2020	17	1							244	10.1186/s12974-020-01919-w			20	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	NL0SI	WOS:000567135500001	32819407	Green Submitted, Green Published, gold			2022-02-06	
J	Ciftci, E; Karacay, R; Caglayan, A; Altunay, S; Ates, N; Altintas, MO; Doeppner, TR; Yulug, B; Kilic, E				Ciftci, Elvan; Karacay, Reyda; Caglayan, Aysun; Altunay, Serdar; Ates, Nilay; Altintas, Mehmet O.; Doeppner, Thorsten R.; Yulug, Burak; Kilic, Ertugrul			Neuroprotective effect of lithium in cold- induced traumatic brain injury in mice	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Hippocampal volume; Lithium; Cell signaling	GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM POTENTIATION; HIPPOCAMPAL NEUROGENESIS; PREFRONTAL CORTEX; MOOD STABILIZERS; BIPOLAR DISORDER; STRESS; VOLUME; INCREASES; MILD	Apart from its well-established therapeutic activity on bipolar disorder and depression, lithium exerts neuroprotective activity upon neurodegenerative disorders, such as traumatic brain injury (TBI). However, the cellular signaling mechanisms mediating lithium's neuroprotective activity and long-term dose- and time-dependent effects on close and remote proximity are largely unknown. Herein, we tested prophylactic and acute effects of lithium (2 mmol/kg) after cold- induced TBI. In both conditions, treatments with lithium resulted in reduced infarct volume and apoptosis. Its acute treatment resulted in the increase of Akt, ERK-1/2 and GSK-3 alpha/beta phosphoylations. Interestingly, its prophylactic treatment instead resulted in decreased phosphorylations of Akt, ERK-1/2, p38, JNK-1 moderately and GSK-3 alpha/beta significantly. Then, we tested subacute (35-day follow-up) role of low (0.2 mmol/kg) and high dose (2 mmol/kg) lithium and revealed that high dose lithium group was the most mobile so the least depressed in the tail suspension test. Anxiety level was assessed by light-dark test, all groups' anxiety levels were decreased with time, but lithium had no effect on anxiety like behavior. When subacute effects of injury and drug treatment were evaluated on the defined brain regions, infarct volume was decreased in the high dose lithium group significantly. In contrast to other brain regions, hippocampal atrophies were observed in both lithium treatment groups, which were significant in the low dose lithium group in both hemispheres, which was associated with the reduced cell proliferation and neurogenesis. Our data demonstrate that lithium treatment protects neurons from TBI. However, long term particularly low-dose lithium causes hippocampal atrophy and decreased neurogenesis.	[Ciftci, Elvan; Karacay, Reyda; Caglayan, Aysun; Altunay, Serdar; Ates, Nilay; Altintas, Mehmet O.; Kilic, Ertugrul] Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Istanbul, Turkey; [Ciftci, Elvan; Karacay, Reyda; Caglayan, Aysun; Altunay, Serdar; Altintas, Mehmet O.; Kilic, Ertugrul] Istanbul Medipol Univ, Fac Med, Dept Physiol, Istanbul, Turkey; [Ates, Nilay] Istanbul Medipol Univ, Fac Med, Dept Pharmacol, Istanbul, Turkey; [Doeppner, Thorsten R.] Univ Gottingen, Med Sch, Dept Neurol, Gottingen, Germany; [Yulug, Burak] Alanya Alaaddin Keykubat Univ, Fac Med, Dept Neurol, Antalya, Turkey		Kilic, E (corresponding author), Istanbul Medipol Univ, Regenerat & Restorat Med Res Ctr, Dept Physiol, Ekinciler Cad 19, TR-34810 Istanbul, Turkey.	ekilic@medipol.edu.tr	Yulug, Burak/AAD-3930-2022; Yulug, Burak/O-8322-2016	Yulug, Burak/0000-0002-9704-6173	Turkish Academy of Sciences (TUBA)Turkish Academy of Sciences	This study was supported by The Turkish Academy of Sciences (TUBA).	Abdul AURM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.030874; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beker MC, 2018, MOL NEUROBIOL, V55, P2565, DOI 10.1007/s12035-017-0524-4; Bian QM, 2007, BRAIN RES, V1184, P270, DOI 10.1016/j.brainres.2007.09.054; Carlson SW, 2018, J NEUROTRAUM, V35, P2827, DOI 10.1089/neu.2017.5509; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Chen RW, 1999, J BIOL CHEM, V274, P6039, DOI 10.1074/jbc.274.10.6039; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doeppner TR, 2017, J CEREBR BLOOD F MET, V37, P914, DOI 10.1177/0271678X16647738; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Evrensel A., 2014, BMJ CASE REP, V2014; Fisar Z, 2010, FOLIA BIOL-PRAGUE, V56, P135; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Gray JD, 2013, ACTA PSYCHIAT SCAND, V128, P347, DOI 10.1111/acps.12139; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hajek T, 2012, BIPOLAR DISORD, V14, P261, DOI 10.1111/j.1399-5618.2012.01013.x; Hongisto V, 2003, MOL CELL BIOL, V23, P6027, DOI 10.1128/MCB.23.17.6027-6036.2003; Inkster B, 2009, ARCH GEN PSYCHIAT, V66, P721, DOI 10.1001/archgenpsychiatry.2009.70; Javadapour A, 2010, J NEUROPSYCH CLIN N, V22, P55, DOI 10.1176/appi.neuropsych.22.1.55; Johnson SA, 2009, NEUROSCIENCE, V163, P34, DOI 10.1016/j.neuroscience.2009.06.005; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Kapczinski Flavio, 2008, Expert Rev Neurother, V8, P1101, DOI 10.1586/14737175.8.7.1101; Karege F, 2007, BIOL PSYCHIAT, V61, P240, DOI 10.1016/j.biopsych.2006.04.036; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kilic U, 2013, NEUROSCIENCE, V237, P268, DOI 10.1016/j.neuroscience.2013.01.059; Kim JS, 2009, ACTA HISTOCHEM, V111, P150, DOI 10.1016/j.acthis.2008.05.002; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; KROPF D, 1979, ACTA PSYCHIAT SCAND, V59, P97, DOI 10.1111/j.1600-0447.1979.tb06951.x; LEDOUARIN C, 1983, EUR J PHARMACOL, V93, P55, DOI 10.1016/0014-2999(83)90030-4; Lopez-Jaramillo C, 2017, BIPOLAR DISORD, V19, P41, DOI 10.1111/bdi.12467; Ma J, 2003, NEUROSCI LETT, V348, P185, DOI 10.1016/S0304-3940(03)00784-5; Maruta S, 2005, PSYCHIAT CLIN NEUROS, V59, P358, DOI 10.1111/j.1440-1819.2005.01383.x; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; O'Leary OF, 2012, NEUROPHARMACOLOGY, V62, P247, DOI 10.1016/j.neuropharm.2011.07.015; Pan JQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1397, DOI 10.1038/npp.2011.24; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Polter A, 2010, NEUROPSYCHOPHARMACOL, V35, P1761, DOI 10.1038/npp.2010.43; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Rajkowska G, 2016, BIPOLAR DISORD, V18, P41, DOI 10.1111/bdi.12364; Ren M, 2003, P NATL ACAD SCI USA, V100, P6210, DOI 10.1073/pnas.0937423100; Roh MS, 2005, BIOL PSYCHIAT, V57, P278, DOI 10.1016/j.biopsych.2004.10.039; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sanacora G, 2008, J CLIN PSYCHIAT, V69, P22; Sani G, 2018, J AFFECT DISORDERS, V232, P341, DOI 10.1016/j.jad.2018.02.042; Sasaki T, 2006, BRAIN RES, V1108, P98, DOI 10.1016/j.brainres.2006.06.009; Schloesser RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P110, DOI 10.1038/sj.npp.1301575; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shim SS, 2013, INT J NEUROPSYCHOPH, V16, P1373, DOI 10.1017/S1461145712001423; Shim SS, 2012, NEUROSCI LETT, V524, P5, DOI 10.1016/j.neulet.2012.06.047; Silva R, 2008, NEUROSCIENCE, V152, P656, DOI 10.1016/j.neuroscience.2007.12.026; Simonetti A, 2016, BIPOLAR DISORD, V18, P352, DOI 10.1111/bdi.12394; Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x; Strakowski SM, 1999, ARCH GEN PSYCHIAT, V56, P254, DOI 10.1001/archpsyc.56.3.254; Tsai SY, 2019, J AFFECT DISORDERS, V244, P60, DOI 10.1016/j.jad.2018.10.093; Wang ZY, 2011, INT J DEV NEUROSCI, V29, P415, DOI 10.1016/j.ijdevneu.2011.03.001; Wood GE, 2004, P NATL ACAD SCI USA, V101, P3973, DOI 10.1073/pnas.0400208101; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yucel K, 2008, NEUROPSYCHOPHARMACOL, V33, P361, DOI 10.1038/sj.npp.1301405; Yucel K, 2007, PSYCHOPHARMACOLOGY, V195, P357, DOI 10.1007/s00213-007-0906-9	67	5	5	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	AUG 17	2020	392								112719	10.1016/j.bbr.2020.112719			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	MQ1JW	WOS:000552654000017	32479849				2022-02-06	
J	Kahouadji, S; Salamin, P; Praz, L; Coiffier, J; Frochaux, V; Durif, J; Pereira, B; Arlettaz, L; Oris, C; Sapin, V; Bouvier, D				Kahouadji, Samy; Salamin, Pauline; Praz, Laurent; Coiffier, Julien; Frochaux, Vincent; Durif, Julie; Pereira, Bruno; Arlettaz, Lionel; Oris, Charlotte; Sapin, Vincent; Bouvier, Damien			S100B Blood Level Determination for Early Management of Ski-Related Mild Traumatic Brain Injury: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						S100B; mTBI (mild traumatic brain injury); ski; ski accidents; biomarker	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; PROTEIN; RISK; EPIDEMIOLOGY; SCANS	Background:Mild traumatic brain injury (mTBI) management in emergency departments is a complex process involving clinical evaluation, laboratory testing, and computerized tomography (CT) scanning. Protein S100B has proven to be a useful blood biomarker for early evaluation of mTBI, as it reduces the required CT scans by one-third. However, to date, the ability of S100B to identify positive abnormal findings in the CT scans of patients suffering from mTBI caused by ski practice has not been investigated. Thus, the primary aim of this study was to investigate the diagnostic performance of S100B as an mTBI management biomarker in patients with ski-related mTBI. Materials and Methods:One hundred and thirty adult mTBI patients presenting to the emergency department of Hopital du Valais in Sion, Switzerland, with a Glasgow Coma Scale (GCS) score of 13-15 and clinical indication for a CT scan were included in the study. Blood samples for S100B measurement were collected from each patient and frozen in 3-hour post-injury intervals. CT scans were performed for all patients. Later, serum S100B levels were compared to CT scan findings in order to evaluate the biomarker's performance. Results:Of the 130 included cases of mTBI, 87 (70%) were related to ski practice. At the internationally established threshold of 0.1 mu g/L, the receiver operating characteristic curve of S100B serum levels for prediction of abnormal CT scans showed 97% sensitivity, 11% specificity, and a 92% negative predictive value. Median S100B concentrations did not differ according to sex, age, or GCS score. Additionally, there was no significant difference between skiers and non-skiers. However, a statistically significant difference was found when comparing the median S100B concentrations of patients who suffered fractures or had polytrauma and those who did not suffer fractures. Conclusion:The performance of S100B in post-mTBI brain lesion screenings seems to be affected by peripheral lesions and/or ski practice. The lack of neurospecificity of the biomarker in this context does not allow unnecessary CT scans to be reduced by one-third as expected.	[Kahouadji, Samy; Durif, Julie; Oris, Charlotte; Sapin, Vincent; Bouvier, Damien] CHU Clermont Ferrand, Biochem & Mol Genet Dept, Clermont Ferrand, France; [Salamin, Pauline; Praz, Laurent; Coiffier, Julien; Frochaux, Vincent] Valais Hosp, Dept Emergency Med, Sion, Switzerland; [Pereira, Bruno] CHU Clermont Ferrand, Biostat Unit DRCI, Clermont Ferrand, France; [Arlettaz, Lionel] Valais Hosp, ICH, Dept Biol, Sion, Switzerland; [Oris, Charlotte; Sapin, Vincent; Bouvier, Damien] Univ Clermont Auvergne, CNRS, INSERM, GReD, Clermont Ferrand, France		Bouvier, D (corresponding author), CHU Clermont Ferrand, Biochem & Mol Genet Dept, Clermont Ferrand, France.; Bouvier, D (corresponding author), Univ Clermont Auvergne, CNRS, INSERM, GReD, Clermont Ferrand, France.	dbouvier@chu-clermontferrand.fr		Oris, Charlotte/0000-0002-7360-4142	program in the Auvergne Rhone-Alpes region for international academic and scientific cooperation	This work was supported by the program in the Auvergne Rhone-Alpes region for international academic and scientific cooperation between French and Swiss teams (SCUSI 2018).	Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], **NON-TRADITIONAL**; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200394; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schulte S, 2014, J ATHL TRAINING, V49, P830, DOI 10.4085/1062-6050-49.3.33; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	39	5	5	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 14	2020	11								856	10.3389/fneur.2020.00856			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NJ7FA	WOS:000566207900001	32922357	Green Published, gold			2022-02-06	
J	Zhou, D; Liu, JM; Hang, Y; Li, T; Li, PF; Guo, SC; Liu, T; Xia, Z; Wang, Y				Zhou, Dan; Liu, Jiamiao; Hang, Yang; Li, Teng; Li, Pengfei; Guo, Shichao; Liu, Tao; Xia, Zian; Wang, Yang			TMT-based proteomics analysis reveals the protective effects of Xuefu Zhuyu decoction in a rat model of traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Xuefu zhuyu decoction; Traditional Chinese medicine; Traumatic brain injury; Proteomics	TRANEXAMIC ACID; FACTOR-XIIA; COMPLEMENT; PLASMINOGEN; IDENTIFICATION; COAGULOPATHY; COAGULATION; MODULATION; ACTIVATION; MECHANISMS	Ethnopharmacological relevance: Xuefu Zhuyu decoction (XFZYD) is a traditional Chinese herbal prescription. It is effective in treating traumatic brain injury (TBI). However, the underlying molecular mechanisms remain unclear. Aim of the study: This study aimed to reveal the possible mechanisms of XFZYD in treating acute TBI through proteomics clues. Materials and methods: Controlled Cortical Impact (CCI) rats were given gavage administration of XFZYD (9 g/ kg/d) or distilled water (equal volume) for three days. The Modified Neurological Severity Score (mNSS), brain water content, HE staining, Nissl staining and immunohistochemistry were performed to assess the effects of XFZYD for TBI treatment. Additionally, tandem mass tag-based (TMT) quantitative proteomics technology was applied to detect proteins of brain cortex. Bioinformatics analysis including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and Protein-protein interaction (PPI) networks were used to analyze differentially expressed proteins (DEPs). Bioinformatics Analysis Tool for Molecular mechanism of TCM (BATMAN-TCM) was conducted to anchor diseases and pathways. Besides, western blotting and immunofluorescence were exerted to verify related proteins. Results: XFZYD improved neurologic functions, reduced encephaledema and ameliorated cell morphology around the injured area in CCI rats. A total of 6099 proteins were identified with false discovery rate (FDR) < 1%. Overlapping DEPs (105 DEPs) were identified (295 DEPs and 804 DEPs in CCI/Sham or XFZYD/CCI group, respectively). Of these DEPs, 17 were regulated by XFZYD. Bioinformatics analysis showed that the 17 DEPs were predominantly related to platelet activation and PI3K-Akt signaling pathway. Next, PLG and CD34 were verified with molecular biotechnology. Conclusions: XFZYD exerts therapeutic effects through multi-pathways regulation in the treatment of TBI. This work may provide proteomics clues for the continuation of research on TBI treatment with XFZYD.	[Zhou, Dan; Li, Teng; Xia, Zian; Wang, Yang] Cent South Univ, Inst Integrat Med, Dept Integrated Tradit Chinese & Western Med, Xiangya Hosp, Changsha 410008, Peoples R China; [Liu, Jiamiao; Hang, Yang] Cent South Univ, Xiangya Sch Med, Changsha 410013, Peoples R China; [Li, Pengfei] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Zhengzhou 450052, Peoples R China; [Guo, Shichao] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Dept Neurosurg, Zhengzhou 450052, Henan, Peoples R China; [Liu, Tao] Xinjiang Med Univ, Dept Gerontol, Tradit Chinese Med Hosp, Urumqi 830000, Peoples R China		Wang, Y (corresponding author), Cent South Univ, Xiangya Hosp, Inst Integrat Med, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81973665, 81673719, 81874409, 81803948]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2019JJ30042]; Innovation-Driven Project of Central South University [2020CX047]	This work was funded by grants from the National Natural Science Foundation of China (No. 81973665, 81673719, 81874409 and 81803948), Hunan Provincial Natural Science Foundation of China (No. 2019JJ30042) and Innovation-Driven Project of Central South University (No. 2020CX047).	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; ASTRUP T, 1952, P SOC EXP BIOL MED, V81, P675; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Badhiwala JH, 2019, LANCET NEUROL, V18, P24, DOI 10.1016/S1474-4422(18)30444-7; Furness SGB, 2006, IMMUNOL RES, V34, P13, DOI 10.1385/IR:34:1:13; Beacham GM, 2018, ELIFE, V7, DOI 10.7554/eLife.32242; Beck F, 2017, BLOOD, V129, pE1, DOI 10.1182/blood-2016-05-714048; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; COLMAN RW, 1969, BIOCHEM BIOPH RES CO, V35, P273, DOI 10.1016/0006-291X(69)90278-2; Draxler DF, 2017, SEMIN THROMB HEMOST, V43, P143, DOI 10.1055/s-0036-1586227; El Hage R., 2009, DFD, V94, P1632; Friedli M, 2003, GENE, V320, P31, DOI 10.1016/S0378-1119(03)00830-8; Gong H, 2017, TRANSL EPIGENET SER, P141, DOI 10.1016/B978-0-12-800226-1.00008-3; Griffon N, 2003, MOL BRAIN RES, V117, P47, DOI 10.1016/S0169-328X(03)00283-3; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hoff JT, 2003, ACT NEUR S, V86, P11; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Hughes CS, 2017, J PROTEOME RES, V16, P1839, DOI 10.1021/acs.jproteome.7b00091; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jin XL, 2014, MICROCIRCULATION, V21, P696, DOI 10.1111/micc.12150; Krause DS, 1996, BLOOD, V87, P1; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Liu T, 2019, J ETHNOPHARMACOL, V232, P244, DOI 10.1016/j.jep.2018.11.032; Liu X, 2011, BIOCHEM SOC T, V39, P1348, DOI 10.1042/BST0391348; Liu ZK, 2018, J ETHNOPHARMACOL, V217, P11, DOI 10.1016/j.jep.2018.02.004; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Masilamoni GJ, 2018, CURR OPIN PHARMACOL, V38, P72, DOI 10.1016/j.coph.2018.03.004; Massimi I, 2019, THROMB HAEMOSTASIS, V119, P726, DOI 10.1055/s-0039-1678707; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizuguchi T, 2019, J HUM GENET, V64, P347, DOI 10.1038/s10038-018-0556-2; Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qihua L.S.W.J., 2015, MOD J INTEGR TRAD CH, V24, P350; Reis C, 2015, INT J MOL SCI, V16, P11903, DOI 10.3390/ijms160611903; Righetti PG, 2003, CLIN CHEM LAB MED, V41, P425, DOI 10.1515/CCLM.2003.065; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schousboe I, 1999, THROMB HAEMOSTASIS, V82, P1041; Shah S, 2019, SEMIN CANCER BIOL, V54, P29, DOI 10.1016/j.semcancer.2018.03.005; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shen YC, 2015, J ETHNOPHARMACOL, V173, P370, DOI 10.1016/j.jep.2015.07.018; Smolenski A, 2012, J THROMB HAEMOST, V10, P167, DOI 10.1111/j.1538-7836.2011.04576.x; Song T., 2019, INT J MOL SCI, V20, P20; Sowers JL, 2018, CURR OPIN NEUROL, V31, P709, DOI 10.1097/WCO.0000000000000613; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Sucher NJ, 2013, EXPERT OPIN DRUG DIS, V8, P21, DOI 10.1517/17460441.2013.739602; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Teng F, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/537014; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Verstak B, 2009, J BIOL CHEM, V284, P24192, DOI 10.1074/jbc.M109.023044; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Z.W., 2010, SHANXI ZHONG YI, V31, P850; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; WILSON EL, 1980, CANCER RES, V40, P933; Xiao-qin H., 2007, CHIN J NEUROL, V40, P373; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yeh CW, 2017, J ETHNOPHARMACOL, V209, P50, DOI 10.1016/j.jep.2017.07.036; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zhang LY, 2016, ONCOTARGET, V7, P76551, DOI 10.18632/oncotarget.10388; Zhong YY, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/8916938; Zhou J, 2017, ONCOTARGET, V8, P72069, DOI 10.18632/oncotarget.18895; Zhuang SF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050968	81	5	5	11	35	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741	1872-7573		J ETHNOPHARMACOL	J. Ethnopharmacol.	AUG 10	2020	258								112826	10.1016/j.jep.2020.112826			14	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	LT2FI	WOS:000536887800040	32298754				2022-02-06	
J	Pais-Hrit, C; Wong, D; Gould, KR; Ponsford, J				Pais-Hrit, Celia; Wong, Dana; Gould, Kate Rachel; Ponsford, Jennie			Behavioural and functional correlates of post-traumatic growth following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						PTGI-SF; CIOQ-S; Post-traumatic growth; TBI; Post-injury adjustment	PSYCHIATRIC-DISORDERS; NEGATIVE CHANGES; HEAD-INJURY; SHORT-FORM; AFTERMATH; ADVERSITY	Post-traumatic growth (PTG) can emerge following traumatic brain injury (TBI), however measures of PTG rely on the cognitive capacity to reflect on psychological growth. Positive associations between scores on PTG measures and behavioural and functional indicators of growth would help establish the clinical utility of measuring PTG after TBI. We examined the degree of association of the Post-traumatic Growth Inventory - Short form (PTGI-SF) and Changes in Outlook Questionnaire - Short form (CiOQ-S), with (1) PTG-consistent behaviours; (2) valued living (behaving in ways consistent with one's values); and (3) post-injury functional outcomes. Participants had moderate to severe TBI and were 1-5 years post-injury (n = 70). Participants with higher scores on the CiOP-S (the positive subscale of the CiOQ-S) reported more frequent PTG-consistent behaviours post-injury, such as showing care towards family and friends, and appreciation of life. Higher CiOP-S scores were also positively associated with valued living and return to work/study. There were fewer associations between PTGI-SF scores and behavioural and functional outcomes. PTG after TBI, as measured by the CiOQ-S, was associated with behavioural and functional indicators of positive growth, highlighting the strength and utility of this scale and the importance of measuring and fostering PTG in rehabilitation.	[Pais-Hrit, Celia; Wong, Dana; Gould, Kate Rachel; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Pais-Hrit, Celia; Wong, Dana; Gould, Kate Rachel; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Pais-Hrit, Celia; Wong, Dana; Gould, Kate Rachel; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia		Wong, D (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.; Wong, D (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia.; Wong, D (corresponding author), Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.; Wong, D (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia.	d.wong@latrobe.edu.au	Gould, Kate Rachel/AAA-5511-2020; Wong, Dana/AAD-3410-2020; Ponsford, Jennie/H-8341-2014	Gould, Kate Rachel/0000-0002-3564-7408; Wong, Dana/0000-0001-9619-1929; Ponsford, Jennie/0000-0003-0430-125X			Brooks M, 2016, PERS INDIV DIFFER, V98, P199, DOI 10.1016/j.paid.2016.04.051; Cann A, 2010, ANXIETY STRESS COPIN, V23, P127, DOI 10.1080/10615800903094273; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; Gangstad B, 2009, REHABIL PSYCHOL, V54, P69, DOI 10.1037/a0014639; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hayes AM, 2007, CLIN PSYCHOL REV, V27, P715, DOI 10.1016/j.cpr.2007.01.008; Hobfoll SE, 2007, APPL PSYCHOL-INT REV, V56, P345, DOI 10.1111/j.1464-0597.2007.00292.x; JOSEPH S, 1993, J TRAUMA STRESS, V6, P271, DOI 10.1002/jts.2490060209; Joseph S, 2006, J LOSS TRAUMA, V11, P85, DOI 10.1080/15325020500358241; Joseph S, 2005, PSYCHOL ASSESSMENT, V17, P70, DOI 10.1037/1040-3590.17.1.70; Lelorain S, 2010, J CLIN PSYCHOL MED S, V17, P14, DOI 10.1007/s10880-009-9183-6; McGrath J, 2004, CLIN REHABIL, V18, P767, DOI 10.1191/0269215504cr802oa; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; McMillen JC, 2004, PSYCHOL INQ, V15, P48; Pais C, 2019, NEUROPSYCHOL REHABIL, V29, P625, DOI 10.1080/09602011.2017.1313745; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; Powell T, 2012, DISABIL REHABIL, V34, P1461, DOI 10.3109/09638288.2011.644384; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Shakespeare-Finch J, 2012, J TRAUMA STRESS, V25, P433, DOI 10.1002/jts.21730; Silva J, 2011, BRAIN IMPAIR, V12, P93, DOI 10.1375/brim.12.2.93; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tedeschi, 1991, J TRAINING PRACTICE, V5, P45; Tedeschi R.G., 2006, HDB POSTTRAUMATIC GR; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Wilson KG, 2010, PSYCHOL REC, V60, P249, DOI 10.1007/BF03395706; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	30	5	5	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 8	2020	30	7					1205	1223		10.1080/09602011.2019.1569536			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MH9SO	WOS:000547060000001	30698079				2022-02-06	
J	Underwood, E; Redell, JB; Zhao, J; Moore, AN; Dash, PK				Underwood, Erica; Redell, John B.; Zhao, Jing; Moore, Anthony N.; Dash, Pramod K.			A method for assessing tissue respiration in anatomically defined brain regions	SCIENTIFIC REPORTS			English	Article							DENTATE GYRUS; MITOCHONDRIAL BIOENERGETICS; PATTERN COMPLETION; OXIDATIVE STRESS; INJURY; CA3; DYSFUNCTION; MODEL; VULNERABILITY; DAMAGE	The survival and function of brain cells requires uninterrupted ATP synthesis. Different brain structures subserve distinct neurological functions, and therefore have different energy production/consumption requirements. Typically, mitochondrial function is assessed following their isolation from relatively large amounts of starting tissue, making it difficult to ascertain energy production/failure in small anatomical locations. In order to overcome this limitation, we have developed and optimized a method to measure mitochondrial function in brain tissue biopsy punches excised from anatomically defined brain structures, including white matter tracts. We describe the procedures for maintaining tissue viability prior to performing the biopsy punches, as well as provide guidance for optimizing punch size and the drug doses needed to assess various aspects of mitochondrial respiration. We demonstrate that our method can be used to measure mitochondrial respiration in anatomically defined subfields within the rat hippocampus. Using this method, we present experimental results which show that a mild traumatic brain injury (mTBI, often referred to as concussion) causes differential mitochondrial responses within these hippocampal subfields and the corpus callosum, novel findings that would have been difficult to obtain using traditional mitochondrial isolation methods. Our method is easy to implement and will be of interest to researchers working in the field of brain bioenergetics and brain diseases.	[Underwood, Erica; Redell, John B.; Zhao, Jing; Moore, Anthony N.; Dash, Pramod K.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA		Dash, PK (corresponding author), Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA.	p.dash@uth.tmc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS101686-01, NS086301, NS88298]; NIGM [5T32GM008792]	This work was supported by Grants from NIH (NS101686-01, NS086301, NS88298). Dr. Underwood was supported by a training grant from NIGM (5T32GM008792). The authors would like to thank metal work specialist, Mr. Spencer Elliot (Houston, TX) for his assistance.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Aisen PS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0283-5; Alexiou A, 2018, CURR PROTEIN PEPT SC, V19, P850, DOI 10.2174/1389203718666170810150151; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Bartsch T, 2015, J CEREBR BLOOD F MET, V35, P1836, DOI 10.1038/jcbfm.2015.137; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bugge A, 2014, METHOD ENZYMOL, V538, P233, DOI 10.1016/B978-0-12-800280-3.00013-X; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cai Q, 2017, J ALZHEIMERS DIS, V57, P1087, DOI 10.3233/JAD-160726; Cameron MA, 2017, JOVE-J VIS EXP, DOI 10.3791/55396; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Dasgupta S, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.08.22; Devenney E, 2015, JAMA NEUROL, V72, P1501, DOI 10.1001/jamaneurol.2015.2061; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dondzillo A, 2015, J NEUROPHYSIOL, V114, P2053, DOI 10.1152/jn.00289.2014; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Ferrick A. N. T. W., 2007, United States patent, Patent No. [US20070087401A1, 20070087401]; Fischer TD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006169; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Fried NT, 2014, AM J PHYSIOL-CELL PH, V307, pC1017, DOI 10.1152/ajpcell.00332.2013; FUNAHASHI M, 1990, PHARMACOL BIOCHEM BE, V36, P345, DOI 10.1016/0091-3057(90)90415-E; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; GoodSmith D, 2017, NEURON, V93, P677, DOI 10.1016/j.neuron.2016.12.026; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037; Hase Y, 2018, J NEUROCHEM, V144, P617, DOI 10.1111/jnc.14271; Hinman JD, 2007, NEUROCHEM RES, V32, P2023, DOI 10.1007/s11064-007-9341-x; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Iuso A, 2017, METHODS MOL BIOL, V1567, P217, DOI 10.1007/978-1-4939-6824-4_13; Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/bse0470053, 10.1042/BSE0470053]; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Kesner RP, 2018, BEHAV BRAIN RES, V354, P84, DOI 10.1016/j.bbr.2017.07.033; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Knierim JJ, 2016, NEUROBIOL LEARN MEM, V129, P38, DOI 10.1016/j.nlm.2015.10.008; Le Duigou C, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00262; Leung DTH, 2018, METHODS MOL BIOL, V1710, P285, DOI 10.1007/978-1-4939-7498-6_22; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Matsuda H, 2016, AGEING RES REV, V30, P17, DOI 10.1016/j.arr.2016.01.003; Maynard ME, 2019, J NEUROTRAUM, V36, P2147, DOI 10.1089/neu.2018.6155; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Medvedeva YV, 2017, J NEUROSCI, V37, P726, DOI [10.1523/JNEUROSCI.3270-16.2016, 10.1523/JNEUROSCI.3270-16.2017]; Mkrtchyan GV, 2018, BBA-BIOENERGETICS, V1859, P925, DOI 10.1016/j.bbabio.2018.05.005; Narendra DP, 2012, NATURE, V483, P418, DOI 10.1038/nature10952; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Neville KE, 2018, J NEUROSCI METH, V296, P32, DOI 10.1016/j.jneumeth.2017.12.020; Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Halloran KD, 2016, EXP PHYSIOL, V101, P258, DOI 10.1113/EP085634; Orrell J. A. N. S. Y. J., 2014, United States patent, Patent No. [US 20160077083 A1, 20160077083]; Panchal K, 2019, MITOCHONDRION, V47, P151, DOI 10.1016/j.mito.2018.11.002; Pandya JD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00605; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Papouin T, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2699; PARR J, 1975, Annals of Clinical and Laboratory Science, V5, P167; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Rebola N, 2017, NAT REV NEUROSCI, V18, P209, DOI 10.1038/nrn.2017.10; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Schniertshauer D, 2018, J AGING RES, V2018, DOI 10.1155/2018/6354680; Schuh RA, 2011, J NEUROSCI RES, V89, P1979, DOI 10.1002/jnr.22650; Shintaku J, 2016, METHODS MOL BIOL, V1460, P337, DOI 10.1007/978-1-4939-3810-0_23; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Song HM, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00278; Sperling JA, 2019, NEUROMOL MED, V21, P493, DOI 10.1007/s12017-019-08552-8; Tuncdemir SN, 2019, BEHAV BRAIN RES, V374, DOI 10.1016/j.bbr.2019.112112; Veitch DP, 2019, ALZHEIMERS DEMENT, V15, P106, DOI 10.1016/j.jalz.2018.08.005; Ware AL, 2020, BRAIN IMAGING BEHAV, V14, P772, DOI 10.1007/s11682-018-0018-7; Wilde EA, 2019, J NEUROTRAUM, V36, P3164, DOI 10.1089/neu.2019.6377; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Yu SB, 2018, J MOL BIOL, V430, P3922, DOI 10.1016/j.jmb.2018.07.027; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	88	5	5	1	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	AUG 6	2020	10	1							13179	10.1038/s41598-020-69867-2			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT9BN	WOS:000573233300008	32764697	Green Published, gold			2022-02-06	
J	Krishna, G; Bromberg, C; Connell, EC; Mian, E; Hu, CC; Lifshitz, J; Adelson, PD; Thomas, TC				Krishna, Gokul; Bromberg, Caitlin; Connell, Emily Charlotte; Mian, Erum; Hu, Chengcheng; Lifshitz, Jonathan; Adelson, P. David; Thomas, Theresa Currier			Traumatic Brain Injury-Induced Sex-Dependent Changes in Late-Onset Sensory Hypersensitivity and Glutamate Neurotransmission	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; sex difference; glutamate; behavior; neurotransmitters; whisker; microelectrode arrays; estrous	BEHAVIORAL MORBIDITY; GENDER-DIFFERENCES; WHISKER CIRCUIT; WOMEN; CORTEX; ACTIVATION; SYMPTOMS; OUTCOMES; MODEL; CONCUSSION	Women approximate one-third of the annual 2.8 million people in the United States who sustain traumatic brain injury (TBI). Several clinical reports support or refute that menstrual cycle-dependent fluctuations in sex hormones are associated with severity of persisting post-TBI symptoms. Previously, we reported late-onset sensory hypersensitivity to whisker stimulation that corresponded with changes in glutamate neurotransmission at 1-month following diffuse TBI in male rats. Here, we incorporated intact age-matched naturally cycling females into the experimental design while monitoring daily estrous cycle. We hypothesized that sex would not influence late-onset sensory hypersensitivity and associatedin vivoamperometric extracellular recordings of glutamate neurotransmission within the behaviorally relevant thalamocortical circuit. At 28 days following midline fluid percussion injury (FPI) or sham surgery, young adult Sprague-Dawley rats were tested for hypersensitivity to whisker stimulation using the whisker nuisance task (WNT). As predicted, both male and female rats showed significantly increased sensory hypersensitivity to whisker stimulation after FPI, with females having an overall decrease in whisker nuisance scores (sex effect), but no injury and sex interaction. In males, FPI increased potassium chloride (KCl)-evoked glutamate overflow in primary somatosensory barrel cortex (S1BF) and ventral posteromedial nucleus of the thalamus (VPM), while in females the FPI effect was discernible only within the VPM. Similar to our previous report, we found the glutamate clearance parameters were not influenced by FPI, while a sex-specific effect was evident with female rats showing a lower uptake rate constant both in S1BF and VPM and longer clearance time (in S1BF) in comparison to male rats. Fluctuations in estrous cycle were evident among brain-injured females with longer diestrus (low circulating hormone) phase of the cycle over 28 days post-TBI. Together, these findings add to growing evidence indicating both similarities and differences between sexes in a chronic response to TBI. A better understanding of the influence of gonadal hormones on behavior, neurotransmission, secondary injury and repair processes after TBI is needed both clinically and translationally, with potential impact on acute treatment, rehabilitation, and symptom management.	[Krishna, Gokul; Bromberg, Caitlin; Connell, Emily Charlotte; Mian, Erum; Lifshitz, Jonathan; Adelson, P. David; Thomas, Theresa Currier] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Krishna, Gokul; Bromberg, Caitlin; Connell, Emily Charlotte; Mian, Erum; Lifshitz, Jonathan; Adelson, P. David; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85012 USA; [Connell, Emily Charlotte] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Hu, Chengcheng] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA; [Lifshitz, Jonathan; Thomas, Theresa Currier] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA		Thomas, TC (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.; Thomas, TC (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85012 USA.; Thomas, TC (corresponding author), Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA.	theresathomas@email.arizona.edu	Gokul, Krishna/H-3365-2019	Gokul, Krishna/0000-0001-5869-2204; Thomas, Theresa/0000-0002-9619-7666	National Institute of Neurological Disorders and Stroke/National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100793]; Phoenix Children's Hospital Mission Support	This work was supported by the National Institute of Neurological Disorders and Stroke/National Institutes of Health (Grant No. R01NS100793) and Phoenix Children's Hospital Mission Support to TT. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Phoenix VA Health Care System.	Adibi M, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00040; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Balasco L, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3331; Banati RB, 2002, GLIA, V40, P206, DOI 10.1002/glia.10144; Barger SW, 2007, J NEUROCHEM, V101, P1205, DOI 10.1111/j.1471-4159.2007.04487.x; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bay E, 2008, J HEAD TRAUMA REHAB, V23, P351, DOI 10.1097/01.HTR.0000336876.99972.cd; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beitchman JA, 2020, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01434; Bishop KM, 1999, BRAIN RES, V815, P358, DOI 10.1016/S0006-8993(98)01088-9; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Claassen V., 1994, TECHNIQUES BEHAV NEU, V12, p1 ; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Cyrenne DM, 2011, DEV PSYCHOBIOL, V53, P670, DOI 10.1002/dev.20542; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; De Koning ME, 2018, BRAIN INJURY, V32, P540, DOI 10.1080/02699052.2018.1431844; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dhandapani KM, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-6; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Eakin K, 2015, BRAIN NEUROTRAUMA MO, P259, DOI [10.1201/b18126-23, DOI 10.1201/B18126-23]; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fortress AM, 2019, EXP NEUROL, V315, P42, DOI 10.1016/j.expneurol.2019.01.017; Friedman SA, 2011, WOMEN HEALTH ISS, V21, pS103, DOI 10.1016/j.whi.2011.04.025; Gadea A, 2001, J NEUROSCI RES, V63, P453, DOI 10.1002/jnr.1039; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Giuliano S, 2017, ENDOCRINE, V58, P115, DOI 10.1007/s12020-016-1183-3; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Ho D, 1993, BRAIN RES, V620, P167, DOI [10.1016/0006-8993(93)90287-W 8402193, DOI 10.1016/0006-8993(93)90287-W]; Holtzman B, 2019, CURR OPIN ENDOCR MET, V9, P78, DOI [10.1016/j.coemr.2019.08.003, DOI 10.1016/J.COEMR.2019.08.003]; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Jones EG., 2012, THALAMUS; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Kippin TE, 2005, PSYCHOPHARMACOLOGY, V182, P245, DOI 10.1007/s00213-005-0071-y; Krishna G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020588; Kumar S, 2005, PSYCHIAT CLIN NEUROS, V59, P466, DOI 10.1111/j.1440-1819.2005.01400.x; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Li SH, 2017, LANCET PSYCHIAT, V4, P73, DOI 10.1016/S2215-0366(16)30358-3; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Locklear MN, 2016, CEREB CORTEX, V26, P599, DOI 10.1093/cercor/bhu222; Mayer AR, 2015, HUM BRAIN MAPP, V36, P4394, DOI 10.1002/hbm.22930; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Mong JA, 2006, NEUROSCIENCE, V138, P967, DOI 10.1016/j.neuroscience.2005.10.017; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; NCIPC, 2003, REP C MILD TRAUM BRA; NICHOLSON C, 1995, BIOPHYS J, V68, P1699, DOI 10.1016/S0006-3495(95)80348-6; Nillni YI, 2015, J TRAUMA STRESS, V28, P1, DOI 10.1002/jts.21984; Ntali G, 2019, PITUITARY, V22, P283, DOI 10.1007/s11102-019-00944-0; Ortiz JB, 2020, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01410; Patel DR, 1997, EUR J PHARMACOL, V332, P143, DOI 10.1016/S0014-2999(97)01077-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Povlishock JT, 2001, HEAD TRAUMA, P281; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Ripley DL, 2008, ARCH PHYS MED REHAB, V89, P1090, DOI 10.1016/j.apmr.2007.10.038; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sajjad J, 2016, NEUROSCIENCE, V333, P311, DOI 10.1016/j.neuroscience.2016.07.036; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Sato K, 2003, J NEUROCHEM, V86, P1498, DOI 10.1046/j.1471-4159.2003.01953.x; Sato K, 2002, NEUROENDOCRINOLOGY, V76, P223, DOI 10.1159/000065948; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarz JM, 2008, NEURON, V58, P584, DOI 10.1016/j.neuron.2008.03.008; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Singh R, 2014, BRAIN INJURY, V28, P336, DOI 10.3109/02699052.2013.873142; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Strom JO, 2011, INT J MOL SCI, V12, P1533, DOI 10.3390/ijms12031533; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Thomas TC, 2017, BRAIN RES, V1672, P10, DOI 10.1016/j.brainres.2017.07.003; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wu CS, 2011, EUR J NEUROSCI, V34, P1663, DOI 10.1111/j.1460-9568.2011.07892.x; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86	108	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 5	2020	11								749	10.3389/fneur.2020.00749			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NF3PM	WOS:000563210300001	32849211	gold, Green Published			2022-02-06	
J	Bendinelli, C; Ku, DI; King, KL; Nebauer, S; Balogh, ZJ				Bendinelli, Cino; Ku, Dominic; King, Kate Louise; Nebauer, Shane; Balogh, Zsolt Janos			Trauma patients with prehospital Glasgow Coma Scale less than nine: not a homogenous group	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Glasgow Coma Scale; Traumatic brain injury; Prehospital; Paramedic; Intubation	BRAIN-INJURY; INTUBATION; MANAGEMENT; SCORE	Purpose Prehospital guidelines stratify and manage patients with Glasgow Coma Scale (GCS) less than nine and any sign of head injury as affected by severe traumatic brain injury (STBI). We hypothesized that this group of patients is so inhomogeneous that uniform treatment guidelines cannot be advocated. Methods Patients (2005-2012) with prehospital GCS below nine and abbreviated injury scale head and neck above two were identified from trauma registry. Patients with acute lethal injuries, isolated neck injuries, extubated within 24 h or transferred interhospitally were excluded. Patients were dichotomized based on the worst prehospital GCS (recorded before sedatives) into two groups: GCS 3-5 and GCS 6-8. These were statistically compared using univariate analysis. Results The GCS 3-5 group (99 patients) when compared with the GCS 6-8 group (49 patients) had shorter prehospital times (63 vs. 79 min;p < 0.05), more frequent episodes of both hypoxia (30.3% vs. 7.7%;p < 0.05) and hypotension (26.7% vs. 6.4%;p < 0.05), more often required craniectomy (15.1% vs. 4.0%;p = 0.05) and higher mortality (33.3% vs. 2%;p < 0.05). In the GCS 3-5 group, prehospital endotracheal intubation was attempted more often (57.5% vs. 28.6%,p < 0.05) and was more often successful (39.3% vs. 10.2%;p = 0.05). Length of stay in ICU did not differ. Conclusions STBI patients are fundamentally different based on whether their initial GCS falls into 3-5 or 6-8 category. Recommendations from trials investigating trauma patients with GCS less than nine as one group should be translated with caution to clinical practice.	[Bendinelli, Cino; Ku, Dominic; King, Kate Louise; Nebauer, Shane; Balogh, Zsolt Janos] Univ Newcastle, Dept Traumatol, John Hunter Hosp, Newcastle, NSW, Australia		Balogh, ZJ (corresponding author), Univ Newcastle, Dept Traumatol, John Hunter Hosp, Newcastle, NSW, Australia.	Cino.Bendinelli@hnehealth.nsw.gov.au; Dominic.joey.ku@gmail.com; Kate.King@hnehealth.nsw.gov.au; Shane.nebauer@uon.edu.au; Zsolt.Balogh@hnehealth.nsw.gov.au					Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2016, J TRAUMA ACUTE CARE, V80, P296, DOI [10.1097/TA.0000000000000892, DOI 10.1097/TA.0000000000000892]; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Garner AA, 2015, EMERG MED J, V32, P869, DOI 10.1136/emermed-2014-204390; Gomez D, 2017, J AM COLL SURGEONS, V225, P755, DOI 10.1016/j.jamcollsurg.2017.08.020; Haltmeier T, 2016, J TRAUMA ACUTE CARE, V80, P296, DOI 10.1097/TA.0000000000000892; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Kerby JD, 2012, SURG CLIN N AM, V92, P823, DOI 10.1016/j.suc.2012.04.009; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; Murray GD, 2018, J NEUROSURG, V128, P1621, DOI 10.3171/2017.12.JNS172782; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; TEASDALE G, 1974, LANCET, V2, P81; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yeh DD, 2012, ANZ J SURG, V82, P484, DOI 10.1111/j.1445-2197.2012.06130.x	19	5	5	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	AUG	2020	46	4					873	878		10.1007/s00068-019-01139-9			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	NA4ON	WOS:000559797500025	31062034				2022-02-06	
J	Bookbinder, HA; Houston, MN; Peck, KY; Habecker, S; Colsant, BJ; Kelly, TF; Roach, SP; Malvasi, SR; McGinty, GT; Campbell, DE; Svoboda, SJ; Cameron, KL				Bookbinder, Haley A.; Houston, Megan N.; Peck, Karen Y.; Habecker, Stephanie; Colsant, Brian J.; Kelly, Tim F.; Roach, Sean P.; Malvasi, Steven R.; McGinty, Gerald T.; Campbell, Darren E.; Svoboda, Steven J.; Cameron, Kenneth L.			Factors Associated With Delayed Concussion Reporting by United States Service Academy Cadets	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; concussion recognition; education strategies; collegiate athletes	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; GENDER; SEX; EPIDEMIOLOGY; MANAGEMENT; SYMPTOMS; CARE	Context: Approximately half of individuals who sustain a concussion do not immediately report their injuries. Motivators for not reporting include thinking the suspected concussion was not a serious injury and wanting to continue participating in activity. Additionally, military personnel have concerns about how concussions may affect their careers. However, delayed reporting can prolong neurobehavioral recovery. Understanding the frequency of delayed reporting and contributing factors will aid in identifying individuals who may be more likely to delay reporting. Objective: To describe the frequency of delayed concussion reporting by service academy cadets and determine if sex, injury setting, sport level, or medical history is capable of predicting delayed reporting. Design: Cohort study. Setting: Service academies. Patients or Other Participants: A total of 316 patients with concussions were observed from January 2014 to August 2016. Main Outcome Measure(s): All cadets completed an annual concussion baseline collection of demographic, medical history, and sports participation information. Delayed concussion reporting served as the outcome variable. Predictor variables were sex, injury setting, and sport level, as well as concussion, headache, and learning disorder history. Frequencies were calculated to describe the proportion of participants who delayed reporting. Univariable and multivariable logistic regression models were used to assess if the predictor variables were associated with delayed concussion reporting. Odds ratios (ORs) and 95% confidence intervals were calculated for all variables included in the final model. Results: Of the patients with concussion, 51% were classified as delayed reporting. In univariable models, females (OR = 1.70) and National Collegiate Athletic Association cadetathletes (OR = 1.98) were more likely to delay reporting than males and intramural cadet-athletes, respectively. The multivariable model yielded similar findings. Conclusions: Roughly half of the cadets who sustained a concussion failed to immediately report their injury. Specifically, our data suggested that female cadets, cadets injured outside of competition, and highly competitive cadet-athletes were almost twice as likely to delay reporting as others.	[Bookbinder, Haley A.; Houston, Megan N.; Colsant, Brian J.; Roach, Sean P.; Malvasi, Steven R.; Cameron, Kenneth L.] Keller Army Community Hosp, 900 Washington Rd, West Point, NY 10996 USA; [Peck, Karen Y.; Kelly, Tim F.] US Mil Acad, West Point, NY 10996 USA; [Habecker, Stephanie] Hobart & William Smith Coll, Geneva, NY 14456 USA; [McGinty, Gerald T.] US Air Force Acad, Colorado Springs, CO 80840 USA; [Campbell, Darren E.] Logan Reg Orthoped, Logan, UT USA; [Svoboda, Steven J.] MedStar Hlth, Washington, DC USA		Houston, MN (corresponding author), Keller Army Community Hosp, 900 Washington Rd, West Point, NY 10996 USA.	megan.n.houston.ctr@mail.mil			Grand Alliance Concussion Assessment, Research and Education Consortium - National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	We thank the research and medical staff at the US Military Academy and the US Air Force Academy, as well as the members of the surge team that assisted with baseline data collection at both sites. This project was supported, in part, by the Grand Alliance Concussion Assessment, Research and Education Consortium, funded by the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.	[Anonymous], DEF VET BRAIN INJ CT; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Charek DB, 2020, J HEAD TRAUMA REHAB, V35, P85, DOI 10.1097/HTR.0000000000000476; Corman SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215424; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Fisher M, 2019, INT J ATHL THER TRAI, V24, P181, DOI 10.1123/ijatt.2018-0089; Foster CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215030; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kabat-Farr D, 2014, LAW HUMAN BEHAV, V38, P58, DOI 10.1037/lhb0000045; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGuine TA, 2018, J ATHL TRAINING, V53, P1017, DOI 10.4085/1062-6050-209-18; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Register-Mihalik JK, 2019, J SCI MED SPORT, V22, P509, DOI 10.1016/j.jsams.2018.11.003; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06	34	5	5	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2020	55	8					843	849		10.4085/1062-6050-362-19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK5CJ	WOS:000566748600009	32607554	gold, Green Published			2022-02-06	
J	Charkviani, M; Muradashvili, N; Sulimai, N; Lominadze, D				Charkviani, Mariam; Muradashvili, Nino; Sulimai, Nurul; Lominadze, David			Fibrinogen-cellular prion protein complex formation on astrocytes	JOURNAL OF NEUROPHYSIOLOGY			English	Article						astrocytes; cortical contusion injury; Fg-PrPC complex; traumatic brain injury; tyrosine (tropomyosin) receptor kinase B	TRAUMATIC BRAIN-INJURY; SHORT-TERM-MEMORY; VASCULAR CONTRIBUTIONS; COGNITIVE IMPAIRMENT; LONG-TERM; ALZHEIMERS-DISEASE; PERMEABILITY; MECHANISMS; DEMENTIA; TRKB	Traumatic brain injury (TBI) is one of the most common neurological disorders causing memory reduction, particularly short-term memory (STM). We showed that, during TBI-induced inflammation, increased blood content of fibrinogen (Fg) enhanced vascular protein transcytosis and deposition of extravasated Fg in vasculo-astrocyte interfaces. In addition, we found that deposition of cellular prion protein (PrPC) was also increased in the vasculoastrocyte endfeet interface. However, association of Fg and PrPC was not confirmed. Presently. we aimed to define whether Fg can associate with PrP(C )on astrocytes and cause their activation. Cultured mouse brain astrocytes were treated with medium alone (control), Fg (2 mg/mL or 4 mg/mL). 4 mg/mL of Fg in the presence of a function-blocking anti-PrPC peptide or anti-mouse IgG, function-blocking anti-PrPC peptide, or anti-mouse IgG alone. After treatment, either cell lysates were collected and analyzed via Western blot or coimmunoprecipitation was performed, or astrocytes were fixed and their activation was assessed with immunohistochemistry. Results showed that Fg dose-dependently activated astrocytes, increased expressions of PrPC and tyrosine (tropomyosin) receptor kinase B (TrkB), and PrP gene. Blocking the function of PrP(C )reduced these effects. Coimmunoprecipitation demonstrated Fg and PrPC association. Since it is known that prion protein has a greater effect on memory reduction than amyloid beta, and that activation of TrkB is involved in neurodegeneration, our findings confirming the possible formation of Fg-PrPC and Fg-induced overexpression of TrkB on astrocytes suggest a possible triggering mechanism for STM reduction that was seen previously during mild-to-moderate TBI. NEW & NOTEWORTHY For the first time we showed that fibrinogen (Fg) can associate with cellular prion protein (PrPC) on the surface of cultured mouse brain astrocytes. At high levels, Fg causes upregulation of astrocyte PrPC and astrocyte activation accompanied with overexpression of tyrosine receptor kinase B (TrkB). which results in nitric oxide (NO) production and generation of reactive oxygen species (ROS). Fg/PrPC interaction can be a triggering mechanism for TrkB-NO-ROS axis activation and the resultant astrocyte-mediated neurodegeneration.	[Charkviani, Mariam; Muradashvili, Nino; Lominadze, David] Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40292 USA; [Muradashvili, Nino] Caucasus Int Univ, Dept Basic Med, Tbilisi, Georgia; [Sulimai, Nurul; Lominadze, David] Univ S Florida, Dept Surg, USF Hlth Morsani Coll Med, Tampa, FL 33620 USA; [Lominadze, David] Univ Louisville, Sch Med, Kentucky Spinal Cord Res Ctr, Louisville, KY 40292 USA		Lominadze, D (corresponding author), Univ Louisville, Sch Med, Dept Physiol, Louisville, KY 40292 USA.; Sulimai, N; Lominadze, D (corresponding author), Univ S Florida, Dept Surg, USF Hlth Morsani Coll Med, Tampa, FL 33620 USA.; Lominadze, D (corresponding author), Univ Louisville, Sch Med, Kentucky Spinal Cord Res Ctr, Louisville, KY 40292 USA.	nurulsulimai@usf.edu; dlominadze@usf.edu		Charkviani, Mariam/0000-0002-8854-8796; Sulimai, Nurul/0000-0003-1590-5710	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-084823, HL-146832]; American Heart AssociationAmerican Heart Association [17SDG33670372]	This work was supported in part by funding from the National Institutes of Health (NS-084823 and HL-146832) and the American Heart Association (17SDG33670372).	Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Bertuchi FR, 2012, BIOCHEM BIOPH RES CO, V418, P27, DOI 10.1016/j.bbrc.2011.12.098; Brown DR, 1999, J NEUROCHEM, V73, P1105, DOI 10.1046/j.1471-4159.1999.0731105.x; Chhabra G, 2010, NEUROL INDIA, V58, P756, DOI 10.4103/0028-3886.72175; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Clark VD, 2018, BRAIN RES, V1699, P158, DOI 10.1016/j.brainres.2018.08.023; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Corriveau RA, 2016, CELL MOL NEUROBIOL, V36, P281, DOI 10.1007/s10571-016-0334-7; Cortes-Canteli M, 2010, NEURON, V66, P695, DOI 10.1016/j.neuron.2010.05.014; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; del Zoppo GJ, 2009, STROKE, V40, P1687, DOI 10.1161/STROKEAHA.108.527804; Fahimi A, 2017, BRAIN STRUCT FUNCT, V222, P1797, DOI 10.1007/s00429-016-1308-8; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Genius J, 2000, FREE RADICAL BIO MED, V29, P515, DOI 10.1016/S0891-5849(00)00343-9; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Gupta VK, 2013, INT J MOL SCI, V14, P10122, DOI 10.3390/ijms140510122; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Holt LM, 2019, ELIFE, V8, DOI 10.7554/eLife.44667; Ishii T, 2017, AGING CELL, V16, P39, DOI 10.1111/acel.12523; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; LETCHER RL, 1981, AM J MED, V70, P1195, DOI 10.1016/0002-9343(81)90827-5; Liebert A, 2014, SIGNAL TRANSDUCT INS, V3, P11; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Lominadze D, 2010, ACTA PHYSIOL, V198, P1, DOI 10.1111/j.1748-1716.2009.02037.x; MARTINEZ J, 1974, J CLIN INVEST, V53, P600, DOI 10.1172/JCI107595; Muradashvili N., 2018, TRAUMATIC BRAIN INJU, P105; Muradashvili N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070077; Muradashvili N, 2016, J PHYSIOL-LONDON, V594, P5941, DOI 10.1113/JP272558; Muradashvili N, 2015, METAB BRAIN DIS, V30, P411, DOI 10.1007/s11011-014-9550-3; Muradashvili N, 2014, J CEREBR BLOOD F MET, V34, P1472, DOI 10.1038/jcbfm.2014.102; Muradashvili N, 2014, AM J PHYSIOL-CELL PH, V307, pC169, DOI 10.1152/ajpcell.00305.2013; Muradashvili N, 2014, CELL BIOCHEM BIOPHYS, V69, P283, DOI 10.1007/s12013-013-9797-z; Muradashvili N, 2013, BRAIN INJURY, V27, P1508, DOI 10.3109/02699052.2013.823562; Muradashvili N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00166; Muradashvili N, 2012, J CEREBR BLOOD F MET, V32, P150, DOI 10.1038/jcbfm.2011.144; Muradashvili N, 2011, BIOCHEM BIOPH RES CO, V413, P509, DOI 10.1016/j.bbrc.2011.07.133; Murphy MP, 2016, BBA-MOL BASIS DIS, V1862, P857, DOI 10.1016/j.bbadis.2016.02.010; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Onodera T, 2017, P JPN ACAD B-PHYS, V93, P155, DOI 10.2183/pjab.93.010; Pahatouridis D, 2010, BRAIN INJURY, V24, P1189, DOI 10.3109/02699052.2010.490510; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tyagi N, 2008, MOL CELL BIOCHEM, V307, P13, DOI 10.1007/s11010-007-9579-2; Vos CMP, 2005, NEUROBIOL DIS, V20, P953, DOI 10.1016/j.nbd.2005.06.012; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668; Zhou JY, 2013, INTRACTABLE RARE DIS, V2, P35, DOI 10.5582/irdr.2013.v2.2.35; Zlokovic BV, 2011, TRENDS NEUROSCI, V34, P198, DOI 10.1016/j.tins.2011.01.005	63	5	5	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	AUG	2020	124	2					536	543		10.1152/jn.00224.2020			8	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	NS7GA	WOS:000572424600020	32697670	Bronze, Green Published			2022-02-06	
J	Chen, P; Xiong, XH; Chen, Y; Wang, K; Zhang, QT; Zhou, W; Deng, YB				Chen, Peng; Xiong, Xue-Hua; Chen, Ying; Wang, Ke; Zhang, Qing-Tao; Zhou, Wei; Deng, Yong-Bing			Perioperative management strategy of severe traumatic brain injury during the outbreak of COVID-19	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						COVID-19; Traumatic brain injury; Perioperative period; Management strategy		Since December 2019, a pneumonia caused by a new coronavirus, i.e. COVID-19 occurred in Wuhan, Hubei Province, China. Although the epidemic in China has been bought under control, the global COVID-19 situation is still grim. Severe traumatic brain injury (TBI), as one of critical conditions in the department of neurosurgery, requires an early and effective treatment, especially surgery. There were currently no reliable guidelines on how to perform perioperative protection in TBI patients with suspected or confirmed coronavirus infection. According to the corresponding treatment regulations and guidelines issued by the authorities, we summarized the management strategy of TBI patients in perioperative period during the COVID-19 outbreak based on medical and nursing practice, in order to provide a reference for clinicians. (C) 2020 Production and hosting by Elsevier B.V. on behalf of Chinese Medical Association.	[Chen, Peng; Xiong, Xue-Hua; Chen, Ying; Wang, Ke; Zhang, Qing-Tao; Zhou, Wei; Deng, Yong-Bing] Chongqing Univ, Chongqing Emergency Med Ctr, Dept Neurosurg, Cent Hosp, Chongqing 400014, Peoples R China		Deng, YB (corresponding author), Chongqing Univ, Chongqing Emergency Med Ctr, Dept Neurosurg, Cent Hosp, Chongqing 400014, Peoples R China.	1422495819@qq.com			Science and Technology Research Project of Chongqing Education Commission [KJQN201800122]; Scientific Research Project of Science and Technology Commission of Yuzhong District, Chongqing [20180131]	Science and Technology Research Project of Chongqing Education Commission (KJQN201800122), Scientific Research Project of Science and Technology Commission of Yuzhong District, Chongqing (20180131).	Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Darnell MER, 2004, J VIROL METHODS, V121, P85, DOI 10.1016/j.jviromet.2004.06.006; Gao Z C, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE001, DOI 10.3760/cma.j.issn.1001-0939.2020.0001; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; [李阳 Li Yang], 2020, [中华创伤杂志, Chinese Journal of Trauma], V36, P97; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang X, 2021, JAMA-J AM MED ASSOC, V325, P50, DOI 10.1001/jama.2020.23370	7	5	5	1	2	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	AUG	2020	23	4					202	206		10.1016/j.cjtee.2020.05.006			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	OA0FT	WOS:000577473500004	32540201	gold, Green Published			2022-02-06	
J	Dudley, J; Yuan, WH; Diekfuss, J; Foss, KDB; DiCesare, CA; Altaye, M; Logan, K; Leach, JL; Myer, GD				Dudley, Jonathan; Yuan, Weihong; Diekfuss, Jed; Foss, Kim D. Barber; DiCesare, Christopher A.; Altaye, Mekibib; Logan, Kelsey; Leach, James L.; Myer, Gregory D.			Altered Functional and Structural Connectomes in Female High School Soccer Athletes After a Season of Head Impact Exposure and the Effect of a Novel Collar	BRAIN CONNECTIVITY			English	Article						connectivity; DTI; graph theory; neck collar; rs-fMRI; sub-concussive impact	DEFAULT MODE NETWORK; WHITE-MATTER ALTERATIONS; TRAUMATIC BRAIN-INJURY; COMPRESSION COLLAR; FOOTBALL PLAYERS; CONNECTIVITY; INTEGRITY	Background: Characterization of, and evaluation of strategies to mitigate, the effects of sub-concussive impacts (SCI) on brain structure and function are crucial to understanding potential long-term neurological risks associated with sports participation. Objectives:To evaluate the efficacy of a jugular vein compression collar for preserving functional and structural measures of brain network organization in a cohort of female high school soccer players throughout a season of competitive play. Methods:Athletes were assigned to a collar (N = 72) or non-collar (N = 56) group before engaging in a season of play, during which head impact data were recorded via accelerometer for every practice and competition. Participants completed neuroimaging sessions before and following the season. A graph theoretical framework was applied to the functional and structural connectivity measures computed from resting state functional magnetic resonance imaging (rs-fMRI) and diffusion tensor imaging (DTI) data. Results:Non-collar-wearing athletes exhibited significantly increased rs-fMRI-derived global clustering coefficients (p = 0.032) and DTI-derived modularity (p = 0.042), compared to collar-wearing athletes. No longitudinal changes in any graph measures were observed for the collar group (p > 0.05). Conclusion:The observed increase in graph measures in the non-collar group is congruent with previous studies of SCI and is similar to graph theoretical studies of traumatic brain injury. The absence of alterations in graph metrics in the collar group indicates a potential ameliorating effect of the collar device against network reorganization, in line with previous literature.	[Dudley, Jonathan; Yuan, Weihong; Diekfuss, Jed; Foss, Kim D. Barber; DiCesare, Christopher A.; Altaye, Mekibib; Logan, Kelsey; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Yuan, Weihong; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA; [Diekfuss, Jed; Foss, Kim D. Barber; DiCesare, Christopher A.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Leach, James L.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA; [Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Sports Med, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	greg.myer@cchmc.org	DiCesare, Christopher/ABH-9573-2020; DiCesare, Christopher/AAA-3327-2021; Diekfuss, Jed/ABD-7372-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Diekfuss, Jed/0000-0003-3835-363X; Myer, Gregory/0000-0002-9983-8422	Q30 Sports Sciences LLC	Funding for this study was provided to Cincinnati Children's Hospital by Q30 Sports Sciences LLC. Q30 Sports Sciences has financial interests in the development of the Q-Collar. One author (GDM) has consulted for Q30 Innovations to support applications with the U.S. Food and Drug Administration but has no financial interest in commercialization of the Q-Collar.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Jeub LGS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21352-7; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Lancichinetti A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00336; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Myer GD, 2019, BRIT J SPORT MED, V53, P1539, DOI 10.1136/bjsports-2018-099571; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Yuan W, J NEUROTRAUMA, V35, P1248; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834	47	5	5	3	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	AUG 1	2020	10	6					292	301		10.1089/brain.2019.0729			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NB7HF	WOS:000560684700005	32283941				2022-02-06	
J	Liu, MJ; Xie, JH; Sun, YX				Liu, Moujie; Xie, Juhua; Sun, Yingxian			TLR4/MyD88/NF-kappa B-Mediated Inflammation Contributes to Cardiac Dysfunction in Rats of PTSD	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Single-prolonged stress; Post-traumatic stress disorder; TLR4; MyD88; Nf-kappa b	POSTTRAUMATIC-STRESS-DISORDER; SINGLE-PROLONGED STRESS; INJURY; TLR4	Post-traumatic stress disorder (PTSD) is related with myocardial injury and cardiac dysfunction, while the molecular mechanism has not been clear. This study investigated whether TLR4/MyD88/NF-kappa B-mediated inflammation involved in myocardial injury of PTSD. Adult male Wistar rats were exposed to single-prolonged stress (SPS), which was used broadly as a animal model of PTSD. Morris Water Maze (MWM) test and forced swimming test (FST) was carried out for behavioral testing. The protein expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in the left ventricular of heart and TLR4/MyD88/NF-kappa B-mediated inflammation were examined. Our results showed that there were obvious increased in the protein expression of ANP and BNP in heart after exposure to SPS, SPS also significantly enhanced the serum level of IL-1 beta and TNF-alpha, and meanwhile, the TLR4/MyD88/NF-kappa B pathway were activated. These results demonstrated that the TLR4/MyD88/NF-kappa B pathway were involved in the myocardial injury of PTSD, which might be one of possible molecular mechanism contributed to the pathogenesis of cardiac dysfunction in PTSD.	[Liu, Moujie; Sun, Yingxian] China Med Univ, Dept Cardiol, Hosp 1, Shenyang 110001, Peoples R China; [Xie, Juhua] Shenyang Med Coll, Dept Histol & Embryol, Coll Basic Med Sci, Shenyang 110034, Peoples R China		Sun, YX (corresponding author), China Med Univ, Dept Cardiol, Hosp 1, Shenyang 110001, Peoples R China.; Xie, JH (corresponding author), Shenyang Med Coll, Dept Histol & Embryol, Coll Basic Med Sci, Shenyang 110034, Peoples R China.	xjh814@126.com; Sunyingxian12@126.com			Doctoral Start-up Foundation of Liaoning Province [20170520016] Funding Source: Medline		American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Azam S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01000; Britvic D, 2015, INT J CLIN HLTH PSYC, V15, P81, DOI 10.1016/j.ijchp.2014.11.002; Buckley TC, 2001, PSYCHOSOM MED, V63, P585, DOI 10.1097/00006842-200107000-00011; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Cho JH, 2014, P NATL ACAD SCI USA, V111, P3188, DOI 10.1073/pnas.1400113111; de Laat MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00120; Dyball D, 2019, INT REV PSYCHIATR, V31, P34, DOI 10.1080/09540261.2019.1580686; Felger JC, 2018, CURR NEUROPHARMACOL, V16, P533, DOI 10.2174/1570159X15666171123201142; Georgopoulos Apostolos P, 2018, J Ment Health Clin Psychol, V2, P9; Girgenti MJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0841-3; Gomez-Beneyto M, 2006, BRIT J GEN PRACT, V56, P349; Hieda M, 2019, AM J PHYSIOL-REG I, V317, pR108, DOI 10.1152/ajpregu.00002.2019; Hoerster KD, 2019, PREV MED REP, V15, DOI 10.1016/j.pmedr.2019.100930; Kibler JL, 2009, J TRAUMA DISSOCIATIO, V10, P135, DOI 10.1080/15299730802624577; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Kubzansky Laura D, 2009, Cleve Clin J Med, V76 Suppl 2, pS60, DOI 10.3949/ccjm.76.s2.12; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Lai SH, 2018, CELL PHYSIOL BIOCHEM, V45, P2529, DOI 10.1159/000488271; Levine AB, 2014, CARDIOLOGY, V127, P1, DOI 10.1159/000354910; Liberzon I, 1999, J NEUROENDOCRINOL, V11, P11; Liu M, 2016, PSYCHOSOM MED, V78, P888, DOI 10.1097/PSY.0000000000000353; Michopoulos V, 2017, NEUROPSYCHOPHARMACOL, V42, P254, DOI 10.1038/npp.2016.146; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Morris MC, 2016, CLIN PSYCHOL REV, V49, P79, DOI 10.1016/j.cpr.2016.09.001; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2009, CIRC-CARDIOVASC QUAL, V2, P279, DOI 10.1161/CIRCOUTCOMES.109.868299; Rorabaugh BR, 2020, STRESS, V23, P125, DOI 10.1080/10253890.2019.1641081; Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025; Souza RR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00615; Speer K, 2018, J INFLAMM RES, V11, P111, DOI 10.2147/JIR.S155903; Takahashi T, 2006, PSYCHOPHARMACOLOGY, V189, P165, DOI 10.1007/s00213-006-0545-6; von Kanel R, 2011, J CARDIOL, V58, P61, DOI 10.1016/j.jjcc.2011.02.007; Wang YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070995; Wang ZW, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00222; Xie JH, 2015, MOL CELL BIOCHEM, V399, P209, DOI 10.1007/s11010-014-2247-4; Xu DH, 2015, CELL PHYSIOL BIOCHEM, V37, P27, DOI 10.1159/000430330; Yamamoto S, 2009, DEPRESS ANXIETY, V26, P1110, DOI 10.1002/da.20629; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Yu B, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0115-5; Zhang XS, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0359-2	41	5	7	1	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	AUG	2020	40	6					1029	1035		10.1007/s10571-020-00791-9			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	MD8EN	WOS:000544201700012	31939007				2022-02-06	
J	Merritt, VC; Jurick, SM; Crocker, LD; Sullan, MJ; Sakamoto, MS; Davey, DK; Hoffman, SN; Keller, AV; Jak, AJ				Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Sullan, Molly J.; Sakamoto, McKenna S.; Davey, Delaney K.; Hoffman, Samantha N.; Keller, Amber, V; Jak, Amy J.			Associations Between Multiple Remote Mild TBIs and Objective Neuropsychological Functioning and Subjective Symptoms in Combat-Exposed Veterans	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Posttraumatic stress disorder; Everyday functioning	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MILITARY SERVICE MEMBERS; POST-CONCUSSIVE SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; CLINICAL UTILITY; PERFORMANCE; SOLDIERS; OUTCOMES; HISTORY	Objective: The purpose of this study was to evaluate relationships between multiple mild traumatic brain injuries (mTBIs) and objective and subjective clinical outcomes in a sample of combat-exposed Veterans, adjusting for psychiatric distress and combat exposure. Method: In this cross-sectional study, 73 combat-exposed Iraq/Afghanistan Veterans were divided into three groups based on mTBI history: 0 mTBIs (n = 31), 1-2 mTBIs (n = 21), and 3+ mTBIs (n = 21). Veterans with mTBI were assessed, on average, 7.78 years following their most recent mTBI. Participants underwent neuropsychological testing and completed self-report measures assessing neurobehavioral, sleep, and pain symptoms. Results: MANCOVAs adjusting for psychiatric distress and combat exposure showed no group differences on objective measures of attention/working memory, executive functioning, memory, and processing speed (all p's > .05; eta(2)(p) =.00-.06). In contrast, there were significant group differences on neurobehavioral symptoms (p's = <.001-.036; eta(2)(p) =.09-.43), sleep difficulties (p =.037; eta(2)(p) =.09), and pain symptoms (p <.001; eta(2)(p) =.21). Pairwise comparisons generally showed that the 3+ mTBI group self-reported the most severe symptoms, followed by comparable symptom reporting between the 0 and 1-2 mTBI groups. Conclusions: History of multiple, remote mTBIs is associated with elevated subjective symptoms but not objective neuropsychological functioning in combat-exposed Veterans. These results advance understanding of the long-term consequences of repetitive mTBI in this population and suggest that Veterans with 3+ mTBIs may especially benefit from tailored treatments aimed at ameliorating specific neurobehavioral, sleep, and pain symptoms.	[Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Sullan, Molly J.; Sakamoto, McKenna S.; Davey, Delaney K.; Keller, Amber, V; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, Res & Psychol Serv, San Diego, CA USA; [Jurick, Sarah M.; Crocker, Laura D.; Jak, Amy J.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Hoffman, Samantha N.] State Univ Univ Calif San Diego SDSU UCSD, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst 151B, San Diego, CA 92161 USA.	ajak@ucsd.edu		Hoffman, Samantha/0000-0002-2792-8576	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; VA Clinical Science Research & Development Service [IK2 CX001952]; VA Rehabilitation Research & Development Service [IK2 RX002459]	This work was supported by grant funding from the Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and the Department of Veterans Affairs CENC Award [I01 CX001135]. Additionally, Victoria Merritt received salary support during this work from a Career Development Award [IK2 CX001952] from the VA Clinical Science Research & Development Service, and Laura Crocker received salary support during this work from a Career Development Award [IK2 RX002459] from the VA Rehabilitation Research & Development Service.	Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Ashendorf L, 2019, J CLIN EXP NEUROPSYC, V41, P432, DOI 10.1080/13803395.2019.1567693; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bodapati AS, 2019, CLIN NEUROPSYCHOL, V33, P539, DOI 10.1080/13854046.2018.1482003; Bosco MA, 2013, HEADACHE, V53, P1518, DOI 10.1111/head.12172; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2018, BRAIN INJURY, V32, P1149, DOI 10.1080/02699052.2018.1496274; Cooper DB, 2018, J HEAD TRAUMA REHAB, V33, P81, DOI 10.1097/HTR.0000000000000375; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fields L., 2019, ARCH CLIN NEUROPSYCH; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Heaton R., 2000, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kansagara D., 2013, COMPLICATIONS MILD T; Karr J. E., 2019, J CLIN EXPT NEUROPSY; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lu LH, 2019, ARCH CLIN NEUROPSYCH, V34, P236, DOI 10.1093/arclin/acy031; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; Mashima P, 2019, TOP LANG DISORD, V39, P293, DOI 10.1097/TLD.0000000000000189; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Mitchell Katherine L, 2017, Fed Pract, V34, P16; Nelson N., 2019, NEUROPSYCHOLOGY; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The Management of Concussion/mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2019, REHABIL PSYCHOL, V64, P1, DOI 10.1037/rep0000255; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2016, BRAIN INJURY, V30, P1469, DOI 10.1080/02699052.2016.1219061; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Zhang YJ, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080199	80	5	5	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	AUG	2020	35	5					491	505		10.1093/arclin/acaa006			15	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NY8KY	WOS:000576633100004	32128559	hybrid			2022-02-06	
J	Pan, MX; Li, J; Ma, C; Fu, K; Li, ZQ; Wang, ZF				Pan, Meng-Xian; Li, Jie; Ma, Chao; Fu, Kai; Li, Zhi-Qiang; Wang, Ze-Fen			Sex-dependent effects of GPER activation on neuroinflammation in a rat model of traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						GPER; Microglia; Neuroinflammation; Estrogen; Traumatic brain injury	PROTEIN-COUPLED RECEPTOR; INFLAMMATORY RESPONSE; ESTROGEN; GPR30; 17-BETA-ESTRADIOL; NEUROPROTECTION; ALPHA; EXPRESSION; MICROGLIA; ISCHEMIA	The G protein-coupled estrogen receptor (GPER) plays a role in estrogen-mediated neuroprotection and has been considered a potential therapeutic target for treating various neurological diseases. It is increasingly recognized that sex is a biological variable affecting treatment outcomes and efficacy, and that neuroinflammation is a key secondary injury mechanism following brain injury, though it is unknown whether the neuroprotective effects exerted by GPER involve modulation of inflammatory processes. The aim of this study was to investigate whether activation of GPER has a sex-dependent effect on neuroinflammation following traumatic brain injury (TBI), a sexually dimorphic disease. In male and ovariectomized (OVX) female rats, the GPER agonist, G1, inhibited the upregulated expression of pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha), increased the expression of the anti-inflammatory cytokine IL-4, and shifted microglia/macrophage polarization toward the M2 phenotype. In gonadally-intact females, G1 caused more pro-inflammatory (IL-6 and TNF-alpha) and less anti-inflammatory cytokine (IL-4) production, without altering microglia/macrophage polarization. Estradiol supplementation blocked the effects of G1 in OVX females. We also found that post-injury GPER expression was increased in males and OVX females but not in intact females. G1 administration increased Akt phosphorylation in males and OVX females, but had no significant effect in intact females, while Akt inhibition blocked the effects of G1 in males and OVX females. These results indicate that G1 exerts anti-inflammatory effects in males and OVX females but not in intact females; these sex-specific effects are dependent on circulating estrogen levels and are partially mediated through Akt signaling. Future studies are needed to elucidate the relevant molecular mechanisms, especially in females. A better understanding of the sex differences in treatment efficacy with GPER agonists may help improve personalized therapeutic strategies for males and pre- and postmenopausal females with TBI.	[Pan, Meng-Xian; Li, Jie; Wang, Ze-Fen] Wuhan Univ, Dept Physiol, Sch Basic Med Sci, Wuhan 430071, Peoples R China; [Ma, Chao; Fu, Kai; Li, Zhi-Qiang] Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430071, Peoples R China		Wang, ZF (corresponding author), Wuhan Univ, Dept Physiol, Sch Basic Med Sci, Wuhan 430071, Peoples R China.; Li, ZQ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430071, Peoples R China.	lizhiqiang@whu.edu.cn; wangzf@whu.edu.cn		Zhiqiang, LI/0000-0002-4148-780X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671072]; Natural Science Foundation of Hubei ProvinceNatural Science Foundation of Hubei Province [2017CFA028]; Health Commission of Hubei Province Scientific Research Project [WJ2019H055]	This research was supported by grants from the National Natural Science Foundation of China (No. 81671072), the Natural Science Foundation of Hubei Province (2017CFA028), and Health Commission of Hubei Province Scientific Research Project (WJ2019H055).	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Arifin WN, 2017, MALAYS J MED SCI, V24, P101, DOI 10.21315/mjms2017.24.5.11; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Boscia F, 2015, J CELL PHYSIOL, V230, P1290, DOI 10.1002/jcp.24864; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Broughton BRS, 2014, STROKE, V45, P835, DOI 10.1161/STROKEAHA.113.001499; Broughton BRS, 2013, NEUROSIGNALS, V21, P229, DOI 10.1159/000338019; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Brunsing RL, 2011, IMMUNOLOGY, V134, P93, DOI 10.1111/j.1365-2567.2011.03471.x; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Chen JY, 2015, MOL MED REP, V12, P1733, DOI 10.3892/mmr.2015.3601; Chou CP, 2008, ARCH TOXICOL, V82, P729, DOI 10.1007/s00204-008-0288-8; Clipperton-Allen AE, 2012, PHYSIOL BEHAV, V105, P915, DOI 10.1016/j.physbeh.2011.10.025; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Fuente-Martin E, 2013, REV ENDOCR METAB DIS, V14, P331, DOI 10.1007/s11154-013-9263-7; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Gunther M, 2015, ACTA NEUROCHIR, V157, P649, DOI 10.1007/s00701-014-2331-2; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Hart D, 2014, STEROIDS, V81, P49, DOI 10.1016/j.steroids.2013.11.004; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jia BN, 2016, ENDOCRINOLOGY, V157, P3023, DOI 10.1210/en.2016-1035; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Lamprecht MR, 2014, BRAIN RES, V1563, P131, DOI 10.1016/j.brainres.2014.03.037; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Liu SB, 2012, J NEUROSCI, V32, P4887, DOI 10.1523/JNEUROSCI.5828-11.2012; Liu SB, 2011, CLIN EXP PHARMACOL P, V38, P577, DOI 10.1111/j.1440-1681.2011.05549.x; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; MALEFYT RD, 1991, J EXP MED, V174, P1209; McIntosh TK, 1996, LAB INVEST, V74, P315; Mendes-Oliveira J, 2017, BRAIN BEHAV IMMUN, V64, P296, DOI 10.1016/j.bbi.2017.04.016; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rodriguez P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.478; Roque C, 2019, J NEUROCHEM, V149, P27, DOI 10.1111/jnc.14648; Roque L, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00749; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Tang H, 2014, MOL CELL ENDOCRINOL, V387, P52, DOI 10.1016/j.mce.2014.01.024; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang ZL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1246-x; Zhao TZ, 2016, NEUROSCIENCE, V328, P117, DOI 10.1016/j.neuroscience.2016.04.026	56	5	6	2	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2020	88						421	431		10.1016/j.bbi.2020.04.005			11	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	MU5JL	WOS:000555709500054	32272225				2022-02-06	
J	Schindler, CR; Woschek, M; Vollrath, JT; Kontradowitz, K; Lustenberger, T; Stormann, P; Marzi, I; Henrich, D				Schindler, Cora Rebecca; Woschek, Mathias; Vollrath, Jan Tilmann; Kontradowitz, Kerstin; Lustenberger, Thomas; Stoermann, Philipp; Marzi, Ingo; Henrich, Dirk			miR-142-3p Expression Is Predictive for Severe Traumatic Brain Injury (TBI) in Trauma Patients	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						miR-142-3p; miRNA; serum; plasma; SNORD95; traumatic brain injury (TBI); polytrauma; Injury Severity Score (ISS)	CEREBROSPINAL-FLUID; INFLAMMATORY RESPONSE; BLOOD; BIOMARKERS; PROTEINS; PLASMA; MICRORNAS; MIRNAS; SERUM	Background: Predictive biomarkers in biofluids are the most commonly used diagnostic method, but established markers in trauma diagnostics lack accuracy. This study investigates promising microRNAs (miRNA) released from affected tissue after severe trauma that have predictive values for the effects of the injury. Methods: A retrospective analysis of prospectively collected data and blood samples ofn= 33 trauma patients (ISS >= 16) is provided. Levels of miR-9-5p, -124-3p, -142-3p, -219a-5p, -338-3p and -423-3p in severely injured patients (PT) without traumatic brain injury (TBI) or with severe TBI (PT + TBI) and patients with isolated TBI (isTBI) were measured within 6 h after trauma. Results: The highest miR-423-3p expression was detected in patients with severe isTBI, followed by patients with PT + TBI, and lowest levels were found in PT patients without TBI (2(- increment increment Ct),p= 0.009). A positive correlation between miR-423-3p level and increasing AIS(head)(p= 0.001) and risk of mortality (RISC II,p= 0.062) in trauma patients (n= 33) was found. ROC analysis of miR-423-3p levels revealed them as statistically significant to predict the severity of brain injury in trauma patients (p= 0.006). miR-124-3p was only found in patients with severe TBI, miR-338-3p was shown in all trauma groups. miR-9-5p, miR-142-3p and miR-219a-5p could not be detected in any of the four groups. Conclusion: miR-423-3p expression is significantly elevated after isolated traumatic brain injury and predictable for severe TBI in the first hours after trauma. miR-423-3p could represent a promising new biomarker to identify severe isolated TBI.	[Schindler, Cora Rebecca; Woschek, Mathias; Vollrath, Jan Tilmann; Kontradowitz, Kerstin; Lustenberger, Thomas; Stoermann, Philipp; Marzi, Ingo; Henrich, Dirk] Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60596 Frankfurt, Germany; [Lustenberger, Thomas] Cantonal Hosp Aarau, Dept Traumatol, Tellstr, CH-5001 Aarau, Switzerland		Schindler, CR (corresponding author), Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60596 Frankfurt, Germany.	cora.schindler@kgu.de; mathias.woschek@kgu.de; tilmann.vollrath@kgu.de; kerstin.kontradowitz@kgu.de; thomas.lustenberger@ksa.ch; philipp.stoermann@kgu.de; marzi@trauma.uni-frankfurt.de; d.henrich@trauma.uni-frankfurt.de		Henrich, Dirk/0000-0002-9728-4032; Stormann, Philipp/0000-0003-3584-2518			Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Backstrom D, 2018, EUR J TRAUMA EMERG S, V44, P589, DOI 10.1007/s00068-017-0827-1; Balogh ZJ, 2018, EUR J TRAUMA EMERG S, V44, P299, DOI 10.1007/s00068-018-0964-1; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Burmeister AR, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00458; Cer RZ, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/6489383; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Chen X, 2013, FEBS LETT, V587, P3729, DOI 10.1016/j.febslet.2013.09.044; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Cohen SS, 2013, NEUROIMMUNOMODULAT, V20, P264, DOI 10.1159/000350470; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Devaux Y, 2016, JAMA CARDIOL, V1, P305, DOI 10.1001/jamacardio.2016.0480; Dufourd T, 2019, BIOL METHODS PROTOC, V4, DOI 10.1093/biomethods/bpz006; Frohlich M, 2020, EUR J TRAUMA EMERG S, V46, P1463, DOI 10.1007/s00068-019-01285-0; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Howe JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177661; Huang S, 2018, FASEB J, V32, P2315, DOI 10.1096/fj.201700673RERR; Kitagishi Y, 2013, ALZHEIMERS RES THER, V5, DOI [10.1186/alzrt208, 10.1186/1758-9193-5-42]; Kong PF, 2017, MOL THER, V25, P1027, DOI 10.1016/j.ymthe.2017.01.013; Kumar V, 2018, MOL THER-NUCL ACIDS, V12, P490, DOI 10.1016/j.omtn.2018.06.004; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li D, 2019, NEUROCHEM RES, V44, P1903, DOI 10.1007/s11064-019-02825-1; Li ZZ, 2019, IN VITRO CELL DEV-AN, V55, P52, DOI 10.1007/s11626-018-0310-2; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Ma FF, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113094; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mitra B, 2017, J CLIN NEUROSCI, V38, P37, DOI 10.1016/j.jocn.2016.12.009; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Schindler CR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061667; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Stormann P, 2020, EUR J TRAUMA EMERG S, V46, P31, DOI 10.1007/s00068-019-01098-1; Sunderland N, 2017, CIRC RES, V120, P418, DOI 10.1161/CIRCRESAHA.116.309303; Terrinoni A, 2019, CLIN CHEM LAB MED, V57, P932, DOI 10.1515/cclm-2018-0838; Tigchelaar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01299-x; van Wessem KJP, 2018, SHOCK, V49, P33, DOI 10.1097/SHK.0000000000000938; Verboket R, 2019, UNFALLCHIRURG, V122, P618, DOI 10.1007/s00113-018-0566-8; von Elm E, 2008, INTERNIST, V49, P688, DOI 10.1007/s00108-008-2138-4; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Vuokila N, 2018, CELL MOL LIFE SCI, V75, P4557, DOI 10.1007/s00018-018-2911-z; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wrba L, 2019, SHOCK, V52, pe45, DOI 10.1097/SHK.0000000000001271; Yan J, 2019, J NEUROCHEM, V150, P202, DOI 10.1111/jnc.14717; Yang Q., 2018, FRONT LAB MED, V2, P83, DOI [10.1016/j.flm.2018.08.001, DOI 10.1016/J.FLM.2018.08.001]; Zhao H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19458-z	56	5	5	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	AUG	2020	21	15							5381	10.3390/ijms21155381			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	MZ4RF	WOS:000559110600001	32751105	Green Published, gold			2022-02-06	
J	Wan, XY; Gan, C; You, C; Fan, T; Zhang, SJ; Zhang, HQ; Wang, S; Shu, K; Wang, X; Lei, T				Wan, Xueyan; Gan, Chao; You, Chao; Fan, Ting; Zhang, Suojun; Zhang, Huaqiu; Wang, Sheng; Shu, Kai; Wang, Xiong; Lei, Ting			Association of APOE epsilon 4 with progressive hemorrhagic injury in patients with traumatic intracerebral hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						APOE genotype; coagulopathy; progressive hemorrhagic injury; therapeutic approach; traumatic brain injury	APOLIPOPROTEIN-E GENOTYPE; ANGIOGRAPHY SPOT SIGN; BRAIN-INJURY; RISK-FACTORS; COAGULATION DISORDERS; ELDERLY-PATIENTS; ALLELE; COAGULOPATHY; PATHOLOGY; METAANALYSIS	OBJECTIVE The intracranial hematoma volume in patients with traumatic brain injury is a key parameter for the determination of the management approach and outcome. Apolipoprotein E (APOE) epsilon 4 is reported to be a risk factor for larger hematoma volume, which might contribute to a poor outcome. However, whether APOE epsilon 4 is related to progressive hemorrhagic injury (PHI), a common occurrence in the clinical setting, remains unclear. In this study, the authors aimed to investigate the association between the APOE genotype and occurrence of PHI. METHODS This prospective study included a cohort of 123 patients with traumatic intracerebral hemorrhage who initially underwent conservative treatment. These patients were assigned to the PHI or non-PHI group according to the follow-up CT scan. A polymerase chain reaction and sequencing method were carried out to determine the APOE genotype. Multivariate logistic regression analysis was applied to identify predictors of PHI. RESULTS The overall frequency of the alleles was as follows: E2/2, 0%; E2/3, 14.6%; E3/3, 57.8%; E2/4, 2.4%; E3/4, 22.8%; and E4/4, 2.4%. Thirty-four patients carried at least one allele of e4. In this study 60 patients (48.8%) experienced PHI, and the distribution of the alleles was as follows: E2/2, 0%; E2/3, 5.7%; E3/3, 22.8%; E2/4, 2.4%; E3/4, 16.3%; and E4/4, 1.6%, which was significantly different from that in the non-PHI group (p = 0.008). Additionally, the late operation rate in the PHI group was significantly higher than that in the non-PHI group (24.4% vs 11.4%, p = 0.002). Multivariate logistic regression identified APOE epsilon 4 (OR 5.14, 95% CI 2.40-11.62), an elevated international normalized ratio (OR 3.57, 95% CI 1.61-8.26), and higher glucose level (>= 10 mmol/L) (OR 3.88, 95% CI 1.54-10.77) as independent risk factors for PHI. Moreover, APOE epsilon 4 was not a risk factor for the coagulopathy and outcome of the patients with traumatic intracerebral hemorrhage. CONCLUSIONS The presence of APOE epsilon 4, an elevated international normalized ratio, and a higher glucose level (>= 10 mmol/L) are predictors of PHI. Additionally, APOE epsilon 4 is not associated with traumatic coagulopathy and patient outcome.	[Wan, Xueyan; Gan, Chao; You, Chao; Fan, Ting; Zhang, Suojun; Zhang, Huaqiu; Wang, Sheng; Shu, Kai; Lei, Ting] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan, Peoples R China; [Wang, Xiong] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan, Peoples R China		Lei, T (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China.	naowai1@tjh.tjmu.edu.cn		zhang, huaqiu/0000-0003-3023-2040; Wan, Xueyan/0000-0002-7148-9857	National Clinical Key Specialty Construction Project	This work was supported by the National Clinical Key Specialty Construction Project.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Dowlatshahi D, 2014, STROKE, V45, P277, DOI 10.1161/STROKEAHA.113.003387; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Greenberg SM, 2018, STROKE, V49, P491, DOI 10.1161/STROKEAHA.117.016990; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jiang Y, 2007, J NEUROTRAUM, V24, P1802, DOI 10.1089/neu.2007.0299; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Olivecrona M, 2010, J NEUROSURG, V112, P1113, DOI 10.3171/2009.8.JNS09636; Orito K, 2018, J NEUROTRAUM, V35, P760, DOI 10.1089/neu.2017.5247; Padgett CR, 2016, NEUROPSYCHOLOGY, V30, P775, DOI 10.1037/neu0000270; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Stein SC, 2005, NEUROSCI LETT, V387, P28, DOI 10.1016/j.neulet.2005.07.011; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thompson AL, 2009, CAN J NEUROL SCI, V36, P456, DOI 10.1017/S0317167100007782; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Tzioras M, 2019, NEUROPATH APPL NEURO, V45, P327, DOI 10.1111/nan.12529; Wan XY, 2017, WORLD NEUROSURG, V103, P584, DOI 10.1016/j.wneu.2017.04.069; Wan XY, 2017, ACTA NEUROCHIR, V159, P227, DOI 10.1007/s00701-016-3043-6; Wan XY, 2016, WORLD NEUROSURG, V89, P147, DOI 10.1016/j.wneu.2016.01.084; Weir CJ, 2001, NEUROLOGY, V57, P1097, DOI 10.1212/WNL.57.6.1097; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Yip AG, 2005, NEUROLOGY, V65, P259, DOI 10.1212/01.wnl.0000168863.49053.4d; Yousuf A, 2015, J MOL NEUROSCI, V56, P597, DOI 10.1007/s12031-015-0554-1; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	43	5	5	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2020	133	2					496	503		10.3171/2019.4.JNS183472			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM5TQ	WOS:000586087300026	31323634				2022-02-06	
J	Dennis, EL; Caeyenberghs, K; Asarnow, RF; Babikian, T; Bartnik-Olson, B; Bigler, ED; Figaji, A; Giza, CC; Goodrich-Hunsaker, NJ; Hodges, CB; Hoskinson, KR; Konigs, M; Levin, HS; Lindsey, HM; Livny, A; Max, JE; Merkley, TL; Newsome, MR; Olsen, A; Ryan, NP; Spruiell, MS; Suskauer, SJ; Thomopoulos, SI; Ware, AL; Watson, CG; Wheeler, AL; Yeates, KO; Zielinski, BA; Thompson, PM; Tate, DF; Wilde, EA				Dennis, Emily L.; Caeyenberghs, Karen; Asarnow, Robert F.; Babikian, Talin; Bartnik-Olson, Brenda; Bigler, Erin D.; Figaji, Anthony; Giza, Christopher C.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Hoskinson, Kristen R.; Konigs, Marsh; Levin, Harvey S.; Lindsey, Hannah M.; Livny, Abigail; Max, Jeffrey E.; Merkley, Tricia L.; Newsome, Mary R.; Olsen, Alexander; Ryan, Nicholas P.; Spruiell, Matthew S.; Suskauer, Stacy J.; Thomopoulos, Sophia, I; Ware, Ashley L.; Watson, Christopher G.; Wheeler, Anne L.; Yeates, Keith Owen; Zielinski, Brandon A.; Thompson, Paul M.; Tate, David F.; Wilde, Elisabeth A.			Challenges and opportunities for neuroimaging in young patients with traumatic brain injury: a coordinated effort towards advancing discovery from the ENIGMA pediatric moderate/severe TBI group	BRAIN IMAGING AND BEHAVIOR			English	Article						traumatic brain injury (TBI); Pediatric; Neuroimaging; ENIGMA; Moderate-severe TBI	MAGNETIC-RESONANCE SPECTROSCOPY; SURFACE-BASED ANALYSIS; WHITE-MATTER; CORPUS-CALLOSUM; SEX-DIFFERENCES; WORKING-MEMORY; DIFFUSION MRI; FUNCTIONAL PLASTICITY; PITUITARY DYSFUNCTION; STRUCTURAL CONNECTOME	Traumatic brain injury (TBI) is a major cause of death and disability in children in both developed and developing nations. Children and adolescents suffer from TBI at a higher rate than the general population, and specific developmental issues require a unique context since findings from adult research do not necessarily directly translate to children. Findings in pediatric cohorts tend to lag behind those in adult samples. This may be due, in part, both to the smaller number of investigators engaged in research with this population and may also be related to changes in safety laws and clinical practice that have altered length of hospital stays, treatment, and access to this population. The ENIGMA (Enhancing NeuroImaging Genetics through Meta-Analysis) Pediatric Moderate/Severe TBI (msTBI) group aims to advance research in this area through global collaborative meta-analysis of neuroimaging data. In this paper, we discuss important challenges in pediatric TBI research and opportunities that we believe the ENIGMA Pediatric msTBI group can provide to address them. With the paucity of research studies examining neuroimaging biomarkers in pediatric patients with TBI and the challenges of recruiting large numbers of participants, collaborating to improve statistical power and to address technical challenges like lesions will significantly advance the field. We conclude with recommendations for future research in this field of study.	[Dennis, Emily L.; Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Lindsey, Hannah M.; Merkley, Tricia L.; Zielinski, Brandon A.; Tate, David F.; Wilde, Elisabeth A.] Univ Utah, Sch Med, Dept Neurol, TBI & Concuss Ctr, Salt Lake City, UT 84132 USA; [Dennis, Emily L.; Thomopoulos, Sophia, I; Thompson, Paul M.] Keck Sch Med USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Los Angeles, CA 90033 USA; [Dennis, Emily L.] Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA; [Caeyenberghs, Karen; Ryan, Nicholas P.] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Geelong, Vic, Australia; [Asarnow, Robert F.; Babikian, Talin] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Babikian, Talin; Giza, Christopher C.] Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Bartnik-Olson, Brenda] Loma Linda Univ, Med Ctr, Dept Radiol, Loma Linda, CA USA; [Bigler, Erin D.; Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Lindsey, Hannah M.; Merkley, Tricia L.; Tate, David F.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.; Merkley, Tricia L.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Figaji, Anthony] Univ Cape Town, Div Neurosurg, Cape Town, South Africa; [Figaji, Anthony] Univ Cape Town, Neurosci Inst, Cape Town, South Africa; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Goodrich-Hunsaker, Naomi J.; Hodges, Cooper B.; Lindsey, Hannah M.; Tate, David F.; Wilde, Elisabeth A.] George E Wahlen Vet Affairs Salt Lake City Health, Salt Lake City, UT USA; [Hoskinson, Kristen R.] Nationwide Childrens Hosp, Ctr Biobehav Hlth, Abigail Wexner Res Inst, Columbus, OH USA; [Hoskinson, Kristen R.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Konigs, Marsh] Univ Amsterdam, Emma Childrens Hosp, Emma Neurosci Grp, Amsterdam UMC, Amsterdam, Netherlands; [Levin, Harvey S.; Newsome, Mary R.; Spruiell, Matthew S.; Wilde, Elisabeth A.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.; Newsome, Mary R.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Livny, Abigail] Sheba Med Ctr, Dept Diagnost Imaging, Tel Hashomer, Israel; [Livny, Abigail] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Max, Jeffrey E.] Rady Childrens Hosp, Dept Psychiat, San Diego, CA USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Ryan, Nicholas P.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Ryan, Nicholas P.] Murdoch Childrens Res Inst, Dept Clin Sci, Melbourne, Vic, Australia; [Suskauer, Stacy J.] Kennedy Krieger Inst, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Ware, Ashley L.; Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Watson, Christopher G.] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, Houston, TX 77030 USA; [Wheeler, Anne L.] Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON, Canada; [Wheeler, Anne L.] Univ Toronto, Physiol Dept, Toronto, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Pediat & Clin Neurosci, Calgary, AB, Canada; [Zielinski, Brandon A.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; [Tate, David F.] Missouri Inst Mental Hlth, St Louis, MO USA; [Tate, David F.] Univ Missouri, St Louis, MO 63121 USA		Dennis, EL (corresponding author), Univ Utah, Sch Med, Dept Neurol, TBI & Concuss Ctr, Salt Lake City, UT 84132 USA.; Dennis, EL (corresponding author), Keck Sch Med USC, Imaging Genet Ctr, Stevens Neuroimaging & Informat Inst, Los Angeles, CA 90033 USA.; Dennis, EL (corresponding author), Brigham & Womens Hosp, Psychiat Neuroimaging Lab, 75 Francis St, Boston, MA 02115 USA.	emily.dennis@hsc.utah.edu	Yeates, Keith/AAJ-4223-2020; Merkley, Tricia L./AAN-2989-2020; Thompson, Paul M/C-4194-2018; Dennis, Emily/AAD-5223-2021; Tate, David/G-5166-2011	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009; Livny, Abigail/0000-0003-2216-7357; Ryan, Nicholas/0000-0002-0878-8889; Tate, David/0000-0003-0213-1920; Spruiell, Matthew/0000-0001-5311-7956; Thomopoulos, Sophia I/0000-0002-0046-4070; Bartnik-Olson, Brenda/0000-0002-1137-9437	Australian Catholic University (ACU); NRF SARChI Chair of Clinical Neurosciences; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R43HD09703901, R01 HD088438, U54 EB020403, R01 MH116147, R56 AG058854, P41 EB015922, R01 MH111671]; Ronald and Irene Ward Chair in Pediatric Brain Injury - Alberta Children's Hospital Foundation; NHMRC Career Development FellowshipNational Health and Medical Research Council of Australia;  [K99 NS096116]	We wish to acknowledge multiple funding sources, including the following: K99 NS096116 to Dr. Dennis, NHMRC Career Development Fellowship and an ACURF Program grant by the Australian Catholic University (ACU) to Dr. Caeyenberghs, NRF SARChI Chair of Clinical Neurosciences to Dr. Figaji, NICHD R43HD09703901 to Dr. Levin, R01 HD088438 to Dr. Max, and U54 EB020403, R01 MH116147, R56 AG058854, P41 EB015922, R01 MH111671 to Dr. Thompson. Dr. Yeates is supported by the Ronald and Irene Ward Chair in Pediatric Brain Injury, funded by the Alberta Children's Hospital Foundation. The authors wish to acknowledge the leadership of Dr. Paul Thompson (ENIGMA PI) as well as the leadership of Drs. Frank Hillary, Alexander Olsen, Inga Koerte, David Baron, Alexander Lin, Brenda Bartnik-Olson, Carrie Esopenko, and Neda Jahanshad, as well as ENIGMA support personnel and all working group members and contributors. We alos wish to acknowledge the constructive feedback and suggestions of anonymous reviewers. Finally, we wish to acknowledge the participation of the children and family members and the efforts of our many colleagues that make this work possible.	Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Adelson P, 2010, PEDIAT TRAUMATIC BRA, P54, DOI DOI 10.1017/CB09780511676383.005; Adhikari BM, 2019, BRAIN IMAGING BEHAV, V13, P1453, DOI 10.1007/s11682-018-9941-x; Alexander B, 2017, NEUROIMAGE, V147, P841, DOI 10.1016/j.neuroimage.2016.09.068; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V., 2010, PEDIAT TRAUMATIC BRA; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Arambula SE, 2019, EXP NEUROL, V317, P168, DOI 10.1016/j.expneurol.2019.02.016; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Au AK, 2017, CURR OPIN NEUROL, V30, P565, DOI 10.1097/WCO.0000000000000504; Avants BB, 2014, NEUROIMAGE, V84, P698, DOI 10.1016/j.neuroimage.2013.09.048; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Bartnik-Olson BL, 2021, BRAIN IMAGING BEHAV, V15, P504, DOI 10.1007/s11682-020-00330-6; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; Bauer PJ, 2013, MONOGR SOC RES CHILD, V78, P133, DOI 10.1111/mono.12039; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bennett KS, 2017, PEDIATR CRIT CARE ME, V18, P54, DOI 10.1097/PCC.0000000000000948; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bookheimer SY, 2000, MENT RETARD DEV D R, V6, P161, DOI 10.1002/1098-2779(2000)6:3<161::AID-MRDD2>3.0.CO;2-W; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Chen CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8549; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crawford AM, 2019, J TRAUMA ACUTE CARE, V87, pS146, DOI 10.1097/TA.0000000000002256; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dalamagkas K, 2020, BRAIN IMAGING BEHAV, V14, P696, DOI 10.1007/s11682-018-0006-y; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; de Bie HMA, 2010, EUR J PEDIATR, V169, P1079, DOI 10.1007/s00431-010-1181-z; Delaney-Black V, 2002, ARCH PEDIAT ADOL MED, V156, P280, DOI 10.1001/archpedi.156.3.280; Dell'italia J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00439; Dennis EL, 2015, WHITE MATTER DISRUPT; Dennis EL, 2021, MOL PSYCHIATR, V26, P4315, DOI 10.1038/s41380-019-0631-x; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2018, I S BIOMED IMAGING, P1386, DOI 10.1109/ISBI.2018.8363830; Dennis EL, 2018, HUM BRAIN MAPP, V39, P3759, DOI 10.1002/hbm.24209; Dennis EL, 2017, PROC SPIE, V10572, DOI 10.1117/12.2285245; Dennis EL, 2017, 2017 IEEE 14TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2017), P105, DOI 10.1109/ISBI.2017.7950479; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2013, INT J DEV NEUROSCI, V31, P525, DOI 10.1016/j.ijdevneu.2013.05.007; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Edwards AD, 2011, PEDIATR RADIOL, V41, P1353, DOI 10.1007/s00247-011-2147-7; Etchell A, 2018, NEUROPSYCHOLOGIA, V114, P19, DOI 10.1016/j.neuropsychologia.2018.04.011; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fonov V., 2011, NEUROIMAGE; Gabrielsen TP, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0248-y; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Gennatas ED, 2017, J NEUROSCI, V37, P5065, DOI 10.1523/JNEUROSCI.3550-16.2017; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goh SYM, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00019; Goldstein FC, 2017, J NEUROTRAUM, V34, P115, DOI 10.1089/neu.2015.4313; Groenewold N, 2018, BIOL PSYCHIAT, V83, pS247, DOI 10.1016/j.biopsych.2018.02.640; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Hasan KM, 2018, NEUROIMAG CLIN N AM, V28, P31, DOI 10.1016/j.nic.2017.09.001; Hebb D. O., 1949, WILEY BOOK CLIN PSYC, P62; Hernandez F, 2019, BIOMECH MODEL MECHAN, V18, P631, DOI 10.1007/s10237-018-01106-0; Herting MM, 2017, FRONT NEUROENDOCRIN, V44, P122, DOI 10.1016/j.yfrne.2016.12.003; Hicks Ramona, 2015, Handb Clin Neurol, V128, P743, DOI 10.1016/B978-0-444-63521-1.00046-7; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Holshouser B, 2019, J NEUROTRAUM, V36, P1352, DOI 10.1089/neu.2018.5919; Hoogman M, 2019, AM J PSYCHIAT, V176, P531, DOI 10.1176/appi.ajp.2019.18091033; Huisman T. A. G. M, 2015, PEDIAT NEURORADIOLOG, P1; Hunter JV, 2005, AM J NEURORADIOL, V26, P482; Hunter LE, 2019, J NEUROTRAUM, V36, P1222, DOI 10.1089/neu.2018.5838; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; Ismail FY, 2017, EUR J PAEDIATR NEURO, V21, P23, DOI 10.1016/j.ejpn.2016.07.007; Jahanshad N, 2017, J NEUROSCI RES, V95, P371, DOI 10.1002/jnr.23919; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jia T., 2018, BIORXIV, DOI [10.1101/460444v1, DOI 10.1101/460444V1]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kandel BM, 2015, METHODS, V73, P43, DOI 10.1016/j.ymeth.2014.10.016; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Keller TA, 2009, NEURON, V64, P624, DOI 10.1016/j.neuron.2009.10.018; Khetani A, 2019, J NEUROTRAUM, V36, P3274, DOI 10.1089/neu.2018.6117; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; King DJ, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101844; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Kramer ME, 2009, J PEDIATR REHAB MED, V2, P255, DOI 10.3233/PRM-2009-0091; Krogsrud SK, 2016, NEUROIMAGE, V124, P473, DOI 10.1016/j.neuroimage.2015.09.017; Lee JK, 2019, JAMA NEUROL, V76, P412, DOI 10.1001/jamaneurol.2018.4882; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Lindsey HM, 2020, BRAIN IMAGING BEHAV, V14, P1626, DOI 10.1007/s11682-019-00093-9; LODER RT, 1995, J PEDIATR ORTHOPED, V15, P41, DOI 10.1097/01241398-199501000-00010; Lorenzen P, 2006, MED IMAGE ANAL, V10, P440, DOI 10.1016/j.media.2005.03.002; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Maria NSS, 2019, EXP NEUROL, V318, P78, DOI 10.1016/j.expneurol.2019.04.016; Max JE, 1998, J NERV MENT DIS, V186, P325, DOI 10.1097/00005053-199806000-00001; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P272, DOI 10.1176/appi.neuropsych.15030073; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Moyer D., 2019, SCANNER INVARIANT RE; Natu VS, 2019, P NATL ACAD SCI USA, V116, P20750, DOI 10.1073/pnas.1904931116; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Nir TM, 2019, MATH VIS, P203, DOI 10.1007/978-3-030-05831-9_17; Nir TM, 2017, MAGN RESON MED, V78, P2322, DOI 10.1002/mrm.26623; Olsen A, 2020, J NEUROTRAUM, V37, P397, DOI 10.1089/neu.2019.6532; Olsen A, 2015, CEREB CORTEX, V25, P2170, DOI 10.1093/cercor/bhu023; Olsen A, 2013, J COGNITIVE NEUROSCI, V25, P903, DOI 10.1162/jocn_a_00358; Ornstein TJ, 2014, J INT NEUROPSYCH SOC, V20, P971, DOI 10.1017/S1355617714000903; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Raj SP, 2018, J HEAD TRAUMA REHAB, V33, P158, DOI 10.1097/HTR.0000000000000331; Rao S, 2016, J AM COLL RADIOL, V13, P788, DOI 10.1016/j.jacr.2016.02.022; Resnik DB, 2009, J MED ETHICS, V35, P656, DOI 10.1136/jme.2009.030338; Rivkin MJ, 2000, MENT RETARD DEV D R, V6, P68, DOI 10.1002/(SICI)1098-2779(2000)6:1<68::AID-MRDD9>3.0.CO;2-9; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Rose SR, 2012, PITUITARY, V15, P267, DOI 10.1007/s11102-011-0360-x; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Russell KL, 2011, J NEUROSCI METH, V199, P214, DOI 10.1016/j.jneumeth.2011.05.008; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Sairanen V, 2018, NEUROIMAGE, V181, P331, DOI 10.1016/j.neuroimage.2018.07.003; Sanchez CE, 2012, DEV NEUROPSYCHOL, V37, P379, DOI 10.1080/87565641.2012.688900; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Sheeler CA, 2016, J NEUROSCI, V36, P7341, DOI 10.1523/JNEUROSCI.1418-16.2016; Shores DR, 2018, J PEDIATR-US, V193, P14, DOI 10.1016/j.jpeds.2017.08.077; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Stein, 2019, NEUROIMAGE; Stephens JA, 2018, DEV NEUROREHABIL, V21, P423, DOI 10.1080/17518423.2017.1338777; Tang Y., 2019, AM J PSYCHIAT; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson P., 2019, PSYARXIV, DOI 10.31234/osf.io/qnsh7.; Thompson P. M., 2019, BIORXIV, DOI [10.1101/673012v1, DOI 10.1101/673012V1]; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Veer I., 2019, ENIGMA TASK BASED FM; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wilde E A., 2019, BRAIN IMAGING BEHAV; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2019, J NEUROTRAUM, V36, P239, DOI 10.1089/neu.2017.5513; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Wilke M, 2003, NEUROPEDIATRICS, V34, P225; Wright D. W., 2015, NEW ENGLAND J MED; Wu T. C., 2010, DEV NEUROSCIENCE; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Zavaliangos-Petropulu A, 2018, PROC SPIE, V10975, DOI 10.1117/12.2506694; Zhu AH, 2019, MATH VIS, P157, DOI 10.1007/978-3-030-05831-9_13; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107	205	5	5	3	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2021	15	2					555	575		10.1007/s11682-020-00363-x		JUL 2020	21	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	RK3RJ	WOS:000554054300005	32734437				2022-02-06	
J	Negah, SS; Shirzad, MM; Biglari, G; Naseri, F; Ravandi, HH; Dooghabadi, AH; Gorji, A				Negah, Sajad Sahab; Shirzad, Mohammad Moein; Biglari, Ghazale; Naseri, Farzin; Ravandi, Hassan Hosseini; Dooghabadi, Ali Hassani; Gorji, Ali			Transplantation of R-GSIK scaffold with mesenchymal stem cells improves neuroinflammation in a traumatic brain injury model	CELL AND TISSUE RESEARCH			English	Article						Head injury; Stem cells; Nano-scaffold; Neuroinflammation	STROMAL CELLS; REACTIVE ASTROCYTES; DIFFERENTIATION; PROGESTERONE; INFLAMMATION; PHENOTYPE; CYTOKINES; HYDROGEL; REPAIR; MSCS	Neural tissue engineering has been introduced as a novel therapeutic strategy for traumatic brain injury (TBI). Transplantation of mesenchymal stem cells (MSCs) has been demonstrated to improve functional outcome of brain injury, and RADA4GGSIKVAV (R-GSIK), a self-assembling nano-peptide scaffold, has been suggested to promote the behavior of stem cells. This study was designed to determine the ability of the R-GSIK scaffold in supporting the effects of MSCs on motor function activity and inflammatory responses in an experimental TBI model. A significant recovery of motor function was observed in rats that received MSCs+R-GSIK compared with the control groups. Further analysis showed a reduction in the number of reactive astrocytes and microglial cells in the MSCs and MSCs+R-GSIK groups compared with the control groups. Furthermore, western blot analysis indicated a significant reduction in pro-inflammatory cytokines, such as TLR4, TNF, and IL6, in the MSCs and MSCs+R-GSIK groups compared with the TBI, vehicle, and R-GSIK groups. Overall, this study strengthens the idea that the co-transplantation of MSCs with R-GSIK can increase functional outcomes by preparing a beneficial environment. This improvement may be explained by the immunomodulatory effects of MSCs and the self-assembling nano-scaffold peptide.	[Negah, Sajad Sahab; Gorji, Ali] Mashhad Univ Med Sci, Neurosci Res Ctr, Mashhad, Razavi Khorasan, Iran; [Negah, Sajad Sahab; Gorji, Ali] Mashhad Univ Med Sci, Fac Med, Dept Neurosci, Mashhad, Razavi Khorasan, Iran; [Negah, Sajad Sahab; Ravandi, Hassan Hosseini; Gorji, Ali] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Shirzad, Mohammad Moein; Biglari, Ghazale; Naseri, Farzin; Dooghabadi, Ali Hassani] Mashhad Univ Med Sci, Student Res Comm, Mashhad, Razavi Khorasan, Iran; [Gorji, Ali] Westfalische Wilhelms Univ, Dept Neurosurg, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ, Dept Neurol, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Munster, Germany		Gorji, A (corresponding author), Mashhad Univ Med Sci, Neurosci Res Ctr, Mashhad, Razavi Khorasan, Iran.; Gorji, A (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Neurosci, Mashhad, Razavi Khorasan, Iran.; Gorji, A (corresponding author), Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran.; Gorji, A (corresponding author), Westfalische Wilhelms Univ, Dept Neurosurg, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ, Dept Neurol, Munster, Germany.; Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Munster, Germany.	gorjial@uni-muenster.de		Gorji, Ali/0000-0002-4557-3270	Projekt DEAL; Iran National Science Foundation (INSF)Iran National Science Foundation (INSF); National Institute for Medical Research (NIMAD) [964650]; Student Research Committee of Mashhad University of Medical Sciences	Open Access funding provided by Projekt DEAL. This study was supported by the Iran National Science Foundation (INSF), National Institute for Medical Research (NIMAD; 964650) to AG. This study was also supported by the Student Research Committee of Mashhad University of Medical Sciences.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Ahmadabad RA, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01785-6; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cho KJ, 2005, STEM CELLS, V23, P383, DOI 10.1634/stemcells.2004-0251; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Cox CS, 2018, PEDIATR RES, V83, P325, DOI 10.1038/pr.2017.253; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Darkazalli A, 2016, RESTOR NEUROL NEUROS, V34, P433, DOI 10.3233/RNN-150628; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Galipeau J, 2018, CELL STEM CELL, V22, P824, DOI 10.1016/j.stem.2018.05.004; Guo L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt327; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Munoz JL, 2012, DIFFERENTIATION, V84, P214, DOI 10.1016/j.diff.2012.07.002; Negah SS, 2019, ACTA BIOMATER, V92, P132, DOI 10.1016/j.actbio.2019.05.010; Negah SS, 2018, CELL TISSUE RES, V371, P223, DOI 10.1007/s00441-017-2717-6; Negah SS, 2017, MOL NEUROBIOL, V54, P8050, DOI 10.1007/s12035-016-0295-3; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Sahab-Negah S, 2020, MOL NEUROBIOL, V57, P3391, DOI 10.1007/s12035-020-01922-5; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Wang JA, 2015, MAT SCI ENG C-MATER, V46, P140, DOI 10.1016/j.msec.2014.10.019; Wang YC, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7848901; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Zeng Y, 2013, NEUROCHEM RES, V38, P2483, DOI 10.1007/s11064-013-1186-x; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou L, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/5024175; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	45	5	5	2	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2020	382	3					575	583		10.1007/s00441-020-03247-0		JUL 2020	9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	OV2PN	WOS:000552587300001	32715374	Green Published, hybrid			2022-02-06	
J	Iverson, GL; Gardner, AJ				Iverson, Grant L.; Gardner, Andrew J.			Risk for Misdiagnosing Chronic Traumatic Encephalopathy in Men With Anger Control Problems	FRONTIERS IN NEUROLOGY			English	Article						athletes; anger; depression; suicidal ideation; suicide; brain concussion; brain injuries; chronic traumatic encephalopathy	MAJOR DEPRESSIVE DISORDER; REPLICATION NCS-R; BRAIN-INJURY; DEMENTIA-PUGILISTICA; AGGRESSIVE-BEHAVIOR; DISEASE; HOSTILITY; TAU; PERSONALITY; PREVALENCE	Background:There are no validated or agreed upon criteria for diagnosing chronic traumatic encephalopathy (CTE) in a living person. In recent years, it has been proposed that anger dyscontrol represents a behavioral clinical phenotype of CTE. This is the first study to examine the specificity of the diagnostic research criteria for traumatic encephalopathy syndrome (TES, the clinical condition proposed to be CTE) in men from the US general population who have anger dyscontrol problems. It was hypothesized that a substantial percentage of these men would meet the research criteria for TES. Methods:Data from 4,139 men who participated in the National Comorbidity Survey Replication, an in-person survey that examined the prevalence and correlates of mental disorders in the United States, were included in this study. Men who were diagnosed with intermittent explosive disorder in the past year were the clinical sample of interest (n= 206; 5.0% of all men in the database), and the remaining men were used as a comparison sample. They were classified as meeting the research criteria for TES if they presented with the purported supportive clinical features of CTE (e.g., impulsivity/substance abuse, anxiety, apathy, suicidality, headache). Results:In this sample of men from the general population with intermittent explosive disorder, 27.3% met a conservative definition of the proposed research criteria for CTE (i.e., traumatic encephalopathy syndrome). If one assumes the delayed-onset criterion is present, meaning that the men in the sample are compared to former athletes or military veterans presenting with mental health problems years after retirement, then 65.0% of this sample would meet the research criteria for TES. Conclusions:These results have important implications. Using conservative criteria, at least one in four men from the general population, who have serious anger control problems, will meet the symptom criteria for TES. If one considers former athletes and military veterans with anger control problems who present many years after retirement and who experienced a documented decline in their mental health, nearly two-thirds will meet these research criteria. More research is needed to examine risks for misdiagnosing TES and to determine whether anger dyscontrol is a clinical phenotype of CTE.	[Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Iverson, Grant L.] Spaulding Res Inst, Charlestown, MA 02129 USA; [Iverson, Grant L.] MassGen Hosp Children, Sport Concuss Program, Boston, MA 02114 USA; [Iverson, Grant L.] Home Base, Charlestown, MA 02129 USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA 02129 USA; [Gardner, Andrew J.] Hunter New England Local Hlth Dist, Sports Concuss Program, Newcastle, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Newcastle, NSW, Australia		Iverson, GL (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA.; Iverson, GL (corresponding author), Spaulding Rehabil Hosp, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Spaulding Res Inst, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), MassGen Hosp Children, Sport Concuss Program, Boston, MA 02114 USA.; Iverson, GL (corresponding author), Home Base, Charlestown, MA 02129 USA.; Iverson, GL (corresponding author), Massachusetts Gen Hosp Program, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu		Gardner, Andrew/0000-0001-5031-5586	National Football League; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia; Australian-American Fulbright Commission	This study was funded in part by the National Football League for a program of research entitled The Spectrum of Concussion: Predictors of Clinical Recovery, Treatment and Rehabilitation, and Possible Long-Term Effects. Unrestricted philanthropic support was provided by ImPACT Applications, Inc., the Mooney-Reed Charitable Foundation, Spaulding Research Institute, and the National Rugby League. AG was funded by an NHMRC Early Career Fellowship and a Postgraduate Award from the Australian-American Fulbright Commission.	Alonso AD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00338; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Angst J, 2010, AM J PSYCHIAT, V167, P1194, DOI 10.1176/appi.ajp.2010.09071011; Aseltine RH, 2000, J HEALTH SOC BEHAV, V41, P256, DOI 10.2307/2676320; Baird SM, 2009, QUEST, V61, P377, DOI 10.1080/00336297.2009.10483622; Ballard C, 2013, CURR OPIN PSYCHIATR, V26, P252, DOI 10.1097/YCO.0b013e32835f414b; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Borges G, 2006, PSYCHOL MED, V36, P1747, DOI 10.1017/S0033291706008786; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Capaldi DM, 1998, DEV PSYCHOL, V34, P1175, DOI 10.1037/0012-1649.34.6.1175; Carroll EJ, 1936, AM J MED SCI, V191, P706, DOI 10.1097/00000441-193619150-00014; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Collins K, 1997, PERS INDIV DIFFER, V22, P751, DOI 10.1016/S0191-8869(96)00248-6; Constantinidis J, 1967, Schweiz Arch Neurol Neurochir Psychiatr, V100, P117; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Critchley M., 1949, C VINCENT, P131; Davis GD, 2004, CONSEQUENCES FINANCI; Drachman DA, 1999, NEW ENGL J MED, V340, P1269, DOI 10.1056/NEJM199904223401609; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Fox NA, 2014, SOCIAL WITHDRAWAL IN, P81; Gao A. F., 2017, INT J PATHOL CLIN RE, V3, P50, DOI [10.23937/2469-5807/1510050, DOI 10.23937/2469-5807/1510050]; Gardner BO, 2015, PSYCHOL ASSESSMENT, V27, P534, DOI 10.1037/pas0000065; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Goldfinger MH, 2018, ACTA NEUROPATHOL, V136, P973, DOI 10.1007/s00401-018-1926-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004862; Gonzalez OI, 2016, PSYCHOL TRAUMA-US, V8, P9, DOI 10.1037/tra0000042; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; HARVEY PKP, 1974, LANCET, V2, P928; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Iverson GL, 2020, J NEUROPSYCH CLIN N, V32, P139, DOI 10.1176/appi.neuropsych.19010021; Iverson GL, 2019, J NEUROPATH EXP NEUR, V78, P615, DOI 10.1093/jnen/nlz045; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; JEDLINSKI J, 1970, Polish Medical Journal (English Translation of Polskie Archiwum Medycyny Wewnetrznej), V9, P743; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Keeler L.A., 2007, J SPORT BEHAV, V30, P57; Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900; Kessler RC, 2005, PSYCHOL MED, V35, P1073, DOI 10.1017/S0033291705004538; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Laffey M, 2018, NEUROREHABILITATION, V43, P431, DOI 10.3233/NRE-182452; [李董平 Li Dongping], 2012, [心理学报, Acta Psychologica Sinica], V44, P211; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nicholas KB, 1996, CHILD ABUSE NEGLECT, V20, P1195, DOI 10.1016/S0145-2134(96)00115-9; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Painuly N, 2005, EUR ARCH PSY CLIN N, V255, P215, DOI 10.1007/s00406-004-0539-5; Painuly NP, 2011, PSYCHIAT CLIN NEUROS, V65, P165, DOI 10.1111/j.1440-1819.2010.02177.x; Paradiso S, 1996, J NERV MENT DIS, V184, P746, DOI 10.1097/00005053-199612000-00005; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; RAEVUORI-NALLINMAA S, 1950, Duodecim, V66, P398; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Reilly PM, 2002, J DRUG ADDIT ED ERAD, V10, P198, DOI [10.1037/e436412005-001, DOI 10.1037/E436412005-001]; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Santos CO, 2006, EUR J NEUROL, V13, P351, DOI 10.1111/j.1468-1331.2006.01242.x; SERCL M., 1962, WORLD NEUROL, V3, P351; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taft CT, 2017, CURR OPIN PSYCHOL, V14, P67, DOI 10.1016/j.copsyc.2016.11.008; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Vitaro F, 2006, J ABNORM CHILD PSYCH, V34, P685, DOI 10.1007/s10802-006-9055-6; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Widom CS, 2014, CHILD ABUSE NEGLECT, V38, P650, DOI 10.1016/j.chiabu.2013.11.004; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zahodne LB, 2015, AM J GERIAT PSYCHIAT, V23, P130, DOI 10.1016/j.jagp.2013.03.014; Zarshenas L, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1511-z	94	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 24	2020	11								739	10.3389/fneur.2020.00739			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ND3AL	WOS:000561776100001	32849206	gold, Green Published			2022-02-06	
J	Gradisnik, L; Maver, U; Bosnjak, R; Velnar, T				Gradisnik, Lidija; Maver, Uros; Bosnjak, Roman; Velnar, Tomaz			Optimised isolation and characterisation of adult human astrocytes from neurotrauma patients	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Human brain; Astrocytes; Cell isolation; Cell characterisation; Astrocytic markers	HETEROGENEITY; NEUROSCIENCE; EXPRESSION; NEUROGLIA; CULTURES; SYSTEM; MOUSE; FORM	Background: Astrocytes are the main cellular constituent in the central nervous system. Astrocyte cultures from rodent brains are most commonly used in the experimental practice. However, important differences between rodent and human astrocytes exist. The aim of this study was to develop an improved protocol for routine preparation of primary astrocyte culture from adult human brain, obtained after trauma. New Method: Tissue obtained during neurotrauma operation was mechanically decomposed and centrifuged. The cell sediment was resuspended in cell culture medium, plated in T25 tissue flasks and incubated for one month at 37 degrees C in 5% CO2. The medium was replaced twice weekly and microglia were removed. Once confluent, the purity of cultures was assessed. The culture was characterised immunocytochemically for specific astrocytic markers (GFAP, GLAST and S100B). Cell morphology was examined through the actin cytoskeleton labelling with fluorescent phalloidin. Results: Under basal conditions, adult astrocytes exhibited astrocyte-specific morphology and expressed specific markers. Approximately 95% of cells were positive for the main glial markers (GFAP, GLAST, S100B). Comparison with Existing Method: We established an easy and cost-effective method for a highly enriched primary astrocyte culture from adult human brain. Conclusion: The isolation technique provides sufficient quantities of isolated cells. The culture obtained in this study exhibits the biochemical and physiological properties of astrocytes. It may be useful for elucidating the mechanisms related to the adult brain, exploring changes between neonatal and adult astrocytes, novel therapeutic targets, cell therapy experiments, as well as investigating compounds involved in cytotoxicity and cytoprotection.	[Gradisnik, Lidija; Maver, Uros] Univ Maribor, Med Fac, Inst Biomed Sci, Taborska 8, Maribor 2000, Slovenia; [Gradisnik, Lidija; Velnar, Tomaz] AMEU ECM, Slovenska 17, Maribor 2000, Slovenia; [Bosnjak, Roman; Velnar, Tomaz] Univ Med Ctr Ljubljana, Dept Neurosurg, Zaloska 7, Ljubljana 1000, Slovenia		Velnar, T (corresponding author), Univ Med Ctr Ljubljana, Dept Neurosurg, Zaloska 7, Ljubljana 1000, Slovenia.	tvelnar@hotmail.com		Velnar, Tomaz/0000-0002-6283-4348			Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Araque A, 1999, CAN J PHYSIOL PHARM, V77, P699, DOI 10.1139/cjpp-77-9-699; Barres Ben A, 2014, Cold Spring Harb Protoc, V2014, P1342, DOI 10.1101/pdb.ip073999; Bedner P, 2020, GLIA, V68, P756, DOI 10.1002/glia.23725; Bellaver B, 2017, MOL NEUROBIOL, V54, P2969, DOI 10.1007/s12035-016-9880-8; Chaboub LS, 2012, DEV NEUROSCI-BASEL, V34, P379, DOI 10.1159/000343723; Chew LJ, 2014, J NEUROSCI METH, V236, P125, DOI 10.1016/j.jneumeth.2014.08.017; Condic M, 2014, BRAIN BEHAV IMMUN, V41, P116, DOI 10.1016/j.bbi.2014.05.003; de Majo M, 2020, GLIA, V68, P685, DOI 10.1002/glia.23771; DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; Giffard R. G., 2009, ENCY NEUROSCIENCE, P633; Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409; Grupp L, 2010, J COMP NEUROL, V518, P4277, DOI 10.1002/cne.22481; HANSSON E, 1988, PROG NEUROBIOL, V30, P369, DOI 10.1016/0301-0082(88)90008-1; He YB, 2019, METHODS MOL BIOL, V1938, P37, DOI 10.1007/978-1-4939-9068-9_3; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Jakovcevski I, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.005.2009; John GR, 2012, METHODS MOL BIOL, V814, P401, DOI 10.1007/978-1-61779-452-0_27; Kettenmann H, 2011, FORTSCHR NEUROL PSYC, V79, P588, DOI 10.1055/s-0031-1281704; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Kimelberg HK, 2000, J NEUROSCI RES, V61, P577, DOI 10.1002/1097-4547(20000915)61:6<577::AID-JNR1>3.0.CO;2-T; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; LEE SHC, 1992, LAB INVEST, V67, P465; Minchev G, 2020, J NEUROSURG, V132, P150, DOI 10.3171/2018.8.JNS182096; Mizee MR, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0418-8; MONTGOMERY DL, 1994, VET PATHOL, V31, P145, DOI 10.1177/030098589403100201; Morga E, 1999, J NEUROSCI RES, V57, P941, DOI 10.1002/(SICI)1097-4547(19990915)57:6<941::AID-JNR20>3.3.CO;2-Q; Nakagawa T, 2004, NEUROCHEM INT, V45, P203, DOI 10.1016/j.neuint.2003.09.007; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Rustenhoven J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19371; Shandra O, 2019, METHODS MOL BIOL, V1938, P233, DOI 10.1007/978-1-4939-9068-9_16; Sharif A, 2006, ONCOGENE, V25, P4076, DOI 10.1038/sj.onc.1209443; Sharif A, 2012, METHODS MOL BIOL, V814, P137, DOI 10.1007/978-1-61779-452-0_11; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tanti GK, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00333; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765; Verkhratsky A, 2014, CELL TISSUE RES, V357, P493, DOI 10.1007/s00441-014-1814-z; Verkhratsky A, 2010, NEUROCHEM INT, V57, P332, DOI 10.1016/j.neuint.2010.02.002; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wolf F, 2008, SCIENCE, V320, P1597, DOI 10.1126/science.1160122; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	52	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2020	341								108796	10.1016/j.jneumeth.2020.108796			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	MG8SH	WOS:000546302200030	32450111				2022-02-06	
J	Clair, R; Allen, SL; Goodman, A; McCloskey, G				Clair, Ruta; Allen, Sarah Levin; Goodman, Arlene; McCloskey, George			Gender differences in quality of life and symptom expression during recovery from concussion	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Mild traumatic brain injury; PCSS; pediatric; quality of life	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; CHILDREN; SCALE; YOUTH; EPIDEMIOLOGY; MANAGEMENT; DURATION; SEX	Pediatric concussion is a significant health concern for parents, medical providers, and schools. This study was designed to gain insight into gender differences in perspectives of children and adolescents recovering from concussion. Specifically, the study explored whether males and females reported different symptom loads for physical symptoms and quality of life after concussion. The Pediatric Life After Concussion Evaluation Scale (PLACES) and the Post Concussion Symptom Scale (PCSS) were completed by 277 participants ages 9-21, with a mean age of 14.8 years. The sample was 47.5% female and 52.5% male. The study showed that overall, females reported more physical and somatic symptoms (Total PCSS,p = .001), worse quality of life during recovery (PLACES,p = .008), difficulty with cognition (p = .001), and elevated emotional symptoms than males (p = .02). When an interaction between gender and time since injury was considered, there were significant interactions for the PCSS, with females experiencing higher physical and cognitive symptom load during the period spanning 1-12 weeks (1-4 weeks:M = 33.18,SD = 27.03; 5-11 weeks:M = 15.0,SD = 16.76). However, for those individuals experiencing symptoms for longer than 12 weeks, males expressed a higher physical and cognitive symptom load (M = 32.36,SD = 26.59). Findings indicate that there are gender differences in the expression of symptoms and perceptions of quality of life after concussion.	[Clair, Ruta] Cabrini Univ, Dept Psychol, 610 King Prussia Rd, Radnor, PA 19087 USA; [Allen, Sarah Levin; McCloskey, George] Philadelphia Coll Osteopath Med, Dept Psychol, Philadelphia, PA USA; [Goodman, Arlene] St Peters Sports Med Inst, Somerset, NJ USA		Clair, R (corresponding author), Cabrini Univ, Dept Psychol, 610 King Prussia Rd, Radnor, PA 19087 USA.	Ruta.Dr.Clair@cabrini.edu	Clair, Ruta/AAT-3097-2021				Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Clair R. M., 2016, M AM AC CLIN NEUR; Clair R. M., 2016, M 9 WORLD C NEUR; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Crowe L, 2016, BRIT J SPORT MED, V50, P311, DOI 10.1136/bjsports-2015-094663; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Gerrald L., 2018, M INT NEUR SOC; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Purcell L, 2016, CLIN PEDIATR, V55, P452, DOI 10.1177/0009922815589915; Raikes A., 2015, CURRENT RES CONCUSSI, V2, P25; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Valovich McLeod TC, 2015, KINESIOL REV, V4, P131, DOI DOI 10.1123/KR.2015-0007; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	41	5	5	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	JUL 2	2020	9	3					206	214		10.1080/21622965.2018.1556102			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MI0RW	WOS:000547125800002	30822135				2022-02-06	
J	Rapport, LJ; Wong, CG; Hanks, RA				Rapport, Lisa J.; Wong, Christina G.; Hanks, Robin A.			Resilience and well-being after traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; resilience; outcomes; psychosocial; positive psychology	COMMUNITY INTEGRATION MEASURE; POSITIVE PSYCHOLOGY; LIFE SATISFACTION; RATING-SCALE; REHABILITATION; INDIVIDUALS; DEPRESSION; SEVERITY; VALIDITY; ILLNESS	Purpose:This study examined the extent to which resilience is associated with well-being outcomes after traumatic brain injury, and whether those relationships are independent of global personality traits, such as affectivity. Materials and methods:Sixty-seven adults with complicated-mild to severe traumatic brain injury participated. Measures included the Connor-Davidson Resilience Scale, Modified Cumulative Illness Rating Scale, Disability Rating Scale, SF-12 Health Survey, Satisfaction with Life Scale, and Community Integration Measure. Results:Objective physical health and disability showed modest relation to resilience, indicating that adverse health conditions and disability decreased with increasing resilience. The three measures of subjective well-being showed modest-to-strong positive relation to resilience. These correlations between resilience and well-being generally remained significant after accounting for negative and positive affectivity. Results also suggest that the influence of resilience on well-being has a threshold effect: a greater influence on outcome among people with low or inadequate resilience than among people with average or high resilience. Conclusion:The experience of brain injury does not diminish the positive influence resilience may have on long-term well-being. Resilience may function as a buffer to trauma even in the challenging context of cognitive insult. Routine assessment of resilience might be beneficial to the rehabilitation team.	[Rapport, Lisa J.; Wong, Christina G.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523			American Psychological Association, 2010, AM PSYCH ASS ETH PRI; Bertisch H, 2014, NEUROREHABILITATION, V34, P573, DOI 10.3233/NRE-141059; Bodde MI, 2014, DISABIL REHABIL, V36, P838, DOI 10.3109/09638288.2013.822023; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Frain MP, 2008, REHABIL COUNS BULL, V52, P16, DOI 10.1177/0034355208316344; Fredrickson B.L., 1998, REV GEN PSYCHOL, V2, P300, DOI [DOI 10.1037/1089-2680.2.3.300, 10.1037/1089-2680.2.3.300]; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Griffen JA, 2010, REHABIL PSYCHOL, V55, P292, DOI 10.1037/a0020503; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hocomb EM, 2012, ARCH PHYS MED REHAB, V93, P1338, DOI 10.1016/j.apmr.2012.04.029; Jacobsson L, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0405-y; Johnston-Brooks CH, 2002, PSYCHOSOM MED, V64, P43, DOI 10.1097/00006842-200201000-00007; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Min JA, 2014, DISABIL REHABIL, V36, P1196, DOI 10.3109/09638288.2013.834985; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Nalder E, 2019, DISABIL REHABIL, V41, P2708, DOI 10.1080/09638288.2018.1474495; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Ostir GV, 2000, J AM GERIATR SOC, V48, P473, DOI 10.1111/j.1532-5415.2000.tb04991.x; Pavot W, 1993, PSYCHOL ASSESSMENT, V5, P117; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Richman LS, 2005, HEALTH PSYCHOL, V24, P422, DOI 10.1037/0278-6133.24.4.422; Roebuck-Spencer TM, 2010, CASEBOOK CLIN NEUROP, P213; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Sarre S, 2014, DISABIL REHABIL, V36, P716, DOI 10.3109/09638288.2013.814724; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Sherer M, 2015, REHABIL PSYCHOL, V60, P138, DOI 10.1037/rep0000030; Silverman AM, 2017, DISABIL REHABIL, V39, P14, DOI 10.3109/09638288.2016.1138556; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Southwick SM, 2012, RESILIENCE: THE SCIENCE OF MASTERING LIFE'S GREATEST CHALLENGES, P1; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Stoner CR, 2015, DEMENT GERIATR COGN, V40, P340, DOI 10.1159/000439044; TEASDALE G, 1978, ANESTHESIOLOGY, V49, P225, DOI 10.1097/00000542-197809000-00023; Tugade MM, 2004, J PERS SOC PSYCHOL, V86, P320, DOI 10.1037/0022-3514.86.2.320; Wardlaw C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00563; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WechslerD, 2001, WECHSLER TEST ADULT; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wright LJ, 2008, ANN BEHAV MED, V36, P70, DOI 10.1007/s12160-008-9048-5; Yi JP, 2008, BRIT J HEALTH PSYCH, V13, P311, DOI 10.1348/135910707X186994	55	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 2	2020	42	14					2049	2055		10.1080/09638288.2018.1552327			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MJ3NG	WOS:000547997700015	31155974				2022-02-06	
J	Snell, DL; Martin, R; Surgenor, LJ; Siegert, RJ; Hay-Smith, EJC; Melzer, TR; Anderson, TJ; Hooper, GJ				Snell, Deborah L.; Martin, Rachelle; Surgenor, Lois J.; Siegert, Richard J.; Hay-Smith, E. Jean C.; Melzer, Tracy R.; Anderson, Tim J.; Hooper, Gary J.			Wrestling with uncertainty after mild traumatic brain injury: a mixed methods study	DISABILITY AND REHABILITATION			English	Article						Mild traumatic brain injury; MTBI; educational interventions; injury recovery expectations	CONCUSSION SYMPTOMS QUESTIONNAIRE; MINOR HEAD-INJURY; COLLABORATING-CENTER; HOSPITAL ANXIETY; TASK-FORCE; DEPRESSION SCALE; POSTCONCUSSION SYNDROME; PSYCHOLOGICAL-FACTORS; PERCEPTION; RISK	Purpose:Our objective was to explore the intersection between mild traumatic brain injury (MTBI) recovery experiences and injury understandings, using both quantitative and qualitative methods. Materials and Methods:The quantitative component was a descriptive case-control study comparing participants (n = 76) who had recovered or not recovered after an MTBI, across demographic and psychological variables. A subset of participants (n = 10) participated in a semi-structured interview to explore experiences of recovery in more detail. We followed threads across the datasets to integrate findings from component methods. Results:The quantitative analyses revealed differences between the two groups in terms of injury recovery understandings and expectations. The qualitative analyses suggested that achieving consistency across information sources was important. By tracing threads back and forth between the component datasets, we identified a super-ordinate meta-theme that captured participants' experiences of wrestling with uncertainty about their recovery and the impacts in terms of heightened anxiety, confusion, and feelings of invalidation. Conclusion:The effectiveness of psychoeducation and reassurance after MTBI may be optimized when content is tailored to the individual. Clinicians are urged to attend both to the subjective interpretations patients make of information gained from formal and informal, internal and external sources, and where information across these sources conflicts and creates uncertainty.	[Snell, Deborah L.] Burwood Hosp, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.; Hooper, Gary J.] Univ Otago, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand; [Martin, Rachelle; Hay-Smith, E. Jean C.] Univ Otago, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Surgenor, Lois J.] Univ Otago, Dept Psychol Med, Christchurch, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Studies, Auckland, New Zealand; [Melzer, Tracy R.; Anderson, Tim J.] Univ Otago, Dept Med, Christchurch, New Zealand; [Melzer, Tracy R.; Anderson, Tim J.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Melzer, Tracy R.; Anderson, Tim J.] Brain Res New Zealand Ctr Res Excellence, Auckland, New Zealand		Snell, DL (corresponding author), Univ Otago, Christchurch, New Zealand.	debbie.snell@otago.ac.nz		Martin, Rachelle/0000-0002-9533-3195			Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Driskell LD, 2016, REHABIL PSYCHOL, V61, P112, DOI 10.1037/rep0000079; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; IBM Corp, 2016, IBM SPSS STAT MAC VE; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2018, J NEUROTRAUM, V35, P1156, DOI 10.1089/neu.2017.5402; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Miller W.R., 2002, MOTIVATIONAL INTERVI; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Norton S, 2013, J PSYCHOSOM RES, V74, P74, DOI 10.1016/j.jpsychores.2012.10.010; NZGG, 2006, TRAUM BRAIN INJ DIAG; O'Cathain A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-85; O'Cathain Alicia, 2010, BMJ, V341, pc4587, DOI 10.1136/bmj.c4587; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Snell D, 2018, BRAIN INJURY, V1, P1; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2011, J HEAD TRAUMA REHAB, V26, P468, DOI 10.1097/HTR.0b013e3181fc5e1e; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	62	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	JUL 2	2020	42	14					1942	1953		10.1080/09638288.2018.1542461			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	MJ3NG	WOS:000547997700002	30676112				2022-02-06	
J	Brennan, PM; Murray, GD; Teasdale, GM				Brennan, Paul M.; Murray, Gordon D.; Teasdale, Graham M.			A practical method for dealing with missing Glasgow Coma Scale verbal component scores	JOURNAL OF NEUROSURGERY			English	Article						Glasgow Coma Scale; GCS; head injury; missing data; verbal score; traumatic brain injury	LINEAR-REGRESSION PREDICTION; TRAUMATIC BRAIN-INJURY; INTUBATED PATIENTS; IMPACT; EYE	OBJECTIVE The Glasgow Coma Scale (GCS) is used for the assessment of impaired consciousness; however, it is not always possible to test each component, most commonly the verbal component. This affects the derivation of the GCS sum score, which has a role in systems for predicting patient outcome. Imputation of missing scores does not add extra information, but it does allow use of tools for predicting outcome that require complete data. The authors devised a simple and practical tool to employ when verbal component data are missing. They then assessed the tool's utility by application to the GCS-Pupils plus age plus CT findings (GCS-PA CT) prognostic model. METHODS The authors inspected data from the International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (IMPACT) cohort to characterize the frequency of missing verbal scores. The authors identified a single verbal score to impute for each eye and motor combined sum (EM) score from distributions of verbal scores in a published database of 54,069 patients. The effectiveness of the imputed verbal score was assessed using a dataset containing information from the IMPACT and Corticosteroid Randomisation After Significant Head Injury (CRASH) data-bases. The authors compared the performance of the prognostic model using actual verbal scores with the performance using imputed verbal scores and assessed the information yield using Nagelkerke's R-2 statistic. RESULTS Verbal data were most commonly missing in patients with no eye opening and with a motor score of 4 or less. The "simple" imputation model that was developed performed as well as a more complex model involving distinct combinations of eye and motor scores. The imputation model consisted of the following: EM scores 2-6, add 1; EM score 7, add 2; EM score 8 or 9, add 4; and EM score 10, add 5 to provide the GCS sum score. Modeling without information about the verbal score reduced the R-2 from 32.1% to 31.4% and from 34.9% to 34.0% for predictions of death and favorable outcome at 6 months, respectively, compared with using full verbal score information. CONCLUSIONS This strategy is particularly valuable for imputation in clinical practice, enabling clinicians to make a rapid and reliable determination of the GCS sum score when the verbal component is not testable. This will support clinical communication and decisions based on estimates of injury severity as well as enable estimation of prognosis. The authors suggest that external validation of their imputation strategy and the performance of the GCS-PA charts should be undertaken in other clinical populations.	[Brennan, Paul M.] Univ Edinburgh, Ctr Clin Brain Sci, Translat Neurosurg, Edinburgh, Midlothian, Scotland; [Murray, Gordon D.] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Teasdale, Graham M.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland		Brennan, PM (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Translat Neurosurg, Edinburgh, Midlothian, Scotland.	paul.brennan@ed.ac.uk		Brennan, Paul/0000-0002-7347-830X	Muriel Cooke bequest	The authors report support from a Muriel Cooke bequest to the University of Glasgow for incidental costs.	BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Cheng K, 2017, J NEUROTRAUM, V34, P1603, DOI 10.1089/neu.2016.4657; Glance LG, 2009, ANN SURG, V249, P143, DOI 10.1097/SLA.0b013e31818e544b; Hannan EL, 2000, J TRAUMA, V48, P76, DOI 10.1097/00005373-200001000-00013; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; JENNETT B, 1976, LANCET, V1, P1031; Kappen Teus H, 2018, Diagn Progn Res, V2, P11, DOI 10.1186/s41512-018-0033-6; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1984, CRIT CARE MED, V12, P975; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Murray GD, 2018, J NEUROSURG, V128, P1621, DOI 10.3171/2017.12.JNS172782; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; O'Reilly GM, 2012, INJURY, V43, P1917, DOI 10.1016/j.injury.2012.07.185; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Teasdale G, 2014, NURS TIMES, V110, P12; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6	29	5	5	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2020	135	1					214	219		10.3171/2020.6.JNS20992			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TH0UB	WOS:000671809600002	32898843	Green Submitted			2022-02-06	
J	Che, XR; Wang, YJ; Zheng, HY				Che, Xiao-ru; Wang, Yong-jie; Zheng, Hai-yan			Prognostic value of intracranial pressure monitoring for the management of hypertensive intracerebral hemorrhage following minimally invasive surgery	WORLD JOURNAL OF EMERGENCY MEDICINE			English	Article						Hypertensive intracerebral hemorrhage; Intracranial pressure; Minimally invasive surgery	TRAUMATIC BRAIN-INJURY; MORTALITY; HEMATOMA; IMPACT	BACKGROUND: The incidence of hypertensive intracerebral hemorrhage (HICH) has been increasing during the recent years in low- and middle-income countries. With high mortality and morbidity rates, it brings huge burden to the families. It lacks evidence regarding the application of intracranial pressure (ICP) monitoring in HICH. In the current study, the authors aimed to evaluate whether ICP monitoring could make any difference on the prognosis of HICH patients after minimally invasive surgery. METHODS: A retrospective review of 116 HICH patients admitted to the Second Affiliated Hospital of Zhejiang University School of Medicine, between 2014 and 2016, was performed. The effects of ICP monitoring on 6-month mortality and favorable outcomes were evaluated by univariate and logistic regression analysis. RESULTS: ICP monitors were inserted into 50 patients. Patients with ICP monitoring had a significantly better outcome (P<0.05). The average in-hospital duration in patients with ICP monitoring was shorter than that in the patients without ICP monitoring (16.68 days vs. 20.47 days, P<0.05). Mortality rates between ICP monitoring and no ICP monitoring did not differ significantly (16.0% vs. 15.1%, P=0.901). On univariate analysis, age, Glasgow Coma Scale (GCS) on admission and presence of ICP monitor were independent predictors of 6-month favorable outcomes. CONCLUSION: ICP monitoring is associated with a better 6-month functional outcome compared with no ICP monitoring. Future study is still needed to confirm our results and elucidate which subgroup of HICH patients will benefit most from the minimally invasive surgical intervention and ICP monitoring.	[Che, Xiao-ru; Zheng, Hai-yan] Zhejiang Prov Peoples Hosp, Dept Cardiol, Hangzhou, Peoples R China; [Che, Xiao-ru] Hangzhou Med Coll, Dept Cardiol, Peoples Hosp, Hangzhou, Peoples R China; [Wang, Yong-jie] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China; [Zheng, Hai-yan] Zhejiang Univ, Affiliated Hosp 4, Sch Med, Dept Neurosurg, Yiwu, Peoples R China		Zheng, HY (corresponding author), Zhejiang Prov Peoples Hosp, Dept Cardiol, Hangzhou, Peoples R China.; Zheng, HY (corresponding author), Zhejiang Univ, Affiliated Hosp 4, Sch Med, Dept Neurosurg, Yiwu, Peoples R China.	zhengzbb@163.com					Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Badheka A, 2019, WORLD J EMERG MED, V10, P187, DOI 10.5847/wjem.j.1920-8642.2019.03.010; Chesnut RM, 2012, NEUROSURGERY, V71, P1055, DOI 10.1227/NEU.0b013e31827276b7; Di Ieva A, 2013, NEUROSCIENTIST, V19, P592, DOI 10.1177/1073858412474845; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; El Muntasar A, 2018, WORLD J EMERG MED, V9, P85, DOI 10.5847/wjem.j.1920-8642.2018.02.001; Ferrete-Araujo AM, 2015, MED INTENSIVA, V39, P422, DOI 10.1016/j.medin.2014.10.008; Li SS, 2019, INTERACT COMPUT, V31, P1, DOI 10.1093/iwc/iwz001; Maas A, 2016, NEUROSURGERY, V78, P368; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Moussa WMM, 2017, NEUROSURG REV, V40, P115, DOI 10.1007/s10143-016-0743-6; Rennert RC, 2015, EXPERT REV NEUROTHER, V15, P919, DOI 10.1586/14737175.2015.1059755; Rincon F, 2010, CURR OPIN NEUROL, V23, P59, DOI 10.1097/WCO.0b013e3283352c01; Ritsma B, 2014, CASE REP NEUROL MED, V2014, DOI 10.1155/2014/102307; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Sykora M, 2014, J NEUROL SCI, V342, P141, DOI 10.1016/j.jns.2014.05.012; Todd SR, 2015, AM J SURG, V210, P1086; Velnar T, 2018, BOSNIAN J BASIC MED, V18, P375, DOI 10.17305/bjbms.2017.2289; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050; Zhang HT, 2013, J CRANIOFAC SURG, V24, P2073, DOI 10.1097/SCS.0b013e3182a4c2dd; Zhou HG, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-76	22	5	6	1	8	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	SECOND AFFILIATED HOSPITAL, 88 JIEFANG RD, HANGZHOU, 310009, PEOPLES R CHINA	1920-8642			WORLD J EMERG MED	World J. Emerg. Med.	JUL	2020	11	3					169	173		10.5847/wjem.j.1920-8642.2020.03.007			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LE8EN	WOS:000526956500007	32351650	Green Published, Bronze			2022-02-06	
J	Iverson, KM; Sayer, NA; Meterko, M; Stolzmann, K; Suri, P; Gormley, K; Seibert, MN; Yan, K; Pogoda, TK				Iverson, Katherine M.; Sayer, Nina A.; Meterko, Mark; Stolzmann, Kelly; Suri, Pradeep; Gormley, Katelyn; Seibert, Marjorie Nealon; Yan, Kun; Pogoda, Terri K.			Intimate Partner Violence Among Female OEF/OIF/OND Veterans Who Were Evaluated for Traumatic Brain Injury in the Veterans Health Administration: A Preliminary Investigation	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article						concussion; mental health; partner abuse; reintegration; women veterans	WOMEN VETERANS; MENTAL-HEALTH; PSYCHIATRIC DIAGNOSES; GENDER-DIFFERENCES; IRAQI FREEDOM; SUBSTANCE USE; US MILITARY; CARE NEEDS; ASSOCIATION; PREFERENCES	Many female veterans have deployed to Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND), and some experience traumatic brain injury (TBI). Although TBI is increasingly recognized as an important health issue for female OEF/OIF/OND veterans, there is little attention to stressful experiences that may exacerbate health problems or hinder recovery among veterans who may have experienced TBI. Lifetime intimate partner violence (IPV) is common among general samples of female veterans. Given the negative implications of IPV on women's health, it is important to understand whether there is a relationship between lifetime IPV and health functioning among female veterans who have experienced possible TBI. This study provides an exploration of lifetime IPV and its associations with physical and mental health, as well as community reintegration, among female OEF/OIF/OND veterans who have been evaluated for TBI. The sample comprised 127 female veterans who participated in a larger study that examined reintegration among OEF/OIF/OND veterans who received a TBI evaluation in the Veterans Heath Administration (VHA) and completed an assessment of lifetime IPV. Primary and secondary data sources included survey responses (e.g., health symptoms and reintegration) and VHA administrative data (e.g., health diagnoses). Results indicated that nearly two thirds (63.0%) of women who completed a TBI evaluation reported lifetime IPV, though clinician-confirmed TBI was not associated with IPV. Women who experienced IPV, compared with those who did not, reported higher levels of neurobehavioral symptoms and were significantly more likely to have diagnoses of back pain (48.6% vs. 30.0%, respectively) and substance abuse (12.2% vs. 0%, respectively). Notwithstanding, women with and without lifetime IPV reported similar levels of reintegration. Findings provide evidence that lifetime IPV may be common among female OEF/OIF/OND veterans who are evaluated for TBI, and that IPV is associated with several treatable health problems among this population.	[Iverson, Katherine M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Womens Hlth Sci Div, Boston, MA 02130 USA; [Iverson, Katherine M.; Stolzmann, Kelly; Gormley, Katelyn; Seibert, Marjorie Nealon; Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA 02130 USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sayer, Nina A.] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Sayer, Nina A.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Sayer, Nina A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Meterko, Mark] VHA Off Reporting Analyt Performance Improvement, Performance Measurement, Bedford, MA USA; [Meterko, Mark; Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Suri, Pradeep] VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr ERIC, Washington, DC USA; [Suri, Pradeep] VA Puget Sound Hlth Care Syst, Div Rehabil Care Serv, Washington, DC USA; [Suri, Pradeep] Univ Washington, Rehabil Med, Seattle, WA 98195 USA; [Yan, Kun] Northern Calif VA Healthcare Syst, Sacramento, CA USA		Iverson, KM (corresponding author), VA Boston Healthcare Syst, 150 S Huntington Ave,116B-3, Boston, MA 02130 USA.	katherine.iverson@va.gov	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780	Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development (HSRD) servicesUS Department of Veterans Affairs [IIR 11-078]; Dr. Iverson's HSR&D Career Development Award [CDA 10-029]; Presidential Early Career Award for Scientists and EngineersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [USA 14-275]; Dr. Iverson's fellowship with the Implementation Research Institute (IRI), at the George Warren Brown School of Social Work, Washington University in Saint Louis; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5R25MH08091607]; VA HSR&D Service, Quality Enhancement Research Initiative	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development (HSR&D) services (IIR 11-078) awarded to Dr. Pogoda. In addition, this work was supported by Dr. Iverson's HSR&D Career Development Award (CDA 10-029) and her Presidential Early Career Award for Scientists and Engineers (USA 14-275). The preparation of this article was also supported in part by Dr. Iverson's fellowship with the Implementation Research Institute (IRI), at the George Warren Brown School of Social Work, Washington University in Saint Louis; through an award from the National Institute of Mental Health (5R25MH08091607) and VA HSR&D Service, Quality Enhancement Research Initiative. This material is also the result of work supported with resources and the use of facilities at the VA Boston Healthcare System and computer resources for manuscript preparation at the VA Northern California Health Care System in Sacramento, California (Dr. Yan).	Amara J, 2014, WOMEN HEALTH ISS, V24, pE171, DOI 10.1016/j.whi.2013.12.004; [Anonymous], 2016, IEEE ASME T MECHATRO, VPP, P1; Black M C., 2011, NATL INTIMATE PARTNE; Breiding MJ, 2008, AM J PREV MED, V34, P112, DOI 10.1016/j.amepre.2007.10.001; Campbell JC, 2003, VIOLENCE AGAINST WOM, V9, P1072, DOI 10.1177/1077801203255291; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chavez LJ, 2012, J STUD ALCOHOL DRUGS, V73, P391, DOI 10.15288/jsad.2012.73.391; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Cucciare MA, 2016, WOMEN HEALTH ISS, V26, P232, DOI 10.1016/j.whi.2015.07.010; Cucciare MA, 2013, J ADDICT DIS, V32, P119, DOI 10.1080/10550887.2013.795465; Dardis CM, 2017, PSYCHOL TRAUMA-US, V9, P67, DOI 10.1037/tra0000171; Defense Manpower Data Center, 2016, ACT DUT MIL PERS SER; Dichter M.E., 2013, MILITARY BEHAV HLTH, V1, P107, DOI [10.1080/21635781.2013.830062, DOI 10.1080/21635781.2013.830062]; Dichter ME, 2018, J INTERPERS VIOLENCE, V33, P843, DOI 10.1177/0886260516669166; Dichter ME, 2015, WOMEN HEALTH ISS, V25, P555, DOI 10.1016/j.whi.2015.06.006; Dichter ME, 2014, SOC WORK MENT HEALTH, V12, P411, DOI 10.1080/15332985.2013.870104; Dichter ME, 2011, WOMEN HEALTH ISS, V21, pS190, DOI 10.1016/j.whi.2011.04.008; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Frayne S, 2014, SOURCEBOOK WOMEN VET, V3; Gerber MR, 2014, J WOMENS HEALTH, V23, P302, DOI 10.1089/jwh.2013.4513; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, 2011, CLIN PREV SERV WOM C; Iverson K. M., 2012, RETRAUMATIZATION ASS, P253; Iverson KM, 2016, GEN HOSP PSYCHIAT, V40, P33, DOI 10.1016/j.genhosppsych.2016.03.001; Iverson KM, 2015, J AM BOARD FAM MED, V28, P772, DOI 10.3122/jabfm.2015.06.150154; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2014, RES NURS HEALTH, V37, P302, DOI 10.1002/nur.21602; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kimerling R, 2016, J GEN INTERN MED, V31, P888, DOI 10.1007/s11606-016-3701-7; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Latta RE, 2016, J FAM VIOLENCE, V31, P595, DOI 10.1007/s10896-016-9798-y; Maguen S, 2010, AM J PUBLIC HEALTH, V100, P2450, DOI 10.2105/AJPH.2009.166165; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; National Center for Veterans Analysis and Statistics, 2015, VET POP; Pogoda T. K., 2016, 2016 ANN RES M ACADE; Ritchie E.C., 2015, WOMEN AT WAR; Rogers TJ, 2014, BRAIN INJURY, V28, P1406, DOI 10.3109/02699052.2014.919537; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J TRAUMA STRESS, V24, P660, DOI 10.1002/jts.20706; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Tanielian T., 2008, INVISIBLE WOUNDS WAR, V2009; Timko C, 2016, J CLIN NURS, V25, P3131, DOI 10.1111/jocn.13244; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Veterans Health Administration Domestic Violence Task Force, 2013, PLAN IMPL DOM VIOL I; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Washington DL, 2015, MED CARE, V53, pS23, DOI 10.1097/MLR.0000000000000312; World Health Organization, 2000, DIS ASS SCHED 2 WHOD	59	5	5	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence	JUL	2020	35	13-14					2422	2445		10.1177/0886260517702491			24	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	LU9YF	WOS:000538101300003	29294714				2022-02-06	
J	Koo, AB; Elsamadicy, AA; David, WB; Zogg, CK; Santarosa, C; Sujijantarat, N; Robert, SM; Kundishora, AJ; Cord, BJ; Hebert, R; Bahrassa, F; Ajay, M; Matouk, CC				Koo, Andrew B.; Elsamadicy, Aladine A.; David, Wyatt B.; Zogg, Cheryl K.; Santarosa, Corrado; Sujijantarat, Nanthiya; Robert, Stephanie M.; Kundishora, Adam J.; Cord, Branden J.; Hebert, Ryan; Bahrassa, Farhad; Ajay, Malhotra; Matouk, Charles C.			Thirty- and 90-Day Readmissions After Treatment of Traumatic Subdural Hematoma: National Trend Analysis	WORLD NEUROSURGERY			English	Article						Readmissions; Subdural hematoma; Trauma	HOSPITALIZATION; ASSOCIATION; MANAGEMENT; RATES	OBJECTIVE: Subdural hematoma (SDH), a form of traumatic brain injury, is a common disease that requires extensive patient management and resource utilization; however, there remains a paucity of national studies examining the likelihood of readmission in this patient population. The aim of this study is to investigate differences in 30- and 90-day readmissions for treatment of traumatic SDH using a nationwide readmission database. METHODS: The Nationwide Readmission Database years 2013-2015 were queried. Patients with a diagnosis of traumatic SDH and a primary procedure code for incision of cerebral meninges for drainage were identified using the International Classification of Diseases, Ninth Revision, Clinical Modification coding system. Patients were grouped by no readmission (Non-R), readmission within 30 days (30-R), and readmission within 31-90 days (90-R). RESULTS: We identified a total of 14,355 patients, with 3106 (21.6%) patients encountering a readmission (30-R: n = 2193 [15.3%]; 90-R: n = 913 [6.3%]; Non-R: n = 11,249). The most prevalent 30- and 90-day diagnoses seen among the readmitted cohorts were postoperative infection (30-R: 10.5%, 90-R: 13.0%) and epilepsy (30-R: 3.7%, 90-R: 1.1%). On multivariate logistic regression analysis, Medicare, Medicaid, hypertension, diabetes, renal failure, congestive heart failure, and coagulopathy were independently associated with 30-day readmission; Medicare and rheumatoid arthritis/collagen vascular disease were independently associated with 90-day readmission. CONCLUSIONS: In this study, we determine the relationship between readmission rates and complications associated with surgical intervention for traumatic subdural hematoma.	[Koo, Andrew B.; Elsamadicy, Aladine A.; David, Wyatt B.; Zogg, Cheryl K.; Santarosa, Corrado; Sujijantarat, Nanthiya; Robert, Stephanie M.; Kundishora, Adam J.; Cord, Branden J.; Hebert, Ryan; Bahrassa, Farhad; Matouk, Charles C.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Ajay, Malhotra; Matouk, Charles C.] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA		Matouk, CC (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.; Matouk, CC (corresponding author), Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA.	charles.matouk@yale.edu		Cord, Branden/0000-0002-9120-5989	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001863] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F30 AG066371] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM007205] Funding Source: Medline		[Anonymous], 2018, NAT READM DAT; Awan AS, 2019, J UROL SURG, V6, P1, DOI 10.4274/jus.galenos.2018.2032; Brito A, 2019, J SURG RES, V244, P332, DOI 10.1016/j.jss.2019.06.071; Court J, 2019, CLIN NEUROL NEUROSUR, V186, DOI 10.1016/j.clineuro.2019.105464; Dickinson H, 2015, J NEUROSURG, V122, P61, DOI 10.3171/2014.8.JNS1498; Dumont TM, 2013, WORLD NEUROSURG, V80, P889, DOI 10.1016/j.wneu.2012.06.026; Epstein AM, 2009, NEW ENGL J MED, V360, P1457, DOI 10.1056/NEJMe0901006; Franko LR, 2018, J NEUROSURG, V129, P1008, DOI 10.3171/2017.6.JNS17188; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Guido D, 2015, AGING CLIN EXP RES, V27, P849, DOI 10.1007/s40520-015-0360-1; Ho T, 2019, INT J SURG OPEN, V20, P20, DOI 10.1016/j.ijso.2019.09.007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Konig SA, 2003, ACTA NEUROL SCAND, V107, P110, DOI 10.1034/j.1600-0404.2003.01340.x; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Mellergard P, 1996, ACTA NEUROCHIR, V138, P708, DOI 10.1007/BF01411476; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; Morris NA, 2016, NEUROCRIT CARE, V24, P226, DOI 10.1007/s12028-015-0178-x; Rumalla K, 2018, NEUROSURGERY, V82, P441, DOI 10.1093/neuros/nyx289; Schmidt LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136023; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Song Dae Hyo, 2014, Korean J Neurotrauma, V10, P41, DOI 10.13004/kjnt.2014.10.2.41; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Teo DB, 2018, INTERN MED J, V48, P1048, DOI 10.1111/imj.13794; Tsermoulas G, 2016, WORLD NEUROSURG, V88, P569, DOI 10.1016/j.wneu.2015.10.045; Wasfie T, 2017, AM SURGEON, V83, pE231; You WD, 2018, ACTA NEUROCHIR, V160, P893, DOI 10.1007/s00701-018-3513-0	29	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUL	2020	139						E212	E219		10.1016/j.wneu.2020.03.168			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	MM7MI	WOS:000550337100024	32272271	Green Accepted			2022-02-06	
J	Rietdijk, R; Power, E; Attard, M; Heard, R; Togher, L				Rietdijk, Rachael; Power, Emma; Attard, Michelle; Heard, Robert; Togher, Leanne			A Clinical Trial Investigating Telehealth and In-Person Social Communication Skills Training for People With Traumatic Brain Injury: Participant-Reported Communication Outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregivers; clinical trial; cognitive communication disorder; family; self-report; social communication disorder; speech-language pathology; telehealth; telemedicine; traumatic brain injuries	ADULTS; COGNITION; PARTNERS; RELIABILITY; MANAGEMENT; DISORDERS; VALIDITY; SUPPORT; ABILITY; TBI	Objective: To investigate the efficacy of telehealth-based and in-person social communication skills training (TBIconneCT) for people with moderate to severe traumatic brain injury (TBI) based on outcomes reported by the survivor and a close communication partner. Setting: Australia. Two telehealth dyads were located outside Australia. Participants: Adults (n= 51) at least 6 months after moderate-severe TBI with social communication skills deficits, and their usual communication partners (family members, friends, or paid carers). Design: Partially randomized controlled trial, with a telehealth intervention group, in-person intervention group, and a historical control group. Main Measures: La Trobe Communication Questionnaire (LCQ) (total score, and number of items with perceived positive change). Both self- and other-reports. Results: Trained participants had significantly more items with perceived positive change than did historical controls. A medium effect size in the sample was observed for improvements in total score reported by trained communication partners after treatment. Comparisons between telehealth and in-person groups found medium to large effect sizes in the sample, favoring the telehealth group on some LCQ variables. Conclusions: Whether delivered via telehealth or in-person, social communication skills training led to perceived positive change in communication skills. It was unexpected that outcomes for the telehealth group were better than for the in-person group on some variables.	[Rietdijk, Rachael; Power, Emma; Attard, Michelle; Heard, Robert; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW 1826, Australia; [Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW 1826, Australia.	rman7827@uni.sydney.edu.au	Togher, Leanne/AAC-7083-2019; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406	Australian Postgraduate AwardAustralian Government	This research was supported by a grant from icare NSW and an Australian Postgraduate Award.	Appleton S, 2011, BRAIN IMPAIR, V12, P210; Australian Bureau of Statistics, AUSTR STAT GEOGR STA; Australian Government, HLTH WORKF LOC; Avramovic P, 2017, BRAIN INJURY, V31, P502, DOI 10.1080/02699052.2017.1280854; Behn N, 2019, INT J LANG COMM DIS, V54, P465, DOI 10.1111/1460-6984.12452; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Chang HF, 2018, INT J LANG COMM DIS, V53, P1094, DOI 10.1111/1460-6984.12421; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2019, NEUROPSYCHOL REHABIL, V29, P73, DOI 10.1080/09602011.2016.1259114; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Faul F, 2008, G POWER SAMPLE SIZE; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Harrison-Felix C, 2018, ARCH PHYS MED REHAB, V99, P2131, DOI 10.1016/j.apmr.2018.05.030; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Lohne C, 2018, NAT HIST COLLECTION, P37, DOI 10.1007/978-3-319-44321-8_5; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Meulenbroek P, 2019, INT J SPEECH-LANG PA, V21, P128, DOI 10.1080/17549507.2019.1583281; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rietdijk R, J SPEECH LANG HEAR R; Rietdijk R, 2020, BRAIN IMPAIR, V21, P110, DOI 10.1017/BrImp.2019.9; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Rietdijk R, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000282; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L., 2010, TBI EXPRESS SOCIAL C; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, BRAIN IMPAIR, V14, P130, DOI 10.1017/BrImp.2013.3; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Welkowitz J., 1976, INTRO STAT BEHAV SCI; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663	45	5	5	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		241	253		10.1097/HTR.0000000000000554			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300001	31996605	Bronze			2022-02-06	
J	Salazar, LRM; Agrawal, D; Deora, H; Agrawal, A				Salazar, Luis Rafael Moscote; Agrawal, Deepak; Deora, Harsh; Agrawal, Amit			Neurotrauma in the Time of SARS-COV 2: A Checklist for Its Safe Management	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						neurotrauma; COVID-19; pandemic; coronavirus		Neurotrauma is a critical public health problem that deserves the attention of the world health community. The unprecedented pandemic of SARS-COV 2 has led to a tremendous strain on medical facilities including intensive care and availability of blood products. In addition, due to lockdown in most nations and diverting of medical attention elsewhere, neurotrauma has taken a back seat. Despite this, any case of trauma presenting during this time should receive the best possible care. However, it is also imperative to safeguard the health care workers from this infection, too. The number of health care workers losing their lives to this infection is ever rising. We here present a possible workflow using a checklist approach such that errors and cross-infections are minimized and there is no reduction in the level of care received by any trauma case. This article has been written with a special focus on middle-income countries where resources may already be strained due to the sudden case burden. We hope to minimize death "caused" by COVID-19 and "related" to it.	[Salazar, Luis Rafael Moscote] Univ Surcolombiana, Fac Med, Neiva, Colombia; [Agrawal, Deepak] All India Inst Med Sci, Dept Neurosurg & Gamma Knife, New Delhi, India; [Deora, Harsh] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India; [Agrawal, Amit] All India Inst Med Sci, Dept Neurosurg, Bhopal, Madhya Pradesh, India		Deora, H (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore, Karnataka, India.	demo5601@gmail.com	DEORA, HARSH/A-5817-2019; Agrawal, Amit/C-1511-2011	DEORA, HARSH/0000-0003-3247-1117; Agrawal, Amit/0000-0002-3287-5448			Chua Charleston, 2010, J Trauma Nurs, V17, P163, DOI 10.1097/JTN.0b013e3181fb38a6; de Vries EN, 2009, QUAL SAF HEALTH CARE, V18, P121, DOI 10.1136/qshc.2008.027524; de Vries EN, 2011, ANN SURG, V253, P624, DOI 10.1097/SLA.0b013e3182068880; Honeybul S, 2013, J NEUROSCI RURAL PRA, V4, P33, DOI 10.4103/0976-3147.105607; Tan YT, 2020, CURR MED SCI, V40, P281, DOI 10.1007/s11596-020-2173-5	5	5	5	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JUL	2020	11	03					474	477		10.1055/s-0040-1712553			4	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	MT2BS	WOS:000554772000023	32753815	Green Published, gold			2022-02-06	
J	Vekaria, HJ; Hubbard, WB; Scholpa, NE; Spry, ML; Gooch, JL; Prince, SJ; Schnellmann, RG; Sullivan, PG				Vekaria, Hemendra J.; Hubbard, W. Brad; Scholpa, Natalie E.; Spry, Malinda L.; Gooch, Jennifer L.; Prince, Sydney J.; Schnellmann, Rick G.; Sullivan, Patrick G.			Formoterol, a beta(2)-adrenoreceptor agonist, induces mitochondrial biogenesis and promotes cognitive recovery after traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Mitochondrial bioenergetics; PGC1-alpha; Novel object recognition; Controlled cortical impact; Calcium buffering	CONTROLLED CORTICAL IMPACT; SPINAL-CORD; NONSYNAPTIC MITOCHONDRIA; SYNAPTIC MITOCHONDRIA; DYSFUNCTION; CYCLOSPORINE; CALCIUM; DAMAGE; BIOENERGETICS; PHARMACOLOGY	Traumatic brain injury (TBI) leads to acute necrosis at the site of injury followed by a sequence of secondary events lasting from hours to weeks and often years. Targeting mitochondrial impairment following TBI has shown improvements in brain mitochondrial bioenergetics and neuronal function. Recently formoterol, a highly selective beta(2)-adrenoreceptor agonist, was found to induce mitochondrial biogenesis (MB) via G beta gamma-Akt-eNOS-sGC pathway. Activation of MB is a novel approach that has been shown to restore mitochondrial function in several disease and injury models. We hypothesized that activation of MB as a target of formoterol after TBI would mitigate mitochondrial dysfunction, enhance neuronal function and improve behavioral outcomes. TBI-injured C57BL/6 male mice were injected (i.p.) with vehicle (normal saline) or formoterol (0.3 mg/kg) at 15 min, 8 h, 16 h, 24 h and then daily after controlled cortical impact (CCI) until euthanasia. After CCI, mitochondrial copy number and bioenergetic function were decreased in the ipsilateral cortex of the CCI-vehicle group. Compared to CCI-vehicle, cortical and hippocampal mitochondrial respiration rates as well as cortical mitochondrial DNA copy number were increased in the CCI-formoterol group. Mitochondrial Ca2+ buffering capacity in the hippocampus was higher in the CCI-formoterol group compared to CCI-vehicle group. Both assessments of cognitive performance, novel object recognition (NOR) and Morris water maze (MWM), decreased following CCI and were restored in the CCI-formoterol group. Although no changes were seen in the amount of cortical tissue spared between CCI-formoterol and CCI-vehicle groups, elevated levels of hippocampal neurons and improved white matter sparing in the corpus callosum were observed in CCI-formoterol group. Collectively, these results indicate that formoterol-mediated MB activation may be a potential therapeutic target to restore mitochondrial bioenergetics and promote functional recovery after TBI.	[Vekaria, Hemendra J.; Hubbard, W. Brad; Spry, Malinda L.; Gooch, Jennifer L.; Prince, Sydney J.; Sullivan, Patrick G.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, 475 BBSRB,741 South Limestone St, Lexington, KY 40536 USA; [Vekaria, Hemendra J.; Hubbard, W. Brad; Sullivan, Patrick G.] Univ Kentucky, Coll Med, Dept Neurosci, Lexington, KY 40536 USA; [Scholpa, Natalie E.; Schnellmann, Rick G.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Hubbard, W. Brad; Spry, Malinda L.; Gooch, Jennifer L.; Sullivan, Patrick G.] Lexington VA Hlth Care Syst, Lexington, KY USA; [Scholpa, Natalie E.; Schnellmann, Rick G.] SAVAHCS, Tucson, AZ USA		Sullivan, PG (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr SCoBIRC, 475 BBSRB,741 South Limestone St, Lexington, KY 40536 USA.	patsullivan@uky.edu			VA Merit awardUS Department of Veterans Affairs [1I01BX003405-01A1]; Kentucky Spinal Cord and Head Injury Research Trust [15-14A]	This work was supported by VA Merit award 1I01BX003405-01A1 and Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS).	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Cameron RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11030-5; Cameron RB, 2016, J MED CHEM, V59, P10411, DOI 10.1021/acs.jmedchem.6b00669; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; Garrett SM, 2014, J PHARMACOL EXP THER, V350, P257, DOI 10.1124/jpet.114.214700; Geddes JW, 2009, EXP NEUROL, V218, P169, DOI 10.1016/j.expneurol.2009.05.011; Gibbs WS, 2018, AM J PHYSIOL-RENAL, V315, pF1119, DOI 10.1152/ajprenal.00077.2018; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hang WJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01121; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hill RL, 2019, J NEUROTRAUM, V36, P1231, DOI 10.1089/neu.2018.5946; Hill RL, 2018, NEUROSCIENCE, V386, P265, DOI 10.1016/j.neuroscience.2018.06.028; Hubbard WB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45568-3; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hubbard WB, 2018, ACUTE NEURONAL INJUR, P63, DOI [10.1007/978-3-319-77495-4_4, DOI 10.1007/978-3-319-77495-4_4]; Jesinkey SR, 2014, J AM SOC NEPHROL, V25, P1157, DOI 10.1681/ASN.2013090952; Karlsson M, 2019, J NEUROTRAUM, V36, P14, DOI 10.1089/neu.2018.5706; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Krishna G, 2017, BBA-MOL BASIS DIS, V1863, P1204, DOI 10.1016/j.bbadis.2017.03.007; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Lebesgue D, 2006, J NEUROTRAUM, V23, P1814, DOI 10.1089/neu.2006.23.1814; Li X, 2018, J CELL MOL MED, V22, P883, DOI 10.1111/jcmm.13313; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Maxwell W.L., 2015, BRAIN NEUROTRAUMA MO; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2011, BRAIN RES, V1384, P151, DOI 10.1016/j.brainres.2011.01.102; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Peterson YK, 2013, BIOORG MED CHEM LETT, V23, P5376, DOI 10.1016/j.bmcl.2013.07.052; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Qiu L, 2018, BIOMED PHARMACOTHER, V103, P1585, DOI 10.1016/j.biopha.2018.05.003; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Saha P, 2018, NEUROBIOL DIS, V118, P108, DOI 10.1016/j.nbd.2018.07.010; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scholpa NE, 2019, J NEUROTRAUM, V36, P962, DOI 10.1089/neu.2018.5669; Scholpa NE, 2018, BRIT J PHARMACOL, V175, P348, DOI 10.1111/bph.14076; Scholpa NE, 2017, J PHARMACOL EXP THER, V363, P303, DOI 10.1124/jpet.117.244806; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Sullivan PG, 2006, CIRC RES, V99, P109, DOI 10.1161/01.RES.0000234949.61052.9f; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155; Wills LP, 2012, J PHARMACOL EXP THER, V342, P106, DOI 10.1124/jpet.112.191528; Xiong Y, 1997, J NEUROTRAUM, V14, P907, DOI 10.1089/neu.1997.14.907; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007; Yonutas HM, 2015, J BIOENERG BIOMEMBR, V47, P149, DOI 10.1007/s10863-014-9593-5; Youdim Moussa Bh, 2013, Exp Neurobiol, V22, P167, DOI 10.5607/en.2013.22.3.167; Zhu YJ, 2015, J NEUROSCI METH, V254, P73, DOI 10.1016/j.jneumeth.2015.07.022	85	5	5	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2020	140								104866	10.1016/j.nbd.2020.104866			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LV0EP	WOS:000538117900015	32289370	hybrid			2022-02-06	
J	Wei, L; Wen, YT; Thompson, HJ; Liu, CY; Su, YK; Chen, PY; Chen, CY; Chuang, YH; Lin, YJ; Chen, CT; Chen, CC; Chiu, HT; Chiu, HY				Wei, Li; Wen, Ya-Ting; Thompson, Hilaire J.; Liu, Cyong-Yi; Su, Yu-Kai; Chen, Pin-Yuan; Chen, Ching-Yi; Chuang, Yeu-Hui; Lin, Ya-Jui; Chen, Chun-Ting; Chen, Ching-Chang; Chiu, Hsiao-Ting; Chiu, Hsiao-Yean			Sleep Disturbances Following Traumatic Brain Injury in Older Adults: A Comparison Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						older adults; sleep disturbance; traumatic brain injury	MONTREAL COGNITIVE ASSESSMENT; QUALITY-OF-LIFE; DAYTIME SLEEPINESS; PREVALENCE; DISORDERS; VALIDATION; DEPRESSION; PATTERNS; INSOMNIA; FATIGUE	Objectives: To compare the prevalence of sleep disturbances in older adults with traumatic brain injury (TBI) with that of age- and gender-matched controls and to determine the risk factors for post-TBI sleep disturbances and the effects of post-TBI disturbances on quality of life (QOL). Design: Cross-sectional case-comparison study. Participants: Eighty older adults (aged >= 65 years) with first-time TBI more than 3 months since injury and 80 older adults controls without TBI who completed sleep and health-related QOL questionnaires. Results: Older adults with TBI showed a higher prevalence of obstructive sleep apnea (OSA), insomnia, and daytime sleepiness than older adult controls. Being male, having higher levels of depression and pain, and the presence of insomnia were significantly correlated with the risks of OSA, insomnia, and daytime sleepiness following TBI, respectively. Both OSA and insomnia were significantly correlated with low QOL in older adults with TBI. Conclusions: Sleep disturbances are highly prevalent in older adults with TBI. Gender differences, depression severity, and pain level are correlated with the occurrence of post-TBI sleep disturbances. Both OSA and insomnia are regarded as major contributors to low QOL in older people with TBI. Interventions targeted at post-TBI sleep disturbances may improve QOL of older adults.	[Wei, Li; Wen, Ya-Ting] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Wei, Li] Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth, Taipei, Taiwan; [Liu, Cyong-Yi; Chen, Ching-Yi; Chuang, Yeu-Hui; Chiu, Hsiao-Yean] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei 110, Taiwan; [Chiu, Hsiao-Yean] Taipei Med Univ, Res Ctr Sleep Med, Taipei, Taiwan; [Thompson, Hilaire J.] Univ Washington, Biobehav Nursing & Hlth Informat, Seattle, WA 98195 USA; [Thompson, Hilaire J.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Su, Yu-Kai] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Chen, Pin-Yuan] Chang Gung Mem Hosp, Dept Neurosurg, Keelung, Taiwan; [Chen, Pin-Yuan] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Lin, Ya-Jui; Chen, Chun-Ting; Chen, Ching-Chang] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Chiu, Hsiao-Ting] Minist Hlth & Welf, Taoyuan Gen Hosp, Dept Rehabil, Sinwu Branch, Taoyuan, Taiwan		Chiu, HY (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei 110, Taiwan.	hychiu0315@tmu.edu.tw			Taipei Medical University-Wan Fang Hospital [106TMU-WFH-08]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 106-2314-B-038-058-MY3]	This work was supported by the Taipei Medical University-Wan Fang Hospital (106TMU-WFH-08) to L.W., and Ministry of Science and Technology, Taiwan (MOST 106-2314-B-038-058-MY3) to H.Y.C.	Ahn SH, 2013, J CLIN NEUROL, V9, P9, DOI 10.3988/jcn.2013.9.1.9; Alsaadi SM, 2014, CLIN J PAIN, V30, P755, DOI 10.1097/AJP.0000000000000055; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bijur PE, 2003, ACAD EMERG MED, V10, P390, DOI 10.1197/aemj.10.4.390; Brennan C, 2010, J PSYCHOSOM RES, V69, P371, DOI 10.1016/j.jpsychores.2010.04.006; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen NH, 2002, QUAL LIFE RES, V11, P817, DOI 10.1023/A:1020818417949; Chen PY, 2015, J HEAD TRAUMA REHAB, V30, pE50, DOI 10.1097/HTR.0000000000000086; Chiang H-L, 2009, TAIWAN J PSYCHIARY, V23, P43, DOI DOI 10.29478/TJP.200903.0005; Chiu HY, 2016, J AM GERIATR SOC, V64, P2051, DOI 10.1111/jgs.14316; Chiu HY, 2016, J PSYCHOSOM RES, V87, P85, DOI 10.1016/j.jpsychores.2016.06.010; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Helbig AK, 2013, SLEEP MED, V14, P1356, DOI 10.1016/j.sleep.2013.09.004; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lin YN, 2016, J NEUROTRAUM, V33, P1363, DOI 10.1089/neu.2015.4094; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Masel BE, 2001, ARCH PHYS MED REHAB, V82, P1526, DOI 10.1053/apmr.2001.26093; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ono D, 2017, NEUROSCI RES, V118, P74, DOI 10.1016/j.neures.2017.03.013; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; Peeters W, 2017, NEUROEPIDEMIOLOGY, V48, P63, DOI 10.1159/000471877; Phillips BA, 1996, CHEST, V110, P654, DOI 10.1378/chest.110.3.654; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Quintana-Gallego E, 2004, RESP MED, V98, P984, DOI 10.1016/j.rmed.2004.03.002; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saint Martin M, 2014, REJUV RES, V17, P11, DOI 10.1089/rej.2013.1457; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sivertsen B, 2012, PSYCHOSOM MED, V74, P758, DOI 10.1097/PSY.0b013e3182648619; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor Laurie Jowers, 2003, Pain Manag Nurs, V4, P87; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	5	6	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2020	35	4			SI		288	295		10.1097/HTR.0000000000000563			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MR1MK	WOS:000553355300006	32108713				2022-02-06	
J	Woo, PYM; Mak, CHK; Mak, HKF; Tsang, ACO				Woo, Peter Yat Ming; Mak, Calvin Hoi Kwan; Mak, Henry Ka Fung; Tsang, Anderson Chun On			Neurocognitive recovery and global cerebral perfusion improvement after cranioplasty in chronic sinking skin flap syndrome of 18 years: Case report using arterial spin labelling magnetic resonance perfusion imaging	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Cranioplasty; Cerebral perfusion; Arterial spin labeling; MR perfusion; Decompressive craniectomy	DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW; COMPLICATIONS; INFARCTION; IMPACT; TRIAL	Sinking skin flap syndrome (SSFS) is a complication among long-term survivors of stroke or traumatic brain injury treated by decompressive craniectomy. The syndrome encompasses a wide spectrum of neurological symptoms including cognitive decline, seizures, speech and sensorimotor deficits. Early cranio-plasty appears to improve cerebral perfusion, but the efficacy of cranioplasty in neurocognitive outcome in long-standing SSFS patient is unclear. We report a 64-year-old patient who suffered from traumatic brain injury and underwent decompressive craniectomy 18 years ago. She had chronic SSFS with pre-cranioplasty assessments demonstrating severe neurocognitive impairments which were static over time. After cranioplasty with custom-made polyetheretherketone flap to restore the 264 cm(2) skull defect, magnetic resonance perfusion scan with pseudo-continuous arterial spin labelling technique showed a two-fold augmentation of cerebral blood flow in both frontal lobes, as well as areas distal to the sunken skin flap compared to baseline. This is accompanied by improvement of neurocognitive function as assessed by Montreal Cognitive Assessment, Neurobehavioral Cognitive State Examination, and Rivermead Behavioural Memory Test three and six months after cranioplasty. The patient's quality of life and that of her primary carer also showed improvement. This report describes a case of neurocognitive and global cerebral perfusion improvement after cranioplasty in the setting of prolonged SFSS of 18 years, and adds to the growing body of literature supporting the therapeutic role of cranioplasty beyond purely protective or cosmetic indications. The advantages and clinical utility of pCASL MR perfusion in assessing serial CBF before and after cranioplasty is illustrated. (C) 2020 Elsevier Ltd. All rights reserved.	[Woo, Peter Yat Ming] Kwong Wah Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Mak, Calvin Hoi Kwan] Queen Elizabeth Hosp, Dept Neurosurg, Hong Kong, Peoples R China; [Mak, Henry Ka Fung] Univ Hong Kong, Dept Diagnost Radiol, Hong Kong, Peoples R China; [Tsang, Anderson Chun On] Univ Hong Kong, Dept Surg, Div Neurosurg, Hong Kong, Peoples R China		Tsang, ACO (corresponding author), Queen Mary Hosp, Dept Surg, Div Neurosurg, 102 Pokfulam Rd, Hong Kong, Peoples R China.	acotsang@hku.hk	Mak, Calvin/ABA-5717-2021	Mak, Calvin/0000-0002-1443-2109	Hong Kong Neurosurgical Society Research Subcommittee	This study is funded by the Hong Kong Neurosurgical Society Research Subcommittee and conducted in cooperation with the MRI unit of Department of Diagnostic Radiology, The University of Hong Kong.	Annan M, 2015, BRIT J NEUROSURG, V29, P314, DOI 10.3109/02688697.2015.1012047; Borger V, 2016, WORLD NEUROSURG, V92, P83, DOI 10.1016/j.wneu.2016.04.113; Brissenden JA, 2016, J NEUROSCI, V36, P6083, DOI 10.1523/JNEUROSCI.0344-16.2016; De Cola MC, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1106; Grade M, 2015, NEURORADIOLOGY, V57, P1181, DOI 10.1007/s00234-015-1571-z; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jezzard P, 2018, J CEREBR BLOOD F MET, V38, P603, DOI 10.1177/0271678X17743240; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yoshida K, 1996, J NEUROL NEUROSUR PS, V61, P166, DOI 10.1136/jnnp.61.2.166	19	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	JUL	2020	77						213	217		10.1016/j.jocn.2020.05.031			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MB4PE	WOS:000542584900039	32409216				2022-02-06	
J	Younsi, A; Fischer, J; Habel, C; Riemann, L; Scherer, M; Unterberg, A; Zweckberger, K				Younsi, Alexander; Fischer, Jessica; Habel, Cleo; Riemann, Lennart; Scherer, Moritz; Unterberg, Andreas; Zweckberger, Klaus			Mortality and functional outcome after surgical evacuation of traumatic acute subdural hematomas in octa- and nonagenarians	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						TBI; Acute subdural hematoma; Surgical evacuation; Elderly patients; Octogenarians; Quality of life; Outcome	BRAIN-INJURY; CLASSIFICATION; EXPERIENCE; AGE	Purpose The incidence of acute subdural hematomas (aSDH) is rising. However, beneficial effects of surgery for the oldest aSDH patients remain unclear. We hence describe the postoperative outcome of octa- and nonagenarians with aSDH in comparison to a younger patient cohort. Methods Patients aged >= 80 years surgically treated for traumatic aSDH at a single institution between 2006 and 2016 were retrospectively reviewed. Clinical and imaging variables were assessed, and univariate analysis was performed to identify factors predicting outcome at discharge. Results were compared to a cohort of younger aSDH patients and statistical analysis was performed. Long-term outcome was prospectively evaluated with the GOSE and QOLIBRI. Results 27 aSDH patients aged >= 80 years were identified. On admission, 41% were in a comatose state and in-hospital mortality was 33%. At discharge, 22% had a favorable outcome (GOS 4 + 5). In univariate statistical analysis, better neurological status (GCS > 8), <= 1 comorbidity and smaller aSDH volumes were significant predictors for a favorable outcome. Comparison to 27 younger aSDH patients revealed significant differences in the prevalence of comorbidities and antithrombotics. At long-term follow-up, quality of life of aSDH patients was reduced (median QOLIBRI 54%). Conclusion Outcome after surgical treatment of aSDH in octa- and nonagenarians is not detrimental per se. Predictors for a favorable outcome are a non-comatose state on admission (GCS > 8), <= 1 preexisting comorbidity and a lower aSDH volume in patients aged >= 80 years. In individual patients, surgical evacuation of aSDH might remain a treatment option even in high ages.	[Younsi, Alexander; Fischer, Jessica; Habel, Cleo; Riemann, Lennart; Scherer, Moritz; Unterberg, Andreas; Zweckberger, Klaus] Heidelberg Univ, Univ Hosp Heidelberg, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany		Younsi, A (corresponding author), Heidelberg Univ, Univ Hosp Heidelberg, Dept Neurosurg, INF 400, D-69120 Heidelberg, Germany.	alexander.younsi@med.uni-heidelberg.de	Younsi, Alexander/AAW-7869-2020	Younsi, Alexander/0000-0002-8218-9243	Projekt DEAL	Open Access funding provided by Projekt DEAL. We thank Julia Mattern and Madlen Radel for their help with this study.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2001, INJ FACT BOOK; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Evans LR, 2019, J NEUROTRAUM, V36, P517, DOI 10.1089/neu.2018.5829; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Heller RA, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050421; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JENNETT B, 1976, LANCET, V1, P1031; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kunftige Bevolkerungsentwicklung in Deutschland, 2019, KUNFT BEV DEUTSCHL; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Mazur MD, 2017, NEUROSURGERY, V81, DOI 10.1093/neuros/nyx276; McGinity MJ, 2017, BRIT J NEUROSURG, V31, P714, DOI 10.1080/02688697.2017.1341041; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; Vilcinis R, 2017, WORLD NEUROSURG, V101, P335, DOI 10.1016/j.wneu.2017.02.010; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wilson JR, 2020, J NEUROTRAUM, V37, P1740, DOI 10.1089/neu.2020.6985; Won SY, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17417; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]; Yanaka Kiyoyuki, 1993, Neurologia Medico-Chirurgica, V33, P552, DOI 10.2176/nmc.33.552	31	5	5	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1499	1510		10.1007/s00068-020-01419-9		JUN 2020	12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000543680700001	32594213	Green Published, hybrid			2022-02-06	
J	Chen, HL; Wang, YH; Tu, WJ; Wang, H; Yin, HJ; Sha, H; Li, YX				Chen, Hongli; Wang, Yunhao; Tu, Wenjun; Wang, Hong; Yin, Huijuan; Sha, Hong; Li, Yingxin			Effects of photobiomodulation combined with MSCs transplantation on the repair of spinal cord injury in rat	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						functional recovery; mesenchymal stem cell; PBM; spinal cord injury; transplantation	MESENCHYMAL STEM-CELLS; LEVEL LASER IRRADIATION; TRAUMATIC BRAIN-INJURY; BONE-MARROW; FUNCTIONAL RECOVERY; ADIPOSE-TISSUE; THERAPY; REGENERATION	Stem cell transplantation has shown promising regenerative effects against neural injury, and photobiomodulation (PBM) can aid tissue recovery. This study aims to evaluate the therapeutic effect of human umbilical cord mesenchymal stem cells (hUCMSCs) and laser alone or combined on spinal cord injury (SCI). The animals were divided into SCI, hUCMSCs, laser treatment (LASER) and combination treatment (hUCMSCs + LASER) groups. Cell-enriched grafts of hUCMSCs (1 x 10(6)cells/ml) were injected at the site of antecedent trauma in SCI model rats. A 2 cm(2)damaged area was irradiated with 630 nm laser at 100 mW/cm(2)power for 20 min. Locomotion was evaluated using Basso-Beattie-Bresnahan (BBB) scores, and neurofilament repair were monitored by histological staining and diffusion tensor imaging (DTI). First, after SCI, the motor function of each group was restored with different degrees, the combination treatment significantly increased the BBB scores compared to either monotherapy. In addition, Nissl bodies were more numerous, and the nerve fibers were longer and thicker in the combination treatment group. Consistent with this, the in situ expression of NF-200 and glial fibrillary acidic protein in the damaged area was the highest in the combination treatment group. Finally, DTI showed that the combination therapy optimally improved neurofilament structure and arrangement. These results may show that the combination of PBM and hUCMSCs transplantation is a feasible strategy for reducing secondary damage and promoting functional recovery following SCI.	[Chen, Hongli; Wang, Yunhao; Tu, Wenjun; Wang, Hong] Tiangong Univ, Sch Life Sci, Tianjin, Peoples R China; [Chen, Hongli] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin, Peoples R China; [Tu, Wenjun; Wang, Hong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, 238 Baidi Rd, Tianjin 300192, Peoples R China; [Yin, Huijuan; Sha, Hong; Li, Yingxin] Chinese Acad Med Sci & Peking Union Med Coll, Inst Biomed Engn, 236 Baidi Rd, Tianjin 300192, Peoples R China		Tu, WJ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, 238 Baidi Rd, Tianjin 300192, Peoples R China.; Wang, H (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Biomed Engn, 236 Baidi Rd, Tianjin 300192, Peoples R China.	tuwenjun@irm-cams.ac.cn; wanghong@bme.pumc.edu.cn	Tu, Wen-Jun/AAC-5696-2019	Tu, Wen-Jun/0000-0002-1703-1802	Natural Science Foundation of Tianjin CityNatural Science Foundation of Tianjin [19JCQNJC01600]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61705164, 81602800]; Tianjin Municipal Education Commission [2018KJ214]	Natural Science Foundation of Tianjin City, Grant/Award Number: 19JCQNJC01600; National Natural Science Foundation of China, Grant/Award Numbers: 61705164, 81602800; Tianjin Municipal Education Commission, Grant/Award Number: 2018KJ214	Abrahamse H, 2012, PHOTOMED LASER SURG, V30, P681, DOI 10.1089/pho.2012.9881; Ahmed A, 2018, MOL CELL BIOCHEM, V441, P181, DOI 10.1007/s11010-017-3184-9; Ando T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.098002; Assinck P, 2017, NAT NEUROSCI, V20, P637, DOI 10.1038/nn.4541; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chen HL, 2019, LASER MED SCI, V34, P667, DOI 10.1007/s10103-018-2638-y; Cui B., 2014, EXPT THERAPEUTIC MED, V14, P17986; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Jang S. H., 2017, NEURAL REGENERATION, V12, P95; Janzadeh A, 2017, NEUROPEPTIDES, V65, P90, DOI 10.1016/j.npep.2017.06.002; Jendelova P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103200; Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986; Jones Zachary B, 2016, Int J Physiol Pathophysiol Pharmacol, V8, P52; Kim J, 2017, TISSUE ENG REGEN MED, V14, P57, DOI 10.1007/s13770-016-0003-4; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025837; Lee JM, 2009, TISSUE ENG REGEN MED, V6, P179; Liu SJ, 2019, SPINAL CORD, V57, P972, DOI 10.1038/s41393-019-0317-x; Manteifel VM, 2005, BIOL BULL+, V32, P556, DOI 10.1007/s10525-005-0143-x; Manuguerra-Gagne R, 2013, STEM CELLS, V31, P1136, DOI 10.1002/stem.1364; Marino L, 2019, INT J STEM CELLS, V12, P218, DOI 10.15283/ijsc18034; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2015, PROC SPIE, V9467, DOI 10.1117/12.2176345; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Patrocinio-Silva TL, 2014, LASER MED SCI, V29, P1357, DOI 10.1007/s10103-013-1418-y; Paula AA, 2014, LASER MED SCI, V29, P1849, DOI 10.1007/s10103-014-1586-4; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Shahrezaie M, 2017, BIOLOGICALS, V50, P73, DOI 10.1016/j.biologicals.2017.08.009; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Snyder EY, 2012, NEW ENGL J MED, V366, P1940, DOI 10.1056/NEJMcibr1200138; Song J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42521; Sotoudeh A, 2015, ACTA CIR BRAS, V30, P611, DOI 10.1590/S0102-865020150090000005; Torres-Espin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076141; Wang T, 2018, NEURAL REGEN RES, V13, P887, DOI 10.4103/1673-5374.232484; Wu J, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-5; Yamasaki K, 2009, SPINE, V34, P323, DOI 10.1097/BRS.0b013e318193a1de; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yu WY, 2015, EUR REV MED PHARMACO, V19, P3340	37	5	5	5	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	FEB	2021	236	2					921	930		10.1002/jcp.29902		JUN 2020	10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	OU0IY	WOS:000542558300001	32583437				2022-02-06	
J	Savino, AK; Huang, LH; Yang, JZ; Pizzimenti, NM; McCarthy, MT; Rose, SC				Savino, Anthony K.; Huang, Lihong; Yang, Jingzhen; Pizzimenti, Natalie M.; McCarthy, Matthew T.; Rose, Sean C.			Head Impact Burden Differs Between Seasons in Youth and High School US Football Players	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Sports; Mild traumatic brain injury	1ST EXPOSURE; LATER-LIFE; AGE; ACCELERATIONS	Retrospective estimates of head impact burden in contact sports are often used in studies assessing for correlation of head impact exposure with neurocognitive outcomes later in life. These estimations assume a consistent impact burden from year to year. We monitored head impacts in youth tackle football players in the 6th-8th grades and high school varsity players using helmet-based sensors during two consecutive seasons. Helmet-based pressure sensors were used to measure head impacts, and estimates of peak linear acceleration (g's) were then grouped and summed for cumulative impact. After each season, players estimated whether they experienced an average, below average, or above average head impact burden in relation to their teammates. Of the 98 players who participated, 54 played in both seasons and sustained a median of 102.5 impacts (2206 cumulative g's) in season 1 and 161 impacts (3682 cumulative g's) in season 2. Using pairwise comparisons, number of impacts and cumulative g's increased in the youth players from season 1 to season 2 (p = 0.0021 andp = 0.0018, respectively), but there was a trend towards a decrease in number of impacts and g's at the high school level. In an exploratory analysis, perceived cumulative head impact and measured cumulative g's weakly correlated (Pearson's correlation coefficient = 0.26 for season 1 and 0.02 for season 2). In conclusion, cumulative head impacts differ significantly from one season to the next, and players have difficulty estimating their cumulative head impacts in relation to their team mates, especially at the youth level. Retrospective estimations of head impact burden should account for this variability.	[Savino, Anthony K.] Illinois Bone & Joint Inst, Sports Neurol, Morton Grove, IL USA; [Huang, Lihong] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghai, Peoples R China; [Yang, Jingzhen] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Pizzimenti, Natalie M.] MORE Fdn, Clin Res, Novi, MI USA; [McCarthy, Matthew T.] Summit Med Grp, Neurosci, Florham Pk, NJ USA; [Rose, Sean C.] Nationwide Childrens Hosp, Pediat Neurol, 700 Childrens Dr, Columbus, OH 43205 USA; [Rose, Sean C.] Ohio State Univ, 700 Childrens Dr, Columbus, OH 43205 USA		Rose, SC (corresponding author), Nationwide Childrens Hosp, Pediat Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.; Rose, SC (corresponding author), Ohio State Univ, 700 Childrens Dr, Columbus, OH 43205 USA.	rose@nationwidechildrens.org		Rose, Sean/0000-0001-5177-7715	MORE Foundation; Riddell; ElMindA	MORE Foundation provided administrative support and administered funding. This study was investigator-initiated and funded through grants and equipment from Riddell and ElMindA. The Sports Neurology Clinic helped with data collection and provided support staff and clinic space. The following groups and individuals helped with data collection: Brighton High School and its football coaches, Brighton Bulldogs Football and Cheer and its football coaches, Andrew Cavey, Sandro Corti, Kate Essad, Stephanie Alessi-LaRosa, and Rebecca Kahn. Junxin Shi helped with statistical analysis.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Beckwith J. G, 2014, 38 ANN M AM SO BIOM; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Caccese JB, 2020, J NEUROTRAUM, V37, P334, DOI 10.1089/neu.2019.6571; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Chu JJ, 2012, ANN BIOMED ENG, V40, P203, DOI 10.1007/s10439-011-0410-6; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fesharaki-Zadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00713; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Pianosi PT, 2015, ANN AM THORAC SOC, V12, P718, DOI 10.1513/AnnalsATS.201410-477OC; Rose SC, 2019, J NEUROTRAUM, V1, P2; Rose SC, 2019, J HEAD TRAUMA REHAB, V34, P87, DOI 10.1097/HTR.0000000000000441; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358	26	5	4	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2020	48	12					2763	2771		10.1007/s10439-020-02548-3		JUN 2020	9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PD4VU	WOS:000541196800001	32556646				2022-02-06	
J	Ware, JB; Dolui, S; Duda, J; Gaggi, N; Choi, R; Detre, J; Whyte, J; Diaz-Arrastia, R; Kim, JJ				Ware, Jeffrey B.; Dolui, Sudipto; Duda, Jeffrey; Gaggi, Naomi; Choi, Robin; Detre, John; Whyte, John; Diaz-Arrastia, Ramon; Kim, Junghoon J.			Relationship of Cerebral Blood Flow to Cognitive Function and Recovery in Early Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; ASL; blood flow; CBF; cognitive function; MRI; TBI; vascular injury	TENSOR-BASED MORPHOMETRY; VASCULAR INJURY; PERFUSION; PREDICTION; DECLINE; ATROPHY; MRI; CONSEQUENCES; DYSFUNCTION; IMPACT	Traumatic brain injury (TBI) is a leading cause of morbidity worldwide, for which biomarkers are needed to better understand the underlying pathophysiology. Microvascular injury represents a subset of pathological mechanisms contributing to cognitive dysfunction after TBI, which may also impair subsequent neural repair thereby inhibiting cognitive recovery. Magnetic resonance imaging (MRI)-based measurement of cerebral blood flow (CBF) by arterial spin labeling (ASL) provides an appealing means of assessing microvascular disruption in TBI; however, the relationship between CBF alterations in the early chronic post-TBI setting and cognitive dysfunction as well as subsequent cognitive recovery remain poorly understood. Structural MRI and ASL were performed in 42 TBI subjects 3 months post-injury and 35 matched healthy controls. Neuropsychological testing was performed in each subject, as well as in a subset of TBI patients (n = 33) at 6 and/or 12 months post-injury. TBI and control subject CBF data were compared between groups in a voxel-wise fashion while controlling for the effects of structural atrophy. A region-of-interest approach was then used to compare CBF to clinical and neuropsychological measures within the TBI group in a cross-sectional fashion, as well as to the degree of subsequent cognitive recovery among subjects with follow-up testing. At 3 months post-injury, the TBI group demonstrated lower performance in each cognitive domain (p < 0.05), as well as widespread reductions in gray matter CBF independent of structural atrophy (p < 0.05). Within the TBI group, CBF was moderately correlated with injury severity (r = -0.43;p = 0.009) and executive function (r = 0.43;p = 0.01). In the longitudinal analysis, there was a positive correlation between initial CBF and processing speed recovery (r = 0.43;p = 0.015) independent of age, education level, and initial test score. Early chronic TBI is associated with widespread gray matter CBF deficits, which are correlated with injury severity and cognitive dysfunction. CBF may predict subsequent recovery in some cognitive domains.	[Ware, Jeffrey B.; Dolui, Sudipto; Duda, Jeffrey] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Gaggi, Naomi; Kim, Junghoon J.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Choi, Robin; Whyte, John] CUNY, Sch Med, Dept Mol Cellular & Biomed Sci, Harris Hall 202,160 Convent Ave, New York, NY 10031 USA; [Detre, John; Diaz-Arrastia, Ramon] Moss Rehabil Res Inst, Philadelphia, PA USA		Kim, JJ (corresponding author), CUNY, Sch Med, Dept Mol Cellular & Biomed Sci, Harris Hall 202,160 Convent Ave, New York, NY 10031 USA.	junghoonkimphd@gmail.com		Ware, Jeffrey/0000-0002-3495-9733; Gaggi, Naomi/0000-0002-7745-4655	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS R01NS065980]	This work was supported by the National Institutes of Health (NINDS R01NS065980; PI: J.J.K.).	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andersen SM, 2010, NEUROIMAGE, V53, P78, DOI 10.1016/j.neuroimage.2010.06.003; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Benedictus MR, 2017, EUR RADIOL, V27, P1169, DOI 10.1007/s00330-016-4450-z; Castejon OJ, 2011, FOLIA NEUROPATHOL, V49, P162; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dolui S., 2016, 24 ANN M EXH ISMRM S; Dolui S, 2017, J MAGN RESON IMAGING, V45, P1786, DOI 10.1002/jmri.25436; Fridley J, 2015, J NEUROTRAUM, V32, P75, DOI 10.1089/neu.2014.3350; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Honda M, 2016, NEUROL MED-CHIR, V56, P501, DOI 10.2176/nmc.oa.2015-0341; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Castejon OJ, 2014, FOLIA NEUROPATHOL, V52, P10, DOI 10.5114/fn.2014.41740; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kisler K, 2017, NAT NEUROSCI, V20, P406, DOI 10.1038/nn.4489; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marsh NV, 2018, NEUROREHABILITATION, V43, P377, DOI 10.3233/NRE-182457; Olm CA, 2016, J NEUROL, V263, P1927, DOI 10.1007/s00415-016-8221-1; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Rabinowitz AR, 2018, J INT NEUROPSYCH SOC, V24, P237, DOI 10.1017/S1355617717000996; Sandsmark DK, 2019, NEURON, V103, P367, DOI 10.1016/j.neuron.2019.06.002; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silver JM, 2019, TXB TRAUMATIC BRAIN; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stamatakis EA, 2002, J NUCL MED, V43, P476; Sweeney MD, 2018, NAT NEUROSCI, V21, P1318, DOI 10.1038/s41593-018-0234-x; Szarka N, 2018, J NEUROTRAUM, V35, P930, DOI 10.1089/neu.2017.5056; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Xekardaki A, 2015, RADIOLOGY, V274, P490, DOI 10.1148/radiol.14140680; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067	54	5	5	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2020	37	20					2180	2187		10.1089/neu.2020.7031		JUN 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	OA4HP	WOS:000541529400001	32349614	Green Published			2022-02-06	
J	Greybe, DG; Jones, CM; Brown, MR; Williams, EMP				Greybe, Desney G.; Jones, Christopher M.; Brown, M. Rowan; Williams, Elisabeth M. P.			Comparison of head impact measurements via an instrumented mouthguard and an anthropometric testing device	SPORTS ENGINEERING			English	Article							RUGBY LEAGUE; INJURY; ACCELERATION; VALIDATION; SEVERITY; EXPOSURE; PLAYERS; AMATEUR; SYSTEM; HELMET	The purpose of this study was to determine and compare the efficacy of head impact measurements via an electronic sensor framework, embedded within a mouthguard, against an anthropometric testing device. Development of the former is in response to the growing issue of head impacts and concussion in rugby union. Testing was conducted in a vehicle safety laboratory using a standard impact protocol utilising the headforms of anthropometric testing devices. The headforms were subjected to controlled front and side impacts. For each impact, the linear acceleration and rotational velocity was measured over a 104-ms interval at a frequency of 1 kHz. The magnitude of peak linear acceleration and peak rotational velocity was determined from the measured time-series traces and statistically compared. The peak linear acceleration and rotational velocity had intraclass correlation coefficients of 0.95 and 0.99, respectively. The root-mean-square error between the measurement systems was 4.3 g with a standard deviation of 3.5 g for peak linear acceleration and 0.7 rad/s with a standard deviation of 0.4 rad/s for rotational velocity. Bland and Altman analysis indicated a systematic bias of 2.5 g and - 0.5 rad/s and limits of agreement (1.96 x standard deviation) of +/- 13.1 g and +/- 1.25 rad/s for the instrumented mouthguard. These results provide the basis on which the instrumented mouthguard can be further developed for deployment and application within professional rugby, with a view to accurately and reliably quantify head collision dynamics.	[Greybe, Desney G.; Jones, Christopher M.; Williams, Elisabeth M. P.] Swansea Univ, Coll Engn, ASTEM, Swansea, W Glam, Wales; [Jones, Christopher M.] Sports & Wellbeing Analyt Ltd, Swansea, W Glam, Wales; [Brown, M. Rowan] Swansea Univ, Coll Engn, Syst & Proc Engn, Swansea, W Glam, Wales		Jones, CM (corresponding author), Swansea Univ, Coll Engn, ASTEM, Swansea, W Glam, Wales.; Jones, CM (corresponding author), Sports & Wellbeing Analyt Ltd, Swansea, W Glam, Wales.	Christopher.m.jones@swansea.ac.uk		Williams, Elisabeth/0000-0002-8422-5842	Sports and Wellbeing Analytics Limited	This research was funded by Sports and Wellbeing Analytics Limited. Sports and Wellbeing Analytics Limited have been granted patents for (1) novel electronic architecture (GB2570726), (2) system protocols (GB257076), and (3) associated firmware criteria (GB2572677). OPRO make the surrounding mouthguard while Sports and Wellbeing Analytics Limited provide parylene coated electronics.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; [Anonymous], 2016, IT WORKS; [Anonymous], 2019, BBC; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Backaitis SH, 1993, HYBRID, P830; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bartsch Adam, 2014, Stapp Car Crash J, V58, P1; Bartsch A, 2013, PROC SPIE, V8723, DOI 10.1117/12.2027366; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Baumgatner T., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI [10.1207/S15327841MPEE0503_4, DOI 10.1207/S15327841MPEE0503_4]; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Carey L, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0182-3; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Crisco JJ, 2005, P 20 C INT SOC BIOM; Crisco JJ, 2002, 4 WORLD C BIOM CALG; Gadd CW, 1966, SAE TECHNICAL PAPERS; Greenwald, 2006, J BIOMECHANICS S1, P39, DOI [https://doi.org/10.1016/s0021-9290(06)83517-7, DOI 10.1016/s0021-9290(06)83517-7]; Greenwald R. M, 2003, P AM SOC BIOM ANN M; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Hanlon E, 2010, J APPL BIOMECH, V26, P424, DOI 10.1123/jab.26.4.424; Henn H.W., 1998, TEACH MATH APPL, V17, P162, DOI 10.1093/teamat/17.4.162.; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Kara TM, 2012, P 12 PAN AM C APPL M; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2017, SPORTS MED, V47, P197, DOI 10.1007/s40279-016-0576-z; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; King DA, 2018, J SCI MED SPORT, V21, P139, DOI 10.1016/j.jsams.2017.10.026; Kleiven, 2002, FINITE ELEMENT MODEL; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; MITAL NK, 1979, J APPL MECH-T ASME, V46, P925, DOI 10.1115/1.3424679; Murayama H, 2020, NEUROL MED-CHIR, V60, P101, DOI 10.2176/nmc.oa.2019-0206; Nevins D, 2018, P I MECH ENG P-J SPO, V232, P242, DOI 10.1177/1754337117739458; Nevins D, 2015, PROCEDIA ENGINEER, V112, P175, DOI 10.1016/j.proeng.2015.07.195; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Paris AJ, 2010, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, 2010, P815; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Payne AR, 1996, SAE TECHNICAL PAPERS; RFU, 2018, ENGL PROF RUGB UN IN; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Siegmund GP, 2014, ANN BIOMED ENG, V42, P1834, DOI 10.1007/s10439-014-1052-2; Stephens VM, 1993, P INT TECHN C ENH SA, P668; World Rugby, 2019, WORLD RUGB LAWS; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; 1999, J SPORT SCI, V17, P3	66	5	5	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	JUN 6	2020	23	1							12	10.1007/s12283-020-00324-z			11	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	LV3QS	WOS:000538354800001		hybrid, Green Published			2022-02-06	
J	de Grau, S; Post, A; Meehan, A; Champoux, L; Hoshizaki, TB; Gilchrist, MD				de Grau, Santiago; Post, Andrew; Meehan, Andrew; Champoux, Luc; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Protective capacity of ice hockey helmets at different levels of striking compliance	SPORTS ENGINEERING			English	Article						Helmet performance; Impact compliance; Brain injury risk; Concussion risk; Contact sports	SYSTEMATIC VIDEO ANALYSIS; TRAUMATIC BRAIN-INJURY; ACCIDENT RECONSTRUCTION; INTRACRANIAL-PRESSURE; LEAGUE NHL; HEAD; CONCUSSION; ACCELERATION; PREDICTORS; THRESHOLD	In elite ice hockey, concussions occur from a variety of impact sources with different compliances, such as player-to-player collisions, impacts on the ice, boards, and glass. The effectiveness of ice hockey helmets to manage an impact under varying compliance conditions is currently unknown. The objective of this research was to determine the effect of striker compliance on ice hockey helmet performance. Striking caps of different compliance were used to impact a helmeted and unhelmeted Hybrid III headform at three locations. The headform kinematics was measured in linear and rotational acceleration, rotational velocity. The linear and rotational time histories were then used as input to a finite element model of the human brain to determine maximum principal strain response. Helmeted conditions produced significantly lower linear and rotational acceleration, and rotational velocity for the three levels of compliance at the three impact locations. The reductions through the use of a helmet were higher at low compliance in comparison to the other compliance conditions. Considering player-to-player collisions are the most common source of concussion in adult ice hockey, and also the most compliant, these data support the development of helmet technologies that can mitigate impacts under higher compliance conditions to reduce the risk of brain trauma.	[de Grau, Santiago; Post, Andrew; Meehan, Andrew; Champoux, Luc; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada; [Post, Andrew; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.; Post, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			[Anonymous], 2014, INSTR IMP TEST 1, VJ211; Association CS, 2015, ICE HOCKEY HELMETS, VCSA Z262.1-15; Baumgart F, 2000, INJURY, V31, P14; Clark JM, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4045403; Clark JM, 2018, ANN BIOMED ENG, V46, P986, DOI 10.1007/s10439-018-2017-7; de Grau S, 2020, P I MECH ENG P-J SPO, V234, P98, DOI 10.1177/1754337119871866; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki TB, 2016, INT CYCL SAF C BOL I; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Karton C, 2014, BRIT J SPORT MED, V48, P46, DOI 10.1136/bjsports-2012-091583; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2005, INFLUENCE DIRECTION; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Maw S, 2012, PROCEDIA ENGINEER, V34, P819, DOI 10.1016/j.proeng.2012.04.140; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Nahum A, 1977, 21 STAPP CAR CRASH C; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Post A, 2019, COMPUT METHOD BIOMEC, V22, P631, DOI 10.1080/10255842.2019.1577827; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Potvin BM, 2019, J BIOMECH, V91, P43, DOI 10.1016/j.jbiomech.2019.05.002; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; RUAN JS, 1995, J NEUROTRAUM, V12, P725, DOI 10.1089/neu.1995.12.725; SCHER IS, 2020, SPORTS ENG, V23, P1, DOI DOI 10.1007/s12283-019-0315-4; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; Taylor K, 2019, P I MECH ENG P-J SPO, V233, P503, DOI 10.1177/1754337119857434; Taylor K, 2019, COMPUT METHOD BIOMEC, V22, P1047, DOI 10.1080/10255842.2019.1626840; Turquier F, 1996, 40 STAPP CAR CRASH C; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, 39 STAPP CAR CRASH C	47	5	5	4	7	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	JUN 5	2020	23	1							11	10.1007/s12283-020-00325-y			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	LV2AV	WOS:000538243300001					2022-02-06	
J	Li, B; Zhou, X; Yi, TL; Xu, ZW; Peng, DW; Guo, Y; Guo, YM; Cao, YL; Zhu, L; Zhang, S; Cheng, SX				Li, Bo; Zhou, Xiu; Yi, Tai-Long; Xu, Zhong-Wei; Peng, Ding-Wei; Guo, Yi; Guo, Yong-Ming; Cao, Yu-Lin; Zhu, Lei; Zhang, Sai; Cheng, Shi-Xiang			Bloodletting Puncture at Hand TwelveJing-Well Points Improves Neurological Recovery by Ameliorating Acute Traumatic Brain Injury-Induced Coagulopathy in Mice	FRONTIERS IN NEUROSCIENCE			English	Article						traumatic brain injury; coagulopathy; bloodletting puncture at hand twelveJing-well points; controlled cortical impact; model; mouse	VASCULAR OCCLUSIVE EVENTS; TRANEXAMIC ACID; HEMORRHAGIC PROGRESSION; INTRACRANIAL HEMORRHAGE; COAGULATION DISORDERS; PLATELET TRANSFUSION; FACTOR VIIA; FIBRINOGEN; INFLAMMATION; THERAPY	Traumatic brain injury (TBI) contributes to hypocoagulopathy associated with prolonged bleeding and hemorrhagic progression. Bloodletting puncture therapy at hand twelveJing-well points (BL-HTWP) has been applied as a first aid measure in various emergent neurological diseases, but the detailed mechanisms of the modulation between the central nervous system and systemic circulation after acute TBI in rodents remain unclear. To investigate whether BL-HTWP stimulation modulates hypocoagulable state and exerts neuroprotective effect, experimental TBI model of mice was produced by the controlled cortical impactor (CCI), and treatment with BL-HTWP was immediately made after CCI. Then, the effects of BL-HTWP on the neurological function, cerebral perfusion state, coagulable state, and cerebrovascular histopathology post-acute TBI were determined, respectively. Results showed that BL-HTWP treatment attenuated cerebral hypoperfusion and improve neurological recovery post-acute TBI. Furthermore, BL-HTWP stimulation reversed acute TBI-induced hypocoagulable state, reduced vasogenic edema and cytotoxic edema by regulating multiple hallmarks of coagulopathy in TBI. Therefore, we conclude for the first time that hypocoagulopathic state occurs after acute experimental TBI, and the neuroprotective effect of BL-HTWP relies on, at least in part, the modulation of hypocoagulable state. BL-HTWP therapy may be a promising strategy for acute severe TBI in the future.	[Li, Bo; Zhou, Xiu; Yi, Tai-Long; Peng, Ding-Wei; Zhang, Sai; Cheng, Shi-Xiang] Chinese Peoples Armed Police Force PAP, Inst Neurotrauma Repair Characterist Med Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Li, Bo; Guo, Yi; Guo, Yong-Ming] Tianjin Univ Tradit Chinese Med, Acupuncture Res Ctr, Tianjin, Peoples R China; [Xu, Zhong-Wei] Logist Univ Chinese Peoples Armed Police Force PA, Cent Lab, Tianjin, Peoples R China; [Cao, Yu-Lin] Zhenxigu Med Res Ctr, Beijing, Peoples R China; [Zhu, Lei] Xi An Jiao Tong Univ, Xian Honghui Hosp, Dept Spine Surg, Xian, Peoples R China		Zhang, S; Cheng, SX (corresponding author), Chinese Peoples Armed Police Force PAP, Inst Neurotrauma Repair Characterist Med Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China.; Zhu, L (corresponding author), Xi An Jiao Tong Univ, Xian Honghui Hosp, Dept Spine Surg, Xian, Peoples R China.	zhulei_phd@126.com; zhangsai718@vip.126.com; shixiangcheng@vip.126.com		Zhu, Lei/0000-0002-6043-7162	National Natural Science FoundationMajor Program of ChinaNational Natural Science Foundation of China (NSFC) [81891003]; National HighTech RAMP;D Program of China [2016YFC1101502]; Science and Technology Program of Tianjin [15ZXLCSY00040]; Technology Research Projects of PAL [AWS15J001]; Key Project of Natural Science Foundation for University of Anhui Province of China [KJ2018ZD027]	This study was funded by the National Natural Science FoundationMajor Program of China (81891003), National HighTech R&D Program of China (2016YFC1101502), Science and Technology Program of Tianjin (15ZXLCSY00040), Technology Research Projects of PAL (AWS15J001), and Key Project of Natural Science Foundation for University of Anhui Province of China (KJ2018ZD027).	Atefi G, 2016, SHOCK, V46, P83, DOI 10.1097/SHK.0000000000000675; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Baydyuk M, 2015, J NEUROSCI, V35, P4676, DOI 10.1523/JNEUROSCI.2695-14.2015; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Brown CVR, 2010, J TRAUMA, V68, P348, DOI 10.1097/TA.0b013e3181bbfb6b; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chang S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax1342; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Chen YH, 2018, P NATL ACAD SCI USA, V115, pE10720, DOI 10.1073/pnas.1807991115; Cheng SX, 2018, NEUROTHERAPEUTICS, V15, P216, DOI 10.1007/s13311-017-0591-2; Cybularz PA, 2015, MED ACUPUNCT, V27, P224, DOI 10.1089/acu.2015.1099; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Filippidis AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010055; Foley JH, 2016, CIRC RES, V118, P1392, DOI 10.1161/CIRCRESAHA.116.306853; Genet GF, 2017, J NEUROTRAUM, V34, P1054, DOI 10.1089/neu.2016.4574; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gonzalez E, 2014, SCAND J SURG, V103, P89, DOI 10.1177/1457496914531927; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Hoyt DB, 2008, J TRAUMA, V65, P755, DOI 10.1097/TA.0b013e318185fa9f; Huang HY, 2018, J NEURORESTORATOLOGY, V6, P67, DOI 10.26599/JNR.2018.9040001; Huang HY, 2019, J NEURORESTORATOLOGY, V7, P8, DOI 10.26599/JNR.2019.9040003; Jenkins DR, 2018, J NEUROTRAUM, V35, P2259, DOI 10.1089/neu.2017.5291; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang Y, 2011, NEUROSCIENCE, V172, P398, DOI 10.1016/j.neuroscience.2010.10.054; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lee SH, 2017, BIOCHEM PHARMACOL, V146, P1, DOI 10.1016/j.bcp.2017.06.137; Leeper CM, 2019, ANN SURG, V270, P528, DOI 10.1097/SLA.0000000000003464; Li Bo, 2019, Zhongguo Zhen Jiu, V39, P1075, DOI 10.13703/j.0255-2930.2019.10.012; Li XH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8460145; Lopez-Hernandez B, 2012, EXP NEUROL, V233, P543, DOI 10.1016/j.expneurol.2011.11.040; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Silverberg ND, 2020, JAMA-J AM MED ASSOC, V323, P177, DOI 10.1001/jama.2019.18134; SPAHN D, 2019, CRIT CARE, V23, DOI DOI 10.1186/s13054-019-2347-2343; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tong WS, 2012, BRAIN INJURY, V26, P1136, DOI 10.3109/02699052.2012.666437; Tovar-y-Romo LB, 2016, J NEUROCHEM, V136, P13, DOI 10.1111/jnc.13362; Tu Y, 2016, NEURAL REGEN RES, V11, P931, DOI 10.4103/1673-5374.184491; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vignoli A, 2018, ANN HEMATOL, V97, P1555, DOI 10.1007/s00277-018-3343-4; Wang N, 2014, NEUROPHARMACOLOGY, V79, P282, DOI 10.1016/j.neuropharm.2013.12.004; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Xu XH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-423; Yanamadala V, 2014, J CLIN NEUROSCI, V21, P1881, DOI 10.1016/j.jocn.2014.05.001; Yu NN, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1979-6; Yuan Q, 2016, J NEUROTRAUM, V33, P1279, DOI 10.1089/neu.2015.4205; Yue Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/827305; Zhang DF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/261825; [张健斌 Zhang Jianbin], 2003, [中国针灸, Chinese Acupuncture and Moxibustion], V23, P44; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zhang Q, 2016, J JESUIT STUD, V3, P514, DOI 10.1163/22141332-00303008-09; Zhou G.-P., 1999, ACUPUNCT RES, V02, P108; Zhou GP, 1998, ZHENCI YANJIU, V4, P268; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	83	5	5	2	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUN 5	2020	14								403	10.3389/fnins.2020.00403			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD3AQ	WOS:000543844500001	32581664	Green Published, gold			2022-02-06	
J	Rana, A; Singh, S; Deshmukh, R; Kumar, A				Rana, Arti; Singh, Shamsher; Deshmukh, Rahul; Kumar, Anoop			Pharmacological potential of tocopherol and doxycycline against traumatic brain injury-induced cognitive/motor impairment in rats	BRAIN INJURY			English	Article						Traumatic brain injury; oxidative stress; doxycycline; tocopherol; neuroinflammation; neurotransmitters	OXIDATIVE STRESS; MICE; RECOGNITION; MODULATION; MODEL; ACID	Primary Objective The primary objective of this study was to explore the pharmacological potential of tocopherol and doxycycline against traumatic brain injury-induced cognitive/motor impairment in rats. Research Design Weight drop model of traumatic brain injury. Methods and Procedures After TBI, the animals were treated with doxycycline (50 and 100 mg/kg; p.o), tocopherol (5 and 10 mg/kg; p.o) alone and in combination as doxycycline and tocopherol (50 and 10 mg/kg; p.o) from 1st day to 28th day. The behavioral parameters were performed on a weekly basis from 1st day to 28th day. On 29th day, animals were sacrificed and striatum and cortex were homogenized for the estimation of biochemical (LPO, nitrite, and GSH), neuroinflammatory (IL-6, IL-1 beta, and TNF-alpha), and neurotransmitters (dopamine, norepinephrine, serotonin, GABA, and glutamate) analysis. Main Outcomes and Results Induction of TBI had significantly reduced locomotor activity, recognition memory, increased neuroinflammatory markers, and imbalance neurotransmitter levels. The treatment with doxycycline and tocopherol alone and in combination significantly attenuated locomotor activity, memory recognition, reduced neuroinflammation, preserved oxidative balance, and restored the level of neurotransmitters. Conclusions The neuroprotective effect of doxycycline and tocopherol might be due to its anti-inflammatory and free radical scavenging mechanisms.	[Rana, Arti; Singh, Shamsher; Kumar, Anoop] ISF Coll Pharm, Dept Neuropharmacol, Moga, Punjab, India; [Deshmukh, Rahul] Maharaja Ranjit Singh Punjab Tech Univ MRSPTU, Dept Pharmaceut Sci & Technol, Bathinda, Punjab, India; [Kumar, Anoop] Natl Inst Pharmaceut Educ & Res NIPER Raebareli, Dept Pharmacol & Toxicol, Lucknow 226002, Uttar Pradesh, India		Kumar, A (corresponding author), Natl Inst Pharmaceut Educ & Res NIPER Raebareli, Dept Pharmacol & Toxicol, Lucknow 226002, Uttar Pradesh, India.	abitmesra@gmail.com	Rana, Arti/AAT-6506-2021; Kumar, Anoop/A-3723-2016	Kumar, Anoop/0000-0002-7806-9986			Anderson KD, 2005, EXP NEUROL, V194, P161, DOI 10.1016/j.expneurol.2005.02.006; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; Ben-Azu B, 2018, BRAIN RES BULL, V139, P114, DOI 10.1016/j.brainresbull.2018.02.007; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Chen W., 2017, OPT EXPRESS, V25, pA253; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Elewa HF, 2006, PHARMACOTHERAPY, V26, P515, DOI 10.1592/phco.26.4.515; Ellman M, 1995, ANAL BIOCHEM, V74; Mello BSF, 2013, J PSYCHIATR RES, V47, P1521, DOI 10.1016/j.jpsychires.2013.06.008; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Ishaq GM, 2013, J NEUROSCI RURAL PRA, V4, P292, DOI 10.4103/0976-3147.118784; Jamwal S, 2015, NEUROTOX RES, V28, P171, DOI 10.1007/s12640-015-9535-y; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Kumar A, 2019, ENDOCR METAB IMMUNE, V19, P171, DOI 10.2174/1871530318666180801144822; Kumar B, 2011, PSYCHOPHARMACOLOGY, V214, P819, DOI 10.1007/s00213-010-2094-2; Kumar M, 2017, NEUROSCI RES, V120, P8, DOI 10.1016/j.neures.2017.02.003; Lazzarini M, 2013, GLIA, V61, P1084, DOI 10.1002/glia.22496; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Liu MY, 2018, NEUROPSYCH DIS TREAT, V14, P787, DOI 10.2147/NDT.S157441; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mark KA, 2004, J NEUROSCI, V24, P11449, DOI 10.1523/JNEUROSCI.3597-04.2004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nelson ML, 2011, ANN NY ACAD SCI, V1241, P17, DOI 10.1111/j.1749-6632.2011.06354.x; Rana A, 2019, CURR NEUROPHARMACOL, V17, P614, DOI 10.2174/1570159X16666180911121847; Samarghandian S, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1753-9; Santa-Cecilia FV, 2016, NEUROTOX RES, V29, P447, DOI 10.1007/s12640-015-9592-2; Singh S, 2017, NEUROSCI RES; Spaulding K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192720; Sukanya Saha, 2017, Neuroprotective natural products: clinical aspects and mode of action, P23; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wang ZH, 2012, J MOL NEUROSCI, V47, P89, DOI 10.1007/s12031-011-9689-x; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; Yang J., 2013, J SURG RES, V182, pe69	40	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 2	2020	34	8					1039	1050		10.1080/02699052.2020.1772508		JUN 2020	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MK8SK	WOS:000542756600001	32493074				2022-02-06	
J	Sakata, K; Kawano, G; Suda, M; Yokochi, T; Yae, Y; Imagi, T; Akita, Y; Ohbu, K; Matsuishi, T				Sakata, Kensuke; Kawano, Go; Suda, Masao; Yokochi, Takaoki; Yae, Yukako; Imagi, Toru; Akita, Yukihiro; Ohbu, Keizo; Matsuishi, Toyojiro			Determinants of outcomes for acute encephalopathy with reduced subcortical diffusion	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; GLUTAMATE TRANSPORTER; BIPHASIC SEIZURES; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; DELAYED HYPOTHERMIA; PROGNOSTIC-FACTORS; HYPOXIA-ISCHEMIA; EXPRESSION; GLT-1	Acute encephalopathy with reduced subcortical diffusion (AED), characterised by seizure onset and widespread reduced apparent diffusion coefficient in the cortex/subcortical white matter, is one of the most common acute encephalopathies in children in East Asia. This 14-year single-centre retrospective study on 34 patients with AED showed that therapeutic hypothermia was used for patients with more severe consciousness disturbance after the first seizure or second phase initiation, extrapolating from neonatal hypoxic encephalopathy and adult post-cardiac arrest syndrome. The basal ganglia/thalamus lesions and the Tada score were the poor outcome determinants in the multivariate analysis. The correlation between the worse outcomes and the duration from the first seizure to the initiation of therapeutic hypothermia was observed only in the patients with AED cooled before the second phase. This correlation was not observed in the overall AED population. There was a moderate negative association between the worse outcomes and the duration between the first seizure and the second phase. Therefore, the basal ganglia/thalamus lesions and the Tada score were the outcome determinants for patients with AED. Further investigation is required to examine the efficacy of therapeutic hypothermia in this population while considering the timing of the therapeutic hypothermia initiation and the second phase.	[Sakata, Kensuke; Kawano, Go; Suda, Masao; Yokochi, Takaoki; Imagi, Toru; Akita, Yukihiro; Ohbu, Keizo; Matsuishi, Toyojiro] St Marys Hosp, Dept Paediat, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan; [Yae, Yukako] Kurume Univ Hosp, Dept Paediat, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan; [Matsuishi, Toyojiro] St Marys Hosp, Res Ctr Children, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan; [Matsuishi, Toyojiro] St Marys Hosp, Res Ctr Rett Syndrome, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan		Kawano, G (corresponding author), St Marys Hosp, Dept Paediat, 422 Tsubukuhonmachi, Kurume, Fukuoka 8308543, Japan.	g-kawano@st-mary-med.or.jp	Kawano, Go/AAI-5080-2021	Kawano, Go/0000-0003-2962-0556			Azuma J, 2015, BRAIN DEV-JPN, V37, P191, DOI 10.1016/j.braindev.2014.04.001; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Duff JP, 2019, CIRCULATION, V140, pE904, DOI 10.1161/CIR.0000000000000731; Ezzati M, 2014, ACTA ANAESTH SCAND, V58, P733, DOI 10.1111/aas.12318; Ezzati M, 2017, DEV NEUROSCI-BASEL, V39, P156, DOI 10.1159/000458438; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hayashi N, 2012, BRAIN DEV-JPN, V34, P632, DOI 10.1016/j.braindev.2011.11.007; Holzer M, 2002, NEW ENGL J MED, V346, P549; HORAN M J, 1987, Pediatrics, V79, P1; Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2010, DEV NEUROSCI-BASEL, V32, P406, DOI 10.1159/000323260; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Japanese Society of Cild Neurology, 2016, GUID MAN HEL PYL INF, P46; Kawano G, 2011, ARCH DIS CHILD, V96, P936, DOI 10.1136/adc.2009.180554; Lee S, 2016, J NEUROL SCI, V370, P39, DOI 10.1016/j.jns.2016.09.018; Li YH, 2015, MOL MED REP, V11, P1991, DOI 10.3892/mmr.2014.2928; Mahmoud S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020184; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Murata S, 2016, BRAIN DEV-JPN, V38, P317, DOI 10.1016/j.braindev.2015.09.003; O'Mara K, 2018, AJP REP, V8, pe168, DOI 10.1055/s-0038-1669938; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Okumura A, 2009, AM J NEURORADIOL, V30, P825, DOI 10.3174/ajnr.A1431; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Tada H, 2004, NEUROLOGY, V63, P1854, DOI 10.1212/01.WNL.0000144274.12174.CB; Tada H, 2015, J NEUROL SCI, V358, P62, DOI 10.1016/j.jns.2015.08.016; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Takanashi JI, 2018, BRAIN DEV-JPN, V40, P947, DOI 10.1016/j.braindev.2018.06.004; Wang B, 2016, NEUROSCIENCE, V316, P296, DOI 10.1016/j.neuroscience.2015.12.046; Yadav Saroj S, 2013, J Pediatr Neurosci, V8, P64, DOI 10.4103/1817-1745.111429; Yokochi T, 2016, BRAIN DEV-JPN, V38, P217, DOI 10.1016/j.braindev.2015.07.007; Zhang W, 2017, PEDIATR NEUROL, V74, P51, DOI 10.1016/j.pediatrneurol.2017.04.023	38	5	5	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 4	2020	10	1							9134	10.1038/s41598-020-66167-7			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LY3VJ	WOS:000540456100006	32499614	Green Published, gold			2022-02-06	
J	Lagerstedt, L; Azurmendi, L; Tenovuo, O; Katila, AJ; Takala, RSK; Blennow, K; Newcombe, VFJ; Maanpaa, HR; Tallus, J; Hossain, I; van Gils, M; Menon, DK; Hutchinson, PJ; Zetterberg, H; Posti, JP; Sanchez, JC				Lagerstedt, Linnea; Azurmendi, Leire; Tenovuo, Olli; Katila, Ari J.; Takala, Riikka S. K.; Blennow, Kaj; Newcombe, Virginia F. J.; Maanpaa, Henna-Riikka; Tallus, Jussi; Hossain, Iftakher; van Gils, Mark; Menon, David K.; Hutchinson, Peter J.; Zetterberg, Henrik; Posti, Jussi P.; Sanchez, Jean-Charles			Interleukin 10 and Heart Fatty Acid-Binding Protein as Early Outcome Predictors in Patients With Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						biomarker; heart fatty-acid binding protein; interleukin 10; panel; protein; outcome; traumatic brain injury	TISSUE DISTRIBUTION; S100B; BIOMARKER; CLASSIFICATION; CONSCIOUSNESS; DIAGNOSIS; PANEL	Background:Patients with traumatic brain injury (TBI) exhibit a variable and unpredictable outcome. The proteins interleukin 10 (IL-10) and heart fatty acid-binding protein (H-FABP) have shown predictive values for the presence of intracranial lesions. Aim:To evaluate the individual and combined outcome prediction ability of IL-10 and H-FABP, and to compare them to the more studied proteins S100 beta, glial fibrillary acidic protein (GFAP), and neurofilament light (NF-L), both with and without clinical predictors. Methods:Blood samples from patients with acute TBI (all severities) were collected 6 months post injury using the Glasgow Outcome Scale Extended (GOSE) score, dichotomizing patients into: (i) those with favorable (GOSE >= 5)/unfavorable outcome (GOSE <= 4) and complete (GOSE = 8)/incomplete (GOSE <= 7) recovery, and (ii) patients with mild TBI (mTBI) and patients with TBIs of all severities. Results:When sensitivity was set at 95-100%, the proteins' individual specificities remained low. H-FABP showed the best specificity (%) and sensitivity (100%) in predicting complete recovery in patients with mTBI. IL-10 had the best specificity (50%) and sensitivity (96%) in identifying patients with favorable outcome in patients with TBIs of all severities. When individual proteins were combined with clinical parameters, a model including H-FABP, NF-L, and ISS yielded a specificity of 56% and a sensitivity of 96% in predicting complete recovery in patients with mTBI. In predicting favorable outcome, a model consisting IL-10, age, and TBI severity reached a specificity of 80% and a sensitivity of 96% in patients with TBIs of all severities. Conclusion:Combining novel TBI biomarkers H-FABP and IL-10 with GFAP, NF-L and S100 beta and clinical parameters improves outcome prediction models in TBI.	[Lagerstedt, Linnea; Azurmendi, Leire; Sanchez, Jean-Charles] Univ Geneva, Dept Special Internal Med, Fac Med, Geneva, Switzerland; [Tenovuo, Olli; Maanpaa, Henna-Riikka; Hossain, Iftakher; Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Tenovuo, Olli; Maanpaa, Henna-Riikka; Tallus, Jussi; Hossain, Iftakher; Posti, Jussi P.] Univ Turku, Dept Clin Neurosci, Turku, Finland; [Katila, Ari J.; Takala, Riikka S. K.] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Katila, Ari J.; Takala, Riikka S. K.] Univ Turku, Turku, Finland; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Sahlgrenska Acad, Molndal, Sweden; [Newcombe, Virginia F. J.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Dept Med, Cambridge, England; [Maanpaa, Henna-Riikka; Hossain, Iftakher; Posti, Jussi P.] Turku Univ, Div Clin Neurosci, Dept Neurosurg, Hosp Turku, Turku, Finland; [van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Knowledge Intens Prod & Serv, Tampere, Finland; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Hutchinson, Peter J.] Cambridge BRC, Natl Inst Hlth Res, Cambridge, England; [Hutchinson, Peter J.] Royal Coll Surgeons England, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England		Sanchez, JC (corresponding author), Univ Geneva, Dept Special Internal Med, Fac Med, Geneva, Switzerland.		Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Hossain, Iftakher/0000-0003-4836-1158; van Gils, Mark/0000-0002-0029-1771; Newcombe, Virginia/0000-0001-6044-9035	Academy of FinlandAcademy of FinlandEuropean Commission [17379]; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Finnish Brain Foundation; Emil Aaltonen Foundation; Maire Taponen Foundation	Dr. Posti has received funding from the Academy of Finland (Grant #17379) and Government's Special Financial Transfer tied to academic research in Health Sciences (Finland). Dr. Posti has also received a grant from the Finnish Brain Foundation, a grant from the Emil Aaltonen Foundation, as well as a grant from the Maire Taponen Foundation.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Azurmendi L, 2017, J TRANSL SCI, V3, P1, DOI [10.15761/JTS.1000184, DOI 10.15761/JTS.1000184]; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Calderon-Santiago M, 2015, ANAL BIOANAL CHEM, V407, P5381, DOI 10.1007/s00216-015-8700-8; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Hainard A, 2013, TRANSLANT PROTEOMICS, V1, P57, DOI [10.1016/J.TRPROT.2013.04.003, DOI 10.1016/J.TRPROT.2013.04.003, 10.1016/j.trprot.2013.04.003]; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200394; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; NICE, 2019, HEAD INJURY ASSESSME; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Robin X, 2009, EXPERT REV PROTEOMIC, V6, P675, DOI 10.1586/EPR.09.83; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tiberti N, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-1; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; VEERKAMP JH, 1990, MOL CELL BIOCHEM, V98, P11, DOI 10.1007/BF00231362; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	47	5	5	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 2	2020	11								376	10.3389/fneur.2020.00376			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MD3DT	WOS:000543852600001	32581990	Green Published, gold			2022-02-06	
J	Acton, AS; Gaw, CE; Chounthirath, T; Smith, GA				Acton, Amy S.; Gaw, Christopher E.; Chounthirath, Thitphalak; Smith, Gary A.			Nonfatal horse-related injuries treated in emergency departments in the United States, 1990-2017	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Equestrian; Horse; Trauma; Injury	TRAUMATIC BRAIN-INJURY; EQUESTRIAN INJURIES; ACCIDENTS; CHILDREN; IMPACT; SPORT; RISK	Background: Horse -related injuries can cause severe morbidity and mortality. The objective of this study is to in- vestigate the epidemiological features of horse -related injuries treated in emergency departments (EDs) in the United States. Methods: A retrospective analysis of horse -related injuries from 1990 through 2017 was conducted utilizing the National Electronic Injury Surveillance System (NEISS). Cases were identi fied using the NEISS code 1239 (Horse- back Riding: Activity, Apparel, or Equipment). Analyses performed included calculation of national injury esti- mates, relative risks (RRs) with 95% con fidence intervals (CIs), and linear regression. Results: From 1990 through 2017, an estimated 1,836,536 (95% CI: 1,494,788-2,178,284) individuals presented to United States EDs with horse -related injuries. The annual injury rate decreased by 30.8% from 1990 to 1996, in- creased by 33.0% from 1996 to 2000, and then decreased by 46.0% from 2000 to 2017. Among older adults 60 years of age, the annual injury rate increased by 139.6% during the study period. The number of concussion and closed head injury diagnoses increased by 337.2% from 1990 to 2009. The most common mounted mecha- nism of injury was a fall or being thrown (73.9%), while the most common unmounted mechanism was being kicked (42.1%). Mounted injuries were more likely to lead to hospitalization than unmounted injuries (RR, 2.10, 95% CI: 1.59 -2.77). Conclusions: Despite the recent decline in horse -related injuries, these injuries are still common. Clinicians should be aware of the spectrum of ED presentations of horse -related injuries. Prevention efforts focused on older adults and concussions and closed head injuries warrant special attention.	[Acton, Amy S.; Gaw, Christopher E.; Chounthirath, Thitphalak; Smith, Gary A.] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA; [Acton, Amy S.] Columbus Fdn, Columbus, OH USA; [Gaw, Christopher E.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Smith, Gary A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Smith, Gary A.] Child Injury Prevent Alliance, Columbus, OH USA		Smith, GA (corresponding author), Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	gary.smith@nationwidechildrens.org	Gaw, Christopher/ABI-2314-2020	Gaw, Christopher/0000-0002-2847-6372			Abdulkarim A, 2018, EMERG MED INT, V2018, DOI 10.1155/2018/7394390; Allen CG, 2019, CANCER CONTROL, V26, DOI 10.1177/1073274819846603; ASTMInternational, 2015, F116315 ASTM ASTM IN; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Bier G, 2018, BRIT J NEUROSURG, V32, P37, DOI 10.1080/02688697.2017.1409874; Bixby-Hammett Doris M, 2006, N C Med J, V67, P161; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; BIXBYHAMMETT DM, 1992, PEDIATRICS, V89, P1173; BIXBYHAMMETT DM, 1987, AM FAM PHYSICIAN, V36, P209; BOND GR, 1995, PEDIATRICS, V95, P487; Carrillo EH, 2007, SCAND J SURG, V96, P79, DOI 10.1177/145749690709600115; Chapman M, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6050033; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; CHRISTEY GL, 1994, J FAM PRACTICE, V39, P148; Clarke CN, 2008, AM J SURG, V195, P702, DOI 10.1016/j.amjsurg.2007.11.007; Cripps RA, 2000, AUSTR INJURY PREVENT, V24; Davidson SB, 2015, J EMERG MED, V49, P605, DOI 10.1016/j.jemermed.2015.03.025; DeAraugo J, 2016, ANIMALS, V6, DOI 10.3390/ani6020012; Forrester JA, 2018, WILD ENVIRON MED, V29, P36, DOI 10.1016/j.wem.2017.10.004; Ghosh A, 2000, J PEDIATR SURG, V35, P1766, DOI 10.1053/jpsu.2000.19247; Nguyen HS, 2016, PEDIATR NEUROSURG, V51, P279, DOI 10.1159/000446402; Havlik HS, 2010, CURR SPORT MED REP, V9, P299, DOI 10.1249/JSR.0b013e3181f32056; Hawson LA, 2010, J VET BEHAV, V5, P324, DOI 10.1016/j.jveb.2010.06.001; Kleine K., CURRENT TRENDS HORSE; Kriss TC, 1997, J TRAUMA, V43, P97, DOI 10.1097/00005373-199707000-00022; Kruger L, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000408; Lang J, 2014, J TRAUMA ACUTE CARE, V76, P205, DOI 10.1097/TA.0b013e3182a9007e; McCrory P, 2005, MED SPORT SCI, V48, P8, DOI 10.1159/000084280; Meredith L, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000398; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; NELSON DE, 1994, AM J PREV MED, V10, P15, DOI 10.1016/S0749-3797(18)30641-X; NELSON MA, 1992, PEDIATRICS, V89, P512; Newton AM, 2005, J EMERG NURS, V31, P442, DOI 10.1016/j.jen.2005.08.009; Pollard K, 2010, INT J HEALTH CARE Q, V23, DOI 10.1108/ijhcqa.2010.06223cae.003; Riders4Helmets, 2019, RIDERS4HELMETS INT A; Salem DJ, 2007, STATE ANIMALS 4 2007; Sandiford Nemandra, 2013, JRSM Short Rep, V4, p2042533313476688, DOI 10.1177/2042533313476688; Schroeder T., 2001, NEISS SAMPLE DESIGN; Smartt P, 2009, J SCI MED SPORT, V12, P376, DOI 10.1016/j.jsams.2008.04.001; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Sport & Fitness Industry Association, 2013, SPORTS MARK SURV US; Thomas K., 2008, NEW YORK TIMES; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; Thompson K, 2015, ANIMALS, V5, P561, DOI 10.3390/ani5030372; U.S. Consumer Product Safety Commission, 2000, NEISS NAT EL INJ SUR; US Census Bureau, 2018, ANN EST RES POP SING; USEF Communications Department, USEF PASS NEW SAF HE; Watt GM, 1996, SPORTS MED, V22, P187, DOI 10.2165/00007256-199622030-00005; Wolyncewicz GEL, 2018, INJURY, V49, P933, DOI 10.1016/j.injury.2017.12.003	49	5	5	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUN	2020	38	6					1062	1068		10.1016/j.ajem.2019.158366			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	MB9VR	WOS:000542946100004	31402233				2022-02-06	
J	Grasset, L; Glymour, MM; Yaffe, K; Swift, SL; Gianattasio, KZ; Power, MC; Al Hazzouri, AZ				Grasset, Leslie; Glymour, M. Maria; Yaffe, Kristine; Swift, Samuel L.; Gianattasio, Kan Z.; Power, Melinda C.; Al Hazzouri, Adina Zeki			Association of traumatic brain injury with dementia and memory decline in older adults in the United States	ALZHEIMERS & DEMENTIA			English	Article						cognitive decline; dementia; longitudinal; traumatic brain injury	ALZHEIMERS-DISEASE; HEAD-INJURY; EARLIER AGE; RISK; ONSET; HISTORY; CONSCIOUSNESS; EPIDEMIOLOGY; COGNITION; MODERATE	Introduction: To examine associations of history of traumatic brain injuries (TBIs) with loss of consciousness (LOC) with dementia incidence and memory decline. Methods: We studied 2718 participants from the 1992 enrollment cohort of the Health and Retirement Study (HRS) aged 65 years or older in 2000. History of TBI with LOC was self-reported in 1992. Dementia was assessed using four algorithms established in HRS. Participants were followed from 2000 to 2014 with repeated measures of dementia and memory performance. Cox models and linear mixed-effects models were used. Results: In 1992, 11.9% of the participants reported a history of TBI with LOC. In fully adjusted models for all four algorithms, participants with a history of TBI with LOC had no statistically significant difference in dementia incidence nor in memory decline, compared to participants without TBI history. Discussion: Our study did not find evidence of a long-term association between history of TBI with LOC (of unknown frequency and severity) and dementia incidence or memory decline.	[Grasset, Leslie] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, Team VINTAGE,UMR 1219, Bordeaux, France; [Grasset, Leslie] INSERM, CIC1401 EC, Bordeaux, France; [Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol Epidemiol & Biostat, San Francisco, CA 94143 USA; [Swift, Samuel L.] Univ Miami, Dept Publ Hlth Sci, Div Epidemiol, Coral Gables, FL 33124 USA; [Gianattasio, Kan Z.; Power, Melinda C.] George Washington Univ, Milken Inst Sch Publ Heath, Dept Epidemiol & Biostat, Washington, DC USA; [Al Hazzouri, Adina Zeki] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA		Grasset, L (corresponding author), Univ Bordeaux, INSERM U1219, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	leslie.grasset@u-bordeaux.fr	Grasset, Leslie/A-3351-2016	Grasset, Leslie/0000-0003-2812-0103	National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG055486, R03AG055485]	National Institute of Aging, Grant/AwardNumber: RF1AG055486; National Institute of Aging, Grant/Award Number: R03AG055485	Alzheimer's Association, 2010, ALZHEIMERS DEMENT, V6, DOI [DOI 10.1016/J.JALZ.2014.02.001, 10.1016/j.jalz.2010.01.009]; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002246; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Gianattasio KZ, 2019, EPIDEMIOLOGY, V30, P291, DOI [10.1097/EDE.0000000000000945, 10.1097/ede.0000000000000945]; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Herzog AR, 1997, J GERONTOL B-PSYCHOL, V52, P37, DOI 10.1093/geronb/52B.Special_Issue.37; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nichols E, 2019, LANCET NEUROL, V18, P88, DOI 10.1016/S1474-4422(18)30403-4; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prince M, 2015, ALZHEIMERS DIS INT W; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sugarman MA, 2019, ALZHEIMERS DEMENT, V15, P686, DOI 10.1016/j.jalz.2018.12.015; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tripodis Y, 2017, J ALZHEIMERS DIS, V59, P251, DOI 10.3233/JAD-160585; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Weiner MW, 2017, NEUROLOGY, V89, P1923, DOI 10.1212/WNL.0000000000004608; Weiner Michael W, 2017, Alzheimers Dement (N Y), V3, P177, DOI 10.1016/j.trci.2017.02.005; Wu Q, 2013, ALZ DIS ASSOC DIS, V27, P207, DOI 10.1097/WAD.0b013e31826cfe90; Yaffe K, 2019, NEUROLOGY, V92, pE205, DOI 10.1212/WNL.0000000000006778	47	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2020	16	6					853	861		10.1002/alz.12080			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OA6CF	WOS:000577870000004	32323483	Green Accepted			2022-02-06	
J	Ma, XT; Cheng, YM; Garcia, R; Haorah, J				Ma, Xiaotang; Cheng, Yiming; Garcia, Ricardo; Haorah, James			Hemorrhage Associated Mechanisms of Neuroinflammation in Experimental Traumatic Brain Injury	JOURNAL OF NEUROIMMUNE PHARMACOLOGY			English	Article						Traumatic brain injury; Hemorrhage; CSF; Coagulation; Neuronal death	HEAD-INJURY; ALZHEIMERS-DISEASE; SUBARACHNOID HEMORRHAGE; UNITED-STATES; COAGULATION; PREVALENCE; NEURONS; RISK; COAGULOPATHY; MICROTHROMBI	Traumatic brain injury (TBI) is a major health problem for over 3.17 million people in the US, attracting increasing public attentions. Understanding the underlying mechanism of TBI is urgent for better diagnosis and treatment. Here, we examined the hypothesis that cerebral hemorrhagic coagulation and subsequent immune cells infiltration causes the progressive mechanisms of brain injury in moderate fluid percussion injury model. This represents a subdural hematoma and hemorrhagic head injury. We found increased hemorrhagic lesions and infarct volume in the injured brain with increment of pressure. The extent of hemorrhage was also validated by the bio-distribution of fluorescent tracer in cerebrospinal fluid (CSF) pathway after the injury. Bio-distribution of tracer was specifically diminished at the site of hemorrhage resulting from coagulation, which blocked the interstitial and CSF movement of the tracer. Increased expression of coagulation factor XII and necrotic cell death in and around the impact site confirmed the reason for this blockade. Different biomarkers, including immune cells accumulation and neuronal death showed that blood-brain barrier disruption played an important role for induction of neuroinflammation and neurodegeneration around the impact site. Our results suggest that instant hemorrhagic injury resulting from rupturing the brain blood vessels intertwined with coagulation causes onsite perivascular inflammation and neurodegeneration. Understanding of this sequential event should be valuable for development of therapeutic treatment in TBI. Underlying mechanisms in moderate/severe blunt TBI: hemorrhage following cerebrovascular disruption results in coagulation, thrombotic necrosis, and acute immune cell infiltration.	[Ma, Xiaotang; Cheng, Yiming; Garcia, Ricardo; Haorah, James] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, Lab Neurovasc Inflammat & Neurodegenerat, Newark, NJ 07102 USA		Haorah, J (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, Lab Neurovasc Inflammat & Neurodegenerat, Newark, NJ 07102 USA.	james.haorah@njit.edu	Ma, Xiaotang/AAX-9062-2020	Cheng, Yiming/0000-0001-5428-9418; Garcia, Ricardo/0000-0002-5659-6048	NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21AA022734-01A1] Funding Source: Medline		Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Albert-Weissenberger C, 2019, J NEUROIMMUNOL, V326, P9, DOI 10.1016/j.jneuroim.2018.10.011; Allingstrup M, 2016, INTENS CARE MED, V42, P505, DOI 10.1007/s00134-016-4225-7; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Charolidi N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128463; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dijkland SA, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6401; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Faust K, 2014, CLIN NEUROL NEUROSUR, V125, P36, DOI 10.1016/j.clineuro.2014.06.023; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Goldberg AS, 2007, SPORTS MED, V37, P265, DOI 10.2165/00007256-200737030-00005; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grenander A, 2001, J NEUROSURG ANESTH, V13, P49, DOI 10.1097/00008506-200101000-00010; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kooijman E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090584; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Liu DZ, 2014, J NEUROTRAUM, V31, P1268, DOI 10.1089/neu.2013.3250; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Merlini M, 2016, ACTA NEUROPATHOL, V131, P737, DOI 10.1007/s00401-016-1560-2; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ofengeim D, 2017, P NATL ACAD SCI USA, V114, pE8788, DOI 10.1073/pnas.1714175114; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Ray Jeremiah W, 2017, J Calif Dent Assoc, V45, P285; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Robba C, 2017, CURR OPIN ANESTHESIO, V30, P527, DOI 10.1097/ACO.0000000000000496; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Schamasch P, 2006, NEUROSURG FOCUS, V21, DOI DOI 10.3171/FOC.2006.21.4.4; Schwarzmaier SM, 2016, J NEUROTRAUM, V33, P1634, DOI 10.1089/neu.2015.4173; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shen X, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000077; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Su XF, 2015, NEUROCHEM RES, V40, P643, DOI 10.1007/s11064-014-1510-0; Tang QL, 2017, NEUROREHABILITATION, V40, P23, DOI 10.3233/NRE-161387; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	67	5	5	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1557-1890	1557-1904		J NEUROIMMUNE PHARM	J. Neuroimmune Pharm.	JUN	2020	15	2					181	195		10.1007/s11481-019-09882-x			15	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy	LU1DJ	WOS:000537502100004	31773643				2022-02-06	
J	Ono, Y; Tanaka, Y; Sako, K; Tanaka, M; Fujimoto, J				Ono, Yoshiaki; Tanaka, Yuto; Sako, Kazuki; Tanaka, Masahiro; Fujimoto, Junya			Association between Sports-Related Concussion and Mouthguard Use among College Sports Players: A Case-Control Study Based on Propensity Score Matching	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						concussion; mouthguard; propensity score	PROTECTIVE EQUIPMENT; NONRESPONSE BIAS; FOOTBALL PLAYERS; RUGBY UNION; PREVENTION; EPIDEMIOLOGY; INJURY; IMPACT; RATES	Sports-related concussion (SRC) is a major public health concern. This study aimed to assess the association between mouthguard use and the incidence of SRC in college students through a case-control study using propensity score matching. In total, 195 of 2185 potential participants volunteered to participate in this study. We used Google Forms online to capture participants' information, including: age; gender; height; weight; sports contact level; level of play; exposure time; frequency of mouthguard use; mouthguard type; and SRC experience. Data for 115 participants who played collision and contact sports were used for the analysis. The difference in the frequency of mouthguard use was assessed between matched pairs and the overall association between SRC and mouthguard use was evaluated. In the matched groups, those who had not experienced SRC wore a mouthguard more frequently than those who had experienced SRC (7/28 vs. 1/28;p= 0.051). Logistic regression analysis showed there was a significant negative association between the frequency of mouthguard use and the incidence of SRC (odds ratio 0.101;p= 0.041). Within the limitations of this study, these results suggest that mouthguard use may offer some benefit in preventing SRC.	[Ono, Yoshiaki; Tanaka, Yuto] Osaka Dent Univ Hosp, Dept Special Care Dent, Chuo Ku, 1-5-17 Otemae, Osaka 5700008, Japan; [Sako, Kazuki; Tanaka, Masahiro] Osaka Dent Univ, Dept Fixed Prosthodont & Occlus, Osaka 5400008, Japan; [Fujimoto, Junya] Osaka Univ Hlth & Sport Sci, Dept Hlth & Sport Management, Osaka 5900496, Japan		Tanaka, Y (corresponding author), Osaka Dent Univ Hosp, Dept Special Care Dent, Chuo Ku, 1-5-17 Otemae, Osaka 5700008, Japan.	yoshiaki@cc.osaka-dent.ac.jp; tanaka-y@cc.osaka-dent.ac.jp; sako-k@cc.osaka-dent.ac.jp; tanaka-m@cc.osaka-dent.ac.jp; fujimoto@ouhs.ac.jp		Sako, Kazuki/0000-0002-2881-4896; Tanaka, Yuto/0000-0001-5859-5519	KakenhiMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [19K19964]	This study was supported by Kakenhi (Grant-in-Aid for Early-Career Scientists No. 19K19964 to Y.T.).	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Chisholm DA, 2020, BRIT J SPORT MED, V54, P866, DOI 10.1136/bjsports-2019-101011; Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Fernandes LM, 2019, DENT TRAUMATOL, V35, P54, DOI 10.1111/edt.12441; Galic T, 2018, DENT TRAUMATOL, V34, P175, DOI 10.1111/edt.12394; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; Jennings D C, 1990, Br J Sports Med, V24, P159; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Phillips AW, 2016, MED TEACH, V38, P217, DOI 10.3109/0142159X.2015.1105945; ROSENBAUM PR, 1987, BIOMETRIKA, V74, P13, DOI 10.2307/2336017; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Takeda T, 2004, DENT TRAUMATOL, V20, P12, DOI 10.1111/j.1600-4469.2004.00210.x; Tanaka Y, 2015, INT J SPORTS MED, V36, P254, DOI 10.1055/s-0034-1390498; Tanaka Y, 2017, DENT TRAUMATOL, V33, P51, DOI 10.1111/edt.12283; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Winters Jackson, 2014, General Dentistry, V62, P34; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	29	5	5	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JUN	2020	17	12							4493	10.3390/ijerph17124493			9	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	MR9SU	WOS:000553929900001	32580527	gold, Green Published			2022-02-06	
J	Schindler, CR; Lustenberger, T; Woschek, M; Stormann, P; Henrich, D; Radermacher, P; Marzi, I				Schindler, Cora Rebecca; Lustenberger, Thomas; Woschek, Mathias; Stoermann, Philipp; Henrich, Dirk; Radermacher, Peter; Marzi, Ingo			Severe Traumatic Brain Injury (TBI) Modulates the Kinetic Profile of the Inflammatory Response of Markers for Neuronal Damage	JOURNAL OF CLINICAL MEDICINE			English	Article						multiple trauma; traumatic brain injury (TBI); risk prediction; biomarker; IL-6; IL-10; posttraumatic inflammation; S100b; NSE; GFAP	FIBRILLARY ACIDIC PROTEIN; EARLY IL-6; PLASMA; INTERLEUKIN-6; EXPRESSION; BIOMARKERS; CORRELATE; BARRIER; ENOLASE	The inflammatory response plays an important role in the pathophysiology of multiple injuries. This study examines the effects of severe trauma and inflammatory response on markers of neuronal damage. A retrospective analysis of prospectively collected data in 445 trauma patients (Injury Severity Score (ISS) >= 16) is provided. Levels of neuronal biomarkers (calcium-binding Protein B (S100b), Enolase2 (NSE), glial fibrillary acidic protein (GFAP)) and Interleukins (IL-6, IL-10) in severely injured patients (with polytrauma (PT)) without traumatic brain injury (TBI) or with severe TBI (PT+TBI) and patients with isolated TBI (isTBI) were measured upon arrival until day 5. S100b, NSE, GFAP levels showed a time-dependent decrease in all cohorts. Their expression was higher after multiple injuries (p= 0.038) comparing isTBI. Positive correlation of marker level after concomitant TBI and isTBI (p= 0.001) was noted, while marker expression after PT appears to be independent. Highest levels of IL-6 and -10 were associated to PT und lowest to isTBI (p< 0.001). In all groups pro-inflammatory response (IL-6/-10 ratio) peaked on day 2 and at a lower level on day 4. Severe TBI modulates kinetic profile of inflammatory response by reducing interleukin expression following trauma. Potential markers for neuronal damage have a limited diagnostic value after severe trauma because undifferentiated increase.	[Schindler, Cora Rebecca; Lustenberger, Thomas; Woschek, Mathias; Stoermann, Philipp; Henrich, Dirk; Marzi, Ingo] Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60596 Frankfurt, Germany; [Radermacher, Peter] Univ Med Sch, Inst Anesthesiol Pathophysiol & Proc Engn, D-89070 Ulm, Germany		Schindler, CR (corresponding author), Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, D-60596 Frankfurt, Germany.	cora.schindler@kgu.de; tom.lustenberg@gmail.com; mathias.woschek@kgu.de; philipp.stoermann@kgu.de; d.henrich@trauma.uni-frankfurt.de; peter.radermacher@uni-ulm.de; marzi@trauma.uni-frankfurt.de		Stormann, Philipp/0000-0003-3584-2518; Henrich, Dirk/0000-0002-9728-4032	 [CRC 1149]	P.R. was funded by the CRC 1149.	Backstrom D, 2018, EUR J TRAUMA EMERG S, V44, P589, DOI 10.1007/s00068-017-0827-1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balogh ZJ, 2018, EUR J TRAUMA EMERG S, V44, P299, DOI 10.1007/s00068-018-0964-1; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Bouillon B, 2004, UNFALLCHIRURG, V107, P844, DOI 10.1007/s00113-004-0847-2; Burmeister AR, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00458; Cohen SS, 2013, NEUROIMMUNOMODULAT, V20, P264, DOI 10.1159/000350470; Crawford AM, 2019, J TRAUMA ACUTE CARE, V87, pS146, DOI 10.1097/TA.0000000000002256; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; de Souza DF, 2013, PROG NEURO-PSYCHOPH, V43, P14, DOI 10.1016/j.pnpbp.2012.12.001; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Foerch C, 2014, NERVENARZT, V85, P982, DOI 10.1007/s00115-014-4128-1; Frink M, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-49; Frohlich M, 2020, EUR J TRAUMA EMERG S, V46, P1463, DOI 10.1007/s00068-019-01285-0; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Haasper C, 2010, UNFALLCHIRURG, V113, P366, DOI 10.1007/s00113-010-1778-8; Hainfellner JA, 2001, J NEUROPATH EXP NEUR, V60, P449, DOI 10.1093/jnen/60.5.449; Halbgebauer R, 2018, J CRIT CARE, V44, P229, DOI 10.1016/j.jcrc.2017.11.025; Hsieh YH, 2011, SHOCK, V36, P424, DOI 10.1097/SHK.0b013e3182295f91; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nomellini V, 2018, SHOCK, V49, P4, DOI 10.1097/SHK.0000000000000939; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Pan PF, 2019, NEUROL SCI, V40, P1105, DOI 10.1007/s10072-019-03739-0; Park DW, 2019, CHILD NERV SYST, V35, P343, DOI 10.1007/s00381-018-3955-y; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Sapan HB, 2017, CHIN J TRAUMATOL, V20, P318, DOI 10.1016/j.cjtee.2017.05.003; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stormann P, 2020, EUR J TRAUMA EMERG S, V46, P31, DOI 10.1007/s00068-019-01098-1; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; van Wessem KJP, 2018, SHOCK, V49, P33, DOI 10.1097/SHK.0000000000000938; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Verboket R, 2019, UNFALLCHIRURG, V122, P618, DOI 10.1007/s00113-018-0566-8; Vogt N, 2018, SHOCK, V49, P164, DOI 10.1097/SHK.0000000000000943; von Elm E, 2008, INTERNIST, V49, P688, DOI 10.1007/s00108-008-2138-4; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wrba L, 2019, SHOCK, V52, pe45, DOI 10.1097/SHK.0000000000001271; Xu CM, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20192732; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6	52	5	5	3	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	JUN	2020	9	6							1667	10.3390/jcm9061667			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ML1HA	WOS:000549224800001	32492963	Green Published, gold			2022-02-06	
J	Wilkerson, GB; Nabhan, DC; Crane, RT				Wilkerson, Gary B.; Nabhan, Dustin C.; Crane, Ryan T.			Concussion History and Neuromechanical Responsiveness Asymmetry	JOURNAL OF ATHLETIC TRAINING			English	Article						reactive agility; logistic regression; musculoskeletal injury risk	REACTION-TIME; RISK-FACTORS; INJURY RISK; ABNORMALITIES; PREDICTORS	Context: Detection of subtle changes in brain sensorimotor processes may enable clinicians to identify athletes who would derive the greatest benefit from interventions designed to reduce the risk for future injury and progressive neurologic or musculoskeletal dysfunction. Objective: To develop a generalizable statistical model for identifying athletes who possess subtle alterations in sensorimotor processes that may be due to previous concussion. Design: Cross-sectional study. Setting: Residential Olympic Training Center sports medicine clinic. Patients or Other Participants: A primary cohort of 35 elite athletes and a secondary cohort of 40 elite athletes who performed identical tests the preceding year. Intervention(s): Two upper extremity tests of visual-motor reaction time and 2 tests of whole-body reactive agility were administered. The whole-body tests required lateral or diagonal responses to virtual-reality targets, which provided measures of reaction time, speed, acceleration, and deceleration. Main Outcome Measure(s): Sport-related concussion history, which was reported by 54% (n = 19) of the athletes in the primary cohort and 45% (n =18) of the athletes in the secondary cohort. Results: Univariable analyses identified 12 strong predictors of sport-related concussion history, which we combined to create a composite metric with maximum predictive value. Composite lateral asymmetry for whole-body reactive movements and persisting effects of previous musculoskeletal injury yielded a logistic regression model with exceptionally good discrimination (area under the curve = 0.845) and calibration (predicted-observed probabilities within 7 subgroups: r = 0.959, P = .001). Application of the derived model to compatible data acquired from another cohort of elite athletes demonstrated very good discrimination (area under the curve = 0.772) and calibration (within 8 subgroups: r = 0.849, P = .008). Conclusions: Asymmetry in whole-body reactive movement capabilities may be a manifestation of a subtle abnormality in the functional connectivity of brain networks that might be relevant to previously reported associations between sportrelated concussion history and musculoskeletal injury occurrence.	[Wilkerson, Gary B.] Univ Tennessee, 615 McCallie Ave,Dept 6606, Chattanooga, TN 37403 USA; [Nabhan, Dustin C.] US Olymp Comm, Colorado Springs, CO USA; [Crane, Ryan T.] Emory Healthcare, Atlanta, GA USA		Wilkerson, GB (corresponding author), Univ Tennessee, 615 McCallie Ave,Dept 6606, Chattanooga, TN 37403 USA.	Gary-Wilkerson@utc.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329			Alba AC, 2017, JAMA-J AM MED ASSOC, V318, P1377, DOI 10.1001/jama.2017.12126; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Bartolomeo P, 2019, CURR OPIN PSYCHOL, V29, P90, DOI 10.1016/j.copsyc.2018.12.023; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Briles MW, RELIABILITY CONCURRE; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; Dieterich M, 2018, CURR OPIN NEUROL, V31, P96, DOI 10.1097/WCO.0000000000000516; Dutta T, 2012, APPL ERGON, V43, P645, DOI 10.1016/j.apergo.2011.09.011; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Edmed S, 2012, PSYCHIAT RES, V200, P41, DOI 10.1016/j.psychres.2012.05.022; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Fueger C, 2018, J CLIN EXP NEUROPSYC, V40, P1074, DOI 10.1080/13803395.2018.1458823; Halilaj E, 2018, J BIOMECH, V81, P1, DOI 10.1016/j.jbiomech.2018.09.009; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Lawrence EL, 2017, J BIOMECH, V63, P1, DOI 10.1016/j.jbiomech.2017.09.013; Lunven M, 2015, BRAIN, V138, P746, DOI 10.1093/brain/awu389; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McGrath TM, 2016, J SPORT SCI, V34, P289, DOI 10.1080/02640414.2015.1050601; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Naito E, 2007, EUR J NEUROSCI, V25, P3476, DOI 10.1111/j.1460-9568.2007.05587.x; Opie GM, 2019, J NEUROTRAUM, V36, P2774, DOI 10.1089/neu.2018.6353; Parr T, 2017, NEUROPSYCHOLOGIA, V104, P92, DOI 10.1016/j.neuropsychologia.2017.08.003; Read PJ, 2018, SCAND J MED SCI SPOR, V28, P1244, DOI 10.1111/sms.13013; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Wilkerson GB, 2018, MED SCI SPORT EXER, V50, P1750, DOI 10.1249/MSS.0000000000001647; Wilkerson GB, 2017, CURR SPORT MED REP, V16, P419, DOI 10.1249/JSR.0000000000000430; Wilkerson GB, 2017, J SPORT REHABIL, V26, P26, DOI 10.1123/jsr.2015-0068; Wilkerson GB, 2016, CLIN J SPORT MED, V26, P423, DOI 10.1097/JSM.0000000000000280; Womack KB, 2017, J NEUROTRAUM, V34, P1539, DOI 10.1089/neu.2016.4670	38	5	5	0	0	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2020	55	6					594	600		10.4085/1062-6050-0401.19			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4ZE	WOS:000566740300006	32396473	gold, Green Published			2022-02-06	
J	Duncan, KA				Duncan, Kelli A.			Estrogen Formation and Inactivation Following TBI: What we Know and Where we Could go	FRONTIERS IN ENDOCRINOLOGY			English	Article						TBI; estrogen; aromatase; androgen; sulfatase; HSD17B	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; AROMATASE MESSENGER-RNA; KAPPA-B ACTIVATION; ZEBRA FINCH; STEROID SULFATASE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-2; DEHYDROEPIANDROSTERONE-SULFATE; NEUROPROTECTIVE ACTIONS; SEXUAL-DIFFERENTIATION	Traumatic brain injury (TBI) is responsible for various neuronal and cognitive deficits as well as psychosocial dysfunction. Characterized by damage inducing neuroinflammation, this response can cause an acute secondary injury that leads to widespread neurodegeneration and loss of neurological function. Estrogens decrease injury induced neuroinflammation and increase cell survival and neuroprotection and thus are a potential target for use following TBI. While much is known about the role of estrogens as a neuroprotective agent following TBI, less is known regarding their formation and inactivation following damage to the brain. Specifically, very little is known surrounding the majority of enzymes responsible for the production of estrogens. These estrogen metabolizing enzymes (EME) include aromatase, steroid sulfatase (STS), estrogen sulfotransferase (EST/SULT1E1), and some forms of 17 beta-hydroxysteroid dehydrogenase (HSD17B) and are involved in both the initial conversion and interconversion of estrogens from precursors. This article will review and offer new prospective and ideas on the expression of EMEs following TBI.	[Duncan, Kelli A.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA; [Duncan, Kelli A.] Vassar Coll, Program Neurosci & Behav, Poughkeepsie, NY 12601 USA		Duncan, KA (corresponding author), Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA.; Duncan, KA (corresponding author), Vassar Coll, Program Neurosci & Behav, Poughkeepsie, NY 12601 USA.	keduncan@vassar.edu		Duncan, Kelli/0000-0002-4488-4456	Vassar College Salmon Fund	This work was supported by Vassar College Salmon Fund to KD.	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Adjei AA, 2003, BRIT J PHARMACOL, V139, P1373, DOI 10.1038/sj.bjp.0705369; AKSOY IA, 1994, BIOCHEM BIOPH RES CO, V200, P1621, DOI 10.1006/bbrc.1994.1637; Almadhidi J, 1996, J STEROID BIOCHEM, V59, P55, DOI 10.1016/S0960-0760(96)00085-4; ARNOLD AP, 1993, BRAIN BEHAV EVOLUT, V42, P231, DOI 10.1159/000114157; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Bae YH, 2000, J KOREAN MED SCI, V15, P327, DOI 10.3346/jkms.2000.15.3.327; Balthazart J, 1998, TRENDS NEUROSCI, V21, P243, DOI 10.1016/S0166-2236(97)01221-6; BALTHAZART J, 1994, BRAIN RES BULL, V35, P339, DOI 10.1016/0361-9230(94)90111-2; Beyer C, 1999, ANAT EMBRYOL, V199, P379, DOI 10.1007/s004290050236; Blackshear K, 2018, J NEUROSCI RES, V96, P545, DOI 10.1002/jnr.24060; Blair IA, 2010, STEROIDS, V75, P297, DOI 10.1016/j.steroids.2010.01.012; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cardounel A, 1999, P SOC EXP BIOL MED, V222, P145, DOI 10.1046/j.1525-1373.1999.d01-124.x; Charlier TD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00083; Cirigliano M, 2007, J WOMENS HEALTH, V16, P600, DOI 10.1089/jwh.2006.0311; Cook S, 2018, NEUROIMMUNOMODULAT, V25, P193, DOI 10.1159/000493506; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Coughtrie M. W. H., 2002, Pharmacogenomics Journal, V2, P297; Cox A, 2015, J NEUROTRAUM, V32, P1413, DOI 10.1089/neu.2014.3730; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; DUMONT M, 1992, J STEROID BIOCHEM, V41, P605, DOI 10.1016/0960-0760(92)90391-U; Duncan K.A., 2013, INDUCIBLE AROMATASE, DOI [10.1093/acprof:oso/9780199841196.003.0020, DOI 10.1093/ACPROF:OSO/9780199841196.003.0020]; Duncan KA, 2020, FRONT NEUROENDOCRIN, V56, DOI 10.1016/j.yfrne.2019.100816; Duncan KA, 2013, HORM BEHAV, V63, P208, DOI 10.1016/j.yhbeh.2012.02.026; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Engler-Chiurazzi EB, 2017, PROG NEUROBIOL, V157, P188, DOI 10.1016/j.pneurobio.2015.12.008; Engler-Chiurazzi EB, 2017, EXP GERONTOL, V94, P99, DOI 10.1016/j.exger.2016.10.013; FALANY CN, 1989, BIOCHEM J, V260, P641, DOI 10.1042/bj2600641; Fitch MT, 1999, J NEUROSCI, V19, P8182; GARCIASEGURA LM, 1994, GLIA, V10, P59, DOI 10.1002/glia.440100108; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; Gursoy E, 2001, NEUROCHEM RES, V26, P15, DOI 10.1023/A:1007668213330; Han D, 2015, MOL CELL ENDOCRINOL, V400, P21, DOI 10.1016/j.mce.2014.11.010; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hilborn E, 2017, ONCOTARGET, V8, P30552, DOI 10.18632/oncotarget.15547; Hill RA, 2009, MOL CELL NEUROSCI, V41, P1, DOI 10.1016/j.mcn.2008.12.009; HOBKIRK R, 1993, TRENDS ENDOCRIN MET, V4, P69, DOI 10.1016/S1043-2760(05)80018-9; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Kaasik A, 2001, NEUROSCIENCE, V102, P427, DOI 10.1016/S0306-4522(00)00489-9; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; Kimonides VG, 1998, P NATL ACAD SCI USA, V95, P1852, DOI 10.1073/pnas.95.4.1852; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Koos RD, 2011, ENDOCRINOLOGY, V152, P4481, DOI 10.1210/en.2011-1449; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JY, 2015, ENDOCRINOLOGY, V156, P1838, DOI 10.1210/en.2014-1832; LEE JH, 2012, ACTA OPHTHALMOL, V2012, DOI DOI 10.1155/2012/361218; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li Zhan-Kui, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P441; Liu XX, 2013, DRUG METAB DISPOS, V41, P602, DOI 10.1124/dmd.112.047910; London SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-47; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Mao XR, 1998, NEUROREPORT, V9, P759, DOI 10.1097/00001756-199803090-00036; Matsuoka R, 2002, STEROIDS, V67, P655, DOI 10.1016/S0039-128X(02)00016-8; McCullough LD, 2003, J NEUROSCI, V23, P8701; McCutcheon V, 2017, J NEUROTRAUM, V34, P1382, DOI 10.1089/neu.2016.4497; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; NAFTOLIN F, 1994, J REPROD MED, V39, P257; Naftolin F, 1996, NEUROENDOCRINOLOGY, V63, P149, DOI 10.1159/000126951; Nardi A, 2009, J STEROID BIOCHEM, V115, P68, DOI 10.1016/j.jsbmb.2009.02.017; Newman SP, 2000, J STEROID BIOCHEM, V75, P259, DOI 10.1016/S0960-0760(00)00177-1; OSAWA Y, 1993, J STEROID BIOCHEM, V44, P469, DOI 10.1016/0960-0760(93)90252-R; Pasqualini JR, 1996, J CLIN ENDOCR METAB, V81, P1460, DOI 10.1210/jc.81.4.1460; Pedersen AL, 2018, PHYSIOL BEHAV, V187, P51, DOI 10.1016/j.physbeh.2017.10.013; Pedersen AL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1040-1; Pedersen AL, 2016, ENDOCRINOLOGY, V157, P2041, DOI 10.1210/en.2015-1991; PELTOKETO H, 1988, FEBS LETT, V239, P73, DOI 10.1016/0014-5793(88)80548-9; Perez E, 2005, BRAIN RES, V1038, P216, DOI 10.1016/j.brainres.2005.01.026; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Pozzi S, 2006, ANN NY ACAD SCI, V1089, P302, DOI 10.1196/annals.1386.035; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Purohit A, 1998, CHEM-BIOL INTERACT, V109, P183, DOI 10.1016/S0009-2797(97)00132-4; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Regan RF, 1997, BRAIN RES, V764, P133, DOI 10.1016/S0006-8993(97)00437-X; Remage-Healey Luke, 2011, Front Endocrinol (Lausanne), V2, P28, DOI 10.3389/fendo.2011.00028; Ren X, 2015, J STEROID BIOCHEM, V150, P54, DOI 10.1016/j.jsbmb.2015.03.010; Rizner TL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00030; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Saldanha CJ, 2005, J NEUROBIOL, V64, P192, DOI 10.1002/neu.20147; Saldanha CJ, 2011, ENDOCR REV, V32, P532, DOI 10.1210/er.2011-0004; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Secky L, 2013, J DRUG DELIV, V2013, DOI DOI 10.1155/2013/957605; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Stocco C, 2012, STEROIDS, V77, P27, DOI 10.1016/j.steroids.2011.10.013; Stoffel-Wagner B, 1999, J ENDOCRINOL, V160, P119, DOI 10.1677/joe.0.1600119; Stoffel-Wagner B, 1999, J STEROID BIOCHEM, V70, P237, DOI 10.1016/S0960-0760(99)00114-4; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; THE VL, 1989, MOL ENDOCRINOL, V3, P1301, DOI 10.1210/mend-3-8-1301; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; Tsutsui Kazuyoshi, 2011, Front Endocrinol (Lausanne), V2, P37, DOI 10.3389/fendo.2011.00037; Tsutsui KSBA, AVIAN ENDOCRINOLOGY, P59; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Voskuhl RR, 2012, NAT REV NEUROL, V8, P255, DOI 10.1038/nrneurol.2012.43; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Wang CL, 2013, MOL BIOL REP, V40, P1073, DOI 10.1007/s11033-012-2149-z; Weaver CE, 1997, P NATL ACAD SCI USA, V94, P10450, DOI 10.1073/pnas.94.19.10450; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; WU L, 1993, J BIOL CHEM, V268, P12964; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Xu YL, 2013, MOL CELL ENDOCRINOL, V369, P140, DOI 10.1016/j.mce.2013.01.020; Yague JG, 2008, BRAIN RES, V1209, P115, DOI 10.1016/j.brainres.2008.02.061; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zaichuk T, 2007, J STEROID BIOCHEM, V105, P76, DOI 10.1016/j.jsbmb.2006.12.101; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019; Zhu C, 2015, NEUROSCIENCE, V304, P328, DOI 10.1016/j.neuroscience.2015.07.057; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	140	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	MAY 29	2020	11								345	10.3389/fendo.2020.00345			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	MA9FQ	WOS:000542216200001	32547495	gold, Green Published			2022-02-06	
J	Lavender, AP; Rawlings, S; Warnock, A; McGonigle, T; Hiles-Murison, B; Nesbit, M; Lam, V; Hackett, MJ; Fitzgerald, M; Takechi, R				Lavender, Andrew P.; Rawlings, Samuel; Warnock, Andrew; McGonigle, Terry; Hiles-Murison, Bailey; Nesbit, Michael; Lam, Virginie; Hackett, Mark J.; Fitzgerald, Melinda; Takechi, Ryusuke			Repeated Long-Term Sub-concussion Impacts Induce Motor Dysfunction in Rats: A Potential Rodent Model	FRONTIERS IN NEUROLOGY			English	Article						beamwalk; mild traumatic brain injury; neuromotor function; rotarod; sub-concussion	TRAUMATIC BRAIN-INJURY; HEAD IMPACTS; SPORT	Whilst detrimental effects of repeated sub-concussive impacts on neurophysiological and behavioral function are increasingly reported, the underlying mechanisms are largely unknown. Here, we report that repeated sub-concussion with a light weight drop (25 g) in wild-type PVG rats for 2 weeks does not induce detectable neuromotor dysfunction assessed by beamwalk and rotarod tests. However, after 12 weeks of repeated sub-concussion, the rats exhibited moderate neuromotor dysfunction. This is the first study to demonstrate development of neuromotor dysfunction following multiple long-term sub-concussive impacts in rats. The outcomes may offer significant opportunity for future studies to understand the mechanisms of sub-concussion-induced neuropsychological changes.	[Lavender, Andrew P.] Federat Univ, Sch Hlth & Life Sci, Ballarat, Vic, Australia; [Lavender, Andrew P.; Rawlings, Samuel] Curtin Univ, Fac Hlth Sci, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia; [Warnock, Andrew; McGonigle, Terry; Hiles-Murison, Bailey; Nesbit, Michael; Lam, Virginie; Hackett, Mark J.; Fitzgerald, Melinda; Takechi, Ryusuke] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Warnock, Andrew; McGonigle, Terry; Fitzgerald, Melinda] Ralph & Patricia Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Nedlands, WA, Australia; [Hiles-Murison, Bailey] Curtin Univ, Fac Hlth Sci, Sch Pharm & Biomed Sci, Perth, WA, Australia; [Nesbit, Michael; Lam, Virginie; Takechi, Ryusuke] Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia; [Hackett, Mark J.] Curtin Univ, Fac Sci & Engn, Sch Mol & Life Sci, Perth, WA, Australia; [Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA, Australia		Takechi, R (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.; Takechi, R (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Publ Hlth, Perth, WA, Australia.	r.takechi@curtin.edu.au	Takechi, Ryu/T-9970-2019; Lavender, Andrew/I-5065-2019; Lavender, Andrew/AAH-9570-2021; Takechi, Ryusuke/D-3692-2012; Fitzgerald, Melinda/C-4235-2011	Takechi, Ryu/0000-0001-6359-3382; Lavender, Andrew/0000-0001-6222-880X; Takechi, Ryusuke/0000-0001-6359-3382; Fitzgerald, Melinda/0000-0002-4823-8179; Lam, Virginie/0000-0001-8463-645X; hackett, mark/0000-0002-3296-7270	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [GNT1135590]	This project was supported by National Health and Medical Research Council of Australia (GNT1135590).	Abada YSK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071633, 10.1371/journal.pone.0068584]; Agoston DV, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00092; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Mao YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113408; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McGill JK, 2005, STROKE, V36, P135, DOI 10.1161/01.STR.0000149629.32525.b7; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Sawers A, 2015, GAIT POSTURE, V41, P619, DOI 10.1016/j.gaitpost.2015.01.007; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8	15	5	5	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 29	2020	11								491	10.3389/fneur.2020.00491			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MA8YB	WOS:000542195800001	32547485	Green Published, gold			2022-02-06	
J	Goh, PK; Martel, MM; Barkley, RA				Goh, Patrick K.; Martel, Michelle M.; Barkley, Russell A.			Clarifying ADHD and Sluggish Cognitive Tempo Item Relations with Impairment: A Network Analysis	JOURNAL OF ABNORMAL CHILD PSYCHOLOGY			English	Article						ADHD; Impairment; Network analysis; Bridge items; Co-occurrence	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; CHILDREN; CHILDHOOD; VALIDITY; HETEROGENEITY; IMPULSIVITY; SYMPTOMS; OUTCOMES; YOUTH	Despite the pervasive nature of various forms of impairment associated with attention-deficit/hyperactivity disorder (ADHD), the precise nature of their associations with ADHD and related sluggish cognitive tempo (SCT), particularly at the heterogeneous item level, remains ambiguous. Using innovative network analysis techniques, we sought to identify and examine the concurrent validity of ADHD and SCT bridge items (i.e., those demonstrating the most robust relations with various forms of impairment) with respect to Overall, Home-School, and Community-Leisure impairment domains. Parents of a nationally representative sample of 1742 children (50.17% male) aged 6-17 years completed rating scales of ADHD, SCT, and impairment. Assessment of Bridge Expected Influence suggested eight bridge items primarily from impulsive and Task Completion (i.e., overlapping SCT and inattentive) domains that demonstrated relations with impairment in school performance, completing chores at home, interacting with family members, following rules, and playing sports. Sum scores only including bridge items exhibited relations with Overall, Home-School, and Community-Leisure impairment domains comparable to that of sum scores including all items. Bridge impairment areas were generally consistent across "Childhood" (6-11 years) and "Adolescence" (12-17 years). Problems listening and slowness emerged as bridge items in Childhood, whereas difficulties following through on instructions, problems waiting one's turn, and social withdrawal emerged in Adolescence. Given the comparable validity of ADHD- and SCT-related bridge items versus all items, bridge items, together, may be the most efficient indicators of impairment. Further clarification is needed across development to inform personalized assessment and intervention protocols that account for item-level heterogeneity in ADHD, SCT, and impairment phenotypes.	[Goh, Patrick K.; Martel, Michelle M.] Univ Kentucky, Dept Psychol, 171 Funkhouser Dr, Lexington, KY 40506 USA; [Barkley, Russell A.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA		Goh, PK (corresponding author), Univ Kentucky, Dept Psychol, 171 Funkhouser Dr, Lexington, KY 40506 USA.	pat.goh@uky.edu			Guilford Publications	This study was funded by a grant from Guilford Publications.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Barkley, 2012, BARKLEY FUNCTIONAL I; Barkley R.A., 2011, BARKLEY ADULT ADHD R; Barkley R.A., 2018, BARKLEY SLUGGISH COG; Barkley RA, 2019, J ATTEN DISORD, V23, P907, DOI 10.1177/1087054718816164; Barkley RA, 2016, J ABNORM PSYCHOL, V125, P248, DOI 10.1037/abn0000125; Barkley RA, 2015, ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS AND CHILDREN, P53; Barkley RA, 2013, J CLIN CHILD ADOLESC, V42, P161, DOI 10.1080/15374416.2012.734259; Becker SP, 2020, J ABNORM CHILD PSYCH, V48, P391, DOI 10.1007/s10802-019-00603-9; Becker SP, 2016, J AM ACAD CHILD PSY, V55, P163, DOI 10.1016/j.jaac.2015.12.006; Becker SP, 2014, J ABNORM CHILD PSYCH, V42, P49, DOI 10.1007/s10802-013-9719-y; Becker SP, 2013, J ATTEN DISORD, V17, P681, DOI 10.1177/1087054711435411; Belmar M, 2017, J ATTEN DISORD, V21, P667, DOI 10.1177/1087054715597470; Borsboom D, 2017, WORLD PSYCHIATRY, V16, P5, DOI 10.1002/wps.20375; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Bringmann LF, 2019, J ABNORM PSYCHOL, V128, P892, DOI 10.1037/abn0000446; Caswell AJ, 2015, PERS INDIV DIFFER, V76, P68, DOI 10.1016/j.paid.2014.11.059; Chacko A, 2014, CLIN CHILD FAM PSYCH, V17, P368, DOI 10.1007/s10567-014-0171-5; DIEDENHOFEN B, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0121945; DuPaul G. J., 2014, ATTENTION DEFICIT HY; Epskamp S, 2018, PSYCHOL METHODS, V23, P617, DOI 10.1037/met0000167; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Foygel R, 2010, ADV NEURAL INFORM PR, V23, P604; Fried EI, 2017, PERSPECT PSYCHOL SCI, V12, P999, DOI 10.1177/1745691617705892; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Garner AA, 2013, J DEV BEHAV PEDIATR, V34, P469, DOI 10.1097/DBP.0b013e3182a39890; Greenhill LL, 1998, J CLIN PSYCHIAT, V59, P31; Zou GY, 2007, PSYCHOL METHODS, V12, P399, DOI 10.1037/1082-989X.12.4.399; Haslbeck J. M. B., 2015, STRUCTURE ESTIMATION; Johnson R., 2000, J ATTEN DISORD, V4, P150, DOI [10.1177/108705470000400302, DOI 10.1177/108705470000400302]; Johnston C, 2001, CLIN CHILD FAM PSYCH, V4, P183, DOI 10.1023/A:1017592030434; Jones PJ, 2021, MULTIVAR BEHAV RES, V56, P353, DOI 10.1080/00273171.2019.1614898; Jones PJ, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01742; Kamradt JM, 2018, J PSYCHOPATHOL BEHAV, V40, P206, DOI 10.1007/s10862-017-9631-9; Karpenko V, 2009, J CLIN PSYCHOL, V65, P76, DOI 10.1002/jclp.20549; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Langberg JM, 2014, J ABNORM CHILD PSYCH, V42, P91, DOI 10.1007/s10802-013-9722-3; Lee S, 2014, J ABNORM CHILD PSYCH, V42, P7, DOI 10.1007/s10802-013-9714-3; Leopold DR, 2016, J CHILD PSYCHOL PSYC, V57, P1066, DOI 10.1111/jcpp.12505; Lewandowski LJ, 2009, ASSESSING IMPAIRMENT, P5; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Luo YY, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00042; Milich R, 2001, CLIN PSYCHOL-SCI PR, V8, P463, DOI 10.1093/clipsy/8.4.463; Mota VL, 2000, J AM ACAD CHILD PSY, V39, P1144, DOI 10.1097/00004583-200009000-00014; O'Connor BC, 2015, J DEV BEHAV PEDIATR, V36, P106, DOI 10.1097/DBP.0000000000000124; Owens J.S., 2009, SCH MENT HEAL, V1, P183, DOI [DOI 10.1007/S12310-009-9020-Y, 10.1007/s12310-009-9020-y]; Penny AM, 2009, PSYCHOL ASSESSMENT, V21, P380, DOI 10.1037/a0016600; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Smith ZR, 2017, EUR CHILD ADOLES PSY, V26, P1141, DOI 10.1007/s00787-017-1003-1; van Borkulo C. D., 2017, COMP NETWORK S UNPUB; Votruba KL, 2008, J HEAD TRAUMA REHAB, V23, P65, DOI 10.1097/01.HTR.0000314525.93381.69; Wehmeier PM, 2010, J ADOLESCENT HEALTH, V46, P209, DOI 10.1016/j.jadohealth.2009.09.009; Willcutt EG, 2014, J ABNORM CHILD PSYCH, V42, P21, DOI 10.1007/s10802-013-9800-6; Willcutt EG, 2012, J ABNORM PSYCHOL, V121, P991, DOI 10.1037/a0027347; Zoromski AK, 2015, J ABNORM CHILD PSYCH, V43, P1243, DOI 10.1007/s10802-015-0017-8	57	5	5	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0091-0627	1573-2835		J ABNORM CHILD PSYCH	J. Abnorm. Child Psychol.	AUG	2020	48	8					1047	1061		10.1007/s10802-020-00655-2		MAY 2020	15	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	MH7WF	WOS:000534858300001	32445104				2022-02-06	
J	Hogg, FRA; Kearney, S; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Hogg, Florence R. A.; Kearney, Siobhan; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Acute Spinal Cord Injury: Correlations and Causal Relations Between Intraspinal Pressure, Spinal Cord Perfusion Pressure, Lactate-to-Pyruvate Ratio, and Limb Power	NEUROCRITICAL CARE			English	Article						Blood pressure; Intraspinal pressure; LPR; Management; Microdialysis; Monitoring; Spinal cord injury	CONTROLLED-TRIAL; METHYLPREDNISOLONE; MANAGEMENT; SURGERY; PROFILE	Background/Objective We have recently developed monitoring from the injury site in patients with acute, severe traumatic spinal cord injuries to facilitate their management in the intensive care unit. This is analogous to monitoring from the brain in patients with traumatic brain injuries. This study aims to determine whether, after traumatic spinal cord injury, fluctuations in the monitored physiological, and metabolic parameters at the injury site are causally linked to changes in limb power. Methods This is an observational study of a cohort of adult patients with motor-incomplete spinal cord injuries, i.e., grade C American spinal injuries association Impairment Scale. A pressure probe and a microdialysis catheter were placed intradurally at the injury site. For up to a week after surgery, we monitored limb power, intraspinal pressure, spinal cord perfusion pressure, and tissue lactate-to-pyruvate ratio. We established correlations between these variables and performed Granger causality analysis. Results Nineteen patients, aged 22-70 years, were recruited. Motor score versus intraspinal pressure had exponential decay relation (intraspinal pressure rise to 20 mmHg was associated with drop of 11 motor points, but little drop in motor points as intraspinal pressure rose further, R-2 = 0.98). Motor score versus spinal cord perfusion pressure (up to 110 mmHg) had linear relation (1.4 motor point rise/10 mmHg rise in spinal cord perfusion pressure, R-2 = 0.96). Motor score versus lactate-to-pyruvate ratio (greater than 20) also had linear relation (0.8 motor score drop/10-point rise in lactate-to-pyruvate ratio, R-2 = 0.92). Increased intraspinal pressure Granger-caused increase in lactate-to-pyruvate ratio, decrease in spinal cord perfusion, and decrease in motor score. Increased spinal cord perfusion Granger-caused decrease in lactate-to-pyruvate ratio and increase in motor score. Increased lactate-to-pyruvate ratio Granger-caused increase in intraspinal pressure, decrease in spinal cord perfusion, and decrease in motor score. Causality analysis also revealed multiple vicious cycles that amplify insults to the cord thus exacerbating cord damage. Conclusion Monitoring intraspinal pressure, spinal cord perfusion pressure, lactate-to-pyruvate ratio, and intervening to normalize these parameters are likely to improve limb power.	[Hogg, Florence R. A.; Kearney, Siobhan; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, London, England; [Zoumprouli, Argyro] St George Hosp, Neuroanaesthesia Neuro Intens Care, London, England		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, London, England.	ssaadoun@sgul.ac.uk		Saadoun, Samira/0000-0002-5480-5678	Wings for Life Spinal Cord Research Foundation; Neurosciences Research Foundation (Fletcher Fund); NIHR CRN	Supported by grants to SS and MCP from Wings for Life Spinal Cord Research Foundation and to MCP from the Neurosciences Research Foundation (Fletcher Fund). FRAH is a Royal College of Surgeons of England research fellow. SK is supported by NIHR CRN.	[Anonymous], 2014, J Spinal Cord Med, V37, P659, DOI 10.1179/1079026814Z.000000000341; Batchelor PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072659; Black N, 1996, BRIT MED J, V312, P1215; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Chen ZR, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108672; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Fehlings MG, 2017, GLOB SPINE J, V7, p203S, DOI 10.1177/2192568217703085; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; Gallagher MJ, 2018, CRIT CARE MED; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hennekens CH, 2011, JAMA-J AM MED ASSOC, V305, P1134, DOI 10.1001/jama.2011.322; Hogg FRA, 2019, NEUROCRIT CARE, V30, P421, DOI 10.1007/s12028-018-0616-7; Jacobs WB, 2014, MEAN ARTERIAL BLOOD; Kadoya, 1994, SEKITSUI SEKIZUI J, V7, P633; Kobayakawa K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009430; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; Park KS, 2020, J NEUROTRAUM, V37, P1165, DOI 10.1089/neu.2019.6724; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Saadoun S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1490-3; Sanson-Fisher RW, 2007, AM J PREV MED, V33, P155, DOI 10.1016/j.amepre.2007.04.007; Seth AK, 2015, J NEUROSCI, V35, P3293, DOI 10.1523/JNEUROSCI.4399-14.2015; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; TATOR CH, 1984, CAN J SURG, V27, P289; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; WAGNER FC, 1982, J NEUROSURG, V56, P699, DOI 10.3171/jns.1982.56.5.0699; Walters BC, 2013, NEUROSURGERY, V60, P82, DOI 10.1227/01.neu.0000430319.32247.7f; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Wilson JR, 2012, SPINAL CORD, V50, P840, DOI 10.1038/sc.2012.59; Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206	40	5	5	1	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					121	129		10.1007/s12028-020-00988-2		MAY 2020	9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000534460700002	32435965	hybrid, Green Published, Green Accepted			2022-02-06	
J	Rodionov, A; Savolainen, S; Kirveskari, E; Makela, JP; Shulga, A				Rodionov, Andrei; Savolainen, Sarianna; Kirveskari, Erika; Makela, Jyrki P.; Shulga, Anastasia			Effects of Long-Term Paired Associative Stimulation on Strength of Leg Muscles and Walking in Chronic Tetraplegia: A Proof-of-Concept Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						paired associative stimulation; walking; TMS; spinal cord injury; neuroplasticity	SPINAL-CORD-INJURY; NONINVASIVE BRAIN-STIMULATION; MOTOR CORTEX; PLASTICITY; EXCITABILITY; INDUCTION; RECOVERY; NERVE	Recovery of lower-limb function after spinal cord injury (SCI) is dependent on the extent of remaining neural transmission in the corticospinal pathway. The aim of this proof-of-concept pilot study was to explore the effects of long-term paired associative stimulation (PAS) on leg muscle strength and walking in people with SCI. Five individuals with traumatic incomplete chronic tetraplegia (>34 months post-injury, motor incomplete, 3 females, mean age 60 years) with no contraindications to transcranial magnetic stimulation (TMS) received PAS to one or both legs for 2 months (28 sessions in total, 5 times a week for the first 2 weeks and 3 times a week thereafter). The participants were evaluated with the Manual Muscle Test (MMT), AIS motor and sensory examination, Modified Asworth Scale (MAS), and the Spinal Cord Independence Measure (SCIM) prior to the intervention, after 1 and 2 months of PAS, and after a 1-month follow-up. The study was registered at (NCT03459885). During the intervention, MMT scores and AIS motor scores increased significantly (p = 0.014 and p = 0.033, respectively). Improvements were stable in follow-up. AIS sensory scores, MAS, and SCIM were not modified significantly. MMT score prior to intervention was a good predictor of changes in walking speed (Radj2 = 0.962). The results of this proof-of-concept pilot study justify a larger trial on the effect of long-term PAS on leg muscle strength and walking in people with chronic incomplete SCI.	[Rodionov, Andrei; Savolainen, Sarianna; Kirveskari, Erika; Makela, Jyrki P.; Shulga, Anastasia] Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland; [Rodionov, Andrei; Savolainen, Sarianna; Kirveskari, Erika; Makela, Jyrki P.; Shulga, Anastasia] Helsinki Univ Hosp, Helsinki, Finland; [Kirveskari, Erika] Univ Helsinki, HUS Med Imaging Ctr, Clin Neurosci, Clin Neurophysiol, Helsinki, Finland; [Shulga, Anastasia] Helsinki Univ Hosp, Clin Neurosci, Neurol, Helsinki, Finland		Shulga, A (corresponding author), Univ Helsinki, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland.; Shulga, A (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.; Shulga, A (corresponding author), Helsinki Univ Hosp, Clin Neurosci, Neurol, Helsinki, Finland.	anastasia.shulga@helsinki.fi		Shulga, Anastasia/0000-0003-0262-3570; Rodionov, Andrei/0000-0002-4603-9555	Instrumentarium Science Foundation [180031]; Academy of FinlandAcademy of FinlandEuropean Commission [307951]	AR was supported by the Instrumentarium Science Foundation personal grant [180031], AS was supported by the Academy of Finland grant [307951]. Research costs and open access publication fee were covered by University of Helsinki Library's Open Agreement with Frontiers. The funding agencies did not participate in study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit it for publication.	Alizadeh A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00282; Bunday KL, 2018, BRAIN STIMUL, V11, P1083, DOI 10.1016/j.brs.2018.05.006; Bunday KL, 2012, CURR BIOL, V22, P2355, DOI 10.1016/j.cub.2012.10.046; Burns AS, 2001, SPINE, V26, pS137, DOI 10.1097/00007632-200112151-00023; Burns SP, 1997, ARCH PHYS MED REHAB, V78, P1169, DOI 10.1016/S0003-9993(97)90326-9; Calabro RS, 2017, J SPINAL CORD MED, V40, P118, DOI 10.1080/10790268.2016.1153275; Carson RG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00823; Casula EP, 2014, NEUROIMAGE, V98, P225, DOI 10.1016/j.neuroimage.2014.04.065; Dietrich W Dalton, 2015, Top Spinal Cord Inj Rehabil, V21, P174, DOI 10.1310/sci2102-174; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Fakhoury M, 2015, REV NEUROSCIENCE, V26, P397, DOI 10.1515/revneuro-2015-0001; GAJRAJ NM, 1994, ANESTH ANALG, V78, P574; Gunduz A, 2017, NEURAL REGEN RES, V12, P1933, DOI 10.4103/1673-5374.221143; Kumpulainen S, 2012, EXP BRAIN RES, V221, P241, DOI 10.1007/s00221-012-3165-x; Mrachacz-Kersting N, 2007, J NEUROPHYSIOL, V97, P1951, DOI 10.1152/jn.01176.2006; Naro A, 2015, BRAIN TOPOGR, V28, P238, DOI 10.1007/s10548-014-0396-0; Neptune RR, 2005, J EXP BIOL, V208, P799, DOI 10.1242/jeb.01435; Page SJ, 2015, ARCH PHYS MED REHAB, V96, pS89, DOI 10.1016/j.apmr.2014.09.019; Quartarone A, 2006, J PHYSIOL-LONDON, V575, P657, DOI 10.1113/jphysiol.2006.114025; Rodionov A, 2019, SPINAL CORD SER CASE, V5, DOI 10.1038/s41394-019-0225-5; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Shulga Anastasia, 2016, Spinal Cord Ser Cases, V2, P16016, DOI 10.1038/scsandc.2016.16; Shulga A, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00470; Shulga A, 2015, J NEUROSCI METH, V242, P112, DOI 10.1016/j.jneumeth.2015.01.012; Skalak AF, 2008, SURG RADIOL ANAT, V30, P41, DOI 10.1007/s00276-007-0282-5; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Stinear JW, 2005, J PHYSIOL-LONDON, V567, P701, DOI 10.1113/jphysiol.2005.090654; Suppa A, 2017, CLIN NEUROPHYSIOL, V128, P2140, DOI 10.1016/j.clinph.2017.08.003; Tolmacheva A, 2019, CLIN NEUROPHYS PRACT, V4, P178, DOI 10.1016/j.cnp.2019.07.002; Tolmacheva A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40474-0; Tolmacheva A, 2017, J NEUROTRAUM, V34, P2668, DOI 10.1089/neu.2017.4996; Uy J, 2003, NEUROLOGY, V61, P982, DOI 10.1212/01.WNL.0000078809.33581.1F; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; Vloka JD, 1999, ANESTH ANALG, V89, P1467, DOI 10.1097/00000539-199912000-00028; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Yang JF, 2011, PHYS THER, V91, P931, DOI 10.2522/ptj.20100163	36	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 20	2020	11								397	10.3389/fneur.2020.00397			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW7LI	WOS:000539324500001	32508738	gold, Green Published			2022-02-06	
J	Zhang, X; Liu, BH; Li, N; Li, YY; Hou, J; Duan, GP; Wu, DY				Zhang, Xu; Liu, Baohu; Li, Nan; Li, Yuanyuan; Hou, Jun; Duan, Guoping; Wu, Dongyu			Transcranial Direct Current Stimulation Over Prefrontal Areas Improves Psychomotor Inhibition State in Patients With Traumatic Brain Injury: A Pilot Study	FRONTIERS IN NEUROSCIENCE			English	Article						brain stimulation; transcranial direct current stimulation; traumatic brain injury; neurobehavioral disorder; non-linear dynamics; electroencephalogram	ACUPUNCTURE STIMULATION; CORTICAL EXCITABILITY; VEGETATIVE STATE; DISORDERS; FMRI; SPECIFICITY; ACTIVATION; GUIDELINES; APATHY	Objectives Many post-traumatic patients with minimally conscious state are complicated by psychomotor inhibition state (PIS), which impedes further rehabilitation. The treatment of PIS is not satisfactory. This pilot study aimed to investigate effects of anodal transcranial direct current stimulation (A-tDCS) on PIS in post-traumatic patients and examine the altered cortical activation after tDCS using non-linear electroencephalogram (EEG). Methods The study included 10 patients with post-traumatic PIS. An A-B design was used. The patients received 4 weeks of sham tDCS during Phase A, and they received A-tDCS over the prefrontal area and left dorsolateral prefrontal cortex (DLPFC) for 4 weeks (40 sessions) during Phase B. Conventional treatments were administered throughout both phases. JFK Coma Recovery Scale-Revised (CRS-R), apathy evaluation scale (AES), and the EEG non-linear indices of approximate entropy (ApEn) and cross approximate entropy (C-ApEn) were measured before Phase A, before Phase B, and after Phase B. Results After A-tDCS treatment, CRS-R and AES were improved significantly. ApEn and C-ApEn results showed that the local cortical connection of bilateral sensorimotor areas with their peripheral areas could be activated by affected painful stimuli, while bilateral cerebral hemispheres could be activated by the unaffected painful-stimuli condition. Linear regression analysis revealed that the affected sensorimotor cortex excitability and unaffected local and distant cortical networks connecting the sensorimotor area to the prefrontal area play a major role in AES improvement. Conclusion A-tDCS over the prefrontal area and left DLPFC improves PIS. The recovery might be related to increased excitability in local and distant cortical networks connecting the sensorimotor area to the prefrontal area. Thus, tDCS may be an alternative treatment for post-traumatic PIS.	[Zhang, Xu; Liu, Baohu; Li, Yuanyuan; Hou, Jun; Duan, Guoping; Wu, Dongyu] China Acad Chinese Med Sci, Wangjing Hosp, Dept Rehabil, Beijing, Peoples R China; [Li, Nan] Peking Univ, Hosp 3, Res Ctr Clin Epidemiol, Beijing, Peoples R China		Wu, DY (corresponding author), China Acad Chinese Med Sci, Wangjing Hosp, Dept Rehabil, Beijing, Peoples R China.	wudongyu73@hotmail.com	Wu, Dongyu/AAW-6037-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171011, 81572220]; Science and Technology projects of Beijing [Z121107001012144, Z171100001017111]; Key Field Project of the 13th Five-Year Plan of China Academy of Chinese Medical Sciences [ZZ10-015]; International Cooperation Base of Chinese Medicine [GZYYGJ2018032]; project of National Administration of Traditional Chinese Medicine [GZT-KJS-2017-10]	This work was supported by the National Natural Science Foundation of China (Grant Numbers 81171011 and 81572220), the Science and Technology projects of Beijing (Grant Numbers Z121107001012144 and Z171100001017111), the Key Field Project of the 13th Five-Year Plan of China Academy of Chinese Medical Sciences (Grant Number ZZ10-015), the International Cooperation Base of Chinese Medicine (Grant Number GZYYGJ2018032), and the project of National Administration of Traditional Chinese Medicine (Grant Number GZT-KJS-2017-10).	Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Bai LJ, 2010, J MAGN RESON IMAGING, V31, P71, DOI 10.1002/jmri.22006; Bai Y, 2017, NEUROIMAGE-CLIN, V15, P702, DOI 10.1016/j.nicl.2017.01.025; Caeyenberghs K, 2018, NEUROREHAB NEURAL RE, V32, P99, DOI 10.1177/1545968317753076; Chae Y, 2015, NEUROSCI LETT, V591, P48, DOI 10.1016/j.neulet.2015.02.025; Chen JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096777; Cho SY, 2010, J ALTERN COMPLEM MED, V16, P489, DOI 10.1089/acm.2009.0395; Corlier J, 2019, CEREB CORTEX, V29, P4958, DOI 10.1093/cercor/bhz035; DeBoussard CN, 2017, CLIN REHABIL, V31, P555, DOI 10.1177/0269215516652184; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; DOLAN RJ, 1993, J NEUROL NEUROSUR PS, V56, P1290, DOI 10.1136/jnnp.56.12.1290; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Hudetz AG, 2002, BRAIN RES, V954, P123, DOI 10.1016/S0006-8993(02)03358-9; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kamp D, 2019, SCHIZOPHR RES, V204, P445, DOI 10.1016/j.schres.2018.09.017; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; Leonardi M, 2013, BRAIN INJURY, V27, P473, DOI 10.3109/02699052.2012.750758; Levin H, 2016, ANN PHYS REHABIL MED, V59, P74, DOI 10.1016/j.rehab.2015.06.005; Levy R, 2012, REV NEUROL-FRANCE, V168, P585, DOI 10.1016/j.neurol.2012.05.003; Li A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013655; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Mackeprang T, 2002, BIOL PSYCHIAT, V52, P863, DOI 10.1016/S0006-3223(02)01409-9; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Mattson DT, 1997, J GENET PSYCHOL, V158, P487, DOI 10.1080/00221329709596685; Merzagora AC, 2010, NEUROIMAGE, V49, P2304, DOI 10.1016/j.neuroimage.2009.10.044; Meyer T, 2015, BIOL PSYCHOL, V108, P62, DOI 10.1016/j.biopsycho.2015.03.018; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; O'Neil-Pirozzi TM, 2017, INT J NEUROSCI, V127, P592, DOI 10.1080/00207454.2016.1216415; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Silveira R, 2019, PHYSIOL BEHAV, V208, DOI 10.1016/j.physbeh.2019.112580; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Wang J, 2013, NEUROSCI LETT, V549, P29, DOI 10.1016/j.neulet.2013.06.019; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Williams NR, 2014, WORLD J RADIOL, V6, P756, DOI 10.4329/wjr.v6.i10.756; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P1956, DOI 10.1016/j.clinph.2011.03.018; Wu DY, 2011, CLIN NEUROPHYSIOL, V122, P490, DOI 10.1016/j.clinph.2010.05.036; Wu DY, 2015, NEUROSCI LETT, V589, P115, DOI 10.1016/j.neulet.2015.01.045; Wu DY, 2013, ARCH PHYS MED REHAB, V94, P1, DOI 10.1016/j.apmr.2012.07.022; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Yuan Y, 2017, TOP STROKE REHABIL, V24, P503, DOI 10.1080/10749357.2017.1322250; Zasler Nathan D, 2013, Handb Clin Neurol, V110, P377, DOI 10.1016/B978-0-444-52901-5.00032-0; Zhang WT, 2004, NEUROSCI LETT, V354, P50, DOI 10.1016/j.neulet.2003.09.080	44	5	5	2	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 20	2020	14								386	10.3389/fnins.2020.00386			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW7NE	WOS:000539329300001	32508560	Green Published, gold			2022-02-06	
J	Zhang, LS; Lu, XY; Gong, LH; Cui, LL; Zhang, HQ; Zhao, W; Jiang, PY; Hou, GG; Hou, Y				Zhang, Lianshuang; Lu, Xueyan; Gong, Lihua; Cui, Linlu; Zhang, Hongqin; Zhao, Wei; Jiang, Pengyu; Hou, GuiGe; Hou, Yun			Tetramethylpyrazine Protects Blood-Spinal Cord Barrier Integrity by Modulating Microglia Polarization Through Activation of STAT3/SOCS3 and Inhibition of NF-kB Signaling Pathways in Experimental Autoimmune Encephalomyelitis Mice	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Tetramethylpyrazine; Blood-spinal cord barrier; Microglia activation; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Tight junctions	MESENCHYMAL STEM-CELLS; BRAIN-BARRIER; ISCHEMIA-REPERFUSION; RAT-BRAIN; INJURY; MINOCYCLINE; ALPHA; NEUROPROTECTION; PERMEABILITY; ROLES	We previously reported that tetramethylpyrazine (TMP) alleviates experimental autoimmune encephalomyelitis (EAE) by decreasing glia activation. Activated microglia has been shown to mediate blood-spinal cord barrier (BSCB) disruption, which is a primary and continuous pathological characteristic of multiple sclerosis (MS). Therefore, in this study, we further investigated whether TMP protects the BSCB integrity by inhibition of glia activation to alleviate EAE. Extravasation of evans blue was used to detect the BSCB disruption. Tumor necrosis factor-alpha (TNF-alpha)/interlukine-1 beta (IL-1 beta) and interlukine-4 (IL-4)/interlukine-10 (IL-10) were determined by enzyme-linked immunosorbent assay. BV2 glial cells stimulated by interferon-gamma (IFN-gamma) were co-cultured with human brain microvascular endothelial cells to investigate the effect of TMP on the BSCB disruption. Flow cytometry was used to analyze the microglia phenotype. Western blot was performed to reveal the signaling pathways involved in the microglia activation. In this study, most importantly, we found that TMP protects the BSCB integrity by modulating microglia polarization from M1 phenotype to M2 phenotype through activation of STAT3/SOCS3 and inhibition of NF-kB signaling pathways. Moreover, TMP significantly preserves the tight junction proteins, reduces the secretion of pro-inflammatory cytokines (TNF-alpha, IL-1 beta) and increases the secretion of anti-inflammatory cytokines (IL-4, IL-10) from IFN-gamma-stimulated BV2 microglia cells. Consequently, protection of the BSCB integrity leads to alleviation of clinical symptoms and demyelination in EAE mice. Therefore, TMP might be an effective therapeutic agent for cerebral disorders with BBB or BSCB disruption, such as ischemic stroke, MS, and traumatic brain injury.	[Zhang, Lianshuang; Lu, Xueyan; Gong, Lihua; Cui, Linlu; Zhang, Hongqin; Zhao, Wei; Jiang, Pengyu; Hou, Yun] Binzhou Med Univ, Dept Histol & Embryol, Yantai 264003, Peoples R China; [Hou, GuiGe] Binzhou Med Univ, State Adm Tradit Chinese Med China, Key Lab Prescript Effect & Clin Evaluat, Yantai 264003, Peoples R China		Hou, Y (corresponding author), Binzhou Med Univ, Dept Histol & Embryol, Yantai 264003, Peoples R China.; Hou, GG (corresponding author), Binzhou Med Univ, State Adm Tradit Chinese Med China, Key Lab Prescript Effect & Clin Evaluat, Yantai 264003, Peoples R China.	guigehou@163.com; houyun820424@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601049, 21402010]; Nature Science Foundation of Shandong ProvinceNatural Science Foundation of Shandong Province [ZR2019MB032]; Key Research and Development Program of Shandong Province [2018GSF118129]	This study was supported by The National Natural Science Foundation of China [81601049, 21402010], Nature Science Foundation of Shandong Province [ZR2019MB032], Key Research and Development Program of Shandong Province [2018GSF118129].	Al Zoubi S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02996; Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Bai XY, 2018, BIOCHEM BIOPH RES CO, V503, P1968, DOI 10.1016/j.bbrc.2018.07.143; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Cevey AC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01267; Chang Y, 2007, ACTA PHARMACOL SIN, V28, P327, DOI 10.1111/j.1745-7254.2007.00514.x; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Fan LH, 2011, J VASC SURG, V54, P192, DOI 10.1016/j.jvs.2010.12.030; Feng L, 2011, J SURG RES, V166, P298, DOI 10.1016/j.jss.2009.04.005; Galbraith NJ, 2018, IMMUNOBIOLOGY, V223, P365, DOI 10.1016/j.imbio.2017.10.045; Gong P, 2019, EUR J PHARMACOL, V854, P289, DOI 10.1016/j.ejphar.2019.04.028; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Gu XH, 2015, EXP NEUROL, V267, P135, DOI 10.1016/j.expneurol.2015.02.029; Hou Y, 2014, J NEUROIMMUNOL, V274, P20, DOI 10.1016/j.jneuroim.2014.06.001; Hou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt228; Kao TK, 2006, NEUROCHEM INT, V48, P166, DOI 10.1016/j.neuint.2005.10.008; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Laffer B, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00430; Li H, 2015, CYTOTHERAPY, V17, P1560, DOI 10.1016/j.jcyt.2015.07.018; Liu Q, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1398-3; Lv L, 2012, CLIN EXP PHARMACOL P, V39, P20, DOI 10.1111/j.1440-1681.2011.05628.x; Meireles M, 2016, BEHAV BRAIN RES, V305, P223, DOI 10.1016/j.bbr.2016.03.010; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Wang AM, 2017, EXP THER MED, V14, P2392, DOI 10.3892/etm.2017.4754; Xiao XL, 2010, NEUROL RES, V32, P547, DOI 10.1179/174313209X414533; Yan GJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23092090; Yang G, 2017, CELL MOL NEUROBIOL, V37, P619, DOI 10.1007/s10571-016-0398-4; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4	34	5	5	3	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAY	2021	41	4					717	731		10.1007/s10571-020-00878-3		MAY 2020	15	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	RD3PJ	WOS:000533844400005	32424774				2022-02-06	
J	Walker, PF; Bozzay, JD; Johnston, LR; Elster, EA; Rodriguez, CJ; Bradley, MJ				Walker, Patrick F.; Bozzay, Joseph D.; Johnston, Luke R.; Elster, Eric A.; Rodriguez, Carlos J.; Bradley, Matthew J.			Outcomes of tranexamic acid administration in military trauma patients with intracranial hemorrhage: a cohort study	BMC EMERGENCY MEDICINE			English	Article						Tranexamic acid; TXA; Traumatic brain injury; TBI; Military	CRASH-2; INJURY	Background Tranexamic acid (TXA) may be a useful adjunct for military patients with severe traumatic brain injury (TBI). These patients are often treated in austere settings without immediate access to neurosurgical intervention. The purpose of this study was to evaluate any association between TXA use and progression of intracranial hemorrhage (ICH), neurologic outcomes, and venous thromboembolism (VTE) in TBI. Methods This was a retrospective cohort study of military casualties from October 2010 to December 2015 who were transferred to a military treatment facility (MTF) in the United States. Data collected included: demographics, types of injuries, initial and interval head computerized tomography (CT) scans, Glasgow Coma Scores (GCS), and six-month Glasgow Outcome Scores (GOS). Results were stratified based on TXA administration, progression of ICH, and VTE. Results Of the 687 active duty service members reviewed, 71 patients had ICH (10.3%). Most casualties were injured in a blast (80.3%), with 36 patients (50.7%) sustaining a penetrating TBI. Mean ISS was 28.2 +/- 12.3. Nine patients (12.7%) received a massive transfusion within 24 h of injury, and TXA was administered to 14 (19.7%) casualties. Patients that received TXA had lower initial reported GCS (9.2 +/- 4.4 vs. 12.5 +/- 3.4, p = 0.003), similar discharge GCS (13.3 +/- 4.0 vs. 13.8 +/- 3.2, p = 0.58), and a larger improvement between initial and discharge GCS (3.7 +/- 3.9 vs. 1.3 +/- 3.1, p = 0.02). However, there was no difference in mortality (7.1% vs. 7.0%, p = 1.00), progression of ICH (45.5% vs. 14.7%, p = 0.09), frequency of cranial decompression (50.0% vs. 42.1%, p = 0.76), or mean GOS (3.5 +/- 0.9 vs. 3.8 +/- 1.0, p = 0.13). Patients administered TXA had a higher rate of VTE (35.7% vs. 7.0%, p = 0.01). On multivariate analysis, however, TXA was not independently associated with VTE. Conclusions Patients that received TXA were associated with an improvement in GCS but not in progression of ICH or GOS. TXA was not independently associated with VTE, although this may be related to a paucity of patients receiving TXA. Decisions about TXA administration in military casualties with ICH should be considered in the context of the availability of neurosurgical intervention as well as severity of extracranial injuries and need for massive transfusion.	[Walker, Patrick F.; Bozzay, Joseph D.; Johnston, Luke R.; Elster, Eric A.; Bradley, Matthew J.] Uniformed Serv Univ Hlth Sci, Dept Surg, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Walker, Patrick F.; Bozzay, Joseph D.; Johnston, Luke R.; Elster, Eric A.; Bradley, Matthew J.] Walter Reed Natl Mil Med Ctr, 8901 Rockville Pike, Bethesda, MD 20889 USA; [Rodriguez, Carlos J.] John Peter Smith Hosp, Dept Surg, Ft Worth, TX 76104 USA		Walker, PF (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Surg, 8901 Rockville Pike, Bethesda, MD 20889 USA.; Walker, PF (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Rockville Pike, Bethesda, MD 20889 USA.	patrick.f.walker.mil@mail.mil	Elster, Eric/ABG-6091-2021	Elster, Eric/0000-0002-0981-2748			[Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Edavettal M, 2014, AM SURGEON, V80, P372; Edwards MJ, 2018, J AM COLL SURGEONS, V226, P1190, DOI 10.1016/j.jamcollsurg.2018.03.001; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Hannon M, 2016, AM J SURG, V212, P230, DOI 10.1016/j.amjsurg.2016.01.031; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Howard JT, 2017, J TRAUMA ACUTE CARE, V83, P579, DOI 10.1097/TA.0000000000001613; JENNETT B, 1976, LANCET, V1, P1031; Johnston LR, 2018, JAMA SURG, V153, P169, DOI 10.1001/jamasurg.2017.3821; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Morte D, 2019, J TRAUMA ACUTE CARE, V87, P125, DOI 10.1097/TA.0000000000002269; Myers SP, 2019, J TRAUMA ACUTE CARE, V86, P20, DOI 10.1097/TA.0000000000002061; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rosenfeld JV, 2015, WORLD J SURG, V39, P1352, DOI 10.1007/s00268-014-2874-7; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; System Improvements for Machine Type Communications (MTC), 2012, TR23888 TS 3GPP, P1; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	21	5	5	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	MAY 14	2020	20	1							39	10.1186/s12873-020-00335-w			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LS0CO	WOS:000536061800001	32410581	Green Published, gold			2022-02-06	
J	Liaudanskaya, V; Chung, JY; Mizzoni, C; Rouleau, N; Berk, AN; Wu, LM; Turner, JA; Georgakoudi, I; Whalen, MJ; Nieland, TJF; Kaplan, DL				Liaudanskaya, Volha; Chung, Joon Yong; Mizzoni, Craig; Rouleau, Nicolas; Berk, Alexander N.; Wu, Limin; Turner, Julia A.; Georgakoudi, Irene; Whalen, Michael J.; Nieland, Thomas J. F.; Kaplan, David L.			Modeling Controlled Cortical Impact Injury in 3D Brain-Like Tissue Cultures	ADVANCED HEALTHCARE MATERIALS			English	Article						3D in vitro models; brain tissue; controlled cortical impact; neurodegeneration; tissue engineering; traumatic brain injuries	SIGNALING PATHWAY; MAMMALIAN TARGET; ANIMAL-MODELS; CELLS; RAT; AKT; QUANTIFICATION; ASTROCYTES; RAPAMYCIN; NEURONS	Traumatic brain injury (TBI) survivors suffer long term from mental illness, neurodegeneration, and neuroinflammation. Studies of 3D tissue models have provided new insights into the pathobiology of many brain diseases. Here, a 3D in vitro contusion model is developed consisting of mouse cortical neurons grown on a silk scaffold embedded in collagen and used outcomes from an in vivo model for benchmarking. Molecular, cellular, and network events are characterized in response to controlled cortical impact (CCI). In this model, CCI induces degradation of neural network structure and function and release of glutamate, which are associated with the expression of programmed necrosis marker phosphorylated Mixed Lineage Kinase Domain Like Pseudokinase (pMLKL). Neurodegeneration is observed first in the directly impacted area and it subsequently spreads over time in 3D space. CCI reduces phosphorylated protein kinase B (pAKT) and Glycogen synthase kinase 3 beta (GSK3 beta) in neurons in vitro and in vivo, but discordant responses are observed in phosphprylated ribosomal S6 kinase (pS6) and phosphorylated Tau (pTau) expression. In summary, the 3D brain-like culture system mimicked many aspects of in vivo responses to CCI, providing evidence that the model can be used to study the molecular, cellular, and functional sequelae of TBI, opening up new possibilities for discovery of therapeutics.	[Liaudanskaya, Volha; Mizzoni, Craig; Rouleau, Nicolas; Berk, Alexander N.; Turner, Julia A.; Georgakoudi, Irene; Nieland, Thomas J. F.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Chung, Joon Yong; Wu, Limin; Whalen, Michael J.] Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA 02129 USA		Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu		Chung, Joon Yong/0000-0002-3980-2065	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092847, NIH S10 OD021624]	The authors thank the NIH R01NS092847 to D.L.K. and M.J.W. for support of this research and NIH Research Infrastructure grant NIH S10 OD021624 for the purchase of microscope. The authors also thank Martin Hunter for his help with confocal and multiphoton microscope.	Amin ND, 2018, NEURON, V100, P389, DOI 10.1016/j.neuron.2018.10.007; Arrazola MS, 2019, J NEUROSCI, V39, P3832, DOI 10.1523/JNEUROSCI.0881-18.2019; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cantley WL, 2018, ACS BIOMATER SCI ENG, V4, P4278, DOI 10.1021/acsbiomaterials.8b00622; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Chung JY, 2019, J NEUROTRAUM, V36, P370, DOI 10.1089/neu.2018.5659; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Donna K. B. S., 2006, J NEUROTRAUM, V23, P193; Donna R. S. C. I., 2003, J NEUROTRAUM, V20, P10; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Graham NSN, 2019, J NEUROL NEUROSUR PS, V90, P1221, DOI 10.1136/jnnp-2017-317557; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kim HJ, 2011, METHODS MOL BIOL, V793, P63, DOI 10.1007/978-1-61779-328-8_4; Kim YH, 2018, J NEUROSCI RES, V96, P501, DOI 10.1002/jnr.24099; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Lee SW, 2019, CLIN EXP EMERG MED, V6, P125, DOI 10.15441/ceem.18.019; Liu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.69; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Liu ZY, 2017, BIOMATERIALS, V116, P34, DOI 10.1016/j.biomaterials.2016.11.041; Liu ZY, 2015, BIOMED OPT EXPRESS, V6, P2294, DOI 10.1364/BOE.6.002294; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Schafer DP, 2015, IMMUNITY, V42, P600, DOI 10.1016/j.immuni.2015.04.002; Scheid R, 2010, DTSCH ARZTEBL INT, V107, P199, DOI 10.3238/arztebl.2010.0199; Sellgren CM, 2019, NAT NEUROSCI, V22, P374, DOI 10.1038/s41593-018-0334-7; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Skotak M, 2012, J NEUROSCI METH, V205, P159, DOI 10.1016/j.jneumeth.2012.01.001; Song YM, 2019, NEURAL REGEN RES, V14, P1796, DOI 10.4103/1673-5374.257534; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tekin H, 2018, NAT BIOMED ENG, V2, P540, DOI 10.1038/s41551-018-0219-9; Vadlakonda L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00165; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Wagner A. K., 2013, BRAIN INJURY MED PRI; Wang L, 2017, J MOL NEUROSCI, V61, P379, DOI 10.1007/s12031-016-0872-y; Warren KM, 2016, ACS APPL MATER INTER, V8, P21869, DOI 10.1021/acsami.5b12064; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008; Xiong T, 2018, J NEUROPATH EXP NEUR, V77, P383, DOI 10.1093/jnen/nly015; Yildirimer L, 2019, BIOFABRICATION, V11, DOI 10.1088/1758-5090/ab17aa; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang F, 2016, J CONTROL RELEASE, V240, P212, DOI 10.1016/j.jconrel.2015.12.013; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	60	5	6	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2192-2640	2192-2659		ADV HEALTHC MATER	Adv. Healthc. Mater.	JUN	2020	9	12							2000122	10.1002/adhm.202000122		MAY 2020	14	Engineering, Biomedical; Nanoscience & Nanotechnology; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Science & Technology - Other Topics; Materials Science	ME8XL	WOS:000532516300001	32406202	Green Accepted			2022-02-06	
J	Johnston, W; Heiderscheit, B; Sanfilippo, J; Brooks, MA; Caulfield, B				Johnston, William; Heiderscheit, Bryan; Sanfilippo, Jennifer; Brooks, M. Alison; Caulfield, Brian			Athletes with a concussion history in the last two years have impairments in dynamic balance performance	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						balance; digital health; Mild traumatic brain injury; physiotherapy; postural control; rehabilitation; wearable sensor	POSTURAL-CONTROL DEFICITS; LOWER-EXTREMITY; CEREBRAL CONCUSSION; TRUNK ACCELEROMETRY; INJURY RISK; RECOVERY; GAIT	The purpose of this study was to determine if National Collegiate Athletics Association Division 1 American Football and Ice Hockey athletes with a history of concussion have impaired dynamic balance control when compared to healthy control athletes. This cross-sectional observational study recruited 146 athletes; 90 control athletes and 56 athletes with a history of concussion. Athletes were tested during a pre-season evaluation using the inertial-sensor instrumented Y Balance Test. Independent variables were normalized reach distance, gyroscope magnitude sample entropy, and jerk magnitude root mean square. Kruskal-Wallis H test and Dunn-Bonferroni analysis demonstrated that individuals with a concussion history within the last 2 years have statistically significantly lower jerk magnitude root mean square in the posteromedial (Z = 23.22, P = .015) and posterolateral (Z = 24.64, P = .010) reach directions, when compared to the control group. There was no significant difference between those who sustained a concussion longer than two years ago and the control group for the posteromedial (Z = -1.25; P = .889) and posterolateral (Z = 6.44; P = .469) directions. These findings show that athletes with a concussion history within the last two years possess dynamic balance deficits, when compared to healthy control athletes. Conversely, athletes whose injury occurred greater than 2 years ago possessed comparable performance to the healthy controls. This suggests that sensorimotor control deficits may persist beyond clinical recovery, for up to 2 years. Therefore, clinicians should integrate balance training interventions into the return-to-play process to accelerate sensorimotor recovery and mitigate the risk of future injury.	[Johnston, William; Caulfield, Brian] Univ Coll Dublin, Insight Ctr Data Analyt, Belfield, Ireland; [Johnston, William; Caulfield, Brian] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Belfield, Ireland; [Heiderscheit, Bryan; Brooks, M. Alison] Univ Wisconsin, Dept Orthopaed & Rehabil, Madison, WI USA; [Heiderscheit, Bryan; Sanfilippo, Jennifer; Brooks, M. Alison] Univ Wisconsin, Badger Athlet Performance, Madison, WI USA		Johnston, W (corresponding author), Univ Coll Dublin, OBrien Sci Ctr, Insight Ctr Data Analyt C27, Belfield, Ireland.	William.Johnston@insight-centre.org		Johnston, Willliam/0000-0003-0525-6577	Science Foundation of IrelandScience Foundation Ireland [12/RC/2289_P2]	Science Foundation of Ireland, Grant/Award Number: 12/RC/2289_P2	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Buckley TA, 2020, MED SCI SPORTS EXERC, P1; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Doherty C, 2017, CLIN BIOMECH, V42, P79, DOI 10.1016/j.clinbiomech.2017.01.007; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Johnston W., 2018, 6 INT C SPORTS SCI R; Johnston W, 2019, 2019 41 ANN INT C IE; Johnston W., 2019, THESIS; Johnston W, 2019, SPORTS MED, V49, P783, DOI 10.1007/s40279-019-01095-9; Johnston William, 2017, Digit Biomark, V1, P106, DOI 10.1159/000485470; Johnston W, 2019, AM J SPORT MED, V47, P197, DOI 10.1177/0363546518812820; Johnston W, 2017, QJM-INT J MED, V110, P779, DOI 10.1093/qjmed/hcw228; Kang MH, 2015, PM&R, V7, P1152, DOI 10.1016/j.pmrj.2015.05.004; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lynall RC, 2019, J SCI MED SPORT, V22, P503, DOI 10.1016/j.jsams.2018.10.012; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Mahato V, 2019, SCORING PERFORMANCE; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Merritt ED, 2017, J SPORT REHABIL, V26, P518, DOI 10.1123/jsr.2016-0119; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Ness BM, 2015, INT J SPORTS PHYS TH, V10, P168; Pantall A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01044; Plisky Phillip J, 2009, N Am J Sports Phys Ther, V4, P92; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Schmidt JD, 2018, J ATHL TRAINING, V53, P109, DOI 10.4085/1062-6050-326-16; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stiffler MR, 2017, J ORTHOP SPORT PHYS, V47, P339, DOI 10.2519/jospt.2017.6974; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	39	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	AUG	2020	30	8					1497	1505		10.1111/sms.13691		MAY 2020	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NE7LG	WOS:000531378200001	32311175	Green Accepted			2022-02-06	
J	Eagle, SR; Kontos, AP; Sinnott, A; Beckner, M; Nindl, BC; Flanagan, SD; Lovalekar, M; Connaboy, C				Eagle, Shawn R.; Kontos, Anthony P.; Sinnott, Aaron; Beckner, Meaghan; Nindl, Bradley C.; Flanagan, Shawn D.; Lovalekar, Mita; Connaboy, Chris			Utility of a novel perceptual-motor control test for identification of sport-related concussion beyond current clinical assessments	JOURNAL OF SPORTS SCIENCES			English	Article						Concussion; perception-action coupling; motor control		Clinically feasible metrics, that can inform the concussion recovery decision making process by evaluating a unique domain beyond current testing domains (e.g., balance, neurocognition, symptoms, vestibular/ocular function) are still in need. The purpose of this study was to compare perceptual-motor control in adolescent athletes <= 21 days of sport-related concussion and healthy controls and evaluate the association of perceptual-motor control to the outcomes of commonly-used sport-related concussion clinical assessments. Athletes (age: 12-18 years) with sport-related concussion (n = 48) and healthy controls (n = 24) completed the Perception-Action Coupling Task (PACT), whose outcomes are mean reaction, movement, initiation, response time, and accuracy. ImPACT outcomes are verbal/visual memory scores, motor processing speed, and reaction time. Vestibular-Ocular Motor Screen (VOMS) outcomes are symptoms from: smooth pursuit, horizontal/vertical saccades, near-point of convergence, horizontal/vestibular ocular-reflex, and visual motion sensitivity. CONCUSSED demonstrated similar to 5% deficit in overall perceptual-motor accuracy during PACT compared to CONTROLS (p = 0.03). PACT accuracy negatively correlated with smooth pursuits(r = -0.29), and horizontal (r = -0.35)/vertical (r = -0.30) saccades. The C5.0 decision tree determined PACT accuracy was the most relevant predictor of sport-related concussion when no visual motion sensitivity symptoms were reported and Visual Memory was >66. Perceptual-motor control tests may complement current sport-related concussion assessments when neurocognition and vestibular/ocular motor system are not grossly impaired.	[Eagle, Shawn R.; Sinnott, Aaron; Beckner, Meaghan; Nindl, Bradley C.; Flanagan, Shawn D.; Lovalekar, Mita; Connaboy, Chris] Univ Pittsburgh, Warrior Human Performance Res Ctr, Neuromuscular Res Lab, Pittsburgh, PA USA; [Eagle, Shawn R.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA USA		Eagle, SR (corresponding author), 3850 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu	Eagle, Shawn/ABG-1388-2020; Connaboy, Christopher/AAH-4514-2020; Flanagan, Shawn/AAC-6018-2021	Eagle, Shawn/0000-0001-6767-1042; Connaboy, Christopher/0000-0002-9031-2192; Flanagan, Shawn/0000-0002-6531-4567; Sinnott, Aaron/0000-0002-8887-759X	American College of Sports Medicine	This work was supported by the American College of Sports Medicine [Doctoral Research Grant].	Brown JA, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0019-4; Connaboy C, 2019, AEROSP MED HUM PERF, V90, P77, DOI 10.3357/AMHP.5190.2019; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; DALECKI M, 2016, CONCUSSION, V1, DOI DOI https://doi.org/10.2217/cnc-2016-0001; Dalecki M, 2019, EUR J SPORT SCI, V19, P1257, DOI 10.1080/17461391.2019.1584249; Eagle SR, 2020, SPORTS MED, V50, P15, DOI 10.1007/s40279-019-01144-3; Eagle SR, 2019, MED SCI SPORT EXER, V51, P1619, DOI 10.1249/MSS.0000000000001974; Eagle SR, 2021, CLIN J SPORT MED, V31, P273, DOI 10.1097/JSM.0000000000000731; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fajen BR, 2005, PERCEPTION, V34, P717, DOI 10.1068/p5405; Fajen BR, 2009, INT J SPORT PSYCHOL, V40, P79; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, BRAIN INJURY, V32, P1129, DOI 10.1080/02699052.2018.1482424; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kaye S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00396; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell M, 2000, IMPACT IMMEDIATE POS; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nematollahi Mohtaram, 2018, Asian J Neurosurg, V13, P697, DOI 10.4103/ajns.AJNS_336_16; Smith J, 2010, ECOL PSYCHOL, V22, P119, DOI 10.1080/10407411003720080; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324	25	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	AUG 2	2020	38	15					1799	1805		10.1080/02640414.2020.1756675		MAY 2020	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NA8NP	WOS:000538606000001	32412332				2022-02-06	
J	Taghdiri, F; Multani, N; Ozzoude, M; Tarazi, A; Khodadadi, M; Wennberg, R; Mikulis, D; Green, R; Colella, B; Davis, KD; Blennow, K; Zetterberg, H; Tator, C; Tartaglia, MC				Taghdiri, F.; Multani, N.; Ozzoude, M.; Tarazi, A.; Khodadadi, M.; Wennberg, R.; Mikulis, D.; Green, R.; Colella, B.; Davis, K. D.; Blennow, K.; Zetterberg, H.; Tator, C.; Tartaglia, M. C.			Neurofilament-light in former athletes: a potential biomarker of neurodegeneration and progression	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						biomarker; chronic-traumatic-encephalopathy; concussion; diffusion tensor imaging; repetitive-concussions	TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; HIPPOCAMPUS; DEGENERATION; SYMPTOMS; HISTORY; DISEASE	Background/Objective This study aimed to evaluate serum neurofilament light chain (NF-L) levels in former professional contact sports athletes with multiple concussions (ExPro) as a potential biomarker of neurodegeneration and predictor of white-matter (WM) abnormality progression. Methods Concentrations of NF-L in the serum of fifty-two cognitively normal ExPro and twenty-one healthy controls (HC) with no history of concussions were measured using single molecule array (Simoa) technology. Both groups underwent neuroimaging at the time of serum collection. Eighteen of the participants in the ExPro underwent follow-up imaging after 2 years. Results Levels of serum NF-L were not significantly different between the ExPro and HC. However, in the ExPro group, NF-L levels were positively correlated with the mean diffusivity (MD) of corpus callosum (CC) and fornix, and total ventricular volume. Moreover, NF-L levels in the ExPro group at the first visit were positively correlated with the amount of increase in CC MD at the 2-year follow-up. Conclusions NF-L levels reflect neuronal changes in the ExPro group and predict the extent of decrease in white matter integrity over time. Serum NF-L might be a biomarker of neurodegeneration and WM abnormality progression in ExPro.	[Taghdiri, F.; Multani, N.; Ozzoude, M.; Tartaglia, M. C.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Tarazi, A.; Wennberg, R.; Tartaglia, M. C.] Krembil Neurosci Ctr, Div Neurol, Toronto, ON, Canada; [Tarazi, A.; Khodadadi, M.; Wennberg, R.; Mikulis, D.; Green, R.; Colella, B.; Davis, K. D.; Tator, C.; Tartaglia, M. C.] Univ Hlth Network, Toronto Western Hosp, Canadian Concuss Ctr, Krembil Brain Inst, Toronto, ON, Canada; [Wennberg, R.; Mikulis, D.; Davis, K. D.; Tartaglia, M. C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Mikulis, D.] Univ Hlth Network, Joint Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [Green, R.; Colella, B.] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada; [Davis, K. D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Davis, K. D.] Univ Hlth Network, Krembil Brain Inst, Div Brain Imaging & Behav Syst Neurosci, Toronto, ON, Canada; [Blennow, K.; Zetterberg, H.] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Molndal, Sweden; [Blennow, K.; Zetterberg, H.] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, H.] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England; [Zetterberg, H.] UCL, UK Dementia Res Inst UCL, London, England; [Tator, C.] Univ Hlth Network, Toronto Western Hosp, Krembil Brain Inst, Div Neurosurg, Toronto, ON, Canada		Tartaglia, MC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Krembil Discovery Tower,60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	carmela.tartaglia@uhn.ca		Ozzoude, Miracle/0000-0003-4154-2765; Taghdiri, Foad/0000-0002-3280-2804	Swedish Research CouncilSwedish Research CouncilEuropean Commission [2018-02532]; European Research CouncilEuropean Research Council (ERC)European Commission [681712]; Swedish State Support for Clinical Research [ALFGBG-720931]	We'd like to thank all participants for generous donation of their time to participate in this research program. We'd like to thank Leo Ezerins, director of CFLAA for his help with this study. We thank E. Hlasny, K. Ta, B. Li and Dr. A. Crawley for their support in image acquisition. HZ is a Wallenberg Academy Fellow supported by grants from the Swedish Research Council (#2018-02532), the European Research Council (#681712) and Swedish State Support for Clinical Research (#ALFGBG-720931).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Ashton NJ, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0649-3; Bagley J, 1997, NEUROSCIENCE, V77, P65, DOI 10.1016/S0306-4522(96)00435-6; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Chen HL, 2020, J CLIN SLEEP MED, V16, P293, DOI 10.5664/jcsm.8186; Duvernoy H.M, 2013, HUMAN HIPPOCAMPUS AT; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; GLOOR P, 1993, BRAIN, V116, P1249, DOI 10.1093/brain/116.5.1249; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Lacuey N, 2015, BRAIN STRUCT FUNCT, V220, P2617, DOI 10.1007/s00429-014-0810-0; Lewczuk P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0404-9; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Misquitta K, 2018, NEUROIMAGE-CLIN, V19, P551, DOI 10.1016/j.nicl.2018.05.014; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Papp KV, 2014, AGING NEUROPSYCHOL C, V21, P197, DOI 10.1080/13825585.2013.795513; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Reuben A, 2011, J INT NEUROPSYCH SOC, V17, P56, DOI 10.1017/S135561771000127X; Sabisz A, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00035; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Taghdiri F, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000286; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Xu JS, 2013, HUM BRAIN MAPP, V34, P1044, DOI 10.1002/hbm.21491; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	33	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	JUL	2020	27	7					1170	1177		10.1111/ene.14251		MAY 2020	8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MB2MT	WOS:000530920300001	32281206	Green Published			2022-02-06	
J	Jacinto, J; Varriale, P; Pain, E; Lysandropoulos, A; Esquenazi, A				Jacinto, Jorge; Varriale, Pasquale; Pain, Emilie; Lysandropoulos, Andreas; Esquenazi, Alberto			Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity	FRONTIERS IN NEUROLOGY			English	Article						botulinum toxin; patient survey; spasticity; waning of effect; patient perspectives	ADULT SPASTICITY; ABOBOTULINUMTOXINA; STROKE; TOXIN	Background: Botulinum toxin-A (BoNT-A) injections are first-line treatment for adult spasticity. Prior patient surveys have reported that BoNT-A treatment improves quality of life but that symptoms usually recur before the next injection. We aimed to explore, in-depth, patient perceptions of the impact of spasticity and the waning of BoNT-A therapeutic effects. Methods: An internet-based survey was conducted through Carenity, an online patient community, from May to September 2019 in France, Germany, Italy, UK and USA. Eligible respondents were adult patients with spasticity due to stroke, traumatic brain injury (TBI) or spinal cord injury (SCI) who had >= 2 previous BoNT-A injections. Results: Two hundred and ten respondents (mean 47.2 years) met screening criteria and had their responses analyzed. Overall, 43% of respondents had spasticity due to stroke, 30% due to TBI and 27% due to SCI. The mean [95% CI] injection frequency for spasticity management was 3.6 [3.4-3.7] injections/year. Respondents described the time profile of their response to BoNT-A. The mean reported onset of therapeutic effect was 12.9 [12.1-13.7] days and the mean time to peak effect was 5.0 [4.7-5.4] weeks. Symptom re-emergence between injections was common (83%); the time from injection to symptom re-emergence was 89.4 [86.3-92.4] days. Muscle spasms usually re-emerge first (64%), followed by muscle stiffness or rigidity (40%), and limb pain (20%). Over half (52%) of respondents said they had lost their self-confidence, 46% experienced depression and 41% experienced a lack of sleep due to their spasticity symptoms in the past 12 months. Following a report of symptom re-emergence, the most common management approaches were to add adjunctive treatments (36%), increase the BoNT-A dose (28%), and wait for the next injection (26%). Seventy two percentage of respondents said they would like a longer lasting BoNT-A treatment. Conclusions: Patients with spasticity can expect a characteristic profile of BoNT-A effects, namely time lag to onset and peak effect followed by a gradual decline in the symptomatic benefits. Symptom re-emergence is common and has significant impact on quality of life. Greater patient/clinician awareness of this therapeutic profile should lead to better level of overall satisfaction with treatment, informed therapeutic discussions and treatment schedule planning.	[Jacinto, Jorge] Ctr Med Reabilitacaode Alcoitao, Serv Reabilitacao Adultos 3, Alcabideche, Portugal; [Varriale, Pasquale; Pain, Emilie] Carenity, Paris, France; [Lysandropoulos, Andreas] Ipsen, Cambridge, MA USA; [Esquenazi, Alberto] MossRehab, Elkins Pk, PA 19027 USA; [Esquenazi, Alberto] Albert Einstein Med Ctr, Elkins Pk, PA 19027 USA		Esquenazi, A (corresponding author), MossRehab, Elkins Pk, PA 19027 USA.; Esquenazi, A (corresponding author), Albert Einstein Med Ctr, Elkins Pk, PA 19027 USA.	aesquena@einstein.edu			Ipsen PharmaIpsen	This work was funded by Ipsen Pharma.	Barnes M, 2017, DISABIL REHABIL, V39, P1428, DOI 10.1080/09638288.2016.1198432; Benner JL, 2017, DEV MED CHILD NEUROL, V59, P762, DOI 10.1111/dmcn.13423; Bensmail Djamel, 2014, J Med Econ, V17, P618, DOI 10.3111/13696998.2014.925462; Dashtipour K, 2015, AM J PHYS MED REHAB, V94, P229, DOI 10.1097/PHM.0000000000000208; Doan QV, 2012, PM&R, V4, P4, DOI 10.1016/j.pmrj.2011.10.001; ESQUENAZI A, 2004, CLIN GERIATR MED, V12, P27; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Francisco GE, 2012, STROKE, V43, P3132, DOI 10.1161/STROKEAHA.111.639831; Ganapathy Vaidyanathan, 2015, Clin Interv Aging, V10, P1793, DOI 10.2147/CIA.S91123; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Rais S, 2017, ISPOR; RCP, 2018, SPAST AD MAN US BOT; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Sommerfeld DK, 2012, AM J PHYS MED REHAB, V91, P814, DOI 10.1097/PHM.0b013e31825f13a3; Sunnerhagen KS, 2013, NEUROLOGY, V80, pS35, DOI 10.1212/WNL.0b013e3182764aa2; Truong DD, 2006, PARKINSONISM RELAT D, V12, P331, DOI 10.1016/j.parkreldis.2006.06.002; Turner-Stokes L, 2018, TOXICON, V156, pS110, DOI 10.1016/j.toxicon.2018.11.266; Turner-Stokes L, 2018, EUR J PHYS REHAB MED, V54, P605, DOI 10.23736/S1973-9087.17.04808-0; Zorowitz RD, 2013, NEUROLOGY, V80, pS45, DOI 10.1212/WNL.0b013e3182764c86	20	5	5	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 7	2020	11								388	10.3389/fneur.2020.00388			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT7WS	WOS:000537277400001	32477251	Green Published, gold			2022-02-06	
J	Lier, J; Ondruschka, B; Bechmann, I; Dressler, J				Lier, Julia; Ondruschka, Benjamin; Bechmann, Ingo; Dressler, Jan			Fast microglial activation after severe traumatic brain injuries	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Chronic traumatic encephalopathy; Immunohistochemistry; Inflammation; Microglia; Traumatic brain injury	CONSEQUENCES; TIME; NSE	Traumatic brain injury is among the leading causes of death in individuals under 45 years of age. However, since trauma mechanisms and survival times differ enormously, the exact mechanisms leading to the primary and secondary injury and eventually to death after traumatic brain injury (TBI) remain unclear. Several studies showed the versatile functions of microglia, the innate macrophages of the brain, following a TBI. Earlier being characterized as rather neurotoxic, neuroprotective capacities were recently demonstrated, therefore, making microglia one of the key players following TBI. Especially in cases with only short survival times, immediate microglial reactions are of great forensic interest in questions of wound age estimation. Using standardized immunohistochemical methods, we examined 8 cases which died causatively of TBI with survival times between minutes and 7 days and 5 control cases with cardiovascular failure as the cause of death to determine acute changes in microglial morphology and antigen expression after TBI. In this pilot study, we detected highly localized changes in microglial morphology already early after traumatic damage, e.g., activated microglia and phagocyted erythrocytes in the contusion areas in cases with minute survival. Furthermore, an altered antigen expression was observed with increasing trauma wound age, showing similar effects like earlier transcriptomic studies. There is minute data on the direct impact of shear forces on microglial morphology. We were able to show localization-depending effects on microglial morphology causing localized dystrophy and adjacent activation. While rodent studies are widespread, they fail to mimic the exact mechanisms in human TBI response. Therefore, more studies focusing on cadaveric samples need to follow to thoroughly define the mechanisms leading to cell destruction and eventually evaluate their forensic value.	[Lier, Julia; Bechmann, Ingo] Univ Leipzig, Inst Anat, Liebigstr 13, D-04103 Leipzig, Germany; [Ondruschka, Benjamin; Dressler, Jan] Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de			Projekt DEAL	Open Access funding provided by Projekt DEAL.	Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bremicker K, 2013, RECHTSMEDIZIN, V23, P327, DOI [10.1007/s00194-013-0903-8, DOI 10.1007/s00194-013-0903-8]; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Gimeno-Bayon J, 2014, J NEUROSCI RES, V92, P723, DOI 10.1002/jnr.23356; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; Hausmann Roland, 2006, Forensic Sci Med Pathol, V2, P85, DOI 10.1385/FSMP:2:2:85; Izzy S, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00307; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Lou NH, 2016, P NATL ACAD SCI USA, V113, P1074, DOI 10.1073/pnas.1520398113; Maxeiner H, 2009, RECHTSMEDIZIN, V19, P111, DOI 10.1007/s00194-008-0585-9; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mildner A, 2017, GLIA, V65, P375, DOI 10.1002/glia.23097; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Riboldi E, 2013, INT IMMUNOL, V25, P67, DOI 10.1093/intimm/dxs110; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Trautz F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48145-w; Wang CF, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6460	25	5	5	1	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	NOV	2020	134	6					2187	2193		10.1007/s00414-020-02308-x		MAY 2020	7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	OE5OZ	WOS:000530614500001	32372233	Green Published, hybrid			2022-02-06	
J	Mosbacher, Y; Khoyratee, F; Goldin, M; Kanner, S; Molokai, Y; Silva, M; Grassia, F; Ben Simon, Y; Cortes, J; Barzilai, A; Levi, T; Bonifazi, P				Mosbacher, Yossi; Khoyratee, Farad; Goldin, Miri; Kanner, Sivan; Molokai, Yenehaetra; Silva, Moises; Grassia, Filippo; Ben Simon, Yoav; Cortes, Jesus; Barzilai, Ari; Levi, Timothee; Bonifazi, Paolo			Toward neuroprosthetic real-time communication from in silico to biological neuronal network via patterned optogenetic stimulation	SCIENTIFIC REPORTS			English	Article							CORTICAL-NEURONS; HUB NEURONS; MOVEMENT; MODEL	Restoration of the communication between brain circuitry is a crucial step in the recovery of brain damage induced by traumatic injuries or neurological insults. In this work we present a study of real-time unidirectional communication between a spiking neuronal network (SNN) implemented on digital platform and an in-vitro biological neuronal network (BNN), generating similar spontaneous patterns of activity both spatial and temporal. The communication between the networks was established using patterned optogenetic stimulation via a modified digital light projector (DLP) receiving real-time input dictated by the spiking neurons' state. Each stimulation consisted of a binary image composed of 8 x 8 squares, representing the state of 64 excitatory neurons. The spontaneous and evoked activity of the biological neuronal network was recorded using a multi-electrode array in conjunction with calcium imaging. The image was projected in a sub-portion of the cultured network covered by a subset of the all electrodes. The unidirectional information transmission (SNN to BNN) is estimated using the similarity matrix of the input stimuli and output firing. Information transmission was studied in relation to the distribution of stimulus frequency and stimulus intensity, both regulated by the spontaneous dynamics of the SNN, and to the entrainment of the biological networks. We demonstrate that high information transfer from SNN to BNN is possible and identify a set of conditions under which such transfer can occur, namely when the spiking network synchronizations drive the biological synchronizations (entrainment) and in a linear regime response to the stimuli. This research provides further evidence of possible application of miniaturized SNN in future neuro-prosthetic devices for local replacement of injured micro-circuitries capable to communicate within larger brain networks.	[Mosbacher, Yossi] Weizmann Inst Sci, Dept Particle Phys & Astrophys, Rehovot, Israel; [Khoyratee, Farad; Levi, Timothee] Univ Bordeaux, CNRS, UMR 5218, IMS Lab, Talence 33405, France; [Kanner, Sivan; Ben Simon, Yoav; Barzilai, Ari] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, Tel Aviv 69978, Israel; [Molokai, Yenehaetra] Univ Bordeaux, IUT Bordeaux, GEII Dept, Gradignan 33175, France; [Silva, Moises] Univ Basque Country, Fac Informat, San Sebastian 20018, Spain; [Grassia, Filippo] Univ Picardie Jules Verne, Fac Informat, Amiens 80025, France; [Cortes, Jesus] Univ Basque Country, Dept Cell Biol & Histol, Leioa 48940, Spain; [Barzilai, Ari] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv 69978, Israel; [Cortes, Jesus; Bonifazi, Paolo] Basque Fundat, IKERBASQUE, Bilbao 48013, Spain; [Goldin, Miri; Cortes, Jesus; Bonifazi, Paolo] Biocruces Hlth Res Inst, Baracaldo 48903, Spain; [Levi, Timothee] Univ Tokyo, CNRS, IIS, LIMMS, Tokyo 1538505, Japan; [Levi, Timothee] Univ Tokyo, IIS, Tokyo 1538505, Japan; [Mosbacher, Yossi] Tel Aviv Univ, Sch Phys & Astron, Tel Aviv 69978, Israel; [Kanner, Sivan] Univ Basel, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, Basel 4058, Switzerland		Levi, T (corresponding author), Univ Bordeaux, CNRS, UMR 5218, IMS Lab, Talence 33405, France.; Bonifazi, P (corresponding author), Basque Fundat, IKERBASQUE, Bilbao 48013, Spain.; Bonifazi, P (corresponding author), Biocruces Hlth Res Inst, Baracaldo 48903, Spain.; Levi, T (corresponding author), Univ Tokyo, CNRS, IIS, LIMMS, Tokyo 1538505, Japan.; Levi, T (corresponding author), Univ Tokyo, IIS, Tokyo 1538505, Japan.	timothee.levi@u-bordeaux.fr; paol.bonifazi@gmail.com	Bonifazi, Paolo/AAA-8035-2020; Bonifazi, Paolo/N-9737-2018	Bonifazi, Paolo/0000-0001-6374-8997; Bonifazi, Paolo/0000-0001-6374-8997; Levi, Timothee/0000-0003-0378-8529; Goldin, Miri/0000-0002-4228-9944; Silva, Moises/0000-0003-2417-4833	European Union's Seventh Framework Programme (ICT-FET FP7/2007-2013, FET Young Explorers scheme) [284772 BRAINBOW]; Italian Ministry of Foreign AffairsMinistry of Foreign Affairs and International Cooperation (Italy); Ikerbasque (Basque Foundation for Science); Ministerio Economia, Industria y Competitividad of Spain [SAF2015-69484-R]	The presented research results have received funding from the European Union's Seventh Framework Programme (ICT-FET FP7/2007-2013, FET Young Explorers scheme) under grant agreement n 284772 BRAINBOW (www.brainbowproject.eu).This work has been realized within the activity of the Joint Italian-Israeli Laboratory on Integrative Network Neuroscience financed by the Italian Ministry of Foreign Affairs (P.B., A.B.). The authors acknowledge financial support from from Ikerbasque (The Basque Foundation for Science) (P.B.) and from the Ministerio Economia, Industria y Competitividad of Spain (grant SAF2015-69484-R (MINECO/FEDER)) (PB). We would like acknowledge the late Prof. Eshel Ben-Jacob whose pioneering research inspired the current study.	Adam GC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07565-4; Ambroise M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00215; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Bonifazi P, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00040; Broccard FD, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa67a9; Buccelli S, 2019, ISCIENCE, V19, P402, DOI 10.1016/j.isci.2019.07.046; Cassidy A., 2011, P 45 ANN C INF SCI S, P1, DOI DOI 10.1109/CISS.2011.5766099; Chou ZN, 2015, IEEE ENG MED BIO, P3949, DOI 10.1109/EMBC.2015.7319258; Davies M, 2018, IEEE MICRO, V38, P82, DOI 10.1109/MM.2018.112130359; Destexhe A., 1998, METHODS NEURONAL MOD, P1; Dieter A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09980-7; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Gewaltig M.-O., 2007, SCHOLARPEDIA, V2, P1430, DOI [10.4249/scholarpedia.1430, DOI 10.4249/SCHOLARPEDIA.1430]; Goodman DFM, 2009, FRONT NEUROSCI-SWITZ, V3, P192, DOI 10.3389/neuro.01.026.2009; Grassia F, 2016, J Physiol Paris, V110, P409, DOI 10.1016/j.jphysparis.2017.02.002; Gupta I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12805; Herzog N, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056008; Hill AAV, 2001, J COMPUT NEUROSCI, V10, P281, DOI 10.1023/A:1011216131638; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Jarvis S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00157; Jimbo Y, 2000, BIOL CYBERN, V83, P1, DOI 10.1007/PL00007970; Kanner S, 2018, P NATL ACAD SCI USA, V115, P8025, DOI 10.1073/pnas.1718582115; Keren H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00432; Khoyratee F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00377; Levi T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00026; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luhmann HJ, 2016, FRONT NEURAL CIRCUIT, V10, DOI [10.3389/fncir.2016.00040, 10.3389/fneir.2016.00040]; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Martinez-Losa M, 2018, NEURON, V98, P75, DOI 10.1016/j.neuron.2018.02.029; McClure MJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2084; Mei Y, 2012, BIOL PSYCHIAT, V71, P1033, DOI 10.1016/j.biopsych.2012.02.019; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Natarajan A, 2018, IEEE T BIOMED CIRC S, V12, P918, DOI 10.1109/TBCAS.2018.2837055; Picardo MA, 2011, NEURON, V71, P695, DOI 10.1016/j.neuron.2011.06.018; Qiao N, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00141; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; van Albada SJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00291; Vassanelli S., 2016, FRONTIERS NEUROSCIEN, V10; Wagenaar DA, 2005, J NEUROSCI, V25, P680, DOI 10.1523/JNEUROSCI.4209-04.2005; Zhao HB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081751	44	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 5	2020	10	1							7512	10.1038/s41598-020-63934-4			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM7OD	WOS:000532437000014	32371937	gold, Green Published			2022-02-06	
J	Asken, BM; Houck, ZM; Bauer, RM; Clugston, JR				Asken, Breton M.; Houck, Zachary M.; Bauer, Russell M.; Clugston, James R.			SCAT5 vs. SCAT3 Symptom Reporting Differences and Convergent Validity in Collegiate Athletes	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Brain injury; Assessment; Baseline; Sport concussion assessment tool	POST-CONCUSSION SYNDROME; POOR SLEEP QUALITY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; NORMATIVE DATA; HIGH-SCHOOL; SPORT HELD; SOMATIZATION; DEPRESSION; PREVALENCE	Objective: The Sport Concussion Assessment Tool (SCAT), fifth Edition, Symptom Evaluation (S5SE) differs from previous versions by having examinees report trait (i.e. "typical" feelings) as opposed to state (i.e., "how you feel right now") concussion-like symptoms at baseline. This study assessed differences among, and convergent validity of, scores on the S5SE, SCAT3 Symptom Evaluation (S3SE), and the Brief Symptom Inventory (BSI-18). Methods: A total of 113 University of Florida varsity athletes completed symptom questionnaires on the same day in a counterbalanced administration. The final sample consisted of 94 participants (mean age +/- SD = 18.4 +/- 0.8 years, 57% male, 65% white) from 17 sports. We assessed convergent validity using Spearman rank-order correlations. Within-participant differences were analyzed with Wilcoxon Signed-Rank tests. We qualitatively described free-response answers to the S5SE question that asks, "if not feeling 100%, why?". Results: S5SE total severity score demonstrated adequate convergent validity with both the S3SE (rho = .407, p < .001) and BSI-18 (rho = .432, p < .001). Domain-specific analyses indicated variable convergent validity (rho < 0.4 to rho > 0.6). Severity scores did not differ between the S3SE and S5SE (p = .500), but 24.5% of participants reported S3SE > S5SE and 34.0% S5SE > S3SE. Three themes emerged from qualitative examination of reasons for "not feeling 100%": (1) tiredness/sleep, (2) adjustment difficulties, and (3) academic/athletic stress. Conclusions: Adequate convergent validity exists between SCAT5 and SCAT3 symptom severity in collegiate athletes. However, most examinees report different baseline symptom severity when asked to describe their trait (S5SE) versus state symptoms (S3SE). Clinicians should consider using the new SCAT5 Symptom Evaluation as a screening tool for identifying otherwise healthy or "undiagnosed" individuals who would benefit from targeted interventions.	[Asken, Breton M.; Houck, Zachary M.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Clugston, James R.] Univ Florida, Univ Athlet Assoc, Dept Community Hlth & Family Med, Gainesville, FL 32610 USA		Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	basken8@phhp.ufl.edu		Clugston, James/0000-0002-2103-1039; Asken, Breton/0000-0001-8419-142X	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG047266-01A1]; Veterans' AdministrationUS Department of Veterans Affairs [I21RX001730-01]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR001427]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001427]; Banyan Biomarkers, Inc.; Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DOD); Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	RMB receives support from grant P50AG047266-01A1 from the National Institute on Aging, grant I21RX001730-01 from the Veterans' Administration, and grant UL1TR001427 from the National Institutes of Health and the National Center for Advancing Translational Sciences. JRC receives support from Banyan Biomarkers, Inc., and the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds). The funding sources had no role in the planning, design, or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Asken BM, 2017, CLIN NEUROPSYCHOL, V31, P138, DOI 10.1080/13854046.2016.1246672; Beck A.T., 1996, BECK DEPRESSION INVE, DOI DOI 10.1037/T00742-000; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Derogatis LR., 2001, BSI 18 BRIEF SYMPTOM; Drew B, 2019, J CLIN SPORT PSYCHOL, V13, P421, DOI 10.1123/jcsp.2017-0043; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Hunter LR, 2010, PSYCHOL BULL, V136, P211, DOI 10.1037/a0018133; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; KATON W, 1982, AM J MED, V72, P127, DOI 10.1016/0002-9343(82)90599-X; KATON W, 1991, AM J PSYCHIAT, V148, P34; Mah CD, 2018, SLEEP HEALTH, V4, P251, DOI 10.1016/j.sleh.2018.02.005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; Williams MT, 2012, PSYCHIAT RES, V199, P31, DOI 10.1016/j.psychres.2012.03.049; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	31	5	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		291	301		10.1093/arclin/acz007			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800007	30796799	Bronze			2022-02-06	
J	Bender, M; Stein, M; Schoof, B; Kolodziej, MA; Uhl, E; Scholler, K				Bender, Michael; Stein, Marco; Schoof, Bennet; Kolodziej, Malgorzata Anna; Uhl, Eberhard; Schoeller, Karsten			Troponin I as an early biomarker of cardiopulmonary parameters during the first 24 h of intensive care unit treatment in isolated traumatic brain injury patients	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Troponin I; Traumatic brain injury; Intensive care unit treatment; Cardiopulmonary parameters; Critical care biomarker	SUBARACHNOID HEMORRHAGE; ELEVATION; STROKE; SCALE	Objective: Cardiopulmonary (CP) complications are well-known phenomena after an isolated traumatic brain injury (iTBI) and they may be associated with an elevated serum troponin I (TnI) value. However, the influence of an elevated TnI level on CP parameters within the first 24 h after an iTBI is still unknown. The current study was conducted to assess the associations between the initial TnI value on admission and CP parameters during the first 24 h of intensive care unit (ICU) treatment in iTBI patients. Patients and Methods: A total of 288 patients with iTBIs, who were admitted to our emergency department between January 2010 and November 2016 were retrospectively analyzed. Blood samples were taken on admission to determine TnI value. Each patient's demographic data, treatment regime, computed tomography results, and intra-hospital outcomes were evaluated, as well as several CP parameters, within the first 24 h of ICU treatment. The entire study population was stratified into patients with an initial TnI elevation (TnI positive) and without an initial TnI elevation (TnI negative). Results: Increased TnI values on admission were found in 59 (20.5%) patients. There were significant correlations between an initially elevated TnI value and a lower Glasgow Coma Scale score (p = 0.003), higher head Abbreviated Injury Scale score (p<0.0001), and higher Acute Physiology and Chronic Health Evaluation II score (p = 0.005) on admission, as well as a lower Glasgow Outcome Scale score (p = 0.0002) and higher modified Rankin Scale score (p = 0.0001) at discharge. In addition, a significantly higher norepinephrine application rate (NAR) (p<0.0001) and inspiratory oxygen fraction (FiO2) (p = 0.028) were needed in the TnI positive group. Conclusion: Patients with elevated TnI values on admission require more circulation support (NAR and FiO2) within the first 24 h of ICU treatment after an iTBI. Therefore, the TnI may be a useful biomarker to improve ICU treatment of these patients. (C) 2020 Elsevier Ltd. All rights reserved.	[Bender, Michael; Stein, Marco; Kolodziej, Malgorzata Anna; Uhl, Eberhard; Schoeller, Karsten] Justus Liebig Univ Giessen, Dept Neurosurg, Klin Str 33, D-35392 Giessen, Germany; [Schoof, Bennet] Sana Klinikum Dusseldorf, Dept Trauma Orthoped & Reconstruct Surg, D-40625 Dusseldorf, Germany		Bender, M (corresponding author), Justus Liebig Univ Giessen, Dept Neurosurg, Klin Str 33, D-35392 Giessen, Germany.	michael.bender@neuro.med.uni-giessen.de					Ako J, 2006, AM J MED, V119, P10, DOI 10.1016/j.amjmed.2005.08.022; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Bhoi S, 2014, INT J CRIT IIIN INJ, V4, P4253; Bhoi Sanjeev, 2014, Int J Crit Illn Inj Sci, V4, P253, DOI 10.4103/2229-5151.141471; Cai SS, 2016, J TRAUMA ACUTE CARE, V80, P477, DOI 10.1097/TA.0000000000000916; Christensen H, 2004, CEREBROVASC DIS, V18, P194, DOI 10.1159/000079941; Chung PW, 2009, J KOREAN NEUROSURG S, V45, P355, DOI 10.3340/jkns.2009.45.6.355; COOPER DKC, 1989, ANN ROY COLL SURG, V71, P261; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; El-Menyar A, 2018, J NEUROSURG, V129, P1541, DOI 10.3171/2017.7.JNS17675; El-Menyar A, 2019, AM J EMERG MED, V37, P133, DOI 10.1016/j.ajem.2018.10.002; El-Menyar A, 2017, CARDIOL REV, V25, P279, DOI 10.1097/CRD.0000000000000167; Gerner ST, 2018, CEREBROVASC DIS, V46, P72, DOI 10.1159/000492395; Gupte M, 2013, NEUROCRIT CARE, V18, P368, DOI 10.1007/s12028-012-9813-y; Hamm CW, 2002, CIRCULATION, V106, P2871, DOI 10.1161/01.CIR.0000044342.50593.63; Hays A, 2006, NEUROLOGY, V66, P1330, DOI 10.1212/01.wnl.0000210523.22944.9b; JENNETT B, 1975, LANCET, V1, P480; Jeon IC, 2009, J KOREAN NEUROSURG S, V46, P99, DOI 10.3340/jkns.2009.46.2.99; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lambert E, 2002, J NEUROL SCI, V198, P43, DOI 10.1016/S0022-510X(02)00073-4; Lin XP, 2016, EXP THER MED, V12, P2341, DOI 10.3892/etm.2016.3615; Loftis KL, 2018, TRAFFIC INJ PREV, V19, pS109, DOI 10.1080/15389588.2018.1512747; Mashaly HA., 2008, CLEVE CLIN J MED, V75, P26, DOI DOI 10.3949/CCJM.75.SUPPL_2.S26; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Nastasovic T, 2017, ACTA NEUROCHIR, V159, P705, DOI 10.1007/s00701-017-3091-6; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Riera Maria, 2010, J Trauma, V68, pE13, DOI 10.1097/TA.0b013e3181469d5b; Roongsritong C, 2004, CHEST, V125, P1877, DOI 10.1378/chest.125.5.1877; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; TEASDALE G, 1974, LANCET, V2, P81; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Zhang LM, 2015, J STROKE CEREBROVASC, V24, P2375, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.030	35	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2020	51	5					1189	1195		10.1016/j.injury.2020.01.002			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	LS1SW	WOS:000536172500008	31926612				2022-02-06	
J	Castelli, L; De Giglio, L; Haggiag, S; Traini, A; De Luca, F; Ruggieri, S; Prosperini, L				Castelli, Letizia; De Giglio, Laura; Haggiag, Shalom; Traini, Arianna; De Luca, Francesca; Ruggieri, Serena; Prosperini, Luca			Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosis	NEUROLOGICAL SCIENCES			English	Article						Multiple sclerosis; Reserve; Rehabilitation	TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; PERSONALITY-TRAITS; TEMPERAMENT; RECOVERY; NEUROPLASTICITY; ATTACHMENT; VALIDITY; FEATURES; IMPACT	Background Premorbid physically and intellectually enriching lifestyles have increasingly been recognized as able to mitigate the risk of disease-related disability in patients with multiple sclerosis (MS). Objective To explore if premorbid physical activity, cognitive reserve and trait personality act as proxies for functional reserve that contributes to rehabilitation outcome. Methods We recruited all patients previously enrolled in two pilot trials investigating the effect of home-based video game training in improving balance (Study 1) and attention (Study 2) for additional assessments with the Historical Leisure Activity Questionnaire (HLAQ; a proxy for premorbid physical activity), Cognitive Reserve Index Questionnaire (CRIQ), and Temperament and Character Inventory (TCI). Hierarchical logistic regression (HLR) analyses tested the association of HLAQ, CRIQ, and TCI with training effect on balance (static posturography) and on attention (Symbol Digit Modalities Test). Results We identified 94% (34/36) and 74% (26/35) of patients participating at the original Study 1 and Study 2, respectively. HLR analyses showed an exclusive "intra-modal" modulation of rehabilitation outcome by functional reserve, given that (1) larger training effect on balance was associated with higher HLAQ (OR = 2.03, p = 0.031); (2) larger training effect on attention was associated with higher CRIQ (OR = 1.27, p = 0.033). Furthermore, we found specific personality traits associated with (1) greater training effect on balance (self-directedness; OR = 1.40, p = 0.051) and lower training effect on attention (harm avoidance; OR = 0.66, p = 0.075). Conclusion We hypothesize that premorbid physical and intellectual activities not only act as a buffer for limiting the MS-related damage but also as functional reserve that can be retrieved by task-oriented training to promote recovery through rehabilitation.	[Castelli, Letizia] IRCCS Don Carlo Gnocchi Fdn, Piazzale Morandi 6, Milan 20121, Italy; [De Giglio, Laura] S Filippo Neri Hosp, Via G Martinotti 20, Rome 00135, Italy; [De Giglio, Laura] Sapienza Univ, Dept Human Neurosci, Viale Univ 30, Rome 00185, Italy; [Haggiag, Shalom; Ruggieri, Serena; Prosperini, Luca] S Camillo Forlanini Hosp, Cne Gianicolense 87, Rome 00152, Italy; [Traini, Arianna] S Andrea Hosp, Phys Therapy Unit, Via Grottarossa 1035, Rome 00189, Italy; [De Luca, Francesca] Sapienza Univ, Dept Psychol, Viale Univ 30, Rome 00185, Italy		Prosperini, L (corresponding author), S Camillo Forlanini Hosp, Cne Gianicolense 87, Rome 00152, Italy.	letizia.castelli@gmail.com; lauradegiglio@gmail.com; lyshalom@hotmail.com; arianna_traini@yahoo.com; francideluca84@libero.it; serena.ruggieri@gmail.com; luca.prosperini@gmail.co	Ruggieri, Serena/K-2294-2016; Haggiag, Shalom/AAL-8385-2021; DE GIGLIO, Laura/J-4796-2016	Ruggieri, Serena/0000-0001-5287-3290; DE GIGLIO, Laura/0000-0001-9018-7320; Prosperini, Luca/0000-0003-3237-6267; Haggiag, Shalom/0000-0002-5569-4121			Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Cheng ST, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0721-2; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; De Giglio L, 2016, RADIOLOGY, V280, P202, DOI 10.1148/radiol.2016150710; De Giglio L, 2015, NEUROREHAB NEURAL RE, V29, P453, DOI 10.1177/1545968314554623; Elmstahl S, 1996, ARCH GERONTOL GERIAT, V22, P233, DOI 10.1016/0167-4943(96)00696-6; Fazekas C, 2013, CLIN NEUROL NEUROSUR, V115, P293, DOI 10.1016/j.clineuro.2012.05.022; Fossati A, 2007, COMPR PSYCHIAT, V48, P380, DOI 10.1016/j.comppsych.2007.02.003; Gazioglu S, 2014, J NERV MENT DIS, V202, P408, DOI 10.1097/NMD.0000000000000114; Jokinen H, 2016, J NEUROL NEUROSUR PS, V87, P1296, DOI 10.1136/jnnp-2016-313914; Karaahmet OZ, 2018, IRAN J NEUROL, V17, P38; Kleim JA, 2011, J COMMUN DISORD, V44, P521, DOI 10.1016/j.jcomdis.2011.04.006; Krieger SC, 2018, NEUROL CLIN, V36, P13, DOI 10.1016/j.ncl.2017.08.003; Leavitt VM, 2017, MULT SCLER J, V23, P1786, DOI 10.1177/1352458516685417; Motl RW, 2012, J NEUROL SCI, V323, P123, DOI 10.1016/j.jns.2012.08.033; Nucci Massimo, 2012, Aging Clin Exp Res, V24, P218, DOI 10.3275/7800; Piccinini G, 2018, EUR J PHYS REHAB MED, V54, P554, DOI 10.23736/S1973-9087.17.04837-7; Prosperini L, 2015, MULT SCLER J, V21, P492; Prosperini L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/481574; Prosperini L, 2014, RADIOLOGY, V273, P529, DOI 10.1148/radiol.14140168; Prosperini L, 2013, NEUROREHAB NEURAL RE, V27, P516, DOI 10.1177/1545968313478484; Roy S, 2018, MULT SCLER J, V24, P1909, DOI 10.1177/1352458517753720; Santangelo G, 2019, NEUROPSYCHOLOGY, V33, P379, DOI 10.1037/neu0000520; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Strober L, 2019, MULT SCLER J, V25, P1781, DOI 10.1177/1352458518808204; Sumowsk JF, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00176; Sumowski JF, 2013, MULT SCLER J, V19, P1122, DOI 10.1177/1352458513498834; Sunwoo MK, 2017, PARKINSONISM RELAT D, V34, P49, DOI 10.1016/j.parkreldis.2016.10.023; Tomassini V, 2012, NAT REV NEUROL, V8, P635, DOI 10.1038/nrneurol.2012.179; Yamaguchi T, 2018, EUR REV AGING PHYS A, V15, DOI 10.1186/s11556-018-0208-8; Zarbo IR, 2016, MULT SCLER J, V22, P551, DOI 10.1177/1352458515594045	35	5	5	0	1	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2020	41	5					1251	1257		10.1007/s10072-019-04237-z			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LI8WX	WOS:000529759800031	31919697				2022-02-06	
J	Cepeda, S; Castano-Leon, AM; Munarriz, PM; Paredes, I; Panero, I; Eiriz, C; Gomez, PA; Lagares, A				Cepeda, Santiago; Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Panero, Irene; Eiriz, Carla; Gomez, Pedro A.; Lagares, Alfonso			Effect of decompressive craniectomy in the postoperative expansion of traumatic intracerebral hemorrhage: a propensity score-based analysis	JOURNAL OF NEUROSURGERY			English	Article						contusion; traumatic intracerebral hematoma; decompressive craniectomy; hemorrhagic progression; traumatic brain injury; trauma	BRAIN-INJURY; CEREBRAL CONTUSIONS; RISK-FACTORS; INTRAPARENCHYMAL HEMORRHAGE; PROGRESSION; IMPACT; MECHANISM; INCREASE; MODERATE; DESIGN	OBJECTIVE Traumatic intracerebral hemorrhage (TICH) represents approximately 13%-48% of the lesions after a traumatic brain injury (TBI), and hemorrhagic progression (HP) occurs in 38%-63% of cases. In previous studies, decompressive craniectomy (DC) has been characterized as a risk factor in the HP of TICH; however, few studies have focused exclusively on this relationship. The object of the present study was to analyze the relationship between DC and the growth of TICH and to reveal any correlation with the size of the craniectomy, degree of cerebral parenchymal herniation (CPH), or volumetric expansion of the TICH. METHODS The authors retrospectively analyzed the records of 497 adult patients who had been consecutively admitted after suffering a severe or moderate closed TBI. An inclusion criterion was presentation with one or more TICHs on the initial or control CT. Demographic, clinical, radiological, and treatment variables were assessed for associations. RESULTS Two hundred three patients presenting with 401 individual TICHs met the selection criteria. TICH growth was observed in 281 cases (70.1%). Eighty-two cases (20.4%) underwent craniectomy without TICH evacuation. In the craniectomy group, HP was observed in 71 cases (86.6%); in the noncraniectomy group (319 cases), HP occurred in 210 cases (65.8%). The difference in the incidence of HP between the two groups was statistically significant (OR 3.41, p < 0.01). The mean area of the craniectomy was 104.94 +/- 27.5 cm(2), and the mean CPH distance through the craniectomy was 17.85 +/- 11.1 mm. The mean increase in the TICH volume was greater in the groups with a craniectomy area > 115 cm(2) and CPH > 25 mm (16.12 and 14.47 cm(3), respectively, p = 0.01 and 0.02). After calculating the propensity score (PS), the authors followed three statistical methods-matching, stratification, and inverse probability treatment weighting (IPTW)-thereby obtaining an adequate balance of the covariates. A statistically significant relationship was found between HP and craniectomy (OR 2.77, p = 0.004). This correlation was confirmed with the three methodologies based on the PS with odds greater than 2. CONCLUSIONS DC is a risk factor for the growth of TICH, and there is also an association between the size of the DC and the magnitude of the volume increase in the TICH.	[Cepeda, Santiago] Univ Hosp Rio Hortega, Dept Neurosurg, Valladolid, Spain; [Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Panero, Irene; Eiriz, Carla; Gomez, Pedro A.; Lagares, Alfonso] Univ Hosp 12 Octubre, Inst Invest I 12, Dept Neurosurg, Madrid, Spain; [Cepeda, Santiago; Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Panero, Irene; Eiriz, Carla; Gomez, Pedro A.; Lagares, Alfonso] Univ Complutense, Madrid, Spain		Cepeda, S (corresponding author), Univ Hosp Hortega, Valladolid, Spain.	cepeda_santiago@hotmail.com	Paredes, Igor/AAW-6313-2021; Castano-Leon, Ana M/ABF-6322-2020; Cepeda, Santiago/AAE-3200-2021; Lagares, Alfonso/B-2969-2011; Gomez, Pedro/E-2411-2014; Munarriz, Pablo/S-3398-2018	Paredes, Igor/0000-0002-3846-4164; Castano-Leon, Ana M/0000-0002-7918-5049; Cepeda, Santiago/0000-0003-1667-8548; Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238; Munarriz, Pablo/0000-0002-9888-7046			Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Besenski N, 1996, NEURORADIOLOGY, V38, pS36; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Cepeda S, 2016, J NEUROTRAUM, V33, P1034, DOI 10.1089/neu.2015.4153; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chieregato A, 2005, ACTA NEUROCHIR SUPPL, V95, P159; Depreitere B, 2008, ACTA NEUROCHIR SUPPL, V102, P259, DOI 10.1007/978-3-211-85578-2_49; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; Gean AD, 1994, IMAGING HEAD TRAUMA; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Katayama Y, 1998, ACT NEUR S, V71, P289; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kuss O, 2016, DTSCH ARZTEBL INT, V113, P597, DOI 10.3238/arztebl.2016.0597; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Ratnaike TE, 2011, BRIT J NEUROSURG, V25, P410, DOI 10.3109/02688697.2010.548879; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Weitzen S, 2004, PHARMACOEPIDEM DR S, V13, P841, DOI 10.1002/pds.969; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Williamson EJ, 2014, RESPIROLOGY, V19, P625, DOI 10.1111/resp.12312; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; ZEGER SL, 1989, BIOMETRICS, V45, P347	45	5	6	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2020	132	5					1623	1635		10.3171/2019.2.JNS182025			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LK4KT	WOS:000530830500037	31026834				2022-02-06	
J	Chico-Fernandez, M; Sanchez-Casado, M; Barea-Mendoza, JA; Garcia-Saez, I; Ballesteros-Sanz, MA; Guerrero-Lopez, F; Quintana-Diaz, M; Molina-Diaz, I; Martin-Iglesias, L; Toboso-Casado, JM; Perez-Barcena, J; Llompart-Pou, JA				Chico-Fernandez, M.; Sanchez-Casado, M.; Barea-Mendoza, J. A.; Garcia-Saez, I; Ballesteros-Sanz, M. A.; Guerrero-Lopez, F.; Quintana-Diaz, M.; Molina-Diaz, I; Martin-Iglesias, L.; Toboso-Casado, J. M.; Perez-Barcena, J.; Llompart-Pou, J. A.		Spanish Soc Intensive Care Med SEM	Outcomes of very elderly trauma ICU patients. Results from the Spanish trauma ICU registry	MEDICINA INTENSIVA			English	Article						Very elderly patients; RETRAUCI; Geriatric trauma; Traumatic brain injury; Intensive care unit; Mortality	GERIATRIC TRAUMA; BRAIN-INJURY; TRISS METHODOLOGY; MORTALITY; OLD; ASSOCIATION; PREDICTORS; SURVIVAL; CARE; AGE	Objective: To analyze outcomes and factors related to mortality among very elderly trauma patients admitted to intensive care units (ICUs) participating in the Spanish trauma ICU registry. Design: A multicenter nationwide registry. Retrospective analysis. November 2012-May 2017. Setting: Participating ICUs. Patients: Trauma patients aged >= 80 years. Interventions: None. Main variables of interest: The outcomes and influence of limitation of life sustaining therapy (LLST) were analyzed. Comparisons were established using the Wilcoxon test, Chi-squared test or Fisher's exact test as appropriate. Multiple logistic regression analysis was performed to analyze variables related to mortality. A p-value <0.05 was considered statistically significant. Results: The mean patient age was 83.4 +/- 3.3 years; 281 males (60.4%). Low-energy falls were the mechanisms of injury in 256 patients (55.1%). The mean ISS was 20.5 +/- 11.1, with a mean ICU stay of 7.45 +/- 9.9 days. The probability of survival based on the TRISS methodology was 69.8 +/- 29.7%. The ICU mortality rate was 15.5%, with an in-hospital mortality rate of 19.2%. The main cause of mortality was intracranial hypertension (42.7%). The ISS, the need for first- and second-tier measures to control intracranial pressure, and being admitted to the ICU for organ donation were independent mortality predictors. LLST was applied in 128 patients (27.9%). Patients who received LLST were older, with more severe trauma, and with more severe brain injury. Conclusions: Very elderly trauma ICU patients presented mortality rates lower than predicted on the basis of the severity of injury. (C) 2019 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.	[Chico-Fernandez, M.; Barea-Mendoza, J. A.] Hosp Univ 12 Octubre, UCI Trauma & Emergencias, Serv Med Intens, Madrid, Spain; [Sanchez-Casado, M.] Hosp Virgen de la Salud, Serv Med Intens, Toledo, Spain; [Garcia-Saez, I] Hosp Univ Donostia, Serv Med Intens, Donostia San Sebastian, Spain; [Ballesteros-Sanz, M. A.] Hosp Univ Marques de Valdecilla, Serv Med Intens, Santander, Spain; [Guerrero-Lopez, F.] Hosp Virgen de las Nieves, Serv Med Intens, UCI Neurotraumatol, Granada, Spain; [Quintana-Diaz, M.] Hosp Univ La Paz, Serv Med Intens, Madrid, Spain; [Molina-Diaz, I] Hosp Univ Nuestra Senora de la Candelaria, Serv Med Intens, Santa Cruz De Tenerife, Spain; [Martin-Iglesias, L.] Hosp Univ Cent Asturias, Serv Med Intens, Asturias, Spain; [Toboso-Casado, J. M.] Hosp Badalona Germans Trias & Pujol, Serv Med Intens, Barcelona, Spain; [Perez-Barcena, J.; Llompart-Pou, J. A.] Hosp Univ Son Espases, Inst Invest Sanitaria Illes Balears IdISBa, Serv Med Intens, Palma De Mallorca, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Espases, Inst Invest Sanitaria Illes Balears IdISBa, Serv Med Intens, Palma De Mallorca, Spain.	juanantonio.llompart@ssib.es		Ballesteros, Maria A/0000-0002-4032-9973; Barea-mendoza, Jesus A/0000-0002-1858-525X			Barea-Mendoza JA, 2018, CIR ESPAN, V96, P357, DOI 10.1016/j.ciresp.2018.02.014; Llompart-Pou JA, 2016, INJURY, V47, pS61, DOI 10.1016/S0020-1383(16)30608-8; Badenes R, 2017, MINERVA ANESTESIOL, V83, P1121, DOI 10.23736/S0375-9393.17.12373-4; Ball IM, 2017, CAN J ANESTH, V64, P260, DOI 10.1007/s12630-016-0798-4; Ball IM, 2016, J CRIT CARE, V35, P206, DOI 10.1016/j.jcrc.2016.05.026; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Brooks SE, 2017, SURG CLIN N AM, V97, P1157, DOI 10.1016/j.suc.2017.06.006; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P395, DOI 10.1016/j.medin.2015.11.003; Chico-Fernandez M, 2016, MED INTENSIVA, V40, P327, DOI 10.1016/j.medin.2015.07.011; Davidson GH, 2011, JAMA-J AM MED ASSOC, V305, P1001, DOI 10.1001/jama.2011.259; Dominguez-Gil B, 2017, MED INTENSIVA, V41, P162, DOI 10.1016/j.medin.2016.07.011; Dominguez-Gil B, 2017, TRANSPLANTATION, V101, pE265, DOI 10.1097/TP.0000000000001701; Flaatten H, 2017, INTENS CARE MED, V43, P1319, DOI 10.1007/s00134-017-4718-z; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Guidet B, 2018, ACTA ANAESTH SCAND, V62, P207, DOI 10.1111/aas.13021; Guidet B, 2018, INTENS CARE MED, V44, P1926, DOI 10.1007/s00134-018-5054-7; Guidet B, 2018, INTENS CARE MED, V44, P1027, DOI 10.1007/s00134-018-5196-7; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hwabejire JO, 2014, JAMA SURG, V149, P1054, DOI 10.1001/jamasurg.2014.473; Joseph B, 2017, J TRAUMA ACUTE CARE, V82, P575, DOI 10.1097/TA.0000000000001329; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, P1197, DOI [10.1097/TA.0000000000000656, 10.1097/TA.0000000000000652]; Llompart-Pou JA, 2019, MED INTENSIVA, V43, P44, DOI 10.1016/j.medin.2018.02.009; Merzo A, 2016, ACTA NEUROCHIR, V158, P125, DOI 10.1007/s00701-015-2639-6; Mock K, 2016, AM SURGEON, V82, P926; Penasco Y, 2017, MED INTENSIVA, V41, P394, DOI 10.1016/j.medin.2017.03.009; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	28	5	5	1	6	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	MAY	2020	44	4					210	215		10.1016/j.medin.2019.01.006			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LQ0YM	WOS:000534738400002	30799042				2022-02-06	
J	Corbin-Berrigan, LA; Faubert, J; Gagnon, I				Corbin-Berrigan, Laurie-Ann; Faubert, Jocelyn; Gagnon, Isabelle			Neurotracker as a potential mean of active rehabilitation in children with atypical mild traumatic brain injury recovery: A pilot safety study	TRANSLATIONAL SPORTS MEDICINE			English	Article						concussion; mild traumatic brain injury; neurotracker; perceptual training; persistent symptoms; three-dimensional multiple object tracking	MULTIPLE-OBJECT TRACKING; COGNITIVE REHABILITATION; CONCUSSION; SPORT; SYMPTOMS; MANAGEMENT; SLOW	The main objective of this research was to determine the safety of using three-dimensional multiple object tracking (3D-MOT) with children who experience delayed recovery after sustaining a mild traumatic brain injury (mTBI). Nine youth aged 12 to 17 years old who visited the Montreal Children's Hospital's Trauma Center Concussion Clinic and were experiencing delayed recovery after sustaining a mTBI and being followed by a multimodal approach to mTBI management were recruited. Children were trained over six visits using 3D-MOT, every 2 to 7 days. Each visit consisted of 3 reaction time calculations on the task, as well as symptom reporting. In addition, at visit 1 and 6, clinical measures specific to mTBI management were administered. Primary outcome measures included safety of a 3D-MOT training regimen. Safety was measured through reporting of adverse events, and tolerability was assessed through protocol deviations and adherence. Results demonstrate that symptomatic children after mTBI can safely perform a 3D-MOT training regimen.	[Corbin-Berrigan, Laurie-Ann] Univ Quebec Trois Rivieres, Dept Sci Activite Phys, 3351 Blvd Forges,Pavillon Albert Tessier 4245, Trois Rivieres, PQ G9A 5H7, Canada; [Corbin-Berrigan, Laurie-Ann; Gagnon, Isabelle] Mcgill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Faubert, Jocelyn] Univ Montreal, Ecole Optometrie, Montreal, PQ, Canada; [Faubert, Jocelyn] Faubert Lab, Montreal, PQ, Canada; [Gagnon, Isabelle] Trauma Montreal Childrens Hosp, Montreal, PQ, Canada		Corbin-Berrigan, LA (corresponding author), Univ Quebec Trois Rivieres, Dept Sci Activite Phys, 3351 Blvd Forges,Pavillon Albert Tessier 4245, Trois Rivieres, PQ G9A 5H7, Canada.	laurie-ann.corbin-berrigan@uqtr.ca					[Anonymous], 2011, IMM POSTC ASS TEST I; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Boivin MJ, 2010, NEUROPSYCHOLOGY, V24, P667, DOI 10.1037/a0019312; Bruininks RH, 2006, BRUININKSS OSERETSKY; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Faubert J, 2012, ESPACE SCI, V8, P13; Faubert J, 2012, J CLIN SPORT PSYCHOL, V6, P85, DOI 10.1123/jcsp.6.1.85; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Go Canada, GO CAN CONC; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hahler E-M, 2014, PSYCHOPHYSICAL ASSES; Hotting K, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-73; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Legault I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00323; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makovski T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002228; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Parsons B, 2016, CLIN EEG NEUROSCI, V47, P37, DOI 10.1177/1550059414563746; Persson J, 2007, NEUROPSYCHOLOGIA, V45, P1571, DOI 10.1016/j.neuropsychologia.2006.12.007; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Trick LM, 2005, COGNITIVE DEV, V20, P373, DOI 10.1016/j.cogdev.2005.05.009; Tullo D, 2017, J VIS, V17, P1307; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	39	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		2573-8488		TRANSL SPORTS MED	Transl. Sports Med.	MAY	2020	3	3					235	242		10.1002/tsm2.132			8	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	RY0OL	WOS:000647614600007					2022-02-06	
J	de Munter, L; Polinder, S; Haagsma, JA; Kruithof, N; van de Ree, CLP; Steyerberg, EW; de Jongh, M				de Munter, Leonie; Polinder, Suzanne; Haagsma, Juanita A.; Kruithof, Nena; van de Ree, Cornelis L. P.; Steyerberg, Ewout W.; de Jongh, Mariska			Prevalence and Prognostic Factors for Psychological Distress After Trauma	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anxiety; Depression; Post-traumatic stress disorders; Prevalence; Prognosis; Prospective studies; Rehabilitation; Wounds and injuries	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; HOSPITAL ANXIETY; DEPRESSION SCALE; PHYSICAL INJURY; BRAIN-INJURY; EVENT SCALE; FOLLOW-UP; IMPACT; PREDICTORS	Objective: To describe the prevalence and prognostic factors of symptoms of anxiety and depression and posttraumatic stress symptoms (PTSS) after injury in the clinical trauma population. Design: Multicenter, prospective, observational cohort study. Setting: Ten hospitals in Noord-Brabant, The Netherlands. Participants: Four thousand two hundred thirty-nine adult patients (N=4239) admitted due to injury between August 2015 and December 2016. Interventions: Patients were asked to complete a questionnaire at 1 week and at 1, 3, 6, and 12 months after injury. Main Outcome Measures: The Hospital Anxiety and Depression Scale was used to assess anxiety and depressive symptoms and the Impact of Event Scale was used to assess PTSS. Results: The prevalence of symptoms of anxiety and depression decreased from 10% and 12%, respectively, at 1 week after injury to 7% and 7% at 12 months after injury. Acute traumatic stress symptoms were present in 13% at 1 week and PTSS was prevalent in 10% of the participants at 12 months after injury. Strong prognostic factors for poor psychological outcome in multivariable logistic mixed models were preinjury frailty, psychological complaints and nonworking status preinjury, female sex, low educational level, and accident category (ie, traffic accident, work-related accident, or accidents at home compared to sport injuries). Conclusions: Psychological distress is a common health problem during the first year after injury. Important prognostic factors for psychological distress include psychological complaints before injury and frailty. Early recognition of psychological problems after injury could facilitate discussion between caregivers and patients and improve recovery. (C) 2019 by the American Congress of Rehabilitation Medicine	[de Munter, Leonie; Kruithof, Nena; van de Ree, Cornelis L. P.; de Jongh, Mariska] Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Hilvarenbeekseweg 60, NL-5000 LC Tilburg, Netherlands; [Polinder, Suzanne; Haagsma, Juanita A.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [de Jongh, Mariska] Network Emergency Care Brabant, Brabant Trauma Registry, Tilburg, Netherlands		de Munter, L (corresponding author), Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Hilvarenbeekseweg 60, NL-5000 LC Tilburg, Netherlands.	l.demunter@etz.nl		de Munter, Leonie/0000-0001-6573-2032	Netherlands Organisation for Health Research and Development TopCare projects [80-84200-98-14226]	Supported by The Netherlands Organisation for Health Research and Development TopCare projects (grant no. 80-84200-98-14226).	Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; Bell Melanie L, 2016, BMC Res Notes, V9, P479; Birkeland MS, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1302692; Bisson J, 2007, PSYCHOL TREATMENT PO; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bocci MG, 2016, MINERVA ANESTESIOL, V82, P22; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Mello-Silva ACC, 2012, TEXTO CONTEXTO ENFER, V21, P558, DOI 10.1590/S0104-07072012000300010; Corrigan Ingrid, 2007, Intensive Crit Care Nurs, V23, P206, DOI 10.1016/j.iccn.2007.01.004; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; DiGallo A, 1996, BRIT J PSYCHIAT, V169, P405, DOI 10.1192/bjp.169.4.405; Drapeau A, 2012, MENTAL ILLNESSES UND, P111; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gouin JP, 2011, IMMUNOL ALLERGY CLIN, V31, P81, DOI 10.1016/j.iac.2010.09.010; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Kazak AE, 2011, J PEDIAT HEMATOL ONC, V33, P289, DOI 10.1097/MPH.0b013e31820c3b52; Kellezi B, 2017, SOC PSYCH PSYCH EPID, V52, P855, DOI 10.1007/s00127-016-1299-z; Kendrick D, 2017, QUAL LIFE RES, V26, P1233, DOI 10.1007/s11136-016-1439-7; LNAZ, 2018, TRAUM BEELD LAND TRA; Mason S, 2006, BRIT J CLIN PSYCHOL, V45, P217, DOI 10.1348/014466505X50158; Mason S, 2002, EMERG MED J, V19, P400, DOI 10.1136/emj.19.5.400; Mayou R, 2001, AM J PSYCHIAT, V158, P1231, DOI 10.1176/appi.ajp.158.8.1231; Myhren H, 2010, CRIT CARE, V14, DOI 10.1186/cc8870; O'Donnell ML, 2008, CLIN PSYCHOL REV, V28, P387, DOI 10.1016/j.cpr.2007.07.008; O'Donnell ML, 2008, J CONSULT CLIN PSYCH, V76, P923, DOI 10.1037/a0012918; Pajonk FG, 2005, EUR PSYCHIAT, V20, P115, DOI 10.1016/j.eurpsy.2004.10.003; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Quale AJ, 2009, INJURY, V40, P498, DOI 10.1016/j.injury.2008.11.006; Richmond TS, 2003, AM J CRIT CARE, V12, P197, DOI 10.4037/ajcc2003.12.3.197; Ryan H, 2005, EUR J CANCER CARE, V14, P7, DOI 10.1111/j.1365-2354.2005.00482.x; Santiago PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059236; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Skogstad L, 2014, INJURY, V45, P289, DOI 10.1016/j.injury.2012.10.001; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Steverink N, 2001, GERONTOLOGIST, V41, P236; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Sutherland AG, 2006, J TRAUMA, V61, P1408, DOI 10.1097/01.ta.0000197562.34651.df; van Buuren S, 1999, PGVGZ99054 TNO; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wiseman T, 2013, INJURY, V44, P1383, DOI 10.1016/j.injury.2012.02.015; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Wohlfarth TD, 2003, PSYCHOL ASSESSMENT, V15, P101, DOI 10.1037/1040-3590.15.1.101; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	55	5	5	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2020	101	5					877	884		10.1016/j.apmr.2019.10.196			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MC0ZD	WOS:000543025400016	31874154				2022-02-06	
J	Doud, AK; Hoepner, JK; Holland, AL				Doud, Aspen K.; Hoepner, Jerry K.; Holland, Audrey L.			A Survey of Counseling Curricula Among Accredited Communication Sciences and Disorders Graduate Student Programs	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							SPEECH-LANGUAGE PATHOLOGISTS; TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIOR THERAPY; APHASIA; PEOPLE; ADULTS; MODEL; WELL	Purpose: The purpose of this article is to examine the current state of counseling curriculum within the discipline. The last systematic survey of counseling curriculum within the disciplines of communication sciences and disorders was completed with data from 1983 (McCarthy et al., 1986). The Council on Academic Accreditation in Audiology and Speech-Language Pathology (2017) states that counseling should be included in accredited programs but does not specify to what extent. Currently, there are no standards to specify number of credits, need for a stand-alone course, or guidance regarding content delivered. Method: The present investigation collected data on the status of counseling curricula in accredited communication sciences and disorders graduate programs. A Qualtrics survey was distributed to identify counseling curriculum practices across accredited programs. Quantitative data such as percentages and frequency counts were compiled to summarize program offerings. Qualitative analyses were used to characterize written responses. Survey responses were also cross-validated with a review of offerings listed on program websites. Results: Of programs currently accredited by the Council on Academic Accreditation in Audiology and Speech-Language Pathology, 42.4% responded to the current survey. Fifty-nine percent of programs offer a stand-alone course. Review of curricula from program websites indicated that only 40% of accredited programs offer a stand-alone counseling course. Quantitative details about requirements, number of credits, and embedding counseling within other courses were compared to data from the 1983 survey. Qualitative analyses identified common learner outcomes and the nature of course or curricular content. Conclusions: Investigators found a lack of consistency in incorporating counseling across programs and discussed implications of this in speech-language pathology practice. A decrease in the number of programs that offer a stand-alone counseling course was identified as compared to offerings in 1983, as well as a disparity regarding how programs provide training in counseling. Furthermore, survey responses differed from curriculum listings on program websites. Information derived from this study may serve as a starting point for the development of flexible standards that provide direction for achieving consistent preparation of counseling skills.	[Doud, Aspen K.; Hoepner, Jerry K.] Univ Wisconsin, Commun Sci & Disorders, Eau Claire, WI 54701 USA; [Holland, Audrey L.] Univ Arizona, Dept Speech & Hearing Sci, Tucson, AZ 85721 USA		Hoepner, JK (corresponding author), Univ Wisconsin, Commun Sci & Disorders, Eau Claire, WI 54701 USA.	hoepnejk@uwec.edu					American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; American Speech-Language-Hearing Association, 2008, GUID AUD PROV INF AD; American Speech-Language-Hearing Association, 2018, SCOP PRACT AUD; Attard MC, 2020, APHASIOLOGY, V34, P1, DOI 10.1080/02687038.2019.1670016; Attard MC, 2018, APHASIOLOGY, V32, P105, DOI 10.1080/02687038.2017.1381877; BARAK A, 1975, J COUNS PSYCHOL, V22, P471, DOI 10.1037/0022-0167.22.6.471; Barnes CJ, 2018, INT J LANG COMM DIS, V53, P615, DOI 10.1111/1460-6984.12375; Beck A, 2014, CONT ISSUES COMMUNIC, V41, P133, DOI DOI 10.1044/CICSD_41_F_133; Behrman A, 2006, AM J SPEECH-LANG PAT, V15, P215, DOI 10.1044/1058-0360(2006/020); Beilby J, 2014, SEMIN SPEECH LANG, V35, DOI 10.1055/s-0034-1371756; Beilby JM, 2012, J FLUENCY DISORD, V37, P289, DOI 10.1016/j.jfludis.2012.05.003; Bogdan R. C., 2003, QUALITATIVE RES ED I, P14; BOLES L, 2000, ASIA PACIFIC J SPEEC, V5, P73, DOI DOI 10.1179/136132800805576988; Boles L., 2003, ASIA PACIFIC J SPEEC, V8, P153, DOI DOI 10.1179/136132803805576110; Brown K, 2012, INT J SPEECH-LANG PA, V14, P141, DOI 10.3109/17549507.2011.632026; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Council for Clinical Certification in Audiology and Speech-Language Pathology of the American Speech-Language-Hearing Association, 2018, 2020 STAND CERT CLIN; Council on Academic Accreditation in Audiology and Speech-Language Pathology, 2017, STAND ACCR GRAD ED P; Culpepper N. B., 1994, ASHA, V36, P55; Douglas JM, 2019, NEUROPSYCHOL REHABIL, V29, P73, DOI 10.1080/09602011.2016.1259114; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; English K, 1999, Am J Audiol, V8, P34, DOI 10.1044/1059-0889(1999/007); English K., 2005, HEARING J, V58, P54; Flasher Lydia V, 2012, COUNSELING SKILLS SP; Geller E, 2009, AM J SPEECH-LANG PAT, V18, P22, DOI 10.1044/1058-0360(2008/07-0053); Hoepner J. K., 2019, CLIN ARCH COMMUNICAT, V4, P98, DOI [10.21849/cacd.2019.00101, DOI 10.21849/CACD.2019.00101]; Hoepner JK, 2018, CLIN ARCH COMMUN DIS, V3, P22, DOI [10.21849/cacd.2018.00262, DOI 10.21849/CACD.2018.00262]; Holland A. L., 2007, COUNSELING COMMUNICA, V2nd; Holland A. L., 2014, COUNSELING COMMUNICA; Holland A, 2007, TOP LANG DISORD, V27, P339, DOI 10.1097/01.TLD.0000299888.24241.dd; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Kaderavek J. N., 2004, CONT ISSUES COMMUNIC, V31, P153, DOI [DOI 10.1044/CICSD_31_F_153, 10.1044/cicsd_31_F_153]; Kaldo-Sandstrom Viktor, 2004, Am J Audiol, V13, P185, DOI 10.1044/1059-0889(2004/023); Kelly EM, 1997, LANG SPEECH HEAR SER, V28, P195, DOI 10.1044/0161-1461.2803.195; Luterman D., 2017, COUNSELING PERSONS C, V6th; Luterman D. L., 2008, COUNSELING FAMILIES; McCarthy P, 1986, ASHA, V28, P49; McFarlane LA, 2012, CAN J SPEECH-LANG PA, V36, P8; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Meibos A, 2017, INT J AUDIOL, V56, P903, DOI 10.1080/14992027.2017.1347291; Menzies RG, 2009, J FLUENCY DISORD, V34, P187, DOI 10.1016/j.jfludis.2009.09.002; Menzies RG, 2008, J SPEECH LANG HEAR R, V51, P1451, DOI 10.1044/1092-4388(2008/07-0070); Neilson M. D., 1999, STUTTERING RELATED D, P181; Palasik S., 2013, PERSPECTIVES FLUENCY, V23, P54, DOI DOI 10.1044/FFD23.2.54; Phillips D. T., 2008, CONT ISSUES COMMUNIC, V35, P44, DOI [10.1044/CICSD_35_S_44, DOI 10.1044/CICSD_35_S_44]; Rose M, 2014, INT J SPEECH-LANG PA, V16, P169, DOI 10.3109/17549507.2013.794474; Sekhon JK, 2015, INT J SPEECH-LANG PA, V17, P252, DOI 10.3109/17549507.2015.1024170; SHARP T, 2011, COACHING INT J THEOR, V4, P42, DOI DOI 10.1080/17521882.2010.550897; Sharp T, 2012, INT J SPEECH-LANG PA, V14, P209, DOI 10.3109/17549507.2011.622787; Solheim Jorunn, 2018, J Am Acad Audiol, V29, P696, DOI 10.3766/jaaa.16184; Stone J R, 1989, ASHA, V31, P27; Strauss A., 1990, BASICS QUALITATIVE R; Tellis C. M., 2016, COUNSELING INTERVIEW; van Leer E, 2008, J VOICE, V22, P688, DOI 10.1016/j.jvoice.2007.01.011; Whicker J. J., 2017, HEARING J, V70, P36, DOI DOI 10.1097/01.HJ.0000524323.42011.95; Worrall L, 2010, APHASIOLOGY, V24, P497, DOI 10.1080/02687030802698152; Zebrowski PM, 2011, J FLUENCY DISORD, V36, P144, DOI 10.1016/j.jfludis.2010.08.001	57	5	5	1	3	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2020	29	2					789	803		10.1044/2020_AJSLP-19-00042			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MM5FZ	WOS:000550183600017	32320624				2022-02-06	
J	Fields, L; Didehbani, N; Hart, J; Cullum, CM				Fields, Lindy; Didehbani, Nyaz; Hart, John, Jr.; Cullum, C. Munro			No Linear Association Between Number of Concussions or Years Played and Cognitive Outcomes in Retired NFL Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Football; NFL; Aging; Neuropsychology; Cognition	HIGH-SCHOOL FOOTBALL; HEAD IMPACT EXPOSURE; ALZHEIMERS-DISEASE; LATER-LIFE; IMPAIRMENT; SEASON	Objective: The aim of the current study is to examine whether concussion history and years played are linearly associated with cognitive outcomes in retired National Football League (NFL) players. Method: Thirty-five retired NFL players over the age of 50 who had sustained at least one concussion completed a clinical interview and brief neuropsychological battery. Correlational analyses were conducted between exposure variables [number of total concussions, concussions with loss of consciousness (LOC), and years played] and cognitive performance as characterized by cognitive composite scores based on performance on neuropsychological measures (attention/processing speed, language, memory, and overall composite scores). Results: Correlational analyses corrected for multiple comparisons did not reveal any statistically significant correlations between exposure variables and cognitive outcomes. Conclusions: We did not find a significant linear association between cognitive outcomes and either number of total concussions, concussions with LOC, or years played in the NFL. These findings do not support a dose-response relationship between sports-related exposure to head impacts and cognitive outcomes later in life. Rather, the findings suggest that cognitive difficulties experienced by some retired players later in life are not directly linearly associated with quantified exposure to head impacts sustained throughout a football career, but related to factors or combinations of factors that have yet to be elucidated.	[Fields, Lindy; Didehbani, Nyaz; Hart, John, Jr.; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Hart, John, Jr.] Univ Texas Dallas, Dallas, TX USA		Cullum, CM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Munro.Cullum@UTSouthwestern.edu			Texas Institute for Brain Injury and Repair in the Peter J. O'Donnell Jr.; Brain Institute at UT Southwestern Medical Center	This work was supported in part by the Texas Institute for Brain Injury and Repair in the Peter J. O'Donnell Jr. Brain Institute at UT Southwestern Medical Center.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Clark MD, 2018, RADIOLOGY, V286, P975, DOI 10.1148/radiol.2017170539; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Didehbani N., 2017, ANN SPORT MED RES, V4, P1115; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Kelly JP, 1997, NEUROLOGY, V48, P581; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Wilmoth K, 2018, CLIN NEUROPSYCHOL, V32, P524, DOI 10.1080/13854046.2017.1378371	24	5	5	2	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		233	239		10.1093/arclin/acz008			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800001	30844072	Bronze			2022-02-06	
J	Kim, LH; Quon, JL; Cage, TA; Lee, MB; Pham, L; Singh, H				Kim, Lily H.; Quon, Jennifer L.; Cage, Tene A.; Lee, Marco B.; Lan Pham; Singh, Harminder			Mortality prediction and long-term outcomes for civilian cerebral gunshot wounds: A decision-tree algorithm based on a single trauma center	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Gunshot wound; Traumatic brain injury; Decision tree algorithm; Mortality outcome	PROGNOSTIC-FACTORS; BRAIN-INJURY; HEAD; MANAGEMENT; CHILDREN	Gunshot wounds (GSW) are one of the most lethal forms of head trauma. The lack of clear guidelines for civilian GSW complicates surgical management. We aimed to develop a decision-tree algorithm for mortality prediction and report long-term outcomes on survivors based on 15-year data from our level 1 trauma center. We retrospectively reviewed 96 consecutive patients who presented with cerebral GSWs between 2003 and 2018. Clinical information from our trauma database, EMR, and relevant imaging scans was reviewed. A decision-tree model was constructed based on variables showing significant differences between survivors and non-survivors. After excluding patients who died at arrival, 54 patients with radiologically confirmed intracranial injury were included. Compared to survivors (51.9%), non-survivors (48.1%) were significantly more likely to have perforating (entry and exit wound), as opposed to penetrating (entry wound only), injuries. Bi-hemispheric and posterior fossa involvement, cerebral herniation, and intraventricular hemorrhage were more commonly present in non-survivors. Based on the decision-tree, Glasgow Coma Scale (GCS) > 8 and penetrating, uni-hemispheric injury predicted survival. Among patients with GCS <= 8 and normal pupillary response, lack of 1) posterior fossa involvement, 2) cerebral herniation, 3) bi-hemispheric injury, and 4) intraventricular hemorrhage, were associated with survival. Favorable long-term outcomes (mean follow-up 34.4 months) were possible for survivors who required neurosurgery and stable patients who were conservatively managed. We applied clinical and radiological characteristics that predicted survival to construct a decision-tree to facilitate surgical decision-making for GSW. Further validation of the algorithm in a large patient setting is recommended. (C) 2020 Elsevier Ltd. All rights reserved.	[Kim, Lily H.; Quon, Jennifer L.; Cage, Tene A.; Lee, Marco B.; Singh, Harminder] Stanford Univ, Dept Neurosurg, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA; [Cage, Tene A.; Lee, Marco B.; Lan Pham; Singh, Harminder] Santa Clara Valley Med Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA		Singh, H (corresponding author), Stanford Univ, Sch Med, 300 Pasteur Dr,Room R200, Stanford, CA 94305 USA.	harman@stanford.edu					AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Ambrosi PB, 2012, NEUROSURG REV, V35, P429, DOI 10.1007/s10143-012-0377-2; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bizhan Aarabi, 2015, Handb Clin Neurol, V127, P181, DOI 10.1016/B978-0-444-52892-6.00012-X; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2016, BRIT J NEUROSURG, V30, P235, DOI 10.3109/02688697.2015.1096905; Cook A, 2017, INJURY, V48, P621, DOI 10.1016/j.injury.2017.01.044; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; DeCuypere M, 2016, J NEUROSURG-PEDIATR, V17, P595, DOI 10.3171/2015.7.PEDS15285; Glapa M, 2009, AM SURGEON, V75, P223; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; JENNETT B, 1975, LANCET, V1, P480; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Khan MB, 2014, WORLD NEUROSURG, V82, P14, DOI 10.1016/j.wneu.2013.01.026; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; Kong VY, 2018, EUR J TRAUMA EMERG S, V44, P615, DOI 10.1007/s00068-017-0835-1; Kuhls DA, 2017, J TRAUMA ACUTE CARE, V82, P877, DOI 10.1097/TA.0000000000001405; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Liebenberg WA, 2005, NEUROSURGERY, V57, P293, DOI 10.1227/01.NEU.0000166662.77797.EC; Lin DJ., 2012, SURG NEUROL INT, V3, P98, DOI [DOI 10.4103/2152-7806, 10.4103/2152-7806.100187, DOI 10.4103/2152-7806.100187]; Maragkos GA, 2018, J NEUROTRAUM, V35, P2605, DOI 10.1089/neu.2018.5682; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Paret G, 1998, J NEUROTRAUM, V15, P967, DOI 10.1089/neu.1998.15.967; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Stoffel M, 2009, ANZ J SURG, V79, P789, DOI 10.1111/j.1445-2197.2009.05096.x; Tsuei Yuang-Seng, 2005, J Chin Med Assoc, V68, P126, DOI 10.1016/S1726-4901(09)70233-3; Turco L, 2017, WORLD NEUROSURG, V104, P653, DOI 10.1016/j.wneu.2017.05.068; Zafonte RD, 2001, NEUROL RES, V23, P219, DOI 10.1179/016164101101198370	36	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2020	75						71	79		10.1016/j.jocn.2020.03.027			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LG7IU	WOS:000528270700014	32241644				2022-02-06	
J	Kneavel, ME; Ernst, W; McCarthy, KS				Kneavel, Meredith E.; Ernst, William; McCarthy, Kevin S.			Randomized Controlled Trial of a Novel Peer Concussion-Education Program for Collegiate Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; randomized trial; concussion reporting; attitudes	EFFECT SIZES; SPORT; TIME	Context: The National Collegiate Athletic Association and US Department of Defense have called for educational programs to change the culture of concussion reporting, increase reporting behavior, and enhance the safety of players and service members. Objective: To evaluate the effects of a novel peer concussion-education program (PCEP) in changing knowledge, attitudes, and norms about concussion reporting among collegiate student-athletes and assess program implementation. Design: Randomized controlled trial and qualitative analysis of interviews. Setting: National Collegiate Athletic Association athletic teams from randomly selected colleges or universities. Patients or other participants: A total of 1614 male and female student-athletes from 60 teams at 10 colleges and universities and 8 athletic trainers. Intervention(s): The PCEP intervention trains 2 peer concussion educators to provide 2 education modules to their teammates. Knowledge, attitudes (oneself and teammates), and concussion occurrence or reporting were assessed at baseline, postintervention, and 1 month later. Eight athletic trainers were interviewed about program implementation. Results: Compared with the control group, the intervention group showed greater increases occurred postintervention and at 1 month in concussion knowledge (F-1,F-2648 = 51.3, P < .0001), intention to report (oneself, F-2,F-2633 = 82.3, P < .0001; teammates, F-2,F-2624 = 53.9, P < .0001), return-to-play protocol knowledge, (F-2,F-2632 = 28.4, P < .0001), direct subjective norms (oneself, F-2,F-2625 = 51.7, P < .0001; teammates, F-2,F-2644 = 40.6, P < .0001), direct perceived behavioral control (oneself, F-2,F-2628 = 53.7, P < .0001; teammates, F-2,F-2615 = 68.2, P < .0001), and indirect attitudes (oneself, F-2,F-2626 = 47.1, P < .001; teammates, F-2,F-2623 = 40.9, P < .0001). Peer concussion-education program participants discussed concussion more often with a teammate (F-1,F-1396 = 13.96, P < .0001) or athletic staff (F-1,F-1396 = 6.62, P < .001). Qualitative program analysis revealed both positive aspects of the PCEP and areas for improvement. Conclusions: The PCEP showed promise in increasing concussion knowledge, intention to report concussion, reporting a teammate's concussion, and facilitating attitudinal changes that support reporting among student-athletes.	[Kneavel, Meredith E.] La Salle Univ, Sch Nursing & Hlth Sci, 1900 West Olney Ave, Philadelphia, PA 19141 USA; [Kneavel, Meredith E.; Ernst, William] Chestnut Hill Coll, Ctr Concuss Educ & Res, Philadelphia, PA USA; [Ernst, William; McCarthy, Kevin S.] Chestnut Hill Coll, Dept Profess Psychol, Philadelphia, PA USA		Kneavel, ME (corresponding author), La Salle Univ, Sch Nursing & Hlth Sci, 1900 West Olney Ave, Philadelphia, PA 19141 USA.	kneavel@lasalle.edu	Kneavel, Meredith/ABG-5233-2021	Kneavel, Meredith/0000-0002-9820-6909	National Collegiate Athletic Association - US Department of Defense Mind Matters Challenge	This publication was made possible, in part, with support from the National Collegiate Athletic Association - US Department of Defense Mind Matters Challenge.	Adefolalu AO, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.762; Ajzen I, CONSTRUCTING TPB QUE; [Anonymous], 2018, NCAA US; [Anonymous], SELF REP CONC NCAA S; Azjen I., 2007, PREDICTION CHANGE HL; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Cheung ACK, 2016, EDUC RESEARCHER, V45, P283, DOI 10.3102/0013189X16656615; Chia SC, 2006, J COMMUN, V56, P585, DOI 10.1111/j.1460-2466.2006.00302.x; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Creswell J. W., 2016, QUAL INQ; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dart EH, 2014, SCHOOL PSYCHOL REV, V43, P367, DOI 10.17105/SPR-14-0009.1; Dawson P, 2014, REV EDUC RES, V84, P609, DOI 10.3102/0034654314540007; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Ernst W, 2020, J ATHL TRAINING, V55, P448, DOI 10.4085/1062-6050-212-19; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Gioia G, ACUTE CONCUSSION EVA; Hill CJ, 2008, CHILD DEV PERSPECT, V2, P172, DOI 10.1111/j.1750-8606.2008.00061.x; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; Kneavel M, 2021, J AM COLL HEALTH, V69, P435, DOI 10.1080/07448481.2019.1679816; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; Morgan DL., 2019, BASIC ADV FOCUS GROU; Moustakas C.E., 1994, PHENOMENOLOGICAL RES; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wenke BD, 2019, THESIS; Yard EE, 2009, RES SPORTS MED, V17, P35, DOI 10.1080/15438620802678495	34	5	5	1	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2020	55	5					456	468		10.4085/1062-6050-0182.19			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	NK4YN	WOS:000566738600003	32298143	Green Published, gold			2022-02-06	
J	Kozminski, BU; Ahmed, N; Cautela, FS; Shah, NV; Shangguan, X; Doran, JP; Newman, JM; Horowitz, EH; Gonzales, AS; Lee, CJ; Persaud, CS; Urban, WP; Stickevers, SM				Kozminski, Barbara U.; Ahmed, Natasha; Cautela, Frank S.; Shah, Neil, V; Shangguan, Xingzi; Doran, James P.; Newman, Jared M.; Horowitz, Evan H.; Gonzales, Anter S.; Lee, Caroline J.; Persaud, Christine S.; Urban, William P.; Stickevers, Susan M.			Surfing-related head injuries presenting to United States emergency departments	JOURNAL OF ORTHOPAEDICS			English	Article						Surfing; Head injury; Epidemiology; Mild traumatic brain injury; Concussion; Sports-related injury	TRAUMATIC BRAIN-INJURY; CONCUSSION; SURFERS	This study examined the incidence and trends of surfing-related and mild traumatic brain injuries that presented to United States emergency departments between 2001 and 2016. Subjects with surging-related head injuries were retrieved from the National Electronic Injury Surveillance System. A weighted total of 34,337 surfing-related head injuries were identified. The annual incidence of surfing-related head injuries insignificantly decreased from 2001 to 2016 (R-2 =.119; p =.19). Most common injuries included lacerations (50.4%), blunt head injuries (25.7%), and mild traumatic brain injuries (16.1%). Mild traumatic brain injury incidence and annual percentage increased significantly during the study period (R-2 =.251; p =.05 and R-2 =.346; p =.02, respectively).	[Kozminski, Barbara U.] Univ Washington, Dept Phys Med & Rehabil, Seattle, WA 98195 USA; [Ahmed, Natasha] Rush Copley Med Ctr, Dept Family Med, Aurora, IL USA; [Cautela, Frank S.; Shah, Neil, V; Doran, James P.; Newman, Jared M.; Horowitz, Evan H.; Gonzales, Anter S.; Lee, Caroline J.; Persaud, Christine S.; Urban, William P.; Stickevers, Susan M.] State Univ New York SUNY Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, Brooklyn, NY USA; [Shangguan, Xingzi] NYU Langone Hosp Brooklyn, Dept Family Med, Brooklyn, NY USA		Shah, NV (corresponding author), SUNY Downstate Med Ctr, Dept Orthopaed Surg & Rehabil Med, 450 Clarkson Ave,MSC 30, Brooklyn, NY 11203 USA.	neil.shah@downstate.edu		Horowitz, Evan/0000-0002-3851-0132; Shah, Neil/0000-0002-3439-3071			Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chatterjee Dipal, 2015, Critical Reviews in Biomedical Engineering, V43, P371, DOI 10.1615/CritRevBiomedEng.2016016393; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Dimmick SJ, 2013, MED J AUSTRALIA, V198, P418, DOI 10.5694/mja13.10006; Furness J, 2015, AM J SPORT MED, V43, P1246, DOI 10.1177/0363546514567062; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Klick C, 2016, AM J EMERG MED, V34, P1491, DOI 10.1016/j.ajem.2016.05.008; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Moran K., 2013, International Journal of Aquatic Research and Education, V7, P192; Myers SE, 2010, PM&R, V1, pS51; Nathanson A, 2002, AM J EMERG MED, V20, P155, DOI 10.1053/ajem.2002.32650; Nathanson A, 2007, AM J SPORT MED, V35, P113, DOI 10.1177/0363546506293702; Phillips S, 2015, PRIMARY CARE, V42, P243, DOI 10.1016/j.pop.2015.01.010; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schroeder T., 2001, NEISS SAMPLE DESIGN; Swinney Christian, 2015, Hawaii J Med Public Health, V74, P403; Taylor DM, 2004, J SCI MED SPORT, V7, P429, DOI 10.1016/S1440-2440(04)80260-3; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Woodacre T, 2015, INJURY, V46, P162, DOI 10.1016/j.injury.2014.07.019	21	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0972-978X			J ORTHOP	J. Orthop.	MAY-JUN	2020	19						184	188		10.1016/j.jor.2019.11.042			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	LQ7NP	WOS:000535186500040	32025130	Green Published			2022-02-06	
J	Lecci, L; Williams, M; Taravath, S; Frank, HG; Dugan, K; Page, R; Keith, J				Lecci, Len; Williams, Mark; Taravath, Sasidharan; Frank, Harrison G.; Dugan, Kelly; Page, Ryan; Keith, Julian			Validation of a Concussion Screening Battery for Use in Medical Settings: Predicting Centers for Disease Control Concussion Symptoms in Children and Adolescents	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Traumatic brain injury; Assessment	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; ATTENTION; GAIT; METAANALYSIS; PERFORMANCE; STATEMENT; RECOVERY; VALIDITY	Objective: Effective screening for concussion is increasingly important, and medical professionals play a critical role in diagnostic and return-to-play decisions. However, few well-validated measures are available to assist in those decisions. This study aims to determine whether previously validated measures assessing neurocognitive and neurobehavioral abilities can predict Centers for Disease Control (CDC) concussion symptom endorsement in a sample of child or youth athletes. Method: Participants were 113 individuals, aged 6-17, representing 29 consecutive cases undergoing a post-concussion evaluation by a pediatric neurologist and 84 consecutive cases completing standardized baseline assessments (i.e., not being evaluated as a follow-up to a concussion). All participants completed the same standardized battery of tests comprised of the Connors' Continuous Performance Test (CPT 3), the Balance Error Scoring System (BESS), and the NIH 4-Meter Gait Test as well as completing a checklist of CDC concussion symptoms. Results: Regression analyses indicate that the screening battery explained 33% of the variance (d = 1.4) in concussion symptom endorsement, after controlling for age. The neurocognitive test alone (CPT 3) accounts for 21.5% of the variance (d = 1.05) in symptoms after controlling for age, and the neurobehavioral measures (BESS and NIH 4-Meter Gait) then account for an additional 11.5% variance (accounting for 18.6% variance, d = .96, when entered first). These effect sizes are considered large to very large and reflect a marked increase in predictive validity relative to existing measures commonly used in concussion assessments. Conclusions: A relatively brief screening battery can function inmedical settings to predict significant and substantial variability in CDC concussion symptoms in a pediatric sample.	[Lecci, Len; Dugan, Kelly; Page, Ryan; Keith, Julian] Univ North Carolina Wilmington, Dept Psychol, 601 South Coll Rd,Box 5612, Wilmington, NC 28403 USA; [Williams, Mark] New Hanover Reg Med Ctr, Internal Med, Wilmington, NC 28403 USA; [Taravath, Sasidharan] New Hanover Reg Med Ctr, Pediat Neurol, Wilmington, NC 28403 USA; [Frank, Harrison G.] Frank Inst Hlth & Wellness, Wilmington, NC 28403 USA		Lecci, L (corresponding author), Univ North Carolina Wilmington, Dept Psychol, 601 South Coll Rd,Box 5612, Wilmington, NC 28403 USA.	leccil@uncw.edu					Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Alsalaheen B, 2017, J ATHL TRAINING, V52, P834, DOI 10.4085/1062-6050-52.7.05; Alsalaheen BA, 2014, PEDIATR PHYS THER, V26, P191, DOI 10.1097/PEP.0000000000000037; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Centers for Disease Control and Prevention & National Center for Injury Prevention, 2010, CONC SIGNS SYMPT CHE; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Conners C., 2014, CONNERS CONTINUOUS P; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gibson DB, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00126; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kirelik SB, 2016, J EMERG MED, V50, P320, DOI 10.1016/j.jemermed.2015.02.054; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lecci L., 2018, J URGENT CARE ME JUN, P33; McCrea M, 2004, SPORTS MED UPDATE, V38, P369, DOI DOI 10.1001/JAMA.290.19.2556.[; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meyer GJ, 2001, AM PSYCHOL, V56, P128, DOI 10.1037//0003-066X.56.2.128; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Moser RS, 2019, ARCH CLIN NEUROPSYCH, V34, P50, DOI 10.1093/arclin/acy007; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Parker T. M., 2008, MED ENG PHYS, V12, P1360; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Peters DM, 2013, J GERIATR PHYS THER, V36, P24, DOI 10.1519/JPT.0b013e318248e20d; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Shaked D, 2020, APPL NEUROPSYCH-ADUL, V27, P478, DOI 10.1080/23279095.2019.1570199; Tsushima WT, 2019, ARCH CLIN NEUROPSYCH, V34, P60, DOI 10.1093/arclin/acy019	52	5	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2020	35	3			SI		265	274		10.1093/arclin/acz041			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	NN7WL	WOS:000568997800004	31553427	Bronze			2022-02-06	
J	Lynall, RC; Campbell, KR; Mauntel, TC; Blackburn, JT; Mihalik, JP				Lynall, Robert C.; Campbell, Kody R.; Mauntel, Timothy C.; Blackburn, J. Troy; Mihalik, Jason P.			Single-Legged Hop and Single-Legged Squat Balance Performance in Recreational Athletes With a History of Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						time to stabilization; mild traumatic brain injury; functional movement; recovery	EXTREMITY MUSCULOSKELETAL INJURY; POSTURAL STABILITY; GAIT; STABILIZATION; INDIVIDUALS; ASSOCIATION; RECOVERY; DEFICITS; RETURN; RATES	Context: Researchers have suggested that balance deficiencies may linger during functional activities after concussion recovery. Objective: To determine whether participants with a history of concussion demonstrated dynamic balance deficits as compared with control participants during single-legged hops and single-legged squats. Design: Cross-sectional study. Setting: Laboratory. Patients or other participants: A total of 15 previously concussed participants (6 men, 9 women; age = 19.7 & PLUMSN; 0.9 years, height = 169.2 & PLUMSN; 9.4 cm, mass = 66.0 & PLUMSN; 12.8 kg, median time since concussion = 126 days [range = 28-432 days]) were matched with 15 control participants (6 men, 9 women; age = 19.7 & PLUMSN; 1.6 years, height = 172.3 & PLUMSN; 10.8 cm, mass = 71.0 & PLUMSN; 10.4 kg). Intervention(s): During single-legged hops, participants jumped off a 30-cm box placed at 50% of their height behind a force plate, landed on a single limb, and attempted to achieve a stable position as quickly as possible. Participants performed single-legged squats while standing on a force plate. Main outcome measure(s): Time to stabilization (TTS; time for the normalized ground reaction force to stabilize after landing) was calculated during the single-legged hop, and center-of-pressure path and speed were calculated during single-legged squats. Groups were compared using analysis of covariance, controlling for average days since concussion. Results: The concussion group demonstrated a longer TTS than the control group during the single-legged hop on the nondominant leg (mean difference = 0.35 seconds [95% confidence interval = 0.04, 0.64]; F-2,F-27 = 5.69, P = .02). No TTS differences were observed for the dominant leg (F-2,F-27 = 0.64, P = .43). No group differences were present for the single-legged squat on either leg (P >= .11). Conclusions: Dynamic balance-control deficits after concussion may contribute to an increased musculoskeletal injury risk. Given our findings, we suggest that neuromuscular deficits currently not assessed after concussion may linger. Time to stabilization is a clinically applicable measure that has been used to distinguish patients with various pathologic conditions, such as chronic ankle instability and anterior cruciate ligament reconstruction, from healthy control participants. Whereas the single-legged squat may not sufficiently challenge balance control, future study of the more dynamic single-legged hop is needed to determine its potential diagnostic and prognostic value after concussion.	[Lynall, Robert C.] Univ Georgia, UGA Concuss Res Lab, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Campbell, Kody R.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Mauntel, Timothy C.] US Dept Def, Walter Reed Natl Mil Med Ctr, Vet Affairs Extrem Trauma & Amputat Ctr Excellenc, Bethesda, MD USA; [Mauntel, Timothy C.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [Blackburn, J. Troy] Univ N Carolina, Human Movement Sci Curriculum, Div Allied Hlth Sci, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Lynall, RC (corresponding author), Univ Georgia, UGA Concuss Res Lab, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	University of North Carolina at Chapel Hill Junior Faculty Development Award	This study was funded by The University of North Carolina at Chapel Hill Junior Faculty Development Award (Dr Mihalik). The views expressed in this paper are our own and do not reflect the official policy of the Departments of the Army, Navy, and Air Force; Department of Defense; the Uniformed Services University of the Health Sciences; or the US government.	Baracks J, 2018, J ATHL TRAINING, V53, P597, DOI 10.4085/1062-6050-174-17; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Colby SM, 1999, J ORTHOP SPORT PHYS, V29, P444, DOI 10.2519/jospt.1999.29.8.444; DiStefano LJ, 2010, J STRENGTH COND RES, V24, P332, DOI 10.1519/JSC.0b013e3181cc2225; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Inness EL, 2019, J HEAD TRAUMA REHAB, V34, pE37, DOI 10.1097/HTR.0000000000000431; Krill ML, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118790552; Lapointe AP, 2018, INT J PSYCHOPHYSIOL, V132, P93, DOI 10.1016/j.ijpsycho.2017.08.003; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Pietrosimone BG, 2012, KNEE, V19, P939, DOI 10.1016/j.knee.2012.03.002; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ross SE, 2008, J ATHL TRAINING, V43, P44, DOI 10.4085/1062-6050-43.1.44; Ross SE, 2005, J ATHL TRAINING, V40, P298; Ross SE, 2004, CLIN J SPORT MED, V14, P332, DOI 10.1097/00042752-200411000-00002; Talarico MK, 2017, J SPORT SCI, V35, P1118, DOI 10.1080/02640414.2016.1211307; Webster KA, 2010, J ATHL TRAINING, V45, P580, DOI 10.4085/1062-6050-45.6.580	31	5	5	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY	2020	55	5					488	493		10.4085/1062-6050-185-19			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NK4YN	WOS:000566738600007	32216655	Green Published, gold			2022-02-06	
J	Madhok, DY; Yue, JK; Sun, XY; Suen, CG; Coss, NA; Jain, S; Manley, GT				Madhok, Debbie Y.; Yue, John K.; Sun, Xiaoying; Suen, Catherine G.; Coss, Nathan A.; Jain, Sonia; Manley, Geoffrey T.		TRACK-TBI Investigators	Clinical Predictors of 3- and 6-Month Outcome for Mild Traumatic Brain Injury Patients with a Negative Head CT Scan in the Emergency Department: A TRACK-TBI Pilot Study	BRAIN SCIENCES			English	Article						mild traumatic brain injury; emergency department; clinical predictors; outcome	COMMON DATA ELEMENTS; POSTTRAUMATIC-STRESS-DISORDER; TRANSFORMING RESEARCH; FUNCTIONAL OUTCOMES; MANAGEMENT; REHABILITATION; RISK; RECOMMENDATIONS; CONCUSSION; GUIDELINES	A considerable subset of mild traumatic brain injury (mTBI) patients fail to return to baseline functional status at or beyond 3 months postinjury. Identifying at-risk patients for poor outcome in the emergency department (ED) may improve surveillance strategies and referral to care. Subjects with mTBI (Glasgow Coma Scale 13-15) and negative ED initial head CT < 24 h of injury, completing 3- or 6-month functional outcome (Glasgow Outcome Scale-Extended; GOSE), were extracted from the prospective, multicenter Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Pilot study. Outcomes were dichotomized to full recovery (GOSE = 8) vs. functional deficits (GOSE < 8). Univariate predictors with p < 0.10 were considered for multivariable regression. Adjusted odds ratios (AOR) were reported for outcome predictors. Significance was assessed at p < 0.05. Subjects who completed GOSE at 3- and 6-month were 211 (GOSE < 8: 60%) and 185 (GOSE < 8: 65%). Risk factors for 6-month GOSE < 8 included less education (AOR = 0.85 per-year increase, 95% CI: (0.74-0.98)), prior psychiatric history (AOR = 3.75 (1.73-8.12)), Asian/minority race (American Indian/Alaskan/Hawaiian/Pacific Islander) (AOR = 23.99 (2.93-196.84)), and Hispanic ethnicity (AOR = 3.48 (1.29-9.37)). Risk factors for 3-month GOSE < 8 were similar with the addition of injury by assault predicting poorer outcome (AOR = 3.53 (1.17-10.63)). In mTBI patients seen in urban trauma center EDs with negative CT, education, injury by assault, Asian/minority race, and prior psychiatric history emerged as risk factors for prolonged disability.	[Madhok, Debbie Y.] Univ Calif San Francisco, Dept Emergency Med & Neurol, Suite 6A,1001 Potrero Ave,Bldg 5,Suite 6A, San Francisco, CA 94110 USA; [Yue, John K.; Coss, Nathan A.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,Rm M779, San Francisco, CA 94143 USA; [Yue, John K.; Suen, Catherine G.; Coss, Nathan A.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Rm 101, San Francisco, CA 94110 USA; [Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, 9500 Gilman Dr, San Diego, CA 92093 USA; [Suen, Catherine G.] Univ Utah, Dept Neurol, Sch Med, 175 North Med Dr East, Salt Lake City, UT 84132 USA		Madhok, DY (corresponding author), Univ Calif San Francisco, Dept Emergency Med & Neurol, Suite 6A,1001 Potrero Ave,Bldg 5,Suite 6A, San Francisco, CA 94110 USA.	debbie.madhok@ucsf.edu; john.yue@ucsf.edu; xisun@ucsd.edu; catherine.suen@hsc.utah.edu; Nathan.Coss@ucsf.edu; sojain@ucsd.edu; ManleyG@ucsf.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US Department of DefenseUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]	This work was supported by the National Institute of Neurological Disorders and Stroke [grant numbers 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, and 5U01NS086090-03] and the US Department of Defense [grant numbers W81XWH-13-1-0441 and W81XWH-14-2-0176] for GTM. The funders had no role in the study design; data collection, analysis, and interpretation; writing of the report; and the decision to submit the article for publication.	Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bossers SM, 2018, EUR J TRAUMA EMERG S, V44, P889, DOI 10.1007/s00068-017-0861-z; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Einstadter D, 1996, J GEN INTERN MED, V11, P684, DOI 10.1007/BF02600160; Elliott TR, 2017, J CLIN PSYCHOL, V73, P1160, DOI 10.1002/jclp.22414; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Janak JC, 2017, J HEAD TRAUMA REHAB, V32, P1, DOI 10.1097/HTR.0000000000000202; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Si B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198741; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	72	5	5	3	4	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	MAY	2020	10	5							269	10.3390/brainsci10050269			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LZ2CN	WOS:000541036100041	32369967	Green Published, gold			2022-02-06	
J	Ord, AS; Miskey, HM; Lad, S; Richter, B; Nagy, K; Shura, RD				Ord, Anna S.; Miskey, Holly M.; Lad, Sagar; Richter, Beth; Nagy, Kristina; Shura, Robert D.			Examining embedded validity indicators in Conners continuous performance test-3 (CPT-3)	CLINICAL NEUROPSYCHOLOGIST			English	Article						CPT-3; continuous performance; validity; PVT; EVI	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLASSIFICATION ACCURACY; RESPONSE BIAS; TEST-II; TRIAL 1; SYMPTOM; NEUROPSYCHOLOGISTS; EFFICIENCY; ADULTS	Objective: Prior research has identified a variety of embedded performance validity indicators on the Conners' Continuous Performance Test-II (CPT-II). The purpose of this study was to examine embedded validity indicators within the updated third edition of the Conners Continuous Performance Test (CPT-3). Method: This study used a retrospective chart review from an ADHD evaluation clinic at a Mid-Atlantic VA hospital. Participants were 197 military veterans who completed a clinical assessment for ADHD. All participants were consecutive referrals to the ADHD clinic who completed the CPT-3 and the Test of Memory Malingering, Trial 1 (TOMM1). Results: Logistic regression analyses indicated that the following five variables were able to significantly predict validity status on the TOMM1: detectability (d'), omissions (OMI), commissions (COM), hit reaction time (HRT) standard deviation (SD), and HRT inter-stimulus interval (ISI) change. Among these measures, HRT SD and HRT ISI change were identified as the scores with the highest AUC values. Optimal cutoffs for all significant predictors were identified. A number of composite EVIs were created using various combinations of CPT-3 scores. All composite EVIs significantly differentiated between pass and fail status on the TOMM1. Conclusions: Several CPT-3 variables have clinical utility as embedded validity indicators; however, due to low sensitivity, they should not be used in isolation. These scores may be used as indicators of invalid performance but should not be used to rule out invalid performance. Identified CPT-3 scores may be useful as one component in a multivariate, multi-point continuous approach to performance validity sampling.	[Ord, Anna S.; Miskey, Holly M.; Lad, Sagar; Richter, Beth; Nagy, Kristina; Shura, Robert D.] WG Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA; [Ord, Anna S.; Miskey, Holly M.; Lad, Sagar; Shura, Robert D.] Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Miskey, Holly M.; Shura, Robert D.] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Miskey, Holly M.; Shura, Robert D.] Via Coll Osteopath Med, Blacksburg, VA USA		Ord, AS (corresponding author), WG Hefner VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	shirokova.anna@gmail.com		Ord, Anna/0000-0003-3373-2016; Shura, Robert/0000-0002-9505-0080; Lad, PsyD, Sagar/0000-0002-1278-8355	MidAtlantic Mental Illness Research, Education, and Clinical Center; Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and TreatmentUS Department of Veterans Affairs; Salisbury Veterans Affairs Medical Center	This work was supported by resources of Salisbury Veterans Affairs Medical Center; the MidAtlantic Mental Illness Research, Education, and Clinical Center; and the Department of Veterans Affairs Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Conners C. K., 2014, CONNERS CPT 3 MANUAL; Denning JH, 2019, APPL NEUROPSYCH-ADUL, V26, P1, DOI 10.1080/23279095.2017.1350684; Denning JH, 2014, ARCH CLIN NEUROPSYCH, V29, P729, DOI 10.1093/arclin/acu051; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Losier BJ, 1996, J CHILD PSYCHOL PSYC, V37, P971, DOI 10.1111/j.1469-7610.1996.tb01494.x; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Shura RD, 2017, PSYCHOL ASSESSMENT, V29, P1458, DOI 10.1037/pas0000436; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL	36	5	5	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2021	35	8					1426	1441		10.1080/13854046.2020.1751301		MAY 2020	16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WT9WI	WOS:000532211000001	32364040				2022-02-06	
J	Purcell, LN; Reiss, R; Eaton, J; Kumwenda, KK; Quinsey, C; Charles, A				Purcell, Laura N.; Reiss, Rachel; Eaton, Jessica; Kumwenda, Ken-Kellar; Quinsey, Carolyn; Charles, Anthony			Survival and Functional Outcomes at Discharge After Traumatic Brain Injury in Children versus Adults in Resource-Poor Setting	WORLD NEUROSURGERY			English	Article						Head injury; Traumatic brain injury; Traumatic brain injury in adults and children	HEAD-INJURY; INPATIENT REHABILITATION; EPIDEMIOLOGY; IMPACT	BACKGROUND: More than 90% of trauma mortality occurs in low- and middle-income countries, especially in sub-Saharan Africa. Head injury is the primary driver of trauma mortality in the prehospital and in-hospital setting. METHODS: An observational study was performed on patients presenting with traumatic brain injury (TBI) from October 2016 through May 2017 at Kamuzu Central Hospital, Malawi. Bivariate analysis and logistic regression were performed to determine the odds of favorable functional outcomes and mortality after controlling for significant covariates. RESULTS: Of the 356 patients with TBI, 72 (20.2%) were children <18 years of age. Males comprised 202 (87.1%) and 46 (63.9%) of the adult and pediatric cohorts, respectively. Motor vehicle crash was the leading etiology in adults and children. There was no significant difference between adult and pediatric Glasgow Coma Scale score on admission, 10.8 +/- 3.9 versus 10.9 +/- 3.5, respectively (P = 0.8). More adult (n = 76, 32.3%) than pediatric (n = 13, 18.1%) patients died. On multivariable analysis, pediatric patients were more likely to have a favorable outcome defined by a Glasgow Outcome Scale of good recovery or moderate disability (odds ratio 3.70, 95% confidence interval 1.22-11.17, P = 0.02) and were less likely to die after TBI (odds ratio 0.29, 95% confidence interval 0.09-0.93, P = 0.04). CONCLUSIONS: We show a survival advantage and better functional outcomes in children following TBI. This may be attributable to increased resiliency to TBI in children or the prioritization of children in a resource-poor environment. Investments in neurosurgical care following TBI are needed to improve outcomes.	[Purcell, Laura N.; Charles, Anthony] Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA; [Quinsey, Carolyn] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Reiss, Rachel] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Eaton, Jessica] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Kumwenda, Ken-Kellar; Charles, Anthony] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi		Charles, A (corresponding author), Univ N Carolina, Dept Surg, Chapel Hill, NC 27515 USA.; Charles, A (corresponding author), Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi.	anthchar@med.unc.edu		Quinsey, Carolyn/0000-0002-5232-8492; , Rachel/0000-0003-4969-1028	National Institutes of Health, Fogarty International CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW009340]	The National Institutes of Health, Fogarty International Center, funded this work (grant D43TW009340).	ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Areas FZ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00432; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Coburn K, 1992, AACN Clin Issues Crit Care Nurs, V3, P9; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fleminger S, 2012, J NEUROL NEUROSUR PS, V83, P1036, DOI 10.1136/jnnp-2012-303015; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas A, 2016, CHIN J TRAUMATOL, V19, P3, DOI 10.1016/j.cjtee.2016.01.001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Mehmood Amber, 2018, Trauma Surg Acute Care Open, V3, pe000253, DOI 10.1136/tsaco-2018-000253; Murray CJ, 2020, GLOBAL BURDEN DIS CO, P23; Nahmani M, 2014, NEUROSCIENCE, V283, P4, DOI 10.1016/j.neuroscience.2014.04.029; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Savage RC, 2009, INT BRAIN INJ ASS, V4; Sophie Su YR, 2016, TRANSLATIONAL RES TR; Udoh David O, 2013, Afr J Paediatr Surg, V10, P154, DOI 10.4103/0189-6725.115043; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zia N, 2019, TRAUMA SURG ACUTE CA, V4, DOI 10.1136/tsaco-2018-000259; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418	34	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2020	137						E597	E602		10.1016/j.wneu.2020.02.062			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LN1SV	WOS:000532726200020	32084614	Green Published, Green Accepted			2022-02-06	
J	Seguin, M; Degeilh, F; Bernier, A; El-Jalbout, R; Beauchamp, MH				Seguin, Marilou; Degeilh, Fanny; Bernier, Annie; El-Jalbout, Ramy; Beauchamp, Miriam H.			It's a Matter of Surgency: Traumatic Brain Injury Is Associated With Changes in Preschoolers' Temperament	NEUROPSYCHOLOGY			English	Article						children; traumatic brain injury; temperament; linear mixed-model analysis; surgency	GOOD OLD DAYS; POSTTRAUMATIC-STRESS; POSTCONCUSSION-SYNDROME; EXECUTIVE FUNCTIONS; PERSONALITY-CHANGE; INDIVIDUAL-DIFFERENCES; SOCIAL COMPETENCE; EFFORTFUL CONTROL; EARLY-CHILDHOOD; YOUNG-CHILDREN	Traumatic brain injury (TBI) can disrupt cognitive, social, and behavioral functioning. Temperament is often used to reflect emotional and behavioral tendencies in young children, but has never been assessed after TBI. Objective: Evaluate whether early TBI disrupts the trajectory of temperament. Method: Primary caregivers of 173 young children (age: 36 +/- 12 months) with uncomplicated mild 'FBI (n = 83), more severe TBI (msTBl; mild complicated, moderate and severe, n = 21) and with orthopedic injuries (n = 69) reported on their child's temperament retrospectively to assess preinjury profiles and at 6 and 18 months postinjury. For each domain of temperament (Surgency, Negative Affectivity, Effortful Control), linear mixed-model analyses were conducted to explore group differences on the rate of change across time. Results: There were no preinjury temperament differences between groups for any domains, chi(2)(2) = 2.84; p = .24; chi(2)(2) = 0.27; p = .87; chi(2)(2) = 1.47; p = .48. There was a significant effect of group on the rate of change across time for Surgency, chi(2)(2) = 6.77; p = .03, but not for Negative Affectivity, chi(2)(2) = 1.47; p = .48, or Effortful Control, chi(2)(2) = 2.21; p = .33. Children with msTBI showed a lower rate of increase in Surgency compared to children with mild TBI and orthopedic injuries. Conclusions: Developmental trajectories of Surgency appear to be affected by msTBl. Disruptions in expected developmental trajectories of temperament could underlie some of the sociobehavioral manifestations of TBI in this young age group.	[Seguin, Marilou; Degeilh, Fanny] Univ Montreal, Dept Psychol, St Justine Res Ctr, Montreal, PQ, Canada; [Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [El-Jalbout, Ramy] St Justine Hosp, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] St Justine Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Jalbout, Ramy El/AAT-6880-2020; Degeilh, Fanny/AAA-7445-2019	Beauchamp, Miriam/0000-0002-8637-6361; Seguin, Marilou/0000-0002-6017-6898; Degeilh, Fanny/0000-0002-5802-4975	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP11036]	The data that support the findings of this study are available on request from the corresponding author. They are not publicly available because they contain information that could compromise research participant privacy and consent. The authors declare that they have no significant competing financial, professional, or personal interests that might have influenced the performance or presentation of the work described in this article. We thank all the children and their families who participated in the Learning to Interact Optimizes Neurons (LION) study as well as all the members of the Developmental Neuropsychology Laboratory ABCs who were involved in the project. This work was supported by the Canadian Institutes of Health Research (Grant MOP11036 to Miriam H. Beauchamp).	Achenbach TM, 2001, ASEBA SCH AGE FORMS; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bridgett DJ, 2013, EMOTION, V13, P47, DOI 10.1037/a0029536; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Buss A.H., 1975, TEMPERAMENT THEORY P; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dollar JM, 2012, J EXP CHILD PSYCHOL, V112, P178, DOI 10.1016/j.jecp.2012.02.004; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Falk AC, 2009, J CHILD HEALTH CARE, V13, P227, DOI 10.1177/1367493509336691; FARVER JAM, 1994, DEV PSYCHOL, V30, P334, DOI 10.1037/0012-1649.30.3.334; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Gartstein MA, 2012, INFANT MENT HEALTH J, V33, P197, DOI 10.1002/imhj.21312; Goldsmith H., 1996, PRELOCOMOTOR LOCOMOT; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; HEDEKER D, 2004, QUANTITATIVE METHODO, DOI DOI 10.4135/9781412986311.N12; Hoffman L, 2015, MULTIVAR APPL SER, P1; HUTTENLOCHER J, 1991, DEV PSYCHOL, V27, P236, DOI 10.1037/0012-1649.27.2.236; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keppel-Benson JM, 2002, J CHILD PSYCHOL PSYC, V43, P203, DOI 10.1111/1469-7610.00013; Kochanska G, 1997, CHILD DEV, V68, P263, DOI 10.2307/1131849; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Laceulle OM, 2012, EUR J PERSONALITY, V26, P276, DOI 10.1002/per.832; Lalonde G, 2018, J NEUROPSYCHOL, V12, P1, DOI 10.1111/jnp.12104; Landolt MA, 2003, J CHILD PSYCHOL PSYC, V44, P1199, DOI 10.1111/1469-7610.00201; Lockenhoff CE, 2009, J TRAUMA STRESS, V22, P53, DOI 10.1002/jts.20385; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Mirman D, 2014, GROWTH CURVE ANAL VI; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mulder RT, 1997, PSYCHOL MED, V27, P99, DOI 10.1017/S0033291796004114; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; NEALE MC, 1989, J PERS SOC PSYCHOL, V56, P446, DOI 10.1037/0022-3514.56.3.446; Oldehinkel AJ, 2004, DEV PSYCHOPATHOL, V16, P421, DOI 10.1017/S0954579404044591; Olino TM, 2011, J CHILD PSYCHOL PSYC, V52, P792, DOI 10.1111/j.1469-7610.2010.02331.x; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Putnam S. P., 2010, INT C INF STUD BALT; Putnam S.P., 2001, ADV RES TEMPERAMENT, P165; Putnam SP, 2006, J PERS ASSESS, V87, P102, DOI 10.1207/s15327752jpa8701_09; Putnam SP, 2006, INFANT BEHAV DEV, V29, P386, DOI 10.1016/j.infbeh.2006.01.004; Rothbart M.K., 2015, DEV PSYCHOPATHOL, DOI [10.1002/9780470939390.ch11, DOI 10.1002/9780470939390.CH11]; Rothbart M.K., 2006, HDB CHILD PSYCHOL, V6th ed., P99, DOI DOI 10.1002/9780470147658.CHPSY0303; Rothbart M.K., 1989, TEMPERAMENT CHILDHOO, P187; Rothbart M. K., 1981, ADV DEV PSYCHOL, P37; ROTHBART MK, 1994, J ABNORM PSYCHOL, V103, P55, DOI 10.1037/0021-843X.103.1.55; Rothbart MK, 2001, CHILD DEV, V72, P1394, DOI 10.1111/1467-8624.00355; Rothbart MK, 2000, J PERS SOC PSYCHOL, V78, P122, DOI 10.1037/0022-3514.78.1.122; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; SAARNI C, 1998, HDB CHILD PSYCHOL SO, P237; Sanson A, 2004, SOC DEV, V13, P142, DOI 10.1046/j.1467-9507.2004.00261.x; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shiner RL, 2012, CHILD DEV PERSPECT, V6, P436, DOI 10.1111/j.1750-8606.2012.00254.x; Shiner RL, 2012, DEV PSYCHOPATHOL, V24, P507, DOI 10.1017/S0954579412000120; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; Verron H, 2018, EARLY EDUC DEV, V29, P655, DOI 10.1080/10409289.2018.1449504; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; White L. K., 2010, INFORM PROCESSING BI, P233, DOI DOI 10.1002/9780470661468.CH10; Whittle S, 2006, NEUROSCI BIOBEHAV R, V30, P511, DOI 10.1016/j.neubiorev.2005.09.003; Widiger TA, 2009, DEV PSYCHOPATHOL, V21, P771, DOI 10.1017/S095457940900042X; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Youngblade LM, 1998, J APPL DEV PSYCHOL, V19, P593, DOI 10.1016/S0193-3973(99)80057-4; 2006, MONOGR SOC RES CHILD, V71, P65	90	5	5	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2020	34	4					375	387		10.1037/neu0000618			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	LI2VA	WOS:000529340500001	31985239				2022-02-06	
J	Takahashi, T; Marushima, A; Nagasaki, Y; Hirayama, A; Muroi, A; Puentes, S; Mujagic, A; Ishikawa, E; Matsumura, A				Takahashi, Toshihide; Marushima, Aiki; Nagasaki, Yukio; Hirayama, Aki; Muroi, Ai; Puentes, Sandra; Mujagic, Arnela; Ishikawa, Eiichi; Matsumura, Akira			Novel neuroprotection using antioxidant nanoparticles in a mouse model of head trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Nanoparticles; neuroprotection; reactive oxygen species; traumatic brain injury; mice	BRAIN-INJURY; MICE; PATHOPHYSIOLOGY; INFLAMMATION; CHEMISTRY; EDARAVONE; RADICALS; FERRITIN; EDEMA	INTRODUCTION Free radicals and reactive oxygen species are related to deteriorating pathological conditions after head trauma because of their secondary effects. 2,2,6,6-Tetramethylpiperidine-1-oxyl (TEMPO) scavenges free radicals; however, this molecule is also toxic. Here, we have evaluated the neuroprotective effect of antioxidant nanoparticles, which consisted of a novel core-shell type nanoparticle containing 4-amino-TEMPO, that is, redox-active nitroxide radical-containing nanoparticles (RNPs). METHODS Institute of Cancer Research mice were subjected to a head-impact procedure, randomly divided into four groups and intravenously (3 mg/kg) administered phosphate-buffered saline, TEMPO, micelle (a self-assembling block copolymer micelle without a TEMPO moiety), or RNP through the tail vein immediately thereafter and intraperitoneally at days 1, 3, and 5 after traumatic brain injury (TBI). The RNP distribution was detected by rhodamine labeling. Cognitive behavior was assessed using the neurological severity score and a rotarod test at days 1, 3, and 7 following TBI, and contusion volume was measured at day 7 after TBI. Free radical-scavenging capacity was analyzed by electron paramagnetic resonance on day 1 after TBI, and immunostaining was used to observe mobilization of microglia (Iba-1) and rescued neuronal cells (NeuN). RESULTS Redox-active nitroxide radical-containing nanoparticle was detected in the microvessels around the injured area in the brain. Cognitive behavior assessment was significantly better, and contusion volume was significantly smaller in the RNP group compared with the other groups. Superoxide anion scavenging capacity was significantly higher in the RNP group, and neuronal loss was significantly suppressed around the injured area at day 7 after TBI. Furthermore, in the RNP group, neurodegenerative microglia production was suppressed at days 3 and 7 after TBI, whereas neuroprotective microglia production was higher at day 7 after TBI. CONCLUSION The RNP administration after TBI improved cognitive behavior and reduced contusion volume by improving reactive oxygen species scavenging capacity. Therefore, RNP may have a neuroprotective effect after TBI.	[Takahashi, Toshihide; Marushima, Aiki; Muroi, Ai; Ishikawa, Eiichi; Matsumura, Akira] Univ Tsukuba, Dept Neurosurg, Tsukuba, Ibaraki, Japan; [Takahashi, Toshihide; Mujagic, Arnela; Ishikawa, Eiichi; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Nagasaki, Yukio] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tennodai 1-1-1, Tsukuba, Ibaraki, Japan; [Hirayama, Aki] Tsukuba Univ Technol, Ctr Integrat Med, Tsukuba, Ibaraki, Japan; [Puentes, Sandra] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan		Nagasaki, Y (corresponding author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tennodai 1-1-1, Tsukuba, Ibaraki, Japan.; Marushima, A (corresponding author), Univ Tsukuba, Fac Med, Dept Neurosurg, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.	aiki.marushima@md.tsukuba.ac.jp; happyhusband@nagalabo.jp	Hirayama, Aki/G-7842-2017	Hirayama, Aki/0000-0001-5777-4208; Puentes, Sandra/0000-0002-6209-6445	JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25220203]; AMED [JP17ek0210099h0001]	This work was funded by JSPS KAKENHI Grant-in-Aid for Scientific Research (C) under grant number JP17K10819 and AMED under grant number JP17ek0210099h0001. The preparation of the materials used in this work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (S) under grant number 25220203.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; ALTURA BM, 1984, SCIENCE, V223, P1315, DOI 10.1126/science.6701524; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; BIEMOND P, 1984, J CLIN INVEST, V73, P1576, DOI 10.1172/JCI111364; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHOI DW, 1987, J NEUROSCI, V7, P357; Chonpathompikunlert P, 2012, NANOMEDICINE-UK, V7, P1029, DOI [10.2217/nnm.12.2, 10.2217/NNM.12.2]; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hahn SM, 1999, FREE RADICAL BIO MED, V27, P529, DOI 10.1016/S0891-5849(99)00099-4; Hosoo H, 2017, STROKE, V48, P2238, DOI 10.1161/STROKEAHA.116.016356; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Itoh T, 2009, NEUROTOX RES, V16, P378, DOI 10.1007/s12640-009-9081-6; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; KOCHANEK PM, 1988, J CEREBR BLOOD F MET, V8, P546, DOI 10.1038/jcbfm.1988.95; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Lapchak PA, 2010, EXPERT OPIN PHARMACO, V11, P1753, DOI 10.1517/14656566.2010.493558; Lee SY, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/49/495101; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marushima A, 2011, NEUROSURGERY, V68, P1418, DOI 10.1227/NEU.0b013e31820c02d9; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; Mei T, 2019, BIOMATERIALS, V215, DOI 10.1016/j.biomaterials.2019.05.020; Oowada S, 2012, J CLIN BIOCHEM NUTR, V51, P117, DOI 10.3164/jcbn.11-113; Petty MA, 1996, EUR J PHARMACOL, V307, P149, DOI 10.1016/0014-2999(96)00235-X; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Soule BP, 2007, FREE RADICAL BIO MED, V42, P1632, DOI 10.1016/j.freeradbiomed.2007.02.030; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Yoshitomi T, 2009, BIOCONJUGATE CHEM, V20, P1792, DOI 10.1021/bc900214f; Yoshitomi T, 2009, BIOMACROMOLECULES, V10, P596, DOI 10.1021/bm801278n	40	5	5	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2020	88	5					677	685		10.1097/TA.0000000000002617			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	NE5OT	WOS:000562650900016	32039974				2022-02-06	
J	Vedung, F; Hanni, S; Tegner, Y; Johansson, J; Marklund, N				Vedung, Fredrik; Hanni, Sofie; Tegner, Yelverton; Johansson, Jakob; Marklund, Niklas			Concussion incidence and recovery in Swedish elite soccer - Prolonged recovery in female players	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						female; questionnaire; return-to-play; soccer; Sports Concussion Assessment Tool (SCAT); sports-related concussion	SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; HEAD-INJURIES; RISK-FACTORS; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; NECK INJURIES; TIME-LOSS; ASSOCIATION; MECHANISMS	Objectives Sport-related concussions are an increasingly recognized health problem. Soccer is the most popular sport in the world although recent studies on concussion incidence are scarce. Here, a nationwide prospective study on concussion incidence, symptom severity, risk factors, gender differences, and return-to-play after concussion was performed in 51 Swedish elite soccer teams during the 2017 season. Methods In the 1st and 2nd soccer leagues for men and women, a Sport Concussion Assessment Tool (SCAT)-based questionnaire study was performed at preseason (baseline) and from 48 hours to 3 months post-concussion. Results We followed 959 players (389 women, 570 men) for 25 146 player game hours (9867 hours for women, 15 279 hours for men). Concussion incidence (n = 36 concussions during the season) was 1.19/1000 player game hours (females 1.22/1000 hours, males 1.18/1000 hours; P = .85). Twenty-seven percent of all players (8% of females, 40% of males) continued to play immediately after the concussion. When compared to male players, female players had worse initial symptom severity scores (median and IQR 30 (17-50.5) vs 11 (4-26.25), P = .02) on SCAT and longer return-to-play (P = .02). Risk factors for concussion were baseline symptoms and previous concussion. Conclusion In Swedish elite soccer, the concussion incidence was 1.19/1000 without gender differences. Most players recovered to play within 4 weeks post-injury. Almost one third of players continued to play at time of concussion. Female players had worse initial symptoms and longer return-to-play time than males, and a prolonged recovery beyond 3 months was only observed among female players.	[Vedung, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden; [Hanni, Sofie; Johansson, Jakob] Uppsala Univ, Dept Surg Sci Anesthesiol, Uppsala, Sweden; [Tegner, Yelverton] Lulea Univ Technol, Dept Hlth Sci, Lulea, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund Neurosurg, S-22220 Lund, Sweden		Marklund, N (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund Neurosurg, S-22220 Lund, Sweden.	niklas.marklund@med.lu.se		Vedung, Fredrik/0000-0003-3321-768X; Marklund, Niklas/0000-0002-9797-5626	Swedish Research Council for Sport Science Funding Source: Medline; ALF funds from Uppsala University Hospital Funding Source: Medline		Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Association FIdF, 2007, FIFA MAGAZINE, P11; Beaudouin Florian, 2019, Sports Med Int Open, V3, pE6, DOI 10.1055/a-0808-2551; Brooks BL, 2018, AM J SPORT MED, V46, P961, DOI 10.1177/0363546517749588; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hagglund M, 2009, SCAND J MED SCI SPOR, V19, P819, DOI 10.1111/j.1600-0838.2008.00861.x; Hanni SVF, 2018, SWED SOCC ASS YEARL; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Helmich I, 2018, J SPORT MED PHYS FIT, V58, P172, DOI 10.23736/S0022-4707.16.06677-9; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobson I, 2007, SCAND J MED SCI SPOR, V17, P84, DOI 10.1111/j.1600-0838.2006.00524.x; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Putukian M, 2017, J ATHL TRAINING, V52, P236, DOI 10.4085/1062-6050-52.1.08; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Tegner Yelverton, 2007, Lakartidningen, V104, P1220; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Voormolen DC, 2018, J NEUROTRAUM, V35, P1233, DOI 10.1089/neu.2017.5257; Werner J, 2019, BRIT J SPORT MED, V53, P539, DOI 10.1136/bjsports-2017-097796; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005	40	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	MAY	2020	30	5					947	957		10.1111/sms.13644			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LC3QR	WOS:000525240300015	32100894	Green Published, hybrid			2022-02-06	
J	Gazdzinski, LM; Mellerup, M; Wang, T; Adel, SAA; Lerch, JP; Sled, JG; Nieman, BJ; Wheeler, AL				Gazdzinski, Lisa M.; Mellerup, Miranda; Wang, Tong; Adel, Seyed Amir Ali; Lerch, Jason P.; Sled, John G.; Nieman, Brian J.; Wheeler, Anne L.			White Matter Changes Caused by Mild Traumatic Brain Injury in Mice Evaluated Using Neurite Orientation Dispersion and Density Imaging	JOURNAL OF NEUROTRAUMA			English	Article						behavior; mTBI; NODDI; white matter	AXONAL INJURY; DIFFUSION; MODEL; MRI; MICROSTRUCTURE; PATHOLOGY; NODDI; ABNORMALITIES; BIOMARKERS; RECOVERY	Mild traumatic brain injury (mTBI) is common and can lead to persistent cognitive and behavioral symptoms. Although diffusion tensor imaging (DTI) has demonstrated some sensitivity to changes in white matter following mTBI, recent studies have suggested that more complex geometric models of diffusion, including the neurite orientation dispersion and density imaging (NODDI) model, may be more sensitive and specific. Here, we evaluate microstructural changes in white matter following mTBI using DTI and NODDI in a mouse model, and compare the time course of these changes to behavioral impairment and recovery. We also assess volumetric changes for a comprehensive picture of the structural alterations in the brain and histological staining to identify cellular changes that may contribute to the differences detected in the imaging data. Increased orientation dispersion index (ODI) was observed in the optic tracts of mTBI mice compared with shams. Changes in fractional anisotropy (FA) were not statistically significant. Volume deficits were detected in the optic tract as well as in several gray matter regions: the lateral geniculate nuclei of the thalamus, the entorhinal cortex, and the superior colliculi. Glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1 (Iba1) staining was increased in the optic tracts of mTBI brains, and this staining correlated with ODI values. A transient impairment in working memory was observed, which resolved by 6 weeks, whereas increased ODI, GFAP, and Iba1 persisted to 18 weeks post-injury. We conclude that the optic tracts are particularly vulnerable to damage from the closed-skull impact model used in this study, and that ODI may be a more sensitive metric to this damage than FA. Differences in ODI and in histological measures of astrogliosis, neuroinflammation, and axonal degeneration persist beyond behavioral impairment in this model.	[Gazdzinski, Lisa M.; Mellerup, Miranda; Wang, Tong; Adel, Seyed Amir Ali; Lerch, Jason P.; Wheeler, Anne L.] Hosp Sick Children, Neurosci & Mental Hlth, Toronto, ON, Canada; [Sled, John G.; Nieman, Brian J.] Hosp Sick Children, Translat Med, Toronto, ON, Canada; [Sled, John G.; Nieman, Brian J.] Hosp Sick Children, Ctr Phenogen, Mouse Imaging Ctr, Toronto, ON, Canada; [Mellerup, Miranda; Wang, Tong; Adel, Seyed Amir Ali; Wheeler, Anne L.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Lerch, Jason P.; Sled, John G.; Nieman, Brian J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Lerch, Jason P.] Univ Oxford, John Radcliffe Hosp, Wellcome Ctr Integrat Neuroimaging, Dept Clin Neurosci, Oxford, England; [Nieman, Brian J.] Ontario Inst Canc Res, Toronto, ON, Canada		Wheeler, AL (corresponding author), Univ Toronto, Hosp Sick Children, Dept Physiol, Neurosci & Mental Hlth, 686 Bay St, Toronto, ON M5G 0A4, Canada.	anne.wheeler@sickkids.ca	Sled, John G/D-8268-2012; Adel, Seyed Amir Ali/AAE-1753-2021	Sled, John G/0000-0002-4461-283X; Nieman, Brian/0000-0001-8914-3814; Adel, Amir Ali/0000-0003-3596-0362	Scottish Rite Charitable Foundation of Canada [19119]; Brain Canada; Azrieli Foundation	This work was supported by an award from The Scottish Rite Charitable Foundation of Canada (ID#19119). MRI scan costs were covered by the Mouse Brain Imaging for Neurodevelopmental Disorders Platform Support Grant from Brain Canada and the Azrieli Foundation.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Barnett BP, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0329-y; Bennett RE, 2015, J NEUROSCI METH, V245, P25, DOI 10.1016/j.jneumeth.2015.02.005; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chung S, 2019, AM J NEURORADIOL, V40, P1438, DOI 10.3174/ajnr.A6146; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Crombe A, 2018, NEUROIMAGE, V172, P357, DOI 10.1016/j.neuroimage.2018.01.061; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Dazai Jun, 2011, J Vis Exp, DOI 10.3791/2497; de Guzman AE, 2016, NEUROIMAGE, V142, P687, DOI 10.1016/j.neuroimage.2016.06.028; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Friedel M, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00067; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gray M, 2020, BRAIN INJURY, V34, P535, DOI 10.1080/02699052.2020.1725979; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hatcher JP, 2001, BEHAV BRAIN RES, V125, P43, DOI 10.1016/S0166-4328(01)00275-3; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Lerch J., 2017, RMINC STAT TOOLS MED; Luo T, 2019, J MAGN RESON IMAGING, V49, P1750, DOI 10.1002/jmri.26328; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; McCunn P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215974; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Nieman Brian J, 2018, Curr Protoc Mouse Biol, V8, pe44, DOI 10.1002/cpmo.44; Noakes TLS, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3802; Palacios EM, 2018, EVOLUTION WHITE MATT, DOI [10.1101/345629, DOI 10.1101/345629]; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; R Core Team, 2019, R LANG ENV STAT COMP; Rao D., 2017, C OPEN, V5, pE301, DOI 10.9778/cmajo.20160115; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; West KL, 2018, NEUROIMAGE, V167, P366, DOI 10.1016/j.neuroimage.2017.11.064; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu YC, 2018, J NEUROTRAUM, V35, P2377, DOI 10.1089/neu.2017.5566; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yi SY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00081; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	67	5	5	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2020	37	16					1818	1828		10.1089/neu.2020.6992		APR 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MW0CL	WOS:000530003700001	32242488				2022-02-06	
J	Di Battista, AP; Rhind, SG; Richards, D; Hutchison, MG				Di Battista, Alex P.; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.			An investigation of plasma interleukin-6 in sport-related concussion	PLOS ONE			English	Article							BASE-LINE; IL-6; EXPRESSION; DEPRESSION; RISK; NEUROINFLAMMATION; INFLAMMATION; BIOMARKERS; CORTISOL; ANXIETY	Background Increasing evidence suggests inflammation is an important component of concussion pathophysiology. However, its etiology, restitution, and potential clinical repercussions remain unknown. The purpose of the current study was to compare the blood concentrations of interleukin (IL) -6, a prominent inflammatory cytokine, between healthy athletes and athletes with a sport-related concussion (SRC), while addressing the potential confounds of sex, recent physical activity, and the interacting effect of concussion history. Method A prospective, observational cohort study was conducted on athletes at a single academic institute participating across 13 interuniversity sports. Follow-up of 96 athletes who agreed to provide a blood sample was completed: 41 athletes with a physician diagnosed SRC, and 55 healthy athletes. Ella (TM), the high sensitivity immunoassay system by ProteinSimple was used to measure peripheral plasma concentrations of IL-6 within the first week (median = 4 days, range = 2-7) following injury. A resampled ordinary least squares regression was used to evaluate the relationship between IL-6 concentrations and concussion status, while partial least squares regression was used to evaluate the relationship between IL-6 and both symptom burden and time to clinical recovery. Results Regression analysis identified a negative relationship between plasma IL-6 concentrations and the interaction between an acute SRC and a history of concussion (beta = -0.29, p = 0.029). IL-6 did not differ between healthy athletes and those with an acute SRC independent of concussion history, and was not correlated with either recovery time or symptom burden in athletes with SRC. Conclusion Perturbations to circulating IL-6 concentrations, a key inflammatory cytokine, may be more pronounced following SRC in athletes who have a history of concussion. These results add to a growing body of evidence supporting the involvement of inflammation at all phases of recovery following SRC, and potentially support a concomitant effect of prior concussion on acute SRC pathophysiology.	[Di Battista, Alex P.; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Di Battista, Alex P.; Rhind, Shawn G.] Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada; [Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, David L MacIntosh Sport Med Clin, Toronto, ON, Canada; [Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada		Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.; Di Battista, AP (corresponding author), Toronto Res Ctr, Def Res & Dev Canada, Toronto, ON, Canada.	dibattista.alex@gmail.com		Di Battista, Alex/0000-0002-3325-6833; Rhind, Shawn/0000-0003-2300-0620	Canadian Institute of Military and Veteran Health Research	The study was funded by the Canadian Institute of Military and Veteran Health Research, received by MGH (CIMVHR -Task 7).	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Ai AL, 2010, J CLIN PSYCHOL, V66, P1057, DOI 10.1002/jclp.20716; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Carpenter LL, 2010, NEUROPSYCHOPHARMACOL, V35, P2617, DOI 10.1038/npp.2010.159; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Di Battista AP, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-0339-3; Di Battista AP, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1402-y; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Du YJ, 2013, PROG NEURO-PSYCHOPH, V47, P69, DOI 10.1016/j.pnpbp.2013.08.004; Ebert SE, 2019, EUR J NEUROL, V26, P1426, DOI 10.1111/ene.13971; Engler H, 2015, BRAIN BEHAV IMMUN, V49, pe6, DOI [10.1016/j.bbi.2015.06.041, DOI 10.1016/J.BBI.2015.06.041]; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liu YM, 2006, J AM SOC NEPHROL, V17, P863, DOI 10.1681/ASN.2005050465; Maes M, 1999, BIOL PSYCHIAT, V45, P833, DOI 10.1016/S0006-3223(98)00131-0; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Meyer T, 2011, BEHAV MED, V37, P105, DOI 10.1080/08964289.2011.609192; Morozink JA, 2010, HEALTH PSYCHOL, V29, P626, DOI 10.1037/a0021360; Murphy TM, 2015, PSYCHIAT GENET, V25, P71, DOI 10.1097/YPG.0000000000000055; Narazaki M, 2017, EXPERT REV CLIN IMMU, V13, P535, DOI 10.1080/1744666X.2017.1295850; Nishimoto N, 2006, NAT CLIN PRACT RHEUM, V2, P619, DOI 10.1038/ncprheum0338; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; O'Donovan A, 2010, BRAIN BEHAV IMMUN, V24, P1074, DOI 10.1016/j.bbi.2010.03.003; Prodan CI, 2016, J NEUROTRAUM, V33, P818, DOI 10.1089/neu.2014.3846; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Rose-John S, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028415; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.iy.08.040190.001345; Virtanen M, 2015, PSYCHOL MED, V45, P2137, DOI 10.1017/S0033291715000070; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 28	2020	15	4							e0232053	10.1371/journal.pone.0232053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8WP	WOS:000536661300030	32343752	Green Published, gold			2022-02-06	
J	Shao, XF; Yang, P; Shen, J; Chen, SS; Jiang, XC; Wang, QF; Di, Q				Shao, Xuefei; Yang, Xiping; Shen, Jun; Chen, Sansong; Jiang, Xiaochun; Wang, Qifu; Di, Qiang			TNF-alpha-induced p53 activation induces apoptosis in neurological injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						apoptosis; apoptotic signalling pathway; p53; TNF-alpha; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; CELL-DEATH; CASPASE-3; INCREASES; INFANTS; PROTEIN; STRESS; BCL-2; RAT	It was previously confirmed that the apoptotic and necrotic neurons are found during the acute post-traumatic period, suggesting the induction of apoptosis after traumatic brain injury (TBI). To further explore the involvement of apoptotic factors in TBI, an apoptosis antibody array was conducted to measure the alterations of apoptotic factors in rat brain cortex after TBI. As a result, the Neurological Severity Scale (NSS) scores after TBI were increased, and the cell morphology of the brain cortex was destructed with increased neuronal apoptosis. Furthermore, the caspase-3 activity was increased, and the apoptotic-related factors TNF-alpha and p53 were up-regulated in the brain cortex. More importantly, in vitro experiments demonstrated that down-regulation of TNF-alpha in oxygen-glucose deprivation/reoxygenation (OGD/R) cells increased cell viability and decreased apoptosis and the p53 expression. These results suggested the involvement of TNF-alpha-induced apoptotic signalling pathway by activating p53 in the molecular mechanism of neurological injury.	[Shao, Xuefei; Shen, Jun; Chen, Sansong; Jiang, Xiaochun; Wang, Qifu] Wannan Med Coll, Dept Neurosurg, Yi Ji Shan Hosp, Zheshan West Rd 2nd, Wuhu 241000, Anhui, Peoples R China; [Yang, Xiping] Chinese Peoples Armed Police Force, Characterist Med Ctr, Tianjin, Peoples R China; [Di, Qiang] Wannan Med Coll, Dept Dermatol & STD, Yi Ji Shan Hosp, Zheshan West Rd 2nd, Wuhu 241000, Anhui, Peoples R China		Wang, QF (corresponding author), Wannan Med Coll, Dept Neurosurg, Yi Ji Shan Hosp, Zheshan West Rd 2nd, Wuhu 241000, Anhui, Peoples R China.; Di, Q (corresponding author), Wannan Med Coll, Dept Dermatol & STD, Yi Ji Shan Hosp, Zheshan West Rd 2nd, Wuhu 241000, Anhui, Peoples R China.	wangqf881008@163.com; drqiangdi@163.com		Qiang, Di/0000-0001-8857-7805	Wannan Medical College [WK2017ZF04]; Teaching Quality and Teaching Reform Project of Wannan Medical College [2018jyxm58]; Collegiate Major Natural Science Research Projects [KJ2018ZD027, KJ2017A267]; youth project of Natural Science Foundation of Anhui Province [1908085QH362]	This study was funded by the priority of research funds of Wannan Medical College (Grant no. WK2017ZF04), the Teaching Quality and Teaching Reform Project of Wannan Medical College (Grant no. 2018jyxm58), the Collegiate Major Natural Science Research Projects (Grant no. KJ2018ZD027, Anhui Province, China), Collegiate Major Natural Science Research Projects (Grant no. KJ2017A267, Anhui Provincial Department of Education, China), and youth project of Natural Science Foundation of Anhui Province (No. 1908085QH362.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Cai ZZ, 1997, ONCOGENE, V15, P2817, DOI 10.1038/sj.onc.1201445; Cheng Y, 2008, BIOCHEM BIOPH RES CO, V376, P483, DOI 10.1016/j.bbrc.2008.09.018; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Lampron A, 2013, NEURON, V78, P214, DOI 10.1016/j.neuron.2013.04.005; Lee S, 2019, CELL REP, V26, P2194, DOI 10.1016/j.celrep.2019.01.081; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rokhlin OW, 2000, ONCOGENE, V19, P1959, DOI 10.1038/sj.onc.1203453; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Wawryk-Gawda E, 2014, PROTOPLASMA, V251, P525, DOI 10.1007/s00709-013-0548-1; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; YIN DL, 1995, NEUROSURGERY, V37, P758, DOI 10.1227/00006123-199510000-00021	23	5	5	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	JUN	2020	24	12					6796	6803		10.1111/jcmm.15333		APR 2020	8	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	LY6PW	WOS:000529052800001	32344470	gold, Green Published			2022-02-06	
J	Wang, XY; Guo, YK; Zhang, YG; Li, JJ; Gao, ZQ; Li, YX; Zhou, TL; Zhang, H; He, JH; Cong, FY				Wang, Xiaoyu; Guo, Yongkun; Zhang, Yunge; Li, Jinju; Gao, Zhongqi; Li, Yingxin; Zhou, Tianlin; Zhang, Hui; He, Jianghong; Cong, Fengyu			Combined Behavioral and Mismatch Negativity Evidence for the Effects of Long-Lasting High-Definition tDCS in Disorders of Consciousness: A Pilot Study	FRONTIERS IN NEUROSCIENCE			English	Article						high-definition transcranial direct current stimulation; disorder of consciousness; coma recovery scale-revised; mismatch negativity; event-related potentials	DIRECT-CURRENT STIMULATION; TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; UNRESPONSIVE WAKEFULNESS; VEGETATIVE STATE; DC-STIMULATION; FREQUENCY; PRECUNEUS; CORTEX	Objective To evaluate the effects of long-term High-definition transcranial direct current stimulation (HD-tDCS) over precuneus on the level of consciousness (LOC) and the relationship between Mismatch negativity (MMN) and the LOC over the therapy period in patients with Disorders of consciousness (DOCs). Methods We employed a with-in group repeated measures design with an anode HD-tDCS protocol (2 mA, 20 min, the precuneus) on 11 (2 vegetative state and nine minimally conscious state) patients with DOCs. MMN and Coma Recovery Scale-Revised (CRS-R) scores were measured at four time points: before the treatment of HD-tDCS (T0), after a single session of HD-tDCS (T1), after the treatment of 7 days (T2) and 14 days (T3). A frequency-deviant oddball paradigm with two deviation magnitudes (standard stimulus: 1000 Hz, small deviant stimuli: 1050 Hz, large deviant stimuli: 1200 Hz) was adopted to elicit MMN. Results Significant improvements of CRS-R score were found after 7-day (T2) and 14-day (T3) treatment compared with baseline (T0). Regarding the MMN, significant improvements of MMN amplitudes were observed after a single session of stimulation (T1), 7-day (T2) and 14-day treatment (T3) compared with baseline (T0). Additionally, there were significant negative correlations between CRS-R scores and MMN amplitudes elicited by both large and small deviant stimuli. Conclusion Long-term HD-tDCS over precuneus might improve signs of consciousness in patients with DOCs as measured by CRS-R total scores, and MMN could be an assistant assessment in the course of tDCS treatment.	[Wang, Xiaoyu; Zhang, Yunge; Gao, Zhongqi; Li, Yingxin; Zhou, Tianlin; Cong, Fengyu] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Sch Biomed Engn, Dalian, Peoples R China; [Guo, Yongkun; Li, Jinju; Zhang, Hui] Zhengzhou Cent Hosp, Dept Neurosurg, Zhengzhou, Peoples R China; [Guo, Yongkun] Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 5, Zhengzhou, Peoples R China; [He, Jianghong] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China; [Cong, Fengyu] Univ Jyvaskyla, Fac Informat Technol, Jyvaskyla, Finland		Cong, FY (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Sch Biomed Engn, Dalian, Peoples R China.; Guo, YK (corresponding author), Zhengzhou Cent Hosp, Dept Neurosurg, Zhengzhou, Peoples R China.; Guo, YK (corresponding author), Zhengzhou Univ, Dept Neurosurg, Affiliated Hosp 5, Zhengzhou, Peoples R China.; Cong, FY (corresponding author), Univ Jyvaskyla, Fac Informat Technol, Jyvaskyla, Finland.	yongkunhope@126.com; concg@dlut.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91748105]; Fundamental Research Funds for the Central Universities [DUT2019] in Dalian University of Technology in China; Key Scientific Research Projects of Henan Province Universities and Colleges [19A320041]; Medicine and Health Science and Technology Project of Zhejiang Province [2019RC254]	This research was supported by National Natural Science Foundation of China (Grant No. 91748105), the Fundamental Research Funds for the Central Universities [DUT2019] in Dalian University of Technology in China, the Key Scientific Research Projects of Henan Province Universities and Colleges (19A320041), and the Medicine and Health Science and Technology Project of Zhejiang Province (2019RC254).	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Angelakis E, 2014, ARCH PHYS MED REHAB, V95, P283, DOI 10.1016/j.apmr.2013.09.002; Bai Y, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00471; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Calabro RS, 2016, NEUROL SCI, V37, P503, DOI 10.1007/s10072-016-2474-4; Castillo-Saavedra L, 2016, J PAIN, V17, P14, DOI 10.1016/j.jpain.2015.09.009; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavinato M, 2015, BRAIN TOPOGR, V28, P570, DOI 10.1007/s10548-014-0383-5; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Daltrozzo J, 2009, COGN BEHAV NEUROL, V22, P53, DOI 10.1097/WNN.0b013e318192ccc8; Della Pepa GM, 2013, STEREOT FUNCT NEUROS, V91, P275, DOI 10.1159/000348271; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fishman YI, 2014, BRAIN TOPOGR, V27, P500, DOI 10.1007/s10548-013-0337-3; FrodlBauch T, 1997, BRAIN TOPOGR, V10, P3, DOI 10.1023/A:1022214905452; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Guo YK, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00412; Harrison AH, 2013, NEUROSCI BIOBEHAV R, V37, P1403, DOI 10.1016/j.neubiorev.2013.05.004; Huang HY, 2017, J NEURORESTORATOLOGY, V5, P111, DOI 10.2147/JN.S132589; Huang WS, 2017, BRAIN STIMUL, V10, P718, DOI 10.1016/j.brs.2017.02.001; Impey D, 2017, J PSYCHOPHARMACOL, V31, P614, DOI 10.1177/0269881116665336; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kang EK, 2012, J REHABIL MED, V44, P346, DOI 10.2340/16501977-0947; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; Koch G, 2018, NEUROIMAGE, V169, P302, DOI 10.1016/j.neuroimage.2017.12.048; Koenig MA, 2014, NEUROCRIT CARE, V20, P348, DOI 10.1007/s12028-014-9953-3; Kuo HI, 2013, BRAIN STIMUL, V6, P644, DOI 10.1016/j.brs.2012.09.010; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Legostaeva L, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050103; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naccache L, 2005, CLIN NEUROPHYSIOL, V116, P988, DOI 10.1016/j.clinph.2004.10.009; Naro A, 2015, RESTOR NEUROL NEUROS, V33, P159, DOI 10.3233/RNN-140448; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Raduntz T, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa69d1; Poiani GDR, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2414-5; Richardson J, 2015, NEUROREHABILITATION, V36, P115, DOI 10.3233/NRE-141199; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Sabri M, 2002, J SLEEP RES, V11, P123, DOI 10.1046/j.1365-2869.2002.00292.x; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Tervaniemi M, 1999, CLIN NEUROPHYSIOL, V110, P1388, DOI 10.1016/S1388-2457(99)00108-X; Thibaut A, 2017, BRAIN INJURY, V31, P466, DOI 10.1080/02699052.2016.1274776; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Tristan Bekinschtein, 2015, Handb Clin Neurol, V127, P195, DOI 10.1016/B978-0-444-52892-6.00013-1; Tucker C, 2016, NEUROCRIT CARE, V24, P488, DOI 10.1007/s12028-015-0227-5; Tzovara A, 2013, BRAIN, V136, P81, DOI 10.1093/brain/aws264; Wang XY, 2018, NEUROSCI BULL, V34, P700, DOI 10.1007/s12264-018-0260-4; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Xia XY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00182; Xie G, 2011, BRIT J ANAESTH, V106, P548, DOI 10.1093/bja/aeq415	63	5	6	5	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 28	2020	14								381	10.3389/fnins.2020.00381			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LO1YW	WOS:000533424400001	32410950	Green Published, gold			2022-02-06	
J	Fortenbaugh, FC; Fonda, JR; Fortier, CB; Amick, MM; Milberg, WP; McGlinchey, RE				Fortenbaugh, Francesca C.; Fonda, Jennifer R.; Fortier, Catherine B.; Amick, Melissa M.; Milberg, William P.; McGlinchey, Regina E.			The Impact of Common Psychiatric and Behavioral Comorbidities on Functional Disability Across Time and Individuals in Post-9/11 Veterans	JOURNAL OF TRAUMATIC STRESS			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; STRUCTURED CLINICAL INTERVIEW; MENTAL-HEALTH PROBLEMS; OEF/OIF VETERANS; CROSS-VALIDATION; WAR VETERANS; COMBAT; IRAQ; AFGHANISTAN	Returning veterans often face multiple concurrent psychiatric and behavioral conditions that negatively impact reintegration into civilian life and are associated with functional disability. Understanding how conditions interact to negatively impact functioning is an important step toward developing holistic treatment approaches optimized for this population. This study utilized a cross-sectional and prospective longitudinal cohort design, applying regression algorithms to understand the relative contribution of common clinical issues to functional disability in U.S. veterans who served after the September 11, 2001 (9/11), terror attacks. Community-dwelling post-9/11 veterans (N = 397) completed detailed assessments, including common clinical condition diagnoses, combat experience, and demographics, which were used to predict functional disability (World Health Organization Disability Assessment Schedule); 205 participants were reassessed approximately 1-2 years after enrollment. Regression analyses showed a strong association between the predictor variables and functional disability, f (2) = 1.488. Validation analyses showed a high prediction ability of functional disability to independent samples, r = .719, and across time in the same individuals, r = .780. The strongest predictors included current posttraumatic stress disorder, depressive disorder, sleep disturbance, and pain diagnoses. These results demonstrate the importance of considering multiple common co-occurring conditions when assessing functional disability in post-9/11 veterans and suggest that certain syndromes contribute the most unique information to predicting functional disability with high confidence. As most U.S. veterans utilize private healthcare systems, these results have clinical utility for both Veterans Affairs and civilian healthcare practitioners in assessing and monitoring functional disability in post-9/11 veterans over time.	[Fortenbaugh, Francesca C.; Fonda, Jennifer R.; Fortier, Catherine B.; Amick, Melissa M.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Fortenbaugh, Francesca C.; Fonda, Jennifer R.; Fortier, Catherine B.; Amick, Melissa M.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA USA; [Fortenbaugh, Francesca C.; Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Fonda, Jennifer R.; Amick, Melissa M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Fortenbaugh, FC (corresponding author), 150 S Huntington Ave, Boston, MA 02130 USA.	Francesca_Fortenbaugh@hms.harvard.edu	Fonda, Jennifer R./ABG-2890-2021; Fortier, Catherine/AAS-2163-2021	Fonda, Jennifer R./0000-0001-9482-2918; Fortier, Catherine/0000-0002-8953-9904	U.S. Department of Veterans Affairs (VA) through the Translational Research Center for TBI and Stress Disorders (TRACTS)US Department of Veterans Affairs; Department of Veterans Affairs Rehabilitation Research DevelopmentUS Department of Veterans Affairs [1IK2RX002268-01A2]; VA Clinical Science Research & Development Merit Review [CX001327]; National Institute of Health NCCIH grant [R21 AT009430-01]; VA Rehabilitation Research & Development Traumatic Brain Injury National Research Center [B9254-C]	This research was supported by the U.S. Department of Veterans Affairs (VA) through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research & Development Traumatic Brain Injury National Research Center (B9254-C), a Career Development award from the Department of Veterans Affairs Rehabilitation Research & Development (1IK2RX002268-01A2) to F.C.F., a VA Clinical Science Research & Development Merit Review (CX001327) to R.E.M., and a National Institute of Health NCCIH grant (R21 AT009430-01) to W.P.M. The contents within do not represent the views of the Department of Veterans Affairs or the United States government.	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Atkinson MP, 2009, MANAGE SCI, V55, P1454, DOI 10.1287/mnsc.1090.1042; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; Berry KJ, 2002, PSYCHOL REP, V90, P495, DOI 10.2466/PR0.90.2.495-502; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bleich A, 1997, BRIT J PSYCHIAT, V170, P479, DOI 10.1192/bjp.170.5.479; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cornis-Pop Micaela, 2019, Phys Med Rehabil Clin N Am, V30, P261, DOI 10.1016/j.pmr.2018.08.007; Epidemiology Program Post-Deployment Health Group, 2012, AN VA HLTH CAR UT OP; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; First M.B., 1996, STRUCTURED CLIN INTE; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Fortier CB, 2018, J HEAD TRAUMA REHAB, V33, pE17, DOI 10.1097/HTR.0000000000000362; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Goetter EM, 2015, J TRAUMA STRESS, V28, P401, DOI 10.1002/jts.22038; Gold LH, 2014, J AM ACAD PSYCHIATRY, V42, P173; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Hawkins DM, 2004, J CHEM INF COMP SCI, V44, P1, DOI 10.1021/ci0342472; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; National Center for Veterans Analysis and Statistics, 2017, PROF VET 2015 DAT AM; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Ustun T, 2010, MEASURING HLTH DISAB; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; World Health Organization, 2010, MEAS HLTH DIS MAN WH; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	52	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867	1573-6598		J TRAUMA STRESS	J. Trauma Stress	OCT	2020	33	5					750	761		10.1002/jts.22501		APR 2020	12	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	OA2DV	WOS:000528764000001	32339323	Green Accepted			2022-02-06	
J	Fokin, AA; Wycech, J; Katz, JK; Tymchak, A; Teitzman, RL; Koff, S; Puente, I				Fokin, Alexander A.; Wycech, Joanna; Katz, Jeffrey K.; Tymchak, Alexander; Teitzman, Richard L.; Koff, Susan; Puente, Ivan			Palliative Care Consultations in Trauma Patients and Role of Do-Not-Resuscitate Orders: Propensity-Matched Study	AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE			English	Article						palliative care consultations; trauma; do-not-resuscitate order; goals of care; level 1 trauma center; advanced directives; propensity matched control; acute traumatic injury	ADVANCE DIRECTIVES; UNIT; MEDICINE; OUTCOMES	Objective: To delineate characteristics of trauma patients associated with a palliative care consultation (PCC) and to analyze the role of do-not-resuscitate (DNR) orders and related outcomes. Methods: Retrospective study included 864 patients from 2 level one trauma centers admitted between 2012 and 2019. Level 1 trauma centers are designated for admission of the most severe injured patients. Palliative care consultation group of 432 patients who received PCC and were compared to matched control (MC) group of 432 patients without PCC. Propensity matching covariates included Injury Severity Score, mechanism of injury, gender, and hospital length of stay (HLOS). Analysis included patient demographics, injury parameters, intensive care unit (ICU) admissions, ICU length of stay (ICULOS), duration of mechanical ventilation, timing of PCC and DNR, and mortality. Palliative care consultation patients were further analyzed based on DNR status: prehospital DNR, in-hospital DNR, and no DNR (NODNR). Results: Palliative care consultation compared to MC patients were older, predominantly Caucasian, with more frequent traumatic brain injury (TBI), ICU admissions, and mechanical ventilation. The average time to PCC was 5.3 days. Do-not-resuscitate orders were significantly more common in PCC compared to MC group (71.5% vs 11.1%, P < .001). Overall mortality was 90.7% in PCC and 6.0% in MC (P < .001). In patients with DNR, mortality was 94.2% in PCC and 18.8% in MC. In-hospital DNR-PCC compared to NODNR-PCC patients had shorter ICULOS (5.0 vs 7.3 days, P = .04), HLOS (6.2 vs 13.2 days, P = .006), and time to discharge (1.0 vs 6.3 days, P = .04). Conclusions: Advanced age, DNR order, and TBI were associated with a PCC in trauma patients and resulted in significantly higher mortality in PCC than in MC patients. Combination of DNR and PCC was associated with shorter ICULOS, HLOS, and time from PCC to discharge.	[Fokin, Alexander A.; Wycech, Joanna; Katz, Jeffrey K.; Tymchak, Alexander; Puente, Ivan] Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA; [Fokin, Alexander A.; Katz, Jeffrey K.; Puente, Ivan] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Surg, Boca Raton, FL 33431 USA; [Wycech, Joanna; Puente, Ivan] Broward Hlth Med Ctr, Div Trauma & Crit Care Serv, Ft Lauderdale, FL USA; [Teitzman, Richard L.; Koff, Susan] TrustBridge Hlth, W Palm Beach, FL USA; [Puente, Ivan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Surg, Miami, FL 33199 USA		Fokin, AA (corresponding author), Delray Med Ctr, Div Trauma & Crit Care Serv, 5352 Linton Blvd, Delray Beach, FL 33484 USA.	alexander.fokin@tenethealth.com		Knight, Joanna/0000-0002-8869-8575; Katz, Jeffrey/0000-0003-4525-4912			Adams SD, 2013, J TRAUMA ACUTE CARE, V74, P1327, DOI 10.1097/TA.0b013e31828c4698; Haines KL, 2018, AM J HOSP PALLIAT ME, V35, P1081, DOI 10.1177/1049909117753377; Heron Melonie, 2019, Natl Vital Stat Rep, V68, P1; Hua MS, 2014, AM J RESP CRIT CARE, V189, P428, DOI 10.1164/rccm.201307-1229OC; Huang YC, 2010, J FORMOS MED ASSOC, V109, P201, DOI 10.1016/S0929-6646(10)60043-5; Jawa RS, 2015, AM J SURG, V210, P814, DOI 10.1016/j.amjsurg.2015.04.007; Karlekar M, 2014, PALLIATIVE MED, V28, P1062, DOI 10.1177/0269216314534514; Kupensky D, 2015, J TRAUMA NURS, V22, P261, DOI 10.1097/JTN.0000000000000151; Marco CA, 2015, AM J EMERG MED, V33, P1770, DOI 10.1016/j.ajem.2015.08.026; Matsushima K, 2016, J SURG RES, V200, P631, DOI 10.1016/j.jss.2015.09.024; Morrell ED, 2008, J MED ETHICS, V34, P642, DOI 10.1136/jme.2007.022517; Mosenthal AC, 2003, J AM COLL SURGEONS, V197, P509, DOI 10.1016/S1072-7515(03)00651-3; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Mosenthal AC, 2012, CRIT CARE MED, V40, P1199, DOI 10.1097/CCM.0b013e31823bc8e7; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Nelson JE, 2010, CRIT CARE MED, V38, P1765, DOI 10.1097/CCM.0b013e3181e8ad23; O'Connell K, 2016, CURR OPIN CRIT CARE, V22, P584, DOI 10.1097/MCC.0000000000000357; Olufajo OA, 2016, J AM COLL SURGEONS, V222, P1029, DOI 10.1016/j.jamcollsurg.2015.12.058; Rivet EB, 2017, AM J SURG, V214, P657, DOI 10.1016/j.amjsurg.2017.06.010; Salottolo K, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0094-2; Toevs CC, 2014, J AM COLL SURGEONS, V219, pS49, DOI 10.1016/j.jamcollsurg.2014.07.108; Toevs CC, 2011, SURG CLIN N AM, V91, P325, DOI 10.1016/j.suc.2010.12.008; Wade CE, 2013, J TRAUMA ACUTE CARE, V75, pS89, DOI 10.1097/TA.0b013e31828fa422; Wooster M, 2018, AM J HOSP PALLIAT ME, V35, P1063, DOI 10.1177/1049909117752670	24	5	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-9091	1938-2715		AM J HOSP PALLIAT ME	Am. J. Hosp. Palliat. Med.	DEC	2020	37	12					1068	1075	1049909120919672	10.1177/1049909120919672		APR 2020	8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	NL5VC	WOS:000527998000001	32319314				2022-02-06	
J	Hanko, M; Sorsak, J; Snopko, P; Opsenak, R; Zelenak, K; Kolarovszki, B				Hanko, Martin; Sorsak, Jakub; Snopko, Pavol; Opsenak, Rene; Zelenak, Kamil; Kolarovszki, Branislav			Incidence and risk factors of early postoperative complications in patients after decompressive craniectomy: a 5-year experience	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Decompressive craniectomy; Complications; Reoperation; Risk factors	TRAUMATIC BRAIN-INJURY; RESIDENT INVOLVEMENT; SUBDURAL-HEMATOMA; AMERICAN-COLLEGE; IMPACT; HEMICRANIECTOMY; HYDROCEPHALUS; NEUROSURGERY; MANAGEMENT; INFARCTION	Purpose Decompressive craniectomy is an effective measure to reduce a pathologically elevated intracranial pressure. Patients' survival and life quality following this surgery have been a subject of several studies and significantly differ according to the primary diagnosis. Since this operation is often associated with a wide spectrum of possibly serious complications, we aimed to describe their incidence and possible associated risk factors. Methods We evaluated 118 patients who underwent decompressive craniectomy at our clinic during years 2013-2017. The indications included traumatic brain injuries, ischaemic or haemorrhagic strokes and postoperative complications of planned neurosurgical procedures. Subsequently, we assessed the incidence of early postoperative complications (occurring during the first 3 postoperative weeks). The results were statistically analysed with relation to a wide selection of possible risk factors. Results At least one early surgical postoperative complication occurred in 87 (73.73%) patients, the most frequent being a development of an extraaxial fluid collection in 41 (34.75%) patients. We were able to identify risk factors linked with extraaxial fluid collections, subcutaneous and extradural haematomas, postoperative seizures and meningitis. An overall need for reoperation was 13.56%. Neither the duration of the surgery nor the qualification of the operating surgeon had any effect on the complications' occurrence. Conclusions Decompressive craniectomy is associated with numerous early postoperative complications with a various degree of severity. Most cases of complications can, however, be managed in a conservative way. The risk factors linked with postoperative complications should be taken into account during the indication process in each individual patient.	[Hanko, Martin; Snopko, Pavol; Opsenak, Rene; Kolarovszki, Branislav] Comenius Univ, Jessenius Fac Med Martin, Clin Neurosurg, Kollarova 2, Martin 03659, Slovakia; [Hanko, Martin; Sorsak, Jakub; Snopko, Pavol; Opsenak, Rene; Zelenak, Kamil; Kolarovszki, Branislav] Univ Hosp Martin, Kollarova 2, Martin 03659, Slovakia; [Sorsak, Jakub; Zelenak, Kamil] Comenius Univ, Jessenius Fac Med Martin, Clin Radiol, Kollarova 2, Martin 03659, Slovakia		Kolarovszki, B (corresponding author), Comenius Univ, Jessenius Fac Med Martin, Clin Neurosurg, Kollarova 2, Martin 03659, Slovakia.; Kolarovszki, B (corresponding author), Univ Hosp Martin, Kollarova 2, Martin 03659, Slovakia.	branislav.kolarovszki@uniba.sk	Hanko, Martin/AAF-5292-2021; Zelenak, Kamil/X-6293-2018; Opsenak, Rene/F-8310-2018	Hanko, Martin/0000-0002-6524-6517; Zelenak, Kamil/0000-0002-0416-2985; Snopko, Pavol/0000-0001-5742-9869; Sorsak, Jakub/0000-0002-6815-4263; Opsenak, Rene/0000-0003-0059-0154	European UnionEuropean Commission [ITMS 26210120004]; Comenius University in Bratislava, Slovak Republic [UK/136/2019]	This work was supported by following grants: the application of PACS (Picture Archiving and Communication System) in the research and development, ITMS 26210120004 (Structural project of the European Union with a funding to the Government of the Slovak Republic). Dynamics and risk factors of progression in posttraumatic intracerebral haematomas-a comparison of surgical and conservative treatment, UK/136/2019 (Grant of the Comenius University in Bratislava, Slovak Republic).	Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Desai VR, 2016, CUREUS, V8, DOI 10.7759/cureus.616; Di GF, 2018, WORLD NEUROSURG, V116, pE406, DOI 10.1016/j.wneu.2018.04.216; Di Rienzo Alessandro, 2016, Surg Neurol Int, V7, pS737; Ding K, TRANSLATIONAL RES TR, P299; Fattahian Reza, 2018, Med Arch, V72, P214, DOI 10.5455/medarh.2018.72.214-219; Feng JF, 2008, MED HYPOTHESES, V70, P1147, DOI 10.1016/j.mehy.2007.11.014; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Frank JI, 2014, STROKE, V45, P781, DOI 10.1161/STROKEAHA.113.003200; Gopalakrishnan MS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00977; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Hanko M, 2019, ROMAN NEUROSURG, V33, P166, DOI [10.33962/roneuro-2019-031, DOI 10.33962/RONEURO-2019-031]; Hu PJ, 2017, AM J PHYSIOL-LUNG C, V313, pL1, DOI 10.1152/ajplung.00485.2016; Huang YH, 2015, SEIZURE-EUR J EPILEP, V25, P150, DOI 10.1016/j.seizure.2014.10.008; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kim Byeong Oh, 2018, Korean J Neurotrauma, V14, P93, DOI 10.13004/kjnt.2018.14.2.93; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lim S, 2015, J NEUROSURG, V122, P962, DOI 10.3171/2014.11.JNS1494; Lonjaret L, 2012, J CLIN NEUROSCI, V19, P1293, DOI 10.1016/j.jocn.2012.01.014; Malliti M, 2004, NEUROSURGERY, V54, P599, DOI 10.1227/01.NEU.0000108640.45371.1A; Mraek J, 2007, ROZHL CHIR, V86, P217; Mraek J, 2016, CESK SLOV NEUROL N, V79/112, P7; Mraek J, 2016, DEKOMPRESIVNI KRANIE; Nasi D, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01186; Nasi D, 2018, ACTA NEUROCHIR, V160, P1691, DOI 10.1007/s00701-018-3639-0; Quintard H, STRESS RESPONSE CRIT, P197; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Salunke P, 2015, J NEUROSURG, V122, P602, DOI 10.3171/2014.10.JNS14780; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Seicean A, 2018, NEUROSPINE, V15, P54, DOI 10.14245/ns.1836008.004; Seifman MA, 2011, NEUROSURG REV, V34, P393, DOI 10.1007/s10143-010-0304-3; Sheskin DJ., 2011, HDB PARAMETRIC NONPA; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Wang QP, 2016, NEUROSCIENCES, V21, P10, DOI 10.17712/nsj.2016.1.20150543; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc	49	5	5	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2021	47	5			SI		1635	1647		10.1007/s00068-020-01367-4		APR 2020	13	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	UW8UR	WOS:000527906600001	32307561				2022-02-06	
J	Maggio, MG; Maresca, G; Stagnitti, MC; Anchesi, S; Casella, C; Pajno, V; De Luca, R; Manuli, A; Calabro, RS				Maggio, Maria Grazia; Maresca, Giuseppa; Stagnitti, Maria Chiara; Anchesi, Smeralda; Casella, Carmela; Pajno, Valentina; De Luca, Rosaria; Manuli, Alfredo; Calabro, Rocco Salvatore			Social cognition in patients with acquired brain lesions: An overview on an under-reported problem	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article; Early Access						Empathy; infectious diseases; stroke; theory of mind; traumatic brain injury; tumors	PREFRONTAL LESIONS; NEURAL SYSTEMS; MIRROR-NEURON; INJURY; MIND; EMOTION; DEFICITS; RECOGNITION; IMPAIRMENTS; PERSONALITY	Social cognition (SC) consists of mental representations of interpersonal relationships, which are used flexibly by the individual to promote functional social behaviors and achieve the goals. SC is a multidimensional construct and is supported by the activity of distributed neural networks in which different cortical and subcortical regions of the brain are involved. The review aims to evaluate the current literature on SC taking into account how it is compromised in acquired brain injury. Studies performed between 2010 and 2019 and fulfilling the selected criteria were searched on PubMed, Scopus, Cochrane and Web of Sciences databases. Impairment of SC is a neglected but common consequence of ABI, often leading to disordered interpersonal functioning and poor regulation of personal behavior with impaired social adaptation and quality of life of both the patient and his/her family. This review supports the idea that SC could have an important role in the management of neurological patients by both clinicians and caregivers.	[Maggio, Maria Grazia; Maresca, Giuseppa; Stagnitti, Maria Chiara; Anchesi, Smeralda; Pajno, Valentina; De Luca, Rosaria; Manuli, Alfredo; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy; [Casella, Carmela] AOU Policlin Univ, Stroke Unit, Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Manuli, Alfredo/ABF-3128-2020; Maresca, Giusy/AAB-2242-2021; Maggio, Maria Grazia/ABA-1852-2020; Calabro, Rocco S/K-7520-2016	Manuli, Alfredo/0000-0002-4030-1399; /0000-0003-0757-2389			Aben HP, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/1045039; Adolfi F, 2017, CORTEX, V88, P124, DOI 10.1016/j.cortex.2016.12.019; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 2019, IMMUNE NETW, V19, pe34; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bardenhagen FJ, 1999, NEUROCASE, V5, P325; Baron-Cohen S, 2001, INT REV RES MENT RET, V23, P169; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Beer JS, 2006, BRAIN RES, V1079, P1, DOI 10.1016/j.brainres.2006.02.001; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bosco FM, 2018, ARCH CLIN NEUROPSYCH, V33, P875, DOI 10.1093/arclin/acy041; Bosco FM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00827; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Braver TS, 2014, COGN AFFECT BEHAV NE, V14, P443, DOI 10.3758/s13415-014-0300-0; Burdea GC, 2003, METHOD INFORM MED, V42, P519; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Campanella F, 2015, NEURO-ONCOLOGY, V17, P1121, DOI 10.1093/neuonc/nov065; Campanella F, 2014, BRAIN, V137, P2532, DOI 10.1093/brain/awu183; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Cattran CJ, 2011, BRAIN INJURY, V25, P1035, DOI 10.3109/02699052.2011.607787; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chen P, 2016, COGN AFFECT BEHAV NE, V16, P962, DOI 10.3758/s13415-016-0445-0; Costa A, 2013, BEHAV NEUROL, V27, P523, DOI [10.1155/2013/903127, 10.3233/BEN-129018]; Cruz Maria Leticia S, 2015, World J Virol, V4, P277, DOI 10.5501/wjv.v4.i3.277; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; De Luca R, 2018, J STROKE CEREBROVASC, V27, P1055, DOI 10.1016/j.jstrokecerebrovasdis.2017.11.008; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Friedler B, 2015, ACTA NEUROPATHOL, V129, P493, DOI 10.1007/s00401-014-1377-9; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Genova HM, 2015, SOC NEUROSCI-UK, V10, P27, DOI 10.1080/17470919.2014.959618; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Giussani C, 2010, J NEUROSURG, V112, P520, DOI 10.3171/2009.5.JNS081522; Goebel S, 2018, J NEURO-ONCOL, V140, P687, DOI 10.1007/s11060-018-3000-8; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Hestad KA, 2019, JAIDS-J ACQ IMM DEF, V80, P110, DOI 10.1097/QAI.0000000000001880; Jenkins LM, 2014, PSYCHIAT RES-NEUROIM, V224, P192, DOI 10.1016/j.pscychresns.2014.08.007; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; Kumfor F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067457; Lam A, 2019, JAIDS-J ACQ IMM DEF, V80, P198, DOI 10.1097/QAI.0000000000001898; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Lehtonen A, 2013, DEV MED CHILD NEUROL, V55, P111, DOI 10.1111/j.1469-8749.2012.04399.x; Limongi R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00380; Lovely MP, 2013, ONCOL NURS FORUM, V40, P267, DOI 10.1188/13.ONF.267-274; Luherne-du Boullay V, 2014, BRAIN COGNITION, V92, P92, DOI 10.1016/j.bandc.2014.10.003; Maggio MG, 2019, J NATL MED ASSOC, V111, P457, DOI 10.1016/j.jnma.2019.01.003; Maggio MG, 2019, J NEUROSCI NURS, V51, P101, DOI 10.1097/JNN.0000000000000423; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Martory MD, 2015, EUR NEUROL, V74, P288, DOI 10.1159/000442412; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; Milders M, 2019, BRAIN INJURY, V33, P62, DOI 10.1080/02699052.2018.1531301; Mu YG, 2012, NEURO-ONCOLOGY, V14, P81, DOI 10.1093/neuonc/nos215; Neumann DR, 2011, J HEAD TRAUMA REHAB, V26, P375, DOI 10.1097/HTR.0b013e3181f8d52d; Nijsse B, 2019, ARCH PHYS MED REHAB, V100, P1300, DOI 10.1016/j.apmr.2019.01.023; Njomboro P, 2017, BEHAV NEUROL, V2017, DOI 10.1155/2017/2627487; Nummenmaa L, 2008, NEUROIMAGE, V43, P571, DOI 10.1016/j.neuroimage.2008.08.014; Olson B, 2019, CANCERS, V11, DOI 10.3390/cancers11050687; Ownsworth T, 2011, NEUROPSYCHOL REHABIL, V21, P117, DOI 10.1080/09602011.2010.537073; Papagno C, 2016, NEUROPSYCHOLOGIA, V84, P29, DOI 10.1016/j.neuropsychologia.2016.01.036; Pertz M, 2020, NEUROSCI BIOBEHAV R, V108, P370, DOI 10.1016/j.neubiorev.2019.11.018; Pluta A, 2017, NEUROPSYCHOLOGY, V31, P666, DOI 10.1037/neu0000379; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Quemada José Ignacio, 2017, rev.colomb.psiquiatr., V46, P36, DOI 10.1016/j.rcp.2017.05.005; Rincon F, 2013, CURR OPIN NEUROL, V26, P29, DOI 10.1097/WCO.0b013e32835c4f04; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosenberg H, 2019, NEUROPSYCHOL REHABIL, V29, P232, DOI 10.1080/09602011.2016.1273118; Rotenberg-Shpigelman S, 2012, NEUROPSYCHOL REHABIL, V22, P532, DOI 10.1080/09602011.2012.665610; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Scott CL, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-56; Semple BD, 2019, NEUROBIOL DIS, V123, P27, DOI 10.1016/j.nbd.2018.07.018; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Shany-Ur T, 2012, CORTEX, V48, P1329, DOI 10.1016/j.cortex.2011.08.003; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sutcliffe T, 2017, NEURO-ONCOLOGY, V19, P139; Theadom A, 2019, NEUROPSYCHOLOGY, V33, P560, DOI 10.1037/neu0000516; Thoma P, 2013, NEUROSCI BIOBEHAV R, V37, P448, DOI 10.1016/j.neubiorev.2013.01.024; Tompkins CA, 2012, ARCH PHYS MED REHAB, V93, pS61, DOI 10.1016/j.apmr.2011.10.015; Torrisi M, 2019, APPL NEUROPSYCH-ADUL, V26, P392, DOI 10.1080/23279095.2017.1421536; Turkstra LS, 2017, BRAIN IMPAIR, V18, P49, DOI 10.1017/BrImp.2016.29; van Deudekom FJ, 2018, J GERIATR ONCOL, V9, P560, DOI 10.1016/j.jgo.2018.03.019; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Waytz A, 2011, CURR DIR PSYCHOL SCI, V20, P197, DOI 10.1177/0963721411409007; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wilkos Ewelina, 2015, Neuropsychiatr Dis Treat, V11, P1031, DOI 10.2147/NDT.S78037; Williams C, 2019, BRAIN INJURY, V33, P69, DOI 10.1080/02699052.2018.1531302; Xiao H, 2017, BRAIN INJURY, V31, P1331, DOI 10.1080/02699052.2017.1319576; Yuksek E, 2015, PSYCHIAT QUART, V86, P533, DOI 10.1007/s11126-015-9349-3	104	5	5	3	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult												10.1080/23279095.2020.1753058		APR 2020	13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	LF6HB	WOS:000527517400001	32301351				2022-02-06	
J	Anderson, ED; Giudice, JS; Wu, TT; Panzer, MB; Meaney, DF				Anderson, Erin D.; Giudice, J. Sebastian; Wu, Taotao; Panzer, Matthew B.; Meaney, David F.			Predicting Concussion Outcome by Integrating Finite Element Modeling and Network Analysis	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						concussion; biomechanics; networks; structural connectivity; graph theory	TRAUMATIC BRAIN-INJURY; STRUCTURAL CONNECTIVITY; HUMAN CONNECTOME; FOOTBALL PLAYERS; HEAD-INJURY; STRAIN; CHILDREN; RISK; ACCELERATIONS; BIOMECHANICS	Concussion is a significant public health problem affecting 1.6-2.4 million Americans annually. An alternative to reducing the burden of concussion is to reduce its incidence with improved protective equipment and injury mitigation systems. Finite element (FE) models of the brain response to blunt trauma are often used to estimate injury potential and can lead to improved helmet designs. However, these models have yet to incorporate how the patterns of brain connectivity disruption after impact affects the relay of information in the injured brain. Furthermore, FE brain models typically do not consider the differences in individual brain structural connectivities and their purported role in concussion risk. Here, we use graph theory techniques to integrate brain deformations predicted from FE modeling with measurements of network efficiency to identify brain regions whose connectivity characteristics may influence concussion risk. We computed maximum principal strain in 129 brain regions using head kinematics measured from 53 professional football impact reconstructions that included concussive and non-concussive cases. In parallel, using diffusion spectrum imaging data from 30 healthy subjects, we simulated structural lesioning of each of the same 129 brain regions. We simulated lesioning by removing each region one at a time along with all its connections. In turn, we computed the resultant change in global efficiency to identify regions important for network communication. We found that brain regions that deformed the most during an impact did not overlap with regions most important for network communication (Pearson's correlation, rho = 0.07; p = 0.45). Despite this dissimilarity, we found that predicting concussion incidence was equally accurate when considering either areas of high strain or of high importance to global efficiency. Interestingly, accuracy for concussion prediction varied considerably across the 30 healthy connectomes. These results suggest that individual network structure is an important confounding variable in concussion prediction and that further investigation of its role may improve concussion prediction and lead to the development of more effective protective equipment.	[Anderson, Erin D.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Giudice, J. Sebastian; Wu, Taotao; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, Charlottesville, VA USA; [Panzer, Matthew B.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Anderson, Erin/0000-0003-0575-6707; Giudice, Sebastian/0000-0003-1074-4890	Paul G. Allen Foundation	This work was funded by the Paul G. Allen Foundation.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alshareef A, 2020, J NEUROTRAUM, V37, P1546, DOI 10.1089/neu.2019.6847; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beleites C, 2005, CHEMOMETR INTELL LAB, V79, P91, DOI 10.1016/j.chemolab.2005.04.008; Betzel RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30770; Beusenberg MC., 2000, P INT RES C BIOM IMP; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Collin G., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43, DOI 10.1093/schbul/sbt162; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Danelson KA, 2008, STAPP CAR C, V52, P59; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giudice JS, 2019, ANN BIOMED ENG, V47, P464, DOI 10.1007/s10439-018-02155-3; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Hinault T, 2019, NEUROBIOL AGING, V82, P30, DOI 10.1016/j.neurobiolaging.2019.06.013; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kim DJ, 2016, NEUROIMAGE, V124, P550, DOI 10.1016/j.neuroimage.2015.09.012; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S., 2014, STAPP CAR CRASH J, V58, P29, DOI [DOI 10.4271/2014-22-0002, 10.4271/2014-22-0002]; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Kraft RH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002619; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Mao HJ, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P469, DOI 10.1016/B978-0-12-809831-8.00012-X; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller LE, 2019, J NEUROTRAUM, V36, P1561, DOI 10.1089/neu.2018.6037; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Newman J., 1999, INT RES COUNC BIOM I, P17; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nir TM, 2015, NEUROBIOL AGING, V36, pS113, DOI 10.1016/j.neurobiolaging.2014.04.038; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Park G, 2017, COMPUT METHOD BIOMEC, V20, P1151, DOI 10.1080/10255842.2017.1340459; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Roman FJ, 2017, NEUROBIOL LEARN MEM, V141, P33, DOI 10.1016/j.nlm.2017.03.010; Rousseau P., 2014, THESIS; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shu N, 2018, RADIOLOGY, V286, P229, DOI 10.1148/radiol.2017162696; Solmaz B, 2017, HUM BRAIN MAPP, V38, P2913, DOI 10.1002/hbm.23561; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sun Y, 2019, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01178; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van der Horn HJ, 2017, J NEUROTRAUM, V34, P1035, DOI 10.1089/neu.2016.4659; Vasa F, 2015, NEUROIMAGE, V118, P456, DOI 10.1016/j.neuroimage.2015.05.042; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang ZN, 2021, J NEUROTRAUM, V38, P464, DOI 10.1089/neu.2018.6196; Watson CG, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101673; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Wu TT, 2020, J NEUROTRAUM, V37, P410, DOI 10.1089/neu.2019.6576; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Yan TY, 2018, THERANOSTICS, V8, P3237, DOI 10.7150/thno.23772; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhou Z., 2020, BRAIN STRAIN MOTION, DOI [10.4271/2019-22-0001, DOI 10.4271/2019-22-0001]; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	97	5	5	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	APR 15	2020	8								309	10.3389/fbioe.2020.00309			13	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	LL0II	WOS:000531240700001	32351948	Green Published, gold			2022-02-06	
J	Siman, R; Cui, HM; Wewerka, SS; Hamel, L; Smith, DH; Zwank, MD				Siman, Robert; Cui Hongmei; Wewerka, Sandi S.; Hamel, Lydia; Smith, Douglas H.; Zwank, Michael D.			Serum SNTF, a Surrogate Marker of Axonal Injury, Is Prognostic for Lasting Brain Dysfunction in Mild TBI Treated in the Emergency Department	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; prognostic biomarker; diffuse axonal injury; blood test; post-concussion syndrome; calpain; SNTF	SPECTRIN BREAKDOWN PRODUCTS; CALPAIN-I; FLUID BIOMARKERS; CONCUSSION; ACTIVATION; SYMPTOMS; PROTEINS; DAMAGE; DEGRADATION; PROTEOLYSIS	Mild traumatic brain injury (mTBI) causes persisting post-concussion syndrome for many patients without abnormalities on conventional neuroimaging. Currently, there is no method for identifying at-risk cases at an early stage for directing concussion management and treatment. SNTF is a calpain-derived N-terminal proteolytic fragment of spectrin (alpha(II)-spectrin1-1176) generated in damaged axons following mTBI. Preliminary human studies suggest that elevated blood SNTF on the day of mTBI correlates with white matter disruption and lasting brain dysfunction. Here, we further evaluated serum SNTF as a prognostic marker for persistent brain dysfunction in uncomplicated mTBI patients treated in a Level I trauma center emergency department. Compared with healthy controls (n = 40), serum SNTF increased by 92% within 24 h of mTBI (n = 95; p < 0.0001), and as a diagnostic marker exhibited 100% specificity and 37% sensitivity (AUC = 0.87). To determine whether the subset of mTBI cases positive for SNTF preferentially developed lasting brain dysfunction, serum levels on the day of mTBI were compared with multiple measures of brain performance at 90 days post-injury. Elevated serum SNTF correlated significantly with persistent impairments in cognition and sensory-motor integration, and predicted worse performance in each test on a case by case basis (AUC = 0.68 and 0.76, respectively). SNTF also predicted poorer recovery of cognitive stress function from 30 to 90 days (AUC = 0.79-0.90). These results suggest that serum SNTF, a surrogate marker for axonal injury after mTBI, may have potential for the rapid prognosis of lasting post-concussion syndrome and impaired functional recovery following CT-negative mTBI. They provide further evidence linking axonal injury to persisting brain dysfunction after uncomplicated mTBI. A SNTF blood test, either alone or combined with other markers of axonal injury, may have important utilities for research, prognosis, management and treatment of concussion.	[Siman, Robert; Cui Hongmei; Smith, Douglas H.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Wewerka, Sandi S.; Hamel, Lydia; Zwank, Michael D.] Reg Hosp, Dept Emergency Med, St Paul, MN 55101 USA		Siman, R (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Zwank, MD (corresponding author), Reg Hosp, Dept Emergency Med, St Paul, MN 55101 USA.	siman@pennmedicine.upenn.edu; michael.d.zwank@healthpartners.com			Department of Neurosurgery of the University of Pennsylvania Perelman School of Medicine; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092398]; HealthPartners Institute Internal Grant; Fred C. and Katherine B. Andersen Foundation	This work was supported by the Department of Neurosurgery of the University of Pennsylvania Perelman School of Medicine, the National Institutes of Health (R01 NS092398 to DS), a HealthPartners Institute Internal Grant, and the Fred C. and Katherine B. Andersen Foundation.	Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bi XN, 1996, BRAIN RES, V726, P98, DOI 10.1016/0006-8993(95)01360-1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; GEDDES JW, 1995, NEUROBIOL AGING, V16, P651, DOI 10.1016/0197-4580(95)00062-J; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Hall CB, 2007, NEUROLOGY, V69, P1657, DOI 10.1212/01.wnl.0000278163.82636.30; Hamilton LD, 2017, EXP GERONTOL, V97, P9, DOI 10.1016/j.exger.2017.07.003; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karnati HK, 2019, J NEUROTRAUM, V36, P975, DOI 10.1089/neu.2018.5898; Kausler DH, 1994, LEARNING MEMORY NORM, P544; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lenehan ME, 2015, PSYCHOGERIATRICS, V15, P154, DOI 10.1111/psyg.12083; Lezak M. D., 1995, NEUROPSYCHOLOGICAL A, P545; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Ma M, 2012, J NEUROTRAUM, V29, P2555, DOI 10.1089/neu.2012.2473; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Moran B, 2015, SOUTH MED J, V108, P553, DOI 10.14423/SMJ.0000000000000340; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Riggio S, 2016, INT REV PSYCHIATR, V28, P579, DOI 10.1080/09540261.2016.1220927; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sturgeon CM, 2011, ANN CLIN BIOCHEM, V48, P418, DOI 10.1258/acb.2011.011073; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Vicini-Chilovi B, 2010, DEMENT GERIATR COGN, V30, P212, DOI 10.1159/000318839; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	67	5	5	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 8	2020	11								249	10.3389/fneur.2020.00249			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LH8MK	WOS:000529036600001	32322237	Green Published, gold			2022-02-06	
J	Zeiler, FA; Mathieu, F; Monteiro, M; Glocker, B; Ercole, A; Beqiri, E; Cabeleira, M; Stocchetti, N; Smielewski, P; Czosnyka, M; Newcombe, V; Menon, DK				Zeiler, Frederick A.; Mathieu, Francois; Monteiro, Miguel; Glocker, Ben; Ercole, Ari; Beqiri, Erta; Cabeleira, Manuel; Stocchetti, Nino; Smielewski, Peter; Czosnyka, Marek; Newcombe, Virginia; Menon, David K.		CENTER-TBI High-Resolution ICU HR	Diffuse Intracranial Injury Patterns Are Associated with Impaired Cerebrovascular Reactivity in Adult Traumatic Brain Injury: A CENTER-TBI Validation Study	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; computed tomography; CT; image segmentation; injury patterns; PRx	CEREBRAL PERFUSION-PRESSURE; NEUROTRAUMA EFFECTIVENESS RESEARCH; LOWER LIMIT; PART II; AUTOREGULATION; CLASSIFICATION; MICRODIALYSIS; PREDICTION; MANAGEMENT; ASYMMETRY	Recent single-center retrospective analysis displayed the association between admission computed tomography (CT) markers of diffuse intracranial injury and worse cerebrovascular reactivity. The goal of this study was to further explore these associations using the prospective multi-center Collaborative European Neurotrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) high-resolution intensive care unit (HR ICU) data set. Using the CENTER-TBI HR ICU sub-study cohort, we evaluated those patients with both archived high-frequency digital physiology (100 Hz or higher) and the presence of a digital admission CT scan. Physiological signals were processed for pressure reactivity index (PRx) and both the percent (%) time above defined PRx thresholds and mean hourly dose above threshold. Admission CT injury scores were obtained from the database. Quantitative contusion, edema, intraventricular hemorrhage (IVH), and extra-axial lesion volumes were obtained via semi-automated segmentation. Comparison between admission CT characteristics and PRx metrics was conducted using Mann-U, Jonckheere-Terpstra testing, with a combination of univariate linear and logistic regression techniques. A total of 165 patients were included. Cisternal compression and high admission Rotterdam and Helsinki CT scores, and Marshall CT diffuse injury sub-scores were associated with increased percent (%) time and hourly dose above PRx threshold of 0, +0.25, and +0.35 (p < 0.02 for all). Logistic regression analysis displayed an association between deep peri-contusional edema and mean PRx above a threshold of +0.25. These results suggest that diffuse injury patterns, consistent with acceleration/deceleration forces, are associated with impaired cerebrovascular reactivity. Diffuse admission intracranial injury patterns appear to be consistently associated with impaired cerebrovascular reactivity, as measured through PRx. This is in keeping with the previous single-center retrospective literature on the topic. This study provides multi-center validation for those results, and provides preliminary data to support potential risk stratification for impaired cerebrovascular reactivity based on injury pattern.	[Zeiler, Frederick A.; Mathieu, Francois; Ercole, Ari; Newcombe, Virginia; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Div Anesthesia, Cambridge, England; [Beqiri, Erta; Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Mathieu, Francois] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Monteiro, Miguel; Glocker, Ben] Imperial Coll London, Biomed Image Anal Grp, London, England; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Ercole, Ari/B-6288-2009; Monteiro, Miguel/AAE-6334-2021; Sahuquillo, Juan/B-3577-2008; Raj, Rahul/K-7693-2012; Moller, Kirsten/A-4751-2009	Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Sakowitz, Oliver/0000-0003-3248-6335; Raj, Rahul/0000-0003-4243-9591; Kondziella, Daniel/0000-0001-5562-9808; Moller, Kirsten/0000-0003-3058-1072; Newcombe, Virginia/0000-0001-6044-9035; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544	European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (United States); Integra LifeSciences Corporation (United States); National Institute for Health Research (NIHR, UK)National Institute for Health Research (NIHR); Cambridge Biomedical Research Center at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust; NIHR Clinical Research Network; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Center Foundation Winnipeg; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); University of Manitoba Centre on Aging Fellowship; Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship; NIHR Cambridge (UK) Center	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (United States), and Integra LifeSciences Corporation (United States). DKM was also supported by funding from the National Institute for Health Research (NIHR, UK) through a Senior Investigator Award and the Cambridge Biomedical Research Center at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust. The study also received additional support from the NIHR Clinical Research Network. FAZ receives research support from the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund, the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Rudy Falk Clinician-Scientist Professorship, the Health Sciences Center Foundation Winnipeg, the Canadian Institutes of Health Research (CIHR), and the University of Manitoba Centre on Aging Fellowship. VFJN is supported by an Academy of Medical Sciences/The Health Foundation Clinician Scientist Fellowship. MC is supported by NIHR Cambridge (UK) Center.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Burkhart CS, 2011, BRIT J ANAESTH, V107, P742, DOI 10.1093/bja/aer252; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Momjian S, 2004, BRAIN, V127, P965, DOI 10.1093/brain/awh131; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schmidt EA, 2002, ACT NEUR S, V81, P133; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zeiler FA, 2019, J NEUROSURG ANESTHES; Zeiler FA, 2020, BR J ANAESTH; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, NEUROL RES, V32, P425, DOI 10.1179/174313209X459165	49	5	5	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2020	37	14					1597	1608		10.1089/neu.2019.6959		APR 2020	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	MG9ML	WOS:000524305300001	32164482	Green Submitted, Green Published			2022-02-06	
J	Clark, AL; Weigand, AJ; Bangen, KJ; Merritt, VC; Bondi, MW; Delano-Wood, L				Clark, Alexandra L.; Weigand, Alexandra J.; Bangen, Katherine J.; Merritt, Victoria C.; Bondi, Mark W.; Delano-Wood, Lisa			Repetitive mTBI is associated with age-related reductions in cerebral blood flow but not cortical thickness	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						mild TBI; repetitive mTBI; cerebral blood flow; cortical thickness; accelerated aging	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEUROVASCULAR DYSFUNCTION; COGNITIVE IMPAIRMENT; BARRIER DYSFUNCTION; AD DEMENTIA; MILD; CONCUSSION; VETERANS; ABNORMALITIES	Mild traumatic brain injury (mTBI) is a risk factor for Alzheimer's disease (AD), and evidence suggests cerebrovascular dysregulation initiates deleterious neurodegenerative cascades. We examined whether mTBI history alters cerebral blood flow (CBF) and cortical thickness in regions vulnerable to early AD-related changes. Seventy-four young to middle-aged Veterans (mean age = 34, range = 23-48) underwent brain scans. Participants were divided into: (1) Veteran Controls (n = 27), (2) 1-2 mTBIs (n = 26), and (2) 3+ mTBIs (n = 21) groups. Resting CBF was measured using MP-PCASL. T1 structural scans were processed with FreeSurfer. CBF and cortical thickness estimates were extracted from nine AD-vulnerable regions. Regression analyses examined whether mTBI moderated the association between age, CBF, and cortical thickness. Regressions adjusting for sex and posttraumatic stress revealed mTBI moderated the association between age and CBF of the precuneus as well as superior and inferior parietal cortices (p's < .05); increasing age was associated with lower CBF in the 3+ mTBIs group, but not in the VCs or 1-2 mTBIs groups. mTBI did not moderate associations between age and cortical thickness (p's >.05). Repetitive mTBI is associated with cerebrovascular dysfunction in AD-vulnerable regions and may accelerate pathological aging trajectories.	[Clark, Alexandra L.; Bangen, Katherine J.; Merritt, Victoria C.; Bondi, Mark W.; Delano-Wood, Lisa] VA San Diego Healthcare Syst VASDHS, San Diego, CA USA; [Clark, Alexandra L.; Bangen, Katherine J.; Merritt, Victoria C.; Bondi, Mark W.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Weigand, Alexandra J.] Univ Calif San Diego, San Diego State Univ, San Diego SDSU UCSD Joint Doctoral Program Clin P, San Diego, CA 92103 USA; [Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Department of DefenseUnited States Department of Defense [829-MR-NB-25860, W81XWH-10-2-0169]; National Institutes of Health (National Institute of Neurological Disorders and Stroke Ruth-Kirschstein Fellowship) [F31NS09870]; Veterans Affairs Advanced Polytrauma and TBI Rehabilitation Research Fellowship; Veterans AffairsUS Department of Veterans Affairs [829-MR-NB-25860, W81XWH-10-2-0169]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by HVeterans Affairs and Department of Defense grants awarded to Dr. Delano-Wood (829-MR-NB-25860; W81XWH-10-2-0169). This work was further supported by The National Institutes of Health (National Institute of Neurological Disorders and Stroke Ruth-Kirschstein Fellowship: F31NS09870) and a Veterans Affairs Advanced Polytrauma and TBI Rehabilitation Research Fellowship awarded to Dr. Clark.	Alexopoulos P, 2012, EUR ARCH PSY CLIN N, V262, P69, DOI 10.1007/s00406-011-0226-2; Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.3.CO;2-#; American Psychatric Association, 2000, DIAGN STAT MAN MENT; Bangen KJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00159; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Boyle PA, 2018, ANN NEUROL, V83, P74, DOI 10.1002/ana.25123; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chao LL, 2010, ALZ DIS ASSOC DIS, V24, P19, DOI 10.1097/WAD.0b013e3181b4f736; Clark AL., 2019, THESIS; Clark AL, 2017, NEUROIMAGE-CLIN, V14, P308, DOI 10.1016/j.nicl.2016.12.017; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crocker LD, 2019, J INT NEUROPSYCH SOC, V25, P79, DOI 10.1017/S1355617718000851; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; de la Torre J, 2018, J ALZHEIMERS DIS, V63, P35, DOI 10.3233/JAD-180004; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Dickerson BC, 2011, NEUROLOGY, V76, P1395, DOI 10.1212/WNL.0b013e3182166e96; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Eierued C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101793; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haber M, 2018, J NEUROTRAUM, V35, P2250, DOI 10.1089/neu.2018.5684; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; IBM Corp, 2017, SPSS STAT WIND; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kisler K, 2017, NAT REV NEUROSCI, V18, P419, DOI 10.1038/nrn.2017.48; Klimova A, 2019, BIOL PSYCHIAT-COGN N, V4, P81, DOI 10.1016/j.bpsc.2018.10.004; Lee S, 2016, ANN NEUROL, V79, P929, DOI 10.1002/ana.24647; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Lynch CE, 2016, BRAIN INJURY, V30, P1414, DOI 10.1080/02699052.2016.1219060; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Management of Concussion-mTBI Working Group, 2016, VA DOD CLIN PRACT GU; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Montagne A, 2016, ACTA NEUROPATHOL, V131, P687, DOI 10.1007/s00401-016-1570-0; Muza P, 2019, NEUROSCIENCE, V404, P297, DOI 10.1016/j.neuroscience.2019.01.049; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Rius-Perez S, 2018, NEUROLOGIA, V33, P112, DOI 10.1016/j.nrl.2015.07.010; Santhanam P, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1161; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Shin DD, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00021; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Sullivan DR, 2019, J HEAD TRAUMA REHAB, V34, pE18, DOI 10.1097/HTR.0000000000000449; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; The R Team, 2013, R LANG ENV STAT COMP; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Wang ML, 2017, NEUROSCI LETT, V655, P115, DOI 10.1016/j.neulet.2017.06.055; Weathers FW, 1993, INT SOC TRAUMATIC ST, V462; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Weston PSJ, 2016, NEUROLOGY, V87, P2050, DOI 10.1212/WNL.0000000000003322; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	87	5	5	2	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2021	41	2					431	444	0271678X19897443	10.1177/0271678X19897443		APR 2020	14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	PS9BL	WOS:000527745800001	32248731	Green Published			2022-02-06	
J	Olson, A; Ellis, MJ; Selci, E; Russell, K				Olson, Ashley; Ellis, Michael J.; Selci, Erin; Russell, Kelly			Delayed Symptom Onset Following Pediatric Sport-Related Concussion	FRONTIERS IN NEUROLOGY			English	Article						sports-related concussion; pediatric; symptom onset; delayed symptoms; clinical outcomes	INTERNATIONAL-CONFERENCE; MANAGEMENT; STATEMENT; RELIABILITY; DIAGNOSIS	Objective: (1) To examine the prevalence of delayed symptom onset (DSO) among pediatric sport-related concussion (SRC) patients as well as the effect of symptom onset on initial symptom severity, length of recovery, and development of delayed recovery; (2) to evaluate the impact of symptom onset on sideline management. Methods: We conducted a prospective study of pediatric SRC patients (<20 years of age) evaluated at a multi-disciplinary concussion program. Patients underwent initial medical assessment by a single neurosurgeon and a structured interview by a research assistant. Patients were classified as experiencing early symptom onset (symptom onset <15 min from the time of the suspected injury; ESO) or DSO (>= 15 min from the time of the suspected injury). Results: A total of 144 SRC patients (61.1% male; mean age 14.6 years, SD 1.8) evaluated a median of 5.0 days (IQR 4.0, 9.0) post-injury were included in the study. Among these patients, 120 (83.3%) reported experiencing ESO while 24 (16.7%) experienced DSO following injury. Among those that experienced DSO the median length of time from the suspected injury to symptom onset was 60.0 min (IQR 20.0, 720.0). No significant differences were observed in symptom severity at initial medical assessment (median Post-Concussion Symptom Scale score 20.0 vs. 18.0, p = 0.35), length of physician-document clinical recovery (median 22.0 vs. 24.0 days; p = 0.46) or the proportion of those who developed delayed physician-documented clinical recovery (34.4 vs. 42.1%, p = 0.52) among patients with ESO or DSO. Patients who reported experiencing ESO were significantly more likely to be immediately removed from play at the time of their suspected injury compared to those who experienced DSO (71.6% vs. 29.2%; p < 0.0001). Conclusions: This study suggests that an important proportion of children and adolescents who sustain an acute SRC experience DSO. DSO is associated with lower rates of immediate removal from play at the time of suspected injury. Secondary study findings highlight the need for improved sport stakeholder concussion education and standardized concussion protocols that mandate the immediate and permanent removal of all youth with a suspected concussion until they undergo medical assessment.	[Olson, Ashley] Univ Manitoba, Max Rady Coll Med Sci, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Selci, Erin; Russell, Kelly] Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; Selci, Erin; Russell, Kelly] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Canada North Concuss Network, Winnipeg, MB, Canada		Russell, K (corresponding author), Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada.; Russell, K (corresponding author), Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.; Russell, K (corresponding author), Canada North Concuss Network, Winnipeg, MB, Canada.	krussell@chrim.ca			University of Manitoba [463232]	This work was funded by the University of Manitoba (UM Project #463232).	Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P837, DOI 10.1136/bjsports-2017-097878; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Parachute, 2017, CAN GUID CONC SPORT; Tator CH, 2013, CAN MED ASSOC J, V185, P975, DOI 10.1503/cmaj.120039	20	5	4	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 3	2020	11								220	10.3389/fneur.2020.00220			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LH1KQ	WOS:000528548600001	32318012	gold, Green Published			2022-02-06	
J	Wu, P; Sisniega, A; Stayman, JW; Zbijewski, W; Foos, D; Wang, X; Khanna, N; Aygun, N; Stevens, RD; Siewerdsen, JH				Wu, P.; Sisniega, A.; Stayman, J. W.; Zbijewski, W.; Foos, D.; Wang, X.; Khanna, N.; Aygun, N.; Stevens, R. D.; Siewerdsen, J. H.			Cone-beam CT for imaging of the head/brain: Development and assessment of scanner prototype and reconstruction algorithms	MEDICAL PHYSICS			English	Article						artifact correction; cone-beam CT; image quality; model-based image reconstruction; point-of-care neuroimaging; traumatic brain injury	FLAT-PANEL-DETECTOR; COMPUTED-TOMOGRAPHY; QUALITY; HEAD; SYSTEM; PRINCIPLES; PROJECTION; TRANSPORT; GUIDANCE; SURGERY	Purpose Our aim was to develop a high-quality, mobile cone-beam computed tomography (CBCT) scanner for point-of-care detection and monitoring of low-contrast, soft-tissue abnormalities in the head/brain, such as acute intracranial hemorrhage (ICH). This work presents an integrated framework of hardware and algorithmic advances for improving soft-tissue contrast resolution and evaluation of its technical performance with human subjects. Methods Four configurations of a CBCT scanner prototype were designed and implemented to investigate key aspects of hardware (including system geometry, antiscatter grid, bowtie filter) and technique protocols. An integrated software pipeline (c.f., a serial cascade of algorithms) was developed for artifact correction (image lag, glare, beam hardening and x-ray scatter), motion compensation, and three-dimensional image (3D) reconstruction [penalized weighted least squares (PWLS), with a hardware-specific statistical noise model]. The PWLS method was extended in this work to accommodate multiple, independently moving regions with different resolution (to address both motion compensation and image truncation). Imaging performance was evaluated quantitatively and qualitatively with 41 human subjects in the neurosciences critical care unit (NCCU) at our institution. Results The progression of four scanner configurations exhibited systematic improvement in the quality of raw data by variations in system geometry (source-detector distance), antiscatter grid, and bowtie filter. Quantitative assessment of CBCT images in 41 subjects demonstrated: similar to 70% reduction in image nonuniformity with artifact correction methods (lag, glare, beam hardening, and scatter); similar to 40% reduction in motion-induced streak artifacts via the multi-motion compensation method; and similar to 15% improvement in soft-tissue contrast-to-noise ratio (CNR) for PWLS compared to filtered backprojection (FBP) at matched resolution. Each of these components was important to improve contrast resolution for point-of-care cranial imaging. Conclusions This work presents the first application of a high-quality, point-of-care CBCT system for imaging of the head/ brain in a neurological critical care setting. Hardware configuration iterations and an integrated software pipeline for artifacts correction and PWLS reconstruction mitigated artifacts and noise to achieve image quality that could be valuable for point-of-care detection and monitoring of a variety of intracranial abnormalities, including ICH and hydrocephalus.	[Wu, P.; Sisniega, A.; Stayman, J. W.; Zbijewski, W.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Foos, D.; Wang, X.] Carestream Hlth, Rochester, NY 14608 USA; [Khanna, N.; Aygun, N.; Stevens, R. D.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21205 USA; [Stevens, R. D.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Stevens, R. D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Stevens, R. D.; Siewerdsen, J. H.] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21205 USA		Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu		Siewerdsen, Jeffrey/0000-0001-6644-1317; Sisniega, Alejandro/0000-0003-2030-2711	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB-017226, U01-NS-107133]; Carestream Health (Rochester NY)	This work was supported by NIH R01-EB-017226, NIH U01-NS-107133, and academic-industry partnership with Carestream Health (Rochester NY). Dr. Jennifer Xu and Dr. Hao Dang (Biomedical Engineering, Johns Hopkins University) contributed previous work on the development of the scanner prototype and reconstruction algorithms. Dr. Jason Hostetter (Radiology, Johns Hopkins University) provided additional feedback on image quality. The clinical study was coordinated by Eusebia Calvillo (Anesthesia and Critical Care, Johns Hopkins Medical Institution).	Abdullah AC, 2017, MALAYS J MED SCI, V24, P104, DOI 10.21315/mjms2017.24.1.11; Baba R, 2004, DENTOMAXILLOFAC RAD, V33, P285, DOI 10.1259/dmfr/87440549; Boone JM, 2001, RADIOLOGY, V221, P657, DOI 10.1148/radiol.2213010334; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen B, 2002, MED PHYS, V29, P755, DOI 10.1118/1.1461843; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Dang H, 2017, PHYS MED BIOL, V62, P8693, DOI 10.1088/1361-6560/aa90fd; Dang H, 2017, PHYS MED BIOL, V62, P539, DOI 10.1088/1361-6560/aa52b8; DAY GJ, 1983, PHYS MED BIOL, V28, P1429, DOI 10.1088/0031-9155/28/12/008; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Fessler JA, 1996, IEEE T IMAGE PROCESS, V5, P493, DOI 10.1109/83.491322; Hansen N, 2004, LECT NOTES COMPUT SC, V3242, P282; Helm PA, 2015, IEEE T MED IMAGING, V34, P1738, DOI 10.1109/TMI.2015.2391200; Hirota S, 2006, CARDIOVASC INTER RAD, V29, P1034, DOI 10.1007/s00270-005-0287-6; Hodez C, 2011, EUR ANN OTORHINOLARY, V128, P65, DOI 10.1016/j.anorl.2010.10.008; Hsieh J, 2000, PROC SPIE, V3977, P298, DOI 10.1117/12.384505; Huber P. J., 1992, BREAKTHROUGHS STAT, P492, DOI DOI 10.1007/978-1-4612-4380-9_35; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; Kidwell CS, 2008, LANCET NEUROL, V7, P256, DOI 10.1016/S1474-4422(08)70041-3; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Letourneau D, 2005, RADIOTHER ONCOL, V75, P279, DOI 10.1016/j.radonc.2005.03.001; Long Y, 2010, IEEE T MED IMAGING, V29, P1839, DOI 10.1109/TMI.2010.2050898; Maier J, 2018, PROC SPIE, V10573, DOI 10.1117/12.2292919; Miracle AC, 2009, AM J NEURORADIOL, V30, P1285, DOI 10.3174/ajnr.A1654; Nesterov Y, 2005, MATH PROGRAM, V103, P127, DOI 10.1007/s10107-004-0552-5; Orth RC, 2008, J VASC INTERV RADIOL, V19, P814, DOI 10.1016/j.jvir.2008.02.002; Parizel PM, 2001, EUR RADIOL, V11, P1770, DOI 10.1007/s003300000800; PETERS TM, 1981, IEEE T NUCL SCI, V28, P3641, DOI 10.1109/TNS.1981.4331812; Poludniowski G, 2011, PHYS MED BIOL, V56, P1837, DOI 10.1088/0031-9155/56/6/019; Rumboldt Z, 2009, AM J NEURORADIOL, V30, P1630, DOI 10.3174/ajnr.A1603; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Sisniega A, 2018, PROC SPIE, V10573, DOI 10.1117/12.2293872; Sisniega A, 2017, PHYS MED BIOL, V62, P3712, DOI 10.1088/1361-6560/aa6869; Sisniega A, 2015, PHYS MED BIOL, V60, P1415, DOI 10.1088/0031-9155/60/4/1415; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; Sisniega A, 2019, 15 INT M FULL 3 DIM, P94; Sisniega A, 2019, MED IMAGING 2019 PHY, P59; Sisniega A, 2018, 5 INT C IM FORM XRAY, P4; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Star-Lack J, 2009, MED IMAGING 2009 PHY; Stayman JW, 2012, IEEE T MED IMAGING, V31, P1837, DOI 10.1109/TMI.2012.2199763; Tilley II S, 2018, ARXIV180511631PHYSIC; Uneri A, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab3036; Wallace MJ, 2008, J VASC INTERV RADIOL, V19, P799, DOI 10.1016/j.jvir.2008.02.018; Wang AS, 2015, MED PHYS, V42, P2699, DOI 10.1118/1.4914378; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Waydhas C, 1999, CRIT CARE, V3, pR83, DOI 10.1186/cc362; Wu P, 2019, PROC SPIE, V11072, DOI 10.1117/12.2534887; Wu P, 2019, PROC SPIE, V10948, DOI 10.1117/12.2513417; Wu P, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aaf0b4; Wu P, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aac225; Xu J, 2016, PHYS MED BIOL, V61, P3180, DOI 10.1088/0031-9155/61/8/3180; Xu J, 2016, MED PHYS, V43, P5745, DOI 10.1118/1.4963220; Xu J, 2016, PHYS MED BIOL, V61, P5973, DOI 10.1088/0031-9155/61/16/5973; Zbijewski W, 2014, PROC SPIE, V9033, DOI 10.1117/12.2043463; Zbijewski W, 2011, MED PHYS, V38, P4700, DOI 10.1118/1.3611039	59	5	5	2	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0094-2405	2473-4209		MED PHYS	Med. Phys.	JUN	2020	47	6					2392	2407		10.1002/mp.14124		APR 2020	16	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	NE8AH	WOS:000523291900001	32145076	Green Accepted			2022-02-06	
J	Dolmans, RGF; Hulsbergen, AFC; Gormley, WB; Broekman, MLD				Dolmans, Rianne G. F.; Hulsbergen, Alexander F. C.; Gormley, William B.; Broekman, Marike L. D.			Routine Blood Tests for Severe Traumatic Brain Injury: Can They Predict Outcomes?	WORLD NEUROSURGERY			English	Article						Blood tests; Closed head injuries; Outcome prediction; Traumatic brain injury	ADMISSION HYPERGLYCEMIA; CLINICAL-SIGNIFICANCE; CELL TRANSFUSION; HEAD-INJURY; COAGULOPATHY; MODERATE; COMPLICATIONS; BIOMARKERS; PARAMETERS; MORTALITY	OBJECTIVE: Outcome prediction in severe traumatic brain injury (sTBI) has been studied using clinical and radiographic measurements and by using biomarkers such as glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and tau. Routine blood tests are regularly performed in patients with sTBI and could be used to predict outcomes. This study aims to investigate whether routine blood tests on admission can be predictive of outcome in patients with sTBI. METHODS: Patients with sTBI were selected from 2 institutional databases based on International Classification of Diseases Ninth and Tenth Revision codes for traumatic brain injury (TBI), ventilatory assistance >24 hours, intracranial pressure monitoring, and Glasgow Coma Score (GCS) score =8. Laboratory parameters included blood urea nitrogen, creatinine, glucose, hematocrit, hemoglobin, red blood cells, white blood cells, monocytes, lymphocytes, neutrophils, neutrophil lymphocyte ratio, platelets, international normalized ratio, prothrombin time, sodium, and potassium. Clinical outcome was measured as hospital length of stay, 30-day mortality, and favorable versus unfavorable outcome based on Glasgow Outcome Scale at 3 months. RESULTS: A total of 255 adult patients were selected. Median Injury Severity Score was 14.00 (interquartile range, 9.00-22.00). Of patients, 25.9% died within 30 days and 56.1% had an unfavorable outcome at 3 months. On multivariate analysis, low sodium level was significant for 30-day mortality and high sodium level was significant for unfavorable outcome at 3 months. However, after correction for multiple testing, no routine blood test remained significant. CONCLUSIONS: No routine blood tests measured on admission were significant predictors of outcome in patients with sTBI. Other clinical and radiologic factors may be better suited to predicting outcomes in this patient population.	[Dolmans, Rianne G. F.; Hulsbergen, Alexander F. C.; Gormley, William B.; Broekman, Marike L. D.] Harvard Med Sch, Computat Neurosci Outcomes Ctr, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA; [Dolmans, Rianne G. F.; Hulsbergen, Alexander F. C.] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands; [Hulsbergen, Alexander F. C.; Broekman, Marike L. D.] Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands; [Hulsbergen, Alexander F. C.; Broekman, Marike L. D.] Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands		Broekman, MLD (corresponding author), Harvard Med Sch, Computat Neurosci Outcomes Ctr, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA 02115 USA.; Broekman, MLD (corresponding author), Leiden Univ, Dept Neurosurg, Med Ctr, Leiden, Netherlands.; Broekman, MLD (corresponding author), Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands.	m.broekman@haaglandenmc.nl	Dolmans, Rianne/ABB-3266-2021	Dolmans, Rianne/0000-0002-3010-7111			Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Boutin A, 2018, J CRIT CARE, V45, P133, DOI 10.1016/j.jcrc.2018.01.023; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Ferreira S, 2017, TRAFFIC INJ PREV, V18, P515, DOI 10.1080/15389588.2016.1246724; Fluckiger C, 2010, ACTA NEUROCHIR, V152, P627, DOI 10.1007/s00701-009-0579-8; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Izzo J L Jr, 1999, Curr Hypertens Rep, V1, P254, DOI 10.1007/s11906-999-0030-9; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Leo P, TRANSLATIONAL RES TR; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; Loftis KL, 2016, TRAFFIC INJ PREV, V17, P1, DOI 10.1080/15389588.2016.1191069; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marshall SA, 2012, MIL MED, V177, P76, DOI 10.7205/MILMED-D-12-00142; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; PENTELENYI T, 1977, INJURY, V8, P264, DOI 10.1016/0020-1383(77)90099-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Rafiq Mirza Faisal Ahmed, 2013, J Ayub Med Coll Abbottabad, V25, P162; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Salim A, 2009, AM SURGEON, V75, P25; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Stansbury LG, 2013, TRANSFUSION, V53, P783, DOI 10.1111/j.1537-2995.2012.03828.x; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Taha MM, 2015, INTERNET J NEUROSURG, V11; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; White NJ, 2013, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2013.1.660; Yang SY, 1995, SURG NEUROL, V44, P373, DOI 10.1016/0090-3019(96)80243-6; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	55	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2020	136						E60	E67		10.1016/j.wneu.2019.10.086			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KW0BN	WOS:000520838600006	31655234				2022-02-06	
J	Fu, YM; Lu, HT; Nian, GD; Wang, P; Lin, N; Hu, XC; Zhou, HF; Yu, HH; Qu, SX; Yang, W				Fu, Yimou; Lu, Haotian; Nian, Guodong; Wang, Peng; Lin, Nan; Hu, Xiaocheng; Zhou, Haofei; Yu, Honghui; Qu, Shaoxing; Yang, Wei			Size-dependent inertial cavitation of soft materials	JOURNAL OF THE MECHANICS AND PHYSICS OF SOLIDS			English	Article						Cavitation; Defect; Size effect; Impact; Soft materials	MICROBUBBLE SIZE; STRAIN-RATE; SURFACE; NUCLEATION; GELATIN; BUBBLE; MODEL; FLOW; DEFORMATION; SIMULATION	High-rate loading induced cavitation of soft materials, including brain and muscle, has increasingly been studied due to its importance in a variety of biomedical applications, such as potential impact-related traumatic brain injury and high-intensity focused ultrasound therapy. The size of cavitation nuclei or defects is crucial to the onset of cavitation. However, it remains challenging to introduce gaseous defects with controllable size into soft materials and to understand the underlying mechanism of impact-bubble interaction in soft materials. Here, we set up a drop-tower system to perform impact loading tests on gelatin samples with controllable monodispersed microbubbles, allowing us to mimic the general cavitation behavior of human tissues. The microbubbles are inserted into the soft matrix as cavitation nuclei by taking advantage of microfluidic flow focusing. A high-speed camera paired with a signal acquisition system is utilized to determine the critical pressure at which cavitation initiates for different defect sizes. Meanwhile, we propose a theoretical model based on surface tension to predict the time-dependent spherically symmetric cavitation of a pre-existing gas bubble in elastomers under high-speed loading. Our experiments and theoretical modeling demonstrate the strong effect of gas-filled defects on cavitation and indicate the necessity and significance of controlling defect size in mimicking targeted organs using soft gels. Our work provides a promising route to predict cavitation-induced injury in tissues with variable materials stiffness and initial defect size. (C) 2019 Elsevier Ltd. All rights reserved.	[Fu, Yimou; Nian, Guodong; Wang, Peng; Hu, Xiaocheng; Zhou, Haofei; Qu, Shaoxing; Yang, Wei] Zhejiang Univ, Key Lab Soft Machines & Smart Devices Zhejiang Pr, State Key Lab Fluid Power & Mechatron Syst, Ctr X Mech,Dept Engn Mech, 38 Zheda Rd, Hangzhou 310027, Peoples R China; [Lu, Haotian] Univ Illinois, Coll Engn, Urbana, IL 61801 USA; [Lin, Nan] Zhejiang Univ, Coll Life Sci, Inst Genet & Regenerat Biol, 38 Zheda Road, Hangzhou 310027, Peoples R China; [Zhou, Haofei; Yu, Honghui] CUNY City Coll, Dept Mech Engn, New York, NY 10031 USA		Zhou, HF; Qu, SX (corresponding author), Zhejiang Univ, Key Lab Soft Machines & Smart Devices Zhejiang Pr, State Key Lab Fluid Power & Mechatron Syst, Ctr X Mech,Dept Engn Mech, 38 Zheda Rd, Hangzhou 310027, Peoples R China.	haofei_zhou@zju.edu.cn; squ@zju.edu.cn	Yu, Honghui/AAE-9705-2020; QU, SHAOXING/AAU-5290-2020	Yu, Honghui/0000-0003-4095-2084; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11525210, 11621062, 91748209]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities	This work is supported by the National Natural Science Foundation of China (Nos. 11525210, 11621062, 91748209), and the Fundamental Research Funds for the Central Universities.	Al-Muhanna MK, 2015, J CHEM THERMODYN, V89, P112, DOI 10.1016/j.jct.2015.05.007; Ambrosi D, 2017, J ELASTICITY, V129, P107, DOI 10.1007/s10659-016-9619-9; APFEL RE, 1984, ULTRASONICS, V22, P167, DOI 10.1016/0041-624X(84)90032-5; ARNDT REA, 1981, ANNU REV FLUID MECH, V13, P273, DOI 10.1146/annurev.fl.13.010181.001421; Bayraktar E, 2008, FATIGUE FRACT ENG M, V31, P184, DOI 10.1111/j.1460-2695.2007.01213.x; BENJAMIN TB, 1966, PHILOS TR R SOC S-A, V260, P221, DOI 10.1098/rsta.1966.0046; BLANDER M, 1975, AICHE J, V21, P833, DOI 10.1002/aic.690210502; Brennen CE, 2014, CAVITATION AND BUBBLE DYNAMICS, P1; Brittle S, 2015, CHEM ENG RES DES, V104, P357, DOI 10.1016/j.cherd.2015.08.002; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Burgess MT, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab05c; Burgin LV, 2007, MED ENG PHYS, V29, P525, DOI 10.1016/j.medengphy.2006.06.002; Cao XJ, 2018, POLYM ADVAN TECHNOL, V29, P1779, DOI 10.1002/pat.4284; CHOUWANG MS, 1989, INT J ENG SCI, V27, P967, DOI 10.1016/0020-7225(89)90037-2; Cohen T, 2015, INT J SOLIDS STRUCT, V69-70, P544, DOI 10.1016/j.ijsolstr.2015.04.029; CRUM LA, 1979, NATURE, V278, P148, DOI 10.1038/278148a0; Cui J, 2011, SOFT MATTER, V7, P7827, DOI 10.1039/c1sm05340j; Dhanaliwala AH, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-014-9914-9; Dixon H.H., 1909, Scientific Proceedings of the Royal Dublin Society, V12, P60; Dixon HH, 1914, SCI P ROY DUBLIN SOC, V14, P229; Dollhofer J, 2004, INT J SOLIDS STRUCT, V41, P6111, DOI 10.1016/j.ijsolstr.2004.04.041; Du YK, 2019, SOFT MATTER, V15, P8468, DOI 10.1039/c9sm01563a; Erfanian MR, 2018, APPL MATH MODEL, V62, P163, DOI 10.1016/j.apm.2018.05.026; Estrada JB, 2017, BIOPHYS J, V112, p159A, DOI 10.1016/j.bpj.2016.11.877; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; GENT AN, 1990, RUBBER CHEM TECHNOL, V63, pG49; GENT AN, 1984, J MATER SCI, V19, P1947, DOI 10.1007/BF00550265; GENT AN, 1959, PROC R SOC LON SER-A, V249, P195, DOI 10.1098/rspa.1959.0016; GENT AN, 1969, J POLYM SCI A2, V7, P1483, DOI 10.1002/pol.1969.160070904; HARVEY EN, 1947, J APPL PHYS, V18, P162, DOI 10.1063/1.1697598; Hong Y, 2016, EXP MECH, V56, P97, DOI 10.1007/s11340-015-0024-2; Jakub M.T., 1965, ARCH RATION MECH AN, V18, P367; Kalkandelen C, 2018, IOP CONF SER-MAT SCI, V293, DOI 10.1088/1757-899X/293/1/012001; Kang W, 2018, ACTA BIOMATER, V67, P295, DOI 10.1016/j.actbio.2017.11.030; Kang W, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.5000512; Kundu S, 2009, SOFT MATTER, V5, P3963, DOI 10.1039/b909237d; Li B, 2012, SOFT MATTER, V8, P5728, DOI 10.1039/c2sm00011c; Li B, 2011, J MECH PHYS SOLIDS, V59, P758, DOI 10.1016/j.jmps.2011.01.010; Liu HF, 2019, J MECH BEHAV BIOMED, V92, P188, DOI 10.1016/j.jmbbm.2019.01.007; Liu L, 2013, J PHYS CONF SER, V451, DOI 10.1088/1742-6596/451/1/012035; Liu L, 2014, INT J IMPACT ENG, V71, P106, DOI 10.1016/j.ijimpeng.2014.04.007; Long XP, 2018, INT J MULTIPHAS FLOW, V100, P41, DOI 10.1016/j.ijmultiphaseflow.2017.12.002; Martarelli M, 2018, MEAS SCI TECHNOL, V29, DOI 10.1088/1361-6501/aa9136; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Pan Z, 2017, P NATL ACAD SCI USA, V114, P8470, DOI 10.1073/pnas.1702502114; Peng XX, 2016, INT J MULTIPHAS FLOW, V79, P10, DOI 10.1016/j.ijmultiphaseflow.2015.10.006; Poulain X, 2018, SOFT MATTER, V14, P4633, DOI 10.1039/c8sm00238j; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; SATO H, 1979, MAKROMOL CHEM, V180, P829; SHIMA A, 1983, AIAA J, V21, P55, DOI 10.2514/3.8027; Shull KR, 2004, J POLYM SCI POL PHYS, V42, P4023, DOI 10.1002/polb.20258; Stigh U, 2018, ENG FRACT MECH, V203, P266, DOI 10.1016/j.engfracmech.2018.07.011; Sun T, 2017, P NATL ACAD SCI USA, V114, pE10281, DOI 10.1073/pnas.1713328114; Talu E, 2008, LANGMUIR, V24, P1745, DOI 10.1021/la703065v; Van Sligtenhorst C, 2006, J BIOMECH, V39, P1852, DOI 10.1016/j.jbiomech.2005.05.015; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114; Wu SK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46689; Xiang YH, 2019, J MECH PHYS SOLIDS, V128, P208, DOI 10.1016/j.jmps.2019.04.010; Xiang YH, 2018, J MECH PHYS SOLIDS, V117, P110, DOI 10.1016/j.jmps.2018.04.016; Zhang H, 2015, BIOMATERIALS, V56, P104, DOI 10.1016/j.biomaterials.2015.03.043; Zhong DM, 2019, INT J SOLIDS STRUCT, V176, P121, DOI 10.1016/j.ijsolstr.2019.05.018; Zhong DM, 2019, J APPL MECH-T ASME, V86, DOI 10.1115/1.4042764; Zhou YF, 2018, ULTRASONICS, V84, P296, DOI 10.1016/j.ultras.2017.11.012; Zhu J, 2011, J ADHESION, V87, P466, DOI 10.1080/00218464.2011.575332; Zimberlin JA, 2007, SOFT MATTER, V3, P763, DOI 10.1039/b617050a	65	5	6	7	38	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-5096	1873-4782		J MECH PHYS SOLIDS	J. Mech. Phys. Solids	APR	2020	137								103859	10.1016/j.jmps.2019.103859			14	Materials Science, Multidisciplinary; Mechanics; Physics, Condensed Matter	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics; Physics	KT2UF	WOS:000518870400022					2022-02-06	
J	Hoursan, H; Farahmand, F; Ahmadian, MT				Hoursan, Hesam; Farahmand, Farzam; Ahmadian, Mohammad Taghi			A Three-Dimensional Statistical Volume Element for Histology Informed Micromechanical Modeling of Brain White Matter	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Statistical volume element; Representative volume element; Diffusion tensor imaging; Histology-informed model; White matter structures	AXON DIAMETER; CORPUS-CALLOSUM; IN-VIVO; TENSION; TISSUE; BEHAVIOR; STRAIN	This study presents a novel statistical volume element (SVE) for micromechanical modeling of the white matter structures, with histology-informed randomized distribution of axonal tracts within the extracellular matrix. The model was constructed based on the probability distribution functions obtained from the results of diffusion tensor imaging as well as the histological observations of scanning electron micrograph, at two structures of white matter susceptible to traumatic brain injury, i.e. corpus callosum and corona radiata. A simplistic representative volume element (RVE) with symmetrical arrangement of fully alligned axonal fibers was also created as a reference for comparison. A parametric study was conducted to find the optimum grid and edge size which ensured the periodicity and ergodicity of the SVE and RVE models. A multi-objective evolutionary optimization procedure was used to find the hyperelastic and viscoelastic material constants of the constituents, based on the experimentally reported responses of corpus callosum to axonal and transverse loadings. The optimal material properties were then used to predict the homogenized and localized responses of corpus callosum and corona radiata. The results indicated similar homogenized responses of the SVE and RVE under quasi-static extension, which were in good agreement with the experimental data. Under shear strain, however, the models exhibited different behaviors, with the SVE model showing much closer response to the experimental observations. Moreover, the SVE model displayed a significantly better agreement with the reports of the experiments at high strain rates. The results suggest that the randomized fiber architecture has a great influence on the validity of the micromechanical models of white matter, with a distinguished impact on the model's response to shear deformation and high strain rates. Moreover, it can provide a more detailed presentation of the localized responses of the tissue substructures, including the stress concentrations around the low caliber axonal tracts, which is critical for studying the axonal injury mechanisms.	[Hoursan, Hesam; Farahmand, Farzam; Ahmadian, Mohammad Taghi] Sharif Univ Technol, Dept Mech Engn, Tehran, Iran; [Farahmand, Farzam] Univ Tehran Med Sci, RCBTR, Tehran, Iran		Farahmand, F (corresponding author), Sharif Univ Technol, Dept Mech Engn, Tehran, Iran.	farahmand@sharif.edu	Farahmand, Farzam/B-3921-2011	Farahmand, Farzam/0000-0001-8900-7003	Tehran University of Medical Sciences and Health ServicesTehran University of Medical Sciences [1398] Funding Source: Medline		Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Arbogast KB., 1997, SAE T, V106, P3807; Atashpaz-Gargari E, 2007, IEEE C EVOL COMPUTAT, P4661, DOI 10.1109/cec.2007.4425083; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Budday S, 2017, ACTA BIOMATER, V60, P315, DOI 10.1016/j.actbio.2017.06.024; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Costa AR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00319; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Gupta RK, 2017, DEF LIFE SCI J, V2, P3, DOI DOI 10.14429/dlsj.2.10369; Hakulinen U, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-30; HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X; Hollister SJ., 1992, COMPUT MECH, V10, P73, DOI [10.1007/BF00369853, DOI 10.1007/BF00369853]; Holzapfel GA, 2015, EUR J MECH A-SOLID, V49, P561, DOI 10.1016/j.euromechsol.2014.09.005; Hoursan H, 2020, SCI IRAN, V27, P784, DOI 10.24200/sci.2018.50940.1928; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson CL, 2013, NEUROIMAGE, V79, P145, DOI 10.1016/j.neuroimage.2013.04.089; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Kouznetsova V, 2002, COMPUTATIONAL HOMOGE; Labus KM, 2016, J MECH BEHAV BIOMED, V62, P195, DOI 10.1016/j.jmbbm.2016.05.003; Latorre M, 2017, INT J NONLIN MECH, V89, P14, DOI 10.1016/j.ijnonlinmec.2016.11.005; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Moerman KM, 2016, J MECH BEHAV BIOMED, V56, P218, DOI 10.1016/j.jmbbm.2015.11.027; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Pan Yi, 2013, Front Bioeng Biotechnol, V1, P19, DOI 10.3389/fbioe.2013.00019; Pesaresi M, 2015, NEUROIMAGE, V115, P191, DOI 10.1016/j.neuroimage.2015.04.048; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Sepehrband F, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00059; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P79; Tsao J., 2012, TRAUMATIC BRAIN INJU; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Yousefsani SA, 2018, J MECH BEHAV BIOMED, V88, P288, DOI 10.1016/j.jmbbm.2018.08.042; Yousefsani SA, 2018, J MECH BEHAV BIOMED, V80, P194, DOI 10.1016/j.jmbbm.2018.02.002; Zemmoura I, 2016, BRAIN STRUCT FUNCT, V221, P2477, DOI 10.1007/s00429-015-1050-7	47	5	5	1	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	APR	2020	48	4					1337	1353		10.1007/s10439-020-02458-4			17	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KW4ZG	WOS:000521173900018	31965358				2022-02-06	
J	Huie, JR; Mondello, S; Lindsell, CJ; Antiga, L; Yuh, EL; Zanier, ER; Masson, S; Rosario, BL; Ferguson, AR				Huie, J. Russell; Mondello, Stefania; Lindsell, Christopher J.; Antiga, Luca; Yuh, Esther L.; Zanier, Elisa R.; Masson, Serge; Rosario, Bedda L.; Ferguson, Adam R.		Transforming Res Clinical Knowle; Collaborative European NeuroTrauma	Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; data sharing; traumatic brain injury	NET RECLASSIFICATION INDEX; DIFFUSE AXONAL INJURY; COMMON DATA ELEMENTS; OUTCOME PREDICTION; TERMINAL HYDROLASE-L1; CT; TBI; TRACK; MICROARRAY; DISCOVERY	Recent biomarker innovations hold potential for transforming diagnosis, prognostic modeling, and precision therapeutic targeting of traumatic brain injury (TBI). However, many biomarkers, including brain imaging, genomics, and proteomics, involve vast quantities of high-throughput and high-content data. Management, curation, analysis, and evidence synthesis of these data are not trivial tasks. In this review, we discuss data management concepts and statistical and data sharing strategies when dealing with biomarker data in the context of TBI research. We propose that application of biomarkers involves three distinct steps-discovery, evaluation, and evidence synthesis. First, complex/big data has to be reduced to useful data elements at the stage of biomarker discovery. Second, inferential statistical approaches must be applied to these biomarker data elements for assessment of biomarker clinical utility and validity. Last, synthesis of relevant research is required to support practice guidelines and enable health decisions informed by the highest quality, up-to-date evidence available. We focus our discussion around recent experiences from the International Traumatic Brain Injury Research (InTBIR) initiative, with a specific focus on four major clinical projects (Transforming Research and Clinical Knowledge in TBI, Collaborative European NeuroTrauma Effectiveness Research in TBI, Collaborative Research on Acute Traumatic Brain Injury in Intensive Care Medicine in Europe, and Approaches and Decisions in Acute Pediatric TBI Trial), which are currently enrolling subjects in North America and Europe. We discuss common data elements, data collection efforts, data-sharing opportunities, and challenges, as well as examine the statistical techniques required to realize successful adoption and use of biomarkers in the clinic as a foundation for precision medicine in TBI.	[Huie, J. Russell; Yuh, Esther L.; Ferguson, Adam R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA 94110 USA; [Mondello, Stefania] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Lindsell, Christopher J.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Antiga, Luca] Orobix Srl, Bergamo, Italy; [Zanier, Elisa R.; Masson, Serge] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy; [Rosario, Bedda L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Ferguson, Adam R.] SFVAMC, San Francisco, CA USA		Ferguson, AR (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	Adam.ferguson@ucsf.edu	Poca, Maria A./B-8475-2008; Laureys, Steven/AAN-2097-2021; Posti, Jussi P./Y-2908-2019; Cooper, D. James/G-7961-2013; Zanier, Elisa/AAA-8095-2020; Castano-Leon, Ana M/ABF-6322-2020; Vande Vyvere, Thijs/AAB-5180-2022; Mondello, Stefania/A-1813-2012; Santos, Edgar/AAV-2506-2021; Sahuquillo, Juan/B-3577-2008; Gomez, Pedro/E-2411-2014; Ercole, Ari/B-6288-2009; Raj, Rahul/K-7693-2012	Poca, Maria A./0000-0002-3831-0536; Laureys, Steven/0000-0002-3096-3807; Posti, Jussi P./0000-0002-5925-5193; Cooper, D. James/0000-0002-5872-9051; Zanier, Elisa/0000-0002-3011-8718; Castano-Leon, Ana M/0000-0002-7918-5049; Vande Vyvere, Thijs/0000-0003-4032-5443; Mondello, Stefania/0000-0002-8587-3614; Santos, Edgar/0000-0002-8976-5549; Sahuquillo, Juan/0000-0003-0713-5875; Stewart, William/0000-0003-2199-2582; Ferguson, Adam/0000-0001-7102-1608; Van Essen, Thomas/0000-0003-4657-5283; Kolias, Angelos/0000-0003-3992-0587; Hemphill, Claude/0000-0003-4019-7525; Dippel, Diederik/0000-0002-9234-3515; Badenes, Rafael/0000-0001-7017-0150; Kondziella, Daniel/0000-0001-5562-9808; , Johnny/0000-0003-4138-2589; Gomez, Pedro/0000-0002-4185-5238; Newcombe, Virginia/0000-0001-6044-9035; Radoi, Andreea/0000-0002-0677-3544; Wessels, lars/0000-0001-8056-9659; Rossi, Sandra/0000-0002-9963-8121; Sakowitz, Oliver/0000-0003-3248-6335; Ercole, Ari/0000-0001-8350-8093; Coles, Jonathan/0000-0003-4013-679X; Raj, Rahul/0000-0003-4243-9591; Zeiler, Frederick/0000-0003-1737-0510; Sanchez-Porras, Renan/0000-0002-9084-8114	Department of Defense (DoD)United States Department of Defense [W81XWH-13-1-0441]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069409, NS069409-02S1, NS086090, NS106899, NS088475]	This work was supported by Department of Defense (DoD) grant W81XWH-13-1-0441 (G.T.M.), and NIH/NINDS grants NS069409 (G.T.M.), NS069409-02S1 (G.T.M.), NS086090 (G.T.M.), NS106899 (A.R.F.), and NS088475 (A.R.F.).	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Alba AC, 2018, JAMA-J AM MED ASSOC, V319, P617, DOI 10.1001/jama.2017.20548; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Berk M, 2011, BIOINFORMATICS, V27, P1979, DOI 10.1093/bioinformatics/btr289; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bouvier D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027365; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Burch PM, 2017, TOXICOL SCI, V156, P11, DOI 10.1093/toxsci/kfw225; Chen R, 2012, NEUROIMAGE, V59, P2330, DOI 10.1016/j.neuroimage.2011.09.023; Cnossen MC, 2016, J NEUROTRAUM; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Datta S, 2005, BIOINFORMATICS, V21, P1987, DOI 10.1093/bioinformatics/bti301; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Drazen JM, 2016, NEW ENGL J MED, V375, P1182, DOI 10.1056/NEJMe1611027; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Edlow BL, 2016, NEUROCRIT CARE, V24, P342, DOI 10.1007/s12028-015-0216-8; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Ferguson AR, 2014, NAT NEUROSCI, V17, P1442, DOI 10.1038/nn.3838; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huie JR, 2019, J NEUROTRAUM, V36, P100, DOI 10.1089/neu.2017.5449; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Khoo NC, 2007, EMERG MED AUSTRALAS, V19, P122, DOI 10.1111/j.1742-6723.2007.00914.x; Kim J, 2007, HUM BRAIN MAPP, V28, P85, DOI 10.1002/hbm.20259; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2018, LANCET NEUROL, V17, P737, DOI 10.1016/S1474-4422(18)30275-8; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Montana G, 2011, ADV EXP MED BIOL, V696, P307, DOI 10.1007/978-1-4419-7046-6_31; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Nitta ME, 2019, NEUROLOGY, V93, pE497, DOI 10.1212/WNL.0000000000007864; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Palacios EM, 2017, AM J NEURORADIOL, V38, P537, DOI 10.3174/ajnr.A5025; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Platt R, 2018, JAMA-J AM MED ASSOC, V320, P753, DOI 10.1001/jama.2018.9342; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Schiff ND, 2006, J HEAD TRAUMA REHAB, V21, P388, DOI 10.1097/00001199-200609000-00003; Shokraneh F, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3229; Simmonds M, 2017, J CLIN EPIDEMIOL, V91, P38, DOI 10.1016/j.jclinepi.2017.08.008; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Strimbu K, 2010, CURR OPIN HIV AIDS, V5, P463, DOI 10.1097/COH.0b013e32833ed177; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Synnot A, 2021, J NEUROTRAUM, V38, P1069, DOI 10.1089/neu.2015.4124; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; U.S. Food and Drug Administration, 2018, FDA AUTH MARK 1 BLOO; van den Brink RL, 2018, NEUROIMAGE-CLIN, V17, P43, DOI 10.1016/j.nicl.2017.10.003; Warren E, 2016, NEW ENGL J MED, V375, P401, DOI 10.1056/NEJMp1607282; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yan Shulin, 2014, Brain Inform, V1, P11; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yuh EL, 2008, J NEUROTRAUM, V25, P1163, DOI 10.1089/neu.2008.0590; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583	85	5	5	3	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2021	38	18					2514	2529		10.1089/neu.2019.6762		APR 2020	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	US2IV	WOS:000522970800001	32046588				2022-02-06	
J	Iihara, K; Tominaga, T; Saito, N; Suzuki, M; Date, I; Fujii, Y; Hongo, K; Houkin, K; Kato, A; Kato, Y; Kawamata, T; Kim, P; Kinouchi, H; Kohmura, E; Kurisu, K; Maruyama, K; Mikuni, N; Miyamoto, S; Morita, A; Nakase, H; Narita, Y; Nishikawa, R; Nozaki, K; Ogasawara, K; Ohata, K; Sakai, N; Sakamoto, H; Shiokawa, Y; Sonoda, Y; Takahashi, JC; Ueki, K; Wakabayashi, T; Yamamoto, T; Yoshida, K; Kayama, T; Arai, H				Iihara, Koji; Tominaga, Teiji; Saito, Nobuhito; Suzuki, Michiyasu; Date, Isao; Fujii, Yukihiko; Hongo, Kazuhiro; Houkin, Kiyohiro; Kato, Amami; Kato, Yoko; Kawamata, Takakazu; Kim, Phyo; Kinouchi, Hiroyuki; Kohmura, Eiji; Kurisu, Kaoru; Maruyama, Keisuke; Mikuni, Nobuhiro; Miyamoto, Susumu; Morita, Akio; Nakase, Hiroyuki; Narita, Yoshitaka; Nishikawa, Ryo; Nozaki, Kazuhiko; Ogasawara, Kuniaki; Ohata, Kenji; Sakai, Nobuyuki; Sakamoto, Hiroaki; Shiokawa, Yoshiaki; Sonoda, Yukihiko; Takahashi, Jun C.; Ueki, Keisuke; Wakabayashi, Toshihiko; Yamamoto, Takamitsu; Yoshida, Kazunari; Kayama, Takamasa; Arai, Hajime		Japan Neurosurg Soc	The Japan Neurosurgical Database: Overview and Results of the First-year Survey	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						board certification; neurosurgery; real world data; registry; resident training		The Japan Neurosurgical Database (JND) is a prospective observational study registry established in 2017 by the Japan Neurosurgical Society (JNS) to visualize real-world clinical practice, promote science, and improve the quality of care and neurosurgery board certification in Japan. We summarize JND's aims and methods, and describes the 2018 survey results. The JND registered in-hospital patients' clinical data mainly from JNS training institutions in 2018. Caseload, patient demographics, and in-hospital outcomes of the overall cohort and a neurosurgical subgroup were examined according to major classifications of main diagnosis. Neurosurgical caseload per neurosurgeon in training in core hospitals in 2018 was calculated as an indicator of neurosurgical training. Of 523,283 cases (male 55.3%) registered from 1360 participating institutions, the neurosurgical subgroup comprised of 33.9%. Among the major classifications, cerebrovascular diseases comprised the largest proportion overall and in the neurosurgical subgroup (53.1%, 41.0%, respectively), followed by neurotrauma (19.1%, 25.5%), and brain tumor (10.4%, 12.8%). Functional neurosurgery (6.4%, 3.7%), spinal and peripheral nerve disorders (5.1%, 10.1%), hydrocephalus/developmental anomalies (2.9%, 5.3%), and encephalitis/infection/inflammatory and miscellaneous diseases (2.9%, 1.6%) comprised smaller proportions. Most patients were aged 70-79 years in the overall cohort and neurosurgical subgroup (27.8%, 29.4%). Neurotrauma and cerebrovascular diseases in the neurosurgical subgroup comprised a higher and lower proportion, respectively, than in the overall cohort in elderly patients (e.g. 80 years, 46.9% vs. 33.5%, 26.8% vs. 54.4%). The 2018 median neurosurgical caseload per neurosurgeon in training was 80.7 (25-75th percentile 51.5-117.5). These initial results from 2018 reveal unique aspects of neurosurgical practice in Japan.	[Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Fukuoka, Japan; [Tominaga, Teiji] Tohoku Univ, Grad Sch Med Sci, Dept Neurosurg, Sendai, Miyagi, Japan; [Saito, Nobuhito] Univ Tokyo, Dept Neurosurg, Tokyo, Japan; [Suzuki, Michiyasu] Yamaguchi Univ, Dept Neurosurg, Grad Sch Med, Ube, Yamaguchi, Japan; [Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med, Okayama, Japan; [Fujii, Yukihiko] Niigata Univ, Brain Res Inst, Dept Neurosurg, Niigata, Japan; [Hongo, Kazuhiro] Shinshu Univ, Sch Med, Dept Neurosurg, Matsumoto, Nagano, Japan; [Hongo, Kazuhiro] Ina Cent Hosp, Dept Neurosurg, Ina, Nagano, Japan; [Houkin, Kiyohiro] Hokkaido Univ, Dept Neurosurg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Kato, Amami] Kindai Univ, Dept Neurosurg, Fac Med, Osaka, Japan; [Kato, Yoko] Fujita Hlth Univ, Dept Neurosurg, Bantane Hosp, Nagoya, Aichi, Japan; [Kawamata, Takakazu] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Kim, Phyo; Ueki, Keisuke] Dokkyo Med Univ, Neurol Surg, Mibu, Tochigi, Japan; [Kinouchi, Hiroyuki] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Neurosurg, Chuo Ku, Yamanashi, Japan; [Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo, Japan; [Kurisu, Kaoru] Hiroshima Univ, Dept Neurosurg, Hiroshima, Japan; [Maruyama, Keisuke; Shiokawa, Yoshiaki] Kyorin Univ, Sch Med, Dept Neurosurg, Mitaka, Tokyo, Japan; [Mikuni, Nobuhiro] Sapporo Med Univ, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Miyamoto, Susumu] Kyoto Univ, Dept Neurosurg, Grad Sch Med, Kyoto, Japan; [Morita, Akio] Nippon Med Sch, Dept Neurosurg, Tokyo, Japan; [Nakase, Hiroyuki] Nara Med Univ, Dept Neurosurg, Nara, Japan; [Narita, Yoshitaka] Natl Canc Ctr, Dept Neurosurg & Neurooncol, Tokyo, Japan; [Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Saitama, Japan; [Nozaki, Kazuhiko] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga, Japan; [Ogasawara, Kuniaki] Iwate Med Univ, Dept Neurosurg, Morioka, Iwate, Japan; [Ohata, Kenji] Osaka City Univ, Dept Neurosurg, Osaka, Japan; [Sakai, Nobuyuki] Kobe City Med Ctr Gen Hosp, Dept Neurosurg, Kobe, Hyogo, Japan; [Sakamoto, Hiroaki] Osaka City Gen Hosp, Dept Pediat Neurosurg, Osaka, Japan; [Sonoda, Yukihiko] Yamagata Univ, Fac Med, Dept Neurosurg, Yamagata, Japan; [Takahashi, Jun C.] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Wakabayashi, Toshihiko] Nagoya Univ, Dept Neurosurg, Grad Sch Med, Nagoya, Aichi, Japan; [Yamamoto, Takamitsu] Sonodakai Rehabil Hosp, Tokyo, Japan; [Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo, Japan; [Kayama, Takamasa] Yamagata Univ, Sch Med, Dept Adv Med, Yamagata, Japan; [Arai, Hajime] Juntendo Univ, Fac Med, Dept Neurosurg, Tokyo, Japan		Iihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka, Fukuoka, Japan.	kiihara@ns.med.kyushu-u.ac.jp		Morita, Akio/0000-0002-2497-5772	Practical Research Project for Life-Style related Diseases by the Japan Agency for Medical Research and Development [16hk0102037h0001, 17hk0102037h0002, 18hk0102037h0003]	Creation of the JND was supported by the Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus managed by the Japan Agency for Medical Research and Development (16hk0102037h0001, 17hk0102037h0002, 18hk0102037h0003). We also thank all the collaborators of the participating hospitals in the JND, and the secretarial assistance provided by Ms. Kei Watanabe of the Japan Neurosurgical Society.	[Anonymous], 2019, Neurol Med Chir (Tokyo), V59, P13, DOI 10.2176/nmc.si.2019-0001; Brennum J, 2000, ACTA NEUROCHIR, V142, P1081, DOI 10.1007/s007010070034; Kerezoudis P, 2019, NEUROSURGERY, V84, pE392, DOI 10.1093/neuros/nyy429; McGirt MJ, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2012.10.FOCUS12297; Reponen E, 2019, NEUROSURGERY, V85, P500, DOI 10.1093/neuros/nyy380; Stienen MN, 2019, ACTA NEUROCHIR, V161, P1977, DOI 10.1007/s00701-019-04048-3; Vaziri S, 2018, J NEUROSURG, V128, P942, DOI 10.3171/2016.11.JNS161377	7	5	5	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2020	60	4					165	190		10.2176/nmc.st.2019-0211			26	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LH7RE	WOS:000528981400001	32238620	Green Published, gold			2022-02-06	
J	Lee, SH; Kim, HS; Yun, SJ				Lee, Sun Hwa; Kim, Hyun Soo; Yun, Seong Jong			Optic nerve sheath diameter measurement for predicting raised intracranial pressure in adult patients with severe traumatic brain injury: A meta-analysis	JOURNAL OF CRITICAL CARE			English	Article						Intracranial pressure; Head trauma; Ocular ultrasound; Crain computed tomography; Critical care	DIAGNOSTIC-TEST ACCURACY; TOMOGRAPHIC SCAN CHARACTERISTICS; LINEAR RELATIONSHIP; PUBLICATION; MANAGEMENT; MORTALITY; STATE	Objective: To evaluate and compare the diagnostic feasibility of measuring the optic nerve sheath diameter (ONSD), via brain computed tomography (CT) and ocular ultrasonography (US) for prediction of raised intracranial pressure (ICP) in severe traumatic brain injury (TBI) patients. Methods: The PubMed and EMBASE databases were searched for studies assessing the diagnostic accuracy of brain CT or ocular US for predicting raised ICP. Bivariate and hierarchical summary receiver operating characteristic modeling were performed to evaluate and compare the diagnostic feasibility of measuring the ONSD in adult patients with severe TBI according to modality (ocular US vs. brain CT). Results: Five studies (four with ocular US and one with brain CT) were included. The ONSD had a pooled sensitivity of 0.91, pooled specificity of 0.77, and area under the HSROC curve of 0.92 for predicting raised ICP. More importantly, studies using ocular US found an almost equal sensitivity (0.91 vs. 0.90; p = .35) and higher specificity (0.82 vs. 0.58; p = .01) than those using brain CT. Conclusions: Measurement of the ONSD may be a useful method for predicting raised ICP in adult patients with severe TBI. (C) 2020 Elsevier Inc. All rights reserved.	[Lee, Sun Hwa] Ewha Womans Univ, Dept Emergency Med, Mokdong Hosp, 1071 Anyangcheon Ro, Seoul 07985, South Korea; [Kim, Hyun Soo] Kyung Hee Univ, Grad Sch, Dept Med, 26 Kyungheedae Ro, Seoul 02447, South Korea; [Yun, Seong Jong] G SAM Hosp, Dept Radiol, 591 Gunpo Ro, Gunpo 15839, South Korea		Yun, SJ (corresponding author), G SAM Hosp, Dept Radiol, 591 Gunpo Ro, Gunpo 15839, South Korea.	zoomknight@khu.ac.kr		lee, sunhwa/0000-0002-3491-6223			Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Higgins J., 2008, COCHRANE HDB SYSTEMA; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Kim KW, 2015, KOREAN J RADIOL, V16, P1175, DOI 10.3348/kjr.2015.16.6.1175; Kim SE, 2018, ACTA RADIOL; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Lee J, 2015, KOREAN J RADIOL, V16, P1188, DOI 10.3348/kjr.2015.16.6.1188; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; McInnes MDF, 2018, JAMA-J AM MED ASSOC, V319, P388, DOI 10.1001/jama.2017.19163; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Nash JE, 2016, TRAUMA, V18, P28, DOI 10.1177/1460408615606752; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Selhorst JB, 2009, SEMIN NEUROL, V29, P29, DOI 10.1055/s-0028-1124020; Sheth S, 2009, RADIOGRAPHICS, V29, P1045, DOI 10.1148/rg.294085743; Siranovic M, 2011, SIGNA VITAE, V6, P33, DOI 10.22514/SV61.042011.5; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Soliman I, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3589762; Suh CH, 2016, KOREAN J RADIOL, V17, P5, DOI 10.3348/kjr.2016.17.1.5; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Wang D, 2004, J TRAUMA, V56, P972; Waqas M, 2016, J NEURORADIOLOGY, V43, P25, DOI 10.1016/j.neurad.2015.07.003; Whitaker-Lea WA, 2017, PHYS MED REH CLIN N, V28, P227, DOI 10.1016/j.pmr.2016.12.002; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	33	5	5	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2020	56						182	187		10.1016/j.jcrc.2020.01.006			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU2RN	WOS:000519555700030	31945584				2022-02-06	
J	Lozano, A; Franchi, F; Seastres, RJ; Oddo, M; Lheureux, O; Badenes, R; Scolletta, S; Vincent, JL; Creteur, J; Taccone, FS				Lozano, Angels; Franchi, Federico; Seastres, Ramon J.; Oddo, Mauro; Lheureux, Olivier; Badenes, Rafael; Scolletta, Sabino; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio S.			Glucose and Lactate Concentrations in Cerebrospinal Fluid After Traumatic Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						brain monitoring; cerebral metabolism; lactate; glucose; traumatic brain injury	TIGHT GLYCEMIC CONTROL; HEAD-INJURY; EXTRACELLULAR LACTATE; METABOLIC DISTRESS; MICRODIALYSIS; HYPOXIA; IMPACT	Background: Studies in which brain metabolism has been monitored using microdialysis have indicated decreases in cerebral glucose concentration and increases in lactate concentration in patients with traumatic brain injury (TBI). However, few data are available on glucose and lactate concentrations in the cerebrospinal fluid (CSF) of TBI patients. This study investigates the relationship between CSF glucose and lactate concentrations and outcomes after TBI. Methods: Consecutive adult (>18 y) TBI patients were admitted to our 35-bed medicosurgical between 2011 and 2014 and were included in the study if they met the following inclusion criteria: presence of an external ventricular drain (EVD) for intracranial pressure monitoring, daily analysis of CSF glucose and lactate concentrations for 4 consecutive days, and concomitant measurements of blood glucose/lactate concentrations. Neurological outcome was assessed at 3 months using the extended Glasgow Outcome Scale (GOS), and unfavorable outcome defined as a GOS 1 to 4. Results: Of 151 TBI patients who had an EVD, 56 met the inclusion criteria. Most EVDs were placed on the day of intensive care unit admission, and maintained for 10 (interquartile range: 6 to 14) days. On day 1, there was a weak but significant correlation between blood and CSF glucose concentrations (R-2=0.07, P=0.04), and a greater correlation between blood and CSF lactate (R-2=0.32, P<0.001). In multivariable analysis, day 1 CSF glucose/lactate ratio was independently associated with mortality (odds ratio: 0.22, 95% confidence interval: 0.08-0.61; P=0.003), and day 1 CSF lactate concentration with unfavorable outcome (odds ratio: 4.86; 95% confidence interval: 1.86-12.67; P=0.001). Conclusions: Low CSF glucose/lactate ratio is observed in nonsurvivors after severe TBI and may have prognostic value.	[Lozano, Angels; Franchi, Federico; Lheureux, Olivier; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio S.] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium; [Lozano, Angels; Badenes, Rafael] Hosp Clin Univ, Dept Anesthesia & Intens Care, Valencia, Spain; [Franchi, Federico; Scolletta, Sabino] Univ Siena, Azienda Osped Univ Senese, Dept Anesthesia & Intens Care, Siena, Italy; [Seastres, Ramon J.] Royal Melbourne Hosp, Dept Intens Care Med, Parkville, Vic, Australia; [Oddo, Mauro] Lausanne Univ Hosp, CHUV, Dept Intens Care Med, Lausanne, Switzerland		Taccone, FS (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium.	ftaccone@ulb.ac.be	Badenes, Rafael/K-6628-2019	Badenes, Rafael/0000-0001-7017-0150; Vincent, Jean-Louis/0000-0001-6011-6951			Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bilotta Federico, 2007, J Neurosurg Anesthesiol, V19, P156, DOI 10.1097/ANA.0b013e3180338e69; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Ho KM, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0166-z; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jalloh I, 2018, J NEUROTRAUM, V35, P2025, DOI 10.1089/neu.2017.5459; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Kurtz P, 2013, NEUROCRIT CARE, V19, P311, DOI 10.1007/s12028-013-9919-x; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	25	5	5	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	APR	2020	32	2					162	169		10.1097/ANA.0000000000000582			8	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	LB4DU	WOS:000524587000009	30893283				2022-02-06	
J	Sokoloff, C; Williamson, D; Serri, K; Albert, M; Odier, C; Charbonney, E; Bernard, F				Sokoloff, C.; Williamson, D.; Serri, K.; Albert, M.; Odier, C.; Charbonney, E.; Bernard, F.		ERESI Res Grp Equipe Rech Soins	Clinical Usefulness of Transcranial Doppler as a Screening Tool for Early Cerebral Hypoxic Episodes in Patients with Moderate and Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Transcranial Doppler; Brain oxygenation	BLOOD-FLOW; MORTALITY; THERAPY; OXYGEN; HYPOPERFUSION; METABOLISM; PRESSURE; VELOCITY	Background Brain tissue oxygenation (PbtO(2)) in traumatic brain injury (TBI) is known to be dependent on cerebral blood flow (CBF) which remains difficult to assess during the very early phase of TBI management. This study evaluates if blood flow velocity measurement with 2D color-coded transcranial Doppler (TCD) can predict cerebral hypoxic episodes in moderate-to-severe TBI measured with a PbtO(2) probe. Methods This is a prospective observational study of serial TCD measurements to assess blood flow velocity and its association with PbtO(2). Measurements were done bilaterally on the middle cerebral artery (MCA) early after the insertion of PbtO(2) monitoring, daily for 5 days and during dynamic challenge tests. Physiological parameters affecting PbtO(2) and Doppler velocities were collected simultaneously (PaO2, PaCO2, hemoglobin [Hb] level, intracranial pressure, and cerebral perfusion pressure [CPP]). Results We enrolled 17 consecutive patients with a total of 85 TCD studies. Using 2D color-coded TCD, signal acquisition was successful in 96% of the cases. Twenty-nine (34%) TCD measures were performed during an episode of cerebral hypoxia (PbtO(2) <= 20 mmHg). For early episodes of cerebral hypoxia (occurring <= 24 h from trauma), all Vmean < 40 cm/s were associated with an ipsilateral PbtO(2) <= 20 mmHg (positive predictive value 100%). However, when considering all readings over the course of the study, however, we found no correlation between PbtO(2) and MCA's mean blood flow velocity (Vmean). Vmean is also positively correlated with PaCO2, whereas PbtO2 is also correlated with PaO2, CPP, and Hb level. Conclusions Early TCD measurements compatible with low CBF (mean velocity < 40 cm/s) detect brain tissue hypoxia early after TBI (<= 24 h) and could potentially be used as a screening tool before invasive monitoring insertion to help minimize time-sensitive secondary injury. Various factors influence the relationship between Vmean and PbtO(2), affecting interpretation of their interaction after 24 h.	[Sokoloff, C.; Serri, K.; Albert, M.; Charbonney, E.; Bernard, F.] CIUSSS Nord de Ille de Montreal, Hop Sacre Coeur Montreal, Dept Med, 5400 Boul Gouin O, Montreal, PQ H4J 1C5, Canada; [Williamson, D.; Serri, K.; Albert, M.; Charbonney, E.; Bernard, F.] CIUSSS Nord de Ille de Montreal, Hop Sacre Coeur Montreal, Res Ctr, Montreal, PQ, Canada; [Williamson, D.] Univ Montreal, Pharm Fac, Montreal, PQ, Canada; [Serri, K.; Albert, M.; Charbonney, E.; Bernard, F.] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Odier, C.] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada; [Odier, C.] Univ Montreal, Fac Neurosci, Montreal, PQ, Canada		Bernard, F (corresponding author), CIUSSS Nord de Ille de Montreal, Hop Sacre Coeur Montreal, Dept Med, 5400 Boul Gouin O, Montreal, PQ H4J 1C5, Canada.	bernard.francis@gmail.com					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bouzat P, 2016, ANESTHESIOLOGY, V125, P346, DOI 10.1097/ALN.0000000000001165; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Brandi G, 2010, ACTA NEUROCHIR, V152, P965, DOI 10.1007/s00701-010-0643-4; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Dellazizzo L, 2019, J NEUROSURG, V131, P1639, DOI 10.3171/2018.5.JNS18651; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Lu J, 2005, ACT NEUR S, V95, P281; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878	25	5	5	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2020	32	2					486	491		10.1007/s12028-019-00763-y			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KV8ES	WOS:000520711600019	31218643				2022-02-06	
J	Vuokila, N; Aronica, E; Korotkov, A; van Vliet, EA; Nuzhat, S; Puhakka, N; Pitkanen, A				Vuokila, Niina; Aronica, Eleonora; Korotkov, Anatoly; van Vliet, Erwin Alexander; Nuzhat, Salma; Puhakka, Noora; Pitkanen, Asla			Chronic Regulation of miR-124-3p in the Perilesional Cortex after Experimental and Human TBI	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						bioinformatics; biomarker; epileptogenesis; microRNA; miR-124-3p; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CELL-DEATH MECHANISMS; RAT CEREBRAL-CORTEX; SMALL RNAS; HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; MIRNA EXPRESSION; DOWN-REGULATION; PROLIFERATION; PATHWAY	Traumatic brain injury (TBI) dysregulates microRNAs, which are the master regulators of gene expression. Here we investigated the changes in a brain-enriched miR-124-3p, which is known to associate with major post-injury pathologies, such as neuroinflammation. RT-qPCR of the rat tissue sampled at 7 d and 3 months in the perilesional cortex adjacent to the necrotic lesion core (aPeCx) revealed downregulation of miR-124-3p at 7 d (fold-change (FC) 0.13, p < 0.05 compared with control) and 3 months (FC 0.40, p < 0.05) post-TBI. In situ hybridization confirmed the downregulation of miR-124-3p at 7 d and 3 months post-TBI in the aPeCx (both p < 0.01). RT-qPCR confirmed the upregulation of the miR-124-3p target Stat3 in the aPeCx at 7 d post-TBI (7-fold, p < 0.05). mRNA-Seq revealed 312 downregulated and 311 upregulated miR-124 targets (p < 0.05). To investigate whether experimental findings translated to humans, we performed in situ hybridization of miR-124-3p in temporal lobe autopsy samples of TBI patients. Our data revealed downregulation of miR-124-3p in individual neurons of cortical layer III. These findings indicate a persistent downregulation of miR-124-3p in the perilesional cortex that might contribute to post-injury neurodegeneration and inflammation.	[Vuokila, Niina; Nuzhat, Salma; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 627, FI-70211 Kuopio, Finland; [Aronica, Eleonora; Korotkov, Anatoly; van Vliet, Erwin Alexander] Univ Amsterdam, Dept Neuro Pathol, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Stichting Epilepsie Instellingen Nederland SEIN, NL-0397 Heemstede, Netherlands; [van Vliet, Erwin Alexander] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Sci Pk 90,POB 926, NL-1090 GE Amsterdam, Netherlands		Puhakka, N (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 627, FI-70211 Kuopio, Finland.	niina.vuokila@uef.fi; e.aronica@amsterdamumc.nl; a.korotkov@amc.uva.nl; e.a.vanVliet@uva.nl; salnu@student.uef.fi; noora.puhakka@uef.fi; asla.pitkanen@uef.fi	van Vliet, Erwin/AAS-4753-2020	van Vliet, Erwin/0000-0001-5747-3202	Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 2285733-9]; European UnionEuropean Commission [642881, 602102]	This study was supported by the Medical Research Council of the Academy of Finland (Grants 272249, 273909, and 2285733-9) and by the European Union's Seventh Framework Program (FP7/2007-2013) under grant agreement no 602102 (EPITARGET) and the European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement no 642881 (ECMED).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; An FM, 2017, ONCOTARGET, V8, P114065, DOI 10.18632/oncotarget.23119; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bitetti A, 2018, NAT STRUCT MOL BIOL, V25, P244, DOI 10.1038/s41594-018-0032-x; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cao J, 2018, J CANCER, V9, P3006, DOI 10.7150/jca.25956; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen GW, 2017, ONCOTARGETS THER, V10, P5783, DOI 10.2147/OTT.S150678; Chen JJ, 2017, BIOCHEM BIOPH RES CO, V494, P126, DOI 10.1016/j.bbrc.2017.10.068; Chen ZH, 2019, EXP NEUROL, V313, P37, DOI 10.1016/j.expneurol.2018.12.003; Cheng Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1303-0; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Das SK, 2010, P NATL ACAD SCI USA, V107, P11948, DOI 10.1073/pnas.0914143107; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Pietro V, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00429; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Dong RF, 2018, J CELL BIOCHEM, V119, P269, DOI 10.1002/jcb.26170; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fang MR, 2012, TOXICOL LETT, V209, P94, DOI 10.1016/j.toxlet.2011.11.032; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fu WG, 2013, J SURG RES, V183, P876, DOI 10.1016/j.jss.2013.01.044; Gascon E, 2014, NAT MED, V20, P1444, DOI 10.1038/nm.3717; Gaudet AD, 2018, NEUROSCIENTIST, V24, P221, DOI 10.1177/1073858417721150; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Gong X, 2016, AM J TRANSL RES, V8, P2127; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He RQ, 2018, ONCOL LETT, V15, P5517, DOI 10.3892/ol.2018.8045; Hu ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039357; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Jiang YJ, 2019, J NEUROTRAUM, V36, P1018, DOI 10.1089/neu.2018.5647; Johnson D, 2017, J TRAUMA ACUTE CARE, V83, pS145, DOI 10.1097/TA.0000000000001475; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Liu C, 2019, CELL CYCLE, V18, P2215, DOI 10.1080/15384101.2019.1638182; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YX, 2013, BIOCHEM BIOPH RES CO, V441, P873, DOI 10.1016/j.bbrc.2013.10.157; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Marcinowski L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002510; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Papadimitriou E, 2017, GLIA, V65, pE125; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Qi MM, 2019, EUR REV MED PHARMACO, V23, P5242, DOI 10.26355/eurrev_201906_18190; Qin XJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204051; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Sheu-Gruttadauria J, 2019, MOL CELL, V75, P1243, DOI 10.1016/j.molcel.2019.06.019; Shi PF, 2019, MOL MED REP, V19, P3667, DOI 10.3892/mmr.2019.10044; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Veremeyko T, 2019, J NEUROSCI RES, V97, P162, DOI 10.1002/jnr.24344; Vuokila N, 2018, CELL MOL LIFE SCI, V75, P4557, DOI 10.1007/s00018-018-2911-z; Wang RJ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0911-0; Wang SX, 2018, ONCOL LETT, V16, P5875, DOI 10.3892/ol.2018.9341; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Wang Y, 2012, EXP BIOL MED, V237, P1424, DOI 10.1258/ebm.2012.012123; Wong VS, 2016, NEUROSCI LETT, V625, P26, DOI 10.1016/j.neulet.2016.04.009; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Yao LP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1053-4; Yu AY, 2017, IMMUNOL LETT, V182, P1, DOI 10.1016/j.imlet.2016.12.003; Zhang PP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36443-8; Zhang QC, 2017, AM J TRANSL RES, V9, P971; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao RT, 2018, J NEUROTRAUM, V35, P2056, DOI 10.1089/neu.2017.5502; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	109	5	5	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	APR	2020	21	7							2418	10.3390/ijms21072418			24	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	LR3DN	WOS:000535574200160	32244461	gold, Green Published			2022-02-06	
J	Polito, F; Fama, F; Oteri, R; Raffa, G; Vita, G; Conti, A; Daniele, S; Macaione, V; Passalacqua, M; Cardali, S; Di Giorgio, RM; Gioffre, M; Angileri, FF; Germano, A; Aguennouz, M				Polito, Francesca; Fama, Fausto; Oteri, Rosaria; Raffa, Giovanni; Vita, Gianluca; Conti, Alfredo; Daniele, Sacco; Macaione, Vincenzo; Passalacqua, Marcello; Cardali, Salvatore; Di Giorgio, Rosa Maria; Gioffre, Maria; Angileri, Flavio F.; Germano, Antonino; Aguennouz, M'Hammed			Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury	MOLECULAR BIOLOGY REPORTS			English	Article						Mild traumatic brain injury; miRNA; Biomarkers; Pain; Inflammation	MESSENGER-RNAS; MICRORNAS; HOMEOSTASIS; DIAGNOSIS; TARGETS; IMPACT; BLOOD; SERUM	TBI is the main cause of death and disability in individuals aged 1-45 in Western countries. One of the main challenges of TBI at present is the lack of specific diagnostic biomarkers, especially for mild TBI (mTBI), which remains currently difficult to value in clinical practice. In this context MiRNAs may be important mediators of the profound molecular and cellular changes that occur after TBI in both the short and the long term. Recently, plasma miRNAs profiling in human TBI, have revealed dynamic temporal regulation of miRNA expression within the cortex. Aim of this study was to select a specific miRNAs panel for mTBI, by focusing the research on the prognostic meaning of miRNAs in the hours following the trauma, in order to be able to use this MIRNAs as potential biomarkers useful for monitoring the follow up of mild TBI. Serum levels of 17 miRNAs were measured by RT-quantitative polymerase chain reaction (qPCR) in 20 patients with mTBI at three different time-points (0 h, 24 h, 48 h) and in 10 controls. For 15 miRNAs we found a significant differences in the comparison among the three time points: for each of these miRNAs the values were greater at baseline and progressively reduced at 24 h and 48 h. These data allow us to consider the miRNAs included in panel as sensitive and specific biomarkers for mTBI, useful in monitoring the post-trauma period.	[Polito, Francesca; Fama, Fausto; Raffa, Giovanni; Conti, Alfredo; Daniele, Sacco; Passalacqua, Marcello; Cardali, Salvatore; Angileri, Flavio F.; Germano, Antonino] Univ Messina, Dept Human Pathol Adulthood & Childhood G Barresi, Messina, Italy; [Oteri, Rosaria; Vita, Gianluca; Macaione, Vincenzo; Di Giorgio, Rosa Maria; Aguennouz, M'Hammed] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Gioffre, Maria] Univ Messina, Unit Neurosurg, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy		Aguennouz, M (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	aguenoz@unime.it	Raffa, Giovanni/K-7972-2016; Vita, Gianluca/AAR-4587-2020; Conti, Alfredo/H-3022-2019	Raffa, Giovanni/0000-0001-8623-4964; Vita, Gianluca/0000-0003-4190-8042; Conti, Alfredo/0000-0002-9408-2662			Backes C, 2016, MOL DIAGN THER, V20, P509, DOI 10.1007/s40291-016-0221-4; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ganau M, 2013, MINERVA ANESTESIOL, V79, P310; Gerlach CV, 2017, ARCH TOXICOL, V91, P2781, DOI 10.1007/s00204-017-1974-1; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hu HJ, 2017, J STROKE CEREBROVASC, V26, P2706, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.011; Jung HJ, 2014, J GENET GENOMICS, V41, P465, DOI 10.1016/j.jgg.2014.07.003; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Keller A, 2017, RNA BIOL, V14, P1791, DOI 10.1080/15476286.2017.1367888; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li YQ, 2016, ONCOTARGET, V7, P35607, DOI 10.18632/oncotarget.9597; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lyskjaer I, 2016, EPIGENOMICS-UK, V8, P1449, DOI 10.2217/epi-2016-0128; Martinez B, 2017, NEURAL REGEN RES, V12, P1749, DOI 10.4103/1673-5374.219025; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Shrestha A, 2017, DEV DYNAM, V246, P285, DOI 10.1002/dvdy.24477; Siddeek B, 2014, MUTAT RES-GEN TOX EN, V764, P46, DOI 10.1016/j.mrgentox.2014.01.010; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Tan Ping-Heng, 2013, Acta Anaesthesiol Taiwan, V51, P171, DOI 10.1016/j.aat.2013.11.001; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vemuganti R, 2010, TRANSL STROKE RES, V1, P158, DOI 10.1007/s12975-010-0030-8; Vetere G, 2014, HIPPOCAMPUS, V24, P1458, DOI 10.1002/hipo.22326; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Wang W, 2018, BIOCHEM BIOPH RES CO, V505, P917, DOI 10.1016/j.bbrc.2018.09.194; Wang ZG, 2013, COMPR PHYSIOL, V3, P599, DOI 10.1002/cphy.c110002; Watson CN, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00364; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yang GL, 2018, SCI CHINA TECHNOL SC, V1, P1, DOI DOI 10.3171/2018.5.JNS173061; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Zhan LY, 2018, BIOMED PHARMACOTHER, V107, P818, DOI 10.1016/j.biopha.2018.08.053; Zhang XL, 2018, CELL PHYSIOL BIOCHEM, V48, P2483, DOI 10.1159/000492686	41	5	5	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851	1573-4978		MOL BIOL REP	Mol. Biol. Rep.	APR	2020	47	4					2941	2949		10.1007/s11033-020-05386-7		MAR 2020	9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE1CZ	WOS:000521915400003	32219772				2022-02-06	
J	Wangnoo, T; Zavorsky, GS; Owen-Smith, A				Wangnoo, Tahira; Zavorsky, Gerald Stanley; Owen-Smith, Ashli			Association between Concussions and Suicidal Behaviors in Adolescents	JOURNAL OF NEUROTRAUMA			English	Article						concussions; mental health; suicidal behaviors; suicide; YRBS	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; RISK; SYMPTOMS; SPORTS; MORTALITY; PLAYERS	While there is increasing evidence on the long-term risks associated with concussions, the association between hopelessness, suicidal ideation, suicidal planning, and suicidal attempts in high school aged adolescents has not yet been explored. The current study aims to estimate the association between concussions and suicidal behaviors in Utah high school students. We analyzed the 2013 Utah Youth Risk Behavior Survey (YRBS), a state, representative survey of 2,195 ninth through 12th grade high school students. Bivariate and multi-variate logistic regressions controlling for race/ethnicity, sex, grade, and alcohol use were conducted to evaluate the adjusted odds ratio (OR) and 95% confidence interval (CI) of suicidal behaviors comparing students exposed to one or more concussions with those unexposed. Students with self-reported concussion exposure had significantly greater odds of reporting feeling sad or hopeless (OR = 1.7; 95% CI 1.4, 2.2, suicidal ideations [adjusted odds ratio (AOR) = 2.0; 95% CI 1.4, 2.7], suicidal planning [AOR = 2.0; 95% CI 1.4, 2.8], and suicidal attempts [OR = 2.3; 95% CI 1.4, 3.7]) after controlling for grade, sex, race, and alcohol-use. Results from this study suggest that high school students who have had a concussion are more likely to report suicidal behaviors, compared with high school students who did not report a concussion. Given the results, concussion prevention education efforts in high schools are warranted. In addition, it is imperative to educate parents, teachers, and health professionals how to recognize a concussion and any possible mental health outcomes as a result. Future longitudinal research is needed to better understand temporality of this association.	[Wangnoo, Tahira; Zavorsky, Gerald Stanley; Owen-Smith, Ashli] Georgia State Univ, Atlanta, GA 30303 USA		Wangnoo, T (corresponding author), Georgia State Univ, Atlanta, GA 30303 USA.	twangnoo@gmail.com	Zavorsky, Gerald/AAI-1422-2021; Zavorsky, Gerald S./I-7753-2013	Zavorsky, Gerald S./0000-0002-4473-1601			Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bethune A., 2016, ARCH SUICIDE RES, P1; Brener ND, 2013, MMWR RECOMM REP, V62, P1; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Centers for Disease Control and Prevention, 2015, SUIC PREV; Centers for Disease Control and Prevention, 2015, SUIC FACTS GLANC; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dudovitz RN, 2015, ACAD PEDIATR, V15, P41, DOI 10.1016/j.acap.2014.06.022; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Heron M., 2014, NATL VITAL STAT REP, V65, P1; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kontos AP, 2016, BRIT J SPORT MED, V50, P139, DOI 10.1136/bjsports-2015-095564; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Legome E.L., 2016, POSTCONCUSSIVE SYNDR; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Schneeweiss S, 2010, ARCH GEN PSYCHIAT, V67, P497, DOI 10.1001/archgenpsychiatry.2010.39; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Shepard DS, 2016, SUICIDE LIFE-THREAT, V46, P352, DOI 10.1111/sltb.12225; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Zavorsky GS, 2017, JAMA NEUROL, V74, P485, DOI 10.1001/jamaneurol.2016.6068; Zavorsky GS, 2016, JAMA NEUROL, V73, P1368, DOI 10.1001/jamaneurol.2016.0795	37	5	5	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1401	1407		10.1089/neu.2018.5721		MAR 2020	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000525519900001	30520366				2022-02-06	
J	Mellett, K; Ren, DX; Alexander, S; Osier, N; Beers, SR; Okonkwo, DO; Puccio, AM; Conley, YP				Mellett, Kaleigh; Ren, Dianxu; Alexander, Sheila; Osier, Nicole; Beers, Sue R.; Okonkwo, David O.; Puccio, Ava M.; Conley, Yvette P.			Genetic Variation in the TP53 Gene and Patient Outcomes Following Severe Traumatic Brain Injury	BIOLOGICAL RESEARCH FOR NURSING			English	Article						traumatic brain injury; TBI; p53; patient outcomes; genetic; TP53	MESENCHYMAL STEM-CELLS; TUMOR-SUPPRESSOR GENE; RATING-SCALE; P53; APOPTOSIS; POLYMORPHISM; EXPRESSION; VALIDITY; IMPACT; RISK	Traumatic brain injury (TBI) is a leading cause of death and disability, with more than 5 million people in the United States living with long-term complications related to TBI. This study examined the relationship between TP53, the gene that codes for the protein p53, and outcome variability following severe TBI. The p53 protein impacts neuronal apoptosis following TBI, thus investigation into TP53 genetic variability as a prognosticator for TBI outcomes (mortality, Glasgow Outcome Scale [GOS], Neurobehavioral Rating Scale [NRS], and Disability Rating Scale [DRS]) is warranted. Participants (N = 429) with severe TBI (Glasgow Coma Scale score <= 8) were enrolled into a prospective study with outcomes assessed over 24 months following injury. The single-nucleotide polymorphism Arg72Pro (rs1042522), a functional missense polymorphism for which the CC homozygous genotype is most efficient at inducing apoptosis, was investigated. Individuals with the CC genotype (arginine homozygotes) were more likely to have poorer outcomes at 24 months following TBI compared to individuals with CG/GG genotypes (GOS: p = .048, DRS: p = .022). These findings add to preliminary evidence that p53 plays a role in recovery following TBI and, if further replicated, could support investigations into p53-based therapies for treating TBI.	[Mellett, Kaleigh; Ren, Dianxu; Alexander, Sheila] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Osier, Nicole] Univ Texas Austin, Sch Nursing, Austin, TX 78712 USA; [Osier, Nicole] Univ Texas Austin, Dell Med Sch, Dept Neurol, Austin, TX 78712 USA; [Beers, Sue R.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15261 USA; [Okonkwo, David O.; Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Dept Human Genet, 440 Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA		Conley, YP (corresponding author), Univ Pittsburgh, Sch Nursing, Dept Human Genet, 440 Victoria Bldg,3500 Victoria St, Pittsburgh, PA 15261 USA.	yconley@pitt.edu		Conley, Yvette/0000-0002-1784-6067; Alexander, Sheila/0000-0001-5866-027X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NR013342, P50NS30318]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (grant numbers R01NR013342, P50NS30318).	Centers for Disease Control and Prevention, 2019, TBI GET THE FACTS; Chopp M, 1999, BRAIN RES, V828, P197, DOI 10.1016/S0006-8993(99)01354-2; Christensen B., 2014, GLASGOW OUTCOME SCAL; Chuang TJ, 2012, J TRAUMA ACUTE CARE, V73, P1161, DOI 10.1097/TA.0b013e318265d128; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Deepika A, 2017, NEUROL INDIA, V65, P83, DOI 10.4103/0028-3886.198228; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Faul M, 2010, TRAUMATIC BRAIN INJU; Genetics Home Reference, 2020, TP53 GEN; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; He J, 2017, AGING-US, V9, P852, DOI 10.18632/aging.101196; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morrison RS, 1996, J NEUROSCI, V16, P1337; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; National Institute of Neurological Disorders and Stroke, 2015, NIH PUBLICATION; Orsted DD, 2007, J EXP MED, V204, P1295, DOI 10.1084/jem.20062476; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wan CH, 2014, TOXICOL APPL PHARM, V281, P294, DOI 10.1016/j.taap.2014.10.013; Wan CH, 2013, J MOL NEUROSCI, V51, P695, DOI 10.1007/s12031-013-0050-4; Weaver SM, 2014, CURR PHARM DESIGN, V20, P4275; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012	27	5	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1099-8004	1552-4175		BIOL RES NURS	Biol. Res. Nurs.	JUL	2020	22	3					334	340	1099800420912335	10.1177/1099800420912335		MAR 2020	7	Nursing	Science Citation Index Expanded (SCI-EXPANDED)	Nursing	LV5OA	WOS:000523908200001	32207313	Green Published			2022-02-06	
J	Aggarwal, SS; Ott, SD; Padhye, NS; Schulz, PE				Aggarwal, Seema S.; Ott, Summer D.; Padhye, Nikhil S.; Schulz, Paul E.			Sex, race, ADHD, and prior concussions as predictors of concussion recovery in adolescents	BRAIN INJURY			English	Article						Concussion; recovery; sex; adolescent; race; attention deficit disorder	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; BASE-LINE; NEUROCOGNITIVE PERFORMANCE; PROTRACTED RECOVERY; SYMPTOMS; INJURY; CHILDREN; AMERICAN; DISORDER	Objective: Concussions in adolescents are a growing public health concern as the popularity of high school sports increases. The aim of this study was to identify clinical (e.g., prior concussion, migraine history, learning disabilities/attention deficit hyperactivity disorders [ADHD]) and demographic factors (e.g., sex, race, health insurance, mechanism of injury/sport, education) that predict concussion recovery times. Design: In a retrospective cohort study of adolescents 13-19 years old evaluated for an acute concussion (<= 10 days from injury), recovery times were calculated from the date of concussive injury to the date of clearance to return to play or normal activities. Results: The sample (N = 227) was primarily male (75%), and the median age was 15 years. Predictors of protracted recovery were ADHD (hazard ratio [HR] =.449, 95% confidence interval [CI] =.272-.741, p = .002) and prior concussion (HR =.574, 95% CI =.397-.828, p = .003) in all sex and race groups, while shorter recovery times were predicted by Hispanic and African American race (HR = 2.12, 95% CI = 1.30-3.46, p = .003), with White females as the reference group. Conclusions: Further research is needed to examine the role of sex, race, ADHD, and concussion history on concussion outcomes.	[Aggarwal, Seema S.; Padhye, Nikhil S.] Univ Texas Hlth Sci Ctr Houston, Ctr Nursing Res, Cizik Sch Nursing, Houston, TX 77030 USA; [Ott, Summer D.] Univ Texas Hlth Sci Ctr Houston, Dept Orthoped, McGovern Med Sch UTHlth, Houston, TX 77030 USA; [Schulz, Paul E.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, McGovern Med Sch, Houston, TX 77030 USA		Aggarwal, SS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Cizik Sch Nursing, 6901 Bertner Ave,Ste 535-C, Houston, TX 77030 USA.	seema.s.aggarwal@uth.tmc.edu		Padhye, Nikhil/0000-0001-5738-7486			Aggarwal SS, 2019, APPL NEUROPSYCH-CHIL, V8, P50, DOI 10.1080/21622965.2017.1381099; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baker JG, 2015, CLIN PEDIATR, V54, P961, DOI 10.1177/0009922815588820; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Bramley H, 2015, PEDIATR NEUROL, V52, P493, DOI 10.1016/j.pediatrneurol.2015.01.008; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Chand MR, 2020, CLIN J SPORT MED, V30, pS36, DOI 10.1097/JSM.0000000000000554; Christino MA, 2015, J AM ACAD ORTHOP SUR, V23, P501, DOI 10.5435/JAAOS-D-14-00173; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Dillard C, 2017, DISABIL REHABIL, V39, P544, DOI 10.3109/09638288.2016.1152602; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Hang B, 2015, PEDIATR EMERG CARE, V31, P688, DOI 10.1097/PEC.0000000000000438; Harmon KG, 2019, CLIN J SPORT MED, V29, P87, DOI 10.1097/JSM.0000000000000720; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey KP, 2017, J CONCUSSION, V1, p205970021770708, DOI [10.1177/2059700217707084, DOI 10.1177/2059700217707084]; Holmes L, 2016, SPORTS MED-OPEN, V2, DOI 10.1186/s40798-016-0058-8; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Morris JC, 2019, JAMA NEUROL, V76, P264, DOI 10.1001/jamaneurol.2018.4249; National Federation of State High School Associations, 2018, 2017-18 High School Athletics Participation Survey; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Pinto SM, 2017, PM&R, V9, P847, DOI 10.1016/j.pmrj.2016.12.009; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Ruiz-Goikoetxea M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018027; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Wallace J., 2017, J ATHL TRAINING, V52, P422, DOI [10.4085/1062-6050-52.3.05, DOI 10.4085/1062-6050-52.3.05]; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P894, DOI 10.1007/s40615-017-0437-y; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Womble MN, 2021, CLIN J SPORT MED, V31, pE193, DOI 10.1097/JSM.0000000000000761; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	65	5	5	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 11	2020	34	6					811	819		10.1080/02699052.2020.1740942		MAR 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MT6UU	WOS:000524119900001	32200661				2022-02-06	
J	Merritt, VC; Clark, AL; Evangelista, ND; Sorg, SF; Schiehser, DM; Delano-Wood, L				Merritt, Victoria C.; Clark, Alexandra L.; Evangelista, Nicole D.; Sorg, Scott F.; Schiehser, Dawn M.; Delano-Wood, Lisa			Dissociation of BDNF Val66Met polymorphism on neurocognitive functioning in military veterans with and without a history of remote mild traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						Brain-derived neurotrophic factor; cognition; mild traumatic brain injury; neuropsychological assessment; military Veterans	NEUROTROPHIC FACTOR VAL66MET; VAL(66)MET POLYMORPHISM; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; HUMAN-MEMORY; FACTOR GENE; COGNITION; ALLELE; IMPACT; PTSD	Objective: Since neurocognitive functioning following mild traumatic brain injury (mTBI) may be influenced by genetic factors that mediate synaptic survival and repair, we examined the influence of a common brain-derived neurotrophic factor (BDNF) polymorphism (Val66Met) on cognition using a well-defined sample of military Veterans with and without a history of mTBI. Method: Participants included 138 Veterans (mTBI = 75; military controls [MCs] = 63) who underwent neuropsychological testing, including completion of self-report measures assessing psychiatric distress, and BDNF genotyping. The mTBI group was tested roughly 66.7 months following their most recent mTBI. Veterans were divided into two groups-Met+ (Met/Met and Met/Val; n = 49) and Met- (Val/Val; n = 89) and compared on domain-specific cognitive composite scores representing memory, executive functioning, and visuospatial speed. Results: ANCOVAs adjusting for psychiatric distress, sex, years of education, and ethnicity/race revealed a significant group (mTBI vs. MC) by BDNF genotype (Met + vs. Met-) interaction for the memory (p = .024; eta(2)(p) = .039) and executive functioning (p = .010; eta(2)(p) = .050) composites, such that Met+ mTBI Veterans demonstrated better performance than Met- mTBI Veterans on the cognitive measures, whereas Met+ MCs demonstrated worse performance relative to Met- MCs on the cognitive measures. No significant interaction was observed for the visuospatial speed composite (p = .938; eta(2)(p) < .001). Conclusions: These findings offer preliminary evidence to suggest that the Met allele may be protective in the context of remote mTBI. Findings need to be replicated using larger samples, and future studies are necessary to elucidate the precise mechanisms and neural underpinnings of this interaction.	[Merritt, Victoria C.; Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Res & Psychol Serv, San Diego, CA USA; [Merritt, Victoria C.; Clark, Alexandra L.; Sorg, Scott F.; Schiehser, Dawn M.; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Evangelista, Nicole D.] Univ Florida, Coll Publ Hlth & Hlth Profess, Ctr Cognit Aging & Memory, Dept Clin & Hlth Psychol,McKnight Brain Inst, Gainesville, FL USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Veterans Affairs grants [829-MR-NB25860, CDA-2-065-10S]; Department of DefenseUnited States Department of Defense [W81XWH-10-2-0169]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS09870]; VA Clinical Science Research & Development Service [IK2 CX001952, CDA-2-CX001508]	This work was supported by Veterans Affairs grants awarded to Drs. Delano-Wood (829-MR-NB25860) and Schiehser (CDA-2-065-10S). This work was further supported by grants awarded by the Department of Defense (W81XWH-10-2-0169) to Dr. Delano-Wood and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (F31NS09870) to Dr. Clark. Finally, Drs. Merritt and Sorg received salary support during this work from Career Development Awards from the VA Clinical Science Research & Development Service (IK2 CX001952 and CDA-2-CX001508, respectively).	Adachi Naoki, 2014, World J Biol Chem, V5, P409, DOI 10.4331/wjbc.v5.i4.409; Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barbey AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088733; Bath KG, 2006, COGN AFFECT BEHAV NE, V6, P79, DOI 10.3758/CABN.6.1.79; Bekinschtein P, 2008, NEUROSCIENTIST, V14, P147, DOI 10.1177/1073858407305850; Belanger H. G., 2018, TXB CLIN NEUROPSYCHO; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bennett E. R., 2016, TRANSLATIONAL RES TR, P1; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boosman H, 2017, NEUROPSYCHOL REHABIL, V27, P581, DOI 10.1080/09602011.2015.1113996; Borodinova A.A., 2017, NEUROSCIENCE BEHAV P, V47, P251, DOI [10.1007/s11055-017-0391-5, DOI 10.1007/S11055-017-0391-5, DOI 10.1007/s11055-017-0391-5]; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Chen Zhe-Yu, 2008, Novartis Found Symp, V289, P180; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dincheva I, 2012, NEUROSCIENTIST, V18, P439, DOI 10.1177/1073858411431646; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; DVBIC. Defense and Veterans Brain Injury Center, 2018, DOD NUMB TRAUM BRAIN; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Finan JD, 2018, J ALZHEIMERS DIS, V65, P1055, DOI 10.3233/JAD-180585; Forde NJ, 2014, NEUROIMAGE, V90, P280, DOI 10.1016/j.neuroimage.2013.12.050; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Griesbach GS, 2018, J NEUROTRAUM, V35, P17, DOI 10.1089/neu.2017.5103; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Heaton R., 2000, WISCONSIN CARD SORTI; Ho BC, 2006, ARCH GEN PSYCHIAT, V63, P731, DOI 10.1001/archpsyc.63.7.731; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Keane T.M., 1991, PCL M DSM 4; Keen S. M., 2008, J REHABILITATION RES, V45, P1; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kim SN, 2013, PSYCHIAT INVEST, V10, P173, DOI 10.4306/pi.2013.10.2.173; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Mandelman SD, 2012, GENES BRAIN BEHAV, V11, P127, DOI 10.1111/j.1601-183X.2011.00738.x; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; Mata J, 2010, HEALTH PSYCHOL, V29, P130, DOI 10.1037/a0017261; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Meyers JE., 1995, REY COMPLEX FIGURE T; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Narayanan V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158838; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Qin LY, 2014, J NEUROSCI, V34, P2493, DOI 10.1523/JNEUROSCI.4140-13.2014; Qin LY, 2011, J NEUROSCI, V31, P775, DOI 10.1523/JNEUROSCI.4547-10.2011; Reid MW, 2014, J NEUROTRAUM, V31, P1899, DOI 10.1089/neu.2014.3455; Rybakowski JK, 2003, BIPOLAR DISORD, V5, P468, DOI 10.1046/j.1399-5618.2003.00071.x; Rybakowski JK, 2006, PSYCHIAT CLIN NEUROS, V60, P70, DOI 10.1111/j.1440-1819.2006.01462.x; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shen T, 2018, AGING DIS, V9, P523, DOI 10.14336/AD.2017.0717; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Toh YL, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1009; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tost H, 2013, NEUROPSYCHOPHARMACOL, V38, P525, DOI 10.1038/npp.2012.214; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D, 2011, WASI 2 WECHSLER ABBR; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	88	5	5	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1226	1247		10.1080/13854046.2020.1740324		MAR 2020	22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000524154400001	32204647	Green Accepted			2022-02-06	
J	Swain, NR; Eadie, PA; Snow, PC				Swain, Nathaniel R.; Eadie, Patricia A.; Snow, Pamela C.			Speech and language therapy for adolescents in youth justice: A series of empirical single-case studies	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						intervention; language; literacy; developmental language disorder; adolescents; speech and language therapy; service delivery	TRAUMATIC BRAIN-INJURY; YOUNG OFFENDERS; COMMUNICATIVE ABILITY; JUVENILE-OFFENDERS; IMPAIRMENT; CHILDREN; INTERVENTION; COMPETENCE; RISK; COMPREHENSION	Background Adolescents in contact with youth justice are a vulnerable and marginalized group at high risk of developmental language disorder (DLD) and other communication difficulties. Though preliminary studies have demonstrated the benefits of speech and language therapy (SLT) services in youth justice, limited research has empirically tested the efficacy of intervention in these settings. Aims To evaluate the extent to which intensive, one-to-one language intervention improved the communication skills of incarcerated adolescents with below-average (> 1 SD below the mean) language and/or literacy skills. Methods & Procedures A series of four empirical single case studies was conducted, using multiple baseline intervention design. Individualized intervention programmes were administered, and progress on outcome measures (probes) was evaluated throughout the baseline, intervention and maintenance phases using Tau-U, a non-parametric distribution-free statistic. Additional measures were used as secondary outcomes of the intervention, including standardized language subtests, subjective rating tools by participants and their teachers collected pre- and post-intervention, and a brief structured participant interview, independently administered by youth justice staff. Outcomes & Results Medium-to-large effect sizes, the majority of which were statistically significant, were detected on the primary outcome measure across the four cases, indicating improvements in the targeted communication skills. Positive results were also evident in comparisons of pre- and post-measures on standardized language subtests, subjective self- and teacher ratings of communication, and the participants' impressions of the interventions. For those participants who could be followed up, gains in language skills were generally maintained at 1 month post-intervention. Conclusions & Implications This study provides further evidence of the efficacy of one-to-one SLT intervention for adolescents in youth justice in order to address language and literacy difficulties. These findings inform future SLT service provision for adolescents in these settings, with clear policy and practice implications. Future research should investigate the wider benefits to individuals' engagement in youth justice intervention and recidivism, as well as assessing maintenance of gains over a longer period. What this paper adds What this paper adds to existing knowledgeWhat is already known on this subject What are the potential or actual clinical implications of this work? The high rates of DLD in youth justice is well known, with difficulties spanning multiple areas of language and literacy. SLTs are increasingly working in community and custodial youth justice settings, and a few preliminary studies have demonstrated the effectiveness of such work. This study extends the evidence base of the efficacy of SLT for language and literacy difficulties in youth justice, using a series of four empirical single case studies. It is also argued that SLT should be more actively considered in planning multidisciplinary interventions for young people in custody. The results of this research support current moves to include SLT services in youth justice systems, and illustrate for clinicians currently working in this sector a way of structuring and measuring the impact of intervention services.	[Swain, Nathaniel R.] Parkville Coll, Dept Educ & Training, 930 Pk St, Parkville, Vic 3052, Australia; [Eadie, Patricia A.] Univ Melbourne, Melbourne Grad Sch Educ, Parkville, Vic, Australia; [Snow, Pamela C.] La Trobe Univ, Sch Educ, Bendigo, Vic, Australia		Swain, NR (corresponding author), Parkville Coll, Dept Educ & Training, 930 Pk St, Parkville, Vic 3052, Australia.	nrswain@outlook.com	Swain, Nathaniel/C-7178-2014	Swain, Nathaniel/0000-0002-4608-2246; Eadie, Tricia/0000-0001-5555-8325	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1074831]	The authors thank the VictorianGovernmentDepartment ofHealth andHuman Services for approval of this research, and well as theNational Health and Medical Research Council (Grant ID: 1074831) for funding of this study. We also greatly appreciate the time given by the participants. Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Anderson P, 2001, CLIN NEUROPSYCHOL, V15, P81, DOI 10.1076/clin.15.1.81.1905; Anderson PJ., 2000, CLIN NEUROPSYCHOL AS, V1, P247; Anderson SAS, 2016, CHILD YOUTH SERV REV, V65, P195, DOI 10.1016/j.childyouth.2016.04.004; Andrews DA, 2010, PSYCHOL PUBLIC POL L, V16, P39, DOI 10.1037/a0018362; Antoniazzi D, 2010, INT J SPEECH-LANG PA, V12, P244, DOI 10.3109/17549500903104447; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Asscher JJ, 2013, J EXP CRIMINOL, V9, P169, DOI 10.1007/s11292-012-9165-9; Australian Bureau of Statistics, 2011, AUSTR NZ STAND OFF C; Beitchman JH, 1999, J CLIN CHILD PSYCHOL, V28, P312, DOI 10.1207/S15374424jccp280303; Bishop DVM, 2017, J CHILD PSYCHOL PSYC, V58, P1068, DOI 10.1111/jcpp.12721; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Bryan K, 2013, CHILD LANG TEACH THE, V29, P359, DOI 10.1177/0265659013482930; Burgess P.W., 1996, BEHAV ASSESSMENT DYS, P18; BURGOON JK, 1984, HUM COMMUN RES, V10, P601, DOI 10.1111/j.1468-2958.1984.tb00034.x; Conti-Ramsden G, 2012, LANG SPEECH HEAR SER, V43, P507, DOI 10.1044/0161-1461(2012/11-0067); Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Ebbels SH, 2014, INT J LANG COMM DIS, V49, P30, DOI 10.1111/1460-6984.12047; Finn JD, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P97, DOI 10.1007/978-1-4614-2018-7_5; Gast D. L., 2010, SINGLE SUBJECT RES M, DOI [10.1177/1088357610391087, DOI 10.1177/1088357610391087]; Goncalves LC, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0803-z; Gregory J, 2011, INT J LANG COMM DIS, V46, P202, DOI 10.3109/13682822.2010.490573; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Griffiths AJ, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P563, DOI 10.1007/978-1-4614-2018-7_27; Howick J., 2009, OXFORD CTR EVIDENCE; Hughes N, 2017, J CHILD PSYCHOL PSYC, V58, P1106, DOI 10.1111/jcpp.12791; Jordan K. P., 2014, NO KENTUCKY LAW REV, V311, P187; Justice LM, 2017, AM J SPEECH-LANG PAT, V26, P57, DOI 10.1044/2016_AJSLP-15-0058; Ledford JR, 2014, NEUROPSYCHOL REHABIL, V24, P332, DOI 10.1080/09602011.2013.861352; Lipsey MW, 2009, VICTIMS OFFENDERS, V4, P124, DOI 10.1080/15564880802612573; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Martens R, 2014, CLIN NEUROPSYCHOL, V28, P954, DOI 10.1080/13854046.2014.939228; McDonald S., 2011, AWARENESS SOCIAL INF; McKean C, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1684; Murphy A, 2017, CHILD LANG TEACH THE, V33, P129, DOI 10.1177/0265659016656906; National Health and Medical Research Council, 2018, GUID GUID ASS CERT E; Nippold M. A., 2007, LATER LANGUAGE DEV S; Noel KK, 2014, TOP LANG DISORD, V34, P344, DOI 10.1097/TLD.0000000000000036; Offender Health Research Network, 2013, COMPR HLTH ASS TOOL; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; Prior M, 2011, INT J LANG COMM DIS, V46, P489, DOI 10.1111/j.1460-6984.2011.00003.x; Quinn S, 2018, J COMMUN DISORD, V72, P1, DOI 10.1016/j.jcomdis.2018.02.001; Reed V. A., 2005, INTRO CHILDREN LANGU, P168; Reyes MR, 2012, J EDUC PSYCHOL, V104, P700, DOI 10.1037/a0027268; Richards K, 2014, YOUTH JUSTICE, V14, P122, DOI 10.1177/1473225414526799; Rispoli M, 2013, J BEHAV EDUC, V22, P66, DOI 10.1007/s10864-012-9164-y; Ross A, 2006, APHASIOLOGY, V20, P427, DOI 10.1080/02687030500532786; Rost GC, 2012, AM J SPEECH-LANG PAT, V21, P101, DOI 10.1044/1058-0360(2011/10-0094); Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Salter W., 2007, PHONOLOGICAL AWARENE; Semel E., 2006, CLIN EVALUATION LANG; Snow P., 2004, CURRENT ISSUES CRIMI, V16, DOI 10.1080/10345329.2004.12036317; Snow P. C., 2009, COMMUNICATION HEALTH, P101; Snow P.C., 2004, INT J SPEECH LANGUAG, V6, P221, DOI [DOI 10.1080/14417040400010132, 10.1080/14417040400010132]; Snow P, 2012, TRENDS ISS CRIME CRI, P1; Snow PC, 2008, CHILD SOC, V22, P16, DOI 10.1111/j.1099-0860.2006.00076.x; Snow PC, 2017, INT J SPEECH-LANG PA, V19, P392, DOI 10.1080/17549507.2016.1216600; Snow PC, 2016, INT J SPEECH-LANG PA, V18, P20, DOI 10.3109/17549507.2015.1081291; Snow PC, 2015, INT J LANG COMM DIS, V50, P1, DOI 10.1111/1460-6984.12117; Snow PC, 2011, INT J SPEECH-LANG PA, V13, P480, DOI 10.3109/17549507.2011.578661; Starling J, 2012, LANG SPEECH HEAR SER, V43, P474, DOI 10.1044/0161-1461(2012/11-0066); Stein N. L., 1975, NEW DIRECTIONS DISCO, P53; Swain N. R., SOCIAL COGNITION EXE; Syngelaki EM, 2009, CRIM JUSTICE BEHAV, V36, P1213, DOI 10.1177/0093854809343095; Tan XY, 2014, DEV NEUROREHABIL, V17, P125, DOI 10.3109/17518423.2013.863236; The Civil Rights Project, 2000, OPP SUSP DEV CONS ZE; Wagner RK., 1999, COMPREHENSIVE TEST P; Wald Johanna, 2003, New Dir Youth Dev, P9, DOI 10.1002/yd.51; Woodcock R. W., 2001, WOODCOCK JOHNSON TES, V3rd	69	5	5	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	JUL	2020	55	4					458	479		10.1111/1460-6984.12529		MAR 2020	22	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	MI8XS	WOS:000520767700001	32196891				2022-02-06	
J	Zhou, RZ; Li, Y; Cavanaugh, JM; Zhang, LY				Zhou, Runzhou; Li, Yan; Cavanaugh, John M.; Zhang, Liying			Investigate the Variations of the Head and Brain Response in a Rodent Head Impact Acceleration Model by Finite Element Modeling	FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY			English	Article						traumatic brain injury; head impact acceleration model; diffuse axonal injury; finite element rat model; brain strain; head linear acceleration; head angular velocity	IMPAIRED AXONAL-TRANSPORT; INJURY; DIFFUSE; RAT; TRAUMA; ENERGY; MOTOR; STEM; EXPRESSION; SEVERITY	Diffuse axonal injury (DAI) is a severe form of traumatic brain injury and often induced by blunt trauma. The closed head impact acceleration (IA) model is the most widely used rodent DAI model. However, this model results in large variations of injury severity. Recently, the impact device/system was modified to improve the consistency of the impact energy, but variations of the head kinematics and subsequent brain injuries were still observed. This study was aimed to utilize a Finite Element (FE) model of a rat head/body and simulation to investigate the potential biomechanical factors influencing the impact energy transfer to the head. A detailed FE rat head model containing detailed skull and brain anatomy was developed based on the MRI, microCT and atlas data. The model consists of over 722,000 elements, of which 310,000 are in the brain. The white matter structures consisting of highly aligned axonal fibers were simulated with transversely isotropic material. The rat body was modeled to provide a realistic boundary at the spine-medulla junction. Rodent experiments including dynamic cortical deformation, brain-skull displacement, and IA kinematics were simulated to validate the FE model. The model was then applied to simulate the rat IA experiments. Parametric studies were conducted to investigate the effect of the helmet inclination angles (0 degrees-5 degrees) and skull stiffness (varied 20%) on the resulting head kinematics and maximum principal strain in the brain. The inclination angle of the helmet at 5 degrees could vary head linear acceleration by 8-31%. The change in head rotational velocity was inversely related to the change in linear acceleration. Varying skull stiffness resulted in changes in head linear acceleration by 3% but with no effect on rotational velocity. The brain strain in the corpus callosum was only affected by head rotation while the strain in the brainstem was influenced by the combined head kinematics, local skull deformation, and head-neck position. Validated FE models of rat impact head injury can assist in exploring various biomechanical factors influencing the head impact response and internal brain response. Identification of these variables may help explain the variability of injury severity observed among experiments and across different labs.	[Zhou, Runzhou; Li, Yan; Cavanaugh, John M.; Zhang, Liying] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA		Zhang, LY (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.	lzhang@wayne.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 EB006508]	The study was supported by NIH R01 EB006508.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Arora Tushar, 2019, Stapp Car Crash J, V63, P65; Bain AC, 2003, J BIOMECH ENG-T ASME, V125, P798, DOI 10.1115/1.1632627; Baumgartner D, 2004, REV EUROPEENNE ELEME, V14, P421; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fei Z, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-96; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Fijalkowski RJ, 2009, STAPP CAR CRASH JO, V53, P193; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; Jin X, 2014, ANN BIOMED ENG, V42, P812, DOI 10.1007/s10439-013-0948-6; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; Kallakuri S, 2003, EXP BRAIN RES, V148, P419, DOI 10.1007/s00221-002-1307-2; Kallakuri S, 2007, NEUROL RES, V29, P362, DOI 10.1179/016164107X204675; Kallemeyn N, 2010, MED ENG PHYS, V32, P482, DOI 10.1016/j.medengphy.2010.03.001; Karami G, 2009, J MECH BEHAV BIOMED, V2, P243, DOI 10.1016/j.jmbbm.2008.08.003; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Li Yan, 2011, Stapp Car Crash J, V55, P25; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Macdonald RL, 2005, NEUROSURGERY, V56, P588; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Pena A, 2005, ACT NEUR S, V95, P333; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; Prange M T, 2000, Stapp Car Crash J, V44, P205; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Rhodes JKJ, 2002, NEUROSCI LETT, V335, P1, DOI 10.1016/S0304-3940(02)00811-X; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Sengul G, 2008, J CLIN NEUROSCI, V15, P1125, DOI 10.1016/j.jocn.2007.11.005; Shreiber D. I., 1997, P 41 STAPP CAR CRASH; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2011, J NEUROSCI METH, V198, P93, DOI 10.1016/j.jneumeth.2011.03.024; Zhang QH, 2006, J BIOMECH, V39, P189, DOI 10.1016/j.jbiomech.2004.10.029; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	71	5	5	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-4185			FRONT BIOENG BIOTECH	Front. Bioeng. Biotechnol.	MAR 18	2020	8								172	10.3389/fbioe.2020.00172			16	Biotechnology & Applied Microbiology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Science & Technology - Other Topics	LD0CY	WOS:000525702400001	32258009	Green Published, gold			2022-02-06	
J	Tomura, S; Seno, S; Kawauchi, S; Miyazaki, H; Sato, S; Kobayashi, Y; Saitoh, D				Tomura, Satoshi; Seno, Soichiro; Kawauchi, Satoko; Miyazaki, Hiromi; Sato, Shunichi; Kobayashi, Yasushi; Saitoh, Daizoh			A novel mouse model of mild traumatic brain injury using laser-induced shock waves	NEUROSCIENCE LETTERS			English	Article						Shock waves; Blast injury; Mild TBI; Neurobehavioral change; Cell proliferation	DENTATE GYRUS; BLAST INJURY; ENHANCED NEUROGENESIS; CELL-PROLIFERATION; EXPRESSING NEURONS; ADULT RATS; NEUROTRAUMA; HIPPOCAMPAL; DEFICITS; IMPACT	Blast-induced mild traumatic brain injury (mild bTBI) has been a frequent battlefield injury in soldiers during the conflicts in Iraq and Afghanistan. Understanding the pathophysiology and determining effective treatments for mild bTBI has become an international problem in the field of neurotrauma research. Contributing to this problem is a lack of an experimental model that accurately mimics the characteristics of mild bTBI. To date, the "mild" versions of common experimental models of TBI have simply been less severe degrees of traumatic injury; these animals do not necessarily exhibit the clinical characteristics of mild bTBI seen in humans. Therefore, our first objective was to develop a highly controlled mouse model of bTBI using laser-induced shockwaves (LISWs). We established the parameters necessary to cause a reproducible injury of very mild severity, the most important feature seen in clinical practice. We defined very mild bTBI as having no traumatic change on the head visible to the naked eye after the insult was applied using very mild shockwaves to the heads of mice. Our very mild bTBI mouse model exhibited neurobehavioral changes in the chronic phase, such as cognitive impairment and depression-like behavior. We also observed an increase in 5-bromo-2'-deoxyuridine-positive, proliferating cells in the dentate gyrus during the acute phase and a subsequent decrease during the chronic phase. This model appears to be an accurate representation of the damage occurring in actual mild bTBI patients. We also found that an increase in cell proliferation in the dentate gyrus during the acute phase is the most prominent feature after a TBI.	[Tomura, Satoshi; Seno, Soichiro; Miyazaki, Hiromi; Saitoh, Daizoh] Natl Def Med Coll, Res Inst, Div Traumatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan; [Kawauchi, Satoko; Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Bioinformat & Therapeut Syst, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan; [Kobayashi, Yasushi] Natl Def Med Coll, Dept Anat & Neurobiol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan		Tomura, S (corresponding author), Natl Def Med Coll, Res Inst, Div Traumatol, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	tomura@ndmc.ac.jp					Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Anegawa E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143909; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bodian D, 1936, ANAT REC, V65, P89, DOI 10.1002/ar.1090650110; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Covolan L, 2000, HIPPOCAMPUS, V10, P169, DOI 10.1002/(SICI)1098-1063(2000)10:2<169::AID-HIPO6>3.0.CO;2-W; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; HATANO B, 2011, PROC SPIE, DOI DOI 10.1117/12.875909; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Miyazaki H, 2015, ACTA NEUROCHIR, V157, P2111, DOI 10.1007/s00701-015-2613-3; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Satoh Y, 2010, LASER SURG MED, V42, P313, DOI 10.1002/lsm.20899; Sawyer TW, 2018, SHOCK WAVES, V28, P85, DOI 10.1007/s00193-017-0756-2; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sundaramurthy A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00253; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	37	5	5	1	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 16	2020	721								134827	10.1016/j.neulet.2020.134827			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW1QA	WOS:000520944800021	32036028				2022-02-06	
J	Jak, AJ; Jurick, S; Hoffman, S; Evangelista, ND; Deford, N; Keller, A; Merritt, VC; Sanderson-Cimino, M; Sorg, S; Delano-Wood, L; Bangen, KJ				Jak, Amy J.; Jurick, Sarah; Hoffman, Samantha; Evangelista, Nicole D.; Deford, Nicole; Keller, Amber; Merritt, Victoria C.; Sanderson-Cimino, Mark; Sorg, Scott; Delano-Wood, Lisa; Bangen, Katherine J.			PTSD, but not history of mTBI, is associated with altered myelin in combat-exposed Iraq and Afghanistan Veterans	CLINICAL NEUROPSYCHOLOGIST			English	Article						Mild TBI; myelin; neuroimaging; neuropsychology; PTSD; Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; TENSOR IMAGING FINDINGS; WHITE-MATTER; COGNITIVE IMPAIRMENT; MAJOR DEPRESSION; ENDURING FREEDOM; MILD TBI; DEPLOYMENT; RISK	Objective: To investigate the biological, cognitive, and psychological presentations of combat-exposed Veterans with a history of mild traumatic brain injury (mTBI) and/or posttraumatic stress disorder (PTSD) using a novel white matter imaging technique and comprehensive neuropsychological assessment. Method: 74 Iraq and Afghanistan Veterans (mean age 33.89, 90.5% male) with history of mTBI (average 7.25 years since injury), PTSD, both, or neither underwent magnetic resonance imaging (MRI) exams including acquisition of a novel imaging technique, multicomponent-driven equilibrium single-pulse observation of T1/T2 (mcDESPOT) to quantify myelin water fraction (MWF), a surrogate measure of myelin content. Participants also underwent comprehensive neuropsychological assessment and three cognitive composite scores (memory, working memory/processing speed, and executive functioning) were created. Results: There were no significant group differences on the neuropsychological composite scores. ANCOVAs revealed a main effect of PTSD across all a priori regions of interest (ROI) in which PTSD was associated with higher MWF. There was no main effect of mTBI history or TBI by PTSD interaction on any ROI. Significant positive associations were observed between myelin and PTSD symptoms, but no significant associations were found between myelin and neurobehavioral symptoms. No significant associations were found between myelin in the a priori ROIs and the cognitive composite scores. Conclusion: This study did not find neuropsychological or MWF differences in combat Veterans with a remote history of mTBI but did find myelin alterations related to PTSD. Psychological trauma should be a primary target for intervention in Veterans with comorbid PTSD and mTBI reporting subjective complaints, given its salience.	[Jak, Amy J.; Jurick, Sarah; Hoffman, Samantha; Keller, Amber; Merritt, Victoria C.; Sorg, Scott; Delano-Wood, Lisa; Bangen, Katherine J.] VASDHS, San Diego, CA USA; [Jak, Amy J.; Jurick, Sarah; Delano-Wood, Lisa] VASDHS Ctr Excellence Stress & Mental Hlth CESAMH, San Diego, CA USA; [Jak, Amy J.; Hoffman, Samantha; Sanderson-Cimino, Mark; Sorg, Scott; Delano-Wood, Lisa; Bangen, Katherine J.] Univ Calif San Diego, Dept Psychiat, San Diego Sch Med, San Diego, CA 92103 USA; [Evangelista, Nicole D.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Deford, Nicole] Naval Med Ctr San Diego, San Diego, CA USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA.	ajak@ucsd.edu		Hoffman, Samantha/0000-0002-2792-8576	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095]; Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001135]; VA San Diego Center of Excellence for Stress and Mental Health (CESAMH)	This work was supported by Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) under Award W81XWH-13-2-0095 and Department of Veterans Affairs under Award I01 CX001135 with additional support and resources of the VA San Diego Center of Excellence for Stress and Mental Health (CESAMH).	Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Benedict R. H. B., 1997, BRIEF VISUOSPATIAL M, DOI [10.1037/1040-3590.8.2.145, DOI 10.1037/1040-3590.8.2.145]; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bodapati AS, 2019, CLIN NEUROPSYCHOL, V33, P539, DOI 10.1080/13854046.2018.1482003; Bolzenius JD, 2018, J HEAD TRAUMA REHAB, V33, P393, DOI 10.1097/HTR.0000000000000378; Bouhrara M, 2016, MAGN RESON MED, V75, P2406, DOI 10.1002/mrm.25801; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chao LDL, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00333; Chetty S, 2014, MOL PSYCHIATR, V19, P1275, DOI 10.1038/mp.2013.190; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Deoni SCL, 2015, MAGN RESON MED, V73, P161, DOI 10.1002/mrm.25108; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Green P, 2004, GREENS MED SYMPTOM V; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jak A, 2017, CURR TREAT OPTIONS P, V4, P231, DOI [10.1007/s40501-017-0119-8, DOI 10.1007/s40501-017-0119-8]; Jak AJ, 2019, J NEUROL NEUROSUR PS, V90, P333, DOI 10.1136/jnnp-2018-319315; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Jurick SM, 2018, BRAIN INJURY, V32, P1256, DOI 10.1080/02699052.2018.1493225; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Kongs K. S., 2000, WISCONSIN CARD SORTI; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mattson EK, 2019, NEUROPSYCHOLOGY, V33, P913, DOI 10.1037/neu0000560; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Merritt VC, 2019, J CLIN EXP NEUROPSYC, V41, P665, DOI 10.1080/13803395.2019.1610161; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nelson LD, 2019, JAMA NEUROL, V76, P1049, DOI 10.1001/jamaneurol.2019.1313; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Purger D, 2016, NEUROPHARMACOLOGY, V110, P563, DOI 10.1016/j.neuropharm.2015.08.001; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sheehan DV., 2014, MINI INT NEUROPSYCHI; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spader HS, 2019, J NEUROSURG, V130, P1321, DOI 10.3171/2017.12.JNS171597; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Taber Katherine H, 2013, J Neuropsychiatry Clin Neurosci, V25, P1, DOI 10.1176/appi.neuropsych.12120401; Takase H, 2018, BEHAV BRAIN RES, V340, P205, DOI 10.1016/j.bbr.2016.10.042; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tombaugh T.N., 1996, TEST MEMORY MALINGER; VA/DoD, 2016, VA DOD CLIN PRACT GU; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, BRAIN INJURY, V29, P1581, DOI 10.3109/02699052.2015.1075151; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler, 2008, WAIS 4 ADM SCORING M; West DJ, 2019, NEUROIMAGE, V195, P78, DOI 10.1016/j.neuroimage.2019.03.049; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	83	5	5	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 22	2020	34	6			SI		1070	1087		10.1080/13854046.2020.1730975		MAR 2020	18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MV0HS	WOS:000520350000001	32176590				2022-02-06	
J	Kim, J; Adams, AA; Gokina, P; Zambrano, B; Jayakumaran, J; Dobrowolski, R; Maurel, P; Pfister, BJ; Kim, HA				Kim, Jihyun; Adams, Alexandra A.; Gokina, Pradeepa; Zambrano, Brayan; Jayakumaran, Jeyanthan; Dobrowolski, Radek; Maurel, Patrice; Pfister, Bryan J.; Kim, Haesun A.			Mechanical stretch induces myelin protein loss in oligodendrocytes by activating Erk1/2 in a calcium-dependent manner	GLIA			English	Article						calcium; Erk1; 2; MBP; mechanotransduction; myelin; oligodendrocytes; TBI	MAPK ACTIVATION; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; INJURY; GROWTH; DAMAGE; RAT; MECHANOTRANSDUCTION; DIFFERENTIATION; INVOLVEMENT	Myelin loss in the brain is a common occurrence in traumatic brain injury (TBI) that results from impact-induced acceleration forces to the head. Fast and abrupt head motions, either resulting from violent blows and/or jolts, cause rapid stretching of the brain tissue, and the long axons within the white matter tracts are especially vulnerable to such mechanical strain. Recent studies have shown that mechanotransduction plays an important role in regulating oligodendrocyte progenitors cell differentiation into oligodendrocytes. However, little is known about the impact of mechanical strain on mature oligodendrocytes and the stability of their associated myelin sheaths. We used an in vitro cellular stretch device to address these questions, as well as characterize a mechanotransduction mechanism that mediates oligodendrocyte responses. Mechanical stretch caused a transient and reversible myelin protein loss in oligodendrocytes. Cell death was not observed. Myelin protein loss was accompanied by an increase in intracellular Ca2+ and Erk1/2 activation. Chelating Ca2+ or inhibiting Erk1/2 activation was sufficient to block the stretch-induced loss of myelin protein. Further biochemical analyses revealed that the stretch-induced myelin protein loss was mediated by the release of Ca2+ from the endoplasmic reticulum (ER) and subsequent Ca2+-dependent activation of Erk1/2. Altogether, our findings characterize an Erk1/2-dependent mechanotransduction mechanism in mature oligodendrocytes that de-stabilizes the myelination program.	[Kim, Jihyun; Adams, Alexandra A.; Gokina, Pradeepa; Zambrano, Brayan; Jayakumaran, Jeyanthan; Dobrowolski, Radek; Maurel, Patrice; Kim, Haesun A.] Rutgers State Univ, Dept Biol Sci, Boyden Hall Rm 206,195 Univ Ave, Newark, NJ 07102 USA; [Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Kim, HA (corresponding author), Rutgers State Univ, Dept Biol Sci, Boyden Hall Rm 206,195 Univ Ave, Newark, NJ 07102 USA.	haekim@newark.rutgers.edu		Dobrowolski, Radek/0000-0002-1805-5806	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS109708]; New Jersey Commission on Brain Injury Research [CBIR11PJT012]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG062475]	National Institute of Neurological Disorders and Stroke, Grant/Award Number: NS109708; New Jersey Commission on Brain Injury Research, Grant/Award Number: CBIR11PJT012; National Institute of Aging, Grant/Award Number: AG062475	Arulmoli J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08499; Baraban M, 2018, NAT NEUROSCI, V21, P19, DOI 10.1038/s41593-017-0040-x; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Colognato H, 2011, DEV NEUROBIOL, V71, P924, DOI 10.1002/dneu.20966; Duncan ID, 2018, P NATL ACAD SCI USA, V115, pE11807, DOI 10.1073/pnas.1808064115; Fyffe-Maricich SL, 2013, J NEUROSCI, V33, P18402, DOI 10.1523/JNEUROSCI.2381-13.2013; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guyton MK, 2010, J NEUROSCI RES, V88, P2398, DOI 10.1002/jnr.22408; Hernandez M, 2016, J NEUROSCI, V36, P806, DOI 10.1523/JNEUROSCI.2873-15.2016; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Ishii A, 2016, J NEUROSCI, V36, P6471, DOI 10.1523/JNEUROSCI.0299-16.2016; Ishii A, 2013, J NEUROSCI, V33, P175, DOI 10.1523/JNEUROSCI.4403-12.2013; Ishii A, 2012, J NEUROSCI, V32, P8855, DOI 10.1523/JNEUROSCI.0137-12.2012; Jagielska A, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00093; Jagielska A, 2012, STEM CELLS DEV, V21, P2905, DOI 10.1089/scd.2012.0189; Jeffries MA, 2016, J NEUROSCI, V36, P9186, DOI 10.1523/JNEUROSCI.1444-16.2016; Jurick SM, 2016, BRAIN INJURY, V30, P1452, DOI 10.1080/02699052.2016.1219064; Kippert A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-71; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; Lourenco T, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00277; Lourenco T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21563; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Magou GC, 2011, J NEUROTRAUM, V28, P2203, DOI 10.1089/neu.2010.1596; Makhija E, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00059; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Martineau LC, 2001, J APPL PHYSIOL, V91, P693, DOI 10.1152/jappl.2001.91.2.693; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Momberger TS, 2006, MATRIX BIOL, V25, P306, DOI 10.1016/j.matbio.2006.01.008; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Ray SK, 2002, J NEUROSCI RES, V70, P561, DOI 10.1002/jnr.10414; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Ryder JW, 2000, J BIOL CHEM, V275, P1457, DOI 10.1074/jbc.275.2.1457; Sasamoto A, 2005, AM J PHYSIOL-CELL PH, V288, pC1012, DOI 10.1152/ajpcell.00314.2004; Shimizu T, 2017, GLIA, V65, P360, DOI 10.1002/glia.23096; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sloane JA, 2003, J NEUROCHEM, V84, P157, DOI 10.1046/j.1471-4159.2003.01541.x; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; Urbanski MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33751; Wang XY, 2003, J NEUROCHEM, V86, P351, DOI 10.1046/j.1471-4159.2003.01838.x; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Xu J, 2018, CELL, V173, P762, DOI 10.1016/j.cell.2018.03.076; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yeung MSY, 2019, NATURE, V566, P538, DOI 10.1038/s41586-018-0842-3; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	51	5	5	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	OCT	2020	68	10					2070	2085		10.1002/glia.23827		MAR 2020	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MX2EH	WOS:000519471900001	32170885	Green Accepted			2022-02-06	
J	Zheng, T; Du, J; Yuan, Y; Wu, S; Jin, YL; Wang, ZQ; Liu, DF; Shi, QL; Wang, XH; Liu, LX				Zheng, Tao; Du, Juan; Yuan, Yi; Wu, Shuo; Jin, Yinglan; Wang, Zhanqiu; Liu, Defeng; Shi, Qinglei; Wang, Xiaohan; Liu, Lanxiang			Neuroprotective Effect of Low-Intensity Transcranial Ultrasound Stimulation in Moderate Traumatic Brain Injury Rats	FRONTIERS IN NEUROSCIENCE			English	Article						LITUS; traumatic brain injury; ultrasound; therapy; neuroprotective	PULSED ULTRASOUND; MILD; DAMAGE; BARRIER; IMPACT	Traumatic brain injury (TBI) is a kind of severe brain injury characterized with a high incidence rate and a high disability rate. Low-intensity transcranial ultrasound stimulation (LITUS) is a promising neuroprotective method for improving the functional prognosis of TBI. The fractional anisotropy (FA) value and mean diffusivity (MD) value can be sensitive to abnormal brain structure and function and can thus be used to evaluate the effect of LITUS on TBI. Our purpose was to evaluate the therapeutic effect of LITUS in a moderate TBI rat model with FA and MD values. For our method, we used 45 male Sprague Dawley rats (15 sham normal, 15 TBI, and 15 LITUS treatment rats). We used single-shot spin echo echo-planar imaging sequences at 3.0T to obtain the DTI parameters. Parameters of FA and MD on the treated side of the injury cortex were measured to evaluate the therapeutic effect of LITUS in a TBI rat model. For FA and MD values, groups were compared by using a two-way analysis of variance for repeated measures, and this was followed by Tukey's post hoc test. Differences were considered significant at P < 0.05. The results were that the FA value in the LITUS treatment group at 1 day after TBI was significantly higher than that in the control group (adjusted P = 0.0422) and significantly lower than that in the TBI group at 14, 21, and 35 days after TBI (adjusted P = 0.0015, 0.0064, and 0.0173, respectively). At the end of the scan time point, the differences between the two groups were not significant (adjusted P = 0.3242). The MD values in the LITUS treatment group were significantly higher in the early stage than that in the TBI group (adjusted P = 0.0167) and significantly lower at the following time points than in the TBI group. In conclusion, daily treatment with LITUS for 10 min effectively improved the brain damage in the Controlled Cortical Impact (CCI)-caused TBI model. FA and MD values can serve as evaluation indicators for the neuro-protective effect of LITUS.	[Zheng, Tao; Du, Juan; Wu, Shuo; Wang, Zhanqiu; Liu, Defeng; Wang, Xiaohan; Liu, Lanxiang] Qinhuangdao Municipal 1 Hosp, Dept Magnet Resonance Imaging, Qinhuangdao, Hebei, Peoples R China; [Yuan, Yi] Yanshan Univ, Inst Elect Engn, Qinhuangdao, Hebei, Peoples R China; [Jin, Yinglan] Peking Univ, Hlth Sci Ctr, Beijing, Peoples R China; [Shi, Qinglei] Siemens Ltd, Beijing, Peoples R China		Liu, LX (corresponding author), Qinhuangdao Municipal 1 Hosp, Dept Magnet Resonance Imaging, Qinhuangdao, Hebei, Peoples R China.	liulanxiang66@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81871029]	This research was supported by the National Natural Science Foundation of China (81871029).	Armstead WM, 2019, EXP NEUROL, V317, P291, DOI 10.1016/j.expneurol.2019.03.015; AXIOTIS CA, 1991, AM J PATHOL, V138, P799; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Chen CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23929-8; de Lanerolle NC, 2015, SEMIN NEUROL, V35, P12, DOI 10.1055/s-0035-1544240; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Hameroff S, 2013, BRAIN STIMUL, V6, P409, DOI 10.1016/j.brs.2012.05.002; Hanks R, 2019, BRAIN INJURY, V33, P355, DOI 10.1080/02699052.2018.1553073; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Li Bo, 2019, Zhongguo Zhen Jiu, V39, P1075, DOI 10.13703/j.0255-2930.2019.10.012; Li WT, 2015, NEUROCHEM INT, V90, P107, DOI 10.1016/j.neuint.2015.07.020; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Liu LX, 2020, MAGN RESON IMAGING, V67, P79, DOI 10.1016/j.mri.2019.06.013; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Monti MM, 2016, BRAIN STIMUL, V9, P940, DOI 10.1016/j.brs.2016.07.008; Morris MC, 2019, J SURG RES, V244, P1, DOI 10.1016/j.jss.2019.06.022; Mukai S, 2005, ULTRASOUND MED BIOL, V31, P1713, DOI 10.1016/j.ultrasmedbio.2005.07.012; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; O'Phelan KH, 2018, J NEUROTRAUM, V35, P739, DOI 10.1089/neu.2016.4944; Pan MX, 2018, CHIN J TRAUMATOL, V21, P224, DOI 10.1016/j.cjtee.2018.04.003; PANCZYKOWSKI DM, 2014, NEUROSURGERY, V74; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444; Sant'Anna EF, 2005, J ORTHOP RES, V23, P646, DOI 10.1016/j.orthres.2004.09.007; Scott LK, 2009, J NEUROS-PEDIATR, V3, P484, DOI 10.3171/2009.2.PEDS08292; Su WS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15916-2; Su WS, 2017, BRAIN STIMUL, V10, P1032, DOI 10.1016/j.brs.2017.09.003; Su WS, 2015, ONCOTARGET, V6, P42290, DOI 10.18632/oncotarget.5978; Tal S, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00508; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Tsai SJ, 2015, MED HYPOTHESES, V84, P381, DOI 10.1016/j.mehy.2015.01.030; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wettervik TS, 2020, WORLD NEUROSURG, V133, pE567, DOI 10.1016/j.wneu.2019.09.099; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yuan Y, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00562; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang M, 2018, INT IMMUNOPHARMACOL, V65, P64, DOI 10.1016/j.intimp.2018.09.046	48	5	5	2	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAR 10	2020	14								172	10.3389/fnins.2020.00172			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LC0ZV	WOS:000525059600001	32218720	gold, Green Published			2022-02-06	
J	Vaca, SD; Feng, AY; Ku, S; Jin, MC; Kakusa, BW; Ho, AL; Zhang, M; Fuller, A; Haglund, MM; Grant, G				Vaca, Silvia D.; Feng, Austin Y.; Ku, Seul; Jin, Michael C.; Kakusa, Bina W.; Ho, Allen L.; Zhang, Michael; Fuller, Anthony; Haglund, Michael M.; Grant, Gerald			Boda Bodas and Road Traffic Injuries in Uganda: An Overview of Traffic Safety Trends from 2009 to 2017	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						Uganda; road traffic injury; motorcycle; Africa; trauma; road safety; traumatic brain injury		Introduction: Road traffic injuries (RTIs) are an important contributor to the morbidity and mortality of developing countries. In Uganda, motorcycle taxis, known as boda bodas, are responsible for a growing proportion of RTIs. This study seeks to evaluate and comment on traffic safety trends from the past decade. Methods: Traffic reports from the Ugandan police force (2009 to 2017) were analyzed for RTI characteristics. Furthermore, one month of casualty ward data in 2015 and 2018 was collected from the Mulago National Referral Hospital and reviewed for casualty demographics and trauma type. Results: RTI motorcycle contribution rose steadily from 2009 to 2017 (24.5% to 33.9%). While the total number of crashes dropped from 22,461 to 13,244 between 2010 and 2017, the proportion of fatal RTIs increased from 14.7% to 22.2%. In the casualty ward, RTIs accounted for a greater proportion of patients and traumas in 2018 compared to 2015 (10%/41% and 36%/64%, respectively). Conclusions: Although RTIs have seen a gross reduction in Uganda, they have become more deadly, with greater motorcycle involvement. Hospital data demonstrate a rising need for trauma and neurosurgical care to manage greater RTI patient burden. Combining RTI prevention and care pathway improvements may mitigate current RTI trends.	[Vaca, Silvia D.; Feng, Austin Y.; Ku, Seul; Jin, Michael C.; Kakusa, Bina W.; Ho, Allen L.; Zhang, Michael; Grant, Gerald] Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA; [Vaca, Silvia D.; Feng, Austin Y.; Ku, Seul; Jin, Michael C.; Kakusa, Bina W.; Ho, Allen L.; Zhang, Michael; Grant, Gerald] Stanford Ctr Global Hlth Innovat, Palo Alto, CA 94305 USA; [Fuller, Anthony; Haglund, Michael M.] Duke Univ, Dept Neurosurg, Div Global Neurosurg & Neurol, Durham, NC 27710 USA		Grant, G (corresponding author), Stanford Univ, Dept Neurosurg, Sch Med, Stanford, CA 94305 USA.; Grant, G (corresponding author), Stanford Ctr Global Hlth Innovat, Palo Alto, CA 94305 USA.	svaca@stanford.edu; fenga@stanford.edu; skku@stanford.edu; mjin2@stanford.edu; bkakusa@stanford.edu; aho5@stanford.edu; zhangm@stanford.edu; anthony.fuller@duke.edu; michael.haglund@duke.edu; ggrant2@stanford.edu		Ku, Seul/0000-0003-3494-2955; Kakusa, Bina/0000-0003-0907-2505; Zhang, Michael/0000-0002-7067-0689; Fuller, Anthony/0000-0001-8841-6948	Stanford School of Medicine Medical Scholars Program	This work was supported by the Stanford School of Medicine Medical Scholars Program.	Adogu P O U, 2009, Niger J Med, V18, P393; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; [Anonymous], 2013, YOUTUBE VIDEO, V1, p[36, 38]; BAKER SP, 1975, AM J PUBLIC HEALTH, V65, P524, DOI 10.2105/AJPH.65.5.524; Chalya Phillipo L, 2012, J Trauma Manag Outcomes, V6, P1, DOI 10.1186/1752-2897-6-1; Craft G, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121486; Dalal K., 2015, Health, V7, P487; Galukande M., 2009, East and Central African Journal of Surgery, V14, P33; Haworth N.L., 1994, MOTORCYCLE RELATED I; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kamulegeya LH, 2015, AFR HEALTH SCI, V15, P1016, DOI 10.4314/ahs.v15i3.41; Khorasani-Zavareh D., 2017, J INJ VIOLENCE RES, V9, P17; KIGERA L, 2010, E CENT AFRICAN J SUR, V0015, P00057; Kitara DL, 2011, E CENTRAL AFRICAN J, V16, P97; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Ministry of Works and Transport, 2004, STAT INSTR 2004 NO 3; Ministry of Works and Transport, 2010, STUD GREAT KAMP ROAD, P172; Naddumba E K., 2001, E CENT AFRICAN J SUR, V9, P1; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Nordfjaern T, 2012, SAFETY SCI, V50, P1862, DOI 10.1016/j.ssci.2012.05.003; Roehler DR, 2013, GLOB HEALTH PROMOT, V20, P37, DOI 10.1177/1757975913509657; Safeboda, 2016, SAF OBS SURV; Safeboda, 2016, Q2 2016 IMP SCOR; Tran TM, 2017, ANN SURG, V266, P389, DOI 10.1097/SLA.0000000000001970; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; UBOS Uganda Bureau of Statistics, 2018, 2018 STAT ABSTR, P345; Uganda Police, 2014, UG POL FORC ANN TRAF; Uganda Police, 2016, UG POL FORC ANN TRAF; Uganda Police, 2011, UG POL FORC ANN TRAF; Uganda Police, 2013, UG POL FORC ANN TRAF; Uganda Police, 2017, UG POL FORC ANN TRAF; Uganda Police, 2015, UG POL FORC ANN TRAF; Uganda Police, 2012, UG POL FORC ANN TRAF; Uganda Police, 2018, UG POL FORC ANN TRAF; Waters H R, 2004, Asia Pac J Public Health, V16, P23, DOI 10.1177/101053950401600105; WHO, WHO GLOB STAT REP RO; Zwi AB, 1996, T ROY SOC TROP MED H, V90, P593, DOI 10.1016/S0035-9203(96)90399-5	38	5	5	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	MAR 2	2020	17	6							2110	10.3390/ijerph17062110			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	LI2VS	WOS:000529342300300	32235768	gold, Green Published			2022-02-06	
J	Fahmy, C; Jackson, DB; Pyrooz, DC; Decker, SH				Fahmy, Chantal; Jackson, Dylan B.; Pyrooz, David C.; Decker, Scott H.			Head injury in prison: Gang membership and the role of prison violence	JOURNAL OF CRIMINAL JUSTICE			English	Article						Head injury; TBI; Gang members; Violence; Victimization; Prison	TRAUMATIC BRAIN-INJURY; CRIMINAL BEHAVIOR; AGGRESSIVE-BEHAVIOR; GENERAL-POPULATION; SUBSTANCE-ABUSE; SELF-CONTROL; PREVALENCE; VICTIMIZATION; EPIDEMIOLOGY; HEALTH	Purpose: Serious head injuries, also known as traumatic brain injuries (TBIs), are associated with an increase in aggression and violent tendencies. The current study extends the literature on head injuries by examining whether gang membership is associated with an elevated risk of head injury in prison, and the extent to which this relationship is mediated by different forms of prison violence. Methods: We use data from the LoneStar Project, a representative sample of 802 men imprisoned in Texas. We assess the gang membership-head injury link using logistic regression and Karlson-Holm-Breen (KHB) mediation. Results: Prison gang members were >2.5 times as likely to report a head injury in prison compared to non-gang members (OR = 2.593; 95% CI = 1.220-5.509), net of controls. KHB mediation analyses reveal that violent misconduct and violent victimization collectively reduced the magnitude of the relationship between gang membership and in-prison head injury by 34.84%. Conclusions: Prison gang members have a higher risk of head injury in prison, which we demonstrate is largely a function of their increased involvement in prison violence. Cognitive behavioral therapy (CBT) interventions should be used to lessen the negative repercussions from head injury and would be beneficial for reentry preparation.	[Fahmy, Chantal; Jackson, Dylan B.] Univ Texas San Antonio, Dept Criminol & Criminal Justice, 501 West Cesar E Chavez Blvd, San Antonio, TX 78207 USA; [Pyrooz, David C.] Univ Colorado Boulder, Dept Sociol, 327 UCB, Boulder, CO 80309 USA; [Decker, Scott H.] Arizona State Univ, Sch Criminol & Criminal Justice, 411 N Cent Ave,Suite 600, Phoenix, AZ 85004 USA		Fahmy, C (corresponding author), Univ Texas San Antonio, Dept Criminol & Criminal Justice, 501 West Cesar E Chavez Blvd, San Antonio, TX 78207 USA.	Chantal.Fahmy@utsa.edu; Dylan.Jackson@utsa.edu; David.Pyrooz@colorado.edu; Scott.Decker@asu.edu		Fahmy, Chantal/0000-0002-6010-8457	National Institute of Justice, Office of Justice Programs, U.S. Department of Justice [2014-MU-CX-0111]; Texas Department of Criminal Justice [723-AR15]	This project was supported by Grant No. 2014-MU-CX-0111 awarded by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice. The research contained in this document was coordinated in part by the Texas Department of Criminal Justice (723-AR15). The contents of this article, including its opinions, findings, and conclusions, are those of the authors and do not necessarily reflect the views or policies of the U.S. Department of Justice or the Texas Department of Criminal Justice.	Auty KM, 2017, AGGRESS VIOLENT BEH, V33, P126, DOI 10.1016/j.avb.2017.01.018; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Blitz CL, 2008, INT J LAW PSYCHIAT, V31, P385, DOI 10.1016/j.ijlp.2008.08.005; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Boxer P, 2009, CRIM JUSTICE BEHAV, V36, P793, DOI 10.1177/0093854809336453; Bronson Jennifer, 2019, PRISONERS 2017; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Bruns J., 2010, EPILEPSIA, V44, P2, DOI [10.1097/HTR.0b013e3181e5fda0, DOI 10.1097/HTR.0B013E3181E5FDA0]; Bureau of Justice Statistics, 2007, ICPSR4572 BUR JUST S; Carr, 2013, REDUCING CRIMINAL RE; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ UN, DOI [10.3171/2011.3.jns102010, DOI 10.3171/2011.3.JNS102010.]; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Souza Carlos Alberto Crespo de, 2003, Rev. Bras. Psiquiatr., V25, P206, DOI 10.1590/S1516-44462003000400005; Daigle LE, 2018, J CRIM JUST, V58, P78, DOI 10.1016/j.jcrimjus.2018.07.005; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Decker ScottH., 1996, JUSTICE Q, V13, P243, DOI [10.1080/07418829600092931, DOI 10.1080/07418829600092931]; DeLisi M., 2004, CRIMINAL JUSTICE STU, V17, P369; DeLisi Matt, 2012, AM J CRIM JUSTICE, V38, P1; Dougherty DM, 2007, AGGRESSIVE BEHAV, V33, P574, DOI 10.1002/ab.20219; Elbogen EB, 2015, J HEAD TRAUMA REHAB, V30, pE3, DOI 10.1097/HTR.0000000000000083; Fabian JM, 2010, AGGRESS VIOLENT BEH, V15, P209, DOI 10.1016/j.avb.2009.12.004; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8.]; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Fox KA, 2010, J CRIM JUST, V38, P720, DOI 10.1016/j.jcrimjus.2010.04.046; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gaes GG, 2002, PRISON J, V82, P359, DOI 10.1177/003288550208200304; Griffin ML, 2006, CRIM JUSTICE BEHAV, V33, P419, DOI 10.1177/0093854806288038; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Huebner BM, 2003, J CRIM JUST, V31, P107, DOI 10.1016/S0047-2352(02)00218-0; Hughes LA, 2005, CRIMINOLOGY, V43, P43, DOI 10.1111/j.0011-1348.2005.00002.x; Jackson TL, 2017, J EPIDEMIOL COMMUN H, V71, P800, DOI 10.1136/jech-2016-208582; Jacobs J., 1977, STATEVILLE PENITENTI; James D.J., 2006, MENTAL HLTH PROBLEMS; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Kim E, 2002, NEUROREHABILITATION, V17, P297; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Kupers TA, 2005, J CLIN PSYCHOL, V61, P713, DOI 10.1002/jclp.20105; Lahm KF, 2009, INT J OFFENDER THER, V53, P348, DOI 10.1177/0306624X08316504; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Levan K, 2012, SOLV SOC PROB, P1; Lichenstein A., 2001, NATL PUBLIC RADIO; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Massoglia M, 2008, LAW SOC REV, V42, P275, DOI 10.1111/j.1540-5893.2008.00342.x; MCCORKLE RC, 1995, CRIME DELINQUENCY, V41, P317, DOI 10.1177/0011128795041003003; McCrea M., 2014, CLIN NEUROPSYCHOLOGY, P208; McIsaac Kathryn E, 2016, CMAJ Open, V4, pE746, DOI 10.9778/cmajo.20160072; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Melde C, 2013, J QUANT CRIMINOL, V29, P143, DOI 10.1007/s10940-012-9164-z; Meyers TJ, 2018, INT J OFFENDER THER, V62, P4585, DOI 10.1177/0306624X18778451; Mitchell MM, 2017, DEVIANT BEHAV, V38, P1197, DOI 10.1080/01639625.2016.1246028; Mitchell MM, 2018, TRENDS ORGAN CRIME, DOI [10.1007/s12117-018-9331-1, DOI 10.1007/S12117-018-9331-1]; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; O'Rourke C, 2016, BRAIN INJURY, V30, P839, DOI 10.3109/02699052.2016.1146967; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Papachristos AV, 2009, AM J SOCIOL, V115, P74, DOI 10.1086/597791; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Pyrooz DC, 2019, COMPETING FOR CONTROL: GANGS AND THE SOCIAL ORDER OF PRISONS, P1; Pyrooz DC, 2016, CRIM JUSTICE BEHAV, V43, P365, DOI 10.1177/0093854815605528; Pyrooz DC, 2014, J RES CRIME DELINQ, V51, P315, DOI 10.1177/0022427813516128; Pyrooz DC, 2011, J AGGRESS CONFL PEAC, V3, P12, DOI 10.5042/jacpr.2011.0018; Pyrooz DC, 2019, COMPETING FOR CONTROL: GANGS AND THE SOCIAL ORDER OF PRISONS, P1, DOI 10.1017/9781108653473; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosen DL, 2012, J HEALTH CARE POOR U, V23, P254, DOI 10.1353/hpu.2012.0033; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Sariaslan A, 2016, JAMA PSYCHIAT, V73, P796, DOI 10.1001/jamapsychiatry.2016.1349; Schnittker J, 2007, J HEALTH SOC BEHAV, V48, P115, DOI 10.1177/002214650704800202; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Schofield PW, 2019, BRAIN INJURY, V33, P412, DOI 10.1080/02699052.2018.1552020; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Schwartz JA, 2021, JUSTICE Q, V38, P196, DOI 10.1080/07418825.2019.1599044; Schwartz JA, 2019, CURR OPIN PSYCHOL, V27, P67, DOI 10.1016/j.copsyc.2018.09.006; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sorensen JR, 2011, J CRIM JUST, V39, P143, DOI 10.1016/j.jcrimjus.2011.01.002; Steiner B., 2016, RESTRICTIVE HOUSING, P165; Steiner B, 2017, TRAUMA VIOLENCE ABUS, V18, P17, DOI 10.1177/1524838015588503; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Texas Department of Criminal Justice, 2010, NEW REG REL CTR NOW; THOMPSON EH, 1986, AM BEHAV SCI, V29, P531, DOI 10.1177/000276486029005003; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Toman EL, 2019, JUSTICE Q, V36, P350, DOI 10.1080/07418825.2017.1402072; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Vasquez EA, 2015, AGGRESSIVE BEHAV, V41, P242, DOI 10.1002/ab.21581; Veeh CA, 2018, PSYCHOL CRIME LAW, V24, P1016, DOI 10.1080/1068316X.2018.1497632; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Winterdyk J, 2010, J CRIM JUST, V38, P730, DOI 10.1016/j.jcrimjus.2010.04.047; Wolff N, 2007, CRIM JUSTICE BEHAV, V34, P588, DOI 10.1177/0093854806296830; Wooldredge JD, 1998, J RES CRIME DELINQ, V35, P480, DOI 10.1177/0022427898035004006; Wooldredge J, 2014, J QUANT CRIMINOL, V30, P141, DOI 10.1007/s10940-013-9197-y; Worrall JL, 2012, J CRIM JUST, V40, P425, DOI 10.1016/j.jcrimjus.2012.06.002	111	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0047-2352	1873-6203		J CRIM JUST	J. Crim. Justice	MAR-APR	2020	67								101658	10.1016/j.jcrimjus.2020.101658			11	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	LG6ID	WOS:000528201400001					2022-02-06	
J	Gicas, KM; Jones, AA; Thornton, AE; Petersson, A; Livingston, E; Waclawik, K; Panenka, WJ; Barr, AM; Lang, DJ; Vila-Rodriguez, F; Leonova, O; Procyshyn, RM; Buchanan, T; MacEwan, GW; Honer, WG				Gicas, Kristina M.; Jones, Andrea A.; Thornton, Allen E.; Petersson, Anna; Livingston, Emily; Waclawik, Kristina; Panenka, William J.; Barr, Alasdair M.; Lang, Donna J.; Vila-Rodriguez, Fidel; Leonova, Olga; Procyshyn, Ric M.; Buchanan, Tari; MacEwan, G. William; Honer, William G.			Cognitive decline and mortality in a community-based sample of homeless and precariously housed adults: 9-year prospective study	BJPSYCH OPEN			English	Article						Mortality; comorbidity; cognition; marginalisation; ageing	TRAUMATIC BRAIN-INJURY; HIGH-INCOME COUNTRIES; IMPAIRMENT; PEOPLE; HEALTH; COHORT; INDIVIDUALS; MORBIDITY; DEMENTIA; MODELS	Background Homeless and precariously housed individuals experience a high burden of comorbid illnesses, and excess mortality. Cross-sectional studies report a high rate of cognitive impairment. Long-term trajectories have not been well investigated in this group. Aims To longitudinally assess risks for premature and/or accelerated cognitive ageing, and the relationship with early mortality in homeless and precariously housed people. Method This is a 9-year community-based study of 375 homeless and precariously housed individuals from Vancouver, Canada. Annual cognitive testing assessed verbal learning and memory, and inhibitory control. Linear mixed-effects models examined associations between clinical risk factors (traumatic brain injury, psychotic disorders, viral exposure, alcohol dependence) and cognitive change over 9 years. Cox regression models examined the association between cognition and mortality. Results Traumatic brain injury and alcohol dependence were associated with decline in verbal memory. Inhibitory control declined, independent of risk factors and to a greater extent in those who died during the study. Better inhibitory control was associated with a 6.6% lower risk of mortality at study entry, with a 0.3% greater effect for each year of life. For each one-point increase in the Charlson Comorbidity Index score at study entry, the risk of mortality was 9.9% higher, and was consistent across age. Adjusting for comorbidities, inhibitory control remained a significant predictor of mortality. Conclusions Findings raise the possibility of a premature onset, and accelerated trajectory, of cognitive ageing in this group of homeless and precariously housed people. Traumatic brain injury, alcohol dependence and cognition could be treatment priorities.	[Gicas, Kristina M.] York Univ, Dept Psychol, Toronto, ON, Canada; [Gicas, Kristina M.; Jones, Andrea A.; Panenka, William J.; Vila-Rodriguez, Fidel; Leonova, Olga; Procyshyn, Ric M.; Buchanan, Tari; MacEwan, G. William; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Thornton, Allen E.; Petersson, Anna; Livingston, Emily; Waclawik, Kristina] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesiol Pnarmacol & Therapeut, Vancouver, BC, Canada; [Lang, Donna J.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Honer, William G.] British Columbia Mental Hlth & Surkstanck Use Ser, Vancouver, BC, Canada		Gicas, KM (corresponding author), York Univ, Dept Psychol, Toronto, ON, Canada.; Gicas, KM (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	william.honer@ubc.ca		Barr, Alasdair/0000-0002-3407-1574; Vila-Rodriguez, Fidel/0000-0002-8273-8820; Lang, Donna/0000-0001-9373-1555; Procyshyn, Ric/0000-0002-4348-0855; Panenka, William/0000-0001-7143-6512	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CBG-101827, MOP-137103]; BC Mental Health and Addictions Services; William and Ada Isabelle Steel Fund; Jack Bell Chair in Schizophrenia	This study was funded by grants from the Canadian Institutes of Health Research (W.G.H., CBG-101827, MOP-137103), BC Mental Health and Addictions Services (W.G.H.), and the William and Ada Isabelle Steel Fund (A.E.T.). W.G.H. was supported by the Jack Bell Chair in Schizophrenia.	Aldridge RW, 2018, LANCET, V391, P241, DOI 10.1016/S0140-6736(17)31869-X; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barbic SP, 2018, CAN J PUBLIC HEALTH, V109, P204, DOI 10.17269/s41997-018-0087-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarke PJ, 2015, ANN EPIDEMIOL, V25, P849, DOI 10.1016/j.annepidem.2015.07.001; Czepielewski LS, 2018, SCHIZOPHRENIA BULL, V44, P158, DOI 10.1093/schbul/sbx015; Depp CA, 2015, J NERV MENT DIS, V203, P126, DOI 10.1097/NMD.0000000000000248; Ennis N, 2015, MEMORY, V23, P695, DOI 10.1080/09658211.2014.921714; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fry CE, 2017, CHILD NEUROPSYCHOL, V23, P907, DOI 10.1080/09297049.2016.1207758; Gicas KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218201; Gicas KM, 2017, NEUROPSYCHOLOGY, V31, P28, DOI 10.1037/neu0000304; Guggenmos M, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0037-y; Honer WG, 2017, CAN J PSYCHIAT, V62, P482, DOI 10.1177/0706743717693781; Hughes ML, 2018, J INT NEUROPSYCH SOC, V24, P805, DOI 10.1017/S1355617718000425; Hurstak E, 2017, DRUG ALCOHOL DEPEN, V178, P562, DOI 10.1016/j.drugalcdep.2017.06.002; Karr JE, 2018, PSYCHOL AGING, V33, P195, DOI 10.1037/pag0000236; Kovacs-Burns K, 2012, CANADIAN DEFINITION; Krausz M, 2015, LANCET PSYCHIAT, V2, pE5, DOI 10.1016/S2215-0366(15)00045-0; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Lieberman JA, 2018, NEW ENGL J MED, V379, P270, DOI 10.1056/NEJMra1801490; Luchenski S, 2018, LANCET, V391, P266, DOI 10.1016/S0140-6736(17)31959-1; Noppert GA, 2018, EPIDEMIOL INFECT, V146, P1975, DOI 10.1017/S095026881800153X; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pfefferbaum A, 2018, BIOL PSYCHIAT-COGN N, V3, P844, DOI 10.1016/j.bpsc.2018.06.006; Salthouse TA, 2019, PSYCHOL AGING, V34, P17, DOI 10.1037/pag0000288; Schmitt T, 2017, J NEUROTRAUM, V34, P3301, DOI 10.1089/neu.2017.5076; Schultz-Larsen K, 2008, J CLIN EPIDEMIOL, V61, P1227, DOI 10.1016/j.jclinepi.2007.12.007; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Therneau T.M., 2000, STAT BIOL HEALTH; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Waclawik K, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00270; Wilson RS, 2018, NEUROBIOL AGING, V66, P122, DOI 10.1016/j.neurobiolaging.2018.02.016; Wood RL, 2017, BRAIN INJURY, V31, P1270, DOI 10.1080/02699052.2017.1332387; Woods AJ, 2016, ALCOHOL CLIN EXP RES, V40, P2435, DOI 10.1111/acer.13211	41	5	5	0	1	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	2056-4724			BJPSYCH OPEN	BJPsych Open	MAR	2020	6	2							e21	10.1192/bjo.2020.3			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	KJ9BG	WOS:000512349200001	32043436	gold, Green Published			2022-02-06	
J	Gray, M; Wilson, JC; Potter, M; Provance, AJ; Howell, DR				Gray, Margot; Wilson, Julie C.; Potter, Morgan; Provance, Aaron J.; Howell, David R.			Female adolescents demonstrate greater oculomotor and vestibular dysfunction than male adolescents following concussion	PHYSICAL THERAPY IN SPORT			English	Article						Postural balance; Mild traumatic brain injury; Adolescence; Pediatric; Sports; Sex differences	SPORT-RELATED CONCUSSION; RECOVERY TRAJECTORIES; SEX; REHABILITATION; SYMPTOMS; BALANCE; OUTCOMES; CONVERGENCE; PREDICTORS; CHILDREN	Objective: To examine differences between male and female adolescents on measures of balance, vestibular and oculomotor function within 3 weeks of concussion among a group of pediatric patients presenting to a sports medicine clinic. Design: Medical record review. Setting: Sports medicine clinic. Participants: 197 female (median age = 15.2 years) and 381 male (median age = 14.6 years) pediatric patients seen for a concussion, evaluated 9.3 +/- 5.2 (mean +/- SD) days post-concussion. Main outcome measures: Patients completed Balance Error Scoring System (BESS), tandem gait, gaze stability, and near point of convergence (NPC) tests. Results: A higher proportion of female patients exhibited abnormal NPC (22% vs. 14%; p = 0.017), gaze stability (53% vs. 43%; p = 0.028), and tandem gait tests (20% vs. 13%; p = 0.026) compared to male patients. Multivariable analysis indicated an independent association between female sex and increased odds of abnormal NPC (adjusted odds ratio (aORJ = 1.79, 95% CI = 1.07-3.00), and tandem gait tests (aOR = 1.96, 95% CI = 1.12-3.41) following concussion. Conclusions: Our results indicate that within the first three weeks of a concussion, female pediatric patients demonstrated increased odds of exhibiting abnormal near point of convergence, and tandem gait test performance compared to male patients. (C) 2020 Elsevier Ltd. All rights reserved.	[Gray, Margot] Childrens Hosp Colorado, Phys Therapy Dept, Vestibular Disorders Program, Aurora, CO 80045 USA; [Wilson, Julie C.; Potter, Morgan; Provance, Aaron J.; Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Wilson, Julie C.; Provance, Aaron J.; Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA; [Wilson, Julie C.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO 80045 USA		Howell, DR (corresponding author), Univ Colorado, Dept Orthoped, Sch Med, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Childrens Hosp Colorado, ATC Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	david.howell@cuanschutz.edu		Howell, David/0000-0002-2955-0191	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD094560]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, R41N5103698]	The authors declare no conflicts of interest related to this study. Dr. Howell receives research support not related to this study from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD094560), the National Institute of Neurological Disorders and Stroke (R01NS100952 and R41N5103698).	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Buttner F, 2020, BRIT J SPORT MED, V54, P94, DOI 10.1136/bjsports-2018-100164; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Davis-Hayes C, 2017, J AM ACAD ORTHOP SUR, V25, P818, DOI 10.5435/JAAOS-D-17-00276; Desai N, 2019, CLIN J SPORT MED, V29, P361, DOI 10.1097/JSM.0000000000000646; Dunlap Pamela M, 2018, J Am Acad Audiol, DOI 10.3766/jaaa.18015; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Helm MR, 2005, HEADACHE, V45, P332, DOI 10.1111/j.1526-4610.2005.05070.x; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Herdman SJ, 2014, VESTIBULAR REHABILIT; Howell D. R., 2019, J NEUROSURGERY PEDIA; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2017, CLIN J SPORT MED, V27, P444, DOI 10.1097/JSM.0000000000000374; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lagman-Bartolome AM, 2019, NEUROL CLIN, V37, P835, DOI 10.1016/j.ncl.2019.07.002; Leveille E, 2017, J INT NEUROPSYCH SOC, V23, P65, DOI 10.1017/S1355617716001004; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Oyegbile TO, 2017, SLEEP MED, V40, P110, DOI 10.1016/j.sleep.2017.09.026; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Thompson TL, 2009, OCHSNER J, V9, P20; Worster A, 2004, ACAD EMERG MED, V11, P187, DOI 10.1197/j.aem.2003.03.002; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	43	5	5	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	MAR	2020	42						68	74		10.1016/j.ptsp.2020.01.001			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KS7NE	WOS:000518492600010	31935640				2022-02-06	
J	Guan, Y; Li, LF; Chen, JQ; Lu, H				Guan, Ying; Li, Lifeng; Chen, Jianqiang; Lu, Hong			Effect of AQP4-RNAi in treating traumatic brain edema: Multi-modal MRI and histopathological changes of early stage edema in a rat model	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						aquaporin 4; multi-modal MRI; traumatic brain edema	AQP4 EXPRESSION; AQUAPORIN-4; INJURY; BARRIER	Traumatic brain injury (TBI) is one of the leading causes of mortality and permanent disabilities worldwide. Brain edema following TBI remains to be the predominant cause of mortality and disability in patients worldwide. Previous studies have reported that brain edema is closely associated with aquaporin-4 (AQP4) expression. AQP4 is a water channel protein and mediates water homeostasis in a variety of brain disorders. In the current study, a rat TBI model was established, and the features of brain edema following TBI were assessed using multimodal MRI. The results of the multimodal MRI were useful, reliable and were used to evaluate the extent and the type of brain edema following TBI. Brain edema was also successfully alleviated using an intracerebral injection of AQP4 small interfering (si)RNA. The expression of AQP4 and its role in brain edema were also examined in the present study. The AQP4 siRNA was demonstrated to downregulate AQP4 expression following TBI and reduced brain edema at the early stages of TBI (6 and 12 h). The current study revealed the MRI features of brain edema and the changes in AQP4 expression exhibited following TBI, and the results provide important information that can be used to improve the early diagnosis and treatment of brain edema.	[Guan, Ying] Hainan Med Univ, Affiliated Hosp 1, Dept Ultrasonog, Haikou 570102, Hainan, Peoples R China; [Li, Lifeng] Changsha Cent Hosp, Dept Radiol, Changsha 410004, Hunan, Peoples R China; [Chen, Jianqiang] Haikou Peoples Hosp, Dept Radiol, Haikou 570208, Hainan, Peoples R China; [Lu, Hong] Seventh Peoples Hosp Chongqing, Dept Radiol, 1 One Village, Chongqing 400054, Peoples R China		Lu, H (corresponding author), Seventh Peoples Hosp Chongqing, Dept Radiol, 1 One Village, Chongqing 400054, Peoples R China.	hnguanying@163.com			Finance science and technology project of Hainan Province [ZDYF2018175]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]; Key Projects of Chongqing Health and Family Planning Commission [2016ZDXM040]; Technology Program of Banan District Chongqing Science and Technology Commission [2018-25]; Industry Project of Hainan Health Department [16A200107]	The current study was funded by the Finance science and technology project of Hainan Province (grant no. ZDYF2018175), the National Natural Science Foundation of China (grant no. 81160181), Key Projects of Chongqing Health and Family Planning Commission (grant no. 2016ZDXM040), Technology Program of Banan District Chongqing Science and Technology Commission (grant no. 2018-25) and Industry Project of Hainan Health Department (grant no. 16A200107).	Badaut J, 2014, BBA-GEN SUBJECTS, V1840, P1554, DOI 10.1016/j.bbagen.2013.10.032; Chen JQ, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898190; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Gatidis S, 2016, J MAGN RESON IMAGING, V43, P824, DOI 10.1002/jmri.25044; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hsu CCT, 2016, J NEUROIMAGING, V26, P383, DOI 10.1111/jon.12360; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Kunkel A, 2018, COGN AFFECT BEHAV NE, V18, P389, DOI 10.3758/s13415-018-0577-5; Lescot T, 2010, J NEUROTRAUM, V27, P463, DOI 10.1089/neu.2009.0982-C; Lu H, 2013, CHINESE MED J-PEKING, V126, P4316, DOI 10.3760/cma.j.issn.0366-6999.20131139; Maegele M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614555142; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Oshio K, 2016, MAGN RESON MED SCI, V15, P146, DOI 10.2463/mrms.2015-0001; Stein DM, 2017, CRIT CARE CLIN, V33, P1, DOI 10.1016/j.ccc.2016.08.008; Tang GH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101413; Tang GH, 2014, STEM CELLS, V32, P3150, DOI 10.1002/stem.1808; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Vajda Z, 2000, BIOCHEM BIOPH RES CO, V270, P495, DOI 10.1006/bbrc.2000.2472; Vindedal GF, 2016, MOL CELL NEUROSCI, V77, P47, DOI 10.1016/j.mcn.2016.10.004; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200	25	5	5	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	MAR	2020	19	3					2029	2036		10.3892/etm.2020.8456			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	KU5CC	WOS:000519726400052	32104262	Green Published, gold			2022-02-06	
J	Hattrup, N; Gray, H; Krumholtz, M; McLeod, TCV				Hattrup, Nicholas; Gray, Hannah; Krumholtz, Mark; McLeod, Tamara C. Valovich			Early Controlled Exercise and Timing of Treatment Following Concussion: A Critically Appraised Topic	JOURNAL OF SPORT REHABILITATION			English	Article						brain concussion; rehabilitation; exercise; running	ACTIVE REHABILITATION; MEDICINE; REST	Clinical Scenario: Recent systematic reviews have shown that extended rest may not be beneficial to patients following concussion. Furthermore, recent evidence has shown that patient with postconcussion syndrome benefit from an active rehabilitation program. There is currently a gap between the ability to draw conclusions to the use of aerobic exercise during the early stages of recovery along with the safety of these programs. Clinical Question: Following a concussion, does early controlled aerobic exercise, compared with either usual care or delayed exercise, improve recovery as defined by symptom duration and severity? Summary of Key Findings: After a thorough literature search, 5 studies relevant to the clinical question were selected. Of the 5 studies, 1 study was a randomized control trial, 2 studies were pilot randomized controlled trials, and 2 studies were retrospective. All 5 studies showed that implementing controlled aerobic exercise did not have an adverse effect on recovery. One study showed early aerobic exercise had a quicker return to school, and another showed a 2-day decrease in symptom duration. Clinical Bottom Line: There is sufficient evidence to suggest that early controlled aerobic exercise is safe following a concussion. Although early aerobic exercise may not always result in a decrease in symptom intensity and duration, it may help to improve the psychological state resulting from the social isolation of missing practices and school along with the cessation of exercise. Although treatments continue to be a major area of research following concussion, management should still consist of an interdisciplinary approach to individualized patient care. Strength of Recommendation: There is grade B evidence to support early controlled aerobic exercise may reduce the duration of symptoms following recovery while having little to no adverse events.	[Hattrup, Nicholas; Gray, Hannah; Krumholtz, Mark; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA; [McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, Mesa, AZ 85206 USA		Hattrup, N (corresponding author), AT Still Univ, Athlet Training Programs, Mesa, AZ 85206 USA.	sa199462@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Craton N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7090119; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Edwards MK, 2016, MAYO CLIN PROC, V91, P984, DOI 10.1016/j.mayocp.2016.03.021; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hunt AW, 2018, BRAIN INJURY, V32, P1534, DOI 10.1080/02699052.2018.1502894; Hunt Tamerah N, 2017, J Allied Health, V46, pe81; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117745033; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Micay R, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000404; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658	25	5	5	6	10	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	MAR	2020	29	3					360	366		10.1123/jsr.2019-0187			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	LX7OX	WOS:000540017800016	31628271	Bronze			2022-02-06	
J	Hoursan, H; Farahmand, F; Ahmadian, MT				Hoursan, H.; Farahmand, F.; Ahmadian, M. T.			A novel procedure for micromechanical characterization of white matter constituents at various strain rates	SCIENTIA IRANICA			English	Article						Characterization; Hyperelastic coefficients; Representative volume element; Finite element; Periodic boundary conditions; Strain rate	TRAUMATIC BRAIN-INJURY; MECHANICS; BEHAVIOR; TISSUE; STEM	Optimal hyperplastic coefficients of the micromechanical constituents of the human brain stein were investigated. An evolutionary optimization algorithm was combined with a Finite Element (FE) model of a Representative Volume Element (RVE) to find the optimal material properties of axon and Extra Cellular Matrix (ECM). The tension and compression test results of a previously published experiment were used for optimizing the material coefficients, and the shear experiment was used for the validation of the resulting constitutive model. The optimization algorithm was used to search for optimal shear moduli and fiber stiffness of axon and ECM by fitting the average stress in the axonal direction with the results of the experiment. The resulting constitutive model was validated against the shear stress results of the same experiment, showing strong agreement. The instantaneous shear moduli and fiber stiffness of both axon and ECM increased at higher strain rates, while the axon-to-ECM shear modulus ratio decreased from the value of 10 at a strain rate of 0.5/s to the value of 5 at a strain rate of 30/s. The proposed characterization procedure and the resulting coefficients may be applied to future multi-scale FE studies of the human brain. (C) 2020 Sharif University of Technology. All rights reserved.	[Hoursan, H.; Farahmand, F.; Ahmadian, M. T.] Sharif Univ Technol, Sch Mech Engn, POB 145888-9496, Tehran, Iran		Ahmadian, MT (corresponding author), Sharif Univ Technol, Sch Mech Engn, POB 145888-9496, Tehran, Iran.	Hesam.hoursan74@student.sharif.edu; Farahmand@sharif.edu; Ahmadian@sharif.edu			INSFIran National Science Foundation (INSF)	This paper is supported by INSF.	Abolfathi N, 2009, COMPUT METHOD BIOMEC, V12, P249, DOI [10.1080/10255840802430587, 10.1080/10255840903097871]; Arbogast K., 1990, J BIOMECH, V32, P865; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Atashpaz-Gargari E, 2007, IEEE C EVOL COMPUTAT, P4661, DOI 10.1109/cec.2007.4425083; Budday S, 2017, J MECH BEHAV BIOMED, V74, P463, DOI 10.1016/j.jmbbm.2017.07.014; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Carlsen RW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00028; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Eslaminejad A, 2018, SCI IRAN, V25, P3141, DOI 10.24200/sci.2018.20888; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; HILL R, 1963, J MECH PHYS SOLIDS, V11, P357, DOI 10.1016/0022-5096(63)90036-X; Hollister SJ., 1992, COMPUT MECH, V10, P73, DOI [10.1007/BF00369853, DOI 10.1007/BF00369853]; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Hoursan H., 2018, VALIDITY EXTENT LINE, DOI [10.25071/10315/35365, DOI 10.25071/10315/35365]; Hoursan H., 2013, ASME INT MECH ENG C, P3, DOI [10.1115/IMECE2013-63053, DOI 10.1115/IMECE2013-63053]; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Javid S, 2014, J MECH BEHAV BIOMED, V30, P290, DOI 10.1016/j.jmbbm.2013.11.010; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karami G., 2011, SIMULIA CUST C, P1, DOI 10.21236/ada548703; Latorre M, 2017, INT J NONLIN MECH, V89, P14, DOI 10.1016/j.ijnonlinmec.2016.11.005; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Saboori P, 2011, SCI IRAN, V18, P1492, DOI 10.1016/j.scient.2011.11.032; Shafiee A., 2015, J MECH ENG MODARES, V15, P248; Stephane L., 2011, 10 NAT S CALC STRUCT; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418	34	5	5	0	0	SHARIF UNIV TECHNOLOGY	TEHRAN	PO BOX 11155-8639, TEHRAN, 00000, IRAN	1026-3098			SCI IRAN	Sci. Iran.	MAR-APR	2020	27	2					784	794		10.24200/sci.2018.50940.1928			11	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	OE5SQ	WOS:000580590300008		gold			2022-02-06	
J	Li, TT; Yang, WC; Wang, YZ; Sun, T; Cao, HL; Chen, JF; Li, WZ				Li, Ting-Ting; Yang, Wan-Chao; Wang, Yue-Zhen; Sun, Tian; Cao, Hong-Ling; Chen, Jian-Feng; Li, Wen-Zhi			Effects of a high concentration of hydrogen on neurological function after traumatic brain injury in diabetic rats	BRAIN RESEARCH			English	Article						Hydrogen; TBI; Neuron; Oxidative stress; Apoptosis	SUBARACHNOID HEMORRHAGE; SIGNALING PATHWAY; RICH SALINE; APOPTOSIS; NEURONS; MODEL; PERMEABILITY; INHALATION; FAMILY	Reactive oxygen species, inflammation, and apoptosis are major contributors to secondary injuries that follow traumatic brain injury (TBI) in diabetic patients. Hydrogen (H-2) can selectively neutralize reactive oxygen species and downregulate inflammatory and apoptotic factors. Therefore, we investigated the effects of inhaled high and low concentrations of hydrogen on neurological function after TB1 in diabetic rats and the potential mechanism. We found that the inhalation of high concentrations of H-2 significantly improved outcomes following TBI in diabetic rats. The inhalation of 42% H-2 for one hour per day for 48 h significantly reduced brain edema, decreased the extravasation of sodium fluorescein, and reduced oxidative stress markers (p < 0.05). In addition, the inhalation of a high concentration of H-2 (42% for one hour per day for 7 days) improved neurological deficits (p < 0.05) and reduced the expression of apoptotic protein markers (p < 0.05). However, the inhalation of 3% H-2 did not yield significant effects. These results showed that the inhalation of 42% H-2 can alleviate nerve damage and improve neurological function after TBI in diabetic rats. Therefore, the inhalation of a high concentration of H-2 may be associated with the treatment of traumatic brain injuries.	[Li, Ting-Ting; Yang, Wan-Chao; Wang, Yue-Zhen; Sun, Tian; Cao, Hong-Ling; Chen, Jian-Feng; Li, Wen-Zhi] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 2, 246 XueFu Rd, Harbin 150086, Peoples R China		Yang, WC; Li, WZ (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 2, 246 XueFu Rd, Harbin 150086, Peoples R China.	Dachao_1980@126.com; Wenzhili9@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400989]	This study was supported by a grant-in-aid (no. 81400989) from the National Natural Science Foundation of China.	Abou-El-Hassan H, 2017, MED HYPOTHESES, V108, P69, DOI 10.1016/j.mehy.2017.08.008; Air M., 2017, LANCET NEUROL, V16; Amitani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053913; BASILE DP, 1997, AM J PHYSIOL, V272, pF64; Brizuela M, 2017, J NEUROTRAUM, V34, P2504, DOI 10.1089/neu.2017.4977; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Chen KY, 2017, CELL PHYSIOL BIOCHEM, V43, P1634, DOI 10.1159/000484024; Chen X, 2018, CELL PHYSIOL BIOCHEM, V47, P176, DOI 10.1159/000489764; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cui J, 2016, NEUROSCIENCE, V335, P232, DOI 10.1016/j.neuroscience.2016.08.021; Davanzo JR, 2017, SURG CLIN N AM, V97, P1237, DOI 10.1016/j.suc.2017.08.001; de Zeeuw D, 2010, LANCET, V376, P1543, DOI 10.1016/S0140-6736(10)61032-X; Deng CH, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/3094504; Dressler Jan, 2009, Leg Med (Tokyo), V11 Suppl 1, pS54, DOI 10.1016/j.legalmed.2009.02.024; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; El-Menyar Ayman, 2016, J Emerg Trauma Shock, V9, P64, DOI 10.4103/0974-2700.179461; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Iwata N., 2015, BIOMED RES INT, V2015, P1; Ji X., 2012, BRAIN RES, V178, P196; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kafaki SB, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMEDED.S40330; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Li Q, 2016, NEUROCHEM RES, V41, P2655, DOI 10.1007/s11064-016-1978-x; Li T., 2018, FASEB J; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lustenberger T, 2013, BRAIN INJURY, V27, P281, DOI 10.3109/02699052.2012.743178; Matchett GA, 2009, BRAIN RES, V1259, P90, DOI 10.1016/j.brainres.2008.12.066; Mayhan WG, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12653; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nemeth J, 2016, J PHYSIOL PHARMACOL, V67, P677; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Satoh Y, 2018, J NEUROPATH EXP NEUR, V77, P827, DOI 10.1093/jnen/nly060; Shao AW, 2016, MOL NEUROBIOL, V53, P18, DOI 10.1007/s12035-014-8986-0; Shukla V, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0774-5; Simao F, 2012, EUR J NEUROSCI, V36, P2899, DOI 10.1111/j.1460-9568.2012.08229.x; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Takeuchi S., 2015, TURKISH NEUROSURGERY; Takeuchi S, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0165-3; Tamatani M, 1998, J NEUROCHEM, V71, P1588; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Voutilainen-Kaunisto RM, 2000, DIABETES CARE, V23, P1672, DOI 10.2337/diacare.23.11.1672; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang L., 2017, SHOCK, V1; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Xin Y., 2017, NEUROREPORT, V28; Xu Z., 2016, NEUROIMAGE; Yang WC, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1427-2; Yuan J, 2018, J SURG RES, V228, P238, DOI 10.1016/j.jss.2018.03.024; Yuan J, 2016, BRAIN RES BULL, V127, P171, DOI 10.1016/j.brainresbull.2016.09.010; Zhang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23742; Zhou YF, 2014, BRAIN RES BULL, V100, P14, DOI 10.1016/j.brainresbull.2013.10.013	61	5	6	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAR 1	2020	1730								146651	10.1016/j.brainres.2020.146651			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KR8GO	WOS:000517854200002	31926128				2022-02-06	
J	Lundine, JP; Hall, A				Lundine, Jennifer P.; Hall, Audrey			Using Nonstandardized Assessments to Evaluate Cognitive-Communication Abilities following Pediatric Traumatic Brain Injury	SEMINARS IN SPEECH AND LANGUAGE			English	Article						traumatic brain injury; students; adolescent; cognitive-communication; nonstandardized assessment; curriculum-based assessment; discourse analysis	HEALTH-CARE; BEHAVIOR PROBLEMS; UNITED-STATES; CHILDREN; ADOLESCENTS; SCHOOL; STUDENTS; PREDICTORS; TBI; IDENTIFICATION	The subtle cognitive-communication challenges experienced by students with traumatic brain injury (TBI) are often missed, leaving these students with unmet needs in the school environment and increasing the likelihood for negative social, academic, and vocational outcomes. For children and adolescents with TBI, nonstandardized assessment offers several advantages over standardized assessment procedures, and may improve speech-language pathologists' ability to identify students who might benefit from intervention services. This article discusses curriculum-based assessment and discourse analysis specifically and uses case studies to demonstrate how these procedures can be used within the school environment. Nonstandardized assessment procedures are a valuable tool to measure a student's cognitive-communication abilities and the effects of intervention in real-world contexts.	[Lundine, Jennifer P.; Hall, Audrey] Ohio State Univ, Dept Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies & Inpatient Rehabil Program, Columbus, OH USA		Lundine, JP (corresponding author), Ohio State Univ, 101A Pressey Hall,1070 Carmack Rd, Columbus, OH 43210 USA.	lundine.4@osu.edu	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875; Hall, Audrey/0000-0002-4896-6942			American Speech-Language-Hearing Association, 2016, SCOP PRACT SPEECH LA; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; [Anonymous], PED TRAUM BRAIN INJ; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Campbell JM, 2008, J PEDIATR PSYCHOL, V33, P1015; Campbell JM, 2008, J PEDIATR PSYCHOL, V33, P999, DOI 10.1093/jpepsy/jsm138; Cermak CA, 2019, J HEAD TRAUMA REHAB, V34, pE13, DOI 10.1097/HTR.0000000000000419; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chevignard MP, 2012, BRAIN INJURY, V26, P1033, DOI 10.3109/02699052.2012.666366; Chitsabesan P, 2015, J HEAD TRAUMA REHAB, V30, P106, DOI 10.1097/HTR.0000000000000129; Ciccia AH, 2009, TOP LANG DISORD, V29, P249, DOI 10.1097/TLD.0b013e3181b53211; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Davies S., 2013, PHYS DISABILITIES ED, V32, P55; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Dawson P., 2018, EXECUTIVE SKILLS CHI; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dennis M, 2010, J CLIN EXP NEUROPSYC, V32, P417, DOI 10.1080/13803390903164355; Dettmer JL, 2007, J HEAD TRAUMA REHAB, V22, P339, DOI 10.1097/01.HTR.0000300229.13490.c7; Ettel D, 2016, EXCEPTIONALITY ED IN, V26, P1, DOI DOI 10.5206/EEI.V26I1.7732; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Knippel T, 2016, 10 YEAR TRENDS PEDIA; Koutsoftas AD, 2012, LANG SPEECH HEAR SER, V43, P395, DOI 10.1044/0161-1461(2012/11-0018); LeBlanc JM, 2000, J HEAD TRAUMA REHAB, V15, P1022, DOI 10.1097/00001199-200008000-00005; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lundine J P, 2020, TOP LANG DISORD; Lundine JP, 2018, AM J SPEECH-LANG PAT, V27, P247, DOI 10.1044/2017_AJSLP-16-0131; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; Meaux AB, 2018, LANG SPEECH HEAR SER, V49, P165, DOI 10.1044/2017_LSHSS-17-0057; Nelson N. W., 1989, LANG SPEECH HEAR SER, V20, P170, DOI [10.1044/0161-1461.2002.170, DOI 10.1044/0161-1461.2002.170]; Paul-Brown D, 2003, TECHNICAL REPORT; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Shaw SR, 2008, PSYCHOL SCHOOLS, V45, P74, DOI 10.1002/pits.20280; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sohlberg M., 2001, COGNITIVE REHABILITA; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; TEASDALE G, 1974, LANCET, V2, P81; Todis B, 2018, NEUROREHABILITATION, V42, P269, DOI 10.3233/NRE-172383; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2015, DEV MED CHILD NEUROL, V57, P217, DOI 10.1111/dmcn.12600; Turkstra LS, 2008, NEUROREHABILITATION, V23, P501; Wagner M., 2004, TRANSITION PLANNING; Wiig EH, 2013, CLIN EVALUATION LANG, V5th; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; World Health Organization, 2007, INT CLASS FUNCT DIS; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	80	5	5	0	6	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	MAR	2020	41	2					170	182		10.1055/s-0040-1701685			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	LE5NF	WOS:000526765100004	32155652				2022-02-06	
J	Remigio-Baker, RA; Bailie, JM; Gregory, E; Cole, WR; McCulloch, KL; Cecchini, A; Stuessi, K; Andrews, TR; Mullins, L; Ettenhofer, ML				Remigio-Baker, Rosemay A.; Bailie, Jason M.; Gregory, Emma; Cole, Wesley R.; McCulloch, Karen L.; Cecchini, Amy; Stuessi, Keith; Andrews, Taylor R.; Mullins, Lynita; Ettenhofer, Mark L.			Activity Level During Acute Concussion May Predict Symptom Recovery Within an Active Duty Military Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activity; concussion; confounding by acute symptoms; interaction by acute symptoms; mild traumatic brain injury; military; Neurobehavioral Symptom Inventory; service members; symptom; symptom recovery	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SPORT-RELATED CONCUSSION; PROGRESSIVE RETURN; COGNITIVE REST; REHABILITATION; EXERCISE; RECOMMENDATIONS; ADOLESCENTS; PROGNOSIS	Objective: To evaluate the impact on symptom resolution of activity acutely following a concussion and the role of acute-phase symptoms on this relationship among active duty service members (SMs). Setting: Three military installations. Participants: Sixty-two SMs aged 18 to 44 years who sustained a concussion within 72 hours of enrollment. Design: Longitudinal design with data collected within 72 hours of injury (baseline, n = 62) and at 1 week (n = 57), 1 month (n = 50), 3 months (n = 41), and 6 months (n = 40) postinjury. Main Measures: Baseline activity level using a 60-item Activity Questionnaire. Symptom level at baseline and during follow-up using Neurobehavioral Symptoms Inventory. Results: Significant interaction (P-i < .05) was found, with significant main effects (P < .05) limited to SMs with elevated baseline symptomatology. Among these participants, greater baseline total activity was significantly related to greater vestibular symptoms at 1, 3, and 6 months (beta = .61, .63, and .59, respectively). Significant associations were also found for particular types of baseline activity (eg, physical; vestibular/balance; military-specific) and symptoms at 1, 3, and/or 6 months postinjury. Conclusion: These results provide support for clinical guidance that symptomatic SMs, particularly those with high levels of acute symptoms, may need to avoid excessive activity acutely following concussion.	[Remigio-Baker, Rosemay A.; Bailie, Jason M.; Gregory, Emma; Cole, Wesley R.; Stuessi, Keith; Andrews, Taylor R.; Mullins, Lynita; Ettenhofer, Mark L.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Remigio-Baker, Rosemay A.; Bailie, Jason M.; Stuessi, Keith] Naval Hosp Camp Pendleton, Concuss Care Clin, Camp Pendleton, CA USA; [Remigio-Baker, Rosemay A.; McCulloch, Karen L.; Andrews, Taylor R.] Venesco LLC, Chantilly, VA USA; [Bailie, Jason M.; Stuessi, Keith] Gen Dynam Hlth Solut, Silver Spring, MD USA; [Andrews, Taylor R.; Mullins, Lynita; Ettenhofer, Mark L.] Naval Med Ctr San Diego, San Diego, CA USA; [Cole, Wesley R.; Cecchini, Amy] Womack Army Med Ctr, Dept Brain Injury Med, Ft Bragg, NC USA; [McCulloch, Karen L.] Univ N Carolina, Dept Allied Hlth Sci, Chapel Hill, NC 27515 USA; [Ettenhofer, Mark L.] Amer Hosp Serv Grp LLC, Exton, PA USA		Remigio-Baker, RA (corresponding author), Venesco LLC, Def & Vet Brain Injury Ctr, Concuss Care Clin, Camp Pendleton, CA 92058 USA.	rremigiobaker@gmail.com			Defense Health Program 6.7 [D6.7_14_C2_I_14_J9_1077]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This work was supported by the Defense Health Program 6.7 (award number: D6.7_14_C2_I_14_J9_1077) and the Defense and Veterans Brain Injury Center.	Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks BL, 2016, J NEUROTRAUM, V33, P2091, DOI 10.1089/neu.2015.4301; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, PROGR RET ACT FOLL M; Department of Defense, DOD POL GUID MAN MIL; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gagnon I, 2009, J HEAD TRAUMA REHAB, V24, P355, DOI 10.1097/HTR.0b013e3181b97a4e; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Gregory E, 2017, CONTEMP CLIN TRIALS, V52, P95, DOI 10.1016/j.cct.2016.11.005; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Halstead ME, 2017, BRIT J SPORT MED, V51, P147, DOI 10.1136/bjsports-2016-096674; Howell DR, 2020, CLIN J SPORT MED, V30, pS42, DOI 10.1097/JSM.0000000000000570; Iverson GL, 2015, OXFORD HDB SPORTS RE; Kennedy C. H., 2010, MILITARY NEUROPSYCHO; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Studerus-Germann AM, 2017, INT J NEUROSCI, V127, P900, DOI 10.1080/00207454.2017.1278589; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979	45	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2020	35	2			SI		92	103		10.1097/HTR.0000000000000498			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LC0HT	WOS:000525012500004	31246876				2022-02-06	
J	Rietdijk, R; Power, E; Brunner, M; Togher, L				Rietdijk, Rachael; Power, Emma; Brunner, Melissa; Togher, Leanne			Protocol for a clinical trial of telehealth-based social communication skills training for people with traumatic brain injury and their communication partners	BRAIN IMPAIRMENT			English	Article						Telemedicine; social communication disorder; caregivers; clinical trial; brain injuries; traumatic	FAMILY CAREGIVERS; HEAD-INJURY; INDIVIDUALS; ADULTS; CONVERSATION; SUPPORT; PARTICIPATION; PERSPECTIVES; RELIABILITY; MANAGEMENT	Background:A previous clinical trial of training communication partners of people with traumatic brain injury (TBI) demonstrated positive outcomes [Togher, Power, McDonald, Tate, & Rietdijk (2009). Brain Impairment, 10(2), 188-204]. Adapting communication partner training for delivery via telehealth could improve access to this intervention. Objectives:To compare outcomes across in-person communication partner training, telehealth communication partner training and a control group Method:Protocol for a partially randomised controlled trial. People with moderate-severe TBI will be allocated to either an in-person or telehealth-based training program. Comparison data will be drawn from the original trial control group, which was recruited using the same eligibility criteria as this protocol. Outcomes after training will be compared between the in-person training group, the telehealth training group and the historical control group. Discussion:This protocol uses specific design features with the aim of maximising the study's power, including a partially randomised allocation process and a historical control group. The results will inform about the feasibility and effectiveness of delivering TBI rehabilitation via telehealth.	[Rietdijk, Rachael; Power, Emma; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Power, Emma; Brunner, Melissa] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia.	rman7827@uni.sydney.edu.au	Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Brunner, Melissa/0000-0001-6823-5189; Togher, Leanne/0000-0002-4518-6748; Power, Emma/0000-0002-2638-0406	Australian Postgraduate AwardAustralian Government; Lifetime Care and Support Authority of New South Wales	This work was supported by an Australian Postgraduate Award. The clinical trial described in the protocol has received funding from the Lifetime Care and Support Authority of New South Wales.	American Speech-Language-Hearing Association, 2018, TRAUM BRAIN INJ AD P; Australian Government Department of Human Services, 2019, TEL AR; Avramovic P, 2017, BRAIN INJURY, V31, P502, DOI 10.1080/02699052.2017.1280854; Babbitt EM, 2011, APHASIOLOGY, V25, P727, DOI 10.1080/02687038.2010.537347; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown AW, 2015, BRAIN INJURY, V29, P1530, DOI 10.3109/02699052.2015.1075173; Cahill J, 2012, PSYCHOTHER RES, V22, P241, DOI 10.1080/10503307.2011.643253; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Cherney LR, 2011, TOP STROKE REHABIL, V18, P352, DOI 10.1310/tsr1804-352; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Finch E, 2016, BRAIN INJURY, V30, P883, DOI 10.3109/02699052.2016.1146959; Galusha-Glasscock JM, 2016, ARCH CLIN NEUROPSYCH, V31, P8, DOI 10.1093/arclin/acv058; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Hawthorne G, 2011, J CLIN NEUROSCI, V18, P197, DOI 10.1016/j.jocn.2010.06.015; Hines M, 2015, J TELEMED TELECARE, V21, P469, DOI 10.1177/1357633X15604555; Hoepner JK, 2018, CLIN ARCH COMMUN DIS, V3, P22, DOI [10.21849/cacd.2018.00262, DOI 10.21849/CACD.2018.00262]; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; IBM Corp, 2016, IBM SPSS STAT WIND V; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Pearce B, 2016, BRAIN INJURY, V30, P1708, DOI 10.1080/02699052.2016.1202450; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Randolph C., 2012, RBANS UPDATE REPEATA; Rietdijk R, 2020, NEUROPSYCHOL REHABIL, V30, P1074, DOI 10.1080/09602011.2018.1554533; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Rietdijk R, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000282; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Saldert C, 2018, APHASIOLOGY, V32, P1167, DOI 10.1080/02687038.2018.1470317; Sealed Envelope Ltd, 2012, POW CALC CONT OUTC S; Shepherd-Banigan ME, 2018, J GEN INTERN MED, V33, P1177, DOI 10.1007/s11606-018-4417-7; Simpson GK, 2016, J HEAD TRAUMA REHAB, V31, pE26, DOI 10.1097/HTR.0000000000000160; Sinnakaruppan I, 2005, BRAIN INJURY, V19, P283, DOI 10.1080/02699050400003924; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wiltshire GE, 2014, J SOC INCL, V5, P9, DOI 10.36251/josi.73	60	5	5	0	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAR	2020	21	1					110	123	PII S1443964619000093	10.1017/BrImp.2019.9			14	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	OB2QS	WOS:000578318900008					2022-02-06	
J	Sagiraju, HKR; Zivkovic, S; VanCott, AC; Patwa, H; de Porras, DGR; Amuan, ME; Pugh, MJV				Sagiraju, Hari Krishna Raju; Zivkovic, Sasa; VanCott, Anne C.; Patwa, Huned; de Porras, David Gimeno Ruiz; Amuan, Megan E.; Pugh, Mary Jo V.			Amyotrophic Lateral Sclerosis Among Veterans Deployed in Support of Post-9/11 US Conflicts	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; FREQUENCY MAGNETIC-FIELDS; MILITARY SERVICE; OCCUPATIONAL-EXPOSURE; NEURODEGENERATIVE DISEASE; HEAD-INJURY; RISK-FACTOR; BODY-MASS; CANCER; COMORBIDITY	Introduction Amyotrophic lateral sclerosis (ALS) is a recognized military service-connected condition. Prior prevalence studies of ALS among U.S. war Veterans were not able to address concerns related to neurodegenerative sequelae of traumatic brain injury (TBI) and disregarded risk heterogeneity from occupational categories within service branches. Materials and Methods We identified the prevalence of definite and possible ALS and cumulative incidence of definite ALS among Post-9/11 U.S. Veterans deployed in support of Post-9/11 conflicts (mean age 36.3) who received care in the Veterans Health Administration during fiscal years 2002-2015. Using a case-control study design, we also evaluated the association of TBI and major military occupation groups with ALS adjusting for demographics and comorbidities. Results The prevalence of ALS was 19.7 per 100,000 over 14 years. Both prevalence and cumulative incidence of definite ALS were significantly higher among Air Force personnel compared to other service branches and among tactical operation officers and health care workers compared to general and administrative officers. Neither TBI nor younger age (<45 years) was associated with ALS. Depression, cardiac disease, cerebrovascular disease, high blood pressure, and obstructive sleep apnea were clinical comorbidities significantly associated with ALS in this population of Veterans. Conclusion This study among a cohort of relatively young Veterans showed a high ALS prevalence, suggesting an early onset of ALS among deployed military service members. The higher prevalence among some military specific occupations highlights the need to determine which occupational exposures specific to these occupations (particularly, Air Force personnel, tactical operations officers, and health care workers) might be associated with early onset ALS.	[Sagiraju, Hari Krishna Raju; Amuan, Megan E.; Pugh, Mary Jo V.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, 500 Foothill Dr,Bldg 182, Salt Lake City, UT 84148 USA; [Sagiraju, Hari Krishna Raju; Pugh, Mary Jo V.] Univ Utah, Div Epidemiol, 383 Colorow Dr,Suite203, Salt Lake City, UT 84108 USA; [Zivkovic, Sasa; VanCott, Anne C.] Univ Pittsburgh, Dept Neurol, 3471 Fifth Ave, Pittsburgh, PA 15213 USA; [VanCott, Anne C.] VA Pittsburgh Hlth Care Syst, Dept Neurol, 4100 Allequippa St, Pittsburgh, PA 15213 USA; [Patwa, Huned] VA Connecticut Hlth Care Syst, VA Neurol Serv, 950 Campbell Ave, West Haven, CT 06516 USA; [de Porras, David Gimeno Ruiz] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth San Antonio, Dept Epidemiol Human Genet & Environm Sci, 7411 John Smith Dr 1100, San Antonio, TX 78229 USA		Sagiraju, HKR (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, 500 Foothill Dr,Bldg 182, Salt Lake City, UT 84148 USA.; Sagiraju, HKR (corresponding author), Univ Utah, Div Epidemiol, 383 Colorow Dr,Suite203, Salt Lake City, UT 84108 USA.			Sagiraju, Hari Krishna Raju/0000-0002-9719-9380	VA Health Services Research and Development ServiceUS Department of Veterans Affairs [DHI 09-237]; VA Clinical Sciences Research and Development [I01 CX001246]; VA Health Services Research and Development Service grant [RCS 17-297]	VA Health Services Research and Development Service (Grant no. DHI 09-237). VA Clinical Sciences Research and Development (Grant no. I01 CX001246). VA Health Services Research and Development Service grant (Grant no. RCS 17-297).	Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Beard JD, 2016, ENVIRON INT, V91, P104, DOI 10.1016/j.envint.2016.02.014; Blettner M, 1998, RADIAT ENVIRON BIOPH, V37, P75, DOI 10.1007/s004110050097; Charatan F, 2002, BRIT MED J, V324, P65, DOI 10.1136/bmj.324.7329.65/a; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Fang F, 2013, AMYOTROPH LAT SCL FR, V14, P362, DOI 10.3109/21678421.2013.775309; Gallo V, 2016, EUR J EPIDEMIOL, V31, P255, DOI 10.1007/s10654-016-0119-9; Genetics Home Reference- U. S National Library of Medicine, 2019, AM LAT SCLER GEN; Gibson SB, 2016, NEUROLOGY, V87, P289, DOI 10.1212/WNL.0000000000002757; Gunnarsson LG, 2014, WORK HLTH SYSTEMATIC, V48; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Handy CR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/403808; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Huss A, 2018, BIOELECTROMAGNETICS, V39, P156, DOI 10.1002/bem.22104; Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505; Institute of medicine, 2006, AM LAT SCLER VET REV, DOI [10.17226/11757, DOI 10.17226/11757]; Kioumourtzoglou MA, 2016, AMYOTROPH LAT SCL FR, V17, P548, DOI 10.1080/21678421.2016.1208247; Kioumourtzoglou MA, 2015, JAMA NEUROL, V72, P905, DOI 10.1001/jamaneurol.2015.0910; Koeman T, 2017, OCCUP ENVIRON MED, V74, P578, DOI 10.1136/oemed-2016-103780; Korner S, 2013, EUR J NEUROL, V20, P647, DOI 10.1111/ene.12015; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mehta P, 2018, MMWR-MORBID MORTAL W, V67, P1285, DOI 10.15585/mmwr.mm6746a1; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; Nicholas JS, 1998, AM J IND MED, V34, P574, DOI 10.1002/(SICI)1097-0274(199812)34:6<574::AID-AJIM5>3.0.CO;2-X; Nicholas JS, 1998, J OCCUP ENVIRON MED, V40, P980, DOI 10.1097/00043764-199811000-00008; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; Oskarsson B, 2015, NEUROL CLIN, V33, P877, DOI 10.1016/j.ncl.2015.07.009; Pamphlett R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080993; Paul MM, 2016, MMWR SURVEILL SUMM, V65, p[2012, 1]; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Phukan J, 2007, LANCET NEUROL, V6, P994, DOI 10.1016/S1474-4422(07)70265-X; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Quaranta VN, 2017, NEURODEGENER DIS, V17, P14, DOI 10.1159/000447560; Raj R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002316; Rose MR, 2003, NEUROLOGY, V61, P730, DOI 10.1212/WNL.61.6.730; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P295, DOI 10.3109/17482960802430799; Tabares-Seisdedos R, 2013, NAT REV NEUROSCI, V14, P293, DOI 10.1038/nrn3464; Tai HF, 2017, J CLIN NEUROSCI, V45, P337, DOI 10.1016/j.jocn.2017.08.035; Tumer MR, 2016, J NEUROL NEUROSUR PS, V87, P244, DOI 10.1136/jnnp-2015-311157; Turner MR, 2016, ANN NEUROL, V80, P935, DOI 10.1002/ana.24801; Vergara X, 2013, J OCCUP ENVIRON MED, V55, P135, DOI 10.1097/JOM.0b013e31827f37f8; Weisskopf MG, 2015, EPIDEMIOLOGY, V26, P831, DOI 10.1097/EDE.0000000000000376; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Yamaguchi M., 2016, J CARCINOG MUTAGEN, V7, pe22, DOI [10.4172/2157-2518.1000e122, DOI 10.4172/2157-2518.1000E122]	50	5	5	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2020	185	3-4					E501	E509		10.1093/milmed/usz350			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR7HU	WOS:000535866100028	31642489	hybrid			2022-02-06	
J	Warnock, A; Toomey, LM; Wright, AJ; Fisher, K; Won, Y; Anyaegbu, C; Fitzgerald, M				Warnock, Andrew; Toomey, Lillian M.; Wright, Alexander J.; Fisher, Katherine; Won, Yerim; Anyaegbu, Chidozie; Fitzgerald, Melinda			Damage Mechanisms to Oligodendrocytes and White Matter in Central Nervous System Injury: The Australian Context	JOURNAL OF NEUROTRAUMA			English	Article						dysmyelination; magnetic resonance imaging; oligodendrocytes; oligodendrocyte precursor cells; oxidative damage; white matter	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; AMYLOID PRECURSOR PROTEIN; NEURITE ORIENTATION DISPERSION; ENDOPLASMIC-RETICULUM STRESS; RETINAL GANGLION-CELLS; EXCITATORY AMINO-ACIDS; DIFFUSE AXONAL INJURY; LARGE ANIMAL-MODELS; HEAD IMPACT MODEL	Traumatic brain injury (TBI) and spinal cord injury (SCI) present a significant contribution to the global disease burden. White matter tracts are susceptible to both the physical forces of trauma and cascades of pathological secondary degeneration. Oligodendrocytes, the myelinating cells of the central nervous system (CNS), and their precursors are particularly vulnerable cell populations and their disruption results in a loss of white matter, dysmyelination, and poor myelin repair. White matter aberrations in TBI and SCI can be visualized in vivo using a number of magnetic resonance imaging (MRI)-based modalities. Recent advances in diffusion MRI allow researchers to investigate subtle abnormalities in white matter microstructure and connectivity, resting state networks, and metabolic perturbations associated with injury. Damage to oligodendroglia underlies white matter aberrations and occurs as a result of glutamate excitotoxicity, intracellular calcium ion (Ca2+) overload, and oxidative damage to lipids, proteins, and DNA. Structural changes to myelin include myelin decompaction, loosening of myelin lamellae, and disruption to the node of Ranvier complex. Neuronal and functional loss accompany dysmyelination together with an increase in astro- and microgliosis. Remyelination is often partial, and more work is needed to understand deficits in remyelination post-injury to develop strategies to both protect and repair myelin and thereby preserve function. This review covers disruptions to oligodendrocyte function and white matter tract structure in the context of TBI and SCI, with an emphasis on Australian contributions in recognition of the International Neurotrauma Symposium held in Melbourne, Australia in 2020.	[Warnock, Andrew; Toomey, Lillian M.; Wright, Alexander J.; Anyaegbu, Chidozie; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Toomey, Lillian M.; Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia; [Fisher, Katherine; Won, Yerim] Univ Western Australia, Sch Human Sci, Perth, WA, Australia		Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Toomey, Lillian/0000-0001-9435-6128; Anyaegbu, Chidozie/0000-0002-0618-3173	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [APP1160691]	The work was supported by the National Health and Medical Research Council of Australia (APP1160691).	Abderezaei J, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.014058; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Allen NJ, 2001, NAT NEUROSCI, V4, P676, DOI 10.1038/89443; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Anderson Aileen J, 2002, J Spinal Cord Med, V25, P70; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arai K, 2010, J NEUROSCI RES, V88, P758, DOI 10.1002/jnr.22256; Arai K, 2009, BIOL PHARM BULL, V32, P1639, DOI 10.1248/bpb.32.1639; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Arancibia-Carcamo IL, 2014, ACTA NEUROPATHOL, V128, P161, DOI 10.1007/s00401-014-1305-z; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Astradsson A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E5; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Ayton S, 2020, MOL PSYCHIATR, V25, P2932, DOI 10.1038/s41380-019-0375-7; Baloescu C, 2018, ANN EMERG MED, V72, P637, DOI 10.1016/j.annemergmed.2018.06.034; Banoei MM, 2018, J NEUROTRAUM, V35, P1831, DOI 10.1089/neu.2017.5326; Barger SW, 2007, J NEUROCHEM, V101, P1205, DOI 10.1111/j.1471-4159.2007.04487.x; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Baumann N., 2017, PHYSIOL REV, V81, P871; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Belli A., 2017, BRIT J SPORT MED, V51, pA4; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Bernardo A, 2009, J NEUROPATH EXP NEUR, V68, P797, DOI 10.1097/NEN.0b013e3181aba2c1; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Blair M, 2005, INVEST OPHTH VIS SCI, V46, P884, DOI 10.1167/iovs.04-0731; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BONGARZONE ER, 1995, J NEUROSCI RES, V41, P213, DOI 10.1002/jnr.490410209; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; BORGES K, 1994, NEUROSCIENCE, V63, P135, DOI 10.1016/0306-4522(94)90012-4; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Braeckman K, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2019.101669; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Broadway JM, 2019, CORTEX, V120, P240, DOI 10.1016/j.cortex.2019.06.011; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buss A, 2004, BRAIN, V127, P34, DOI 10.1093/brain/awh001; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Caeyenberghs K, 2016, J NEUROSCI, V36, P4056, DOI 10.1523/JNEUROSCI.1973-15.2016; Camargo N, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002605; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Centers for Disease Control and Prevention, 2014, CDC INJ CTR GET FACT, VFacts, P2009; Challenor M, 2015, BIOCHIMIE, V112, P160, DOI 10.1016/j.biochi.2015.03.008; Chanraud S, 2010, NEUROPSYCHOL REV, V20, P209, DOI 10.1007/s11065-010-9129-7; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Chuang KH, 2017, NEUROIMAGE, V163, P419, DOI 10.1016/j.neuroimage.2017.09.038; Chung S, 2019, AM J NEURORADIOL, V40, P1438, DOI 10.3174/ajnr.A6146; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Clark AL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00873; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Collins JM, 2019, J NEUROTRAUM, V36, P1876, DOI 10.1089/neu.2018.5982; Collins-Praino L., 2018, J NEUROINFLAMM, V2, P1; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Conti AC, 1998, J NEUROSCI, V18, P5663; Corpas FJ, 2009, PLANT SIGNAL BEHAV, V4, P920, DOI 10.4161/psb.4.10.9466; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crawford AH, 2016, CELL REP, V15, P761, DOI 10.1016/j.celrep.2016.03.069; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cummins N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-98; D'souza MM, 2017, INJURY, V48, P880, DOI 10.1016/j.injury.2017.02.016; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; de Rooij R, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00144; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Doan N, 2016, INT J PHYS MED REHAB, V4, P120, DOI [10.4172/2329-9096.1000e120, DOI 10.4172/2329-9096.1000e120]; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Donaldson HH, 1905, J COMP NEUROL PSYCHO, V15, P1, DOI 10.1002/cne.920150102; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1200506109, 10.1073/pnas.1101934108]; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Ek CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043484; Elbaz B, 2019, TRENDS NEUROSCI, V42, P263, DOI 10.1016/j.tins.2019.01.002; Emery B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020461; Farooqui A.A., 2008, NEUROCHEMICAL ASPECT; Fehily B, 2019, J NEUROCHEM, V149, P660, DOI 10.1111/jnc.14673; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Figlia G, 2018, GLIA, V66, P693, DOI 10.1002/glia.23273; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fisher BM, 2013, AM J SURG, V206, P987, DOI 10.1016/j.amjsurg.2013.08.021; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Floriddia E.M., 2019, 580985 BIORXIV; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Foerster S, 2019, GLIA, V67, P1797, DOI 10.1002/glia.23607; Foster AY, 2019, GLIA, V67, P2038, DOI 10.1002/glia.23629; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gebauer G, 2012, CLIN ORTHOP RELAT R, V470, P1652, DOI 10.1007/s11999-012-2286-7; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Gorgoraptis N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1993; Griffin AD, 2019, BRAIN, V142, P3550, DOI 10.1093/brain/awz290; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guo Dong Mao, 1993, J BIOL CHEM, V268, P416; Guo Y, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00011; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; He DY, 2017, NEURON, V93, P362, DOI 10.1016/j.neuron.2016.11.044; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Hetz C, 2017, NAT REV NEUROL, V13, P477, DOI 10.1038/nrneurol.2017.99; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hornig J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003907; Hughes AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12059-y; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; HUSAIN J, 1995, BRAIN RES, V698, P86, DOI 10.1016/0006-8993(95)00832-B; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Initiative T.V.N., 2009, EC COST SPINAL CORD, P31; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jang M, 2019, ELIFE, V8, DOI 10.7554/eLife.42156; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kanda H, 2019, NEURON, V104, P960, DOI 10.1016/j.neuron.2019.08.042; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Khetani A, 2019, J NEUROTRAUM, V36, P3274, DOI 10.1089/neu.2018.6117; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Koreman E, 2018, MOL CELL NEUROSCI, V87, P18, DOI 10.1016/j.mcn.2017.11.010; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Kruman I, 1997, J NEUROSCI, V17, P5089; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Land E. T., 1990, INT J RADIAT BIOL, V58, P725, DOI [10.1080/09553009014552071, DOI 10.1080/09553009014552071]; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Laval J, 1998, MUTAT RES-FUND MOL M, V402, P93, DOI 10.1016/S0027-5107(97)00286-8; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lee I, 2002, MOL CELL BIOCHEM, V234, P63, DOI 10.1023/A:1015921513720; Lehtinen MK, 2006, CURR MOL MED, V6, P871, DOI 10.2174/156652406779010786; Lenaz G, 2001, IUBMB LIFE, V52, P159, DOI 10.1080/15216540152845957; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li HY, 2014, NEURAL REGEN RES, V9, P565, DOI 10.4103/1673-5374.130093; Li YL, 2018, NEUROREPORT, V29, P1121, DOI 10.1097/WNR.0000000000001083; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Lin TH, 2019, J NEUROTRAUM, V36, P2308, DOI 10.1089/neu.2018.6016; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Liu ZJ, 2007, DEV BIOL, V302, P683, DOI 10.1016/j.ydbio.2006.10.007; Lotocki G, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2010.0011; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lozic I, 2014, METALLOMICS, V6, P455, DOI 10.1039/c3mt00336a; Lu L, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/249102; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; LUDWIN SK, 1984, J NEUROL SCI, V64, P193, DOI 10.1016/0022-510X(84)90037-6; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; MAKI T, 2017, CLIN EXP NEUROIMMUNO, V8, P33, DOI DOI 10.1111/CEN3.12358; Maki T, 2015, NEUROSCI LETT, V597, P164, DOI 10.1016/j.neulet.2015.04.047; Mao YL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113408; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Mark LP, 2001, AM J NEURORADIOL, V22, P1813; Mark RJ, 1997, J NEUROCHEM, V68, P255; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; Maxwell W.L., 2003, ENCY NEUROLOGICAL SC, P10; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; McDonald S, 2019, BRAIN IMAGING BEHAV, V13, P819, DOI 10.1007/s11682-018-9906-0; McDonald S, 2018, SOC NEUROSCI-UK, V13, P471, DOI 10.1080/17470919.2017.1356370; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Metzler-Baddeley C, 2017, J COGNITIVE NEUROSCI, V29, P1509, DOI 10.1162/jocn_a_01127; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Miron VE, 2017, J LEUKOCYTE BIOL, V101, P1103, DOI 10.1189/jlb.3RI1116-494R; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mishra VR, 2019, HUM BRAIN MAPP, V40, P5108, DOI 10.1002/hbm.24761; Mitew S, 2014, NEUROSCIENCE, V276, P29, DOI 10.1016/j.neuroscience.2013.11.029; Mitew S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02719-2; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Miyamoto N, 2014, CELL MOL LIFE SCI, V71, P1055, DOI 10.1007/s00018-013-1488-9; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nakano M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42041; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nave KA, 2019, NAT MED, V25, P364, DOI 10.1038/s41591-019-0388-4; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Norman RS, 2019, BRAIN INJURY, V33, P1173, DOI 10.1080/02699052.2019.1632487; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Oluich LJ, 2012, J NEUROSCI, V32, P8317, DOI 10.1523/JNEUROSCI.1053-12.2012; Palacios E., 2018, BIORXIV345629; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Pelzer EA, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00050; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Philips T, 2017, J CLIN INVEST, V127, P3277, DOI 10.1172/JCI90610; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; Plummer SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190449; Podbielska M, 2013, BRAIN SCI, V3, P1282, DOI 10.3390/brainsci3031282; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Potts Mathew B, 2006, NeuroRx, V3, P143; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Quintard H, 2015, ANAESTH CRIT CARE PA, V34, P79, DOI 10.1016/j.accpm.2014.09.002; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rami A, 2003, NEUROBIOL DIS, V13, P75, DOI 10.1016/S0969-9961(03)00018-4; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rasband MN, 2003, J NEUROSCI RES, V73, P465, DOI 10.1002/jnr.10675; Rasband MN, 2001, DEV BIOL, V236, P5, DOI 10.1006/dbio.2001.0326; Ravera S, 2015, FREE RADICAL RES, V49, P1156, DOI 10.3109/10715762.2015.1050962; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Richter-Landsberg C, 2008, J MOL NEUROSCI, V35, P55, DOI 10.1007/s12031-007-9017-7; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Ruet A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00120; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Sanchez MA, 2018, EXP NEUROL, V299, P122, DOI 10.1016/j.expneurol.2017.10.010; Saunders LL, 2009, BRAIN INJURY, V23, P866, DOI 10.1080/02699050903283213; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Schweser F, 2019, NEUROIMAGE, V200, P250, DOI 10.1016/j.neuroimage.2019.06.024; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seif M, 2018, J NEUROTRAUM, V35, P2941, DOI 10.1089/neu.2017.5522; Selt M, 2010, BRAIN RES BULL, V81, P467, DOI 10.1016/j.brainresbull.2009.11.004; Seo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103174; Shaikh AY, 1998, NEUROSCIENTIST, V4, P88, DOI 10.1177/107385849800400205; Sharif-Alhoseini M, 2017, SPINAL CORD, V55, P714, DOI 10.1038/sc.2016.187; Sharwood LN, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0207-0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith NM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1227-0; Smith NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22595; Smith PM, 2006, BRAIN PATHOL, V16, P99, DOI 10.1111/j.1750-3639.2006.00001.x; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soni N, 2019, J NEUROTRAUM, V36, P1306, DOI 10.1089/neu.2018.5972; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P550, DOI 10.1007/s11682-015-9424-2; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stirling DP, 2014, ANN NEUROL, V75, P220, DOI 10.1002/ana.24099; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00642; Stricker NH, 2013, J INT NEUROPSYCH SOC, V19, P925, DOI 10.1017/S1355617713000660; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Terry DP, 2019, J INT NEUROPSYCH SOC, V25, P950, DOI 10.1017/S1355617719000754; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Toomey LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51886-3; Toomey LM, 2019, EXP BRAIN RES, V237, P161, DOI 10.1007/s00221-018-5414-0; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tripathi RB, 2011, J NEUROSCI, V31, P6809, DOI 10.1523/JNEUROSCI.6474-10.2011; Tseng WC, 2011, J TRAUMA, V71, P1611, DOI 10.1097/TA.0b013e31823a8a60; Turgeon AF, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013779; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tymianski M, 1996, NEUROSURGERY, V38, P1176; Vakil E, 2019, NEUROPSYCHOL REV, V29, P270, DOI 10.1007/s11065-019-09413-8; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valerio-Gomes B, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00090; van der Horn HJ, 2018, BRAIN IMAGING BEHAV, V12, P912, DOI 10.1007/s11682-017-9743-6; Vaziri ND, 2004, BRAIN RES, V995, P76, DOI 10.1016/j.brainres.2003.09.056; Vegliante G, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081134; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Walsh DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165673; Walsh DM, 2016, J THEOR BIOL, V406, P17, DOI 10.1016/j.jtbi.2016.06.028; Wang GJ, 2019, NEUROTOX RES, V36, P1, DOI 10.1007/s12640-018-9984-1; Wang ML, 2018, AM J NEURORADIOL, V39, P1650, DOI 10.3174/ajnr.A5737; Wang ML, 2018, NEUROSCIENCE, V392, P180, DOI 10.1016/j.neuroscience.2018.09.030; Wang WZ, 2019, J NEUROTRAUM, V36, P2348, DOI [10.1089/neu.2018.6205, 10.1155/2019/6342475]; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Wang Y, 2017, J MAGN RESON IMAGING, V46, P951, DOI 10.1002/jmri.25693; Ware JB, 2016, RADIOLOGY, V280, P212, DOI 10.1148/radiol.2016151013; Watkins TA, 2008, NEURON, V60, P555, DOI 10.1016/j.neuron.2008.09.011; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wei CW, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00175; Weider M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03336-3; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaya Y, 2002, J NEUROSCI RES, V70, P588, DOI 10.1002/jnr.10425; Yates NJ, 2017, EXP BRAIN RES, V235, P2133, DOI 10.1007/s00221-017-4958-8; Yeung MSY, 2019, NATURE, V566, P538, DOI 10.1038/s41586-018-0842-3; Yin B, 2019, FRONT NEURAL CIRCUIT, V13, DOI 10.3389/fncir.2019.00028; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Yuen TJ, 2014, CELL, V158, P383, DOI 10.1016/j.cell.2014.04.052; Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	407	5	5	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					739	769		10.1089/neu.2019.6890			31	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200006	32027208				2022-02-06	
J	Xu, ZH; Liu, W; Huang, H				Xu, ZhengHu; Liu, Wei; Huang, Huai			Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway	PHARMACOLOGY			English	Article						Astragaloside IV; Oxygen - glucose deprivation reoxygenation; Apoptosis; Janus kinase 2 and signal transducer and activator of transcription 3	TRAUMATIC BRAIN-INJURY; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; JAK2/STAT3 PATHWAY; PROTECTS; STROKE; GROWTH; RATS	Astragaloside IV (AS-IV) is an active component extracted from the traditional Chinese herbal medicine. AS-IV is a neuroprotective component in cerebral ischemic models. However, roles of AS-IV in cerebral ischemia-reperfusion (I/R) injury and the underlying mechanisms are rarely investigated. The role of AS-IV in oxygen - glucose deprivation reoxygenation (OGD/R)-induced cell proliferation and apoptosis assays were analyzed by Cell Counting Kit-8 and Flow cytometric. Western Blot assays were performed to measure the related expression levels in SH-SY5Y cells. Meanwhile, activities of reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) in OGD/R-induced cells were determined by relative commercial kits. AS-IV was also used in cerebral I/R rat model, aimed to investigate the effects on cerebral infarct. The results indicated that OGD/R suppressed viability, enhanced apoptosis, which could be reversed by AS-IV treatment. Compared with the control group, the expression of p-JAK2 and p-STAT3 was significantly increased by AS-IV (60 mu g/mL) under the OGD/R condition. Furthermore, AS-IV (60 mu g/mL) treatment markedly increased SOD activity, whereas significantly decreased MDA activity and production of ROS in OGD/R-induced cells. The protective effects of AS-IV mentioned above were weaken or abolished while adding JAK2 inhibitor AG490. In addition, the effects of AS-IV on Janus kinase 2 and signal transducer and activator of transcription 3 (JAK2/STAT3) signaling in cerebral I/R injury were also verified in vivo. AS-IV protected against cerebral I/R injury and reversed by AG490. Therefore, in vitro and in vivo analyses suggested that AS-IV may protect against cerebral I/R injury partly mediated by JAK2/STAT3 signaling pathway and antioxidative effects. AS-IV may serve as a novel therapeutic regimen for cerebral I/R injury.	[Xu, ZhengHu; Liu, Wei; Huang, Huai] Chinese Natl Petr Corp Cent Hosp, Dept Neurosurg, 51 Xinkailu Rd, Langfang 065000, Hebei, Peoples R China		Liu, W (corresponding author), Chinese Natl Petr Corp Cent Hosp, Dept Neurosurg, 51 Xinkailu Rd, Langfang 065000, Hebei, Peoples R China.	weiliu353@sina.com					Cao JY, 2014, J ETHNOPHARMACOL, V155, P1053, DOI 10.1016/j.jep.2014.05.061; Chen XY, 2017, MOL NEUROBIOL, V54, P7555, DOI 10.1007/s12035-016-0227-2; Galasso C, 2018, MAR DRUGS, V16, DOI 10.3390/md16060186; Jian ZH, 2016, BRAIN RES, V1643, P123, DOI 10.1016/j.brainres.2016.05.002; Kanzaki H, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00351; Leng B, 2018, LIFE SCI, V209, P111, DOI 10.1016/j.lfs.2018.07.053; Li L, 2017, FUND CLIN PHARMACOL, V31, P17, DOI 10.1111/fcp.12232; Li M, 2012, NEUROCHEM INT, V60, P458, DOI 10.1016/j.neuint.2012.01.026; Liu B, 2015, MOL NEUROBIOL, V52, P1245, DOI 10.1007/s12035-014-8909-0; Liu X, 2014, NEUROSCIENCE, V268, P318, DOI 10.1016/j.neuroscience.2014.03.032; Lorenzano S, 2018, STROKE, V49, P630, DOI 10.1161/STROKEAHA.117.018440; Lv ZQ, 2018, CELL PHYSIOL BIOCHEM, V45, P2246, DOI 10.1159/000488170; Peng C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/831841; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Rodrigo R, 2013, CNS NEUROL DISORD-DR, V12, P698; Shao AW, 2014, INT J MED SCI, V11, P1073, DOI 10.7150/ijms.9282; Tang YY, 2018, NEUROSCI LETT, V662, P219, DOI 10.1016/j.neulet.2017.10.037; Wang HL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8424326; Wang RX, 2019, EUR REV MED PHARMACO, V23, P1762, DOI 10.26355/eurrev_201902_17138; Wang SG, 2013, MOLECULES, V18, P12809, DOI 10.3390/molecules181012809; Wu GZ, 2017, ANTIOXID REDOX SIGN, V27, P754, DOI 10.1089/ars.2016.6885; Wu MY, 2018, CELL PHYSIOL BIOCHEM, V46, P1650, DOI 10.1159/000489241; Xia DJ, 2018, BIOL PHARM BULL, V41, P1645, DOI 10.1248/bpb.b18-00210; Yan W, 2017, FREE RADICAL RES, V51, P669, DOI 10.1080/10715762.2017.1361532; Yang Y, 2013, J PINEAL RES, V55, P275, DOI 10.1111/jpi.12070; Yang YM, 2013, CARBOHYD POLYM, V98, P1383, DOI 10.1016/j.carbpol.2013.07.045; Yu X, 2018, BIOL CHEM, V399, P1313, DOI 10.1515/hsz-2018-0253; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao J, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-8; Zhu P, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/701970	30	5	7	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0031-7012	1423-0313		PHARMACOLOGY	Pharmacology	MAR	2020	105	3-4					181	189		10.1159/000503361			9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	LE6FS	WOS:000526820000006	31825924				2022-02-06	
J	Long, JY; Chen, JM; Liao, YJ; Zhou, YJ; Liang, BY; Zhou, Y				Long, Jiang-yi; Chen, Jian-min; Liao, Yuan-jun; Zhou, Yi-jun; Liang, Bing-yu; Zhou, Yan			Naringin provides neuroprotection in CCL2-induced cognition impairment by attenuating neuronal apoptosis in the hippocampus	BEHAVIORAL AND BRAIN FUNCTIONS			English	Article						Naringin; Cognitive impairment; Anti-inflammation; Antioxidants; Apoptosis; Glutamate metabolism	MONOCYTE CHEMOATTRACTANT PROTEIN-1; ACUTE EXCITOTOXIC INJURY; TRAUMATIC BRAIN-INJURY; CHEMOKINE CCL2; OXIDATIVE STRESS; MCP-1; DYSFUNCTION; RECEPTOR; EXPRESSION; ENHANCEMENT	Background Chemokine C-C motif ligand 2 (CCL2) is one of the most widely recognised proinflammatory chemokines in cognitive disorders. Currently, CCL2-targeting drugs are extremely limited. Thus, this study aimed to explore the neuroprotection afforded by naringin in CCL2-induced cognitive impairment in rats. Methods Before the CCL2 intra-hippocampal injection, rats were treated with naringin for 3 consecutive days via intraperitoneal injection. Two days post-surgery, the Morris water maze (MWM) and novel object recognition (NORT) tests were performed to detect spatial learning and memory and object cognition, respectively. Nissl staining and dUTP nick-end labelling (TUNEL) staining were performed to assess histopathological changes in the hippocampus. Commercial kits were used to measure the activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) and the content of malondialdehyde (MDA). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to examine the relative mRNA expression of interleukin 1 beta, (IL-1 beta), interleukin 6 (IL-6), glutamate/aspartate transporter (GLAST), glutamate transporter-1 (GLT-1), phosphate-activated glutaminase (PAG), cysteine aspartic acid-specific protease 8 (caspase-8), cysteine aspartic acid-specific protease 3 (caspase-3), cell lymphoma/leukaemia-2 (Bcl-2), and Bcl-2 associated X protein (Bax). Results In the MWM, the average escape latency and average swimming distance were significantly reduced and the crossing times were increased in the naringin-treated groups, compared with the CCL2 group. The NORT results revealed that, compared with the CCL2 rats, the discrimination index in the naringin-treated rats increased significantly. Nissl and TUNEL staining revealed that naringin protected the structure and survival of the neurons in the CA1 zone of the hippocampus. In the naringin-treated groups, the SOD and GSH-Px activities were increased, whereas the MDA levels were decreased. Furthermore, in the naringin-treated groups, the relative mRNA expression of IL-1 beta and IL-6 was significantly decreased; GLAST and GLT-1 mRNA expression levels were increased, whereas PAG was decreased. In the naringin-treated groups, the relative mRNA expression levels of caspase-8, caspase-3, and Bax were decreased, whereas that of Bcl-2 was increased. Conclusion Collectively, these data indicated that naringin alleviated the CCL2-induced cognitive impairment. The underlying mechanisms could be associated with the inhibition of neuroinflammation, oxidative stress, apoptosis, and the regulation of glutamate metabolism.	[Long, Jiang-yi; Chen, Jian-min; Liao, Yuan-jun; Zhou, Yi-jun; Zhou, Yan] Guangxi Med Univ, Dept Pharmacol, Nanning 53002, Guangxi, Peoples R China; [Liang, Bing-yu] Guangxi Med Univ, Guangxi Key Lab AIDS Prevent & Treatment, Nanning 530021, Guang, Peoples R China		Zhou, Y (corresponding author), Guangxi Med Univ, Dept Pharmacol, Nanning 53002, Guangxi, Peoples R China.	zhouyan@stu.gxmu.edu.cn			National Natural Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660213, 81360192, 81660706]; National Foundation of Guangxi [2017GXNSFAA198187, 2018JJA140536]; Guangxi First-class Discipline Project for Pharmaceutical Sciences	This work was supported by the National Natural Foundation of China (No 81660213, 81360192, 81660706), the National Foundation of Guangxi (No 2017GXNSFAA198187, 2018JJA140536), and the Guangxi First-class Discipline Project for Pharmaceutical Sciences (No. GXFCDP-PS-2018).	Bose S, 2013, ARCH PHARM RES, V36, P1039, DOI 10.1007/s12272-013-0161-z; Carvallo L, 2015, J IMMUNOL, V194, P3246, DOI 10.4049/jimmunol.1302647; Chen JM, 2019, CHINESE PHARMACOL B, V35, P62; Cui J, 2018, FOOD CHEM TOXICOL, V121, P95, DOI 10.1016/j.fct.2018.08.028; Dhillon NK, 2008, FRONT BIOSCI, V13, P3913, DOI 10.2741/2979; Galasso JM, 2000, EXP NEUROL, V165, P295, DOI 10.1006/exnr.2000.7466; Galasso JM, 2000, NEUROSCIENCE, V101, P737, DOI 10.1016/S0306-4522(00)00399-7; Gaur V, 2009, EUR J PHARMACOL, V616, P147, DOI 10.1016/j.ejphar.2009.06.056; Hirt-Minkowski P, 2016, TRANSPLANTATION, V100, P1988, DOI 10.1097/TP.0000000000001304; Hsueh TP, 2016, MOLECULES, V21, DOI 10.3390/molecules21020195; Hu XY, 2018, FOOD CHEM TOXICOL, V113, P1, DOI 10.1016/j.fct.2018.01.023; Igase M, 2018, JPAD-J PREV ALZHEIM, V5, P197, DOI 10.14283/jpad.2017.47; Jeong KH, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/354326; King AE, 2016, EXP NEUROL, V275, P162, DOI 10.1016/j.expneurol.2015.09.019; Lawrence DMP, 2006, GLIA, V53, P81, DOI 10.1002/glia.20261; Lee CH, 2001, BIOCHEM BIOPH RES CO, V284, P681, DOI 10.1006/bbrc.2001.5001; Lee WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19807-y; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; Li JN, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182109; Liu HC, 2015, EUR REV MED PHARMACO, V19, P3459; Liu S, 2013, J MOL NEUROSCI, V51, P1021, DOI 10.1007/s12031-013-0091-8; Liu XC, 2016, IRAN J BASIC MED SCI, V19, P417; Liu YW, 2013, PSYCHOPHARMACOLOGY, V228, P585, DOI 10.1007/s00213-013-3061-5; Lopez NE, 2012, BRAIN RES, V1489, P140, DOI 10.1016/j.brainres.2012.10.031; Muratori C, 2010, GLIA, V58, P1893, DOI 10.1002/glia.21059; Nookala AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078855; Persidsky Y, 2016, J CEREBR BLOOD F MET, V36, P794, DOI 10.1177/0271678X15606149; Pu BF, 2015, MOL MED REP, V12, P3704, DOI 10.3892/mmr.2015.3830; Qi ZH, 2015, MOL MED REP, V12, P7093, DOI 10.3892/mmr.2015.4232; Qin SS, 2016, BRAIN RES BULL, V124, P164, DOI 10.1016/j.brainresbull.2016.04.020; Rubio C, 2019, CEREBELLUM, V18, P750, DOI 10.1007/s12311-019-01030-8; Sawyer AJ, 2014, BIOMATERIALS, V35, P6698, DOI 10.1016/j.biomaterials.2014.05.008; Shimamoto A, 2018, NEUROSCIENCE, V391, P104, DOI 10.1016/j.neuroscience.2018.09.009; Sun C, 2013, MOL HUM REPROD, V19, P676, DOI 10.1093/molehr/gat038; Thames AD, 2015, AIDS, V29, P1483, DOI 10.1097/QAD.0000000000000706; Tian DS, 2017, J NEUROSCI, V37, P7878, DOI 10.1523/JNEUROSCI.0315-17.2017; Tong HC, 2017, INT J BIOCHEM CELL B, V85, P75, DOI 10.1016/j.biocel.2017.01.017; Tremblay Marie-Eve, 2013, Commun Integr Biol, V6, pe27670, DOI 10.4161/cib.27670; Viswanatha GL, 2017, BIOMED PHARMACOTHER, V94, P909, DOI 10.1016/j.biopha.2017.07.072; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang DM, 2015, CELL MOL NEUROBIOL, V35, P1061, DOI 10.1007/s10571-015-0201-y; Wang HC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/720870; Xie RG, 2017, NEUROSCI BULL, V34, P1; Xu JW, 2017, BEHAV BRAIN RES, V332, P145, DOI 10.1016/j.bbr.2017.05.066; Yang WJ, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00169; Yao Q, 2018, CANCER BIOMARK, V21, P899, DOI 10.3233/CBM-170967; Yu FPS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20052-6; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhao TF, 2018, IUBMB LIFE, V70, P60, DOI 10.1002/iub.1704; Zhou Y, 2017, J NEUROIMMUNE PHARM, V12, P314, DOI 10.1007/s11481-016-9719-0; Zhou Y, 2016, J NEUROIMMUNE PHARM, V11, P306, DOI 10.1007/s11481-016-9660-2	51	5	5	7	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1744-9081		BEHAV BRAIN FUNCT	Behav. Brain Funct.	FEB 27	2020	16	1							4	10.1186/s12993-020-00166-6			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	KU8JY	WOS:000519959600001	32103758	Green Published, gold			2022-02-06	
J	Rowland, JA; Martindale, SL; Spengler, KM; Shura, RD; Taber, KH				Rowland, Jared A.; Martindale, Sarah L.; Spengler, Kayla M.; Shura, Robert D.; Taber, Katherine H.			Sequelae of Blast Events in Iraq and Afghanistan War Veterans using the Salisbury Blast Interview: A CENC Study	BRAIN INJURY			English	Article						Explosion; traumatic brain injury; military; assessment	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL CONNECTIVITY; STRUCTURED-INVENTORY; EXPOSURE; CONCUSSION; SYMPTOMS; TOOL	Objective: To comprehensively characterize blast exposure across the lifespan and relationship to TBI. Participants: Post-deployment veterans and service members (N = 287). Design: Prospective cohort recruitment. Main Measures: Salisbury Blast Interview (SBI). Results: 94.4% of participants reported at least one blast event, 75% reported a pressure gradient during a blast event. Participants reported an average of 337.7 (SD = 984.0) blast events (range 0-4857), 64.8% occurring during combat. Across participants, 19.7% reported experiencing a traumatic brain injury (TBI) during a blast event. Subjective ratings of blast characteristics (wind, debris, ground shaking, pressure, temperature, sound) were significantly higher when TBI was experienced and significantly lower when behind cover. Pressure had the strongest association with resulting TBI (AUC = 0.751). Pressure rating of 3 had the best sensitivity (.54)/specificity (.87) with TBI. Logistic regression demonstrated pressure, temperature and distance were the best predictors of TBI, and pressure was the best predictor of primary blast TBI. Conclusion: Results demonstrate the ubiquitous nature of blast events and provide insight into blast characteristics most associated with resulting TBI (pressure, temperature, distance). The SBI provides comprehensive characterization of blast events across the lifespan including the environment, protective factors, blast characteristics and estimates of distance and munition.	[Rowland, Jared A.; Martindale, Sarah L.; Spengler, Kayla M.; Shura, Robert D.; Taber, Katherine H.] Salisbury VA Med Ctr, Res & Acad Affairs Serv Line, Salisbury, NC USA; [Rowland, Jared A.; Martindale, Sarah L.; Shura, Robert D.; Taber, Katherine H.] Mid Atlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA; [Martindale, Sarah L.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Shura, Robert D.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27101 USA; [Taber, Katherine H.] Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Rowland, JA (corresponding author), Salisbury VA Med Ctr, 1601 Brenner Ave, Salisbury, NC 28144 USA.	Jared.Rowland@va.gov	Rowland, Jared A./AAN-3030-2021; Martindale, Sarah L/O-8553-2018	Rowland, Jared A./0000-0002-3655-3411; Martindale, Sarah L/0000-0002-0059-3454; Shura, Robert/0000-0002-9505-0080	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC)United States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENCUS Department of Veterans Affairs [I01 CX001135-01 [I01RX002172-01]]; Salisbury VA Health Care System; Mid-Atlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC)	This research was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and Department of Veterans Affairs CENC Award I01 CX001135-01 [I01RX002172-01]. This research was also supported by the Salisbury VA Health Care System and Mid-Atlantic (VISN 6) Mental Illness Research, Education, and Clinical Center (MIRECC).	Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Carr W, 2015, J HEAD TRAUMA REHAB, V30, P47, DOI 10.1097/HTR.0000000000000064; Cernak Ibolja, 2017, Concussion, V2, pCNC42, DOI 10.2217/cnc-2017-0006; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Davenport ND, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00085; First M.B., 1996, STRUCTURED CLIN INTE; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Haran FJ, 2021, APPL NEUROPSYCH-ADUL, V28, P297, DOI 10.1080/23279095.2019.1630627; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Rhea CK, 2017, MIL MED, V182, P147, DOI 10.7205/MILMED-D-16-00140; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker W, 2014, ARCH PHYS MED REHAB, V95, P464; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486	28	5	5	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 15	2020	34	5					642	652		10.1080/02699052.2020.1729418		FEB 2020	11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LB9LL	WOS:000516679300001	32096666				2022-02-06	
J	Boccella, S; Lannotta, M; Cristiano, C; Iannotti, FA; Del Bello, F; Guida, F; Belardo, C; Infantino, R; Ricciardi, F; Giannella, M; Calignano, A; Di Matzo, V; Maione, S; Luongo, L				Boccella, Serena; Lannotta, Monica; Cristiano, Claudia; Iannotti, Fabio Arturo; Del Bello, Fabio; Guida, Francesca; Belardo, Carmela; Infantino, Rosmara; Ricciardi, Flavia; Giannella, Mario; Calignano, Antonio; Di Matzo, Vincenzo; Maione, Sabatino; Luongo, Livio			Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions	FRONTIERS IN PHARMACOLOGY			English	Article						traumatic brain injury; behaviour; electrophyiology; pain; plant metabolite	MODEL; PAIN; TRANSMISSION; IMPAIRMENT; MODULATION; CORTEX; MICE	Traumatic brain injury (TBI) represents an important public health problem and is followed by neuroinflammation and neurological dysfunctions. It has been suggested that brain trauma is often associated to deep behavioral alterations and chronic pain-like syndrome. Despite inducing minimal brain damage, mild TBI (mTBI) leads to persistent behavioral changes, including anxiety, depression, social interaction impairment, and aggressiveness. The clinical management of these symptoms is still unsatisfactory and new pharmacological treatments are needed, especially for the aggressiveness and depression. In a mouse model of mTBI, we investigated the effect of 2-Pentadecyl-2-Oxazoline (PEA-OXA), a natural compound, that is a secondary metabolite, found in green and roasted coffee beans, on both the pain perception, and neuropsychiatric dysfunctions. We found that the compound acts as a alpha 2 adrenergic antagonist and this mechanism is here described for the first time. Mild TBI mice, starting from 14-d post-trauma, developed anxious and aggressive behavior, whilst depressive-like behavior and impaired social interactions were observed from the 60th d onward. PEA-OXA normalized all the behavioral changes investigated. We also investigated the memory impairments through Morris Water Maze (MWM) test. Both sham and mTBI mice treated with PEA-OXA showed amelioration in the reversal task of the MWM. Nevertheless, the main symptom of the long-term mTBI is represented by the depressive-like behavior, which was completely reversed by PEA-OXA repeated administration. In humans, mTBI-induced depression precedes the appearance of dementias and is characterized by a massive deficit of GABAergic transmission in the cortices. We found that PEA-OXA normalized the GABA changes in the prefrontal cortex. In order to prove the alpha 2-mediated effect of the PEA-OXA we have performed open field test in naive animals by microinjecting into the medial prefrontal cortex the dexomedetomidine, a selective alpha 2 agonist with or without PEA-OXA co-injection. We found that PEA-OXA antagonized the alpha 2 agonist effect on the locomotor activity. Moreover, PEA-OXA microinjection into the medial prefrontal cortex induced an enhancement of dopamine release. Collectively, these data suggest that this natural compound, through its multi-target activity is able to: i) ameliorate behavioral alterations (i.e. depression), ii) selectively normalize cortical GABA levels, iii) rescue the impaired neuronal activity in the prefrontal cortex.	[Boccella, Serena; Lannotta, Monica; Guida, Francesca; Belardo, Carmela; Infantino, Rosmara; Ricciardi, Flavia; Maione, Sabatino; Luongo, Livio] Univ Campania L Vanvitelli, Pharmacol Div, Dept Expt Med, Naples, Italy; [Cristiano, Claudia; Calignano, Antonio] Univ Naples Federico II, Sch Med, Dept Pharm, Naples, Italy; [Iannotti, Fabio Arturo; Di Matzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy; [Del Bello, Fabio; Giannella, Mario] Univ Camerino, Sch Pharm, Camerino, Italy		Maione, S; Luongo, L (corresponding author), Univ Campania L Vanvitelli, Pharmacol Div, Dept Expt Med, Naples, Italy.	sabatino.maione@unicampania.it; livio.luongo@unicampania.it	Belardo, Carmela/AAA-9319-2022; Cristiano, Claudia/ABH-2794-2021; iannotti, fabio a/K-5704-2016	Cristiano, Claudia/0000-0002-4806-1764; iannotti, fabio a/0000-0003-4480-8370; Infantino, Rosmara/0000-0003-1266-6881; Maione, Sabatino/0000-0003-3850-6704	PRIN 2015Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN); Epitech group	The paper is supported by PRIN 2015 of SM and LL. MI and SB are supported by Epitech group.	Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P98, DOI 10.1097/HTR.0b013e31820516cb; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belardo C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00352; Cordaro M, 2018, MOL NEUROBIOL, V55, P9251, DOI 10.1007/s12035-018-1064-2; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; D'Agostino G, 2015, MOL METAB, V4, P528, DOI 10.1016/j.molmet.2015.04.005; D'Agostino G, 2012, NEUROPSYCHOPHARMACOL, V37, P1784, DOI 10.1038/npp.2012.25; deBoer T, 1996, J PHARMACOL EXP THER, V277, P852; FAGNI L, 1987, EXP BRAIN RES, V65, P513; Floresco SB, 2007, J NEUROSCI, V27, P2045, DOI 10.1523/JNEUROSCI.5474-06.2007; Fusco R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194845; Ghosh AK, 2012, AM J PHYSIOL-RENAL, V303, pF1225, DOI 10.1152/ajprenal.00135.2012; Giordano C, 2012, CEREB CORTEX, V22, P2495, DOI 10.1093/cercor/bhr328; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Iannotti FA, 2010, J PHARMACOL EXP THER, V332, P811, DOI 10.1124/jpet.109.162800; Impellizzeri D, 2019, NEUROBIOL DIS, V125, P77, DOI 10.1016/j.nbd.2019.01.007; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Impellizzeri D, 2016, PHARMACOL RES, V108, P23, DOI 10.1016/j.phrs.2016.04.007; Jung HY, 1997, J NEUROSCI, V17, P6639; Kandimalla R, 2017, J ALZHEIMERS DIS, V57, P1049, DOI 10.3233/JAD-161118; Kelso ML, 2014, CURR PHARM DESIGN, V20, P4284; Kolata SM, 2018, NEUROPSYCHOPHARMACOL, V43, P1445, DOI 10.1038/npp.2017.296; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luongo L, 2013, NEUROPHARMACOLOGY, V66, P317, DOI 10.1016/j.neuropharm.2012.05.047; Manns ID, 2003, EUR J NEUROSCI, V18, P723, DOI 10.1046/j.1460-9568.2003.02788.x; Marcinkiewcz CA, 2016, NATURE, V537, P97, DOI 10.1038/nature19318; Marcus MM, 2010, INT J NEUROPSYCHOPH, V13, P891, DOI 10.1017/S1461145709990794; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Paxinos G., 1997, PAXINOS FRANKLINS MO; Petrosino S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00308; Priyanka HP, 2013, INT IMMUNOPHARMACOL, V17, P774, DOI 10.1016/j.intimp.2013.08.020; Sandu RE, 2015, NEURAL REGEN RES, V10, P1349, DOI 10.4103/1673-5374.165208; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Simone Donald A., 2008, Shengli Xuebao, V60, P635; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Uys MM, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00144; Yang S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133130; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	39	5	5	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	FEB 25	2020	11								91	10.3389/fphar.2020.00091			15	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	LC4SH	WOS:000525313600001	32161542	Green Published, gold			2022-02-06	
J	Fraunberger, EA; DeJesus, P; Zanier, ER; Shutt, TE; Esser, MJ				Fraunberger, Erik A.; DeJesus, Pauline; Zanier, Elisa R.; Shutt, Timothy E.; Esser, Michael J.			Acute and Persistent Alterations of Cerebellar Inflammatory Networks and Glial Activation in a Rat Model of Pediatric Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebellum; mild traumatic brain injury; network analysis; neuroinflammation; pediatric brain injury	FIBRILLARY ACIDIC PROTEIN; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; CYTOKINES; NEUROINFLAMMATION; SYSTEM; INTERLEUKIN-1-BETA; CONNECTOME; RECEPTORS; SINGLE	Following a traumatic brain injury (TBI), inflammation is a well-documented but poorly understood phenomenon, especially at later time-points (i.e., beyond 72 h) and in brain areas outside the cortex. The cerebellum, important for motor and cognitive functioning, represents an area of the brain equally affected by TBI that is seldom evaluated despite its potential involvement in persistent deficits after injury. In the context of TBI and inflammation, most studies focus on severe TBI in adult males, with fewer studies on pediatric mild TBI in both sexes. Our study addresses this gap by profiling neurological function and cerebellar inflammation over time in the juvenile male and female rat brain following a mild, closed-head weight-drop injury (mTBI). At 24 h, 72 h, 7 days, and 21 days post-mTBI, animals were subjected to behavioral testing to evaluate TBI effects over time. Alongside behavioral deficits up to 7 days post-injury, inflammatory profiling by multi-plex enzyme-linked immunosorbent assay (ELISA) revealed increased inflammatory markers, including CXCL1, interleukin (IL)-5, and vascular endothelial growth factor alpha (VEGF alpha), in plasma at 24-72 h and in the cerebellum at 72 h post-injury. Network analysis of cytokines also showed increased inter-relationships between multiple mediators at all time-points, emphasizing the persistent and dynamic changes to inflammatory patterns after mTBI. Transcript levels of microglia/macrophage activation markers, including Iba1 and CX3CR1, were significantly elevated at 7 days post-TBI in both sexes, and at 21 days in females, suggesting activation of immune cells in the cerebellum. When examining the protein expression of GFAP and CX3CR1, a significant increase in CX3CR1 was noted in males at 21 days but not in females. Characterizing the evolution of cerebellar inflammation in pediatric mTBI provides insight into potential mechanisms of persistent changes that could contribute to neurological dysfunction.	[Fraunberger, Erik A.; DeJesus, Pauline; Shutt, Timothy E.; Esser, Michael J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Shutt, Timothy E.] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Shutt, Timothy E.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Esser, Michael J.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB, Canada; [Fraunberger, Erik A.; DeJesus, Pauline; Shutt, Timothy E.; Esser, Michael J.] Alberta Childrens Prov Gen Hosp, Res Inst, C4-629,48 Oki Dr NW, Calgary, AB T3B 6A8, Canada; [Zanier, Elisa R.] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Lab Acute Brain Injury & Therapeut Strategies, Milan, Italy		Esser, MJ (corresponding author), Alberta Childrens Prov Gen Hosp, Res Inst, C4-629,48 Oki Dr NW, Calgary, AB T3B 6A8, Canada.	michael.esser@ahs.ca	Zanier, Elisa/AAA-8095-2020	Zanier, Elisa/0000-0002-3011-8718; Shutt, Timothy/0000-0001-5299-2943	Ministerodella Salute (Italy)Ministry of Health, Italy; Canadian Institute for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (ACHRI); Alberta Children's Hospital Foundation (ACHF);  [EIN-150762]	This work was supported by EIN-150762 (Canada) and by the Ministerodella Salute (Italy) within the framework of ERA-NET NEURON, Canadian Institute for Health Research (CIHR), Alberta Children's Hospital Research Institute (ACHRI), and the Alberta Children's Hospital Foundation (ACHF).	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; BANKS WA, 1994, NEUROSCI LETT, V179, P53, DOI 10.1016/0304-3940(94)90933-4; Banks WA, 2018, J CEREBR BLOOD F MET, V38, P1104, DOI 10.1177/0271678X17740793; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bartee E, 2013, CYTOKINE, V63, P237, DOI 10.1016/j.cyto.2013.04.036; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cavaillon JM, 2001, CELL MOL BIOL, V47, P695; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742, DOI 10.1128/CMR.10.4.742; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Dumcke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107955; Ebner F, 2013, J IMMUNOL, V191, P5594, DOI 10.4049/jimmunol.1203331; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujita Andre, 2009, Journal of Bioinformatics and Computational Biology, V7, P663, DOI 10.1142/S0219720009004230; Gaceb A, 2018, J CEREBR BLOOD F MET, V38, P45, DOI 10.1177/0271678X17719645; Galic MA, 2012, FRONT NEUROENDOCRIN, V33, P116, DOI 10.1016/j.yfrne.2011.12.002; Gao WW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00281; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goenawan IH, 2016, BIOINFORMATICS, V32, P2713, DOI 10.1093/bioinformatics/btw187; Hanisch UK, 1995, BRAIN RES REV, V21, P246, DOI 10.1016/0165-0173(95)00015-1; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Iraji A, 2016, NEUROIMAGE-CLIN, V12, P100, DOI 10.1016/j.nicl.2016.06.012; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Jaehne EJ, 2014, BEHAV BRAIN RES, V261, P31, DOI 10.1016/j.bbr.2013.12.006; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Kuter K, 2018, MOL NEUROBIOL, V55, P3049, DOI 10.1007/s12035-017-0529-z; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MEYER FA, 1990, ARTHRITIS RHEUM, V33, P1518, DOI 10.1002/art.1780331009; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Moelants EAV, 2013, IMMUNOL CELL BIOL, V91, P402, DOI 10.1038/icb.2013.16; Mousa A, 2013, INT J MOL SCI, V14, P13931, DOI 10.3390/ijms140713931; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; NISTICO G, 1991, TRENDS NEUROSCI, V14, P146, DOI 10.1016/0166-2236(91)90086-A; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Presta I, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123856; Rahimian R, 2019, NEUROSCIENCE, V405, P14, DOI 10.1016/j.neuroscience.2018.02.048; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Romeu-Mejia R, 2019, CURR REV MUSCULOSKE, V12, P105, DOI 10.1007/s12178-019-09536-8; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Rowland B., 2019, SHOCK; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schetters STT, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01905; Scuteri A, 2011, ATHEROSCLEROSIS, V215, P459, DOI 10.1016/j.atherosclerosis.2010.12.023; Sharma R, 2011, J AUTOIMMUN, V36, P91, DOI 10.1016/j.jaut.2011.01.001; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Snedecor G.W., 1989, STAT METHODS, P249; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Subramanian N, 2015, WIRES SYST BIOL MED, V7, P13, DOI 10.1002/wsbm.1288; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tohidpour A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00276; Tonelli LH, 2005, NEUROL RES, V27, P679, DOI 10.1179/016164105X49463; Tramontina F, 2007, J NEUROSCI METH, V162, P282, DOI 10.1016/j.jneumeth.2007.01.001; Turner BM, 2007, NEUROPSYCHOLOGIA, V45, P1331, DOI 10.1016/j.neuropsychologia.2006.09.023; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Vetter-O'Hagen CS, 2012, DEV PSYCHOBIOL, V54, P523, DOI 10.1002/dev.20610; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Wortzel HS, 2015, J AM ACAD PSYCHIATRY, V43, P499; Zehendner CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13497; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	92	5	5	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1315	1330		10.1089/neu.2019.6714		FEB 2020	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000517891300001	31808365	Bronze			2022-02-06	
J	Hasan, S; Mielke, MM; Turcano, P; Ahlskog, JE; Bower, JH; Savica, R				Hasan, Shemonti; Mielke, Michelle M.; Turcano, Pierpaolo; Ahlskog, J. Eric; Bower, James H.; Savica, Rodolfo			Traumatic brain injury preceding clinically diagnosed alpha-synucleinopathies: A case-control study	NEUROLOGY			English	Article							MEDICAL-RECORDS-LINKAGE; PARKINSONS-DISEASE; RISK-FACTORS; HEAD-INJURY; LEWY BODIES; EPIDEMIOLOGY; POPULATION; HISTORY; SYSTEM; CLASSIFICATION	ObjectiveTo determine the association between traumatic brain injury (TBI) and any clinically diagnosed alpha -synucleinopathy including Parkinson disease (PD), dementia with Lewy bodies (DLB), PD dementia (PDD), and multiple system atrophy (MSA).MethodsUsing the medical records-linkage system of the Rochester Epidemiology Project, we identified incident cases of alpha -synucleinopathies in Olmsted County, Minnesota, from 1991 to 2010, matching by age (1 year) at symptom onset and sex to controls. We reviewed records of cases and controls to detect TBI prior to clinical-motor onset of any alpha -synucleinopathies. We based severity (possible, probable, and definite) upon the Mayo Classification System for TBI Severity. Using conditional-logistic regression, we calculated the odds ratio (OR) of all alpha -synucleinopathies and type, adjusting for coffee intake and smoking.ResultsTBI frequency was lower among cases (7.0%) than controls (8.2%). No association was found between TBI and all alpha -synucleinopathies in multivariable analyses (OR 0.90, 95% confidence interval [CI] 0.54-1.52). No association presented when examining the number of TBIs, TBI severity, time between TBI exposure and index date, age at index date, or sex. When stratifying by each individual alpha -synucleinopathy, we did not identify any associations between TBI and PD, DLB, or PDD. Among the MSA group, 1 (6.4%) and 0 controls experienced a TBI (OR could not be estimated).ConclusionsIn this nested case-control population-based analysis, TBI was not associated with subsequent alpha -synucleinopathies in general or any individual alpha -synucleinopathy. This did not change based on the temporality or the severity of the TBI. Our findings may be limited by the study power.	[Hasan, Shemonti] Mayo Clin, Alix Sch Med, Rochester, MN USA; [Mielke, Michelle M.; Savica, Rodolfo] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55901 USA; [Turcano, Pierpaolo; Ahlskog, J. Eric; Bower, James H.; Savica, Rodolfo] Mayo Clin, Dept Neurol, Rochester, MN 55901 USA		Savica, R (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55901 USA.; Savica, R (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55901 USA.	savica.rodolfo@mayo.ed			CTSA from the National Center for Advancing Translational Sciences, a component of the NIH [UL1 TR002377]; National Institute on Aging of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG034676]; Mayo Foundation for Medical Education and Research [R01 AG034676]	Study funded by CTSA grant number UL1 TR002377 from the National Center for Advancing Translational Sciences, a component of the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. This study was also supported by grant R01 AG034676 from the National Institute on Aging of the NIH and by the Mayo Foundation for Medical Education and Research.	[Anonymous], 1977, 9 REV C 1975 29 WORL; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350; Bower JH, 1999, NEUROLOGY, V52, P1214, DOI 10.1212/WNL.52.6.1214; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; DeMichele G, 1996, MOVEMENT DISORD, V11, P17, DOI 10.1002/mds.870110105; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; GODWINAUSTEN RB, 1982, J NEUROL NEUROSUR PS, V45, P577, DOI 10.1136/jnnp.45.7.577; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; HOFMAN A, 1989, NEUROEPIDEMIOLOGY, V8, P296, DOI 10.1159/000110197; Huang CH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1187-0; HUBBLE JP, 1993, NEUROLOGY, V43, P1693, DOI 10.1212/WNL.43.9.1693; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MORANO A, 1994, ACTA NEUROL SCAND, V89, P164; National Center for Health Statistics, 1973, H ICDA HOSP AD ICDA; Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076; Rocca WA, 2012, MAYO CLIN PROC, V87, P1202, DOI 10.1016/j.mayocp.2012.08.012; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Savica R, 2017, JAMA NEUROL, V74, P839, DOI 10.1001/jamaneurol.2017.0603; Savica R, 2016, JAMA NEUROL, V73, P981, DOI 10.1001/jamaneurol.2016.0947; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Savica R, 2013, JAMA NEUROL, V70, P859, DOI 10.1001/jamaneurol.2013.114; Savica R, 2013, HORM BEHAV, V63, P308, DOI 10.1016/j.yhbeh.2012.05.013; Seidler A, 1996, NEUROLOGY, V46, P1275, DOI 10.1212/WNL.46.5.1275; SEMCHUK KM, 1993, NEUROLOGY, V43, P1173, DOI 10.1212/WNL.43.6.1173; St Sauver JL, 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; STERN M, 1991, ARCH NEUROL-CHICAGO, V48, P903, DOI 10.1001/archneur.1991.00530210029018; TANNER CM, 1987, CAN J NEUROL SCI, V14, P419, DOI 10.1017/S0317167100037835; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005	39	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	FEB 25	2020	94	8					E764	E773		10.1212/WNL.0000000000008995			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LK4RV	WOS:000530853800009	31992680	Green Published			2022-02-06	
J	Meeuws, S; Yue, JK; Huijben, JA; Nair, N; Lingsma, HF; Bell, MJ; Manley, GT; Maas, AIR				Meeuws, Sacha; Yue, John K.; Huijben, Jilske A.; Nair, Nandesh; Lingsma, Hester F.; Bell, Michael J.; Manley, Geoffrey T.; Maas, Andrew I. R.			Common Data Elements: Critical Assessment of Harmonization between Current Multi-Center Traumatic Brain Injury Studies	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; Common Data Elements; data standards; InTBIR; standardization; traumatic brain injury	CENTER-TBI; CARE	Standardization and harmonization of data collection in studies on traumatic brain injury (TBI) is of paramount importance for meta-analyses across studies. Nearly 10 years ago, the first set of Common Data Elements for TBI (TBI-CDEs v1) were introduced to achieve these goals. The TBI-CDEs version 2 were developed in 2012 to broaden the approach to all ages, injury severity, and phases of recovery. We aimed to quantify the degree of harmonization of these data elements in three large, prospective multi-center studies conducted within the International Initiative for TBI Research (InTBIR). Data variables of the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI; adult and pediatric patients in Europe and Israel), Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI; adult and pediatric patients in the U.S.), and Approaches and Decisions in Acute Pediatric TBI (ADAPT; international study on severe pediatric TBI) studies were indexed and matched to the second version of the TBI CDEs. We focused on the CDE sub-categories of "Acute Hospitalized" (AH) and "Moderate/Severe TBI: Rehabilitation (Rehab). All "Core" and "Basic" level CDEs were considered. Closely related elements were reduced to one variable to prevent over-representation. Categorical elements and text elements for the same variable were likewise merged to one element for analysis. Following reduction and merging of related elements, 21 Core, 46 Basic AH, and 50 Basic Rehab elements were deemed harmonizable across studies. Gaps in global applicability were identified for four of the TBI CDEs and many of the outcome instruments, which are only available in the English language. Agreements of Core and Basic study CDEs for the AH domain with the TBI CDEs were respectively 81% and 91% for CENTER-TBI, 76% and 93% for TRACK-TBI, and 85% in ADAPT for both domains. For the domain Rehab, agreement with Basic TBI CDEs was 84% for CENTER-TBI, 94% for TRACK-TBI, and 71% for ADAPT. Non-harmonization was largely caused by absence of the elements in the studies. For elements present, the compatibility of coding with TBI CDEs was 90-99%. The degree of harmonization was greatest between CENTER-TBI and TRACK-TBI with 81-87% overlap within the TBI CDE sub-categories. The high degree of harmonization of study variables among these studies demonstrates the importance and utility of common data elements in TBI research. It also confirms the potential for future meta-analyses across these large studies, especially for CENTER TBI and TRACK TBI. The global applicability of the TBI CDEs needs to be improved for them to become a global standard for TBI research. CENTER-TBI, TRACK-TBI, and ADAPT, along with other studies within the InTBIR Initiative, provide a platform to inform further refinement and internationalization for the next version of the TBI CDEs.	[Meeuws, Sacha; Nair, Nandesh; Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurol Surg, Wilrijkst 10, B-2650 Edegem, Belgium; [Meeuws, Sacha; Nair, Nandesh; Maas, Andrew I. R.] Univ Antwerp, Wilrijkst 10, B-2650 Edegem, Belgium; [Yue, John K.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Huijben, Jilske A.; Lingsma, Hester F.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Bell, Michael J.] Childrens Natl Med Ctr, Div Crit Care Med, Washington, DC 20010 USA		Maas, AIR (corresponding author), Antwerp Univ Hosp, Dept Neurol Surg, Wilrijkst 10, B-2650 Edegem, Belgium.; Maas, AIR (corresponding author), Univ Antwerp, Wilrijkst 10, B-2650 Edegem, Belgium.	Andrew.Maas@uza.be	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722	European UnionEuropean Commission [602150]; OneMind; Hannelore Kohl Foundation; Integra Lifesciences and NeuroTrauma Sciences; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2 NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01 NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U0 1NS086090-02, 5U01NS086090-03]; U.S. DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176];  [NS081041]	CENTER-TBI was supported by the Framework 7th program of the European Union (Grant No 602150). Additional support was provided by OneMind, the Hannelore Kohl Foundation, Integra Lifesciences and NeuroTrauma Sciences. TRACK-TBI was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2 NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01 NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U0 1NS086090-02, 5U01NS086090-03; U.S. DOD W81XWH-13-1-0441, U.S. DOD W81XWH-14-2-0176.; ADAPT was supported by NS081041.	Bell MJ, 2017, CHILD NERV SYST, V33, P1663, DOI 10.1007/s00381-017-3530-y; Ding LL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-622; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	11	5	5	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1283	1290		10.1089/neu.2019.6867		FEB 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000517890500001	32000562	Green Submitted, Green Published, hybrid			2022-02-06	
J	Rashno, M; Ghaderi, S; Nesari, A; Khorsandi, L; Farbood, Y; Sarkaki, A				Rashno, Masome; Ghaderi, Shahab; Nesari, Ali; Khorsandi, Layasadat; Farbood, Yaghoob; Sarkaki, Alireza			Chrysin attenuates traumatic brain injury-induced recognition memory decline, and anxiety/depression-like behaviors in rats: Insights into underlying mechanisms	PSYCHOPHARMACOLOGY			English	Article						Traumatic brain injury; Chrysin; Behavioral deficits; Anti-apoptosis; Anti-inflammatory	OBJECT RECOGNITION; PREFRONTAL CORTEX; AQUEOUS EXTRACT; NEURONAL LOSS; DEPRESSION; PATHOPHYSIOLOGY; INFLAMMATION; HIPPOCAMPUS; DYSFUNCTION; MODEL	Rationale Cortical and hippocampal neuronal apoptosis and neuroinflammation are associated with behavioral deficits following traumatic brain injury (TBI). Objectives The present study was designed to investigate the potential protective effects of flavonoid chrysin against TBI-induced vestibulomotor impairment, exploratory/locomotor dysfunctions, recognition memory decline, and anxiety/depression-like behaviors, as well as the verified possible involved mechanisms. Methods Chrysin (25, 50, or 100 mg/kg/day; P.O.) was administered to rats immediately after diffuse TBI induction, and it was continued for 3 or 14 days. Behavioral functions were assessed by employing standard behavioral paradigms at scheduled points in time. Three days post-TBI, inflammation status was assayed in both cerebral cortex and hippocampus using ELISA kits. Moreover, apoptosis and expression of Bcl-2 family proteins were examined by TUNEL staining and immunohistochemistry, respectively. Results The results indicated that treatment with chrysin improved vestibulomotor dysfunction, ameliorated recognition memory deficit, and attenuated anxiety/depression-like behaviors in the rats with TBI. Chrysin treatment also modulated inflammation status, reduced apoptotic index, and regulated Bcl-2 family proteins expression in the brains of rats with TBI. Conclusions In conclusion, the results suggest that chrysin could be beneficial for protection against TBI-associated behavioral deficits, owing to its anti-apoptotic and anti-inflammatory properties.	[Rashno, Masome; Nesari, Ali; Farbood, Yaghoob; Sarkaki, Alireza] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Fac Med, Dept Physiol, Ahwaz, Iran; [Ghaderi, Shahab] Hamadan Univ Med Sci, Sch Sci & Adv Technol Med, Dept Neurosci, Hamadan, Iran; [Khorsandi, Layasadat] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahwaz, Iran		Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Fac Med, Dept Physiol, Ahwaz, Iran.	sarkaki145@gmail.com	Rashno, Masome/AAW-6382-2020; Farbood, Yaghoob/M-3076-2017	Rashno, Masome/0000-0002-1290-3499; Farbood, Yaghoob/0000-0002-6390-0079; nesari, ali/0000-0003-3260-7846; rashno, mohammad/0000-0001-5473-1384; Ghaderi, Shahab/0000-0002-4494-2011	Ahvaz Physiology Research Center - Ahvaz Jundishapur University of Medical Sciences (Iran) [APRC-9704]	This research was supported financially by a grant (APRC-9704) from Ahvaz Physiology Research Center, funded by the Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran).	Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anand KV, 2011, TOXICOL IND HEALTH, V27, P923, DOI 10.1177/0748233711399324; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Borges C, 2016, CHEM-BIOL INTERACT, V260, P154, DOI 10.1016/j.cbi.2016.11.005; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Brown Eric 'Walter', 2007, AANA J, V75, P333; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Daumas S, 2005, LEARN MEMORY, V12, P375, DOI 10.1101/lm.81905; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; El Khashab IH, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108619; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Farbood Y, 2019, LIFE SCI, V225, P8, DOI 10.1016/j.lfs.2019.03.078; Filho CB, 2015, NEUROSCIENCE, V289, P367, DOI 10.1016/j.neuroscience.2014.12.048; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griffiths S, 2008, NEURON, V58, P186, DOI 10.1016/j.neuron.2008.02.022; Guo BJ, 2016, J AGR FOOD CHEM, V64, P5324, DOI 10.1021/acs.jafc.6b01707; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Habr Soraya Ferreira, 2011, Psychol. Neurosci., V4, P115, DOI 10.3922/j.psns.2011.1.013; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Jiang Y, 2014, INT J MOL SCI, V15, P12270, DOI 10.3390/ijms150712270; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kosari-Nasab M, 2018, LIFE SCI, V213, P198, DOI 10.1016/j.lfs.2018.10.040; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; Krishnamoorthy A, 2019, NEUROSCI LETT, V709, DOI 10.1016/j.neulet.2019.134382; Lim SW, 2017, WORLD NEUROSURG, V100, P128, DOI 10.1016/j.wneu.2016.12.118; Liu H, 2016, BIOCHEM BIOPH RES CO, V472, P648, DOI 10.1016/j.bbrc.2016.03.003; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McQuade JM, 2002, PHYSIOL BEHAV, V76, P315, DOI 10.1016/S0031-9384(02)00716-3; Mitkovski M, 2015, J CEREBR BLOOD F MET, V35, P1233, DOI 10.1038/jcbfm.2015.100; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Ng CF, 2016, J ETHNOPHARMACOL, V185, P87, DOI 10.1016/j.jep.2016.03.018; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Pawlak A, 2018, BIOORG MED CHEM LETT, V28, P1171, DOI 10.1016/j.bmcl.2018.03.006; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Rashno M, 2019, LIFE SCI, V228, P285, DOI 10.1016/j.lfs.2019.05.007; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Sarkaki A, 2019, LIFE SCI, V226, P202, DOI 10.1016/j.lfs.2019.04.027; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Schwab N, 2019, LAB INVEST, V1; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Shijo K, 2015, BRAIN RES, V1614, P94, DOI 10.1016/j.brainres.2015.04.022; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tabatabaei SRF, 2017, BIOMED PHARMACOTHER, V96, P279, DOI 10.1016/j.biopha.2017.09.146; Tabatabaei SRF, 2016, IRAN J PHARM RES, V15, P561; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Thangarajan S, 2016, BIOMED PHARMACOTHER, V84, P514, DOI 10.1016/j.biopha.2016.09.070; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wu Z, 2005, J NEUROIMMUNOL, V167, P90, DOI 10.1016/j.jneuroim.2005.06.025; Youdim KA, 2003, J NEUROCHEM, V85, P180, DOI 10.1046/j.1471-4159.2003.01652.x; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhang Z, 2019, J NEUROTRAUM, V36, P74, DOI 10.1089/neu.2017.5450; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; Zogg CK, 2016, J AM COLL SURGEONS, V223, pS158, DOI 10.1016/j.jamcollsurg.2016.06.343	69	5	5	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2020	237	6					1607	1619		10.1007/s00213-020-05482-3		FEB 2020	13	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	LQ2AD	WOS:000516365700001	32088834				2022-02-06	
J	Wang, Z; Wang, SN; Xu, TY; Hong, C; Cheng, MH; Zhu, PX; Lin, JS; Su, DF; Miao, CY				Wang, Zhi; Wang, Shu-Na; Xu, Tian-Ying; Hong, Chen; Cheng, Ming-He; Zhu, Peng-Xi; Lin, Jian-Sheng; Su, Ding-Feng; Miao, Chao-Yu			Cerebral organoids transplantation improves neurological motor function in rat brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						brain injury; cerebral organoids; functional recovery; neural repair; transplantation	NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; CELL TRANSPLANTATION; STEM-CELLS; NEURONS INTEGRATE; ISCHEMIC-STROKE; NEUROGENESIS; MODEL; EXPRESSION; RESPONSES; PROTECTS	Background and Purpose Cerebral organoids (COs) have been used for studying brain development, neural disorders, and species-specific drug pharmacology and toxicology, but the potential of COs transplantation therapy for brain injury remains to be answered. Methods With preparation of traumatic brain injury (TBI) model of motor dysfunction, COs at 55 and 85 days (55 and 85 d-CO) were transplanted into damaged motor cortex separately to identify better transplantation donor for brain injury. Further, the feasibility, effectiveness, and underlying mechanism of COs transplantation therapy for brain injury were explored. Results 55 d-CO was demonstrated as better transplantation donor than 85 d-CO, evidenced by more neurogenesis and higher cell survival rate without aggravating apoptosis and inflammation after transplantation into damaged motor cortex. Cells from transplanted COs had the potential of multilinage differentiation to mimic in-vivo brain cortical development, support region-specific reconstruction of damaged motor cortex, form neurotransmitter-related neurons, and migrate into different brain regions along corpus callosum. Moreover, COs transplantation upregulated hippocampal neural connection proteins and neurotrophic factors. Notably, COs transplantation improved neurological motor function and reduced brain damage. Conclusions This study revealed 55 d-CO as better transplantation donor and demonstrated the feasibility and efficacy of COs transplantation in TBI, hoping to provide first-hand preclinical evidence of COs transplantation for brain injury.	[Wang, Zhi; Wang, Shu-Na; Xu, Tian-Ying; Hong, Chen; Cheng, Ming-He; Zhu, Peng-Xi; Su, Ding-Feng; Miao, Chao-Yu] Naval Med Univ, Mil Med Univ 2, Dept Pharmacol, 325 Guo He Rd, Shanghai 200433, Peoples R China; [Lin, Jian-Sheng] Claude Bernard Univ, Sch Med, Integrat Physiol Brain Arousal Syst, CRNL,INSERM U1028 CNRS UMR 5292, Lyon, France		Miao, CY (corresponding author), Naval Med Univ, Mil Med Univ 2, Dept Pharmacol, 325 Guo He Rd, Shanghai 200433, Peoples R China.	cymiao@smmu.edu.cn	Lin, Jian-Sheng/G-4395-2013	Lin, Jian-Sheng/0000-0002-2004-6079; Wang, Shu-Na/0000-0002-3091-1281	Medical Innovation Major Project [16CXZ009]; National Natural Science Foundation of China Major ProjectNational Natural Science Foundation of China (NSFC) [81730098]; Shanghai Science and Technology Commission Projects [16140904500, 16431901400]	Medical Innovation Major Project, Grant/Award Number: 16CXZ009; National Natural Science Foundation of China Major Project, Grant/Award Number: 81730098; Shanghai Science and Technology Commission Projects, Grant/Award Number: 16140904500 and 16431901400	Arlotta P, 2018, NAT METHODS, V15, P27, DOI 10.1038/nmeth.4557; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Daviaud N, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0219-18.2018; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Espuny-Camacho I, 2018, CELL REP, V23, P2732, DOI 10.1016/j.celrep.2018.04.094; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Gopalakrishnan A, 2019, TRANSL STROKE RES, V10, P1, DOI 10.1007/s12975-018-0655-6; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Huang J, 2017, CHEM ECOL, V8, P1, DOI DOI 10.3389/FNEUR.2017.00626]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kilkenny C, 2011, J CEREBR BLOOD F MET, V31, P991, DOI 10.1038/jcbfm.2010.220; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Li ZY, 2015, DIABETES, V64, P4011, DOI 10.2337/db15-0274; Liu FK, 2019, NEUROSCIENCE, V404, P530, DOI 10.1016/j.neuroscience.2018.12.047; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127; Nishino H, 2000, Prog Brain Res, V127, P461; Pamies D, 2018, TOXICOL APPL PHARM, V354, P101, DOI 10.1016/j.taap.2018.02.003; Partoazar A, 2017, FUND CLIN PHARMACOL, V31, P185, DOI 10.1111/fcp.12244; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Raynald, 2019, CNS NEUROSCI THER, V25, P951, DOI 10.1111/cns.13135; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Vonderwalde I, 2020, TRANSL STROKE RES, V11, P93, DOI 10.1007/s12975-019-0691-x; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Wang P, 2015, TRENDS PHARMACOL SCI, V36, P891, DOI 10.1016/j.tips.2015.08.012; Wang P, 2014, CARDIOVASC RES, V104, P477, DOI 10.1093/cvr/cvu220; Wang P, 2011, ANN NEUROL, V69, P360, DOI 10.1002/ana.22236; Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1; Wang SN, 2016, CNS NEUROSCI THER, V22, P431, DOI 10.1111/cns.12539; Wang Z, 2017, CNS NEUROSCI THER, V23, P771, DOI 10.1111/cns.12754; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wei CC, 2017, BRIT J PHARMACOL, V174, P3823, DOI 10.1111/bph.13979; Wei L, 2017, PROG NEUROBIOL, V157, P49, DOI 10.1016/j.pneurobio.2017.03.003; Weston NM, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0812-z; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yan YW, 2018, TISSUE ENG PT A, V24, P1125, DOI [10.1089/ten.tea.2017.0423, 10.1089/ten.TEA.2017.0423]; Yang B, 2011, J NEUROSCI RES, V89, P833, DOI 10.1002/jnr.22614; Yasuhara T, 2006, FRONT BIOSCI-LANDMRK, V11, P760, DOI 10.2741/1834; Yasuhara T, 2020, CNS NEUROSCI THER, V26, P595, DOI 10.1111/cns.13247; Zarate YA, 2017, AM J MED GENET A, V173, P327, DOI 10.1002/ajmg.a.38022; Zhao Y, 2015, STROKE, V46, P1966, DOI 10.1161/STROKEAHA.115.009216; Zhu YJ, 2017, INTEGR BIOL-UK, V9, P968, DOI 10.1039/c7ib00105c	48	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUL	2020	26	7					682	697		10.1111/cns.13286		FEB 2020	16	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	LY5VO	WOS:000514967900001	32087606	gold, Green Published			2022-02-06	
J	Snell, DL; Siegert, RJ; Silverberg, ND				Snell, Deborah L.; Siegert, Richard J.; Silverberg, Noah D.			Rasch analysis of the World Health Organization Disability Assessment Schedule 2.0 in a mild traumatic brain injury sample	BRAIN INJURY			English	Article						MTBI; outcome measures; 12-item WHODAS 2; 0; Rasch Analysis	PSYCHOMETRIC PROPERTIES; MENTAL-DISORDERS; SYMPTOMS; POST; 12-ITEM; POPULATION; VALIDATION; VERSION; SCALE	In this study we examined the psychometric properties of the World Health Organization Disability Assessment Schedule (WHODAS 2.0 12-item version) in a mild traumatic brain injury (MTBI) sample. Materials and Methods: Treatment-seeking adults (n = 131) with MTBI recruited from outpatient clinics in Vancouver Canada, were assessed 1- and 3-months following clinic intake. Dimensionality, reliability, and differential item functioning of the WHODAS 2.0 were examined with Rasch analysis. Associations between change in WHODAS 2.0 scores and symptom, work and perceived improvement outcomes were examined. Results: Adequate fit to the Rasch model was achieved for 1-month follow-up assessment WHODAS 2.0 scores without altering the response format or item content [X-2 (24, n = 130) = 21.2, p = .6]. The best model fit for 3-month follow-up assessment scores was achieved when two items (problems with dressing and washing) were combined [X-2 (22, n = 115) = 20.9, p = .5]. Associations were evident between changes in WHODAS total Rasch scores and other outcome indicators such as return to productivity and percieved improvement. Conclusions: The WHODAS 2.0 (12-item version) is a psychometrically sound measure of functional outcome for adults seeking treatment following MTBI. Our table of ordinal to interval score conversions is recommended for future research examining MTBI outcomes.	[Snell, Deborah L.] Canterbury Dist Hlth Board, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.] Univ Otago Christchurch, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Studies, Auckland, New Zealand; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Silverberg, Noah D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA		Snell, DL (corresponding author), Univ Otago, Concuss Clin, Christchurch, New Zealand.	debbie.snell@otago.ac.nz			VGH+UBC Hospital Foundation; Michael Smith Foundation for Health Research and Vancouver Coastal Health Research Institute	The study was partially funded by the VGH+UBC Hospital Foundation. NS receives salary support from the Michael Smith Foundation for Health Research and Vancouver Coastal Health Research Institute.	Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Andrich D., 2009, RUMM 2030; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; de Haan S, 2017, NEURORADIOLOGY, V59, P963, DOI 10.1007/s00234-017-1898-8; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen S, 2019, J NEUROTRAUM, V36, P1; Federici S, 2017, DISABIL REHABIL, V39, P2347, DOI 10.1080/09638288.2016.1223177; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; IBM Corporation, 2016, BM SPSS STAT MAC VER; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirchberger I, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0027-8; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Luciano JV, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-45; MacLeod MA, 2016, INT J METH PSYCH RES, V25, P243, DOI 10.1002/mpr.1523; Mitchell-Parker K, 2018, AUST J PSYCHOL, V70, P258, DOI 10.1111/ajpy.12192; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Ranson J, 2019, J NEUROTRAUM, V36, P2493, DOI 10.1089/neu.2018.5998; Resnik L, 2017, ARCH PHYS MED REHAB, V98, P561, DOI 10.1016/j.apmr.2016.08.463; Saltychev M, 2017, CLIN REHABIL, V31, P262, DOI 10.1177/0269215516631385; Siegert RJ, 2010, DISABIL REHABIL, V32, P8, DOI 10.3109/09638280902971398; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Sjonnesen K, 2016, CAN J PSYCHIAT, V61, P227, DOI 10.1177/0706743716632514; Smedema SM, 2016, J REHABIL, V82, P28; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Snell DL, 2017, J NEUROTRAUM, V34, P3256, DOI 10.1089/neu.2017.5234; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Tarvonen-Schroder S, 2019, J REHABIL MED, V51, P675, DOI 10.2340/16501977-2583; Tarvonen-Schroder S, 2019, J REHABIL MED, V51, P40, DOI 10.2340/16501977-2501; Tarvonen-Schroder S, 2018, J REHABIL MED, V50, P514, DOI 10.2340/16501977-2345; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Ustun T, 2010, MEASURING HLTH DISAB; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weeks M, 2016, CAN J PSYCHIAT, V61, p56S, DOI 10.1177/0706743716628853; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2001, ICF INT CLASFUNCT; Zahniser E, 2019, ARCH CLIN NEUROPSYCH, V34, P1165, DOI 10.1093/arclin/acy103	45	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 15	2020	34	5					610	618		10.1080/02699052.2020.1729417		FEB 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LB9LL	WOS:000515008900001	32078408				2022-02-06	
J	Wolfson, DI; Kuhn, AW; Kerr, ZY; Brett, BL; Yengo-Kahn, AM; Solomon, GS; Zuckerman, SL				Wolfson, Daniel I.; Kuhn, Andrew W.; Kerr, Zachary Y.; Brett, Benjamin L.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.			Chronic traumatic encephalopathy research viewed in the public domain: What makes headlines?	BRAIN INJURY			English	Article						Chronic traumatic encephalopathy; sports; concussion; traumatic brain injury; social media	NATIONAL-FOOTBALL-LEAGUE; CITATIONS; ARTICLES; PLAYERS	Objective: To determine chronic traumatic encephalopathy (CTE)-related publication characteristics associated with higher Altmetric scores. Methods: A systematic review of the CTE literature was conducted using PubMed. Publications were coded for: journal impact factor (JIF); publication type (primary versus non-primary data collection); discussion of American football; contact sport-CTE association conclusion (yes versus no/neutral); and Altmetric score. Multivariable ordinal logistic regression identified predictors of higher Altmetric scores. Results: Most of the 270 CTE-related publications did not include primary data collection (60%). The median Altmetric score was 12 (range = 0-3745). Higher Altmetric scores were associated with primary data collection [Odds ratio (OR)(Adjusted) = 2.29; 95% confidence interval (CI) = 1.35-3.89] and discussing American football (ORAdjusted = 2.11; 95%CI = 1.24-3.59). Among publications concluding contact sport-CTE associations, higher Altmetric scores were associated with higher JIF (3-point-JIF-increase ORAdjusted = 2.11; 95%CI = 1.24-3.59); however, the association of higher Altmetric scores with higher JIF was not found among neutral publications or those concluding no contact sport-CTE associations (3-point-JIF-increase ORAdjusted = 1.07; 95%CI = 0.94-1.22). Conclusions: Most CTE-related publications (60%) did not involve primary data collection. Publication characteristics such as higher JIF and concluding contact sport-CTE associations were associated with higher Altmetric scores. It is important for the academic community to consider strategies to counter publication and promotion bias in the presentation of CTE literature.	[Wolfson, Daniel I.; Kuhn, Andrew W.; Brett, Benjamin L.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Vanderbilt Sports Concuss Ctr, Nashville, TN USA; [Wolfson, Daniel I.; Yengo-Kahn, Aaron M.; Solomon, Gary S.; Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA; [Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Kerr, Zachary Y.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27515 USA; [Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Brett, Benjamin L.] Med Coll Wisconsin, Dept Neurol Surg, Milwaukee, WI 53226 USA; [Solomon, Gary S.] Natl Football League, Hlth & Safety Dept, New York, NY USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vumc.org	Yengo-Kahn, Aaron/AAV-7647-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kuhn, Andrew/0000-0003-1836-7575			Abbasi J, 2018, JAMA-J AM MED ASSOC, V320, P2188, DOI 10.1001/jama.2018.17934; [Anonymous], 2018, ALTMETRIC SUPPORT; [Anonymous], 2018, WELC J CIT REP; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Barr WB, 2013, NEUROPSYCHOL REV, V23, P271, DOI 10.1007/s11065-013-9244-3; Campbell EG, 2012, J GEN INTERN MED, V27, P403, DOI 10.1007/s11606-012-1989-5; Castellani RJ, 2015, J NEUROPATH EXP NEUR, V74, P493, DOI 10.1097/NEN.0000000000000193; Dardas LA, 2019, J ADV NURS, V75, P1394, DOI 10.1111/jan.13921; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Dumas-Mallet E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172650; Hughes H, 2017, CUREUS, V9, DOI 10.7759/cureus.1931; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Lincoln AE, 2018, MED SCI SPORT EXER, V50, P486, DOI 10.1249/MSS.0000000000001466; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pershad Y, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060121; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Powell AGMT, 2018, WORLD J SURG, V42, P2745, DOI 10.1007/s00268-018-4579-9; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Ruan QZ, 2018, PLAST RECONSTR SURG, V141, P801, DOI 10.1097/PRS.0000000000004128; Serghiou S, 2018, JAMA-J AM MED ASSOC, V319, P402, DOI 10.1001/jama.2017.21168; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Solomon GS, 2014, PHYSICIAN SPORTSMED, V42, P26, DOI 10.3810/psm.2014.09.2072; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; Thoma B, 2018, CAN J EMERG MED, V20, P300, DOI 10.1017/cem.2017.394; Venkataramani AS, 2018, JAMA-J AM MED ASSOC, V319, P800, DOI 10.1001/jama.2018.0140; Wang J, 2017, WORLD NEUROSURG, V103, P883, DOI 10.1016/j.wneu.2017.04.157; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	32	5	5	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					528	534		10.1080/02699052.2020.1725843		FEB 2020	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000514498800001	32064946				2022-02-06	
J	Wu, YY; Cui, J				Wu, Yinyin; Cui, Jing			(-)-Epigallocatechin-3-gallate provides neuroprotection via AMPK activation against traumatic brain injury in a mouse model	NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY			English	Article						(-)-Epigallocatechin-3-gallate; Controlled cortical impact; Neurological function; Inflammation; Oxidative stress; AMPK	NF-KAPPA-B; GREEN TEA CATECHINS; GLUCOSE-METABOLISM; OXIDATIVE STRESS; IN-VITRO; KEY ROLE; KINASE; EDEMA; PATHOGENESIS; INFLAMMATION	Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. (-)-Epigallocatechin-3-gallate (EGCG) has shown robust neuroprotective effects on various brain injury models in rodents. Herein, we aimed to investigate if EGCG protects against TBI and unravel the underlying mechanisms. A total of 102 mice were used for this study. TBI was induced by controlled cortical impact (CCI). EGCG was given immediately after TBI injury. Neurological functions were accessed by corner test, paw placement, modified neurological severity score, rotarod test, and Morris water maze test. AMPK inhibitor and AMPK alpha 1-knockout mice were used to further study the signaling pathways involved in the observed effects. Our results show that EGCG significantly ameliorated CCI-induced neurological impairment, including spatial learning and memory. EGCG suppressed CCI-induced inflammation and oxidative stress. Furthermore, EGCG downregulated the phosphorylation of IKK alpha/beta, I kappa B alpha, and nuclear translocation of NF-kappa B p65; upregulated AMPK phosphorylation; and altered corresponding changes in the phosphorylation of the downstream target's ribosomal protein S6, AS160, and CaMKKss. Our data demonstrate that EGCG protects against CCI-induced TBI through the activation of the AMPK pathway in mice, suggesting that EGCG might be a promising therapeutic intervention preventing locomotor and cognitive impairments after TBI.	[Wu, Yinyin; Cui, Jing] Second Peoples Hosp Hefei City, Intersect Guangde Rd & Leshui Rd, Hefei 230011, Anhui, Peoples R China		Wu, YY (corresponding author), Second Peoples Hosp Hefei City, Intersect Guangde Rd & Leshui Rd, Hefei 230011, Anhui, Peoples R China.	wuyinyintree@163.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Chu C., 2017, BIOMED RES INT, V2017, P1, DOI [10.1155/2017/5615647, DOI 10.1155/2017/5615647]; Ding L, 2018, MOL MED REP, V18, P4813, DOI 10.3892/mmr.2018.9548; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ge R, 2013, BRAIN RES, V1527, P40, DOI 10.1016/j.brainres.2013.06.009; Harun-Or-Rashid M, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1346-7; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Ide K, 2018, MOLECULES, V23, DOI 10.3390/molecules23092357; Ikeda I, 2008, ASIA PAC J CLIN NUTR, V17, P273; Itoh T, 2012, J NEURAL TRANSM, V119, P877, DOI 10.1007/s00702-011-0764-9; Jalloh I, 2015, METAB BRAIN DIS, V30, P615, DOI 10.1007/s11011-014-9628-y; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Khan M, 2018, J NEUROSCI RES, V96, P1900, DOI 10.1002/jnr.24279; Kondo T, 2002, CANCER LETT, V180, P139, DOI 10.1016/S0304-3835(02)00007-1; Krishan S, 2015, MOL PHARMACOL, V87, P363, DOI 10.1124/mol.114.095810; Lecumberri E, 2013, CLIN NUTR, V32, P894, DOI 10.1016/j.clnu.2013.03.008; Lee SR, 2000, NEUROSCI LETT, V287, P191, DOI 10.1016/S0304-3940(00)01159-9; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Li F, 2018, EXPERT OPIN DRUG DIS, V13, P643, DOI 10.1080/17460441.2018.1465923; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mancini SJ, 2017, MOL CELL ENDOCRINOL, V440, P44, DOI 10.1016/j.mce.2016.11.010; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Meng QY, 2008, REJUV RES, V11, P649, DOI 10.1089/rej.2007.0645; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Nagai K, 2002, BRAIN RES, V956, P319, DOI 10.1016/S0006-8993(02)03564-3; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pushkarna A, 2010, Med J Armed Forces India, V66, P321, DOI 10.1016/S0377-1237(10)80008-5; Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Scheff SW, 2017, J NEUROTRAUM, V34, P1491, DOI 10.1089/neu.2016.4718; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tang FY, 2003, INT J CANCER, V106, P871, DOI 10.1002/ijc.11325; Tedeschi E, 2004, MOL PHARMACOL, V65, P111, DOI 10.1124/mol.65.1.111; Wang ZF, 2008, J NEUROCHEM, V106, P1594, DOI 10.1111/j.1471-4159.2008.05504.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	49	5	5	0	0	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0028-1298	1432-1912		N-S ARCH PHARMACOL	Naunyn-Schmiedebergs Arch. Pharmacol.	NOV	2020	393	11					2209	2220		10.1007/s00210-020-01841-1		FEB 2020	12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	OE5GV	WOS:000516151000001	32062732				2022-02-06	
J	Nielsen, AI; Power, E; Jensen, LR				Nielsen, Annesofie Ishoy; Power, Emma; Jensen, Lise Randrup			Communication with patients in post-traumatic confusional state: perception of rehabilitation staff	BRAIN INJURY			English	Article						Traumatic brain Injury; communication; post-Traumatic Confusional State; post-Traumatic Amnesia; health care professionals	TRAUMATIC BRAIN-INJURY; COGNITIVE-COMMUNICATION; SUPPORTED CONVERSATION; CHALLENGING BEHAVIOR; PEOPLE; AMNESIA; ADULTS; EXPERIENCE; RECOVERY; PARTNERS	Objective: People in Post-Traumatic Confusional State (PTCS) present with communication difficulties that are well described in literature. However, limited study has been conducted on the experiences of their communication partners. The current study aimed to understand the experience of rehabilitation staff of their communication with patients in PTCS prior to communication partner training (CPT). Methods: Staff on a subacute inpatient TBI rehabilitation unit were invited to complete a 10-item questionnaire. The questionnaire contained quantitative and open-ended text response formats, analyzed with descriptive statistics and content analysis, respectively. Results: 78 interdisciplinary staff members completed the questionnaire. The majority of staff found communication to be difficult and time-consuming with half not feeling comfortable communicating with patients in PTCS. Confidence in communication was not associated with length of clinical experience. The majority of staff reported utilizing strategies to support communication, largely focused on augmenting activities with supportive objects and ensuring patient's comprehension through modification of verbal language. Conclusions: Staff are aware of the need for creating a structured environment for patients in PTCS and less aware of communication-specific strategies aiming at helping patients' expression, which underlines the need to emphasize these strategies as part of CPT in this type of setting.	[Nielsen, Annesofie Ishoy] Rigshosp, Copenhagen Univ Hosp, Dept Neurorehabil, TBI Unit, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark; [Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Ultimo, Australia; [Power, Emma] Univ Sydney, Sch Hlth Sci, Fac Med & Hlth, Lidcombe, Australia; [Jensen, Lise Randrup] Univ Copenhagen, Dept Nord Studies & Linguist, Copenhagen, Denmark		Nielsen, AI (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neurorehabil, TBI Unit, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	Annesofie.ishoey.nielsen@regionh.dk	Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; Nielsen, Annesofie Ishoy/0000-0003-0564-3462			Affolter F, 1981, Int Rehabil Med, V3, P3; Bartlett G, 2008, CAN MED ASSOC J, V178, P1555, DOI 10.1503/cmaj.070690; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Farrell GA, 2010, J ADV NURS, V66, P1644, DOI 10.1111/j.1365-2648.2010.05340.x; Hagen C., 1972, LEVELS COGNITIVE FUN; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jensen LR, 2015, APHASIOLOGY, V29, P57, DOI 10.1080/02687038.2014.955708; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Kivunja S, 2018, J CLIN NURS, V27, P1304, DOI 10.1111/jocn.14283; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Krishnamoorthy A, 2011, PROG NEUROL PSYCHIAT, V15, P20, DOI 10.1002/pnp.199; MacDonald S, 2010, BRAIN INJURY, V24, P486, DOI 10.3109/02699050903518118; Oyesanya TO, 2018, J CLIN NURS, V27, P1408, DOI 10.1111/jocn.14298; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Steel J, 2017, BRAIN INJURY, V31, P1889, DOI 10.1080/02699052.2017.1373200; Steel J, 2015, NEUROREHABILITATION, V37, P221, DOI 10.3233/NRE-151255; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; World Health Organization, 2001, ICF INT CLASS FUNCT	29	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 20	2020	34	4					447	455		10.1080/02699052.2020.1725839		FEB 2020	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8TS	WOS:000513751900001	32050798	Green Submitted			2022-02-06	
J	Berginstrom, N; Nordstrom, P; Nyberg, L; Nordstrom, A				Berginstrom, Nils; Nordstrom, Peter; Nyberg, Lars; Nordstrom, Anna			White matter hyperintensities increases with traumatic brain injury severity: associations to neuropsychological performance and fatigue	BRAIN INJURY			English	Article						Traumatic Brain Injury; magnetic Resonance Imaging; white matter hyperintensities; neuropsychology; fatigue	ATTENUATED INVERSION-RECOVERY; ALZHEIMERS-DISEASE; COGNITIVE RESERVE; CORPUS-CALLOSUM; AXONAL INJURY; HEAD-INJURY; SYMPTOMS; LESION; DEMENTIA; CONCUSSION	Objective: To examine the prevalence of white matter hyperintensities (WMHs) in patients with traumatic brain injury (TBI) as compared to healthy controls, and to investigate whether there is an association between WMH lesion burden and performance on neuropsychological tests in patients with TBI. Methods: A total of 59 patients with TBI and 27 age- and gender-matched healthy controls underwent thorough neuropsychological testing and magnetic resonance imaging. The quantification of WMH lesions was performed using the fully automated Lesion Segmentation Tool. Results: WMH lesions were more common in patients with TBI than in healthy controls (p = .032), and increased with higher TBI severity (p = .025). Linear regressions showed that WMH lesions in patients with TBI were not related to performance on any neuropsychological tests (p > .05 for all). However, a negative relationship between number of WMH lesions in patients with TBI and self-assessed fatigue was found (r = - 0.33, p = .026). Conclusion: WMH lesions are more common in patients with TBI than in healthy controls, and WMH lesions burden increases with TBI severity. These lesions could not explain decreased cognitive functioning in patients with TBI but did relate to decreased self-assessment of fatigue after TBI.	[Berginstrom, Nils; Nordstrom, Peter] Umea Univ, Dept Community Med & Rehabil, Geriatr Med, Umea, Sweden; [Berginstrom, Nils] Umea Univ, Dept Psychol, S-90187 Umea, Sweden; [Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging UFBI, Umea, Sweden; [Nyberg, Lars] Umea Univ, Physiol Sect, Dept Integrat Med Biol, Umea, Sweden; [Nordstrom, Anna] Umea Univ, Dept Publ Hlth & Clin Med, Occupat & Environm Med, Umea, Sweden; [Nordstrom, Anna] Arctic Univ Norway, Sch Sport Sci, Tromso, Norway; [Nyberg, Lars] Umea Univ, Dept Radiat Sci, Umea, Sweden		Berginstrom, N (corresponding author), Umea Univ, Dept Psychol, S-90187 Umea, Sweden.	nils.berginstrom@umu.se	Nordstrom, Anna/F-2238-2010	Nordstrom, Anna/0000-0003-3534-456X; Berginstrom, Nils/0000-0003-1192-4527	Torsten & Ragnar Soderberg's Foundation; Umea University; Vasterbotten County Council	This work was supported by the Torsten & Ragnar Soderberg's Foundation; and A regional agreement between Umea University and Vasterbotten County Council on cooperation in the field of Medicine, Odontology, and Health.	Bakshi Rohit, 2005, NeuroRx, V2, P277, DOI 10.1007/BF03206672; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Berginstrom N, 2018, J HEAD TRAUMA REHAB, V33, P266, DOI 10.1097/HTR.0000000000000340; Berginstrom N, 2017, J HEAD TRAUMA REHAB, V32, pE46, DOI 10.1097/HTR.0000000000000236; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Brickman AM, 2015, NEUROBIOL AGING, V36, P27, DOI 10.1016/j.neurobiolaging.2014.07.019; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Clark AL, 2016, BRAIN INJURY, V30, P864, DOI 10.3109/02699052.2016.1144894; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DECARLI C, 1995, NEUROLOGY, V45, P2077, DOI 10.1212/WNL.45.11.2077; Delis D.C., 2001, D KEFS DELIS KAPLAN; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Grysiewicz R, 2012, CURR NEUROL NEUROSCI, V12, P703, DOI 10.1007/s11910-012-0315-2; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Miyaoka T, 2005, EUR PSYCHIAT, V20, P327, DOI 10.1016/j.eurpsy.2004.12.012; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Pekala JS, 2003, AM J NEURORADIOL, V24, P855; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Rey A., 1964, EXAMEN CLIN PSYCHOL; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Schmidt P., 2017, LST LESION SEGMENTAT; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Schonberger M, 2017, NEUROPSYCHOL REHABIL, V27, P1056, DOI 10.1080/09602011.2016.1154875; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Tamura Y, 2015, GERIATR GERONTOL INT, V15, P34, DOI 10.1111/ggi.12666; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	52	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					415	420		10.1080/02699052.2020.1725124		FEB 2020	6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000513366800001	32037894	Green Published, hybrid			2022-02-06	
J	Cai, XF; Lin, S; Geng, Z; Luo, LL; Liu, YJ; Zhang, Z; Liu, WY; Chen, X; Li, X; Yan, J; Ye, J				Cai, Xiao-Feng; Lin, Sen; Geng, Zhao; Luo, Lin-Lin; Liu, Yun-Jia; Zhang, Zhou; Liu, Wen-Yi; Chen, Xi; Li, Xue; Yan, Jun; Ye, Jian			Integrin CD11b Deficiency Aggravates Retinal Microglial Activation and RGCs Degeneration After Acute Optic Nerve Injury	NEUROCHEMICAL RESEARCH			English	Article						CD11b; Microglia; Retina; Rgcs degeneration; Optic nerve crush; Mice	GANGLION-CELL SURVIVAL; AXON REGENERATION; DEATH; RECEPTOR; INFLAMMATION; PATHWAY; CRUSH; BETA; INTERLEUKIN-10; MINOCYCLINE	Neuroinflammation plays a vital role in the process of a variety of retinal ganglion cells (RGCs) degenerative diseases including traumatic optic neuropathy (TON). Retinal microglial activation is believed as a harbinger of TON, and robust microglial activation can aggravate trauma-induced RGCs degeneration, which ultimately leads to RGCs loss. Toll like receptor 4 (TLR4)-triggered inflammation is of great importance in retinal inflammatory response after optic nerve injury. CD11b on macrophage and brain microglia can inhibit TLR4-triggered inflammation. However, the functional role of CD11b in retinal microglia is not well understood. Here, using an optic nerve crush model and CD11b gene deficient mice, we found that CD11b protein expression was mainly on retinal microglia, significantly increased after optic nerve injury, and still maintained at a high level till at least 28 days post crush. Compared with wild type mice, following acute optic nerve injury, CD11b deficient retinae exhibited more exacerbated microglial activation, accelerated RGCs degeneration, less growth associated protein-43 expression, as well as more proinflammatory cytokines such as interleukin-6 and tumor necrosis factor alpha while less anti-inflammatory factors such as arginase-1 and interleukin-10 production. We conclude that CD11b is essential in regulating retinal microglial activation and neuroinflammatory responses after acute optic nerve injury, which is critical for subsequent RGCs degeneration and loss.	[Cai, Xiao-Feng; Lin, Sen; Geng, Zhao; Luo, Lin-Lin; Liu, Yun-Jia; Zhang, Zhou; Liu, Wen-Yi; Chen, Xi; Li, Xue; Ye, Jian] Army Med Univ, Dept Ophthalmol, Res Inst Surg, Chongqing 400042, Peoples R China; [Cai, Xiao-Feng; Lin, Sen; Geng, Zhao; Luo, Lin-Lin; Liu, Yun-Jia; Zhang, Zhou; Liu, Wen-Yi; Chen, Xi; Li, Xue; Yan, Jun; Ye, Jian] Army Med Univ, Army Med Ctr PLA, Daping Hosp, Chongqing 400042, Peoples R China; [Yan, Jun] Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing 400042, Peoples R China		Ye, J (corresponding author), Army Med Univ, Dept Ophthalmol, Res Inst Surg, Chongqing 400042, Peoples R China.; Yan, J; Ye, J (corresponding author), Army Med Univ, Army Med Ctr PLA, Daping Hosp, Chongqing 400042, Peoples R China.; Yan, J (corresponding author), Army Med Univ, State Key Lab Trauma Burns & Combined Injury, Res Inst Surg, Chongqing 400042, Peoples R China.	13883092250@163.com; yejian1979@163.com			Funds of National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81570840, 81371006]; Basic Research and Frontier Fund of Chongqing [cstc2019jcyj-msxmX0010]; Research Foundation of Dept. Ophthalmology in Daping Hospital, AMU [9-2543]	We thank Prof. Yuan-Guo Zhou from Army Medical Center of PLA and Prof. Feng Mei from Army Medical University for project consultation and kind review of the manuscript, and thank Prof. Bo Peng from ShenZhen Institutes of Advanced Technology, Chinese Academy of Sciences for his technical support. This work was supported by the Funds of National Natural Science Foundation of China (Nos. 81570840 and 81371006), Basic Research and Frontier Fund of Chongqing (cstc2019jcyj-msxmX0010) and Research Foundation of Dept. Ophthalmology in Daping Hospital, AMU (No. 9-2543).	Abram CL, 2009, ANNU REV IMMUNOL, V27, P339, DOI 10.1146/annurev.immunol.021908.132554; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Baptiste DC, 2005, NEUROSCIENCE, V134, P575, DOI 10.1016/j.neuroscience.2005.04.011; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Boyd ZS, 2003, INVEST OPHTH VIS SCI, V44, P5206, DOI 10.1167/iovs.03-0534; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chen CL, 2009, J NEUROCHEM, V110, P1628, DOI 10.1111/j.1471-4159.2009.06264.x; Choudhury S, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0039-2; Darshit BS, 2016, MOL NEUROBIOL, V53, P6716, DOI 10.1007/s12035-015-9598-z; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Heskamp A, 2013, NEUROBIOL DIS, V55, P76, DOI 10.1016/j.nbd.2013.04.001; Hilla AM, 2017, J NEUROSCI, V37, P6113, DOI 10.1523/JNEUROSCI.0584-17.2017; Hu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep26252; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Koeberle PD, 2004, NEUROSCIENCE, V125, P903, DOI 10.1016/S0306-4522(03)00398-1; Kourtzelis I, 2017, J LEUKOCYTE BIOL, V102, P677, DOI 10.1189/jlb.3MR0117-024R; Lefort CT, 2009, J IMMUNOL, V183, P6460, DOI 10.4049/jimmunol.0900983; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2006, ARCH OPHTHALMOL-CHIC, V124, P520, DOI 10.1001/archopht.124.4.520; Levkovitch-Verbin H, 2010, EXP EYE RES, V91, P127, DOI 10.1016/j.exer.2009.11.014; Li Y, 2000, EXP EYE RES, V71, P209, DOI 10.1006/exer.2000.0873; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-39; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mac Nair CE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0558-y; Morzaev D, 2015, CLIN EXP OPHTHALMOL, V43, P655, DOI 10.1111/ceo.12521; Nakano Y, 2017, J PHARMACOL SCI, V133, P176, DOI 10.1016/j.jphs.2017.02.012; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Noailles A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0186-3; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Palin K, 2008, NEUROBIOL DIS, V30, P19, DOI 10.1016/j.nbd.2007.11.012; Perego C, 2016, NEUROBIOL DIS, V96, P284, DOI 10.1016/j.nbd.2016.09.017; Rathnasamy G, 2019, PROG NEUROBIOL, V173, P18, DOI 10.1016/j.pneurobio.2018.05.006; Sakai S, 2019, NEUROCHEM INT, V130, DOI 10.1016/j.neuint.2018.10.013; Smith NM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1227-0; Solovjov DA, 2005, J BIOL CHEM, V280, P1336, DOI 10.1074/jbc.M406968200; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Todd L, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1505-5; Tse BC, 2018, INVEST OPHTH VIS SCI, V59, P2905, DOI 10.1167/iovs.18-24431; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Yang M, 2018, MOL PAIN, V14, DOI 10.1177/1744806918808150; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang QR, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.256; Zheng Z, 2012, BRAIN RES, V1489, P90, DOI 10.1016/j.brainres.2012.10.014; Zhou H, 2013, J IMMUNOL, V190, P115, DOI 10.4049/jimmunol.1202136; Zhou JX, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00160; Zhou T, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00077	58	5	5	2	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAY	2020	45	5					1072	1085		10.1007/s11064-020-02984-6		FEB 2020	14	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LE0KF	WOS:000513051300001	32052258				2022-02-06	
J	Cecchi, NJ; Monroe, DC; Oros, TJ; Small, SL; Hicks, JW				Cecchi, Nicholas J.; Monroe, Derek C.; Oros, Theophil J.; Small, Steven L.; Hicks, James W.			Laboratory evaluation of a wearable head impact sensor for use in water polo and land sports	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Head acceleration; headgear; kinematics; biomechanics; concussion	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; HYBRID III; ACCELERATION; EPIDEMIOLOGY; CONCUSSIONS; EXPOSURE; DEVICES	The SIM-G is a waterproof head impact sensor that has been previously evaluated for use in a headband, but not yet in a mode of attachment suitable for water polo. For this study, a CADEX linear impactor was used to impact a Hybrid III headform while wearing either a headband or modified water polo cap, each housing a SIM-G. In both headgears, the SIM-G consistently underestimated peak linear acceleration (p < .001) and peak rotational velocity (p < .001), and consistently overestimated peak rotational acceleration (p < .001) relative to the headform. These inaccuracies are consistent with previous evaluations of the SIM-G, but notably, impact magnitudes did not differ between the different modes of attachment (p > .198). The proprietary SIM-G algorithm used for classifying false/true positives performed poorly at the back and crown impact locations in both the water polo cap and headband, but accuracy of this algorithm did not significantly differ between the water polo cap and headband (60.5% vs 49.4%, respectively). The SIM-G's ability to correctly predict impact location also performed poorly in both headgears when impacts occurred at the crown location, but was significantly better overall in the water polo cap than the headband (80.2% vs 55.6%, respectively). These results demonstrate that the SIM-G exhibits shared limitations and a similar performance overall when placed in either a headband or water polo cap. Potential explanations for the inaccuracies of the SIM-G, as well as methods of optimizing its application in sports, are discussed.	[Cecchi, Nicholas J.; Oros, Theophil J.; Hicks, James W.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA; [Monroe, Derek C.; Small, Steven L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Small, Steven L.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA		Hicks, JW (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	jhicks@uci.edu	Cecchi, Nicholas J/AAC-6547-2021	Cecchi, Nicholas J/0000-0001-9319-4163; Small, Steven/0000-0002-5293-6172; Monroe, Derek/0000-0003-3885-6878	Center for Exercise Medicine and Sport Sciences at the University of California, IrvineUniversity of California System; UC Irvine Multidisciplinary Exercise Science Training Program under NIH [5T32AR047752-15]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this study was provided by the Center for Exercise Medicine and Sport Sciences at the University of California, Irvine and the UC Irvine Multidisciplinary Exercise Science Training Program under NIH grant 5T32AR047752-15.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Cecchi NJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216369; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Funk JR, 2009, 2009010251 SAE; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hayes A.F., 2017, INTRO MEDIATION MODE; Hayes Andrew F., 2012, CISC VIS NETW IND GL; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; King AI, 2003, P IRCOBI C LISB; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mountjoy M, 2010, BRIT J SPORT MED, V44, P522, DOI 10.1136/bjsm.2010.071720; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Oeur RA, 2016, 34 INT C BIOM SPORTS; Ovaska SJ, 1998, IEEE IMTC P, P875, DOI 10.1109/IMTC.1998.676850; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004	31	5	5	2	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	JUN	2020	234	2					162	169	1754337120901974	10.1177/1754337120901974		FEB 2020	8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	LM6GS	WOS:000513321000001					2022-02-06	
J	Munsell, M; De Oliveira, E; Saxena, S; Godlove, J; Kiran, S				Munsell, Michael; De Oliveira, Emily; Saxena, Sadhvi; Godlove, Jason; Kiran, Swathi			Closing the Digital Divide in Speech, Language, and Cognitive Therapy: Cohort Study of the Factors Associated With Technology Usage for Rehabilitation	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						aphasia; stroke; traumatic brain injury; technology	APHASIA POSTSTROKE; ACUTE STROKE; USUAL CARE; MULTICENTER; RECOVERY	Background: For stroke, traumatic brain injury (TBI), and other neurologic conditions associated with speech-language disorders, speech and language therapy is the standard of care for promoting recovery. However, barriers such as clinician time constraints and insurance reimbursement can inhibit a patient's ability to receive the support needed to optimize functional gain. Although digital rehabilitation has the potential to increase access to therapy by allowing patients to practice at home, the clinical and demographic characteristics that impact a patient's level of engagement with technology-based therapy are currently unknown. Objective: This study aimed to evaluate whether the level of engagement with digital therapy differs by various patient characteristics, including age, gender, diagnosis, time from disease onset, and geographic location (urban vs rural). Methods: Data for patients with stroke or TBI that initiated the use of Constant Therapy, a remotely delivered, cloud-based rehabilitation program for patients with speech-language disorders, were retrospectively analyzed. Only data from therapeutic sessions completed at home were included. The following three activity metrics were evaluated: (1) the number of active weeks of therapy, (2) the average number of active therapy days per week, and (3) the total number of therapeutic sessions completed during the first 20 weeks of program access. An active day or week was defined as having at least one completed therapeutic session. Separate multiple linear regression models were performed with each activity measure as the dependent variable and all available patient demographics as model covariates. Results: Data for 2850 patients with stroke or TBI were analyzed, with the average patient completing 8.6 weeks of therapy at a frequency of 1.5 days per week. Contrary to known barriers to technological adoption, older patients were more active during their first 20 weeks of program access, with those aged 51 to 70 years completing 5.01 more sessions than patients aged 50 years or younger (P=.04). Similarly, patients living in a rural area, who face greater barriers to clinic access, were more digitally engaged than their urban counterparts, with rural patients completing 11.54 more (P=.001) sessions during their first 20 weeks of access, after controlling for other model covariates. Conclusions: An evaluation of real-world data demonstrated that patients with stroke and TBI use digital therapy frequently for cognitive and language rehabilitation at home. Usage was higher in areas with limited access to clinical services and was unaffected by typical barriers to technological adoption, such as age. These findings will help guide the direction of future research in digital rehabilitation therapy, including the impact of demographics on recovery outcomes and the design of large, randomized controlled trials.	[Munsell, Michael; De Oliveira, Emily; Saxena, Sadhvi; Godlove, Jason; Kiran, Swathi] Learning Corp, 65 Chapel St, Newton, MA 02458 USA; [Kiran, Swathi] Boston Univ, Aphasia Res Lab, Speech Language & Hearing Sci, Boston, MA 02215 USA		Munsell, M (corresponding author), Learning Corp, 65 Chapel St, Newton, MA 02458 USA.	michael.munsell@thelearningcorp.com		Kiran, Swathi/0000-0003-1586-8913			Anderson M., 2017, TECHNOLOGY USE SENIO; Bersano A, 2009, INT J STROKE, V4, P443, DOI 10.1111/j.1747-4949.2009.00349.x; Berthier ML, 2005, DRUG AGING, V22, P163, DOI 10.2165/00002512-200522020-00006; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Centers for Disease Control and Prevention, TBI REL EM DEP VIS H; Cohen J, 1998, STAT POWER ANAL BEHA; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Doogan C, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0891-x; Flowers HL, 2016, ARCH PHYS MED REHAB, V97, P2188, DOI 10.1016/j.apmr.2016.03.006; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Godlove J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00140; Guyomard V, 2009, J AM GERIATR SOC, V57, P2101, DOI 10.1111/j.1532-5415.2009.02526.x; Harnish SM, 2014, AM J SPEECH-LANG PAT, V23, P285, DOI 10.1044/2014_AJSLP-13-0081; Kiran S, 2016, SEMIN SPEECH LANG, V37, P48, DOI 10.1055/s-0036-1571358; Kiran S, 2014, SEMIN SPEECH LANG, V35, P38, DOI 10.1055/s-0033-1362995; Kurland J, 2018, J SPEECH LANG HEAR R, V61, P1140, DOI 10.1044/2018_JSLHR-L-17-0277; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lazar RM, 2008, J NEUROL NEUROSUR PS, V79, P530, DOI 10.1136/jnnp.2007.122457; Palmer R, 2019, LANCET NEUROL, V18, P821, DOI 10.1016/S1474-4422(19)30192-9; Palmer R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200096; Palmer R, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0527-7; Palmer R, 2012, STROKE, V43, P1904, DOI 10.1161/STROKEAHA.112.650671; Perrin A., 2019, DIGITAL GAP RURAL NO; Plowman E, 2012, J EVAL CLIN PRACT, V18, P689, DOI 10.1111/j.1365-2753.2011.01650.x; Pugliese M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210725; R Foundation for Statistical Computing, 2011, R LANG ENV STAT COMP; Rapoliene J, 2018, REHABIL RES PRACT, V2018, DOI 10.1155/2018/9367942; Seabold S., 2010, P 9 PYTHON SCI C; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; US Census Bureau, 2016, NEW CENS DAT SHOW DI; Woolf C, 2016, CLIN REHABIL, V30, P359, DOI 10.1177/0269215515582074	35	5	6	1	26	JMIR PUBLICATIONS, INC	TORONTO	130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	FEB 11	2020	22	2							e16286	10.2196/16286			11	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	KK5AG	WOS:000512754000001	32044752	Green Published, gold			2022-02-06	
J	Chen, J; Wang, HC; Luo, CL; Gao, C; Zhang, YL; Chen, G; Chen, W; Chen, XP; Tao, LY				Chen, Jie; Wang, Haochen; Luo, Chengliang; Gao, Cheng; Zhang, Yalai; Chen, Guang; Chen, Wei; Chen, Xiping; Tao, Luyang			Chd8 Rescued TBI-Induced Neurological Deficits by Suppressing Apoptosis and Autophagy Via Wnt Signaling Pathway	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Chromodomain helicase DNA binding protein 8; Traumatic brain injury; Wnt; Apoptosis; Autophagy	TRAUMATIC BRAIN-INJURY; CELL-CYCLE; MODEL; NEUROPROTECTION; EMOTION; MEMORY; DAMAGE; LEADS	Traumatic brain injury (TBI) and autism spectrum disorder (ASDs) share several same biochemical mechanisms and symptoms, such as learning memory impairments and communication deficits. Chromodomain helicase DNA binding protein 8 (CHD8), a member of the CHD family of ATP-dependent chromatin remodeling factors, is one of the top risk genetic factors in ASDs and is highly associated with Wnt/beta-catenin signaling. Yet, the possible effect of CHD8 on TBI remains poorly understood. In vivo, we found that Chd8 co-localized in neurons, astrocytes, and microglia, but predominantly presented in neurons in the prefrontal cortex, hippocampus, and cortex. Both Chd8 and beta-catenin expression peaked at 12 h and shared the similar change tendency after TBI. Chd8 knockdown inhibited wnt pathway, promoted the activation of apoptosis and autophagy, and caused learning and memory impairments both at normal and TBI condition. In addition, overexpression of Chd8 via 17 beta-estrogen (E2) treatment enhanced wnt signaling pathway and suppressed TBI-induced apoptosis and autophagic activation. In vitro, a significant increase of Chd8 and beta-catenin expression was observed in HT22 cells after lipopolysaccharide (lps) treatment or mechanical injury, respectively. Chd8 knockdown inhibited wnt signaling pathway and increased apoptosis and autophagy activation in lps-stimulated HT22 cells. But activation of wnt signaling inverted the effects of Chd8-siRNA. Our results demonstrated that Chd8 exerted neuroprotection and promoted cognitive recovery through inhibiting apoptosis and autophagy activation following TBI, at least partially by wnt signaling pathway.	[Chen, Jie; Wang, Haochen; Luo, Chengliang; Gao, Cheng; Zhang, Yalai; Chen, Guang; Chen, Wei; Chen, Xiping; Tao, Luyang] Soochow Univ, Dept Forens Med, Med Sch, 178 East Ganjiang Rd, Suzhou 215023, Peoples R China		Chen, XP; Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, Med Sch, 178 East Ganjiang Rd, Suzhou 215023, Peoples R China.	xipingchen@suda.edu.cn; taoluyang@suda.edu.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81530062, 81871536, 81971800]; PAPD	This study was supported by the National Nature Science Foundation of China (Grant Nos. 81530062, 81871536, 81971800) and PAPD.	Breuss MW, 2016, NAT NEUROSCI, V19, P1430, DOI 10.1038/nn.4431; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Catharine V, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101827; Ceballos-Chavez M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005174; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Durak O, 2016, NAT NEUROSCI, V19, P1477, DOI 10.1038/nn.4400; Ewing-Cobbs L, 2019, J NEUROTRAUM, V36, P1738, DOI 10.1089/neu.2018.6071; Fan XX, 2018, NEUROCHEM INT, V121, P19, DOI 10.1016/j.neuint.2018.10.018; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Flores LE, 2017, EMOTION, V17, P577, DOI 10.1037/emo0000265; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Gao Y, 2017, MOL NEUROBIOL, V54, P3879, DOI 10.1007/s12035-016-9947-6; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gluck ME, 2017, CURR OBES REP, V6, P380, DOI 10.1007/s13679-017-0289-0; Hui K, 2020, NEUROSCI BIOBEHAV R, V110, P77, DOI 10.1016/j.neubiorev.2018.08.001; Jung H, 2018, NAT NEUROSCI, V21, P1218, DOI 10.1038/s41593-018-0208-z; Katayama Y, 2016, NATURE, V537, P675, DOI 10.1038/nature19357; Leung LY, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00612; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Ma JX, 2017, TOXICOL RES-UK, V6, P290, DOI 10.1039/c7tx00016b; Menon V, 2018, NAT NEUROSCI, V21, P1142, DOI 10.1038/s41593-018-0218-x; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Platt RJ, 2017, CELL REP, V19, P335, DOI 10.1016/j.celrep.2017.03.052; Rogers A, 2019, BRAIN INJURY, V33, P649, DOI 10.1080/02699052.2019.1567936; Rolls ET, 2015, CORTEX, V62, P119, DOI 10.1016/j.cortex.2013.12.005; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Shang JL, 2014, BRAZ J MED BIOL RES, V47, P1050, DOI 10.1590/1414-431X20143601; Shen X, 2016, NEUROCHEM INT, V96, P100, DOI 10.1016/j.neuint.2016.03.004; Singh R, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8781725; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Wang CF, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6460; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang MY, 2017, CELL MOL NEUROBIOL, V37, P291, DOI 10.1007/s10571-016-0369-9; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhao ZA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.98	41	5	5	1	7	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	OCT	2020	40	7					1165	1184		10.1007/s10571-020-00806-5		FEB 2020	20	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	NA4SR	WOS:000515955100001	32034634				2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Baseline vs. cross-sectional MRI of concussion: distinct brain patterns in white matter and cerebral blood flow	SCIENTIFIC REPORTS			English	Article							COLLEGIATE FOOTBALL PLAYERS; SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; INJURY; DTI; RECOVERY; HISTORY; PROJECT; RISK; AGE	Neuroimaging has been used to describe the pathophysiology of sport-related concussion during early injury, with effects that may persist beyond medical clearance to return-to-play (RTP). However, studies are typically cross-sectional, comparing groups of concussed and uninjured athletes. It is important to determine whether these findings are consistent with longitudinal change at the individual level, relative to their own pre-injury baseline. A cohort of N= 123 university-level athletes were scanned with magnetic resonance imaging (MRI). Of this group, N = 12 acquired a concussion and were re-scanned at early symptomatic injury and at RTP. A sub-group of N= 44 uninjured athletes were also re-imaged, providing a normative reference group. Among concussed athletes, abnormalities were identified for white matter fractional anisotropy and mean diffusivity, along with grey matter cerebral blood flow, using both cross-sectional (CS) and longitudinal (LNG) approaches. The spatial patterns of abnormality for CS and LNG were distinct, with median fractional overlap below 0.10 and significant differences in the percentage of abnormal voxels. However, the analysis methods did not differ in the amount of change from symptomatic injury to RTP and in the direction of observed abnormalities. These results highlight the impact of using pre-injury baseline data when evaluating concussion-related brain abnormalities at the individual level.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON M5B 1M8, Canada; [Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1M8, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 2C9, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Graham, Simon J.] Sunnybrook Med Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON M5T 1P5, Canada		Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, Toronto, ON M5B 1M8, Canada.; Churchill, NW (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1M8, Canada.	nchurchill.research@gmail.com			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN356342 - 401065, RN294001-367456]; Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [Grant Numbers RN356342 - 401065, RN294001-367456]; the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967]; and funding from Siemens Canada Ltd.	Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2019, HUM BRAIN MAPP, V40, P1908, DOI 10.1002/hbm.24500; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cubon VA, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1165; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jang I, 2019, NEUROIMAGE-CLIN, V24, DOI 10.1016/j.nicl.2019.101930; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kim J, 2012, J MACH LEARN RES, V13, P2529; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Kochunov P, 2015, NEUROIMAGE, V111, P300, DOI 10.1016/j.neuroimage.2015.02.050; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Liu YN, 2012, MAGN RESON MED, V68, P912, DOI 10.1002/mrm.23286; Manley G. T., 2017, BRIT J SPORT MED; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; RUDEMO M, 1982, SCAND J STAT, V9, P65; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Schneider DK, 2019, J NEUROTRAUM, V36, P2831, DOI 10.1089/neu.2019.6398; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Tan H, 2009, J MAGN RESON IMAGING, V29, P1134, DOI 10.1002/jmri.21721; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00868; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yeh FC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005203; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	67	5	5	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 3	2020	10	1							1643	10.1038/s41598-020-58073-9			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NE7TY	WOS:000562806900004	32015365	Green Published, gold			2022-02-06	
J	de Wit, K; Parpia, S; Varner, C; Worster, A; McLeod, S; Clayton, N; Kearon, C; Mercuri, M				de Wit, Kerstin; Parpia, Sameer; Varner, Catherine; Worster, Andrew; McLeod, Shelley; Clayton, Natasha; Kearon, Clive; Mercuri, Mathew			Clinical Predictors of Intracranial Bleeding in Older Adults Who Have Fallen: A Cohort Study	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						falls; traumatic brain injury; older adults; diagnosis	TRAUMATIC BRAIN-INJURY; HEAD IMPACT; RISK; ANTICOAGULATION; EPIDEMIOLOGY; HEMORRHAGE; RATES; AGE	OBJECTIVES Emergency department (ED) visits among older adults are frequently instigated by a fall at home. Some of these patients develop intracranial bleeding. The aim of this study was to identify the incidence of intracranial bleeding and the associated clinical features in older adults who present to the ED after falling. DESIGN Prospective cohort study. SETTING Three Canadian EDs. PARTICIPANTS A total of 2 176 patients age 65 years or older who presented to the ED with a fall were assessed, and 1753 were included. Inclusion criteria were a fall on level ground, off a bed, chair, or toilet, or from one or two steps within 48 hours. MEASUREMENTS Emergency physicians recorded predefined clinical findings on initial assessment. The primary outcome was intracranial bleeding, diagnosed either by computed tomography at the index visit or within 42 days. Associations between baseline clinical findings and the presence of intracranial bleeding were assessed with multivariable logistic regression. RESULTS A total of 1753 patients (median age = 82 y) were enrolled, of whom 39% were male, 35% were on antiplatelet therapy, and 25% were on an anticoagulant. The incidence of intracranial bleeding was 5.0% (95% confidence interval [CI] = 4.1-6.1). Overall, 76 patients were diagnosed at the index ED visit, and 12 were diagnosed during follow-up. Multivariable regression identified four clinical variables that were independently associated with intracranial bleeding: new abnormalities on neurologic examination (odds ratio [OR] = 4.4; 95% CI = 2.4-8.1), bruise or laceration on the head (OR = 4.3; 95% CI = 2.7-7.0), chronic kidney disease (OR = 2.4; 95% CI = 1.3-4.6), and reduced Glasgow Coma Scale from normal (OR = 1.9; 95% CI = 1.0-3.4). CONCLUSION The incidence of intracranial bleeding in our study was 5.0%. We found significant associations between intracranial bleeding and four simple clinical variables. We did not find significant associations between intracranial bleeding and antiplatelet or anticoagulant use.	[de Wit, Kerstin; Worster, Andrew; Clayton, Natasha; Kearon, Clive; Mercuri, Mathew] McMaster Univ, Dept Med, Hamilton, ON, Canada; [de Wit, Kerstin; Parpia, Sameer; Worster, Andrew] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Varner, Catherine; McLeod, Shelley] Sinai Hlth Syst, Schwartz Reisman Emergency Med Res Inst, Toronto, ON, Canada; [Varner, Catherine; McLeod, Shelley] Univ Toronto, Dept Family & Community Med, Div Emergency Med, Toronto, ON, Canada; [Clayton, Natasha] Hamilton Hlth Sci, Emergency Dept, Hamilton, ON, Canada		de Wit, K (corresponding author), Hamilton Gen Hosp, Emergency Dept, 237 Barton St East, Hamilton, ON L8L 2X2, Canada.	dewitk@mcmaster.ca	McLeod, Shelley/AAE-9636-2019	McLeod, Shelley/0000-0003-2686-6307; de Wit, Kerstin/0000-0003-2763-6474; Varner, Catherine/0000-0002-9696-1329	Hamilton Health Sciences Foundation New Investigator Fund; Hamilton Niagara Haldimand Brant Emergency Services Steering Committee	This study was funded by Hamilton Health Sciences Foundation New Investigator Fund and the Hamilton Niagara Haldimand Brant Emergency Services Steering Committee.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; American College of Emergency Physicians, GER EM DEP GUID; Brazinova A, 2015, AGE AGEING, V44, P502, DOI 10.1093/ageing/afu194; Chan V, 2012, BRAIN INJURY, V26, P548; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Do MT, 2015, HEALTH PROMOT CHRON, V35, P99, DOI 10.24095/hpcdp.35.7.01; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Ganetsky M, 2017, ACAD EMERG MED, V24, P1258, DOI 10.1111/acem.13217; Hamden K, 2014, AM J EMERG MED, V32, P890, DOI 10.1016/j.ajem.2014.04.051; Hastings DL, 2017, J AM GERIATR SOC, V65, pS8; Jeanmonod R, 2019, AM J EMERG MED, V37, P1470, DOI 10.1016/j.ajem.2018.10.049; Kerr Zachary Y, 2014, N C Med J, V75, P8; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Nishijima DK, 2018, J NEUROTRAUM, V35, P750, DOI 10.1089/neu.2017.5232; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Prevention CfDCa, 2016, FALLS FALL INJ AD AG; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sung KC, 2015, J NEUROTRAUM, V32, P1078, DOI 10.1089/neu.2014.3509; Yang YJ, 2016, BRAIN INJURY, V30, P801	26	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAY	2020	68	5					970	976		10.1111/jgs.16338		FEB 2020	7	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	LO3QF	WOS:000510495800001	32010977				2022-02-06	
J	Giammattei, L; Starnoni, D; Maduri, R; Bernini, A; Abed-Maillard, S; Rocca, A; Cossu, G; Simonin, A; Eckert, P; Bloch, J; Levivier, M; Oddo, M; Messerer, M; Daniel, RT				Giammattei, Lorenzo; Starnoni, Daniele; Maduri, Rodolfo; Bernini, Adriano; Abed-Maillard, Samia; Rocca, Alda; Cossu, Giulia; Simonin, Alexandre; Eckert, Philippe; Bloch, Jocelyne; Levivier, Marc; Oddo, Mauro; Messerer, Mahmoud; Daniel, Roy Thomas			Implementation of cisternostomy as adjuvant to decompressive craniectomy for the management of severe brain trauma	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Decompressive craniectomy; Intracranial hypertension; Cisternostomy	INTRACRANIAL-PRESSURE; NEUROSURGERY READY; INJURY	Objective To evaluate the value of an adjuvant cisternostomy (AC) to decompressive craniectomy (DC) for the management of patients with severe traumatic brain injury (sTBI). Methods A single-center retrospective quality control analysis of a consecutive series of sTBI patients surgically treated with AC or DC alone between 2013 and 2018. A subgroup analysis, "primary procedure" and "secondary procedure", was also performed. We examined the impact of AC vs. DC on clinical outcome, including long-term (6 months) extended Glasgow outcome scale (GOS-E), the duration of postoperative ventilation, and intensive care unit (ICU) stay, mortality, Glasgow coma scale at discharge, and time to cranioplasty. We also evaluated and analyzed the impact of AC vs. DC on post-procedural intracranial pressure (ICP) and brain tissue oxygen (PbO2) values as well as the need for additional osmotherapy and CSF drainage. Results Forty patients were examined, 22 patients in the DC group, and 18 in the AC group. Compared with DC alone, AC was associated with significant shorter duration of mechanical ventilation and ICU stay, as well as better Glasgow coma scale at discharge. Mortality rate was similar. At 6-month, the proportion of patients with favorable outcome (GOS-E >= 5) was higher in patients with AC vs. DC [10/18 patients (61%) vs. 7/20 (35%)]. The outcome difference was particularly relevant when AC was performed as primary procedure (61.5% vs. 18.2%; p = 0.04). Patients in the AC group also had significant lower average post-surgical ICP values, higher PbO2 values and required less osmotic treatments as compared with those treated with DC alone. Conclusion Our preliminary single-center retrospective data indicate that AC may be beneficial for the management of severe TBI and is associated with better clinical outcome. These promising results need further confirmation by larger multicenter clinical studies. The potential benefits of cisternostomy should not encourage its universal implementation across trauma care centers by surgeons that do not have the expertise and instrumentation necessary for cisternal microsurgery. Training in skull base and vascular surgery techniques for trauma care surgeons would avoid the potential complications associated with this delicate procedure.	[Giammattei, Lorenzo; Starnoni, Daniele; Maduri, Rodolfo; Rocca, Alda; Cossu, Giulia; Simonin, Alexandre; Bloch, Jocelyne; Levivier, Marc; Messerer, Mahmoud; Daniel, Roy Thomas] Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Serv Neurosurg, Lausanne, Switzerland; [Bernini, Adriano; Abed-Maillard, Samia; Eckert, Philippe; Oddo, Mauro] Lausanne Univ Hosp CHUV, Dept Intens Care Med, Lausanne, Switzerland; [Eckert, Philippe; Bloch, Jocelyne; Levivier, Marc; Oddo, Mauro; Messerer, Mahmoud; Daniel, Roy Thomas] Univ Lausanne UniL, Lausanne, Switzerland		Daniel, RT (corresponding author), Lausanne Univ Hosp CHUV, Dept Clin Neurosci, Serv Neurosurg, Lausanne, Switzerland.	roy.daniel@chuv.ch	Abed-Maillard, Samia/AAI-1052-2021; Bernini, Adriano/AAR-7408-2020; Rodolfo MADURI, FEBNS/A-7297-2019; Messerer, Mahmoud/AAZ-3527-2020; Cossu, Giulia/ABF-6396-2020; Bloch, Jocelyne/A-9668-2017	Bernini, Adriano/0000-0003-0207-0064; Rodolfo MADURI, FEBNS/0000-0001-6649-5585; Bloch, Jocelyne/0000-0002-6405-1590			Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; Baucher G, 2019, WORLD NEUROSURG, V126, pE944, DOI 10.1016/j.wneu.2019.02.194; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Bruno A, 2017, J NEUROSCI METH, V280, P11, DOI 10.1016/j.jneumeth.2017.01.021; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian I, 2018, J NEUROSCI RES, V96, P744, DOI 10.1002/jnr.24145; Cherian Iype, 2016, Surg Neurol Int, V7, pS711; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di Cristofori A, 2018, WORLD NEUROSURG, V111, P427, DOI 10.1016/j.wneu.2017.11.139; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Giammattei L, 2018, WORLD NEUROSURG, V111, P428, DOI 10.1016/j.wneu.2017.12.049; Giammattei L, 2018, WORLD NEUROSURG, V109, P460, DOI 10.1016/j.wneu.2017.10.085; Goulay R, 2017, STROKE, V48, P2301, DOI 10.1161/STROKEAHA.117.017014; Honeybul S, 2017, J CLIN NEUROSCI, V43, P11, DOI 10.1016/j.jocn.2017.04.032; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jiang YZ, 2014, CELL BIOCHEM BIOPHYS, V69, P461, DOI 10.1007/s12013-014-9818-6; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2010, ANESTH ANALG, V111, P736, DOI 10.1213/ANE.0b013e3181e75cd1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Oreskovic D, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-16; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Phan K, 2017, WORLD NEUROSURG, V101, P677, DOI 10.1016/j.wneu.2017.03.024; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Plog BA, 2020, J NEUROSURG, V133, P210, DOI 10.3171/2019.2.JNS182675; Sauvigny T, 2018, J NEUROSURG, V128, P819, DOI 10.3171/2016.11.JNS162263; Shi L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00535; Smith M, 2015, INTENS CARE MED, V41, P123, DOI 10.1007/s00134-014-3548-5; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20	35	5	6	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAR	2020	162	3					469	479		10.1007/s00701-020-04222-y		FEB 2020	11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KQ5WX	WOS:000515775100002	32016585	Green Published, hybrid			2022-02-06	
J	Chang, CY; Liang, MZ; Wu, CC; Huang, PY; Chen, HI; Yet, SF; Tsai, JW; Kao, CF; Chen, LY				Chang, Chu-Yuan; Liang, Min-Zong; Wu, Ching-Chih; Huang, Pei-Yuan; Chen, Hong-, I; Yet, Shaw-Fang; Tsai, Jin-Wu; Kao, Cheng-Fu; Chen, Linyi			WNT3A Promotes Neuronal Regeneration upon Traumatic Brain Injury	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						neuronal regeneration; traumatic brain injury; WNT3A; cortical neurons	ASTROCYTE SCAR	The treatment of traumatic brain injury (TBI) remains a challenge due to limited knowledge about the mechanisms underlying neuronal regeneration. This current study compared the expression of WNT genes during regeneration of injured cortical neurons. Recombinant WNT3A showed positive effect in promoting neuronal regeneration via in vitro, ex vivo, and in vivo TBI models. Intranasal administration of WNT3A protein to TBI mice increased the number of NeuN(+) neurons without affecting GFAP(+) glial cells, compared to control mice, as well as retained motor function based on functional behavior analysis. Our findings demonstrated that WNT3A, 8A, 9B, and 10A promote regeneration of injured cortical neurons. Among these WNTs, WNT3A showed the most promising regenerative potential in vivo, ex vivo, and in vitro.	[Chang, Chu-Yuan; Liang, Min-Zong; Huang, Pei-Yuan; Chen, Hong-, I; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 30013, Taiwan; [Wu, Ching-Chih] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Yet, Shaw-Fang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan; [Tsai, Jin-Wu] Natl Yang Ming Univ, Inst Brain Sci, Taipei 11221, Taiwan; [Kao, Cheng-Fu] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11574, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan		Chen, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu 30013, Taiwan.; Kao, CF (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 11574, Taiwan.; Chen, LY (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 30013, Taiwan.	chyju13180@hotmail.com; liang4646@gmail.com; liz110645@gmail.com; shps982104@gmail.com; red81820@gmail.com; shawfang@icloud.com; tsaijw@ym.edu.tw; ckao@gate.sinica.edu.tw; lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020	Chen, Linyi/0000-0001-7258-8817; Wu, Ching-Chih/0000-0003-3826-4717; Tsai, Jin-Wu/0000-0003-0135-759X	National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX109-10813NI]; Ministry of Science and Technology [MOST 108-2320-B-007 005 -MY3]	This research was funded by National Health Research Institutes, Taiwan (Grant#NHRI-EX109-10813NI) and by Ministry of Science and Technology (Grant#: MOST 108-2320-B-007 005 -MY3).	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bayod S, 2015, NEUROBIOL AGING, V36, P720, DOI 10.1016/j.neurobiolaging.2014.09.017; Brusehafer K, 2014, TOXICOL SCI, V140, P94, DOI 10.1093/toxsci/kfu058; Chen CJ, 2015, J BIOL CHEM, V290, P6010, DOI 10.1074/jbc.M114.603795; Chen KW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030571; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; El-Amouri SS, 2013, MOL BIOTECHNOL, V53, P63, DOI 10.1007/s12033-012-9519-6; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060558; Marzo A, 2016, CURR BIOL, V26, P2551, DOI 10.1016/j.cub.2016.07.024; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ohtake Y, 2016, NEURAL REGEN RES, V11, P1050, DOI 10.4103/1673-5374.187022; Pandey PK, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2015.1129476; Pardridge WM, 2015, CLIN PHARMACOL THER, V97, P347, DOI 10.1002/cpt.18; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Shih CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079619; Wei ZZ, 2018, J CEREBR BLOOD F MET, V38, P404, DOI 10.1177/0271678X17702669; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yen TL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041100; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871; Zhang LS, 2016, J GENET GENOMICS, V43, P587, DOI 10.1016/j.jgg.2016.05.002; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	29	5	5	2	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB	2020	21	4							1463	10.3390/ijms21041463			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KY4FE	WOS:000522524400290	32098078	Green Published, gold			2022-02-06	
J	Cheng, H; Deaton, LM; Qiu, MH; Ha, S; Pacoma, R; Lao, JM; Tolley, V; Moran, R; Keeton, A; Lamb, JR; Fathman, J; Walker, JR; Schumacher, AM				Cheng, Hank; Deaton, Lisa M.; Qiu, Minhua; Ha, Sukwon; Pacoma, Reynand; Lao, Jianmin; Tolley, Valerie; Moran, Rita; Keeton, Amber; Lamb, John R.; Fathman, John; Walker, John R.; Schumacher, Andrew M.			Tau overexpression exacerbates neuropathology after repeated mild head impacts in male mice	NEUROBIOLOGY OF DISEASE			English	Article						Traumatic brain injury; Chronic traumatic encephalopathy; White matter; Tau; Neuroinflammation	TRAUMATIC BRAIN-INJURY; COUPLED RECEPTOR GPR17; WHITE-MATTER INJURY; T-CELLS; OLIGODENDROCYTE DIFFERENTIATION; OPTIC-NERVE; MICROGLIA; ENCEPHALOPATHY; MODEL; ACTIVATION	Repeated mild traumatic brain injury (rmTBI) can lead to development of chronic traumatic encephalopathy (CTE), which is characterized by progressive neurodegeneration with presence of white matter damage, gliosis and hyper-phosphorylated tau. While animal models of rmTBI have been documented, few characterize the molecular pathogenesis and expression profiles of relevant injured brain regions. Additionally, while the usage of transgenic tau mice in rmTBI is prevalent, the effects of tau on pathological outcomes has not been well studied. Here we characterized a 42-impact closed-head rmTBI paradigm on 3-4 month old male C57BL/6 (WT) and Tau-overexpressing mice (Tau58.4). This injury paradigm resulted in chronic gliosis, T-cell infiltration, and demyelination of the optic nerve and associated white matter tracts at 1-month post-injury. At 3-months postinjury, Tau58.4 mice showed progressive neuroinflammation and neurodegeneration in multiple brain regions compared to WT mice. Corresponding to histopathology, RNAseq of the optic nerve tract at 1-month post-injury showed significant upregulation of inflammatory pathways and downregulation of myelin synthetic pathways in both genotypes. However, Tau58.4 mice showed additional changes in neurite development, protein processing, and cell stress. Comparisons with published transcriptomes of human Alzheimer's Disease and CTE revealed common signatures including neuroinflammation and downregulation of protein phosphatases. We next investigated the demyelination and T-cell infiltration phenotypes to determine whether these offer potential avenues for therapeutic intervention. Tau58.4 mice were treated with the histamine H3 receptor antagonist GSK239512 for 1-month post-injury to promote remyelination of white matter lesions. This restored myelin gene expression to sham levels but failed to repair the histopathologic lesions. Likewise, injured T-cell-deficient Rag2/Il2rg (R2G2) mice also showed evidence for inflammation and loss of myelin. However, unlike immune-competent mice, R2G2 mice had altered myeloid cell gene expression and fewer demyelinated lesions. Together this data shows that rmTBI leads to chronic white matter inflammatory demyelination and axonal loss exacerbated by human tau overexpression but suggests that immune-suppression and remyelination alone are insufficient to reverse damage.	[Cheng, Hank; Deaton, Lisa M.; Qiu, Minhua; Ha, Sukwon; Pacoma, Reynand; Lao, Jianmin; Tolley, Valerie; Moran, Rita; Keeton, Amber; Lamb, John R.; Fathman, John; Walker, John R.; Schumacher, Andrew M.] Genom Inst Novartis Res Fdn, Dept Gen Med Biol, San Diego, CA 92121 USA		Schumacher, AM (corresponding author), Genom Inst Novartis Res Fdn, Dept Gen Med Biol, San Diego, CA 92121 USA.	hcheng@gnf.org; Ldeaton@gnf.org; Mqiu@gnf.org; Sha@gnf.org; Rpacoma@gnf.org; Jlao@gnf.org; Vtolley@gnf.org; Rmoran@gnf.org; Akeeton@gnf.org; Jfathman@gnf.org; Jwalker@gnf.org; aschumacher@gnf.org		Cheng, Hank/0000-0003-3793-0394	Novartis Institute for Biomedical Research; Genomics Institute for the Novartis Research Foundation's postdoctoral program	This work was funded by the Novartis Institute for Biomedical Research and The Genomics Institute for the Novartis Research Foundation's postdoctoral program.	Acabchuk R., 2016, CONCUSSION, V1, DOI [10.2217/cnc-2015-12, DOI 10.2217/CNC-2015-12]; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Alonso-Escalante J.C., 2017, ACAD SURG C, V3, P6; ALOSCO M, 2017, ALZHEIMERS DEMENT, V10, P56, DOI DOI 10.1016/J.DADM.2017.10.003; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Armstrong RA, 2017, OPTOMETRY VISION SCI, V94, P33, DOI 10.1097/OPX.0000000000000911; Bai RJ, 2017, NEUROCHEM RES, V42, P2892, DOI 10.1007/s11064-017-2310-0; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Braithwaite SP, 2012, PROG MOL BIOL TRANSL, V106, P343, DOI 10.1016/B978-0-12-396456-4.00012-2; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Chen YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189380; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Delay-Goyet Philippe, 2016, Alzheimers Dement (N Y), V2, P267, DOI 10.1016/j.trci.2016.10.002; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Galgano M., 2015, J NEUROL NEUROBIOL, V2, P117, DOI [10. 16966/2379-7150.117, DOI 10.16966/2379-7150.117, 10.16966/2379-7150.117]; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gold EM, 2018, ASN NEURO, V10, DOI 10.1177/1759091418781921; Hellstrom T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13628-1; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Hirschberg DL, 1998, J NEUROIMMUNOL, V89, P88, DOI 10.1016/S0165-5728(98)00118-0; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Huber B.R., 2018, SOC NEUR 2018 M, V565, P10; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kopper TJ, 2018, J NEUROSCI RES, V96, P969, DOI 10.1002/jnr.24114; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meeker RB, 2012, CELL ADHES MIGR, V6, P390, DOI 10.4161/cam.21054; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Qu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067094; Saher G, 2015, BBA-MOL CELL BIOL L, V1851, P1083, DOI 10.1016/j.bbalip.2015.02.010; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Schetters STT, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01905; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Schwartzbach CJ, 2017, J NEUROL, V264, P304, DOI 10.1007/s00415-016-8341-7; Schwerk C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/307231; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Simon K, 2016, J BIOL CHEM, V291, P705, DOI 10.1074/jbc.M115.683953; Smith BM, 2017, NEUROSCIENCE, V358, P49, DOI 10.1016/j.neuroscience.2017.06.006; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; van Eersel J, 2015, NEUROPATH APPL NEURO, V41, P906, DOI 10.1111/nan.12233; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xu LY, 2015, NEURAL REGEN RES, V10, P1731, DOI 10.4103/1673-5374.165319; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Yin ZR, 2017, J ALZHEIMERS DIS, V60, pS41, DOI 10.3233/JAD-161206; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; ZHANG WH, 2016, EXP NEUROL, V7, DOI DOI 10.1016/J.EXPNEURO1.2014.11.004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; ZISMAN E, 1993, CYTOKINE, V5, P309, DOI 10.1016/1043-4666(93)90062-A; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	95	5	5	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	FEB	2020	134								104683	10.1016/j.nbd.2019.104683			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KG3BV	WOS:000509818400050	31765727	hybrid			2022-02-06	
J	Howell, DR; Brilliant, AN; Oldham, JR; Berkstresser, B; Wang, F; Meehan, WP				Howell, David R.; Brilliant, Anna N.; Oldham, Jessie R.; Berkstresser, Brant; Wang, Francis; Meehan, William P., III			Exercise in the first week following concussion among collegiate athletes: Preliminary findings	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Mild traumatic brain injury; Exercise; Treatment; Postural balance	DUAL-TASK GAIT; MANAGEMENT; SPORT; ASSOCIATION; ATTENTION; SYMPTOMS; UTILITY; FALLS	Objectives: Our purpose was to examine the association between exercise after concussion with symptom severity, postural control, and time to symptom-resolution. Design: Longitudinal cohort. Methods: Collegiate athletes (n=72; age=20.2 +/- 1.3 years; 46% female) with concussion completed a symptom questionnaire at initial (0.6 +/- 0.8 days post-injury) and follow-up (2.9 +/- 1.4 days post-injury) evaluations, and a postural control assessment at follow-up. Participants were grouped into those who exercised in between the time of injury and the follow-up evaluation and those who did not. Decisions regarding post-concussion exercise were made by a sports medicine team consisting of a single team physician and athletic trainers. Results: Thirteen athletes were not included in the current study, resulting in an 85% response rate. Thirteen of the athletes who completed the study exercised between evaluations (18%). There was no symptom resolution time difference between groups (median =13 [IQR= 7-18] days vs. 13 [7-23] days; p = 0.83). Symptom ratings were similar between groups at the acute post-injury assessment (median PCSS = 18.5 [7.5-26] vs. 17 [14-40]; p= 0.21), but a main effect of group after adjusting for time from injury to assessment indicated the exercise group reported lower symptom severity than the no exercise group across both assessments (p= 0.044). The dual-task gait speed of the exercise group was higher than the no exercise group (0.90 +/- 0.15 vs. 0.78 +/- 0.16 m/s; p= 0.02). Conclusions: Athletes who were recommended aerobic exercise after concussion did not have worse outcomes than those who were not. Exercise within the first week after concussion does not appear to be associated with detrimental clinical outcomes. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA; [Howell, David R.; Brilliant, Anna N.; Oldham, Jessie R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Brilliant, Anna N.; Oldham, Jessie R.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Berkstresser, Brant; Wang, Francis] Harvard Univ Hlth Serv, Cambridge, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat & Orthopaed, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA.; Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.	David.Howell@CUAnschutz.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS100952, R03HD094560]; Eastern Athletic Trainers Association, Inc.	This study was funded by research grants from the National Institutes of Health (R01NS100952 and R03HD094560) and the Eastern Athletic Trainers Association, Inc.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; McCrory P, 1997, PHYSICIAN SPORTSMED, V25, P33, DOI 10.3810/psm.1997.02.1133; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mirelman A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-85; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneiders AG, 2008, BRIT J SPORT MED, V42, P1011, DOI 10.1136/bjsm.2007.041665; Sorond FA, 2010, NEUROLOGY, V74, P1627, DOI 10.1212/WNL.0b013e3181df0982; Springer S, 2006, MOVEMENT DISORD, V21, P950, DOI 10.1002/mds.20848; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	32	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2020	23	2					112	117		10.1016/j.jsams.2019.08.294			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	KN9VT	WOS:000515196100003	31522997	Green Accepted			2022-02-06	
J	Lele, AV; Alunpipatthanachai, B; Qiu, Q; Clark-Bell, C; Watanitanon, A; Moore, A; Chesnut, RM; Armstead, W; Vavilala, MS				Lele, Abhijit V.; Alunpipatthanachai, Bhunyawee; Qiu, Qian; Clark-Bell, Crystalyn; Watanitanon, Arraya; Moore, Anne; Chesnut, Randall M.; Armstead, William; Vavilala, Monica S.			Plasma Levels, Temporal Trends and Clinical Associations between Biomarkers of Inflammation and Vascular Homeostasis after Pediatric Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Angiopoietin-2; Endocan-1; Endothelin-1; Interleukin-6; Children; Traumatic brain injury; Endothelium	NEURON-SPECIFIC ENOLASE; ANGIOPOIETIN LEVELS; BINDING PROTEIN; INTERLEUKIN-6; CHILDREN; BREVISCAPINE; SEVERITY; SURGERY	Expression of inflammatory (interleukin-6 [IL-6]) and vascular homeostatic (angiopoietin-2 [AP-2], endothelin-1 [ET-1], endocan-2 [EC-2]) biomarkers in pediatric traumatic brain injury (TBI) was examined in this prospective, observational cohort study of 28 children hospitalized with mild, moderate, and severe TBI by clinical measures (age, sex, Glasgow Coma Scale score [GCS], Injury Severity Score [ISS], and cerebral autoregulation status). Biomarker patterns suggest an inverse relationship between GCS and AP-2, GCS and IL-6, ISS and ET-1, but a direct relationship between GCS and ET-1 and ISS and AP-2. Biomarker patterns suggest an inverse relationship between AP-2 and ET-1, AP-2 and EC-2, but a direct relationship between AP-2 and IL-6, IL-6 and EC-2, and IL-6 and ET-1. Plasma concentrations of inflammatory and vascular homeostatic biomarkers suggest a role for inflammation and disruption of vascular homeostasis during the first 10 days across the severity spectrum of pediatric TBI. Although not statistically significant, without impact on cerebral autoregulation, biomarker patterns suggest a relationship between inflammation and alterations in vascular homeostasis. The large variation in biomarker levels within TBI severity and age groups, and by sex suggests other contributory factors to biomarker expression.	[Lele, Abhijit V.; Qiu, Qian; Vavilala, Monica S.] Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA USA; [Lele, Abhijit V.; Alunpipatthanachai, Bhunyawee; Clark-Bell, Crystalyn; Watanitanon, Arraya; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Moore, Anne; Chesnut, Randall M.] Harborview Med Ctr, Dept Neurol Surg & Orthoped, Seattle, WA USA; [Armstead, William] Univ Penn, Dept Anethesiol & Crit Care, Philadelphia, PA 19104 USA		Lele, AV (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA.	abhijit2@uw.edu			National Institutes of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke (R21NS095321-02: Vavilala).	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Armstead WM, 2012, J NEUROTRAUM, V29, P1483, DOI 10.1089/neu.2011.2248; Bakr AM, 2002, J PEDIATR GASTR NUTR, V35, P149, DOI 10.1097/00005176-200208000-00009; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Chang XW, 2015, INT J CLIN EXP PATHO, V8, P14733; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; El-Gamal Y, 2002, ANN ALLERG ASTHMA IM, V88, P370, DOI 10.1016/S1081-1206(10)62366-6; Fujimura M, 2017, CEREBROVASC DIS, V44, P59, DOI 10.1159/000475824; Giuliano JS, 2007, SHOCK, V28, P650, DOI 10.1097/shk.0b013e318123867b; Giuliano JS, 2014, PEDIATR CRIT CARE ME, V15, pE1, DOI 10.1097/PCC.0b013e3182a553bb; Gozal D, 2017, OBESITY, V25, P1083, DOI 10.1002/oby.21859; Gu M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2075463; Hentschke MR, 2015, CYTOKINE, V74, P152, DOI 10.1016/j.cyto.2015.04.013; Hung VKL, 2015, J CEREBR BLOOD F MET, V35, P1687, DOI 10.1038/jcbfm.2015.109; Huseynova SA, 2017, J PAK MED ASSOC, V67, P1857; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Kageyama K, 2007, PEDIATR ANESTH, V17, P1071, DOI 10.1111/j.1460-9592.2007.02296.x; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lele AV, 2018, PEDIAT CRITICAL CARE; Liu XW, 2018, J CRIT CARE, V45, P14, DOI 10.1016/j.jcrc.2018.01.010; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Millipore Sigma, 2018, MILL MAP HUM CARD DI; Millipore Sigma, 2018, MILL MAP HUM ANG GRO; OZAWA T, 1991, JPN CIRC J, V55, P1158, DOI 10.1253/jcj.55.1158; Park SH, 2018, WORLD NEUROSURG, V118, pE534, DOI 10.1016/j.wneu.2018.06.234; Rong WL, 2016, AM J THER, P1075; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; SCHONMANN SM, 1986, INT J CANCER, V37, P255, DOI 10.1002/ijc.2910370214; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Sigma M, 2018, MILL MAP HUM CYT CHE; Spray S, 2017, ACTA PHYSIOL, V220, P417, DOI 10.1111/apha.12834; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; StataCorp, 2017, STAT IC; VANENGELEN BGM, 1992, CLIN CHEM, V38, P813; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; Zan LK, 2011, NEUROCHEM INT, V58, P872, DOI 10.1016/j.neuint.2011.02.014	44	5	6	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.	FEB	2020	41	3-4					177	192		10.1159/000502276			16	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	KS8YA	WOS:000518593300003	31553988	Green Accepted, Bronze			2022-02-06	
J	Li, YZ; Glotfelty, EJ; Namdar, I; Tweedie, D; Olson, L; Hoffer, BJ; DiMarchi, RD; Pick, CG; Greig, NH				Li, Yazhou; Glotfelty, Elliot J.; Namdar, Inbar; Tweedie, David; Olson, Lars; Hoffer, Barry J.; DiMarchi, Richard D.; Pick, Chagi G.; Greig, Nigel H.			Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Triagonist; Mild traumatic brain injury; Incretin; Incretin mimetic; Glucagon-like peptide-1 (GLP-1); Glucose-dependent insulinotropic polypeptide (GIP); Glucagon (Gcg); Exendin-4; Neurotrophic; Neuroprotective	GLUCAGON-LIKE PEPTIDE-1; COGNITIVE DEFICITS; MOUSE MODEL; AGONIST RG7697; GLP-1; EXENDIN-4; OBESITY; PHARMACOKINETICS; PHARMACODYNAMICS; EPIDEMIOLOGY	A synthetic monomeric peptide triple receptor agonist, termed "Triagonist" that incorporates glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP) and glucagon (Gcg) actions, was previously developed to improve upon metabolic and glucose regulatory benefits of single and dual receptor agonists in rodent models of diet-induced obesity and type 2 diabetes. In the current study, the neurotrophic and neuroprotective actions of this Triagonist were probed in cellular and mouse models of mild traumatic brain injury (mTBI), a prevalent cause of neurodegeneration in both the young and elderly. Triagonist dose- and time-dependently elevated cyclic AMP levels in cultured human SH-SY5Y neuronal cells, and induced neurotrophic and neuroprotective actions, mitigating oxidative stress and glutamate excitotoxicity. These actions were inhibited only by the co-administration of antagonists for all three receptor types, indicating the balanced co-involvement of GLP-1, GIP and Gcg receptors. To evaluate physiological relevance, a clinically translatable dose of Triagonist was administered subcutaneously, once daily for 7 days, to mice following a 30 g weight drop close head injury. Triagonist fully mitigated mTBI-induced visual and spatial memory deficits, evaluated at 7 and 30 days post injury. These results establish Triagonist as a novel neurotrophic/protective agent worthy of further evaluation as a TBI treatment strategy.	[Li, Yazhou; Glotfelty, Elliot J.; Tweedie, David; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Glotfelty, Elliot J.; Olson, Lars] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Namdar, Inbar; Pick, Chagi G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Hoffer, Barry J.] Case Western Reserve Univ, Dept Neurosurg, Sch Med, Cleveland, OH 44106 USA; [DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA		Li, YZ; Greig, NH (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	liyaz@mail.nih.gov; Greign@Grc.nia.nih.gov		Glotfelty, Elliot/0000-0001-5125-8720	National Institute on Aging, National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R56AG057028]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [K2012-62X-03185-42-4]; Swedish Brain Foundation; Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Disease at Tel-Aviv University	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA, (ii) NIH grant R56AG057028, (iii) the Swedish Research Council K2012-62X-03185-42-4, (iv) the Swedish Brain Foundation, (v) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (vi) the Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Disease at Tel-Aviv University.	Abu Fanne R, 2011, AM J PHYSIOL-REG I, V301, pR668, DOI 10.1152/ajpregu.00058.2011; Aggleton JP, 1997, BRAIN RES BULL, V43, P279, DOI 10.1016/S0361-9230(97)00007-5; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Athauda D, 2018, J PARKINSON DIS, V8, P247, DOI 10.3233/JPD-181329; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295; Bader M, 2019, NEUROBIOL DIS, V124, P439, DOI 10.1016/j.nbd.2018.11.023; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Brown CVR, 2006, J TRAUMA, V61, P572, DOI 10.1097/01.ta.0000200842.19740.38; Buhren BA, 2009, J NEUROSCI RES, V87, P1858, DOI 10.1002/jnr.22001; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P591, DOI 10.1080/10408440802026307; Capozzi ME, 2018, ENDOCR REV, V39, P719, DOI 10.1210/er.2018-00117; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chabok SY, 2014, EUR J TRAUMA EMERG S, V40, P51, DOI 10.1007/s00068-013-0314-2; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Darsalia V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103114; de Graaf C, 2016, PHARMACOL REV, V68, P954, DOI 10.1124/pr.115.011395; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Dreer LE, 2018, J HEAD TRAUMA REHAB, V33, P246, DOI 10.1097/HTR.0000000000000408; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; El-Menyar Ayman, 2016, J Emerg Trauma Shock, V9, P64, DOI 10.4103/0974-2700.179461; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Feng P, 2018, NEUROPHARMACOLOGY, V133, P385, DOI 10.1016/j.neuropharm.2018.02.012; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Frias JP, 2017, CELL METAB, V26, P343, DOI 10.1016/j.cmet.2017.07.011; Gardner RC, 2017, NEUROLOGY, V88; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gejl M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00108; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; Glotfelty EJ, 2019, ACS PHARMACOL TRANSL, V2, P66, DOI 10.1021/acsptsci.9b00003; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Hamilton A, 2009, NEUROREPORT, V20, P1161, DOI 10.1097/WNR.0b013e32832fbf14; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; HOOSEIN NM, 1984, P NATL ACAD SCI-BIOL, V81, P4368, DOI 10.1073/pnas.81.14.4368; Jakaria M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00307; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Li M, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030059; Li T, 2018, HIPPOCAMPUS, V28, P358, DOI 10.1002/hipo.22837; Li YZ, 2017, EXP NEUROL, V288, P104, DOI 10.1016/j.expneurol.2016.11.010; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Mangmool S, 2015, MOL ENDOCRINOL, V29, P583, DOI 10.1210/me.2014-1346; Mao Juan-Juan, 2017, Shengli Xuebao, V69, P135, DOI 10.13294/j.aps.2017.0005; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mroz PA, 2019, MOL METAB, V20, P51, DOI 10.1016/j.molmet.2018.12.001; Muller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2002, J PHARMACOL EXP THER, V300, P958, DOI 10.1124/jpet.300.3.958; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Portron A, 2017, DIABETES OBES METAB, V19, P1446, DOI 10.1111/dom.13025; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Reiner DJ, 2016, J NEUROSCI, V36, P3531, DOI 10.1523/JNEUROSCI.3579-15.2016; Rusnak M, 2013, NAT REV NEUROL, V9, P186, DOI 10.1038/nrneurol.2013.38; Samadani U, 2016, AANS NEUROSURGEON, V25; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Schmitt C, 2017, DIABETES OBES METAB, V19, P1436, DOI 10.1111/dom.13024; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Sherman M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0641-4; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tai JJ, 2018, BRAIN RES, V1678, P64, DOI 10.1016/j.brainres.2017.10.012; Tamargo IA, 2017, EXP NEUROL, V288, P176, DOI 10.1016/j.expneurol.2016.11.005; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tengholm A, 2017, DIABETES OBES METAB, V19, P42, DOI 10.1111/dom.12993; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; U.S. Food and Drug Administration, 2018, TRAUM BRAIN INJ FDA; Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200; Yang JL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091861; Yu YW, 2016, J NEUROTRAUM, V33, P2044, DOI 10.1089/neu.2015.4229; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zhou ZW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030779	83	5	5	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2020	324								113113	10.1016/j.expneurol.2019.113113			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KF7MN	WOS:000509423400002	31730763				2022-02-06	
J	Makinde, HM; Just, TB; Gadhvi, GT; Winter, DR; Schwulst, SJ				Makinde, Hadijat M.; Just, Talia B.; Gadhvi, Gaurav T.; Winter, Deborah R.; Schwulst, Steven J.			Microglia Adopt Longitudinal Transcriptional Changes After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						TBI; Microglia; FACS; RNA Sequencing	ALZHEIMERS-DISEASE; MYELOID CELLS; ACTIVATION; ETIOLOGY; MODEL; MILD	Background: Traumatic brain injury (TBI) is an under-recognized public health threat. Even mild brain injuries can lead to long-term neurologic impairment. Microglia play a fundamental role in the development and progression of this ensuing neurologic impairment. Despite this, a microglia-specific injury signature has yet to be identified. We hypothesized that TBI would lead to long-term changes in the transcriptional profile of microglial pathways associated with the development of subsequent neurologic impairment. Materials and methods: Male C57BL/6 mice underwent TBI via a controlled cortical impact and were followed longitudinally. FACSorted microglia from TBI mice were subjected to Quantiseq 3'-biased RNA sequencing at 7, 30, and 90 d after TBI. K-means clustering on 396 differentially expressed genes was performed, and gene ontology enrichment analysis was used to determine corresponding enriched processes. Results: Differentially expressed genes in microglia exhibited four main patterns of expression over the course of TBI. In particular, we identified four gene clusters which corresponded to the host defense response, synaptic plasticity, lipid remodeling, and membrane polarization. Conclusions: Transcriptional profiling within individual populations of microglia after TBI remains a critical unmet research need within the field of TBI. This focused study identified several physiologic processes within microglia that may be associated with development of long-termneurologic impairment after TBI. These data demonstrate the capability of longitudinal transcriptional profiling to uncover potential cell-specific targets for the treatment of TBI. (C) 2019 Elsevier Inc. All rights reserved.	[Makinde, Hadijat M.; Just, Talia B.; Schwulst, Steven J.] Northwestern Univ, Dept Surg, Div Trauma & Crit Care, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA; [Gadhvi, Gaurav T.; Winter, Deborah R.] Northwestern Univ, Dept Med, Div Rheumatol, Chicago, IL 60611 USA		Schwulst, SJ (corresponding author), Northwestern Univ, Dept Surg, Div Trauma & Crit Care, 676 N St Clair St,Suite 650, Chicago, IL 60611 USA.	sschwuls@nmh.org	Winter, Deborah R./AAQ-9253-2020	Winter, Deborah R./0000-0003-1806-673X; Makinde, Hadijat-Kubura/0000-0001-8492-4187; Just, Talia/0000-0002-6372-7974	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM117341]; American College of Surgeons C. James Carrico Research Fellowship	This study was supported by NIH grant GM117341 and The American College of Surgeons C. James Carrico Research Fellowship to S.J.S.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Braithwaite SP, 2006, EUR J NEUROSCI, V23, P2847, DOI 10.1111/j.1460-9568.2006.04837.x; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Faul M, 2010, TRAUMATIC BRAIN INJU; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goebel-Goody SM, 2012, GENES BRAIN BEHAV, V11, P586, DOI 10.1111/j.1601-183X.2012.00781.x; Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Makinde HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202722; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mike EV, 2019, J AUTOIMMUN, V96, P59, DOI 10.1016/j.jaut.2018.08.005; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Noristani HN, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00090; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Silva AJ, 2003, J NEUROBIOL, V54, P224, DOI 10.1002/neu.10169; Tian M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36684; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107	52	5	5	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2020	246						113	122		10.1016/j.jss.2019.08.024			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JW1BS	WOS:000502794400015	31563831	Green Accepted			2022-02-06	
J	Misch, MR; Raukar, NP				Misch, Michael Robert; Raukar, Neha P.			Sports Medicine Update Concussion	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Concussion; Mild traumatic brain injury; Return to play; Head injury; Persistent postconcussion symptoms	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; HEAD-IMPACT EXPOSURE; EMERGENCY-DEPARTMENT; RECURRENT CONCUSSION; EARLY INTERVENTION; SEX-DIFFERENCES; COGNITIVE REST; ACTIVITY LEVEL; CDC HEADS	A systematic approach is required for patients with a suspected concussion. Although standardized tools can aid in assessment, the diagnosis of concussion remains a clinical one. At the time of diagnosis, patients should be given both verbal and written review of the common symptoms of concussion, expected course of recovery, as well as strategies to manage symptoms. Most patients benefit from a brief period of rest, followed by a gradual reintroduction of activities, and a graduated return-to-sport protocol. Patients with prolonged recovery from a concussion may benefit from exercise, vestibular, and cognitive rehabilitation programs.	[Misch, Michael Robert] Univ Toronto, Div Emergency Med, Dept Family & Community Med, Toronto, ON, Canada; [Raukar, Neha P.] Mayo Clin, Dept Emergency Med, 200 First St, Rochester, MN 55905 USA		Misch, MR (corresponding author), North York Gen Hosp, 1NW-126,4001 Leslie St, N York, ON M2K 1E1, Canada.	Michael.r.misch@gmail.com					Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; CPSC, PUBL PLAYGR SAF HDB; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Dick RW, 2009, BRIT J SPORT MED, V43, P146; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Eliyahu L, 2016, ACAD EMERG MED, V23, P531, DOI 10.1111/acem.12924; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Granito V.J., 2002, J SPORT BEHAV, V25, P243; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2017, BRIT J SPORT MED, V51, P147, DOI 10.1136/bjsports-2016-096674; Hedlund J, 2000, Inj Prev, V6, P82, DOI 10.1136/ip.6.2.82; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Irvine A, 2017, CAN FAM PHYSICIAN, V63, P859; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; King A. I., 2003, IRCOBI C LISB PORT; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lumbabrown A, 2018, JAMA PEDIAT, V172; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2017, BRIT J SPORT MED, V51, P1557, DOI 10.1136/bjsports-2017-098065; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Safinia Cyrus, 2016, J Vasc Interv Neurol, V9, P34; Satarasinghe P, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069518824125; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; SCHNEIDER K, 1988, INT J SPORT BIOMECH, V4, P358, DOI 10.1123/ijsb.4.4.358; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Varner CE, 2017, ACAD EMERG MED, V24, P75, DOI 10.1111/acem.13073; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	92	5	5	0	36	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	FEB	2020	38	1					207	+		10.1016/j.emc.2019.09.010			17	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JY4DB	WOS:000504366200013	31757251				2022-02-06	
J	Rietdijk, R; Power, E; Attard, M; Heard, R; Togher, L				Rietdijk, Rachael; Power, Emma; Attard, Michelle; Heard, Robert; Togher, Leanne			Improved Conversation Outcomes After Social Communication Skills Training for People With Traumatic Brain Injury and Their Communication Partners: A Clinical Trial Investigating In-Person and Telehealth Delivery	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							FAMILY CAREGIVERS; ADULTS; INDIVIDUALS; SUPPORT; INTERVENTIONS; PERSPECTIVES; INFORMATION; MANAGEMENT; COGNITION	Purpose: The aim of the study was to investigate the effectiveness of social communication skills training (TBlconneCT) for people with traumatic brain injury (TBI) and their communication partners, delivered in-person or via telehealth, on quality of conversations. Method: This study is a clinical trial, including an in-person intervention group (n = 17), a telehealth intervention group (n = 19), and a historical control group (n = 15). Participants were adults at least 6 months post moderate-to-severe TBI with social communication skills deficits and their usual communication partners. Participants completed a casual and purposeful conversation task at pre-intervention, postintervention, and a follow-up assessment. A blinded assessor evaluated conversations using the Adapted Measure of Participation in Conversation and the Adapted Measure of Support in Conversation. Treatment effects were examined by comparing groups on change in ratings between pre- and posttraining. Maintenance of effects was examined using change between posttraining and follow-up assessment. The trial protocol was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12615001024538). Results: Trained participants with TBI had significant improvements in participation in casual conversation compared to controls. Trained communication partners also had significant improvements compared to controls on ratings of support in casual conversations. However, treatment effects were not maintained at follow-up for two of eight measures. Comparisons between outcomes of in-person and telehealth groups found negligible to small effect sizes for six of eight measures. Conclusions: The findings reinforce previous studies demonstrating the efficacy of communication partner training after TBI. Telehealth delivery produced similar outcomes to in-person delivery.	[Rietdijk, Rachael; Power, Emma; Attard, Michelle; Heard, Robert; Togher, Leanne] Univ Sydney, Sydney Sch Hlth Sci, Sydney, NSW, Australia; [Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia		Rietdijk, R (corresponding author), Univ Sydney, Sydney Sch Hlth Sci, Sydney, NSW, Australia.	rachael.rietdijk@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406	icare NSW; Australian Postgraduate AwardAustralian Government	This research was supported by a grant from icare NSW and an Australian Postgraduate Award. We wish to thank our research participants for their time and involvement with this study. We would also like to thank the following brain injury services and private speech pathologists in New South Wales that assisted with participant recruitment: Hunter Brain Injury Service, Liverpool Brain Injury Rehabilitation Unit, Mid North Coast Brain Injury Rehabilitation Service, Mid Western Brain Injury Rehabilitation Program, New England Brain Injury Rehabilitation Service, Royal Rehabilitation Centre NSW, Westmead Brain Injury Unit, and Beth Causa. We would like to thank speech pathologists Petra Avramovic, Melissa Brunner, Elise Elbourn, Catherine Mason, and Sarah Tran for their assistance with data collection.	Avramovic P, 2017, BRAIN INJURY, V31, P502, DOI 10.1080/02699052.2017.1280854; Behn N, 2019, INT J LANG COMM DIS, V54, P465, DOI 10.1111/1460-6984.12452; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Cassel A, 2019, NEUROPSYCHOL REHABIL, V29, P22, DOI 10.1080/09602011.2016.1257435; Chang H, 2018, STROKE, V49; Chang HF, 2018, INT J LANG COMM DIS, V53, P1094, DOI 10.1111/1460-6984.12421; Chia AA, 2019, BRAIN INJURY, V33, P690, DOI 10.1080/02699052.2019.1571632; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Damianakis T, 2016, J HEAD TRAUMA REHAB, V31, pE12, DOI 10.1097/HTR.0000000000000178; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; Finch E, 2016, ARCH PHYS MED REHAB, V97, P1352, DOI [10.1016/j.apmr.2015.11.005, 10.1016/j.apmr.20.15.11.005]; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Harrison-Felix C, 2018, ARCH PHYS MED REHAB, V99, P2131, DOI 10.1016/j.apmr.2018.05.030; Hart T, 2018, BRAIN INJURY, V32, P1295, DOI 10.1080/02699052.2018.1493226; Hines M, 2015, J TELEMED TELECARE, V21, P469, DOI 10.1177/1357633X15604555; Hoepner JK, 2018, CLIN ARCH COMMUN DIS, V3, P22, DOI [10.21849/cacd.2018.00262, DOI 10.21849/CACD.2018.00262]; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Honan CA, 2019, NEUROPSYCHOL REHABIL, V29, P896, DOI 10.1080/09602011.2017.1339616; Horton S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011207; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 2018, SET OBSERVATIONAL ME; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Keegan LC, 2020, NEUROPSYCHOL REHABIL, V30, P1497, DOI 10.1080/09602011.2019.1591464; Kratochwill TR, 2013, REM SPEC EDUC, V34, P26, DOI 10.1177/0741932512452794; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacDonald S., 2005, FUNCTIONAL ASSESSMEN; MacDonald S, 2017, BRAIN INJURY, V31, P1760, DOI 10.1080/02699052.2017.1379613; Meulenbroek P, 2019, INT J SPEECH-LANG PA, V21, P128, DOI 10.1080/17549507.2019.1583281; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; Neumann D. M., 2019, TXB TRAUMATIC BRAIN, V3rd, P281; O'Rourke A, 2018, INT J LANG COMM DIS, V53, P1150, DOI 10.1111/1460-6984.12428; Ontario Neurotrauma Foundation, 2016, CLIN PRACT GUID REH; Ownsworth T, 2018, J HEAD TRAUMA REHAB, V33, pE33, DOI 10.1097/HTR.0000000000000350; Pearce B, 2016, BRAIN INJURY, V30, P1708, DOI 10.1080/02699052.2016.1202450; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; Rietdijk R., 2019, TBICONNECT CLIN MANU; Rietdijk R, 2020, BRAIN IMPAIR, V21, P110, DOI 10.1017/BrImp.2019.9; Rietdijk R, 2020, J HEAD TRAUMA REHAB, V35, P241, DOI 10.1097/HTR.0000000000000554; Rietdijk R, 2020, NEUROPSYCHOL REHABIL, V30, P1074, DOI 10.1080/09602011.2018.1554533; Rietdijk R, 2019, BRAIN INJURY, V33, P94, DOI 10.1080/02699052.2018.1531313; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Sealed Envelope Ltd, 2012, POW CALC CONT OUTC S; Sohlberg MM, 2019, INT J SPEECH-LANG PA, V21, P115, DOI 10.1080/17549507.2019.1583280; Steel J, 2019, BRAIN INJURY, V33, P48, DOI 10.1080/02699052.2018.1531304; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L., 2010, TBI EXPRESS SOCIAL C; Togher L, 2016, NEUROREHABILITATION, V38, P243, DOI 10.3233/NRE-151316; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2012, DISABIL REHABIL, V34, P1562, DOI 10.3109/09638288.2012.656788; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Togher L, 2009, BRAIN IMPAIR, V10, P188, DOI 10.1375/brim.10.2.188; Tran S, 2018, BRAIN INJURY, V32, P1700, DOI 10.1080/02699052.2018.1537006; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Welkowitz J., 1976, INTRO STAT BEHAV SCI; Wiltshire GE, 2014, J SOC INCL, V5, P9, DOI 10.36251/josi.73; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	70	5	5	1	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	FEB	2020	63	2					615	632		10.1044/2019_JSLHR-19-00076			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	ND2WB	WOS:000561764300020	32078409				2022-02-06	
J	Carabias, CS; Gomez, PA; Panero, I; Eiriz, C; Castano-Leon, AM; Egea, J; Lagares, A				Sanchez Carabias, Cristina; Gomez, Pedro A.; Panero, Irene; Eiriz, Carla; Maria Castano-Leon, Ana; Egea, Javier; Lagares, Alfonso		I 12 Neurotraumatology Grp Collabo	Chitinase-3-Like Protein 1, Serum Amyloid A1, C-Reactive Protein, and Procalcitonin Are Promising Biomarkers for Intracranial Severity Assessment of Traumatic Brain Injury: Relationship with Glasgow Coma Scale and Computed Tomography Volumetry	WORLD NEUROSURGERY			English	Article						Biomarkers; CT volumetry; Glasgow Coma Scale; Intracranial hemorrhage; Traumatic brain injury	FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; INTRACEREBRAL HEMORRHAGE; NEUROBIOCHEMICAL MARKERS; PROGNOSTIC VALUE; SUBARACHNOID HEMORRHAGE; CEREBRAL-ISCHEMIA; DIAGNOSTIC MARKER; TEMPORAL PROFILE; PLASMA-LEVELS	OBJECTIVE: The volume and location of intracranial hematomas are well-known prognostic factors for traumatic brain injury. The aim of this study was to determine the relationship of serum biomarkers sloop, glial fibrillary acidic protein, neuron-specific enolase, total tau, phosphorylated neurofilament heavy chain, serum amyloid A1 (SAA1), C-reactive protein, procalcitonin (PCT), and chitinase-3-like protein 1 (YKL-40) with traumatic brain injury severity and the amount and location of hemorrhagic traumatic lesions. METHODS: A prospective observational cohort of 115 patients with a Glasgow Coma Scale (GCS) score of 3-15 were evaluated. Intracranial lesion volume was measured from the semiautomatic segmentation of hematoma on computed tomography using Analyze software. The establishment of possible biomarker cutoff points for intracranial lesion detection was estimated using the Youden Index (J) obtained from the area under the receiver operating characteristic curve. RESULTS: SAA1, YKL-40, PCT, and S100 beta showed the most robust association with level of consciousness, both with total GCS and motor score. Biomarkers significantly correlated with volumetric measurements of subdural hematoma, traumatic subarachnoid hemorrhage, intraparenchymal hemorrhage, intraventricular hemorrhage, and total amount of bleeding. The type of intracranial hemorrhage was associated with various release patterns of neurobiochemical markers. CONCLUSIONS: YKL-40, SAA1, C-reactive protein, and PCT combined with S100 beta were the most promising biomarkers to determine the presence, location, and extent of traumatic intracranial lesions. Combination of biomarkers further increased the discriminatory capacity for the detection of intracranial bleeding.	[Sanchez Carabias, Cristina; Lagares, Alfonso] Hosp 12 Octubre I 12, Inst Invest, Neurotraumatol & Subarachnoid Hemorrhage Res Unit, Madrid, Spain; [Gomez, Pedro A.; Panero, Irene; Eiriz, Carla; Maria Castano-Leon, Ana; Lagares, Alfonso] Hosp Univ 12 Octubre, Dept Neurosurg, Madrid, Spain; [Gomez, Pedro A.; Panero, Irene; Eiriz, Carla; Maria Castano-Leon, Ana; Lagares, Alfonso] Univ Complutense Madrid, Fac Med, Dept Surg, Madrid, Spain; [Egea, Javier] Univ La Princesa, Inst Invest Sanitaria Hosp, Mol Neuroinflammat & Neuronal Plastic Res Lab, Hosp Univ Santa Cristina,Res Unit, Madrid, Spain; [I 12 Neurotraumatology Grp Collabo] Hosp Univ 12 Octubre, Dept Intens Care Med, Madrid, Spain		Carabias, CS (corresponding author), Hosp 12 Octubre I 12, Inst Invest, Neurotraumatol & Subarachnoid Hemorrhage Res Unit, Madrid, Spain.	csanchezcarabias@gmail.com	Lagares, Alfonso/B-2969-2011; Castano-Leon, Ana M/ABF-6322-2020; Gomez, Pedro/E-2411-2014	Lagares, Alfonso/0000-0003-3996-0554; Castano-Leon, Ana M/0000-0002-7918-5049; Barea-mendoza, Jesus A/0000-0002-1858-525X; Fernandez Alen, Jose/0000-0002-3321-983X; , DANIEL/0000-0002-0298-5283; Gomez, Pedro/0000-0002-4185-5238	Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) [PI18/01387, PI14/01457]; Programa Miguel Servet [CP14/00008]; Fundacion Mutua MadrilenaInstituto de Salud Carlos III [PI16/00735]	This work was supported by grants from Fondo de Investigaciones Sanitarias (FIS) (ISCIII/FEDER) (grant numbers PI18/01387, PI14/01457) to A.L.; Programa Miguel Servet (grant number CP14/00008); and Fundacion Mutua Madrilena (grant number PI16/00735) to J.E.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Aly H, 2011, J PERINATOL, V31, P263, DOI 10.1038/jp.2010.130; Anada RP, 2018, ELECTROPHORESIS, V39, P2308, DOI 10.1002/elps.201700407; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Brea D, 2009, ATHEROSCLEROSIS, V205, P561, DOI 10.1016/j.atherosclerosis.2008.12.028; CHESNUT RM, 1994, NEUROSURGERY, V34, P840, DOI 10.1227/00006123-199405000-00008; De Vos A, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0945-8; Deng SX, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-48; Deng WJ, 2015, CELL MOL NEUROBIOL, V35, P355, DOI 10.1007/s10571-014-0131-0; Di Napoli M, 2014, STROKE, V45, P59, DOI 10.1161/STROKEAHA.113.001721; Di Napoli M, 2012, NEUROLOGY, V79, P690, DOI 10.1212/WNL.0b013e318264e3be; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Fountas KN, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS08311; Fullerton HJ, 2016, STROKE, V47, P2221, DOI 10.1161/STROKEAHA.116.013719; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Han Yong Y, 2002, Pediatr Crit Care Med, V3, P39, DOI 10.1097/00130478-200201000-00010; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Hu YY, 2010, SHOCK, V33, P134, DOI 10.1097/SHK.0b013e3181ad5c88; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jiang YX, 2014, CLIN BIOCHEM, V47, P302, DOI 10.1016/j.clinbiochem.2014.09.015; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Lagares A, 2015, NEUROSURGERY, V77, P898, DOI 10.1227/NEU.0000000000000927; Li GZ, 2018, NEUROSCI LETT, V662, P242, DOI 10.1016/j.neulet.2017.10.040; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lopponen P, 2014, J NEUROSURG, V121, P1374, DOI 10.3171/2014.7.JNS132678; Luger S, 2017, CLIN CHEM, V63, P377, DOI 10.1373/clinchem.2016.263335; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MABE H, 1991, SURG NEUROL, V36, P170, DOI 10.1016/0090-3019(91)90108-L; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Naghibi T, 2017, J CLIN DIAGN RES, V11, pPC6, DOI 10.7860/JCDR/2017/19132.9198; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; O'Connor E, 2004, ANAESTH INTENS CARE, V32, P465, DOI 10.1177/0310057X0403200402; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Rothoerl RD, 2006, J NEUROSURG ANESTH, V18, P68, DOI 10.1097/01.ana.0000181693.30750.af; Sauerland S, 2003, J NEUROTRAUM, V20, P953, DOI 10.1089/089771503770195803; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Sogut O, 2010, J INT MED RES, V38, P1708, DOI 10.1177/147323001003800516; Stelzl T, 1995, Eur J Emerg Med, V2, P24, DOI 10.1097/00063110-199503000-00006; TEASDALE G, 1974, LANCET, V2, P81; Tian D, 2015, NEUROREPORT, V26, P33, DOI 10.1097/WNR.0000000000000298; Unden J, 2005, BRIT J NEUROSURG, V19, P43, DOI 10.1080/02688690500089381; Vos PE, 2006, EUR J NEUROL, V13, P632, DOI 10.1111/j.1468-1331.2006.01332.x; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zanier ER, 2011, J NEUROL NEUROSUR PS, V82, P157, DOI 10.1136/jnnp.2009.177667; Zhang LJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-130; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	66	5	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2020	134						E120	E143		10.1016/j.wneu.2019.09.143			24	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KK6VS	WOS:000512878200017	31606503				2022-02-06	
J	Shu, SY; Zhang, Z; Spicer, D; Kulikowicz, E; Hu, K; Babapoor-Farrokhran, S; Kannan, S; Koehler, RC; Robertson, CL				Shu, Shiyu; Zhang, Zhi; Spicer, Dawn; Kulikowicz, Ewa; Hu, Ke; Babapoor-Farrokhran, Savalan; Kannan, Sujatha; Koehler, Raymond C.; Robertson, Courtney L.			Administration of a 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor Improves Outcome in a Rat Model of Pediatric Traumatic Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						20-Hydroxyeicosatetraenoic acid; N-hydroxy-N-4-butyl-2-methylphenylformamidine; Microglia; Neuroinflammation	CEREBRAL-BLOOD-FLOW; OXYGEN-GLUCOSE DEPRIVATION; 20-HETE CONTRIBUTES; HET0016; NEUROPROTECTION; ISCHEMIA; DYSFUNCTION; PLASTICITY; EDEMA	The arachidonic acid pathway metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to ischemia/reperfusion brain injury. Inhibition of 20-HETE formation can protect the developing brain from global ischemia. Here, we examined whether treatment with the 20-HETE synthesis inhibitor N-hydroxy-N-4-butyl-2-methylphenylformamidine (HET0016) can protect the immature brain from traumatic brain injury (TBI). Male rats at postnatal day 9-10 underwent controlled cortical impact followed by intraperitoneal injection with vehicle or HET0016 (1 mg/kg, 5 min and 3 h post-injury). HET0016 decreased the lesion volume by over 50% at 3 days of recovery, and this effect persisted at 30 days as the brain matured. HET0016 decreased peri-lesion gene expression of proinflammatory cytokines (tumor necrosis factor-alpha [TNF-alpha], interleukin-1 beta [IL-1 beta]) at 1 day and increased reparative cytokine (IL-4, IL-10) expression at 3 days. It also partially preserved microglial ramified processes, consistent with less activation. HET0016 decreased contralateral hindlimb foot faults and improved outcome on the novel object recognition memory task 30 days after TBI. In cultured BV2 microglia, HET0016 attenuated the lipopolysaccharide-evoked increase in release of TNF-alpha. Our data show that HET0016 improves acute and long-term histologic and functional outcomes, in association with an attenuated neuroinflammatory response after contusion of an immature rat brain.	[Shu, Shiyu; Zhang, Zhi; Spicer, Dawn; Kulikowicz, Ewa; Kannan, Sujatha; Koehler, Raymond C.; Robertson, Courtney L.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Hu, Ke; Babapoor-Farrokhran, Savalan] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol,Retina Div, Baltimore, MD 21205 USA; [Kannan, Sujatha; Robertson, Courtney L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Robertson, CL (corresponding author), Johns Hopkins Univ Hosp, Charlotte R Bloomberg Childrens Ctr, Dept Anesthesiol & Crit Care Med, Room 6321,1800 Orleans St, Baltimore, MD 21287 USA.; Shu, SY (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Anesthesiol, 83 Fenyang Rd, Shanghai 200031, Peoples R China.	shushiyu@hotmail.com; crober48@jhmi.edu		Zhang, Zhi/0000-0001-6256-9516	Chongqing Science and Technology Commission grants of China [cstc2015jcyjA10095]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS092747]; Johns Hopkins Institute for Clinical and Translational Research (ICTR) ATIP Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092747] Funding Source: NIH RePORTER	This work was funded by Chongqing Science and Technology Commission grants of China (no. cstc2015jcyjA10095); National Institutes of Health grants NS092747 (C.L.R.); and by the Johns Hopkins Institute for Clinical and Translational Research (ICTR) ATIP Grant (C.L.R.).	Abrams DJ, 2008, SCHIZOPHR RES, V100, P86, DOI 10.1016/j.schres.2007.10.012; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Dunn KM, 2008, AM J PHYSIOL-HEART C, V295, pH2455, DOI 10.1152/ajpheart.00512.2008; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Gebremedhin D, 2016, PROSTAG OTH LIPID M, V124, P16, DOI 10.1016/j.prostaglandins.2016.04.003; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Hoff U, 2011, KIDNEY INT, V79, P57, DOI 10.1038/ki.2010.377; Homayoun P, 1997, J NEUROCHEM, V69, P199; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Kawasaki T, 2012, J CEREBR BLOOD F MET, V32, P1737, DOI 10.1038/jcbfm.2012.68; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kehl F, 2002, AM J PHYSIOL-HEART C, V282, pH1556, DOI 10.1152/ajpheart.00924.2001; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Liu XG, 2008, AM J PHYSIOL-HEART C, V295, pH619, DOI 10.1152/ajpheart.01211.2007; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lu LY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00207; Lu LY, 2018, MOL MED REP, V17, P7339, DOI 10.3892/mmr.2018.8780; Miyata N, 2005, J PHARMACOL EXP THER, V314, P77, DOI 10.1124/jpet.105.083964; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Omura T, 2006, STROKE, V37, P1307, DOI 10.1161/01.STR.0000217398.37075.07; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Poloyac SM, 2006, J CEREBR BLOOD F MET, V26, P1551, DOI 10.1038/sj.jcbfm.9600309; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Renic M, 2012, AM J PHYSIOL-HEART C, V302, pH1285, DOI 10.1152/ajpheart.00340.2011; Renic M, 2009, J CEREBR BLOOD F MET, V29, P629, DOI 10.1038/jcbfm.2008.156; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Robertson CL, 2015, PEDIATR CRIT CARE ME, V16, P236, DOI 10.1097/PCC.0000000000000323; Roman RJ, 2006, NEUROL RES, V28, P738, DOI 10.1179/016164106X152016; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Shaik JSB, 2015, J CEREBR BLOOD F MET, V35, P1757, DOI 10.1038/jcbfm.2015.117; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Takeuchi K, 2005, AM J PHYSIOL-HEART C, V289, pH2203, DOI 10.1152/ajpheart.00556.2005; YAKSH TL, 1991, LIFE SCI, V48, P623, DOI 10.1016/0024-3205(91)90537-L; Yang ZJ, 2012, J NEUROCHEM, V121, P168, DOI 10.1111/j.1471-4159.2012.07666.x; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zhang H, 2017, CELL MOL NEUROBIOL, V37, P1279, DOI 10.1007/s10571-017-0462-8; Zhu JC, 2015, DEV NEUROSCI-BASEL, V37, P376, DOI 10.1159/000369007	47	5	5	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.	FEB	2020	41	3-4					166	176		10.1159/000500895			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	KS8YA	WOS:000518593300002	31553983	Green Accepted, Bronze			2022-02-06	
J	Wyse, JJ; Pogoda, TK; Mastarone, GL; Gilbert, T; Carlson, KF				Wyse, Jessica J.; Pogoda, Terri K.; Mastarone, Ginnifer L.; Gilbert, Tess; Carlson, Kathleen F.			Employment and Vocational Rehabilitation Experiences Among Veterans With Polytrauma/Traumatic Brain Injury History	PSYCHOLOGICAL SERVICES			English	Article						supported employment; vocational rehabilitation; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; SUPPORTED EMPLOYMENT; FREEDOM VETERANS; SERVICES; ASSOCIATIONS; SYMPTOMS	Evidence suggests that Iraq and Afghanistan war veterans with polytrauma/traumatic brain injury (TBI) history and neurobehavioral symptoms may face difficulties returning to work, yet also encounter barriers to accessing, navigating, and engaging in Department of Veterans Affairs (VA) vocational rehabilitation programs. This study utilized qualitative interviews and focus groups with veterans with documented polytrauma/TBI history to explore veterans' perceived barriers to employment and vocational rehabilitation program participation, as well as to solicit thoughts regarding interest in an evidence-based vocational rehabilitation program, the Individual Placement and Support model of Supported Employment (IPS-SE). Veterans identified physical, emotional, cognitive, and interpersonal barriers to finding and maintaining work that they described as linked with their polytrauma/TBI symptoms and sequelae. Communication and logistical issues were described as the primary barriers to vocational rehabilitation program access. while barriers to program utilization included eligibility characteristics, fear of losing financial benefits. and a military-cultural belief of self-sufficiency that made help-seeking difficult. Finally, veterans endorsed key aspects of IPS-SE, such as staff serving as translators, advocates, and navigators of the job search and maintenance process. Policy recommendations are addressed.	[Wyse, Jessica J.; Mastarone, Ginnifer L.; Gilbert, Tess; Carlson, Kathleen F.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA; [Wyse, Jessica J.; Carlson, Kathleen F.] Oregon Hlth & Sci Univ, OHSU PSU Sch Publ Hlth, Portland, OR 97201 USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, CHOIR, Boston, MA USA; [Pogoda, Terri K.] Boston Univ, Dept Hlth Law Policy & Management, Sch Publ Hlth, Boston, MA 02215 USA; [Carlson, Kathleen F.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA		Wyse, JJ (corresponding author), VA Portland Hlth Care Syst R&D 66, Ctr Improve Vet Involvement Care, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	jessica.wyse@va.gov	; Pogoda, Terri/F-6243-2012	Wyse, Jessica/0000-0003-4789-4390; Pogoda, Terri/0000-0003-1397-8780	Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development (HSRD) ServicesUS Department of Veterans Affairs [PPO 13-123, CDA 08-025]; U.S. Department of Veterans Affairs Health Services Research and Development Center to Improve Veteran Involvement in Care (CIVIC) at the VA Portland Health Care SystemUS Department of Veterans Affairs [CIN 13-404]	This material is based upon work supported by the Department of Veterans Affairs (VA), Veterans Health Administration, Health Services Research and Development (HSR&D) Services (PPO 13-123; CDA 08-025). Support and resources for this project were also provided by the U.S. Department of Veterans Affairs Health Services Research and Development Center to Improve Veteran Involvement in Care (CIVIC; CIN 13-404, PI: Dobscha) at the VA Portland Health Care System. The views expressed in this article are those of the authors and do not reflect the position or policy of the Department of Veterans Affairs or the United States government.	Abraham KM, 2017, PSYCHIAT SERV, V68, P938, DOI 10.1176/appi.ps.201600412; Amick M. M., 2017, J HEAD TRAUMA REHAB, V33, pE30; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Davis LL, 2018, JAMA PSYCHIAT, V75, P316, DOI 10.1001/jamapsychiatry.2017.4472; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; Department of Veterans Affairs, 2011, VHA HDB, V1163.02; Department of Veterans Affairs, 2017, VA VA HIST; Department of Veterans Affairs, 2015, POL TBI SYST CAR; Department of Veterans Affairs, 2013, VHA HDB, V1172.01; Department of Veterans Affairs, 2010, SCREEN EV POSS TRAUM; Donnelly K, 2018, CLIN NEUROPSYCHOL, V32, P436, DOI 10.1080/13854046.2017.1390163; Gade DM, 2013, J PUBL ADM RES THEOR, V23, P267, DOI 10.1093/jopart/mus030; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; O'Connor MK, 2011, J REHABIL RES DEV, V48, P597, DOI 10.1682/JRRD.2010.06.0117; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Resnick S.G., 2006, PSYCHOL SERV, V3, P239; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T., 2008, INVISIBLE WOUNDS WAR, DOI [10.7249/MG720.1, DOI 10.7249/MG720.1]; The Management of Concussion-Mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027	31	5	5	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	FEB	2020	17	1					65	74		10.1037/ser0000283			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	KF7DO	WOS:000509400100008	30265073	Green Accepted, Bronze			2022-02-06	
J	Huguenard, CJC; Cseresznye, A; Evans, JE; Oberlin, S; Langlois, H; Ferguson, S; Darcey, T; Nkiliza, A; Dretsch, M; Mullan, M; Crawford, F; Abdullah, L				Huguenard, Claire J. C.; Cseresznye, Adam; Evans, James E.; Oberlin, Sarah; Langlois, Heather; Ferguson, Scott; Darcey, Teresa; Nkiliza, Aurore; Dretsch, Michael; Mullan, Michael; Crawford, Fiona; Abdullah, Laila			Plasma Lipidomic Analyses in Cohorts With mTBI and/or PTSD Reveal Lipids Differentially Associated With Diagnosis and APOE epsilon 4 Carrier Status	FRONTIERS IN PHYSIOLOGY			English	Article						traumatic brain injury; post-traumatic stress disorder; biomarkers; lipids; apolipoprotein epsilon 4; mass spectrometry	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; APOLIPOPROTEIN-E; AMYLOID-BETA; BIOMARKERS; TBI; INSTRUMENT; DEPLOYMENT; SYMPTOMS; VETERANS	The differential diagnosis between mild Traumatic Brain Injury (mTBI) sequelae and Post-Traumatic Stress Disorder (PTSD) is challenging due to their symptomatic overlap and co-morbidity. As such, there is a need to develop biomarkers which can help with differential diagnosis of these two conditions. Studies from our group and others suggest that blood and brain lipids are chronically altered in both mTBI and PTSD. Therefore, examining blood lipids presents a minimally invasive and cost-effective approach to identify promising biomarkers of these conditions. Using liquid chromatography-mass spectrometry (LC-MS) we examined hundreds of lipid species in the blood of healthy active duty soldiers (n = 52) and soldiers with mTBI (n = 21), PTSD (n = 34) as well as co-morbid mTBI and PTSD (n = 13) to test whether lipid levels were differentially altered with each. We also examined if the apolipoprotein E (APOE) epsilon 4 allele can affect the association between diagnosis and peripheral lipid levels in this cohort. We show that several lipid classes are altered with diagnosis and that there is an interaction between diagnosis and the epsilon 4 carrier status on these lipids. Indeed, total lipid levels as well as both the degree of unsaturation and chain lengths are differentially altered with diagnosis and epsilon 4 status, specifically long chain unsaturated triglycerides (TG) and both saturated and mono-unsaturated diglycerides (DG). Additionally, an examination of lipid species reveals distinct profiles in each diagnostic group stratified by epsilon 4 status, mainly in TG, saturated DG species and polyunsaturated phosphatidylserines. In summary, we show that peripheral lipids are promising biomarker candidates to assist with the differential diagnosis of mTBI and PTSD. Further, epsilon 4 carrier status alone and in interaction with diagnosis has a strong influence on peripheral lipid levels. Therefore, examining epsilon 4 status along with peripheral lipid levels could help with differential diagnosis of mTBI and PTSD.	[Huguenard, Claire J. C.; Cseresznye, Adam; Evans, James E.; Oberlin, Sarah; Langlois, Heather; Ferguson, Scott; Darcey, Teresa; Nkiliza, Aurore; Mullan, Michael; Crawford, Fiona; Abdullah, Laila] Roskamp Inst, Sarasota, FL 34243 USA; [Huguenard, Claire J. C.; Ferguson, Scott; Mullan, Michael; Crawford, Fiona; Abdullah, Laila] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England; [Huguenard, Claire J. C.; Cseresznye, Adam; Evans, James E.; Oberlin, Sarah; Langlois, Heather; Ferguson, Scott; Darcey, Teresa; Nkiliza, Aurore; Mullan, Michael; Crawford, Fiona; Abdullah, Laila] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Dretsch, Michael] US Army, Med Res Directorate West, Walter Reed Army Inst Res, Joint Base Lewis McChord, Tacoma, WA USA; [Dretsch, Michael] US Army, Aeromed Res Lab, Ft Rucker, AL USA		Huguenard, CJC (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Huguenard, CJC (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England.; Huguenard, CJC (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.	chuguenard@roskampinstitute.org			U.S. Army Medical Research and Development Command (USAMRDC), Military Operational Medicine Research Program (MOMRP); CDMRPUnited States Department of Defense [AZ1600065]	Primary funding for this study was provided by the U.S. Army Medical Research and Development Command (USAMRDC), Military Operational Medicine Research Program (MOMRP) (PI: MD). Research was also supported by the CDMRP funding AZ1600065 (PIs: LA and FC).	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Ahmadian AJ, 2019, J AFFECT DISORDERS, V250, P1, DOI 10.1016/j.jad.2019.02.048; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Avallone KM, 2019, MIL MED, V184, pE118, DOI 10.1093/milmed/usy225; Begum H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19139; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Brelstaff J, 2018, CELL REP, V24, P1939, DOI 10.1016/j.celrep.2018.07.072; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Burla B, 2018, J LIPID RES, V59, P2001, DOI 10.1194/jlr.S087163; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cartocci V, 2017, J CELL PHYSIOL, V232, P281, DOI 10.1002/jcp.25488; Catalucci D., 2015, GEN METHODS BIOMARKE, P439, DOI [10.1007/978-94-007-7696-8_22, DOI 10.1007/978-94-007-7696-8_22]; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dretsch M., 2010, 71F ADVANTAGE APPL R; Dretsch MN, 2019, J EXP NEUROSCI, V13, DOI [10.1177/1179069519833966, 10.1177/1179069619833966]; Dretsch Michael N, 2017, Open Neuroimag J, V11, P46, DOI 10.2174/1874440001711010046; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Grosch S, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/5378284; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hauer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062741; He M, 2018, CURR PHARM DESIGN, V24, P4051, DOI 10.2174/1381612824666181120094749; Jendricko T, 2009, PROG NEURO-PSYCHOPH, V33, P134, DOI 10.1016/j.pnpbp.2008.11.002; Jergovic M, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00049; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Joshi U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31242-7; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kim Susan, 2017, Concussion, V2, pCNC48, DOI 10.2217/cnc-2017-0013; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Knobloch Marlen, 2017, Brain Plast, V3, P61, DOI 10.3233/BPL-160035; Laskowitz D., 2016, TRANSLATIONAL RES TR; Lejbman N, 2016, BRAIN INJURY, V30, P1436, DOI 10.1080/02699052.2016.1219054; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Liu JJ, 2015, BRAIN RES, V1597, P220, DOI 10.1016/j.brainres.2014.11.059; Lundin A, 2015, ALCOHOL CLIN EXP RES, V39, P158, DOI 10.1111/acer.12593; Malgrange B, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00003; Marais AD, 2019, PATHOLOGY, V51, P165, DOI 10.1016/j.pathol.2018.11.002; Mellon SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213839; Michopoulos V, 2015, BIOL PSYCHIAT, V78, P344, DOI 10.1016/j.biopsych.2015.01.005; Missler U, 1999, CLIN CHEM, V45, P138; Mitchell RW, 2011, PROSTAG LEUKOTR ESS, V85, P293, DOI 10.1016/j.plefa.2011.04.007; Mota NP, 2018, DEPRESS ANXIETY, V35, P168, DOI 10.1002/da.22698; National Center for PTSD, 2018, TRAUM BRAIN INJ PTSD; Ojo JO, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00893; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; Posti JP, 2019, J NEUROTRAUM, V36, P2178, DOI 10.1089/neu.2018.6254; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Rasmussen KL, 2016, ATHEROSCLEROSIS, V255, P145, DOI 10.1016/j.atherosclerosis.2016.10.037; Reisenberg M, 2012, PHILOS T R SOC B, V367, P3264, DOI 10.1098/rstb.2011.0387; Schmidt U, 2013, DIS MARKERS, V2013, P43, DOI 10.1155/2013/835876; Schwab KA, 2006, NEUROLOGY, V66, pA235; Sepe F., 2018, FUTURE MED, V13; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Song F, 2011, J ALZHEIMERS DIS, V26, P365, DOI 10.3233/JAD-2011-101977; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sulhan S, 2020, J NEUROSCI RES, V98, P19, DOI 10.1002/jnr.24331; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; Tracey TJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00010; Tudorache IF, 2017, COMPUT STRUCT BIOTEC, V15, P359, DOI 10.1016/j.csbj.2017.05.003; Vasterling JJ, 2018, J INT NEUROPSYCH SOC, V24, P311, DOI 10.1017/S1355617717001059; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zung W W, 1974, Mod Probl Pharmacopsychiatry, V7, P170; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	89	5	5	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	JAN 31	2020	11								12	10.3389/fphys.2020.00012			15	Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Physiology	KN1GU	WOS:000514588800001	32082186	Green Published, gold			2022-02-06	
J	Bhat, SA; Henry, RJ; Blanchard, AC; Stoica, BA; Loane, DJ; Faden, AI				Bhat, Shahnawaz A.; Henry, Rebecca J.; Blanchard, Alexa C.; Stoica, Bogdan A.; Loane, David J.; Faden, Alan I.			Enhanced Akt/GSK-3 beta/CREB signaling mediates the anti-inflammatory actions of mGluR5 positive allosteric modulators in microglia and following traumatic brain injury in male mice	JOURNAL OF NEUROCHEMISTRY			English	Article						Akt/GSK-3 beta/CREB signaling; anti-inflammatory; metabotropic glutamate receptor 5; microglia; positive allosteric modulator; traumatic brain injury	GLUTAMATE-RECEPTOR 5; NF-KAPPA-B; IMPROVES FUNCTIONAL RECOVERY; SYNTHASE KINASE-3 GSK3; MOUSE MODEL; FRAGILE-X; PROTEIN-SYNTHESIS; IN-VIVO; ACTIVATION; INFLAMMATION	We have previously shown that treatment with a mGluR5 positive allosteric modulator (PAM) is neuroprotective after experimental traumatic brain injury (TBI), limiting post-traumatic neuroinflammation by reducing pro-inflammatory microglial activation and promoting anti-inflammatory and neuroprotective responses. However, the specific molecular mechanisms governing this anti-inflammatory shift in microglia remain unknown. Here we show that the mGluR5 PAM, VU0360172 (VuPAM), regulates microglial inflammatory responses through activation of Akt, resulting in the inhibition of GSK-3 beta. GSK-3 beta regulates the phosphorylation of CREB, thereby controlling the expression of inflammation-related genes and microglial plasticity. The anti-inflammatory action of VuPAM in microglia is reversed by inhibiting Akt/GSK-3 beta/CREB signaling. Using a well-characterized TBI model and CX3CR1(gfp/+) mice to visualize microglia in vivo, we demonstrate that VuPAM enhances Akt/GSK-3 beta/CREB signaling in the injured cortex, as well as anti-inflammatory microglial markers. Furthermore, in situ analysis revealed that GFP + microglia in the cortex of VuPAM-treated TBI mice co-express pCREB and the anti-inflammatory microglial phenotype marker YM1. Taken together, our data show that VuPAM decreases pro-inflammatory microglial activation by modulating Akt/GSK-3 beta/CREB signaling. These findings serve to clarify the potential neuroprotective mechanisms of mGluR5 PAM treatment after TBI, and suggest novel therapeutic targets for post-traumatic neuroinflammation.	[Bhat, Shahnawaz A.; Henry, Rebecca J.; Blanchard, Alexa C.; Stoica, Bogdan A.; Loane, David J.; Faden, Alan I.] Univ Maryland, Sch Med, Dept Anesthesiol, 685 West Baltimore St,MSTF 6-02, Baltimore, MD 21201 USA; [Bhat, Shahnawaz A.; Henry, Rebecca J.; Blanchard, Alexa C.; Stoica, Bogdan A.; Loane, David J.; Faden, Alan I.] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Loane, David J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland		Faden, AI (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, 685 West Baltimore St,MSTF 6-02, Baltimore, MD 21201 USA.	afaden@som.umaryland.edu	Loane, David/ABD-5177-2021	Loane, David/0000-0003-0393-3503; Henry, Rebecca/0000-0001-8548-1170; Blanchard, Alexa/0000-0002-6790-2151	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037313, R01NS082308, R01NS096002]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [17/FRL/4860]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	National Institute of Neurological Disorders and Stroke, Grant/Award Number: R01NS037313, R01NS082308 and R01NS096002; National Institutes of Health; Science Foundation Ireland, Grant/Award Number: 17/FRL/4860	Alexaki VI, 2018, MOL PSYCHIATR, V23, P1410, DOI 10.1038/mp.2017.167; Andreou KE, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00251; Atkins RJ, 2012, J CLIN NEUROSCI, V19, P1558, DOI 10.1016/j.jocn.2012.07.002; Batista EML, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0259-6; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhat SA, 2019, MOL NEUROBIOL, V56, P3005, DOI 10.1007/s12035-018-1272-9; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2009, GLIA, V57, P550, DOI 10.1002/glia.20783; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Doria JG, 2015, NEUROBIOL DIS, V73, P163, DOI 10.1016/j.nbd.2014.08.021; Doria JG, 2013, BRIT J PHARMACOL, V169, P909, DOI 10.1111/bph.12164; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Farr SA, 2019, J NEUROTRAUM, V36, P1869, DOI 10.1089/neu.2018.5999; Foster DJ, 2017, NEURON, V94, P431, DOI 10.1016/j.neuron.2017.03.016; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Jha SK, 2015, INT J MOL CELL MED, V4, P67; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kim JY, 2015, CNS NEUROSCI THER, V21, P309, DOI 10.1111/cns.12360; Lindemann L, 2011, J PHARMACOL EXP THER, V339, P474, DOI 10.1124/jpet.111.185660; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Loane DJ, 2009, J BIOL CHEM, V284, P15629, DOI 10.1074/jbc.M806139200; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Maixner Dylan Warren, 2013, J Pharm Pharmacol (Los Angel), V1, P001; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mead EL, 2012, J NEUROCHEM, V121, P287, DOI 10.1111/j.1471-4159.2012.07659.x; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nickols HH, 2014, NEUROBIOL DIS, V61, P55, DOI 10.1016/j.nbd.2013.09.013; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Parry GCN, 1997, J IMMUNOL, V159, P5450; Piers TM, 2011, NEUROSCI LETT, V505, P140, DOI 10.1016/j.neulet.2011.10.007; Qian L, 2007, J IMMUNOL, V179, P1198, DOI 10.4049/jimmunol.179.2.1198; Qiao XM, 2018, J AFFECT DISORDERS, V235, P96, DOI 10.1016/j.jad.2018.04.039; Ribeiro FM, 2017, PHARMACOL RES, V115, P179, DOI 10.1016/j.phrs.2016.11.013; Ribeiro FM, 2014, EXPERT OPIN THER TAR, V18, P1293, DOI 10.1517/14728222.2014.948419; Richter JD, 2015, NAT REV NEUROSCI, V16, P595, DOI 10.1038/nrn4001; Rodriguez AL, 2010, MOL PHARMACOL, V78, P1105, DOI 10.1124/mol.110.067207; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Stansley BJ, 2019, TRENDS PHARMACOL SCI, V40, P240, DOI 10.1016/j.tips.2019.02.006; Steidinger TU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056092; Stoppel LJ, 2017, CELL REP, V18, P2807, DOI 10.1016/j.celrep.2017.02.075; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vergadi E, 2017, J IMMUNOL, V198, P1006, DOI 10.4049/jimmunol.1601515; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang JW, 2013, BIOCHEM BIOPH RES CO, V430, P1016, DOI 10.1016/j.bbrc.2012.12.046; Wang JW, 2012, BRAIN RES, V1464, P73, DOI 10.1016/j.brainres.2012.05.014; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Xue FT, 2014, CNS NEUROL DISORD-DR, V13, P558, DOI 10.2174/18715273113126660199; Zuena AR, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00804	71	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JAN	2021	156	2					225	248		10.1111/jnc.14954		JAN 2020	24	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QB0NH	WOS:000509597300001	31926033	Green Accepted			2022-02-06	
J	Rabinowitz, AR; Fisher, AJ				Rabinowitz, Amanda R.; Fisher, Aaron J.			Person-Specific Methods for Characterizing the Course and Temporal Dynamics of Concussion Symptomatology: A Pilot Study	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOMS; ANXIETY; SYSTEM; MODEL	Better characterization of acute concussion symptomatology is needed in order to advance clinical and scientific understanding of persistent concussion symptoms. This paper aims to illustrate a novel framework for conceptualizing, collecting, and analyzing concussion symptom data. To that end, we describe the temporal and structural dynamics of acute concussion symptoms at the individual-patient level. Ten recently concussion adolescents and young adults completed 20 days of ecological momentary assessment (EMA) of post-concussion symptoms. Follow-up assessments were completed at 3 months post-injury. Network modeling revealed marked heterogeneity across participants. In the overall sample, temporal patterns explained the most variance in light sensitivity (48%) and the least variance in vomiting (5%). About half of the participants had symptom networks that were sparse after controlling for temporal variation. The other individualized symptom networks were densely interconnected clusters of symptoms. Networks were highly idiosyncratic in nature, yet emotional symptoms (nervousness, emotional, sadness), cognitive symptoms (mental fogginess, slowness), and symptoms of hyperacusis (sensitivity to light, sensitivity to noise) tended to cluster together across participants. Person-specific analytic techniques revealed a number of idiosyncratic features of post-concussion symptomatology. We propose applying this framework to future research to better understand individual differences in concussion recovery.	[Rabinowitz, Amanda R.] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Fisher, Aaron J.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA		Rabinowitz, AR (corresponding author), Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA.	Rabinowa@einstein.edu; afisher@berkeley.edu		Fisher, Aaron/0000-0001-9754-4618	Albert Einstein Society	This research was funded by the Albert Einstein Society. We would like to thank Dr. Thomas Watanabe, Dr. Max Shmidheiser, and Jacqueline Donohue for their assistance with this project.	Borkenau P, 1998, J RES PERS, V32, P202, DOI 10.1006/jrpe.1997.2206; Borsboom D, 2017, WORLD PSYCHIATRY, V16, P5, DOI 10.1002/wps.20375; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Epskamp S, 2017, PSYCHOMETRIKA, V82, P904, DOI 10.1007/s11336-017-9557-x; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fernandez KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178806; Fisher A. J, 2018, P NATL ACAD SCI; Fisher AJ, 2017, J ABNORM PSYCHOL, V126, P1044, DOI 10.1037/abn0000311; Fisher AJ, 2016, BEHAV RES THER, V79, P46, DOI 10.1016/j.brat.2016.02.006; Fisher AJ, 2015, J CONSULT CLIN PSYCH, V83, P825, DOI 10.1037/ccp0000026; Flury BD, 1999, ECOLOGY, V80, P2254, DOI 10.1890/0012-9658(1999)080[2254:PLR]2.0.CO;2; Fried EI, 2017, PERSPECT PSYCHOL SCI, V12, P999, DOI 10.1177/1745691617705892; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Molenaar P. C. M., 2004, MEASUREMENT, p[2, 248]; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wichers M, 2015, EMOT REV, V7, P362, DOI 10.1177/1754073915590623	23	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 27	2020	10	1							1248	10.1038/s41598-019-57220-1			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NA7LI	WOS:000559997900002	31988354	Green Published, gold			2022-02-06	
J	Amorim, RL; Oliveira, LM; Malbouisson, LM; Nagumo, MM; Simoes, M; Miranda, L; Bor-Seng-Shu, E; Beer-Furlan, A; De Andrade, AF; Rubiano, AM; Teixeira, MJ; Kolias, AG; Paiva, WS				Amorim, Robson Luis; Oliveira, Louise Makarem; Malbouisson, Luis Marcelo; Nagumo, Marcia Mitie; Simoes, Marcela; Miranda, Leandro; Bor-Seng-Shu, Edson; Beer-Furlan, Andre; De Andrade, Almir Ferreira; Rubiano, Andres M.; Teixeira, Manoel Jacobsen; Kolias, Angelos G.; Paiva, Wellingson Silva			Prediction of Early TBI Mortality Using a Machine Learning Approach in a LMIC Population	FRONTIERS IN NEUROLOGY			English	Article						prognostic; traumatic brain injury; machine learning; mortality; LMICs	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; SCORE; VALIDATION; EXPERIENCE; CHILDREN	Background: In a time when the incidence of severe traumatic brain injury (TBI) is increasing in low- to middle-income countries (LMICs), it is important to understand the behavior of predictive variables in an LMIC's population. There are few previous attempts to generate prediction models for TBI outcomes from local data in LMICs. Our study aim is to design and compare a series of predictive models for mortality on a new cohort in TBI patients in Brazil using Machine Learning. Methods: A prospective registry was set in Sao Paulo, Brazil, enrolling all patients with a diagnosis of TBI that require admission to the intensive care unit. We evaluated the following predictors: gender, age, pupil reactivity at admission, Glasgow Coma Scale (GCS), presence of hypoxia and hypotension, computed tomography findings, trauma severity score, and laboratory results. Results: Overall mortality at 14 days was 22.8%. Models had a high prediction performance, with the best prediction for overall mortality achieved through Naive Bayes (area under the curve = 0.906). The most significant predictors were the GCS at admission and prehospital GCS, age, and pupil reaction. When predicting the length of stay at the intensive care unit, the Conditional Inference Tree model had the best performance (root mean square error = 1.011), with the most important variable across all models being the GCS at scene. Conclusions: Models for early mortality and hospital length of stay using Machine Learning can achieve high performance when based on registry data even in LMICs. These models have the potential to inform treatment decisions and counsel family members.	[Amorim, Robson Luis; Oliveira, Louise Makarem] Fed Univ Amazonas UFAM, Sch Med, Manaus, Amazonas, Brazil; [Amorim, Robson Luis; Nagumo, Marcia Mitie; Bor-Seng-Shu, Edson; De Andrade, Almir Ferreira; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil; [Malbouisson, Luis Marcelo; Miranda, Leandro] Univ Sao Paulo, Hosp Clin, Dept Anesthesiol, Sao Paulo, Brazil; [Simoes, Marcela] Anhembi Morumbi Univ, Sao Paulo, Brazil; [Beer-Furlan, Andre] Ohio State Univ, Dept Neurosurg, Wexner Med Ctr, Columbus, OH 43210 USA; [Rubiano, Andres M.] El Bosque Univ, Neurosci Inst, Bogota, Colombia; [Kolias, Angelos G.] Univ Cambridge, NIHR Global Hlth Res Grp Neurotrauma, Cambridge, England		Paiva, WS (corresponding author), Univ Sao Paulo, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	BOR-SENG-SHU, EDSON/AAC-9762-2019; Amorim, Robson/AAK-1368-2021; Paiva, Wellingson S/G-5517-2013; RUBIANO, ANDRES M/K-6704-2012	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; Amorim, Robson/0000-0003-2391-7519; Paiva, Wellingson S/0000-0002-5165-7040; RUBIANO, ANDRES M/0000-0001-8931-3254; Kolias, Angelos/0000-0003-3992-0587	National Institute for Health Research (NIHR) Global Health Research Group on NeurotraumaNational Institute for Health Research (NIHR) [16/137/105]; UK Government	This research was commissioned by the National Institute for Health Research (NIHR) Global Health Research Group on Neurotrauma (project 16/137/105) using UK aid from the UK Government. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Brennan PM, 2018, J NEUROSURG, V128, P1612, DOI 10.3171/2017.12.JNS172780; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; Johnson K., 2013, APPL PREDICTIVE MODE, V26, DOI [10.1007/978-1-4614-6849-3, DOI 10.1007/978-1-4614-6849-3]; Lehmkuhl DI, 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199308020-00010; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ramos MR, 2013, MEDICC REV, V15, P30, DOI 10.37757/MR2013V15.N3.7; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tu CJ, 2011, J INT MED RES, V39, P1757, DOI 10.1177/147323001103900518; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; van der Ploeg T, 2016, J CLIN EPIDEMIOL, V78, P83, DOI 10.1016/j.jclinepi.2016.03.002; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Yuan Q, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0471-0	33	5	5	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 24	2020	10								1366	10.3389/fneur.2019.01366			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KJ2GB	WOS:000511875100001	32038454	Green Published, gold			2022-02-06	
J	Liao, JY; Lee, CTC; Lin, TY; Liu, CM				Liao, Jung-Yu; Lee, Charles Tzu-Chi; Lin, Tsung-Yi; Liu, Chin-Mei			Exploring prior diseases associated with incident late-onset Alzheimer's disease dementia	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; HEARING-LOSS; GUT-BRAIN; HIPPOCAMPAL ATROPHY; MICROBIOTA; RISK; HEALTH; METAANALYSIS; DEPRESSION; DISORDERS	Studies have identified prior conditions associated with late-onset Alzheimer's disease dementia (LOAD), but all prior diseases have rarely been screened simultaneously in the literature. Our objective in the present study was to identify prior conditions associated with LOAD and construct pathways for them. We conducted a population-based matched case-control study based on data collected in the National Health Insurance Research database of Taiwan and the Catastrophic Illness Certificate database for the years 1997-2013. Prior diseases definitions were based on the first three digits of the codes listed in the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Inclusion criteria required that each ICD-code existed for at least 1 year and incurred at least 2 outpatient visits or inpatient diagnosis. The case group comprised 4,600 patients newly diagnosed with LOAD in 2007-2013. The LOAD patients were matched by sex and age to obtain 4,600 controls. Using stepwise multivariate logistic regression analysis, diseases were screened for 1, 2 ..., 9 years prior to the first diagnosis of LOAD. Path analysis was used to construct pathways between prior diseases and LOAD. Our results revealed that the following conditions were positively associated with the incidence of LOAD: anxiety (ICD-code 300), functional digestive disorder (ICD code 564), psychopathology-specific symptoms (ICD-code 307), disorders of the vestibular system (ICD-code 386), concussion (ICD-code 850), disorders of the urethra and urinary tract (ICD-code 599), disorders of refraction and accommodation (ICD-code 367), and hearing loss (ICD-code 389). A number of the prior diseases have previously been described in the literature in a manner identical to that in the present study. Our study supports the assertion that mental, hearing, vestibular system, and functional digestive disorders may play an important role in the pathogenesis of LOAD.	[Liao, Jung-Yu; Lee, Charles Tzu-Chi; Lin, Tsung-Yi; Liu, Chin-Mei] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan; [Lin, Tsung-Yi] Hsing Wu Univ, Dept Mkt & Distribut Management, New Taipei, Taiwan; [Liu, Chin-Mei] Taiwan Ctr Dis Control, Taipei, Taiwan		Liu, CM (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.; Liu, CM (corresponding author), Taiwan Ctr Dis Control, Taipei, Taiwan.	uu0850@gmail.com	Liao, Jung-Yu/AAG-4350-2021	Liao, Jung-Yu/0000-0001-5083-9531; Lin, Tsung-Yi/0000-0002-0358-2523			Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bate A, 2017, PHARMACOEPIDEM DR S, V26, P1013, DOI 10.1002/pds.4305; Boyle PA, 2008, NEUROLOGY, V70, P1534, DOI 10.1212/01.wnl.0000304345.14212.38; Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; Campbell J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00071; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chen CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144589; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cole J, 2011, J AFFECT DISORDERS, V134, P483, DOI 10.1016/j.jad.2011.05.057; da Silva J, 2013, BRIT J PSYCHIAT, V202, P177, DOI 10.1192/bjp.bp.111.101931; Daulatzai MA, 2014, NEUROCHEM RES, V39, P624, DOI 10.1007/s11064-014-1266-6; Davies HR, 2017, J AM GERIATR SOC, V65, P2074, DOI 10.1111/jgs.14986; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; Deal JA, 2017, J GERONTOL A-BIOL, V72, P703, DOI 10.1093/gerona/glw069; Fan YC, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0236-z; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Guthrie DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192971; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hooper D., 2008, STRUCTURAL EQUATION, DOI DOI 10.1080/10705519909540118; Hughes SE, 2018, EAR HEARING, V39, P922, DOI 10.1097/AUD.0000000000000553; Kowalski K, 2019, J NEUROGASTROENTEROL, V25, P48, DOI 10.5056/jnm18087; Leue C, 2017, NAT REV UROL, V14, P153, DOI 10.1038/nrurol.2016.227; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lin F-C, 2015, MEDICINE, V94; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Liu CM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8112; Livingston GSA, 2017, LANCET, DOI http://dx.doi; Lucieer F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00026; Lucieer F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00352; Mah L, 2016, CURR OPIN PSYCHIATR, V29, P56, DOI 10.1097/YCO.0000000000000223; Martin S, 2014, DISBILITY DEMENTIA F; Moon B, 2017, J ALZHEIMERS DIS, V58, P1255, DOI 10.3233/JAD-170225; Moonga I, 2017, EUR J NEUROL, V24, P1173, DOI 10.1111/ene.13374; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Powell N, 2017, NAT REV GASTRO HEPAT, V14, P143, DOI 10.1038/nrgastro.2016.191; Previc FH, 2013, MED HYPOTHESES, V80, P360, DOI 10.1016/j.mehy.2012.12.023; Ronnberg J, 2010, NOISE HEALTH, V12, P263, DOI 10.4103/1463-1741.70505; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Shen YL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00394; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Smith PA, 2015, NATURE, V526, P312, DOI 10.1038/526312a; Strupp Michael, 2010, Front Neurol, V1, P121, DOI 10.3389/fneur.2010.00121; Su PJ, 2017, EUR ARCH OTO-RHINO-L, V274, P2327, DOI 10.1007/s00405-017-4471-5; Szablewski L, 2018, J ALZHEIMERS DIS, V62, P549, DOI 10.3233/JAD-170908; Tapiainen V, 2017, EUR PSYCHIAT, V43, P92, DOI 10.1016/j.eurpsy.2017.02.486; Thomson RS, 2017, LARYNGOSCOPE INVEST, V2, P69, DOI 10.1002/lio2.65; Tolppanen AM, 2017, ALZHEIMERS DEMENT, V13, P1371, DOI 10.1016/j.jalz.2017.04.010; Tsai CP, 2019, AMYOTROPH LAT SCL FR, V20, P82, DOI 10.1080/21678421.2018.1522354; Van der Mussele S, 2014, J ALZHEIMERS DIS, V42, P1239, DOI 10.3233/JAD-140405; Wen YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003658; WHO, 2004, INT STAT CLASS DIS R; Zheng YQ, 2017, NEUROL SCI, V38, P233, DOI 10.1007/s10072-016-2779-3	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2020	15	1							e0228172	10.1371/journal.pone.0228172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LP8WY	WOS:000534599100122	31978130	gold, Green Published			2022-02-06	
J	Kahali, S; Townsend, M; Nguyen, MM; Kim, J; Alay, E; Skotak, M; Chandra, N				Kahali, Sudeepto; Townsend, Molly; Nguyen, Melissa Mendez; Kim, Jeffrey; Alay, Eren; Skotak, Maciej; Chandra, Namas			The evolution of secondary flow phenomena and their effect on primary shock conditions in shock tubes: Experimentation and numerical model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; VORTEX RING; OPEN-END; SIMULATION; WAVES	Compressed gas-driven shock tubes are widely used for laboratory simulation of primary blasts by accurately replicating pressure profiles measured in live-fire explosions. These investigations require sound characterization of the primary blast wave, including the temporal and spatial evolution of the static and dynamic components of the blast wave. The goal of this work is to characterize the propagation of shock waves in and around the exit of a shock tube via analysis of the primary shock flow, including shock wave propagation and decay of the shock front, and secondary flow phenomena. To this end, a nine-inch shock tube and a cylindrical sensing apparatus were used to determine incident and total pressures outside of the shock tube, highlighting the presence of additional flow phenomena. Blast overpressure, impulse, shock wave arrival times, positive phase duration, and shock wave planarity were examined using a finite element model of the system. The shock wave remained planar inside of the shock tube and lost its planarity upon exiting. The peak overpressure and pressure impulse decayed rapidly upon exit from the shock tube, reducing by 92-95%. The primary flow phenomenon, or the planar shock front, is observed within the shock tube, while two distinct flow phenomena are a result of the shock wave exiting the confines of the shock tube. A vortex ring is formed as the shock wave exited the shock tube into the still, ambient air, which induces a large increase in the total pressure impulse. Additionally, a rarefaction wave was formed following shock front expansion, which traveled upstream into the shock tube, reducing the total and incident pressure impulses for approximately half of the simulated region.	[Kahali, Sudeepto] New Jersey Inst Technol, Dept Mech Engn, Newark, NJ 07102 USA; [Townsend, Molly; Nguyen, Melissa Mendez; Kim, Jeffrey; Alay, Eren; Skotak, Maciej; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA		Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Kahali, Sudeepto/G-9413-2018; Skotak, Maciej/H-4769-2019	Kahali, Sudeepto/0000-0001-8675-7466; Skotak, Maciej/0000-0003-2584-7294	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81-XWH-15-1-0303]	This work was funded by the United States Army Medical Research and Materiel Command under award number W81-XWH-15-1-0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2002, PROG AEROSP SCI, V38, P23, DOI 10.1016/S0376-0421(01)00016-1; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; ABE A, 1990, JSME INT J II-FLUID, V33, P216, DOI 10.1299/jsmeb1988.33.2_216; Arakeri JH, 2004, PHYS FLUIDS, V16, P1008, DOI 10.1063/1.1649339; Chandra N., 2015, BRAIN NEUROTRAUMA MO, P199; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; CHISNELL RF, 1957, J FLUID MECH, V2, P286, DOI 10.1017/S0022112057000130; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; Condon JA, 1997, CONSTRUCTION TESTING; Coulter GA, 1982, BLAST WAVE LOADING 2; ELDER FK, 1952, J APPL PHYS, V23, P1065, DOI 10.1063/1.1701987; FROHN A, 1969, PHYS FLUIDS, V12, pI54; GRIFFITH W, 1952, J AERONAUT SCI, V19, P249, DOI 10.2514/8.2242; Henshall BD, 1957, AERONAUTICAL RES C; HERTZBERG A, 1951, J AERONAUT SCI, V18, P803, DOI 10.2514/8.2124; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmberg A., 2010, DEV CHARACTERIZATION; Jiang Z, 1999, SHOCK WAVES, V9, P1, DOI 10.1007/s001930050133; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Koroteeva EY, 2016, SHOCK WAVES, V26, P269, DOI 10.1007/s00193-016-0650-3; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Maeno K, 2005, SHOCK WAVES, V14, P239, DOI 10.1007/s00193-005-0256-7; Mariani R, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3520187; Masel BE, 2012, J NEUROTRAUM, V29, P2143, DOI 10.1089/neu.2011.2258; Mohseni K, 2006, BIOINSPIR BIOMIM, V1, pS57, DOI 10.1088/1748-3182/1/4/S08; Murugan T, 2016, SHOCK WAVES, V26, P311, DOI 10.1007/s00193-015-0611-2; Murugan T, 2013, FLUID DYN RES, V45, DOI 10.1088/0169-5983/45/2/025506; Murugan T, 2012, SHOCK WAVES, V22, P69, DOI 10.1007/s00193-011-0344-9; Murugan T, 2018, J VISUAL-JAPAN, V21, P921, DOI 10.1007/s12650-018-0503-5; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Onodera O, 1998, JSME INT J B-FLUID T, V41, P408, DOI 10.1299/jsmeb.41.408; SKEWS BW, 1967, J FLUID MECH, V29, P705, DOI 10.1017/S0022112067001132; Skotak M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00052; Southard EE, 1919, SHELL SHOCK OTHER NE; Stuhmiller JH, 2008, BLAST INJURY TRANSLA; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Zare-Behtash H, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3054151	38	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2020	15	1							e0227125	10.1371/journal.pone.0227125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5PQ	WOS:000534370100020	31945083	Green Published, gold			2022-02-06	
J	Forstner, P; Knoll, B				Foerstner, Philip; Knoell, Bernd			Interference of neuronal activity-mediated gene expression through serum response factor deletion enhances mortality and hyperactivity after traumatic brain injury	FASEB JOURNAL			English	Article						c-Fos; Egr; hematoma; hyperactivity; immediate early gene; transcription	CLOSED-HEAD INJURY; TRANSCRIPTION FACTORS; SYNAPSE DEVELOPMENT; C-JUN; ACTIVATION; SRF; RECEPTORS; MEMORY; CREB; NEUROINFLAMMATION	Traumatic brain injury (TBI) is one of the most frequent causes of brain injury and mortality in young adults with detrimental sequelae such as cognitive impairments, epilepsy, and attention-deficit hyperactivity disorder. TBI modulates the neuronal excitability resulting in propagation of a neuronal activity-driven gene expression program. However, the impact of such neuronal activity mediated gene expression in TBI has been poorly studied. In this study we analyzed mouse mutants of the prototypical neuronal activity-dependent transcription factor SRF (serum response factor) in a weight-drop TBI model. Neuron-restricted SRF deletion elevated TBI inflicted mortality suggesting a neuroprotective SRF function during TBI. Behavioral inspection uncovered elevated locomotor activity in Srf mutant mice after TBI in contrast to hypoactivity observed in wild-type littermates. This indicates an SRF role in modulation of TBI-associated alterations in locomotor activity. Finally, induction of a neuronal activity induced gene expression program composed of immediate early genes (IEGs) such as Egr1, Egr2, Egr3, Npas4, Atf3, Arc, Ptgs2, and neuronal pentraxins (Nptx2) was compromised upon SRF depletion. Overall, our data show a role of neuronal activity-mediated gene transcription during TBI and suggest a molecular link between TBI and such post-TBI neurological comorbidities involving hyperactivity phenotypes.	[Foerstner, Philip; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany		Knoll, B (corresponding author), Ulm Univ, Inst Physiol Chem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	bernd.knoell@uni-ulm.de			Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [SFB1149]	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB1149	Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Aid S, 2011, BIOCHIMIE, V93, P46, DOI 10.1016/j.biochi.2010.09.009; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anastasiadou S, 2016, EXP NEUROL, V279, P243, DOI 10.1016/j.expneurol.2016.03.012; Anastasiadou S, 2015, GLIA, V63, P958, DOI 10.1002/glia.22794; Benito E, 2015, MOL NEUROBIOL, V51, P1071, DOI 10.1007/s12035-014-8772-z; Benito E, 2011, J NEUROSCI, V31, P18237, DOI 10.1523/JNEUROSCI.4554-11.2011; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Coutellier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046604; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Heuvel FO, 2019, BRAIN BEHAV IMMUN, V81, P228, DOI 10.1016/j.bbi.2019.06.019; Hu BR, 2004, J CEREBR BLOOD F MET, V24, P934, DOI 10.1097/01.WCB.0000125888.56462.A1; Kim S, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0025-1; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Losing P, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0310-2; Luckow KS, 2015, EURASIP J EMBED SYST, DOI 10.1186/s13639-015-0020-8; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Mokalled MH, 2010, DEVELOPMENT, V137, P2365, DOI 10.1242/dev.047605; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nader K, 2019, BRAIN STRUCT FUNCT; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Needham EJ, 2019, J NEUROIMMUNOL, V332, P112, DOI 10.1016/j.jneuroim.2019.04.005; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Ohnishi YN, 2011, BIOL PSYCHIAT, V70, P487, DOI 10.1016/j.biopsych.2011.04.021; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pacchioni AM, 2009, J PHARMACOL EXP THER, V328, P183, DOI 10.1124/jpet.108.143115; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Parkitna JR, 2010, FASEB J, V24, P2427, DOI 10.1096/fj.09-151423; Patel TP, 2014, J NEUROSCI, V34, P4200, DOI 10.1523/JNEUROSCI.4172-13.2014; Pelkey KA, 2015, NEURON, V85, P1257, DOI 10.1016/j.neuron.2015.02.020; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Stern S, 2013, J NEUROSCI, V33, P18836, DOI 10.1523/JNEUROSCI.3029-13.2013; Stern S, 2012, J NEUROINFLAMM, V9, DOI [10.1186/1742-2094-9-79, 10.1186/1742-2094-9-78]; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Tomasevic G, 2010, J NEUROSCI RES, V88, P3414, DOI 10.1002/jnr.22491; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vos BC, 2018, CLIN J SPORT MED, V28, P91, DOI 10.1097/JSM.0000000000000432; Wang MY, 2018, MOL MED REP, V17, P4925, DOI 10.3892/mmr.2018.8525; Whitfield PC, 2000, NEUROL RES, V22, P138, DOI 10.1080/01616412.2000.11741050; Wong CT, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12506; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zimmermann AM, 2015, BIOL PSYCHIAT, V78, P95, DOI 10.1016/j.biopsych.2014.03.011; Zimprich A, 2017, MOL NEUROBIOL, V54, P8242, DOI 10.1007/s12035-016-0300-x; Zimprich A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00125	74	5	5	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2020	34	3					3855	3873		10.1096/fj.201902257RR		JAN 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KT7UL	WOS:000507880600001	31930559	hybrid			2022-02-06	
J	Coverdale, NS; Fernandez-Ruiz, J; Champagne, AA; Mark, CI; Cook, DJ				Coverdale, Nicole S.; Fernandez-Ruiz, Juan; Champagne, Allen A.; Mark, Clarisse, I; Cook, Douglas J.			Co-localized impaired regional cerebrovascular reactivity in chronic concussion is associated with BOLD activation differences during a working memory task	BRAIN IMAGING AND BEHAVIOR			English	Article						Working memory; Concussion; Cerebrovascular reactivity; Cerebral blood flow	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; RECOVERY; HYPERCAPNIA; EFFICIENCY; DEFICITS; STROKE; HUMANS; IMAGES; MODEL	The purpose of this study was to quantify differences in blood oxygen level dependent (BOLD) activation on a working memory task, baseline cerebral blood flow (CBF0), and cerebrovascular reactivity (CVR) between participants with and without a history of concussion. A dual-echo pseudo-continuous arterial spin labelling (pCASL) sequence was performed on a group of 10 subjects with a previous concussion (126 +/- 15 days prior) and on a control group (n = 10) during a visual working memory protocol. A separate dual-echo pCASL sequence was used to derive CVR and CBF0 measurements from a boxcar hypercapnic breathing protocol. Brain areas with significant activation differences on the working memory task between groups were identified and combined as an aggregate region of interest for CBF and CVR analyses. Areas of reduced BOLD activation during the working memory task in the concussed group included the ventral anterior cingulate cortex (ACC), the medial temporal gyrus (MTG), and the lateral occipital cortex in two loci. A single area of increased activation was located in the parietal operculum. Further analyses of CBF0 and CVR in these regions revealed reduced CVR in the concussed group in the MTG and ACC, while CBF0 did not differ. The differences in CVR between the two groups in these regions suggest that concussive injury may result in microvascular dysfunction. In turn, the decreased BOLD response during the task could be due to altered neurovascular coupling, rather than an impairment in neural activation alone. However, in other regions associated with working memory, unchanged CBF0 and CVR suggests that neural injury also persists after concussion. In the future, BOLD results should be normalized to CVR in order achieve a clearer understanding of the neural and vascular contributions to the differences in the signal.	[Coverdale, Nicole S.; Champagne, Allen A.; Mark, Clarisse, I; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Fernandez-Ruiz, Juan] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Ciudad De Mexico, Mexico; [Cook, Douglas J.] Queens Univ, Dept Surg, Kingston, ON, Canada		Cook, DJ (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada.; Cook, DJ (corresponding author), Queens Univ, Dept Surg, Kingston, ON, Canada.	dj.cook@queensu.ca	Fernandez-Ruiz, Juan/B-6154-2012	Fernandez-Ruiz, Juan/0000-0002-4038-0904	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [315705]	This work was supported by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC) through a Collaborative Health Research Project Grant (#315705).	Amyot F, 2018, J NEUROTRAUM, V35, P1116, DOI 10.1089/neu.2017.5114; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Bright MG, 2013, NEUROIMAGE, V83, P559, DOI 10.1016/j.neuroimage.2013.07.007; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Champagne AA, 2019, NEUROIMAGE, V187, P154, DOI 10.1016/j.neuroimage.2017.11.044; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chu PPW, 2018, NEUROIMAGE, V173, P72, DOI 10.1016/j.neuroimage.2018.02.004; Chukwudelunzu FE, 2002, EUR J NEUROL, V9, P423, DOI 10.1046/j.1468-1331.2002.00432.x; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Duffin J, 2015, NEUROIMAGE, V114, P207, DOI 10.1016/j.neuroimage.2015.04.029; Fierstra J, 2013, J PHYSIOL-LONDON, V591, P5809, DOI 10.1113/jphysiol.2013.259150; Germuska M, 2016, NEUROIMAGE, V139, P313, DOI 10.1016/j.neuroimage.2016.06.004; Halani S, 2015, NEUROIMAGE, V110, P110, DOI 10.1016/j.neuroimage.2015.01.050; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Handwerker DA, 2007, HUM BRAIN MAPP, V28, P846, DOI 10.1002/hbm.20307; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; Liu PY, 2019, NEUROIMAGE, V187, P104, DOI 10.1016/j.neuroimage.2018.03.047; Liu PY, 2017, NEUROIMAGE, V146, P320, DOI 10.1016/j.neuroimage.2016.11.054; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Manoach DS, 2003, NEUROIMAGE, V20, P1670, DOI 10.1016/j.neuroimage.2003.08.002; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mutch WAC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00023; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Nee DE, 2013, NEUROIMAGE, V74, P1, DOI 10.1016/j.neuroimage.2013.02.019; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Para AE, 2017, J MAGN RESON IMAGING, V46, P1448, DOI 10.1002/jmri.25639; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Portegies MLP, 2014, STROKE, V45, P42, DOI 10.1161/STROKEAHA.113.002348; Reinhard M, 2014, NEUROLOGY, V83, P1424, DOI 10.1212/WNL.0000000000000888; Shah-Basak PP, 2018, J NEUROTRAUM, V35, P267, DOI 10.1089/neu.2017.5117; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stobart JLL, 2013, P NATL ACAD SCI USA, V110, P3149, DOI 10.1073/pnas.1215929110; Suri S, 2015, ALZHEIMERS DEMENT, V11, P648, DOI 10.1016/j.jalz.2014.05.1755; Svaldi DO, 2020, BRAIN IMAGING BEHAV, V14, P164, DOI 10.1007/s11682-018-9983-0; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Thomason ME, 2007, HUM BRAIN MAPP, V28, P59, DOI 10.1002/hbm.20241; Tukey JW, 1977, EXPLORATORY DATA ANA, V2, P131; van Niftrik CHB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215294; van Niftrik CHB, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.705; van Niftrik CHB, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.426; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Wright AD, 2017, J NEUROTRAUM, V34, P3097, DOI 10.1089/neu.2017.5020; Wu WC, 2007, MAGN RESON MED, V58, P1020, DOI 10.1002/mrm.21403; Zhang X, 2013, MAGN RESON MED, V70, P1082, DOI 10.1002/mrm.24550; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	71	5	5	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2020	14	6					2438	2449		10.1007/s11682-019-00194-5		JAN 2020	12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OO1HQ	WOS:000505416100001	31903527				2022-02-06	
J	Scott, BR; Uomoto, JM; Barry, ES				Scott, Beverly R.; Uomoto, Jay M.; Barry, Erin S.			Impact of Pre-Existing Migraine and Other Co-Morbid or Co-Occurring Conditions on Presentation and Clinical Course Following Deployment-Related Concussion	HEADACHE			English	Article						migraine; headache; post-traumatic headaches; traumatic brain injury; concussion; post-traumatic stress disorder	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; US SOLDIERS; SERVICE MEMBERS; HEAD TRAUMA; HEADACHES; DEPRESSION; ASSOCIATION; IMPAIRMENT; SYMPTOMS	Objective To describe the clinical presentation and early clinical course of a sample of deployed U.S. military service members following concussion, underscoring the impact of pre-existing migraine and other co-occurring conditions. It is important to obtain a comprehensive clinical history to identify evidence of underlying migraine and other health conditions which may contribute to an individual's presenting symptoms influencing early management and outcomes following concussion. Early outcome measures assessed include headache treatment response and fitness for return to duty. Background Acute concussion is reported to result in an array of somatic, cognitive, and behavioral symptoms. It is well established that these symptoms are not specific for concussion and may result from exacerbation of pre-existing or underlying medical conditions and factors. Although most symptoms attributable to concussion resolve within days to weeks, there is evidence that persistent symptoms beyond that specific recovery time may be attributable to factors other than concussion. Military populations are at risk for a number of recognized co-morbid and co-occurring conditions, as well as special situational and psychosocial factors which may influence symptoms and clinical course following concussion. In addition, combat-related concussion frequently occurs in the setting of a blast or military vehicle accidents thus causing concurrent injuries where musculoskeletal injuries may contribute to the clinical presentation. The resultant acute stress reaction, secondary to the traumatic experience associated with concussion, may also cause or aggravate underlying psychological co-morbidities that may influence presenting symptoms. Prior studies identified co-morbidities associated with chronic post-concussive syndrome, which we find are also present during the early phase following deployment-related concussion, thereby influencing presentation and impacting recovery. This retrospective chart review was intended to demonstrate the presence and potential impact of co-morbid and co-occurring conditions contributing to symptoms following concussion, especially migraine due to its high prevalence among post-traumatic headaches. Methods Retrospective chart review was performed by the treating neurologist of 40 service members following concussion in the deployed environment. Clinical symptoms and co-morbid and co-occurring conditions including evidence of pre-existing migraine identified during comprehensive neurologic evaluations were collected. Both pre-deployment/pre-traumatic and post-traumatic headache features supporting migraine and early instituted headache management and treatment response are described. Rates of return to duty in this sample were also tabulated. Results Headaches were the most frequently reported acute symptom following concussion in this deployed service member population (38/40 patients [98%]), followed by insomnia, tinnitus, impaired concentration, nausea, dizziness, anxiety, impaired balance, depression, and hearing loss. Co-occurring acute injuries, acute stress reaction, and recent onset medication overuse were the most frequent co-occurring conditions identified by the treating neurologist as potentially contributing to the service member's presentation. Chronic co-morbidities identified included chronic headache, anxiety/depression, insomnia, and post-traumatic stress disorder. Service members with 3 or more identified co-morbidities or co-occurring conditions were more likely to require evacuation from theater. Pre-deployment headaches were reported by 25/40 [63%] service members, with 5/40 [12.5%] reporting known prior personal history of migraine. Of those reporting pre-deployment headaches, 21/25 [84%] described migraine features and/or triggers, though most [(15/25) 60%] reported as infrequent. Daily post-traumatic headaches were frequent (26/38 [68%]) and associated with typical migraine features and/or triggers. Of those treated with triptans (16/40 patient [42%]), most (12/16 patient [75%]) showed positive treatment response. Conclusions Concussion in the deployed settings does not occur in isolation, with co-morbid and co-occurring conditions being common. Presence of multiple co-morbidities appears to influence clinical course and overall recovery. Post-traumatic headaches are often phenotypically fully consistent with migraine, and appear related to pre-existing migraine if supported by detailed pre-deployment headache history suggesting same. Careful and comprehensive history taking and evaluation is invaluable in identifying associated conditions including migraine, potentially helping clinicians with more accurate symptom attribution, diagnoses, and improved clinical management following acute concussion.	[Scott, Beverly R.] Madigan Army Med Ctr, Traumat Brain Injury Program, Joint Base Lewis Mcchord, WA USA; [Uomoto, Jay M.] Def & Vet Brain Injury Ctr, Gen Dynam Hlth Solut, Joint Base Lewis Mcchord, WA USA; [Barry, Erin S.] Uniformed Serv Univ Hlth Sci, Mil & Emergency Med, Bethesda, MD 20814 USA		Uomoto, JM (corresponding author), Def & Vet Brain Injury Ctr, Intrepid Spirit Ctr, TBI Program, Gen Dynam Hlth Solut, Joint Base Lewis Mcchord, WA 98433 USA.	jay.m.uomoto.ctr@mail.mil		Uomoto, Jay/0000-0003-4565-7906			Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Dodick D, 2006, HEADACHE, V46, pS202, DOI 10.1111/j.1526-4610.2006.00604.x; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; HAAS DC, 1975, ARCH NEUROL-CHICAGO, V32, P727, DOI 10.1001/archneur.1975.00490530049003; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LIPTON RB, 1994, NEUROLOGY, V44, P4; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Management of Concussion/m TBIWG, 2009, J REHABIL RES DEV, V46, pCP1; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; OKA H, 1977, BRAIN, V100, P287, DOI 10.1093/brain/100.2.287; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; PARKER W, 1991, AM J OTOL, V12, P25; Peterlin BL, 2009, HEADACHE, V49, P541, DOI 10.1111/j.1526-4610.2009.01368.x; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Samson K, 2017, NEUROL TODAY, V17, P8; Soloman S, 1998, HEADACHE, V38, P772, DOI 10.1046/j.1526-4610.1998.3810772.x; Suhr JA, 2012, CEPHALALGIA, V32, P39, DOI 10.1177/0333102411430265; Szirmai A, 1997, EUR ARCH OTO-RHINO-L, V254, pS55, DOI 10.1007/BF02439724; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, CEPHALALGIA, V32, P589, DOI 10.1177/0333102412445220; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2010, HEADACHE, V50, P790, DOI 10.1111/j.1526-4610.2009.01571.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	53	5	5	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAR	2020	60	3					526	541		10.1111/head.13709		JAN 2020	16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KQ3YL	WOS:000505291900001	31898813				2022-02-06	
J	Copley, M; Jimenez, N; Kroshus, E; Chrisman, SPD				Copley, M.; Jimenez, N.; Kroshus, E.; Chrisman, S. P. D.			Disparities in Use of Subspecialty Concussion Care Based on Ethnicity	JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES			English	Article						Brain concussion; Child; Adolescent; Ethnicity; Hispanic; Spanish; Disparities; Access; Limited English proficiency	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; CHILDREN; ACCESS; LANGUAGE; COMMUNITY; RECOVERY; SYMPTOMS; BARRIERS	Concussion is common and subspecialty care can be essential to ensure recovery. However, barriers may exist to accessing care. This study aimed to assess disparities in subspecialty concussion care related to ethnicity, limited English proficiency (LEP), and insurance status. We utilized logistic regression to analyze 2010-2015 administrative data from four Sports Medicine clinics, comparing odds of being seen for concussion to odds of being seen for fracture by ethnicity, insurance type, and interpreter usage, controlling for demographic factors. ICD-9 codes were used to identify concussion and fracture. Our final sample contained 25,294 subjects: 5621 with concussion and 19,673 with fracture. In bivariate analysis, youth seen for concussion had 83% lower odds of being Hispanic compared with youth seen for fracture (95%CI: 75-92%). Due to interactions between ethnicity and interpreter use, we utilized a stratified multivariate model as our final model. Youth with concussion had 1.8x greater odds of having private insurance compared with youth with fracture (Hispanic OR 1.8, 95% CI 1.5-2.3; Non-Hispanic OR 1.8, 95% CI 1.7-2.0). Youth with concussion also had greater odds of not using an interpreter, though the strength of this association was weaker for Hispanic youth compared with non-Hispanic youth (Hispanic OR 1.68, 95% CI 1.30-2.17; Non-Hispanic OR 4.36, 95% CI 3.00-6.35). Age and sex were included as covariates. In conclusion, our analysis suggests disparities in subspecialty concussion care for Hispanic youth, as well as for individuals with LEP and non-private insurance. Further research should explore means for improving access to concussion care for all youth.	[Copley, M.] Univ Washington, Sch Med, Seattle, WA USA; [Jimenez, N.; Kroshus, E.; Chrisman, S. P. D.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371 CW 8-6, Seattle, WA 98145 USA; [Jimenez, N.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Kroshus, E.; Chrisman, S. P. D.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371 CW 8-6, Seattle, WA 98145 USA.; Chrisman, SPD (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	University of Washington Medical Student Research Training Program	This research was made possible by a grant from the University of Washington Medical Student Research Training Program.	Applebaum B, 2016, J HEALTH CARE POOR U, V27, P416, DOI 10.1353/hpu.2016.0064; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cook NL, 2007, HEALTH AFFAIR, V26, P1459, DOI 10.1377/hlthaff.26.5.1459; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Crane J A, 1997, J Emerg Med, V15, P1, DOI 10.1016/S0736-4679(96)00261-2; De Netto RK, 2020, DISABIL REHABIL, V42, P2444, DOI 10.1080/09638288.2019.1637948; DeWalt Darren A, 2009, Pediatrics, V124 Suppl 3, pS265, DOI 10.1542/peds.2009-1162B; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eneriz-Wiemer M, 2014, PEDIAT DB A UNDEFINE; Flores A., 2017, US HISPANIC POPULATI; Hacker K, 2015, RISK MANAG HEALTHC P, V8, P175, DOI 10.2147/RMHP.S70173; Haderxhanaj LT, 2014, J ADOLESCENT HEALTH, V55, P716, DOI 10.1016/j.jadohealth.2014.06.018; Jacobs E, 2006, MILBANK Q, V84, P111, DOI 10.1111/j.1468-0009.2006.00440.x; Jimenez N, 2015, ARCH PHYS MED REHAB, V96, P1255, DOI 10.1016/j.apmr.2015.02.019; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kroshus E, 2019, HEALTH PROMOT PRACT, V20, P372, DOI 10.1177/1524839918790231; Kuhlthau K, 2001, PEDIATRICS, V108, P906, DOI 10.1542/peds.108.4.906; Malgosa J, 2017, 2017 SIXTH INTERNATIONAL CONFERENCE ON FUTURE GENERATION COMMUNICATION TECHNOLOGIES (FGCT), P15; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Pappadis M, 2017, B A PHYS UNDEFINED E; Ryan C, 2013, LANGUAGE USE US 2011; Skaggs DL, 2001, PEDIATRICS, V107, P1405, DOI 10.1542/peds.107.6.1405; Skinner AC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-194; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Wildsmith E., 2016, NATL PORTRAIT HISPAN; Wilson E, 2005, J GEN INTERN MED, V20, P800, DOI 10.1111/j.1525-1497.2005.0174.x; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	31	5	5	0	0	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2197-3792	2196-8837		J RACIAL ETHN HEALTH	J. Racial Ethn. Health Disparities	JUN	2020	7	3					571	576		10.1007/s40615-019-00686-6		JAN 2020	6	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	LN6XD	WOS:000505358900002	31898059				2022-02-06	
J	Ponsford, J; Downing, M; Pechlivanidis, H				Ponsford, Jennie; Downing, Marina; Pechlivanidis, Helen			The impact of cultural background on outcome following traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Ethnicity; Cultural background; Outcome	ETHNIC DISPARITIES; FUNCTIONAL OUTCOMES; EMPLOYMENT OUTCOMES; DEPRESSION SCALE; HOSPITAL ANXIETY; MINORITY STATUS; REHABILITATION; RACE; ASSOCIATION; PERFORMANCE	Most traumatic brain injury (TBI) outcome studies have been conducted in developed countries involving individuals from the dominant culture. The present study compared outcomes following TBI in individuals from Culturally and Linguistically Diverse (CALD) backgrounds with those from non-CALD backgrounds. 103 CALD and 103 non-CALD participants with predominantly moderate to severe TBI completed a series of questionnaires an average of 22 months post-injury. Groups were comparable in most demographic and injury-related variables, but CALD participants had lower pre-injury employment rates. Individuals in the CALD group were significantly less independent in light domestic duties, shopping, and financial management and reported significantly lower cognitive independence, mobility, and participation in occupational and social activities than non-CALD participants post-injury. They also reported heightened awareness of post-injury deficits, different beliefs regarding injury consequences and factors aiding recovery, more anxiety and depression symptoms, and less problem-focused coping. Higher functional outcome was associated with having a value system that is Australian, younger age at injury, and higher education. Overall, independent of rehabilitation access, individuals from a CALD background showed poorer functional outcome following TBI than those from a non-CALD background. Addressing this discrepancy should be a priority for rehabilitation programmes.	[Ponsford, Jennie; Downing, Marina] Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Pechlivanidis, Helen] Ryde Hosp, Graythwaite Rehabil Ctr, Eastwood, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Ponsford, Jennie/0000-0003-0430-125X			Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arango-Lasprilla JC, 2011, PM&R, V3, P1083, DOI 10.1016/j.pmrj.2011.05.023; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Berry C, 2010, J SURG RES, V163, P303, DOI 10.1016/j.jss.2010.03.018; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blackmer J, 1999, BRAIN INJURY, V13, P627; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; Chervinsky A. B., 1998, MOTIVATION TRAUMATIC; Cohen J, 1977, STAT POWER ANAL BEHA; Cardoso EDS, 2007, J HEAD TRAUMA REHAB, V22, P85, DOI 10.1097/01.HTR.0000265096.44683.6b; Faleafa Monique, 2009, Pac Health Dialog, V15, P28; Field A., 2011, DISCOVERING STAT USI; Frydenberg E, 1997, COPING SCALE ADULTS; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lequerica A, 2014, NEUROREHABILITATION, V34, P645, DOI 10.3233/NRE-141079; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Paniagua, 1998, ASSESSING TREATING C; Perrin PB, 2014, ARCH PHYS MED REHAB, V95, P2288, DOI 10.1016/j.apmr.2014.07.409; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Snaith R., 1994, HOSP ANXIETY DEPRESS; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519	47	5	5	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2020	30	1					85	100		10.1080/09602011.2018.1453367			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OP0HF	WOS:000587755700006	29607708				2022-02-06	
J	Alberts, JL; Modic, MT; Udeh, BL; Zimmerman, N; Cherian, K; Lu, XY; Gray, R; Figler, R; Russman, A; Linder, SM				Alberts, Jay L.; Modic, Michael T.; Udeh, Belinda L.; Zimmerman, Nicole; Cherian, Kay; Lu, Xiaoyang; Gray, Robert; Figler, Richard; Russman, Andrew; Linder, Susan M.			A Technology-Enabled Concussion Care Pathway Reduces Costs and Enhances Care	PHYSICAL THERAPY			English	Article							POSITION STATEMENT CONCUSSION; AMERICAN MEDICAL SOCIETY; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; HIGH-SCHOOL; REHABILITATION; CHILDREN; MANAGEMENT; SYMPTOMS; RULE	Background. The standardization of care along disease lines is recommended to improve outcomes and reduce health care costs. The multiple disciplines involved in concussion management often result in fragmented and disparate care. A fundamental gap exists in the effective utilization of rehabilitation services for individuals with concussion. Purpose. The purpose of this project was to (1) characterize changes in health care utilization following implementation of a concussion carepath, and (2) present an economic evaluation of patient charges following carepath implementation. Design. This was a retrospective cohort study. Methods. A review of electronic medical and financial records was conducted of individuals (N = 3937), ages 18 to 45 years, with primary diagnosis of concussion who sought care in the outpatient or emergency department settings over a 7-year period (2010-2016). Outcomes including encounter length, resource utilization, and charges were compared for each year to determine changes from pre- to post-carepath implementation. Results. Concussion volumes increased by 385% from 2010 to 2015. Utilization of physical therapy increased from 9% to 20% while time to referral decreased from 72 to 23 days post-injury. Utilization of emergency medicine and imaging were significantly reduced. Efficient resource utilization led to a 20.7% decrease in median charges (estimated ratio of means [CI] 7.72 [0.53, 0.96]) associated with concussion care. Limitations. Encounter lengths served as a proxy for recovery time. Conclusions. The implementation of the concussion carepath was successful in optimizing clinical practice with respect to facilitating continuity of care, appropriate resource utilization, and effective handoffs to physical therapy. The utilization of enabling technology to facilitate the collection of common outcomes across providers was vital to the success of standardizing clinical care without compromising patient outcomes.	[Alberts, Jay L.; Cherian, Kay; Linder, Susan M.] Cleveland Clin Fdn, Dept Biomed Engn, 9500 Euclid Ave,ND 20, Cleveland, OH 44195 USA; [Alberts, Jay L.] Cleveland Clin Fdn, Ctr Neurol Restorat, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Alberts, Jay L.; Modic, Michael T.; Udeh, Belinda L.; Zimmerman, Nicole; Lu, Xiaoyang] Cleveland Clin Fdn, Off Clin Transformat, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Alberts, Jay L.; Gray, Robert; Figler, Richard; Russman, Andrew; Linder, Susan M.] Cleveland Clin Fdn, Concuss Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Udeh, Belinda L.] Cleveland Clin Fdn, Neurol Inst Ctr Outcomes Res, 9500 Euclid Ave, Cleveland, OH 44195 USA		Alberts, JL (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn, 9500 Euclid Ave,ND 20, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Cleveland Clin Fdn, Ctr Neurol Restorat, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Cleveland Clin Fdn, Off Clin Transformat, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Alberts, JL (corresponding author), Cleveland Clin Fdn, Concuss Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org			Edward F. and Barbara A. Bell Family Endowed Chair	This project was supported by the Edward F. and Barbara A. Bell Family Endowed Chair to J.L. Alberts.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alberts JL, J VIS EXP; Alberts JL, 2016, BRIDGE LINKING ENG S, V46, P23; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baker DR, 2018, AM J SPORT MED, V46, P396, DOI 10.1177/0363546517738742; Baker JG, 2012, REHABIL RES PRACTICE, V2012, P654; Bernstein JPK, 2018, APPL NEUROPSYCH-ADUL; Blumenthal D, 2007, NEW ENGL J MED, V356, P2527, DOI 10.1056/NEJMhpr066212; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Burke D, 2016, ASSESSMENT, V24, P654; Carson J, CAN FAM PHYS; Critical-Path Planning KJE, 1961, OPER RES, V9, P296; Davis GA, 2009, BRIT J SPORT MED, V43, P4; Faul M, 2010, TRAUMATIC BRAIN INJU; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P354; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ho SJK, 1999, HEALTH CARE MANAGE R, V24, P19, DOI 10.1097/00004010-199904000-00003; Jagoda AS, ANN EMERG MED; Katzan IL, 2015, CIRC-CARDIOVASC QUAL, V8, pS179, DOI 10.1161/CIRCOUTCOMES.115.001808; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Linder SM, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014948; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Porter ME, 2013, HARVARD BUS REV, V91, P24; Porter ME, 2013, HEALTH AFFAIR, V32, P516, DOI 10.1377/hlthaff.2012.0961; Prevention CfDCa, 2015, C TRAUM BRAIN INJ US; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Reengineering Work HM Automate D., 1990, HARVARD BUS REV, V68, P104; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Soliman AM, 2018, ADV THER, V35, P408, DOI 10.1007/s12325-018-0667-3; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; United States Department of Labor, CONS PRIC IND; Valovich McLeod, 2017, DEV NEUROPSYCHOL, P1, DOI DOI 10.1007/978-3-319-45438-2; Vanhaecht K, 2007, HEALTH SERV MANAG RE, V20, P189, DOI 10.1258/095148407781395964	48	5	5	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JAN	2020	100	1					136	148		10.1093/ptj/pzz141			13	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation	KS8CK	WOS:000518533000013	31584666				2022-02-06	
J	Besecker, EM; Blanke, EN; Deiter, GM; Holmes, GM				Besecker, Emily M.; Blanke, Emily N.; Deiter, Gina M.; Holmes, Gregory M.			Gastric vagal afferent neuropathy following experimental spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Gastric emptying; Gastrointestinal motility; Vago-vagal reflexes; Stomach; Cholecystokinin; CCK-1 receptor; CCK-A receptor; Capsaicin; TRPV1; Neurotrauma	RECEPTOR POTENTIAL CHANNELS; SENSORY NEURONS; NODOSE GANGLIA; GASTROINTESTINAL-TRACT; VANILLOID RECEPTOR; VAGUS NERVE; CHOLECYSTOKININ; RAT; EXPRESSION; TRPV1	Dramatic impairment of gastrointestinal (GI) function accompanies high-thoracic spinal cord injury (T3-SCI). The vagus nerve contains mechano- and chemosensory fibers as well as the motor fibers necessary for the central nervous system (CNS) control of GI reflexes. Cell bodies for the vagal afferent fibers are located within the nodose gangla (NG) and the majority of vagal afferent axons are unmyelinated C fibers that are sensitive to capsaicin through activation of transient receptor potential vanilloid-1 (TRPV1) channels. Vagal afferent fibers also express receptors for GI hormones, including cholecystokinin (CCK). Previously, T3-SCI provokes a transient GI inflammatory response as well as a reduction of both gastric emptying and centrally-mediated vagal responses to GI peptides, including CCK. TRPV1 channels and CCK-A receptors (CCKar) expressed in vagal afferents are upregulated in models of visceral inflammation. The present study investigated whether T3-SCI attenuates peripheral vagal afferent sensitivity through plasticity of TRPV1 and CCK receptors. Vagal afferent response to graded mechanical stimulation of the stomach was significantly attenuated by T3-SCI at 3-day and 3-week recovery. Immunocytochemical labeling for CCKar and TRPV1 demonstrated expression on dissociated gastric-projecting NG neurons. Quantitative assessment of mRNA expression by qRT-PCR revealed significant elevation of CCKar and TRPV1 in the whole NG following T3-SCI in 3-day recovery, but levels returned to normal after 3-weeks. Three days after injury, systemic administration of CCK-8 s showed a significantly diminished gastric vagal afferent response in T3-SCI rats compared to control rats while systemic capsaicin infusion revealed a significant elevation of vagal response in T3-SCI vs control rats. These findings demonstrate that T3-SCI provokes peripheral remodeling and prolonged alterations in the response of vagal afferent fibers to the physiological signals associated with digestion.	[Besecker, Emily M.; Blanke, Emily N.; Deiter, Gina M.; Holmes, Gregory M.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Besecker, Emily M.] Gettysburg Coll, Dept Hlth Sci, Gettysburg, PA 17325 USA		Holmes, GM (corresponding author), Penn State Univ, Coll Med, 500 Univ Dr,H109, Hershey, PA 17033 USA.	gmh16@psu.edu		Holmes, Gregory/0000-0001-5176-8376	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-049177, F31-NS-087834]	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) Grants R01-NS-049177 and F31-NS-087834.	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Altschuler S.M., 1992, NEUROANATOMY PHYSL A, P21; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Anthony DC, 2014, EXP NEUROL, V258, P105, DOI 10.1016/j.expneurol.2014.03.013; Banerjee B, 2007, NEUROGASTROENT MOTIL, V19, P681, DOI 10.1111/j.1365-2982.2007.00947.x; Baptista V, 2005, J NEUROPHYSIOL, V94, P2763, DOI 10.1152/jn.00351.2005; BERLLY MH, 1984, ARCH PHYS MED REHAB, V65, P687; BERTHOUD HR, 1992, J COMP NEUROL, V319, P261, DOI 10.1002/cne.903190206; Besecker E.M., 2018, MOTIL; Besecker EM, 2017, AM J PHYSIOL-REG I, V312, pR146, DOI 10.1152/ajpregu.00347.2016; Bielefeldt K, 2008, AM J PHYSIOL-GASTR L, V294, pG130, DOI 10.1152/ajpgi.00388.2007; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG987, DOI 10.1152/ajpgi.00080.2006; Blum E, 2017, EXP CELL RES, V350, P236, DOI 10.1016/j.yexcr.2016.11.026; Broberger C, 2001, BRAIN RES, V903, P128, DOI 10.1016/S0006-8993(01)02468-4; Browning KN, 2010, NEUROGASTROENT MOTIL, V22, P361, DOI 10.1111/j.1365-2982.2010.01475.x; BUELKESAM J, 1978, LAB ANIM SCI, V28, P157; Burdyga G, 2006, NEUROSCIENCE, V137, P1405, DOI 10.1016/j.neuroscience.2005.10.057; Burdyga G, 2006, AM J PHYSIOL-GASTR L, V290, pG1289, DOI 10.1152/ajpgi.00543.2005; Burdyga G, 2010, AM J PHYSIOL-GASTR L, V299, pG63, DOI 10.1152/ajpgi.00059.2010; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Christianson J.A., 2010, TRANSLATIONAL PAIN R, V3, P1; Christianson JA, 2009, BRAIN RES REV, V60, P171, DOI 10.1016/j.brainresrev.2008.12.004; Cosman B C, 1991, J Am Paraplegia Soc, V14, P175; Czaja K, 2008, NEUROSCIENCE, V154, P621, DOI 10.1016/j.neuroscience.2008.03.055; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; de Haan JJ, 2013, AM J PHYSIOL-GASTR L, V305, pG383, DOI 10.1152/ajpgi.00333.2012; Demir IE, 2013, ACTA NEUROPATHOL, V125, P491, DOI 10.1007/s00401-013-1099-4; Dockray GJ, 2014, J PHYSIOL-LONDON, V592, P2927, DOI 10.1113/jphysiol.2014.270850; DOUGLAS BR, 1988, EXPERIENTIA, V44, P21, DOI 10.1007/BF01960229; Duca FA, 2013, HORM BEHAV, V64, P812, DOI 10.1016/j.yhbeh.2013.09.004; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Dyavanapalli J, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0630-0; FEALEY RD, 1984, GASTROENTEROLOGY, V87, P69; Feldman-Goriachnik R, 2015, GLIA, V63, P2121, DOI 10.1002/glia.22881; Furuta A, 2012, INT J UROL, V19, P429, DOI 10.1111/j.1442-2042.2012.02966.x; Gallaher ZR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00012; Gebhart GF, 2016, COMPR PHYSIOL, V6, P1609, DOI 10.1002/cphy.c150049; Hanani M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00412; Hayes D, 2013, LUNG, V191, P445, DOI 10.1007/s00408-013-9496-y; HELKE CJ, 1988, NEUROSCIENCE, V26, P539, DOI 10.1016/0306-4522(88)90166-2; Herrity AN, 2014, J COMP NEUROL, V522, P3667, DOI 10.1002/cne.23629; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Holmes G.M., 2008, APPETITE, V51, P374; Holmes G.M., 2017, NEUROLOGICAL ASPECTS, P397; Holmes GM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00277; Holmes GM, 2009, AM J PHYSIOL-GASTR L, V296, pG621, DOI 10.1152/ajpgi.90567.2008; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; Jia YL, 2007, BBA-MOL BASIS DIS, V1772, P915, DOI 10.1016/j.bbadis.2007.01.013; Kang YM, 2004, J NEUROPHYSIOL, V91, P1981, DOI 10.1152/jn.01097.2003; Kao CH, 1999, DIGEST DIS SCI, V44, P1512, DOI 10.1023/A:1026690305537; Kentish S. J., 2014, J PHYSL, V593, P775; Kentish SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135892; KEWALRAMANI LS, 1979, J TRAUMA, V19, P259, DOI 10.1097/00005373-197904000-00008; Kinch DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034755; KIRSHBLUM SC, 2002, ARCH PHYS MED REHAB, V83, pS5; Kishimoto E, 2011, AM J PHYSIOL-GASTR L, V301, pG230, DOI 10.1152/ajpgi.00436.2009; Kwong K, 2008, J PHYSIOL-LONDON, V586, P1321, DOI 10.1113/jphysiol.2007.146365; Labouesse MA, 2012, J NEUROENDOCRINOL, V24, P1505, DOI 10.1111/j.1365-2826.2012.02364.x; Lee LY, 2009, CURR OPIN PHARMACOL, V9, P243, DOI 10.1016/j.coph.2009.02.002; Liddle RA, 1997, ANNU REV PHYSIOL, V59, P221, DOI 10.1146/annurev.physiol.59.1.221; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Matsubayashi Y, 2008, J NEUROSCI METH, V174, P71, DOI 10.1016/j.jneumeth.2008.07.003; Mawe GM, 2009, NEUROGASTROENT MOTIL, V21, P481, DOI 10.1111/j.1365-2982.2009.01291.x; Mazzone SB, 2016, PHYSIOL REV, V96, P975, DOI 10.1152/physrev.00039.2015; Nilius B, 2007, BIOCHEM SOC T, V35, P105, DOI 10.1042/BST0350105; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; NINOMURCIA M, 1992, AM J ROENTGENOL, V158, P279, DOI 10.2214/ajr.158.2.1729781; Okano-Matsumoto S, 2011, J PHYSIOL-LONDON, V589, P371, DOI 10.1113/jphysiol.2010.196832; Page AJ, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12973; Page AJ, 2002, J NEUROPHYSIOL, V87, P2095, DOI 10.1152/jn.00785.2001; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Powley TL, 2002, AM J PHYSIOL-GASTR L, V283, pG1217, DOI 10.1152/ajpgi.00249.2002; PRECHTL JC, 1990, ANAT EMBRYOL, V181, P101; Primeaux SD, 2007, AM J PHYSIOL-REG I, V293, pR1102, DOI 10.1152/ajpregu.00224.2007; Qualls-Creekmore E, 2010, NEUROGASTROENT MOTIL, V22, P181, DOI 10.1111/j.1365-2982.2009.01393.x; Qualls-Creekmore E., 2010, NEUROGASTROENT MOTIL, V22, P69; RAJENDRAN SK, 1992, AM J GASTROENTEROL, V87, P1614; RAYBOULD HE, 1988, AM J PHYSIOL, V255, pG242, DOI 10.1152/ajpgi.1988.255.2.G242; Raybould HE, 2007, CURR OPIN PHARMACOL, V7, P570, DOI 10.1016/j.coph.2007.09.006; Ryu V, 2010, NEUROSCIENCE, V167, P1227, DOI 10.1016/j.neuroscience.2010.02.049; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; SEGAL JL, 1995, AM J GASTROENTEROL, V90, P466; Simasko SM, 2003, AM J PHYSIOL-GASTR L, V285, pG1204, DOI 10.1152/ajpgi.00132.2003; STINNEFORD JG, 1993, PARAPLEGIA, V31, P384, DOI 10.1038/sc.1993.64; Strain GM, 2005, DIGEST DIS SCI, V50, P2037, DOI 10.1007/s10620-005-3004-z; Surdenikova L, 2012, NEUROGASTROENT MOTIL, V24, pe517, DOI 10.1111/nmo.12002; Swartz EM, 2014, NEUROGASTROENT MOTIL, V27, P2; Tong M, 2011, NEUROGASTROENT MOTIL, V23, pe69, DOI 10.1111/j.1365-2982.2010.01616.x; Tong M, 2009, NEUROGASTROENT MOTIL, V21, P197, DOI 10.1111/j.1365-2982.2008.01215.x; Trancikova A, 2018, DIGEST DIS SCI, V63, P383, DOI 10.1007/s10620-017-4883-5; Troy AE, 2016, J PHYSIOL-LONDON, V594, P99, DOI 10.1113/JP271558; Ward SM, 2003, J COMP NEUROL, V465, P121, DOI 10.1002/cne.10801; Williams RE, 2012, SPINAL CORD, V50, P81, DOI 10.1038/sc.2011.92; Wolf C, 2003, SPINAL CORD, V41, P347, DOI 10.1038/sj.sc.3101440; Wu HY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/283525; Young RL, 2008, NEUROGASTROENT MOTIL, V20, P708, DOI 10.1111/j.1365-2982.2007.01071.x; Yu XY, 2016, SEMIN IMMUNOPATHOL, V38, P385, DOI 10.1007/s00281-015-0528-y; Yu Y, 2019, J PHYSIOL-LONDON, V597, P1487, DOI [10.1113/JP276894, 10.1113/jp276894]; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Zhao HA, 2010, ENDOCRINOLOGY, V151, P5237, DOI 10.1210/en.2010-0504; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009	102	5	5	1	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JAN	2020	323								113092	10.1016/j.expneurol.2019.113092			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JZ0OC	WOS:000504802800026	31697943	Green Accepted			2022-02-06	
J	Campbell-Sills, L; Stein, MB; Liu, HW; Agtarap, S; Heeringa, SG; Nock, MK; Ursano, RJ; Kessler, RC				Campbell-Sills, Laura; Stein, Murray B.; Liu, Howard; Agtarap, Stephanie; Heeringa, Steven G.; Nock, Matthew K.; Ursano, Robert J.; Kessler, Ronald C.			Associations of Lifetime Traumatic Brain Injury Characteristics With Prospective Suicide Attempt Among Deployed US Army Soldiers	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attempted suicide; concussion; military personnel; military psychiatry; postconcussion syndrome; traumatic brain injury	ASSESS RISK; MILITARY PERSONNEL; PHYSICAL-ACTIVITY; HEALTH CONDITIONS; RESILIENCE; IRAQ; AFGHANISTAN; SYMPTOMS; VETERANS; VALIDITY	Objective: To estimate associations of lifetime traumatic brain injury (TBI) characteristics with prospective suicide attempt among US Army soldiers. Method: The Army STARRS (Study to Assess Risk and Resilience in Servicemembers) Pre/Post Deployment Study surveyed 3 Brigade Combat Teams that were deployed to Afghanistan in 2012. Lifetime TBI and past-month postconcussive/post-TBI symptoms were evaluated at predeployment baseline. Recency and number of TBIs were quantified, and TBI severity was classified on the basis of reports of alteration/loss of consciousness and memory lapse. Suicide attempt data came from administrative records and surveys administered after return from deployment. Logistic regression models estimated associations of TBI characteristics with prospective suicide attempt among baseline respondents who were deployed (n = 7677), adjusting for other risk factors including lifetime mental disorder. Results: One hundred three soldiers made a suicide attempt over a median follow-up period of 30 months (weighted prevalence = 1.31% [0.14%]). In the final model estimating joint associations of TBI severity/recency and past-month postconcussive/post-TBI symptoms, only postconcussive/post-TBI symptoms were associated with a higher risk of suicide attempt (per standard score increase: AOR [adjusted odds ratio] = 1.31; 95% CI, 1.05-1.63; P = .012). Conclusions: Among the lifetime TBI characteristics evaluated at predeployment baseline, only past-month postconcussive/post-TBI symptoms were prospectively associated with an increased risk of suicide attempt following deployment. Detection of postconcussive/post-TBI symptoms could facilitate targeting of Army suicide prevention programs.	[Campbell-Sills, Laura; Stein, Murray B.; Agtarap, Stephanie] Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mail Code 0855, La Jolla, CA 92093 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Liu, Howard; Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Heeringa, Steven G.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Nock, Matthew K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat, Bethesda, MD 20814 USA		Campbell-Sills, L (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mail Code 0855, La Jolla, CA 92093 USA.	campbell-sills@ucsd.edu	Ursano, Robert/ABE-6533-2020	Liu, Howard/0000-0002-0747-7886	Department of the Army; US Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH) [U01MH087981]; Department of Defense (USUHS)United States Department of Defense [HU0001-15-2-0004]	Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement no. U01MH087981 (2009-2015) with the US Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH). Subsequently, STARRS-LS was sponsored and funded by the Department of Defense (USUHS grant no. HU0001-15-2-0004). The contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health and Human Services, NIMH, the Department of the Army, the Department of Veterans Affairs, or the Department of Defense.	Adler AB, 2005, J OCCUP HEALTH PSYCH, V10, P121, DOI 10.1037/1076-8998.10.2.121; Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; [Anonymous], 2013, SAS 9 4 SOFTW COMP P; Boggs JM, 2018, PSYCHIAT SERV, V69, P677, DOI 10.1176/appi.ps.201700237; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Eaton KM, 2006, SUICIDE LIFE-THREAT, V36, P182, DOI 10.1521/suli.2006.36.2.182; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Heeringa SG, 2013, INT J METH PSYCH RES, V22, P276, DOI 10.1002/mpr.1400; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Kessler RC, 2013, INT J METH PSYCH RES, V22, P303, DOI 10.1002/mpr.1398; Kessler RC, 2013, INT J METH PSYCH RES, V22, P288, DOI 10.1002/mpr.1399; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; LeardMann CA, 2013, JAMA-J AM MED ASSOC, V310, P496, DOI 10.1001/jama.2013.65164; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Miller GK., 2015, SUICIDAL THOUGHTS BE; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Phillips CJ, 2017, AM J EPIDEMIOL, V186, P668, DOI 10.1093/aje/kwx117; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Reger MA, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17l11790; Reger MA, 2018, SUICIDE LIFE-THREAT, V48, P21, DOI 10.1111/sltb.12322; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Shen YC, 2016, LANCET PSYCHIAT, V3, P1039, DOI 10.1016/S2215-0366(16)30304-2; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Skopp Nancy A, 2012, MSMR, V19, P7; Southerland JL, 2016, J PHYS ACT HEALTH, V13, P809, DOI 10.1123/jpah.2015-0315; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Taliaferro LA, 2008, J SCHOOL HEALTH, V78, P545, DOI 10.1111/j.1746-1561.2008.00342.x; Taliaferro Lindsay A, 2011, Int J Adolesc Med Health, V23, P3; Ursano RJ, 2018, JAMA PSYCHIAT, V75, P596, DOI 10.1001/jamapsychiatry.2018.0296; Ursano RJ, 2016, JAMA PSYCHIAT, V73, P741, DOI 10.1001/jamapsychiatry.2016.0600; Ursano RJ, 2015, JAMA PSYCHIAT, V72, P917, DOI 10.1001/jamapsychiatry.2015.0987; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837	44	5	5	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		14	26		10.1097/HTR.0000000000000516			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300004	31306300	Bronze, Green Accepted			2022-02-06	
J	Champagne, AA; Coverdale, NS; Ross, A; Chen, YN; Murray, CI; Dubowitz, D; Cook, DJ				Champagne, Allen A.; Coverdale, Nicole S.; Ross, Andrew; Chen, Yining; Murray, Christopher, I; Dubowitz, David; Cook, Douglas J.			Multi-modal normalization of resting-state using local physiology reduces changes in functional connectivity patterns observed in mTBI patients	NEUROIMAGE-CLINICAL			English	Article						Brain connectivity; Cerebral blood flow; Mild traumatic brain injury; Resting-state fMRI; Cerebrovascular reactivity	CEREBRAL-BLOOD-FLOW; SPORTS-RELATED CONCUSSION; DEFAULT-MODE NETWORK; CEREBROVASCULAR REACTIVITY; FMRI; BOLD; TIME; RECOVERY; ABNORMALITIES; ACTIVATION	Blood oxygenation level dependent (BOLD) resting-state functional magnetic resonance imaging (rs-fMRI) may serve as a sensitive marker to identify possible changes in the architecture of large-scale networks following mild traumatic brain injury (mTBI). Differences in functional connectivity (FC) measurements derived from BOLD rs-fMRI may however be confounded by changes in local cerebrovascular physiology and neurovascular coupling mechanisms, without changes in the underlying neuronally driven connectivity of networks. In this study, multimodal neuroimaging data including BOLD rs-fMRI, baseline cerebral blood flow (CBF0) and cerebrovascular reactivity (CVR; acquired using a hypercapnic gas breathing challenge) were collected in 23 subjects with reported mTBI (14.6 +/- 14.9 months post-injury) and 27 age-matched healthy controls. Despite no group differences in CVR within the networks of interest (P > 0.05, corrected), significantly higher CBF0 was documented in the mTBI subjects (P < 0.05, corrected), relative to the controls. A normalization method designed to account for differences in CBF0 post-mTBI was introduced to evaluate the effects of such an approach on reported group differences in network connectivity. Inclusion of regional perfusion measurements in the computation of correlation coefficients within and across large-scale networks narrowed the differences in FC between the groups, suggesting that this approach may elucidate unique changes in connectivity post-mTBI while accounting for shared variance with CBF0. Altogether, our results provide a strong paradigm supporting the need to account for changes in physiological modulators of BOLD in order to expand our understanding of the effects of brain injury on large-scale FC of cortical networks.	[Champagne, Allen A.; Coverdale, Nicole S.; Chen, Yining; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Room 260, Kingston, ON K7L 3N6, Canada; [Ross, Andrew; Murray, Christopher, I] Performance Phen, 180 John St, Toronto, ON M5T 1X5, Canada; [Dubowitz, David] Univ Auckland, Dept Anat & Med Imaging, Auckland, New Zealand; [Cook, Douglas J.] Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada		Cook, DJ (corresponding author), Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada.	a.champagne@queensu.ca; nc68@queensu.ca; a.ross@performancephenomics.com; 1yc2@queensu.ca; c.murray@performancephenomics.com; dubowitz@auckland.ac.nz; dj.cook@queensu.ca		Cook, Douglas/0000-0002-4353-6716	Performance Phenomics	This work was supported with funding provided by Performance Phenomics.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Andersson J.L., 2007, TR07JA222 FMRIB; [Anonymous], 2018, J NEUROIMAGING; Bandettini PA, 1997, NMR BIOMED, V10, P197, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<197::AID-NBM466>3.0.CO;2-S; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow K.M., 2016, J NEUROTRAUM, DOI [10.1089/neu.2016.4634, DOI 10.1089/NEU.2016.4634.]; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Beckmann CF, 2012, NEUROIMAGE, V62, P891, DOI 10.1016/j.neuroimage.2012.02.020; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bourke TC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0201-2; Brookes M.J., 2011, NEUROIMAGE, DOI [10.1016/j.neuroimage.2011.02.054, DOI 10.1016/J.NEUROIMAGE.2011.02.054.]; Burnett T., 2014, BRAIN INJURY, DOI [10.3109/02699052.2014.892379, DOI 10.3109/02699052.2014.892379.]; Champagne A.A., 2017, NEUROIMAGE, V11; Champagne A.A., 2020, NEUROIMAGE CLIN; Champagne AA, 2019, BRAIN INJURY, V33, P1479, DOI 10.1080/02699052.2019.1644375; Champagne AA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101753; Chang C., 2009, NEUROIMAGE, DOI [10.1016/j.neuroimage, DOI 10.1016/J.NEUROIMAGE.2008.09.029.]; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen G, 2014, NEUROIMAGE, V99, P571, DOI 10.1016/j.neuroimage.2014.06.027; Chu P.P.W., 2018, NEUROIMAGE, DOI [10.1016/j.neuroimage.2018.02.004., DOI 10.1016/J.NEUROIMAGE.2018.02.004.]; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Concussion in Sport Group, 2013, BR J SPORTS MED; Cox R.W., 2016, BIORXIV, DOI [10.1101/065862., DOI 10.1101/065862.]; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; da Costa L., 2016, FRONT NEUROL, V7, P1, DOI [10.3389/fneur.2016.00070, DOI 10.3389/FNEUR.2016.00070.]; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; de Munck J.C., 2007, NEUROIMAGE, DOI [10.1016/j.neuroimage, DOI 10.1016/J.NEUROIMAGE.2007.01.022.]; Donahue MJ, 2016, J CEREBR BLOOD F MET, V36, P1767, DOI 10.1177/0271678X15608643; Doshi H., 2015, PLOS ONE, DOI [10.1371/journal.pone.0118061, DOI 10.1371/JOURNAL.PONE.0118061.]; Ellis Michael J, 2016, Front Neurol, V7, P61, DOI 10.3389/fneur.2016.00061; Fisher JA, 2018, STROKE, V49, P2011, DOI 10.1161/STROKEAHA.118.021012; Fox M.D., 2007, NAT REV NEUROSCI, DOI [10. 1038/nrn2201, DOI 10.1038/NRN2201.]; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gauthier CJ, 2013, HUM BRAIN MAPP, V34, P1053, DOI 10.1002/hbm.21495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldman R.I., 2002, NEUROREPORT, DOI [10.1097/00001756-200212200, DOI 10.1097/00001756-200212200-]; Golestani A.M., 2015, NEUROIMAGE, DOI [10.1016/j.neuroimage.2014.10.031, DOI 10.1016/J.NEUROIMAGE.2014.10.031.]; Golestani AM, 2016, NEUROIMAGE, V132, P301, DOI 10.1016/j.neuroimage.2016.02.051; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Griswold M.A., 2002, MAGN RESON MED, DOI [10.1002/mrm.10171, DOI 10.1002/MRM.10171.]; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hoge RD, 2012, NEUROIMAGE, V62, P930, DOI 10.1016/j.neuroimage.2012.02.022; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lajoie I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163071; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Len T.K., 2011, CLIN PHYSIOL FUNCT I, DOI [10.1111/j.1475-097X, DOI 10.1111/J.1475-097X]; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Lin CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149109; Little CE, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0070-0; Liu P., 2018, NONLINEAR DYNAM, P1, DOI DOI 10.1007/S11071-018-4389-5; Liu PY, 2013, HUM BRAIN MAPP, V34, P2078, DOI 10.1002/hbm.22053; Liu TT, 2013, NEUROIMAGE, V80, P339, DOI 10.1016/j.neuroimage.2013.04.071; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Lord L.D., 2013, J CEREB BLOOD FLOW M, DOI [10.1038/jcbfm, DOI 10.1038/JCBFM.2013.94.]; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mark CI, 2010, MAGN RESON MED, V64, P749, DOI 10.1002/mrm.22405; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan SK, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00005; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Moosmann M, 2003, NEUROIMAGE, V20, P145, DOI 10.1016/S1053-8119(03)00344-6; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Mutch W, 2016, J NEUROSURG, V125, P525; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Nelson Janecek J.K., 2013, NEUROPSYCHOL REV, DOI [10.1007/s11065-013-9240-7, DOI 10.1007/S11065-013-9240-7.]; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Para A.E., 2017, J MAGN RESON IMAGING, DOI [10.1002/jmri.25639., DOI 10.1002/JMRI.25639.]; Poublanc J, 2015, J CEREBR BLOOD F MET, V35, P1746, DOI 10.1038/jcbfm.2015.114; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Qiu ML, 2017, NEUROIMAGE, V148, P130, DOI 10.1016/j.neuroimage.2016.12.080; Rosenthal S, 2018, NEUROIMAG CLIN N AM, V28, P107, DOI 10.1016/j.nic.2017.09.008; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stephens J.A., 2018, J NEUROTRAUM, DOI [10.1089/neu.2017.5237., DOI 10.1089/NEU.2017.5237.]; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tak S, 2015, BRAIN CONNECT, V5, P137, DOI 10.1089/brain.2014.0299; Tak S, 2014, NEUROIMAGE, V84, P672, DOI 10.1016/j.neuroimage.2013.09.057; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Vergara V.M., 2018, NEUROIMAGE-CLIN, DOI [10.1016/j.nicl.2018.03.017., DOI 10.1016/J.NICL.2018.03.017.]; Vergara V.M., 2016, J NEUROTRAUM, DOI [10.1089/neu.2016.4526, DOI 10.1089/NEU.2016.4526.]; Vergara VM, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.809; Vergara Victor M., 2017, NEUROIMAGE, DOI [10.1016/j.neuroimage, DOI 10.1016/J.NEUROIMAGE.2016.03.038.]; Wang YQ, 2019, B ENG GEOL ENVIRON, V78, P2851, DOI 10.1007/s10064-018-1278-6; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Wu CW, 2009, NEUROIMAGE, V45, P694, DOI 10.1016/j.neuroimage.2008.12.066; Xiong K.L., 2016, NEURORADIOLOGY, DOI [10.1007/s00234-016-1675-0., DOI 10.1007/S00234-016-1675-0.]; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	105	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	26								102204	10.1016/j.nicl.2020.102204			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LN7YO	WOS:000533149400022	32058317	Green Published, gold			2022-02-06	
J	Conder, A; Conder, R; Friesen, C				Conder, Alanna; Conder, Robert; Friesen, Christopher			Neurorehabilitation of Persistent Sport-Related Post-Concussion Syndrome	NEUROREHABILITATION			English	Article						Concussion; sport concussion; mild traumatic brain injury; Post-Concussion Syndrome; biofeedback	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; OF-THE-LITERATURE; COGNITIVE REHABILITATION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; CLINICAL RECOVERY; SEX-DIFFERENCES; SYMPTOMS; AGE	BACKGROUND: Persistent Sport-Related Post-Concussion Syndrome is often diagnosed with any type of prolonged PCS symptoms. However, there are not specific diagnostic criteria for PPCS such that misdiagnosis often occurs. Further, the signs and symptoms of PCS overlap with other common illnesses such as depression, anxiety, migraines, ADHD and others. Misdiagnosis may lead to less than efficacious treatment, resulting in prolonged symptoms. OBJECTIVE: This article will review relevant evidence-based literature on PCS, pointing out the lack of a systemic diagnostic framework. It will also provide evidence that highlights the multiple conflicting findings in the literature. This article will posit the BioPsychoSocial framework as the best diagnostic framework for understanding the impact of concussions on the person and to generate individualized and personal interventions. METHODS: A narrative review of sport concussion-related articles was conducted, after extensive searches of relevant and non-relevant literature by each author, as well as articles recommended by colleagues. Articles varied from American Academy of Neurology Class I to IV for evaluation and critique. Class IV articles were reviewed, as there is much public misconception regarding sport and other concussion treatment that needed identification and discussion. RESULTS: Articles reviewed varied by quality of research design and methodology. Multiple symptoms, recovery patterns and rehabilitation treatment approaches are purported in the sport-related concussion literature. Current consensus data as well as the mixed and contradictory findings were explored. CONCLUSIONS: Persistent Sport-Related Post-Concussion Syndrome is a topic of great interest to both professionals and the general public. There is much misunderstanding about the etiology, causation, diagnostic formulations, symptom presentation, prolonging factors and treatment involved in this syndrome. This article posits an individualized multi-system diagnostic formulation, examining all relevant factors, as generating the best interventions for neurorehabilitation of Persistent Sport-Related Post-Concussion Syndrome.	[Conder, Alanna; Conder, Robert] Carolina Neuropsychol Serv, Raleigh, NC 27609 USA; [Friesen, Christopher] Niagara Neuropsychol, Grimsby, ON, Canada		Conder, R (corresponding author), Carolina Neuropsychol Serv, Raleigh, NC 27609 USA.	Bconder10@gmail.com					Ahn S, 2011, J PEDIATR PSYCHOL, V36, P385, DOI 10.1093/jpepsy/jsq107; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Beauchamp MK, 2012, J CLIN SPORT PSYCHOL, V6, P67, DOI 10.1123/jcsp.6.1.67; Beck J.S., 2011, COGNITIVE BEHAV THER, V2nd ed; Bender MC, 2003, WILL TRAUM BRAIN INJ; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown RP, 2009, ANN NY ACAD SCI, V1172, P54, DOI 10.1111/j.1749-6632.2009.04394.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR TRAUM; Choe MC, 2016, J CHILD NEUROL, V31, P76, DOI 10.1177/0883073814568152; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Conder R, 1988, Brain Inj, V2, P365, DOI 10.3109/02699058809150909; Conder R, 1992, NEUROREHABILITATIVE, P7; Conder R, 2015, BRAIN INJURY, V29, P249, DOI 10.3109/02699052.2014.965209; Conder RL, 2015, APPL NEUROPSYCH-CHIL, V4, P141, DOI 10.1080/21622965.2013.816849; Conder Robert L, 2015, N C Med J, V76, P89; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; Covassin T, 2014, J ATHL TRAINING, V49, P462, DOI 10.4085/1062-6059-49.2.03; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Creswell JD, 2017, ANNU REV PSYCHOL, V68, P491, DOI 10.1146/annurev-psych-042716-051139; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Ewing ME, 2002, SUNY SER SPORT, P31; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fletcher D, 2012, PSYCHOL SPORT EXERC, V13, P669, DOI 10.1016/j.psychsport.2012.04.007; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz Kevin, 2015, N C Med J, V76, P93; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey DJ, 2011, TXB TRAUMATIC BRAIN, P453; Helmick K, 2010, NEUROREHABILITATION, V26, P239, DOI 10.3233/NRE-2010-0560; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Institute of Medicine and National Research Council, 2013, SPORTS REL CONC YOUT; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobs GD, 2004, ARCH INTERN MED, V164, P1888, DOI 10.1001/archinte.164.17.1888; Jacobson E., 1938, PROGR RELAXATION; Janicak PG, 2015, NEUROPSYCH DIS TREAT, V11, P1549, DOI 10.2147/NDT.S67477; Khazan IZ., 2013, CLIN HDB BIOFEEDBACK; Kirk JW, 2012, MILD TRAUMATIC BRAIN, P321; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kreutzer JS, 1989, COGNITIVE REHABILITA, V7, P30; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lagos L., 2012, BIOFEEDBACK, V40, P150, DOI [10.5298/1081-5937-40.4.05, DOI 10.5298/1081-5937-40.4.05]; Lagos L., 2013, BIOFEEDBACK, V41, P136, DOI [DOI 10.5298/1081-5937-41.3.02, 10.5298/1081-5937-41.3.02]; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; LeUnes A, 2008, SPORTS PSYCHOL; Lovell MR, 2006, SPORTS NEUROPSYCHOLO, P176; Lumba-Brown Angela, 2019, Concussion, V4, pCNC65, DOI 10.2217/cnc-2019-0005; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; McLeod TCV, 2010, ATHLET THER TODAY, V15, P1, DOI 10.1123/att.15.2.1; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Neidecker JM, 2017, J AM OSTEOPATH ASSOC, V117, P635, DOI 10.7556/jaoa.2017.120; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Norris PA, 2003, BIOFEEDBACK PRACTITI, P175; Pertab JL, 2018, NEUROREHABILITATION, V42, P397, DOI 10.3233/NRE-172298; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Rieck T, 2013, MED SCI SPORT EXER, V45, P1083, DOI 10.1249/MSS.0b013e3182831db1; Rieger B, 2019, J INT NEUROPSYCH SOC, V25, P777, DOI 10.1017/S1355617719000468; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schwartz MS, 2003, BIOFEEDBACK PRACTITI, P265; Sisto A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55110745; Strack B., 2011, BIOFEEDBACK NEUROFEE; Tan G, 2016, EVIDENCE BASED PRACT; Tan G, 2009, PAIN MED, V10, P1237, DOI 10.1111/j.1526-4637.2009.00712.x; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Thatcher RW, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P241, DOI 10.1007/0-387-32565-4_11; Weiss M.R., 2012, OXFORD HDB SPORT PER, P448, DOI DOI 10.1093/OXFORDHB/9780199731763.013.0024; Werthner P, 2013, NEUROCONNECTIONS, V2, P32; Wilson VE, 2011, BIOFEEDBACK NEUROFEE, P107; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	114	5	5	4	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	2					167	180		10.3233/NRE-192966			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	LE6CR	WOS:000526811100004	32083597	Bronze			2022-02-06	
J	Ghadiri, T; Gorji, A; Vakilzadeh, G; Hajali, V; Khodagholi, F; Sharifzadeh, M				Ghadiri, Tahereh; Gorji, Ali; Vakilzadeh, Gelareh; Hajali, Vahid; Khodagholi, Fariba; Sharifzadeh, Mohammad			Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Apoptosis; Convulsive; Hippocampus; Neuroinflammation; Post-traumatic; Seizure	NF-KAPPA-B; LATE POSTTRAUMATIC SEIZURES; BARRIER LEAKAGE; ANIMAL-MODEL; RISK-FACTORS; KAINIC ACID; EPILEPSY; HIPPOCAMPUS; PATHWAY; NRF2	Objective(s): While traumatic brain injury (TBI) is a predisposing factor for development of post-traumatic epilepsy (PTE), the occurrence of seizures following brain trauma can infuriate adverse consequences of brain injury. However, the effect of seizures in epileptogenesis after mild TBI cannot yet be accurately confirmed. This study was designed to investigate the histopathological and molecular modifications induced by seizures on traumatized brain. Materials and Methods: Using a new method, head was traumatized and seizures were evoked by subconvulsive dose of pentylenetetrazole (PTZ) fifteen days after induction of focal mild TBI. Convulsion assessments were performed one hour after PTZ injection and was followed by histopathological and molecular evaluations. Results: A significantly higher score and longer duration of seizure attacks as well as higher number of epileptiform discharges were observed in the TBI+PTZ group compared to sham and TBI groups. An elevated number of apoptotic cells was observed in the TBI+PTZ group compared to sham and TBI rats. Molecular investigations revealed higher levels of Bax/Bcl2 ratio, Caspase 3, and NF-kappa B in the TBI+PTZ group compared to the other animal groups. The value of Nrf2 did not change after mild TBI compared to sham and PTZ control groups. Occurrence of seizures after TBI, however, significantly decreased the level of Nrf2. Conclusion: Our data indicated that seizure occurrence following mild TBI aggravates cell injury and death via activation of neuroinflammatory processes and may increase the risk of PTE. Additionally, our results suggest a potential protective role of Nrf2 after chemically evoked PTE.	[Ghadiri, Tahereh] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Neurosci, Tabriz, Iran; [Ghadiri, Tahereh; Gorji, Ali; Vakilzadeh, Gelareh] Khatamolanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Gorji, Ali] Munster Univ, Dept Neurol, Dept Neurosurg Dept, Munster, Germany; [Gorji, Ali] Munster Univ, Epilepsy Res Ctr, Munster, Germany; [Gorji, Ali] Razavi Hosp, Razavi Neurosci Ctr, Mashhad, Razavi Khorasan, Iran; [Hajali, Vahid] Mashhad Univ Med Sci, Quchan Higher Hlth Educ Ctr, Mashhad, Razavi Khorasan, Iran; [Khodagholi, Fariba] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Sharifzadeh, Mohammad] Univ Tehran Med Sci, Fac Pharm, Dept Toxicol, Tehran, Iran		Ghadiri, T (corresponding author), Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Neurosci, 29 Bahman Blvd, East Azarbayjan, Tabriz, Iran.	ghadirit@tbzmed.ac.ir	Khodagholi, Fariba/AAZ-4436-2020; Ghadiri, Tahereh/AAU-7811-2020	Ghadiri, Tahereh/0000-0002-3568-8699	Tehran University of Medical SciencesTehran University of Medical Sciences; Shefa Neuroscience Research Center [267258]	We thank Dr Philippe Coulon for his critical review of the manuscript. This article was part of a PhD thesis supported by grants from Tehran University of Medical Sciences, and the Shefa Neuroscience Research Center (Dr-Thesis 267258).	Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bao Y. H., 2010, J NEUROTRAUM, V28, P35; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bigford GE, 2009, J NEUROTRAUM, V26, P703, DOI 10.1089/neu.2008.0783; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Conti AC, 1998, J NEUROSCI, V18, P5663; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Eftekhar B, 2009, J NEUROSURG, V110, P319, DOI 10.3171/2008.4.17519; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frye CA, 2000, PSYCHONEUROENDOCRINO, V25, P407, DOI 10.1016/S0306-4530(99)00068-2; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Ghadiri T, 2014, J NEUROSCI METH, V233, P18, DOI 10.1016/j.jneumeth.2014.05.035; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Henshall DC, 2005, J CEREBR BLOOD F MET, V25, P1557, DOI 10.1038/sj.jcbfm.9600149; Herman ST, 2006, EPILEPSY RES, V68, P35, DOI 10.1016/j.eplepsyres.2005.09.015; Iannone M, 2010, NEUROSCI LETT, V469, P93, DOI 10.1016/j.neulet.2009.11.051; Jafarian M, 2015, NEUROSCIENCE, V298, P161, DOI 10.1016/j.neuroscience.2015.04.033; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kharatishvili I, 2010, EPILEPSY RES, V90, P47, DOI 10.1016/j.eplepsyres.2010.03.007; Khodaie B, 2015, BEHAV BRAIN RES, V278, P55, DOI 10.1016/j.bbr.2014.09.034; Kong SZ, 2010, BRAIN RES, V1355, P207, DOI 10.1016/j.brainres.2010.07.088; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Naseer MI, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-20; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Otsuki Y, 2003, PROG HISTOCHEM CYTO, V38, P275, DOI 10.1016/S0079-6336(03)80002-5; Patel M, 2015, EPILEPSY CURR, V15, P39, DOI 10.5698/1535-7597-15.1.39; Pitkanen A., 2012, JASPERS BASIC MECH E, V4th; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Statler KD, 2008, EPILEPSY RES, V80, P163, DOI 10.1016/j.eplepsyres.2008.04.001; Vakilzadeh G, 2015, MOL NEUROBIOL, V52, P130, DOI 10.1007/s12035-014-8857-8; van Vliet EA, 2007, J PHARMACOL EXP THER, V322, P141, DOI 10.1124/jpet.107.121178; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROSCIENCE, V277, P455, DOI 10.1016/j.neuroscience.2014.07.030; van Vliet EA, 2016, EPILEPSIA, V57, P59, DOI 10.1111/epi.13246; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	55	5	6	0	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JAN	2020	23	1					63	70		10.22038/IJBMS.2019.37558.8932			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	JQ3TN	WOS:000498871600009	32405349				2022-02-06	
J	Guberman, GI; Houde, JC; Ptito, A; Gagnon, I; Descoteaux, M				Guberman, Guido I.; Houde, Jean-Christophe; Ptito, Alain; Gagnon, Isabelle; Descoteaux, Maxime			Structural abnormalities in thalamo-prefrontal tracks revealed by high angular resolution diffusion imaging predict working memory scores in concussed children	BRAIN STRUCTURE & FUNCTION			English	Article						Concussion; Mild TBI; Diffusion-weighted imaging; Constrained spherical deconvolution	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; FIBER DENSITY; AXONAL INJURY; MILD; TRACTOGRAPHY; MRI; VALIDATION; ACTIVATION	Because of their high prevalence, heterogeneous clinical presentation, and wide-ranging sequelae, concussions are a challenging neurological condition, especially in children. Shearing forces transmitted across the brain during concussions often result in white matter damage. The neuropathological impact of concussions has been discerned from animal studies and includes inflammation, demyelination, and axonal loss. These pathologies can overlap during the sub-acute stage of recovery. However, due to the challenges of accurately modeling complex white matter structure, these neuropathologies have not yet been differentiated in children in vivo. In the present study, we leveraged recent advances in diffusion imaging modeling, tractography, and tractometry to better understand the neuropathology underlying working memory problems in concussion. Studying a sample of 16 concussed and 46 healthy youths, we used novel tractography methods to isolate 11 working memory tracks. Along these tracks, we measured fractional anisotropy, diffusivities, track volume, apparent fiber density, and free water fraction. In three tracks connecting the right thalamus to the right dorsolateral prefrontal cortex (DLPFC), we found microstructural differences suggestive of myelin alterations. In another track connecting the left anterior-cingulate cortex with the left DLPFC, we found microstructural changes suggestive of axonal loss. Structural differences and tractography reconstructions were reproduced using test-retest analyses. White matter structure in the three thalamo-prefrontal tracks, but not the cingulo-prefrontal track, appeared to play a key role in working memory function. The present results improve understanding of working memory neuropathology in concussions, which constitutes an important step toward developing neuropathologically informed biomarkers of concussion in children.	[Guberman, Guido I.; Ptito, Alain] McGill Univ, Fac Med, Dept Neurol, Neurosurgery, Montreal, QC, Canada; [Houde, Jean-Christophe; Descoteaux, Maxime] Sherbrooke Univ, Dept Comp Sci, Sherbrooke, QC, Canada; [Gagnon, Isabelle] McGill Univ, Montreal Children's Hosp, Fac Med, Dept Pediat, Quebec City, PQ, Canada; [Guberman, Guido I.] Montreal Neurol Inst, 3801 Univ, Montreal, QC H3A 2B4, Canada		Guberman, GI (corresponding author), McGill Univ, Fac Med, Dept Neurol, Neurosurgery, Montreal, QC, Canada.; Guberman, GI (corresponding author), Montreal Neurol Inst, 3801 Univ, Montreal, QC H3A 2B4, Canada.	guido.guberman@mail.mcgill.ca	Guberman, Guido/AAD-2412-2019	Guberman, Guido/0000-0002-4422-2225; Gagnon, Isabelle/0000-0003-2043-1644			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bolkan SS, 2017, NAT NEUROSCI, V20, P987, DOI 10.1038/nn.4568; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Dyrby TB, 2014, NEUROIMAGE, V103, P202, DOI 10.1016/j.neuroimage.2014.09.005; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Faul M, 2010, TRAUMATIC BRAIN INJU; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Girard G, 2014, NEUROIMAGE, V98, P266, DOI 10.1016/j.neuroimage.2014.04.074; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guberman G, 2019, MONTREAL NEUROLOGICA, DOI [10.17605/OSF.IO/QKVS7, DOI 10.17605/0SF.I0/QKVS7]; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Holland RL, 2016, ADV PRECIS MED, V1, P4, DOI [10.18063/APM.2016.01.007, DOI 10.18063/APM.2016.01.007]; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Mito R, 2018, BRAIN, V141, P888, DOI 10.1093/brain/awx355; Orlovska S, 2014, AM J PSYCHIAT, V171, P463, DOI 10.1176/appi.ajp.2013.13020190; Palacios EM, 2018, EVOLUTION WHITE MATT, DOI [10.1101/345629, DOI 10.1101/345629]; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pasternak O, 2016, SCHIZOPHR RES, V173, P200, DOI 10.1016/j.schres.2015.05.034; Pasternak O, 2012, LECT NOTES COMPUT SC, V7511, P305, DOI 10.1007/978-3-642-33418-4_38; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Petrides M, 2001, NEUROIMAGE, V13, pS721; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Powell JL, 2012, NEUROSCIENCE, V207, P227, DOI 10.1016/j.neuroscience.2012.01.016; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt DA, 2017, NEUROIMAGE, V144, P58, DOI 10.1016/j.neuroimage.2016.09.029; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Salter H, 2014, J INTERN MED, V276, P215, DOI 10.1111/joim.12234; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spader HS, 2019, J NEUROSURG, V130, P1321, DOI 10.3171/2017.12.JNS171597; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; St-Jean S, 2016, MED IMAGE ANAL, V32, P115, DOI 10.1016/j.media.2016.02.010; Stern CE, 2000, NEUROIMAGE, V11, P392, DOI 10.1006/nimg.2000.0569; Sun CQ, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00024; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Ware JB, 2017, J NEUROTRAUM, V34, P2243, DOI 10.1089/neu.2016.4817; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; You YY, 2019, BRAIN, V142, P426, DOI 10.1093/brain/awy338; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	99	5	6	1	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	JAN	2020	225	1					441	459		10.1007/s00429-019-02002-8			19	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology; Neurosciences & Neurology	KJ2IQ	WOS:000511881800028	31894406	Green Submitted			2022-02-06	
J	Keenan, HT; Clark, AE; Holubkov, R; Ewing-Cobbs, L				Keenan, Heather T.; Clark, Amy E.; Holubkov, Richard; Ewing-Cobbs, Linda			Changing Healthcare and School Needs in the First Year After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health services; pediatrics; rehabilitation; traumatic brain injury	INPATIENT REHABILITATION; EXECUTIVE FUNCTION; CHILDREN; SERVICES; ADOLESCENTS; CONCUSSION; DISABILITY; DISORDERS; OUTCOMES; QUALITY	Objective: To examine children's unmet and unrecognized healthcare and school needs following traumatic brain injury (TBI). Setting: Two pediatric trauma centers. Participants: Children with all severity of TBI aged 4 to 15 years. Design: Prospective cohort. Main Measures: Caregivers provided child health and school service use 3 and 12 months postinjury. Unmet and unrecognized needs were categorized compared with norms on standardized physical, cognitive, socioemotional health, or academic competence measures in conjunction with caregiver report of needs and services. Modified Poisson models examined child and family predictors of unmet and unrecognized needs. Results: Of 322 children, 28% had unmet or unrecognized healthcare or school needs at 3 months, decreasing to 24% at 12 months. Unmet healthcare needs changed from primarily physical (79%) at 3 months to cognitive (47%) and/or socioemotional needs (68%) at 12 months. At 3 months, low social capital, preexisting psychological diagnoses, and 6 to 11 years of age predicted higher healthcare needs and severe TBI predicted higher school needs. Twelve months postinjury, prior inpatient rehabilitation, low income, and preexisting psychological diagnoses were associated with higher healthcare needs; family function was important for school and healthcare needs. Conclusions: Targeted interventions to provide family supports may increase children's access to services.	[Keenan, Heather T.; Clark, Amy E.; Holubkov, Richard] Univ Utah, Dept Pediat, Div Crit Care, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA; [Ewing-Cobbs, Linda] Univ Texas Houston, McGovern Med Sch, Dept Pediat, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Houston, McGovern Med Sch, Childrens Learning Inst, Houston, TX USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, Div Crit Care, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]	This study was supported by the Centers for Disease Control and Prevention under Cooperative Agreement no. U01/CE002188. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. Dr Keenan was supported by theNational Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (K24HD072984).	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Anderson V, 2017, J NEUROTRAUM, V34, P2261, DOI 10.1089/neu.2016.4692; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; Birken Catherine S, 2004, Paediatr Child Health, V9, P323; Centers for Disease Control and Prevention, HEADS; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ennis SK, 2013, BRAIN INJURY, V27, P179, DOI 10.3109/02699052.2012.729291; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Fuentes MM, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2859; Gioa GA, 2000, BEHAV RATING INVENTO; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Glang A, 2008, NEUROREHABILITATION, V23, P477; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Haarbauer-Krupa J, 2018, NEUROREHABILITATION, V42, P259, DOI 10.3233/NRE-172410; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hooper S R, 2001, N C Med J, V62, P350; IDEA, 2004, PUB L; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lumba-Brown A, 2016, REPORT FORM PEDIAT M; Max JE, 2015, J PEDIATR REHAB MED, V8, P345, DOI 10.3233/PRM-150352; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Moore M, 2016, AM J PHYS MED REHAB, V95, P204, DOI 10.1097/PHM.0000000000000362; National Center for Health Statistics, NAT HLTH INT SURV; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; TEASDALE G, 1974, LANCET, V2, P81; Vittinghoff E, 2012, REGRESSION METHODS B; Ware JE., 1999, CHILD HLTH QUESTIONN; Williams J, 2004, PEDIATRICS, V114, P601, DOI 10.1542/peds.2004-0090; Zonfrillo MR, 2013, PEDIATRICS, V131, pE206, DOI 10.1542/peds.2012-1418; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	46	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		E67	E77		10.1097/HTR.0000000000000499			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300015	31246877	Green Accepted			2022-02-06	
J	King, JA; McCrea, MA; Nelson, LD				King, Jeffrey A.; McCrea, Michael. A.; Nelson, Lindsay D.			Frequency of Primary Neck Pain in Mild Traumatic Brain Injury/Concussion Patients	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Emergency service; hospital; Neck pain; Rehabilitation	WHIPLASH-ASSOCIATED DISORDERS; CERVICAL-SPINE; CONCUSSION; INJURY; PREDICTORS; SYMPTOMS	Objectives: To determine (1) the frequency of neck pain overall and relative to other symptoms in patients presenting to a level I trauma center emergency department (ED) with mild traumatic brain injury (mTBI) and (2) the predictors of primary neck pain in this population. Design: Cohort study. Setting: Level I trauma center ED. Participants: Patients presenting to the ED with symptoms of mTBI having been exposed to an event that could have caused mTBI (N=95). Interventions: Not applicable. Main Outcome Measures: Frequency of self-reported neck pain as measured by Sport Concussion Assessment Tool 3 (SCAT3) symptom questionnaire at <3, 8, 15, and 45 days post injury. Primary neck pain was defined in 2 ways: (1) neck pain rated as equal or greater in severity than all other SCAT3 symptoms and (2) neck pain worse than all other symptoms. Results: The frequency of any reported neck pain was 68.4%, 50.6%, 49%, and 41.9% within 72 hours and at 8, 15, and 45 days, respectively. Frequency of primary neck pain (equal or worse/worse definitions) was 35.8%/17.9%, 34.9%/14.5%, 37%/14.8%, and 39.2%/10.8% across the 4 follow-up assessments. Participants who sustained their injuries in motor vehicle collisions had a higher rate of primary neck pain than those with other mechanisms of injury. Conclusions: A sizable percentage of patients who present to level I trauma center EDs with mTBI report neck pain, which is commonly rated as similar to or worse than other mTBI-related symptoms. Primary neck pain is more common after motor vehicle collisions than with other mechanisms of injury. These findings support consensus statements identifying cervical injury as an important potential concurrent diagnosis in patients with mTBI. (C) 2019 by the American Congress of Rehabilitation Medicine	[King, Jeffrey A.; McCrea, Michael. A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		King, JA (corresponding author), 1155 N Mayfair Rd Wauwatosa, Milwaukee, WI 53226 USA.	jeking@mcw.edu		King, Jeff/0000-0003-2334-3746	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R03NS100691-0l]; Clinical and Translational Science Institute [UL1TR001436]	Supported by the US Army Medical Research and Materiel Command (award no. W81XWH-12-1-0004). Michael A McCrea, PhD, was the principal investigator. Secondary data analyses were supported by the National Institutes of Health (grant no. 1R03NS100691-0l). The REDCap electronic database service used for the study was supported by the Clinical and Translational Science Institute (grant no. UL1TR001436). Funding sources had no role in study design.	Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Eck JC, 2001, AM J MED, V110, P651, DOI 10.1016/S0002-9343(01)00680-5; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrari R, 2005, ANN RHEUM DIS, V64, P1337, DOI 10.1136/ard.2004.034447; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Helmick K, 2006, DEFENSE VETERANS BRA, P1; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nelson LD, 2018, J NEUROTRAUM, V35, P249, DOI 10.1089/neu.2017.4988; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5	19	5	5	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2020	101	1					89	94		10.1016/j.apmr.2019.08.471			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	KA2PR	WOS:000505640300010	31493383	Green Accepted			2022-02-06	
J	Li, XG; Tong, J; Liu, JH; Wang, YB				Li, Xinguo; Tong, Jing; Liu, Jihui; Wang, Yibao			Down-regulation of ROCK2 alleviates ethanol-induced cerebral nerve injury partly by the suppression of the NF-kappa B signaling pathway	BIOENGINEERED			English	Article						Ethanol; brain injury; apoptosis; oxidative stress; inflammatory response; NF-kappa B signaling pathway	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; PARKINSONS-DISEASE; ACTIVATION; KINASE; NEURODEGENERATION; NEUROPROTECTION; EXPRESSION; APOPTOSIS; PROTECTS	Chronic alcohol consumption leads to hippocampal neuronal impairment, which related to neuronal death, oxidative stress, and inflammatory response. Rho-associated protein kinase 2 (ROCK2) is a major regulator in the central nervous system injury. However, the effects of ROCK2 in ethanol-induced brain injury have not been explored. In this work, we investigated the neuroprotective effects and the mechanism of ROCK2 inhibition in vivo. Wistar rats were exposed to 37% ethanol for 8 weeks to establish brain injury models. Morris water maze test was performed to evaluate cognitive function, and we found that the down-regulation of ROCK2 reduced the escape latency and increased the passing times and percentage of time spent in the target quadrant of rats. The results of H&E staining and Nissl staining showed that ROCK2 inhibition alleviated the pathological injury induced by ethanol. PI staining and Western blot confirmed that inhibiting ROCK2 attenuated the neuronal death and apoptosis as reflected by the reduced PI-positive neurons and the decreased expression of cleaved-caspase-3 and cleaved-caspase-9. Furthermore, the down-regulation of ROCK2 ameliorated the oxidative stress and inflammatory response induced by ethanol in rats as reflected by the up-regulation of IL-10, SOD, and GSH and reduction of TNF-alpha, IL-6, and MDA respectively. Additionally, Western blot and EMSA analysis revealed that the down-regulation of ROCK2 suppressed the nuclear transfer of NF-kappa B p65. In conclusion, our data suggested that ROCK2 inhibition ameliorated ethanol-mediated hippocampal neuronal impairment by anti-apoptotic, anti-inflammatory, anti-oxidative effects at least partially through the suppression of the NF-kappa B pathway. [GRAPHICS]	[Li, Xinguo; Liu, Jihui; Wang, Yibao] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Peoples R China; [Tong, Jing] China Med Univ, Hosp 1, Dept Gastroenterol, Shenyang, Peoples R China		Wang, YB (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Peoples R China.	lee04032526@yeah.net		Reis, AlessanRSS/0000-0001-8486-7469	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81700453]	This work was supported by the National Natural Science Foundation of China [No. 81700453].	Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bai X, 2015, SCI REP, V5, P1; Castillo J, 2003, ANN NEUROL, V54, P811, DOI 10.1002/ana.10765; Chen W, 2020, ACTA PHARMACOL SIN B, V10, P1347, DOI 10.1016/j.apsb.2020.01.015; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Das SK, 2007, INDIAN J CLIN BIOCHE, V22, P99, DOI 10.1007/BF02912890; Das S, 2014, AM J RESP CELL MOL, V50, P882, DOI 10.1165/rcmb.2013-0195OC; Ding HS, 2019, J STROKE CEREBROVASC, V28, P149, DOI 10.1016/j.jstrokecerebrovasdis.2018.09.023; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Forgione N, 2014, WORLD NEUROSURG, V82, pE535, DOI 10.1016/j.wneu.2013.01.009; FREUND G, 1994, ALCOHOL, V11, P385, DOI 10.1016/0741-8329(94)90022-1; Henderson BW, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaw9318; Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jung ME, 2005, EXP BIOL MED, V230, P8; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Ku BM, 2007, NEUROSCI LETT, V419, P64, DOI 10.1016/j.neulet.2007.03.049; Kumral A, 2005, DEV BRAIN RES, V160, P146, DOI 10.1016/j.devbrainres.2005.08.006; Lai AY, 2018, J NEUROCHEM, V144, P659, DOI 10.1111/jnc.14130; Lee SJ, 1999, GLIA, V25, P21, DOI 10.1002/(SICI)1098-1136(19990101)25:1<21::AID-GLIA3>3.0.CO;2-R; Lezoualc'h F, 1998, MOL PSYCHIATR, V3, P15, DOI 10.1038/sj.mp.4000295; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Liu J, 2015, NEURAL REGEN RES, V10, P1892, DOI 10.4103/1673-5374.170325; Liu YY, 2019, BRAIN BEHAV IMMUN, V82, P63, DOI 10.1016/j.bbi.2019.07.033; Matthews DB, 2000, HIPPOCAMPUS, V10, P122, DOI 10.1002/(SICI)1098-1063(2000)10:1<122::AID-HIPO13>3.3.CO;2-M; Mong PY, 2009, J IMMUNOL, V182, P2385, DOI 10.4049/jimmunol.0802811; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Nozaki Y, 2015, AM J PHYSIOL-RENAL, V308, pF899, DOI 10.1152/ajprenal.00362.2014; Saal KA, 2015, NEUROBIOL DIS, V73, P150, DOI 10.1016/j.nbd.2014.09.013; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Si WW, 2019, INT J MOL MED, V43, P1452, DOI 10.3892/ijmm.2019.4073; Song Y, 2013, CNS NEUROSCI THER, V19, P603, DOI 10.1111/cns.12116; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Vallieres L, 1999, ENDOCRINOLOGY, V140, P3890, DOI 10.1210/en.140.9.3890; Walter TJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0856-z; Wang P, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4079425; Ward RJ, 2008, PROG NEUROBIOL, V85, P135, DOI 10.1016/j.pneurobio.2008.03.003; Weissbach A, 2017, ANN NEUROL, V82, P543, DOI 10.1002/ana.25035; Yang WJ, 2018, J AUTOIMMUN, V89, P125, DOI 10.1016/j.jaut.2017.12.009; Yang XY, 2013, BRAIN RES, V1533, P16, DOI 10.1016/j.brainres.2013.08.009; Zhao QY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0728-y; Zhu Y, 2004, NEUROSCIENCE, V123, P897, DOI 10.1016/j.neuroscience.2003.10.037	46	5	5	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2165-5979	2165-5987		BIOENGINEERED	Bioengineered	JAN 1	2020	11	1					779	790		10.1080/21655979.2020.1795404			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	MM3UG	WOS:000550084500001	32684089	Green Published, gold			2022-02-06	
J	Manukhina, EB; Tseilikman, VE; Karpenko, MN; Pestereva, NS; Tseilikman, OB; Komelkova, MV; Kondashevskaya, MV; Goryacheva, AV; Lapshin, MS; Platkovskii, PO; Sarapultsev, AP; Alliluev, AV; Downey, HF				Manukhina, Eugenia B.; Tseilikman, Vadim E.; Karpenko, Marina N.; Pestereva, Nina S.; Tseilikman, Olga B.; Komelkova, Maria V.; Kondashevskaya, Marina V.; Goryacheva, Anna V.; Lapshin, Maxim S.; Platkovskii, Pavel O.; Sarapultsev, Alexey P.; Alliluev, Anatoly V.; Downey, H. Fred			Intermittent Hypoxic Conditioning Alleviates Post-Traumatic Stress Disorder-Induced Damage and Dysfunction of Rat Visceral Organs and Brain	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						posttraumatic stress disorder; intermittent hypoxia conditioning; heart; liver; brain; oxidative stress	ELEVATION MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; ANIMAL-MODEL; PROGNOSTIC-SIGNIFICANCE; OXIDATIVE STRESS; PHYSICAL HEALTH; LIVER-ENZYMES; RISK; ISCHEMIA	Posttraumatic stress disorder (PTSD) causes mental and somatic diseases. Intermittent hypoxic conditioning (IHC) has cardio-, vaso-, and neuroprotective effects and alleviates experimental PTSD. IHC's ability to alleviate harmful PTSD effects on rat heart, liver, and brain was examined. PTSD was induced by 10-day exposure to cat urine scent (PTSD rats). Some rats were then adapted to 14-day IHC (PTSD+IHC rats), while PTSD and untreated control rats were cage rested. PTSD rats had a higher anxiety index (AI, X-maze test), than control or PTSD+IHC rats. This higher AI was associated with reduced glycogen content and histological signs of metabolic and hypoxic damage and of impaired contractility. The livers of PTSD rats had reduced glycogen content. Liver and blood alanine and aspartate aminotransferase activities of PTSD rats were significantly increased. PTSD rats had increased norepinephrine concentration and decreased monoamine oxidase A activity in cerebral cortex. The PTSD-induced elevation of carbonylated proteins and lipid peroxidation products in these organs reflects oxidative stress, a known cause of organ pathology. IHC alleviated PTSD-induced metabolic and structural injury and reduced oxidative stress. Therefore, IHC is a promising preventive treatment for PTSD-related morphological and functional damage to organs, due, in part, to IHC's reduction of oxidative stress.	[Manukhina, Eugenia B.; Tseilikman, Vadim E.; Tseilikman, Olga B.; Komelkova, Maria V.; Lapshin, Maxim S.; Platkovskii, Pavel O.; Alliluev, Anatoly V.; Downey, H. Fred] South Ural State Univ, Sch Med Biol, Chelyabinsk 454080, Russia; [Manukhina, Eugenia B.; Goryacheva, Anna V.] Inst Gen Pathol & Pathophysiol, Lab Regulatory Mech Stress & Adaptat, Moscow 125315, Russia; [Manukhina, Eugenia B.; Downey, H. Fred] Univ North Texas, Hlth Sci Ctr, Dept Physiol & Anat, Ft Worth, TX 76107 USA; [Karpenko, Marina N.; Pestereva, Nina S.] Inst Expt Med, IP Pavlov Physiol Dept, St Petersburg 197376, Russia; [Tseilikman, Olga B.] Chelyabinsk State Univ, Sch Basic Med, Chelyabinsk 454001, Russia; [Kondashevskaya, Marina V.] Human Morphol Res Inst, Lab Immunomorphol Inflammat, Moscow 117418, Russia; [Sarapultsev, Alexey P.] Russian Acad Sci, Inst Immunol & Physiol, Lab Immunopathophysiol, Ural Branch, Ekaterinburg 620049, Russia		Manukhina, EB (corresponding author), South Ural State Univ, Sch Med Biol, Chelyabinsk 454080, Russia.; Manukhina, EB (corresponding author), Inst Gen Pathol & Pathophysiol, Lab Regulatory Mech Stress & Adaptat, Moscow 125315, Russia.; Manukhina, EB (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Physiol & Anat, Ft Worth, TX 76107 USA.	manukh@mail.ru; tseylikman.vadim@mail.ru; mnkarpenko@mail.ru; pesterevans@yandex.ru; diol2008@yandex.ru; mkomelkova@mail.ru; actual_probl@mail.ru; goryacheva@mail.ru; lapshin1982@yandex.ru; dominipatris@yandex.ru; asarapultsev@gmail.com; malinanv_1@mail.ru; freddowney@yahoo.com	Sarapultsev, Alexey P./K-7220-2012; Aliluev, Anatoli/AAV-3795-2021; , Nina/AAP-8875-2020; Komelkova, Maria/M-6294-2016	Sarapultsev, Alexey P./0000-0003-3101-9655; Aliluev, Anatoli/0000-0003-1541-732X; , Nina/0000-0002-3104-8790; Komelkova, Maria/0000-0003-2431-8358; Downey, H. Fred/0000-0002-7280-1021; Kondashevskaya, Marina/0000-0002-8096-5974	Russian Science FoundationRussian Science Foundation (RSF) [17-15-013418]; Ministry of Education and Science of the Russian FederationMinistry of Education and Science, Russian Federation [17.7255.2017/8.9]	This research was funded by the Russian Science Foundation, grant number 17-15-013418, and the Ministry of Education and Science of the Russian Federation, grant number 17.7255.2017/8.9.	Altuna ME, 2006, CAN J PHYSIOL PHARM, V84, P977, DOI 10.1139/Y06-046; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Black CN, 2015, PSYCHONEUROENDOCRINO, V51, P164, DOI 10.1016/j.psyneuen.2014.09.025; Boscarino JA, 2003, J TRAUMA STRESS, V16, P301, DOI 10.1023/A:1023708410513; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Chida Y, 2006, J GASTROEN HEPATOL, V21, P202, DOI 10.1111/j.1440-1746.2006.04110.x; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2008, BIOL PSYCHIAT, V64, P708, DOI 10.1016/j.biopsych.2008.05.025; Cohen H, 2012, NEUROPHARMACOLOGY, V62, P715, DOI 10.1016/j.neuropharm.2011.04.023; Crenesse D, 2001, HEPATOLOGY, V34, P972, DOI 10.1053/jhep.2001.28709; Datta D, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050113; DIMSDALE JE, 1987, CIRCULATION, V76, P198; Edmondson D, 2017, LANCET PSYCHIAT, V4, P320, DOI 10.1016/S2215-0366(16)30377-7; Edmondson D, 2013, AM HEART J, V166, P806, DOI 10.1016/j.ahj.2013.07.031; Flatt JD, 2018, ALZHEIMERS DEMENT, V14, P28, DOI 10.1016/j.jalz.2017.04.014; Gasbarrini A, 1997, FREE RADICAL BIO MED, V23, P1067, DOI 10.1016/S0891-5849(97)00141-X; Goryacheva AV, 2010, NITRIC OXIDE-BIOL CH, V23, P289, DOI 10.1016/j.niox.2010.08.005; Grunewald M, 2012, J BIOL CHEM, V287, P24195, DOI 10.1074/jbc.M112.373936; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; Hashmi S, 2015, INT J CLIN EXP PATHO, V8, P8786; Horn SR, 2016, EXP NEUROL, V284, P119, DOI 10.1016/j.expneurol.2016.07.002; Hzhehots'kyi M P, 2006, Fiziol Zh, V52, P90; Johansson L, 2014, NEUROLOGY, V83, P1538, DOI 10.1212/WNL.0000000000000907; Jung ME, 2008, J APPL PHYSIOL, V105, P510, DOI 10.1152/japplphysiol.90317.2008; Kamat PK, 2016, MOL NEUROBIOL, V53, P2451, DOI 10.1007/s12035-015-9212-4; Kanungo S, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.59; Kolesnikova EE, 2009, PHYSIOL LAB CLIN RES, P549; Kondashevskaya M. V., 2019, Doklady Biological Sciences, V485, P30, DOI 10.1134/S0012496619020042; Kondashevskaya MV, 2018, B EXP BIOL MED+, V164, P488, DOI 10.1007/s10517-018-4018-9; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Kushwah N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149309; Lazo M, 2015, J HEPATOL, V62, P841, DOI 10.1016/j.jhep.2014.11.024; Lazuko SS, 2018, CELL MOL NEUROBIOL, V38, P209, DOI 10.1007/s10571-017-0517-x; Lazzeri C, 2014, INT J CARDIOL, V177, P543, DOI 10.1016/j.ijcard.2014.08.103; Lebkova N P, 1999, Ross Fiziol Zh Im I M Sechenova, V85, P403; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liu M, 2016, PSYCHOSOM MED, V78, P888, DOI 10.1097/PSY.0000000000000353; Liu YZ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-106; Malarbi S, 2017, NEUROSCI BIOBEHAV R, V72, P68, DOI 10.1016/j.neubiorev.2016.11.004; Mallet RT, 2018, AM J PHYSIOL-HEART C, V315, pH216, DOI 10.1152/ajpheart.00060.2018; Malyshev IY, 1998, BIOCHEMISTRY-MOSCOW+, V63, P840; Manukhina E.B., 2017, ADAPTATION BIOL MED, V8, P241; Manukhina EB, 2018, J APPL PHYSIOL, V125, P931, DOI 10.1152/japplphysiol.01123.2017; Manukhina EB, 2016, EXP BIOL MED, V241, P1351, DOI 10.1177/1535370216649060; McLeay SC, 2017, MED J AUSTRALIA, V206, P251, DOI 10.5694/mja16.00935; Meerson FZ, 1994, ESSENTIAL ADAPTIVE M; Meyerholz DK, 2009, VET PATHOL, V46, P325, DOI 10.1354/vp.46-2-325; Meyerholz David K, 2018, BMC Res Notes, V11, P763, DOI 10.1186/s13104-018-3855-y; Miller MW, 2018, HARVARD REV PSYCHIAT, V26, P57, DOI 10.1097/HRP.0000000000000167; Moon J, 2014, INT J CARDIOL, V177, P442, DOI 10.1016/j.ijcard.2014.09.002; O'Toole BI, 2008, J PSYCHOSOM RES, V64, P33, DOI 10.1016/j.jpsychores.2007.07.006; Osorio C, 2017, BEHAV MED, V43, P307, DOI 10.1080/08964289.2016.1170661; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Paulus EJ, 2013, J TRAUMA STRESS, V26, P169, DOI 10.1002/jts.21785; Peters Ronald J Jr, 2010, J Ethn Subst Abuse, V9, P143, DOI 10.1080/15332641003772702; Pietrzak RH, 2011, PSYCHOSOM MED, V73, P697, DOI 10.1097/PSY.0b013e3182303775; Plock J, 2007, J HEPATOL, V47, P538, DOI 10.1016/j.jhep.2007.04.016; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Pshennikova M. G., 2003, Uspekhi Fiziologicheskikh Nauk, V34, P55; Pshennikova MG, 2008, ADAPTATION BIOL MED, V5, P153; Reinstadler SJ, 2015, WIEN KLIN WOCHENSCHR, V127, P843, DOI 10.1007/s00508-015-0868-6; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Reznik AG, 2010, KARDIOLOGIYA, V50, P4; Rybnikova E A, 2013, Fiziol Zh, V59, P88; Rybnikova E A, 2008, Neurosci Behav Physiol, V38, P721, DOI 10.1007/s11055-008-9038-x; Ryder AL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0977-9; SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5; Sanchez O, 2007, AM J PHYSIOL-REG I, V293, pR1908, DOI 10.1152/ajpregu.00113.2007; Satav Jagannath G, 2004, Indian J Clin Biochem, V19, P23, DOI 10.1007/BF02894253; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77; Stander VA, 2014, CLIN PSYCHOL REV, V34, P87, DOI 10.1016/j.cpr.2013.12.002; Takahashi A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012890; Takahashi A, 2017, J EPIDEMIOL, V27, P180, DOI 10.1016/j.je.2016.05.006; Tipton Keith F, 2006, Curr Protoc Toxicol, VChapter 4, DOI 10.1002/0471141755.tx0421s30; Tseilikman V, 2019, HORM METAB RES, V51, P618, DOI 10.1055/a-0975-9268; Turner JH, 2013, BIOL PSYCHIAT, V74, P861, DOI 10.1016/j.biopsych.2013.07.012; Uchinami M, 1998, SURGERY, V124, P49, DOI 10.1016/S0039-6060(98)70074-1; Vaccarino V, 2013, J AM COLL CARDIOL, V62, P970, DOI 10.1016/j.jacc.2013.04.085; Volchegorskii IA, 2013, B EXP BIOL MED+, V155, P26, DOI 10.1007/s10517-013-2071-y; von Kanel R, 2010, DIGEST DIS SCI, V55, P2614, DOI 10.1007/s10620-009-1082-z; Wachen JS, 2013, J TRAUMA STRESS, V26, P319, DOI 10.1002/jts.21818; Wang Z, 2013, UPSALA J MED SCI, V118, P65, DOI 10.3109/03009734.2013.766914; Yadav SS, 1999, HEPATOLOGY, V30, P1223, DOI 10.1002/hep.510300513; Yuan F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08388-x; Zhen JL, 2014, BRAIN RES, V1563, P122, DOI 10.1016/j.brainres.2014.03.032; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010	89	5	5	3	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	JAN 1	2020	21	1							345	10.3390/ijms21010345			20	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Chemistry	KO2KF	WOS:000515378000345	31948051	Green Published, gold			2022-02-06	
J	Meng, QM; Yang, GF; Yang, Y; Ding, FC; Hu, FX				Meng, Qingmei; Yang, Guifeng; Yang, Yu; Ding, Fucheng; Hu, Fengxian			Protective effects of histone deacetylase inhibition by Scriptaid on brain injury in neonatal rat models of cerebral ischemia and hypoxia	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Histone deacetylase inhibition; hypoxia-ischemia brain damage; Inflammation; microglial polarization; oligodendrocyte	WHITE-MATTER INTEGRITY; MICROGLIA/MACROPHAGE POLARIZATION; EPIGENETIC MECHANISMS; MICROGLIA; DAMAGE; STROKE; NEURODEGENERATION; ASSOCIATION; ACTIVATION; MICE	Background: Neonatal hypoxia-ischemia brain damage (HBID) can cause a series of neurological sequelae, such as movement and cognitive impairment, and there is currently no clinically effective treatment. Changes in epigenetic processes had been shown to be involved in the development of a series of neurodegenerative diseases, and HDAC inhibition by Scriptaid had been shown to reduce severe traumatic brain injury by suppressing inflammatory responses. This study investigated the protective effect of HDAC inhibition by Scriptaid after HBID. Methods: We established the neonatal rat HBID model, and used intraperitoneal injection of HDAC inhibitor scriptaid as a treatment. 7 days after HBID, nuclear magnetic resonance imaging (MRI) was used to detect infarct volume. The otarod test, wire hang test and Morris water maze were used to evaluate the HBID model of neurobehavioral dysfunction. Immunoblotting, immunofluorescence, and quantitative real-time PCR (RT-qPCR) were used to detect gene expression. Results: HDAC inhibition by Scriptaid treatment could not only reduce the infarct volume and neuronal degeneration in HBID rats, but also helped to improve their neurobehavioral dysfunction. 7 days after HBID, the expression of HDAC-1, HDAC-2 and HDAC-3 in the infarct volume of HBID + Veh group rats were much more than that in sham group (P<0.05), but Scriptaid could significantly inhibit those expression (P<0.05), and significantly increased the acetylation of H3 and H4 in HBID rats. In vivo and vitro results demonstrated that Scriptaid had no significant effect on oligodendrocyte MBP protein expression after OGD, but Scriptaid -treated microglia cultures had protective effects on OGD-treated OLG, M1 microglia suppressed OLG activity after OGD, and M2 enhanced its activity. In vivo experiments at 7 days after HBIDI injury showed that Scriptaid could promote the polarization of microglia into M2 microglia, reduced the expression of pro-inflammatory factors, and enhance the expression of anti-inflammatory cytokines. Conclusion: After HBID, HDAC inhibitor Scriptaid inhibits inflammatory responses and protects the brain by promoting the polarization of microglia in brain tissue to M2 microglia.	[Meng, Qingmei; Yang, Guifeng; Yang, Yu; Ding, Fucheng; Hu, Fengxian] Third Peoples Hosp Qingdao, Dept Radiol, 29 Yongping Rd, Qingdao 266041, Peoples R China		Hu, FX (corresponding author), Third Peoples Hosp Qingdao, Dept Radiol, 29 Yongping Rd, Qingdao 266041, Peoples R China.	hufengx29@163.com					Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Albensi BC, 1998, INVEST RADIOL, V33, P377, DOI 10.1097/00004424-199807000-00001; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brookes RL, 2018, STROKE, V49, P54, DOI 10.1161/STROKEAHA.117.016674; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Kannan V, 2013, J NEUROSCI RES, V91, P1133, DOI 10.1002/jnr.23221; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuribayashi T, 2010, INT J MOL MED, V25, P25, DOI 10.3892/ijmm_00000309; Landgrave-Gomez J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00058; Lee J, 2013, NEUROTHERAPEUTICS, V10, P664, DOI 10.1007/s13311-013-0206-5; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Massaro AN, 2018, J PEDIATR-US, V194, P67, DOI 10.1016/j.jpeds.2017.10.060; Nabetani M, 2018, PEDIATR RES, V83, P356, DOI 10.1038/pr.2017.260; Orrock JE, 2016, PEDIATR RES, V79, P742, DOI 10.1038/pr.2015.280; Patnala R, 2017, MOL NEUROBIOL, V54, P6391, DOI 10.1007/s12035-016-0149-z; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Ramaiah MJ, 2017, GENE, V627, P379, DOI 10.1016/j.gene.2017.06.031; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Fernandez IS, 2017, J CHILD NEUROL, V32, P1065, DOI 10.1177/0883073817726681; Shein NA, 2011, MOL MED, V17, P448, DOI 10.2119/molmed.2011.00038; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tata DA, 2015, BEHAV BRAIN RES, V280, P51, DOI 10.1016/j.bbr.2014.11.033; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Wang B, 2012, FREE RADICAL BIO MED, V52, P928, DOI 10.1016/j.freeradbiomed.2011.12.006; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang J, 2017, STROKE, V48, P2211, DOI 10.1161/STROKEAHA.117.017387; Wang Y, 2017, NEUROSCI BULL, V33, P85, DOI 10.1007/s12264-016-0071-4; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031; Zhang F, 2012, AM J NEURORADIOL, V33, P935, DOI 10.3174/ajnr.A2887	42	5	5	0	3	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2020	13	2					179	191					13	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	KS6CQ	WOS:000518395200008	32211098				2022-02-06	
J	Ortiz-Prado, E; Mascialino, G; Paz, C; Rodriguez-Lorenzana, A; Gomez-Barreno, L; Simbana-Rivera, K; Diaz, AM; Coral-Almeida, M; Espinosa, PS				Ortiz-Prado, Esteban; Mascialino, Guido; Paz, Clara; Rodriguez-Lorenzana, Alberto; Gomez-Barreno, Lenin; Simbana-Rivera, Katherine; Maria Diaz, Ana; Coral-Almeida, Marco; Espinosa, Patricio S.			A Nationwide Study of Incidence and Mortality Due to Traumatic Brain Injury in Ecuador (2004-2016)	NEUROEPIDEMIOLOGY			English	Article						Ecuador; Traumatic brain injury; Epidemiology; Brain; Intracranial injury	INTENSIVE-CARE; EPIDEMIOLOGY; ALCOHOL; BURDEN; IMPACT; LEVEL; HOSPITALIZATIONS; PREVALENCE; DEATHS; VISITS	Objective: Traumatic brain injury (TBI) is a public health problem worldwide. Information regarding TBI from low- and middle-income countries is scarce. The objectives of this study are to determine the incidence, mortality and geodemographic distribution of TBI in Ecuador. Methods: A population-based analytical study from 2004 to 2016 was conducted in Ecuador. Men and women with a diagnosis of TBI from all ages (0-110 years) were included. Data was obtained from official hospital-discharges records and retrieved from the National Institute of Statistics and Census (INEC) Database. We analyzed data by region, province and canton with a monthly resolution. The incidence, mortality, case fatality rates and the risk of developing TBI within the population were calculated based on the last 13 years of available data. Results: A total of 124,576 hospital admissions and 5,264 deaths due to TBI were registered in Ecuador from 2004 to 2016. The overall TBI-related hospital admission rate was 70.68 per 100,000. The sex- and age-specific rate was 90.1 per 100,000 for men and 64.1 per 100,000 for women. Mestizos' population has the highest adjusted incidence rate of 195.6 per 100,000, followed by the indigenous with 61.4 per 100,000 and Afro-Americans with 14.2 per 100,000. The overall annual mortality rate during the study ranged from 2.11 to 3.35 per 100,000. Case fatality rates were significantly higher in older populations, becoming fatal in up to 27% of men >90 years/old and in 15% of women older than 90 years/old. Conclusion: This is the first recorded epidemiological study of the socio-demographic distribution of TBI in Ecuador to date. The study found that young men were almost 4 times more likely to be hospitalized due to TBI than women of this age. Fatalities due to TBI were less likely to occur among younger age groups, increasing significantly among the elderly population. The national incidence rate of TBI has been decreasing since 2011, which coincides with the introduction of stricter alcohol regulation, suggesting that this measure might have played a role in this reduction.	[Ortiz-Prado, Esteban; Gomez-Barreno, Lenin; Simbana-Rivera, Katherine; Maria Diaz, Ana; Coral-Almeida, Marco] Univ Amer, Fac Hlth Sci, Hlth Res Grp 1, Quito, Ecuador; [Ortiz-Prado, Esteban] Univ Barcelona, Programa Biomed, Barcelona, Spain; [Mascialino, Guido; Paz, Clara; Rodriguez-Lorenzana, Alberto] Univ Amer, Sch Psychol, Quito, Ecuador; [Espinosa, Patricio S.] Florida Atlantic Univ, Marcus Neurosci Inst, Neurol, Boca Raton, FL 33431 USA		Ortiz-Prado, E (corresponding author), Univ Amer, Hlth Resfigearch Grp 1, Ecuador Calle Colimes & Ave Granados, Quito 170137, Ecuador.	e.ortizprado@gmail.com	Paz, Clara/I-1722-2014; Ortiz-Prado, Esteban/C-9550-2014	Paz, Clara/0000-0003-1106-9567; Ortiz-Prado, Esteban/0000-0002-1895-7498; Coral, Marco/0000-0003-0211-2906; Gomez, Lenin/0000-0002-4499-0304; Rodriguez Lorenzana, Alberto/0000-0003-0394-9230; Simbana-Rivera, Katherine/0000-0002-8130-5361; MASCIALINO, GUIDO/0000-0001-7408-6546	Universidad de Las Americas	This work was funded by the Universidad de Las Americas through their annual general research projects funds.	Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Algora-Buenafe AF, 2017, AUSTRALAS MED J, V10, P238, DOI 10.21767/AMJ.2017.2951; Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; Ao BT, 2015, NEUROEPIDEMIOLOGY, V44, P255, DOI 10.1159/000431043; Ashley M. J., 1997, J REHABILITATION OUT, V1, P33; Bjarko VV, 2019, WORLD NEUROSURG, V122, pE684, DOI 10.1016/j.wneu.2018.10.122; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Cheever C, 2018, J NEUROSCI NURS, V50, P83, DOI 10.1097/JNN.0000000000000345; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Chicaiza-Ayala W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196650; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; de Turismo M., 2010, REGULACION VENTAS BE; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Esterman Adrian, 2018, Inj Epidemiol, V5, P40, DOI 10.1186/s40621-018-0172-9; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Holmes AH, 2016, LANCET, V387, P176, DOI 10.1016/S0140-6736(15)00473-0; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; INEC, 2018, POBR NEC BAS INS; INEC, 2010, CENS POBL VIV; Kelley MJ., 1997, J NEUROTHER, V2, P24, DOI DOI 10.1300/J184V02N03_03; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Langlois JA, 2006, J HEAD TRAUMA REHABI; Liu GD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201587; Lonsdale AJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1023; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacLeod JBA, 2011, INJURY, V42, P922, DOI 10.1016/j.injury.2010.01.098; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mathias JL, 2018, NEUROPSYCHOL REHABIL, V28, P997, DOI 10.1080/09602011.2016.1224190; McGloin H, 1999, J ROY COLL PHYS LOND, V33, P255; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ortiz-Prado E, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1502-0; Pechey R, 2014, SOC SCI MED, V113, P104, DOI 10.1016/j.socscimed.2014.05.010; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Posti JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41913-8; Presidencia del Ecuador, 2014, TAR PREST SIST NAC S; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; de Almeida CER, 2016, WORLD NEUROSURG, V87, P540, DOI 10.1016/j.wneu.2015.10.020; Rusli R., 2015, COMP ROAD TRAFFIC CR; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Salazar-Vega J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5485-8; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SRI, 2016, LEY ORG EQ; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Team RC. R Foundation for Statistical Computing, 2018, STAT COMPUT, V2014, P2013; Topolovec-Vranic J, 2017, J PSYCHIATR RES, V87, P53, DOI 10.1016/j.jpsychires.2016.12.004; Uski J, 2018, NEUROLOGY, V91, pE878, DOI 10.1212/WNL.0000000000006077; Wilson MH, 2016, LANCET PUBLIC HEALTH, V1, pE44, DOI 10.1016/S2468-2667(16)30022-6; World Health Organization, 2013, PROJ MORT CAUS DEATH; World Health Organization, 2015, GLOB STAT REP ROAD S	61	5	6	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology	JAN	2020	54	1					33	44		10.1159/000502580			12	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Neurosciences & Neurology	KC6RM	WOS:000507302400003	31461702				2022-02-06	
J	Pettemeridou, E; Kennedy, MRT; Constantinidou, F				Pettemeridou, Eva; Kennedy, Mary R. T.; Constantinidou, Fofi			Executive functions, self-awareness and quality of life in chronic moderate-to-severe TBI	NEUROREHABILITATION			English	Article						Cognitive dysfunction; neuropsychological assessment; patient outcome assessment; recovery of function; health-related quality of life; closed head injury	TRAUMATIC BRAIN-INJURY; POSTACUTE REHABILITATION; EMOTIONAL ADJUSTMENT; UNITED-STATES; RECOMMENDATIONS; PREVALENCE; COGNITION; MEMORY; SKILLS	BACKGROUND: Moderate-to-severe traumatic brain injury (TBI) leads to significant neuropsychological impairment, further affecting quality of life (QOL). OBJECTIVE: Investigate the effects of chronic moderate-to-severe TBI on Executive Functions (EF), Self-awareness (SA), QOL, and the associations between them. METHODS: 33 males with moderate-to-severe TBI (ages 18-51; time since injury 1-19 years) were compared to 24 non-injured males, matched on age and education. EF measures included the Rey Complex Figure Test (copy), the Trail Making Test A & B, the Symbol Digits Modalities Test, and the Control Oral Word Association Test. SA was assessed using the Dysexecutive Questionnaire Revised, and the Self-Regulation Skills Interview. QOL and health-realted QOL were assessed using the WHOQOL-BREF and the QOL after Brain Injury, respectively. RESULTS: TBI participants scored lower on EF, and SA, reported less satisfaction regarding physical health and greater satisfaction with environmental support, than controls. TBI survivors scoring lower on EF, exhibited lower SA. Lower SA correlated with greater satisfaction regarding cognitive skills, self-perception, and overall HRQOL. Lower EF performance correlated with greater satisfaction in social relationships. CONCLUSIONS: The long-term effects of TBI on EF, SA and QOL seem to support the role of EF and SA on QOL, and therefore, the need for personalized interventions in improving recovery outcome.	[Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus; [Pettemeridou, Eva] Univ Cyprus, KIOS Innovat & Res Ctr Excellence, 75 Kallipoleos,POB 20537, CY-1678 Nicosia, Cyprus; [Kennedy, Mary R. T.] Chapman Univ, Commun Sci & Disorders, Irvine, CA USA; [Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus		Pettemeridou, E (corresponding author), Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus.; Pettemeridou, E (corresponding author), Univ Cyprus, KIOS Innovat & Res Ctr Excellence, 75 Kallipoleos,POB 20537, CY-1678 Nicosia, Cyprus.	epette01@ucy.ac.cy		PETTEMERIDOU, EVA/0000-0001-5081-0042	Cyprus Research Innovation Foundation; Republic of Cyprus; European Regional Development Fund under the Framework Programme "RESTART 2016-2020/EXCELLENCE HUBS: PILLAR II" for Research, Technological Development and Innovation [EXCELLENCE/1216/0411]; new infrastructure grant (NEW INFRASTRUCTURE/STRA TEGIC) [0309/37]	Funding for this project was received from the Cyprus Research Innovation Foundation through grants awarded to FC, co-funded by the Republic of Cyprus and the European Regional Development Fund under the Framework Programme "RESTART 2016-2020/EXCELLENCE HUBS: PILLAR II" for Research, Technological Development and Innovation (EXCELLENCE/1216/0411) and a new infrastructure grant (NEW INFRASTRUCTURE/STRA TEGIC/0309/37).	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Caldwell S., 2014, IRISH J PSYCHOL, V35, P53, DOI [https://doi.org/10.1080/03033910.2014.921228, DOI 10.1080/03033910.2014.921228]; Calzada I, 2013, EUR SOC, V15, P514, DOI 10.1080/14616696.2013.836402; Chiaravalloti N. D., 2016, CHANGES BRAIN IMPACT; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fitzgerald LM, 2017, CONSCIOUS COGN, V49, P264, DOI 10.1016/j.concog.2017.01.011; FitzGerald M. C., 2012, IRISH J PSYCHOL, V33, P78, DOI [10.1080/03033910.2012.708898, DOI 10.1080/03033910.2012.708898]; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Iacovou M., 2010, ISER WORKING PAPER S, V2010-10; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; PRESSLEY M, 1990, EDUC PSYCHOL, V25, P19, DOI 10.1207/s15326985ep2501_3; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, ACT NEUR S, V93, P39; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rey A., 1993, CLIN NEUROPSYCHOLOGI; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; SCHACTER DL, 1989, AM J PSYCHOL, V102, P151, DOI 10.2307/1422950; SCHACTER DL, 1990, J CLIN EXP NEUROPSYC, V12, P155, DOI 10.1080/01688639008400962; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Smeets SMJ, 2014, NEUROPSYCHOLOGY, V28, P717, DOI 10.1037/neu0000068; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Toglia J., 2017, CHANGES BRAIN IMPACT, P117, DOI [10.1007/978-0-387-98188-8_6, DOI 10.1007/978-0-387-98188-8_6]; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; World Health Organization, 2007, INT CLASS FUNCT DIS; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301; Zimmermann N, 2017, COGN NEUROPSYCHIATRY, V22, P346, DOI 10.1080/13546805.2017.1330191	46	5	5	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	1					109	118		10.3233/NRE-192963			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NT8RU	WOS:000573205100011	32007965				2022-02-06	
J	Poznanski, P; Lesniak, A; Korostynski, M; Sacharczuk, M				Poznanski, Piotr; Lesniak, Anna; Korostynski, Michal; Sacharczuk, Mariusz			Ethanol consumption following mild traumatic brain injury is related to blood-brain barrier permeability	ADDICTION BIOLOGY			English	Article						blood-brain barrier; ethanol dependence; selected mouse lines; traumatic brain injury	MOUSE LINES; ENHANCED ACTIVITY; BETA-ENDORPHIN; ALCOHOL MISUSE; STRESS; MICE; DRINKING; NUCLEUS; NEUROBIOLOGY; RECEPTORS	Several preclinical and clinical studies that deal with the neuropathological consequences of mild traumatic brain injury (mTBI) have focused on unraveling its effect on ethanol drinking behavior. Previous reports describe changes in ethanol consumption, both in animal models of mTBI as well as in patients, after concussive brain injury. However, the neurobiological mechanisms underlying this phenomenon are still poorly understood. In the present study, we used a unique model of mouse lines divergently selected for high (HA) or low (LA) swim stress-induced analgesia to examine the effect of mTBI on ethanol drinking behavior. In comparison with LA mice, their HA counterparts exhibited increased blood-brain barrier (BBB) permeability, lower basal alcohol preference, and lower level of stress-induced ethanol intake. Here, we showed that mTBI attenuates voluntary ethanol intake in LA, but not in HA mice. Interestingly, BBB disruption after mannitol infusion also decreases the level of ethanol drinking behavior in this line. We conclude that in alcohol-preferring LA mice, BBB disruption as a consequence of mTBI attenuates ethanol consumption. Our results suggest that the innate level of BBB integrity plays a pivotal role in regulation of ethanol consumption in mice showing differential endogenous opioid system activity.	[Poznanski, Piotr; Sacharczuk, Mariusz] Polish Acad Sci, Inst Genet & Anim Breeding, Lab Neurogen, Postepu 36A Str, PL-05552 Magdalenka, Poland; [Lesniak, Anna; Sacharczuk, Mariusz] Med Univ Warsaw, Dept Pharmacodynam, Ctr Preclin Res & Technol, Warsaw, Poland; [Korostynski, Michal] Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Sacharczuk, Mariusz] Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, Warsaw, Poland		Sacharczuk, M (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Lab Neurogen, Postepu 36A Str, PL-05552 Magdalenka, Poland.	m.sacharczuk@ighz.pl	Poznanski, Piotr/AAZ-1709-2020; Korostynski, Michal/AAS-2626-2021	Poznanski, Piotr/0000-0002-1321-2235; Korostynski, Michal/0000-0002-4273-7401; Lesniak, Anna/0000-0002-6014-9208; Sacharczuk, Mariusz/0000-0002-6309-5292	National Leading Research Centre [KNOW2015/CB/PRO1/40]	National Leading Research Centre, Grant/Award Number: KNOW2015/CB/PRO1/40	Al-Sarraf H, 2007, J VASC RES, V44, P99, DOI 10.1159/000098260; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fonareva I, 2009, ALCOHOL CLIN EXP RES, V33, P1956, DOI 10.1111/j.1530-0277.2009.01033.x; Gajkowska B, 2011, FOLIA NEUROPATHOL, V49, P311; Giardino WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026997; Gilpin NW, 2008, ALCOHOL RES HEALTH, V31, P185; Green KT, 2014, ADDICT BEHAV, V39, P406, DOI 10.1016/j.addbeh.2013.08.024; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Haorah J, 2007, J NEUROCHEM, V100, P324, DOI 10.1111/j.1471-4159.2006.04245.x; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Heltemes KJ, 2014, ADDICT BEHAV, V39, P392, DOI 10.1016/j.addbeh.2013.06.001; Joshi S, 2011, J NEURO-ONCOL, V104, P11, DOI 10.1007/s11060-010-0466-4; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kosson A, 2014, ACTA NEUROBIOL EXP, V74, P26; Le AD, 2002, J NEUROSCI, V22, P7844; Leclercq S, 2014, BIOL PSYCHIAT, V76, P725, DOI 10.1016/j.biopsych.2014.02.003; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Lesniak A, 2017, BEHAV BRAIN RES, V326, P209, DOI 10.1016/j.bbr.2017.03.015; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Louboutin JP, 2010, NAT METHODS, V7, P905, DOI 10.1038/nmeth.1518; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McGonigle CE, 2016, ALCOHOL, V53, P51, DOI 10.1016/j.alcohol.2016.04.003; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Merkel SF, 2017, NEUROSCI BIOBEHAV R, V77, P209, DOI 10.1016/j.neubiorev.2017.03.015; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; PANOCKA I, 1986, BRAIN RES, V397, P152, DOI 10.1016/0006-8993(86)91379-X; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Poznanski P, 2017, NEUROPHARMACOLOGY, V118, P90, DOI 10.1016/j.neuropharm.2017.03.016; Rubio-Araiz A, 2017, ADDICT BIOL, V22, P1103, DOI 10.1111/adb.12376; Sacharczuk M, 2008, ALCOHOL, V42, P487, DOI 10.1016/j.alcohol.2008.05.006; Sacharczuk M, 2014, ADDICT BIOL, V19, P643, DOI 10.1111/adb.12030; Sacharczuk M, 2010, PHYSIOL BEHAV, V99, P627, DOI 10.1016/j.physbeh.2010.01.023; Sacharczuk M, 2009, ACTA NEUROBIOL EXP, V69, P459; Shelef, 2011, CARDIOVASC PSYCHIAT, V2011, DOI [DOI 10.1155/2011/765923, 10.1155/2011/765923]; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Tseng A, 2013, NEUROPHARMACOLOGY, V73, P290, DOI 10.1016/j.neuropharm.2013.06.001; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wang HL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06588; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	54	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-6215	1369-1600		ADDICT BIOL	Addict. Biol.	JAN	2020	25	1							e12683	10.1111/adb.12683			8	Biochemistry & Molecular Biology; Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Substance Abuse	NR3ZV	WOS:000571503200004	30334599				2022-02-06	
J	Rabinowitz, AR; Watanabe, TK				Rabinowitz, Amanda R.; Watanabe, Thomas K.			Pharmacotherapy for Treatment of Cognitive and Neuropsychiatric Symptoms After mTBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognition; concussion; drug therapies; depression; traumatic brain injuries	TRAUMATIC BRAIN-INJURY; PLACEBO-CONTROLLED TRIAL; POSTCONCUSSION SYNDROME; METHYLPHENIDATE; DEPRESSION; AMANTADINE; SERTRALINE; PREVALENCE; PREDICTORS; MANAGEMENT	Objectives: Cognitive and neuropsychiatric symptoms are extremely common following mild traumatic brain injury (TBI), also known as concussion. Although most patients will recovery rapidly, a significant minority go on to experience persistent symptoms. There are currently no FDA-approved medications for treatment of cognitive and neuropsychiatric problems in the context of mild TBI, yet a number of agents are prescribed "off-label" for these complaints. Rigorous trials are lacking, but there are a number of open-label studies, and some small randomized controlled trials that support the safety and possible efficacy of pharmacotherapies in this population. Clinical trials conducted in samples with more severe brain injuries can also serve as a guide. Methods: Review of the literature. Results & Conclusions: There is the most support in the literature for the neurostimulant methylphenidate for treatment of mild TBI-related cognitive dysfunction, and the selective serotonin reuptake inhibitor, sertraline, for the treatment of postinjury depression. There is clearly a need for more well-designed studies to guide clinicians in selecting the appropriate medication and dose. Without clear guidance from the literature, a cautious approach of starting low and titrating slowly is recommended.	[Rabinowitz, Amanda R.] Albert Einstein Healthcare Network, MossRehab, Moss Rehabil Res Inst, Elkins Pk, PA USA; [Rabinowitz, Amanda R.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Phys Med & Rehabil, Philadelphia, PA 19107 USA; [Watanabe, Thomas K.] Albert Einstein Healthcare Network, MossRehab, Drucker Brain Injury Ctr, Elkins Pk, PA USA; [Watanabe, Thomas K.] Temple Univ, Sch Med, Dept Phys Med & Rehabil, Philadelphia, PA 19122 USA		Rabinowitz, AR (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowa@einstein.edu			ACL HHS [90DPTB0004] Funding Source: Medline		Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Anand A, 2017, EUR J PHARMACOL, V815, P364, DOI 10.1016/j.ejphar.2017.09.043; Arciniegas DB, 2011, J HEAD TRAUMA REHAB, V26, P319, DOI 10.1097/HTR.0b013e31821ebfb3; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Faul M, 2010, CDC TBI US REPORT TR; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Hosenbocus S, 2013, J CAN ACAD CHILD ADO, V22, P55; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Jacobs BL, 2010, HDB BEHAV NEUROBIOLO; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, pXI, DOI 10.1016/j.psc.2013.12.002; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Khouzam HR, 1998, GEN HOSP PSYCHIAT, V20, P62, DOI 10.1016/S0163-8343(97)00097-2; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Luis CA, 2003, J INT NEUROPSYCH SOC, V9, P1001, DOI 10.1017/S1355617703970044; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; MEGA M, 2001, FRONTAL LOBES NEUROP; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Peters A, 2017, PROG NEUROBIOL, V156, P164, DOI 10.1016/j.pneurobio.2017.05.004; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Stahl SM, 2013, STAHLS ESSENTIAL PSY; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	46	5	5	2	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2020	35	1			SI		76	83		10.1097/HTR.0000000000000537			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KL0UE	WOS:000513147300017	31834058	Green Accepted			2022-02-06	
J	Riegler, KE; Guty, ET; Arnett, PA				Riegler, Kaitlin E.; Guty, Erin T.; Arnett, Peter A.			Neuropsychological Test Performance in Depressed and Nondepressed Collegiate Athletes Following Concussion	NEUROPSYCHOLOGY			English	Article						brain concussion; depression (emotion); cognitive function; athletes	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; PROLONGED RECOVERY; NORMATIVE DATA; RISK-FACTORS; SYMPTOMS; PREVALENCE; IMPACT	Objective: To examine neuropsychological test differences following concussion between collegiate athletes screening positive and negative for depression. Method: Participants included 113 (91 male) college athletes, who were assessed at baseline and following diagnosis of sport-related concussion (SRC). The Beck Depression Inventory-Fast Screen was used as a screener for depression. Athletes were categorized as either depressed (>= 4) or nondepressed (<4) following injury and compared on composites for memory and attention-processing speed. Groups were also compared on reliable change index scores from baseline, as well as on proportion of impaired scores. Results: Depressed athletes performed significantly worse than did nondepressed athletes on the Memory Composite (p = .04, d = .51) but not on the Attention-Processing Speed Composite score (p = .15, d = .46). Chi-square tests indicated that, compared with nondepressed athletes, a significantly higher number of depressed athletes showed reliable decreases on the following test indices: Verbal Memory Composite of the Immediate Post-Concussion Assessment and Cognitive Testing (p = .03, phi = .21), Brief Visuospatial Memory Test-Revised Total (p = .02, phi = .22), and Hopkins Verbal Learning Test-Revised Total (p = .05, phi = .19). Chi-square test indicated that, compared with nondepressed athletes, a significantly higher proportion of depressed athletes met criteria for impairment (p = .02, phi = .23). Conclusion: Whether examining the data at the intraindividual or group level, there are memory deficits associated with the combination of an SRC and depression. The results highlight the importance of screening for depression to provide a more complete picture of an individual's functioning postconcussion.	[Riegler, Kaitlin E.; Guty, Erin T.; Arnett, Peter A.] Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA		Riegler, KE (corresponding author), Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA.	kriegler25@gmail.com					[Anonymous], 2006, MED SCI SPORT EXER, V38, P2030, DOI 10.1249/MSS.0b013e31802b37a6; Appaneal RN, 2009, J SPORT EXERCISE PSY, V31, P60, DOI 10.1123/jsep.31.1.60; Armstrong S, 2009, J AM COLL HEALTH, V57, P521, DOI 10.3200/JACH.57.5.521-526; Arnett P.A., 2019, NEUROPSYCHOLOGY SPOR, DOI DOI 10.1037/0000114-004; Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Basso M. R., 2013, SECONDARY INFLUENCES, P39; Beck ATSB., 2000, BDI FAST SCREEN MED; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; BOHNEN N, 1992, INT J NEUROSCI, V64, P97, DOI 10.3109/00207459209000536; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Cegalis J.A., 1994, VIGIL W CONTINUOUS P; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; Covassin T, 2013, SPORT PSYCHOL, V27, P372, DOI 10.1123/tsp.27.4.372; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Green SL, 2001, J APPL SPORT PSYCHOL, V13, P40, DOI 10.1080/10413200109339003; Gulliver A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-157; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kontos A.P., 2018, CONCUSSION CLIN PROF, P59, DOI DOI 10.1037/0000087-004; Kontos AP, 2013, RES SPORTS MED, V21, P367, DOI 10.1080/15438627.2013.825801; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; LEDDY MH, 1994, RES Q EXERCISE SPORT, V65, P347, DOI 10.1080/02701367.1994.10607639; Lovell M, 2000, IMPACT IMMEDIATE POS; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Merritt VC, 2017, ARCH CLIN NEUROPSYCH, V32, P168, DOI 10.1093/arclin/acw090; Meyer J. E., 2019, NEUROPSYCHOLOGY SPOR, P267, DOI [10.1037/0000114-011, DOI 10.1037/0000114-011]; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Proctor SL, 2010, J CLIN SPORT PSYCHOL, V4, P204, DOI 10.1123/jcsp.4.3.204; Putukian M, 2016, BRIT J SPORT MED, V50, P145, DOI 10.1136/bjsports-2015-095586; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Riegler KE, 2019, ARCH CLIN NEUROPSYCH, V34, P563, DOI 10.1093/arclin/acy081; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Rosenbaum AM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P137, DOI 10.1007/0-387-32565-4_7; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Smith A., 2002, SYMBOL DIGIT MODALIT; Smith A., 1991, SYMBOL DIGIT MODALIT; SPEER DC, 1992, J CONSULT CLIN PSYCH, V60, P402, DOI 10.1037/0022-006X.60.3.402; Stein E, 2017, BRAIN INJURY, V31, P1736, DOI 10.1080/02699052.2017.1380843; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Valovich McLeod T. C., 2017, ATHLETIC TRAINING SP, V9, P271, DOI [10.3928/19425864-20171010-03, DOI 10.3928/19425864-20171010-03]; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Weschler D., 1997, WESCHLER ADULT INTEL; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	73	5	5	0	13	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	2020	34	1					63	76		10.1037/neu0000582			14	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JZ5TF	WOS:000505164800008	31343237				2022-02-06	
S	Rupp, R		Ramsey, NF; Millan, JD		Rupp, Ruediger			Spinal cord lesions	BRAIN-COMPUTER INTERFACES	Handbook of Clinical Neurology		English	Article; Book Chapter							BRAIN-COMPUTER INTERFACES; NEUROPATHIC PAIN; TROSPIUM CHLORIDE; CORTICAL ACTIVITY; QUANTITATIVE EEG; UPPER EXTREMITY; WAVE ACTIVITY; INJURY; PREVALENCE; MOVEMENT	A spinal cord injury (SCI) may result in impairments of motor, sensory, and autonomous functions below the injury level. Worldwide, the prevalence of SCI is 1:1000 and the incidence is between 4 and 9 new cases per 100,000 people per year. Most common causes for traumatic SCI are traffic accidents, falls, and violence. Nowadays, the proportion of patients with tetraplegia and paraplegia is equal. In industrialized countries, the percentage of nontraumatic injuries increases together with age. Most patients with initially preserved motor functions below the injury level show a substantial functional recovery, while three quarters of patients with initially complete SCI remain that way. In SCI, brain-computer interfaces (BCIs) may be used in the subacute phase as part of a restorative therapy program and, later, for control of assistive devices most needed by individuals with high cervical lesions. Research on structural and functional reorganization of the deefferented and deafferented brain after SCI is inconclusive mainly because of varying methods of analysis and the heterogeneity of the investigated populations. A better characterization of study participants with SCI together with documentation of confounding factors such as antispasticity medication or neuropathic pain is indicated.	[Rupp, Ruediger] Heidelberg Univ Hosp, Spinal Cord Injury Ctr, Expt Neurorehabil, Heidelberg, Germany		Rupp, R (corresponding author), Heidelberg Univ Hosp, Spinal Cord Injury Ctr, Schlierbacher Landstr 200a, D-69118 Heidelberg, Germany.	ruediger.rupp@med.uni-heidelberg.de					Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; ASIA, 2011, INT STAND NEUR CLASS; BADR GG, 1983, NEUROPSYCHOBIOLOGY, V10, P13, DOI 10.1159/000117978; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Boland RA, 2011, BRAIN, V134, P495, DOI 10.1093/brain/awq289; Boord P, 2008, SPINAL CORD, V46, P118, DOI 10.1038/sj.sc.3102077; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Bryce TN, 2014, SPINAL CORD, V52, P407, DOI 10.1038/sc.2014.21; Bryden AM, 2016, ARCH PHYS MED REHAB, V97, pS97, DOI 10.1016/j.apmr.2015.11.021; Castro A, 2007, EUR J NEUROSCI, V25, P2927, DOI 10.1111/j.1460-9568.2007.05532.x; Chaudhary U, 2016, NAT REV NEUROL, V12, P513, DOI 10.1038/nrneurol.2016.113; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Crawley AP, 2004, BRAIN RES, V1028, P19, DOI 10.1016/j.brainres.2004.08.060; Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Dahlberg A, 2005, SPINAL CORD, V43, P47, DOI 10.1038/sj.sc.3101616; DECETY J, 1990, EUR ARCH PSY CLIN N, V240, P39, DOI 10.1007/BF02190091; DeVivo MJ, 2011, ARCH PHYS MED REHAB, V92, P332, DOI 10.1016/j.apmr.2010.08.031; DeVivo MJ, 2004, J SPINAL CORD MED, V27, pS4, DOI 10.1080/10790268.2004.11753778; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Downs MB, 2011, J ORTHOP SPORT PHYS, V41, P427, DOI 10.2519/jospt.2011.3506; Exner G, 2004, TRAUMA BERUFSKR, V6, P151; Finnerup NB, 2013, PAIN, V154, pS71, DOI 10.1016/j.pain.2012.12.007; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Gourab K, 2010, CLIN NEUROPHYSIOL, V121, P2017, DOI 10.1016/j.clinph.2010.05.012; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Grosse-Wentrup M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025004; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Gustin SM, 2010, CEREB CORTEX, V20, P1409, DOI 10.1093/cercor/bhp205; Gustin SM, 2008, PAIN, V137, P237, DOI 10.1016/j.pain.2007.08.032; Gustin SM, 2010, PAIN, V148, P438, DOI 10.1016/j.pain.2009.12.001; Halder S, 2011, NEUROIMAGE, V55, P1779, DOI 10.1016/j.neuroimage.2011.01.021; Herbert D, 2007, INT J NEUROSCI, V117, P1731, DOI 10.1080/00207450701242826; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Holz EM, 2011, BIOLOGICAL MED PHYS, P22; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hou JM, 2014, NEUROSCIENCE; Hua R, 2013, SPINAL CORD, V51, P218, DOI 10.1038/sc.2012.133; Itzkovich M, 2007, DISABIL REHABIL, V29, P1926, DOI 10.1080/09638280601046302; Jensen MP, 2013, SPINAL CORD, V51, P55, DOI 10.1038/sc.2012.84; Jensen MP, 2013, APPL PSYCHOPHYS BIOF, V38, P101, DOI 10.1007/s10484-013-9214-9; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kay GG, 2008, INT J CLIN PRACT, V62, P1792, DOI 10.1111/j.1742-1241.2008.01849.x; Kern H, 2008, SPINAL CORD, V46, P293, DOI 10.1038/sj.sc.3102131; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kirshblum SC, 2016, ARCH PHYS MED REHAB, V97, P1647, DOI 10.1016/j.apmr.2016.02.012; Kubler A, 2004, J PSYCHOPHYSIOL, V18, P121, DOI 10.1027/0269-8803.18.23.121; Lacourse MG, 1999, BEHAV BRAIN RES, V104, P73, DOI 10.1016/S0166-4328(99)00052-2; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lotze M, 2006, RESTOR NEUROL NEUROS, V24, P97; Mattia D, 2006, HUM BRAIN MAPP, V27, P510, DOI 10.1002/hbm.20195; McCammon JR, 2011, J SPINAL CORD MED, V34, P6, DOI 10.1179/107902610X12923394765733; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; McKay WB, 2004, NEUROREHAB NEURAL RE, V18, P144, DOI 10.1177/0888439004267674; Mikulis DJ, 2002, NEUROLOGY, V58, P794, DOI 10.1212/WNL.58.5.794; Milicevic S, 2012, VOJNOSANIT PREGL, V69, P1061, DOI 10.2298/VSP1212061M; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Mole TB, 2014, NEUROIMAGE-CLIN, V5, P28, DOI 10.1016/j.nicl.2014.05.014; Muller-Putz GR, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035011; New PW, 2014, SPINAL CORD, V52, P97, DOI 10.1038/sc.2012.165; New PW, 2013, SPINAL CORD, V51, P99, DOI 10.1038/sc.2012.61; Nijendijk JHB, 2014, SPINAL CORD, V52, P258, DOI 10.1038/sc.2013.180; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; NSCISC, 2018, 2018 ANN STAT REP MO; Nwadinigwe C U, 2004, Niger J Med, V13, P161; O'Connor PJ, 2005, SPINAL CORD, V43, P42, DOI 10.1038/sj.sc.3101666; Obalum DC, 2009, SPINAL CORD, V47, P134, DOI 10.1038/sc.2008.93; Onose G, 2012, SPINAL CORD, V50, P599, DOI 10.1038/sc.2012.14; Osuagwu BCA, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/6/065002; Ouzky M, 2002, CONCERTED EFFORTS TR; Pascoal-Faria P, 2015, PAIN PRACT, V15, P371, DOI 10.1111/papr.12237; Perdikis S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003787; Pfurtscheller G, 2009, Comput Intell Neurosci, P104180, DOI 10.1155/2009/104180; PIETZKO A, 1994, EUR J CLIN PHARMACOL, V47, P337; Prochazka A, 2015, OXFORD TXB NEUROREHA; Reed R, 2017, SPINAL CORD, V55, P730, DOI 10.1038/sc.2017.1; Rohm M, 2013, ARTIF INTELL MED, V59, P133, DOI 10.1016/j.artmed.2013.07.004; Rupp R, 2015, OXFORD TXB NEUROREHA; Rupp Rudiger, 2014, Front Neuroeng, V7, P38, DOI 10.3389/fneng.2014.00038; Rupp R, 2015, P IEEE, V103, P954, DOI 10.1109/JPROC.2015.2395253; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Sabre L, 2013, SPINAL CORD, V51, P623, DOI 10.1038/sc.2013.41; Schirmer CM, 2011, J NEUROSURG-SPINE, V15, P64, DOI 10.3171/2011.2.SPINE1068; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Schuld C, 2013, SPINAL CORD, V51, P282, DOI 10.1038/sc.2012.149; SEYFERT S, 1982, EEG-EMG-Z ELEK ELEKT, V13, P161; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Shoham S, 2001, NATURE, V413, P793, DOI 10.1038/35101651; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Smith Eimear, 2014, Top Spinal Cord Inj Rehabil, V20, P158, DOI 10.1310/sci2002-147; Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638; Soekadar SR, 2015, NEUROBIOL DIS, V83, P172, DOI 10.1016/j.nbd.2014.11.025; Thietje R, 2015, COMMUNICATION; Tidoni E, 2015, NEUROPSYCHOLOGIA, V79, P301, DOI 10.1016/j.neuropsychologia.2015.06.029; Todorova A, 2001, J CLIN PHARMACOL, V41, P636, DOI 10.1177/00912700122010528; Tran Y, 2004, SPINAL CORD, V42, P73, DOI 10.1038/sj.sc.3101543; van den Berg MEL, 2010, NEUROEPIDEMIOLOGY, V34, P184, DOI 10.1159/000279335; van den Berg MEE, 2012, ARCH PHYS MED REHAB, V93, P325, DOI 10.1016/j.apmr.2011.08.027; van Hedel HJA, 2007, NEUROREHAB NEURAL RE, V21, P295, DOI 10.1177/1545968306297861; Vogel LC, 2012, HDB CLIN NEUROL, V109, P148; Vuckovic A, 2014, J PAIN, V15, P645, DOI 10.1016/j.jpain.2014.02.005; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; WHO, 2013, INTERNATIONAL PERSPECTIVES ON SPINAL CORD INJURY, P1; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wrigley PJ, 2009, PAIN, V141, P52, DOI 10.1016/j.pain.2008.10.007; Wydenkeller S, 2009, EUR J NEUROSCI, V30, P91, DOI 10.1111/j.1460-9568.2009.06801.x; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007	120	5	5	1	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463933-2; 978-0-44-463934-9	HAND CLINIC			2020	168						51	65		10.1016/B978-0-444-63934-9.00006-8			15	Computer Science, Cybernetics; Engineering, Biomedical; Neurosciences; Rehabilitation	Book Citation Index – Science (BKCI-S)	Computer Science; Engineering; Neurosciences & Neurology; Rehabilitation	BR6QJ	WOS:000662859700007	32164868				2022-02-06	
J	Schilling, S; Mansour, A; Sullivan, L; Ding, KL; Pommering, T; Yang, JZ				Schilling, Samantha; Mansour, Adam; Sullivan, Lindsay; Ding, Kele; Pommering, Thomas; Yang, Jingzhen			Symptom Burden and Profiles in Concussed Children with and without Prolonged Recovery	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						concussion; pediatric; recovery; retrospective case-control study; symptom burden; symptom profile	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; POSTTRAUMATIC MIGRAINE; PROTRACTED RECOVERY; BASE-LINE; PREDICTORS; DURATION; GENDER; TIME; PERFORMANCE	Although symptom burden and symptom profile severity are independent predictors of post-concussion symptom duration, few studies have examined their effects on prolonged recovery simultaneously. This study examined differences in symptom burden and symptom profile scores between concussed children with prolonged recovery and those with typical recovery. We conducted a retrospective case-control study of concussed children aged 10-18 years. Prolonged recovery was defined as symptom duration beyond 28 days post-injury. Symptom burden was measured as total symptom score (TSS) at injury. Symptom profiles included: (1) vestibular, (2) ocular, (3) cognitive/fatigue, (4) migraine, and (5) anxiety. A total of 4380 unique concussions sustained by 3777 patients were included; 80.3% white, 60.0% male, and 44.0% aged 13-15 years. The prolonged recovery group had a significantly higher TSS and greater number of symptoms than the typical recovery group (p < 0.001 and p < 0.001, respectively). The prolonged recovery group had significantly higher scores on all five symptom profiles, including vestibular (p < 0.001), ocular (p < 0.001), cognitive/fatigue (p < 0.001), migraine (p < 0.001) and anxiety (p < 0.001), than the typical recovery group, even after adjusting for number of symptoms and other covariates. Further studies using prospective cohort designs are needed to better understand the influence of symptom burden and profiles on pediatric concussion recovery.	[Schilling, Samantha; Mansour, Adam; Sullivan, Lindsay; Yang, Jingzhen] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA; [Ding, Kele] Kent State Univ, Dept Hlth Sci, Kent, OH 44240 USA; [Pommering, Thomas; Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA; [Pommering, Thomas] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH 43205 USA		Sullivan, L (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, Columbus, OH 43205 USA.	schilling.120@buckeyemail.osu.edu; mansouradam1995@gmail.com; LMSullivan23@gmail.com; kding@kent.edu; thomas.pommering@nationwidechildrens.org; ginger.yang@nationwidechildrens.org		Sullivan, Lindsay/0000-0001-8079-0388			Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2018, INT J PSYCHOPHYSIOL, V132, P9, DOI 10.1016/j.ijpsycho.2017.09.010; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Grubenhoff' JA, 2015, BRAIN INJURY, V29, P1186, DOI 10.3109/02699052.2015.1035325; Guerriero RM, 2018, J CHILD NEUROL, V33, P168, DOI 10.1177/0883073817749655; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kontos A. P., 2018, CONCUSSION CLIN PROF; Kontos AP, 2019, CURR SPORT MED REP, V18, P82, DOI 10.1249/JSR.0000000000000573; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2020, NEUROSURGERY, V86, P2, DOI 10.1093/neuros/nyz332; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P764, DOI 10.1080/13803395.2015.1060950; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Silverstein B, 1999, AM J PSYCHIAT, V156, P480; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Willett W., 2012, NUTR EPIDEMIOLOGY NUTR EPIDEMIOLOGY; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	49	5	5	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	JAN	2020	17	1							351	10.3390/ijerph17010351			11	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	KF7AG	WOS:000509391500351	31947942	gold, Green Published			2022-02-06	
J	Simpson, GK; Anderson, MI; Jones, KF; Genders, M; Gopinath, B				Simpson, Grahame Kenneth; Anderson, Malcolm Ikin; Jones, Kate Fiona; Genders, Michelle; Gopinath, Bamini			Do spirituality, resilience and hope mediate outcomes among family caregivers after traumatic brain injury or spinal cord injury? A structural equation modelling approach	NEUROREHABILITATION			English	Article						Traumatic brain injury; spinal cord injury; spirituality; resilience; hope; family caregiver; burden; depression; psychological adjustment	QUALITY-OF-LIFE; COMMUNITY-DWELLING ADULTS; PSYCHOLOGICAL ADJUSTMENT; INDIVIDUALS; BURDEN; CARE; SATISFACTION; STRESS; SENSE; REHABILITATION	BACKGROUND: A deficits approach to understanding psychological adjustment in family caregivers of individuals with a neurological disability is extensive, but further research in the field of positive psychology (spirituality, resilience, hope) may provide a potential avenue for broadening knowledge of the family caregiver experience after traumatic brain injury (TBI) or spinal cord injury (SCI). OBJECTIVE: To test a proposed model of spirituality among family caregivers of individuals with TBI or SCI, using structural equation modelling (SEM). METHODS: A cross-sectional design was employed to survey ninety-nine family participants (TBI = 76, SCI = 23) from six rehabilitation units from NSW and Queensland. Assessments comprised Functional Assessment of Chronic Illness Therapy-Spiritual Well-being Scale-Expanded, Connor - Davidson Resilience Scale, Herth Hope Index, and three measures of psychological adjustment including Caregiver Burden Scale, Positive and Negative Affect Scale, and Depression Anxiety Stress Scale. RESULTS: SEM showed the proposed model was a good fit. The main findings indicated spirituality had a direct negative link with burden. Spirituality had a direct positive association with hope which, in succession, had a positive link with resilience. Spirituality influenced positive affect indirectly, being mediated by resilience. Positive affect, in turn, had a negative association with depression in caregivers. CONCLUSIONS: This study contributes to better targeting strength-based family interventions.	[Simpson, Grahame Kenneth; Genders, Michelle] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Simpson, Grahame Kenneth; Genders, Michelle; Gopinath, Bamini] Univ Sydney, John Walsh Ctr Rehabil Res, Kolling Inst, Sydney, NSW, Australia; [Anderson, Malcolm Ikin] Avondale Univ Coll, Fac Nursing, Sydney, NSW, Australia; [Jones, Kate Fiona] Royal Rehab, Ryde, NSW, Australia; [Jones, Kate Fiona] Griffith Univ, Menzies Hlth Inst, Gold Coast, QLD, Australia		Simpson, GK (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	grahame.simpson@health.nsw.gov.au	Jones, Kate/AAV-7641-2021	Jones, Kate/0000-0002-5964-3479; Simpson, Grahame/0000-0001-8156-9060			Agyemang A, 2017, ARCH PHYS MED REHAB, V98, pe81, DOI [10.1016/j.apmr.2016.12.016, DOI 10.1016/J.APMR.2016.12.016]; Anderson MI, 2020, NEUROPSYCHOL REHABIL, V30, P1925, DOI 10.1080/09602011.2019.1620787; Anderson MI, 2015, ANNU REV NURS RES-SE, V33, P219, DOI 10.1891/0739-6686.33.219; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P83, DOI 10.3233/NRE-2010-0583; Austin PD, 2016, J STUDY SPIRITUAL, V6, P20, DOI 10.1080/20440243.2016.1158453; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Best M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5090077; Boschen KA, 2005, REHABIL PSYCHOL, V50, P397, DOI 10.1037/0090-5550.50.4.397; Brady M. J., 1999, Annals of Behavioral Medicine,, V21, P129; Bredle JM, 2011, RELIGIONS, V2, P77, DOI 10.3390/rel2010077; Canda E.R, 2009, SPIRITUAL DIVERSITY; Chan RCK, 2000, CLIN REHABIL, V14, P137, DOI 10.1191/026921500675826560; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Cohn MA, 2009, EMOTION, V9, P361, DOI 10.1037/a0015952; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davis DE, 2015, J COUNS PSYCHOL, V62, P503, DOI 10.1037/cou0000082; DeSanto-Madeya S, 2006, WESTERN J NURS RES, V28, P265, DOI 10.1177/0193945905283178; Dorsett P, 2010, AUST SOC WORK, V63, P83, DOI 10.1080/03124070903464293; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Feigin R, 1998, MARRIAGE FAM REV, V27, P71, DOI 10.1300/J002v27n01_06; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gloster AT, 2008, J AFFECT DISORDERS, V110, P248, DOI 10.1016/j.jad.2008.01.023; Godwin EE, 2015, FAM RELAT, V64, P347, DOI 10.1111/fare.12122; GREGORYALLEN RB, 2012, OXFORD HDB PSYCHOL S, P437, DOI DOI 10.1016/B978-0-12-387724-6.00030-1; Heo GJ, 2014, CLIN GERONTOLOGIST, V37, P368, DOI 10.1080/07317115.2014.907588; HERTH K, 1992, J ADV NURS, V17, P1251, DOI 10.1111/j.1365-2648.1992.tb01843.x; Ho R., 2014, HDB UNIVARIATE MULTI, V2nd ed.; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Jazayeri SB, 2015, EUR SPINE J, V24, P905, DOI 10.1007/s00586-014-3424-6; Jones K. F., 2019, INT C SOC WORK HLTH; Jones K. F., 2019, NEUROREHABILITATION; Jones K, 2016, DISABIL REHABIL, V38, P921, DOI 10.3109/09638288.2015.1066884; Jones KF, 2018, BRAIN INJURY, V32, P1612, DOI 10.1080/02699052.2018.1511066; Jones KF, 2019, CLIN REHABIL, V33, P1503, DOI 10.1177/0269215519845034; Jones KF, 2018, REHABIL PSYCHOL, V63, P521, DOI 10.1037/rep0000229; Jones Kate Fiona, 2018, Spinal Cord Ser Cases, V4, P54, DOI 10.1038/s41394-018-0078-3; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Kennedy P, 2010, BRIT J HEALTH PSYCH, V15, P611, DOI 10.1348/135910709X478222; Kennedy P, 2009, PSYCHOL HEALTH MED, V14, P17, DOI 10.1080/13548500802001801; Kirshblum S., 2009, SPINAL CORD INJURIES, P1, DOI DOI 10.1016/B978-032300699-6.10001-2; Kortte KB, 2010, REHABIL PSYCHOL, V55, P40, DOI 10.1037/a0018624; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lazarus RS, 1987, EUR J PERSONAL, V1, P141, DOI [10.1002/per.2410010304, DOI 10.1002/PER.2410010304]; Lohne Vibeke, 2009, Can J Neurosci Nurs, V31, P20; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lustig DC, 2005, REHABIL COUNS BULL, V48, P146, DOI 10.1177/00343552050480030301; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; McSherry W, 2011, J CLIN NURS, V20, P1757, DOI 10.1111/j.1365-2702.2010.03547.x; Meredith P, 2012, J RELIG HEALTH, V51, P879, DOI 10.1007/s10943-010-9399-7; Middleton JW, 2014, ARCH PHYS MED REHAB, V95, P1312, DOI 10.1016/j.apmr.2014.03.017; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Puchalski C, 2009, J PALLIAT MED, V12, P885, DOI 10.1089/jpm.2009.0142; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Saleebey D, 1996, SOC WORK, V41, P296; Simpson G, 2013, CLIN REHABIL, V27, P367, DOI 10.1177/0269215512457961; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Snyder CR, 1996, J PERS SOC PSYCHOL, V70, P321, DOI 10.1037/0022-3514.70.2.321; Tovell A., 2018, SPINAL CORD INJURY A; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson D., 1994, PANAS X MANUAL POSIT; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; YRI H, 2013, BRAIN IMPAIR, V14, DOI DOI 10.1186/1129-2377-14-S1-P167	71	5	5	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2020	46	1					3	15		10.3233/NRE-192945			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	NT8RU	WOS:000573205100002	32039872				2022-02-06	
J	Snider, SB; Bodien, YG; Frau-Pascual, A; Bianciardi, M; Foulkes, AS; Edlow, BL				Snider, Samuel B.; Bodien, Yelena G.; Frau-Pascual, Aina; Bianciardi, Marta; Foulkes, Andrea S.; Edlow, Brian L.			Ascending arousal network connectivity during recovery from traumatic coma	NEUROIMAGE-CLINICAL			English	Article						Coma; Traumatic brain injury; MRI; Consciousness; Brainstem	BRAIN-INJURY; CONSCIOUSNESS; WITHDRAWAL	Background: It is not currently possible to predict which patients will develop chronic disorders of consciousness (DoC) after severe traumatic brain injury (TBI). Although the ascending arousal network (AAN) supports human consciousness, it is unknown which AAN pathways must be preserved for patients to recover consciousness. Methods: Sixteen patients with acute traumatic coma and 16 matched healthy controls were scanned with high angular resolution diffusion imaging (HARDI). All patients recovered consciousness (Recovery Cohort). Nine were scanned longitudinally: first in the ICU (Acute), then at >= 5 months post-injury (Follow-up). Six separate patients with post-traumatic DoC were scanned >= 5 months post-injury (Chronic DoC Cohort). For each AAN pathway, we computed the median relative change in Acute-to-Follow-up Connectivity Probability (CP) in the Recovery Cohort. We then used Wilcoxon tests with Bonferroni correction to compare CP in each AAN pathway in the Recovery Cohort at Follow-up versus the Chronic DoC Cohort. In an exploratory analysis, we used principal component analysis (PCA) to determine whether linear combinations of AAN CP values could separate the Chronic DoC Cohort from the Recovery Cohort and the healthy controls. Results: In the Recovery Cohort, the largest relative AAN CP changes were in the brainstem-to-thalamus (median [IQR] = 0.7 [0.09, 0.9]) and forebrain-to-occipital lobe (-0.8 [-0.9, 0.8]) pathways. The AAN connections that differed in the cross-sectional analysis between the Recovery Cohort at Follow-up and the Chronic DoC Cohort included brainstem-to-hypothalamus (W = 53, P-Bonf = 0.02), brainstem-to-temporal lobe (W = 52, P-Bonf = 0.04), and thalamus-to-temporal lobe (W = 54, P-Bonf = 0.009). Plotting the first two principal components of AAN connectivity resulted in a linear separation of Chronic DoC patients from other study groups. Conclusions: We provide evidence for a longitudinal increase in brainstem-thalamic connectivity during recovery of consciousness after traumatic coma. Cross-sectional analyses revealed that brainstem-hypothalamus, brainstem-temporal lobe, and thalamus-temporal lobe connectivity differed between patients who recovered consciousness and those with a chronic DoC. These observations provide the basis for further investigation into AAN connectivity as a biomarker for recovery of consciousness after traumatic coma.	[Snider, Samuel B.] Brigham & Womens Hosp, Dept Neurol, Div Neurocrit Care & Stroke, 60 Fenwood Rd, Boston, MA 02115 USA; [Snider, Samuel B.] Brigham & Womens Hosp, Dept Neurol, Div Cerebrovasc Dis, 60 Fenwood Rd, Boston, MA 02115 USA; [Bodien, Yelena G.; Frau-Pascual, Aina; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Frau-Pascual, Aina; Bianciardi, Marta; Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Frau-Pascual, Aina; Bianciardi, Marta; Edlow, Brian L.] Harvard Med Sch, Charlestown, MA USA; [Foulkes, Andrea S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Foulkes, Andrea S.] Harvard Med Sch, Boston, MA 02115 USA		Snider, SB (corresponding author), Brigham & Womens Hosp, Dept Neurol, Div Neurocrit Care & Stroke, 60 Fenwood Rd, Boston, MA 02115 USA.; Snider, SB (corresponding author), Brigham & Womens Hosp, Dept Neurol, Div Cerebrovasc Dis, 60 Fenwood Rd, Boston, MA 02115 USA.	ssnider@bwh.harvard.edu			NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R21NS109627, RF1NS115268]; NIH Director's Office [DP2HD101400]; NIH National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K01EB019474]; James S. McDonnell Foundation; Rappaport Foundation; Tiny Blue Dot Foundation; National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services; Administration for Community Living (Spaulding-Harvard TBI Model System) [90DP0039]	This study was supported by the NIH National Institute of Neurological Disorders and Stroke (K23NS094538, R21NS109627, RF1NS115268), NIH Director's Office (DP2HD101400), NIH National Institute of Biomedical Imaging and Bioengineering (K01EB019474), James S. McDonnell Foundation, Rappaport Foundation, Tiny Blue Dot Foundation, and National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (90DP0039, Spaulding-Harvard TBI Model System).	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Blumenfeld H, 2003, NEUROSCIENTIST, V9, P301, DOI 10.1177/1073858403255624; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Ding SL, 2016, J COMP NEUROL, V524, P3127, DOI 10.1002/cne.24080; Edlow BL, 2020, NEUROCRIT CARE, V33, P364, DOI 10.1007/s12028-020-01062-7; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kotter R., 2001, PHIL T R SOC LOND B, V356, P1293; LINDSLEY DB, 1949, ELECTROEN CLIN NEURO, V1, P475, DOI 10.1016/0013-4694(49)90221-7; Lorca-Puls DL, 2018, NEUROPSYCHOLOGIA, V115, P101, DOI 10.1016/j.neuropsychologia.2018.03.014; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maier-Hein KH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01285-x; Marek S, 2020, REPRODUCIBLE BRAIN W; Martinez DE, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1476; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Prckovska V, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/658583; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilkins TE, 2019, J NEUROTRAUM, V36, P3158, DOI 10.1089/neu.2018.6153; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027	26	5	6	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2020	28								102503	10.1016/j.nicl.2020.102503			6	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PH7WY	WOS:000600619100144	33395992	Green Published, gold			2022-02-06	
J	uiHu, Y; Chu, X; Urosevich, TG; Hoffman, SN; Kirchner, HL; Adams, RE; Dugan, RJ; Boscarino, JJ; Shi, WX; Withey, CA; Figley, CR; Boscarino, JA				uiHu, Yir; Chu, Xin; Urosevich, Thomas G.; Hoffman, Stuart N.; Kirchner, H. Lester; Adams, Richard E.; Dugan, Ryan J.; Boscarino, Joseph J.; Shi, Weixing; Withey, Carrie A.; Figley, Charles R.; Boscarino, Joseph A.			Predictors of Current DSM-5 PTSD Diagnosis and Symptom Severity Among Deployed Veterans: Significance of Predisposition, Stress Exposure, and Genetics	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						posttraumatic stress disorder; veterans; combat exposure; trauma; warzone deployment; genetic risk; resilience	ADVERSE CHILDHOOD EXPERIENCES; WORLD-HEALTH-ORGANIZATION; NEW-YORK-CITY; POSTTRAUMATIC-STRESS; MENTAL-HEALTH; DISORDER SYMPTOMS; ENVIRONMENTAL-INFLUENCES; VIETNAM VETERANS; COMBAT EXPOSURE; TRAUMA EXPOSURE	Background: Previously we reported a genetic risk score significantly improved PTSD prediction among a trauma-exposed civilian population. In the current study, we sought to assess this prediction among a trauma-exposed military population. Methods: We examined current PTSD diagnosis and PTSD symptom severity among a random sample of 1042 community-based US military veterans. Main effects and interaction effects were assessed for PTSD genetic risk by trauma exposure using cross-product terms for PTSD x trauma exposures, including combat, lifetime trauma, and adverse childhood exposures. The PTSD risk variants studied were within genetic loci previously associated with PTSD, including CRHR1, CHRNA5, RORA, and FKBP5 genetic variants, which were used to calculate a total PTSD genetic risk score (range=0-8, mean=3.6, SD=1.4). Results: Based on DSM-5 PTSD criteria, 7.1% of veterans (95% CI=5.6-8.8) met criteria for current PTSD. The PTSD genetic risk count was significantly higher among PTSD cases vs non-cases (3.92 vs 3.55, p=0.027). Since the PTSD genetic risk score was not significant in the PTSD diagnosis model, we assessed this association using PTSD symptom severity. Because these symptom data were skewed (mean=9.54, SD=12.71, range=0-76), we used negative binomial regression to assess this outcome. This symptom model included a PTSD genetic risk score, demographic factors, trauma exposures, current insomnia, current depression, concussion history, and attention-deficit disorder, expressed as incident rate ratios (IRR), which is an estimate of one-unit increase in PTSD severity, given other variables are held constant. Variables in the final model included age and sex (both p<0.001), PTSD genetic risk (IRR=1.02, p=0.028), warzone tours (IRR=0.94, p=0.003), childhood abuse (IRR=1.50, p<0.0001), current depression (IRR=1.89, p<0.0001), current insomnia (IRR=2.58, p<0.0001), low social support (IRR=1.19, p<0.0001), attention-deficit disorder (IRR=1.51, p<0.0001), agreeable personality (IRR=0.77, p<0.0001), and concussion (IRR=1.38, p<0.0001). Significant interactions were detected for combat and lifetime trauma exposure by PTSD genetic risk (both p<0.0001), suggesting that the impact of trauma exposures on PTSD severity was lower when the PTSD genetic risk was higher. Conclusion: Both warzone and non-warzone factors predicted current PTSD symptoms among veterans, including a PTSD genetic risk score. Interaction effects were detected for combat exposure and lifetime trauma by genetic risk score for PTSD symptoms, suggesting that PTSD symptom manifestation was more dependent on PTSD risk variants than the level of trauma or combat exposure. This suggests that controlling for other factors, the absence of genetic risk variants may confer PTSD resilience. Further research is planned.	[uiHu, Yir; Kirchner, H. Lester] Geisinger Med Clin, Biomed & Translat Informat, Danville, PA 17822 USA; [Chu, Xin; Shi, Weixing] Geisinger Med Clin, Obes Inst, Danville, PA 17822 USA; [Urosevich, Thomas G.] Geisinger Med Clin, Ophthalmol Serv, Mt Pocono, PA USA; [Hoffman, Stuart N.] Geisinger Med Clin, Sleep Disorders Ctr, Danville, PA 17822 USA; [Adams, Richard E.] Kent State Univ, Dept Sociol, Kent, OH 44242 USA; [Dugan, Ryan J.; Withey, Carrie A.; Boscarino, Joseph A.] Geisinger Med Clin, Dept Populat Hlth Sci, Danville, PA 17822 USA; [Boscarino, Joseph J.] William James Coll, Dept Clin Psychol, Newton, MA USA; [Figley, Charles R.] Tulane Univ, Dept Social Work, New Orleans, LA 70118 USA		Boscarino, JA (corresponding author), Geisinger Med Clin, 100 N Acad Ave,44-00, Danville, PA 17822 USA.	jaboscarino@geisinger.edu					Acierno R, 2000, J TRAUMA STRESS, V13, P381, DOI 10.1023/A:1007772905696; Adams Richard E, 2019, Mil Behav Health, V7, P304, DOI 10.1080/21635781.2019.1580642; Adams Richard E, 2017, Mil Behav Health, V5, P393, DOI 10.1080/21635781.2017.1333067; American Association for Public Opinion Research, 2008, STAND DEF FIN DISP C; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Amstadter AB, 2013, MOL PSYCHIATR, V18, P1148, DOI 10.1038/mp.2012.189; [Anonymous], 1988, JAMA, V259, P2701; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boscarino JA, 1999, PSYCHOSOM MED, V61, P378, DOI 10.1097/00006842-199905000-00019; Boscarino JA, 2004, GEN HOSP PSYCHIAT, V26, P346, DOI 10.1016/j.genhosppsych.2004.05.001; Boscarino JA, 2004, PSYCHIAT SERV, V55, P274, DOI 10.1176/appi.ps.55.3.274; BOSCARINO JA, 1995, J TRAUMA STRESS, V8, P317, DOI 10.1007/BF02109567; Boscarino JA, 1996, J CONSULT CLIN PSYCH, V64, P191, DOI 10.1037/0022-006X.64.1.191; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Boscarino JA, 1999, ANN BEHAV MED, V21, P227, DOI 10.1007/BF02884839; Boscarino JA, 2012, ENCY TRAUMA, P277; Boscarino JA, 2019, GEN HOSP PSYCHIAT; Boscarino JA, 2018, J NERV MENT DIS, V206, P757, DOI 10.1097/NMD.0000000000000879; Boscarino Joseph A, 2015, Mil Behav Health, V3, P244; Boscarino JA, 2016, SUBST ABUSE REHABIL, V7, P131, DOI 10.2147/SAR.S108302; Boscarino Joseph A, 2014, Am J Disaster Med, V9, P107, DOI 10.5055/ajdm.2014.0147; Boscarino JA, 2013, NEUROPSYCH DIS TREAT, V9, P517, DOI 10.2147/NDT.S42422; Boscarino JA, 2012, J NERV MENT DIS, V200, P740, DOI 10.1097/NMD.0b013e318266b5ea; Boscarino JA, 2012, PREV MED, V54, P363, DOI 10.1016/j.ypmed.2012.01.001; Boscarino JA, 2012, NEUROPSYCH DIS TREAT, V8, P131, DOI 10.2147/NDT.S29508; Boscarino JA, 2011, PSYCHIAT RES, V188, P173, DOI 10.1016/j.psychres.2011.03.002; Boscarino JA, 2010, ADDICTION, V105, P1776, DOI 10.1111/j.1360-0443.2010.03052.x; Boscarino JA, 2010, PSYCHOSOM MED, V72, P481, DOI 10.1097/PSY.0b013e3181d9a80c; Boscarino JA, 2009, SOC PSYCH PSYCH EPID, V44, P887, DOI 10.1007/s00127-009-0011-y; Bosearino JA, 2011, AM J CARDIOL, V108, P1052, DOI 10.1016/j.amjcard.2011.07.003; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Bunevicius A, 2008, INT J SOC PSYCHIATR, V54, P494, DOI 10.1177/0020764008090843; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Costa PT, REVISED NEO PERSONAL; Cox KS, 2014, J TRAUMA STRESS, V27, P299, DOI 10.1002/jts.21925; Duncan LE, 2018, MOL PSYCHIATR, V23, P666, DOI 10.1038/mp.2017.77; Erlich PM, 2010, HUM GENET, V128, P491, DOI 10.1007/s00439-010-0876-6; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; First M., 1997, STRUCTURED CLIN INTE; First Michael B., 2004, DSM 4 TR MENTAL DISO; FREEDY JR, 1993, J SOC BEHAV PERS, V8, P49; Frey-Wouters E., 1986, LEGACY WAR AM SOLDIE; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Groves R.M., 2009, SURVEY METHODOLOGY; Hilbe J. M., 2007, NEGATIVE BINOMIAL RE; Hoffman SN., 2019, INT J EMERGENCY MENT, V21, P1; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Kendler KS, 2019, JAMA PSYCHIAT, V76, P1085, DOI 10.1001/jamapsychiatry.2019.1200; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; Koenen KC, 2007, J TRAUMA STRESS, V20, P737, DOI 10.1002/jts.20205; Kulka RA., 1990, NATL VIETNAM VETERAN; Lambert SA, 2019, HUM MOL GENET, V28, pR133, DOI 10.1093/hmg/ddz187; LAUFER RS, 1984, J HEALTH SOC BEHAV, V25, P65, DOI 10.2307/2136705; Lehavot K, 2018, SOC PSYCH PSYCH EPID, V53, P943, DOI 10.1007/s00127-018-1550-x; Lowe SR, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.323; McLeod DS, 2001, J TRAUMA STRESS, V14, P259, DOI 10.1023/A:1011157800050; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Nievergelt CM, 2018, BIOL PSYCHIAT, V83, P831, DOI 10.1016/j.biopsych.2018.01.020; Rauch SL, 2009, STRESS-INDUCED AND FEAR CIRCUITRY DISORDERS: ADVANCING THE RESEARCH AGENDA FOR DSM-V, P215; Schwab KA, 2006, NEUROLOGY, V66, pA235; Sharma S, 2019, PROG NEURO-PSYCHOPH, V90, P197, DOI 10.1016/j.pnpbp.2018.11.010; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Skogstad M, 2013, OCCUP MED-OXFORD, V63, P175, DOI 10.1093/occmed/kqt003; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Still CD, 2011, OBESITY, V19, P1676, DOI 10.1038/oby.2011.3; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P1; Taylor MD, 2009, PSYCHOSOM MED, V71, P631, DOI 10.1097/PSY.0b013e3181a65298; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Urosevich TG, 2018, MIL MED, V183, pE564, DOI 10.1093/milmed/usy102; Vlahov D, 2004, AM J DRUG ALCOHOL AB, V30, P385, DOI 10.1081/ADA-120037384; von Wolff G, 2011, J PSYCHIATR RES, V45, P256, DOI 10.1016/j.jpsychires.2010.06.007; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260	83	5	5	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2020	16						43	54		10.2147/NDT.S228802			12	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	KD7BW	WOS:000508020300001	32021198	Green Published, gold			2022-02-06	
J	Ward, MD; Weber, A; Merrill, VD; Welch, RD; Bazarian, JJ; Christenson, RH				Ward, Matthew D.; Weber, Art; Merrill, VeRonika D.; Welch, Robert D.; Bazarian, Jeffrey J.; Christenson, Robert H.			Predictive Performance of Traumatic Brain Injury Biomarkers in High-Risk Elderly Patients	JOURNAL OF APPLIED LABORATORY MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; MILD	Background: Serum glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal esterase L1 (UCH-L1) have recently received US Food and Drug Administration approval for prediction of abnormal computed tomography (CT) in mild traumatic brain injury patients (mTBI). However, their performance in elderly patients has not been characterized. Methods: We performed a posthoc analysis using the A Prospective Clinical Evaluation of Biomarkers of Traumatic Brain Injury (ALERT-TBI) study data. Previously recorded patient variables and serum values of GFAP and UCH-L1 from mTBI patients were partitioned at 65 years of age (herein referred to as >= 65, high-risk; <65, low-risk). We sought to assess the influence of age on predictive performance, sensitivity, and negative predictive value (NPV) of serum UCH-L1 and GFAP to predict intracranial injury by CT. Results: Elderly mTBI patients constituted 25.7% of the patient cohort (n = 504/1959). Sensitivity and NPV of GFAP/UCH-L1 were 100%, with no significant difference from younger patients (P = 0.5525 and P > 0.9999, respectively). Specificity was significantly lower in elderly patients (0.131 vs 0.442; P < 0.0001) and decreased stepwise with older age. Compared to younger patients, elderly mTBI patients without abnormal (i.e., normal) CT findings also had a significantly higher GFAP (38.6 vs 16.2 pg/mL; P < 0.0001) and UCH-L1 (347.4 vs 232.1 pg/mL; P < 0.0001). Conclusions: Sensitivity and NPV to predict intracranial injury by CT was nearly identical between younger and elderly mTBI patients. Decrements in specificity and increased serum values suggest that special deference may be warranted for elderly patients.	[Ward, Matthew D.; Merrill, VeRonika D.; Christenson, Robert H.] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA; [Weber, Art] Banyan Biomarkers Inc, San Diego, CA USA; [Welch, Robert D.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA		Christenson, RH (corresponding author), Univ Maryland, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA.	rchristenson@umm.edu					Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Banyan Biomarkers, 2019, BANYAN BTI BRAIN TRA, P23; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Fournier N, 2019, EMERG MED J, V36, P617, DOI 10.1136/emermed-2018-208153; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gardner RC, J NEUROTRAUMA; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Papa L, SOURCEBRAIN NEUROTRA; Peters Matthew E, 2018, Concussion, V3, pCNC56, DOI 10.2217/cnc-2018-0001; Scotti G, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02002; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22	20	5	5	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA		2475-7241		J APPL LAB MED	J. Appl. Lab. Med.	JAN	2020	5	1					91	100		10.1093/jalm.2019.031393			10	Medical Laboratory Technology	Emerging Sources Citation Index (ESCI)	Medical Laboratory Technology	LK7XY	WOS:000531076100010	32445344	Bronze			2022-02-06	
J	Watanabe, H; Nosova, O; Sarkisyan, D; Andersen, MS; Zhang, ML; Rorick-Kehn, L; Clausen, F; Gawel, K; Kehr, J; Hallberg, M; Schouenborg, J; Marklund, N; Bakalkin, G				Watanabe, Hiroyuki; Nosova, Olga; Sarkisyan, Daniil; Andersen, Marlene Storm; Zhang, Mengliang; Rorick-Kehn, Linda; Clausen, Fredrik; Gawel, Kinga; Kehr, Jan; Hallberg, Mathias; Schouenborg, Jens; Marklund, Niklas; Bakalkin, Georgy			Ipsilesional versus contralesional postural deficits induced by unilateral brain trauma: a side reversal by opioid mechanism	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; postural deficits; hindlimbs; opioid system	SPINAL-CORD HEMISECTION; FOCAL CEREBRAL-ISCHEMIA; SEGMENTAL REFLEXES; NEUROLOGICAL DEFICITS; NOR-BINALTORPHIMINE; NALOXONE REVERSAL; SPASTIC DYSTONIA; DELTA; RAT; ASYMMETRY	Unilateral traumatic brain injury and stroke result in asymmetric postural and motor deficits including contralateral hemiplegia and hemiparesis. In animals, a localized unilateral brain injury recapitulates the human upper motor neuron syndrome in the formation of hindlimb postural asymmetry with contralesional limb flexion and the asymmetry of hindlimb nociceptive withdrawal reflexes. The current view is that these effects are developed due to aberrant activity of motor pathways that descend from the brain into the spinal cord. These pathways and their target spinal circuits may be regulated by local neurohormonal systems that may also mediate effects of brain injury. Here, we evaluate if a unilateral traumatic brain injury induces hindlimb postural asymmetry, a model of postural deficits, and if this asymmetry is spinally encoded and mediated by the endogenous opioid system in rats. A unilateral right-sided controlled cortical impact, a model of clinical focal traumatic brain injury was centred over the sensorimotor cortex and was observed to induce hindlimb postural asymmetry with contralateral limb flexion. The asymmetry persisted after complete spinal cord transection, implicating local neurocircuitry in the development of the deficits. Administration of the general opioid antagonist naloxone and mu-antagonist beta-funaltrexamine blocked the formation of postural asymmetry. Surprisingly, kappa-antagonists nor-binaltorphimine and LY2444296 did not affect the asymmetry magnitude but reversed the flexion side; instead of contralesional (left) hindlimb flexion the ipsilesional (right) limb was flexed. The postural effects of the right-side cortical injury were mimicked in animals with intact brain via intrathecal administration of the opioid kappa-agonist (2)-(trans)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide that induced hindlimb postural asymmetry with left limb flexion. The delta-antagonist naltrindole produced no effect on the contralesional (left) flexion but inhibited the formation of the ipsilesional (right) limb flexion in brain-injured rats that were treated with kappa-antagonist. The effects of the antagonists were evident before and after spinal cord transection. We concluded that the focal traumatic brain injury-induced postural asymmetry was encoded at the spinal level, and was blocked or its side was reversed by administration of opioid antagonists. The findings suggest that the balance in activity of the mirror symmetric spinal neural circuits regulating contraction of the left and right hindlimb muscles is controlled by different subtypes of opioid receptors; and that this equilibrium is impaired after unilateral brain trauma through side-specific opioid mechanism.	[Watanabe, Hiroyuki; Nosova, Olga; Sarkisyan, Daniil; Hallberg, Mathias; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Andersen, Marlene Storm; Zhang, Mengliang] Univ Southern Denmark, Dept Mol Med, Odense, Denmark; [Zhang, Mengliang; Schouenborg, Jens] Lund Univ, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden; [Rorick-Kehn, Linda] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Gawel, Kinga] Med Univ Lublin, Dept Expt & Clin Pharmacol, Lublin, Poland; [Kehr, Jan] Karolinska Inst, Dept Physiol, Stockholm, Sweden; [Kehr, Jan] Karolinska Inst, Dept Pharmacol, Stockholm, Sweden; [Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden		Bakalkin, G (corresponding author), Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden.	georgy.bakalkin@farmbio.uu.se		Zhang, Mengliang/0000-0001-5945-6625; Andersen, Marlene Storm/0000-0002-0668-7152; Gawel, Kinga/0000-0001-8857-847X	Swedish Science Research Council [K2014-62X-12190-19-5, 2019-01771-3]; P.O. Zetterling foundation; Uppsala University; National Science Center, PolandNational Science Centre, Poland [DEC2015/16/T/NZ7/00171]	This study was supported by the Swedish Science Research Council (Grants K2014-62X-12190-19-5 and 2019-01771-3), P.O. Zetterling foundation, and Uppsala University. K.G. received financial support from the National Science Center, Poland, within a framework of doctoral scholarship (DEC2015/16/T/NZ7/00171).	Altman N, 2015, NAT METHODS, V12, P165, DOI 10.1038/nmeth.3293; BAKALKIN GJ, 1981, DOKL AKAD NAUK SSSR+, V260, P1271; BAKALKIN GY, 1989, BRAIN RES, V480, P268, DOI 10.1016/0006-8993(89)90192-3; BAKALKIN GY, 1989, INT J NEUROSCI, V47, P217, DOI 10.3109/00207458908987436; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; BASKIN DS, 1994, STROKE, V25, P2047, DOI 10.1161/01.STR.25.10.2047; BASKIN DS, 1981, LANCET, V2, P272; BASKIN DS, 1984, BRAIN RES, V290, P289, DOI 10.1016/0006-8993(84)90946-6; Baude M, 2019, ANN PHYS REHABIL MED, V62, P426, DOI 10.1016/j.rehab.2018.10.004; CHAMBERLAIN TJ, 1963, J NEUROPHYSIOL, V26, P662, DOI 10.1152/jn.1963.26.4.662; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; CLARKE RW, 1992, J PHYSIOL-LONDON, V449, P493, DOI 10.1113/jphysiol.1992.sp019098; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Dewald JPA, 1999, MUSCLE NERVE, V22, P1209, DOI 10.1002/(SICI)1097-4598(199909)22:9<1209::AID-MUS7>3.0.CO;2-B; DiGiorgio AM, 1929, ARCH FISIOL, V27, P518; Duarte J, 2019, BRAIN RES, V1717, P182, DOI 10.1016/j.brainres.2019.04.026; Nizhnikov ME, 2009, ALCOHOL, V43, P347, DOI 10.1016/j.alcohol.2009.06.001; Faber ESL, 1997, BRIT J PHARMACOL, V120, P1390, DOI 10.1038/sj.bjp.0701064; Feldman AG, 2016, J HUM KINET, V52, P21, DOI 10.1515/hukin-2015-0191; Frigon A, 2011, J NEUROPHYSIOL, V106, P1669, DOI 10.1152/jn.00504.2011; Frigon A, 2009, J NEUROPHYSIOL, V102, P2667, DOI 10.1152/jn.00572.2009; Fuchigami T, 2011, NEUROSCIENCE, V194, P160, DOI 10.1016/j.neuroscience.2011.08.022; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GACEI G, 1980, FEBS LETT, V118, P245, DOI 10.1016/0014-5793(80)80229-8; Gironi M, 2008, MULT SCLER J, V14, P1076, DOI 10.1177/1352458508095828; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Grau JW, 2014, NEUROBIOL LEARN MEM, V108, P155, DOI 10.1016/j.nlm.2013.08.003; Hanell Anders, 2012, Front Neurol, V3, P29, DOI 10.3389/fneur.2012.00029; HANS P, 1992, INTENS CARE MED, V18, P362, DOI 10.1007/BF01694365; HORAN P, 1992, J PHARMACOL EXP THER, V260, P1237; HOSOBUCHI Y, 1982, SCIENCE, V215, P69, DOI 10.1126/science.6274019; HUISMAN AM, 1982, PROG BRAIN RES, V57, P185, DOI 10.1016/S0079-6123(08)64130-8; HULTBORN H, 1983, ACTA PHYSIOL SCAND, V119, P423, DOI 10.1111/j.1748-1716.1983.tb07358.x; HULTBORN H, 1983, ACTA PHYSIOL SCAND, V119, P405, DOI 10.1111/j.1748-1716.1983.tb07357.x; HULTBORN H, 1991, LIFE SCI R, V50, P49; JABAILY J, 1984, STROKE, V15, P36, DOI 10.1161/01.STR.15.1.36; Jamal K, 2018, EXP BRAIN RES, V236, P2377, DOI 10.1007/s00221-018-5308-1; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Kantonen T, 2020, NEUROIMAGE, V217, DOI 10.1016/j.neuroimage.2020.116922; Kononenko O, 2018, BRAIN RES, V1695, P78, DOI 10.1016/j.brainres.2018.05.043; Kononenko O, 2017, FASEB J, V31, P1953, DOI 10.1096/fj.201601039R; KRYZHANOVSKII G N, 1984, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P68; Lavrov I, 2015, J NEUROPHYSIOL, V114, P3306, DOI 10.1152/jn.00583.2015; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Lorentzen J, 2018, CLIN NEUROPHYSIOL, V129, P89, DOI 10.1016/j.clinph.2017.10.023; Lukoyanov N, 2020, BIORXIV; Lumsden DE, 2019, CLIN NEUROPHYSIOL, V130, P1074, DOI 10.1016/j.clinph.2019.03.010; MALMSTEN J, 1983, ACTA PHYSIOL SCAND, V119, P435, DOI 10.1111/j.1748-1716.1983.tb07359.x; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; MANSOUR A, 1994, J COMP NEUROL, V350, P412, DOI 10.1002/cne.903500307; Melief EJ, 2011, MOL PHARMACOL, V80, P920, DOI 10.1124/mol.111.074195; Miller JF, 1996, J NEUROPHYSIOL, V75, P620, DOI 10.1152/jn.1996.75.2.620; Musienko PE, 2010, J NEUROPHYSIOL, V103, P1080, DOI 10.1152/jn.00575.2009; NAMBA S, 1986, JPN J PSYCHIAT NEUR, V40, P61; Norris JN, 2009, PHARMACOL BIOCHEM BE, V94, P81, DOI 10.1016/j.pbb.2009.07.012; Nusbaum MP, 2017, NAT REV NEUROSCI, V18, P389, DOI 10.1038/nrn.2017.56; Patkar KA, 2013, J PHARMACOL EXP THER, V346, P545, DOI 10.1124/jpet.113.206086; Petko M, 2004, J COMP NEUROL, V480, P364, DOI 10.1002/cne.20356; Petrillo P, 2003, J PHARMACOL EXP THER, V307, P1079, DOI 10.1124/jpet.103.055590; Phelps CE, 2019, PAIN, V160, P1614, DOI 10.1097/j.pain.0000000000001553; Roelofs JMB, 2018, NEUROREHAB NEURAL RE, V32, P953, DOI 10.1177/1545968318804405; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Rutten K, 2018, EUR J PHARMACOL, V827, P41, DOI 10.1016/j.ejphar.2018.03.008; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHMIDT PF, 1991, J PHYSIOL-LONDON, V442, P103, DOI 10.1113/jphysiol.1991.sp018785; Schouenborg J, 2002, BRAIN RES REV, V40, P80, DOI 10.1016/S0165-0173(02)00191-1; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Serrao M, 2012, CLIN NEUROPHYSIOL, V123, P527, DOI 10.1016/j.clinph.2011.07.031; Sheean G, 2009, PM&R, V1, P827, DOI 10.1016/j.pmrj.2009.08.002; Sist B, 2014, EXP NEUROL, V252, P47, DOI 10.1016/j.expneurol.2013.11.019; SKARPHEDINSSON JO, 1989, J CEREBR BLOOD F MET, V9, P515, DOI 10.1038/jcbfm.1989.75; Spaich EG, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-81; Steffens H, 2011, NEUROSCI RES, V70, P44, DOI 10.1016/j.neures.2011.01.011; Tan AM, 2012, J NEUROSCI, V32, P12896, DOI 10.1523/JNEUROSCI.6451-11.2012; Tandon S, 2008, EUR J NEUROSCI, V27, P228, DOI 10.1111/j.1460-9568.2007.05997.x; Team RC, 2018, COMPUTING RFFS; Trompetto C, 2019, CLIN NEUROPHYSIOL, V130, P521, DOI 10.1016/j.clinph.2019.01.012; Valero-Cabre A, 2004, J NEUROPHYSIOL, V91, P2838, DOI 10.1152/jn.01177.2003; VARLINSKAYA E I, 1984, Byulleten' Eksperimental'noi Biologii i Meditsiny, V98, P281; VARTANYAN G A, 1989, Byulleten' Eksperimental'noi Biologii i Meditsiny, V107, P404; Wang D, 2018, NEURON, V98, P90, DOI 10.1016/j.neuron.2018.03.002; Wang X, 2019, ACTA PHARMACOL SIN, V40, P170, DOI 10.1038/s41401-018-0053-3; Watanabe H, 2015, CEREB CORTEX, V25, P97, DOI 10.1093/cercor/bht204; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wobbrock JO, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P143, DOI 10.1145/1978942.1978963; Wolpaw JR, 2012, BRAIN, V135, DOI 10.1093/brain/aws017; Zhang ML, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa055; Zhou HH, 1998, ANESTHESIOLOGY, V88, P955, DOI 10.1097/00000542-199804000-00015	89	5	5	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	2							208	10.1093/braincomms/fcaa208			18	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	RM1PH	WOS:000639431800141	33364602	gold, Green Published			2022-02-06	
J	Wu, DM; Zheng, ZH; Fan, SH; Zhang, ZF; Chen, GQ; Lu, J				Wu, Dong-Mei; Zheng, Zi-Hui; Fan, Shao-Hua; Zhang, Zi-Feng; Chen, Gui-Quan; Lu, Jun			Sulforaphane administration alleviates diffuse axonal injury (DAI) via regulation signaling pathway of NRF2 and HO-1	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						apoptosis; diffuse axonal injury; HO-1; Nrf2; sulforaphane	TRAUMATIC BRAIN-INJURY; TRANSCRIPTION FACTOR NRF2; PIGMENT EPITHELIAL-CELLS; HEME OXYGENASE-1 GENE; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; ACTIVATION; DAMAGE; ACCUMULATION; DEGENERATION	Background Nuclear factor erythroid 2-related factor 2 (Nrf2) can alleviate diffuse axonal injury (DAI)-induced apoptosis by regulating expression of heme oxygenase-1 (HO-1), while sulforaphane (SFN) was shown to reduce oxidative stress by increasing the expression of Nrf2. Therefore, we aimed to investigate therapeutic effect of SFN in the treatment of DAI and the ability of SFN to reduce oxidative stress. Methods The 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay was used to observe the effects of H2O2 and SFN on cell viability. Fluorometric assay, Western blot analysis, and flow cytometry were conducted to validate the protective role of SFN in an animal model of DAI. In addition, the levels of malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GPx) were measured in DAI rats treated by SFN, while Western blot, immunohistochemistry assay, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay were carried out to verify the effect of SFN in different animal groups. Results Cell viability was reduced by H2O2 in a dose-dependent manner, while the treatment by SFN significantly promoted cell growth. Meanwhile the administration of SFN effectively reduced the levels of caspase-3/poly(ADP-ribose) polymerase (PARP) activity increased by the H2O2 treatment, indicating that the protective effect of SFN could be mediated by its ability to suppress caspase-3 activation and PARP cleavage. In addition, the SFN treatment reduced the intracellular reactive oxygen species (ROS) generation induced by H2O2. Moreover, the MDA levels of SOD/GPx activity in various rat groups showed the protective effects of SFN in DAI rats. It is suspected that the protective effect of SFN was exerted via the activation of the Nrf2/HO-1 signaling pathway. In this study, DAI and DAI + phosphate-buffered saline (PBS) groups also showed the presence of more TUNEL-positive cells compared with the sham-operated group, while the SFN treatment reduced the extent of neuronal apoptosis. Conclusions By activating the Nrf2/HO-1 signaling pathway and reducing the activity of caspase-3, SFN reduces the apoptosis of neurons in brain trauma-induced DAI.	[Wu, Dong-Mei; Fan, Shao-Hua; Zhang, Zi-Feng; Lu, Jun] Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, 101 Shanghai Rd, Xuzhou 210061, Jiangsu, Peoples R China; [Wu, Dong-Mei; Fan, Shao-Hua; Zhang, Zi-Feng; Lu, Jun] Jiangsu Normal Univ, Coll Hlth Sci, Xuzhou, Jiangsu, Peoples R China; [Zheng, Zi-Hui] Nanjing Univ Chinese Med, Sch Med & Life Sci, State Key Lab Cultivat Base TCM Qual & Efficacy, Nanjing, Jiangsu, Peoples R China; [Chen, Gui-Quan] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China		Lu, J (corresponding author), Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, 101 Shanghai Rd, Xuzhou 210061, Jiangsu, Peoples R China.; Chen, GQ (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	chenguiquan@nju.edu.cn; lu-jun75@163.com		Lu, Jun/0000-0002-2801-5330			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Buki A, 2000, J NEUROSCI, V20, P2825; Cano MD, 2008, INVEST OPHTH VIS SCI, V49, P2606, DOI 10.1167/iovs.07-0960; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dasgupta N, 2018, CHEM-BIOL INTERACT, V295, P109, DOI 10.1016/j.cbi.2018.07.028; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Hosie KA, 2012, ASN NEURO, V4, P47, DOI 10.1042/AN20110031; Hunot S, 2001, SCIENCE, V292, P865, DOI 10.1126/science.1060885; Hyun H, 2011, BIOMATERIALS, V32, P306, DOI 10.1016/j.biomaterials.2010.08.116; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Ishii T, 2004, CIRC RES, V94, P609, DOI 10.1161/01.RES.0000119171.44657.45; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim YM, 2011, ANTIOXID REDOX SIGN, V14, P137, DOI 10.1089/ars.2010.3153; King AE, 2007, EUR J NEUROSCI, V26, P2151, DOI 10.1111/j.1460-9568.2007.05845.x; King AE, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-59; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lao LF, 2013, ORTHOP SURG, V5, P164, DOI 10.1111/os.12046; Le LL, 2013, CNS NEUROSCI THER, V19, P963, DOI 10.1111/cns.12152; Lee J, 2012, J CONTROL RELEASE, V158, P131, DOI 10.1016/j.jconrel.2011.11.001; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lin H, 2014, DRUG DES DEV THER, V8, P973, DOI 10.2147/DDDT.S65410; Malaguti M, 2009, J APPL PHYSIOL, V107, P1028, DOI 10.1152/japplphysiol.00293.2009; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Shen CB, 2016, MOL MED REP, V14, P3646, DOI 10.3892/mmr.2016.5670; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yoon HY, 2008, BIOCHEM PHARMACOL, V75, P2214, DOI 10.1016/j.bcp.2008.02.029; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhao Y, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6340457	58	5	5	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	JAN	2020	121	1					430	442		10.1002/jcb.29203			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	JQ1VC	WOS:000498739700039	31232487				2022-02-06	
J	Xu, JJ; Zhan, T; Zheng, W; Huang, YK; Chen, K; Zhang, XH; Ren, P; Huang, X				Xu, Jianjun; Zhan, Tian; Zheng, Wan; Huang, Yun-Ke; Chen, Ken; Zhang, Xian-Hua; Ren, Ping; Huang, Xi			Hydroxysafflor yellow A acutely attenuates blood-brain barrier permeability, oxidative stress, inflammation and apoptosis in traumatic brain injury in rats	ACTA CIRURGICA BRASILEIRA			English	Article						Brain Injuries; Traumatic; Blood-Brain Barrier; Oxidative Stress; Apoptosis; Rats	DISRUPTION; MECHANISM; DAMAGE	Purpose: To investigate the therapeutic benefits of Hydroxysafflor yellow A (HSYA) on blood-brain barrier (BBB) vulnerability after traumatic brain injury (TBI) and identify its potential action of mechanisms on TBI-induced injuries. Methods: The rat TBI model was performed by using a controlled cortical impact device. The BBB permeability induced by TBI was measured through Evans Blue dye superflux and western blotting or polymerase chain reaction (PCR) for tight junctional proteins (TJPs). The post-TBI changes in oxidative stress markers, inflammatory response and neuron apoptosis in brain tissue were also tested. Results: Herein, the results showed that HSYA acutely attenuated BBB permeability via increasing the production of the TJPs, including occludin, claudin-1 and zonula occludens protein 24 h after TBI. Additionally, HSYA could suppress the secretion of proinflammatory factors, such as interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha (IL-1 beta, IL-6, and TNF-alpha), and also concurrently down-regulate the expression of inflammation-related Toll-like receptor 4/nuclear factor kappa-B (TLR4/NF-kB) protein. These HSYA challenged changes were accompanied by the decreased TBI induced oxidative stress markers and inhibited the expression of apoptosis proteins Bax, caspase-3 and caspase-9. Conclusions: Taken together, all findings suggested that HSYA (30 mg/kg) are against TBI through improving the integrity in BBB, which are associated with the antioxidant, anti-inflammation and antiapoptosis via the probable mechanism of down-regulation of the TLR4/NF-kB pathway, and its in-detail protective mechanisms are under study.	[Xu, Jianjun; Zheng, Wan] Nanjing Univ Chinese Med, Nanjing, Peoples R China; [Zhan, Tian; Chen, Ken; Huang, Xi] Nanjing Univ Chinese Med, Dept TCM Related Comorbid Depress, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China; [Huang, Yun-Ke] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Peoples R China; [Zhang, Xian-Hua] Xiamen Xianyue Hosp, Xiamen Mental Hlth Ctr, Xiamen, Peoples R China; [Ren, Ping] Nanjing Univ Chinses Med, Dept Geriatr, Affiliated Hosp, Nanjing, Peoples R China		Huang, X (corresponding author), Nanjing Univ Chinese Med, Dept TCM Related Comorbid Depress, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.	tcmhuangx59@163.com		Huang, Yunke/0000-0001-9579-3522	National Natural Science foundation of ChinaNational Natural Science Foundation of China (NSFC) [81973589, 81072967]; Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of Chinese and western medicine); Nanjing University of Chinese Medicine	National Natural Science foundation of China (grant numbers 81973589, 81072967); the Priority Academic Program Development of Jiangsu Higher Education Institutions (integration of Chinese and western medicine) and high-level talents of Nanjing University of Chinese Medicine.	Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Aube B, 2014, J IMMUNOL, V193, P2438, DOI 10.4049/jimmunol.1400401; Bao ZY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00222; Bennett C, 2019, BIOMATERIALS, V188, P144, DOI 10.1016/j.biomaterials.2018.09.040; Chen SN, 2019, MOL MED REP, V19, P3009, DOI 10.3892/mmr.2019.9959; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Dong F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40584; Evran S, 2020, BRAIN RES BULL, V154, P68, DOI 10.1016/j.brainresbull.2019.10.013; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Greene C, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0123-z; Han B, 2010, NEUROCHEM RES, V35, P107, DOI 10.1007/s11064-009-0035-4; Jung SS, 2020, NEUROMOL MED, V22, P31, DOI 10.1007/s12017-019-08560-8; Kanda T, 2004, J NEUROL NEUROSUR PS, V75, P765, DOI 10.1136/jnnp.2003.025692; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Lv YN, 2018, NEUROCHEM INT, V112, P38, DOI 10.1016/j.neuint.2017.10.012; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marin N, 2012, CIRC RES, V111, P553, DOI 10.1161/CIRCRESAHA.112.274548; Pei JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0870-1; Pfeiffer F, 2011, ACTA NEUROPATHOL, V122, P601, DOI 10.1007/s00401-011-0883-2; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Shan H, 2016, NEUROPHARMACOLOGY, V107, P68, DOI 10.1016/j.neuropharm.2016.03.019; Sonar SA, 2018, J LEUKOCYTE BIOL, V103, P839, DOI 10.1002/JLB.1RU1117-428R; Tian RF, 2016, BRAIN RES, V1637, P1, DOI 10.1016/j.brainres.2016.01.029; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yang YL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030491; Zhang XH, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00452; Zheng M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00328	29	5	5	4	6	ACTA CIRURGICA BRASILEIRA	SAO PAULO	ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL	0102-8650	1678-2674		ACTA CIR BRAS	Acta Cir. Bras.		2020	35	12							e351202	10.1590/ACB351202			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PU2XQ	WOS:000609169200001	33503215	gold, Green Published			2022-02-06	
J	Zhang, ML; Watanabe, H; Sarkisyan, D; Andersen, MS; Nosova, O; Galatenko, V; Carvalho, L; Lukoyanov, N; Thelin, J; Schouenborg, J; Bakalkin, G				Zhang, Mengliang; Watanabe, Hiroyuki; Sarkisyan, Daniil; Andersen, Marlene Storm; Nosova, Olga; Galatenko, Vladimir; Carvalho, Liliana; Lukoyanov, Nikolay; Thelin, Jonas; Schouenborg, Jens; Bakalkin, Georgy			Hindlimb motor responses to unilateral brain injury: spinal cord encoding and left-right asymmetry	BRAIN COMMUNICATIONS			English	Article						brain injury; hindlimb motor deficits; lateralization; postural asymmetry; nociceptive withdrawal reflexes	WITHDRAWAL REFLEXES; POSTURAL ASYMMETRY; STRUCTURAL PLASTICITY; SPASTIC DYSTONIA; RECEPTIVE-FIELDS; LIMB; RAT; RECOVERY; STIMULATION; MODULATION	Mechanisms of motor deficits (e.g. hemiparesis and hemiplegia) secondary to stroke and traumatic brain injury remain poorly understood. In early animal studies, a unilateral lesion to the cerebellum produced postural asymmetry with ipsilateral hindlimb flexion that was retained after complete spinal cord transection. Here we demonstrate that hindlimb postural asymmetry in rats is induced by a unilateral injury of the hindlimb sensorimotor cortex, and characterize this phenomenon as a model of spinal neuroplasticity underlying asymmetric motor deficits. After cortical lesion, the asymmetry was developed due to the contralesional hindlimb flexion and persisted after decerebration and complete spinal cord transection. The asymmetry induced by the left-side brain injury was eliminated by bilateral lumbar dorsal rhizotomy, but surprisingly, the asymmetry after the right-side brain lesion was resistant to deafferentation. Pancuronium, a curare-mimetic muscle relaxant, abolished the asymmetry after the right-side lesion suggesting its dependence on the efferent drive. The contra- and ipsilesional hindlimbs displayed different musculo-articular resistance to stretch after the left but not right-side injury. The nociceptive withdrawal reflexes evoked by electrical stimulation and recorded with EMG technique were different between the left and right hindlimbs in the spinalized decerebrate rats. On this asymmetric background, a brain injury resulted in greater reflex activation on the contra- versus ipsilesional side; the difference between the limbs was higher after the right-side brain lesion. The unilateral brain injury modified expression of neuroplasticity genes analysed as readout of plastic changes, as well as robustly impaired coordination of their expression within and between the ipsi- and contralesional halves of lumbar spinal cord; the effects were more pronounced after the left side compared to the right-side injury. Our data suggest that changes in the hindlimb posture, resistance to stretch and nociceptive withdrawal reflexes are encoded by neuroplastic processes in lumbar spinal circuits induced by a unilateral brain injury. Two mechanisms, one dependent on and one independent of afferent input may mediate asymmetric hindlimb motor responses. The latter, deafferentation resistant mechanism may be based on sustained muscle contractions which often occur in patients with central lesions and which are not evoked by afferent stimulation. The unusual feature of these mechanisms is their lateralization in the spinal cord.	[Zhang, Mengliang; Thelin, Jonas; Schouenborg, Jens] Lund Univ, Neuronano Res Ctr, Dept Expt Med Sci, S-22100 Lund, Sweden; [Zhang, Mengliang; Andersen, Marlene Storm] Univ Southern Denmark, Dept Mol Med, DK-5000 Odense, Denmark; [Watanabe, Hiroyuki; Sarkisyan, Daniil; Nosova, Olga; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden; [Galatenko, Vladimir] Lomonosov Moscow State Univ, Fac Mech & Math, Moscow 119234, Russia; [Carvalho, Liliana; Lukoyanov, Nikolay] Univ Porto, Inst Invest & Inovacao Saude, Inst Biol Mol & Celular, Dept Biomed,Fac Med, P-4200319 Porto, Portugal		Bakalkin, G (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden.	georgy.bakalkin@farmbio.uu.se	Lukoyanov, Nikolai/N-1235-2013	Lukoyanov, Nikolai/0000-0002-5206-7819; Carvalho, Liliana S./0000-0001-9081-3184; Thelin, Jonas/0000-0002-6452-1476; Zhang, Mengliang/0000-0001-5945-6625; Andersen, Marlene Storm/0000-0002-0668-7152	Swedish Science Research Council [K2014-62X-12190-19-5, 2019-01771-3]; P.O. Zetterling foundation; Government of the Russian Federation [14.W03.31.0031]; Uppsala University	The study was supported by the Swedish Science Research Council (Grants K2014-62X-12190-19-5 and 2019-01771-3), P.O. Zetterling foundation, Uppsala University, and by grant of the Government of the Russian Federation (14.W03.31.0031).	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; ALELLA A., 1948, ARCH FISIOL, V47, P105; Alvisi E, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1162; ANDERSEN OK, 1995, EUR J APPL PHYSIOL O, V70, P311, DOI 10.1007/BF00865028; ANDERSON MF, 1995, BRAIN RES, V678, P140, DOI 10.1016/0006-8993(95)00177-R; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; BAKALKIN GJ, 1980, DOKL AKAD NAUK SSSR+, V252, P762; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1982, LIFE SCI, V30, P779, DOI 10.1016/0024-3205(82)90613-0; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; Baude M, 2019, ANN PHYS REHABIL MED, V62, P426, DOI 10.1016/j.rehab.2018.10.004; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; CHAMBERLAIN TJ, 1963, J NEUROPHYSIOL, V26, P662, DOI 10.1152/jn.1963.26.4.662; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; Condliffe EG, 2005, CLIN NEUROPHYSIOL, V116, P1870, DOI 10.1016/j.clinph.2005.02.030; CRENNA P, 1984, EXP NEUROL, V85, P336, DOI 10.1016/0014-4886(84)90144-4; de Kovel CGF, 2017, BIOL PSYCHIAT, V82, P204, DOI 10.1016/j.biopsych.2017.01.016; DELWAIDE PJ, 1988, J NEUROL NEUROSUR PS, V51, P1546, DOI 10.1136/jnnp.51.12.1546; Denny-Brown D., 1980, SPASTICITY DISORDERE, P1; Denny-Brown D., 1966, CEREBRAL CONTROL MOV, P210; Dietz V, 2009, BRAIN, V132, P2196, DOI 10.1093/brain/awp124; DiGiorgio AM, 1929, ARCH FISIOL, V27, P518; DiGiorgio AM, 1942, ARCH FISIOL, V42, P25; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dolan S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-91; DUYSENS J, 1992, EXP BRAIN RES, V90, P404; DUYSENS J, 1990, EXP BRAIN RES, V82, P351; Emborg J, 2009, MED BIOL ENG COMPUT, V47, P29, DOI 10.1007/s11517-008-0396-x; Epstein I, 2018, SEMIN CELL DEV BIOL, V77, P63, DOI 10.1016/j.semcdb.2017.09.023; Eriksson J, 1996, EXP BRAIN RES, V111, P296; Feldman AG, 2016, J HUM KINET, V52, P21, DOI 10.1515/hukin-2015-0191; Fernandes CA, 2018, HUM MOVEMENT SCI, V57, P374, DOI 10.1016/j.humov.2017.09.015; Frigon A, 2011, J NEUROPHYSIOL, V106, P1669, DOI 10.1152/jn.00504.2011; Frigon A, 2009, J NEUROPHYSIOL, V102, P2667, DOI 10.1152/jn.00572.2009; Fuchigami T, 2011, NEUROSCIENCE, V194, P160, DOI 10.1016/j.neuroscience.2011.08.022; Gelman A., 2019, PRIOR CHOICE RECOMME; Gervasio S, 2018, IEEE T NEUR SYS REH, V26, P1100, DOI 10.1109/TNSRE.2018.2828221; Gossard JP, 2015, J NEUROSCI, V35, P9446, DOI 10.1523/JNEUROSCI.4502-14.2015; Gracies JM, 2005, MUSCLE NERVE, V31, P535, DOI 10.1002/mus.20284; Grasselli G, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00025; Grau JW, 2014, NEUROBIOL LEARN MEM, V108, P155, DOI 10.1016/j.nlm.2013.08.003; Harris KP, 2016, ELIFE, V5, DOI 10.7554/eLife.13881; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hubli M, 2012, EXP NEUROL, V234, P153, DOI 10.1016/j.expneurol.2011.12.025; HULTBORN H, 1983, ACTA PHYSIOL SCAND, V119, P423, DOI 10.1111/j.1748-1716.1983.tb07358.x; HULTBORN H, 1983, ACTA PHYSIOL SCAND, V119, P405, DOI 10.1111/j.1748-1716.1983.tb07357.x; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jones TA, 2017, NAT REV NEUROSCI, V18, P267, DOI 10.1038/nrn.2017.26; Joynes RL, 2004, BEHAV BRAIN RES, V154, P431, DOI 10.1016/j.bbr.2004.03.030; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kerzoncuf M, 2015, J REHABIL MED, V47, P910, DOI 10.2340/16501977-2014; KLEMENTIEV BI, 1986, DOKL AKAD NAUK SSSR+, V291, P737; Knebel D, 2018, CURR BIOL, V28, pR1290, DOI 10.1016/j.cub.2018.09.063; Kohl MM, 2011, NAT NEUROSCI, V14, P1413, DOI 10.1038/nn.2915; Kononenko O, 2019, RESTOR NEUROL NEUROS, V37, P87, DOI 10.3233/RNN-180882; Kononenko O, 2018, BRAIN RES, V1695, P78, DOI 10.1016/j.brainres.2018.05.043; Kononenko O, 2017, FASEB J, V31, P1953, DOI 10.1096/fj.201601039R; Larsson M, 2008, J NEUROSCI, V28, P7084, DOI 10.1523/JNEUROSCI.5749-07.2008; Lavrov I, 2015, J NEUROPHYSIOL, V114, P3306, DOI 10.1152/jn.00583.2015; Long Q, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0268-1; Lorentzen J, 2018, CLIN NEUROPHYSIOL, V129, P89, DOI 10.1016/j.clinph.2017.10.023; Lukoyanov N, 2018, J NEUROTRAUM, V35, pA201; MALMSTEN J, 1983, ACTA PHYSIOL SCAND, V119, P435, DOI 10.1111/j.1748-1716.1983.tb07359.x; Marinelli L, 2017, J ELECTROMYOGR KINES, V37, P84, DOI 10.1016/j.jelekin.2017.09.005; Marque P, 2001, J NEUROL NEUROSUR PS, V70, P36, DOI 10.1136/jnnp.70.1.36; McElreath R., 2020, STAT RETHINKING BAYE; Miller JF, 1996, J NEUROPHYSIOL, V75, P620, DOI 10.1152/jn.1996.75.2.620; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Musienko PE, 2010, J NEUROPHYSIOL, V103, P1080, DOI 10.1152/jn.00575.2009; NATHAN PW, 1990, BRAIN, V113, P303, DOI 10.1093/brain/113.2.303; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; Ocklenburg S, 2017, ELIFE, V6, DOI 10.7554/eLife.22784; Patterson MM, 2001, SPINAL CORD PLASTICITY: ALTERATIONS IN REFLEX FUNCTION, P77; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Pin-Barre C, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/608581; Pingel J, 2017, J PHYSIOL-LONDON, V595, P1027, DOI 10.1113/JP272767; [R Core Team Computing RFfS], 2018, COMP RFFS; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; Roelofs JMB, 2018, NEUROREHAB NEURAL RE, V32, P953, DOI 10.1177/1545968318804405; ROSSI A, 1994, J PHYSIOL-LONDON, V481, P521, DOI 10.1113/jphysiol.1994.sp020460; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Rousseaux M, 2014, NEUROPHYSIOL CLIN, V44, P59, DOI 10.1016/j.neucli.2013.10.130; Rueterbories J, 2013, GAIT POSTURE, V37, P183, DOI 10.1016/j.gaitpost.2012.06.029; Sainburg RL, 2016, ADV EXP MED BIOL, V957, P257, DOI 10.1007/978-3-319-47313-0_14; Sainburg RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01092; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Schouenborg J, 2002, BRAIN RES REV, V40, P80, DOI 10.1016/S0165-0173(02)00191-1; SCHOUENBORG J, 1992, EXP BRAIN RES, V90, P469; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Serrao M, 2012, CLIN NEUROPHYSIOL, V123, P527, DOI 10.1016/j.clinph.2011.07.031; Sheean G, 2009, PM&R, V1, P827, DOI 10.1016/j.pmrj.2009.08.002; Sist B, 2014, EXP NEUROL, V252, P47, DOI 10.1016/j.expneurol.2013.11.019; Spaich EG, 2006, CLIN NEUROPHYSIOL, V117, P2482, DOI 10.1016/j.clinph.2006.07.139; Spaich EG, 2004, J NEUROPHYSIOL, V91, P258, DOI 10.1152/jn.00360.2003; Spaich EG, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-81; Spinazzola L, 2003, BRAIN, V126, P2656, DOI 10.1093/brain/awg266; Stancher G, 2018, PROG BRAIN RES, V238, P33, DOI 10.1016/bs.pbr.2018.06.002; STRAKA H, 1995, J NEUROPHYSIOL, V73, P1617, DOI 10.1152/jn.1995.73.4.1617; Tan AM, 2012, J NEUROSCI, V32, P12896, DOI 10.1523/JNEUROSCI.6451-11.2012; Tandon S, 2008, EUR J NEUROSCI, V27, P228, DOI 10.1111/j.1460-9568.2007.05997.x; Tappe A, 2006, NAT MED, V12, P677, DOI 10.1038/nm1406; Tasseel-Ponche S, 2015, NEUROPHYSIOL CLIN, V45, P327, DOI 10.1016/j.neucli.2015.09.003; Tedroff K, 2015, DEV MED CHILD NEUROL, V57, P484, DOI 10.1111/dmcn.12665; Tennant KA, 2014, EXP NEUROL, V254, P195, DOI 10.1016/j.expneurol.2014.02.003; THILMANN AF, 1991, J NEUROL NEUROSUR PS, V54, P134, DOI 10.1136/jnnp.54.2.134; Valero-Cabre A, 2004, J NEUROPHYSIOL, V91, P2838, DOI 10.1152/jn.01177.2003; VARLINSKAYA E I, 1984, Byulleten' Eksperimental'noi Biologii i Meditsiny, V98, P281; Vartanyan GA, 1991, CHEM SYMMETRY ASYMME; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Weng HR, 1996, J PHYSIOL-LONDON, V493, P253, DOI 10.1113/jphysiol.1996.sp021380; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wilson LR, 1999, BRAIN, V122, P2079, DOI 10.1093/brain/122.11.2079; Wolpaw JR, 2012, BRAIN, V135, DOI 10.1093/brain/aws017; Won S, 2016, P NATL ACAD SCI USA, V113, pE4736, DOI 10.1073/pnas.1609702113; Woytowicz ET, 2018, J NEUROPHYSIOL, V120, P729, DOI 10.1152/jn.00878.2017; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; You HJ, 2004, BRAIN RES, V1009, P110, DOI 10.1016/j.brainres.2004.02.053; Zhou HH, 1998, ANESTHESIOLOGY, V88, P955, DOI 10.1097/00000542-199804000-00015	122	5	5	1	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2020	2	1							55	10.1093/braincomms/fcaa055			18	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3SX	WOS:000574931600052	32954305	gold, Green Published			2022-02-06	
J	Karr, JE; Iverson, GL; Huang, SJ; Silverberg, ND; Yang, CC				Karr, Justin E.; Iverson, Grant L.; Huang, Sheng-Jean; Silverberg, Noah D.; Yang, Chi-Cheng			Perceived Change in Physical, Cognitive, and Emotional Symptoms after Mild Traumatic Brain Injury in Patients with Pre-Injury Anxiety or Depression	JOURNAL OF NEUROTRAUMA			English	Article						brain concussion; brain injuries; comorbidity; mental health; post-concussion syndrome	OLD-DAYS BIAS; POSTCONCUSSION SYNDROME; SEX-DIFFERENCES; YOUNG-ADULTS; PREDICTORS; CONCUSSION; POPULATION; ASSOCIATION; OUTCOMES	The objective of this study was to compare patients with acute-to-subacute mild traumatic brain injury (mTBI) on post-concussion symptom reporting based on whether they retrospectively recalled experiencing pre-injury anxiety or depression. Patients with mTBI (n = 297; 40.4% men; mean = 38.2 years old, standard deviation [SD] = 14.0, range = 17-65), referred from an emergency department in Taipei, Taiwan, were seen in a neurosurgical outpatient clinic on average 7.7 days since injury (SD = 5.7, range = 0 - 21 days), at which time they completed a checklist of post-concussion symptoms. Patients rated their current symptom severity and retrospectively rated their pre-injury symptom severity on 15 physical, cognitive, and emotional symptoms. Patients were grouped based on whether they did or did not have mild or greater pre-injury anxiety or depression based on this scale. Those with pre-injury anxiety or depression had greater pre-injury (all p's < 0.001, d range: 0.92-2.03) and post-injury (all p's < 0.001, d range: 0.65-1.00) symptom severity. However, when analyzing perceived change in symptoms (i.e., post-injury ratings minus pre-injury ratings), only perceived change in cognitive symptoms differed across groups (p = 0.018, d = 0.29), which became non-significant after controlling for gender. Greater post-concussion symptom severity in patients with pre-existing mental health problems may be mostly attributable to elevated symptoms before injury. These findings demonstrate the clinical value of retrospective pre-injury symptom assessment in mTBI management. Greater post-concussion symptom severity in patients with pre-injury mental health problems may represent a continuation of greater pre-injury symptom severity rather than a greater increase in symptom severity after mTBI.	[Karr, Justin E.; Iverson, Grant L.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Karr, Justin E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Karr, Justin E.; Iverson, Grant L.] Spaulding Rehabil Inst, Boston, MA USA; [Karr, Justin E.; Iverson, Grant L.] A Red Sox Fdn, Home Base, Boston, MA USA; [Huang, Sheng-Jean] Taipei City Hosp, Taipei, Taiwan; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Yang, Chi-Cheng] Natl Chengchi Univ, Dept Psychol, 64,Sec 2,Zhinan Rd, Taipei, Taiwan; [Yang, Chi-Cheng] Taipei City Hosp, Holist Social Prevent & Mental Hlth Ctr, Taipei, Taiwan		Yang, CC (corresponding author), Natl Chengchi Univ, Dept Psychol, 64,Sec 2,Zhinan Rd, Taipei, Taiwan.	yangyang@nccu.edu.tw		YANG, CHI CHENG/0000-0002-4544-3978	Ministry of Science and Technology in TaiwanMinistry of Science and Technology, Taiwan [MOST 108-2410-H-004-087-, MOST 108-2918-I-004-003-]	Dr. Yang was supported by the Ministry of Science and Technology in Taiwan (MOST 108-2410-H-004-087-and MOST 108-2918-I-004-003-). Dr. Iverson acknowledges unrestricted philanthropic support from the Heinz Family Foundation and the Spaulding Research Institute. Dr. Silverberg receives research salary support from the Michael Smith Foundation for Health Research. The other authors received no funding.	[Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Haug TT, 2004, PSYCHOSOM MED, V66, P845, DOI 10.1097/01.psy.0000145823.85658.0c; Iverson GL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00489; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P262; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Nelson LD, 2020, J NEUROTRAUM, V37, P675, DOI 10.1089/neu.2019.6719; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Ponsford J, 2019, J REHABIL MED, V51, P32, DOI 10.2340/16501977-2492; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reed N., 2019, LIVING GUIDELINE DIA; Shimada H, 2014, J PSYCHIATR RES, V57, P149, DOI 10.1016/j.jpsychires.2014.06.004; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vikane E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00639; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312; Yue JK, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00343; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000	36	5	5	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1183	1189		10.1089/neu.2019.6834		DEC 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000504694400001	31797728				2022-02-06	
J	Okamura, Y; Kawakami, I; Watanabe, K; Oshima, K; Niizato, K; Ikeda, K; Akiyama, H; Hasegawa, M				Okamura, Yasushi; Kawakami, Ito; Watanabe, Katsushige; Oshima, Kenichi; Niizato, Kazuhiro; Ikeda, Kenji; Akiyama, Haruhiko; Hasegawa, Masato			Tau progression in single severe frontal traumatic brain injury in human brains	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Chronic traumatic encephalopathy; Traumatic brain injury; Tau; Progression; Strain; Accumulation; Pathology	ALZHEIMERS-DISEASE; PATHOLOGY; ENCEPHALOPATHY; NEUROPATHOLOGY; SCHIZOPHRENIA; STRAINS; NUCLEUS; PROTEIN	The neuropathological features of chronic traumatic encephalopathy (CTE), caused by repeated traumatic brain injury (TBI), include abnormal accumulations of hyper-phosphorylated tau (p-tau) protein in neurons, neurites and astrocytes, considered to progress via neuronal circuits in brains. Some previous reports suggest that a single severe TBI (sTBI) can also induce CTE and p-tau accumulation, but it is not clear whether the pathology is the same as that of repetitive TBI (rTBI). Since prefrontal leucotomy could be regarded as a model of sTBI, in this study we evaluated two autopsied schizophrenia with this procedure. Histopathologically, gliosis and neuronal loss were found not only in the primary ablated prefrontal region, but also in secondary affected areas, i.e., cingulate gyms, medial nucleus of the thalamus, and nucleus accumbens, which are connected to prefrontal areas. Accumulation of p-tau was mostly seen in neurons, neurites and glias around small blood vessels in the leucotomized prefrontal region. In addition, secondary regions showed some p-tau-positive neurons/glias, as well as many axonal spheroids. Regions of neuronal/glial p-tau pathology showed immunoreactivity to both 3R/4R tau antibodies. Immunoblot analyses of sarkosyl-insoluble tau from frozen brains showed an AD-type tau banding pattern with strong immunoreactivities. sTBI patients showed limited comorbidities, such as TDP-43, alpha-synuclein or AD pathology, whereas rTBI patients have high frequencies of them. The findings suggest that p-tau in the primary affected lesion might progress to connected regions via neuronal circuits over time, and a single severe axonal injury might lead to CTE pathology different from that caused by rTBI.	[Okamura, Yasushi; Kawakami, Ito; Oshima, Kenichi; Niizato, Kazuhiro] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan; [Kawakami, Ito; Ikeda, Kenji; Akiyama, Haruhiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Tokyo, Japan; [Okamura, Yasushi; Watanabe, Katsushige] Tokyo Metropolitan Matsuzawa Hosp, Dept Neurosurg, Tokyo, Japan; [Okamura, Yasushi; Kawakami, Ito] Yokohama City Univ, Sch Med, Dept Psychiat, Yokohama, Kanagawa, Japan		Kawakami, I (corresponding author), Tokyo Metropolitan Inst Med Sci, Dementia Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	kawakami-it@igakuken.or.jp			Naito FoundationNaito Memorial Foundation; AMED [JP18dm0908001]	This research was supported by The Naito Foundation (to I.K.) and AMED (JP18dm0908001 to 1.K., K.O., and K.N).	Arai Y, 2001, NEUROPATHOLOGY, V21, P53, DOI 10.1046/j.1440-1789.2001.00363.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2010, ACTA NEUROPATHOL, V120, P67, DOI 10.1007/s00401-010-0683-0; Catts VS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00060; Cauley K.A., BR J RADIOL, V83; Dong DW, 2014, BRAIN RES, V1543, P280, DOI 10.1016/j.brainres.2013.11.004; Eg J, 2018, PSYCHIAT RES, V268, P419, DOI 10.1016/j.psychres.2018.07.016; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Graham D.I., NEUROPATHOL APPL NEU, V21; Greenwood J, 1948, DIS NERV SYST, V9, P279; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Hasegawa M, 2017, PHARMACOL THERAPEUT, V172, P22, DOI 10.1016/j.pharmthera.2016.11.010; Hatsuta H, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0700-z; Higaki J, 1997, J NEUROCHEM, V68, P333; HIROSE S, 1965, AM J PSYCHIAT, V121, P1194, DOI 10.1176/ajp.121.12.1194; Iacono D, 2018, MOV DISORD CLIN PRAC, V5, P492, DOI 10.1002/mdc3.12626; Iritani S, 2007, NEUROPATHOLOGY, V27, P604, DOI 10.1111/j.1440-1789.2007.00798.x; Jellinger KA, 2001, J NEUROL NEUROSUR PS, V71, P707; Jellinger KA, 1999, ACTA NEUROPATHOL, V97, P165, DOI 10.1007/s004010050969; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; KATO T, 1988, ANN NEUROL, V23, P620, DOI 10.1002/ana.410230617; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kawakami I, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-40; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; PAKKENBERG B, 1989, J NEUROL NEUROSUR PS, V52, P156, DOI 10.1136/jnnp.52.2.156; Purushothuman S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059740; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Saleem KS, 2008, J COMP NEUROL, V506, P659, DOI 10.1002/cne.21577; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stewart W, 2019, LANCET NEUROL, V18, P231, DOI 10.1016/S1474-4422(19)30020-1; TAN E, 1971, BRIT J PSYCHIAT, V118, P155, DOI 10.1192/bjp.118.543.155; Tsuchiya M., 1972, SEISHIN SHINKEIGAKU, V74; Uchino A, 2001, AM J NEURORADIOL, V22, P301; Watanabe K., 2013, FUNCT NEUROSURG, V52, P31; YOKOI S, 1957, J NEUROPATH EXP NEUR, V16, P251, DOI 10.1097/00005072-195704000-00004	47	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2019	407								116495	10.1016/j.jns.2019.116495			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW5NC	WOS:000503097600018	31655411				2022-02-06	
J	Zhang, B; Zhu, XL; Wang, L; Hao, SY; Xu, XJ; Niu, F; He, W; Liu, BY				Zhang, Bin; Zhu, Xueli; Wang, Liang; Hao, Shuyu; Xu, Xiaojian; Niu, Fei; He, Wen; Liu, Baiyun			Dexamethasone impairs neurofunctional recovery in rats following traumatic brain injury by reducing circulating endothelial progenitor cells and angiogenesis	BRAIN RESEARCH			English	Article						Traumatic brain injury; Dexamethasone; Endothelial progenitor cells; Angiogenesis	CEREBRAL-ISCHEMIA; BLOOD-FLOW; NEUROGENESIS; DESTRUCTION; EXPRESSION; CROSSTALK; IMPROVES; TISSUE	The administration of glucocorticoids (GCs) after traumatic brain injury (TBI) is controversial. Clinical evidence reveals the deleterious effects of GCs, but the mechanism remains unclear. Previous studies indicate that GCs impair wound healing by affecting endothelial progenitor cell (EPC) function and inhibiting angiogenesis after skin injury. Thus, we hypothesize that the central deleterious effect of GCs is associated with reduced EPCs and angiogenesis after TBI. Using a controlled cortical impact model, we examined the dynamic changes in circulating EPCs and in the regional microcirculation within 14 days of TBI by flow cytometry analysis and contrast-enhanced ultrasound, respectively. The modified neurological severity score (mNSS) and Morris water maze assay were used to assess neurological recovery. Angiogenesis and hippocampal neuron counts were assessed using immunohistochemistry analysis and hematoxylin and eosin staining 14 days after TBI. Compared with the TBI control group, dexamethasone treatment significantly reduced the number of circulating EPCs on days 1, 3, 7 and 14 (P < 0.05); decreased the number of CD31 + cells, the peak intensity and the number of hippocampal neurons on day 14 (P < 0.05); increased the latency on days 12 and 13 (P < 0.05); and reduced the percentage of time spent in the goal quadrant (P < 0.05) on day 14. Similarly, dexamethasone increased the mNSS on days 7 and 14 (P < 0.05). A strong correlation was observed between these results at 14 days after TBI (r = 0.815-0.892, P < 0.05). These data indicate that DEX inhibits the mobilization of EPC levels and angiogenesis around the lesion after TBI, which may contribute to neuronal cell loss and impaired neurofunction.	[Xu, Xiaojian; Niu, Fei; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Beijing Key Lab Cent Nervous Syst Injury, Beijing, Peoples R China; [Zhang, Bin; Hao, Shuyu; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Zhu, Xueli; He, Wen] Capital Med Univ, Beijing Tian Tan Hosp, Dept Ultrasound, Beijing, Peoples R China; [Wang, Liang] Tianjin Fifth Ctr Hosp, Dept Neurosurg, Tianjin, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neurosurg, 119 Nan Si Huan W Rd, Beijing 100070, Peoples R China.	liubaiyun1212@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771327]	This work was funded by a research grant from the National Natural Science Foundation of China (no. 81771327).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Burlacu A, 2013, STEM CELLS DEV, V22, P643, DOI 10.1089/scd.2012.0273; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Carenza E, 2014, NANOMED-NANOTECHNOL, V10, P225, DOI 10.1016/j.nano.2013.06.005; Carolina E, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00276; Chen C, 2013, JOINT BONE SPINE, V80, P70, DOI 10.1016/j.jbspin.2012.02.015; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Edwards P, 2005, LANCET, V365, P1957; Eyding J, 2006, J CEREBR BLOOD F MET, V26, P576, DOI 10.1038/sj.jcbfm.9600216; FRENCH L A, 1964, Clin Neurosurg, V10, P212; Grisar J, 2007, ANN RHEUM DIS, V66, P1284, DOI 10.1136/ard.2006.066605; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Kato T, 2017, BIOCHEM BIOPH RES CO, V493, P1010, DOI 10.1016/j.bbrc.2017.09.100; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kern R, 2004, STROKE, V35, P1665, DOI 10.1161/01.STR.0000129332.10721.7e; Krogias C, 2005, ULTRASOUND MED BIOL, V31, P1007, DOI 10.1016/j.ultrasmedbio.2005.01.001; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu Y, 2019, BRAIN RES, V1708, P160, DOI 10.1016/j.brainres.2018.12.023; Long JA, 2015, J CEREBR BLOOD F MET, V35, P1852, DOI 10.1038/jcbfm.2015.143; Ma FF, 2015, BRAIN RES, V1623, P150, DOI 10.1016/j.brainres.2015.02.010; Miyamoto N, 2014, CELL MOL LIFE SCI, V71, P1055, DOI 10.1007/s00018-013-1488-9; Nauck M, 1998, EUR J PHARMACOL, V341, P309, DOI 10.1016/S0014-2999(97)01464-7; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pang QY, 2017, BRAIN RES, V1663, P9, DOI 10.1016/j.brainres.2017.03.012; Salehi A, 2018, J CEREBR BLOOD F MET, V38, P274, DOI 10.1177/0271678X17744124; Seidel G, 2004, STROKE, V35, P1107, DOI 10.1161/01.STR.0000124125.19773.40; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Vissapragada R, 2014, BRAIN RES, V1565, P8, DOI 10.1016/j.brainres.2014.03.018; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Wei K, 1998, CIRCULATION, V97, P473; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Yip HK, 2011, CRIT CARE, V15, DOI 10.1186/cc10002	41	5	6	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 15	2019	1725								146469	10.1016/j.brainres.2019.146469			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JN9ZS	WOS:000497248100005	31541641				2022-02-06	
J	Pinard, S; Bottari, C; Laliberte, C; Pigot, H; Olivares, M; Couture, M; Giroux, S; Bier, N				Pinard, Stephanie; Bottari, Carolina; Laliberte, Catherine; Pigot, Helene; Olivares, Marisnel; Couture, Melanie; Giroux, Sylvain; Bier, Nathalie			Design and usability evaluation of COOK, an assistive technology for meal preparation for persons with severe TBI	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						User-centred design; cognitive rehabilitation; assistive technology for cognition; traumatic brain injury; meal preparation safety; meal preparation independence	TRAUMATIC BRAIN-INJURY; QUEBEC USER EVALUATION; SATISFACTION; IMPACT; ADULTS; INDIVIDUALS; PERFORMANCE; COGNITION; EFFICACY; VALIDITY	Aim: In Canada, 100,000 people suffer a traumatic brain injury (TBI) every year. The prevalence of moderate to severe TBI is highest for young men, who will live an average of 50 years with this chronic condition associated with physical, emotional and cognitive deficits. Meal preparation, a complex activity with high safety risks, is one of the most significant activities impacted by TBI. Technology shows great promise to support their overall functioning, but no context-aware technology is available to support meal preparation for this population. The main goal of this study was to design and test a technology to support meal preparation with and for persons with severe TBI living in a supported-living residence. Methodology: As part of a transdisciplinary technology project linking rehabilitation and informatics, COOK (Cognitive Orthosis for coOKing) was designed with and for future users and stakeholders with a user-centred design methodology. COOK was implemented in three participants' apartments, and its usability was evaluated at 1, 3 and 6 months post-implementation. Results: COOK is a context-aware assistive technology consisting of two main systems: security and cognitive support system. After implementation of COOK, participants were able to resume safe preparation of meals independently. Usability testing showed good effectiveness and an acceptable level of satisfaction. Conclusion: COOK appears promising for rehabilitating clients with cognitive disabilities, improving safety in a home environment, and diminishing the need for human supervision. Future studies will need to explore how COOK can be adapted to a broader TBI population, other environments, and other clienteles. IMPLICATIONS FOR REHABILITATION This paper presents a promising context-aware assistive technology for cognition designed with and for clients with severe brain injury to support their independence in meal preparation; COOK, (Cognitive Orthesis for coOKing) is the first cooking assistant in which evidence-based cognitive rehabilitation interventions have been translated into smart technological assistance, to support cognition and ensure safety in a real-life context; Its context-aware characteristic ensures that users receive the assistance they need at the right time and at the right moment. The long-term perspective regarding the use of COOK in clinical practice is promising as this technology has the potential of becoming an additional means of supporting the rehabilitation of people with cognitive impairments and becoming part of a comprehensive solution to help them live at home more independently.	[Pinard, Stephanie] Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; [Pinard, Stephanie] Ctr Integre Univ Sante & Serv Sociaux Estrie, Ctr Readaptat Estrie, Sherbrooke, PQ, Canada; [Bottari, Carolina; Bier, Nathalie] Univ Montreal, Fac Med, Sch Rehabil, Occupat Therapy Program, Montreal, PQ, Canada; [Bottari, Carolina; Pigot, Helene] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Laliberte, Catherine; Pigot, Helene; Olivares, Marisnel; Giroux, Sylvain] Univ Sherbrooke, Fac Sci, Dept Comp Sci, DOMUS Lab, Sherbrooke, PQ, Canada; [Pigot, Helene; Giroux, Sylvain] CSSS IUGS, Res Ctr Aging, Sherbrooke, PQ, Canada; [Olivares, Marisnel] IMT Atlantique Bretagne Pays de la Loire, Lab STICC IT, Nantes, France; [Couture, Melanie] CIUSSS West Cent Montreal, Ctr Res & Expertise Social Gerontol CREGES, Montreal, PQ, Canada; [Couture, Melanie] Univ Sherbrooke, Dept Psychol, Sherbrooke, PQ, Canada; [Bier, Nathalie] Inst Univ Geriatrie Montreal Canada, Ctr Rech, Montreal, PQ, Canada		Pinard, S (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ H3C 3J7, Canada.	stephanie.pinard@usherbrooke.ca		Giroux, Sylvain/0000-0003-0602-5957; Bier, Nathalie/0000-0002-2940-694X	Collaborative Health Research Projects initiative by the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [PRCS 508397]; Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC) [CPG 151960]; Fonds de la recherche du Quebec-SanteFonds de la Recherche en Sante du Quebec	This work was supported by the Collaborative Health Research Projects initiative funding opportunity offered by the Canadian Institutes of Health Research under Grant [PRCS 508397] in partnership with the Natural Sciences and Engineering Research Council under Grant [CPG 151960]. N. Bier is supported by a salary award from the Fonds de la recherche du Quebec-Sante.	Alliger GM, 2000, EDUC PSYCHOL MEAS, V60, P59, DOI 10.1177/00131640021970367; Amato A, 2016, ADV P2P PARALLEL GRI, V1; Bauchet J, 2008, IJARM, V9, P53; Bauchet J, 2009, ASSETS'09: PROCEEDINGS OF THE 11TH INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P11; Beetz M, 2008, 2008 17TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P1, DOI 10.1109/ROMAN.2008.4600634; Bier N, 2018, NEUROPSYCHOL REHABIL, V28, P864, DOI 10.1080/09602011.2018.1437677; Billette J., 2011, INJURIES CANADA INSI; Blasco R, 2014, SENSORS-BASEL, V14, P1629, DOI 10.3390/s140101629; Bottari C, 2010, ARCH PHYS MED REHAB, V91, P734, DOI 10.1016/j.apmr.2009.12.023; Bottari C, 2009, NEUROPSYCHOL REHABIL, V19, P177, DOI 10.1080/09602010802188435; Bottari CL, 2010, CAN J OCCUP THER, V77, P90, DOI 10.2182/cjot.2010.77.2.5; Boucher N, 2006, MILIEU VIE STIMULANT, P144; Boudreault A, 2016, INT CONF INTEL ENVIR, P230, DOI 10.1109/IE.2016.52; Brangier E, 2003, CONCEVOIR PRODUIT FA; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; Callaway E, 2013, MODELS SUPPORTED ACC; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Cole EH, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-1; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dabbs AD, 2009, CIN-COMPUT INFORM NU, V27, P175, DOI 10.1097/NCN.0b013e31819f7c7c; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; Demers L, 2002, DISABIL REHABIL, V24, P21, DOI 10.1080/09638280110066352; Demers L, 2001, J REHABIL MED, V33, P187, DOI 10.1080/165019701750300663; Demers L, 2000, ASSIST TECHNOL, V12, P96, DOI 10.1080/10400435.2000.10132015; Demers L, 1996, Assist Technol, V8, P3; Desrochers V, 2002, EVALUATION NEUROPSYC; Dubuc E, 2019, AUST OCCUP THER J, V66, P720, DOI 10.1111/1440-1630.12611; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Dumont C, 2003, THESIS; Faul M, 2010, TRAUMATIC BRAIN INJU; Giroux S, 2015, AAAI SPRING SERIES; GOULD JD, 1985, COMMUN ACM, V28, P300, DOI 10.1145/3166.3170; Groussard PY, 2018, NEUROPSYCHOL REHABIL, V28, P667, DOI 10.1080/09602011.2015.1117499; Haskins E.C., 2012, COGNITIVE REHABILITA; Heerink M, 2006, P 15 IEEE INT S ROB, P521, DOI [10. 1109/ROMAN. 2006. 314442, DOI 10.1109/ROMAN.2006.314442]; Imbeault H, 2018, NEUROPSYCHOL REHABIL, V28, P755, DOI 10.1080/09602011.2016.1172491; ISO, 2018, 924111 ISO; Jasiewicz J, 2011, J REHABIL RES DEV, V48, pVII, DOI 10.1682/JRRD.2011.07.0129; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Julien-Gauthier F., 2011, REV DEV HUMAIN HANDI, V19, P193; Jutai JW, 2005, AM J PHYS MED REHAB, V84, P294, DOI 10.1097/01.PHM.0000157313.88732.DC; KELLEY JF, 1984, ACM T OFF INF SYST, V2, P26, DOI 10.1145/357417.357420; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Levasseur M, 2016, DISABIL REHABIL-ASSI, V11, P636, DOI 10.3109/17483107.2015.1029536; Liu AL, 2008, DISABIL REHABIL-ASSI, V3, P69, DOI 10.1080/17483100701500173; LoPresti EF, 2008, J REHABIL RES DEV, V45, P505, DOI 10.1682/JRRD.2007.06.0078; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahajan H, 2013, ARCH PHYS MED REHAB, V94, pe1; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Mandich A., 2004, ENABLING OCCUPATION; McGee-Lennon Marilyn, 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare, P49, DOI 10.4108/icst.pervasivehealth.2012.248684; Nakauchi Y, 2009, 2009 IEEE WORKSHOP ON ROBOTIC INTELLIGENCE IN INFORMATIONALLY STRUCTURED SPACE, P99, DOI 10.1109/RIISS.2009.4937913; Nam JH, 2018, DISABIL REHABIL-ASSI, V13, P305, DOI 10.1080/17483107.2017.1358304; Olivares M, 2016, P 2 IET INT C TECHN, P1, DOI DOI 10.1109/CISPEE.2016.7777737; Paas F, 2003, EDUC PSYCHOL, V38, P1, DOI 10.1207/S15326985EP3801_1; Paccoud B, 2007, LECT NOTES COMPUT SC, V4541, P179; Pigot H, 2015, 2015 17TH INTERNATIONAL CONFERENCE ON E-HEALTH NETWORKING, APPLICATION & SERVICES (HEALTHCOM), P170, DOI 10.1109/HealthCom.2015.7454493; Pinard S, 2016, MAXIMIZING SAFETY ME; Pinard S, 2016, STUD COMPUT INTELL, V633, P57, DOI 10.1007/978-3-319-30184-6_3; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-105; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Said PZ, 2018, ARCH MENT HLTH, V19, P97; Scherer M. J., 2012, ASSISTIVE TECHNOLOGI; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schulz R, 2015, GERONTOLOGIST, V55, P724, DOI 10.1093/geront/gnu071; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sohlberg M. K. M., 2017, COGNITIVE REHABILITA; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Spinsante S, 2012, INT J TELEMED APPL, V2012, DOI 10.1155/2012/104561; Starkhammar S., 2008, TECHNOL DISABIL, V20, P179; Thomas S, 2012, REVISITING ITERATIVE; Vallee M, 2011, PRISE CHARGE COMPORT; Vas AK, 2015, J CLIN EXP NEUROPSYC, V37, P152, DOI 10.1080/13803395.2014.994478; W.H. Organization, 2006, NEUR DIS PUBL HLTH C	77	5	5	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.	OCT 3	2021	16	7					687	701		10.1080/17483107.2019.1696898		DEC 2019	15	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	UI7AL	WOS:000503177800001	31846395				2022-02-06	
J	Byers, AL; Li, YX; Barnes, DE; Seal, KH; Boscardin, WJ; Yaffe, K				Byers, Amy L.; Li, Yixia; Barnes, Deborah E.; Seal, Karen H.; Boscardin, W. John; Yaffe, Kristine			A national study of TBI and risk of suicide and unintended death by overdose and firearms	BRAIN INJURY			English	Article						Suicide; unintended death; traumatic brain injury; firearms; overdose	TRAUMATIC BRAIN-INJURY; UNITED-STATES; MORTALITY; VETERANS; REHABILITATION; PREVENTION; INCREASES; ACCESS; INDEX; MODEL	Objective: Evidence guiding suicide-prevention efforts in patients with traumatic brain injury (TBI) is imperative. We evaluated association between TBI and risk of death by drug overdose and firearms, including suicide and unintentional injury. Methods: Cohort study of all patients 18 years and older in Veterans Health Administration databases from October 1, 2001 to December 31, 2014 with TBI diagnosis (N = 230,200), and age-matched 1:1 to random sample of patients without TBI (N = 230,200). Results: After adjusting for demographics, comorbidities, and accounting for competing risk of other deaths, hazard ratios for death by drug overdose were 1.40 (95% CI = 1.21-1.62) for mild TBI and 1.51 (95% CI = 1.31-1.74) for moderate-to-severe TBI, while hazard ratios for death by firearms were 1.09 (95% CI = 0.89-1.33) for mild TBI and 1.33 (95% CI = 1.10-1.60) for moderate-to-severe TBI. Risk of overdose death due to TBI severity was mainly observed for middle and older age groups. Conclusions: Findings suggest that veterans with mild and moderate-to-severe TBI are at increased risk of death by drug overdose and firearms, with overdose risk heightened with age. Data indicate that prevention efforts in patients with TBI include targeted means reduction.	[Byers, Amy L.; Li, Yixia; Barnes, Deborah E.; Seal, Karen H.; Boscardin, W. John; Yaffe, Kristine] San Francisco VA Hlth Care Syst, San Francisco, CA USA; [Byers, Amy L.; Barnes, Deborah E.; Seal, Karen H.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Li, Yixia] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Barnes, Deborah E.; Boscardin, W. John; Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Seal, Karen H.; Boscardin, W. John] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Byers, AL (corresponding author), San Francisco Vet Affairs Hlth Care Syst, 4150 Clement St 116H, San Francisco, CA 94121 USA.	Amy.Byers@ucsf.edu			US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium]US Department of Veterans Affairs [W81XWH-13-2-0095, I01 CX001246]; Clinical Science Research & Development Service of the US Department of Veterans Affairs Office of Research and Development [I01 CX001119]	This material is based upon work supported by the US Army Medical Research and Material Command and from the US Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] under Award Nos. W81XWH-13-2-0095 and I01 CX001246. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office. In addition, this work was supported by Award Number I01 CX001119 (PI: Dr. Byers) fromthe Clinical Science Research & Development Service of the US Department of Veterans Affairs Office of Research and Development. Support for the Suicide Data Repository (SDR) is provided by the Department of Veterans Affairs Center of Excellence for Suicide Prevention. The sponsors had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	[Anonymous], 2016, SURV CAS DEF; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Bauman KJ, 2003, ED ATTAINMENT CENSUS; Betz ME, 2016, ANN INTERN MED, V165, P543, DOI 10.7326/M16-0739; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Chen Li Hui, 2014, NCHS Data Brief, P1; Curtin Sally C, 2016, NCHS Data Brief, P1; Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury, 2010, DEF CTR EXC PSYCH HL; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Florentine JB, 2010, SOC SCI MED, V70, P1626, DOI 10.1016/j.socscimed.2010.01.029; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hedegaard Holly, 2017, NCHS Data Brief, P1; Hoffmire CA, 2015, PSYCHIAT SERV, V66, P959, DOI 10.1176/appi.ps.201400031; Hoffmire CA, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041029; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ilgen MA, 2016, PAIN, V157, P1079, DOI 10.1097/j.pain.0000000000000484; Kemp J, 2012, SUICIDE DATA REPORT; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Miller M, 2008, NEW ENGL J MED, V359, P989, DOI 10.1056/NEJMp0805923; Miller M, 2012, AM J PUBLIC HEALTH, V102, pS154, DOI 10.2105/AJPH.2011.300409; Office of Mental Health and Suicide Prevention, 2016, SUIC VET OTH AM 2001; Rockett IRH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197805; Rockett IRH, 2014, JAMA PSYCHIAT, V71, P231, DOI 10.1001/jamapsychiatry.2013.3738; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Sarchiapone M, 2011, INT J ENV RES PUB HE, V8, P4550, DOI 10.3390/ijerph8124550; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Seal KH, 2018, J PAIN, V19, P931, DOI 10.1016/j.jpain.2018.03.005; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; U.S. Department of Health and Human Services, 2012, NAT STRAT SUIC PREV; VA (Department of Veterans Affairs), 2017, MAN OP THER OT CHRON MAN OP THER OT CHRON; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; Weinberger SE, 2015, ANN INTERN MED, V162, P513, DOI 10.7326/M15-0337	40	5	5	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2020	34	3					328	334		10.1080/02699052.2019.1701708		DEC 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KT8UO	WOS:000501921200001	31822136				2022-02-06	
J	Kondrashova, T; Blanchard, J; Knoche, L; Potter, J; Young, BA				Kondrashova, Tatyana; Blanchard, Joshua; Knoche, Lucas; Potter, James; Young, Bruce A.			Intracranial pressure in the American Alligator (Alligator mississippiensis): reptilian meninges and orthostatic gradients	JOURNAL OF COMPARATIVE PHYSIOLOGY A-NEUROETHOLOGY SENSORY NEURAL AND BEHAVIORAL PHYSIOLOGY			English	Article						Optic nerve sheath; Barostatic reflex; Ocular ultrasonography; Cerebrospinal fluid; Reptile	NERVE SHEATH DIAMETER; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; OPTIC-NERVE; CEREBROSPINAL-FLUID; SUBARACHNOID SPACE; LUNG VENTILATION; NOREPINEPHRINE; ULTRASOUND; DOPAMINE	The cranial meninges of reptiles differ from the more widely studied mammalian pattern in that the intraventricular and subarachnoid spaces are, at least partially, isolated. This study was undertaken to investigate the bulk flow of cerebrospinal fluid, and the resulting changes in intracranial pressure, in a common reptilian species. Intracranial pressure was measured using ocular ultrasonography and by surgically implanting pressure cannulae into the cranial subarachnoid space. The system was then challenged by: rotating the animal to create orthostatic gradients, perturbation of the vascular system, administration of epinephrine, and cephalic cutaneous heating. Pressure changes determined from the implanted catheters and through quantification of the optic nerve sheath were highly correlated and showed a significant linear relationship with orthostatic gradients. The catheter pressure responses were phasic, with an initial rapid response followed by a much slower response; each phase accounted for roughly half of the total pressure change. No significant relationship was found between intracranial pressure and either heart rate or blood flow. The focal application of heat and the administration of epinephrine both increased intracranial pressure, the latter influence being particularly pronounced.	[Kondrashova, Tatyana] AT Still Univ, Kirksville Coll Osteopath Med, Dept Family Med Prevent Med & Community Hlth, Kirksville, MO 63501 USA; [Blanchard, Joshua] Northeast Reg Med Ctr, Dept Anesthesiol, Kirksville, MO USA; [Knoche, Lucas; Young, Bruce A.] AT Still Univ, Kirksville Coll Osteopath Med, Dept Anat, Kirksville, MO 63501 USA; [Potter, James] AT Still Univ, Kirksville Coll Osteopath Med, Dept Surg, Kirksville, MO 63501 USA		Young, BA (corresponding author), AT Still Univ, Kirksville Coll Osteopath Med, Dept Anat, Kirksville, MO 63501 USA.	byoung@atsu.edu		Young, Bruce/0000-0002-0988-7731			Alperin N, 2006, CURR MED IMAGING REV, V2, P117, DOI 10.2174/157340506775541622; Andrews PJD, 2004, INTENS CARE MED, V30, P1730, DOI 10.1007/s00134-004-2376-4; BAKER LA, 1972, J COMP PHYSIOL, V80, P313; Brocklehurst RJ, 2017, J EXP BIOL, V220, P3181, DOI 10.1242/jeb.156166; Bruner HL, 1907, AM J ANAT, V7, P1, DOI 10.1002/aja.1000070102; Burleson Gretchen Lyon, 1942, COPEIA, V1942, P246, DOI 10.2307/1438013; Carmelo A, 2002, ACT NEUR S, V81, P109; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Claessens LPAM, 2009, J EXP ZOOL PART A, V311A, P563, DOI 10.1002/jez.530; Cooley SD, 2016, VET RADIOL ULTRASOUN, V57, P49, DOI 10.1111/vru.12300; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; DARDENNE G, 1969, EUR NEUROL, V2, P193, DOI 10.1159/000113796; Dreha-Kulaczewski S, 2015, J NEUROSCI, V35, P2485, DOI 10.1523/JNEUROSCI.3246-14.2015; Ferguson NM, 2016, PEDIATR CRIT CARE ME, V17, P444, DOI 10.1097/PCC.0000000000000709; Fernando SM, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4225; FOLTZ E L, 1990, Neurological Research, V12, P67; Gatson BJ, 2017, J ZOO WILDLIFE MED, V48, P55, DOI 10.1638/2015-0293.1; Geeraerts T, 2008, INTENS CARE MED, V12, P117, DOI DOI 10.1186/cc6338; HANSEN HC, 1994, NEURO-OPHTHALMOLOGY, V14, P345, DOI 10.3109/01658109409024061; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; HEISEY SR, 1970, AM J PHYSIOL, V219, P1564, DOI 10.1152/ajplegacy.1970.219.6.1564; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Jones H, 1980, CELL TISSUE RES, V195, P153; JONES HC, 1979, CELL TISSUE RES, V198, P129; JONES HC, 1978, CELL TISSUE RES, V195, P153; Kappers CUA, 1926, ARCH NEURO PSYCHIATR, V15, P281, DOI 10.1001/archneurpsyc.1926.02200210002001; KAPPERS CUA, 1960, COMP ANATOMY NERVOUS; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Knoche L., 2019, ANAT PHYSL CURR RES, DOI [10.35248/2161-0940.19.9.318, DOI 10.35248/2161-0940.19.9.318]; Komut E, 2016, AM J EMERG MED, V34, P963, DOI 10.1016/j.ajem.2016.02.012; LEVINGER IM, 1972, EUR NEUROL, V8, P325, DOI 10.1159/000114593; Linninger AA, 2016, ANNU REV FLUID MECH, V48, P219, DOI 10.1146/annurev-fluid-122414-034321; LIU D, 1993, AM J OPHTHALMOL, V116, P548, DOI 10.1016/S0002-9394(14)73195-2; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; MALKINSON TJ, 1985, BRAIN RES BULL, V15, P321, DOI 10.1016/0361-9230(85)90158-3; Martin BA, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-17; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Myburgh JA, 1998, ACT NEUR S, V71, P19; Porter WR, 2016, J ANAT, V229, P800, DOI 10.1111/joa.12539; Porter WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139215; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Reitan H, 1941, ACTA RADIOL, V22, P762, DOI 10.3109/00016924109136456; Reyes-Olivares C, 2016, GAYANA, V80, P129; Shi YL, 2018, CLIN SCI, V132, P157, DOI 10.1042/CS20171280; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Smith JJ, 2018, J VET EMERG CRIT CAR, V28, P31, DOI 10.1111/vec.12677; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Stark D, 1969, BIOL REPTILIA, V9, P1; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/jcbfm.2009.29, 10.1038/sj.jcbfm.jcbfm200929]; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Tetrault S, 2008, EUR J NEUROSCI, V28, P1330, DOI 10.1111/j.1460-9568.2008.06443.x; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794; Yang XY, 2017, INT J CLIN EXP MED, V10, P13412; ZAJICOVA A, 1975, Folia Morphologica (Prague), V23, P56; Zamboni P, 2010, INT ANGIOL, V29, P140	63	5	5	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-7594	1432-1351		J COMP PHYSIOL A	J. Comp. Physiol. A -Neuroethol. Sens. Neural Behav. Physiol.	JAN	2020	206	1					45	54		10.1007/s00359-019-01386-6		DEC 2019	10	Behavioral Sciences; Neurosciences; Physiology; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Physiology; Zoology	KI8FH	WOS:000500853100001	31807848				2022-02-06	
J	Pearce, AJ; Kidgell, DJ; Frazer, AK; King, DA; Buckland, ME; Tommerdahl, M				Pearce, Alan J.; Kidgell, Dawson J.; Frazer, Ashlyn K.; King, Doug A.; Buckland, Michael E.; Tommerdahl, Mark			Corticomotor correlates of somatosensory reaction time and variability in individuals with post concussion symptoms	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Concussion; somatosensory reaction time; visuomotor reaction time; transcranial magnetic stimulation	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; INTRAINDIVIDUAL COGNITIVE VARIABILITY; SPORTS CONCUSSION; LONG-TERM; MOTOR PATHWAYS; SILENT PERIOD; ABNORMALITIES; EXCITABILITY; PERFORMANCE	Persistent post concussion symptoms (PPCS) describe the condition when an individual experiences chronic symptoms, particularly fatigue, beyond the expected time of recovery. The aim of this study was to quantify the effect of fatigue and related ongoing symptoms on somatosensory and corticomotor pathways using reaction time (RT) testing, and single-pulse and paired-pulse transcranial magnetic stimulation (TMS). Eighty-three participants (nine female, mean age 37.9 +/- 11.5 years) were divided into two groups (persistent symptoms versus asymptomatic) following self-report based upon previously published clinical symptom scores. All participants completed somatosensory and visuomotor RT testing, as well as corticomotor excitability and inhibition measurements via TMS. Participants in the persistent symptom group (n = 38) reported greater number of previous concussions (t = 2.81, p = 0.006) and significantly higher levels of fatigue and related symptoms in the asymptomatic group (n = 45; t = 11.32, p < 0.006). Somatosensory RT showed significant slowing and increased variability in the persistent symptoms group (p < 0.001), however no significant differences were observed between groups for visuomotor RTs. Transcranial magnetic stimulation revealed differences between groups for intracortical inhibition at all stimulus intensities and paired pulse measures. The results indicate that somatosensory and corticomotor systems reflect on-going fatigue. From a practical perspective, objective and simplistic measures such as somatosensory and corticomotor measures can be used in the assessment of PPCS and gauging the efficacy of post concussion rehabilitation programmes.	[Pearce, Alan J.] La Trobe Univ, Coll Hlth Sci & Engn, Kingsbury Ave, Melbourne, Vic, Australia; [Kidgell, Dawson J.; Frazer, Ashlyn K.] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [King, Doug A.] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland, New Zealand; [Buckland, Michael E.] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Buckland, Michael E.] Univ Sydney, Brain & Mind Ctr, Camperdown, NSW, Australia; [Tommerdahl, Mark] Cort Metr, Carrboro, NC USA; [Tommerdahl, Mark] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA		Pearce, AJ (corresponding author), La Trobe Univ, Coll Hlth Sci & Engn, Kingsbury Ave, Melbourne, Vic, Australia.	alan.pearce@latrobe.edu.au	Frazer, Ashlyn/ABA-7461-2021; Pearce, Alan J/W-1195-2018	Pearce, Alan J/0000-0002-9264-9880; Buckland, Michael/0000-0003-4755-6471; King, Doug/0000-0003-0135-0937			Alibazi RJ, 2019, J SCI SPORT EXER, DOI [10.1007/s42978-019-0026-3, DOI 10.1007/S42978-019-0026-3]; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; BARKER AT, 1986, LANCET, V1, P1325; BARKER AT, 1985, ELECTROEN CLIN NEURO, V61, pS245, DOI 10.1016/0013-4694(85)90926-5; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Block L, 2013, NEUROSCIENCE, V250, P536, DOI 10.1016/j.neuroscience.2013.07.033; BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Carter JW, 1938, PSYCHOL REC, V2, P36, DOI 10.1007/BF03393212; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2018, J INT NEUROPSYCH SOC, V24, P156, DOI 10.1017/S1355617717001187; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; D'Lauro C, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118760854; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Favorov OV, 2019, MIL MED, V184, P228, DOI 10.1093/milmed/usy411; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Guinto G, 2014, WORLD NEUROSURG, V82, P627, DOI 10.1016/j.wneu.2013.10.016; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hermens H.J., 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI 10.1016/S1050-6411(00)00027-4; Holden J, 2019, 726364 BIORXIV, DOI [10.1101/726364, DOI 10.1101/726364]; Johansson B., 2009, BRAIN INJURY, V23, P13; Johansson B., 2014, TRAUMATIC BRAIN INJU; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kofler MJ, 2013, CLIN PSYCHOL REV, V33, P795, DOI 10.1016/j.cpr.2013.06.001; Martini DN, 2018, INT J PSYCHOPHYSIOL, V132, P25, DOI 10.1016/j.ijpsycho.2017.09.019; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Merkel J., 1885, PHILOS STUD, V2, P73; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Orth M, 2004, CLIN NEUROPHYSIOL, V115, P1076, DOI 10.1016/j.clinph.2003.12.025; Pearce AJ, 2000, EXP BRAIN RES, V130, P238, DOI 10.1007/s002219900236; Pearce AJ, 2018, CLOSER LOOK MOTOR EV; Pearce AJ, 2019, NEUROSCIENCE, V408, P272, DOI 10.1016/j.neuroscience.2019.04.019; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pearce AJ, 2016, EBIOMEDICINE, V13, P3, DOI 10.1016/j.ebiom.2016.10.043; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pearce AJ, 2013, BRAIN STIMUL, V6, P306, DOI 10.1016/j.brs.2012.05.010; Pearce AJ, 2010, J SCI MED SPORT, V13, P167, DOI 10.1016/j.jsams.2008.12.632; Pearce AJ, 2009, J SCI MED SPORT, V12, P280, DOI 10.1016/j.jsams.2007.12.005; Placidi F, 2013, SLEEP MED, V14, P288, DOI 10.1016/j.sleep.2012.11.020; Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023; Ronnback L, 2012, LONG LASTING MENTAL; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Skarabot J, 2019, EXP PHYSIOL, V104, P635, DOI 10.1113/EP087557; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WILSON SA, 1993, NEUROSCI LETT, V154, P52, DOI 10.1016/0304-3940(93)90169-L; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Woodley MA, 2013, INTELLIGENCE, V41, P843, DOI 10.1016/j.intell.2013.04.006; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018	69	5	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0899-0220	1369-1651		SOMATOSENS MOT RES	Somatosens. Mot. Res.	JAN 2	2020	37	1					14	21		10.1080/08990220.2019.1699045		DEC 2019	8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KI3WU	WOS:000501108100001	31809669				2022-02-06	
J	Hajmohammadi, M; Khaksari, M; Soltani, Z; Shahrokhi, N; Najafipour, H; Abbasi, R				Hajmohammadi, Mojdeh; Khaksari, Mohammad; Soltani, Zahra; Shahrokhi, Nader; Najafipour, Hamid; Abbasi, Reza			The Effect of Candesartan Alone and Its Combination With Estrogen on Post-traumatic Brain Injury Outcomes in Female Rats	FRONTIERS IN NEUROSCIENCE			English	Article						candesartan; estrogen; intracranial pressure; cerebral perfusion pressure; brain edema; mean arterial pressure	AT(1) RECEPTOR BLOCKADE; CEREBRAL-BLOOD-FLOW; ANGIOTENSIN-II; ISCHEMIC BRAIN; INTRACRANIAL-PRESSURE; EXPERIMENTAL-MODEL; AT1 RECEPTORS; HEAD-INJURY; INFLAMMATION; EDEMA	Aim: The aim of this study was to evaluate the effect of candesartan (angiotensin II type I receptor blocker) alone and its combination with estrogen on the changes in brain edema, intracranial pressure (ICP), and cerebral perfusion pressure (CPP) following diffuse traumatic brain injury (TBI) in female rats. Methods: TBI was induced in ovariectomized female rats using Marmarou's method. The treatment groups received low-dose (LC) and high-dose (HC) candesartan, estrogen (E2), a combination of estrogen vehicle and candesartan vehicle (oil + vehicle), or a combination of estrogen with low-dose (E2 + LC), or with high-dose (E2 + HC) candesartan. ICP and CPP were measured before and several times after TBI, and the brain water content (brain edema) was measured 24 h after TBI. Results: After the TBI, brain edema and ICP in the estrogen group were lower than in the vehicle and TBI groups. Brain edema and ICP in the HC group were lower than in the vehicle group after TBI. Although there was no significant difference in brain edema and ICP between the LC and vehicle groups, significant differences in these variables were observed when the E2 + LC and E2 + HC groups were compared with the oil + vehicle group after TBI. A significant increase in CPP was observed in the estrogen group 4 and 24 h post-TBI, while this increase was found in the HC and E2 + LC groups 24 h post-TBI. Conclusions: A low dose of candesartan did not exert a protective effect on TBI outcomes, but such an effect did appear after combination with estrogen. This finding suggests that interaction between low-dose candesartan and estrogen improves TBI-induced consequences.	[Hajmohammadi, Mojdeh; Abbasi, Reza] Kerman Univ Med Sci, Neurosci Res Ctr, Neuropharmacol Inst, Kerman, Iran; [Khaksari, Mohammad; Soltani, Zahra] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Physiol Res Ctr, Inst Neuropharmacol, Kerman, Iran; [Najafipour, Hamid] Kerman Univ Med Sci, Cardiovasc Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran.	mkhaksari@kmu.ac.ir	Najafipour, Hamid/U-7922-2017; Haddad, Mohammad Khaksari/AAB-9025-2019; Shahrokhi, Nader/AAV-3747-2020	Najafipour, Hamid/0000-0002-8030-8704; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Shahrokhi, Nader/0000-0002-0149-7819; Soltani, Zahra/0000-0002-8423-6189			Almeida-Pereira G, 2016, NEUROSCIENCE, V322, P525, DOI 10.1016/j.neuroscience.2016.02.067; An JB, 2010, HYPERTENS RES, V33, P831, DOI 10.1038/hr.2010.79; Araujo IG, 2013, PHYSIOL BEHAV, V122, P104, DOI 10.1016/j.physbeh.2013.08.018; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bingham D, 2005, J CEREBR BLOOD F MET, V25, P414, DOI 10.1038/sj.jcbfm.9600031; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Carswell HV, 2004, J CEREBR BLOOD F MET, V24, P298, DOI 10.1097/01.WCB.0000112322.75217.FD; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; CHAN RKW, 1994, J COMP NEUROL, V348, P433, DOI 10.1002/cne.903480309; Chen JG, 2008, AM J PHYSIOL-GASTR L, V295, pG1131, DOI 10.1152/ajpgi.90443.2008; Cheng Y, 2015, CAN J PHYSIOL PHARM, V93, P993, DOI 10.1139/cjpp-2015-0087; Ciriello J, 2013, BRAIN RES, V1526, P54, DOI 10.1016/j.brainres.2013.06.038; Consiglio AR, 2000, BRAIN RES PROTOC, V5, P109, DOI 10.1016/S1385-299X(99)00062-8; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; Engelhorn T, 2004, J CEREBR BLOOD F MET, V24, P467, DOI 10.1097/00004647-200404000-00012; Faure S, 2008, J HYPERTENS, V26, P2008, DOI 10.1097/HJH.0b013e32830dd5ee; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Gilkes C., 2007, SURGERY OXFORD, V25, P530, DOI DOI 10.1016/J.MPSUR.2007.10.005; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Iwai M, 2004, CIRCULATION, V110, P843, DOI 10.1161/01.CIR.0000138848.58269.80; Iwai M, 2006, J HYPERTENS, V24, P2023, DOI 10.1097/01.hjh.0000244952.54738.f6; Joukar S, 2013, SLEEP MED, V14, P1277, DOI 10.1016/j.sleep.2013.07.008; Khaksari M, 2018, TRANSL STROKE RES, V9, P393, DOI 10.1007/s12975-017-0588-5; Khaksari M, 2018, IRAN J BASIC MED SCI, V21, P615, DOI 10.22038/IJBMS.2018.26586.6512; Kishi T, 2012, HYPERTENS RES, V35, P940, DOI 10.1038/hr.2012.63; Koyama Y, 2004, EUR J PHARMACOL, V489, P193, DOI 10.1016/j.ejphar.2004.03.018; Krause DN, 2002, INT CONGR SER, V1235, P395, DOI 10.1016/S0531-5131(02)00211-X; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kusaka I, 2004, AM J PHYSIOL-HEART C, V286, pH2442, DOI 10.1152/ajpheart.01169.2003; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Liu H, 2008, J HYPERTENS, V26, P1435, DOI 10.1097/HJH.0b013e3283013b6e; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mecawi AS, 2011, AM J PHYSIOL-REG I, V301, pR905, DOI 10.1152/ajpregu.00800.2010; Meymandi MS, 2018, BRAIN RES BULL, V140, P169, DOI 10.1016/j.brainresbull.2018.05.001; Michel MC, 2013, PHARMACOL REV, V65, P809, DOI 10.1124/pr.112.007278; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Nap A., 2003, Autonomic & Autacoid Pharmacology, V23, P285, DOI 10.1111/j.1474-8673.2004.00301.x; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Ozacmak VH, 2007, NEUROCHEM RES, V32, P1314, DOI 10.1007/s11064-007-9305-1; Panahpour H, 2013, NEUROPHYSIOLOGY+, V45, P441, DOI 10.1007/s11062-013-9391-4; Parchani A, 2014, WORLD NEUROSURG, V82, pE639, DOI 10.1016/j.wneu.2014.06.022; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247; Shahrokhi N, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.37005; Shimada K, 2011, HYPERTENSION, V57, P1161, DOI 10.1161/HYPERTENSIONAHA.110.167650; Shin JA, 2011, BBA-MOL BASIS DIS, V1812, P1154, DOI 10.1016/j.bbadis.2011.05.004; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0; Tota S, 2009, BEHAV BRAIN RES, V199, P235, DOI 10.1016/j.bbr.2008.11.044; Venero JL, 2004, CURR PHARM DESIGN, V10, P2153, DOI 10.2174/1381612043384150; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Walf AA, 2008, NEUROBIOL LEARN MEM, V89, P513, DOI 10.1016/j.nlm.2008.01.008; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; Yoshimura Y, 1996, ENDOCRINOLOGY, V137, P1204, DOI 10.1210/en.137.4.1204; Zhou J, 2005, J CEREBR BLOOD F MET, V25, P878, DOI 10.1038/sj.jcbfm.9600082	65	5	5	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 3	2019	13								1043	10.3389/fnins.2019.01043			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW4TR	WOS:000503046200001	31849571	Green Published, gold			2022-02-06	
J	Calviello, LA; Zeiler, FA; Donnelly, J; Uryga, A; de Riva, N; Smielewski, P; Czosnyka, M				Calviello, Leanne A.; Zeiler, Frederick A.; Donnelly, Joseph; Uryga, Agnieszka; de Riva, Nicolas; Smielewski, Peter; Czosnyka, Marek			Estimation of pulsatile cerebral arterial blood volume based on transcranial doppler signals	MEDICAL ENGINEERING & PHYSICS			English	Article						Neurocritical care; Traumatic brain injury; Spectral pulsatility index; Cerebral arterial blood volume; Transcranial doppler	TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR PRESSURE-REACTIVITY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; FLOW VELOCITY; AUTOREGULATION; INDEX; HYPERCAPNIA; THRESHOLDS; DIAMETER	Objective: Mathematical modeling of cerebral hemodynamics by descriptive equations can estimate the underlying pulsatile component of cerebral arterial blood volume (CaBV). This way, clinical monitoring of changes in cerebral compartmental compliances becomes possible. Our aim is to validate the most adequate method of CaBV estimation in neurocritical care. Approach: We retrospectively reviewed patients with severe traumatic brain injury (TBI) [admitted from 1992-2012] and continuous transcranial Doppler (TCD) monitoring of cerebral blood flow velocity (FV) displaying either plateau waves of intracranial pressure (ICP), episodes of controlled, mild hypocapnia, or vasopressor-induced increases in arterial blood pressure (ABP). Each cohort was analyzed with continuous flow forward (CFF, pulsatile blood inflow and steady blood outflow) or pulsatile flow forward (PFF, both blood inflow and outflow are pulsatile) modeling approaches for estimating the pulse component of CaBV. Spectral pulsatility index (sPI, the first harmonic of the FV pulse/mean FV) can be estimated using the compliance of the vascular bed (Ca) and the cerebrovascular resistance (CVR - here, Ra). We compared three possible methods of assessing Ca (C1: the CFF model, C2 and C3: the PFF models based on ABP or cerebral perfusion pressure (CPP) pulsations, respectively) and combined them with three possible methods of assessing Ra (Ra1= ABP/FV, Ra2= the resistance area product, and Ra3= CPP/FV). Linear regression techniques were applied to describe the strength of each CaBV estimator (a combination of Ca and Ra) against sPI. Main Results: The combination of C1 and Ra3 (PI_C1Ra3) was the superior descriptor of CaBV as approximated by sPI for both the plateau waves and the hypocapnia cohorts (r =0.915 and r = 0.955, respectively). The combination of C1 and Ra1 (PI_C1Ra1) was nearly as robust in the vasopressors cohort (r =0.938 and r= 0.931, respectively). Significance: TCD-based estimation of CaBV pulsations seems to be feasible when employing the CFF modeling approach. (C) 2019 IPEM. Published by Elsevier Ltd. All rights reserved.	[Calviello, Leanne A.; Donnelly, Joseph; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anesthet, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Clinician Investigator Program, Winnipeg, MB, Canada; [Uryga, Agnieszka] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland; [de Riva, Nicolas] Univ Barcelona, Hosp Clin, Anesthesiol Dept, Neuroanesthesia Div, Barcelona, Spain		Calviello, LA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.	lac76@cam.ac.uk; umzeiler@myumanitoba.ca; agnieszka.uryga@pwr.edu.pl; nderiva@clinic.cat; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk	Uryga, Agnieszka/AAV-7610-2020; de Riva, Nicolas/AAN-3347-2020	de Riva, Nicolas/0000-0003-2691-5770; Zeiler, Frederick/0000-0003-1737-0510; Uryga, Agnieszka/0000-0001-8183-7643	NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada -Harry S. Morton Travelling Fellowship in Surgery	MC and PS are both supported by the NIHR Cambridge Biomedical Research Centre and FAZ has received salary support for dedicated research time, during which this project was completed. Such salary support came from: the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada -Harry S. Morton Travelling Fellowship in Surgery and the University of Manitoba Clinician Investigator Program.	Ambarki K, 2007, IEEE T BIO-MED ENG, V54, P483, DOI 10.1109/TBME.2006.890492; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Avezaat C, 1984, RESUSCITATION, V5, P111; AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brothers RM, 2016, J PHYSIOL-LONDON, V594, P4077, DOI 10.1113/JP271884; Calviello LA, 2017, NEUROCRIT CARE, V27, P392, DOI 10.1007/s12028-017-0404-9; Calviello LA, 2017, MINERVA ANESTESIOL, V83, P844, DOI 10.23736/S0375-9393.17.12043-2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1998, ACT NEUR S, V71, P74; de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Haubrich C, 2013, ULTRASOUND MED BIOL, V39, P1521, DOI 10.1016/j.ultrasmedbio.2013.03.020; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Hoiland RL, 2016, J PHYSIOL-LONDON, V594, P4073, DOI 10.1113/JP271981; Horikoshi T, 2002, J NEUROSURG, V96, P697, DOI 10.3171/jns.2002.96.4.0697; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Ito H, 2003, J CEREBR BLOOD F MET, V23, P665, DOI 10.1097/01.WCB.0000067721.64998.F5; Kasprowicz Magdalena, 1800, Acta Neurochir Suppl, V114, P17, DOI 10.1007/978-3-7091-0956-4_4; Kasprowicz M, 2012, NEUROCRIT CARE, V16, P213, DOI 10.1007/s12028-011-9653-1; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Meng L, 2012, BRIT J ANAESTH, V108, P815, DOI 10.1093/bja/aes023; Minciotti P, 1997, ITAL J NEUROL SCI, V18, P21, DOI 10.1007/BF02106226; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Panerai RB, 2011, PHYSIOL MEAS, V32, P467, DOI 10.1088/0967-3334/32/4/007; Panerai RB, 1999, PHYSIOL MEAS, V20, P265, DOI 10.1088/0967-3334/20/3/304; Richards HK, 1998, ACT NEUR S, V71, P229; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2004, INTENS CARE MED, V30, P2180, DOI 10.1007/s00134-004-2463-6; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Uryga A, 2018, J CLIN MONIT COMPUT, P1; Varsos GV, 2013, J CEREBR BLOOD F MET, V33, P235, DOI 10.1038/jcbfm.2012.161; Weiland NHS, 2017, ANAESTHESIA, V72, P49, DOI 10.1111/anae.13631; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	41	5	5	1	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	DEC	2019	74						23	32		10.1016/j.medengphy.2019.07.019			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KT7RK	WOS:000519210400003	31648880	Green Submitted			2022-02-06	
J	Graupensperger, S; Benson, AJ; Bray, BC; Evans, MB				Graupensperger, Scott; Benson, Alex J.; Bray, Bethany C.; Evans, M. Blair			Social cohesion and peer acceptance predict student-athletes' attitudes toward health-risk behaviors: A within- and between-group investigation	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Group dynamics; Peer influence; Alcohol; Concussion; Hazing; Multilevel modeling	SELF-ESTEEM; GROUP ENVIRONMENT; ALCOHOL-USE; SPORT; DRINKING; NORMS; PARTICIPATION; PRESSURE; TOBACCO; FEMALE	Objectives: Collegiate student-athletes often engage in health-risk behaviors such as alcohol misuse and hazing, but the literature in this domain lacks evidence pertaining to how peers shape attitudes towards such behaviors. We investigated how peer acceptance and social cohesion relate to attitudes towards alcohol use, marijuana use, drinking and driving, playing through a concussion, performance enhancing substance use, and hazing. Design: Cross-sectional survey. Methods: Participants were 387 NCAA athletes from 23 intact teams. Multilevel modeling was used to examine the extent that health-risk attitudes clustered within teams and enabled us to disentangle individual-level and group-level effects of peer acceptance and social cohesion. Results: Intraclass correlation coefficients revealed that health-risk attitudes clustered within teams. At the individual-level, student-athletes who perceived higher levels of peer acceptance, relative to teammates, held riskier attitudes towards alcohol use, playing through a concussion, and hazing. Meanwhile, those who perceived higher levels of social cohesion relative to teammates held less risky attitudes towards playing through a concussion. At the group-level, teams with greater peer acceptance held less risky attitudes towards playing through a concussion, whereas teams with greater social cohesion held riskier attitudes toward playing through a concussion. Conclusions: These data indicated that health-risk behaviors may cluster within teams, and that peer acceptance and cohesiveness are differentially associated with attitudes toward risky behavior. Given that peer influence is a multilevel phenomenon, it is prudent that prevention efforts leverage social processes within teams, while reducing pressures to engage in risky behaviors. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Graupensperger, Scott; Evans, M. Blair] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Benson, Alex J.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Bray, Bethany C.] Univ Illinois, Ctr Disseminat & Implementat Sci, Chicago, IL 60680 USA		Graupensperger, S (corresponding author), Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA.	sag40@psu.edu		Evans, Blair/0000-0003-0668-4928; Benson, Alex/0000-0002-5978-065X; Bray, Bethany/0000-0001-8627-3939	NCAA Graduate Student Research Grant; NIH's National Center for Advancing Translational Sciences [TUTR002016]; National Institute for Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [T32 DA017629]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50-DA039838]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002014, TL1TR002016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA027685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA039838, T32DA017629] Funding Source: NIH RePORTER	This research was funded by an NCAA Graduate Student Research Grant awarded to the first author to support the study of intercollegiate athletics. Additionally, the first author is supported by NIH's National Center for Advancing Translational Sciences (TUTR002016) and National Institute for Drug Abuse (T32 DA017629). This work is also supported by NIH Award #: P50-DA039838. No funding sources were involved in any phase of the research. All findings and conclusions represent the views of the authors, and do not represent the views of the NCAA or the NIH.	Abar CC, 2010, J COLL STUDENT DEV, V51, P496, DOI 10.1353/csd.2010.0005; Balestrieri SG, 2018, J STUD ALCOHOL DRUGS, V79, P862, DOI 10.15288/jsad.2018.79.862; Borsari B, 2007, ADDICT BEHAV, V32, P2062, DOI 10.1016/j.addbeh.2007.01.017; Buckman JF, 2013, DRUG ALCOHOL DEPEN, V131, P50, DOI 10.1016/j.drugalcdep.2013.04.023; CARRON AV, 1985, J SPORT PSYCHOL, V7, P244, DOI 10.1123/jsp.7.3.244; Daniels E, 2006, SEX ROLES, V55, P875, DOI 10.1007/s11199-006-9138-4; DIELMAN TE, 1987, HEALTH EDUC QUART, V14, P207, DOI 10.1177/109019818701400207; Elbe AM, 2015, PSYCHOL DOPING SPORT, P165; Elek E, 2006, J DRUG ISSUES, V36, P147, DOI 10.1177/002204260603600107; Evans MB, 2012, CAN PSYCHOL, V53, P301, DOI 10.1037/a0030202; Evans MB, 2019, ROUTLEDGE INT ENCY S; Eys M.A., 2018, ADV SPORT EXERCISE P; Eys M, 2019, PSYCHOL SPORT EXERC, V42, P40, DOI 10.1016/j.psychsport.2018.11.001; Eys MA, 2018, SOC PERSONAL PSYCHOL, V12, DOI 10.1111/spc3.12379; Fearnow-Kenney M, 2016, SPORT PSYCHOL, V30, P113, DOI 10.1123/tsp.2015-0016; Graupensperger SA, 2018, J SPORT EXERCISE PSY, V40, P117, DOI 10.1123/jsep.2017-0339; KANDEL DB, 1978, J PERS SOC PSYCHOL, V36, P306, DOI 10.1037/0022-3514.36.3.306; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Lafferty ME, 2017, INT J SPORT EXERC PS, V15, P438, DOI 10.1080/1612197X.2015.1121507; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; Maggs J.L., 1997, HLTH RISKS DEV TRANS, P345; Martin L, 2014, INT REV SPORT EXER P, V7, P87, DOI 10.1080/1750984X.2014.885553; Mayeux L, 2008, J RES ADOLESCENCE, V18, P49, DOI 10.1111/j.1532-7795.2008.00550.x; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; Prapavessis H., 1997, GROUP DYN-THEOR RES, V1, P231, DOI [10.1037/1089-2699.1.3.231, DOI 10.1037/1089-2699.1.3.231]; RHODES N, 1992, PSYCHOL BULL, V111, P156, DOI 10.1037/0033-2909.111.1.156; Rinker Dipali Venkataraman, 2016, Curr Addict Rep, V3, P356, DOI 10.1007/s40429-016-0126-7; Rovio E, 2009, SMALL GR RES, V40, P421, DOI 10.1177/1046496409334359; Rubin KH., 2006, HDB CHILD PSYCHOL, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Smith A. L., 2007, Social psychology in sport, P41; Smith AL., 2019, KINESIOL REV, V8, P32, DOI [10.1123/kr.2018-0058, DOI 10.1123/KR.2018-0058]; Suls, 1993, PSYCHOL PERSPECTIVES, P1; Taylor EA, 2017, J APPL SPORT MANAG, V9, P56, DOI 10.18666/JASM-2017-V9-I1-7470; Teunissen HA, 2016, J ADOLESCENCE, V53, P45, DOI 10.1016/j.adolescence.2016.08.017; Turrisi R, 2007, PSYCHOL ADDICT BEHAV, V21, P453, DOI 10.1037/0893-164X.21.4.453; Van Raalte J.L., 2007, J SPORT BEHAV J SPORT BEHAV, V30, P491; Van Ryzin MJ, 2016, ADDICT BEHAV, V53, P168, DOI 10.1016/j.addbeh.2015.10.017; Webber TA, 2017, EXP CLIN PSYCHOPHARM, V25, P31, DOI 10.1037/pha0000105; Weiss, 2004, DEV SPORT EXERCISE P, P165; Wild LG, 2004, J CHILD PSYCHOL PSYC, V45, P1454, DOI 10.1111/j.1469-7610.2004.00330.x; Yusko DA, 2008, J AM COLL HEALTH, V56, P281, DOI 10.3200/JACH.57.3.281-290; Zamboanga BL, 2008, J AM COLL HEALTH, V56, P651, DOI 10.3200/JACH.56.6.651-656	44	5	5	5	20	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2019	22	12					1280	1286		10.1016/j.jsams.2019.07.003			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JT2OD	WOS:000500834200002	31349958	Green Accepted			2022-02-06	
J	Jang, SH; Seo, YS				Jang, Sung Ho; Seo, You Sung			Diagnosis of Conversion Disorder Using Diffusion Tensor Tractography and Transcranial Magnetic Stimulation in a Patient with Mild Traumatic Brain Injury	DIAGNOSTICS			English	Article						mild traumatic brain injury; conversion disorder; diffusion tensor imaging; transcranial magnetic stimulation	LIMB-KINETIC APRAXIA; SECONDARY MOTOR AREA; CORTICOSPINAL TRACT; STROKE PATIENTS; WEAKNESS	We report on a patient with mild traumatic brain injury (TBI) who was diagnosed with conversion disorder for severe weakness of an arm, which was demonstrated using diffusion tensor tractography (DTT) and transcranial magnetic stimulation (TMS). A 23-year-old right-handed female suffered from head trauma resulting from a pedestrian car accident. She underwent rehabilitative management for memory impairment and central pain. At 14 months after onset, she complained of severe weakness of her right arm, which was detected in the morning after sleeping (right shoulder abductor: 3/5, elbow flexor: 3/5, wrist extensor: 1/5, finger flexor: 1/5, and finger extensor: 1/5). Electromyography study for peripheral neuropathy performed at 2 weeks after onset of weakness showed no abnormality. On a 14-month DTT configuration, the integrities of the left corticospinal tract (CST), supplementary motor area-corticofugal tract (SMA-CFT), and dorsal premotor cortex (dPMC)-CFT were well-preserved. Significant differences were not observed for the fractional anisotropy (FA), mean diffusivity (MD), and tract volume (TV) values of the CST, SMA-CFT, and dPMC-CFT in both hemispheres between the patient and ten right-handed age- and sex-matched normal subjects (p > 0.05). On a 14-month TMS study, MEPs obtained at the right abductor pollicis brevis muscle showed no abnormality. Using DTT and TMS, conversion disorder was demonstrated in a patient with mild TBI, who showed severe weakness of an arm. Our results suggest the usefulness of an evaluation of the CST and CFTs from the secondary motor areas using DTT, and the CST using TMS for patients who complain of motor weakness due to conversion disorder.	[Jang, Sung Ho; Seo, You Sung] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea		Seo, YS (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	rehab6467@hanmail.net; yousung1008@daum.net		Seo, YouSung/0000-0002-7480-3071	National Research Foundation (NRF) of Korea - Korean Government (MSIP) [NRF-2018R1A6A3A11050913]	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP) (NRF-2018R1A6A3A11050913).	Crawford JR, 2010, COGN NEUROPSYCHOL, V27, P245, DOI 10.1080/02643294.2010.513967; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2017, AM J PHYS MED REHAB, V96, pE53, DOI 10.1097/PHM.0000000000000576; Jang SH, 2016, ACTA NEUROL BELG, V116, P467, DOI 10.1007/s13760-016-0600-y; Jang SH, 2016, AM J PHYS MED REHAB, V95, pE115, DOI 10.1097/PHM.0000000000000474; Jang SH, 2014, NEUROSCI LETT, V572, P1, DOI 10.1016/j.neulet.2014.04.044; Jo HM, 2012, NEUROREHABILITATION, V31, P207, DOI 10.3233/NRE-2012-0790; Krem MM, 2004, J CLIN PSYCHIAT, V65, P783; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P532, DOI 10.1007/s00234-003-0974-4; Lanska DJ, 2006, SEMIN NEUROL, V26, P297, DOI 10.1055/s-2006-945516; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Liepert J, 2011, J PSYCHOSOM RES, V70, P59, DOI 10.1016/j.jpsychores.2010.06.004; Liepert J, 2008, MOVEMENT DISORD, V23, P2171, DOI 10.1002/mds.21994; Liepert J, 2009, J NEUROL, V256, P121, DOI 10.1007/s00415-009-0090-4; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; Morita H, 2008, PSYCHIAT CLIN NEUROS, V62, P286, DOI 10.1111/j.1440-1819.2008.01795.x; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Schoenfeldt-Lecuona C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00140; Schulz R, 2015, NEUROIMAGE-CLIN, V7, P82, DOI 10.1016/j.nicl.2014.11.006; Shahar E, 2012, J CLIN NEUROSCI, V19, P980, DOI 10.1016/j.jocn.2011.11.008; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stone J, 2005, J NEUROL NEUROSUR PS, V76, pI2, DOI 10.1136/jnnp.2004.061655; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yoshor D., 2012, CLIN BRAIN MAPPING	27	5	5	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2075-4418		DIAGNOSTICS	Diagnostics	DEC	2019	9	4							155	10.3390/diagnostics9040155			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KB6YH	WOS:000506637600030	31652549	gold, Green Published			2022-02-06	
J	Kim, H; Lee, HJ; Kim, YT; Son, Y; Smielewski, P; Czosnyka, M; Kim, DJ				Kim, Hakseung; Lee, Hack-Jin; Kim, Young-Tak; Son, Yunsik; Smielewski, Peter; Czosnyka, Marek; Kim, Dong-Joo			Novel index for predicting mortality during the first 24 hours after traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						cerebral autoregulation; cerebral perfusion pressure; cerebrovascular reactivity; neurocritical care; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; CEREBROVASCULAR AUTOREGULATION; REACTIVITY; MANAGEMENT; HYPOTENSION; THRESHOLDS	OBJECTIVE Failure of cerebral autoregulation and subsequent hypoperfusion is common during the acute phase of traumatic brain injury (TBI). The cerebrovascular pressure-reactivity index (PRx) indirectly reflects cerebral autoregulation and has been used to derive optimal cerebral perfusion pressure (CPP). This study provides a method for the use of a combination of PRx, CPP, and intracranial pressure (ICP) to better evaluate the extent of cerebral hypoperfusion during the first 24 hours after TBI, allowing for a more accurate prediction of mortality risk. METHODS Continuous ICP and arterial blood pressure (ABP) signals acquired from 295 TBI patients during the first 24 hours after admission were retrospectively analyzed. The CPP at the lowest PRx was determined as the optimal CPP (CPPopt) The duration of a severe hypoperfusion event (dHP) was defined as the cumulative time that the PRx was > 0.2 and the CPP was < 70 mm Hg with the addition of intracranial hypertension (ICP > 20 or > 22 mm Hg). The outcome was determined as 6-month mortality. RESULTS The cumulative duration of PRx > 0.2 and CPP < 70 mm Hg exhibited a significant association with mortality (p < 0.001). When utilized with basic clinical information available during the first 24 hours after admission (i.e., Glasgow Coma Scale score, age, and mean ICP), a dHP > 25 minutes yielded a significant predictive capacity for mortality (p < 0.05, area under the curve [AUCI = 0.75). The parameter was particularly predictive of mortality for patients with a mean ICP > 20 or > 22 mm Hg (AUC = 0.81 and 0.87, respectively). CONCLUSIONS A short duration (25 minutes) of severe hypoperfusion, evaluated as lowered CPP during worsened cerebrovascular reactivity during the 1st day after TBI, is highly indicative of mortality.	[Kim, Hakseung; Lee, Hack-Jin; Kim, Young-Tak; Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Son, Yunsik] Dongguk Univ, Dept Comp Engn, Seoul, South Korea; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Kim, DJ (corresponding author), Korea Univ, Seoul, South Korea.	dongjookim@korea.ac.kr	Kim, Hakseung/AAZ-8626-2021	Kim, Hakseung/0000-0001-5407-293X	Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1790]; MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program [IITP-2018-2016-0-00464]; IITP grant - Korea government (MSIT) [2017-0-00432]; Korea University; NIHR Brain Research Centre, Cambridge	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant no. HI17C1790); the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2018-2016-0-00464) supervised by the IITP (Institute for Information & communications Technology Promotion); an IITP grant funded by the Korea government (MSIT) (no. 2017-0-00432, Development of non-invasive integrated BCI SW platform to control home appliances and external devices by user's thought via AR/VR interface); a Korea University Grant. M.C. was supported by NIHR Brain Research Centre, Cambridge.; We sincerely thank all staff at the Neurocritical Care Unit in Addenbrookes Hospital, Cambridge, United Kingdom, for their support and professional help with the computer pressure recordings of TBI patients.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2017, ACTA NEUROCHIR, V159, P2063, DOI 10.1007/s00701-017-3310-1; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeWitt DS, 2001, MO CL BI CC, P71; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; Marmarou A, 2005, ACT NEUR S, V95, P277; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Tameem A, 2013, BJA EDUC, V13, P113, DOI 10.1093/bjaceaccp/mkt001; Vigue B, 2012, ANN UPDATE INTENSIVE, P722; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	36	5	6	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2019	131	6					1887	1895		10.3171/2018.7.JNS18995			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JS4CC	WOS:000500253800025	30579283	Green Submitted, Bronze			2022-02-06	
J	Lin, CH; Lin, W; Su, YC; Hsuan, YCY; Chen, YC; Chang, CP; Chou, W; Lin, KC				Lin, Cheng-Hsien; Lin, Willie; Su, Yu-Chin; Hsuan, Yogi Cheng-Yo; Chen, Yu-Chien; Chang, Ching-Ping; Chou, Willy; Lin, Kao-Chang			Modulation of parietal cytokine and chemokine gene profiles by mesenchymal stem cell as a basis for neurotrauma recovery	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						Mesenchymal stem cells; Traumatic brain injury; Inflammation; Chemokines; Cytokines	TRAUMATIC BRAIN-INJURY; NEUROTROPHIC FACTOR; EXPRESSION; SYSTEM; OSTEOPONTIN; NEUROLEUKIN; OCCLUSION; MICROGLIA; ISCHEMIA; DEFICITS	Background & purpose: Following traumatic brain injury (TBI), primary mechanical injury to the brain may cause blood-brain-barrier damage followed by secondary injury, ultimately culminating in cell death. We aimed to test whether one injection of mesenchymal stem cells (MSC) derived from the human umbilical cord can modulate brain cytokine and chemokine gene profiles and attenuate neurological injury in rats with TBI. Methods: One-day post-TBI, the injured rats were treated with one injection of MSC (4 x 10(6)/rat, i.v.). Three days later, immediately after assessment of neurobehavioral function, animals were sacrificed for analysis of neurological injury (evidenced by both brain contusion volume and neurological deficits) and parietal genes encoding 84 cytokines and chemokines in the injured brain by qPCR methods. Results: Three days post-TBI, rats displayed both neurological injury and upgrade of 11 parietal genes in the ipsilateral brain. One set of 8 parietal genes (e.g., chemokine [C-X-C motif] ligand 12, platelet factor 4, interleukin-7, chemokine [C-C motif] ligand (CCL)19, CCL 22, secreted phosphoprotein 1, pro-platelet basic protein 1, and CCL 2) differentially upgraded by TBI was related to pro-inflammatory and/or neurodegenerative processes. Another set of 3 parietal genes up-graded by TBI (e.g., glucose-6-phosphate isomerase, bone morphogenetic protein (BMP) 2, and BMP 4) was related to anti-inflammatory/neuroregenerative events. Administration of MSC attenuated neurological injury, down-regulated these 8 parietal pro-inflammatory genes, and up-regulated these 3 parietal anti-inflammatory genes in the rats with TBI. Conclusion: Our data suggest that modulation of parietal cytokines and chemokines gene profiles by MSC as a basis for neurotrauma recovery. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.	[Lin, Cheng-Hsien] Mackay Med Coll, Dept Med, New Taipei 252, Taiwan; [Lin, Willie; Su, Yu-Chin; Hsuan, Yogi Cheng-Yo] Meridigen Biotech Co Ltd, Taipei 11493, Taiwan; [Chen, Yu-Chien; Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Chou, Willy] Chi Mei Med Ctr, Dept Phys Med & Rehabil, 901 Zhonghua Rd, Tainan 710, Taiwan; [Chou, Willy] Chia Nan Univ Pharm & Sci, Dept Recreat & Healthcare Management, Tainan 717, Taiwan; [Lin, Kao-Chang] Chi Mei Med Ctr, Dept Neurol, 901 Zhonghua Rd, Tainan 710, Taiwan		Chou, W (corresponding author), Chi Mei Med Ctr, Dept Phys Med & Rehabil, 901 Zhonghua Rd, Tainan 710, Taiwan.; Lin, KC (corresponding author), Chi Mei Med Ctr, Dept Neurol, 901 Zhonghua Rd, Tainan 710, Taiwan.	u2001898@hotmail.com; willie.lin@meridigen.com; gili.su@meridigen.com; yogi@meridigen.com; e612520@gmail.com; jessica.cpchang@gmail.com; ufan0101@ms22.hinet.net; gaujang@mail2000.com.tw		Chang, Ching-Ping/0000-0003-0890-9414	Chi Mei Medical Center, Tainan, Taiwan [CMFHT10504]; Ministry of Science and Technology (MOST) of the Republic of ChinaMinistry of Science and Technology, Taiwan [MOST 104-2314-B-384-011-MY3, MOST 1052314-B-384-001-MY3]	This work was supported in part by research grants from Chi Mei Medical Center, Tainan, Taiwan (CMFHT10504) and Ministry of Science and Technology (MOST) of the Republic of China (MOST 104-2314-B-384-011-MY3 and MOST 1052314-B-384-001-MY3).	Almeida CR, 2016, STEM CELL REP, V6, P466, DOI 10.1016/j.stemcr.2016.02.012; ANDERSON JD, 2016, CHIN NEUROSURG J, V2, P36, DOI DOI 10.1186/s41016-016-0053-4; Bayo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095171; Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008; Boekhoff TM, 2012, J SPINAL DISORD TECH, V25, pE81, DOI 10.1097/BSD.0b013e31823f2f55; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; CHAPUT M, 1988, NATURE, V332, P454, DOI 10.1038/332454a0; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen SH, 2014, CELL TRANSPLANT, V23, P959, DOI 10.3727/096368913X667006; Chen TJ, 2016, CLIN CHIM ACTA, V454, P6, DOI 10.1016/j.cca.2015.12.033; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Choi JS, 2007, BRAIN RES, V1151, P195, DOI 10.1016/j.brainres.2007.03.016; de Jong EK, 2008, J NEUROCHEM, V105, P1726, DOI 10.1111/j.1471-4159.2008.05267.x; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Dogan RNE, 2011, J LEUKOCYTE BIOL, V89, P93, DOI 10.1189/jlb.0810442; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Garau A, 2005, CYTOKINE, V30, P125, DOI 10.1016/j.cyto.2004.12.014; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; Haga A, 2000, BBA-PROTEIN STRUCT M, V1480, P235, DOI 10.1016/S0167-4838(00)00075-3; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; Hsuan YCY, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.526; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Jana M, 2014, IMMUNOLOGY, V141, P549, DOI 10.1111/imm.12214; Kalladka D, 2014, STEM CELLS CLONING, V7, P31, DOI 10.2147/SCCAA.S38003; Kim C, 2018, MOL NEUROBIOL, V55, P4870, DOI 10.1007/s12035-017-0683-3; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lu HZ, 2009, ACTA NEUROBIOL EXP, V69, P441; Mastri Michalis, 2014, World J Stem Cells, V6, P82, DOI 10.4252/wjsc.v6.i2.82; Pashenkov M, 2003, J NEUROIMMUNOL, V135, P154, DOI 10.1016/S0165-5728(02)00441-1; Sakurai-Yamashita Y, 2006, CELL MOL NEUROBIOL, V26, P823, DOI 10.1007/s10571-006-9077-1; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; SHAH AB, 1985, STROKE, V16, P643, DOI 10.1161/01.STR.16.4.643; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Szalardy L, 2013, J NEUROL SCI, V331, P38, DOI 10.1016/j.jns.2013.04.024; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; van Roon JAG, 2003, ANN RHEUM DIS, V62, P113, DOI 10.1136/ard.62.2.113; Watanabe H, 1996, CANCER RES, V56, P2960; WEN TC, 1995, NEUROSCIENCE, V65, P513, DOI 10.1016/0306-4522(94)00499-U; Wirths O, 2010, NEUROBIOL AGING, V31, P747, DOI 10.1016/j.neurobiolaging.2008.06.011; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zvejniece L, 2012, J NEUROSCI METH, V208, P197, DOI 10.1016/j.jneumeth.2012.05.018	46	5	5	0	3	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	DEC	2019	118	12					1661	1673		10.1016/j.jfma.2019.01.008			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JR5XS	WOS:000499698200010	30709695	gold			2022-02-06	
J	Phares, TM; Sherin, K; Harrison, SL; Mitchell, C; Freeman, R; Lichtenberg, K				Phares, Tanya M.; Sherin, Kevin; Harrison, Suzanne Leonard; Mitchell, Connie; Freeman, Randall; Lichtenberg, Kate			Intimate Partner Violence Screening and Intervention: The American College of Preventive Medicine Position Statement	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HEALTH-CARE RESPONSE; UNITED-STATES; DOMESTIC VIOLENCE; BARRIERS; WOMEN; PREVALENCE; PREGNANCY; ATTITUDES; STUDENTS	The purpose of this paper is to produce a position statement on intimate partner violence (IPV), a major sociomedical problem with recently updated evidence, systematic reviews, and U.S. Preventive Services Task Force guidelines. This position statement is a nonsystematic, rapid literature review on IPV incidence and prevalence, health consequences, diagnosis and intervention, domestic violence laws, current screening recommendations, barriers to screening, and interventions, focusing on women of childbearing age (15-45 years). The American College of Preventive Medicine (ACPM) recommends an integrated system of care approach to IPV for screening, identification, intervention, and ongoing clinical support. ACPM only recommends screening that is linked to ongoing clinical support for those at risk. ACPM recommends greater training of clinicians in IPV screening and interventions and offers health systems and research recommendations. (C) 2019 American Journal ofPreventive Medicine. Published by Elsevier Inc. All rights reserved.	[Phares, Tanya M.] Univ Nevada, Dept Med, Reno, NV 89557 USA; [Sherin, Kevin; Harrison, Suzanne Leonard] Florida State Univ, Dept Family Med & Rural Hlth, Tallahassee, FL 32306 USA; [Mitchell, Connie] Calif Dept Publ Hlth, Ctr Family Hlth, Sacramento, CA USA; [Freeman, Randall] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Lichtenberg, Kate] Anthem Blue Cross Blue Shield Missouri, St Louis, MO USA		Phares, TM (corresponding author), Univ Nevada, Dept Med, Reno, NV 89557 USA.	tmphares@gmail.com					Agrawal A, 2014, MATERN CHILD HLTH J, V18, P1985, DOI 10.1007/s10995-014-1444-9; Aluko OE, 2015, HEALTH PROMOT PRACT, V16, P540, DOI 10.1177/1524839915571183; *AM COLL EM PHYS, DOM FAM VIOL; Ambuel B, 2013, J FAM VIOLENCE, V28, P833, DOI 10.1007/s10896-013-9550-9; American Academy of Family Physicians, 2012, WOM HLTH REC CURR GU; [Anonymous], 2012, Obstet Gynecol, V119, P412, DOI 10.1097/AOG.0b013e318249ff74; Beynon CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-473; Black M C., 2011, NATL INTIMATE PARTNE; Bohn DK, 2004, JOGNN-J OBST GYN NEO, V33, P561, DOI 10.1177/0884217504269009; Breiding MJ, 2014, MMWR SURVEILL SUMM, V63, P1; Breiding MJ., 2015, INTIMATE PARTNER VIO; Brossoie N, 2015, J ELDER ABUSE NEGL, V27, P470, DOI 10.1080/08946566.2015.1095664; Brown MJ, 2013, J WOMENS HEALTH, V22, P947, DOI 10.1089/jwh.2012.4222; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Catalano S., 2015, SPECIAL REPORT INTIM; Catalano S., 2009, FEMALE VICTIMS VIOLE; Chen Ping-Hsin, 2013, FP Essent, V412, P18; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Conn LG, 2014, CAN J SURG, V57, P371, DOI 10.1503/cjs.000714; Connor PD, 2012, SOUTH MED J, V105, P211, DOI 10.1097/SMJ.0b013e31824f8b01; Costa D, 2016, PUBLIC HEALTH, V139, P44, DOI 10.1016/j.puhe.2016.05.001; Cronholm PF, 2011, AM FAM PHYSICIAN, V83, P1165; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1678, DOI 10.1001/jama.2018.14741; Davies R, 2016, WOMEN HEALTH, V56, P561, DOI 10.1080/03630242.2015.1101741; Davis A, 2014, J TRAUMA NURS, V21, P300, DOI 10.1097/JTN.0000000000000086; Davis RE, 2001, J PROF NURS, V17, P313, DOI 10.1053/jpnu.2001.28181; DeBoer MI, 2013, J TRAUMA NURS, V20, P155, DOI 10.1097/JTN.0b013e3182a171b1; Durbow N, 2010, FAMILY VIOLENCE PREV; Elliott L, 2002, J GEN INTERN MED, V17, P112, DOI 10.1046/j.1525-1497.2002.10233.x; Furniss K, 2007, MCN-AM J MATERN-CHIL, V32, P238, DOI 10.1097/01.NMC.0000281964.45905.89; Gierisch J. M., 2013, INTIMATE PARTNER VIO; Hamberger LK, 2007, TRAUMA VIOLENCE ABUS, V8, P214, DOI 10.1177/1524838007301163; Hamberger LK, 2015, J WOMENS HEALTH, V24, P86, DOI 10.1089/jwh.2014.4861; Harvey A, WHO EXP M MAY 2 3 20; Hegarty K, 2011, BRIT J PSYCHIAT, V198, P169, DOI 10.1192/bjp.bp.110.083758; Hoxmeier JC, 2018, J INTERPERS VIOLENCE, V33, P2379, DOI 10.1177/0886260515625503; Iverson KM, 2018, GEN HOSP PSYCHIAT, V51, P79, DOI 10.1016/j.genhosppsych.2018.01.002; Jaffee KD, 2005, J WOMENS HEALTH, V14, P713, DOI 10.1089/jwh.2005.14.713; Janssen PA, 2003, AM J OBSTET GYNECOL, V188, P1341, DOI 10.1067/mob.2003.274; Kennedy AC, 2018, TRAUMA VIOLENCE ABUS, V19, P512, DOI 10.1177/1524838016673601; Kentucky Board of Medicine, CONT ED REQ; Kiely M, 2010, OBSTET GYNECOL, V115, P273, DOI 10.1097/AOG.0b013e3181cbd482; Kothari CL, 2006, ANN EMERG MED, V47, P190, DOI 10.1016/j.annemergmed.2005.10.016; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; LaPlante LM, 2016, ACAD PSYCHIATR, V40, P825, DOI 10.1007/s40596-016-0529-8; Leppakoski T, 2013, J CLIN NURS, V22, P2273, DOI 10.1111/j.1365-2702.2012.04202.x; Max Wendy, 2004, Violence Vict, V19, P259, DOI 10.1891/vivi.19.3.259.65767; McCall-Hosenfeld JS, 2013, WOMEN HEALTH ISS, V23, pE109, DOI 10.1016/j.whi.2012.12.006; McCaw B, 2001, AM J PREV MED, V21, P170, DOI 10.1016/S0749-3797(01)00347-6; McEwan TE, SCREENING ASSESSMENT; McEwan TE, 2018, ASSESSMENT, V25, P259, DOI 10.1177/1073191116653470; McEwan TE, 2011, BEHAV SCI LAW, V29, P180, DOI 10.1002/bsl.973; McFarlane J, 1996, J Obstet Gynecol Neonatal Nurs, V25, P313, DOI 10.1111/j.1552-6909.1996.tb02577.x; McNamara CL, 2012, J AM COLL HEALTH, V60, P168, DOI 10.1080/07448481.2011.584335; Miller E, 2015, J WOMENS HEALTH, V24, P92, DOI 10.1089/jwh.2014.4870; Modi MN, 2014, J WOMENS HEALTH, V23, P253, DOI 10.1089/jwh.2013.4387; National Center for Injury Prevention and Control, 2003, COSTS INTIMATE PARTN; National Resource Center on Domestic Violence, AD 1996 DOM VIOL AW; O'Campo P, 2011, SOC SCI MED, V72, P855, DOI 10.1016/j.socscimed.2010.12.019; ODOHERTY LJ, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2913; Olive P, 2017, J CLIN NURS, V26, P2229, DOI 10.1111/jocn.13673; Pagels P, 2015, J COMMUN HEALTH, V40, P508, DOI 10.1007/s10900-014-9964-1; PARKER B, 1994, OBSTET GYNECOL, V84, P323; Parsons L, 2000, Matern Child Health J, V4, P135, DOI 10.1023/A:1009578406219; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Reid SA, 1997, ACAD MED, V72, P51; Rhodes KV, 2011, J GEN INTERN MED, V26, P894, DOI 10.1007/s11606-011-1662-4; Rodriguez MA, 1999, JAMA-J AM MED ASSOC, V282, P468, DOI 10.1001/jama.282.5.468; Rothman EF, 2011, TRAUMA VIOLENCE ABUS, V12, P55, DOI 10.1177/1524838010390707; Salazar LF, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3426; Saltzman L.E., 2002, INTIMATE PARTNER VIO; Saltzman Linda E, 2003, Matern Child Health J, V7, P31, DOI 10.1023/A:1022589501039; Samples TC, 2014, J BLACK PSYCHOL, V40, P27, DOI 10.1177/0095798412469228; Smith S. G., 2018, NATL INTIMATE PARTNE; Sorbo MF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009240; Sprague S, 2012, WOMEN HEALTH, V52, P587, DOI 10.1080/03630242.2012.690840; Texas Medical Board, CONT MED ED MDS DOS; Thackeray JD, 2010, PEDIATRICS, V125, P1094, DOI 10.1542/peds.2010-0451; U.S. Attorneys, 2016, NO DISTR GEORG FED D; Ulrich YC, 2003, AM J PREV MED, V24, P9, DOI 10.1016/S0749-3797(02)00577-9; Veterans Health Administration, 2016, INT PARTN VIOL ASS P; Websdale N., NATL DOMESTIC VIOLEN; Williams IR, 2017, TLS-TIMES LIT SUPPL, P27; Young-Wolff KC, 2016, JAMA-J AM MED ASSOC, V315, P2517, DOI 10.1001/jama.2016.4837; Zaher E, 2014, CAN FAM PHYSICIAN, V60, P618	85	5	5	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	DEC	2019	57	6					862	872		10.1016/j.amepre.2019.07.003			11	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; General & Internal Medicine	JN5QQ	WOS:000496953200022	31753269				2022-02-06	
J	Miller, LE; Urban, JE; Whelan, VM; Baxter, WW; Tatter, SB; Stitzel, JD				Miller, Logan E.; Urban, Jillian E.; Whelan, Vincent M.; Baxter, Walt W.; Tatter, Stephen B.; Stitzel, Joel D.			An envelope of linear and rotational head motion during everyday activities	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Brain injury; Finite element model; Strain; Daily head accelerations; Kinematics	DIFFUSE AXONAL INJURY; IMPACT EXPOSURE; BRAIN-INJURY; ACCELERATION; CONCUSSION; SEVERITY	Various studies have characterized head kinematics in specific everyday activities by looking at linear and/or rotational acceleration characteristics, but each has evaluated a limited number of activities. Furthermore, these studies often present dissimilar and sometimes incomplete descriptions of the resulting kinematics, so the characteristics of normal everyday activities as a whole are not easily collectively summarized. The purpose of this study was to evaluate the literature investigating head kinematics associated with everyday activities and to generate a comprehensive kinematic boundary envelope describing these motions. The envelope constructed constitutes the current state of published knowledge regarding 'normally occurring' head accelerations. The envelope of kinematics represents activities commonly encountered and posing zero to minimal risk of injury to healthy individuals. Several kinematic measures, including linear accelerations, rotational velocities, and rotational accelerations, one may encounter as a result of normal everyday activities are summarized. A total of 11 studies encompassing 49 unique activities were evaluated. Examples of activities include sitting in a chair, jumping off a step, running, and walking. The peak resultant linear accelerations of the head reported in the literature were all less than 15 g, while the peak resultant rotational accelerations and rotational velocities approach 1375 rad/s(2) and 12.8 rad/s, respectively. The resulting design envelope can be used to understand the range of acceleration magnitudes a typical active person can expect to experience. The results are also useful to compare to other activities exposing the head to motion or impact including sports, military, automotive, aerospace and other sub-injurious and injurious events.	[Miller, Logan E.; Urban, Jillian E.; Tatter, Stephen B.; Stitzel, Joel D.] Wake Forest Univ, Bowman Gray Sch Med, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA; [Miller, Logan E.; Urban, Jillian E.; Stitzel, Joel D.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA; [Whelan, Vincent M.; Baxter, Walt W.] Medtronic Inc, Minneapolis, MN USA		Miller, LE (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.; Miller, LE (corresponding author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27101 USA.	logmille@wakehealth.edu	Tatter, Stephen/AAD-6524-2021	Tatter, Stephen/0000-0002-1063-0431; Miller, Logan/0000-0002-6348-7536	MedtronicMedtronic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410] Funding Source: NIH RePORTER	This study was funded by Medtronic.	ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Bussone, 2005, LIN ANG HEAD ACC DAI; Bussone William R, 2010, Biomed Sci Instrum, V46, P166; Bussone WR, 2014, SAE TECHNICAL PAPER; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Carriot J, 2014, J NEUROSCI, V34, P8347, DOI 10.1523/JNEUROSCI.0692-14.2014; Chou CC, 1974, SAE TECHNICAL PAPER; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davidsson J., 2009, P INT RES C BIOM IMP, P43; Exponent, 2002, INV AM PARK ROLL COA; Foti D., 2013, THER PRACT SKILLS PH, V7, P157; Funk JR, 2011, ANN BIOMED ENG, V39, P766, DOI 10.1007/s10439-010-0183-3; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; King A. I., 2003, P IRCOBI C; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2017, J NEUROTRAUM, V34, P3198, DOI 10.1089/neu.2016.4893; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Ng TP, 2005, BIOMED SCI INSTRUM, V42, P25; Ommaya A.K., 1985, BIOMECHANICS TRAUMA; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer MB, 2016, INT J AUTOMOT ENG, V7, P37, DOI 10.20485/jsaeijae.7.1_37; Pfister BJ, 2009, AM J FOREN MED PATH, V30, P339, DOI 10.1097/PAF.0b013e318187e0c9; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Urban JE, 2019, J NEUROTRAUM, V36, P275, DOI 10.1089/neu.2018.5699; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7	46	5	5	1	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2020	19	3					1003	1014		10.1007/s10237-019-01267-6		NOV 2019	12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LK5AX	WOS:000501121300002	31786677	Green Accepted			2022-02-06	
J	Spennato, P; Canella, V; Aliberti, F; Russo, C; Ruggiero, C; Nataloni, A; Lombardo, M; Cinalli, G				Spennato, Pietro; Canella, Valentina; Aliberti, Ferdinado; Russo, Carmela; Ruggiero, Claudio; Nataloni, Angelo; Lombardo, Milena; Cinalli, Giuseppe			Hydroxyapatite ceramic implants for cranioplasty in children: a retrospective evaluation of clinical outcome and osteointegration	CHILDS NERVOUS SYSTEM			English	Article						Bioceramics; Biomimetic; Cranioplasty; Custom-made prosthesis; Hydroxyapatite	TRAUMATIC BRAIN-INJURY; CUSTOM-MADE HYDROXYAPATITE; BONE FLAP RESORPTION; DECOMPRESSIVE CRANIECTOMY; SKULL DEFECT; RECONSTRUCTION; TITANIUM; COMPLEX	Introduction Cranioplasty in children is a controversial and challenging issue, since there is still no consensus on the ideal material. Main problems in paediatric age are represented by the child's growing skull, the lower bone thickness and the high incidence of cerebrospinal fluid (CSF) disorders or brain swelling. Autologous bone is still considered the "gold standard". When it is not available, a wide range of alloplastic materials have been proposed. Hydroxyapatite, a ceramic-based derivative, bears a chemical composition very similar to the human natural bone, making this material a valuable alternative to other cranioplasty solutions. Methods All patients implanted with a custom-made porous hydroxyapatite device at Santobono-Pausilipon Hospital in Naples were retrospectively reviewed. A follow-up CT scan of the skull was performed from 1 up to 48 months postoperatively to document the bone ingrowth as well as the osteointegration process. The bone density was measured as according to the Hounsfield scale at the bone-implant interface. Results Between 2014 and 2018, 11 patients (7 males, 4 females) underwent cranioplasty with hydroxyapatite ceramic implants (HAP). Patients' age ranged between 3 and 16 years old. Initial aetiology was trauma in most cases. Two subjects were implanted with HAP as primary cranioplasty, 9 as revision surgery following previous cranioplasty failure. Sites of the cranial defect were unilateral fronto-temporo-parietal (N = 8), unilateral frontal (N = 1) and bifrontal (N = 2). Two patients with large bilateral defects received two prostheses. In one of these, the two prostheses were explanted and replaced with two back-up implants (accounting for a total of 15 implants in 11 patients). Osteointegration was measurable for 12 out of 15 implanted devices. The mean percentage was about 51%. There were six asymptomatic prosthesis fractures (40%), all occurring within 6 months from implant. In one case, the bifrontal prostheses were explanted and replaced. This was the only patient who underwent revision surgery. Conclusion Hydroxyapatite ceramic implants represent a valid alternative to other cranioplasty solutions. Where coaptation occurs correctly, with good osteointegration, implant mechanical resistance increases over time.	[Spennato, Pietro; Aliberti, Ferdinado; Ruggiero, Claudio; Lombardo, Milena; Cinalli, Giuseppe] Santobono Pausipilon Childrens Hosp, Dept Neurosurg, Naples, Italy; [Canella, Valentina; Nataloni, Angelo] Finceram Faenza SpA, Faenza, Ravenna, Italy; [Russo, Carmela] Santobono Pausilipon Childrens Hosp, Dept Neuroradiol, Naples, Italy		Spennato, P (corresponding author), Santobono Pausipilon Childrens Hosp, Dept Neurosurg, Naples, Italy.	pierospen@gmail.com	cinalli, giuseppe/AAC-3889-2022; Russo, Carmela/AAA-3193-2022	Spennato, Pietro/0000-0001-7758-8605; cinalli, giuseppe/0000-0002-7797-8483; Russo, Carmela/0000-0003-1855-7571			Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Beuriat PA, 2016, NEUROCHIRURGIE, V62, P25, DOI 10.1016/j.neuchi.2016.04.003; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; de Oliveira RS, 2007, CHILD NERV SYST, V23, P1097, DOI 10.1007/s00381-007-0413-7; Della Puppa A, 2010, ACTA NEUROCHIR, V152, P155, DOI 10.1007/s00701-009-0374-6; Fong KD, 2003, PLAST RECONSTR SURG, V112, P1312, DOI 10.1097/01.PRS.0000079860.14734.D6; Frassanito P, 2019, CHILD NERV SYST, V35, P1467, DOI 10.1007/s00381-019-04166-4; Frassanito P, 2019, CHILD NERV SYST, V35, P1459, DOI 10.1007/s00381-019-04193-1; Frassanito P, 2018, CHILD NERV SYST, V34, P2283, DOI 10.1007/s00381-018-3905-8; Frassanito P, 2017, CHILD NERV SYST, V33, P1759, DOI 10.1007/s00381-017-3541-8; Frassanito P, 2015, ACTA NEUROCHIR, V157, P115, DOI 10.1007/s00701-014-2254-y; Frassanito P, 2014, J NEUROSURG-PEDIATR, V13, P243, DOI 10.3171/2013.6.PEDS13312; Frassanito P, 2013, CLIN NEUROL NEUROSUR, V115, P1496, DOI 10.1016/j.clineuro.2012.11.032; Fricia M, 2019, WORLD NEUROSURG, V121, P160, DOI 10.1016/j.wneu.2018.09.199; Goiato MC, 2009, J CRANIOFAC SURG, V20, P1512, DOI 10.1097/SCS.0b013e3181b09b9a; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Iaccarino C, 2015, J ORAL MAXIL SURG, V73, P2375, DOI 10.1016/j.joms.2015.07.008; Jaberi J, 2013, J ORAL MAXIL SURG, V71, pE81, DOI 10.1016/j.joms.2012.09.023; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Josan VA, 2005, CHILD NERV SYST, V21, P200, DOI 10.1007/s00381-004-1068-2; Kabbani H, 2004, AM FAM PHYSICIAN, V69, P2863; Klieverik VM, 2019, CHILD NERV SYST, V35, P1481, DOI 10.1007/s00381-018-4025-1; Lam S, 2015, CRANIOMAX TRAUM REC, V8, P159, DOI 10.1055/s-0034-1395880; Lee SC, 2009, J CLIN NEUROSCI, V16, P56, DOI 10.1016/j.jocn.2008.04.001; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Morice A, 2017, J NEUROSURG-PEDIATR, V19, P51, DOI 10.3171/2016.8.PEDS1653; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Rocque BG, 2013, J NEUROSURG-PEDIATR, V12, P120, DOI 10.3171/2013.4.PEDS12605; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini R, 2015, J APPL BIOMATER FUNC, V13, pE136, DOI 10.5301/jabfm.5000211; Stefini Roberto, 2013, Surg Neurol Int, V4, P12, DOI 10.4103/2152-7806.106290; Tubbs RS, 2012, CHILD NERV SYST, V28, P23, DOI 10.1007/s00381-011-1637-0; Williams L, 2016, J CRANIO MAXILL SURG, V44, P789, DOI 10.1016/j.jcms.2016.03.010; Zaccaria L, 2017, CHILD NERV SYST, V33, P343, DOI 10.1007/s00381-016-3327-4	38	5	5	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAR	2020	36	3					551	558		10.1007/s00381-019-04423-6		NOV 2019	8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	KN0OG	WOS:000501455800003	31786632				2022-02-06	
J	Spreij, LA; Sluiter, D; Gosselt, IK; Visser-Meily, JMA; Nijboer, TCW				Spreij, Lauriane A.; Sluiter, David; Gosselt, Isabel K.; Visser-Meily, Johanna M. A.; Nijboer, Tanja C. W.			CoCo-participation: The development and clinical use of a novel inventory measuring cognitive complaints in daily life	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; Cognitive complaints; Daily living; Participation; Questionnaire	TRAUMATIC BRAIN-INJURY; SUBJECTIVE COMPLAINTS; ATTENTION SYSTEM; HEAD-INJURY; REHABILITATION; STROKE; DISORDERS; DEFICITS; RETURN; ALPHA	Cognitive difficulties can be subtle and only come to light when patients return home from inpatient care and start to participate in society. Subjective cognitive complaints often interfere with participation, hence capturing cognitive complaints systematically is important. We developed a patient- and relative-reported measure to assess cognitive complaints during daily life activities across the memory, attention and executive domain for patients with acquired brain injury (ABI). The inventory Cognitive Complaints - Participation (CoCo-P) was created based on a literature review, consultations with experts, semi-structured interviews with patients, and a quantitative study. The inventory was administered to patients with ABI (n = 46), their relatives (n = 33) and healthy controls (n = 102) to finalize the inventory. We examined the reported complaints per daily life activity and cognitive domain of patients and healthy controls, and we compared the patients' and relatives' reports. The majority of patients (87-96%) experienced cognitive complaints, mostly related to attention, at work/education, during leisure activities, and in contact with family/friends and community. Patients reported more cognitive complaints than relatives. The CoCo-P seems appropriate to capture cognitive complaints in daily life in patients with mild ABI. Additional research is needed in terms of reliability and validity.	[Spreij, Lauriane A.; Sluiter, David; Gosselt, Isabel K.; Visser-Meily, Johanna M. A.; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Spreij, Lauriane A.; Sluiter, David; Gosselt, Isabel K.; Visser-Meily, Johanna M. A.; Nijboer, Tanja C. W.] De Hoogstr Rehabil, Utrecht, Netherlands; [Sluiter, David; Visser-Meily, Johanna M. A.] Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Rehabil Phys Therapy Sci & Sports, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Utrecht, Helmholtz Inst, Dept Expt Psychol, Utrecht, Netherlands		Spreij, LA (corresponding author), Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Rehabil Phys Therapy Sci & Sports, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	l.a.spreij@umcutrecht.nl		Nijboer, Tanja/0000-0001-6683-0267	 [R2015010]	This work was supported by the Handicap.nl under [grant number R2015010].	Barreto AD, 2011, NEUROTHERAPEUTICS, V8, P388, DOI 10.1007/s13311-011-0049-x; Barrett AM, 2009, BEHAV NEUROL, V22, P17, DOI 10.3233/BEN-2009-0250; Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P269, DOI 10.1044/1058-0360(2011/10-0084); Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bielak AAM, 2017, RES HUM DEV, V14, P219, DOI 10.1080/15427609.2017.1340050; Boynton PM, 2004, BMJ-BRIT MED J, V328, P1433, DOI 10.1136/bmj.328.7453.1433; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Campbell B. C. V., 2016, ENDOVASCULAR THROMBE, DOI [10.1136/svn-2015-000004, DOI 10.1136/SVN-2015-000004]; Carrigan N, 2016, NEUROSCI BIOBEHAV R, V63, P29, DOI 10.1016/j.neubiorev.2016.01.010; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chung C, 2013, STROKE, V44, pE77, DOI 10.1161/STROKEAHA.113.002049; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cifti DX., 1999, ARCH PHYS MED REH S1, V80, pS35; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Duits A, 2008, J NEUROL NEUROSUR PS, V79, P143, DOI 10.1136/jnnp.2007.114595; Duncan P W, 2001, Top Stroke Rehabil, V8, P19; Dunn TJ, 2014, BRIT J PSYCHOL, V105, P399, DOI 10.1111/bjop.12046; Ezekiel L, 2019, ARCH PHYS MED REHAB, V100, P945, DOI 10.1016/j.apmr.2018.06.017; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FOUGEYROLLAS P, 2002, MESURE HABITUDE VIE; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Hochstenbach J, 2005, ARCH PHYS MED REHAB, V86, P1587, DOI 10.1016/j.apmr.2004.11.050; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Jette AM, 2005, ARCH PHYS MED REHAB, V86, P2087, DOI 10.1016/j.apmr.2005.08.001; Johansson MM, 2016, SCAND J OCCUP THER, V23, P230, DOI 10.3109/11038128.2016.1139621; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; KERKHOFF G, 1990, NERVENARZT, V61, P711; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Maulden SA, 2005, ARCH PHYS MED REHAB, V86, pS34, DOI 10.1016/j.apmr.2005.08.119; MCCLENAHAN R, 1990, J NEUROL NEUROSUR PS, V53, P700, DOI 10.1136/jnnp.53.8.700; MCCLENAHAN R, 1992, EUR J DISORDER COMM, V27, P209; McCulloch Karen, 2007, J Neurol Phys Ther, V31, P104; Meadows Keith A, 2011, Br J Community Nurs, V16, P146; Mole JA, 2020, NEUROPSYCHOL REHABIL, V30, P346, DOI 10.1080/09602011.2018.1464934; Paemeleire F., 2014, LOGOPEDIE, V27, P51; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Post MWM, 2012, DISABIL REHABIL, V34, P478, DOI 10.3109/09638288.2011.608148; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Reeves M, 2018, STROKE, V49, P1549, DOI 10.1161/STROKEAHA.117.018912; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Spielberger C., 2004, ENCY APPL PSYCHOL; Spreij LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00993; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Heugten C, 2007, CLIN NEUROL NEUROSUR, V109, P257, DOI 10.1016/j.clineuro.2006.10.002; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; VERHAGE F, 1965, HUM DEV, V8, P238, DOI 10.1159/000270308; Virk S, 2015, NEUROREHABILITATION, V36, P367, DOI 10.3233/NRE-151225; Viscogliosi C, 2011, APPL NEUROPSYCHOL, V18, P117, DOI 10.1080/09084282.2010.547779; Visser-Keizer AC, 2015, ARCH PHYS MED REHAB, V96, P1056, DOI 10.1016/j.apmr.2014.12.010; Wade DT, 2000, BMJ-BRIT MED J, V320, P1385, DOI 10.1136/bmj.320.7246.1385; Watkins MW, 2017, CLIN NEUROPSYCHOL, V31, P1113, DOI 10.1080/13854046.2017.1317364; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Wiklund I, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0529-0; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Zinbarg RE, 2006, APPL PSYCH MEAS, V30, P121, DOI 10.1177/0146621605278814; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	72	5	5	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2021	31	2					255	277		10.1080/09602011.2019.1691017		NOV 2019	23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QA9MZ	WOS:000500117400001	31790631	hybrid, Green Published			2022-02-06	
J	Walder, K; Molineux, M; Bissett, M; Whiteford, G				Walder, Kim; Molineux, Matthew; Bissett, Michelle; Whiteford, Gail			Occupational adaptation - analyzing the maturity and understanding of the concept through concept analysis	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Adaptation; mastery; occupational challenge; occupational competence; occupational identity	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; LIVED EXPERIENCE; LIFE PARTICIPATION; HOLISTIC APPROACH; THERAPY PRACTICE; OLDER PERSONS; PEOPLE; INTERVENTION; IDENTITY	Background: Occupational adaptation is a key occupational therapy concept, yet lacks clarity and consensus, impacting on its application in practice, theory and research. Concept analysis is a rigorous methodology which enables identification of unique features, gaps in knowledge, and the need for further concept refinement. Aim: This study aimed to determine the conceptual maturity of occupational adaptation, and identify steps needed to understand and use occupational adaptation. Methods: Four databases were searched using the term 'occupational adaptation' and a principle-based concept analysis was conducted from epistemological, pragmatic, linguistic, and logical perspectives. A mapping of the concept's evolution and analysis of the maturity of its structural features also occurred. Results: Seven hundred and fourty-eight papers were identified, which reduced to 161 after abstract and full-text review. A diverse range of applications and two primary theoretical frames of reference were identified. The definition, attributes, preconditions, outcomes, and boundaries of the concept lacked maturity, limiting clinical utility.	[Walder, Kim; Molineux, Matthew; Bissett, Michelle; Whiteford, Gail] Griffith Univ, Sch Allied Hlth Sci, Gold Coast, Australia		Walder, K (corresponding author), Griffith Univ, Sch Allied Hlth Sci, Nathan, Qld 4111, Australia.	k.walder@griffith.edu.au	Molineux, Matthew/ABD-7481-2020; Whiteford, Gail/AAH-9464-2021; Walder, Kim/AAF-9270-2020; Bissett, Michelle/ABD-7529-2020	Molineux, Matthew/0000-0002-6671-4140; Walder, Kim/0000-0002-9692-9054; Bissett, Michelle/0000-0001-7676-4662; Whiteford, Gail/0000-0001-6136-1844			Abelenda J., 2003, OCCUPATIONAL THERAPY, V19, P25, DOI DOI 10.1300/J004V19N01_; Bachman S, 2016, AM J OCCUP THER, V70, p7002360010p1; Ball MJ, 2011, HEALTH INFORM SER, P5, DOI 10.1007/978-1-84996-278-0_1; Bates E, 2014, BRIT J OCCUP THER, V77, P289, DOI 10.4276/030802214X14018723137995; Beagan BL, 2015, J OCCUP SCI, V22, P459, DOI 10.1080/14427591.2014.953670; Beckwith S, 2008, INT J NURS STUD, V45, P1831, DOI 10.1016/j.ijnurstu.2008.06.011; Berenskoetter F, 2017, MILLENNIUM-J INT ST, V45, P151, DOI 10.1177/0305829816651934; Blacker D, 2008, NEUROREHABILITATION, V23, P313; Bonello M, 2001, BRIT J OCCUPATIONAL, V64, P93, DOI DOI 10.1177/030802260106400207; Bontje P, 2004, AM J OCCUP THER, V58, P140, DOI 10.5014/ajot.58.2.140; Boone AE, 2017, BRIT J OCCUP THER, V80, P368, DOI 10.1177/0308022616688018; Bouteloup Z, 2007, AUST OCCUP THER J, V54, P228, DOI 10.1111/j.1440-1630.2007.00620.x; Brayman SJ, 1996, AM J OCCUP THER, V50, P442, DOI 10.5014/ajot.50.6.442; Bryson-Campbell M, 2016, J OCCUP SCI, V23, P208, DOI 10.1080/14427591.2015.1131188; Buddenberg LA, 1998, TOP GERIATR REHABIL, V13, P52; Cahill M, 2010, BRIT J OCCUP THER, V73, P106, DOI 10.4276/030802210X12682330090415; Cheal B, 2001, AUSTR OCCUPATIONAL T, V48, P80, DOI DOI 10.1046/J.1440-1630.2001.00250.X].AUSTRALIAN; Coates Gina L Ferraro, 2004, Occup Ther Health Care, V18, P39, DOI 10.1080/J003v18n01_05; Connell C, 2015, J FORENSIC PSYCHI PS, V26, P94, DOI 10.1080/14789949.2014.981566; Cotton GS, 2012, OCCUP THER HEALTH CA, V26, P270, DOI 10.3109/07380577.2012.726759; Coutinho F, 2006, PHYS OCCUP THER GERI, V25, P47, DOI 10.1300/J148v25n01_04; Crist P, 2005, OCCUP THER HEALTH CA, V19, P193, DOI [10.1300/J003v19n01_14, 10.1080/J003v19n01_14]; Cutchin MP, 2004, AM J OCCUP THER, V58, P303, DOI 10.5014/ajot.58.3.303; Dale Lucinda M, 2002, Work, V19, P35; Ennals P, 2009, OCCUP THER MENT HEAL, V25, P138, DOI 10.1080/01642120902859048; Fallahpour M, 2013, J REHABIL MED, V45, P528, DOI 10.2340/16501977-1143; Fearing VG, 1997, CANADIAN J OCCUPATIO, V64, P7, DOI [10.1177/000841749706400103, DOI 10.1177/000841749706400103]; Fingerhut PE, 2013, AM J OCCUP THER, V67, P37, DOI 10.5014/ajot.2013.005082; Fingerhut PE, 2009, PHYS OCCUP THER PEDI, V29, P113, DOI 10.1080/01942630902784795; Flinn NA, 2010, OCCUP THER INT, V17, P81, DOI 10.1002/oti.286; Forsberg-Warleby G, 1996, SCANDINAVIAN J OCCUP, V3, P114; Frank G., 1996, OCCUPATIONAL SCI EVO, P47; Galvis AT, 2011, INTERNET J ALLIED HE, V9; GARRETT SA, 1995, AM J OCCUP THER, V49, P119, DOI 10.5014/ajot.49.2.119; George LA, 2004, OTJR-OCCUP PART HEAL, V24, P92, DOI 10.1177/153944920402400303; Gibbs D, 2015, BRIT J OCCUP THER, V78, P475, DOI 10.1177/0308022615586799; Gibbs DP, 2016, CAN J OCCUP THER, V83, P91, DOI 10.1177/0008417415625421; Gibson JW, 1997, AM J OCCUP THER, V51, P523, DOI 10.5014/ajot.51.7.523; Gilfoyle E.M., 1990, CHILDREN ADAPT THEOR; Gillot AJ, 2003, AM J OCCUP THER, V57, P168, DOI 10.5014/ajot.57.2.168; Grajo L., 2018, OP J OCCUPAT THERAPY, V6, P2; Grajo L, 2017, PERSPECTIVES HUMAN O, P287; Grajo LC, 2016, J OCC THER SCH EARLY, V9, P74, DOI 10.1080/19411243.2016.1141082; Gray ML., 2003, AUST OCCUP THER J, V50, P127, DOI DOI 10.1046/J.1440-1630.2003.00336.X; Hamera E, 2000, AM J OCCUP THER, V54, P20, DOI 10.5014/ajot.54.1.20; Hoppes S, 2010, AM J OCCUP THER, V64, P133, DOI 10.5014/ajot.64.1.133; Hudson MJ, 2009, CAN J OCCUP THER, V76, P48, DOI 10.1177/000841740907600113; Huot S, 2016, AUST OCCUP THER J, V63, P186, DOI 10.1111/1440-1630.12261; Hupcey J E, 1996, Sch Inq Nurs Pract, V10, P185; Hupcey Judith E, 2005, Res Theory Nurs Pract, V19, P197; Ikiugu MN, 2010, OCCUP THER HEALTH CA, V24, P193, DOI 10.3109/07380570903521641; Jack J, 2010, AM J OCCUP THER, V64, P82, DOI 10.5014/ajot.64.1.82; Johansson A, 2016, SCAND J OCCUP THER, V23, P207, DOI 10.3109/11038128.2015.1093544; Johansson A, 2006, ACT ADAPT AGING, V30, P1, DOI 10.1300/J016v30n01_01; Johansson AEM, 2016, DISABIL REHABIL, V38, P423, DOI 10.3109/09638288.2015.1044034; Johansson C, 2011, SCAND J OCCUP THER, V18, P294, DOI 10.3109/11038128.2010.521950; Johnson JA, 2001, J APPL GERONTOL, V20, P91, DOI 10.1177/073346480102000106; Johnson JA, 2006, OCCUP THER HEALTH CA, V20, P63, DOI [10.1300/J003v20n03_05, 10.1080/J003v20n03_05]; Kerr A, 2010, J OCCUP SCI, V17, P34, DOI 10.1080/14427591.2010.9686670; Kielhofner G, 2001, AM J OCCUP THER, V55, P260, DOI 10.5014/ajot.55.3.260; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Kielhofner G., 1985, MODEL HUMAN OCCUPATI, P12; Kinsella EA, 2009, AUST OCCUP THER J, V56, P249, DOI 10.1111/j.1440-1630.2007.00726.x; Klinger L, 1999, CLIN J PAIN, V15, P275, DOI 10.1097/00002508-199912000-00003; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Kratz G, 1997, DISABIL REHABIL, V19, P26, DOI 10.3109/09638289709166442; Krusen NE, 2012, OCCUP THER HEALTH CA, V26, P64, DOI 10.3109/07380577.2011.637609; Kylberg M, 2013, SCAND J OCCUP THER, V20, P397, DOI 10.3109/11038128.2013.779321; Lee J, 2010, OCCUP THER HEALTH CA, V24, P206, DOI 10.3109/07380577.2010.483270; Lee M, 2006, PHYS OCCUP THER GERI, V25, P63, DOI 10.1300/J148v25n01_05; Lentin P, 2006, J OCCUP SCI, V13, P153, DOI 10.1080/14427591.2006.9726509; Levanon-Erez N, 2017, SCAND J OCCUP THER, V24, P32, DOI 10.1080/11038128.2016.1217927; Lexell EM, 2011, OTJR-OCCUP PART HEAL, V31, P127, DOI 10.3928/15394492-20101025-01; Lim JW, 2016, AUST OCCUP THER J, V63, P303, DOI 10.1111/1440-1630.12307; LLORENS LA, 1970, AM J OCCUP THER, V24, P93; Lopez A, 2011, WORK, V38, P33, DOI 10.3233/WOR-2011-1102; Luck K, 2015, J OCCUP SCI, V22, P183, DOI 10.1080/14427591.2014.887418; Lutz SG, 2018, BRIT J OCCUP THER, V81, P90, DOI 10.1177/0308022617734789; Mallinson T, 1998, CANADIAN J OCCUPATIO, V65, P219, DOI DOI 10.1177/000841749806500407; McClung M., 2001, OCCUPATIONAL ADAPTAT; McDougall C, 2014, AUST OCCUP THER J, V61, P83, DOI 10.1111/1440-1630.12076; McIntyre G., 2002, SCANDINAVIAN J OCCUP, V9, P54, DOI DOI 10.1080/110381202320000034; Meltzer P., 2001, J OCCUPATIONAL SCI, V8, P16, DOI [10.1080/14427591.2001.9686485, DOI 10.1080/14427591.2001.9686485]; MEYER A, 1977, AM J OCCUP THER, V31, P639; Morse J M, 1996, Sch Inq Nurs Pract, V10, P253; Morse JM, 1996, J ADV NURS, V24, P385, DOI 10.1046/j.1365-2648.1996.18022.x; Nayar S, 2015, J OCCUP SCI, V22, P26, DOI 10.1080/14427591.2014.882251; NELSON DL, 1988, AM J OCCUP THER, V42, P633, DOI 10.5014/ajot.42.10.633; Norberg EB, 2014, SCAND J OCCUP THER, V21, P392, DOI 10.3109/11038128.2014.911955; Odawara E, 2010, J OCCUP SCI, V17, P14, DOI 10.1080/14427591.2010.9686667; Paley J, 1996, J ADV NURS, V24, P572, DOI 10.1046/j.1365-2648.1996.22618.x; Parsons L, 2008, AUST OCCUP THER J, V55, P231, DOI 10.1111/j.1440-1630.2008.00753.x; Pasek PB, 1996, AM J OCCUP THER, V50, P24, DOI 10.5014/ajot.50.1.24; Penrod J, 2005, J ADV NURS, V50, P403, DOI 10.1111/j.1365-2648.2005.03405.x; PENTLAND W, 2003, J OCCUPATIONAL SCI, V10, P21, DOI DOI 10.1080/14427591.2003.9686507; Pepin G, 2011, BRIT J OCCUP THER, V74, P419, DOI 10.4276/030802211X13153015305556; PETERSON E, 1999, PHYS OCCUP THER GERI, V0016, P00001; Pierce D, 2001, AM J OCCUP THER, V55, P138, DOI 10.5014/ajot.55.2.138; Precin P, 2011, WORK, V38, P1, DOI 10.3233/WOR-2011-1098; Reed KL., 1984, MODELS PRACTICE OCCU; ROSENFELD MS, 1989, AM J OCCUP THER, V43, P89, DOI 10.5014/ajot.43.2.89; Rowe VT, 2018, OTJR-OCCUP PART HEAL, V38, P190, DOI 10.1177/1539449218762729; Rowe VT, 2018, OTJR-OCCUP PART HEAL, V38, P46, DOI 10.1177/1539449217727120; Ruckser-Scherb R, 2013, BRIT J OCCUP THER, V76, P548, DOI 10.4276/030802213X13861576675286; Rudman DL, 2017, J OCCUP SCI, V24, P470, DOI 10.1080/14427591.2017.1369144; Rudman DL, 2010, OTJR-OCCUP PART HEAL, V30, P87, DOI 10.3928/15394492-20100325-04; Satink T, 2004, OTJR-OCCUP PART HEAL, V24, P144, DOI 10.1177/153944920402400404; Scalzo K, 2016, J OCCUP SCI, V23, P464, DOI 10.1080/14427591.2016.1223742; SCHKADE JK, 1992, AM J OCCUP THER, V46, P829, DOI 10.5014/ajot.46.9.829; Schroeder-Smith Katie, 2002, Occup Ther Health Care, V14, P79, DOI 10.1080/J003v14n02_06; SCHULTZ S, 1992, AM J OCCUP THER, V46, P917, DOI 10.5014/ajot.46.10.917; SCHULTZ S, 2003, WILLARD SPACKMANS OC; Schulz CH, 2012, PHYS OCCUP THER GERI, V30, P109, DOI 10.3109/02703181.2012.687441; Sheridan K, 2016, BRIT J OCCUP THER, V79, P484, DOI 10.1177/0308022616638672; Siebert CA, 1997, AM J OCCUP THER, V51, P423, DOI 10.5014/ajot.51.6.423; Sima L, 2017, J OCCUP SCI, V24, P128, DOI 10.1080/14427591.2017.1306790; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; STARK S, 2013, WFOT B, V68, P20, DOI DOI 10.1179/OTB.2013.68.1.007; Stelter L, 2007, OCCUP THER MENT HEAL, V23, P69, DOI 10.1300/J004v23n01_05; Stevens-Ratchford R, 2005, PHYS OCCUP THER GERI, V22, P31; Strong Jade, 2005, J Hand Ther, V18, P437, DOI 10.1197/j.jht.2005.09.008; Suleman A, 2013, J OCCUP SCI, V20, P201, DOI 10.1080/14427591.2012.755908; Taylor J, 2017, BRIT J OCCUP THER, V80, P440, DOI 10.1177/0308022617698168; Taylor Renee R, 2003, Occup Ther Health Care, V17, P47, DOI 10.1080/J003v17n02_04; Thompson B, 2009, BRIT J OCCUP THER, V72, P405, DOI 10.1177/030802260907200907; Urbanowski R, 2014, OCC THER NOW, V16, P15; van der Steen W.J., 1993, PRACTICAL PHILOS LIF; Vrkljan BH, 2007, J OCCUP SCI, V14, P30, DOI 10.1080/14427591.2007.9686581; Walder K, 2017, J OCCUP SCI, V24, P225, DOI 10.1080/14427591.2016.1269240; Walker C., 2001, J OCCUPATIONAL SCI, V8, P17, DOI DOI 10.1080/14427591.2001.9686481; Walker KF, 2001, AM J OCCUP THER, V55, P129, DOI 10.5014/ajot.55.2.129; Wells SA, 2015, OCCUP THER INT, V22, P174, DOI 10.1002/oti.1394; Whisner SM, 2014, OCCUP THER MENT HEAL, V30, P26, DOI 10.1080/0164212X.2014.878527; Whiteford G, 2007, J OCCUP SCI, V14, P77, DOI 10.1080/14427591.2007.9686587; Wilcock A. A., 1999, AUST OCCUP THER J, V46, P1, DOI [10.1046/j.1440-1630.1999.00174.x, DOI 10.1177/000841749806500501]; Wiley EAM, 2004, PHYS OCCUP THER GERI, V21, P33; Williams KL, 2017, J OCCUP SCI, V24, P302, DOI 10.1080/14427591.2016.1209425; Williams S, 2013, BRIT J OCCUP THER, V76, P370, DOI 10.4276/030802213X13757040168351; Williams S, 2013, AUST OCCUP THER J, V60, P39, DOI 10.1111/1440-1630.12004; Wiseman L, 2009, J OCCUP SCI, V16, P104, DOI 10.1080/14427591.2009.9686649; Wood W, 1998, AM J OCCUP THER, V52, P320, DOI 10.5014/ajot.52.5.320; Yazdani F, 2011, INT J THER REHABIL, V18, P462, DOI 10.12968/ijtr.2011.18.8.462	143	5	5	2	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.	JAN 2	2021	28	1					26	40		10.1080/11038128.2019.1695931		NOV 2019	15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	PM5SX	WOS:000499588300001	31786968	Green Accepted			2022-02-06	
J	Soendergaard, PL; Wolffbrandt, MM; Biering-Sorensen, F; Nordin, M; Schow, T; Arango-Lasprilla, JC; Norup, A				Soendergaard, Pernille Langer; Wolffbrandt, Mia Moth; Biering-Sorensen, Fin; Nordin, Malin; Schow, Trine; Carlos Arango-Lasprilla, Juan; Norup, Anne			A manual-based family intervention for families living with the consequences of traumatic injury to the brain or spinal cord: a study protocol of a randomized controlled trial	TRIALS			English	Article						Traumatic brain injury; Traumatic spinal cord injury; Family intervention; Randomized controlled trial; Study protocol; CONSORT-SPI 2018	QUALITY-OF-LIFE; CAREGIVER BURDEN; EMOTIONAL DISTRESS; 1ST YEAR; HEALTH; RELATIVES; DEPRESSION; SATISFACTION; INDIVIDUALS; ANXIETY	Background Acquiring a traumatic injury constitutes a severe life change for the survivor, but also for the surrounding family. The paradigm of helping the family has primarily been on psychosocial interventions targeting caregivers. However, interventions including both survivor and caregivers should be an essential part of treatment, as the whole family's functional level and mental health can be affected. The current study protocol presents a manualized family intervention for families living with traumatic injury to the brain (TBI) or spinal cord (tSCI). The objectives are to investigate if the intervention improves quality of life (QoL) and decreases burden. It is hypothesized that the family intervention improves problem-solving strategies and family dynamics, which will reduce the burden. This may improve the caregivers' mental health, which will improve the support to the survivor and QoL. Methods The study is an interventional, two-arm, randomized controlled trial. During a 2-year period, a total of 132 families will be included. Participants will be recruited from East-Denmark. Inclusion criteria are (1) TBI or tSCI, (2) >= 18 years of age, (3) >= 6 months to <= 2 years since discharge from hospital, (4) ability to understand and read Danish, (5) cognitive abilities that enable participation, and (6) a minimum of one family member actively involved in the survivor's life. Exclusion criteria are (1) active substance abuse, (2) aphasia, (3) prior neurologic or psychiatric diagnose, and (4) history of violence. Within each disease group, families will be allocated randomly to participate in an intervention or a control group with a ratio 1:1. The intervention groups receive the family intervention consisting of eight sessions of 90 min duration. Families in the control groups receive 2 h of psychoeducation. All participants complete questionnaires on QoL, self-perceived burden, family dynamics, problem-solving strategies, mental health, and resilience at pre-intervention, post-intervention, and 6-month follow up. Conclusion If the intervention is found to have effect, the study will contribute with novel knowledge on the use of a manual-based intervention including the entire family. This would be of clinical interest and would help families living with the consequences of TBI or tSCI.	[Soendergaard, Pernille Langer; Wolffbrandt, Mia Moth; Norup, Anne] Rigshosp, TBI Unit, Dept Neurorehabil, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark; [Soendergaard, Pernille Langer; Norup, Anne] Univ Southern Denmark, Dept Psychol, Campusvej 55, DK-5230 Odense, Denmark; [Biering-Sorensen, Fin] Univ Copenhagen, Rigshosp, Clin Spinal Cord Injuries, Havnevej 25, DK-3100 Hornbaek, Denmark; [Biering-Sorensen, Fin] Univ Copenhagen, Inst Clin Med, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Nordin, Malin] Karolinska Univ Hosp, Dept Neurosurg, Eugeniavagen 3, S-17176 Stockholm, Sweden; [Schow, Trine] Brain Injury Ctr BOMI, Res & Dev, Maglegaardsvej 15, DK-4000 Roskilde, Denmark; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp, BioCruces Vizcaya Hlth Res Inst, Baracaldo, Spain; [Carlos Arango-Lasprilla, Juan] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Carlos Arango-Lasprilla, Juan] Univ Basque Country UPV EHU, Dept Cell Biol, Leioa, Spain		Soendergaard, PL (corresponding author), Rigshosp, TBI Unit, Dept Neurorehabil, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.; Soendergaard, PL (corresponding author), Univ Southern Denmark, Dept Psychol, Campusvej 55, DK-5230 Odense, Denmark.	Pernille.langer.soendergaard@regionh.dk	Janson, Patrick/AAC-7581-2022; Soendergaard, Pernille Langer/C-6149-2019	Norup, Anne/0000-0002-5598-6116; Soendergaard, Pernille Langer/0000-0002-5347-8898	Council of Danish Victims Fund [18-610-00024]; Foreningen Oestifterne [18-077]	The study is financed by The Council of Danish Victims Fund (grant 18-610-00024), and by the Foreningen Oestifterne (j.nr. 18-077). The funders had no influence or role in the design of the study, collection, analysis, or interpretation of data, nor in the writing of the manuscript.	Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; [Anonymous], 2017, FOLKETAL ENKELTE KOM; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P1, DOI 10.3233/NRE-2010-0576; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Baker A, 2017, CLIN REHABIL, V31, P45, DOI 10.1177/0269215516639357; Biering-Sorensen F, 2017, SPINAL CORD, V55, P759, DOI 10.1038/sc.2017.59; Bjorner JB., 1997, DANISH MANUAL SF 36; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Charlifue S, 2012, SPINAL CORD, V50, P672, DOI 10.1038/sc.2012.27; Cousineau N, 2003, MED CARE, V41, P110, DOI 10.1097/00005650-200301000-00013; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Duncan Barry L., 2003, J BRIEF THERAPY, V3, P3; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Friborg O, 2003, INT J METH PSYCH RES, V12, P65, DOI 10.1002/mpr.143; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Hendrick SS, 1998, J SOC PERS RELAT, V15, P137, DOI 10.1177/0265407598151009; HEPPNER PP, 1988, PROBLEM SOLVING INVE; HOWE EI, 2019, COGENT MED, P00001, DOI DOI 10.1080/2331205X.2019.1565614; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreitzer N, 2018, ARCH PHYS MED REHAB, V99, P2342, DOI 10.1016/j.apmr.2018.04.016; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lehan T, 2016, SPINAL CORD INJ REHA, V22, P49, DOI [10.1310/sci2201-49, DOI 10.1310/SCI2201-49]; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Lehan TJ, 2012, NEUROREHABILITATION, V30, P75, DOI 10.3233/NRE-2012-0729; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; McDaniels SH, 1992, MED FAMILY THERAPY B; Montgomery P, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2733-1; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Noe BB, 2015, SPINAL CORD, V53, P436, DOI 10.1038/sc.2014.181; Nogueira PC, 2012, REV LAT-AM ENFERM, V20, P1048, DOI 10.1590/S0104-11692012000600006; Norup A, 2018, REV IBEROAM NEUROPSI, V1, P17; Norup A, 2012, SEVERE BRAIN INJURY; Norup A, 2013, AUST J REHABIL COUNS, V19, P142, DOI 10.1017/jrc.2013.17; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Norup A, 2013, AUST J REHABIL COUNS, V19, P71, DOI 10.1017/jrc.2013.12; Norup A, 2013, J REHABIL MED, V45, P827, DOI 10.2340/16501977-1181; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rask Mikael, 2010, Can J Cardiovasc Nurs, V20, P16; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Sanguinetti M, 1987, J Neurosci Nurs, V19, P271; Scholten EWM, 2018, SPINAL CORD, V56, P436, DOI 10.1038/s41393-017-0047-x; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Sethi AA, 2001, HYPERTENSION, V37, P875, DOI 10.1161/01.HYP.37.3.875; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stevens Lillian Flores, 2016, Top Spinal Cord Inj Rehabil, V22, P49, DOI 10.1310/sci2201-49; Sundhedsstyrelsen Sundhedsdokumentation, 2011, SERIENAVN, V13; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Trujillo M, 2016, REHABIL PSYCHOL, V61, P389, DOI 10.1037/rep0000108; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	71	5	5	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	NOV 27	2019	20	1							646	10.1186/s13063-019-3794-5			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	JR2UB	WOS:000499485400003	31775831	Green Published, gold			2022-02-06	
J	Welsbie, DS; Ziogas, NK; Xu, LY; Kim, BJ; Ge, YS; Patel, AK; Ryu, J; Lehar, M; Alexandris, AS; Stewart, N; Zack, DJ; Koliatsos, VE				Welsbie, Derek S.; Ziogas, Nikolaos K.; Xu, Leyan; Kim, Byung-Jin; Ge, Yusong; Patel, Amit K.; Ryu, Jiwon; Lehar, Mohamed; Alexandris, Athanasios S.; Stewart, Nicholas; Zack, Donald J.; Koliatsos, Vassilis E.			Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury	MOLECULAR NEURODEGENERATION			English	Article						Traumatic axonal injury; Concussion; Cell death; Traumatic brain injury; Optic neuropathy; Dual leucine zipper kinase; DLK; LZK; Retinal ganglion cell	AXONAL INJURY; OPTIC-NERVE; SELF-DESTRUCTION; DEGENERATION; PROTEIN; DISCONNECTION; REGENERATION; MECHANISMS; GLAUCOMA; PROGRAM	Background Traumatic brain injury (TBI) is a major cause of CNS neurodegeneration and has no disease-altering therapies. It is commonly associated with a specific type of biomechanical disruption of the axon called traumatic axonal injury (TAI), which often leads to axonal and sometimes perikaryal degeneration of CNS neurons. We have previously used genome-scale, arrayed RNA interference-based screens in primary mouse retinal ganglion cells (RGCs) to identify a pair of related kinases, dual leucine zipper kinase (DLK) and leucine zipper kinase (LZK) that are key mediators of cell death in response to simple axotomy. Moreover, we showed that DLK and LZK are the major upstream triggers for JUN N-terminal kinase (JNK) signaling following total axonal transection. However, the degree to which DLK/LZK are involved in TAI/TBI is unknown. Methods Here we used the impact acceleration (IA) model of diffuse TBI, which produces TAI in the visual system, and complementary genetic and pharmacologic approaches to disrupt DLK and LZK, and explored whether DLK and LZK play a role in RGC perikaryal and axonal degeneration in response to TAI. Results Our findings show that the IA model activates DLK/JNK/JUN signaling but, in contrast to axotomy, many RGCs are able to recover from the injury and terminate the activation of the pathway. Moreover, while DLK disruption is sufficient to suppress JUN phosphorylation, combined DLK and LZK inhibition is required to prevent RGC cell death. Finally, we show that the FDA-approved protein kinase inhibitor, sunitinib, which has activity against DLK and LZK, is able to produce similar increases in RGC survival. Conclusion The mitogen-activated kinase kinase kinases (MAP3Ks), DLK and LZK, participate in cell death signaling of CNS neurons in response to TBI. Moreover, sustained pharmacologic inhibition of DLK is neuroprotective, an effect creating an opportunity to potentially translate these findings to patients with TBI.	[Welsbie, Derek S.; Patel, Amit K.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92037 USA; [Welsbie, Derek S.; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ziogas, Nikolaos K.; Xu, Leyan; Ge, Yusong; Ryu, Jiwon; Alexandris, Athanasios S.; Stewart, Nicholas; Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Neuropathol, Baltimore, MD 21205 USA; [Kim, Byung-Jin; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Lehar, Mohamed] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD 21205 USA; [Koliatsos, Vassilis E.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Welsbie, DS (corresponding author), Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92037 USA.; Welsbie, DS; Koliatsos, VE (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.	dwelsbie@ucsd.edu; donzack@gmail.com; koliat@jhmi.edu		Alexandris, Athanasios/0000-0002-5324-8355; Ryu, Jiwon/0000-0003-0251-7858	Ziegler Career Development Award; Research to Prevent Blindness Career Development AwardResearch to Prevent Blindness (RPB); DoD Vision Research Program Translational Research Award; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY029342-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5P30EY001765]; BrightFocus FoundationBrightFocus Foundation; Department of DefenseUnited States Department of Defense [W81XWH-14-0396]; Guerrieri Family Foundation; State of Maryland [TEDCO 2015-MSCRFI-1718]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1EY028039]; Sidran Family Foundation; Spyros N. Lemos Memorial Fund; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY028039, R01EY029342] Funding Source: NIH RePORTER	D.S.W. received funding from the Ziegler Career Development Award, Research to Prevent Blindness Career Development Award, DoD Vision Research Program Translational Research Award and NEI R01EY029342-01. D.J.Z. received funding from NIH (including core grant 5P30EY001765), Research to Prevent Blindness, BrightFocus Foundation, the Department of Defense, and the Guerrieri Family Foundation. V.E.K received funding from the Department of Defense W81XWH-14-0396, State of Maryland TEDCO 2015-MSCRFI-1718, National Institutes of Health RO1EY028039, the Sidran Family Foundation, and the Spyros N. Lemos Memorial Fund. In all cases, the funding agencies were not involved in the acquisition, analysis, interpretation and/or presentation/reporting of data.	Adams JH, 1982, ATLAS POSTMORTEM TEC; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Fernandes KA, 2014, NEUROBIOL DIS, V69, P108, DOI 10.1016/j.nbd.2014.05.015; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frieden TR, 2015, CDC REPORT C TRAUMAT; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Holland SM, 2016, P NATL ACAD SCI USA, V113, P763, DOI 10.1073/pnas.1514123113; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lim JHA, 2016, NAT NEUROSCI, V19, P1073, DOI 10.1038/nn.4340; Lobato RD, 2008, NEUROCIRUGIA, V19, P456; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Raghava Narayan, 2017, Neurosci Neuroecon, V6, P15, DOI 10.2147/NAN.S105134; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Shin JE, 2012, P NATL ACAD SCI USA, V109, pE3696, DOI 10.1073/pnas.1216204109; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Summers DW, 2018, P NATL ACAD SCI USA, V115, pE8746, DOI 10.1073/pnas.1806933115; Suzuki S, 2006, ENDOCRINE, V29, P209, DOI 10.1385/ENDO:29:2:209; Tang SC, 2012, INT J CANCER, V130, P223, DOI 10.1002/ijc.26000; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Welsbie DS, 2017, NEURON, V94, P1142, DOI 10.1016/j.neuron.2017.06.008; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Whitmore AV, 2005, PROG RETIN EYE RES, V24, P639, DOI 10.1016/j.preteyeres.2005.04.004; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	43	5	5	3	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1750-1326		MOL NEURODEGENER	Mol. Neurodegener.	NOV 27	2019	14	1							44	10.1186/s13024-019-0345-1			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT5GM	WOS:000501018200002	31775817	Green Published, gold			2022-02-06	
J	Trevena-Peters, J; McKay, A; Ponsford, J				Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie			Activities of daily living retraining and goal attainment during posttraumatic amnesia	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Activities of daily living; Goal attainment scaling; posttraumatic amnesia; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; CLINICALLY IMPORTANT CHANGE; REHABILITATION; MEMORY; DURATION; PEOPLE	It is uncertain whether therapy delivered during posttraumatic amnesia (PTA) following traumatic brain injury can be effective due to risk of agitation and poor learning capacity. This study used goal attainment scaling (GAS) to assess gains in activities of daily living (ADL) retraining during PTA. Occupational therapists? perspectives on goal setting and therapy delivery were also explored qualitatively. Forty-nine rehabilitation inpatients were provided with manualised ADL retraining following errorless and procedural learning principles during PTA. From 104 GAS goals, 90% were achieved at PTA emergence. GAS T-scores changed significantly (p?<?.001) from baseline (M?=?26.94, SD?=?4.90) to post-intervention (M?=?61.44, SD?=?11.45). Mean post-intervention T-scores correlated significantly (p?<?.001) with change in Functional Independence Measure scores. The four therapists reported that GAS was unfamiliar and time-consuming initially, although it aided goal-directed therapy and measurement of patient performance. Application of manualised skill retraining using errorless and procedural learning techniques was described as novel and challenging, but providing valuable structure. The intervention reportedly promoted therapeutic alliance, skill-building and meaningful time-use without elevating agitation, but fatigue impeded therapy. Overall, GAS captured positive individual change following ADL retraining during PTA and therapists indicated that the intervention and use of GAS was generally beneficial and feasible within clinical practice.	[Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, 185-187 Noddle St, Richmond, Vic 3121, Australia; [McKay, Adam] Epworth Healthcare, Richmond, Australia		Trevena-Peters, J (corresponding author), Monash Epworth Rehabil Res Ctr, 185-187 Noddle St, Richmond, Vic 3121, Australia.	jessica.trevena-peters@monash.edu	McKay, Adam/M-6003-2017; Ponsford, Jennie/H-8341-2014	McKay, Adam/0000-0002-0479-7681; Ponsford, Jennie/0000-0003-0430-125X	Epworth Research Institute Grant; William Buckland Foundation; Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research [N-13-089]	Financial support was provided by Epworth Research Institute Grant; William Buckland Foundation Grant; Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research (grant no: N-13-089) but parties did not participate in design or write-up of the study.	Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cohen J., 2013, STAT POWER ANAL BEHA; Cole MB, 2003, OCCUP THER MENT HLTH, V19, P33, DOI DOI 10.1300/J004V19N02_03; Connor-Smith Jennifer K, 2003, Child Adolesc Ment Health, V8, P3, DOI 10.1111/1475-3588.00038; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Doble Susan E, 2008, Can J Occup Ther, V75, P184; Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1993, BRAIN INJURY REHABIL; Glisky EL, 1996, J HEAD TRAUMA REHAB, V11, P31, DOI 10.1097/00001199-199604000-00004; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Langhorn L, 2015, J NEUROSCI NURS, V47, pE2, DOI 10.1097/JNN.0000000000000106; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Palmadottir G., 2006, BR J OCCUP THER, V69, P394, DOI DOI 10.1177/030802260606900902; Pearson K. VII., 1997, P R SOC LOND, V58, P240, DOI [10.1098/rspl.1895.0041, 10.1098/RSPL.1895.0041]; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; ROCKWOOD K, 1993, J CLIN EPIDEMIOL, V46, P1113, DOI 10.1016/0895-4356(93)90110-M; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; SCHUT HA, 1994, DISABIL REHABIL, V16, P223, DOI 10.3109/09638289409166616; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Steenbeek D, 2008, CHILD CARE HLTH DEV, V34, P521, DOI 10.1111/j.1365-2214.2008.00841.x; Symonds CP, 1943, LANCET, V1, P7; TERRACE HS, 1963, SCIENCE, V140, P318, DOI 10.1126/science.140.3564.318; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; World Health Organization, 2007, INT CLASS FUNCT DIS	48	5	5	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	NOV 26	2019	29	10					1655	1670		10.1080/09602011.2018.1441033			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9UD	WOS:000488925000009	29516771				2022-02-06	
J	Christensen, J; Yamakawa, GR; Salberg, S; Wang, MLD; Kolb, B; Mychasiuk, R				Christensen, Jennaya; Yamakawa, Glenn R.; Salberg, Sabrina; Wang, Melinda; Kolb, Bryan; Mychasiuk, Richelle			Caffeine consumption during development alters spine density and recovery from repetitive mild traumatic brain injury in young adult rats	SYNAPSE			English	Article						adolescent; behavior; concussion; dendritic morphology; Golgi-Cox staining; nucleus accumbens; prefrontal cortex	ANXIETY-RELATED BEHAVIOR; PREFRONTAL CORTEX; GENE-EXPRESSION; NUCLEUS-ACCUMBENS; DENDRITIC SPINES; SEX-DIFFERENCES; SLEEP; MODEL; AMPHETAMINE; DISEASE	Caffeine is the most commonly used psychostimulant throughout the world, with its consumption being especially prevalent among adolescents and young adults, as over 75% of this group consumes caffeine daily. Similarly, the adolescent and young adult age group exhibit the highest incidence of traumatic brain injury (TBI). Given that both caffeine consumption and mild TBI (mTBI) are more prevalent among the late adolescent/young adult age group and that changes in dendritic spine morphology during this developmental period are poorly understood, this study sought to examine the effects of caffeine consumption during late adolescence/early adulthood on recovery from repetitive mTBI (RmTBI). The study specifically focused on changes to neuronal dendritic morphology as synaptic changes likely underlie long-term behavioral outcomes. The results demonstrate that during young adulthood caffeine consumption differentially affects the RmTBI outcomes of males and females, where the effects of caffeine and RmTBI were often additive in males while being equally detrimental, but rarely additive, in females. In general, caffeine and RmTBI induced the greatest impairments in males on cognitive and motor tasks whereas in females the most significant detriments were on pain-related tasks. Both caffeine and RmTBI increased spine density in the Cg3 (medial prefrontal cortex [mPFC]), AID (orbitofrontal cortex [OFC]), and nucleus accumbens (NAc), which is proposed to reflect an impairment in the normal pruning processes. Overall, despite caffeine's neuroprotective abilities among other age groups, this study offers concerning results regarding the detrimental effects of caffeine and RmTBI, in isolation, and especially in combination, in this susceptible population.	[Christensen, Jennaya; Wang, Melinda; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Christensen, Jennaya; Yamakawa, Glenn R.; Salberg, Sabrina; Mychasiuk, Richelle] Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia; [Kolb, Bryan] Univ Lethbridge, Dept Neurosci, Lethbridge, AB, Canada; [Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	Richelle.mychasiuk@monash.edu		Yamakawa, Glenn/0000-0003-3079-6532; Kolb, Bryan/0000-0002-2576-0642; Mychasiuk, Richelle/0000-0001-5291-5083	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Foundation; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	Canadian Institutes of Health Research; Alberta Children's Hospital Foundation; Natural Sciences and Engineering Research Council of Canada	Acosta-Pena E, 2015, SYNAPSE, V69, P15, DOI 10.1002/syn.21779; Ardais AP, 2014, NEUROSCIENCE, V270, P27, DOI 10.1016/j.neuroscience.2014.04.003; Ballesteros-Yanez Inmaculada, 2012, J Caffeine Res, V2, P90, DOI 10.1089/jcr.2012.0011; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Campana G., 2014, METHODS MOL BIOL OPI, P229; Casey BJ, 2008, DEV REV, V28, P62, DOI 10.1196/annals.1440.010; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen YW, 2018, SYNAPSE, V72, DOI 10.1002/syn.22034; Cognato GP, 2010, J NEUROCHEM, V112, P453, DOI 10.1111/j.1471-4159.2009.06465.x; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Doyle LW, 2010, ANN NEUROL, V68, P734, DOI 10.1002/ana.22098; Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027; Frith C, 2003, NOVART FDN SYMP, V251, P149; Ghoneim FM, 2015, INT J CLIN EXP PATHO, V8, P7710; Gibb R, 1998, J NEUROSCI METH, V79, P1, DOI 10.1016/S0165-0270(97)00163-5; Greenough WT, 1988, CEREB CORTEX, P391, DOI DOI 10.1007/978-1-4615-6619-9_11; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; James JE, 2011, J ADOLESCENCE, V34, P665, DOI 10.1016/j.adolescence.2010.09.006; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; KESHAVAN MS, 1994, J PSYCHIATR RES, V28, P239, DOI 10.1016/0022-3956(94)90009-4; Kolb B, 2003, CURR DIR PSYCHOL SCI, V12, P1, DOI 10.1111/1467-8721.01210; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; Kolb B., 2015, FUNDAMENTALS HUMAN N; LANDOLT HP, 1995, NEUROPSYCHOPHARMACOL, V12, P229, DOI 10.1016/0893-133X(94)00079-F; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lara DR, 2010, J ALZHEIMERS DIS, V20, pS239, DOI 10.3233/JAD-2010-1378; Laurent C, 2014, NEUROBIOL AGING, V35, P2079, DOI 10.1016/j.neurobiolaging.2014.03.027; Lenroot RK, 2010, BRAIN COGNITION, V72, P46, DOI 10.1016/j.bandc.2009.10.008; Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R., 2018, J NEUROTRAUM, V35, P1; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; National Sleep Foundation, 2006, 2006 SLEEP AM POLL S; NICHOLSON AN, 1980, BRIT J CLIN PHARMACO, V9, P195, DOI 10.1111/j.1365-2125.1980.tb05833.x; O'Neill CE, 2016, PSYCHONEUROENDOCRINO, V67, P40, DOI 10.1016/j.psyneuen.2016.01.030; OKUMA T, 1982, PSYCHOPHARMACOLOGY, V76, P201, DOI 10.1007/BF00432545; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Rath M, 2012, J AM ACAD NURSE PRAC, V24, P70, DOI 10.1111/j.1745-7599.2011.00689.x; Richards G, 2015, J PSYCHOPHARMACOL, V29, P1236, DOI 10.1177/0269881115612404; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 1997, J NEUROSCI, V17, P8491; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Sala C, 2014, PHYSIOL REV, V94, P141, DOI 10.1152/physrev.00012.2013; Salberg S, 2017, NEUROSCIENCE, V365, P146, DOI 10.1016/j.neuroscience.2017.09.053; Sawynok J, 2011, PAIN, V152, P726, DOI 10.1016/j.pain.2010.10.011; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001; Trapp GSA, 2014, DEPRESS ANXIETY, V31, P420, DOI 10.1002/da.22175; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vila-Luna S, 2012, NEUROSCIENCE, V202, P384, DOI 10.1016/j.neuroscience.2011.11.053; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Warzak WJ, 2011, J PEDIATR-US, V158, P508, DOI 10.1016/j.jpeds.2010.11.022; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yoshimura Hiroshi, 2005, Current Neuropharmacology, V3, P309, DOI 10.2174/157015905774322543; Zilles K., 1985, CORTEX RAT STEREOTAX	70	5	5	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	APR	2020	74	4							e22142	10.1002/syn.22142		NOV 2019	13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KI4TA	WOS:000498175600001	31705690				2022-02-06	
J	Lah, S; Phillips, NL; Palermo, TM; Bartlett, D; Epps, A; Teng, A; Brookes, N; Parry, L; Naismith, SL				Lah, Suncica; Phillips, Natalie L.; Palermo, Tonya M.; Bartlett, Delwyn; Epps, Adrienne; Teng, Arthur; Brookes, Naomi; Parry, Louise; Naismith, Sharon L.			A feasibility and acceptability study of cognitive behavioural treatment for insomnia in adolescents with traumatic brain injury: A-B with follow up design, randomized baseline, and replication across participants	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Sleep; therapy; insomnia; brain injury; adolescents	QUALITY-OF-LIFE; MULTIDIMENSIONAL FATIGUE SCALE; GENERIC CORE SCALES; SLEEP DISTURBANCES; CEREBRAL-PALSY; YOUNG-CHILDREN; SEVERITY INDEX; INTERVENTIONS; METAANALYSIS; RELIABILITY	Difficulties falling asleep or staying asleep (symptoms of insomnia) are common following paediatric traumatic brain injury (TBI). Yet, interventions to treat insomnia in this population have not yet been reported. This single-case series examined the feasibility and acceptability of cognitive behavioral treatment for insomnia (CBT-I) for adolescents (n = 5, aged 11-13 years) with TBI, and explored changes in sleep and fatigue post-treatment. Adolescents were randomly assigned to two conditions: a 7- or 14-days baseline, followed by 4 weeks of manualised CBT-I delivered individually. To assess feasibility and acceptability we compared recruitment and retention rates, and questionnaire scores to a-priori set criteria. We explored treatment efficacy and functional gains in sleep and fatigue from baseline to follow-up using structured visual analysis of time-series graphs, and reliable change indices or changes in clinical classification. Feasibility and acceptability indicators met a-priori criteria, but therapists noticed limited adolescent engagement in sessions. Clinically significant improvements were found in sleep, in 3 out of 4 cases, and fatigue, in all cases. Our study provides preliminary evidence that CBT-I is feasible for insomnia treatment in adolescents with TBI and provides directions for development of future treatment studies.	[Lah, Suncica; Phillips, Natalie L.; Naismith, Sharon L.] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Palermo, Tonya M.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Bartlett, Delwyn] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia; [Epps, Adrienne; Brookes, Naomi; Parry, Louise] Sydney Childrens Hosp, Brain Injury Rehabil, Randwick, NSW, Australia; [Teng, Arthur] Sydney Childrens Hosp, Dept Sleep Med, Randwick, NSW, Australia; [Teng, Arthur] Univ New South Wales, Fac Med, Sydney, NSW, Australia		Lah, S (corresponding author), Brain & Mind Ctr, Sch Psychol, Clin Psychol Unit, 94 Mallet St, Camperdown, NSW 20150, Australia.	suncica.lah@sydney.edu.au		Palermo, Tonya/0000-0001-6036-6715; Phillips, Natalie/0000-0001-7505-9670; Naismith, Sharon/0000-0001-9076-2778	School of Psychology, University of Sydney; ARC Centre of Excellence in Cognition and its Disorder, Australian Research CouncilAustralian Research Council	The project was in part funded by the Seed Grant awarded by the School of Psychology, University of Sydney and by the ARC Centre of Excellence in Cognition and its Disorder, Australian Research Council.	Arnold DM, 2009, CRIT CARE MED, V37, pS69, DOI 10.1097/CCM.0b013e3181920e33; Auerbach C, 2013, RES SOCIAL WORK PRAC, V23, P346, DOI 10.1177/1049731513477213; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Beaulieu-Bonneau S, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx002; Berrin SJ, 2007, J PEDIATR PSYCHOL, V32, P330, DOI 10.1093/jpepsy/jsl017; Bogdanov S, 2019, J HEAD TRAUMA REHAB, V34, P122, DOI 10.1097/HTR.0000000000000426; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Bruni O, 1996, J SLEEP RES, V5, P251, DOI 10.1111/j.1365-2869.1996.00251.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Campos-Melady M, 2012, ADDICT BEHAV, V37, P60, DOI 10.1016/j.addbeh.2011.08.010; CARTER BD, 1995, PEDIATRICS, V95, P179; Chung KF, 2011, SLEEP MED, V12, P463, DOI 10.1016/j.sleep.2010.09.019; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; de Bruin EJ, 2015, SLEEP, V38, P1913, DOI 10.5665/sleep.5240; de la Vega R, 2015, PSYCHOL ASSESSMENT, V27, pE22, DOI 10.1037/pas0000128; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Gast D. L., 2010, SINGLE CASE RES METH, P199; HUITEMA BE, 1994, PERCEPT MOTOR SKILL, V78, P323, DOI 10.2466/pms.1994.78.1.323; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; KELLEY ML, 1989, J PSYCHOPATHOL BEHAV, V11, P235, DOI 10.1007/BF00960495; Keshavarzi Z, 2014, WORLD J BIOL PSYCHIA, V15, P609, DOI 10.3109/15622975.2014.922698; Koffel EA, 2015, SLEEP MED REV, V19, P6, DOI 10.1016/j.smrv.2014.05.001; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Meltzer LJ, 2014, J PEDIATR PSYCHOL, V39, P932, DOI 10.1093/jpepsy/jsu041; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Morgenthaler TI, 2006, SLEEP, V29, P1277; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Moss AHB, 2014, J AUTISM DEV DISORD, V44, P1695, DOI 10.1007/s10803-014-2040-y; MURTAGH DRR, 1995, J CONSULT CLIN PSYCH, V63, P79, DOI 10.1037/0022-006X.63.1.79; Nagane M, 2004, PSYCHOL REP, V95, P48, DOI 10.2466/PR0.95.5.48-52; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Palermo TM, 2016, CLIN PRACT PEDIAT PS, V4, P214, DOI DOI 10.1037/CPP0000140; Palermo TM, 2017, J CLIN SLEEP MED, V13, P401, DOI 10.5664/jcsm.6490; Parker RI, 2011, BEHAV THER, V42, P284, DOI 10.1016/j.beth.2010.08.006; R Development Core Team, 2012, R LANG ENV STAT COMP; Ree M, 2017, SLEEP MED, V36, pS43, DOI 10.1016/j.sleep.2017.03.017; Romeiser-Logan L, 2017, DEV MED CHILD NEUROL, V59, P574, DOI 10.1111/dmcn.13405; Schlarb AA, 2011, NAT SCI SLEEP, V3, P13, DOI 10.2147/NSS.S14493; Shah SGS, 2006, INT J HEALTH CARE Q, V19, P500, DOI 10.1108/09526860610687619; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Sumpter R, 2011, BRAIN INJURY, V25, P1288, DOI 10.3109/02699052.2011.613090; Sumpter RE, 2013, J INT NEUROPSYCH SOC, V19, P829, DOI 10.1017/S1355617713000465; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Vannest KJ, 2015, J COUNS DEV, V93, P403, DOI 10.1002/jcad.12038; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428	54	5	5	2	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 16	2021	31	3					345	368		10.1080/09602011.2019.1693404		NOV 2019	24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QP1RY	WOS:000499738100001	31752595				2022-02-06	
J	Skains, RM; Kuppermann, N; Homme, JL; Kharbanda, AB; Tzimenatos, L; Louie, JP; Cohen, DM; Nigrovic, LE; Westphal, JJ; Shah, ND; Inselman, J; Ferrara, MJ; Herrin, J; Montori, VM; Hess, EP				Skains, Rachel M.; Kuppermann, Nathan; Homme, James L.; Kharbanda, Anupam B.; Tzimenatos, Leah; Louie, Jeffrey P.; Cohen, Daniel M.; Nigrovic, Lise E.; Westphal, Jessica J.; Shah, Nilay D.; Inselman, Jonathan; Ferrara, Michael J.; Herrin, Jeph; Montori, Victor M.; Hess, Erik P.			What is the effect of a decision aid in potentially vulnerable parents? Insights from the head CT choice randomized trial	HEALTH EXPECTATIONS			English	Article						decision aid; head trauma; paediatrics; shared decision making	HEALTH LITERACY; VALIDATION; QUESTIONS; MEDICINE; CHILDREN; TRUST; RACE	Objective To test the hypotheses that use of the Head CT Choice decision aid would be similarly effective in all parent/patient dyads but parents with high (vs low) numeracy experience a greater increase in knowledge while those with low (vs high) health literacy experience a greater increase in trust. Methods This was a secondary analysis of a cluster randomized trial conducted at seven sites. One hundred seventy-two clinicians caring for 971 children at intermediate risk for clinically important traumatic brain injuries were randomized to shared decision making facilitated by the DA (n = 493) or to usual care (n = 478). We assessed for subgroup effects based on patient and parent characteristics, including socioeconomic status (health literacy, numeracy and income). We tested for interactions using regression models with indicators for arm assignment and study site. Results The decision aid did not increase knowledge more in parents with high numeracy (P for interaction [P-int] = 0.14) or physician trust more in parents with low health literacy (P-int = 0.34). The decision aid decreased decisional conflict more in non-white parents (decisional conflict scale, -8.14, 95% CI: -12.33 to -3.95; P-int = 0.05) and increased physician trust more in socioeconomically disadvantaged parents (trust in physician scale, OR: 8.59, 95% CI: 2.35-14.83; P-int = 0.04). Conclusions Use of the Head CT Choice decision aid resulted in less decisional conflict in non-white parents and greater physician trust in socioeconomically disadvantaged parents. Decision aids may be particularly effective in potentially vulnerable parents.	[Skains, Rachel M.] Univ Alabama Birmingham, Dept Emergency Med, 619 19th St South, Birmingham, AL 35249 USA; [Kuppermann, Nathan; Tzimenatos, Leah] Univ Calif Davis, Sch Med, Univ Calif Davis Hlth, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Univ Calif Davis Hlth, Dept Pediat, Sacramento, CA 95817 USA; [Homme, James L.] Mayo Clin, Div Pediat Emergency Med, Dept Emergency Med, Rochester, MN USA; [Homme, James L.] Mayo Clin, Div Pediat Emergency Med, Dept Pediat, Rochester, MN USA; [Kharbanda, Anupam B.] Childrens Hosp & Clin Minnesota, Dept Pediat Emergency Med, Crit Care Serv, Minneapolis, MN USA; [Louie, Jeffrey P.] Univ Minnesota, Dept Pediat, Div Pediat Emergency Med, Minneapolis, MN 55455 USA; [Cohen, Daniel M.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH USA; [Nigrovic, Lise E.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Westphal, Jessica J.] Parent Representat, Rochester, MN USA; [Shah, Nilay D.] Mayo Clin, Div Hlth Care Policy & Res, Dept Hlth Sci Res, Coll Med, Rochester, MN USA; [Inselman, Jonathan] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Healthcare Del, Rochester, MN USA; [Ferrara, Michael J.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Emergency Med, Coll Med, Rochester, MN USA; [Ferrara, Michael J.] Mayo Clin, Div Trauma Crit Care & Gen Surg, Dept Surg, Coll Med, Rochester, MN USA; [Herrin, Jeph] Yale Univ, Sch Med, New Haven, CT USA; [Herrin, Jeph] Hlth Res & Educ Trust, Chicago, IL USA; [Montori, Victor M.] Mayo Clin, Knowledge & Evaluat Res Unit, Dept Internal Med, Rochester, MN USA; [Hess, Erik P.] Mayo Clin, Dept Emergency Med, Rochester, MN USA		Hess, EP (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, 619 19th St South, Birmingham, AL 35249 USA.	ehess@uabmc.edu		Skains, Rachel/0000-0003-2001-3899; Kharbanda, Anupam/0000-0001-5231-9855	Patient-Centered Outcomes Research Institute (PCORI) AwardPatient-Centered Outcomes Research Institute - PCORI [12-11-4435]	Research reported in this publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (Contract 12-11-4435). The views presented in this publication are solely the responsibility of the author(s) and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.	Brinkman WB, 2013, PATIENT EDUC COUNS, V93, P95, DOI 10.1016/j.pec.2013.04.009; Centers for Disease Control and Prevention, US PUBL HLTH SERV SY; Chew LD, 2004, FAM MED, V36, P588; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Coylewright M, 2014, CIRC-CARDIOVASC QUAL, V7, P360, DOI 10.1161/HCQ.0000000000000006; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Hess EP, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-253; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Knapp C, 2014, J PALLIAT MED, V17, P559, DOI 10.1089/jpm.2013.0604; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; OCONNOR AM, 1995, MED DECIS MAKING, V15, P25, DOI 10.1177/0272989X9501500105; Peek ME, 2013, HEALTH COMMUN, V28, P616, DOI 10.1080/10410236.2012.710873; Rising KL, 2018, MED DECIS MAKING, V38, P69, DOI 10.1177/0272989X17706363; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shea JA, 2004, FAM MED, V36, P575; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Thom DH, 1999, MED CARE, V37, P510, DOI 10.1097/00005650-199905000-00010; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wyatt KD, 2015, ACAD PEDIATR, V15, P573, DOI 10.1016/j.acap.2015.03.011	23	5	5	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1369-6513	1369-7625		HEALTH EXPECT	Health Expect.	FEB	2020	23	1					63	74		10.1111/hex.12965		NOV 2019	12	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	KF8RL	WOS:000498040200001	31758633	Green Published, gold			2022-02-06	
J	Maze, M; Laitio, T				Maze, Mervyn; Laitio, Timo			Neuroprotective Properties of Xenon	MOLECULAR NEUROBIOLOGY			English	Article						Xenon; Neuroprotection; Medical application	CEREBRAL-BLOOD-FLOW; HOSPITAL CARDIAC-ARREST; INHALED XENON; COMATOSE SURVIVORS; GENERAL-ANESTHESIA; NITROUS-OXIDE; STABLE XENON; DAMAGE; SAFETY; NEUROTOXICITY	Xenon is a rare noble gas that was introduced into clinical practice more than 70 years ago. Xenon's clinical properties are predicated by its ability to fit into preformed cavities of macromolecules thereby altering their biological functions. One such action targets the NMDA-subtype of the glutamate receptors thereby inhibiting its excitatory action. As the glutamate receptors are pivotal for both anesthesia and acute neurological injury, its clinical use has included both general anesthesia as well as neuroprotection. In this manuscript, the efficacy and safety of xenon in clinical trials that address both the anesthetic and neuroprotective applications are discussed. Because of the clinical safety of this chemically inert monatomic gas, the lack of an alternative for neuroprotection, and encouraging phase 2 trial data, a multinational pivotal randomized clinical trial (XePOHCAS) has been launched to assess the utility of xenon for patients that have been successfully resuscitated following an out of hospital cardiac arrest but still remain comatose, indicating ongoing neurological ischemic-perfusion injury. If successful, the trial will herald a new era of treatments for previously intractable conditions such as traumatic brain injury, ischemic and hemorrhagic strokes, and anesthetic-induced developmental neurotoxicity.	[Maze, Mervyn] UCSF, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA; [Laitio, Timo] Univ Turku, Turku Univ Hosp, Div Perioperat Serv Intens Care Med & Pain Manage, Turku, Finland		Maze, M (corresponding author), UCSF, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA.	Mervyn.Maze@ucsf.edu					Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; [Anonymous], 2016, BR J ANAESTH; Arola O, 2017, J AM COLL CARDIOL, V70, P2652, DOI 10.1016/j.jacc.2017.09.1088; Arola OJ, 2013, CRIT CARE MED, V41, P2116, DOI 10.1097/CCM.0b013e31828a4337; Azzopardi D, 2013, ARCH DIS CHILD-FETAL, V98, pF437, DOI 10.1136/archdischild-2013-303786; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Baumert JH, 2005, BRIT J ANAESTH, V95, P166, DOI 10.1093/bja/aei153; BOOMSMA F, 1990, ANAESTHESIA, V45, P273, DOI 10.1111/j.1365-2044.1990.tb14731.x; CHOI DW, 1988, J NEUROSCI, V8, P185; Coburn M, 2005, BRIT J ANAESTH, V94, P198, DOI 10.1093/bja/aei023; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dingley J, 2001, ANAESTHESIA, V56, P829, DOI 10.1046/j.1365-2044.2001.02139.x; Dmochowski I, 2009, NAT CHEM, V1, P250, DOI 10.1038/nchem.230; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Fries M, 2008, CRIT CARE MED, V36, P2420, DOI 10.1097/CCM.0b013e3181802874; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; GILLER CA, 1990, AM J NEURORADIOL, V11, P177; Goto T, 2004, ANAESTHESIA, V59, P1178, DOI 10.1111/j.1365-2044.2004.03900.x; Goto T, 1998, BRIT J ANAESTH, V80, P255, DOI 10.1093/bja/80.2.255; Gruss M, 2004, MOL PHARMACOL, V66, P530; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Laitio RM, 2007, ANESTHESIOLOGY, V106, P1128, DOI 10.1097/01.anes.0000267596.57497.92; Laitio RM, 2009, ANESTH ANALG, V108, P593, DOI 10.1213/ane.0b013e31818ffc9d; Law LSC, 2016, ANESTH ANALG, V122, P678, DOI 10.1213/ANE.0000000000000914; Lo EAG, 2016, BRIT J ANAESTH, V116, P880, DOI 10.1093/bja/aew131; Lockwood GG, 2006, ANESTHESIOLOGY, V104, P458, DOI 10.1097/00000542-200603000-00012; LUTTROPP HH, 1993, ANAESTHESIA, V48, P1045; Ma DQ, 2009, J AM SOC NEPHROL, V20, P713, DOI 10.1681/ASN.2008070712; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Martin JL, 2007, BRIT J ANAESTH, V98, P236, DOI 10.1093/bja/ael340; Nagata A, 2001, ANESTH ANALG, V92, P362, DOI 10.1213/00000539-200102000-00016; Petzelt C, 2003, LIFE SCI, V72, P1909, DOI 10.1016/S0024-3205(02)02439-6; PLOUGMANN J, 1994, J NEUROSURG, V81, P822, DOI 10.3171/jns.1994.81.6.0822; Rex S, 2006, ANESTHESIOLOGY, V105, P936, DOI 10.1097/00000542-200611000-00014; Rossaint R, 2003, ANESTHESIOLOGY, V98, P6, DOI 10.1097/00000542-200301000-00005; Stoppe C, 2016, SPORTS MED, V46, P1753, DOI 10.1007/s40279-016-0505-1; Wappler F, 2007, ANESTHESIOLOGY, V106, P463, DOI 10.1097/00000542-200703000-00010; Wilhelm S, 2002, ANESTHESIOLOGY, V96, P1485, DOI 10.1097/00000542-200206000-00031	41	5	6	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2020	57	1			SI		118	124		10.1007/s12035-019-01761-z		NOV 2019	7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KV1HZ	WOS:000498742100003	31758401	Green Submitted			2022-02-06	
J	Zhai, BP; Zhai, SY; Hao, RL; Xu, JJ; Liu, ZH				Zhai, Baoping; Zhai, Shuyang; Hao, Ruilin; Xu, Jianjun; Liu, Zhi-hong			A FRET-based two-photon probe for in vivo tracking of pH during a traumatic brain injury process	NEW JOURNAL OF CHEMISTRY			English	Article							RATIOMETRIC FLUORESCENT-PROBE; UP-CONVERSION NANOPROBE; OXIDATIVE STRESS; LIVING CELLS; CONSTRUCTION; MITOCHONDRIA; HYPOCHLORITE; DESIGN; HCLO; SO2	The traumatic brain injury (TBI) process, a significant cause of neurodegenerative diseases, is generally thought to be accompanied by a decrease in pH of the intracellular environment. In this work, a fluorescence resonance energy transfer (FRET)-based ratiometric two-photon fluorescent pH probe, FRET-pH, has been designed and fully characterized to monitor the pH change so as to understand the extent of the TBI process. FRET-pH, which has nearly 100% energy transfer efficiency and similar to 100-fold ratio signal changes, is constructed from a naphthalene derivative ADN as a two-photon fluorophore and SRhB as a recognition domain for pH. FRET-pH displays both one- and two-photon ratiometric responses towards pH in aqueous solution. The appropriate pK(a) value (5.89) supports its use in subsequent biological applications. Finally, two-photon microscopic imaging of pH in living HeLa cells, BV-2 cells and rat brain tissue has been achieved.	[Zhai, Baoping; Hao, Ruilin; Xu, Jianjun] Xinzhou Teachers Univ, Dept Chem, Xinzhou 034000, Shanxi, Peoples R China; [Zhai, Shuyang; Liu, Zhi-hong] Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Hubei, Peoples R China		Zhai, BP (corresponding author), Xinzhou Teachers Univ, Dept Chem, Xinzhou 034000, Shanxi, Peoples R China.; Liu, ZH (corresponding author), Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Hubei, Peoples R China.	bpzhai@aliyun.com; zhhliu@whu.edu.cn			Key Disciplines Construction Foundation of Xinzhou Teachers University [XK201305]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21575109]	This work has been financially supported by the Key Disciplines Construction Foundation of Xinzhou Teachers University (XK201305) and the National Natural Science Foundation of China (21575109). All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Hunan University, and experiments were approved by the Animal Ethics Committee of the College of Biology (Hunan University).	Andre-Levigne D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102149; Bao WX, 2018, EXPERT REV MOL DIAGN, V18, P761, DOI 10.1080/14737159.2018.1471985; Chao JB, 2018, NEW J CHEM, V42, P3322, DOI 10.1039/c7nj03903d; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Ding SS, 2015, ANALYST, V140, P4687, DOI [10.1039/c5an00465a, 10.1039/C5AN00465A]; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Dou K, 2017, BIOMATERIALS, V133, P82, DOI 10.1016/j.biomaterials.2017.04.024; Duan C, 2019, ANAL CHEM, V91, P4172, DOI 10.1021/acs.analchem.9b00224; Fan JL, 2013, CHEM SOC REV, V42, P29, DOI 10.1039/c2cs35273g; Han XY, 2018, BIOMATERIALS, V156, P134, DOI 10.1016/j.biomaterials.2017.11.039; Han XY, 2017, CHEM SCI, V8, P6991, DOI 10.1039/c7sc02888a; Han XY, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201700769; Han XY, 2016, CHEM SCI, V7, P5098, DOI 10.1039/c6sc00838k; Hu Q, 2018, DYES PIGMENTS, V149, P253, DOI 10.1016/j.dyepig.2017.10.002; Hu W, 2016, ANALYST, V141, P5450, DOI 10.1039/c6an00905k; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim HM, 2015, CHEM REV, V115, P5014, DOI 10.1021/cr5004425; Lee MH, 2015, CHEM SOC REV, V44, P4185, DOI 10.1039/c4cs00280f; Li RQ, 2017, BIOSENS BIOELECTRON, V87, P73, DOI 10.1016/j.bios.2016.08.008; LI Y, 2017, ADV OPT MATER, V5; Li Z, 2015, J AM CHEM SOC, V137, P11179, DOI 10.1021/jacs.5b06972; Li Z, 2015, J AM CHEM SOC, V137, P3421, DOI 10.1021/jacs.5b01504; Liu Y, 2016, J AM CHEM SOC, V138, P12368, DOI 10.1021/jacs.6b04048; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Mao ZQ, 2018, CHEM SCI, V9, P6035, DOI 10.1039/c8sc01697f; Mao ZQ, 2017, ANAL CHEM, V89, P9620, DOI 10.1021/acs.analchem.7b02697; Mao ZQ, 2017, CHEM SCI, V8, P4533, DOI 10.1039/c7sc00416h; Mao ZQ, 2016, CHEM SCI, V7, P5230, DOI 10.1039/c6sc01313a; Mao ZQ, 2015, SENSOR ACTUAT B-CHEM, V219, P179, DOI 10.1016/j.snb.2015.05.024; Mao ZQ, 2014, ANAL CHEM, V86, P6548, DOI 10.1021/ac501947v; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Tao L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00657; Wang YF, 2017, J LUMIN, V192, P297, DOI 10.1016/j.jlumin.2017.06.033; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wu WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25315; Xiao Y, 2015, ANGEW CHEM INT EDIT, V54, P5323, DOI 10.1002/anie.201500008; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Ye XX, 2019, SMALL, V15, DOI 10.1002/smll.201901673; Yin K, 2015, BIOSENS BIOELECTRON, V74, P156, DOI 10.1016/j.bios.2015.06.039; Zeng LY, 2018, ANAL CHEM, V90, P1317, DOI 10.1021/acs.analchem.7b04191; Zeng LY, 2015, ANAL CHEM, V87, P3004, DOI 10.1021/acs.analchem.5b00172; Zeng LY, 2014, CHEM COMMUN, V50, P11139, DOI 10.1039/c4cc05010j; Zhai BP, 2017, ANALYST, V142, P1545, DOI 10.1039/c7an00058h; Zhang YL, 2018, J NEUROTRAUM, V35, P661, DOI 10.1089/neu.2017.5284; Zhang Z, 2017, SENSOR ACTUAT B-CHEM, V246, P293, DOI 10.1016/j.snb.2017.02.081; Zou H, 2018, CHINESE MED J-PEKING, V131, P2143, DOI 10.4103/0366-6999.240794	47	5	5	6	53	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1144-0546	1369-9261		NEW J CHEM	New J. Chem.	NOV 21	2019	43	43					17018	17022		10.1039/c9nj04049h			5	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Chemistry	JK4SI	WOS:000494834700029					2022-02-06	
J	Chiaravalloti, ND; Moore, NB; Weber, E; DeLuca, J				Chiaravalloti, Nancy D.; Moore, Nancy B.; Weber, Erica; DeLuca, John			The application of Strategy-based Training to Enhance Memory (STEM) in multiple sclerosis: A pilot RCT	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Cognitive rehabilitation; Cognitive functions; Daily life activities; Multiple sclerosis; Disease course	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; TREAT LEARNING IMPAIRMENT; COGNITIVE REHABILITATION; SELF-GENERATION; WORKING-MEMORY; DOUBLE-BLIND; RETRIEVAL PRACTICE; FUNCTIONAL-ACTIVITIES	New learning and memory (NLM) impairments are common in multiple sclerosis (MS), negatively impacting daily life. Few studies seek to remediate these deficits to improve everyday functioning. Self-generation, spaced learning and retrieval practice have been shown to improve NLM in healthy persons and have been incorporated into an 8-session treatment protocol, Strategy-based Training to Enhance Memory (STEM). STEM teaches participants about each of the techniques, how to apply them in daily life and provides practice. Participants are taught to restructure a memory-demanding situation to optimize self-generation, spaced learning and retrieval practice. This pilot double-blind, placebo-controlled, randomized clinical trial (RCT) tested the efficacy of STEM in 20 learning-impaired participants with clinically definite MS (9 treatment, 11 control). Significant treatment effects were noted on self-report measures of daily functioning (primary outcome). Objective neuropsychological testing approached significance, showing a medium-large effect on verbal NLM. Results suggest that STEM may improve everyday functioning in individuals with MS. A full-scale RCT is warranted to validate findings in a larger sample so that findings may be generalized to the broader MS community.	[Chiaravalloti, Nancy D.; Moore, Nancy B.; Weber, Erica; DeLuca, John] Kessler Fdn, Neuropsychol & Neurosci Lab, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Chiaravalloti, Nancy D.; Weber, Erica; DeLuca, John] Rutgers New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA; [DeLuca, John] Rutgers New Jersey Med Sch, Dept Neurol, Newark, NJ USA		Chiaravalloti, ND (corresponding author), Kessler Fdn, Neuropsychol & Neurosci Lab, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	nchiaravalloti@kesslerfoundation.org		DeLuca, John/0000-0003-3745-4156	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [PP1952]; Kessler Foundation	The authors would like to acknowledge grant support from the National Multiple Sclerosis Society (pilot grant #PP1952) to N. Chiaravalloti and Kessler Foundation. The funding agency did not have a role in: study design; collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the article for publication.	Amato MP, 2014, MULT SCLER J, V20, P91, DOI 10.1177/1352458513501571; [Anonymous], 1993, NEUROPSYCHOLOGY, V7, P364, DOI [DOI 10.1037/0894-4105.7.3.364, 10.1037/0894-4105.7.3.364]; Arango-Lasprilla J., 2009, J MINORITY DISABILIT, V1, P47; Audoin B, 2005, HUM BRAIN MAPP, V24, P216, DOI 10.1002/hbm.20083; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P63, DOI 10.1080/13803390601186957; Beatty WW, 1996, J CLIN EXP NEUROPSYC, V18, P56, DOI 10.1080/01688639608408262; Beatty WW, 1995, J NEUROL REHABIL, V9, P167; BEGG I, 1989, J EXP PSYCHOL LEARN, V15, P977, DOI 10.1037/0278-7393.15.5.977; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Benedict RHB, 2001, J NEUROPSYCH CLIN N, V13, P70, DOI 10.1176/appi.neuropsych.13.1.70; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Bergendal G, 2007, EUR NEUROL, V57, P193, DOI 10.1159/000099158; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Bottari C, 2014, AM J OCCUP THER, V68, P67, DOI 10.5014/ajot.2014.008987; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Challis B H, 1993, Memory, V1, P127, DOI 10.1080/09658219308258228; CHALLIS BH, 1993, J EXP PSYCHOL LEARN, V19, P115, DOI 10.1037/0278-7393.19.1.115; Chiaravalloti ND, 2016, NEUROREHAB NEURAL RE, V30, P539, DOI 10.1177/1545968315604395; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2012, J NEUROL, V259, P1337, DOI 10.1007/s00415-011-6353-x; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coyne JH, 2015, ARCH PHYS MED REHAB, V96, P742, DOI 10.1016/j.apmr.2014.09.022; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; das Nair R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008754.pub2; Dawson DR, 2013, ARCH PHYS MED REHAB, V94, P1959, DOI 10.1016/j.apmr.2013.05.021; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; DeLuca J, 2004, J CLIN EXP NEUROPSYC, V26, P550, DOI 10.1080/13803390490496641; Denney DR, 2005, ARCH CLIN NEUROPSYCH, V20, P967, DOI 10.1016/j.acn.2005.04.012; Diamond BJ, 1997, J CLIN EXP NEUROPSYC, V19, P34, DOI 10.1080/01688639708403834; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Downes JJ, 1997, NEUROPSYCHOL REHABIL, V7, P195, DOI 10.1080/713755535; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Edgley K, 1991, CANADIAN J REHABILIT, V4, P127; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Foley FW, 1994, J NEUROLOGIC REHABIL, V8, P165, DOI [DOI 10.1177/136140969400800401, 10.1177/136140969400800401]; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; GASPARRINI B, 1979, Journal of Clinical Neuropsychology, V1, P137, DOI 10.1080/01688637908414447; Gentry T, 2008, BRAIN INJURY, V22, P19, DOI 10.1080/02699050701810688; GIANUTSOS R, 1980, J REHABIL, V46, P36; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; GILEWSKI MJ, 1990, PSYCHOL AGING, V5, P482, DOI 10.1037/0882-7974.5.4.482; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GODFREY HPD, 1985, J CONSULT CLIN PSYCH, V53, P555, DOI 10.1037/0022-006X.53.4.555; Goverover Y, 2007, MULT SCLER, V13, P636, DOI 10.1177/1352458506072984; Goverover Y., 2017, RANDOMIZED CONTROLLE, DOI [10.1177/1352458517709955, DOI 10.1177/1352458517709955]; Goverover Y, 2008, ARCH PHYS MED REHAB, V89, P1514, DOI 10.1016/j.apmr.2007.11.059; Goverover Y, 2018, ARCH PHYS MED REHAB, V99, P390, DOI 10.1016/j.apmr.2017.07.021; Goverover Y, 2016, ARCH PHYS MED REHAB, V97, P1901, DOI 10.1016/j.apmr.2016.05.003; Goverover Y, 2015, AM J OCCUP THER, V69, DOI 10.5014/ajot.2015.014332; Goverover Y, 2014, NEUROPSYCHOL REHABIL, V24, P155, DOI 10.1080/09602011.2013.868815; Goverover Y, 2013, J CLIN EXP NEUROPSYC, V35, P775, DOI 10.1080/13803395.2013.824553; Goverover Y, 2011, MULT SCLER J, V17, P1488, DOI 10.1177/1352458511406310; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; Goverover Y, 2009, AM J OCCUP THER, V63, P543, DOI 10.5014/ajot.63.5.543; Goverover Y, 2009, J CLIN EXP NEUROPSYC, V31, P513, DOI 10.1080/13803390802287042; Gracey F, 2017, NEUROREHAB NEURAL RE, V31, P323, DOI 10.1177/1545968316680484; GRAFMAN J, 1991, ARCH NEUROL-CHICAGO, V48, P1072, DOI 10.1001/archneur.1991.00530220094025; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; GRIGSBY J, 1994, J NEUROL, V241, P125; Grima DT, 2000, MULT SCLER J, V6, P91, DOI 10.1177/135245850000600207; Hallock H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00537; Hancock LM, 2015, J CLIN EXP NEUROPSYC, V37, P113, DOI 10.1080/13803395.2014.989818; Haslam C, 2011, J CLIN EXP NEUROPSYC, V33, P432, DOI 10.1080/13803395.2010.533155; Haslam C, 2010, J CLIN EXP NEUROPSYC, V32, P973, DOI 10.1080/13803391003662686; Hibino S, 2013, NEUROL MED-CHIR, V53, P299, DOI 10.2176/nmc.53.299; Hrabok M, 2013, PEDIATRICS, V131, pE525, DOI 10.1542/peds.2012-1428; Huiskamp M, 2016, MULT SCLER RELAT DIS, V7, P76, DOI 10.1016/j.msard.2016.03.012; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Janculjak D, 2002, CLIN NEUROL NEUROSUR, V104, P221, DOI 10.1016/S0303-8467(02)00042-2; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; Kalmar JH, 2008, NEUROPSYCHOLOGY, V22, P442, DOI 10.1037/0894-4105.22.4.442; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; KESSLER HR, 1992, INT J NEUROSCI, V62, P17, DOI 10.3109/00207459108999754; Kim YH, 2009, NEUROREHAB NEURAL RE, V23, P468, DOI 10.1177/1545968308328728; KRUG D, 1990, J EDUC PSYCHOL, V82, P366, DOI 10.1037/0022-0663.82.2.366; Kujala P, 1996, ACTA NEUROL SCAND, V93, P329; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Lannin N, 2014, CLIN REHABIL, V28, P470, DOI 10.1177/0269215513512216; Lazeron RHC, 2004, MULT SCLER, V10, P549, DOI 10.1191/1352458504ms1072oa; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; Lengenfelder J., 2002, J INT NEUROPSYCH SOC, V8, P173; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Leopold A, 2015, NEUROREHABILITATION, V37, P359, DOI 10.3233/NRE-151267; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136/jnnp.72.1.93; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P281, DOI 10.1001/archneur.1988.00520270059021; Lojovich JM, 2010, J HEAD TRAUMA REHAB, V25, P184, DOI 10.1097/HTR.0b013e3181dc78cd; Marsh EJ, 2001, MEM COGNITION, V29, P798, DOI 10.3758/BF03196409; McCabe JA, 2016, PSYCHOL SCI PUBL INT, V17, P187, DOI 10.1177/1529100616664716; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; Milders M, 1998, MEMORY, V6, P21, DOI 10.1080/741941597; MITCHELL DB, 1986, J GERONTOL, V41, P79, DOI 10.1093/geronj/41.1.79; Mousavi S, 2018, J CLIN EXP NEUROPSYC, V40, P405, DOI 10.1080/13803395.2017.1356269; Nagy H, 2006, J INT NEUROPSYCH SOC, V12, P559, DOI 10.1017/S1355617706060644; Neville IS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0944-2; O'Brien A, 2007, NEUROPSYCHOL REHABIL, V17, P273, DOI 10.1080/09602010600751160; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; Parmenter BA, 2007, J INT NEUROPSYCH SOC, V13, P417, DOI 10.1017/S1355617707070580; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; Pinkston J, 2008, TXB CLIN NEUROPSYCHO, P599; Piras F, 2011, EUR J PHYS REHAB MED, V47, P149; Plohmann A, 1994, Schweiz Arch Neurol Psychiatr (1985), V145, P35; Plohmann AM, 1998, J NEUROL NEUROSUR PS, V64, P455, DOI 10.1136/jnnp.64.4.455; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Powell LE, 2012, NEUROPSYCHOL REHABIL, V22, P85, DOI 10.1080/09602011.2011.640466; Rendell PG, 2007, J INT NEUROPSYCH SOC, V13, P410, DOI 10.1017/S1355617707070579; ROBERTSON IH, 1993, CURR OPIN NEUROL, V6, P756, DOI 10.1097/00019052-199310000-00013; Roediger HL, 2006, PERSPECT PSYCHOL SCI, V1, P181, DOI 10.1111/j.1745-6916.2006.00012.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rosti-Otajarvi E, 2013, J NEUROL SCI, V334, P154, DOI 10.1016/j.jns.2013.08.017; SLAMECKA NJ, 1983, J VERB LEARN VERB BE, V22, P153, DOI 10.1016/S0022-5371(83)90112-3; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Solso R. L., 1974, THEORIES COGNITIVE P; STAPLES D, 1979, RHEUMATOL REHABIL, V18, P153, DOI 10.1093/rheumatology/18.3.153; Stringer AY, 2011, BRAIN INJURY, V25, P169, DOI 10.3109/02699052.2010.541894; Stringer AY, 2003, CLIN NEUROPSYCHOL, V17, P34, DOI 10.1076/clin.17.1.34.15625; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Sumowski J., 2014, ARCH PHYS MED REHAB, V95, P297; Sumowski JF, 2013, MULT SCLER J, V19, P1943, DOI 10.1177/1352458513485980; Sumowski JF, 2010, J INT NEUROPSYCH SOC, V16, P1147, DOI 10.1017/S1355617710001128; Sumowski JF, 2010, NEUROPSYCHOLOGY, V24, P267, DOI 10.1037/a0017533; Thornton AE, 1997, NEUROPSYCHOLOGY, V11, P357, DOI 10.1037/0894-4105.11.3.357; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 1999, NEUROSCIENTIST, V5, P48, DOI 10.1177/107385849900500107; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Waid-Ebbs JK, 2014, J REHABIL RES DEV, V51, P1555, DOI 10.1682/JRRD.2013.12.0266; Weber E, 2012, J INT NEUROPSYCH SOC, V18, P128, DOI 10.1017/S135561771100124X; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; WILSON B, 1981, BEHAV PSYCHOTHER, V9, P338, DOI 10.1017/S0141347300008089; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON B, 1982, CORTEX, V18, P581, DOI 10.1016/S0010-9452(82)80055-5; Woods SP, 2015, AGING NEUROPSYCHOL C, V22, P679, DOI 10.1080/13825585.2015.1027651	156	5	5	1	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2021	31	2					231	254		10.1080/09602011.2019.1685550		NOV 2019	24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	QA9MZ	WOS:000497880500001	31752604				2022-02-06	
J	Deng, WK; Luo, F; Li, BM; Mei, L				Deng, Weike; Luo, Fei; Li, Bao-Ming; Mei, Lin			NRG1-ErbB4 signaling promotes functional recovery in a murine model of traumatic brain injury via regulation of GABA release	EXPERIMENTAL BRAIN RESEARCH			English	Article						NRG1-ErbB4 signaling; Traumatic brain injury; Neuroprotection; GABA	UP-REGULATION; RAT MODEL; NEUROPROTECTION; NEUREGULIN-1; ERBB4; RECEPTOR; SCHIZOPHRENIA; MILD; NEUROPATHOLOGY; NEUROBIOLOGY	Traumatic brain injury (TBI) is a serious health problem in the world. However, little is known about the pathogenesis and molecular mechanisms of TBI. Here, we show that TBI activates neuregulin 1 (NRG1)-ErbB4 signaling, with an increased expression of NRG1 and ErbB4 in the traumatic region. Specifically knocking out ErbB4 in parvalbumin-positive (PV+) interneurons exacerbates motor function deficits in mice after TBI. Consistently, PV-ErbB4(-/-) mice showed larger necrotic area and more edema when compared with PV-ErbB4(+/+) mice. Replenishment of NRG1 through intranasal application of the recombinant protein in PV-ErbB4(+/+) mice enhanced neurological function. Moreover, using an in vitro neuronal culture system, we found that NRG1-ErbB4 signaling protects neurons from glutamate-induced death, and such protective effects could be diminished by GABA receptor antagonist. These results indicate that NRG-ErbB4 signaling protects cortical neurons from TBI-induced damage, and such effect is probably mediated by promoting GABA activity. Taken together, these findings unveil a previously unappreciated role for NRG1-ErB4 signaling in preventing neuronal cell death during functional recovery after TBI.	[Deng, Weike; Li, Bao-Ming] Nanchang Univ, Sch Life Sci, 999 Xuefu Rd, Nanchang 330031, Jiangxi, Peoples R China; [Deng, Weike; Luo, Fei; Li, Bao-Ming] Nanchang Univ, Inst Life Sci, 999 Xuefu Rd, Nanchang 330031, Jiangxi, Peoples R China; [Mei, Lin] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Mei, Lin] Charlie Norwood VA Med Ctr, Augusta, GA 30912 USA		Luo, F (corresponding author), Nanchang Univ, Inst Life Sci, 999 Xuefu Rd, Nanchang 330031, Jiangxi, Peoples R China.	luofei@ncu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31971035, 81471116, 31771182, 81560196]; Natural Science Foundation of Jiangxi ProvinceNatural Science Foundation of Jiangxi Province [20171ACB20002]	This research was supported by the National Natural Science Foundation of China (31971035, 81471116, 31771182, 81560196), and the Natural Science Foundation of Jiangxi Province (20171ACB20002).	Adelson JD, 2012, NEURON, V73, P1100, DOI 10.1016/j.neuron.2012.01.020; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bean JC, 2014, J NEUROSCI, V34, P13549, DOI 10.1523/JNEUROSCI.2021-14.2014; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brickler TR, 2018, J NEUROSCI, V38, P9618, DOI 10.1523/JNEUROSCI.0914-18.2018; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Chen YJ, 2010, P NATL ACAD SCI USA, V107, P21818, DOI 10.1073/pnas.1010669107; Costa C, 2004, STROKE, V35, P596, DOI 10.1161/01.STR.0000113691.32026.06; DeFazio RA, 2009, J CEREBR BLOOD F MET, V29, P375, DOI 10.1038/jcbfm.2008.126; Dorsett CR, 2017, J NEUROTRAUM, V34, P263, DOI 10.1089/neu.2015.4373; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Guan YF, 2015, NEUROSCIENCE, V307, P151, DOI 10.1016/j.neuroscience.2015.08.047; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kim JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163433; Kozlovskaya L, 2014, J CONTROL RELEASE, V189, P133, DOI 10.1016/j.jconrel.2014.06.053; Li YG, 2007, BRAIN RES, V1184, P277, DOI 10.1016/j.brainres.2007.09.037; Li YG, 2012, TOXICOL APPL PHARM, V262, P194, DOI 10.1016/j.taap.2012.05.001; Lu YM, 2016, MOL NEUROBIOL, V53, P2600, DOI 10.1007/s12035-015-9275-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mayor D, 2018, NEUROPHARMACOLOGY, V134, P178, DOI 10.1016/j.neuropharm.2017.11.050; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Takada Y, 2003, J PHARMACOL EXP THER, V306, P772, DOI 10.1124/jpet.103.050104; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Xia YG, 2018, P NATL ACAD SCI USA, V115, pE9230, DOI 10.1073/pnas.1810693115; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Xu ZF, 2005, NEUROSCI LETT, V375, P181, DOI 10.1016/j.neulet.2004.11.039; Yang YJ, 2019, NEUROPSYCHOPHARMACOL, V44, P2054, DOI 10.1038/s41386-019-0437-1; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728	52	5	6	2	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	DEC	2019	237	12					3351	3362		10.1007/s00221-019-05680-2		NOV 2019	12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY3MM	WOS:000496199800001	31720762				2022-02-06	
J	Iboaya, A; Harris, JL; Arickx, AN; Nudo, RJ				Iboaya, Aiwane; Harris, Janna L.; Arickx, Alexandra Nielsen; Nudo, Randolph J.			Models of Traumatic Brain Injury in Aged Animals: A Clinical Perspective	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; aging; animal models; comorbidities; translation	CONTROLLED CORTICAL IMPACT; OLDER-ADULTS; CEREBROVASCULAR REACTIVITY; PERICONTUSIONAL CORTEX; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; PROGESTERONE; RATS; YOUNG; EXPRESSION	Traumatic brain injury (TBI) is a major cause of morbidity and mortality in the United States, with advanced age being one of the major predictors of poor prognosis. To replicate the mechanisms and multifaceted complexities of human TBI and develop prospective therapeutic treatments, various TBI animal models have been developed. These models have been essential in furthering our understanding of the pathophysiology and biochemical effects on brain mechanisms following TBI. Despite these advances, translating preclinical results to clinical application, particularly in elderly individuals, continues to be challenging. This review aims to provide a clinical perspective, identifying relevant variables currently not replicated in TBI animal models, to potentially improve translation to clinical practice, especially as it applies to elderly populations. As background for this clinical perspective, we reviewed articles indexed on PubMed from 1970 to 2019 that used aged animal models for studying TBI. These studies examined end points relevant for clinical translation, such as neurocognitive effects, sensorimotor behavior, physiological mechanisms, and efficacy of neuroprotective therapies. However, compared with the higher incidence of TBI in older individuals, animal studies on the basic science of aging and TBI remain remarkably scarce. Moreover, a fundamental disconnect remains between experiments in animal models of TBI and successful translation of findings for treating the older TBI population. In this article, we aim to provide a clinical perspective on the unique attributes of TBI in older individuals and a critical appraisal of the research to date on TBI in aged animal models as well as recommendations for future studies.	[Iboaya, Aiwane; Harris, Janna L.; Arickx, Alexandra Nielsen; Nudo, Randolph J.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA		Nudo, RJ (corresponding author), Univ Kansas, Med Ctr, Dept Phys Med & Rehabil, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	rnudo@kumc.edu		Nudo, Randolph/0000-0002-4674-0907	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS030853, R21 NS091920]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG058052, P30AG035982] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by funding from the National Institutes of Health Grants R01 NS030853 (RJN) and R21 NS091920 (JLH).	Albrecht JS, 2015, J NEUROTRAUM, V32, P1223, DOI 10.1089/neu.2014.3651; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Bragin DE, 2018, ACTA NEUROCHIR SUPPL, V126, P309, DOI 10.1007/978-3-319-65798-1_60; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caspersen CJ, 2012, AM J PUBLIC HEALTH, V102, P1482, DOI 10.2105/AJPH.2011.300616; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chentli Farida, 2015, Indian J Endocrinol Metab, V19, P744, DOI 10.4103/2230-8210.167553; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Cusack S, 2013, GERONTOLOGY, V59, P114, DOI 10.1159/000343158; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Dai JX, 2018, INT J NEUROSCI, V128, P243, DOI 10.1080/00207454.2017.1380008; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Davis A E, 2000, Crit Care Nurs Q, V23, P1; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Flurkey K, 2007, MOUSE BIOMEDICAL RES, V2, P637; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gupta RK, 2013, BIOGERONTOLOGY, V14, P531, DOI 10.1007/s10522-013-9459-y; Gupta RK, 2016, MOL NEUROBIOL, V53, P3377, DOI 10.1007/s12035-015-9287-y; Gupte R, 2019, BRAIN IMAGING BEHAV, V13, P461, DOI 10.1007/s11682-018-9865-5; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Harris JL, 2014, NEUROBIOL AGING, V35, P1686, DOI 10.1016/j.neurobiolaging.2014.01.018; Hawkins BE, 2013, BRAIN RES, V1496, P28, DOI 10.1016/j.brainres.2012.12.027; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Itoh T, 2013, J NEURAL TRANSM, V120, P361, DOI 10.1007/s00702-012-0895-7; Itoh T, 2013, BRAIN STRUCT FUNCT, V218, P209, DOI 10.1007/s00429-012-0394-5; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Kobeissy, 2015, BRAIN NEUROTRAUMA MO; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Kuchel GA, 2019, J AM GERIATR SOC, V67, P203, DOI 10.1111/jgs.15802; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; LARTAUD I, 1993, AM J PHYSIOL, V264, pH851, DOI 10.1152/ajpheart.1993.264.3.H851; Lee P, 2012, EXP NEUROL, V234, P50, DOI 10.1016/j.expneurol.2011.12.016; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lipsitz LA, 2002, J GERONTOL A-BIOL, V57, pB115, DOI 10.1093/gerona/57.3.B115; Litofsky NS, 2018, BRAIN INJURY, V32, P342, DOI 10.1080/02699052.2018.1425913; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Marklund N, 2016, METHODS MOL BIOL, V1462, P29, DOI 10.1007/978-1-4939-3816-2_3; Marmarou Christina R., 2009, P393, DOI 10.1007/978-1-60327-185-1_34; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Maughan PH, 2000, J NEUROTRAUM, V17, P1141, DOI 10.1089/neu.2000.17.1141; McIntosh TK, 1996, LAB INVEST, V74, P315; Melov S, 2004, TRENDS NEUROSCI, V27, P601, DOI 10.1016/j.tins.2004.08.004; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Michael YL, 2010, ANN INTERN MED, V153, P815, DOI 10.7326/0003-4819-153-12-201012210-00008; Miller DB, 2005, AGEING RES REV, V4, P123, DOI 10.1016/j.arr.2005.03.002; Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829; Mody L, 2008, J AM GERIATR SOC, V56, P2340, DOI 10.1111/j.1532-5415.2008.02015.x; Moor E, 2006, EXP GERONTOL, V41, P303, DOI 10.1016/j.exger.2005.12.006; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Narne P, 2017, MOL CELL NEUROSCI, V82, P176, DOI 10.1016/j.mcn.2017.05.008; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; PANTONI L, 1995, STROKE, V26, P1293, DOI 10.1161/01.STR.26.7.1293; Papa L, 2012, CURR GERIATR REP, V1, P135, DOI 10.1007/s13670-012-0019-0; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Peters ME, 2016, INT PSYCHOGERIATR, V28, P1931, DOI 10.1017/S1041610216001666; Pham L, 2019, J NEUROTRAUM, V36, P2260, DOI 10.1089/neu.2018.6169; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rich MW, 2016, CIRCULATION, V133, P2103, DOI [10.1161/CIR.0000000000000380, 10.1016/j.jacc.2016.03.004]; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Rodriguiz RM., 2006, ANIMAL MODELCOGNIT; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Shahidi B, 2018, J NEUROTRAUM, V35, P398, DOI 10.1089/neu.2017.5172; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Sun D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00095; Sun MJ, 2019, BRAIN BEHAV IMMUN, V80, P536, DOI 10.1016/j.bbi.2019.04.038; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Toescu EC, 2004, TRENDS NEUROSCI, V27, P614, DOI 10.1016/j.tins.2004.07.010; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Volchegorskii I A, 2004, Neurosci Behav Physiol, V34, P303, DOI 10.1023/B:NEAB.0000018736.84877.4f; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Wang JT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23959-2; Wang T, 2016, CELL MOL NEUROBIOL, V36, P1257, DOI 10.1007/s10571-015-0323-2; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yazdanyar A, 2009, CLIN GERIATR MED, V25, P563, DOI 10.1016/j.cger.2009.07.007; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595	120	5	5	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	DEC	2019	33	12					975	988	1545968319883879	10.1177/1545968319883879		NOV 2019	14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JW5GZ	WOS:000496682200001	31722616	Green Accepted			2022-02-06	
J	Vakhtin, AA; Zhang, Y; Wintermark, M; Massaband, P; Robinson, MT; Ashford, JW; Furst, AJ				Vakhtin, Andrei A.; Zhang, Yu; Wintermark, Max; Massaband, Payam; Robinson, Miguel T.; Ashford, John W.; Furst, Ansgar J.			White Matter Asymmetry: A Reflection of Pathology in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						DTI; symmetry; TBI; WM	DIFFUSE AXONAL INJURY; MILD; ABNORMALITIES; TRACT; DTI; TRACTOGRAPHY; PREVALENCE; IMPACT; DAMAGE	Comparisons of white matter (WM) fractional anisotropy (FA) values between mild traumatic brain injury (mTBI) patients and controls have revealed inconsistencies in the directions of the resulting FA changes. To address these discrepancies, we examined hemispheric FA symmetry levels across WM tracts in 150 mTBI patients relative to 96 military controls. Automated fiber quantification was used to extract 18 WM tracts with 100 FA values, which were used to compute correlation strengths between the nine bilateral tract pairs. The Fisher z-transformed Pearson's r values were entered into an analysis of covariance examining the effects of group (mTBI and controls) and age on symmetry levels within each tract pair. The mTBI group displayed lower symmetry levels in the corticospinal tract and the inferior longitudinal fasciculus. Interactions between age and group were detected in the inferior fronto-occipital (IFOF), uncinate (UF), and superior longitudinal fasciculi (SLF). A similar pattern emerged in the IFOF and the UF, revealing age-related symmetry decreases in the mTBI patients despite stable levels of symmetry across ages in controls. In contrast, although the control group's symmetry levels actually increased with age in the SLF, no age-related symmetry changes were detected across the mTBI participants. Here, we proposed WM symmetry measures as a potential means of circumventing directional inconsistencies of trauma-related FA changes, as well as capturing more within-tract and within-subject variances of diffusion tensor imaging (DTI) metrics. Further, we demonstrated the method's utility in detecting mTBI-specific effects and their associated interactions with age.	[Vakhtin, Andrei A.; Zhang, Yu; Wintermark, Max; Robinson, Miguel T.; Ashford, John W.; Furst, Ansgar J.] Vet Affairs Palo Alto, War Related Illness & Injury Study Ctr, 151-Y,3801 Miranda Ave, Palo Alto, CA 94304 USA; [Massaband, Payam] Vet Affairs Palo Alto, Dept Radiol, Palo Alto, CA USA; [Furst, Ansgar J.] Vet Affairs Palo Alto, Polytrauma Syst Care, Palo Alto, CA USA; [Vakhtin, Andrei A.; Ashford, John W.; Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Wintermark, Max] Stanford Univ, Sch Med, Dept Neuroradiol, Stanford, CA 94305 USA; [Massaband, Payam] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Furst, Ansgar J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA		Vakhtin, AA (corresponding author), Vet Affairs Palo Alto, War Related Illness & Injury Study Ctr, 151-Y,3801 Miranda Ave, Palo Alto, CA 94304 USA.	avakhtin@stanford.edu	Ashford, J. Wesson/D-3929-2009	Massaband, Payam/0000-0002-0874-2223; Zhang, Yu/0000-0001-8066-7275	WRIISC of the Palo Alto VA Health Care System; Department of Veterans Affairs Office of Academic AffiliationsUS Department of Veterans Affairs	This work was funded by the WRIISC of the Palo Alto VA Health Care System and the Department of Veterans Affairs Office of Academic Affiliations. The views expressed here are of the authors and do not necessarily represent the views of the Department of Veterans Affairs.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Carper RA, 2016, J AM ACAD CHILD PSY, V55, P1073, DOI 10.1016/j.jaac.2016.09.491; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farmer Carrie M, 2017, Rand Health Q, V6, P11; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Main KL, 2017, NEUROIMAGE-CLIN, V16, P1, DOI 10.1016/j.nicl.2017.06.031; Management of Concussion/m TBIWG, 2009, J REHABIL RES DEV, V46, pCP1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Minkova L, 2017, HUM BRAIN MAPP, V38, P5890, DOI 10.1002/hbm.23772; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2005, MRI ATLAS HUMAN WHIT; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Reich DS, 2007, NEUROIMAGE, V38, P271, DOI 10.1016/j.neuroimage.2007.07.049; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Ryu WS, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010653; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Waltzman D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170564; Wessa M, 2016, BRAIN STRUCT FUNCT, V221, P2831, DOI 10.1007/s00429-015-1075-y; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Zhang S, 2004, MAGNET RESON MED, V51, P140, DOI 10.1002/mrm.10673	48	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					373	381		10.1089/neu.2019.6487		NOV 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000495443900001	31595833				2022-02-06	
J	Eger, M; Bader, M; Bree, D; Hadar, R; Nemerovski, A; Tam, J; Levy, D; Pick, CG; Gabet, Y				Eger, Michal; Bader, Miaad; Bree, Dara; Hadar, Rivka; Nemerovski, Alina; Tam, Joseph; Levy, Dan; Pick, Chaim G.; Gabet, Yankel			Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor	SCIENTIFIC REPORTS			English	Article							INDUCED INFLAMMATION; HEAD-INJURY; MAST-CELLS; OSTEOGENESIS; DEFECTS; SYSTEM; CB1	Brain trauma was clinically associated with increased osteogenesis in the appendicular skeleton. We showed previously in C57BL/6J mice that mild traumatic brain injury (mTBI) transiently induced bone formation in the femur via the cannabinoid-1 (CB1) receptor. Here, we subjected ICR mice to mTBI and examined the bone response in the skull using microCT. We also measured mast cell degranulation (MCD)72 h post-injury. Finally, we measured brain and calvarial endocannabinoids levels post-mTBI. mTBI led to decreased bone porosity on the contralateral (untouched) side. This effect was apparent both in young and mature mice. Administration of rimonabant (CB1 inverse agonist) completely abrogated the effect of mTBI on calvarial porosity and significantly reduced MCD, compared with vehicle-treated controls. We also found that mTBI resulted in elevated levels of anandamide, but not 2-arachidonoylglycerol, in the contralateral calvarial bone, whereas brain levels remained unchanged. In C57BL/6J CB1 knockout mice, mTBI did not reduce porosity but in general the porosity was significantly lower than in WT controls. Our findings suggest that mTBI induces a strain-specific CB1-dependent bone anabolic response in the skull, probably mediated by anandamide, but seemingly unrelated to inflammation. The endocannabinoid system is therefore a plausible target in management of bone response following head trauma.	[Eger, Michal; Bader, Miaad; Pick, Chaim G.; Gabet, Yankel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Bree, Dara; Levy, Dan] Beth Israel Deaconess Med Ctr, Dept Anesthesia, Boston, MA 02215 USA; [Bree, Dara; Levy, Dan] Beth Israel Deaconess Med Ctr, Dept Crit Care & Pain Med, Boston, MA 02215 USA; [Bree, Dara; Levy, Dan] Harvard Med Sch, Boston, MA 02215 USA; [Hadar, Rivka; Nemerovski, Alina; Tam, Joseph] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res,Obes & Metab Lab, IL-9112001 Jerusalem, Israel; [Pick, Chaim G.; Gabet, Yankel] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair & Ctr Forthe, IL-69978 Tel Aviv, Israel		Gabet, Y (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Tel Aviv, Israel.; Gabet, Y (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.	yankel@tauex.tau.ac.il	Levy, Dan/AAF-1871-2021	Gabet, Yankel/0000-0002-7494-0631; Levy, Dan/0000-0003-0630-6660; Nemirovski, Alina/0000-0002-2598-0119	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS101405, R01NS078263, R01NS086830] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS086830, R01 NS078263] Funding Source: Medline		Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Bab I, 2008, BRIT J PHARMACOL, V153, P182, DOI 10.1038/sj.bjp.0707593; Bankova LG, 2014, J IMMUNOL, V192, P2812, DOI 10.4049/jimmunol.1301794; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Gosain AK, 2003, PLAST RECONSTR SURG, V112, P515, DOI 10.1097/01.PRS.0000070728.56716.51; GRAVES L, 1990, J BONE MINER RES, V5, P1113, DOI 10.1002/jbmr.5650051104; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Idris AI, 2005, NAT MED, V11, P774, DOI 10.1038/nm1255; Knani I, 2016, MOL METAB, V5, P1187, DOI 10.1016/j.molmet.2016.10.004; Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049; Kroner J, 2017, J BONE MINER RES, V32, P2431, DOI 10.1002/jbmr.3234; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lind T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167964; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lucey BP, 2003, ARCH PATHOL LAB MED, V127, P94; McColl TJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00372; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Pasqualini M, 2013, BONE, V55, P69, DOI 10.1016/j.bone.2013.03.013; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Salisbury E, 2011, J CELL BIOCHEM, V112, P2748, DOI 10.1002/jcb.23225; Song Y, 2017, EUR REV MED PHARMACO, V21, P1522; Sophocleous A, 2017, AGING CELL, V16, P1051, DOI 10.1111/acel.12638; Tam J, 2008, FASEB J, V22, P285, DOI 10.1096/fj.06-7957com; Tam J, 2006, MOL PHARMACOL, V70, P786, DOI 10.1124/mol.106.026435; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Varanasi SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010692; Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zvejniece L, 2020, J NEUROTRAUM, V37, P295, DOI 10.1089/neu.2019.6524	35	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 7	2019	9								16196	10.1038/s41598-019-51720-w			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JK6IK	WOS:000494945300035	31700010	Green Published, gold			2022-02-06	
J	Asken, BM; Houck, ZM; Clugston, JR; Larrabee, GJ; Broglio, SP; McCrea, MA; McAllister, TW; Bauer, RM; Anderson, S; Benjamin, H; Brooks, A; Buckley, T; Cameron, K; Chrisman, S; Duma, S; Giza, C; Hazzard, J; Jackson, J; Kaminsky, T; Kelly, L; Kontos, A; Lintner, L; Master, C; McGinty, G; Mihalik, J; Miles, C; O'Donnell, P; Ortega, J; Port, N; Putukian, M; Schmidt, J				Asken, Breton M.; Houck, Zachary M.; Clugston, James R.; Larrabee, Glenn J.; Broglio, Steven P.; McCrea, Michael A.; McAllister, Thomas W.; Bauer, Russell M.; Anderson, Scott; Benjamin, Holly; Brooks, Alison; Buckley, Thomas; Cameron, Kenneth; Chrisman, Sara; Duma, Stefan; Giza, Christopher; Hazzard, Joseph, Jr.; Jackson, Jonathan; Kaminsky, Thomas; Kelly, Louise; Kontos, Anthony; Lintner, Laura; Master, Christina; McGinty, Gerald; Mihalik, Jason; Miles, Christopher; O'Donnell, Patrick; Ortega, Justus; Port, Nicholas; Putukian, Margot; Schmidt, Julianne		CARE Consortium Investigators	Word-reading ability as a "hold test" in cognitively normal young adults with history of concussion and repetitive head impact exposure: A CARE Consortium Study	CLINICAL NEUROPSYCHOLOGIST			English	Article						Concussion; brain injury; WTAR; repetitive head impact exposure; word reading	ESTIMATING PREMORBID ABILITY; WECHSLER TEST; LATER-LIFE; 1ST EXPOSURE; FOOTBALL; AGE; IMPAIRMENT; EDUCATION; LITERACY; WTAR	Objective: Neuropsychological evaluations include hold tests like word-reading ability as estimates of premorbid intellect thought to be resilient to the effects of neurologic insult. We tested the alternative hypothesis that exposure to concussion or repetitive subclinical head impacts throughout early life may stunt acquisition of word-reading skills.Method: Data were obtained from student-athletes within the CARE Consortium that completed the Wechsler Test of Adult Reading (WTAR). Measures of head trauma burden included self-reported concussion history and cumulative years of exposure to collision sports. We evaluated the effects of head trauma, sociodemographic (race, SES), and academic (SAT/ACT scores, learning disorder) variables on WTAR standard score using linear regression. Analyses were repeated in a football-only subsample estimating age of first exposure to football as a predictor.Results: We analyzed data from 6,598 participants (72.2% white, 39.6% female, meanSD age = 18.8 +/- 1.2years). Head trauma variables collectively explained 0.1% of the variance in WTAR standard scores, with years of collision sport exposure weakly predicting lower WTAR standard scores (beta = .026-.035, very small effect). In contrast, sociodemographic and academic variables collectively explained 20.9-22.5% of WTAR standard score variance, with strongest effects noted for SAT/ACT scores (beta = .313-.337, medium effect), LD diagnosis (beta = -.115 to -.131, small effect), and SES (beta = .101-.108, small effect). Age of first exposure to football did not affect WTAR scores in a football-only sample.Conclusion: Wechsler Test of Adult Reading performance appears unrelated to history of self-reported concussion(s) and/or repetitive subclinical head trauma exposure in current collegiate athletes. Sociodemographic and academic variables should be incorporated in test score interpretations for diverse populations like athletes.	[Asken, Breton M.] Brown Univ, Dept Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Asken, Breton M.; Houck, Zachary M.; Bauer, Russell M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Univ Athlet Assoc, Gainesville, FL USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Anderson, Scott] Univ Oklahoma, Athlet Dept, Norman, OK 73019 USA; [Benjamin, Holly] Univ Chicago, Dept Rehabil Med & Pediat, Chicago, IL 60637 USA; [Brooks, Alison] Univ Wisconsin, Dept Orthoped, Madison, WI USA; [Buckley, Thomas; Kaminsky, Thomas] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Cameron, Kenneth] US Mil Acad, West Point, NY 10996 USA; [Chrisman, Sara] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Duma, Stefan] Virginia Polytech & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Giza, Christopher] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Hazzard, Joseph, Jr.] Bloomsburg Univ, Dept Exercise Sci, Bloomsburg, PA USA; [Jackson, Jonathan; McGinty, Gerald] US Air Force Acad, Colorado Springs, CO 80840 USA; [Kelly, Louise] Calif Lutheran Univ, Dept Exercise Sci, Thousand Oaks, CA USA; [Kontos, Anthony] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Lintner, Laura] Wake Forest Univ, Bowman Gray Sch Med, Dept Family & Community Med, Winston Salem, NC 27103 USA; [Master, Christina] Childrens Hosp Philadelphia, Div Orthoped, Philadelphia, PA 19104 USA; [Mihalik, Jason] Univ N Carolina, Dept Exercise & Sports Sci, Chapel Hill, NC 27515 USA; [Miles, Christopher] Wake Forest Univ, Dept Family & Community Med, Winston Salem, NC 27101 USA; [O'Donnell, Patrick] US Coast Guard Acad, New London, CT USA; [Ortega, Justus] Humboldt State Univ, Dept Kinesiol & Recreat Adm, Arcata, CA 95521 USA; [Port, Nicholas] Indiana Univ, Sch Optometry, Bloomington, IN USA; [Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Schmidt, Julianne] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Asken, BM (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.	Breton.Asken@ucsf.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Clugston, James/0000-0002-2103-1039; Bauer, Russell/0000-0001-6807-2535; Asken, Breton/0000-0001-8419-142X	Grand Alliance Concussion Assessment, Research, and Education Consortium - National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; US Army Medical Research Acquisition Activity; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was supported in part by the Grand Alliance Concussion Assessment, Research, and Education Consortium, which receives funding from the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program (award W81XWH-14-2-0151). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	ADAMS RL, 1982, J CONSULT CLIN PSYCH, V50, P143, DOI 10.1037/0022-006X.50.1.143; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Ball JD, 2007, CLIN NEUROPSYCHOL, V21, P422, DOI 10.1080/13854040600582577; Bright P, 2020, NEUROPSYCHOL REHABIL, V30, P1, DOI 10.1080/09602011.2018.1445650; Bright P, 2018, NEUROPSYCHOL REHABIL, V28, P1019, DOI 10.1080/09602011.2016.1231121; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Davis AS, 2016, APPL NEUROPSYCH-ADUL, V23, P403, DOI 10.1080/23279095.2016.1163262; Dotson VM, 2009, J INT NEUROPSYCH SOC, V15, P580, DOI 10.1017/S1355617709090821; Duff K, 2019, ARCH CLIN NEUROPSYCH, V34, P395, DOI 10.1093/arclin/acy050; Duff K, 2011, ARCH CLIN NEUROPSYCH, V26, P701, DOI 10.1093/arclin/acr083; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Hollingshead August B., 1975, YALE J SOCIOLOGY, V8; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Houck ZM, 2020, CLIN NEUROPSYCHOL, V34, P561, DOI 10.1080/13854046.2019.1666923; Kerr ZY, 2018, J ATHL TRAINING, V53, P738, DOI 10.4085/1062-6050-144-17; Lanting S. C., 2012, AM C REH MED C VANC; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Maroon JC, 2015, NEUROLOGY, V85, P1007, DOI 10.1212/WNL.0000000000001942; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Meyers JE, 2020, APPL NEUROPSYCH-ADUL, V27, P364, DOI 10.1080/23279095.2018.1550412; Mullen CM, 2014, APPL NEUROPSYCH-ADUL, V21, P69, DOI 10.1080/09084282.2012.727111; Reynolds BB, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117701708; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Ryan EL, 2005, J INT NEUROPSYCH SOC, V11, P889, DOI 10.1017/S1355617705051040; SAT, 2018, SAT UND SCOR; Saykin A J, 1995, Appl Neuropsychol, V2, P79, DOI 10.1207/s15324826an0202_5; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Sisco S, 2015, J GERONTOL B-PSYCHOL, V70, P557, DOI 10.1093/geronb/gbt133; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2015, NEUROLOGY, V85, P1008; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; The Institute for Diversity and Ethics in Sport, 2019, TIFDAEIS RAC GEND RE; Uttl B, 2002, J CLIN EXP NEUROPSYC, V24, P1123, DOI 10.1076/jcen.24.8.1123.8375; Wechsler D, 2001, WTAR WECHSLER TEST A; Whitney KA, 2010, APPL NEUROPSYCHOL, V17, P196, DOI 10.1080/09084282.2010.499787; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004	48	5	5	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 3	2020	34	5					919	936		10.1080/13854046.2019.1680735		NOV 2019	18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ME2MY	WOS:000495156400001	31698991				2022-02-06	
J	Yumoto, T; Naito, H; Yorifuji, T; Aokage, T; Fujisaki, N; Nakao, A				Yumoto, Tetsuya; Naito, Hiromichi; Yorifuji, Takashi; Aokage, Toshiyuki; Fujisaki, Noritomo; Nakao, Atsunori			Association of Japan Coma Scale score on hospital arrival with in-hospital mortality among trauma patients	BMC EMERGENCY MEDICINE			English	Article						Glasgow coma scale; Japan Coma Scale; Mortality; Trauma; Traumatic brain injury	INTERRATER RELIABILITY; BRAIN-INJURY; MOTOR SCORE; GLASGOW; CARE	Background The Japan Coma Scale (JCS) score has been widely used to assess patients' consciousness level in Japan. JCS scores are divided into four main categories: alert (0) and one-, two-, and three-digit codes based on an eye response test, each of which has three subcategories. The purpose of this study was to investigate the utility of the JCS score on hospital arrival in predicting outcomes among adult trauma patients. Methods Using the Japan Trauma Data Bank, we conducted a nationwide registry-based retrospective cohort study. Patients 16 years old or older directly transported from the trauma scene between January 2004 and December 2017 were included. Our primary outcome was in-hospital mortality. We examined outcome prediction accuracy based on area under the receiver operating characteristic curve (AUROC) and multiple logistic regression analysis with multiple imputation. Results A total of 222,540 subjects were included; their in-hospital mortality rate was 7.1% (n = 15,860). The 10-point scale JCS and the total sum of Glasgow Coma Scale (GCS) scores demonstrated similar performance, in which the AUROC (95% CIs) showed 0.874 (0.871-0.878) and 0.878 (0.874-0.881), respectively. Multiple logistic regression analysis revealed that the higher the JCS score, the higher the predictability of in-hospital death. When we focused on the simple four-point scale JCS score, the adjusted odds ratio (95% confidence intervals [CIs]) were 2.31 (2.12-2.45), 4.81 (4.42-5.24), and 27.88 (25.74-30.20) in the groups with one-digit, two-digit, and three-digit scores, respectively, with JCS of 0 as a reference category. Conclusions JCS score on hospital arrival after trauma would be useful for predicting in-hospital mortality, similar to the GCS score.	[Yumoto, Tetsuya; Naito, Hiromichi; Fujisaki, Noritomo; Nakao, Atsunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency Crit Care & Disaster Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan; [Aokage, Toshiyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Geriatr Emergency Med, Okayama, Japan		Yumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Emergency Crit Care & Disaster Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tyumoto@cc.okayama-u.ac.jp		Naito, Hiromichi/0000-0002-7308-1716			Brown JB, 2014, J TRAUMA ACUTE CARE, V77, P95, DOI 10.1097/TA.0000000000000280; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Davis JW, 2017, J TRAUMA ACUTE CARE, V83, P1173, DOI 10.1097/TA.0000000000001623; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Irisawa T, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-24; Janssen KJM, 2010, J CLIN EPIDEMIOL, V63, P721, DOI 10.1016/j.jclinepi.2009.12.008; Japan Trauma Care and Research, JAP TRAUM DAT BANK R; Kimura A, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2014-0; Kong GL, 2015, INJURY, V46, P1784, DOI 10.1016/j.injury.2015.06.002; Kurogi R, 2018, J NEUROSURG, V128, P1318, DOI 10.3171/2016.12.JNS161039; Ohta T, 1974, No Shinkei Geka, V2, P623; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sakai K, 1998, NEUROL MED-CHIR, V38, P131, DOI 10.2176/nmc.38.131; Shigematsu K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002736; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; SUZUKI S, 1989, Neurological Research, V11, P79; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Teoh LSG, 2000, INTENS CARE MED, V26, P157, DOI 10.1007/s001340050039; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081; Wada T, 2017, INJURY PREV, V23, P263, DOI 10.1136/injuryprev-2016-042106; Wada T, 2017, INJURY, V48, P1423, DOI 10.1016/j.injury.2017.05.003; Wada T, 2015, J CRIT CARE, V30, P1227, DOI 10.1016/j.jcrc.2015.07.027; Yumoto T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0341-1	26	5	5	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	NOV 6	2019	19	1							65	10.1186/s12873-019-0282-x			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JL5MC	WOS:000495573700001	31694575	Green Published, gold			2022-02-06	
J	Burghart, M; Craig, J; Radel, J; Huisinga, J				Burghart, Mark; Craig, Jordan; Radel, Jeff; Huisinga, Jessie			Reliability and validity of a motion-based reaction time assessment using a mobile device	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Assessment; concussion; information processing; mobile device; sports	CONCUSSION; SPEED; TESTS	Information processing speed is often altered following a concussion. Few portable assessments exist to evaluate simple reaction time (SRT) in hospitals and clinics. We evaluated the use of a SRT application for mobile device measurement. 27 healthy adults (age?=?30.7???11.5 years) completed SRT tests using a mobile device with Sway, an application for SRT testing. Participants completed computerized SRT tests using the Computerized Test of Information Processing (CTIP). Test?retest reliability was assessed using intraclass correlation coefficients (ICC) between Sway trials. Pearson correlations and Bland-Altman analyses were used to assess criterion validity between Sway and CTIP means. ICC comparisons between Sway tests were all statistically significant. ICCs ranged from 0.84?0.90, with p-values <.001. A one-way analysis of variance (ANOVA) revealed no significant differences between trials (F-3,F-104?=? 1.35, p?=?.26. Pearson correlation between Sway and CTIP outcomes yielded a significant correlation (r?=?0.59, p?=?.001). The mean difference between measurement methods was 43.7?ms, with limits of agreement between ?140.8?53.4?ms. High ICC indicates Sway is a reliable method to assess SRT. A strong correlation and clinically acceptable agreement between Sway and the computer-based test indicates that Sway is suited for rapid administration of SRT testing in healthy individuals. Future research using Sway to assess altered information processing in a population of individuals after concussion is warranted.	[Burghart, Mark; Radel, Jeff] Univ Kansas, Med Ctr, Sch Hlth Profess, Occupat Therapy Educ, Kansas City, KS 66103 USA; [Burghart, Mark; Radel, Jeff] Univ Kansas Hosp, Ctr Concuss Management, Kansas City, KS USA; [Craig, Jordan; Huisinga, Jessie] Univ Kansas, Med Ctr, Landon Ctr Aging, Kansas City, KS 66103 USA; [Craig, Jordan] Univ Kansas, Sch Engn, Dept Bioengn, Lawrence, KS 66045 USA; [Huisinga, Jessie] Univ Kansas, Med Ctr, Sch Hlth Profess, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA		Burghart, M (corresponding author), Univ Kansas, Med Ctr, Occupat Therapy Educ, 3901 Rainbow Blvd,Mail Stop 2003, Kansas City, KS 66160 USA.	mburghart@kumc.edu			National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG 4914A1/2]; NIH National Center for Advancing Translational Science [1KL2TR00011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057850] Funding Source: NIH RePORTER	This project was supported by the National Multiple Sclerosis Society RG 4914A1/2 and the NIH National Center for Advancing Translational Science 1KL2TR00011. Sway Medical, LLC. donated access to the SWAY application and database.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mukaka MM, 2012, MALAWI MED J, V24, P69; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Portney L, 2009, FDN CLIN RES APPL PR, P523; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; Tombaugh TN, 2007, ARCH CLIN NEUROPSYCH, V22, P25, DOI 10.1016/j.acn.2006.06.013; Tombaugh TN, 2010, COGN BEHAV NEUROL, V23, P192, DOI 10.1097/WNN.0b013e3181cc8bd4; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005	16	5	5	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	NOV 2	2019	26	6					558	563		10.1080/23279095.2018.1469491			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	JB9ER	WOS:000488884700006	30183372	Green Accepted			2022-02-06	
J	Ares, WJ; Jankowitz, BT; Tonetti, DA; Gross, BA; Grandhi, R				Ares, William J.; Jankowitz, Brian T.; Tonetti, Daniel A.; Gross, Bradley A.; Grandhi, Ramesh			A comparison of digital subtraction angiography and computed tomography angiography for the diagnosis of penetrating cerebrovascular injury	NEUROSURGICAL FOCUS			English	Article						diagnostic angiography; digital subtraction angiography; computed tomography angiography; penetrating cerebrovascular injury; penetrating neurotrauma; aneurysm; dural fistula; traumatic brain injury	ARTERIAL INJURIES; CT ANGIOGRAPHY; BRAIN-INJURY; ANEURYSMS; HEAD	OBJECTIVE Penetrating cerebrovascular injury (PCVI) is a subset of traumatic brain injury (TBI) comprising a broad spectrum of cerebrovascular pathology, including traumatic pseudoaneurysms, direct arterial injury, venous sinus stenosis or occlusion, and traumatic dural arteriovenous fistulas. These can result in immediate or delayed vascular injury and consequent neurological morbidity. Current TBI guidelines recommend cerebrovascular imaging for detection, but there is no consensus on the optimum modality. The aim of this retrospective cohort study was to compare CT angiography (CTA) and digital subtraction angiography (DSA) for the diagnosis of PCVI. METHODS The records of all patients presenting to two level I trauma centers in the United States between January 2010 and July 2016 with penetrating head or neck trauma were reviewed. Only those who had undergone both CTA and DSA were included. Clinical and neuroimaging data were collected, and PCVIs were stratified using a modified Biffl grading scheme. DSA and CTA results were then compared. RESULTS Of 312 patients with penetrating trauma over the study period, 56 patients (91% male, mean age 32 years) with PCVI met inclusion criteria and constituted the study cohort. The mechanism of injury was a gunshot wound in 86% (48/56) of patients. Twenty-four (43%) patients had sustained an angiographically confirmed arterial or venous injury. Compared with DSA as the gold standard, CTA had a sensitivity and specificity of 72% and 63%, respectively, for identifying PCVI. CTA had a positive predictive value of 61% and negative predictive value of 70%. Seven patients (13%) required immediate endovascular treatment of PCVI, in 3 (43%) of these patients, the injury was not identified on CTA. Twenty-two patients (39%) underwent delayed DSA an average of 25 days after injury; 2 (9%) of these patients were found to harbor new pathological conditions requiring treatment. CONCLUSIONS In this retrospective analysis of PCVI at two large trauma centers, CTA demonstrated low sensitivity, specificity, and positive and negative predictive values for the diagnosis of PCVI. These findings suggest that DSA provides better accuracy than CTA in the diagnosis of both immediate and delayed PCVI and should be considered for patients experiencing penetrating head or neck trauma.	[Ares, William J.] NorthShore Univ Hlth Syst, Dept Neurol Surg, Evanston, IL USA; [Jankowitz, Brian T.] Cooper Univ Hosp, Dept Neurol Surg, Camden, NJ USA; [Tonetti, Daniel A.; Gross, Bradley A.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Grandhi, Ramesh] Univ Utah, Dept Neurosurg, Clin Neurosci Ctr, Salt Lake City, UT USA		Jankowitz, BT (corresponding author), Cooper Neurol Inst, Camden, NJ 08103 USA.	bjankowitz@gmail.com	Tonetti, Daniel/AAB-1158-2020				Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bodanapally UK, 2015, AM J ROENTGENOL, V205, P866, DOI 10.2214/AJR.14.14161; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; Diaz-Daza O, 2003, CARDIOVASC INTER RAD, V26, P213, DOI 10.1007/s00270-002-2619-0; Giladi O, 2016, THROMB RES, V137, P26, DOI 10.1016/j.thromres.2015.11.035; Gonul E, 2005, SURG NEUROL, V63, P24, DOI 10.1016/j.surneu.2004.05.043; Grandhi R, 2018, J NEUROSURG, V128, P1642, DOI 10.3171/2017.2.JNS163264; HADDAD FS, 1991, NEUROSURGERY, V28, P1; International Brain Injury Association: Brain Injury Association American Association of Neurological Surgeons, 2001, J TRAUMA S, V51, pS3; Jagoda P, 2018, AM J ROENTGENOL, V211, P1298, DOI 10.2214/AJR.17.19397; McKinney AM, 2008, AM J NEURORADIOL, V29, P594, DOI 10.3174/ajnr.A0848	14	5	6	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E16	10.3171/2019.8.FOCUS19495			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900016	31675711	gold			2022-02-06	
J	Asgari, S; Adams, H; Kasprowicz, M; Czosnyka, M; Smielewski, P; Ercole, A				Asgari, Shadnaz; Adams, Hadie; Kasprowicz, Magdalena; Czosnyka, Marek; Smielewski, Peter; Ercole, Ari			Feasibility of Hidden Markov Models for the Description of Time-Varying Physiologic State After Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						cerebrovascular circulation; critical care; detection algorithms; intracranial pressure; Markov chains; traumatic brain injury	MANAGEMENT; CARE	Objectives: Continuous assessment of physiology after traumatic brain injury is essential to prevent secondary brain insults. The present work aims at the development of a method for detecting physiologic states associated with the outcome from time-series physiologic measurements using a hidden Markov model. Design: Unsupervised clustering of hourly values of intracranial pressure/cerebral perfusion pressure, the compensatory reserve index, and autoregulation status was attempted using a hidden Markov model. A ternary state variable was learned to classify the patient's physiologic state at any point in time into three categories ("good," "intermediate," or "poor") and determined the physiologic parameters associated with each state. Setting: The proposed hidden Markov model was trained and applied on a large dataset (28,939 hr of data) using a stratified 20-fold cross-validation. Patients: The data were collected from 379 traumatic brain injury patients admitted to Addenbrooke's Hospital, Cambridge between 2002 and 2016. Interventions: Retrospective observational analysis. Measurements and Main Results: Unsupervised training of the hidden Markov model yielded states characterized by intracranial pressure, cerebral perfusion pressure, compensatory reserve index, and autoregulation status that were physiologically plausible. The resulting classifier retained a dose-dependent prognostic ability. Dynamic analysis suggested that the hidden Markov model was stable over short periods of time consistent with typical timescales for traumatic brain injury pathogenesis. Conclusions: To our knowledge, this is the first application of unsupervised learning to multidimensional time-series traumatic brain injury physiology. We demonstrated that clustering using a hidden Markov model can reduce a complex set of physiologic variables to a simple sequence of clinically plausible time-sensitive physiologic states while retaining prognostic information in a dose-dependent manner. Such states may provide a more natural and parsimonious basis for triggering intervention decisions.	[Asgari, Shadnaz] Calif State Univ Long Beach, Dept Biomed Engn, Long Beach, CA 90840 USA; [Asgari, Shadnaz] Calif State Univ Long Beach, Dept Comp Engn & Comp Sci, Long Beach, CA 90840 USA; [Adams, Hadie; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Kasprowicz, Magdalena] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Ercole, Ari] Univ Cambridge, Dept Anesthesia, Div Anesthesia, Cambridge, England		Asgari, S (corresponding author), Calif State Univ Long Beach, Dept Biomed Engn, Long Beach, CA 90840 USA.; Asgari, S (corresponding author), Calif State Univ Long Beach, Dept Comp Engn & Comp Sci, Long Beach, CA 90840 USA.	Shadnaz.Asgari@csulb.edu	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Kasprowicz, Magdalena/0000-0002-2271-7737	Cambridge Enterprise; National Institute for Health Research Cambridge Brain Repair Centre	Drs. Czosnyka and Smielewski received funding from Cambridge Enterprise (part of license fees for the brain monitoring software ICM+ used in this project for data collection and preprocessing); and they are also supported by National Institute for Health Research Cambridge Brain Repair Centre. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Z., 2015, ADV STATE SPACE METH; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; JENNETT B, 1975, LANCET, V1, P480; Kim DJ, 2009, NEUROSURGERY, V64, P494, DOI 10.1227/01.NEU.0000338434.59141.89; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Ruskin KJ, 2015, CURR OPIN ANESTHESIO, V28, P685, DOI 10.1097/ACO.0000000000000260; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010	13	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2019	47	11					E880	E885		10.1097/CCM.0000000000003966			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JD1HE	WOS:000489725000004	31517697	Green Submitted			2022-02-06	
J	Bradt, AD; Rave, DT				Bradt, Andrew D.; Rave, D. Theodore			It's Good to Have the "Haves" on Your Side: A Defense of Repeat Players in Multidistrict Litigation	GEORGETOWN LAW JOURNAL			English	Article							MASS TORTS; AGGREGATE; LAWYERS; ARBITRATION; SETTLEMENT; LIABILITY; DISPUTES; PRIVATE; COURTS; ETHICS	Repeat players in multidistrict litigation (MDL) get a bad rap. When thousands of cases from all over the country are consolidated for pretrial proceedings, it's no wonder that the judge assigned to manage the litigation picks experienced lawyers to lead the effort. But critics argue that the small group of elite lawyers who show up again and again in leadership positions on the plaintiffs' side of MDLs can collude with each other and with repeat players on the defense side to restrict competition and shape the rules of the game to their advantage-all to the detriment of the one-shotter clients that they represent. Those criticisms have gotten louder as MDL has grown to make up more than one-third of the federal civil docket and encompass some of the nation's largest controversies, such as the opioid epidemic, the BP oil spill, the NFL concussion litigation, and many defective product cases. In this Article, we challenge this narrative, drawing on Marc Galanter's seminal explanation for why the "haves" come out ahead in litigation. Although the risks the "haves" pose are real, we argue that repeat players add significant value when they represent one-shotter plaintiffs and that such value may be worth running the risks. We show how MDL's unique structure-its formal commitment to individualism but functional operation as a tight aggregation-allows repeat-player plaintiffs' lawyers to "play for rules" more effectively than either class action suits or traditional one-on-one litigation. And with potential reforms to MDL procedure on the agendas of both Congress and the Advisory Committee on Civil Rules, we urge policymakers and scholars not to lose sight of the significant benefits to plaintiffs of having repeat players on their side.	[Bradt, Andrew D.] Univ Calif Berkeley, Berkeley Sch Law, Law, Boalt Hall, Berkeley, CA 94720 USA; [Rave, D. Theodore] Univ Houston, Law Ctr, Houston, TX 77004 USA		Bradt, AD (corresponding author), Univ Calif Berkeley, Berkeley Sch Law, Law, Boalt Hall, Berkeley, CA 94720 USA.			Bradt, Andrew/0000-0002-1174-0704			Abrams DS, 2007, U CHICAGO LAW REV, V74, P1145, DOI 10.2307/20141859; ABRAMS DS, 2007, U CHICAGO LAW REV, V74, P1149; ABRAMS DS, 2007, CHI L REV, V74, P1166; ADVISORY COMM. ON CIVIL RULES, 2018, REP ADV COMM CIV RUL, p[27, 29]; [Anonymous], 2014, LA LAW REV, V75, P341; [Anonymous], 2014, LA LAW REV, V75, P361; Baker LA, 2017, FORDHAM LAW REV, V85, P1943; Baker Lynn A., 2015, HOFSTRA L REV, V44, P297; Baker Lynn A., 2015, HOFSTRA L REV, V44, P295; BELL DA, 1976, YALE LAW J, V85, P470, DOI 10.2307/795339; BLAIR ROGER D., 2010, MONOPSONY LAW EC, P1; Bookman PK, 2017, NEW YORK U LAW REV, V92, P767; Bookman Pamela K., 2017, NEW YORK U LAW REV, V92, P789; Bradt Andrew, 2018, REV LITIG, V37, P204; Bradt AD, 2018, FORDHAM LAW REV, V87, P87; Bradt AD, 2017, CALIF LAW REV, V105, P1259, DOI 10.15779/Z388P5V874; Bradt AD, 2017, U PENN LAW REV, V165, P1711; Bradt AD, 2017, U PENN LAW REV, V165, P831; Bradt AD, 2012, NOTRE DAME LAW REV, V88, P759; Bradt Andrew D., 2017, U PENN LAW REV, V165, P903; Bradt Andrew D., 2018, FORDHAM L REV, V87, P104; Bradt Andrew D., 2019, GA L REV, V53; Bradt Andrew D., 2018, WM MARY L REV, V59, P1165; Bradt Andrew D., 2018, BOSTON COLL LAW REV, V59, P1251; Bradt Andrew D., 2018, BC L REV, V59, P1296; Bradt Andrew D., 2018, REV LITIG, V37, P226; Brown S. Todd, 2013, CLEV ST L REV, V61, P392; Brown S. Todd, 2013, CLEV ST L REV, V61, P391; Bruhl Aaron, 2011, PRAWFSBLAWG; Burbank SB, 2017, U PENN LAW REV, V165, P1495; Burbank Stephen B., 2017, U PENN LAW REV, V165, P1501; BURBANK STEPHEN B., 2017, RIGHTS RETRENCHMENT, P18; Burch EC, 2014, LOUISIANA LAW REV, V73, P399; Burch EC, 2017, CORNELL LAW REV, V102, P1445; Burch EC, 2017, VANDERBILT LAW REV, V70, P67; Burch EC, 2015, NEW YORK U LAW REV, V90, P71; Burch EC, 2011, BOSTON U LAW REV, V91, P87; Burch Elizabeth Chamblee, 2015, NEW YORK U LAW REV, V90, P95; Burch Elizabeth Chamblee, 2011, B U L REV, V91, P119; Burch Elizabeth Chamblee, 2014, LA LAW REV, V75, P399; Burch Elizabeth Chamblee, 2017, VANDERBILT LAW REV, V70, P74; Cabraser EJ, 2005, STANFORD LAW REV, V57, P1475; Cabraser EJ, 2017, NEW YORK U LAW REV, V92, P846; Cabraser Elizabeth J., 2005, STANFORD LAW REV, V57, P1476; CALABRESI G, 1972, HARVARD LAW REV, V85, P1089, DOI 10.2307/1340059; Campos SJ, 2012, VANDERBILT LAW REV, V65, P1059; Campos Sergio J., 2012, VANDERBILT LAW REV, V65, P1079; CARSTENSEN PETER C., 2017, COMPETITION POLICY C, P1; COFFEE JC, 1995, COLUMBIA LAW REV, V95, P1343, DOI 10.2307/1123132; Coffee JC, 2000, COLUMBIA LAW REV, V100, P370, DOI 10.2307/1123472; Coleman BD, 2018, INDIANA LAW J, V93, P617; Coleman BD, 2016, WASH LAW REV, V91, P1005; Coleman Brooke D., 2018, IND L J, V93, P640; Dixit A., 2004, LAWLESSNESS EC ALTER; Dodge Jaime, 2014, EMORY LJ, V64, P329; Dodge Jaime, 2014, EMORY LJ, V64, P355; Donahue Nathaniel, 2019, CORNELL L REV, V105; Duval Jr Stanwood R., 2014, LA LAW REV, V74, P392; Duval Jr Stanwood R., 2014, LA LAW REV, V74, P391; ELIZABETH CHAMBLEE BURCH, 2019, MASS TORT DEALS BACK; Engstrom DF, 2012, COLUMBIA LAW REV, V112, P1244; Engstrom David Freeman, 2012, COLUMBIA LAW REV, V112, P1298; Engstrom NF, 2011, NEW YORK U LAW REV, V86, P805; Engstrom Nora Freeman, 2011, NEW YORK U LAW REV, V86, P859; EPSTEIN RA, 2003, U CHI LEGAL F, P475; Epstein Richard A., 2003, U CHI LEGAL F, V2003, P478; Erichson HM, 2000, DUKE LAW J, V50, P381, DOI 10.2307/1373094; Erichson HM, 2018, FORDHAM LAW REV, V87, P19; Erichson HM, 2011, CORNELL LAW REV, V96, P265; Erichson Howard M., 2010, U KAN L REV, V58, P979; Erichson Howard M., 2017, VAND L REV EN BANC, V70, P29; Erichson Howard M., 2011, CORNELL LAW REV, V96, P301; Erichson Howard M., 2010, KAN L REV, V58, P993; Erichson Howard M., 2003, U CHI LEGAL F, V2003, P519; Erichson Howard M., 2003, U CHI LEGAL F, P534; Fallon Eldon E., 2008, TUL L REV, V82, P2354; Fallon Eldon E., 2014, LA LAW REV, V74, P371; Fisher JL, 2013, STANFORD LAW REV, V65, P137; Fisher Jeffrey L., 2013, STANFORD LAW REV, V65, P145; Frankel Alison, 2016, REUTERS; GALANTER M, 1994, STANFORD LAW REV, V46, P1339, DOI 10.2307/1229161; Gilles M, 2005, MICH LAW REV, V104, P373; Gilles Myriam, 2012, J TORT L, V5, P173; Gilles Myriam, 2005, MICH LAW REV, V104, P429; GILSON RJ, 1994, COLUMBIA LAW REV, V94, P509, DOI 10.2307/1123202; GILSON RJ, 1990, MD L REV, V49, P900; GILSON RJ, 1994, COLUMBIA LAW REV, V94, P513; Gilson Ronald J., 1990, MD L REV, V49, P902; Gluck AR, 2017, U PENN LAW REV, V165, P1669; Gluck Abbe R., 2017, U PENN LAW REV, V165, P1687; Haire SB, 1999, LAW SOC REV, V33, P667, DOI 10.2307/3115107; Harris Catherine T, 2005, SMU Law Rev, V58, P225; Harris Catherine T, 2008, Yale J Health Policy Law Ethics, V8, P253; HARRIS CT, 2005, SMU L REV, V58, P248; Hensler Deborah, 1993, BROOK L REV, V59, P961; HENSLER DR, 1993, BROOK L REV, V59, P1023; Hirschman A.O., 1970, EXIT VOICE LOYALTY R; Hovenkamp H, 2005, U CHICAGO LAW REV, V72, P147; Issacharoff S, 2002, TEX LAW REV, V80, P1925; ISSACHAROFF S, 2014, DEPAUL L REV, V63, P582; Issacharoff S, 2004, VANDERBILT LAW REV, V57, P1571; Issacharoff Samuel, 1999, SUP CT REV, P337, DOI DOI 10.1016/J.JFINECO.2008.08.006; Issacharoff Samuel, 2008, SUP CT REV, P183; Issacharoff Samuel, 2014, LA LAW REV, V74, P397; Issacharoff Samuel, 2014, DEPAUL L REV, V63, P561; Issacharoff Samuel, 2015, DUK U SCH LAW SNAPSH; Issacharoff Samuel, 2014, LA LAW REV, V74, P413; John G., 2012, LITIGATION, V38, P26; KAKALIK JAMES S., 1984, RAND VARIATION ASBES, pxi; KRITZER HM, 2004, RISKS REPUTATIONS RE, P66; LAHAV A, 2003, IND L REV, V37, P65; Lahav AD, 2008, GEORGE WASH LAW REV, V76, P576; Lahav Alexandra D., 2018, REV LITIG, V37, P192; Lahav Alexandra D., 2018, REV LITIG, V37, P185; LAWYERS FOR CIVIL JUSTICE, 2017, REQ RUL ADV COMM CIV; LAWYERS FOR CIVIL JUSTICE, 2018, COMM ADV COMM CIV RU, P5; Linda S.Mullenix, 2011, U CIN L REV, V80, P391; Marcus David, 2007, WM MARY L REV, V48, P1281; Marcus David, 2007, WM MARY L REV, V48, P1247; Marcus Richard L., 2008, TUL L REV, V82, P2277; Marcus Richard L., 2008, TUL L REV, V82, P2245; McGovern Francis E., 2012, LITIGATION, V38, P30; McKenzie TA, 2012, NEW YORK U LAW REV, V87, P960; McKenzie Troy A., 2012, NEW YORK U LAW REV, V87, P995; Mehran H, 2007, J FINANC ECON, V85, P267, DOI 10.1016/j.jfineco.2006.11.001; Mehran Hamid, 2007, J FINANC ECON, V85, P274; Meier B., 2016, NY TIMES; Miller GP, 2003, UNIV CHICAGO LEG FOR, V2003, P581; Moore NJ, 2011, GEORGE WASH LAW REV, V79, P717; Moore Nancy J., 1999, S TEX L REV, V41, P167; Moore Nancy J., 2011, GEORGE WASH LAW REV, V79, P732; Moore Nancy J., 2008, DEPAUL L REV, V57, P409; Moore Nancy J., 1999, S TEX L REV, V41, P177; Moore Nancy J., 2011, GEORGE WASH LAW REV, V79, P726; MOORE NJ, 1999, S TEX L REV, V41, P149; MOORE NJ, 2008, DEPAUL L REV, V57, P395; Mullenix LS, 2011, U CINCI LAW REV, V80, P389; Mullenix Linda S., 2018, U CIN L REV, V37, P157; Mullenix Linda S., 2018, REV LITIG, V37, P129; Nagareda RA, 2003, COLUMBIA LAW REV, V103, P149, DOI 10.2307/1123693; Nagareda RA, 2006, COLUMBIA LAW REV, V106, P1872; Nagareda Richard A., 2003, COLUMBIA LAW REV, V103, P168; Naidu S, 2018, HARVARD LAW REV, V132, P536; Naidu Suresh, 2018, HARVARD LAW REV, V132, P542; Needham Carol A., 2012, LOY U CHI LJ, V44, P528; Needham Carol A., 2012, LOY U CHI LJ, V44, P513; Needham Carol A., 2012, LOY U CHI LJ, V44, P530; Needham Carol A., 2012, LOY U CHI LJ, V44, P511; OLIVAS MA, 2013, MD L REV, V90, P1151; Olivas Michael A., 2013, MD L REV, V90, P1156; Rave DT, 2018, FIDUCIARY GOVERNMENT, P49; Rave DT, 2018, RES HBK CORP LAW GOV, P418; Rave DT, 2017, FORDHAM LAW REV, V85, P2175; Rave DT, 2013, VANDERBILT LAW REV, V66, P1183; Rave D. Theodore, 2012, J TORT L, V5, P109; Rave D. Theodore, 2016, GA L REV, V50, P508; Rave D. Theodore, 2016, GA L REV, V50, P475; Rave D. Theodore, 2018, RES HDB FIDUCIARY LA, P420; Rave D. Theodore, 2012, J TORT L, V5, P98; Redish MH, 2015, BOSTON U LAW REV, V95, P109; Redish Martin H., 2015, BU L REV, V95, P128; Redish Martin H., 2015, B U L REV, V95, P117; Resnik J, 2000, U PENN LAW REV, V148, P2119, DOI 10.2307/3312782; Resnik J, 1996, NEW YORK U LAW REV, V71, P296; Resnik J, 2017, FORDHAM LAW REV, V85, P1899; Resnik J, 2015, YALE LAW J, V124, P2804; Resnik Judith, 2015, YALE LAW J, V124, P2812; Resnik Judith, 2000, U PENN LAW REV, V148, P2127; Resnik Judith, 2017, FORDHAM L REV, V85, P1916; Rosenberg D, 2002, HARVARD LAW REV, V115, P831, DOI 10.2307/1342663; Rosenberg David, 2002, HARVARD LAW REV, V115, P852; Rubenstein WB, 2001, GEORGETOWN LAW J, V89, P371; Rubenstein WB, 1997, YALE LAW J, V106, P1623, DOI 10.2307/797318; Rubenstein William B., 1997, YALE LAW J, V106, P1632; S. COURTS, 2018, COMMITTEES RULES PRA; Silver C, 2003, NEW YORK U LAW REV, V78, P1357; Silver C, 2011, FORDHAM LAW REV, V79, P1985; Silver C, 2010, VANDERBILT LAW REV, V63, P107; Silver Charles, 1997, WAKE FOREST L REV, V32, P744; Silver Charles, 2010, VANDERBILT LAW REV, V63, P131; Silver Charles, 1997, WAKE FOREST L REV, V32, P733; SINCLAIR UPTON, 1934, CANDIDATE GOVERNOR I, P109; SLOAN FRANK A., 1993, SUING MED MALPRACTIC, P216; SLOAN FRANK A., 1993, SUING MEDICAL MALPRA, P201; Smith Douglas G., 2017, KAN L REV, V66, P225; Smith Douglas G., 2017, U KAN L REV, V66, P219; Sorkin Andrew Ross, 2007, NY TIMES; Steinitz M, 2011, MINN LAW REV, V95, P1268; STIER BG, 2005, UTAH L REV, P919; STIER BG, 2005, UTAH L REV, P863; U.S. COURTS COMMITTEES ON RULES OF PRACTICE AND PROCEDURE, 2017, COMMITTEES RULES PRA; Williams Margaret S., 2012, J TORT L, V5, P142; Williams Margaret S., 2012, J TORT L, V5, P141; Zimmerman AS, 2017, FORDHAM LAW REV, V85, P2275	194	5	5	0	0	GEORGETOWN LAW JOURNAL ASSOC	WASHINGTON	600 NEW JERSEY AVE N W, WASHINGTON, DC 20001 USA	0016-8092			GEORGETOWN LAW J	Georget. Law J.	NOV	2019	108	1					73	123					51	Law	Social Science Citation Index (SSCI)	Government & Law	KG5BX	WOS:000509963600002					2022-02-06	
J	Chen, XQ; Qian, BY; Kong, XL; Hao, J; Ye, Y; Yang, K; Xu, TL; Zhang, F				Chen, Xiaoqing; Qian, Boyu; Kong, Xiaoli; Hao, Jie; Ye, Yong; Yang, Kai; Xu, Tianli; Zhang, Feng			A20 protects neuronal apoptosis stimulated by lipopolysaccharide-induced microglial exosomes	NEUROSCIENCE LETTERS			English	Article						Neuroinflammation; Exosomes; Neuronal apoptosis; A20	SPINAL-CORD-INJURY; NF-KAPPA-B; EXPRESSION; ACTIVATION; INFLAMMATION; MECHANISM; DISEASE; CELLS	LPS-induced microglial activation has a major influence on neuronal damage in the inflammatory process. Integral to this is the cellular and molecular interaction between microglia and neurons. Exosomes, a mediator of communication between cells, can transfer lipids, proteins and nucleic acids, affecting many donor and recipient cells. To investigate the mechanism by which microglial exosomes regulate neuronal inflammation after traumatic brain injury, this study primarily analyzed the effect of microglial exosomes on neuronal apoptosis. Exosomes derived from lipopolysaccharide (LPS)-activated microglial cultures were identified and purified. Neurons treated with these exosomes underwent apoptosis. A20 (also known as TNF-inducible protein 3, TNFAIP3) is a deubiquitinating enzyme with key anti-inflammatory functions. A20 is of huge significance to the degeneration and development of neuron. Importantly, A20 protects the exosomes-induced neuronal death, while A20 knockdown increases neuronal death. This study shows that exosomes may be critical for communication between microglia and neurons.	[Chen, Xiaoqing; Hao, Jie; Zhang, Feng] Nantong Univ, Affiliated Hosp, Dept Orthoped, 20th Xisi Rd, Nantong 226001, Jiangsu, Peoples R China; [Qian, Boyu; Kong, Xiaoli; Ye, Yong; Yang, Kai; Xu, Tianli] Nantong Univ, Sch Med, Nantong 226001, Jiangsu, Peoples R China; [Qian, Boyu; Ye, Yong; Yang, Kai; Xu, Tianli] Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong 226001, Jiangsu, Peoples R China; [Kong, Xiaoli] Anhui 2 Prov Peoples Hosp, Dangshan Rd, Hefei 230041, Anhui, Peoples R China		Zhang, F (corresponding author), Nantong Univ, Affiliated Hosp, Dept Orthoped, 20th Xisi Rd, Nantong 226001, Jiangsu, Peoples R China.	zhangfengdoctor@sina.com			Jiangsu Provincial Key Medical Center [YXZXA2016001]; Jiangsu Commission of Health research projects [H2018026]; Health Commission of Nantong City [MA2019017, QB2019028]	This study was funded by Jiangsu Provincial Key Medical Center (Grant No. YXZXA2016001), Jiangsu Commission of Health research projects (Grant No. H2018026) and Health Commission of Nantong City (MA2019017, QB2019028).	Abbasi A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00021; Anderson MR, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0204-7; Balusu S, 2016, EMBO MOL MED, V8, P1162, DOI 10.15252/emmm.201606271; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Chen XQ, 2016, NEUROCHEM RES, V41, P2645, DOI 10.1007/s11064-016-1977-y; Chen Z, 2018, BIOSENS BIOELECTRON, V122, P211, DOI 10.1016/j.bios.2018.09.033; Chi H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103082; Coleman LG, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0799-4; Cunha C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6986175; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; G'Sell RT, 2015, ARTHRITIS RHEUMATOL, V67, P2292, DOI 10.1002/art.39245; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Hao J, 2016, NEUROCHEM RES, V41, P2391, DOI 10.1007/s11064-016-1952-7; He JC, 2017, CELL PHYSIOL BIOCHEM, V44, P1224, DOI 10.1159/000485452; Horstman LL, 2007, INT REV NEUROBIOL, V79, P227, DOI 10.1016/S0074-7742(07)79010-4; Jiao GL, 2015, MOL MED REP, V12, P7011, DOI 10.3892/mmr.2015.4265; Keatinge M, 2015, HUM MOL GENET, V24, P6640, DOI 10.1093/hmg/ddv369; Kim M, 2014, HISTOL HISTOPATHOL, V29, P1395, DOI 10.14670/HH-29.1395; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Miyamoto A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12540; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Pan JX, 2018, AM J CANCER RES, V8, P154; Pfrieger FW, 2018, J LIPID RES, V59, P2255, DOI 10.1194/jlr.R084210; Pranski EL, 2012, NEUROSCI LETT, V520, P104, DOI 10.1016/j.neulet.2012.05.043; Qu WS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-178; Rosenberger K, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0166-7; Shembade N, 2010, CELL CYCLE, V9, P2481, DOI 10.4161/cc.9.13.12269; Shi XW, 2015, IMMUNOL INVEST, V44, P497, DOI 10.3109/08820139.2015.1037957; Tian Y, 2019, ADV CLIN EXP MED, V28, P421, DOI 10.17219/acem/91826; Turola E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00149; Valdearcos M., 2014, J NEUROINFLAMM, V14, P22; Xu JW, 2017, BEHAV BRAIN RES, V332, P145, DOI 10.1016/j.bbr.2017.05.066; Xu S., 2018, BIOFACTORS; Yang JK, 2019, CNS NEUROL DISORD-DR, V18, P78, DOI 10.2174/1871527317666181105112009; Yu LY, 2006, NEUROCHEM RES, V31, P21, DOI 10.1007/s11064-005-9004-8; Zhan J., 2011, J BIOL CHEM, V286, P7905; Zhan J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0731-3	40	5	5	2	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 1	2019	712								134480	10.1016/j.neulet.2019.134480			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JN0PQ	WOS:000496606900009	31493550				2022-02-06	
J	Cook, NE; Kelshaw, PM; Caswell, SV; Iverson, GL				Cook, Nathan E.; Kelshaw, Patricia M.; Caswell, Shane, V; Iverson, Grant L.			Children with Attention-Deficit/Hyperactivity Disorder Perform Differently on Pediatric Concussion Assessment	JOURNAL OF PEDIATRICS			English	Article							DEFICIT HYPERACTIVITY DISORDER; HIGH-SCHOOL; MEDICATION; SYMPTOMS; SCORES; INJURY; ADHD; SEX	Objective To compare Child Sport Concussion Assessment Tool Fifth Edition (Child SCAT5) performance between uninjured children with attention-deficit/hyperactivity disorder (ADHD) and precisely matched controls without ADHD. Study design A nested case-control study was conducted within a cohort of middle school athletes (age 11-12 years) who completed preseason testing. Students with ADHD were individually matched to students without ADHD based on age, sex, language spoken at home, number of prior concussions, sport, and school they attended. The final sample included 54 students (27 with ADHD and 27 controls), 38 (70.4%) boys and 16 (29.6%) girls (average age: 11.7 years, SD = 0.5). Results Children with ADHD reported more symptoms (M = 13.33, SD = 5.69, P < .001) and greater symptom severity (M = 22.59, SD = 1 1.60, P < .001) compared with controls (total symptoms: M = 6.44, SD = 4.96; symptom severity: M = 8.04, SD = 6.36). Children with ADHD performed similarly to controls on the Child SCAT5 cognitive tests. Children with ADHD committed 3 times as many total balance errors (median = 6) than children without ADHD (median = 2) and committed twice as many errors on single leg stance (ADHD median = 4; No ADHD median = 2) (P values < .001). Conclusions Children with ADHD endorsed more concussion-like symptoms and performed worse on balance testing during preseason Child SCAT5 assessment compared with matched controls without ADHD. These findings highlight the challenges of interpreting Child SCAT5 performance in children with ADHD following a concussion or suspected concussion and illustrate the value of administering the measure to children to document their pre-injury performance.	[Cook, Nathan E.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Cook, Nathan E.; Iverson, Grant L.] MassGen Hosp Children Sport Concuss Program, 101 Merrimac St,10th Floor,Rm 1060, Boston, MA 02114 USA; [Cook, Nathan E.; Iverson, Grant L.] Spaulding Rehabil Hosp & Spaulding Res Inst, Boston, MA USA; [Kelshaw, Patricia M.; Caswell, Shane, V] George Mason Univ, Exercise Fitness & Hlth Promot Program, Fairfax, VA 22030 USA; [Kelshaw, Patricia M.; Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Fairfax, VA 22030 USA; [Caswell, Shane, V] George Mason Univ, Athlet Training Educ Program, Fairfax, VA 22030 USA		Cook, NE (corresponding author), MassGen Hosp Children Sport Concuss Program, 101 Merrimac St,10th Floor,Rm 1060, Boston, MA 02114 USA.	necook@mgh.harvard.edu	Kelshaw, Patricia/AAC-7220-2021		Louis V. Gerstner III Research Scholar Award; Potomac Health Foundation; Center for Disease Control; Virginia Department of Health; US Lacrosse; ImPACT Applications, Inc; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc); National Football League	N.C. acknowledges support from the Louis V. Gerstner III Research Scholar Award. S.C. acknowledges unrestricted grant funding from the Potomac Health Foundation, the Center for Disease Control, the Virginia Department of Health, and US Lacrosse. This study was done in connection with the ACHIEVES project, for which S.C. is the principal investigator. G.I. has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to mild TBI and sport-related concussion at meetings, scientific conferences, and symposiums; has a clinical and consulting practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes); serves as a scientific advisor for BioDirection, Inc, Sway Operations, LLC, and Highmark, Inc; has received research funding from several test publishing companies, including ImPACT Applications, Inc, CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc); has received research funding as a principal investigator from the National Football League, and salary support as a collaborator from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members; and acknowledges unrestricted philanthropic support from ImPACT Applications, Inc, the Heinz Family Foundation, the Boston Bolts, Sunnybrook Research Institute, and the Mooney-Reed Charitable Foundation. The other author declares no conflicts of interest.	Anderson LE, 2015, PEDIATRICS, V136, pE1178, DOI 10.1542/peds.2015-0807; [Anonymous], 2017, BRIT J SPORT MED, V51, P862, DOI [10.1136/bjsports-2016-097270.223, DOI 10.1136/BJSPORTS-2016-097270.223]; Babl FE, 2017, PEDIATRICS, V140; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cohen J., 2013, STAT POWER ANAL BEHA; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Goulardins JB, 2017, PERCEPT MOTOR SKILL, V124, P425, DOI 10.1177/0031512517690607; Goulardins JB, 2013, RES DEV DISABIL, V34, P40, DOI 10.1016/j.ridd.2012.07.014; Itriyeva K, 2017, INT J ADOLESC MED HL; Iverson GL, 2016, J ATTENTION DISORD; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2016, J NEUROTRAUM, V33, P2077, DOI 10.1089/neu.2014.3424; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lotfi Y, 2017, EAR HEARING, V38, pE352, DOI 10.1097/AUD.0000000000000451; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; Ren YC, 2014, CHINESE MED J-PEKING, V127, P4197, DOI 10.3760/cma.j.issn.0366-6999.20141559; Neto FR, 2015, REV BRAS PSIQUIATR, V37, P228, DOI 10.1590/1516-4446-2014-1533; Shum SBM, 2009, J PEDIATR-US, V155, P245, DOI 10.1016/j.jpeds.2009.02.032; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Wojtowicz M, 2017, J NEUROTRAUM, V34, P322, DOI 10.1089/neu.2016.4412; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	31	5	5	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	NOV	2019	214						168	+		10.1016/j.jpeds.2019.07.048			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	JG6PG	WOS:000492192700032	31477384				2022-02-06	
J	Deng, HS; Yue, JK; Winkler, EA; DhaII, SS; Manley, GT; Tarapore, PE				Deng, Hansen; Yue, John K.; Winkler, Ethan A.; DhaII, Sanjay S.; Manley, Geoffrey T.; Tarapore, Phiroz E.			Pediatric firearm-related traumatic brain injury in United States trauma centers	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						firearm epidemiology; pediatric firearm; gunshot wounds to the head; mortality; penetrating brain injury; traumatic brain injury; trauma	INTRACRANIAL GUNSHOT WOUNDS; CHILDREN; SUICIDE; PREDICTORS; OUTCOMES; TRENDS; HOMES	OBJECTIVE Pediatric firearm injury is a leading cause of death and disability in the youth of the United States. The epidemiology of and outcomes following gunshot wounds to the head (GSWHs) are in need of systematic characterization. Here, the authors analyzed pediatric GSWHs from a population-based sample to identify predictors of prolonged hospitalization, morbidity, and death. METHODS All patients younger than 18 years of age and diagnosed with a GSWH in the National Sample Program (NSP) of the National Trauma Data Bank (NTDB) in 2003-2012 were eligible for inclusion in this study. Variables of interest included injury intent, firearm type, site of incident, age, sex, race, health insurance, geographic region, trauma center level, isolated traumatic brain injury (TBI), hypotension in the emergency department, Glasgow Coma Scale (GCS) score, and Injury Severity Score (ISS). Risk predictors for a prolonged hospital stay, morbidity, and mortality were identified. Odds ratios, mean increases or decreases (B), and 95% confidence intervals were reported. Statistical significance was assessed at alpha < 0.001 accounting for multiple comparisons. RESULTS In a weighted sample of 2847 pediatric patients with GSWHs, the mean age was 14.8 +/- 3.3 years, 79.2% were male, and 59.0% had severe TBI (GCS score 3-8). The mechanism of assault (63.0%), the handgun as firearm (45.6%), and an injury incurred in a residential area (40.6%) were most common. The mean hospital length of stay was 11.6 +/- 14.4 days for the survivors, for whom suicide injuries involved longer hospitalizations (B = 5.9-day increase, 95% CI 3.3-8.6, p < 0.001) relative to those for accidental injuries. Mortality was 45.1% overall but was greater with injury due to suicidal intent (mortality 71.5%, p < 0.001) or caused by a shotgun (mortality 56.5%, p < 0.001). Lower GCS scores, higher ISSs, and emergency room hypotension predicted poorer outcomes. Patients with private insurance had lower mortality odds than those with Medicare/Medicaid (OR 2.4, 95% CI 1.7-3.4, p < 0.001) or government insurance (OR 3.6, 95% CI 2.2-5.8, p < 0.001). Management at level II centers, compared to level I, was associated with lower odds of returning home (OR 0.3, 95% CI 0.2-0.5, p < 0.001). CONCLUSIONS From 2003 to 2012, with regard to pediatric TBI hospitalizations due to GSWHs, their proportion remained stable, those caused by accidental injuries decreased, and those attributable to suicide increased. Overall mortality was 45%. Hypotension, cranial and overall injury severity, and suicidal intent were associated with poor prognoses. Patients treated at level II trauma centers had lower odds of being discharged home. Given the spectrum of risk factors that predispose children to GSWHs, emphasis on screening, parental education, and standardization of critical care management is needed to improve outcomes.	[Deng, Hansen] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Deng, Hansen; Yue, John K.; Winkler, Ethan A.; DhaII, Sanjay S.; Manley, Geoffrey T.; Tarapore, Phiroz E.] San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94110 USA; [Yue, John K.; Winkler, Ethan A.; DhaII, Sanjay S.; Manley, Geoffrey T.; Tarapore, Phiroz E.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Tarapore, PE (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	phiroz.tarapore@ucsf.edu	Yue, John/P-1348-2015	Yue, John/0000-0001-9694-7722			American College of Surgeons, 2018, NAT TRAUM DAT BANK N; [Anonymous], 2001, J Trauma, V51, pS3; Baker S, 2012, INJURY RES THEORIES; Bandt SK, 2012, J NEUROSURG-PEDIATR, V10, P511, DOI 10.3171/2012.8.PEDS123; Baxley F, 2006, ARCH PEDIAT ADOL MED, V160, P542, DOI 10.1001/archpedi.160.5.542; Bekelis K, 2015, ANN SURG, V261, P579, DOI 10.1097/SLA.0000000000000672; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; Bridge JA, 2008, JAMA-J AM MED ASSOC, V300, P1025, DOI 10.1001/jama.300.9.1025; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Coughlan MD, 2003, CHILD NERV SYST, V19, P348, DOI 10.1007/s00381-003-0736-y; Cudnik MT, 2009, J TRAUMA, V66, P1321, DOI 10.1097/TA.0b013e3181929e2b; DeCuypere M, 2016, J NEUROSURG-PEDIATR, V17, P595, DOI 10.3171/2015.7.PEDS15285; Deng HS, 2019, J NEUROTRAUM, V36, P322, DOI 10.1089/neu.2017.5591; DiScala C, 2004, PEDIATRICS, V113, P1306, DOI 10.1542/peds.113.5.1306; Doan N, 2016, J SURG CASE REP, V2016, P2016; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; HOLLERMAN JJ, 1990, AM J ROENTGENOL, V155, P685, DOI 10.2214/ajr.155.4.2119095; Irfan FB, 2010, CHILD NERV SYST, V26, P61, DOI 10.1007/s00381-009-0971-y; Jackman GA, 2001, PEDIATRICS, V107, P1247, DOI 10.1542/peds.107.6.1247; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Majidi S, 2013, AM J EMERG MED, V31, P1215, DOI 10.1016/j.ajem.2013.05.026; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; ORDOG GJ, 1988, J TRAUMA, V28, P624, DOI 10.1097/00005373-198805000-00011; Paus T, 2010, HORM BEHAV, V57, P63, DOI 10.1016/j.yhbeh.2009.08.004; Pelosi P, 2011, CRIT CARE MED, V39, P1482, DOI 10.1097/CCM.0b013e31821209a8; Plemmons G, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2426; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Rowhani-Rahbar A, 2016, EPIDEMIOL REV, V38, P111, DOI 10.1093/epirev/mxv006; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schoenfeld AJ, 2013, SPINE J, V13, P1766, DOI 10.1016/j.spinee.2013.03.024; Schwebel DC, 2014, HEALTH EDUC BEHAV, V41, P299, DOI 10.1177/1090198113512126; Shah S, 2000, J ADOLESCENT HEALTH, V26, P157, DOI 10.1016/S1054-139X(99)00064-6; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tandean S, 2017, MED J INDONES, V26, P302, DOI 10.13181/mji.v26i4.1472; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Winkler EA, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15613; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612	45	5	5	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2019	24	5					498	508		10.3171/2019.5.PEDS19119			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JJ2IN	WOS:000493985200003	31491751				2022-02-06	
J	Heredia, M; Rodriguez, N; Robledo, VS; Criado, JM; de la Fuente, A; Devesa, J; Devesa, P; Riolobos, AS				Heredia, Margarita; Rodriguez, Natalia; Sanchez Robledo, Virginia; Criado, Jose Maria; de la Fuente, Antonio; Devesa, Jesus; Devesa, Pablo; Sanchez Riolobos, Adelaida			Factors Involved in the Functional Motor Recovery of Rats with Cortical Ablation after GH and Rehabilitation Treatment: Cortical Cell Proliferation and Nestin and Actin Expression in the Striatum and Thalamus	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						growth hormone; traumatic brain injury; neural plasticity; neurogenesis; actin; nestin; striatum; thalamus	GROWTH-HORMONE GH; FRONTAL-CORTEX LESION; REPLACEMENT THERAPY; HYPOXIA-ISCHEMIA; STEM-CELLS; ADULT-RATS; FACTOR-I; BRAIN; PLASTICITY; NEURONS	Previously we demonstrated, in rats, that treatment with growth hormone (GH) and rehabilitation, carried out immediately after a motor cortical ablation, significantly improved the motor affectation produced by the lesion and induced the re-expression of nestin in the contralateral motor cortex. Here we analyze cortical proliferation after ablation of the frontal motor cortex and investigate the re-expression of nestin in the contralateral motor cortex and the role of the striatum and thalamus in motor recovery. The rats were subjected to ablation of the frontal motor cortex in the dominant hemisphere or sham-operated and immediately treated with GH or the vehicle (V), for five days. At 1 dpi (days post-injury), all rats received daily injections (for four days) of bromodeoxyuridine and five rats were sacrificed at 5 dpi. The other 15 rats (n = 5/group) underwent rehabilitation and were sacrificed at 25 dpi. GH induced the greatest number of proliferating cells in the perilesional cortex. GH and rehabilitation produced the functional recovery of the motor lesion and increased the expression of nestin in the striatum. In the thalamic ventral nucleus ipsilateral to the lesion, cells positive for nestin and actin were detected, but this was independent on GH. Our data suggest that GH-induced striatal nestin is involved in motor recovery.	[Heredia, Margarita; Rodriguez, Natalia; Sanchez Robledo, Virginia; Criado, Jose Maria; de la Fuente, Antonio; Sanchez Riolobos, Adelaida] Univ Salamanca, Dept Physiol & Pharmacol, Inst Neurosci Castilla & Leon INCyL, Ave Alfonso X El Sabio S-N, Salamanca 37007, Spain; [Devesa, Jesus] Med Ctr Foltra, Sci Direct, Travesia Montouto 24, Teo 15894, Spain; [Devesa, Pablo] Med Ctr Foltra, Res & Dev, Travesia Montouto 24, Teo 15894, Spain		Heredia, M (corresponding author), Univ Salamanca, Dept Physiol & Pharmacol, Inst Neurosci Castilla & Leon INCyL, Ave Alfonso X El Sabio S-N, Salamanca 37007, Spain.; Devesa, J (corresponding author), Med Ctr Foltra, Sci Direct, Travesia Montouto 24, Teo 15894, Spain.	mheredia@usal.es; natalia.rguez.gil@gmail.com; robledo@usal.es; jmcriado@usal.es; jfuente@usal.es; jesus.devesa@usc.es; pdevesap@foltra.org; asriolob@usal.es	Devesa, J./C-4910-2018; Criado, Jose M/B-2579-2017	Devesa, J./0000-0002-4153-2543; Criado, Jose M/0000-0002-3457-9896	Foundation Foltra (Teo, Spain) [2018-8]	This research was funded by Foundation Foltra (Teo, Spain), grant number 2018-8.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Acarin L, 1999, NEUROSCIENCE, V92, P827, DOI 10.1016/S0306-4522(99)00022-6; Alba-Betancourt C, 2013, GEN COMP ENDOCR, V183, P17, DOI 10.1016/j.ygcen.2012.12.004; Arce VM, 2013, NEUROSCI RES, V76, P179, DOI 10.1016/j.neures.2013.03.014; Biane JS, 2016, NEURON, V89, P1173, DOI 10.1016/j.neuron.2016.02.001; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Christophidis LJ, 2009, GROWTH HORM IGF RES, V19, P497, DOI 10.1016/j.ghir.2009.05.001; Chu CJ, 2000, EXP NEUROL, V166, P403, DOI 10.1006/exnr.2000.7509; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Devesa J., 2012, BRAIN INJURY PATHOGE, P417; Devesa J, 2016, CLIN MED INSIGHTS-EN, V9, P47, DOI 10.4137/CMEDED.S38201; Devesa J, 2015, INT J MOL SCI, V16, P30470, DOI 10.3390/ijms161226244; Devesa J, 2013, HORM BEHAV, V63, P331, DOI 10.1016/j.yhbeh.2012.02.022; Devesa P, 2011, BRAIN INJURY, V25, P503, DOI 10.3109/02699052.2011.559611; Dubiel R, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00520; ELLWART J, 1985, CYTOMETRY, V6, P513, DOI 10.1002/cyto.990060605; Groenewegen HJ, 2004, RAT NERVOUS SYSTEM, P407; Heredia M, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/6125901; Heredia M, 2013, BEHAV BRAIN RES, V247, P48, DOI 10.1016/j.bbr.2013.03.012; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Isgaard J, 2007, Minerva Endocrinol, V32, P103; Jones EG, 2007, THALAMUS; Jones T. A., 2010, BRAIN REPAIR STROKE, P23, DOI DOI 10.1017/CBO9780511777547.004; JONES TA, 1994, J NEUROSCI, V14, P2140; JONES TA, 1992, BRAIN RES, V581, P156, DOI 10.1016/0006-8993(92)90356-E; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/S0006-8993(96)00792-5; Kartje GL, 1999, ANN NEUROL, V45, P778, DOI 10.1002/1531-8249(199906)45:6<778::AID-ANA12>3.0.CO;2-B; Kolb B, 1999, J NEUROSCI, V19, P2337; Lam YW, 2015, J NEUROPHYSIOL, V113, P3090, DOI 10.1152/jn.00847.2014; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li RC, 2011, NEUROSCIENCE, V196, P237, DOI 10.1016/j.neuroscience.2011.08.029; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lobie PE, 2000, GROWTH HORM IGF RES, V10, P51; Lu X, 1997, J COMP NEUROL, V388, P484; MANCINI WR, 1991, CANCER RES, V51, P870; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; MATTHEWS DA, 1990, J MOL BIOL, V214, P937, DOI 10.1016/0022-2836(90)90347-O; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McNeill TH, 1999, NEUROSCIENCE, V90, P1349, DOI 10.1016/S0306-4522(98)00482-5; Moreau OK, 2013, J NEUROTRAUM, V30, P998, DOI 10.1089/neu.2012.2705; MORRIS SM, 1991, MUTAT RES, V258, P161, DOI 10.1016/0165-1110(91)90007-I; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; Ohab JJ, 2008, NEUROSCIENTIST, V14, P369, DOI 10.1177/1073858407309545; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Pathipati P, 2009, BEHAV BRAIN RES, V204, P93, DOI 10.1016/j.bbr.2009.05.023; Plantier M, 1998, NEUROSCI LETT, V247, P49, DOI 10.1016/S0304-3940(98)00280-8; Rao MS, 1999, ANAT RECORD, V257, P137; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Riolobos AS, 2001, NEUROBIOL LEARN MEM, V75, P274, DOI 10.1006/nlme.2000.3979; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Shen CC, 2010, CURR NEUROVASC RES, V7, P6, DOI 10.2174/156720210790820208; Shin DH, 2004, NEUROSCI LETT, V354, P64, DOI 10.1016/j.neulet.2003.09.070; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; SZELE FG, 1995, J NEUROSCI, V15, P4429; Valero J, 2005, BRAIN RES PROTOC, V15, P127, DOI 10.1016/j.brainresprot.2005.06.001; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; WILSON CJ, 1987, J COMP NEUROL, V263, P567, DOI 10.1002/cne.902630408; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577	63	5	5	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	NOV	2019	20	22							5770	10.3390/ijms20225770			21	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	JW0YW	WOS:000502786800252	31744113	Green Submitted, Green Published, gold			2022-02-06	
J	Luo, HC; Fu, YQ; You, CY; Liu, CJ; Xu, F				Luo, Hong-chun; Fu, Yue-qiang; You, Cheng-yan; Liu, Cheng-jun; Xu, Feng			Comparison of admission serum albumin and hemoglobin as predictors of outcome in children with moderate to severe traumatic brain injury A retrospective study	MEDICINE			English	Article						albumin; hemoglobin; mortality; pediatric; traumatic brain injury	HEAD-INJURY; ANEMIA; MORTALITY; IMPACT; RESUSCITATION; LEVEL; SCORE	Hypoalbuminemia and anemia are frequent among in patients with traumatic brain injury (TBI). We assess whether serum albumin and hemoglobin at admission can predict outcome in children with moderate to severe TBI. This retrospective study was conducted in a tertiary pediatric hospital between May 2012 and Jun 2018 included children with an admission Glasgow Coma Scale of <= 13. A total of 213 patients were included of whom 45 died in hospital. Multivariate logistic regression showed that hypoalbuminemia (serum albumin <30 g/L) was independently associated with mortality (adjusted odds ratio [OR]=3.059; 95% confidence interval [CI]: 1.118-8.371; P=.030) in children with moderate to severe TBI, while anemia (hemoglobin <90 g/L) was not independently associated with mortality (adjusted OR=1.742; 95% CI: 0.617-4.916; P=.295). Serum albumin was significantly superior to hemoglobin (area under the curve [AUC] 0.738 vs AUC 0.689, P<.05) under receiver operating characteristic curve analysis. Hypoalbuminemia was also associated with reduced 14-day ventilation-free days, 14-day intensive care unit (ICU)-free days, and 28-day hospital-free days. Serum albumin at admission was superior to hemoglobin in predicting the mortality in children with moderate to severe TBI and also associated with reduced ventilator-free, ICU-free, and hospital-free days.	[Luo, Hong-chun] Chongqing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Chongqing, Peoples R China; [Fu, Yue-qiang; You, Cheng-yan; Liu, Cheng-jun; Xu, Feng] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, 136 Zhongshan Er Rd, Chongqing 400014, Peoples R China; [Fu, Yue-qiang; You, Cheng-yan; Liu, Cheng-jun; Xu, Feng] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Fu, Yue-qiang; You, Cheng-yan; Liu, Cheng-jun; Xu, Feng] Natl Clin Res Ctr Child Hlth & Disorders Chongqin, Chongqing, Peoples R China; [Fu, Yue-qiang; You, Cheng-yan; Liu, Cheng-jun; Xu, Feng] China Int Sci & Technol Cooperat Base Child Dev &, Chongqing, Peoples R China; [Fu, Yue-qiang; You, Cheng-yan; Liu, Cheng-jun; Xu, Feng] Chongqing Key Lab Pediat, Chongqing, Peoples R China		Fu, YQ (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, 136 Zhongshan Er Rd, Chongqing 400014, Peoples R China.	fuyueqiang@sina.com					Aguayo-Becerra OA, 2013, CLINICS, V68, P940, DOI 10.6061/clinics/2013(07)09; Al-Dorzi HM, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/672639; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093167; Chung AS, 2018, J ORTHOP TRAUMA, V32, P155, DOI 10.1097/BOT.0000000000001081; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Fu YQ, 2017, BRAIN INJURY, V31, P396, DOI 10.1080/02699052.2016.1264629; Kamal Hm, 2007, Libyan J Med, V2, P90, DOI 10.4176/070210; Leite HP, 2016, PEDIATR CRIT CARE ME, V17, pE50, DOI 10.1097/PCC.0000000000000596; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; Morotti A, 2017, J NEUROL, V264, P905, DOI 10.1007/s00415-017-8451-x; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Okoye O, 2013, EUR J TRAUMA EMERG S, V39, P627, DOI 10.1007/s00068-013-0307-1; Rodoman G. V., 2006, Anesteziologiya i Reanimatologiya, P62; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sorby-Adams AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081788; Sung J, 2004, AM SURGEON, V70, P1099; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Yang CJ, 2011, J TRAUMA, V71, pE132, DOI 10.1097/TA.0b013e31820ea36b; Yee KF, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/6803860	28	5	6	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2019	98	44							e17806	10.1097/MD.0000000000017806			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JO7BV	WOS:000497731800123	31689863	Green Published			2022-02-06	
J	Ravn, J; Chalmer, MA; Oehrstroem, EL; Kogelman, LJA; Hansen, TF				Ravn, Julie; Chalmer, Mona A.; Oehrstroem, Emil L.; Kogelman, Lisette J. A.; Hansen, Thomas F.			Characterization of Familial and Sporadic Migraine	HEADACHE			English	Article						aura; comorbidity; treatment response; clinical characteristics; severity	SUSCEPTIBILITY LOCI; QUESTIONNAIRE; METAANALYSIS; VALIDATION	Background It is unknown whether clinical parameters differ between migraineurs with and without first-degree family members with migraine. Objectives The present cross-sectional study describes differences between familial and sporadic migraine with a focus on migraine characteristics, migraine severity, comorbidities, and treatment. Method From the Danish Headache Center we recruited 358 patients with familial migraine and 1727 patients with sporadic migraine. Each participant was assessed using a validated semi-structured interview. Results No differences in age (Mean = 44 and 44 [SD = 12.28 and 12.58] for familial and sporadic migraineurs, respectively; P = .900) or sex (295/358 (82.4%) and 1413/1727 (81.8%) women in familial and sporadic migraineurs, respectively; P = .853) were found. Familial migraineurs had more aphasic aura than sporadic migraineurs (41% vs 27%, P = .001). Sporadic migraineurs had more lifetime attacks ie, >100 attacks (45% vs 70%, P < .001) and prolonged attacks ie, lasting >72 hours (5% vs 12%, P < .001) than familial migraineurs. Further, sporadic migraineurs had a higher incidence of concussions (37% vs 41%, P = .001) compared to familial migraineurs. In agreement with a previous study, there was no difference between familial and sporadic migraine regarding triptan response (84% vs 81%, P = .440). Conclusion Headache characteristics, triptan response, and comorbidities where similar in individulas with and without inherited migraine, suggesting that migraine are to be considered a hmogenoues disease. The difference in the clinical presentation of migraine with aura symptoms among patients with familial migraine should be considered in future studies. Further, more severe migraine among patients with sporadic migraine with aura could suggest that sporadic migraineurs have been exposed to stronger or multiple environmental factors and indicate that an early intervention in migraine treatment could lessen the severity of migraine.	[Ravn, Julie; Chalmer, Mona A.; Oehrstroem, Emil L.; Kogelman, Lisette J. A.; Hansen, Thomas F.] Copenhagen Univ Hosp, Rigshosp Glostrup, Danish Headache Ctr, Dept Neurol, Glostrup, Denmark		Hansen, TF (corresponding author), Copenhagen Univ Hosp, Rigshosp Glostrup, Danish Headache Ctr, Dept Neurol, Glostrup, Denmark.	thomas.hansen@regionh.dk	Chalmer, Mona Ameri/ABF-6630-2021; Hansen, Thomas Folkmann/O-5965-2014	Hansen, Thomas Folkmann/0000-0001-6703-7762; Chalmer, Mona Ameri/0000-0003-4609-1895	LundbeckfondenLundbeckfonden Funding Source: Medline; Candys Foundation Funding Source: Medline		Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Eriksen MK, 2004, CEPHALALGIA, V24, P564, DOI 10.1111/j.1468-2982.2003.00718.x; Esserlind AL, 2013, EUR J NEUROL, V20, P765, DOI 10.1111/ene.12055; Esserlind AL, 2016, CEPHALALGIA, V36, P615, DOI 10.1177/0333102415570492; Gervil M, 1998, CEPHALALGIA, V18, P342, DOI 10.1046/j.1468-2982.1998.1806342.x; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Hudson JI, 2005, EPIDEMIOLOGY, V16, P355, DOI 10.1097/01.ede.0000158224.50593.e3; Kirchmann M, 2006, EUR J NEUROL, V13, P1239, DOI 10.1111/j.1468-1331.2006.01491.x; Mulder EJ, 2003, TWIN RES, V6, P422, DOI 10.1375/136905203770326420; Pelzer N, 2019, CEPHALALGIA, V39, P229, DOI 10.1177/0333102418783295; Rainero I, 2002, FUNCT NEUROL, V17, P193; RASMUSSEN BK, 1991, HEADACHE, V31, P290, DOI 10.1111/j.1526-4610.1991.hed3105290.x; RUSSELL MB, 1995, BRIT MED J, V311, P541, DOI 10.1136/bmj.311.7004.541; Ziegler DK, 1998, HEADACHE, V38, P417, DOI 10.1046/j.1526-4610.1998.3806417.x	14	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	NOV	2019	59	10					1802	1807		10.1111/head.13640			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JL4KM	WOS:000495499400014	31544229	Green Published, hybrid			2022-02-06	
J	Schneider, KJ; Emery, CA; Black, A; Yeates, KO; Debert, CT; Lun, V; Meeuwisse, WH				Schneider, Kathryn J.; Emery, Carolyn A.; Black, Amanda; Yeates, Keith O.; Debert, Chantel T.; Lun, Victor; Meeuwisse, Willem H.			Adapting the Dynamic, Recursive Model of Sport Injury to Concussion: An Individualized Approach to Concussion Prevention, Detection, Assessment, and Treatment	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						assessment; clinical care; concussion; prevention; rehabilitation	TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSION SYMPTOMS; COLLEGIATE-ATHLETIC-ASSOCIATION; WHIPLASH-ASSOCIATED DISORDERS; CLINICAL-PRACTICE GUIDELINE; STATES HIGH-SCHOOL; VESTIBULAR REHABILITATION; RISK-FACTORS; PITUITARY DYSFUNCTION; NECK PAIN	SYNOPSIS: The risk factors of concussion may be categorized as intrinsic (internal factors specific to the individual) or extrinsic (external factors related to the environment or sport). Identifying these factors is part of an individualized, patient-centered approach to prevention, assessment, and management of concussion. In most cases, the symptoms of concussion resolve in the initial few days following the injury, and a strategy involving a gradual return to sport and school is recommended. When symptoms persist for longer than 7 to 10 days, a multifaceted interdisciplinary assessment to guide treatment is recommended. This article applies the dynamic, recursive model of sport injury to sport-related concussion and summarizes the process of individualized assessment and management following concussion in athletes of all ages, with a focus on physical rehabilitation.	[Schneider, Kathryn J.; Emery, Carolyn A.; Black, Amanda; Yeates, Keith O.; Meeuwisse, Willem H.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Schneider, Kathryn J.; Emery, Carolyn A.; Black, Amanda; Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Schneider, Kathryn J.; Emery, Carolyn A.; Black, Amanda; Yeates, Keith O.; Debert, Chantel T.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schneider, Kathryn J.; Lun, Victor] Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; [Black, Amanda; Yeates, Keith O.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Debert, Chantel T.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada		Schneider, KJ (corresponding author), Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca	Emery, Carolyn/AAI-2761-2020; Yeates, Keith/AAJ-4223-2020; Black, Amanda/O-7675-2017	Schneider, Kathryn/0000-0002-5951-5899; Debert, Chantel/0000-0002-2704-0438; Black, Amanda/0000-0001-5668-9706	International Olympic Committee for Prevention of Injury and Protection of Athlete Health	The Sport Injury Prevention Research Centre, Faculty of Kinesiology, University of Calgary is one of eleven International Research Centres supported by the International Olympic Committee for Prevention of Injury and Protection of Athlete Health. The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Auble BA, 2014, J NEUROTRAUM, V31, P321, DOI 10.1089/neu.2013.2916; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Blake TA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022735; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Brodovsky JR, 2013, PHYS THER, V93, P293, DOI 10.2522/ptj.20120057; Brodsky JR, 2018, OTOLARYNG HEAD NECK, V159, P365, DOI 10.1177/0194599818770618; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Clark JF., 2015, OPTOM VIS PERFORM, P116; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P221; Diener HC, 2010, CEPHALALGIA, V30, P804, DOI 10.1177/0333102410364677; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Espie CA, 2007, SLEEP, V30, P574, DOI 10.1093/sleep/30.5.574; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gamble A, 2019, TLS-TIMES LIT SUPPL, P15; Gerschman T, 2017, BRIT J SPORT MED, V51, pA27, DOI [10.1136/bjsports-2016-097270.69, DOI 10.1136/BJSPORTS-2016-097270.69]; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenhill DA, 2016, SPORTS HEALTH, V8, P238, DOI 10.1177/1941738116639027; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hillier SL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub2; Hislop MD, 2017, BRIT J SPORT MED, V51, P1140, DOI 10.1136/bjsports-2016-097434; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Jull G, 2004, MANUAL THER, V9, P89, DOI 10.1016/S1356-689X(03)00086-9; Jull GA, 2008, J MANIP PHYSIOL THER, V31, P525, DOI 10.1016/j.jmpt.2008.08.003; Karaca Z, 2016, PROG MOL BIOL TRANSL, V138, P167, DOI 10.1016/bs.pmbts.2015.10.010; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116664500; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Langelier DM, 2017, CLIN J SPORT MED, V27, pE78, DOI 10.1097/JSM.0000000000000408; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lithgow K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0247-1; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Macias JD, 2000, LARYNGOSCOPE, V110, P1921, DOI 10.1097/00005537-200011000-00029; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Maerlender A, 2013, J NEUROPSYCHIATR CLI, V25, P161, DOI [10.1176/appi.neuropsych.252161, DOI 10.1176/APPI.NEUROPSYCH.252161]; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Robbins MS, 2014, HEADACHE, V54, P1441, DOI 10.1111/head.12442; Rueda S, 2012, AM J PUBLIC HEALTH, V102, P541, DOI 10.2105/AJPH.2011.300401; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Schneider KJ, 2021, CLIN J SPORT MED, V31, P70, DOI 10.1097/JSM.0000000000000673; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Schneider KJ, 2014, BJSM, V48, P659, DOI DOI 10.1136/BJSP0RTS-2014-093494.264; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]; Wiseman-Hakes C, 2013, BRAIN INJURY, V27, P1364, DOI 10.3109/02699052.2013.823663; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	127	5	5	3	4	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	NOV	2019	49	11					799	810		10.2519/jospt.2019.8926			12	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	JJ1VP	WOS:000493950100005	31610760	Bronze			2022-02-06	
J	Scratch, SE; Rumney, P; Agnihotri, S; Reed, N				Scratch, Shannon E.; Rumney, Peter; Agnihotri, Sabrina; Reed, Nick			Pediatric Concussion: Managing Persistent Symptoms With an Interdisciplinary Approach	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; interdisciplinary; mild traumatic brain injury; multidisciplinary; pediatrics; persistent concussion; persistent symptoms	SPORT-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; MANAGEMENT; CHILDREN; HEALTH; CARE; MULTIDISCIPLINARY; REHABILITATION; RECOVERY; VISITS	Objective: We outline the development of a clinic that works directly with youth clients, their caregivers, and family members to help address symptoms that are persisting long after the youth sustained a concussion. Client referral characteristics are described, as well as general clinic flow and procedures. Particular emphasis is placed on a novel interdisciplinary team assessment pathway designed with input from clients and families to help provide consistent treatment plans, education, direction, and conclusions for those clients with complex psychosocial, cognitive, and physical presentations. Setting and Participants: The Persistent Concussion Clinic at Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario, Canada. Conclusions: Youth with persistent concussion symptoms have limited access to interdisciplinary clinics and supports. This article outlines the practices of a large, hospital-based interdisciplinary clinic whose model can inform clinical care pathways and practices for this underserved population. Facilitators and barriers to access are discussed and future directions for the clinic and persistent concussion care in Ontario and internationally are reviewed.	[Scratch, Shannon E.; Rumney, Peter; Agnihotri, Sabrina; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada; [Scratch, Shannon E.] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Scratch, Shannon E.; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Agnihotri, Sabrina] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Scratch, SE (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, 150 Kilgour Rd, Toronto, ON M4G 1R8, Canada.	sscratch@hollandbloorview.ca					Amato MP, 2017, NEUROL SCI, V38, P1849, DOI 10.1007/s10072-017-3081-8; Amen DanielG., 2015, CHANGE YOUR BRAIN CH; Anderson J, 2018, DISABIL REHABIL, V40, P859, DOI 10.1080/09638288.2016.1276973; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Borgermans L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-179; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Comper P, 2012, J CLIN SPORT PSYCHOL, V6, P231, DOI 10.1123/jcsp.6.3.231; Crisp BR, 2000, HEALTH PROMOT INT, V15, P99, DOI 10.1093/heapro/15.2.99; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Hunt AW, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1664-3; Hunt AW, 2018, BRAIN INJURY, V32, P1534, DOI 10.1080/02699052.2018.1502894; Jessup RL, 2007, AUST HEALTH REV, V31, P330, DOI 10.1071/AH070330; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Korner M, 2010, CLIN REHABIL, V24, P745, DOI 10.1177/0269215510367538; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGill M, 2017, J CLIN TRANSL ENDOCR, V7, P21, DOI 10.1016/j.jcte.2016.12.001; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Ojikutu B, 2014, AIDS CARE, V26, P731, DOI 10.1080/09540121.2013.855299; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Zemek R, 2014, GUIDELINES DIAGNOSIN; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	37	5	5	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					385	393		10.1097/HTR.0000000000000542			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200008	31688376				2022-02-06	
J	Sommer, JL; El-Gabalawy, R; Mota, N				Sommer, Jordana L.; El-Gabalawy, Renee; Mota, Natalie			Understanding the association between posttraumatic stress disorder characteristics and physical health conditions: A population-based study	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Article						Posttraumatic stress disorder; Physical health conditions; Comorbidity; Trauma	NATIONAL EPIDEMIOLOGIC SURVEY; TRAUMATIC BRAIN-INJURY; PTSD SYMPTOMS; MENTAL-HEALTH; WAVE 2; ALCOHOL; COMORBIDITY; CHILDHOOD; VETERANS; DISEASE	Posttraumatic stress disorder (PTSD) is commonly comorbid with a range of physical health conditions. The aim of this study was to examine the association between index trauma and PTSD symptom clusters with physical health conditions, among individuals with PTSD in a population-based sample. Data were analyzed from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III; N = 36,309). Past-year PTSD (n = 1779) was assessed using a clinical interview in accordance with DSM-5 criteria. Multiple logistic regression models examined the associations between PTSD symptom clusters and index trauma with physical health conditions. Results of the most stringent model, adjusting for sociodemographics, other psychiatric conditions, and other PTSD symptom clusters, indicated re-experiencing symptoms were associated with cardiovascular and endocrine/metabolic conditions (adjusted odds ratio (AOR) range: 1.18-1.33) and negative alterations in mood and cognition symptoms were associated with sleep disorder (AOR = 1.16, 95% confidence interval (CI) [1.04-1.30], p = .009). Results also demonstrated significant associations between life-threatening illness with cancer, digestive, and neurologic conditions (AOR range: 2.10-3.42) and life-threatening injury with musculoskeletal and neurologic conditions (AOR range: 1.76-2.04). Finally, significant associations emerged between psychological trauma with musculoskeletal and neurologic conditions (AOR range: 0.48-0.66), and other trauma with digestive conditions and anemia (AOR range: 0.38-0.47). Results suggest PTSD symptomatology and index trauma play a differential role in their association with variable physical health conditions. Results may inform screening practices and targeted interventions to mitigate risk of PTSD and physical health conditions.	[Sommer, Jordana L.; El-Gabalawy, Renee] Univ Manitoba, Fac Arts, Dept Psychol, Winnipeg, MB, Canada; [Sommer, Jordana L.; El-Gabalawy, Renee] Univ Manitoba, Dept Anesthesiol Perioperat & Pain Med, Max Rady Coll Med, Winnipeg, MB, Canada; [El-Gabalawy, Renee; Mota, Natalie] Univ Manitoba, Dept Clin Hlth Psychol, Max Rady Coll Med, Winnipeg, MB, Canada; [El-Gabalawy, Renee; Mota, Natalie] Univ Manitoba, Dept Psychiat, Max Rady Coll Med, Winnipeg, MB, Canada		Mota, N (corresponding author), Univ Manitoba, Dept Clin Hlth Psychol, Operat Stress Injury Clin, 2109 Portage Ave, Winnipeg, MB R3J 0L3, Canada.	Natalie.Mota@umanitoba.ca			University of Manitoba	University of Manitoba Start-Up Funding (El-Gabalawy & Mota).	Afifi TO, 2013, PEDIATRICS, V132, pE333, DOI 10.1542/peds.2012-4021; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Atwoli L, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0929-z; Barskova T, 2009, DISABIL REHABIL, V31, P1709, DOI 10.1080/09638280902738441; Baumeister H, 2010, J CLIN EPIDEMIOL, V63, P558, DOI 10.1016/j.jclinepi.2009.08.009; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Bureau of the Census, 2013, AM COMM SURV 2012; Chou PH, 2019, J PSYCHIATR RES, V116, P172, DOI 10.1016/j.jpsychires.2018.12.001; Cordova Matthew J, 2003, Semin Clin Neuropsychiatry, V8, P286; Cordova MJ, 2017, LANCET PSYCHIAT, V4, P330, DOI 10.1016/S2215-0366(17)30014-7; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Edmondson D, 2017, LANCET PSYCHIAT, V4, P320, DOI 10.1016/S2215-0366(16)30377-7; Edmondson D, 2014, SOC PERSONAL PSYCHOL, V8, P118, DOI 10.1111/spc3.12089; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; El-Gabalawy R, 2018, PSYCHOSOM MED, V80, P783, DOI 10.1097/PSY.0000000000000635; El-Gabalawy R, 2018, J AFFECT DISORDERS, V227, P849, DOI 10.1016/j.jad.2017.11.058; El-Gabalawy R, 2014, EXP GERONTOL, V60, P46, DOI 10.1016/j.exger.2014.09.012; El-Solh AA, 2018, CHEST, V154, P427, DOI 10.1016/j.chest.2018.04.007; Fetzner MG, 2012, DEPRESS ANXIETY, V29, P958, DOI 10.1002/da.21976; Fink G, 2017, J ENDOCRINOL, V232, pF1, DOI 10.1530/JOE-16-0547; Fishbain DA, 2017, PAIN MED, V18, P711, DOI 10.1093/pm/pnw065; French-Rosas LN, 2011, J PSYCHIATR PRACT, V17, P270, DOI 10.1097/01.pra.0000400264.30043.ae; Grant BF., 2014, SOURCE ACCURACY STAT; Grant BF, 2015, DRUG ALCOHOL DEPEN, V148, P27, DOI 10.1016/j.drugalcdep.2014.11.026; Hak DJ, 2018, INJURY, V49, P1461, DOI 10.1016/j.injury.2018.04.016; Husarewycz MN, 2014, GEN HOSP PSYCHIAT, V36, P26, DOI 10.1016/j.genhosppsych.2013.06.003; Kangas M, 2002, CLIN PSYCHOL REV, V22, P499, DOI 10.1016/S0272-7358(01)00118-0; Kanis J. A., 2007, WHO TECHNICAL REPORT; Kaster TS, 2019, J ANXIETY DISORD, V65, P11, DOI 10.1016/j.janxdis.2019.04.004; Kilic C, 2016, TRANSCULT PSYCHIATRY, V53, P110, DOI 10.1177/1363461515612963; Koenen KC, 2017, PSYCHOL MED, V47, P209, DOI [10.1017/S0033291716002294, 10.1017/s0033291716002294]; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P591; LEVY P, 1999, SAMPLING POPULATIONS; Lin CE, 2019, GEN HOSP PSYCHIAT, V58, P59, DOI 10.1016/j.genhosppsych.2019.03.004; Lovato N, 2017, NAT SCI SLEEP, V9, P3, DOI 10.2147/NSS.S111521; Magid K., 2018, J PSYCHOL MED SETTIN; Nasehi MM, 2017, IRAN J CHILD NEUROL, V11, P37; Norte CE, 2013, J AFFECT DISORDERS, V150, P136, DOI 10.1016/j.jad.2012.11.039; Pacella ML, 2013, J ANXIETY DISORD, V27, P33, DOI 10.1016/j.janxdis.2012.08.004; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Pietrzak RH, 2011, PSYCHOSOM MED, V73, P697, DOI 10.1097/PSY.0b013e3182303775; Poole L, 2018, INT J BEHAV MED, V25, P151, DOI 10.1007/s12529-017-9703-y; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Roberts AL, 2011, PSYCHOL MED, V41, P71, DOI 10.1017/S0033291710000401; Ryder AL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0977-9; Roman ALS, 2011, WORLD J GASTROENTERO, V17, P2723, DOI 10.3748/wjg.v17.i22.2723; Sareen J, 2007, PSYCHOSOM MED, V69, P242, DOI 10.1097/PSY.0b013e31803146d8; Sawyer A, 2010, CLIN PSYCHOL REV, V30, P436, DOI 10.1016/j.cpr.2010.02.004; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Schnurr Paula P, 2004, Adv Mind Body Med, V20, P18; Schry AR, 2015, PSYCHOSOMATICS, V56, P674, DOI 10.1016/j.psym.2015.07.010; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Short NA, 2017, BEHAV RES THER, V97, P146, DOI 10.1016/j.brat.2017.07.014; Sommer J.L., 2019, PHYS HLTH CONDITIONS; Sommer JL, 2018, J TRAUMA STRESS, V31, P708, DOI 10.1002/jts.22323; Sommer JL, 2018, GEN HOSP PSYCHIAT, V53, P88, DOI 10.1016/j.genhosppsych.2018.02.004; Stata Corporation, 2015, STAT STAT SOFTW REL STAT STAT SOFTW REL; Suglia SF, 2018, CIRCULATION, V137, pE15, DOI 10.1161/CIR.0000000000000536; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Tulloch H, 2015, BEHAV SCI, V5, P27, DOI 10.3390/bs5010027; Ulirsch JC, 2014, EUR J PAIN, V18, P559, DOI 10.1002/j.1532-2149.2013.00395.x; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Vilchinsky N, 2017, CLIN PSYCHOL REV, V55, P92, DOI 10.1016/j.cpr.2017.04.009; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yavne Y, 2018, SEMIN ARTHRITIS RHEU, V48, P121, DOI 10.1016/j.semarthrit.2017.12.011; Zen AL, 2012, HEALTH PSYCHOL, V31, P194, DOI 10.1037/a0025989	71	5	5	1	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	NOV	2019	126								109776	10.1016/j.jpsychores.2019.109776			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	JP5LD	WOS:000498305100003	31327594				2022-02-06	
J	Sufrinko, AM; Howie, EK; Charek, DB; Elbin, RJ; Collins, MW; Kontos, AP				Sufrinko, Alicia M.; Howie, Erin K.; Charek, Daniel B.; Elbin, R. J.; Collins, Michael W.; Kontos, Anthony P.			Mobile Ecological Momentary Assessment of Postconcussion Symptoms and Recovery Outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activity; concussion; ecological momentary assessment; neurocognitive testing; ocular motor; recovery; symptoms; vestibular	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; ADOLESCENTS; YOUTH; SPECIFICITY; RELIABILITY; SENSITIVITY; SEVERITY; DURATION; IMPACT	Objective: Evaluate mobile ecological momentary assessment (mEMA) as an approach to measure sport-related concussion (SRC) symptoms, explore the relationships between clinical outcomes and mEMA, and determine whether mEMA was advantageous for predicting recovery outcomes compared to traditional symptom report. Setting: Outpatient concussion clinic. Participants: 20 athletes aged 12 to 19 years with SRC. Methods: Prospective study of mEMA surveys assessing activity and symptoms delivered via mobile application (3 time blocks daily) and clinical assessment at visit 1 (<72 hours postinjury) and visit 2 (6-18 days postinjury). Linear mixed models examined changes in mEMA symptoms over time and relationships among simultaneous report of activity type (cognitive, physical, sedentary, vestibular) and symptoms. Linear regressions evaluated the association among symptoms for activity types and clinical outcomes. Main Measures: mEMA symptom scores, Post-Concussion Symptom Scale, neurocognitive testing, vestibular/oculomotor screening (VOMS). Results: mEMA response rate was 52.4% (N = 1155) for prompts and 50.4% per participant. Symptoms were lower in the morning (P < .001) compared with afternoon and evening. Higher mEMA symptoms were reported during vestibular compared with physical (P = .035) and sedentary (P = .001) activities. mEMA symptoms were positively associated with Post-Concussion Symptom Scale (PCSS) (P = .007), VOMS (P = 0.001-0.002), and recovery time (P < .001), but not neurocognitive scores. mEMA symptom score (P = .021) was a better predictor of recovery time than PCSS at either clinic visit. Conclusion: mEMA overcomes barriers of traditional symptom scales by eliminating retrospective bias and capturing fluctuations in symptoms by time of day and activity type, ultimately helping clinicians refine symptom management strategies.	[Sufrinko, Alicia M.; Charek, Daniel B.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Sufrinko, Alicia M.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, 3200 S Water Sr, Pittsburgh, PA 15203 USA; [Howie, Erin K.; Elbin, R. J.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, Fayetteville, AR 72701 USA		Sufrinko, AM (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 3200 S Water Sr, Pittsburgh, PA 15203 USA.	sufrinkoam@upmc.edu			Steven D. Manners Faculty Development Award at the University of Pittsburgh	Steven D. Manners Faculty Development Award at the University of Pittsburgh.	Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Borus JS, 2013, J ADOLESCENT HEALTH, V52, P578, DOI 10.1016/j.jadohealth.2012.10.003; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Elbin RJ, 2016, APPL NEUROPSYCH-CHIL, V5, P294, DOI 10.1080/21622965.2015.1077334; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Giza CC, 2001, J ATHL TRAINING, V36, P228; Heron KE, 2017, J PEDIATR PSYCHOL, V42, P1087, DOI 10.1093/jpepsy/jsx078; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Immediate Post-Concussion Assessment Testing (ImPACT<(R)>) Test, 2011, IMMEDIATE POST CONCU; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewandowski L, 2009, ARCH CLIN NEUROPSYCH, V24, P791, DOI 10.1093/arclin/acp087; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ozdalga E, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1994; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Spook JE, 2013, J MED INTERNET RES, V15, P278, DOI 10.2196/jmir.2617; Stinson JN, 2008, PAIN, V136, P281, DOI 10.1016/j.pain.2007.07.002; Stone Arthur S., 1994, Annals of Behavioral Medicine, V16, P199; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wen D, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6874; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979	34	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2019	34	6					E40	E48		10.1097/HTR.0000000000000474			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	JV8JC	WOS:000502605200005	30829823				2022-02-06	
J	Power, E; Weir, S; Richardson, J; Fromm, D; Forbes, M; MacWhinney, B; Togher, L				Power, Emma; Weir, Stephanie; Richardson, Jessica; Fromm, Davida; Forbes, Margaret; MacWhinney, Brian; Togher, Leanne			Patterns of narrative discourse in early recovery following severe Traumatic Brain Injury	BRAIN INJURY			English	Article						Traumatic brain injury; narrative; discourse; early recovery	COMMUNICATION ABILITY; LONGITUDINAL RESEARCH; ADULTS; INDIVIDUALS; MODERATE; IMPROVEMENT; CHILDREN; LANGUAGE; DEFICITS; QUALITY	Primary Objective: To investigate the nature and patterns of narrative discourse impairment in people with severe Traumatic Brain Injury (TBI) during early recovery. Methods and Procedures: A single image picture description task was administered to 42 participants with severe TBI at 3 and 6-months post-injury. The same task was administered to 37 control participants. Discourse samples were analyzed with measures of productivity, informativeness and story organization. The performance of people with TBI was compared with the control group at both 3 and 6 months, and the performance of the participants with TBI was also compared across the two time points. Individual patterns of performance were also examined. Results: Inferential analyses revealed significant differences between the control group and the group with TBI on informativeness at both time points and number of complete episodes at 3 months, but no significant differences for productivity measures. There was no significant change for the group with TBI between 3 and 6 months. However, individual improvement over time was observed. Conclusions: People with TBI have discourse difficulties early post TBI that are also present at 6-months post-injury. In order to understand longer-term discourse recovery, it is necessary to examine participant patterns over further time points on this narrative task.	[Power, Emma] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia; [Power, Emma; Weir, Stephanie; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Discipline Speech Pathol, Sydney, NSW, Australia; [Richardson, Jessica] Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA; [Fromm, Davida; Forbes, Margaret; MacWhinney, Brian] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA		Power, E (corresponding author), Univ Technol Sydney, Grad Sch Hlth, Speech Pathol, POB 123, Broadway, NSW 2007, Australia.	emma.power@uts.edu.au	Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Power, Emma/0000-0002-2638-0406; MacWhinney, Brian/0000-0002-4988-1342; Richardson, Jessica/0000-0003-2769-3014	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1056000]	This work was supported by the National Health and Medical Research Council [1056000].	American Speech-Language-Hearing Association, 2005, KNOWL SKILLS NEED SP, DOI [10.1044/policy.KS2005-00078, DOI 10.1044/POLICY.KS2005-00078]; Australian Institute of Health and Welfare (AIHW), 2007, BULLETIN, V55; Barrie-Blackey S, 1978, CLIN ORAL LANGUAGE S; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; COELHO C A, 1991, Brain Injury, V5, P381, DOI 10.3109/02699059109008111; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COELHO CA, 1990, J PSYCHOLINGUIST RES, V19, P405, DOI 10.1007/BF01068887; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Cupit J, 2010, APHASIOLOGY, V24, P1486, DOI 10.1080/02687031003615235; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Doyle P. J., 1995, AM J SPEECH-LANG PAT, V4, P130, DOI [10.1044/1058-0360.0404.130, DOI 10.1044/1058-0360.0404.130]; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Elbourn E, 2019, BRAIN INJURY, V33, P143, DOI 10.1080/02699052.2018.1539246; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Halliday M. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacWhinney B., 2000, CHILDES PROJECT; MacWhinney B, 2014, CLAN MANUAL; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Matsuoka K, 2012, BRAIN INJURY, V26, P1723, DOI 10.3109/02699052.2012.698789; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Ross KB, 1999, APHASIOLOGY, V13, P113, DOI 10.1080/026870399402235; Schultz R, 2013, BRAIN IMPAIR, V14, P450, DOI 10.1017/BrImp.2013.24; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sherratt S, 2007, APHASIOLOGY, V21, P375, DOI 10.1080/02687030600911435; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Stroup W.W., 2006, SAS MIXED MODELS, V2nd; Stubbs E, 2018, BRAIN INJURY, V32, P167, DOI 10.1080/02699052.2017.1291989; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Trewin D, 2006, ANZSCO AUSTR NZ STAN; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101	60	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					98	109		10.1080/02699052.2019.1682192		OCT 2019	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000493149300001	31661629				2022-02-06	
J	Lawrence, DW; Foster, E; Comper, P; Langer, L; Hutchison, MG; Chandra, T; Bayley, M				Lawrence, David W.; Foster, Evan; Comper, Paul; Langer, Laura; Hutchison, Michael G.; Chandra, Tharshni; Bayley, Mark			Cannabis, alcohol and cigarette use during the acute post-concussion period	BRAIN INJURY			English	Article						Concussion; traumatic brain injury; TBI; cannabis; marijuana; cannabinoids; CBD; cannabidiol; alcohol; tobacco	TRAUMATIC BRAIN-INJURY; MARIJUANA USE; MORTALITY; ASSOCIATION; DEXANABINOL; PREDICTORS; RECOVERY; EFFICACY; SEIZURES; OUTCOMES	Objective: To document the prevalence of acute post-concussion cannabis, alcohol and cigarette use and their association with clinical recovery and symptom burden. Methods: A prospective cohort study was conducted. Concussions were physician-diagnosed and presented to the emergency department and concussion clinic within 7 days post-injury. Participants were assessed weekly and followed for a minimum 4 weeks. A survival analysis (using physician-determined recovery to both cognitive and physical activities) in addition to a weekly symptom score analysis was conducted. Results: A total of 307 acute concussions with a mean age of 33.7 years (SD, 13.0) were included. Acute post-concussion cannabis, alcohol and cigarette use were identified in 43 (14.0%), 125 (40.7%) and 61 (19.9%) individuals. Acute cannabis, alcohol and cigarette use were not associated with recovery to cognitive (p > .05) or physical activity (p > .05). Acute cigarette use was associated with a higher unadjusted symptom severity score at week1 (p = .003). Acute cannabis use was associated with lower symptom severity scores at week-3 (p = .061) and week-4 (p = .029). Conclusion: In conclusion, cannabis, alcohol and cigarette use were prevalent in the acute period post-concussion; however, were not observed to impact recovery within the first 4 weeks post-injury. Amongst unrecovered individuals, acute cannabis use was associated with lower symptom burden, while cigarette use was associated with greater initial symptom burden.	[Lawrence, David W.; Foster, Evan; Comper, Paul; Langer, Laura; Chandra, Tharshni; Bayley, Mark] Univ Hlth Network, Toronto Rehabil Inst, Hull Ellis Concuss & Res Clin, 550 Univ Ave, Toronto, ON M5G 2A2, Canada; [Lawrence, David W.; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Lawrence, DW (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Hull Ellis Concuss & Res Clin, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	dw.lawrence@mail.utoronto.ca		Bayley, Mark/0000-0001-7860-9463; Langer, Laura/0000-0003-4408-355X	Toronto Rehab Foundation	This work was supported by the Toronto Rehab Foundation.	Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; [Anonymous], 2016, CHIEF PUBL HLTH OFF; [Anonymous], 2018, CAN TOB ALC DRUG SUR; Babson KA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0775-9; Bachhuber M, 2019, J PSYCHOACTIVE DRUGS, V51, P400, DOI 10.1080/02791072.2019.1626953; Baron EP, 2015, HEADACHE, V55, P885, DOI 10.1111/head.12570; Berry C, 2011, AM SURGEON, V77, P1416; Berry C, 2010, AM SURGEON, V76, P1067; Brody AL, 2018, NEUROPSYCHOPHARMACOL, V43, P925, DOI 10.1038/npp.2017.261; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; (CCDUS) CCoSAaA, 2018, CAN DRUG SUMM CANN; Crowe MS, 2014, BRAIN BEHAV IMMUN, V42, P1, DOI 10.1016/j.bbi.2014.06.007; Devinsky O, 2018, NEW ENGL J MED, V378, P1888, DOI 10.1056/NEJMoa1714631; Devinsky O, 2017, NEW ENGL J MED, V376, P2011, DOI 10.1056/NEJMoa1611618; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Durazzo TC, 2013, J NEUROTRAUM, V30, P1013, DOI 10.1089/neu.2012.2676; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hayatbakhsh MR, 2007, J AM ACAD CHILD PSY, V46, P408, DOI 10.1097/chi.0b013e31802dc54d; Hingley S, 2016, ARCH DIS CHILDHOOD-E, V101, P58, DOI 10.1136/archdischild-2014-307252; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Khanna A, 2013, J NEUROIMMUNOL, V254, P69, DOI 10.1016/j.jneuroim.2012.09.006; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Lynch ME, 2011, BRIT J CLIN PHARMACO, V72, P735, DOI 10.1111/j.1365-2125.2011.03970.x; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nguyen BM, 2014, AM SURGEON, V80, P979; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Peretti-Watel P, 2003, ADDICTION, V98, P1249, DOI 10.1046/j.1360-0443.2003.00490.x; Piper BJ, 2017, J PSYCHOPHARMACOL, V31, P569, DOI 10.1177/0269881117699616; Rumalla K, 2016, J NEUROL SCI, V364, P191, DOI 10.1016/j.jns.2016.01.066; Sagredo O., 2012, CNS DRUG DISCOVERY, V7, P41, DOI DOI 10.2174/157488912798842278; Sagredo O, 2007, MOL NEUROBIOL, V36, P82, DOI 10.1007/s12035-007-0004-3; Sagredo O, 2007, EUR J NEUROSCI, V26, P843, DOI 10.1111/j.1460-9568.2007.05717.x; Sagredo O, 2011, J NEUROSCI RES, V89, P1509, DOI 10.1002/jnr.22682; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Seifert T, 2018, HAND CLINIC, V158, P119, DOI 10.1016/B978-0-444-63954-7.00012-4; Stockings E, 2018, PAIN, V159, P1932, DOI 10.1097/j.pain.0000000000001293; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vaney C, 2004, MULT SCLER, V10, P417, DOI 10.1191/1352458504ms1048oa; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Wilsey B, 2013, J PAIN, V14, P136, DOI 10.1016/j.jpain.2012.10.009; Yanes JA, 2019, EXP CLIN PSYCHOPHARM, V27, P370, DOI 10.1037/pha0000281; Zale EL, 2015, CLIN PSYCHOL REV, V37, P57, DOI 10.1016/j.cpr.2015.02.005	53	5	5	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					42	51		10.1080/02699052.2019.1679885		OCT 2019	10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000490920200001	31621424				2022-02-06	
J	Pistoia, F; Carolei, A; Bodien, YG; Greenfield, S; Kaplan, S; Sacco, S; Pistarini, C; Casalena, A; De Tanti, A; Cazzulani, B; Bellaviti, G; Sara, M; Giacino, J				Pistoia, Francesca; Carolei, Antonio; Bodien, Yelena G.; Greenfield, Sheldon; Kaplan, Sherrie; Sacco, Simona; Pistarini, Caterina; Casalena, Alfonsina; De Tanti, Antonio; Cazzulani, Benedetta; Bellaviti, Gianluca; Sara, Marco; Giacino, Joseph			The Comorbidities Coma Scale (CoCoS): Psychometric Properties and Clinical Usefulness in Patients With Disorders of Consciousness	FRONTIERS IN NEUROLOGY			English	Article						coma; vegetative state; unresponsive wakefulness syndrome; minimally conscious state; comorbidities	TRAUMATIC BRAIN-INJURY; CHRONIC DISEASE SCORE; CARDIAC-ARREST; ASSOCIATION; OUTCOMES; INDEX; RECOVERY; CANCER; REHABILITATION; MORBIDITY	Although comorbidities have a well-known impact on the functional recovery of patients with disorders of consciousness, including coma, vegetative state (VS), and minimally conscious state (MCS), a specific tool for their assessment in this challenging group of patients is lacking. For this aim, a multistep process was used to develop and validate the Comorbidities Coma Scale (CoCoS) in a sample of 162 patients with a diagnosis of coma, VS or MCS admitted to four Acute Inpatient Rehabilitation Units. To establish the psychometric properties of the scale, content validity, and internal consistency were investigated through Exploratory Factor Analysis in the whole sample (n = 162). Interrater reliability, assessed by the weighted Cohen's kappa (Kw), and concurrent validity of the scale as compared to the Greenfield Scale, assessed by rho Spearman's correlation coefficient, were investigated in a subsample of patients (n = 52) within two of the above units. Our findings provided evidence of a good content validity of the scale, with the identification of a 12-factor structure representing the different comorbid dimensions of the target population. Inter-rater reliability was excellent in both the rehabilitation units where the assessment was made [Kw 0.98 (95% CI 0.96-0.99)]. CoCoS total scores correlated significantly with total scores of the Greenfield Scale (rho = 0.932, 95% CI 0.89-0.96; P < 0.0001) indicating that CoCoS has concurrent validity while being more informative about the specific pattern of comorbidities of these challenging patients. The CoCos is a new tool which standardizes the approach to assessment of comorbid conditions and reliably identifies the category and severity of each comorbidity detected. It may be used for both clinical and research applications.	[Pistoia, Francesca; Carolei, Antonio; Sacco, Simona] Univ Aquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, Laquila, Italy; [Bodien, Yelena G.; Giacino, Joseph] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Bodien, Yelena G.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Greenfield, Sheldon; Kaplan, Sherrie] Univ Calif Irvine, Hlth Policy Res Inst, Irvine, CA USA; [Pistarini, Caterina] Salvatore Maugeri Fdn, Sci Inst Nervi, Nervi, Italy; [Casalena, Alfonsina] Hosp G Mazzini, Teramo, Italy; [De Tanti, Antonio] Cardinal Ferrari Rehabil Ctr, Fontanellato, Italy; [Cazzulani, Benedetta; Bellaviti, Gianluca] Salvatore Maugeri Fdn, Sci Inst Pavia, Pavia, Italy; [Sara, Marco] Osped San Raffaele, Postcoma Rehabil Unit, Cassino, Italy		Pistoia, F (corresponding author), Univ Aquila, Neurol Inst, Dept Biotechnol & Appl Clin Sci, Laquila, Italy.	francesca.pistoia@univaq.it	Giacino, Joseph/AAF-1952-2021; Cazzulani, Benedetta/AAC-1818-2020; Bellaviti, Gianluca/AAC-2770-2020; Sacco, Simona/I-5253-2012; Pistarini, CATERINA/K-5234-2018	Giacino, Joseph/0000-0002-7916-9698; Cazzulani, Benedetta/0000-0002-1219-9163; Bellaviti, Gianluca/0000-0002-0716-314X; Sacco, Simona/0000-0003-0651-1939; Pistarini, CATERINA/0000-0001-8925-0484; Bodien, Yelena/0000-0003-4858-2903			Al-Dorzi HM, 2015, CRIT CARE RES PRACT, V2015, DOI 10.1155/2015/672639; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bhate TD, 2015, RESUSCITATION, V97, P1, DOI 10.1016/j.resuscitation.2015.08.023; Carr KR, 2016, NEUROCRIT CARE, V25, P185, DOI 10.1007/s12028-016-0273-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Colinet B, 2005, BRIT J CANCER, V93, P1098, DOI 10.1038/sj.bjc.6602836; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; El Husseini N, 2018, J STROKE CEREBROVASC, V27, P125, DOI 10.1016/j.jstrokecerebrovasdis.2017.08.017; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GREENFIELD S, 1995, MED CARE, V33, pAS47; GREENFIELD S, 1987, CLIN RES, V35, pA346; Holman CDJ, 2005, J CLIN EPIDEMIOL, V58, P1006, DOI 10.1016/j.jclinepi.2005.01.020; KAPLAN MH, 1974, J CHRON DIS, V27, P387, DOI 10.1016/0021-9681(74)90017-4; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Litofsky NS, 2016, WORLD NEUROSURG, V90, P82, DOI 10.1016/j.wneu.2016.02.076; Litwin MS, 2007, CANCER-AM CANCER SOC, V109, P1777, DOI 10.1002/cncr.22615; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Marini S, 2018, STROKE, V49, P1618, DOI 10.1161/STROKEAHA.117.020091; McCredie VA, 2017, NEUROCRIT CARE, V26, P247, DOI 10.1007/s12028-016-0310-6; Meinert E, 2018, PEDIATR CRIT CARE ME, V19, P345, DOI 10.1097/PCC.0000000000001471; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Piccirillo JF, 2002, ARCH OTOLARYNGOL, V128, P1172, DOI 10.1001/archotol.128.10.1172; Piccirillo JF, 2003, J REGISTRY MANAGEMEN, V30, P8; Pistoia F, 2016, ARCH PHYS MED REHAB, V97, pe126, DOI [10.1016/j.apmr.2016.08.393, DOI 10.1016/J.APMR.2016.08.393]; Pistoia F, 2016, NEUROL SCI S, V37, pS83; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; Plum F, 1972, Contemp Neurol Ser, V10, P1; Rozzini R, 2002, AGE AGEING, V31, P277, DOI 10.1093/ageing/31.4.277; Sarfati D, 2014, MED CARE, V52, P586, DOI 10.1097/MLR.0000000000000149; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Wang CH, 2016, INTERN EMERG MED, V11, P727, DOI 10.1007/s11739-015-1386-2; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Wormsbecker A, 2017, RESUSCITATION, V112, P11, DOI 10.1016/j.resuscitation.2016.12.010; Xia C, 2018, WORLD NEUROSURG, V113, pE521, DOI 10.1016/j.wneu.2018.02.074	41	5	6	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 17	2019	10								1042	10.3389/fneur.2019.01042			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JO6EO	WOS:000497670400001	31681139	Green Published, gold			2022-02-06	
J	Tuerk, C; Degeilh, F; Catroppa, C; Dooley, JJ; Kean, M; Anderson, V; Beauchamp, MH				Tuerk, Carola; Degeilh, Fanny; Catroppa, Cathy; Dooley, Julian J.; Kean, Michael; Anderson, Vicki; Beauchamp, Miriam H.			Altered resting-state functional connectivity within the developing social brain after pediatric traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						functional connectivity; neurodevelopment; resting-state fMRI; RRID; SCR_009550; RRID; SCR_001622; RRID; SCR_007037; social brain; traumatic brain injury	WORKING-MEMORY; STRUCTURAL CONNECTIVITY; NETWORK CONNECTIVITY; ATTENTION DEFICITS; HEAD-INJURY; CHILDREN; MODERATE; IMPAIRMENT; BEHAVIOR; OUTCOMES	Traumatic brain injury (TBI) in childhood and adolescence can interrupt expected development, compromise the integrity of the social brain network (SBN) and impact social skills. Yet, no study has investigated functional alterations of the SBN following pediatric TBI. This study explored functional connectivity within the SBN following TBI in two independent adolescent samples. First, 14 adolescents with mild complex, moderate or severe TBI and 16 typically developing controls (TDC) underwent resting-state functional magnetic resonance imaging 12-24 months post-injury. Region of interest analyses were conducted to compare the groups' functional connectivity using selected SBN seeds. Then, replicative analysis was performed in an independent sample of adolescents with similar characteristics (9 TBI, 9 TDC). Results were adjusted for age, sex, socioeconomic status and total gray matter volume, and corrected for multiple comparisons. Significant between-group differences were detected for functional connectivity in the dorsomedial prefrontal cortex and left fusiform gyrus, and between the left fusiform gyrus and left superior frontal gyrus, indicating positive functional connectivity for the TBI group (negative for TDC). The replication study revealed group differences in the same direction between the left superior frontal gyrus and right fusiform gyrus. This study indicates that pediatric TBI may alter functional connectivity of the social brain. Frontal-fusiform connectivity has previously been shown to support affect recognition and changes in the function of this network could relate to more effortful processing and broad social impairments.	[Tuerk, Carola; Degeilh, Fanny; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, POB 6128, Montreal, PQ H3C 3J7, Canada; [Degeilh, Fanny; Beauchamp, Miriam H.] St Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Catroppa, Cathy; Kean, Michael; Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Dooley, Julian J.] Diagnost Clin, Cuyahoga Cty Juvenile Court, Cleveland, OH USA		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, POB 6128, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca	Degeilh, Fanny/AAA-7445-2019; Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Tuerk, Carola/0000-0002-0910-846X; Degeilh, Fanny/0000-0002-5802-4975	Fonds de recherche du Quebec -Nature et technologies (FRQNT) [261327]; Victoria Neurotrauma Initiative, Australia [CO6E1]; Victorian Government Operational Infrastructure Support Program, Australia	Fonds de recherche du Quebec -Nature et technologies (FRQNT), Grant/Award Number: 261327; Victoria Neurotrauma Initiative, Australia, Grant/Award Number: CO6E1; Victorian Government Operational Infrastructure Support Program, Australia	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alcala-Lopez D, 2018, CEREB CORTEX, V28, P2207, DOI 10.1093/cercor/bhx121; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Ansari AHJ, 2011, IEEE ENG MED BIO, P5056, DOI 10.1109/IEMBS.2011.6091252; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Beauchamp M., 2010, PRINCIPLES PRACTICE, P315, DOI 10.1017/CBO9780511674815.024; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, NEUROREHABILITATION, V32, P707, DOI 10.3233/NRE-130896; Blakemore SJ, 2007, SOC COGN AFFECT NEUR, V2, P130, DOI 10.1093/scan/nsm009; Blakemore SJ, 2012, J ROY SOC MED, V105, P111, DOI 10.1258/jrsm.2011.110221; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Burnett S, 2009, J COGNITIVE NEUROSCI, V21, P1736, DOI 10.1162/jocn.2009.21121; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Cohen J., 2013, STAT POWER ANAL BEHA; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gabard-Durnam LJ, 2014, NEUROIMAGE, V95, P193, DOI 10.1016/j.neuroimage.2014.03.038; Ganel T, 2005, NEUROPSYCHOLOGIA, V43, P1645, DOI 10.1016/j.neuropsychologia.2005.01.012; Gee DG, 2013, J NEUROSCI, V33, P4584, DOI 10.1523/JNEUROSCI.3446-12.2013; Guo H, 2019, WORLD NEUROSURG, V121, pE630, DOI 10.1016/j.wneu.2018.09.178; Ham TE, 2012, CURR OPIN NEUROL, V25, P662, DOI 10.1097/WCO.0b013e328359488f; Hicks AJ, 2017, BRAIN INJURY, V31, P1312, DOI 10.1080/02699052.2017.1317361; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Johnson MH, 2005, DEV PSYCHOPATHOL, V17, P599, DOI 10.1017/S0954579405050297; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Levan A, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000040; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Neumann D, 2016, BRAIN IMAGING BEHAV, V10, P569, DOI 10.1007/s11682-015-9415-3; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Rigon A, 2017, NEUROIMAGE-CLIN, V13, P370, DOI 10.1016/j.nicl.2016.12.010; Rigon A, 2019, BRAIN IMAGING BEHAV, V13, P526, DOI 10.1007/s11682-018-9889-x; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rigon A, 2016, J NEUROTRAUM, V33, P977, DOI 10.1089/neu.2014.3847; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Rosenberg H, 2015, NEUROPSYCHOLOGY, V29, P509, DOI 10.1037/neu0000171; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Ryan NP, 2017, SOC COGN AFFECT NEUR, V12, P1414, DOI 10.1093/scan/nsx066; Ryan NP, 2016, NEUROSCI BIOBEHAV R, V64, P196, DOI 10.1016/j.neubiorev.2016.02.020; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Scheibel RS, 2011, SOC NEUROSCI-UK, V6, P582, DOI 10.1080/17470919.2011.588844; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Stephens JA, 2018, DEV NEUROREHABIL, V21, P423, DOI 10.1080/17518423.2017.1338777; Stephens JA, 2017, J NEUROTRAUM, V34, P3117, DOI 10.1089/neu.2017.5081; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; Tousignant B, 2018, NEUROPSYCHOL REHABIL, V28, P429, DOI 10.1080/09602011.2016.1158114; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wechsler D., 2011, WECHSLER ABBREVIATED; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xiao H, 2015, NEURAL REGEN RES, V10, P2062, DOI 10.4103/1673-5374.172328; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	83	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	FEB 1	2020	41	2					561	576		10.1002/hbm.24822		OCT 2019	16	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	JZ7HS	WOS:000490177400001	31617298	Green Published, hybrid			2022-02-06	
J	Zhang, GL; Ma, PY; Wan, SS; Xu, J; Yang, M; Qiu, GP; Zhuo, F; Xu, SY; Huo, JC; Ju, YC; Liu, H				Zhang, Gaoli; Ma, Peiying; Wan, Shanshan; Xu, Jin; Yang, Mei; Qiu, Gouping; Zhuo, Fei; Xu, Shiye; Huo, Jiechao; Ju, Yuchan; Liu, Hui			Dystroglycan is involved in the activation of ERK pathway inducing the change of AQP4 expression in scratch-injured astrocytes	BRAIN RESEARCH			English	Article						Aquaporin 4; alpha-Dystroglycan; beta-Dystroglycan; Scratch-injured astrocyte; ERK pathway	TRAUMATIC BRAIN-INJURY; IN-VITRO; CULTURED ASTROCYTES; AQUAPORIN-4; PROTEIN; KINASE; CELL; ISCHEMIA; EDEMA; BLOOD	We previously reported that aquaporin 4 (AQP4) played a critical role in formation of brain edema and the altered expression of dystroglycan (DG) could relate with AQP4 expression after traumatic brain injury (TBI). However the mechanisms of this process remain unclear. DG was showed could act as a scaffold involved in adhesion-mediated signaling in ERK/MAPK pathway. We hypothesize that after scratch, extracellular alpha-DG and transmembrane beta-DG may act as the scaffold in scratch mechanical force activating ERK pathway which may regulate the expression of AQP4. Use ERK inhibitor and activator to confirm whether the expression of AQP4 is regulated by the activation of ERK pathway in scratched astrocytes. Use DG siRNA to confirm whether DG takes part in the process that the extracellular signal transduces into cell and activates the ERK pathway. The significant increase of AQP4 and DG expression induced by scratch could be abolished by blocking ERK signaling and enhanced by activating ERK signaling. Blockade of DG by siRNA led to no obvious effect of scratched-injury on the ERK signaling pathway. It demonstrated that DG may act as the scaffold in scratch mechanical force activating ERK pathway which can regulate the expression of AQP4 in astrocytes after scratch.	[Zhang, Gaoli; Ma, Peiying; Xu, Jin; Yang, Mei; Qiu, Gouping; Zhuo, Fei; Xu, Shiye; Huo, Jiechao; Ju, Yuchan; Liu, Hui] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Wan, Shanshan] Sichuan Canc Hosp & Res Inst, Cent Blood Bank, Chengdu, Sichuan, Peoples R China		Liu, H (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.	huiliu@cqmu.edu.cn			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81500978, 81671312, 81000566]; National Science Foundation Project of Chong Qing [cstc2016jcyjA0229, cstc2017jcyjAX0414, cstc2015jcyja10018, cstc2011jjA10093]; Foundation of Chongqing Municipal Education Commission [KJ1600213]	This work was supported by grants from the National Science Foundation of China (81500978, 81671312, 81000566) and the National Science Foundation Project of Chong Qing (cstc2016jcyjA0229, cstc2017jcyjAX0414, cstc2015jcyja10018, cstc2011jjA10093) and the Foundation of Chongqing Municipal Education Commission (KJ1600213).	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Habib P, 2014, NEUROENDOCRINOLOGY, V99, P156, DOI 10.1159/000362279; Hawkins BT, 2013, BRAIN RES, V1503, P89, DOI 10.1016/j.brainres.2013.01.049; Hoffert JD, 2000, J BIOL CHEM, V275, P9070, DOI 10.1074/jbc.275.12.9070; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kornyei Z, 2000, J NEUROSCI RES, V61, P421, DOI 10.1002/1097-4547(20000815)61:4<421::AID-JNR8>3.0.CO;2-4; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu H, 2015, BIOMED RES INT, V2015; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Mandell JW, 1999, NEUROREPORT, V10, P3567, DOI 10.1097/00001756-199911260-00019; Marmarou A, 2003, ACT NEUR S, V86, P7; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mccoy E, 2010, GLIA, V58, P209, DOI 10.1002/glia.20916; Milner R, 2008, J CEREBR BLOOD F MET, V28, P812, DOI 10.1038/sj.jcbfm.9600585; Milner R, 2008, STROKE, V39, P191, DOI 10.1161/STROKEAHA.107.486134; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nguyen H, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-58; Nicchia GP, 2004, NEUROSCIENCE, V129, P935, DOI 10.1016/j.neuroscience.2004.07.055; Noell S, 2011, EUR J NEUROSCI, V33, P2179, DOI 10.1111/j.1460-9568.2011.07688.x; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Pan H, 2012, MEDIATORS INFLAMMATI; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Qiu GP, 2015, NEUROSCI LETT, V588, P42, DOI 10.1016/j.neulet.2014.12.053; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Shi ZF, 2015, BIOMED ENVIRON SCI, V28, P199, DOI 10.3967/bes2015.026; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Steiner E, 2012, GLIA, V60, P1646, DOI 10.1002/glia.22383; Tang ZH, 2013, NEUROPHARMACOLOGY, V67, P8, DOI 10.1016/j.neuropharm.2012.10.017; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Unger JW, 1998, MICROSC RES TECHNIQ, V43, P24, DOI 10.1002/(SICI)1097-0029(19981001)43:1<24::AID-JEMT4>3.0.CO;2-P; Wolburg H, 2012, MOL ASPECTS MED, V33, P579, DOI 10.1016/j.mam.2012.02.003; Wu VW, 1998, J NEUROSCI RES, V51, P675, DOI 10.1002/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.3.CO;2-N; Ye Z.-J, 2010, J NANCHANG U MED SCI, V1; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306	51	5	6	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 15	2019	1721								146347	10.1016/j.brainres.2019.146347			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IZ6BO	WOS:000487167000019	31348910				2022-02-06	
J	Broussard, JI; Redell, JB; Zhao, J; Maynard, ME; Kobori, N; Perez, A; Hood, KN; Zhang, XO; Moore, AN; Dash, PK				Broussard, John, I; Redell, John B.; Zhao, Jing; Maynard, Mark E.; Kobori, Nobuhide; Perez, Alec; Hood, Kimberly N.; Zhang, Xu O.; Moore, Anthony N.; Dash, Pramod K.			Mild Traumatic Brain Injury Decreases Spatial Information Content and Reduces Place Field Stability of Hippocampal CA1 Neurons	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; multi-electrode recording; object location task; place cells; parvalbumin-positive inhibitory neurons	CELL-ACTIVITY; MEMORY; REPRESENTATION; VULNERABILITY; INTERNEURONS; SUPPRESSION; DYSFUNCTION; PHASE; UNITS	Both clinical and experimental studies have reported that mild traumatic brain injury (mTBI) can result in cognitive impairments in the absence of overt brain damage. Whether these impairments result from neuronal dysfunction/altered plasticity is an area that has received limited attention. In this study, we recorded activity of neurons in the cornu Ammonis (CA)1 subfield of the hippocampus in sham and mild lateral fluid percussion injured (mFPI) rats while these animals were performing an object location task. Electrophysiology results showed that the number of excitatory neurons encoding spatial information (i.e., place cells) was reduced in mFPI rats, and that these cells had broader and less stable place fields. Additionally, the in-field firing rate of place cells in sham operated, but not in mFPI, animals increased when objects within the testing arena were moved. Immunostaining indicated no visible damage or overall neuronal loss in mFPI brain sections. However, a reduction in the number of parvalbumin-positive inhibitory neurons in the CA1 subfield of mFPI animals was observed, suggesting that this reduction could have influenced place cell physiology. Alterations in spatial information content, place cell stability, and activity in mFPI rats coincided with poor performance in the object location task. These results indicate that altered place cell physiology may underlie the hippocampus-dependent cognitive impairments that result from mTBI.	[Broussard, John, I; Redell, John B.; Zhao, Jing; Maynard, Mark E.; Kobori, Nobuhide; Perez, Alec; Hood, Kimberly N.; Zhang, Xu O.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas Houston, Dept Neurobiol & Anat, McGovern Med Sch, POB 20708, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas Houston, Dept Neurobiol & Anat, McGovern Med Sch, POB 20708, Houston, TX 77225 USA.	p.dash@uth.tmc.edu		Zhang, Xu O./0000-0001-6062-0381	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS086301, NS090935]; Mission Connect/Gilson Longenbaugh Foundation	This work was supported, in part, by funds provided to P.K.D. by the National Institutes of Health (NS086301; NS090935) and the Mission Connect/Gilson Longenbaugh Foundation.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; Ciupek SM, 2015, J NEUROSCI, V35, P8118, DOI 10.1523/JNEUROSCI.3130-14.2015; Clark RE, 2000, J NEUROSCI, V20, P8853; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Danjo T., 2019, NEUROSCI RES; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; Grienberger C, 2017, NAT NEUROSCI, V20, P417, DOI 10.1038/nn.4486; Hanson, 1993, ADV NEURAL INFORMATI, V5, P1030; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; JUNG MW, 1994, J NEUROSCI, V14, P7347; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Knierim JJ, 2001, J NEUROPHYSIOL, V85, P105, DOI 10.1152/jn.2001.85.1.105; Larkin MC, 2014, HIPPOCAMPUS, V24, P773, DOI 10.1002/hipo.22268; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; McKenzie S, 2018, HIPPOCAMPUS, V28, P659, DOI 10.1002/hipo.22803; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Moser EI, 2017, NAT NEUROSCI, V20, P1448, DOI 10.1038/nn.4653; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Poucet B, 2012, J PHYSIOL-PARIS, V106, P62, DOI 10.1016/j.jphysparis.2011.09.002; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Siegel JJ, 2008, J NEUROPHYSIOL, V99, P60, DOI 10.1152/jn.00731.2007; Spiers HJ, 2015, CEREB CORTEX, V25, P10, DOI 10.1093/cercor/bht198; Yu X, 2006, NEURON, V52, P717, DOI 10.1016/j.neuron.2006.10.003; Zhao R, 2016, CELL REP, V16, P793, DOI 10.1016/j.celrep.2016.06.032	41	5	5	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					227	235		10.1089/neu.2019.6766		OCT 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489733900001	31530217	Green Published			2022-02-06	
J	Murray, NG; Szekely, B; Islas, A; Munkasy, B; Gore, R; Berryhill, M; Reed-Jones, RJ				Murray, Nicholas G.; Szekely, Brian; Islas, Arthur; Munkasy, Barry; Gore, Russell; Berryhill, Marian; Reed-Jones, Rebecca J.			Smooth Pursuit and Saccades after Sport-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; mTBI; oculomotor control; vision	TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; SUPERIOR COLLICULUS; POST-CONCUSSION; DEFICITS; ACCURACY; SPEED; FMRI; FIXATIONS	Smooth pursuit eye movements (SPEMs) and saccadic eye movements are both commonly impaired following sport-related concussion (SRC). Typical oculomotor assessments measure individual eye movements in a series of restrictive tests designed to isolate features such as response times. These measures lack ecological validity for athletes because athletes are adept at simple tasks designed for the general population. Yet, because eye movement metrics are sensitive and well-characterized neuroanatomically, it would be valuable to test whether athletes exhibit abnormal eye movements with more challenging tasks. To address this gap in knowledge, we collected eye-tracking data during a sport-like task to gain insight on gaze behavior during active self-motion. SPEMs and saccadic eye movements were recorded during a sport-like visual task within 24-48 h following SRC. Thirty-six Division I student-athletes were divided into SRC and control (CON) groups. All participants completed two blocks of the Wii Fit (c) soccer heading game (WF) while wearing a monocular infrared eye tracker. Eye movement classification systems quantified saccadic amplitude (SA), velocity (SV), and count (SC); as well as SPEM velocity (SPV) and amplitude (SPA). Separate Mann-Whitney U tests evaluated SPA and SC and found no significant effects (SPA, p = 0.11; SC, p = 0.10). A multi-variate analysis of variance (MANOVA) for remaining variables revealed SPV was significantly greater in CON (p < 0.05), but the SRC group had greater SA and SV (p < 0.05). These findings suggest that during a sport-like task, to maintain foveation SRC subjects used larger amplitude, faster saccades, but exhibited slower SPEMs. Measuring oculomotor function during ecologically valid, sport-like tasks may serve as a concussion biomarker and provide insights into eye movement control after SRC.	[Murray, Nicholas G.] Univ Nevada, Sch Community Hlth Sci, 1664 North Virginia St,M-S 0274, Reno, NV 89557 USA; [Murray, Nicholas G.; Szekely, Brian] Univ Nevada, Neuromech Lab, Reno, NV 89557 USA; [Szekely, Brian] Univ Nevada, Psychol Dept, Reno, NV 89557 USA; [Islas, Arthur] Univ Nevada, Sch Med, Reno, NV 89557 USA; [Berryhill, Marian] Univ Nevada, Psychol Dept, Programs Cognit & Brain Sci & Neurosci, Reno, NV 89557 USA; [Munkasy, Barry] Georgia Southern Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA USA; [Gore, Russell] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Gore, Russell] Emory Univ, Atlanta, GA 30322 USA; [Gore, Russell] Shepherd Ctr, Complex Concuss Clin, Atlanta, GA USA; [Reed-Jones, Rebecca J.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE, Canada		Murray, NG (corresponding author), Univ Nevada, Sch Community Hlth Sci, 1664 North Virginia St,M-S 0274, Reno, NV 89557 USA.	nicholasmurray@unr.edu		Berryhill, Marian/0000-0002-8218-6587	UNR Clinical and Translational Research -Infrastructure Network (CTR-IN) [P20GM 103440, U54GM104944]; UNR Neuroscience COBRE [P2G0GM103650]	The authors would like to thank the UNR Clinical and Translational Research -Infrastructure Network (CTR-IN) (P20GM 103440 and U54GM104944) along with the UNR Neuroscience COBRE (P2G0GM103650) for partially supporting and funding this research.	Akhand O, 2019, CURR OPIN NEUROL, V32, P68, DOI 10.1097/WCO.0000000000000654; Arciniega H, 2019, ATTEN PERCEPT PSYCHO, V81, P2597, DOI 10.3758/s13414-019-01774-9; BAHILL AT, 1975, INVEST OPHTH VISUAL, V14, P468; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; BRONSTEIN AM, 1987, VISION RES, V27, P517, DOI 10.1016/0042-6989(87)90037-X; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Danna-Dos-Santos A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22825-5; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Ding L, 2012, CEREB CORTEX, V22, P1052, DOI 10.1093/cercor/bhr178; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Fukushima K, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00004; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gopal A, 2017, J NEUROPHYSIOL, V118, P1664, DOI 10.1152/jn.00329.2017; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; HOLM S, 1979, SCAND J STAT, V6, P65; Holmqvist K., 2011, EYE TRACKING COMPREH; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kellar D, 2018, NEUROIMAGE-CLIN, V18, P413, DOI 10.1016/j.nicl.2018.01.025; Kelly KM, 2019, J HEAD TRAUMA REHAB, V34, P176, DOI 10.1097/HTR.0000000000000437; Komogortsev OV, 2013, BEHAV RES METHODS, V45, P203, DOI 10.3758/s13428-012-0234-9; Kontos AP, 2017, J ATHL TRAINING, V52, P256, DOI 10.4085/1062-6050-51.11.05; LISBERGER SG, 1987, ANNU REV NEUROSCI, V10, P97, DOI 10.1146/annurev.ne.10.030187.000525; MacInnes J.J., 2018, 299925BIORXIV; Mani R, 2018, BRAIN INJURY, V32, P1315, DOI 10.1080/02699052.2018.1483030; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munia TTK, 2016, IEEE ENG MED BIO, P41, DOI 10.1109/EMBC.2016.7590635; Murray NG, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/aafcd8; Murray N.G., 2017, CLINICAL; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2007, J NEUROPHYSIOL, V97, P1756, DOI 10.1152/jn.00393.2006; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.14.21; Shaikh AG, 2011, BRIT J OPHTHALMOL, V95, P705, DOI 10.1136/bjo.2010.179630; Sharpe JA, 2008, BRAIN COGNITION, V68, P241, DOI 10.1016/j.bandc.2008.08.015; Snegireva N, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaef44; Spering M, 2008, BRAIN RES, V1225, P76, DOI 10.1016/j.brainres.2008.04.061; Stubbs JL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36286-3; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Thier P, 2005, CURR OPIN NEUROBIOL, V15, P645, DOI 10.1016/j.conb.2005.10.013; van Donkelaar P, 2004, J MOTOR BEHAV, V36, P245, DOI 10.3200/JMBR.36.3.245-252; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Zonner SW, 2019, JAMA OPHTHALMOL, V137, P265, DOI 10.1001/jamaophthalmol.2018.6193	63	5	5	3	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					340	346		10.1089/neu.2019.6595		OCT 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489734700001	31524054	Green Published			2022-02-06	
J	Sobrido-Camean, D; Fernandez-Lopez, B; Pereiro, N; Lafuente, A; Rodicio, MC; Barreiro-Iglesias, A				Sobrido-Camean, Daniel; Fernandez-Lopez, Blanca; Pereiro, Natividad; Lafuente, Anunciacion; Celina Rodicio, Maria; Barreiro-Iglesias, Anton			Taurine Promotes Axonal Regeneration after a Complete Spinal Cord Injury in Lampreys	JOURNAL OF NEUROTRAUMA			English	Article						axon regeneration; lampreys; spinal cord injury; taurine	RETICULOSPINAL NEURONS; OUTGROWTH; NEUROTRANSMITTER; RECOVERY; GABA	Taurine is one of the most abundant free amino acids in the brain. It is well known that taurine protects the brain from further damage after a traumatic event. However, only a few ex vivo studies have looked at the possible role of taurine in the regulation of axon regeneration after injury. Here, we aimed to reveal the possible role for taurine in the modulation of axonal regeneration following a complete spinal cord injury (SCI) using lampreys as an animal model. The brainstem of lampreys contains several individually identifiable descending neurons that differ greatly in their capacity for axonal regeneration after SCI. This offers a convenient model to promote or inhibit axonal regrowth in the same in vivo preparation. First, we carried out high performance liquid chromatography experiments to measure taurine levels in the spinal cord following SCI. Our results revealed a statistically significant increase in taurine levels 4 weeks post-lesion, which suggested that taurine might have a positive effect on axonal regrowth. Based on these results, we decided to apply an acute taurine treatment at the site of injury to study its effect on axon regeneration. Results from these experiments show that an acute taurine treatment enhances axonal regeneration following SCI in lampreys. This offers a novel way to try to promote axon regeneration after nervous system injuries in mammalian models.	[Sobrido-Camean, Daniel; Fernandez-Lopez, Blanca; Celina Rodicio, Maria; Barreiro-Iglesias, Anton] Univ Santiago de Compostela, Dept Funct Biol, Compostela, Spain; [Fernandez-Lopez, Blanca] Univ Helsinki, Dept Anat, Helsinki, Finland; [Pereiro, Natividad; Lafuente, Anunciacion] Univ Vigo, Lab Toxicol, Orense, Spain; [Pereiro, Natividad] Tragsatec, Madrid, Spain		Barreiro-Iglesias, A (corresponding author), Univ Santiago de Compostela, Dept Biol Func, Edificio CIBUS,Campus Vida, Santiago De Compostela 15782, A Coruna, Spain.	anton.barreiro@usc.es	Camean, Daniel Sobrido/T-8395-2019; Barreiro-Iglesias, Anton/G-5281-2010	Camean, Daniel Sobrido/0000-0001-8239-2965; Barreiro-Iglesias, Anton/0000-0002-7507-080X; Fernandez-Lopez, Blanca/0000-0003-4691-8346	Spanish Ministry of Economy and CompetitivenessSpanish Government; European Regional Development FundEuropean Commission [BFU-2017-87079-P]	Grant sponsors: Spanish Ministry of Economy and Competitiveness and the European Regional Development Fund 2007-2013 (Grant numbers: BFU-2017-87079-P).	Albrecht J, 2005, NEUROCHEM RES, V30, P1615, DOI 10.1007/s11064-005-8986-6; Barreiro-Iglesias A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5953674; Barreiro-Iglesias A, 2015, NEURAL REGEN RES, V10, P25, DOI 10.4103/1673-5374.150642; Barreiro-Iglesias A, 2014, JOVE-J VIS EXP, DOI 10.3791/51494; Barreiro-Iglesias A, 2015, METHODS MOL BIOL, V1254, P329, DOI 10.1007/978-1-4939-2152-2_23; Barreiro-Iglesias Anton, 2012, Enzyme Res, V2012, P835731, DOI 10.1155/2012/835731; Benton RL, 2001, BRAIN RES, V893, P292, DOI 10.1016/S0006-8993(00)02995-4; Caride A, 2010, J APPL TOXICOL, V30, P84, DOI 10.1002/jat.1472; Rodicio MC, 2012, REV NEUROLOGIA, V55, P157, DOI 10.33588/rn.5503.2012136; Chen AQ, 1996, EXP NEUROL, V138, P261, DOI 10.1006/exnr.1996.0065; Cubillan L, 2009, ADV EXP MED BIOL, V643, P225, DOI 10.1007/978-0-387-75681-3_23; DEMEDIUK P, 1989, J NEUROCHEM, V52, P1529, DOI 10.1111/j.1471-4159.1989.tb09204.x; HOMMA S, 1979, BRAIN RES, V173, P287, DOI 10.1016/0006-8993(79)90628-0; Hu JL, 2013, J NEUROSCI METH, V220, P92, DOI 10.1016/j.jneumeth.2013.08.016; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jacobs AJ, 1997, J NEUROSCI, V17, P5206; Lima L, 2001, NUTR NEUROSCI, V4, P439, DOI 10.1080/1028415X.2001.11747379; LIMA L, 1989, INT J DEV NEUROSCI, V7, P375, DOI 10.1016/0736-5748(89)90058-0; Lima L, 1998, AMINO ACIDS, V15, P195, DOI 10.1007/BF01318859; MATTHEWS G, 1979, J PHYSIOL-LONDON, V293, P393, DOI 10.1113/jphysiol.1979.sp012896; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; Nash HH, 2002, J NEUROSCI, V22, P7111; Ripps H, 2012, MOL VIS, V18, P2673; Romaus-Sanjurjo D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0704-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shifman MI, 2008, J COMP NEUROL, V510, P269, DOI 10.1002/cne.21789; SHUPLIAKOV O, 1994, J COMP NEUROL, V347, P301, DOI 10.1002/cne.903470211; Sobrido-Camean D., 2019, DIS MODEL MECH, V20; Sobrido-Camean D, 2018, DATA BRIEF, V21, P2037, DOI 10.1016/j.dib.2018.11.003; Sobrido-Camean D, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00101; Wang Q, 2016, AMINO ACIDS, V48, P2169, DOI 10.1007/s00726-016-2244-x; Zhang GX, 2005, NEUROREHAB NEURAL RE, V19, P46, DOI 10.1177/1545968305274577	32	5	6	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 15	2020	37	6					899	903		10.1089/neu.2019.6604		OCT 2019	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LB8NM	WOS:000489734600001	31469029	Green Submitted			2022-02-06	
J	O'Connor, S; Moran, K; Burke, C; Whyte, E				O'Connor, Siobhan; Moran, Kieran; Burke, Cian; Whyte, Enda			Sports-Related Concussion in Adolescent Gaelic Games Players	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						Gaelic football; hurling; camogie; nondisclosure; sports-related concussion	REPORTING BEHAVIORS; SCHOOL; PREVALENCE; KNOWLEDGE; FOOTBALL; INJURY	Background: Gaelic games are some of the most popular sports played by Irish adolescents, and the Gaelic Athletic Association has undertaken educational initiatives to improve awareness of a sports-related concussion (SRC). However, SRC underreporting is common among adolescent athletes internationally, potentially due to poor knowledge or attitudes toward SRC. This study aimed to examine previous experiences with, knowledge of, and attitudes toward reporting SRCs, as well as views on future education in adolescent Gaelic games players and their parents. Hypotheses: The hypotheses were as follows: (1) A significant number of adolescent Gaelic games players experienced an SRC, (2) nondisclosure of SRCs will be common, and (3) adolescents display poorer attitudes toward reporting than parents. Study Design: Cross-sectional study. Methods: Adolescent male and female Gaelic games players (n = 113) and parents (n = 151) completed an anonymous questionnaire examining previous experiences with, knowledge of, and attitudes toward reporting SRCs, as well as views on future SRC education initiatives. Results: Overall, 57.5% of adolescent Gaelic games players suspected they had suffered an SRC previously, and a greater number of suspected SRCs were reported than were medically diagnosed. Adolescent players (mean score, 11.4/14) and their parents (mean score, 11.8) displayed good knowledge of SRC signs and symptoms. However, adolescents were less likely to report an SRC during an important game or if an important game was coming up. Both adolescents and their parents would like more SRC education, particularly in the format of online videos or medical professional-led workshops. Conclusion: Underreporting of SRC occurs in adolescent players, despite good knowledge of SRC signs and symptoms. Education is required to highlight the importance of completing a return-to-play program after an SRC regardless of match importance.	[O'Connor, Siobhan; Moran, Kieran; Burke, Cian; Whyte, Enda] Dublin City Univ, Sch Hlth & Human Performance, A144b, Dublin 9, Ireland		O'Connor, S (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, A144b, Dublin 9, Ireland.	siobhan.oconnor@dcu.ie	O'Connor, Siobhan/Q-8568-2018; Moran, Kieran/D-4220-2016	O'Connor, Siobhan/0000-0002-2001-0746; Moran, Kieran/0000-0003-2015-8967			Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Blake C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005059; Cantu RC, 2007, COLLECTIONS, V116, P1; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Chinn N, 2018, NEUROLOGY, V91, pS7; Cover R, 2018, J ATHL TRAINING, V53, P646, DOI 10.4085/1062-6050-338-17; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; DeVellis R, 2016, SCALE DEV THEORY APP; FAHEY T, 2005, SCH CHILDREN SPORT I; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Gaelic Athletic Association, CONC MAN GUID GAEL G; Glang A, 2018, J ADOLESCENT HEALTH, V62, P249, DOI 10.1016/j.jadohealth.2017.12.005; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Kerr Zachary Y, 2018, Inj Epidemiol, V5, P28, DOI 10.1186/s40621-018-0158-7; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Murphy JC, 2012, AM J SPORT MED, V40, P2113, DOI 10.1177/0363546512455315; O'Connor S, 2020, CLIN J SPORT MED, V30, P578, DOI 10.1097/JSM.0000000000000658; O' Connor S, 2016, J SCI MED SPORT, V19, P384, DOI 10.1016/j.jsams.2015.06.002; OConnor S, 2018, Ir Med J, V111, P727; Pallant J., 2013, SPSS SURVIVAL MANUAL; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sallis JF, 2015, HLTH BEHAV THEORY RE, V5, P43; Sullivan L, INT J ADOLESC MED HL, DOI [10.1515/ijamh-2018-0031., DOI 10.1515/IJAMH-2018-0031.]; Sullivan L., 2017, INT J ADOLESC MED HL, V29, P1, DOI [10.1515/ijamh-2015-0084, DOI 10.1515/IJAMH-2015-0084, 10.1515/ijamh-2017-3001]; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07	28	5	5	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2019	11	6					498	506	1941738119875978	10.1177/1941738119875978		OCT 2019	9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JI0QB	WOS:000489411900001	31592720	Green Published			2022-02-06	
J	Bailey, RL; Quattrone, F; Curtin, C; Frangos, S; Maloney-Wilensky, E; Levine, JM; LeRoux, PD				Bailey, Robert L.; Quattrone, Francis; Curtin, Colin; Frangos, Suzanne; Maloney-Wilensky, Eileen; Levine, Joshua M.; LeRoux, Peter D.			The Safety of Multimodality Monitoring Using Triple-Lumen Bolt in Severe Acute Brain Injury	WORLD NEUROSURGERY			English	Article						Brain oxygen; Intracranial hemorrhage; Intracranial pressure; Intraventricular hemorrhage; Multimodality monitoring; Neuromonitoring; Subarachnoid hemorrhage; Traumatic brain injury	INTRACRANIAL-PRESSURE MONITORS; TISSUE OXYGEN; CLINICAL-PRACTICE; MANAGEMENT; COMPLICATIONS; VENTRICULITIS; RELIABILITY; HEMORRHAGE; PLACEMENT; DRAINS	BACKGROUND: Multimodality monitoring is used frequently to guide care of patients with severe acute brain injury. The aim of this study was to examine the safety and reliability of multimodality monitoring. METHODS: From a prospective observational database at a Level I trauma center, 501 patients, including 300 men and 201 women (mean age 58 +/- 39 years) were identified retrospectively. Each patient received a triple-lumen bolt and 3 monitors: intracranial pressure, brain temperature, and brain oxygen. Intensive care unit and hospital records were examined to identify complications, reasons for device replacement, malfunction and infection. Head computed tomography (CT) scans performed before and after the monitors were inserted were examined for evidence of monitor-related adverse effects. RESULTS: A total of 696 triple-lumen bolts were placed. Median duration of monitoring was 78.88 hours (interquartile range, 33.0-133.2 hours). Bilateral monitors were inserted in 22 (3.16%) patients. Ten (1.43%) monitors were replaced to allow magnetic resonance imaging, and 40 (5.74%) monitors were replaced to facilitate additional cranial surgery. Of 35 (5.02%) monitors that were replaced because they were thought to not be functioning properly, 19 (54.29%) were subsequently found to be functioning normally. Follow-up CT scans were compared with CT scans obtained before insertion of monitors; 9 (2.13%) small contusions and 10 (2.36%) extra-axial hematomas associated with the devices were identified. Based on the CT findings, the hematomas were thought to be associated with the insertion technique rather than the device; 4 hematomas required treatment. Twenty-two (3.16%) devices were incorrectly placed (e.g., the probe was in an infarct or an already existing contusion). Only 1 associated infection was identified. CONCLUSIONS: Placement of intracranial monitors for multimodality neuromonitoring using a triple-lumen bolt appears to be safe. The complication rate is similar to published complication rates for single-lumen bolts and single monitors.	[Bailey, Robert L.; LeRoux, Peter D.] Main Line Hlth, Div Neurosurg, Wynnewood, PA 19096 USA; [LeRoux, Peter D.] Lankenau Inst Med Res, Wynnewood, PA 19096 USA; [Quattrone, Francis; Curtin, Colin; Frangos, Suzanne; Maloney-Wilensky, Eileen; Levine, Joshua M.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Levine, Joshua M.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Levine, Joshua M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		LeRoux, PD (corresponding author), Main Line Hlth, Div Neurosurg, Wynnewood, PA 19096 USA.; LeRoux, PD (corresponding author), Lankenau Inst Med Res, Wynnewood, PA 19096 USA.	lerouxpeterd@gmail.com					Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Antes S, 2014, ACTA NEUROCHIR, V156, P1009, DOI 10.1007/s00701-013-1991-7; Barber MA, 2012, J TRAUMA ACUTE CARE, V73, P558, DOI 10.1097/TA.0b013e318265cb75; Bardt TF, 1998, ACT NEUR S, V71, P153; Baum GR, 2017, J NEUROSURG, V127, P1190, DOI 10.3171/2016.9.JNS16367; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Camacho EF, 2011, INFECTION, V39, P47, DOI 10.1007/s15010-010-0073-5; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Doerfler S, 2018, WORLD NEUROSURG, V114, pE483, DOI 10.1016/j.wneu.2018.02.195; Foreman B, 2018, NEUROCRIT CARE, V29, P469, DOI 10.1007/s12028-018-0551-7; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Guyot LL, 1998, ACT NEUR S, V71, P47; Harrop JS, 2010, NEUROSURGERY, V67, P187, DOI 10.1227/01.NEU.0000370247.11479.B6; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Honda H, 2010, INFECT CONT HOSP EP, V31, P1078, DOI 10.1086/656377; Le Roux P, 2016, TRANSLATIONAL RES TR, P315; Le Roux P, 2015, FRONT NEUROSCI, V57, P315; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; McKhann GM, 2004, MANAGEMENT CEREBRAL, P431; Merck LH, 2019, CRIT CARE MED, V47, P623, DOI 10.1097/CCM.0000000000003680; Morton R, 2012, NEUROSURGERY, V71, pE193, DOI 10.1227/NEU.0b013e318232e250; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; National Institute for Health and Clinical Excellence, 2011, NIC GUID HEAD INJ; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238; Scheithauer S, 2009, J NEUROL NEUROSUR PS, V80, P1381, DOI 10.1136/jnnp.2008.165357; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Swadron SP, 2012, NEUROCRIT CARE, V17, P112, DOI 10.1007/s12028-012-9760-7; TEASDALE G, 1974, LANCET, V2, P81; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; Williams TA, 2011, J NEUROSURG, V115, P1040, DOI 10.3171/2011.6.JNS11167	54	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2019	130						E62	E67		10.1016/j.wneu.2019.05.195			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JB0MH	WOS:000488248200008	31195129				2022-02-06	
J	Chen, KH; Lee, CP; Yang, YH; Yang, YH; Chen, CM; Lu, ML; Lee, YC; Chen, VCH				Chen, Kai-Hua; Lee, Chuan-Pin; Yang, Yao-Hsu; Yang, Yun-Hsuan; Chen, Chien-Min; Lu, Mong-Liang; Lee, Yi-Chen; Chen, Vincent Chin-Hung			Incidence of hydrocephalus in traumatic brain injury A nationwide population-based cohort study	MEDICINE			English	Article						brain injuries; hydrocephalus; incidence; propensity score; subarachnoid hemorrhage	POSTTRAUMATIC HYDROCEPHALUS; RISK-FACTORS; PREDICTORS; MODEL	Background: The aim of this study was to investigate the risk and peak time of post-traumatic hydrocephalus (PTH) in traumatic brain injury (TBI) patients with traumatic subarachnoid hemorrhage (SAH), compared to TBI patients without traumatic SAH. Methods: In this retrospective population-based cohort study, the data was extracted from Longitudinal Health Insurance Database from 2000 to 2010 in Taiwan. A total of 23,775 TBI patients who had a first event TBI during 2000 to 2010 were included and divided into TBI with SAH (TBI-S) group and TBI without SAH (TBI-NS) group. We focused on analyzing the PTH in both groups within 2 years after brain injury. Competing risk regression models were performed to assess the risk of developing PTH in the TBI-S group compared to the TBI-NS group. Results: Comparing to the TBI-NS group, there was a significantly higher cumulative incidence of PTH in the TBI-S group during the 2-year follow-up period. The adjusted hazard ratio (HR) of PTH in TBI-S group within 2 years was between 2.90-3.47, and the highest estimates were obtained within 6 months after injury (HR= 3.47, 95% CI: 2.43-4.94). The occurrence percentage of PTH was highest during 0-3rd month follow-up periods (1.95% in TBI-S group; 0.48% in TBI-NS group). Conclusions: The peak time of PTH occurrence was noted during 0-3rd month post brain injury. Traumatic SAH patients had an approximate 3-fold risk of developing PTH, comparing to TBI patients without traumatic SAH.	[Chen, Kai-Hua; Chen, Chien-Min] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Chen, Kai-Hua; Chen, Chien-Min; Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, 259 Wenhua,1st Rd, Taoyuan 333, Taiwan; [Lee, Chuan-Pin; Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Yang, Yun-Hsuan] Chang Gung Mem Hosp, Dept Pediat Neurol, Chiayi, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Wan Fang Hosp, Dept Psychiat, Taipei, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Coll Med, Sch Med, Taipei, Taiwan; [Lee, Yi-Chen; Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan		Chen, VCH (corresponding author), Chang Gung Univ, Sch Med, 259 Wenhua,1st Rd, Taoyuan 333, Taiwan.; Chen, VCH (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Psychiat, Chiayi, Taiwan.; Chen, VCH (corresponding author), 6 W Sec,Jiapu Rd, Puzi 613, Chiayi, Taiwan.	cch1966@gmail.com	; Yang, Yao-Hsu/A-3450-2019	Chen, Chien-Min/0000-0001-9838-0096; Yang, Yao-Hsu/0000-0002-8080-0504; Lu, Mong-Liang/0000-0003-3184-6554	Health Information and Epidemiology Laboratory of Chang Gung Memorial Hospital, Chiayi, Taiwan [CLRPG6G0041, CLRPG6G0043]	The authors are grateful for the support of the Health Information and Epidemiology Laboratory (CLRPG6G0041, CLRPG6G0043) of Chang Gung Memorial Hospital, Chiayi, Taiwan, since 2016. It provided this study a longitudinal health insurance database for analysis.	Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Aydin MD, 2014, ACTA NEUROCHIR, V156, P1311, DOI 10.1007/s00701-014-2088-7; Bata SC, 2014, ANZ J SURG, V84, P438, DOI 10.1111/ans.12582; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Daniere F, 2015, DIAGN INTERV IMAG, V96, P677, DOI 10.1016/j.diii.2015.05.006; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Huang X, 2014, J CRANIOFAC SURG, V25, P1280, DOI 10.1097/SCS.0000000000000583; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; KO LC, 2007, J PUBLIC HLTH, V26, P491; Krauss JK, 1996, STROKE, V27, P24, DOI 10.1161/01.STR.27.1.24; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Miki T, 2006, J TRAUMA, V61, P985, DOI 10.1097/01.ta.0000239665.39237.8c; Oberholzer Michael, 2019, Med Sci (Basel), V7, DOI 10.3390/medsci7030047; Parsons L.S., P 29 ANN SAS USERS G, P165; Penfield W, 1943, CAN MED ASSOC J, V48, P99; Saul FMV, 2014, CAMB MONOGR PART PHY, V36, P1; Shah AH, 2013, WORLD NEUROSURG, V80, P304, DOI 10.1016/j.wneu.2013.01.110; Shakeri M, 2008, NEUROSURG QUART, V18, P216, DOI 10.1097/WNQ.0b013e31817328c9; Suarez Jose I, 2015, Continuum (Minneap Minn), V21, P1263, DOI 10.1212/CON.0000000000000217; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; Tian HL, 2008, SURG NEUROL, V69, P241, DOI 10.1016/j.surneu.2007.02.032; Walcott BP, 2015, NEUROCRIT CARE, V23, P54, DOI 10.1007/s12028-014-0072-y; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Williams Michael A, 2016, Continuum (Minneap Minn), V22, P579, DOI 10.1212/CON.0000000000000305; Xiong GX, 2014, J NEUROTRAUM, V31, P1396, DOI 10.1089/neu.2013.3110	33	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	OCT	2019	98	42							e17568	10.1097/MD.0000000000017568			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JO1CI	WOS:000497322600045	31626123	gold, Green Published			2022-02-06	
J	Chrisman, SPD; Harmon, KG; Schmidt, JD; Kaminski, TW; Buckley, TA; Kontos, AP; Clugston, JR; McCrea, M; McAllister, T; Broglio, SP; Ortega, J				Chrisman, S. P. D.; Harmon, K. G.; Schmidt, J. D.; Kaminski, T. W.; Buckley, T. A.; Kontos, A. P.; Clugston, J. R.; McCrea, M.; McAllister, T.; Broglio, S. P.; Ortega, J.			Impact of Factors that Affect Reading Skill Level on King-Devick Baseline Performance Time	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Mild traumatic brain injury; Learning disorder; Oculomotor; Saccades; Sport; Screening	REFERENCE VALUES; CONCUSSION	The King-Devick (K-D) test is often used as part of a multimodal assessment to screen for sport-related concussion. However, the test involves reading numbers, and little is known about variation in baseline performance on the K-D by reading skill level. We conducted a cross-sectional study analyzing data from the Concussion Assessment, Research and Education (CARE) Consortium to assess differences in baseline performance on the K-D associated with factors that impact reading skill level (learning disorder [LD] and primary home language other than English [PHLOTE]), while controlling for covariates (gender, type of sport, attentional issues, history of concussion and modality of administration). We had a sample of 2311 student-athletes (47% female), and multivariate regression indicated an average K-D performance time of 40.4 s. Presence of LD was associated with a 3.3 s slower K-D time (95% CI 1.9-4.7, p < 0.001), and PHLOTE was associated with a 2.6 s slower K-D time (95% CI 1.2-4.0, p < 0.001), after controlling for other covariates. These results suggest caution in the use of normative data with the K-D. Future studies should explore the impact of factors associated with reading skill level on sensitivity of the K-D in detecting concussion.	[Chrisman, S. P. D.; Harmon, K. G.] Univ Washington, CW8-6,POB 5371, Seattle, WA 98145 USA; [Chrisman, S. P. D.] Seattle Childrens Res Inst, Seattle, WA USA; [Schmidt, J. D.] Univ Georgia, Athens, GA 30602 USA; [Kaminski, T. W.; Buckley, T. A.] Univ Delaware, Newark, DE USA; [Kontos, A. P.] Univ Pittsburgh, Pittsburgh, PA USA; [Clugston, J. R.] Univ Florida, Gainesville, FL USA; [McCrea, M.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [McAllister, T.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Broglio, S. P.] Univ Michigan, Ann Arbor, MI 48109 USA; [Ortega, J.] Humboldt State Univ, Arcata, CA 95521 USA		Chrisman, SPD (corresponding author), Univ Washington, CW8-6,POB 5371, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org	Ugeda Munoz, Fernando/ABH-1537-2021; Buckley, Thomas A/B-7525-2016; ARSLAN, Okan/AAA-3232-2020	Buckley, Thomas A/0000-0002-0515-0150; Chrisman, Sara/0000-0001-5373-7223; Clugston, James/0000-0002-2103-1039	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - Department of Defense (DOD); U.S. ArmyMedical Research Acquisition Activity, Chandler Street, Fort Detrick, MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2- 0151]	This publication was made possible in part with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. ArmyMedical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2- 0151. Opinions, interpretations, conclusions and recommendations are those of the author(s) and are not necessarily endorsed by the Department of Defense or the NCAA.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Ardila A, 2016, ARCH CLIN NEUROPSYCH, V31, P112, DOI 10.1093/arclin/acv081; Balcer L. J, 2015, ANN SPORT MED RES, V2; Beitchman JH, 1997, J AM ACAD CHILD PSY, V36, P1020, DOI 10.1097/00004583-199708000-00009; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Dodick D, 2017, J CHILD NEUROL, V32, P104, DOI 10.1177/0883073816668704; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; Ischebeck A, 2003, MEM COGNITION, V31, P529, DOI 10.3758/BF03196094; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Kulp M T, 1997, J Am Optom Assoc, V68, P589; Kulp MT, 1998, OPTOMETRY VISION SCI, V75, P284, DOI 10.1097/00006324-199804000-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Leong DF, 2014, CLIN PEDIATR, V53, P858, DOI 10.1177/0009922814532520; Lieberman S, 1983, J Am Optom Assoc, V54, P631; Lukasova K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00987; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Proverbio AM, 2020, EUR J NEUROSCI, V52, P4480, DOI 10.1111/ejn.13938; Seassau M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00085; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Shum J, 2013, J NEUROSCI, V33, P6709, DOI 10.1523/JNEUROSCI.4558-12.2013; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307	28	5	5	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2122	2127		10.1007/s10439-018-02150-8			6	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	JQ0HT	WOS:000498636800008	30341738				2022-02-06	
J	Dobitsch, AA; Oleck, NC; Liu, FC; Halsey, JN; Hoppe, IC; Lee, ES; Granick, MS				Dobitsch, Andrew A.; Oleck, Nicholas C.; Liu, Farrah C.; Halsey, Jordan N.; Hoppe, Ian C.; Lee, Edward S.; Granick, Mark S.			Sports-Related Pediatric Facial Trauma: Analysis of Facial Fracture Pattern and Concomitant Injuries	SURGERY JOURNAL			English	Article						facial fracture; sports facial fracture; pediatric facial fracture; pediatric facial trauma		Objective Sports-related injuries, such as facial fractures, are potentially debilitating and may lead to long-term functional and aesthetic deficits in a pediatric patient. In this study, we analyze sports-related facial fractures in the urban pediatric population in an effort to characterize patterns of injury and improve management strategies and outcomes. Methods Retrospective chart review was performed for all facial fractures resulting from sports injuries in the pediatric population at a level-1 trauma center (University Hospital, Newark, NJ). Results Seventeen pediatric patients were identified as having sustained a fracture of the facial skeleton due to sports injury. Mean age was 13.9 years old. A total of 29 fractures were identified. Most common fracture sites included the orbit (n = 12), mandible (n = 5), nasal bone (n = 5), and zygomaticomaxillary complex (n = 3). The most common concomitant injuries included skull fracture (n = 3), intracranial hemorrhage (n = 4), and traumatic brain injury (n = 4). One patient was intubated upon arrival to the emergency department. Hospital admission was required in 13 patients, 4 of which were admitted to an intensive care setting. Nine patients required operative intervention. Mean length of hospital stay was 2.4 days. No patients were expired. Conclusions Sports-related facial fractures are potentially debilitating injuries in the pediatric population. Analysis of fracture pattern and concomitant injuries is imperative to develop effective management strategies and prevention techniques.	[Dobitsch, Andrew A.; Oleck, Nicholas C.; Liu, Farrah C.; Halsey, Jordan N.; Hoppe, Ian C.; Lee, Edward S.; Granick, Mark S.] Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, 140 Bergen St,Suite E1620, Newark, NJ 07103 USA		Granick, MS (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, Div Plast & Reconstruct Surg, 140 Bergen St,Suite E1620, Newark, NJ 07103 USA.	mgranickmd@rutgers.edu	; Halsey, Jordan/D-2545-2011	Dobitsch, Andrew/0000-0002-8211-9587; Halsey, Jordan/0000-0001-5513-5162			Alcala-Galiano A, 2008, RADIOGRAPHICS, V28, P441, DOI 10.1148/rg.282075060; Chandra SR, 2017, FACIAL PLAST SURG CL, V25, P581, DOI 10.1016/j.fsc.2017.06.009; Cole P, 2009, CRANIOMAX TRAUM REC, V2, P77, DOI 10.1055/s-0029-1202592; Danis R P, 2000, Inj Prev, V6, P232, DOI 10.1136/ip.6.3.232; Ghosh R, 2018, J MAXILLOFAC ORAL SU, V17, P158, DOI 10.1007/s12663-016-0965-8; Gleisner D M, PEDIAT FACIAL FRACTU; Hwang K, 2009, J CRANIOFAC SURG, V20, P825, DOI 10.1097/SCS.0b013e3181a14cda; MacIsaac ZM, 2013, PLAST RECONSTR SURG, V131, P1339, DOI 10.1097/PRS.0b013e31828bd191; Marano AA, 2015, CRANIOMAXILLOFAC TRA, V9, P35; Siy RW, 2011, J CRANIOFAC SURG, V22, P1190, DOI [10.1097/SCS.0b013e31821c0cf9, 10.1097/SCS.0b013e31822eaabc]; Viozzi CF, 2017, CLIN SPORT MED, V36, P355, DOI 10.1016/j.csm.2016.11.007; Zimmermann CE, 2005, INT J ORAL MAX SURG, V34, P823, DOI 10.1016/j.ijom.2005.06.015	12	5	5	0	2	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2378-5128	2378-5136		SURG J-NY	Surg. J.	OCT	2019	5	4					E146	E149		10.1055/s-0039-1697627			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	JC4HW	WOS:000489239000002	31602397	Green Published, gold			2022-02-06	
J	Faried, A; Halim, D; Widjaya, IA; Badri, RF; Sulaiman, SF; Arifin, MZ				Faried, Ahmad; Halim, Danny; Widjaya, Ingrid Ayke; Badri, Rendy Febrian; Sulaiman, Syailendra Fii; Arifin, Muhammad Z.			Correlation between the skull base fracture and the incidence of intracranial hemorrhage in patients with traumatic brain injury	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Skull base fracture; Intracranial hemorrhage; Traumatic brain injury		Purpose: A head injury (HI) may cause a skull fracture, which may or may not be associated with injury to the brain. In essence, a skull base fracture (SBF) is a linear fracture at the base of the skull. Loss of consciousness and Glasgow coma score (GCS) may vary depending on an associated intracranial pathology. The pathomechanism is believed to be caused by high energy impact directly to the mastoid and supraorbital bone or indirectly from the cranial vault. Aim of this study is to define the correlation between SBF and intracranial hemorrhage (ICH) in patients with HI. Methods: Analysis of data obtained from a retrospective review of medical records and from a systematized database pertaining to diagnostic criteria of SBF patients based only on clinical symptoms associated with ICH caused by HI treated in the Department of Neurosurgery at Dr. Hasan Sadikin Hospital, Bandung, Indonesia from January 1, 2012 to December 31, 2017. The exclusion criteria included age less than 15 years and no head computed tomography (CT) scan examination provided. Results: A total of 9006 patients were included into this study in which they were divided into 3 groups: group 1, HI with no ICH; group 2, HI with single ICH and group 3, HI with multiple ICH. In all the SBF cases, SBF at anterior fossa accounted for 69.40% of them, which were mostly accompanied with mild HI (64.70%). Severity of HI and site of SBF correlated with the existence of traumatic brain lesions on CT scan, thus these factors were able to predict whether there were traumatic brain lesions or not. Most of the patients with epidural hemorrhage (EDH) has single traumatic lesion on CT scan, whereas most of the patients with cerebral contusion (CC) has multiple traumatic lesions on CT scan. On patients with both traumatic brain injury and SBF, most of the patients with anterior fossa SBF has EDH; whereas most of the patients with middle fossa SBF were accompanied with CC. Surgery was not required for most of the patients with SBF. Conclusion: SBFs were strongly correlated with traumatic ICH lesions patients with anterior fossa SBF were more likely to suffer EDH whereas with middle fossa SBF were more likely to suffer CC. (C) 2019 Chinese Medical Association. Production and hosting by Elsevier B.V.	[Faried, Ahmad; Halim, Danny; Widjaya, Ingrid Ayke; Badri, Rendy Febrian; Sulaiman, Syailendra Fii; Arifin, Muhammad Z.] Univ Padjadjaran, Fac Med, Dept Neurosurg, Dr Hasan Sadikin Hosp, Bandung, Indonesia; [Faried, Ahmad] Univ Padjadjaran, Fac Med, Bandung Injury Res Unit, Bandung, Indonesia		Faried, A (corresponding author), Univ Padjadjaran, Dept Neurosurg, Fac Med, Dr Hasan Sadikin Hosp RSHS, Bandung, Indonesia.	faried.fkup@gmail.com			Ministry of Research, Technology and Higher Education of the Republic of Indonesia "DIKTI" [05/E/KPT/2019]	This work was supported by the Grants-in-Aid from the Ministry of Research, Technology and Higher Education of the Republic of Indonesia "DIKTI" 05/E/KPT/2019 for Faried A.	Ainsworth CR, 2015, MEDSCAPE; Anderson R, 2005, HEAD INJURY PATHOPHY, P26; BEAUMONT A, 2000, NEUROSURGERY SCI BAS, V0001, P00460; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Dobrin I, 2009, ROM NEUROSURG, V16, P43; Faried A, 2018, WORLD NEUROSURG, V116, pE239, DOI 10.1016/j.wneu.2018.04.180; Faried A, 2017, WORLD NEUROSURG, V100, P195, DOI 10.1016/j.wneu.2016.12.133; Geisler FH, 2005, WILKINS PRINCIPLES N, P333; Graham D. I., 2000, HEAD INJURY; Jones RM, 2000, ARCH OTOLARYNGOL, V126, P131, DOI 10.1001/archotol.126.2.131; Lang L, 1999, QUINZAINE LITTERAIRE, P2; Leestma JE., 2008, FORENSIC NEUROPATHOL, V2nd; Narayan RK, 1991, PRINCIPLES NEUROSURG, P235; Orlando regional healthcare education and development, 2004, OV AD TRAUM BRAIN IN; Samad S, 2018, INT J SCI RES, V7, P574; SAMII M, 1989, SURG SKULL BASE INTE; Sastrawan AD, 2017, MAJ KEDOKT GIGI INDO, V3, P111; Stalhammar DA, 1991, ADV NEUROTRAUMATOLOG, P1; Taveres JM, 1996, HEAD INJURIES THEIR, P327; Verive MJ, 2017, MEDSCAPE	20	5	5	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	OCT	2019	22	5					286	289		10.1016/j.cjtee.2019.05.006			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	JA3WN	WOS:000487760400008	31521457	Green Published, gold			2022-02-06	
J	Harnod, D; Harnod, T; Lin, CL; Shen, WC; Kao, CH				Harnod, Dorji; Harnod, Tomor; Lin, Cheng-Li; Shen, Wei-Chih; Kao, Chia-Hung			Increased Risks of Suicide Attempt and Suicidal Drug Overdose Following Admission for Head Injury in Patients with Depression	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						cohort study; depression; suicide; head injury; National Health Insurance	TRAUMATIC BRAIN-INJURY; DEPLOYED MILITARY PERSONNEL; CLINICAL-SAMPLE; PREVENTION; DISORDERS; IMPACT	Aims: To determine the risks of suicide attempt (SA) and suicidal drug overdose (SDO) following the admission for head injury of patients with depression. Design: We analyzed the NHIRD data of patients aged >= 20 years who had received depression diagnoses between 2000 and 2010. They were divided into cohorts of those with admission for head injury (DHI) and those without it (DWI) during the follow-up period and compared against a sex-, age-, comorbidity-, and index-date-matched cohort from the general population. Setting: The Taiwan National Health Insurance Research Database (NHIRD). Participants/Cases: We analyzed the NHIRD data of patients (>= 20 years) who had received depression diagnoses between 2000 and 2010. Intervention(s): Regular interventions. Measurements: We calculated the adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) of SA and SDO in these cohorts after adjustment for age, sex, and comorbidities. Findings: Up to the end of 2011, our results revealed extremely high incidences of SA and SDO with 63.3 and 88.6 per 10,000 person-years, respectively, in the DHI cohort. The DHI cohort had a 37.4-times higher risk for SA and a 17.1-times higher risk for SDO compared with the comparison group and had aHRs of 14.4 and 16.3, respectively, for poisoning by medicinal substances and poisoning by tranquilizers compared with patients in the DWI cohort. Patients with DHI aged <50 years, of female sex, with high incomes, living in more urbanized areas, and without other comorbidities had extraordinarily higher risks for SA. Conclusions: The risks of SA and SDO were proportionally increased by head injury in patients with depression in Taiwan. Our findings provide crucial information to implement efficient suicide prevention strategies in the future.	[Harnod, Dorji] Fu Jen Catholic Univ, Fu Jen Catholic Univ Hosp, Dept Emergency & Crit Care Med, New Taipei 243, Taiwan; [Harnod, Dorji] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei 243, Taiwan; [Harnod, Tomor] Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Hualien Tzu Chi Hosp, Hualien 970, Taiwan; [Harnod, Tomor] Tzu Chi Univ, Coll Med, Hualien 970, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung 404, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung 404, Taiwan; [Shen, Wei-Chih] Asia Univ, Dept Comp Sci & Informat Engn, Taichung 413, Taiwan; [Shen, Wei-Chih] China Med Univ Hosp, Ctr Augmented Intelligence Healthcare, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung 404, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung 404, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung 413, Taiwan		Harnod, T (corresponding author), Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Hualien Tzu Chi Hosp, Hualien 970, Taiwan.; Harnod, T (corresponding author), Tzu Chi Univ, Coll Med, Hualien 970, Taiwan.; Kao, CH (corresponding author), China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung 404, Taiwan.; Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung 404, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung 404, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung 404, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung 413, Taiwan.	A00635@mail.fjuh.fju.edu.tw; nsha@tzuchi.com.tw; orangechengli@gmail.com; wcshen@gmail.com; d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial Center [MOHW108-TDU-B-212-133004]; China Medical University Hospital [CMU107-ASIA-19]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 108-2321-B-039-003]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by the Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW108-TDU-B-212-133004), China Medical University Hospital (CMU107-ASIA-19), Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 108-2321-B-039-003), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Beadle EJ, 2020, DISABIL REHABIL, V42, P1414, DOI 10.1080/09638288.2018.1527954; Bell GS, 2009, CNS DRUGS, V23, P281, DOI 10.2165/00023210-200923040-00002; Bin Abdullah MFIL, 2018, ASIAN J PSYCHIATR, V37, P67, DOI 10.1016/j.ajp.2018.08.017; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Chang CH, 2018, NEUROPSYCH DIS TREAT, V14, P443, DOI 10.2147/NDT.S157494; Chen KL, 2010, RES DEV DISABIL, V31, P1590, DOI 10.1016/j.ridd.2010.05.002; Hegerl U, 2016, DIALOGUES CLIN NEURO, V18, P183; Hsu IL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112457; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Kanner AM, 2003, EPILEPSY BEHAV, V4, pS3, DOI 10.1016/j.yebeh.2003.08.018; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Large MM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4627; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Massenburg BB, 2017, NEUROL INDIA, V65, P305, DOI 10.4103/neuroindia.NI_719_16; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Stanley IH, 2017, J PSYCHIATR RES, V84, P161, DOI 10.1016/j.jpsychires.2016.10.004; Strawbridge R, 2017, NEUROPSYCH DIS TREAT, V13, P1245, DOI 10.2147/NDT.S114542; Verma V, 2017, TROP MED INT HEALTH, V22, P1551, DOI 10.1111/tmi.12991; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Wittchen U., 2010, DEPRESSIVE ERKRANKUN; Wong Sabrina T, 2014, CMAJ Open, V2, pE337, DOI 10.9778/cmajo.20140052; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Ying YW, 2008, CULT DIVERS ETHN MIN, V14, P29, DOI 10.1037/1099-9809.14.1.29	28	5	5	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	OCT	2019	16	19							3524	10.3390/ijerph16193524			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	JK3MF	WOS:000494748600020	31547202	Green Published, gold			2022-02-06	
J	Houston, MN; Hoch, MC; Malvasi, SR; Peck, KY; Svoboda, SJ; Cameron, KL				Houston, Megan N.; Hoch, Matthew C.; Malvasi, Steven R.; Peck, Karen Y.; Svoboda, Steven J.; Cameron, Kenneth L.			Level of Agreement Between Human-Rated and Instrumented Balance Error Scoring System Scores	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Postural stability; Concussion; Pressure mat	CONCUSSION ASSESSMENT	Clinicians have used the Balance Error Scoring System (BESS) to quantify postural control for concussion management. However, the reliability of the human rated BESS has varied prompting the development of instrumented BESSs. A cross-sectional design was used to determine the level of agreement (LOA) between human rated and instrumented BESS scores. Sixty participants completed the BESS on video. An instrumented mat was used to quantify BESS errors while a live human rater simultaneously scored the BESS. A second human rated BESS performance via video. Bland-Altman LOA analyses evaluated agreement between scoring methods (Mat-Human, Mat-Video, Video-Live) for each stance. Mean biases between scores, for each stance, with 95% confidence intervals (95% CIs) were calculated. Agreement between scoring methods was not assessed for the Firm-Double-Limb stance because very few errors were recorded. Agreement between both human raters and the matwas poor based onmean bias estimates > +/- 1 and/or wide 95%CIs for all stances including BESS-Total. Agreement between the human raters was better, having displayed consistently smaller mean bias estimates and tighter 95%CIs for all stances and BESS Total. As a result, human rated and instrumented BESS scores may not be comparable. One method should be used to measure BESS errors for consistency.	[Houston, Megan N.; Malvasi, Steven R.; Peck, Karen Y.; Cameron, Kenneth L.] US Mil Acad, John A Feagin Jr Sports Med Fellowship, Keller Army Hosp, 900 Washington Rd, West Point, NY 10996 USA; [Hoch, Matthew C.] Univ Kentucky, Sports Med Res Inst, Lexington, KY USA; [Svoboda, Steven J.] MedStar Hlth, Washington, DC USA		Houston, MN (corresponding author), US Mil Acad, John A Feagin Jr Sports Med Fellowship, Keller Army Hosp, 900 Washington Rd, West Point, NY 10996 USA.	megan.n.houston.ctr@mail.mil		Cameron, Kenneth/0000-0002-6276-4482	Office of the Assistant Secretary of Defense for Health Affairs [HU0001-15-2-0037/2988]	The views and opinions expressed are those of the investigators and they do not reflect the official position of the U.S. Army, the Department of Defense, or the U.S. Government. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs under Award # HU0001-15-2-0037/2988.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Caccese JB, 2016, J SPORT REHABIL, V25, P133, DOI 10.1123/jsr.2014-0281; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gao JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016749; Glass SM, 2019, J APPL BIOMECH, V35, P32, DOI 10.1123/jab.2018-0056; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Napoli A, 2017, ANN BIOMED ENG, V45, P2784, DOI 10.1007/s10439-017-1911-8; Patterson J.A., 2014, INT J ATHL THER TRAI, V19, P4, DOI [10.1123/ijatt.2013-0094, DOI 10.1123/IJATT.2013-0094]; Powers KC, 2014, GAIT POSTURE, V39, P611, DOI 10.1016/j.gaitpost.2013.05.026; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Teyhen Deydre S, 2012, J Strength Cond Res, V26 Suppl 2, pS61, DOI 10.1519/JSC.0b013e31825d80e6	21	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2019	47	10			SI		2128	2135		10.1007/s10439-019-02274-5			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JQ0HT	WOS:000498636800009	31011917				2022-02-06	
J	Minta, K; Cullen, NC; Al Nimer, F; Thelin, EP; Piehl, F; Clarin, M; Tullberg, M; Jeppsson, A; Portelius, E; Zetterberg, H; Blennow, K; Andreasson, U				Minta, Karolina; Cullen, Nicholas C.; Al Nimer, Faiez; Thelin, Eric P.; Piehl, Fredrik; Clarin, Marcus; Tullberg, Mats; Jeppsson, Anna; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf			Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						brevican; neurocan; tenascin-C; tenascin-R; traumatic brain injury	CHONDROITIN SULFATE PROTEOGLYCANS; TENASCIN-C; SPINAL-CORD; DORSAL-ROOT; EXPRESSION; BIOMARKERS; NEUROCAN; BREVICAN; S100B; ASSOCIATION	Background: Brevican, neurocan, tenascin-C and tenascin-R are extracellular matrix proteins present in brain that show increased expression in experimental animal models of brain injury. However, little is known about the dynamics of these proteins in human body fluids, such as cerebrospinal fluid (CSF) and serum, after traumatic brain injury (TBI). The aims of this study were to investigate if matrix proteins in CSF and serum are associated with functional outcome following traumatic brain injury, if their concentrations change over time and to compare their levels between brain injured patients to controls. Methods: In total, 42 traumatic brain injury patients, nine healthy controls and a contrast group consisting of 38 idiopathic normal pressure hydrocephalus patients were included. Enzyme-linked immunosorbent assays (ELISAs) were used to measure the concentrations of proteins. Results: Increased concentrations of brevican, tenascin-C and tenascin-R in CSF correlated with unfavourable outcome, with stronger outcome prediction ability compared to other biomarkers of brain tissue injury. CSF brevican, tenascin-R and serum neurocan gradually decreased with time (p = 0.04, p = 0.008, p = 0.005, respectively), while serum tenascin-C (p = 0.01) increased. CSF concentrations of brevican, neurocan and tenascin-R (only in time point 3) after TBI were lower than in the idiopathic normal pressure hydrocephalus group (p < 0.0001, p < 0.0001, and p = 0.0008, respectively). In serum, tenascin-C concentration was higher and neurocan lower compared to healthy controls (p = 0.02 and p = 0.0009). Conclusions: These findings indicate that levels of extracellular matrix proteins are associated with clinical outcome following TBI and may act as markers for different pathophysiology than currently used protein biomarkers.	[Minta, Karolina; Clarin, Marcus; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Cullen, Nicholas C.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Al Nimer, Faiez; Thelin, Eric P.; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric P.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Clarin, Marcus; Portelius, Erik; Zetterberg, Henrik; Blennow, Kaj; Andreasson, Ulf] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Tullberg, Mats; Jeppsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci, Gothenburg, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England		Minta, K (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden.	karolina.minta@neuro.gu.se	Nimer, Faiez Al/ABB-9465-2020; Jeppsson, Anna/ABC-7383-2020; Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364; Minta, Karolina/0000-0002-3346-5088; Tullberg, Mats/0000-0003-4997-5266; Al Nimer, Faiez/0000-0003-0937-5995	Swedish Research CouncilSwedish Research CouncilEuropean Commission; European Research CouncilEuropean Research Council (ERC)European Commission; Swedish State Support for Clinical Research; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; Edit Jacobson Foundation; Torsten Soderberg Foundation; Stiftelsen for Gamla Tjanarinnor - Swedish Society for Medical Research	The study was supported by grants from the Swedish Research Council, the European Research Council, Swedish State Support for Clinical Research, the Knut and Alice Wallenberg Foundation, the Edit Jacobson Foundation and the Torsten Soderberg Foundation and Stiftelsen for Gamla Tjanarinnor. EPT is funded by grants from the Swedish Society for Medical Research.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Asher RA, 2000, J NEUROSCI, V20, P2427; Becker T, 2000, GLIA, V29, P330, DOI 10.1002/(SICI)1098-1136(20000215)29:4<330::AID-GLIA4>3.0.CO;2-L; Beggah AT, 2005, NEUROSCIENCE, V133, P749, DOI 10.1016/j.neuroscience.2005.03.005; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Cui H, 2013, IUBMB LIFE, V65, P108, DOI 10.1002/iub.1118; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Fluck M, 2000, J CELL SCI, V113, P3583; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Grumet M, 1996, PERSPECT DEV NEUROBI, V3, P319; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; KIRINO T, 1983, J NEUROSCI, V3, P915; Kurazono S, 2001, BRAIN RES, V898, P36, DOI 10.1016/S0006-8993(01)02128-X; Li X, 2014, J INTERN MED, V275, P418, DOI 10.1111/joim.12164; Lista S, 2013, PROG NEUROBIOL, V101, P1, DOI 10.1016/j.pneurobio.2012.06.007; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Olsson M, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy025; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Probstmeier R, 2000, BRAIN RES, V863, P42, DOI 10.1016/S0006-8993(00)02075-8; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Schafer R, 2008, NEUROSCI LETT, V439, P61, DOI 10.1016/j.neulet.2008.04.098; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Siebert JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/845323; Sommer JB, 2002, EUR NEUROL, V47, P224, DOI 10.1159/000057904; Suzuki Hidenori, 2015, Acta Neurochir Suppl, V120, P117, DOI 10.1007/978-3-319-04981-6_20; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Ulfig N, 2004, BRAIN DEV-JPN, V26, P307, DOI 10.1016/S0387-7604(03)00172-4; von Holst A, 2007, J BIOL CHEM, V282, P9172, DOI 10.1074/jbc.M608067200; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; WHO, WHO INT PROGR CHEM S; Yamaguchi Y, 1996, PERSPECT DEV NEUROBI, V3, P307; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; ZHANG Y, 1995, J NEUROCYTOL, V24, P585, DOI 10.1007/BF01257374; Zhao YY, 2017, CLIN CHIM ACTA, V472, P46, DOI 10.1016/j.cca.2017.07.018	47	5	5	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	OCT	2019	57	10					1565	1573		10.1515/cclm-2019-0034			9	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	IZ2LO	WOS:000486918000023	30980710	Green Published, hybrid			2022-02-06	
J	Pandanaboina, SC; Alghazali, KM; Nima, ZA; Alawajji, RA; Sharma, KD; Watanabe, F; Saini, V; Biris, AS; Srivatsan, M				Pandanaboina, Sahitya Chetan; Alghazali, Karrer M.; Nima, Zeid A.; Alawajji, Raad A.; Sharma, Krishna Deo; Watanabe, Fumiya; Saini, Viney; Biris, Alexandru S.; Srivatsan, Malathi			Plasmonic nano surface for neuronal differentiation and manipulation	NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE			English	Article						Gold nanostructures; Plasmonic surfaces; Stem cells; Neuronal differentiation	EMBRYONIC STEM-CELLS; GOLD NANORODS; NERVOUS-SYSTEM; SELF-RENEWAL; ADHESION; NANOPARTICLES; BIOMATERIALS; ACTIVATION; GENERATION; RESONANCE	Neurodegenerative diseases and traumatic brain injuries can destroy neurons, resulting in sensory and motor function loss. Transplantation of differentiated neurons from stem cells could help restore such lost functions. Plasmonic gold nanorods (AuNR) were integrated in growth surfaces to stimulate and modulate neural cells in order to tune cell physiology. An AuNR nanocomposite system was fabricated, characterized, and then utilized to study the differentiation of embryonic rat neural stem cells (NSCs). Results demonstrated that this plasmonic surface 1) accelerated differentiation, yielding almost twice as many differentiated neural cells as a traditional NSC culture surface coated with poly-D-lysine and laminin for the same time period; and 2) promoted differentiation of NSCs into neurons and astrocytes in a 2:1 ratio, as evidenced by the expression of relevant marker proteins. These results indicate that the design and properties of this AuNR plasmonic surface would be advantageous for tissue engineering to address neural degeneration. (C) 2019 Elsevier Inc. All rights reserved.	[Pandanaboina, Sahitya Chetan; Sharma, Krishna Deo; Srivatsan, Malathi] Arkansas State Univ, Biol Sci, Jonesboro, AR 72401 USA; [Pandanaboina, Sahitya Chetan; Sharma, Krishna Deo; Srivatsan, Malathi] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA; [Alghazali, Karrer M.; Nima, Zeid A.; Alawajji, Raad A.; Watanabe, Fumiya; Saini, Viney; Biris, Alexandru S.] Univ Arkansas, Ctr Integrat Nanotechnol Sci, Little Rock, AR 72204 USA		Biris, AS (corresponding author), Univ Arkansas, Ctr Integrat Nanotechnol Sci, Little Rock, AR 72204 USA.; Srivatsan, M (corresponding author), Arkansas State Univ, Jonesboro, AR 72401 USA.	asbiris@ualr.edu; msrivatsan@astate.edu	Nima, Zeid A./N-2788-2018	Nima, Zeid A./0000-0003-4645-5177; Sharma, Krishna/0000-0002-7724-3452	National Science Foundation (NSF)National Science Foundation (NSF) [1457888]; Arkansas INBRE program; National Institute of General Medical Sciences (NIGMS) of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM103429]; Higher Committee for Education Development in Iraq	This research was supported by 1) funds from the National Science Foundation (NSF #1457888) to AB and MS; 2) the Arkansas INBRE program, with a grant from the National Institute of General Medical Sciences (NIGMS P20 GM103429) of the National Institutes of Health, for providing funds to MS through an equipment grant; and 3) Arkansas Biosciences Institute, Jonesboro, AR, for providing facility support to MS. The Higher Committee for Education Development in Iraq is highly appreciated for providing scholarship funding to KA. We thank Michael Kostrna and Al Cortiz, Electron Microscopy Sciences, Hatfield, Pennsylvania, USA, for helping us with the processing and imaging of cells differentiated on AuNR using SEM.	Alghazali KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16800-9; Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Anselme K, 2014, SCANNING, V36, P11, DOI 10.1002/sca.21067; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s; Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Bao Y, 2012, LANGMUIR, V28, P923, DOI 10.1021/la203993m; Barros CS, 2011, COLD SPRING HARB PER; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Chen WQ, 2018, NANOSCALE, V10, P3556, DOI 10.1039/c7nr05430k; Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923; Choi SY, 2015, INT J NANOMED, V10, P4383, DOI 10.2147/IJN.S78775; Choi WI, 2012, ANN BIOMED ENG, V40, P534, DOI 10.1007/s10439-011-0388-0; CHOU LS, 1995, J CELL SCI, V108, P1563; Eom K, 2014, SMALL, V10, P3853, DOI 10.1002/smll.201400599; Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927; Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Huhn D, 2013, ACS NANO, V7, P3253, DOI 10.1021/nn3059295; Kumari S, 2018, TISSUE ENG PART B-RE, V24, P255, DOI [10.1089/ten.teb.2017.0468, 10.1089/ten.TEB.2017.0468]; Li PG, 2015, RSC ADV, V5, P39252, DOI 10.1039/c5ra06901g; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mathew M, 2010, J NEUROSCI METH, V186, P196, DOI 10.1016/j.jneumeth.2009.11.018; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nakatsuji H, 2015, ANGEW CHEM INT EDIT, V54, P11725, DOI 10.1002/anie.201505534; Nath N, 2004, ANAL CHEM, V76, P5370, DOI 10.1021/ac049741z; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI [10.1021/cm020732l, 10.1021/cm0207321]; Ning CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19047; Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503; Paviolo C, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065002; Peng J, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt73; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Polak P, 2015, NANOMED-NANOTECHNOL, V11, P1467, DOI 10.1016/j.nano.2015.03.005; Prabhu BM, 2010, NANOTOXICOLOGY, V4, P150, DOI 10.3109/17435390903337693; Qi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059022; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Sanchez-Rodriguez SP, 2016, BIOTECHNOL BIOENG, V113, P2228, DOI 10.1002/bit.25984; Schulz TC, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-27; Sharma K, 2017, SFN ABSTR, V37; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014; Stone J, 2011, WIRES NANOMED NANOBI, V3, P100, DOI 10.1002/wnan.120; Sun YR, 2011, J CELL SCI, V124, P1867, DOI 10.1242/jcs.085506; Tan KKB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27653-1; Tang C, 2012, ONCOTARGET, V3, P7; Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z; Tong XM, 2014, BIOMATERIALS, V35, P1807, DOI 10.1016/j.biomaterials.2013.11.064; Wang LM, 2013, NANOSCALE, V5, P8384, DOI 10.1039/c3nr01626a; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yang ZY, 2017, SCI REP-UK, V7, DOI 10.1038/srep46304; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540; Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r; Zhan QQ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/5/055704; Zhang DW, 2014, MAT SCI ENG C-MATER, V42, P70, DOI 10.1016/j.msec.2014.04.042; Zhou JH, 2014, INT J NANOMED, V9, P1243, DOI 10.2147/IJN.S58236	61	5	5	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1549-9634	1549-9642		NANOMED-NANOTECHNOL	Nanomed.-Nanotechnol. Biol. Med.	OCT	2019	21								102048	10.1016/j.nano.2019.102048			12	Nanoscience & Nanotechnology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Research & Experimental Medicine	JW7XO	WOS:000503261200035	31271878				2022-02-06	
J	Pearson, R; Levyim, D; Choe, M; Taraman, S; Langdon, R				Pearson, Rachel; Levyim, Desiree; Choe, Meeryo; Taraman, Sharief; Langdon, Raquel			Survey of Child Neurologists on Management of Pediatric Post-traumatic Headache	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; headache; pediatric; traumatic brain injury; treatment	TRAUMATIC BRAIN-INJURY; DOUBLE-BLIND; AMERICAN ACADEMY; NERVE BLOCKS; MIGRAINE; PLACEBO; PREVENTION; COMPLEMENTARY; SUBCOMMITTEE; PROPHYLAXIS	Traumatic brain injury causes significant morbidity in youth, and headache is the most common postconcussive symptom. No established guidelines exist for pediatric post-traumatic headache management. We aimed to characterize common clinical practices of child neurologists. Of 95 practitioners who completed our survey, most evaluate <50 pediatric concussion patients per year, and 38.9% of practitioners consistently use International Classification of Headache Disorders criteria to diagnose post-traumatic headache. Most recommend nonsteroidal anti-inflammatory drugs as abortive therapy, though timing after injury and frequency of use varies, as does the time when providers begin prophylactic medications. Amitriptyline, topiramate, and vitamins/supplements are most commonly used for prophylaxis. Approach to rest and return to activities varies; one-third recommend rest for 1 to 3 days and then progressive return, consistent with current best practice. With no established guidelines for pediatric post-traumatic headache management, it is not surprising that practices vary considerably. Further studies are needed to define the best, evidence-based management for pediatric post-traumatic headache.	[Pearson, Rachel; Levyim, Desiree; Taraman, Sharief] Univ Calif Irvine, Childrens Hosp Orange Cty, Orange, CA 92668 USA; [Choe, Meeryo] UCLA Mattel Childrens Hosp, Ucla Steve Tisch BrainSPORT Program, Los Angeles, CA USA; [Choe, Meeryo] UCLA Mattel Childrens Hosp, Ucla Brain Injury Res Ctr, Los Angeles, CA USA; [Langdon, Raquel] George Washington Univ, Sch Med & Hlth Sci, Childrens Natl Med Ctr, Washington, DC 20052 USA		Pearson, R (corresponding author), Childrens Hosp Orange Cty, Neurol Div, 505 S Main St, Orange, CA 92868 USA.	rpearsonmd@gmail.com		Pearson, Rachel/0000-0002-9418-8184; Taraman, Sharief/0000-0003-2108-2490			Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blume HK, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0516-x; Blume HK, 2012, HEADACHE, V52, P1377, DOI 10.1111/j.1526-4610.2012.02215.x; Brittner M, 2016, CURR PROB PEDIATR AD, V46, P179, DOI 10.1016/j.cppeds.2015.12.005; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Choe MC, 2016, J CHILD NEUROL, V31, P76, DOI 10.1177/0883073814568152; Condo M, 2009, J HEADACHE PAIN, V10, P361, DOI 10.1007/s10194-009-0142-2; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dise-Lewis JE, 2019, J HEAD TRAUMA REHAB, V34, pE36, DOI 10.1097/HTR.0000000000000469; Dodick DW, 2010, HEADACHE, V50, P921, DOI 10.1111/j.1526-4610.2010.01678.x; Dubrovsky AS, 2014, HEADACHE, V54, P878, DOI 10.1111/head.12334; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hamalainen ML, 1997, NEUROLOGY, V48, P103, DOI 10.1212/WNL.48.1.103; Hershey AD, 2007, HEADACHE, V47, P73, DOI 10.1111/j.1526-4610.2007.00652.x; Holland S, 2012, NEUROLOGY, V78, P1346, DOI 10.1212/WNL.0b013e3182535d0c; Kabbouche M, 2012, CURR NEUROL NEUROSCI, V12, P114, DOI 10.1007/s11910-012-0251-1; Kedia S, 2016, SEMIN PEDIATR NEUROL, V23, P44, DOI 10.1016/j.spen.2016.01.010; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Langdon R, 2018, PEDIATR ANN, V47, pE61, DOI 10.3928/19382359-20180131-01; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Loder E, 2018, HEADACHE, V58, P218, DOI 10.1111/head.13375; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; McClafferty H, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1961; Millstine D, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1805; Ng QX, 2017, HEADACHE, V57, P349, DOI 10.1111/head.13016; O'Brien HL, 2010, CURR TREAT OPTION NE, V12, P178, DOI 10.1007/s11940-010-0069-6; Orr SL, 2014, CEPHALALGIA, V34, P568, DOI 10.1177/0333102413519512; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Pothmann Raymund, 2005, Headache, V45, P196, DOI 10.1111/j.1526-4610.2005.05044.x; Powers SW, 2017, NEW ENGL J MED, V376, P115, DOI 10.1056/NEJMoa1610384; Putukian M, 2021, CLIN J SPORT MED, V31, P15, DOI 10.1097/JSM.0000000000000705; Seeger TA, 2015, J CHILD NEUROL, V30, P1142, DOI 10.1177/0883073814553973; Shah S, 2018, J CHILD NEUROL, V33, P580, DOI 10.1177/0883073818776142; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Slater SK, 2011, CEPHALALGIA, V31, P897, DOI 10.1177/0333102411406755; Wang F, 2003, HEADACHE, V43, P601, DOI 10.1046/j.1526-4610.2003.03102.x; Whitehouse WP, 2017, ARCH DIS CHILDHOOD-E, V102, P58, DOI 10.1136/archdischild-2016-311803	39	5	5	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	OCT	2019	34	12					739	747		10.1177/0883073819856837			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	IY1XT	WOS:000486185700006	31232148				2022-02-06	
J	Popescu, M; Popescu, EA; DeGraba, TJ; Fernandez-Fidalgo, DJ; Riedy, G; Hughes, JD				Popescu, Mihai; Popescu, Elena-Anda; DeGraba, Thomas J.; Fernandez-Fidalgo, David J.; Riedy, Gerard; Hughes, John D.			Post-traumatic stress disorder is associated with altered modulation of prefrontal alpha band oscillations during working memory	CLINICAL NEUROPHYSIOLOGY			English	Article						Post-traumatic stress disorder; Working memory; Alpha band oscillations; Magnetoencephalography	TRAUMATIC BRAIN-INJURY; PATTERN SEPARATION; COMBAT VETERANS; COGNITIVE IMPAIRMENT; NEURAL OSCILLATIONS; QUANTITATIVE EEG; DENTATE GYRUS; CORTEX; PERFORMANCE; MECHANISMS	Objective: To investigate the relationship between the severity of PTSD symptoms, modulation of alpha band oscillations, and behavioral performance in a working memory task. Methods: Magnetoencephalography data were recorded in 35 participants with combat exposure and various degrees of PTSD symptom severity while they performed a modified Sternberg working memory task: briefly presented sets of two or six letters had to be held in memory and participants indicated whether subsequent probe letters were present or absent from these sets. Results: PTSD scores were positively correlated with the false positive rate in the high memory load condition. Higher rates of false recognition were associated with negative probes that were seen in recent previous trials (negative probe recency effect) or were physically similar with the list letters. The relative alpha band power in the left middle frontal gyrus was negatively correlated with both PTSD scores and false positive rates. Conclusions: Reduced task specific modulation of alpha band oscillations in left middle frontal cortex may reflect alterations in the functions of pattern separation and suppression of memory traces for irrelevant or no longer relevant information in PTSD. Significance: The lower amplitude of prefrontal alpha band oscillations may represent an important physiological basis for core PTSD symptoms and can provide a target for interventions to augment response to treatment. (C) 2019 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.	[Popescu, Mihai; Popescu, Elena-Anda; DeGraba, Thomas J.; Fernandez-Fidalgo, David J.; Riedy, Gerard; Hughes, John D.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Hughes, John D.] Walter Reed Army Inst Res, Behav Biol Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Hughes, JD (corresponding author), Walter Reed Army Inst Res, Behav Biol Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	john.d.hughes4.ctr@mail.mil					Association A.P., 2013, DIAGN STAT MAN MENT, P271; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Baars B.J., 1988, COGNITIVE THEORY CON; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bonnefond M, 2012, CURR BIOL, V22, P1969, DOI 10.1016/j.cub.2012.08.029; Bosboom JLW, 2009, CLIN NEUROPHYSIOL, V120, P910, DOI 10.1016/j.clinph.2009.03.004; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brassen S, 2003, PHARMACOPSYCHIATRY, V36, P304; Bremner JD, 2004, J NERV MENT DIS, V192, P643, DOI 10.1097/01.nmd.0000142027.52893.c8; Bruder GE, 2008, BIOL PSYCHIAT, V63, P1171, DOI 10.1016/j.biopsych.2007.10.009; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Busch NA, 2003, NEUROREPORT, V14, P1721, DOI 10.1097/00001756-200309150-00013; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Ciesielski KT, 2007, HUM BRAIN MAPP, V28, P1401, DOI 10.1002/hbm.20365; Claus JJ, 2000, DEMENT GERIATR COGN, V11, P81, DOI 10.1159/000017219; Corson Y, 2007, PSYCHOL SCI, V18, P208, DOI 10.1111/j.1467-9280.2007.01874.x; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Depue BE, 2013, J COGNITIVE NEUROSCI, V25, P1624, DOI 10.1162/jocn_a_00418; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Dumont GJH, 2005, BRIT J CLIN PHARMACO, V59, P495, DOI 10.1111/j.1365-2125.2005.02342.x; Ebert U, 2001, J CLIN PHARMACOL, V41, P51, DOI 10.1177/00912700122009836; Falconer E, 2008, J PSYCHIATR NEUROSCI, V33, P413; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Friedman A, 1996, NAT MED, V2, P1382, DOI 10.1038/nm1296-1382; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Haegens S, 2012, J COGNITIVE NEUROSCI, V24, P677, DOI 10.1162/jocn_a_00164; Haegens S, 2011, J NEUROSCI, V31, P5197, DOI 10.1523/JNEUROSCI.5199-10.2011; Haenschel C, 2009, J NEUROSCI, V29, P9481, DOI 10.1523/JNEUROSCI.1428-09.2009; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hayes JP, 2017, J PSYCHIATR RES, V95, P247, DOI 10.1016/j.jpsychires.2017.09.007; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jaycox, 2008, INVISIBLE WOUNDS WAR; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kikuchi M, 1999, NEUROPSYCHOBIOLOGY, V39, P219, DOI 10.1159/000026588; Kluetsch RC, 2014, ACTA PSYCHIAT SCAND, V130, P123, DOI 10.1111/acps.12229; Kozel FA, 2018, J AFFECT DISORDERS, V229, P506, DOI 10.1016/j.jad.2017.12.046; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange I, 2017, SOC COGN AFFECT NEUR, V12, P1720, DOI 10.1093/scan/nsx104; Luckhaus C, 2008, INT J GERIATR PSYCH, V23, P1148, DOI 10.1002/gps.2042; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MONSELL S, 1978, COGNITIVE PSYCHOL, V10, P465, DOI 10.1016/0010-0285(78)90008-7; Mueller ST, 2012, ACTA PSYCHOL, V139, P19, DOI 10.1016/j.actpsy.2011.09.014; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Payne L, 2014, CURR DIR PSYCHOL SCI, V23, P171, DOI 10.1177/0963721414529145; Pidgeon LM, 2016, NEUROPSYCHOLOGIA, V85, P256, DOI 10.1016/j.neuropsychologia.2016.03.026; Popescu M, 2017, NEUROIMAGE-CLIN, V15, P741, DOI 10.1016/j.nicl.2017.06.029; Popescu M, 2016, CLIN NEUROPHYSIOL, V127, P3075, DOI 10.1016/j.clinph.2016.06.004; Rolls ET, 2013, FRONT SYST NEUROSCI, V7, DOI [10.3389/fnhum.2013.00074, 10.3389/fnsys.2013.00074]; Rolls ET, 2016, CEREBRAL CORTEX PRIN, p[728, 31]; ROUX F, 2014, SCI ENG ETHICS, V18, P16, DOI DOI 10.1016/J.TICS.2013.10.010; SALETU B, 1986, INT J CLIN PHARM TH, V24, P362; Salinsky MC, 2002, EPILEPSIA, V43, P482, DOI 10.1046/j.1528-1157.2002.22501.x; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sebban C, 1999, BRIT J PHARMACOL, V128, P1045, DOI 10.1038/sj.bjp.0702894; Simpson IC, 2013, BEHAV RES METHODS, V45, P431, DOI 10.3758/s13428-012-0271-4; Snyder AC, 2010, J NEUROSCI, V30, P4024, DOI 10.1523/JNEUROSCI.5684-09.2010; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Taghva A, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.27360; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Veltmeyer Melinda D., 2006, Journal of Integrative Neuroscience, V5, P123, DOI 10.1142/S0219635206001057; Wechsler D., 2008, WECHSLER ADULT INTEL; Worden MS, 2000, J NEUROSCI, V20; Yehuda R, 2005, J CLIN EXP NEUROPSYC, V27, P504, DOI 10.1080/138033990520223; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	88	5	5	1	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2019	130	10					1869	1881		10.1016/j.clinph.2019.06.227			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IX6ZA	WOS:000485832400014	31408789	hybrid			2022-02-06	
J	Vander Linden, C; Verhelst, H; Deschepper, E; Vingerhoets, G; Deblaere, K; Caeyenberghs, K				Vander Linden, Catharine; Verhelst, Helena; Deschepper, Ellen; Vingerhoets, Guy; Deblaere, Karel; Caeyenberghs, Karen			Cognitive training benefit depends on brain injury location in adolescents with traumatic brain injury: a pilot study	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Child; Brain injuries; traumatic; Chronic traumatic encephalopathy; Adolescent; Growth and development; Neurological rehabilitation	FALSE DISCOVERY RATE; EXECUTIVE FUNCTIONS; CORTICAL THICKNESS; CORPUS-CALLOSUM; PARENT RATINGS; CHILDREN; REHABILITATION; TOWER; INTERVENTIONS; RELIABILITY	BACKGROUND: Executive dysfunction after pediatric traumatic brain injury (TBI) has been linked to poor outcomes in school performance. social functioning and employment. The credibility of training-induced cognitive enhancement in TBI is threatened by its limited proof of benefit in executive skills of daily living. AIM: Our primary aim was to investigate if cognitive intervention for improving impairments in executive functions in the chronic stage of TBI is effective during adolescence. The secondary aim was to explore whether training benefit is driven by injury location. DESIGN: Prospective observational study. SETTING: Child Rehabilitation Center of a University Hospital. POPULATION: Sixteen adolescents with moderate to severe TBI (mean age 15 years and 8 months) and 16 age and gender matched healthy peers were included. METHODS: Effects of a new cognitive training program (BrainGames) were assessed postintervention and 6 months later utilizing a comprehensive neuropsychological test-battery and the Behavior Rating Inventory of Executive Function. In addition, subgroup analyses were performed to determine long-term training benefit in the presence of lesions in corpus callosum, deep-brain-nuclei and prefrontal cortex. RESULTS: Adolescents with TBI showed significant improvements on measures of executive functioning at completion of the training and at follow-up compared with the pre-tests. The presence or absence of diffuse-axonal-injuries (DAI) in the deep brain nuclei determined a significant difference in long-term training benefit. CONCLUSIONS: This study provides preliminary evidence that cognitive training, beyond the acute rehabilitation period in adolescents with TBI is effective to boost executive functioning in daily living. Furthermore, we indicated that DAI in deep brain nuclei may jeopardize long-term benefit from cognitive training. CLINICAL REHABILITATION IMPACT: Individualized rehabilitation programs arc crucial in adolescents with different locations of TBI-lesions. Long term follow-up of pediatric TBI is essential.	[Vander Linden, Catharine] Ghent Univ Hosp, Child Rehabil Ctr, Ghent, Belgium; [Verhelst, Helena; Vingerhoets, Guy] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Belgium; [Deschepper, Ellen] Univ Ghent, Dept Publ Hlth, Unit Biostat, Ghent, Belgium; [Deblaere, Karel] Ghent Univ Hosp, Dept Neuroradiol, Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia		Vander Linden, C (corresponding author), Ghent Univ Hosp, Child Rehabil Ctr K7, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.	catharine.vanderlinden@uzgent.be		Verhelst, Helena/0000-0002-6861-0249	Special Research Fund (BOF) of the University of Ghent, Belgium [01N00214]	This research was supported by a grant (#01N00214) from the Special Research Fund (BOF) of the University of Ghent, Belgium.	Anderson V, 2012, J NEUROTRAUM, V29, P143, DOI 10.1089/neu.2011.2012; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bettcher BM, 2016, NEUROPSYCHOLOGIA, V85, P100, DOI 10.1016/j.neuropsychologia.2016.03.001; Bissig D, 2007, PSYCHOL SCI, V18, P720, DOI 10.1111/j.1467-9280.2007.01966.x; Calamia M, 2013, CLIN NEUROPSYCHOL, V27, P1077, DOI 10.1080/13854046.2013.809795; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; Diamond A, 2014, MINN SYM CHILD PSYCH, V37, P205; Donders J, 2017, CHILD NEUROPSYCHOL, V23, P554, DOI 10.1080/09297049.2016.1161015; Donolato E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00663; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Georges A, 2017, TRAUMATIC BRAIN INJU; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Hsu NS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00221; Ialongo C, 2016, BIOCHEM MEDICA, V26, P150, DOI 10.11613/BM.2016.015; Insel C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01369-8; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jeon T, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnana.2015.00158, 10.3389/fhana.2015.00158]; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Karver CL, 2014, CHILD NEUROPSYCHOL, V20, P343, DOI 10.1080/09297049.2013.796918; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Kostering L, 2015, PSYCHOL ASSESSMENT, V27, P925, DOI 10.1037/pas0000097; Kostering L, 2015, NEUROPSYCHOLOGIA, V75, P646, DOI 10.1016/j.neuropsychologia.2015.07.017; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; Limond J, 2014, CLIN NEUROPSYCHOL, V28, P181, DOI 10.1080/13854046.2013.873083; Luciana M, 2009, DEV NEUROPSYCHOL, V34, P461, DOI 10.1080/87565640902964540; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald JH., 2014, HDB BIOL STAT; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Peters S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02174-z; Piccolo LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162511; Rackley C, 2012, CHILD NEUROPSYCHOL, V18, P512, DOI 10.1080/09297049.2011.628308; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rossignoli-Palomeque T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00565; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Saar-Ashkenazy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144766; Sinopoli KJ, 2012, INT J DEV NEUROSCI, V30, P207, DOI 10.1016/j.ijdevneu.2011.08.006; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Syvaoja HJ, 2015, PSYCHOL ASSESSMENT, V27, P698, DOI 10.1037/a0038485; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taylor SJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00252, 10.3389/finbeh.2015.00252]; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Verhelst H, 2017, GAMES HEALTH J, V6, P28, DOI 10.1089/g4h.2016.0043; Vijayakumar N, 2016, HUM BRAIN MAPP, V37, P2027, DOI 10.1002/hbm.23154; Westerhausen R, 2018, BRAIN STRUCT FUNCT, V223, P285, DOI 10.1007/s00429-017-1493-0; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Zelinski EM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00617	59	5	5	1	8	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	OCT	2019	55	5					585	594		10.23736/S1973-9087.18.05548-X			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	JC2VO	WOS:000489134800006	30547494				2022-02-06	
J	Veesa, JD; Dehghani, H				Veesa, Joshua D.; Dehghani, Hamid			Functional near infrared spectroscopy using spatially resolved data to account for tissue scattering: A numerical study and arm-cuff experiment	JOURNAL OF BIOPHOTONICS			English	Article						near-infrared spectroscopy; tissue optics; tissue scattering	TRAUMATIC BRAIN-INJURY; OXYGEN-SATURATION; TIME	Functional Near-Infrared Spectroscopy (fNIRS) aims to recover changes in tissue optical parameters relating to tissue hemodynamics, to infer functional information in biological tissue. A widely-used application of fNIRS relies on continuous wave (CW) methodology that utilizes multiple distance measurements on human head for study of brain health. The typical method used is spatially resolved spectroscopy (SRS), which is shown to recover tissue oxygenation index (TOI) based on gradient of light intensity measured between two detectors. However, this methodology does not account for tissue scattering which is often assumed. A new parameter recovery algorithm is developed, which directly recovers both the scattering parameter and scaled chromophore concentrations and hence TOI from the measured gradient of light-attenuation at multiple wavelengths. It is shown through simulations that in comparison to conventional SRS which estimates cerebral TOI values with an error of +/- 12.3%, the proposed method provides more accurate estimate of TOI exhibiting an error of +/- 5.7% without any prior assumptions of tissue scatter, and can be easily implemented within CW fNIRS systems. Using an arm-cuff experiment, the obtained TOI using the proposed method is shown to provide a higher and more realistic value as compared to utilizing any prior assumptions of tissue scatter.	[Veesa, Joshua D.; Dehghani, Hamid] Univ Birmingham, Sch Comp Sci, Birmingham B17 0PP, W Midlands, England		Veesa, JD (corresponding author), Univ Birmingham, Sch Comp Sci, Birmingham B17 0PP, W Midlands, England.	veesajd@cs.bham.ac.uk	Veesa, Joshua Deepak/D-6838-2016	Veesa, Joshua Deepak/0000-0002-0763-7755; Dehghani, Hamid/0000-0003-4117-0412	H2020 Marie Sklodowska-Curie Actions [675332] Funding Source: Medline		Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Clancy M, 2016, J BIOPHOTONICS, V9, P812, DOI 10.1002/jbio.201500302; Dehghani H, 2009, APPL OPTICS, V48, pD137, DOI 10.1364/AO.48.00D137; Dehghani H, 2009, COMMUN NUMER METH EN, V25, P711, DOI 10.1002/cnm.1162; Eames ME, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976425; Eggebrecht AT, 2014, NAT PHOTONICS, V8, P448, DOI 10.1038/nphoton.2014.107; FARRELL TJ, 1992, PHYS MED BIOL, V37, P2281, DOI 10.1088/0031-9155/37/12/009; Fedorow C, 2010, CURR OPIN ANESTHESIO, V23, P89, DOI 10.1097/ACO.0b013e3283346d10; Flexman ML, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3694494; Gagnon L, 2014, NEUROIMAGE, V85, P127, DOI 10.1016/j.neuroimage.2013.01.073; Greisen G, 2011, PHILOS T R SOC A, V369, P4440, DOI 10.1098/rsta.2011.0261; HODGKINSON S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G104; Jacques SL, 2013, PHYS MED BIOL, V58, P5007, DOI 10.1088/0031-9155/58/14/5007; Liu H., 1995, SIMPLIFIED APPROACH, DOI [10.1117/12.209998, DOI 10.1117/12.209998]; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Matcher S. J., 1995, ABSOLUTE QUANTIFICAT, DOI [10.1117/12.209997, DOI 10.1117/12.209997]; Matcher SJ, 1997, APPL OPTICS, V36, P386, DOI 10.1364/AO.36.000386; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; Patterson M. S., 1989, QUANTITATIVE REFLECT, DOI [10.1117/12.978011, DOI 10.1117/12.978011]; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Spinelli L, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.041414; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suzuki S., 1999, BIOS 99 INT BIOM OPT, DOI [10.1117/12.356862, DOI 10.1117/12.356862]; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tosh W, 2016, BJA EDUC, V16, P417, DOI 10.1093/bjaed/mkw024; VANSTAVEREN HJ, 1991, APPL OPTICS, V30, P4507, DOI 10.1364/AO.30.004507; Vohra Hunaid A, 2009, Interact Cardiovasc Thorac Surg, V9, P318, DOI 10.1510/icvts.2009.206367; White H., 2016, VENKATESH OXFORD TXB, P213; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Yalavarthy PK, 2007, MED PHYS, V34, P2085, DOI 10.1118/1.2733803; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104	32	5	5	0	4	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	OCT	2019	12	10							e201900064	10.1002/jbio.201900064			11	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	JB4JF	WOS:000488521300020	31169976	Green Published, hybrid			2022-02-06	
J	Wade, SL; Fisher, AP; Kaizar, EE; Yeates, KO; Taylor, HG; Zhang, NH				Wade, Shari L.; Fisher, Allison P.; Kaizar, Eloise E.; Yeates, Keith O.; Taylor, H. Gerry; Zhang, Nanhua			Recovery Trajectories of Child and Family Outcomes Following Online Family Problem-Solving Therapy for Children and Adolescents after Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Pediatric; Brain injury; Behavior; Treatment; Randomized controlled trial; Parent; Profile analysis	LONG-TERM CAREGIVER; EXECUTIVE FUNCTION; RANDOMIZED-TRIAL; PSYCHIATRIC-DISORDERS; BEHAVIOR PROBLEMS; INTERVENTION; HEALTH; PREDICTORS; BURDEN; EFFICACY	Objectives: We conducted joint analyses from five randomized clinical trials (RCTs) of online family problem-solving therapy (OFPST) for children with traumatic brain injury (TBI) to identify child and parent outcomes most sensitive to OFPST and trajectories of recovery over time. Methods: We examined data from 359 children with complicated mild to severe TBI, aged 5-18, randomized to OFPST or a control condition. Using profile analyses, we examined group differences on parent-reported child (internalizing and externalizing behavior problems, executive function behaviors, social competence) and family outcomes (parental depression, psychological distress, family functioning, parent-child conflict). Results: We found a main effect for measure for both child and family outcomes [F(3, 731) = 7.35, p < .001; F(3, 532) = 4.79, p = .003, respectively], reflecting differing degrees of improvement across measures for both groups. Significant group-by-time interactions indicated that children and families in the OFPST group had fewer problems than controls at both 6 and 18 months post baseline [t(731) = -5.15, p < .001, and t(731) = -3.90, p = .002, respectively, for child outcomes; t(532) = -4.81, p < .001, and t(532) = -3.80, p < .001, respectively, for family outcomes]. Conclusions: The results suggest limited differences in the measures' responsiveness to treatment while highlighting OFPST's utility in improving both child behavior problems and parent/family functioning. Group differences were greatest at treatment completion and after extended time post treatment.	[Wade, Shari L.; Fisher, Allison P.] Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wade, Shari L.; Zhang, Nanhua] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Kaizar, Eloise E.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA; [Yeates, Keith O.] Alberta Childrens Prov Gen Hosp, Dept Psychol, Res Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH 43205 USA; [Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pediat Rehabil Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020	Zhang, Nanhua/0000-0001-5796-3404	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21HD089076-01]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was funded by the NIH grant 1R21HD089076-01 from the National Institutes of Health.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Catroppa C, 2017, J NEUROTRAUM, V34, P1439, DOI 10.1089/neu.2016.4594; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Dennis M, 2013, J INT NEUROPSYCH SOC, V19, P34, DOI 10.1017/S1355617712000884; Derogatis L. R., 1999, USE PSYCHOL TESTING, P679, DOI DOI 10.1037/T07502-000; Durber CM, 2017, NEUROPSYCHOLOGY, V31, P499, DOI 10.1037/neu0000351; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Gioia G.A., 2000, BRIEF BEHAV RATING I; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Harris R.J, 2001, PRIMER MULTIVARIATE; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Jonsson CA, 2009, BRAIN INJURY, V23, P1008, DOI 10.3109/02699050903379354; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2012, J NEUROPSYCH CLIN N, V24, P427, DOI 10.1176/appi.neuropsych.12060149; Merrell KW, 2001, PSYCHOL SCHOOLS, V38, P313, DOI 10.1002/pits.1021; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Narad ME, 2018, JAMA PEDIATR, V172, P437, DOI 10.1001/jamapediatrics.2017.5746; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nezu AM, 2006, PROBLEM SOLVING THER; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; R Core Team, 2017, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Renstrom B, 2012, BRAIN INJURY, V26, P1405, DOI 10.3109/02699052.2012.694559; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Robin AL, 1989, NEGOTIATING PARENT A; Schachar RJ, 2015, J CAN ACAD CHILD ADO, V24, P100; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shultz EL, 2016, NEUROPSYCHOLOGY, V30, P830, DOI 10.1037/neu0000288; Sluys KP, 2015, QUAL LIFE RES, V24, P2689, DOI 10.1007/s11136-015-1002-y; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tlustos SJ, 2016, REHABIL PSYCHOL, V61, P347, DOI 10.1037/rep0000098; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0422; Wade SL, 2018, J DEV BEHAV PEDIATR, V39, P154, DOI 10.1097/DBP.0000000000000519; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Yeates KO, 2013, J INT NEUROPSYCH SOC, V19, P518, DOI 10.1017/S1355617712001531; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	58	5	5	5	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2019	25	9					941	949	PII S1355617719000778	10.1017/S1355617719000778			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	JB3VM	WOS:000488484800005	31405391	Green Accepted			2022-02-06	
J	Yaramothu, C; Goodman, AM; Alvarez, TL				Yaramothu, Chang; Goodman, Arlene M.; Alvarez, Tara L.			Epidemiology and Incidence of Pediatric Concussions in General Aspects of Life	BRAIN SCIENCES			English	Article						concussions; physical education; concussion epidemiology; adolescent concussions	STATES HIGH-SCHOOL; INJURIES; SPORTS; US	Background: Concussions are one of the most common head injuries acquired within the pediatric population. While sport-related concussions are well documented, concussions within other aspects of a child's life are not as well researched. The purpose of this study is to examine the incidence of a large pediatric concussion population in a broad range of daily activities. Methods: Patients' gender and nature of injury were extracted from 1408 medical records of patients who were diagnosed with a concussion at Saint Peter's Sports Medicine Institute. Statistical analyses were conducted for activities and environmental settings using chi-squared tests. Results: Concussions were most prevalent in organized sports (53.3%), followed by injuries within the following settings: school (16.5%), recreational (6.7%), motor vehicle collisions (6.6%), home (5.5%), and other (11.3%). Specifically, soccer (12.9%), school physical education (PE) class (10.6%), and football (9.8%) subcategories recorded the most incidences of concussion. For the PE class cohort (n = 149), significantly more females were diagnosed with a concussion compared to males (p < 0.001). Conclusions: PE-related concussions had the second highest incidence rate after organized sports. A significant gender difference was observed in PE class. Awareness about concussions and methods to reduce the risk of concussion is suggested for PE classes.	[Yaramothu, Chang; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Goodman, Arlene M.] St Peters Univ Hosp, St Peters Sports Med Inst, Somerset, NJ 08873 USA		Alvarez, TL (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	chang.yaramothu@njit.edu; agoodman@saintpetersuh.com; tara.l.alvarez@njit.edu		Alvarez, Tara/0000-0002-8797-1613; Yaramothu, Chang/0000-0003-4442-5409	United States Government, National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY023261]	This work was supported by United States Government, National Institutes of Health (NIH) R01EY023261 to T.L.A.	Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Baron M., 2010, POPULATION NEW JERSE; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Bogage J., 2018, HIGH SCH FOOTBALL PA; Borowski LA, 2008, AM J SPORT MED, V36, P2328, DOI 10.1177/0363546508322893; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Chrisman SP, 2018, MED SCI SPORT EXER, V50, P3; Cook B., 2018, WHY HIGH SCH FOOTBAL; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Ginsburg KR, 2007, PEDIATRICS, V119, P182, DOI 10.1542/peds.2006-2697; Hajian-Tilaki K, 2011, CASP J INTERN MED, V2, P289; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2018, AM J SPORT MED, V46, P1733, DOI 10.1177/0363546518765121; Knego L., 2018, NJ FOOTBALL POP WARN; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Lehren A.W., 2018, FRIDAY NIGHT LIGHTS; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Murphy NA, 2008, PEDIATRICS, V121, P1057, DOI 10.1542/peds.2008-0566; Nelson NG, 2009, PEDIATRICS, V124, P918, DOI 10.1542/peds.2008-3843; Rosene JM, 2018, AM J SPORT MED, V46, pNP11, DOI 10.1177/0363546518765963; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Schonbrun Z., 2018, AMID CONCUSSIONS HIG; Semrud-Clikeman M., 2016, J PEDIATR NEUROPSYCH, V2, P58, DOI [10.1007/s40817-015-0010-8, DOI 10.1007/S40817-015-0010-8, https://doi.org/10.1007/s40817-015-0010-8]; Spano M, 2019, SPORTS, V7, DOI 10.3390/sports7020053; Stanmyre M., 2018, IS FOOTBALL DYING NE; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; U.S. Census Bureau, 2018, QUICKFACTS NEW JERS	30	5	5	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	OCT	2019	9	10							257	10.3390/brainsci9100257			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JI5NX	WOS:000493515400003	31569649	Green Published, gold			2022-02-06	
J	Furlan, JC; Craven, BC; Fehlings, MG				Furlan, Julio C.; Craven, B. Catharine; Fehlings, Michael G.			Sex-related discrepancies in the epidemiology, injury characteristics and outcomes after acute spine trauma: A retrospective cohort study	JOURNAL OF SPINAL CORD MEDICINE			English	Article; Proceedings Paper	8th National Spinal Cord Injury Conference - Sex and Gender, Health of Women	OCT 17-19, 2019	Niagara Falls, CANADA			Spinal cord injury; Acute spine trauma; Neurotrauma; Age; Sex	LENGTH-OF-STAY; CORD-INJURY; REHABILITATION OUTCOMES; CHANGING DEMOGRAPHICS; FUNCTIONAL RECOVERY; UNITED-STATES; GENDER; CARE; MANAGEMENT; AGE	Context/Objective: The potential effects of sex on injury severity and outcomes after acute spine trauma (AST) have been reported in pre-clinical and clinical studies, even though the data are conflicting. This study compared females and males regarding the epidemiology, injury characteristics, and clinical outcomes of AST. Design: Retrospective cohort study. Setting: Acute spine care quaternary center. Participants: All consecutive cases of AST admitted from January/1996 to December/2007 were included. Interventions: None. Outcome Measures: The potential effects of sex on the epidemiology, injury characteristics, and clinical outcomes of AST were studied. Results: There were 504 individuals with AST (161 females, 343 males; mean age of 49.44???0.92 years). Sex was not associated with age or pre-existing co-morbidities as assessed using the Charlson Co-morbidity Index, however, females had a greater number of International Classi?cations of Diseases (ICD) codes at admission and higher Cumulative Illness Rating Scale (CIRS) than males. Over the 12-year period, the male-to-female ratio has not significantly changed. Although there were significant sex-related discrepancies regarding injury etiology, level and severity of AST, males and females had similar lengths of stay in the acute spine center, in-hospital survival post-AST, and need for mechanical ventilation and tracheostomy. Conclusion: This study suggests that females with AST present with a greater number of pre-existing co-morbidities, a higher frequency of thoraco-lumbar trauma, less severe neurological impairment and a greater proportion of MVA-related injuries. However, females and males have a similar length of stay in the acute spine center, and comparable in-hospital survival, need for mechanical ventilation, and tracheostomy after AST.	[Furlan, Julio C.; Craven, B. Catharine] Univ Toronto, Dept Med, Div Phys Med & Rehabil, Toronto, ON, Canada; [Furlan, Julio C.; Craven, B. Catharine] Univ Hlth Network, Toronto Rehab, KITE, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Toronto Western Hosp, Div Neurosurg, Spinal Program, Toronto, ON, Canada		Furlan, JC (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Lyndhurst Ctr, 520 Sutherland Dr,Room 206J, Toronto, ON M4G 3V9, Canada.	jcfurlan@gmail.com	; Craven, Beverley/D-5001-2015; Furlan, Julio/Q-8290-2018	Fehlings, Michael/0000-0002-5722-6364; Craven, Beverley/0000-0001-8234-6803; Furlan, Julio/0000-0002-2038-0018	Toronto Rehab Foundation; Halbert Chair in Neural Repair and Regeneration	Dr. Furlan receives salary support from the Wings for Life Spinal Cord Research Foundation. Dr. Craven acknowledges support from the Toronto Rehab Foundation as the Toronto Rehabilitation Institute Chair in Spinal Cord Injury Rehabilitation. Dr. Fehlings acknowledges support from the Halbert Chair in Neural Repair and Regeneration.	BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Burns AS, 2017, J NEUROTRAUM, V34, P2910, DOI 10.1089/neu.2016.4935; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1774, DOI 10.1016/j.apmr.2004.04.027; Chamberlain Jonviea D, 2015, Inj Epidemiol, V2, P28; CHARLES ED, 1978, PARAPLEGIA, V15, P302, DOI 10.1038/sc.1977.46; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Datto JP, 2015, NEURAL REGEN RES, V10, P1533, DOI 10.4103/1673-5374.165213; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eastwood EA, 1999, ARCH PHYS MED REHAB, V80, P1457, DOI 10.1016/S0003-9993(99)90258-7; Farley JF, 2006, AM J MANAG CARE, V12, P110; FINE PR, 1987, INQUIRY-J HEALTH CAR, V24, P147; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Furlan JC, 2012, TRAUMATIC BRAIN SPIN, P216; Furlan JC, 2013, AGING CLIN EXP RES, V25, P463, DOI 10.1007/s40520-013-0066-1; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Furlan JC, 2009, J NEUROTRAUM, V26, P1707, DOI [10.1089/neu.2009.0888, 10.1089/neu.2009-0888]; Furlan JC, 2009, J NEUROTRAUM, V26, P1361, DOI [10.1089/neu.2008.0764, 10.1089/neu.2008-0764]; Furlan JC, 2010, NEUROBIOL AGING, V31, P434, DOI 10.1016/j.neurobiolaging.2008.05.003; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Greenwald BD, 2001, ARCH PHYS MED REHAB, V82, P1181, DOI 10.1053/apmr.2001.24891; Hadley M, 2002, NEUROSURGERY, V50, pS58; Hagen EM, 2014, J SPINAL CORD MED, V37, P310, DOI 10.1179/2045772313Y.0000000171; Hatch BB, 2017, SPINAL CORD, V55, P540, DOI 10.1038/sc.2016.182; Herren C, 2014, ORTHOPADE, V43, P1043, DOI 10.1007/s00132-014-3033-4; Huntley AL, 2012, ANN FAM MED, V10, P134, DOI 10.1370/afm.1363; Imai K, 1996, J CLIN EPIDEMIOL, V49, P505, DOI 10.1016/0895-4356(95)00576-5; Jain NB, 2015, JAMA-J AM MED ASSOC, V313, P2236, DOI 10.1001/jama.2015.6250; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Krassioukov AV, 2003, J NEUROTRAUM, V20, P391, DOI 10.1089/089771503765172345; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; McCammon JR, 2011, J SPINAL CORD MED, V34, P6, DOI 10.1179/107902610X12923394765733; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; Montoto-Marques A, 2018, SPINAL CORD, V56, P206, DOI 10.1038/s41393-017-0005-7; Mylotte JM, 2001, INFECT CONT HOSP EP, V22, P83, DOI 10.1086/501868; New PW, 2007, J SPINAL CORD MED, V30, P225, DOI 10.1080/10790268.2007.11753930; New PW, 2017, EUR J PHYS REHAB MED, V53, P493, DOI 10.23736/S1973-9087.17.04367-2; Noe BB, 2017, SPINAL CORD, V55, P373, DOI 10.1038/sc.2016.154; NSCIC, 2016, SPIN CORD INJ FACTS; NSCISC, 2017, ANN STAT REP SPIN CO; Quail JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-146; Scivoletto G, 2004, CLIN REHABIL, V18, P709, DOI 10.1191/0269215504cr749oa; Shibahashi K, 2019, SPINE, V44, P479, DOI 10.1097/BRS.0000000000002871; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Van Den Berg M, 2011, J NEUROTRAUM, V28, P469, DOI 10.1089/neu.2010.1608; Wang Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5895830; YEKUTIEL M, 1989, PARAPLEGIA, V27, P58, DOI 10.1038/sc.1989.9	48	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	SEP 30	2019	42			1	SI		S10	S20		10.1080/10790268.2019.1607055			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	JB8LC	WOS:000488819700005	31573442	Green Published			2022-02-06	
J	Ross, DE; Seabaugh, JD; Seabaugh, JM; Alvarez, C; Ellis, LP; Powell, C; Hall, C; Reese, C; Cooper, L; Ochs, AL				Ross, David E.; Seabaugh, John D.; Seabaugh, Jan M.; Alvarez, Claudia; Ellis, Laura Peyton; Powell, Christopher; Hall, Christopher; Reese, Christopher; Cooper, Leah; Ochs, Alfred L.			Patients with chronic mild or moderate traumatic brain injury have abnormal brain enlargement	BRAIN INJURY			English	Article						Traumatic brain injury; magnetic resonance imaging; volumetry; asymmetry	CORTICAL THICKNESS; MENTAL STATUS; ATROPHY; VOLUME; NEUROQUANT(R)	Introduction: Much less is known about brain volume abnormalities in patients with chronic mild or moderate traumatic brain injury (TBI) compared with patients with more severe injury. Commercially available software methods including NeuroQuant (R) are being used increasingly to assess MRI brain volume in patients with TBI. Methods: 50 patients with mild or moderate TBI were compared to the NeuroQuant (R) normal control database (n = thousands) with respect to MRI brain volume. Results: The patients had many areas of abnormal enlargement and fewer areas of atrophy, including abnormally small cerebral white matter (CWM) limited to the first 10 months after injury. Examination of correlations within the patient group between CWM volume and volumes of the abnormally enlarged regions showed multiple significant negative correlations, indicating that CWM atrophy correlated with enlargement of the other regions. Discussion: The finding of many regions of abnormal brain enlargement was relatively new, although a couple of previous studies of patients with mild TBI found similar but more limited findings. The cause of the abnormal enlargement was unknown, but possibilities included: (1) hyperactivity and hypertrophy; or (2) chronic neuro-inflammation and edema.	[Ross, David E.; Seabaugh, John D.; Seabaugh, Jan M.; Alvarez, Claudia; Ellis, Laura Peyton; Powell, Christopher; Hall, Christopher; Reese, Christopher; Cooper, Leah; Ochs, Alfred L.] Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA; [Alvarez, Claudia; Ellis, Laura Peyton] Randolph Macon Coll, Ashland, VA 23005 USA; [Powell, Christopher; Ochs, Alfred L.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Hall, Christopher] Univ Virginia, Charlottesville, VA USA; [Reese, Christopher] Univ North Carolina Wilmington, Wilmington, NC USA; [Cooper, Leah] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA		Ross, DE (corresponding author), Virginia Inst Neuropsychiat, 364 Browns Hill Court, Midlothian, VA 23114 USA.	DRoss@VaNeuropsychiatry.org		Ochs, Alfred/0000-0003-3932-876X			Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Bigler E.D., 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.1155/2009/616581, 10.3233/BEN-2009-0226]; Cohen J., 2013, STAT POWER ANAL BEHA; Epstein DJ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.581; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huppertz HJ, 2010, NEUROIMAGE, V49, P2216, DOI 10.1016/j.neuroimage.2009.10.066; KOKMEN E, 1991, ARCH NEUROL-CHICAGO, V48, P725, DOI 10.1001/archneur.1991.00530190071018; Kovacevic S, 2009, ALZ DIS ASSOC DIS, V23, P139, DOI 10.1097/WAD.0b013e318192e745; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maller JJ, 2014, BEHAV BRAIN RES, V271, P147, DOI 10.1016/j.bbr.2014.05.047; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ochs AL, 2015, J NEUROIMAGING, V25, P721, DOI 10.1111/jon.12229; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Reid MW, 2017, J NEUROIMAGING, V27, P365, DOI 10.1111/jon.12431; Ross D.E., 2012, PSYCHOL INJURY LAW, V5, P1; Ross DE, 2018, BRAIN INJURY, V32, P1437, DOI 10.1080/02699052.2018.1489980; Ross DE, 2018, PSYCHIAT RES-NEUROIM, V278, P69, DOI 10.1016/j.pscychresns.2018.05.007; Ross DE, 2016, NEUROIMAGE, V127, P510, DOI 10.1016/j.neuroimage.2015.11.019; Ross DE, 2015, J NEUROPSYCH CLIN N, V27, P147, DOI 10.1176/appi.neuropsych.13040088; Ross DE, 2014, NEUROIMAGE, V102, P565, DOI 10.1016/j.neuroimage.2014.07.043; Ross DE, 2013, PSYCHOL INJ LAW, V6, P75, DOI 10.1007/s12207-012-9140-9; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2013, J NEUROPSYCHIATRY CL, V25, P1, DOI DOI 10.1176/appi.neuropsych.12120401; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Tang-Wai DF, 2003, ARCH NEUROL-CHICAGO, V60, P1777, DOI 10.1001/archneur.60.12.1777; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wilde EA, 2019, TXB TRAUMATIC BRAIN, P89; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	34	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					11	19		10.1080/02699052.2019.1669074		SEP 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000488042500001	31553632				2022-02-06	
J	Karr, JE; Iverson, GL; Berghem, K; Kotilainen, AK; Terry, DP; Luoto, TM				Karr, Justin E.; Iverson, Grant L.; Berghem, Ksenia; Kotilainen, Anna-Kerttu; Terry, Douglas P.; Luoto, Teemu M.			Complicated mild traumatic brain injury in older adults: Post-concussion symptoms and functional outcome at one week post injury	BRAIN INJURY			English	Article						Mild brain injury; neuroimaging; outcome; functional status; post-concussion syndrome	CT HEAD RULE; SPORTS-RELATED CONCUSSION; NEW-ORLEANS CRITERIA; NEUROBEHAVIORAL CONSEQUENCES; NEUROPSYCHOLOGICAL IMPACT; COMPUTED-TOMOGRAPHY; MODERATE; RELIABILITY; GUIDELINES; EPIDEMIOLOGY	Primary Objective: Mild Traumatic Brain Injury (MTBI) is commonly categorized as complicated when injury severity criteria are mild, but an intracranial abnormality is present on acute neuroimaging. The current study examined whether functional outcomes differed at one week post injury among older adult patients based on injury severity and acute computed tomography (CT) findings. Research Design: Participants (>= 55 years-old; n = 173) presenting sequentially to the emergency department with a head injury were divided into three groups: complicated MTBI (positive CT; n = 22), uncomplicated MTBI (negative CT; n = 68), and mild head injury (unperformed CT, no documented loss of consciousness or post-traumatic amnesia; n = 83). Methods and Procedures: At one week post injury, the Modified Rankin Scale (i.e., difference score between pre/post-injury ratings; increment MRS), Glasgow Outcome Scale-Extended (GOS-E), and Rivermead Post-Concussion Symptoms Questionnaire (RPQ) were administered. Main Outcomes and Results: Participants differed on the increment MRS and GOS-E, but not the RPQ. The complicated MTBI group had worse GOS-E ratings than the uncomplicated MTBI and mild head injury groups and worse increment MRS than the mild head injury group, but the uncomplicated MTBI and mild head injury groups did not differ on either outcome. Conclusions: Macrostructural abnormality on CT was associated with worse functional outcome at one week post MTBI.	[Karr, Justin E.; Iverson, Grant L.; Terry, Douglas P.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Karr, Justin E.; Iverson, Grant L.; Terry, Douglas P.] Spaulding Rehabil Hosp, Boston, MA USA; [Karr, Justin E.; Iverson, Grant L.; Terry, Douglas P.] Home Base, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Berghem, Ksenia] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Kotilainen, Anna-Kerttu] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland		Karr, JE (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	jkarr1@mgh.harvard.edu	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Karr, Justin/0000-0003-3653-332X; Iverson, Grant/0000-0001-7348-9570	Finnish State Research Fund; Finnish Medical Society Duodecim	This work was supported by the Finnish State Research Funding and the Finnish Medical Society Duodecim.	AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Grissom R.J., 2012, EFFECT SIZES RES UNI, V2; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kansagara D., 2013, COMPLICATIONS MILD T; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinsella GJ, 2014, J INT NEUROPSYCH SOC, V20, P663, DOI 10.1017/S1355617714000447; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kristman VL, 2016, J HEAD TRAUMA REHAB, V31, pE33, DOI 10.1097/HTR.0000000000000226; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Rankin J., 1957, SCOTT MED J, V2, P200, DOI [10.1177/003693305700200504, DOI 10.1177/003693305700200504]; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Steffener J., 2017, CLIN NEUROPSYCHOL, V32, P1; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1992, ICD 10 CLASSIFICATIO	52	5	5	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 2	2020	34	1					26	33		10.1080/02699052.2019.1669825		SEP 2019	8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KC5XA	WOS:000487660000001	31550173	Green Accepted			2022-02-06	
J	Yehene, E; Brezner, A; Ben-Valid, S; Golan, S; Bar-Nadav, O; Landa, J				Yehene, Einat; Brezner, Amichai; Ben-Valid, Shani; Golan, Sapir; Bar-Nadav, Ofri; Landa, Janna			Factors associated with parental grief reaction following pediatric acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Pediatric; Brain injury; Rehabilitation; Parental grief; Nonfinite loss	2-TRACK MODEL; AMBIGUOUS-LOSS; BEREAVED PARENTS; ADULT-CHILD; EXPERIENCES; BURDEN; ADOLESCENTS; PREDICTORS; ADJUSTMENT; SYMPTOMS	The present study investigated factors associated with parental grief reaction (PGR) following pediatric acquired brain injury (ABI), and compared PGR to the one exhibited following child death. Fifty-seven parents of 51 children (aged 3-18) whose ABI occurred 1-14 years before participation, completed the multi-scale Two-Track Bereavement Questionnaire; a socio-demographic questionnaire; and a scale assessing perceived behavioural changes in the child. Results from regression analysis indicated that time since injury had no impact on parents' grief other than having an adverse impact on their overall coping and functioning; A higher amount of weekly caring hours predicted only a greater traumatic perception of the loss; Older children's ages but mostly greater parental-perceived behavioural changes, predicted greater PGR on most scales. PGR was compared with the pre-existing data of bereaved parents who completed the same grief questionnaire. Although grief response patterns and intensity were similar in both groups, significant differences were found on scales assessing the continuing bond with the child: relational active grief, close and positive relationship, and conflictual relationship. Our findings indicate that parental grief is multi-dimensional following pediatric ABI and illuminate the interplay between elements characterizing parents' nonfinite vs. finite loss experience.	[Yehene, Einat; Ben-Valid, Shani; Golan, Sapir] Acad Coll Tel Aviv Yafo, Sch Behav Sci, Tel Aviv, Israel; [Yehene, Einat; Brezner, Amichai; Landa, Janna] Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Rehabil Dept, Tel Hashomer, Israel; [Bar-Nadav, Ofri] Univ Haifa, Int Ctr Study Loss Bereavement & Human Resilience, Dept Psychol, Haifa, Israel; [Landa, Janna] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel		Yehene, E (corresponding author), Acad Coll TelAviv Yaffo, Sch Behav Sci, POB 8401, IL-61161 Tel Aviv, Israel.	einat.yehene@gmail.com		Yehene, Einat/0000-0001-9780-3974			Adres I., 2010, THESIS; Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2003, STUD NEUROPSYCHOL DE, P217; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boss P., 1991, LIVING LOSS DEATH FA, P164; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss P, 2014, BEREAVE CARE, V33, P63, DOI 10.1080/02682621.2014.933573; Bowlby J, 1980, ATTACHMENT LOSS VOLU; Braun M, 2012, PSYCHO-ONCOLOGY, V21, P935, DOI 10.1002/pon.1988; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brown FL, 2014, J CHILD PSYCHOL PSYC, V55, P1172, DOI 10.1111/jcpp.12227; Brown FL, 2013, BRAIN INJURY, V27, P1570, DOI 10.3109/02699052.2013.841996; Bruce E., 2002, BRIT J SPEC EDUC, V29, P9; Bruce E.J., 2001, NONFINITE LOSS GRIEF; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Collings C, 2008, BRIT J SOC WORK, V38, P1499, DOI 10.1093/bjsw/bcm055; Doka K. J., 2002, DISENFRANCHISED GRIE, P217; Doka K. J., 1988, DISENFRANCHISED GRIE; du Toit Christine, 2013, S. Afr. j. occup. ther., V43, P17; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Godress J, 2005, AUST NZ J PSYCHIAT, V39, P88, DOI 10.1080/j.1440-1614.2005.01518.x; Guerriere D, 1997, J Soc Pediatr Nurs, V2, P105, DOI 10.1111/j.1744-6155.1997.tb00067.x; Harris DL, 2011, SER DEATH DYING, P1; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; Hickey L, 2018, DEV NEUROREHABIL, V21, P457, DOI 10.1080/17518423.2018.1434697; Hobdell Elizabeth, 2004, J Neurosci Nurs, V36, P82; Jones M., 2010, NZ J OCCUPATIONAL TH, V57, P4; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Kbler-Ross E., 1969, DEATH DYING; Kirk S, 2015, CHILD CARE HLTH DEV, V41, P303, DOI 10.1111/cch.12173; Klass D, 1997, DEATH STUD, V21, P147, DOI 10.1080/074811897202056; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Landolt MA, 2003, J CHILD PSYCHOL PSYC, V44, P1199, DOI 10.1111/1469-7610.00201; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Max JE, 2015, J NEUROPSYCH CLIN N, V27, P272, DOI 10.1176/appi.neuropsych.15030073; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Middleton JA, 2001, ADV PSYCHIAT TREAT, V7, P257, DOI DOI 10.1192/APT.7.4.257; Middleton W, 1998, AUST NZ J PSYCHIAT, V32, P235, DOI 10.3109/00048679809062734; Morris S, 2019, J CLIN PSYCHOL MED S, V26, P321, DOI 10.1007/s10880-018-9590-7; Neimeyer RA, 2000, DEATH STUD, V24, P541, DOI 10.1080/07481180050121480; Neimeyer RA., 2011, SERIES DEATH DYING B, P9, DOI [10.4324/9780203840863, DOI 10.4324/9780203840863]; Norberg AL, 2009, EUR J CANCER CARE, V18, P371, DOI 10.1111/j.1365-2354.2008.00976.x; O'Brien M, 2007, FAM RELAT, V56, P135, DOI 10.1111/j.1741-3729.2007.00447.x; Olshansky S., 1962, SOCIAL CASE WORK, V43, P147; Oreo A, 2007, ADDICT RES THEORY, V15, P71, DOI 10.1080/16066350601036169; RANDO T A, 1983, Journal of Pediatric Psychology, V8, P3, DOI 10.1093/jpepsy/8.1.3; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Robson T., 2005, BRAIN IMPAIR, V6, P45, DOI [10.1375/brim.6.1.45.65477, DOI 10.1375/BRIM.6.1.45.65477]; Rogers CH, 2008, J FAM PSYCHOL, V22, P203, DOI 10.1037/0893-3200.22.2.203; Roos S, 2007, COPING CHRONIC ILLNE, P89, DOI DOI 10.1007/978-0-387-48670-3_5; Roos Susan., 2002, CHRONIC SORROW LIVIN; Roscigno CI, 2011, QUAL HEALTH RES, V21, P1413, DOI 10.1177/1049732311410988; Rubin S.S., 2012, WORKING BEREAVED MUL; Rubin S.S., 2001, HDB BEREAVEMENT RES, P219, DOI DOI 10.1037/10436-009; Rubin Simon Shimshon, 1993, P285, DOI 10.1017/CBO9780511664076.020; Rubin SS, 2012, OMEGA-J DEATH DYING, V66, P365, DOI 10.2190/OM.66.4.f; Rubin SS, 2009, DEATH STUD, V33, P305, DOI 10.1080/07481180802705668; RUBIN SS, 1992, OMEGA-J DEATH DYING, V24, P183, DOI 10.2190/2V09-H301-YMGG-M065; Rubin SS, 1999, DEATH STUD, V23, P681, DOI 10.1080/074811899200731; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Stancin T, 2010, J DEV BEHAV PEDIATR, V31, P317, DOI 10.1097/DBP.0b013e3181dbaf32; Stroebe M.S., 2008, HDB BEREAVEMENT RES; Strong P E, 1985, MANUAL GRIEF EXPERIE; Tonks James, 2011, Clin Child Psychol Psychiatry, V16, P185, DOI 10.1177/1359104511403583; Tyerman E, 2017, BRAIN INJURY, V31, P1553, DOI 10.1080/02699052.2017.1341999; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2008, WECHSLER ADULT INTEL; West S. G., 1991, MULTIPLE REGRESSION; Whittingham K, 2013, CHILD CARE HLTH DEV, V39, P366, DOI 10.1111/j.1365-2214.2012.01396.x; Worden J.W., 1991, GRIEF COUNSELING GRI; Zinner ES, 1997, ARCH CLIN NEUROPSYCH, V12, P435, DOI 10.1016/S0887-6177(96)00034-0	79	5	5	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2021	31	1					105	128		10.1080/09602011.2019.1668280		SEP 2019	24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	PE3DI	WOS:000488095900001	31556807				2022-02-06	
J	Albrecht, JS; Wickwire, EM				Albrecht, Jennifer S.; Wickwire, Emerson M.			Sleep disturbances among older adults following traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article						Traumatic brain injury; older adults; sleep disturbances; insomnia; administrative claims	UNITED-STATES; INSOMNIA; PREVALENCE; DISORDERS; MORTALITY; MEDICARE; VISITS; RISK; AGE	Sleep disturbances are common sequelae of traumatic brain injury (TBI) that are associated with poorer recovery. This is important among older adults, who fare worse following TBI relative to younger adults and have a higher prevalence of sleep disorders. The objective of this study was to assess the risk of newly-diagnosed sleep disorders following TBI among adults >= 65 years. Using a large commercial insurance database, older adults diagnosed with TBI between 2008-2014 (n = 78,044) and non-TBI controls (n = 76,107) were identified. The first dates of diagnosis of four common sleep disorders (hypersomnia, insomnia, obstructive sleep apnea, and restless legs syndrome) and a composite of any sleep disorder were identified. To compare groups, this study used a difference-in-differences (DID) approach, accounting for pre-index differences between cohorts and the trends in sleep diagnoses over time. Individuals with TBI were more likely to have any newly-diagnosed sleep disorder before (14.1% vs 9.4%, p < 0.001) and after (22.7% vs 14.1%, p < 0.001) the index date. In fully adjusted DID models, TBI was associated with an increased risk of insomnia (rate ratio (RR) = 1.17; 95% confidence interval (CI) = 1.08-1.26) and any sleep disorder (RR = 1.13; 95% CI = 1.08-1.19). Following TBI among older adults, screening and education on sleep disorders should be considered.	[Albrecht, Jennifer S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] OptumLabs, Cambridge, MA USA; [Wickwire, Emerson M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Wickwire, Emerson M.] Univ Maryland, Sch Med, Sleep Disorders Ctr, Div Pulm & Crit Care Med,Dept Med, Baltimore, MD 21201 USA		Albrecht, JS (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 South Pine St, Baltimore, MD 21201 USA.	jalbrecht@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	AHRQUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560]; AASM Foundation; Department of DefenseUnited States Department of Defense; MerckMerck & Company; ResMed	Dr Albrecht was supported by AHRQ grant K01HS024560. Dr Albrecht and Dr Wickwire's institution has received research funding from the AASM Foundation, the Department of Defense, Merck, and ResMed. Dr Wickwire has served as a scientific consultant for DayZz, Eisai, Merck, and Purdue, and is an equity shareholder in WellTap	Albrecht JS, 2019, AM J GERIAT PSYCHIAT, V27, P301, DOI 10.1016/j.jagp.2018.10.017; Albrecht JS, 2019, J NEUROTRAUM, V36, P300, DOI 10.1089/neu.2017.5608; Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, P178, DOI 10.1097/HTR.0000000000000266; Albrecht JS, 2015, AM J GERIAT PSYCHIAT, V23, P607, DOI 10.1016/j.jagp.2014.07.006; Ancoli-Israel S, 2009, SLEEP MED, V10, pS7, DOI 10.1016/j.sleep.2009.07.004; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Byhoff E, 2016, JAMA INTERN MED, V176, P1020, DOI 10.1001/jamainternmed.2016.2266; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Cirelli C, 2012, GERONTOLOGY, V58, P441, DOI 10.1159/000336149; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Flanagan SR, 2007, J HEAD TRAUMA REHAB, V22, P67, DOI 10.1097/00001199-200701000-00009; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Lechner M., 2010, ECONOMETRICS, V4, P165, DOI DOI 10.1561/0800000014; Marr A., 2004, CENTRAL NERVOUS SYST; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Neubauer DN, 2018, J CENT NERV SYST DIS, V10, DOI 10.1177/1179573518770672; OptumLabs, 2020, OPTUMLABS OPTUMLABS; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sivertsen B, 2006, JAMA-J AM MED ASSOC, V295, P2851, DOI 10.1001/jama.295.24.2851; Stone KL, 2008, ARCH INTERN MED, V168, P1768, DOI 10.1001/archinte.168.16.1768; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; Tom SE, 2016, SLEEP, V39, P1009, DOI 10.5665/sleep.5742; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wickwire EM, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz007; Wickwire EM, 2018, J NEUROTRAUM, V35, P2615, DOI 10.1089/neu.2017.5243; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Wickwire EM, 2010, CHEST, V137, P1449, DOI 10.1378/chest.09-1485	39	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	JAN 2	2020	32	1			SI		31	38		10.1080/09540261.2019.1656176		SEP 2019	8	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	KB4LE	WOS:000487437500001	31547739	Green Accepted			2022-02-06	
J	Barker-Collo, S; Krishnamurthi, R; Theadom, A; Jones, K; Starkey, N; Feigin, V				Barker-Collo, Suzanne; Krishnamurthi, Rita; Theadom, Alice; Jones, Kelly; Starkey, Nicola; Feigin, Valery		BIONIC Study Grp; ARCOS-IV Study Grp	Incidence of stroke and traumatic brain injury in New Zealand: contrasting the BIONIC and ARCOS-IV studies	NEW ZEALAND MEDICAL JOURNAL			English	Article							REGIONAL COMMUNITY STROKE; POPULATION-BASED STROKE; ISCHEMIC-STROKE; RISK-FACTORS; SEX-DIFFERENCES; GLOBAL BURDEN; CASE-FATALITY; EPIDEMIOLOGY; OUTCOMES; MORTALITY	AIMS: Traumatic Brain Injury (TBI) and stroke are the main causes of acquired brain injury. The differences in demographic profiles of stroke and TBI suggest that high-quality epidemiological studies of the two be compared. This study examined incidence of stroke and TBI by age and ethnicity in New Zealand. METHODS: Incidence rates are presented by age and ethnicity from two New Zealand population-based epidemiological studies (Brain Injury Outcomes New Zealand In the Community (BIONIC); and Auckland Regional Outcomes of Stroke Studies (ARCOS-IV)). RESULTS: Males and females had similar stroke risk, while males had 2x relative risk of mild TBI and 3x the relative risk of moderate/ severe TBI compared to females. More TBI cases (35.6%) were identified through non-medical sources compared to stroke (3%). Incidence of TBI was > 5 times that of stroke. New Zealand European/ Pakeha had the highest TBI incidence when < 5 years of age, while Maori had the highest incidence after five years of age. For stroke, Pacific people and Maori had higher incidences until 75-84 years, after which Europeans had higher incidence. CONCLUSIONS: Differences in TBI and stroke incidence suggest targeting prevention very differently for the two groups. Incidence profiles suggest TBI is much more common; and a need to target males and those of Maori ethnicity for TBI prevention.	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Krishnamurthi, Rita; Theadom, Alice; Jones, Kelly; Feigin, Valery] AUT Univ, NISAN, Auckland, New Zealand; [Starkey, Nicola] Waikato Univ, Sch Psychol, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Clin Psychol Training Programme, Private Bag 92019, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz	Starkey, Nicola/AAJ-3795-2020; Krishnamurthi, Rita/AAU-7841-2021; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Krishnamurthi, Rita/0000-0003-0869-2083; 			AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Alzamora MT, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-5; Amram O, 2015, INT J ENV RES PUB HE, V12, P15594, DOI 10.3390/ijerph121215009; Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Barker-Collo S, 2015, NEUROEPIDEMIOLOGY, V45, P203, DOI 10.1159/000441103; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Excellence NIfHC, 2013, ASS PREV FALLS OLD P; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Feigin V. L., 2007, HDB CLIN NEUROEPIDEM, P197; Feigin V, 2018, STROKE, V49, P2248, DOI 10.1161/STROKEAHA.118.022161; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Feigin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134609; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Group G, 2006, TRAUM BRAINN INJ DIA; Gu YL, 2018, INTERN MED J, V48, P301, DOI 10.1111/imj.13648; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Harmsen P, 2009, STROKE, V40, P2691, DOI 10.1161/STROKEAHA.109.550814; Hillier SL, 1997, BRAIN INJURY, V11, P649; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Krishnamurthi R, 2014, INT J STROKE, V9, P140, DOI 10.1111/ijs.12108; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavados PM, 2007, LANCET NEUROL, V6, P362, DOI 10.1016/S1474-4422(07)70003-0; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R., 2000, GPE DISCUSSION PAPER, V31; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marewa G, 2013, NZ MED J, V126; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Reeves MJ, 2008, LANCET NEUROL, V7, P915, DOI 10.1016/S1474-4422(08)70193-5; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Schneider AT, 2004, STROKE, V35, P1552, DOI 10.1161/01.STR.0000129335.28301.f5; Sridharan SE, 2009, STROKE, V40, P1212, DOI 10.1161/STROKEAHA.108.531293; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Tamas V, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00366; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Theodore R, 2015, AUST NZ J PUBL HEAL, V39, P509, DOI 10.1111/1753-6405.12418; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Torner JC, 1996, HEAD INJURY POSTCONC; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; White H, 2005, CIRCULATION, V111, P1327, DOI 10.1161/01.CIR.0000157736.19739.D0; WHO, 2005, INJ WHO EUR REG BURD; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	64	5	5	1	2	NEW ZEALAND MEDICAL ASSOC	CHRISTCHURCH	C/O BRENNAN EDWARDES, DEPT SURGERY, CHRISTCHURCH HOSPITAL, PO BOX 4345, CHRISTCHURCH, 00000, NEW ZEALAND	0028-8446	1175-8716		NEW ZEAL MED J	N. Z. Med. J.	SEP 20	2019	132	1502					40	54					15	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	IY8CM	WOS:000486621700005	31563926				2022-02-06	
J	Drapela, LA; Lutze, FE; Tollefsbol, ET; Pimley, N				Drapela, Laurie A.; Lutze, Faith E.; Tollefsbol, Elizabeth Thompson; Pimley, Nicholas			Assessing the Behavior and Needs of Veterans with Traumatic Brain Injury in Washington State Prisons: Establishing a Foundation for Policy, Practice, and Education	JUSTICE QUARTERLY			English	Article						Corrections; prison adjustment; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; CRIMINAL-JUSTICE SYSTEM; MENTAL-HEALTH-SERVICES; SOCIAL SUPPORT; SUBSTANCE USE; PREVALENCE; RISK; POPULATION; IRAQ; TBI	A growing awareness of justice-involved veterans is revealing how little is known about this population, to what extent they have experienced a traumatic brain injury (TBI), and how this may relate to institutional behavior, participation in programs, and use of institutional resources. The current study identifies the prevalence of incarcerated veterans in Washington State who have experienced a TBI and how a TBI history may affect their prison experience and use of prison resources. The results of our study show that incarcerated veterans in Washington State with a moderate-to-severe TBI are more likely to use medical services, commit violent infractions, be placed in maximum custody (solitary confinement), and less likely to complete vocational and job skills programs. The importance of these findings to policy and practice is discussed.	[Drapela, Laurie A.] Washington State Univ, Dept Criminal Justice & Criminol, Vancouver, WA 98686 USA; [Lutze, Faith E.; Pimley, Nicholas] Washington State Univ, Dept Criminal Justice & Criminol, Pullman, WA 99164 USA; [Tollefsbol, Elizabeth Thompson] Washington State Univ, Dept Criminal Justice & Criminol, Spokane, WA USA		Drapela, LA (corresponding author), Washington State Univ, Dept Criminal Justice & Criminol, Vancouver, WA 98686 USA.	ldrapela@wsu.edu					Andrews DA, 2010, PSYCHOLOGY OF CRIMINAL CONDUCT, 5TH EDITION, P3; Andrews DA, 2010, PSYCHOL PUBLIC POL L, V16, P39, DOI 10.1037/a0018362; Bagalman E, 2013, MENTAL DISORDERS OEF; Blodgett JC, 2015, EPIDEMIOL REV, V37, P163, DOI 10.1093/epirev/mxu003; Blodgett JC., 2013, STRUCTURED EVIDENCE; Blonigen D.M., 2016, CRIMINAL JUSTICE POL, V27, P812, DOI [DOI 10.1177/0887403414562602, 10.1177/0887403414562602]; Blonigen Daniel M, 2017, Crim Justice Policy Rev, V28, P790, DOI 10.1177/0887403416628601; Blonigen DM, 2014, J SUBST ABUSE TREAT, V47, P122, DOI 10.1016/j.jsat.2014.03.005; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brandt ALS, 2012, J OFFENDER REHABIL, V51, P541, DOI 10.1080/10509674.2012.693902; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Brown GP, 2015, INT J OFFENDER THER, V59, P27, DOI 10.1177/0306624X13507040; Browne A, 1999, INT J LAW PSYCHIAT, V22, P301, DOI 10.1016/S0160-2527(99)00011-4; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BRYANT ET, 1984, J CONSULT CLIN PSYCH, V52, P323, DOI 10.1037/0022-006X.52.2.323; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Colantonio A, 2014, J CORRECT HEALTH CAR, V20, P271, DOI 10.1177/1078345814541529; Cullen F.T., 1994, JUSTICE Q, V11, P527, DOI [https://doi.org/10.1080/07418829400092421, 10.1080/07418829400092421, DOI 10.1080/07418829400092421]; Cullen FT, 1999, CRIME DELINQUENCY, V45, P188, DOI 10.1177/0011128799045002002; CULLEN FT, 2012, CORRECTIONAL THEORY; Culp R, 2013, JUSTICE Q, V30, P651, DOI 10.1080/07418825.2011.615755; DeHart Dana D, 2009, J Correct Health Care, V15, P129, DOI 10.1177/1078345809331444; Drapela L, 2017, DISABILITY US POLITI, V2, P163; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Fazel S, 2016, LANCET PSYCHIAT, V3, P871, DOI 10.1016/S2215-0366(16)30142-0; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Galanek JD, 2015, MED ANTHROPOL Q, V29, P116, DOI 10.1111/maq.12137; Hamilton Z., 2016, AM SOC CRIMINOLOGY D, V1; Haqanee Z, 2015, J OFFENDER REHABIL, V54, P37, DOI 10.1080/10509674.2014.980485; Higgs T, 2015, AGGRESS VIOLENT BEH, V22, P112, DOI 10.1016/j.avb.2015.04.003; Hochstetler A, 2010, CRIME DELINQUENCY, V56, P588, DOI 10.1177/0011128708319926; JOHNSON R, 1996, HARD TIME UNDERSTAND; Lamberty GJ, 2013, BEHAV SCI LAW, V31, P814, DOI 10.1002/bsl.2091; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lipsey MW, 2007, ANNU REV LAW SOC SCI, V3, P297, DOI 10.1146/annurev.lawsocsci.3.081806.112833; Logan M.W., 2017, CRIMINAL JUSTICE POL, V28, P814, DOI [10.1177/0887403415623033, DOI 10.1177/0887403415623033]; Lowenkamp CT, 2006, CRIME DELINQUENCY, V52, P77, DOI 10.1177/0011128705281747; Lutze F., 1998, JUSTICE Q, V15, P547, DOI [10.1080/07418829800093881, DOI 10.1080/07418829800093881]; Lutze F., 2015, ANN M AC CRIM JUST S; Lutze F. E., 2015, WASHINGTON STATE COR; Lutze F. E., 1999, JUSTICE Q, V16, P709; Lutze F. E., 2016, ASSESSING BEHAV NEED; May D.C., 2017, CRIMINAL JUSTICE POL, V28, P770; McCormick Susan Rebecca, 2015, THESIS; Melnikov S, 2017, PERSPECT PSYCHIATR C, V53, P251, DOI 10.1111/ppc.12165; Merbitz C., 1995, J OFFENDER REHABILIT, V22, P11, DOI DOI 10.1300/J076V22N03_02; Miller, 2011, RETURN INVESTMENT EV; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Mumola CJ., 2000, VETERANS PRISON JAIL; Nowotny Kathryn M, 2017, Health Justice, V5, P9, DOI 10.1186/s40352-017-0052-3; Ohio Valley Center for Brain Injury Prevention and Rehabilitation, 2012, OH STAT U TBI ID MET; Osgood DW, 2000, J QUANT CRIMINOL, V16, P21, DOI 10.1023/A:1007521427059; Parsons O., 1993, COMPREHENSIVE HDB PS, P689; Peters RH, 2015, PSYCHIATR REHABIL J, V38, P1, DOI 10.1037/prj0000135; Phillips A, 2013, IDENTIFYING TRAUMATI; Piccolino AL, 2014, J CORRECT HEALTH CAR, V20, P203, DOI 10.1177/1078345814530871; Pinals DA, 2010, J AM ACAD PSYCHIATRY, V38, P163; Prins SJ, 2014, PSYCHIAT SERV, V65, P862, DOI 10.1176/appi.ps.201300166; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Robertson CE, 2015, J FORENSIC PSYCHI PS, V26, P719, DOI 10.1080/14789949.2015.1062994; Rosenthal M, 1987, REHABIL PSYCHOL, P37; Sarteschi CM, 2013, SAGE OPEN, V3, DOI 10.1177/2158244013497029; Saxon AJ, 2001, PSYCHIATR SERV, V52, P959, DOI 10.1176/appi.ps.52.7.959; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Smith C. J., 2006, NCJ PUBLICATION, V214608; Stacer MJ, 2015, PRISON J, V95, P199, DOI 10.1177/0032885515575267; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tamburello A, 2017, INT REV PSYCHIATR, V29, P3, DOI 10.1080/09540261.2016.1248908; TAXMAN FS, 2004, TOOLS TRADE GUIDE IN; Tsai J, 2013, PSYCHIAT SERV, V64, P36, DOI [10.1176/appi.ps.201200188, 10.1176/appi.ps.001882012]; US Department of Veterans Affairs, 2010, TRAUMATIC BRAIN INJU; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Washington State Department of Corrections, 2015, EXP HOUS VETS CHANG; Washington State Department of Corrections, 2016, FACT CARD FACTS OFF; Washington State Department of Corrections, 2014, UNPUB; Washington State Department of Corrections, 2015, DOC MEAS STAT AV DAI; Washington State Department of Corrections, 2015, DOC MEAS STAT FACT C; Washington State Traumatic Brain Injury Council, 2016, WASH STAT DEP SOC HL; White MD, 2012, JUSTICE Q, V29, P258, DOI 10.1080/07418825.2011.560890; Williams H., 2012, REPAIRING SHATTERED; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Woo Y, 2016, INT J COMP APPL CRIM, V40, P145, DOI 10.1080/01924036.2015.1089518; Wortzel HS, 2009, J AM ACAD PSYCHIATRY, V37, P82	89	5	5	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0741-8825	1745-9109		JUSTICE Q	Justice Q.	SEP 19	2019	36	6					1023	1049		10.1080/07418825.2018.1481221			27	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	IR4VP	WOS:000481432700002					2022-02-06	
J	Fu, YQ; Bai, K; Liu, CJ				Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun			The impact of admission serum lactate on children with moderate to severe traumatic brain injury	PLOS ONE			English	Article							BASE DEFICIT; PROGNOSTIC-SIGNIFICANCE; EARLY HYPERGLYCEMIA; ARTERIAL LACTATE; INITIAL LACTATE; BLOOD LACTATE; BLUNT TRAUMA; MORTALITY; CLEARANCE; UTILITY	Background Lactate is used to evaluate the prognosis of adult patients with trauma. However, the prognostic significance of admission serum lactate in the setting of pediatric traumatic brain injury (TBI) is still unclear. We aim to investigate the impact of admission lactate on the outcome in children with moderate to severe TBI. Methods This retrospective study was conducted in a tertiary pediatric hospital between May 2012 and Jun 2018 included children with an admission Glasgow Coma Scale (GCS) of <= 13. Two hundred and thirteen patients were included in the analysis and 45 patients died in hospital. Results Admission lactate and glucose were significantly higher in non-survivors than those in survivors (P < 0.05). Admission lactate was positively correlated with admission glucose and negatively correlated with GCS in all patients (n = 213), subgroup of isolated TBI (n = 112) and subgroup of GCS. 8 (n = 133), respectively. AUCs of lactate could significantly predict the mortality and were higher than those of glucose in all patients, subgroup of isolated TBI and subgroup of GCS. 8, respectively. Multivariate logistic regression showed that admission lactate (Adjusted OR = 1.189; 95% CI: 1.002-1.410; P = 0.047) was independently associated with mortality, while admission glucose (Adjusted OR = 1.077; 95% CI: 0.978-1.186; P = 0.133) wasn't an independent risk factor of death. Elevated admission lactate (> 2 mmol/L) was associated with death, reduced 14-day ventilation-free days, 14-day ICU-free days and 28-day hospital-free days. Conclusions Admission serum lactate can effectively predict the mortality of children with moderate to severe TBI. Elevated admission lactate is associated with death, reduced ventilator-free, ICU-free, and hospital-free days. Admission serum lactate could be used as a prognostic biomarker of mortality in children with moderate to severe TBI.	[Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Chongqing Key Lab Pediat, Chongqing, Peoples R China		Fu, YQ (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China.; Fu, YQ (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Fu, YQ (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.	fuyueqiang@sina.com					Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown JB, 2016, J TRAUMA ACUTE CARE, V81, P445, DOI 10.1097/TA.0000000000001085; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Dekker SE, 2017, EUR J TRAUMA EMERG S, V43, P841, DOI 10.1007/s00068-016-0733-y; Fu YQ, 2017, BRAIN INJURY, V31, P396, DOI 10.1080/02699052.2016.1264629; Gale SC, 2016, J SURG RES, V205, P446, DOI 10.1016/j.jss.2016.06.103; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kong VY, 2018, SAMJ S AFR MED J, V108, P413, DOI [10.7196/SAMJ.2018.v108i5.12837, 10.7196/samj.2018.v108i5.12837]; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lavery RF, 2000, J AM COLL SURGEONS, V190, P656, DOI 10.1016/S1072-7515(00)00271-4; Londono J, 2018, SHOCK, V50, P286, DOI 10.1097/SHK.0000000000001066; Martin MJ, 2006, AM J SURG, V191, P625, DOI 10.1016/j.amjsurg.2006.02.014; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; Okello M, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0020-9; Ouellet JF, 2012, J TRAUMA ACUTE CARE, V72, P1532, DOI 10.1097/TA.0b013e318256dd5a; Pal JD, 2006, J TRAUMA, V60, P583, DOI 10.1097/01.ta.0000205858.82575.55; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Parsikia A, 2014, SHOCK, V42, P199, DOI 10.1097/SHK.0000000000000208; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Ramanathan R, 2015, J PEDIATR SURG, V50, P598, DOI 10.1016/j.jpedsurg.2014.08.013; Raux M, 2017, ANESTHESIOLOGY, V126, P522, DOI 10.1097/ALN.0000000000001490; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Richards JE, 2018, ANESTH ANALG, V126, P904, DOI 10.1213/ANE.0000000000002626; Richards JE, 2016, J ORTHOP TRAUMA, V30, P312, DOI 10.1097/BOT.0000000000000528; Sammour T, 2009, INJURY, V40, P104, DOI 10.1016/j.injury.2008.07.032; Shah A, 2013, PEDIATR EMERG CARE, V29, P715, DOI 10.1097/PEC.0b013e318294ddb1; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Venkatesan M, 2015, INJURY, V46, P2201, DOI 10.1016/j.injury.2015.06.038	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222591	10.1371/journal.pone.0222591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	WOS:000532262800057	31536567	Green Published, gold, Green Submitted			2022-02-06	
J	Harrois, A; Anstey, JR; Taccone, FS; Udy, AA; Citerio, G; Duranteau, J; Ichai, C; Badenes, R; Prowle, JR; Ercole, A; Oddo, M; Schneider, A; van Der Jagt, M; Wolf, S; Helbok, R; Nelson, DW; Skrifvars, MB; Cooper, DJ; Bellomo, R; Long, K; Rodrigues, A; Lozano, A; Saxby, E; Vargiolu, A; Quintard, H; Robba, C; Sisson, A; Allen, G; Baro, N; Kofler, M				Harrois, A.; Anstey, J. R.; Taccone, F. S.; Udy, A. A.; Citerio, G.; Duranteau, J.; Ichai, C.; Badenes, R.; Prowle, J. R.; Ercole, A.; Oddo, M.; Schneider, A.; van Der Jagt, M.; Wolf, S.; Helbok, R.; Nelson, D. W.; Skrifvars, M. B.; Cooper, D. J.; Bellomo, R.; Long, K.; Rodrigues, A.; Lozano, A.; Saxby, E.; Vargiolu, A.; Quintard, H.; Robba, C.; Sisson, A.; Allen, G.; Baro, N.; Kofler, M.		TBI Collaborative	Serum sodium and intracranial pressure changes after desmopressin therapy in severe traumatic brain injury patients: a multi-centre cohort study	ANNALS OF INTENSIVE CARE			English	Article						Traumatic brain injury; Diabetes insipidus; Desmopressin; Sodium; Natremia	DIABETES-INSIPIDUS; V-2 RECEPTORS; HYPONATREMIA; DYSFUNCTION; COPEPTIN; DAMAGE	Background In traumatic brain injury (TBI) patients desmopressin administration may induce rapid decreases in serum sodium and increase intracranial pressure (ICP). Aim In an international multi-centre study, we aimed to report changes in serum sodium and ICP after desmopressin administration in TBI patients. Methods We obtained data from 14 neurotrauma ICUs in Europe, Australia and UK for severe TBI patients (GCS <= 8) requiring ICP monitoring. We identified patients who received any desmopressin and recorded daily dose, 6-hourly serum sodium, and 6-hourly ICP. Results We studied 262 severe TBI patients. Of these, 39 patients (14.9%) received desmopressin. Median length of treatment with desmopressin was 1 [1-3] day and daily intravenous dose varied between centres from 0.125 to 10 mcg. The median hourly rate of decrease in serum sodium was low (- 0.1 [- 0.2 to 0.0] mmol/L/h) with a median period of decrease of 36 h. The proportion of 6-h periods in which the rate of natremia correction exceeded 0.5 mmol/L/h or 1 mmol/L/h was low, at 8% and 3%, respectively, and ICPs remained stable. After adjusting for IMPACT score and injury severity score, desmopressin administration was independently associated with increased 60-day mortality [HR of 1.83 (1.05-3.24) (p = 0.03)]. Conclusions In severe TBI, desmopressin administration, potentially representing instances of diabetes insipidus is common and is independently associated with increased mortality. Desmopressin doses vary markedly among ICUs; however, the associated decrease in natremia rarely exceeds recommended rates and median ICP values remain unchanged. These findings support the notion that desmopressin therapy is safe.	[Harrois, A.; Anstey, J. R.; Bellomo, R.; Long, K.] Royal Melbourne Hosp, Intens Care Unit, Parkville, Vic, Australia; [Harrois, A.; Duranteau, J.] Univ Paris Sud, CHU Bicetre, AP HP, Dept Anesthesia & Surg Intens Care, 78 Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, France; [Taccone, F. S.; Cooper, D. J.; Lozano, A.] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Udy, A. A.; Saxby, E.] Alfred Hosp, Intens Care Unit, Melbourne, Vic, Australia; [Citerio, G.; Vargiolu, A.] Univ Milano Bicocca Neurointens Care, San Gerardo Hosp, Sch Med & Surg, ASST Monza, Monza, Italy; [Ichai, C.; Quintard, H.] Univ Cote dAzur, CHU Nice, Serv Reanimat Polyvalente, Hop Pasteur 2, Nice, France; [Badenes, R.; Robba, C.] Univ Valencia, Hosp Clin Univ Valencia, Dept Anesthesiol & Surg Trauma Intens Care, Valencia, Spain; [Prowle, J. R.; Sisson, A.] Barts Hlth NHS Trust, Adult Crit Care Unit, Royal London Hosp, London, England; [Ercole, A.; Allen, G.] Cambridge Univ Hosp NHS Fdn Trust, Neurosci & Trauma Crit Care Unit, Cambridge, England; [Oddo, M.; Schneider, A.] Univ Lausanne, CHU Vaudois, Fac Biol & Med, Dept Med Surg Intens Care Med, Lausanne, Switzerland; [van Der Jagt, M.] Univ Med Ctr, Dept Intens Care, Erasmus MC, Rotterdam, Netherlands; [Wolf, S.; Baro, N.] Charite Univ Med Berlin, Dept Neurosurg, Berlin, Germany; [Helbok, R.; Kofler, M.] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Nelson, D. W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Skrifvars, M. B.] Univ Helsinki, Dept Emergency Care & Serv, Div Intens Care, Helsinki, Finland; [Skrifvars, M. B.] Helsinki Univ Hosp, Helsinki, Finland; [Udy, A. A.; Cooper, D. J.; Bellomo, R.] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia; [Bellomo, R.] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Bellomo, R.] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Rodrigues, A.] CHU Bicetre, Dept Anesthesia & Surg Intens Care, Le Kremlin Bicetre, France		Harrois, A (corresponding author), Royal Melbourne Hosp, Intens Care Unit, Parkville, Vic, Australia.; Harrois, A (corresponding author), Univ Paris Sud, CHU Bicetre, AP HP, Dept Anesthesia & Surg Intens Care, 78 Rue Gen Leclerc, F-94270 Le Kremlin Bicetre, France.	harroisanatole@yahoo.fr	Prowle, John/D-5014-2009; Ercole, Ari/B-6288-2009; Cooper, D. James/G-7961-2013; Helbok, Raimund/AAA-8361-2021; Robba, Chiara/AAS-7421-2020; Badenes, Rafael/K-6628-2019; van der Jagt, Mathieu/G-1905-2017	Prowle, John/0000-0002-5002-2721; Ercole, Ari/0000-0001-8350-8093; Cooper, D. James/0000-0002-5872-9051; Badenes, Rafael/0000-0001-7017-0150; Nelson, David/0000-0003-2530-8207; Harrois, Anatole/0000-0002-5098-4656; van der Jagt, Mathieu/0000-0003-2566-8325			Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Alharfi IM, 2013, PEDIATR CRIT CARE ME, V14, P203, DOI 10.1097/PCC.0b013e31827127b5; Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Boughey JC, 2004, AM SURGEON, V70, P500; Capatina C, 2015, J CLIN MED, V4, P1448, DOI 10.3390/jcm4071448; DOCZI T, 1982, NEUROSURGERY, V11, P402; Fenske W, 2018, NEW ENGL J MED, V379, P428, DOI 10.1056/NEJMoa1803760; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Hadjizacharia P, 2008, J AM COLL SURGEONS, V207, P477, DOI 10.1016/j.jamcollsurg.2008.04.017; Imaizumi T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016248; Juul KV, 2011, ENDOCRINE, V40, P67, DOI 10.1007/s12020-011-9492-z; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Kleindienst A, 2016, J NEUROTRAUM, V33, P615, DOI 10.1089/neu.2015.3981; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Ranger A, 2010, PEDIATR NEUROSURG, V46, P318, DOI 10.1159/000320146; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; SECKL J, 1989, BRIT MED J, V298, P2, DOI 10.1136/bmj.298.6665.2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Widmayer MA, 2010, NEUROL RES, V32, P1021, DOI 10.1179/016164110X12714125204155	27	5	6	0	2	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	SEP 5	2019	9	1							99	10.1186/s13613-019-0574-z			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IV9KV	WOS:000484583700001	31486921	Green Published, gold			2022-02-06	
J	Wang, XH; Zhang, LM; Chai, YM; Wang, J; Yu, LF; Zhou, SZ				Wang, Xin-Hua; Zhang, Lin-Mei; Chai, Yi-Ming; Wang, Ji; Yu, Li-Fei; Zhou, Shui-Zhen			Clinical Characteristics and Outcomes of Pediatric Cerebra Venous Sinus Thrombosis: An Analysis of 30 Cases in China	FRONTIERS IN PEDIATRICS			English	Article						stroke; cerebral venous sinus thrombosis; CVST; child; retrospective studies	SINOVENOUS THROMBOSIS; GUIDELINE; CHILDREN	Background: Cerebral venous sinus thrombosis (CVST) in children is rare in a clinical setting. The aim of this study was to summarize the etiological, clinical, and imaging characteristics of CVST in children. Methods: We retrospectively analyzed the data of 30 patients with a diagnosis of CVST who were admitted to Children's Hospital of Fudan University from 2008 to 2018. The medical records, including clinical manifestations, laboratory data, neurological findings, treatment, and short-term prognosis were analyzed. Results: Etiologically, the causes of CVST were infection (7/30), tumor (3/30), nephritis or nephrotic syndrome (8/30), traumatic brain injury (1/30), and undefined disease (11/30). All 30 cases were diagnosed with CVST after a neuroimaging examination using brain magnetic resonance imaging (MRI) combined with magnetic angiography venography (MRV). With regard to short-term prognosis, all the patients were treated with anticoagulants, after which 26 cases improved. Conclusions: CVST patients do not typically present with specific clinical manifestations, which leads to a high rate of misdiagnosis and delayed therapy. Increased consideration and prompt MRV checkup plays a key role in achieving an accurate diagnosis. Overall, anticoagulation is a safe and effective treatment for CVST.	[Wang, Xin-Hua; Zhang, Lin-Mei; Chai, Yi-Ming; Wang, Ji; Yu, Li-Fei; Zhou, Shui-Zhen] Fudan Univ, Childrens Hosp, Dept Neurol, Shanghai, Peoples R China		Zhou, SZ (corresponding author), Fudan Univ, Childrens Hosp, Dept Neurol, Shanghai, Peoples R China.	szzhou@shmu.edu.cn					Bousser MG, 2007, LANCET NEUROL, V6, P162, DOI 10.1016/S1474-4422(07)70029-7; Coutinho JM, 2010, STROKE, V41, P2575, DOI 10.1161/STROKEAHA.110.588822; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Dlamini N, 2010, NEUROSURG CLIN N AM, V21, P511, DOI 10.1016/j.nec.2010.03.006; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Gao LS, 2018, THROMB RES, V167, P64, DOI 10.1016/j.thromres.2018.05.012; Ichord R, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00163; Karsy M, 2018, J CLIN NEUROSCI, V53, P34, DOI 10.1016/j.jocn.2018.03.004; Leach JL, 2006, RADIOGRAPHICS, V26, pS19, DOI 10.1148/rg.26si055174; Lebas A, 2012, EUR J PAEDIATR NEURO, V16, P219, DOI 10.1016/j.ejpn.2012.02.005; Masuhr F, 2008, Front Neurol Neurosci, V23, P132; Qu H, 2013, EXP THER MED, V5, P233, DOI 10.3892/etm.2012.796; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Sirachainan N, 2018, J MATERN-FETAL NEO M, V31, P347, DOI 10.1080/14767058.2017.1285892; Wang JW, 2015, NEUROSCIENCES, V20, P292, DOI 10.17712/nsj.2015.3.20140625; Wang Y, 2016, J STROKE CEREBROVASC, V25, P2415, DOI 10.1016/j.jstrokecerebrovasdis.2016.06.013; Warkentin TE, 2005, NEW ENGL J MED, V353, P314	18	5	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-2360			FRONT PEDIATR	Front. Pediatr.	SEP 4	2019	7								364	10.3389/fped.2019.00364			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IU7PX	WOS:000483776900003	31552208	Green Published, gold			2022-02-06	
J	Cantiera, M; Tattevin, P; Sonneuille, R				Cantiera, M.; Tattevin, P.; Sonneuille, R.			Brain abscess in immunocompetent adult patients	REVUE NEUROLOGIQUE			English	Article; Proceedings Paper	International Meeting of the French-Society-of-Neurology (SPILF)	OCT 10-11, 2019	ICM Salpetriere Hosp, Paris, FRANCE	French Soc Neurol, French Soc Infectious Dis	ICM Salpetriere Hosp	Brain abscess; Bacterial; Immunocompetent; Stereotactic surgery; Brain magnetic resonance imaging	CENTRAL-NERVOUS-SYSTEM; DIFFERENTIAL-DIAGNOSIS; MANAGEMENT	Brain abscess is a focal infection of the brain due to contiguous spread of pathogens following otitis, sinusitis, neurosurgery or traumatic brain injury or through hematogenous dissemination. Classical symptoms consisting of headache, fever, and focal signs may be absent on admission and brain MRI with contrast plays a major role in diagnosis. Initial management consists of stereotactic aspiration for microbiological documentation empirical treatment covering common pathogens, including oral streptococci, staphylococci, anaerobes, and Enterobacteriaceae. De-escalation of antimicrobials based on microbiology is safe only when samples have been processed optimally, or when primary diagnosis is endocarditis. A 6-week combination of third-generation cephalosporin and metronidazole will cure most cases of community-acquired brain abscess in immunocompetent adults. Significant advent in brain imaging, minimally invasive surgery, molecular biology, and antibacterial agents, has dramatically improved the prognosis. Main indicators of outcome include altered mental status at presentation and intraventricular rupture. (C) 2019 Published by Elsevier Masson SAS.	[Cantiera, M.; Sonneuille, R.] Paris Diderot Univ, Bichat Hosp, AP HP, UMR1148,LVTS,Dept Intens Care Med & Infect Dis,So, F-75018 Paris, France; [Tattevin, P.] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, F-35000 Rennes, France		Sonneuille, R (corresponding author), Paris Diderot Univ, Bichat Hosp, AP HP, UMR1148,LVTS,Dept Intens Care Med & Infect Dis,So, F-75018 Paris, France.	romain.sonneville@aphp.fr	Sonneville, Romain/AAE-7039-2020	Sonneville, Romain/0000-0003-0245-309X; Cantier, Marie/0000-0002-3307-5258			Al Masalma M, 2012, CLIN INFECT DIS, V54, P202, DOI 10.1093/cid/cir797; Al Masalma M, 2009, CLIN INFECT DIS, V48, P1169, DOI 10.1086/597578; Barlas O, 1999, SURG NEUROL, V52, P404, DOI 10.1016/S0090-3019(99)00118-4; BRITT RH, 1981, J NEUROSURG, V55, P590, DOI 10.3171/jns.1981.55.4.0590; Brouwer MC, 2017, CURR OPIN INFECT DIS, V30, P129, DOI 10.1097/QCO.0000000000000334; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; CHUN CH, 1986, MEDICINE, V65, P415, DOI 10.1097/00005792-198611000-00006; DELOUVOIS J, 1977, BMJ-BRIT MED J, V2, P981, DOI 10.1136/bmj.2.6093.981; DELOUVOIS J, 1980, J CLIN PATHOL, V33, P66, DOI 10.1136/jcp.33.1.66; Dupuis-Girod S, 2007, CLIN INFECT DIS, V44, P841, DOI 10.1086/511645; Gortvai P, 1987, Br J Neurosurg, V1, P189, DOI 10.3109/02688698709035304; Helweg-Larsen J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-332; Jim KK, 2012, J INFECTION, V64, P236, DOI 10.1016/j.jinf.2011.11.011; Laulajainen-Hongisto A, 2016, INFECT DIS-NOR, V48, P310, DOI 10.3109/23744235.2015.1113557; Lu CH, 2006, J CLIN NEUROSCI, V13, P979, DOI 10.1016/j.jocn.2006.01.048; MAMELAK AN, 1995, NEUROSURGERY, V36, P76, DOI 10.1227/00006123-199501000-00010; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; MENDES M, 1980, J NEUROSURG, V52, P772, DOI 10.3171/jns.1980.52.6.0772; Muccio CF, 2014, J NEURORADIOLOGY, V41, P153, DOI 10.1016/j.neurad.2014.05.004; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Nau R, 2010, CLIN MICROBIOL REV, V23, P858, DOI 10.1128/CMR.00007-10; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; ONDERDONK AB, 1979, REV INFECT DIS, V1, P291; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; Saez-Llorens X, 2013, HAND CLINIC, V112, P1127, DOI 10.1016/B978-0-444-52910-7.00032-5; SEYDOUX C, 1992, CLIN INFECT DIS, V15, P394, DOI 10.1093/clind/15.3.394; Sonneville R, 2011, CRIT CARE MED, V39, P1474, DOI 10.1097/CCM.0b013e3182120b41; Takeshita M, 2001, NEUROSURGERY, V48, P310, DOI 10.1097/00006123-200102000-00012; Tattevin P, 2003, AM J MED, V115, P143, DOI 10.1016/S0002-9343(03)00292-4; YANG SY, 1981, J NEUROSURG, V55, P794, DOI 10.3171/jns.1981.55.5.0794	32	5	5	2	6	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.	SEP-OCT	2019	175	7-8					469	474		10.1016/j.neurol.2019.07.002			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	IW7DK	WOS:000485143400012	31447060	Bronze, Green Published			2022-02-06	
J	Cohen, ML; Kisala, PA; Boulton, AJ; Carlozzi, NE; Cook, CV; Tulsky, DS				Cohen, Matthew L.; Kisala, Pamela A.; Boulton, Aaron J.; Carlozzi, Noelle E.; Cook, Christine V.; Tulsky, David S.			Development and Psychometric Characteristics of the TBI-QOL Communication Item Bank	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						communication; language; patient-reported outcome measures; psychometrics; traumatic brain injuries	TRAUMATIC BRAIN-INJURY; PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; RESPONSE THEORY; PROMIS; HEALTH; SELF; FIT; RELIABILITY; PERFORMANCE	Objective: To develop an item response theory (IRT)-based patient-reported outcome measure of functional communication for adults with traumatic brain injury (TBI). Setting: Five medical centers that were TBI Model Systems sites. Participants: A total of 569 adults with TBI (28% complicated-mild; 13% moderate; and 58% severe). Design: Grounded theory-based qualitative item development, large-scale item calibration testing, confirmatory factor analyses, psychometric analyses with graded response model IRT. Main Measure: Traumatic Brain Injury-Quality of Life (TBI-QOL) Communication Item Bank, version 1.0. Results: From an initial pool of 48 items, 31 items were retained in the final instrument based on adequate fit to a unidimensional model and absence of bias across several demographic and clinical subgroupings. The TBI-QOL Communication Item Bank demonstrated excellent score precision (reliability >= 0.95) across a wide range of communication impairment levels, particularly for individuals with more severe difficulties. The TBI-QOL Communication Item Bank is available as a full item bank, fixed-length short form, and as a computerized adaptive test. Conclusions: The TBI-QOL Communication Item Bank permits precise measurement of patient-reported functional communication after TBI. Future development will validate the instrument against performance-based, clinician-reported, and surrogate-reported assessments.	[Cohen, Matthew L.; Cook, Christine V.] Univ Delaware, Dept Commun Sci & Disorders, Newark, DE USA; [Cohen, Matthew L.; Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Cohen, Matthew L.; Kisala, Pamela A.; Boulton, Aaron J.; Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Tulsky, DS (corresponding author), Univ Delaware, 100 Discovery Blvd, Newark, DE 19713 USA.	dtulsky@udel.edu	Cohen, Mathew/W-3982-2019	Cohen, Matthew/0000-0001-9609-2461; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, H133A70038]	This study was supported by grant numbers H133G070138, H133A070037, H133A070043, H133A080045, H133A080044, and H133A70038 from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR).	Amtmann D, 2011, ARCH PHYS MED REHAB, V92, pS12, DOI 10.1016/j.apmr.2011.04.025; Barrett AM, 2009, BEHAV NEUROL, V22, P17, DOI 10.3233/BEN-2009-0250; Bartlett SJ, 2017, J CLIN EPIDEMIOL, V89, P148, DOI 10.1016/j.jclinepi.2017.04.015; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Berwick DM, 2009, HEALTH AFFAIR, V28, pW555, DOI 10.1377/hlthaff.28.4.w555; Bevans M, 2014, NURS OUTLOOK, V62, P339, DOI 10.1016/j.outlook.2014.05.009; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brown M.W., 1993, SOCIOL METHOD RES, P136; Brummel-Smith K, 2016, J AM GERIATR SOC, V64, P15, DOI 10.1111/jgs.13866; Cannizzaro M, 2012, COGNITION ACQUIRED L, P227; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2014, QUAL LIFE RES, V23, P2651, DOI 10.1007/s11136-014-0732-6; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi S, APP PSYCHOL MEAS, V33, P644; Choi SW, 2011, J STAT SOFTW, V39, P1; Crosson B., 2012, COGNITION ACQUIRED L, P167; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Doyle PJ, 2008, APHASIOLOGY, V22, P718, DOI 10.1080/02687030701803093; Embretson S.E., 2013, ITEM RESPONSE THEORY; Eremenco SL, 2005, EVAL HEALTH PROF, V28, P212, DOI 10.1177/0163278705275342; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Gershon Richard C, 2010, J Appl Meas, V11, P304; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Griffen J, 2014, HDB NEUROPSYCHOLOGY; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hays RD, 2000, MED CARE, V38, P28; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hula WD, 2015, J SPEECH LANG HEAR R, V58, P906, DOI 10.1044/2015_JSLHR-L-14-0235; Jobe JB, 2003, QUAL LIFE RES, V12, P219, DOI 10.1023/A:1023279029852; Kim SH, 2007, J EDUC MEAS, V44, P93, DOI 10.1111/j.1745-3984.2007.00029.x; McDonald S, 2014, SOCIAL COMMUNICATION; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; Meulenbroek P, 2016, J VOCAT REHABIL, V44, P15, DOI 10.3233/JVR-150777; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Murdoch BE, 2001, TRAUMATIC BRAIN INJU; Muthen BO, 2010, MPLUS; Nanof T, 2016, ASHA LEADER, V21, P26, DOI [10.1044/leader.BML.21052016.26, DOI 10.1044/LEADER.BML.21052016.26]; National Institute on Disability Independent Living and Rehabilitation Research, 2018, TRAUM BRAIN INJ MOD; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Orlando M, 2003, APPL PSYCH MEAS, V27, P289, DOI 10.1177/0146621603027004004; Patrick DL, 2007, VALUE HEALTH, V10, pS125, DOI 10.1111/j.1524-4733.2007.00275.x; PROMIS Health Organization, 2013, PROMIS INSTR DEV PSY; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roebuck-Spencer T, 2014, HDB NEUROPSYCHOLOGY; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Samejima F, 1997, HDB MODERN ITEM RESP, P123; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Steiger J., 1980, ANN M PSYCH SOC IOW, V758; Stenner A. J., 1996, MEASURING READING CO; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Thomas ML, 2011, ASSESSMENT, V18, P291, DOI 10.1177/1073191110374797; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tulsky DS, 2019, J HEAD TRAUMA REHAB, V34, P281, DOI 10.1097/HTR.0000000000000531; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Velozo CA, 2012, ARCH PHYS MED REHAB, V93, pS154, DOI 10.1016/j.apmr.2012.06.001; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willis GB, 2005, COGNITIVE INTERVIEWI; Willis GB, 1999, M AM STAT ASS; Willis G, 2006, J EMPIR RES HUM RES, V1, P9, DOI 10.1525/jer.2006.1.1.9; [No title captured]	76	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		326	339		10.1097/HTR.0000000000000528			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100013	31498231				2022-02-06	
J	Elbin, RJ; Kontos, AP; Sufrinko, A; McElroy, M; Stephenson-Brown, K; Mohler, S; D'Amico, NR; Collins, MW				Elbin, R. J.; Kontos, Anthony P.; Sufrinko, Alicia; McElroy, Mallory; Stephenson-Brown, Katie; Mohler, Samantha; D'Amico, Nathan R.; Collins, Michael W.			Motion Sickness Susceptibility and Baseline Vestibular and Ocular-Motor Performance in Adolescent Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						VOMS; baseline testing; concussion	TEST-RETEST RELIABILITY; SPORTS-RELATED CONCUSSION; SCREENING VOMS; ONLINE VERSION; HIGH-SCHOOL; IMPACT; SENSITIVITY; RECOVERY; VALIDITY; YOUTH	Context: High school athletes with a history of motion sickness susceptibility exhibit higher baseline vestibular and ocular-motor scores than those without a history of motion sickness susceptibility. Objective: To examine the effects of motion sickness susceptibility on baseline vestibular and ocular-motor functioning, neurocognitive performance, and symptom scores. Design: Cross-sectional study. Setting: Preseason concussion testing. Patients or Other Participants: A convenience sample of high school athletes (N = 308, age = 15.13 +/- 1.21 years) involved in a variety of sports. Main Outcome Measure(s): Vestibular/Ocular Motor Screening, computerized neurocognitive assessment, symptom scale, and Motion Sickness Susceptibility Questionnaire-Short Form (MSSQ-S). Results: Participants were categorized into 3 groups based on a median split of the scores (eg, NONE, LOW, and HIGH). The LOW (n = 95) and HIGH (n = 92) groups (ie, MSSQ-S score > 0) were 2.64 times more likely (chi(2)(1,257) = 7.94, P = .01, 95% confidence interval = 1.32, 5.26) to have baseline Vestibular/ Ocular Motor Screening scores larger than the clinical cutoffs for the NONE group (n =70). No between-groups main effects were present for the NONE (n =52), LOW (n =89), and HIGH (n =90) MSSQ-S groups for verbal (F-2,F-230 = .09, P = .91, eta(2) = .001) and visual (F-2,F-230 = .15, P = .86, eta(2) = .001) memory, processing speed (F-2,F-230 = .78, P = .46, eta(2) = .007), or reaction time (F-2,F-230 = 2.21, P=.11, eta(2 )= .002). The HIGH group exhibited higher total baseline symptom scores than the LOW (U = 3325.50, z = -1.99, P = .05, r = .15) and NONE (U = 1647.50, z = -2.83, P = .005, r = .24) groups. Conclusions: Motion sickness should be considered a preexisting risk factor that might influence specific domains of the baseline concussion assessment and postinjury management.	[Elbin, R. J.; McElroy, Mallory; Stephenson-Brown, Katie; Mohler, Samantha; D'Amico, Nathan R.] Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, 155 Stadium Dr, Fayetteville, AR 72701 USA; [Kontos, Anthony P.; Sufrinko, Alicia; Collins, Michael W.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA 15260 USA		Elbin, RJ (corresponding author), Univ Arkansas, Dept Hlth Human Performance & Recreat, Off Sport Concuss Res, 155 Stadium Dr, Fayetteville, AR 72701 USA.	rjelbin@uark.edu					Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Boldingh MI, 2011, CEPHALALGIA, V31, P1211, DOI 10.1177/0333102411409074; Chang CH, 2012, EXP BRAIN RES, V217, P299, DOI 10.1007/s00221-011-2993-4; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Gaikwad SB, 2018, J NEUROL PHYS THER, V42, P72, DOI 10.1097/NPT.0000000000000216; Golding JF, 2006, AUTON NEUROSCI-BASIC, V129, P67, DOI 10.1016/j.autneu.2006.07.019; Golding JF, 2015, CURR OPIN NEUROL, V28, P83, DOI 10.1097/WCO.0000000000000163; Hsu YS, 2009, INT J PEDIATR OTORHI, V73, P737, DOI 10.1016/j.ijporl.2009.01.016; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Moran RN, 2018, AM J SPORTS MED, V46; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Paillard AC, 2013, J VESTIBUL RES-EQUIL, V23, P203, DOI 10.3233/VES-130501; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	28	5	5	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2019	54	9					939	944		10.4085/1062-6050-347-18			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JC3HA	WOS:000489168600003	31454287	gold, Green Published			2022-02-06	
J	Gargiulo-Monachelli, G; Meyer, M; Lara, A; Garay, L; Lima, A; Roig, P; De Nicola, AF; Deniselle, MCG				Gargiulo-Monachelli, Gisella; Meyer, Maria; Lara, Agustina; Garay, Laura; Lima, Analia; Roig, Paulina; De Nicola, Alejandro F.; Gonzalez Deniselle, Maria Claudia			Comparative effects of progesterone and the synthetic progestin norethindrone on neuroprotection in a model of spontaneous motoneuron degeneration	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Synthetic progestin; Progesterone; Norethindrone; Motoneuron degeneration; Wobbler mouse; Amyotrophic lateral sclerosis	AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; WOBBLER MOUSE MODEL; SPINAL-CORD; NEUROTROPHIC FACTOR; CHOLINE-ACETYLTRANSFERASE; MITOCHONDRIAL DYSFUNCTION; NEURITE OUTGROWTH	The Wobbler mouse has been proposed as an experimental model of the sporadic form of amyotrophic lateral sclerosis (ALS). The administration of natural progesterone (PROG) to Wobbler mice attenuates neuropathology, inhibits oxidative stress, enhances the expression of genes involved in motoneuron function, increases survival and restores axonal transport. However, current pharmacological treatments for ALS patients are still partially effective. This encouraged us to investigate if the synthetic progestin norethindrone (NOR), showing higher potency than PROG and used for birth control and hormone therapy might also afford neuroprotection. Twomonth-old Wobbler mice (wr/wr) were left untreated or received either a 20 mg pellet of PROG or a 1 mg pellet of NOR for 18 days. Untreated control NFR/NFR mice (background strain for Wobbler) were also employed. Wobblers showed typical clinical and spinal cord abnormalities, while these abnormalities were normalized with PROG treatment. Surprisingly, we found that NOR did not increase immunoreactivity and gene expression for choline-acetyltransferase, drastically decreased GFAP + astrogliosis, favored proinflammatory mediators, promoted the inflammatory phenotype of IBA1 + microglia, increased the receptor for advanced glycation end products (RAGE) mRNA and protein expression and the activity of nitric oxide synthase (NOS)/NADPH diaphorase in the cervical spinal cord. Additionally, NOR treatment produced atrophy of the thymus. The combined negative effects of NOR on clinical assessments (forelimb atrophy and rotarod performance) suggest a detrimental effect on muscle trophism and motor function. These findings reinforce the evidence that the type of progestin used for contraception, endometriosis or replacement therapy, may condition the outcome of preclinical and clinical studies targeting neurodegenerative diseases.	[Gargiulo-Monachelli, Gisella; Meyer, Maria; Lara, Agustina; Garay, Laura; Lima, Analia; Roig, Paulina; De Nicola, Alejandro F.; Gonzalez Deniselle, Maria Claudia] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, Lab Neuroendocrine Biochem, Obligado 2490, RA-1428 Buenos Aires, DF, Argentina; [Gonzalez Deniselle, Maria Claudia] Univ Buenos Aires, Fac Med, Dept Ciencias Fisiol, Paraguay 2155, RA-1121 Buenos Aires, DF, Argentina; [Garay, Laura; De Nicola, Alejandro F.] Univ Buenos Aires, Fac Med, Depta Bioquim Humana, Paraguay 2155, RA-1121 Buenos Aires, DF, Argentina		Deniselle, MCG (corresponding author), Inst Biol & Med Expt, Obligado 2490, RA-1428 Buenos Aires, DF, Argentina.	mcgonza@dna.uba.ar			FONCYTFONCyT [PICT 2012-0009]; National Research Council of Argentina [CONICET]Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11220170100002C0]; University of Buenos AiresUniversity of Buenos Aires [UBACYT 20020170100082BA]; Williams Foundation; Salvador Mazza Fellowship from the Faculty of Medicine, University of Buenos AiresUniversity of Buenos Aires; Roemmers Foundation; Rene Baron Foundation	We thank the financial support of FONCYT [PICT 2012-0009], the National Research Council of Argentina [CONICET, PIP 11220170100002C0], the University of Buenos Aires [UBACYT 20020170100082BA], Roemmers, Rene Baron and Williams Foundations, and Dr Hernan Gonzalez Deniselle. Agustina Lara is the recipient of a Salvador Mazza Fellowship from the Faculty of Medicine, University of Buenos Aires. These funding sources did not have a role in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Abe K, 2017, LANCET NEUROL, V16, P505, DOI 10.1016/S1474-4422(17)30115-1; Attardi BJ, 2010, MOL CELL ENDOCRINOL, V328, P16, DOI 10.1016/j.mce.2010.06.010; BAIN SD, 1993, J BONE MINER RES, V8, P219; Barbeito AG, 2010, J NEURAL TRANSM, V117, P981, DOI 10.1007/s00702-010-0429-0; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Basso M, 2013, J BIOL CHEM, V288, P15699, DOI 10.1074/jbc.M112.425066; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bigini P, 2001, NEUROREPORT, V12, P1815, DOI 10.1097/00001756-200107030-00011; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boillee S, 2001, GLIA, V33, P277, DOI 10.1002/1098-1136(20010315)33:4<277::AID-GLIA1026>3.3.CO;2-P; Boillee S, 2003, MOL NEUROBIOL, V28, P65, DOI 10.1385/MN:28:1:65; Bourque M, 2016, NEUROENDOCRINOLOGY, V103, P300, DOI 10.1159/000438789; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Casper RF, 2017, FERTIL STERIL, V107, P533, DOI 10.1016/j.fertnstert.2017.01.003; CASSIDENTI DL, 1991, OBSTET GYNECOL, V78, P103; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Corvino V, 2003, NEUROCHEM RES, V28, P341, DOI 10.1023/A:1022345720852; Costa S, 2002, GLIA, V37, P105, DOI 10.1002/glia.10015; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Deniselle MCG, 2005, EXP NEUROL, V195, P518, DOI 10.1016/j.expneurol.2005.06.015; Deniselle MCG, 2004, BRAIN RES, V1014, P71, DOI 10.1016/j.braines.2004.04.004; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Deniselle MCG, 1997, J STEROID BIOCHEM, V60, P205, DOI 10.1016/S0960-0760(96)00193-8; Deniselle MCG, 1999, BRAIN RES, V841, P78, DOI 10.1016/S0006-8993(99)01783-7; Deniselle MCG, 1999, NEUROCHEM RES, V24, P1, DOI 10.1023/A:1020918310281; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; Diana V, 2010, EXP NEUROL, V225, P163, DOI 10.1016/j.expneurol.2010.06.008; Angelo MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107901; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Gaignard P, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00406; Garay L, 2011, NEUROSCIENCE, V192, P588, DOI 10.1016/j.neuroscience.2011.06.065; Garay LI, 2012, NEUROSCIENCE, V226, P40, DOI 10.1016/j.neuroscience.2012.09.032; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Giatti S., 2018, PROG NEUROBIOL; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gomora-Arrati P, 2010, NEUROSCI LETT, V484, P197, DOI 10.1016/j.neulet.2010.08.052; Deniselle MCG, 2007, EXP NEUROL, V203, P406, DOI 10.1016/j.expneurol.2006.08.019; Deniselle MCG, 2012, J NEUROCHEM, V122, P185, DOI 10.1111/j.1471-4159.2012.07753.x; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hantaz-Ambroise D, 2001, DIFFERENTIATION, V69, P100, DOI 10.1046/j.1432-0436.2001.690204.x; Hedayatpour A, 2018, J MOL NEUROSCI, V66, P251, DOI 10.1007/s12031-018-1163-6; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Ikeda K, 2000, BRAIN RES, V858, P84, DOI 10.1016/S0006-8993(99)02427-0; Ikeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140316; Julien JP, 2007, NAT NEUROSCI, V10, P535, DOI 10.1038/nn0507-535; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Labombarda F, 2011, EXP NEUROL, V231, P135, DOI 10.1016/j.expneurol.2011.06.001; Labombarda F, 2009, GLIA, V57, P884, DOI 10.1002/glia.20814; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu LF, 2010, ENDOCRINOLOGY, V151, P5782, DOI 10.1210/en.2010-0005; Liu LF, 2009, ENDOCRINOLOGY, V150, P3186, DOI 10.1210/en.2008-1447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCombe PA, 2010, GENDER MED, V7, P557, DOI 10.1016/j.genm.2010.11.010; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Meyer M, 2015, NEUROSCIENCE, V308, P51, DOI 10.1016/j.neuroscience.2015.09.007; Meyer M, 2012, NEUROSCIENCE, V201, P267, DOI 10.1016/j.neuroscience.2011.11.034; Meyer M, 2018, NEUROSCIENCE, V384, P384, DOI 10.1016/j.neuroscience.2018.05.042; Meyer M, 2017, J STEROID BIOCHEM, V174, P201, DOI 10.1016/j.jsbmb.2017.09.015; Meyer M, 2014, J STEROID BIOCHEM, V143, P40, DOI 10.1016/j.jsbmb.2014.02.007; Meyer M, 2010, CELL MOL NEUROBIOL, V30, P123, DOI 10.1007/s10571-009-9437-8; MITSUMOTO H, 1994, ANN NEUROL, V36, P142, DOI 10.1002/ana.410360205; MITSUMOTO H, 1982, BRAIN, V105, P811, DOI 10.1093/brain/105.4.811; Montes P, 2019, NEUROL RES, V41, P429, DOI 10.1080/01616412.2019.1576356; Morotti M, 2017, EUR J OBSTET GYN R B, V213, P4, DOI 10.1016/j.ejogrb.2017.03.033; Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0; MULLER HW, 1991, RESTOR NEUROL NEUROS, V2, P229, DOI 10.3233/RNN-1991-245610; Murphy PA, 2008, CONTRACEPTION, V77, P257, DOI 10.1016/j.contraception.2008.01.002; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Neubauer H, 2013, MENOPAUSE, V20, P504, DOI [10.1097/GME.0b013e3182755c97, 10.1097/gme.0b013e3182755c97]; Nieto-Gonzalez JL, 2011, CEREB CORTEX, V21, P625, DOI 10.1093/cercor/bhq134; Oda Y, 1995, PATHOL INT, V45, P933, DOI 10.1111/j.1440-1827.1995.tb03418.x; Pehar M, 2017, CURR PHARM DESIGN, V23, P5010, DOI 10.2174/1381612823666170622095802; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; PHILLIPS A, 1987, CONTRACEPTION, V36, P181, DOI 10.1016/0010-7824(87)90013-8; Puentes F, 2016, BRAIN PATHOL, V26, P248, DOI 10.1111/bpa.12352; Rathke-Hartlieb S, 1999, NEUROREPORT, V10, P3411, DOI 10.1097/00001756-199911080-00028; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Robson E, 2018, NEUROSCIENCE, V377, P161, DOI 10.1016/j.neuroscience.2018.02.032; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Saab AS, 2013, CURR OPIN NEUROBIOL, V23, P1065, DOI 10.1016/j.conb.2013.09.008; Sawada H, 2017, EXPERT OPIN PHARMACO, V18, P735, DOI 10.1080/14656566.2017.1319937; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Singh M, 2013, BRAIN RES, V1514, P98, DOI 10.1016/j.brainres.2013.01.027; Sitruk-Ware R, 2002, MENOPAUSE, V9, P6, DOI 10.1097/00042192-200201000-00003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Kruse MS, 2012, CELL MOL NEUROBIOL, V32, P1031, DOI 10.1007/s10571-012-9820-8; Spiller KJ, 2018, NAT NEUROSCI, V21, P329, DOI 10.1038/s41593-018-0083-7; Stanczyk FZ, 2003, STEROIDS, V68, P879, DOI 10.1016/j.steroids.2003.08.003; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Tibbetts TA, 1999, P NATL ACAD SCI USA, V96, P12021, DOI 10.1073/pnas.96.21.12021; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4; Wetts R, 1996, EXP NEUROL, V141, P248, DOI 10.1006/exnr.1996.0159; Zhu XY, 2019, J STEROID BIOCHEM, V185, P90, DOI 10.1016/j.jsbmb.2018.07.014; Zitzmann M, 2017, ANDROLOGY-US, V5, P516, DOI 10.1111/andr.12328	104	5	5	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	SEP	2019	192								105385	10.1016/j.jsbmb.2019.105385			15	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	IW3IK	WOS:000484873500009	31150830				2022-02-06	
J	Huber, DL; Thomas, DG; Danduran, M; Meier, TB; McCrea, MA; Nelson, LD				Huber, Daniel L.; Thomas, Danny G.; Danduran, Michael; Meier, Timothy B.; McCrea, Michael A.; Nelson, Lindsay D.			Quantifying Activity Levels After Sport-Related Concussion Using Actigraph and Mobile (mHealth) Technologies	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; fitness trackers; mobile applications	HEART-RATE-VARIABILITY; ACTIVITY TRACKERS; CHILDREN; RECOVERY; VALIDITY; REST; ASSOCIATION; RELIABILITY; STATEMENT; SYMPTOMS	Context: Interest in identifying the effects of physical and mental activity on recovery after sport-related concussion is growing. Clinical studies of concussed athletes' activities require well-validated methods for tracking their intensity and timing. Objective: To develop and validate a novel multimodal approach to monitoring activity postconcussion using mobile (mHealth) technologies. Design: Cohort study. Setting: Translational research unit. Patients or Other Participants: A total of 40 high school and collegiate football players were evaluated at preseason and followed longitudinally after either concussion (n = 25; age = 17.88 +/- 1.74 years, height = 182.07 +/- 8.08 cm, mass = 98.36 +/- 21.70 kg) or selection as a nonconcussed control (n = 15; age = 18.27 +/- 1.83 years, height =180.01 +/- 7.19 cm, mass = 93.83 +/- 24.56 kg). Main Outcome Measure(s): Participants wore a commercial actigraph and completed a daily mobile survey for 2 weeks. Analyses focused on comparisons between groups for actigraph-based physical activity and self-reported physical and mental activity during the follow-up period. Results: For the first 2 days postinjury, objective measures showed fewer daily steps in concussed (6663 +/- 2667 steps) than in control (11 148 +/- 3381 steps) athletes (P < .001), and both objective and self-reported measures indicated less moderate to vigorous physical activity in concussed (27.6 +/- 32.6 min/d and 25.0 +/- 43.6 min/d, respectively) than in control (57.3 +/- 38.6 min/d and 67.5 +/- 40.1 min/d, respectively) athletes (both P values < .05). Correlations between objective and self-reported measures of moderate to vigorous physical activity were moderate across select 1-week and 2-week averages. We observed no group differences in self-reported mental activities. Conclusions: Physical activity after sport-related concussion varied widely across athletes but on average was reduced during the acute and early subacute postinjury periods for both objective and self-reported measures. The lack of differences in mental activities between groups may reflect limited change in mental exertion postconcussion or difficulty accurately measuring mental activities. Assessing concussed athletes' activities using actigraphy and self-reported scales may help monitor their compliance with activity recommendations and be useful in studies aimed at better understanding the effects of physical activity on concussion recovery.	[Huber, Daniel L.; Meier, Timothy B.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Thomas, Danny G.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Danduran, Michael] Marquette Univ, Dept Exercise Sci, Milwaukee, WI 53233 USA		Huber, DL (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	dhuber@mcw.edu		Huber, Daniel/0000-0003-2079-0647; Thomas, Danny/0000-0002-7470-9835	Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436] Funding Source: NIH RePORTER	This study was funded by award W81XWH-14-1-0561 from the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research. The REDCap database used in the study was supported by award UL1TR001436 from the National Center for Advancing Translational Sciences, National Institutes of Health. The content is solely the responsibility of the authors, and it does not necessarily represent the official views of the National Institutes of Health and is not necessarily endorsed by the Department of Defense.	Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Fokkema T, 2017, MED SCI SPORT EXER, V49, P793, DOI 10.1249/MSS.0000000000001146; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Leth S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010211; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Nelson MB, 2016, MED SCI SPORT EXER, V48, P1619, DOI 10.1249/MSS.0000000000000933; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Sjostrom M., GUIDELINES DATA PROC; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Terwee CB, 2010, SPORTS MED, V40, P525, DOI 10.2165/11531370-000000000-00000; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Voss C, 2017, CAN J CARDIOL, V33, P799, DOI 10.1016/j.cjca.2016.11.024; Wallen MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154420	42	5	5	0	1	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2019	54	9					929	938		10.4085/1062-6050-93-18			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JC3HA	WOS:000489168600002	31411898	Green Submitted, gold, Green Published			2022-02-06	
J	Kakhki, FD; Freeman, SA; Mosher, GA				Kakhki, Fatemeh Davoudi; Freeman, Steven A.; Mosher, Gretchen A.			Segmentation of Severe Occupational Incidents in Agribusiness Industries Using Latent Class Clustering	APPLIED SCIENCES-BASEL			English	Article						latent class analysis; occupational injuries; safety management	INJURY SEVERITY; ERGONOMICS; ACCIDENTS; MODELS; SAFETY	One of the principle objectives in occupational safety analysis is to identify the key factors that affect the severity of an incident. To identify risk groups of occupational incidents and the factors associated with them, statistical analysis of workers' compensation claims data is performed using latent class clustering, for the segmentation of 1031 severe occupational incidents in agribusiness industries in the Midwest region of the United States between 2008-2016. In this study, severe incidents are those with workers' compensation costs equal to or greater than $100,000 (USD). Based on the latent class clustering results, three risk groups are identified with injury nature as the most statistically distinctive classifier. The highest cost injuries include strain, tear, fracture, contusion, amputation, laceration, burn, concussion, and crushing. The most prevalent and statistically significant injury type is permanent partial disability. The study introduces a novel application of latent class clustering in the segmentation of high severity occupational incidents. The analytical approach and results of this study will aid safety practitioners in identifying occupational risk groups and analyzing injury patterns, and inform safety intervention plans to avoid the occurrence of similar incidents in agribusiness industries.	[Kakhki, Fatemeh Davoudi] San Jose State Univ, Dept Technol, San Jose, CA 95192 USA; [Freeman, Steven A.; Mosher, Gretchen A.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA		Kakhki, FD (corresponding author), San Jose State Univ, Dept Technol, San Jose, CA 95192 USA.	Fatemeh.davoudi@sjsu.edu	Kakhki, Fatemeh Davoudi/M-7901-2019	Kakhki, Fatemeh Davoudi/0000-0001-8088-7948			Adanu EK, 2018, ACCIDENT ANAL PREV, V113, P187, DOI 10.1016/j.aap.2018.01.035; Bevilacqua M, 2008, ACCIDENT ANAL PREV, V40, P1468, DOI 10.1016/j.aap.2008.03.012; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chang DS, 2014, SAFETY SCI, V68, P231, DOI 10.1016/j.ssci.2014.04.005; Chi S, 2013, INT J PROJ MANAG, V31, P1027, DOI 10.1016/j.ijproman.2012.12.004; de Ona J, 2013, ACCIDENT ANAL PREV, V51, P1, DOI 10.1016/j.aap.2012.10.016; Drury CG, 2015, ERGONOMICS, V58, P659, DOI 10.1080/00140139.2015.1025106; Eluru N, 2012, ACCIDENT ANAL PREV, V47, P119, DOI 10.1016/j.aap.2012.01.027; EMANUELE CF, 2017, J ERGON, V7, P1000, DOI DOI 10.4172/2165-7556.1000E164; Field WE, 2014, J AGRIC SAF HEALTH, V20, P147, DOI 10.13031/jash.20.9989; Fop M, 2017, ANN APPL STAT, V11, P2080, DOI 10.1214/17-AOAS1061; Green-McKenzie J., 2004, CLIN OCCUP ENV MED, DOI [10.1016/j.coem.2004.02.012, DOI 10.1016/J.COEM.2004.02.012]; Hastie T., 2009, ELEMENTS STAT; Hola B, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9091878; Kang YS, 2017, TRANSPORT RES REC, P58, DOI 10.3141/2608-07; Kaplan S, 2013, TRAFFIC INJ PREV, V14, P725, DOI 10.1080/15389588.2012.759654; Karwowski W, 2005, ERGONOMICS, V48, P436, DOI 10.1080/00140130400029167; Khan MMA, 2006, INT J OCCUP SAF ERGO, V12, P327, DOI 10.1080/10803548.2006.11076693; Kim, 2016, J ERGON, V6, DOI [10.4172/2165-7556.1000e153, DOI 10.4172/2165-7556.1000E153]; Kumar Sachin, 2016, Journal of Big Data, V3, DOI 10.1186/s40537-016-0044-5; Larsen FB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169426; Occhionero V, 2017, ERGONOMICS, V60, P366, DOI 10.1080/00140139.2016.1176257; Polachek IS, 2018, PSYCHIAT RES, V262, P452, DOI 10.1016/j.psychres.2017.09.023; Prati G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171484; Robert K, 2015, SAFETY SCI, V72, P319, DOI 10.1016/j.ssci.2014.10.004; Sameen MI, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7060476; Sarkar S., 2017, IND SAFETY MANAGEMEN; Sasidharan L, 2015, ACCIDENT ANAL PREV, V85, P219, DOI 10.1016/j.aap.2015.09.020; Schreiber JB, 2017, RES SOC ADMIN PHARM, V13, P1196, DOI 10.1016/j.sapharm.2016.11.011; Shafique M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9102069; Sugama A, 2015, PROCEDIA MANUF, V3, P6632, DOI 10.1016/j.promfg.2015.11.003; Vermunt J.K., 2009, APPL LATENT CLASS AN; Virtanen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143184; Yasmin S, 2016, ACCIDENT ANAL PREV, V95, P157, DOI 10.1016/j.aap.2016.07.015; Yasmin S, 2014, ANAL METHODS ACCID R, V1, P23, DOI 10.1016/j.amar.2013.10.002; Zhang NL, 2004, J MACH LEARN RES, V5, P697	36	5	5	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3417		APPL SCI-BASEL	Appl. Sci.-Basel	SEP	2019	9	18							3641	10.3390/app9183641			13	Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Materials Science; Physics	JC2OB	WOS:000489115200002		Green Published, gold			2022-02-06	
J	Kendall, S; Lighton, S; Sherwood, J; Baldry, E; Sullivan, E				Kendall, Sacha; Lighton, Stacey; Sherwood, Juanita; Baldry, Eileen; Sullivan, Elizabeth			Holistic Conceptualizations of Health by Incarcerated Aboriginal Women in New South Wales, Australia	QUALITATIVE HEALTH RESEARCH			English	Article						prisoners; prison; determinants of health; women's health; inequality; community and public health; trauma; mothers; culture; cultural competence; marginalized or vulnerable populations; qualitative; Australia; in-depth interviews	STRAIT ISLANDER PEOPLE; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; INDIGENOUS WOMEN; SUBSTANCE USE; LIFE-COURSE; PRISON; PREVALENCE; VICTIMIZATION; DISADVANTAGE	While there has been extensive research on the health and social and emotional well-being (SEWB) of Aboriginal women in prison, there are few qualitative studies where incarcerated Aboriginal women have been directly asked about their health, SEWB, and health care experiences. Using an Indigenous research methodology and SEWB framework, this article presents the findings of 43 interviews with incarcerated Aboriginal women in New South Wales, Australia. Drawing on the interviews, we found that Aboriginal women have holistic conceptualizations of their health and SEWB that intersect with the SEWB of family and community. Women experience clusters of health problems that intersect with intergenerational trauma, perpetuated and compounded by ongoing colonial trauma including removal of children. Women are pro-active about their health but encounter numerous challenges in accessing appropriate health care. These rarely explored perspectives can inform a reframing of health and social support needs of incarcerated Aboriginal women establishing pathways for healing.	[Kendall, Sacha] Univ Technol Sydney, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Lighton, Stacey] Univ Technol Sydney, Fac Hlth Publ Hlth, Sydney, NSW, Australia; [Sullivan, Elizabeth] Univ Technol Sydney, Sydney, NSW, Australia; [Sherwood, Juanita] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Baldry, Eileen] Univ New South Wales Sydney, Sydney, NSW, Australia; [Sullivan, Elizabeth] Univ Newcastle, Callaghan, NSW, Australia		Sullivan, E (corresponding author), Univ Newcastle, Fac Hlth & Med, 130 Univ Dr, Callaghan, NSW 2308, Australia.	E.Sullivan@newcastle.edu.au		Baldry, Eileen/0000-0001-5599-5592	National Health and Medical Research Council AustraliaNational Health and Medical Research Council of Australia [630653]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a National Health and Medical Research Council Australia project grant (Grant Number 630653).	Abbott P, 2018, AUST J RURAL HEALTH, V26, P6, DOI 10.1111/ajr.12396; Aday RH, 2014, WOMEN CRIM JUSTICE, V24, P341, DOI 10.1080/08974454.2014.909758; Anthony T, 2013, INDIGENOUS PEOPLE, CRIME AND PUNISHMENT, P1, DOI 10.1109/TCIAIG.2013.2295372; Atkinson J., 2014, WORKING TOGETHER ABO, Ved., P289; *AUSTR BUR STAT, 2017, PRIS AUSTR 2017; Australian Bureau of Statistic, 2013, EST AB TORR STRAIT I; Australian Bureau of Statistics, 2018, CORR SERV AUSTR; Australian Bureau of Statistics, 2012, PRIS AUSTR 2012 MED; Australian Institute of Health and Welfare, 2016, YOUNG PEOPL CHILD PR; Australian Institute of Health and Welfare, 2012, MENT HLTH PRIS ENTR; Baldry, 2016, INDIGENOUS LAW B, V8, P10; Baldry E., 2008, ABORIGINAL WOMEN DEP; BALDRY E, 2010, CURR ISS CRIM JUSTIC, V22, P253, DOI DOI 10.1080/10345329.2010.12035885; Baldry E., 2017, LAW POVERTY 40 YEARS, P103; Baldry E, 2014, AUST NZ J CRIMINOL, V47, P276, DOI 10.1177/0004865813503351; Baldry Eileen, 2013, WOMEN EXITING PRISON, P98; Balfour G, 2013, INT REV VICT, V19, P85, DOI 10.1177/0269758012447213; Barrett EL, 2014, ADDICT BEHAV, V39, P1075, DOI 10.1016/j.addbeh.2014.03.003; Bartels L, 2012, QUT LAW REV, V12, P1, DOI 10.5204/qutlr.v12i2.487; Bastos JL, 2018, SOC SCI MED, V199, P209, DOI 10.1016/j.socscimed.2017.05.010; Berger M, 2015, STRESS, V18, P1, DOI 10.3109/10253890.2014.989204; Bessarab D., 2010, INT J CRIT INDIG STU, V3, P37; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; BLAGG H, 2008, CRIME ABORIGINALITY; Bowleg L, 2012, AM J PUBLIC HEALTH, V102, P1267, DOI 10.2105/AJPH.2012.300750; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown A, 2012, COMMONW J LOCAL GOV, P2, DOI 10.5130/cjlg.v0i10.2685; Browne-Yung K, 2013, SOC SCI MED, V97, P20, DOI 10.1016/j.socscimed.2013.08.002; Butler T, 2011, NATL PRISON ENTRANTS; Butler T, 2007, AUST NZ J PSYCHIAT, V41, P429, DOI 10.1080/00048670701261210; Calma T, 2017, AUST PSYCHOL, V52, P255, DOI 10.1111/ap.12299; Carlton B, 2014, HOWARD J CRIM JUSTIC, V53, P270, DOI DOI 10.1111/H0J0.12066; Charmaz K., 2014, CONSTRUCTING GROUNDE, V2nd edition; Coker AL, 2009, J WOMENS HEALTH, V18, P1179, DOI 10.1089/jwh.2008.1048; Dannefer D, 2003, J GERONTOL B-PSYCHOL, V58, pS327, DOI 10.1093/geronb/58.6.S327; DeHart DD, 2008, VIOLENCE AGAINST WOM, V14, P1362, DOI 10.1177/1077801208327018; Dockery AM, 2010, SOC INDIC RES, V99, P315, DOI 10.1007/s11205-010-9582-y; Douglas N, 2008, INT J PRISON HEALTH, V4, P66, DOI 10.1080/17449200802038256; Dowell Caitlin McMillen, 2018, Health Justice, V6, P2, DOI 10.1186/s40352-018-0060-y; Dudgeon P., 2014, WORKING TOGETHER ABO, Ved., P3; Dupre ME, 2008, SOC SCI RES, V37, P1253, DOI 10.1016/j.ssresearch.2008.05.007; Emerson AM, 2018, QUAL HEALTH RES, V28, P873, DOI 10.1177/1049732318758634; Ferraro KF, 2016, AM SOCIOL REV, V81, P107, DOI 10.1177/0003122415619617; Forsyth SJ, 2014, ADDICTION, V109, P1676, DOI 10.1111/add.12646; Foster H, 2007, SOC PROBL, V54, P399, DOI 10.1525/sp.2007.54.4.399; Fredericks B., 2011, ALAR ACTION LEARNING, V17, P12; Gisev N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-920; Goodman A, 2017, SOC SCI MED, V178, P87, DOI 10.1016/j.socscimed.2017.01.053; Goulding D., 2006, BREAKING CYCLE TRAIN; Grace J, 2013, AUST INDIG HEALTHINF, V12, P1; Grella CE, 2013, WOMEN CRIM JUSTICE, V23, P63, DOI 10.1080/08974454.2013.743376; Harner H, 2011, JOGNN-J OBST GYN NEO, V40, P469, DOI 10.1111/j.1552-6909.2011.01259.x; Harner HM, 2013, QUAL HEALTH RES, V23, P26, DOI 10.1177/1049732312461452; Harris J, 2015, HOUS CARE SUPPORT, V18, P80, DOI 10.1108/HCS-05-2014-0012; Heffernan E, 2015, J TRAUMA STRESS, V28, P523, DOI 10.1002/jts.22051; Heffernan Edward, 2009, Australas Psychiatry, V17 Suppl 1, pS41, DOI 10.1080/10398560902948696; Heffernan EB, 2012, MED J AUSTRALIA, V197, P37, DOI 10.5694/mja11.11352; Honorato Bronwyn, 2016, Health Justice, V4, P3; Human Rights and Equal Opportunity Commission, 1997, BRING THEM HOM NAT I; Indig D., 2010, 2009 NSW INMATE HLTH; Indig D., 2016, COMORBID SUBSTANCE U; Jones R, 2011, AUSTRALAS PSYCHIATRY, V19, P325, DOI 10.3109/10398562.2011.579613; Kariminia A, 2007, AUST NZ J PUBL HEAL, V31, P366, DOI 10.1111/j.1753-6405.2007.00089.x; Kariminia A, 2012, AUST NZ J PUBL HEAL, V36, P274, DOI 10.1111/j.1753-6405.2012.00844.x; Kelaher, 2012, MENTAL HLTH IMPACTS; Kendall E, 2011, QUAL HEALTH RES, V21, P1719, DOI 10.1177/1049732311418124; Larney S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-14; Lippert AM, 2015, SOCIOL INQ, V85, P343, DOI 10.1111/soin.12080; Lloyd JE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0303-0; Lopes J. L., 2016, INT SCHOLARLY SCI RE, V10, P1908, DOI [10.5281/zenodo.1124706, DOI 10.5281/ZENODO.1124706]; Lynch SM, 2014, PSYCHIAT SERV, V65, P670, DOI 10.1176/appi.ps.201300172; Lynch SM, 2012, FEM CRIMINOL, V7, P381, DOI 10.1177/1557085112439224; MacGillivray P., 2015, AUSTR INDIGENOUS WOM; Marmot M, 2005, STATUS SYNDROME SOCI; Martin RE, 2012, BCMJ, V54, P502; Mccausland, 2015, PREDICTABLE PREVENTA; McCausland R., 2013, INCARCERATED MOTHERS, P121; McGlue H., 2016, PRACTICE NZ CORRECTI, V4; Mckendrick J, 2017, TLS-TIMES LIT SUPPL, P20; National Aboriginal Health Strategy Working Party, 1989, NAT AB HLTH STRAT NAT AB HLTH STRAT; National Health and Medical Research Council, 2018, KEEP RES TRACK; New South Wales Bureau of Crime Statistics and Research, 2017, Q UPD MARCH 2017; New South Wales Government Family and Community Services, 2018, Q REP SERV CHILDR YO; New South Wales Government Inspector of Custodial Services, 2015, FULL HOUS GROWTH INM; New South Wales Government Justice Health & Forensic Mental Health Network, 2017, NETW PAT HLTH SURV A; New South Wales Ministry of Health, 2018, NSW CLIN GUID TREATM; Ogloff J.R., 2013, KOORI PRISONER MENTA; Pais J, 2014, DEMOGRAPHY, V51, P1729, DOI 10.1007/s13524-014-0330-9; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Priest NC, 2011, MED J AUSTRALIA, V194, P546; Rigney L., 1999, WICAZO SA REV, V14, P109, DOI [10.2307/1409555, DOI 10.2307/1409555]; Royal Commission into Aboriginal Deaths in Custody, 1991, FIN REP; Rynne J, 2015, INT J CRIME JUSTICE, V4, P96; Sapers H., 2015, ANN REPORT OFFICE CO; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Segrave M., 2010, CURRENT ISSUES CRIMI, V22, P297; Shepherd SM, 2016, HLTH JUSTICE, DOI 10.1186/s40352-016-0045-7; Shepherd SM, 2018, INT J FORENSIC MENT, V17, P111, DOI 10.1080/14999013.2018.1431338; Shepherd SM, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4603-2; Sherwood J, 2015, ALTERNATIVE, V11, P177, DOI 10.1177/117718011501100207; Sherwood J, 2013, CONTEMP NURSE, V46, P83, DOI 10.5172/conu.2013.46.1.83; Sherwood J, 2013, CONTEMP NURSE, V46, P28, DOI 10.5172/conu.2013.46.1.28; Social Health Reference Group for National Aboriginal and Torres Strait Islander Health Council and National Mental Health Working Group, 2004, SOC EM WELL BEING FR; Sullivan EA, 2019, AUST NZ J PUBL HEAL, V43, P241, DOI 10.1111/1753-6405.12892; Walker M, 2014, HEALTH CARE WOMEN IN, V35, P1216, DOI 10.1080/07399332.2013.815754; Walker R., 2014, WORKING TOGETHER ABO, P113; Walmsley R., 2016, WORLD PRISON POPULAT, V11th; Walmsley R., 2017, WORLD FEMALE IMPRISO; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697; Wilson M, 2017, SAGE OPEN, V7, DOI 10.1177/2158244016686814; Wilson M, 2014, AUST ABORIG STUD, P28; Yeo S.S., 2003, CHILD ABUSE REV J BR, V12, P292, DOI DOI 10.1002/CAR.817; [No title captured]; [No title captured]; [No title captured]	115	5	5	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323	1552-7557		QUAL HEALTH RES	Qual. Health Res.	SEP	2019	29	11					1549	1565		10.1177/1049732319846162			17	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	IN3WV	WOS:000478608000002	31079548				2022-02-06	
J	Li, FY; Wang, XD; Zhang, ZJ; Gao, PF; Zhang, XL				Li, Fayin; Wang, Xiaodong; Zhang, Zhijie; Gao, Pengfei; Zhang, Xianlong			Breviscapine provides a neuroprotective effect after traumatic brain injury by modulating the Nrf2 signaling pathway	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						breviscapine; neuronal apoptosis; nuclear factor erythroid 2-related factor 2; traumatic brain injury	RATS; INHIBITION	Breviscapine (BVP) has been widely used in the treatment of several systemic diseases, including those of the cardiovascular and cerebrovascular systems. But, few studies have looked at the neuroprotective effects of BVP and its potential effect in treating traumatic brain injury (TBI). The present study investigated the neuroprotective effect of BVP following TBI and illuminated the underlying mechanism. The weight drop-induced closed diffuse traumatic brain injury method was used to induce TBI in rats. BVP was injected intraperitoneally 30 minutes after TBI. Neurologic scores were performed to measure behavioral outcomes. Nissl staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays were performed on histopathologic tissue sections to evaluate neuronal apoptosis. The nuclear factor erythroid 2-related factor 2 (Nrf2) and its related downstream proteins, including heme oxygenase-1 (HO-1) and quinine oxidoreductase-1 (NQO1) were detected with Western blots. BVP treatment alleviated or attenuated TBI-induced neuron cell apoptosis and improved neurobehavioral functions through the upregulated expression of Nrf2 and its related downstream proteins. This study, using the drug, BVP, we present new mechanisms responsible for neuronal apoptosis in TBI with possible involvement of the Nrf2 pathway.	[Li, Fayin; Zhang, Zhijie; Gao, Pengfei; Zhang, Xianlong] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Anesthesiol, 6 Beijing Rd W, Huaian 223002, Jiangsu, Peoples R China; [Wang, Xiaodong] Nanjing Med Univ, Dept Neurosurg, Affiliated Huaian 1 Peoples Hosp, Huaian, Jiangsu, Peoples R China		Zhang, XL (corresponding author), Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Anesthesiol, 6 Beijing Rd W, Huaian 223002, Jiangsu, Peoples R China.	mzkzhang@126.com					Bao Z, 2018, EXP THER MED, V15, P3582, DOI 10.3892/etm.2018.5834; Bi W, 2018, FOOD FUNCT, V9, P2809, DOI 10.1039/c8fo00054a; Gao F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00357; Gao JL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00289; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; He M, 2012, ACTA PHARMACOL SIN, V33, P606, DOI 10.1038/aps.2012.6; Hu Y, 2018, ENVIRON TOXICOL PHAR, V62, P79, DOI 10.1016/j.etap.2018.05.012; Jiang CS, 2018, J ENZYM INHIB MED CH, V33, P833, DOI 10.1080/14756366.2018.1461856; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Ju AX, 2017, DRUG RES, V67, P271, DOI 10.1055/s-0042-118170; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Lin YZ, 2016, J SURG RES, V203, P268, DOI 10.1016/j.jss.2016.02.013; Lou XY, 2015, ASIAN PAC J TROP MED, V8, P853, DOI 10.1016/j.apjtm.2015.09.017; Piechota-Polanczyk A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2028936; Silva MD, 2018, MOLECULES, V23, DOI 10.3390/molecules23071803; Sun X, 2018, ENVIRON TOXICOL PHAR, V60, P110, DOI 10.1016/j.etap.2018.04.016; Wang J, 2015, PHARMAZIE, V70, P593, DOI 10.1691/ph.2015.5552; Wang M, 2018, MED SCI MONITOR, V24, P4602, DOI 10.12659/MSM.906438; Zeng J, 2017, J BIOSCIENCES, V42, P121, DOI 10.1007/s12038-017-9670-0; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhao XJ, 2018, REDOX BIOL, V18, P124, DOI 10.1016/j.redox.2018.07.002	23	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	SEP	2019	120	9					14899	14907		10.1002/jcb.28751			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	IK7WN	WOS:000476804200066	31042302				2022-02-06	
J	Liu, XC; Li, HT; Ma, H; Xu, CH; Yang, B; Dai, M; Dong, XZ; Fu, F				Liu, Xuechao; Li, Haoting; Ma, Hang; Xu, Canhua; Yang, Bin; Dai, Meng; Dong, Xiuzhen; Fu, Feng			An iterative damped least-squares algorithm for simultaneously monitoring the development of hemorrhagic and secondary ischemic lesions in brain injuries	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Electrical impedance tomography; Intracerebral hemorrhage; Secondary ischemia; Reconstruction algorithm	ELECTRICAL-IMPEDANCE TOMOGRAPHY; INTRAVENTRICULAR HEMORRHAGE; INTRACEREBRAL HEMORRHAGE; RECONSTRUCTION; EIT; STROKE; MODEL	Electrical impedance tomography (EIT) is a non-invasive and real-time imaging method that has the potential to be used for monitoring intracerebral hemorrhage (ICH). Recent studies have proposed that ischemia secondary to ICH occurs simultaneously in the brain. Real-time monitoring of the development of hemorrhage and risk of secondary ischemia is crucial for clinical intervention. However, few studies have explored the performance of EIT monitoring in cases where hemorrhage and secondary ischemia exist. When these lesions get close to each other, or their conductivity and volume changes differ greatly, it becomes challenging for dynamic EIT algorithms to simultaneously reconstruct subtle injuries. To address this, an iterative damped least-squares (IDLS) algorithm is proposed in this study. The quality of the IDLS algorithm was assessed using blur radius and temporal response during computer simulation and a phantom 3D head-shaped model where bidirectional disturbance targets were simulated. The results showed that the IDLS algorithm enhanced contrast and concurrently reconstructed bidirectional disturbance targets in images. Moreover, it showed superior performance in decreasing the blur radius and was time cost-effective. With further improvement, the IDLS algorithm has the potential to be used for monitoring the development of hemorrhage and risk of ischemia secondary to ICH.	[Liu, Xuechao; Li, Haoting; Ma, Hang; Xu, Canhua; Yang, Bin; Dai, Meng; Dong, Xiuzhen; Fu, Feng] Air Force Mil Med Univ, Dept Biomed Engn, Xian, Shaanxi, Peoples R China		Fu, F (corresponding author), Air Force Mil Med Univ, Dept Biomed Engn, Xian, Shaanxi, Peoples R China.	fengfu@fmmu.edu.cn		Yang, Bin/0000-0001-9687-5968; Fu, Feng/0000-0002-4286-5227	National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51837011, 31771073, 61771475]	This study was funded by the National Nature Science Foundation of China (Grant 51837011, 31771073, 61771475).	Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Andrews CM, 2012, NEUROCRIT CARE, V17, P37, DOI 10.1007/s12028-012-9757-2; AVIS NJ, 1994, PHYSIOL MEAS, V15, pA153, DOI 10.1088/0967-3334/15/2A/020; Barber D C, 1988, Clin Phys Physiol Meas, V9 Suppl A, P101, DOI 10.1088/0143-0815/9/4A/017; Boverman G, 2016, PHYSIOL MEAS, V37, P727, DOI 10.1088/0967-3334/37/6/727; Braun F, 2017, IEEE T BIO-MED ENG, V64, P2321, DOI 10.1109/TBME.2017.2659540; Dai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055020; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; Dowrick T, 2016, PHYSIOL MEAS, V37, P765, DOI 10.1088/0967-3334/37/6/765; Dowrick T, 2015, PHYSIOL MEAS, V36, P1273, DOI 10.1088/0967-3334/36/6/1273; Frerichs I, 2017, THORAX, V72, P83, DOI 10.1136/thoraxjnl-2016-208357; Fu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113202; Gregoire SM, 2011, BRAIN, V134, P2376, DOI 10.1093/brain/awr172; Grychtol B, 2013, IEEE ENG MED BIO, P6429, DOI 10.1109/EMBC.2013.6611026; Islam M N, 2014, Mymensingh Med J, V23, P621; Javaherian A, 2013, J VIS COMMUN IMAGE R, V24, P773, DOI 10.1016/j.jvcir.2013.05.003; Kang DW, 2012, NEUROLOGY, V79, P848, DOI 10.1212/WNL.0b013e3182648a79; Kimberly WT, 2009, NEUROLOGY, V72, P1230, DOI 10.1212/01.wnl.0000345666.83318.03; Li HT, 2017, PHYSIOL MEAS, V38, P1776, DOI 10.1088/1361-6579/aa8016; Li YD, 2018, J CARDIOTHOR VASC AN, V32, P2469, DOI 10.1053/j.jvca.2018.05.002; Mamatjan Y, 2013, PHYSIOL MEAS, V34, P1027, DOI 10.1088/0967-3334/34/9/1027; Manwaring PK, 2013, ANESTH ANALG, V117, P866, DOI 10.1213/ANE.0b013e318290c7b7; Markovsky I, 2007, SIGNAL PROCESS, V87, P2283, DOI 10.1016/j.sigpro.2007.04.004; Menon RS, 2012, ANN NEUROL, V71, P199, DOI 10.1002/ana.22668; Menon RS, 2009, STROKE, V40, pE675, DOI 10.1161/STROKEAHA.109.552935; Prabhakaran S, 2012, STROKE, V43, P2258, DOI 10.1161/STROKEAHA.112.655910; Prabhakaran S, 2010, STROKE, V41, P89, DOI 10.1161/STROKEAHA.109.566257; Sadleir RJ, 2009, PHYSIOL MEAS, V30, P63, DOI 10.1088/0967-3334/30/1/005; Shi XT, 2005, P ANN INT IEEE EMBS, P1492, DOI 10.1109/IEMBS.2005.1616714; Shi XT, 2006, PHYSIOL MEAS, V27, P1071, DOI 10.1088/0967-3334/27/11/002; Tang C, 2008, IEEE T BIO-MED ENG, V55, P2286, DOI 10.1109/TBME.2008.923919; Tang T, 2016, PHYSIOL MEAS, V37, P751, DOI 10.1088/0967-3334/37/6/751; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu CH, 2011, PHYSIOL MEAS, V32, P585, DOI 10.1088/0967-3334/32/5/007; Yang L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16111942; YORKEY TJ, 1987, IEEE T BIO-MED ENG, V34, P843, DOI 10.1109/TBME.1987.326032; Zhou Z, 2015, PHYSIOL MEAS, V36, P1193, DOI 10.1088/0967-3334/36/6/1193; Zou Y, 2003, MED ENG PHYS, V25, P79, DOI 10.1016/S1350-4533(02)00194-7	38	5	6	3	13	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	SEP	2019	57	9					1917	1931		10.1007/s11517-019-02003-z			15	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	IS9SN	WOS:000482488300006	31250276				2022-02-06	
J	Marco-Garcia, S; Ferrer-Quintero, M; Usall, J; Ochoa, S; del Cacho, N; Huerta-Ramos, E				Marco-Garcia, Silvia; Ferrer-Quintero, Marta; Usall, Judith; Ochoa, Susana; del Cacho, Nuria; Huerta-Ramos, Elena			Facial emotion recognition in neurologic disorders: a narrative review	REVISTA DE NEUROLOGIA			Spanish	Article						Emotions; Facial expression; Facial recognition; Nervous system diseases; Therapeutic treatment	MILD COGNITIVE IMPAIRMENT; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SOCIAL COGNITION; EXPRESSION RECOGNITION; ALZHEIMERS-DISEASE; INTRANASAL OXYTOCIN; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; WORKING-MEMORY	Facial emotion recognition refers to a person's interpretation of facial features of another to identify a particular emotional state. It is essential in human evolution and encompasses distinct neural networks. Facial emotion recognition is altered in most neurodegenerative diseases, but literature just focus on single neurological pathologies or limited comparison with psychiatric pathologies. It is unknown if a common pattern of affection through pathologies exists or if facial emotion recognition changes according to the underlying pathology. This review discusses its development in healthy population, synthesizes facial emotion recognition studies regarding most common neurological diseases, as well as most relevant findings in neuroimaging and current treatments. Facial emotion recognition, especially negative emotions, is altered in all described neurodegenerative diseases and could constitutes an early marker of cognitive deterioration.	[Marco-Garcia, Silvia; Ferrer-Quintero, Marta; Usall, Judith; Ochoa, Susana; del Cacho, Nuria; Huerta-Ramos, Elena] Parc Sanitari St Joan de Deu, Barcelona, Spain; [Marco-Garcia, Silvia; Ferrer-Quintero, Marta; Usall, Judith; Ochoa, Susana; del Cacho, Nuria; Huerta-Ramos, Elena] Inst Recerca St Joan de Deu, Barcelona, Spain; [Ferrer-Quintero, Marta] Univ Barcelona, Dept Psicol Social & Psicol Cuantitat, Barcelona, Spain; [Ochoa, Susana; del Cacho, Nuria; Huerta-Ramos, Elena] CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain		Huerta-Ramos, E (corresponding author), Parc Sanitari St Joan de Deu, Unitat Recerca, Antoni Pujades 42, E-08830 Sant Boi De Llobregat, Barcelona, Spain.	mehuerta@pssjd.org	Ochoa, "S./E-7362-2015; Ferrer-Quintero, Marta/AAB-7356-2019	Ochoa, "S./0000-0001-6792-1080; Ferrer-Quintero, Marta/0000-0002-7935-9424			Aiello M, 2014, CORTEX, V51, P35, DOI 10.1016/j.cortex.2013.11.003; Albuquerque L, 2014, PARKINSONISM RELAT D, V20, P166, DOI 10.1016/j.parkreldis.2013.10.010; Alonso-Recio L, 2014, J INT NEUROPSYCH SOC, V20, P496, DOI 10.1017/S1355617714000265; Amlerova J, 2014, EPILEPSY BEHAV, V36, P86, DOI 10.1016/j.yebeh.2014.05.001; Garcia-Casal JA, 2017, J ALZHEIMERS DIS, V57, P937, DOI 10.3233/JAD-160940; Asgharpour Mania, 2015, Iran J Psychiatry, V10, P13; Aviezer H, 2009, BRAIN, V132, P1633, DOI 10.1093/brain/awp067; Berneiser J, 2014, MULT SCLER RELAT DIS, V3, P482, DOI 10.1016/j.msard.2014.02.001; Bertoux M, 2015, ALZ DIS ASSOC DIS, V29, P154, DOI 10.1097/WAD.0000000000000023; Bora E, 2017, J GERIATR PSYCH NEUR, V30, P206, DOI 10.1177/0891988717710337; Bora E, 2016, NEUROPSYCHOL REV, V26, P160, DOI 10.1007/s11065-016-9320-6; Bora E, 2016, J GERIATR PSYCH NEUR, V29, P205, DOI 10.1177/0891988716640375; Bora E, 2016, BEHAV BRAIN RES, V297, P131, DOI 10.1016/j.bbr.2015.10.001; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Cawley E, 2017, J PSYCHOPHARMACOL, V31, P1225, DOI 10.1177/0269881117711707; Chaby L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00548; Chronaki G, 2015, BRIT J DEV PSYCHOL, V33, P218, DOI 10.1111/bjdp.12075; Clark US, 2010, NEUROPSYCHOLOGIA, V48, P1901, DOI 10.1016/j.neuropsychologia.2010.03.006; Cotter J, 2016, NEUROLOGY, V87, P1727, DOI 10.1212/WNL.0000000000003236; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Del-Ben CM, 2008, BRAZ J MED BIOL RES, V41, P263, DOI 10.1590/S0100-879X2008000400002; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Ebner NC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00223; Edwards M, 2017, NEUROSCI BIOBEHAV R, V83, P212, DOI 10.1016/j.neubiorev.2017.10.013; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elferink MWO, 2015, TRANSL NEUROSCI, V6, P139, DOI 10.1515/tnsci-2015-0013; Elsherif MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173199; Enrici I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131470; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; Franzmeier N, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00264; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Gaudelus B, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00105; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Guaita A, 2009, ARCH GERONTOL GERIAT, V49, P135, DOI 10.1016/j.archger.2009.09.023; Guo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00559; Hagiya K, 2015, PSYCHIAT CLIN NEUROS, V69, P773, DOI 10.1111/pcn.12329; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; Harry B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00692; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hayes CJ, 2007, NEUROPSYCHOLOGIA, V45, P1135, DOI 10.1016/j.neuropsychologia.2006.10.015; Heck A, 2017, J EXP CHILD PSYCHOL, V153, P155, DOI 10.1016/j.jecp.2016.08.006; Hennenlotter A, 2004, BRAIN, V127, P1446, DOI 10.1093/brain/awh165; Hinojosa JA, 2015, NEUROSCI BIOBEHAV R, V55, P498, DOI 10.1016/j.neubiorev.2015.06.002; Hsu WY, 2015, NEUROBIOL AGING, V36, P2348, DOI 10.1016/j.neurobiolaging.2015.04.016; Kempnich CL, 2017, J INT NEUROPSYCH SOC, V23, P314, DOI 10.1017/S1355617717000145; Krolak-Salmon P, 2006, REV NEUROL-FRANCE, V162, P1037, DOI 10.1016/S0035-3787(06)75116-5; Kumfor F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067457; Lawrence K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00761; Leppanen J, 2017, NEUROSCI BIOBEHAV R, V78, P125, DOI 10.1016/j.neubiorev.2017.04.010; Li YN, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01700; Liao XY, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01110; Lin CY, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0185-5; Lindner JL, 2006, J AUTISM DEV DISORD, V36, P769, DOI 10.1007/s10803-006-0105-2; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Marneweck M, 2014, J NEUROL SCI, V346, P149, DOI 10.1016/j.jns.2014.08.014; Martinez-Corral M, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/930627; McCade D, 2013, PSYCHOL AGING, V28, P840, DOI 10.1037/a0033077; Mondillon L, 2012, NEUROPSYCHOLOGIA, V50, P2869, DOI 10.1016/j.neuropsychologia.2012.08.016; Monti G, 2015, NEUROSCI BIOBEHAV R, V55, P280, DOI 10.1016/j.neubiorev.2015.05.009; Oh SI, 2016, J CLIN NEUROL, V12, P295, DOI 10.3988/jcn.2016.12.3.295; Oliver LD, 2014, NEUROPSYCHOLOGIA, V60, P84, DOI 10.1016/j.neuropsychologia.2014.05.020; Osorio FL, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00529; Ostos MW, 2011, EUR NEUROL, V65, P361, DOI 10.1159/000327979; Park S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00389; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Phillips LH, 2011, NEUROPSYCHOLOGY, V25, P131, DOI 10.1037/a0020752; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; Pietschnig J, 2016, INT PSYCHOGERIATR, V28, P477, DOI 10.1017/S1041610215001520; Raimo S, 2017, NEUROPSYCHOLOGY, V31, P811, DOI 10.1037/neu0000372; Ricciardi L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169110; Rodger H, 2015, DEVELOPMENTAL SCI, V18, P926, DOI 10.1111/desc.12281; Rodrigo-Ruiz D, 2017, REV NEUROLOGIA, V65, P145, DOI 10.33588/rn.6504.2017041; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Russell TA, 2006, BRIT J CLIN PSYCHOL, V45, P579, DOI 10.1348/014466505X90866; Russo-Ponsaran NM, 2016, J NONVERBAL BEHAV, V40, P13, DOI 10.1007/s10919-015-0217-5; Safar K, 2017, DEV PSYCHOBIOL, V59, P507, DOI 10.1002/dev.21515; Sapey-Triomphe LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143586; Shahrestani S, 2013, NEUROPSYCHOPHARMACOL, V38, P1929, DOI 10.1038/npp.2013.86; Sprengelmeyer R, 2003, NEUROPSYCHOLOGIA, V41, P1047, DOI 10.1016/S0028-3932(02)00295-6; Thieben MJ, 2002, BRAIN, V125, P1815, DOI 10.1093/brain/awf179; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Torres B, 2015, ARQ NEURO-PSIQUIAT, V73, P383, DOI 10.1590/0004-282X20150009; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; van Asselen M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00031; Vianin P., 2012, J THERAPIE COMPORTEM, V22, P97; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang HL, 2017, NEUROPSYCHOLOGIA, V99, P306, DOI 10.1016/j.neuropsychologia.2017.03.017; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Wolwer W, 2014, BRAIN STIMUL, V7, P559, DOI 10.1016/j.brs.2014.04.011; Yang CQ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0618-3; Zhang H, 2016, NEUROIMAGE, V130, P77, DOI 10.1016/j.neuroimage.2016.01.045; Zhao K, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00761; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b	98	5	5	5	21	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	SEP 1	2019	69	5					207	219		10.33588/rn.6905.2019047			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IX6VS	WOS:000485823700004	31364150				2022-02-06	
J	Molteni, E; Pagani, E; Strazzer, S; Arrigoni, F; Beretta, E; Boffa, G; Galbiati, S; Filippi, M; Rocca, MA				Molteni, E.; Pagani, E.; Strazzer, S.; Arrigoni, F.; Beretta, E.; Boffa, G.; Galbiati, S.; Filippi, M.; Rocca, M. A.			Fronto-temporal vulnerability to disconnection in paediatric moderate and severe traumatic brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						diffusion tensor imaging; FIM scale; neurobehavioral sequelae; paediatric brain injury; traumatic brain injury	BEHAVIOR RELATIONSHIPS; CORPUS-CALLOSUM; TEMPORAL STEM; VOLUME LOSS; WHITE; CHILDREN; CONNECTIVITY; TRAJECTORIES; TRACTOGRAPHY; HIPPOCAMPAL	Background In patients with moderate and severe paediatric traumatic brain injury (TBI), we investigated the presence and severity of white matter (WM) tract damage, cortical lobar and deep grey matter (GM) atrophies, their interplay and their correlation with outcome rating scales. Methods Diffusion tensor (DT) and 3D T1-weighted MRI scans were obtained from 22 TBI children (13 boys; mean age at insult = 11.6 years; 72.7% in chronic condition) and 31 age-matched healthy children. Patients were tested with outcome rating scales and the Wechsler Intelligence Scale for Children (WISC). DT MRI indices were obtained from several supra- and infra-tentorial WM tracts. Cortical lobar and deep GM volumes were derived. Comparisons between patients and controls, and between patients in acute (<6 months from the event) vs. chronic (>= 6 months) condition were performed. Results Patients showed a widespread pattern of decreased WM FA and GM atrophy. Compared to acute, chronic patients showed severer atrophy in the right frontal lobe and reduced FA in the left inferior longitudinal fasciculus and corpus callosum (CC). Decreased axial diffusivity was observed in acute patients versus controls in the inferior fronto-occipital fasciculus and CC. Chronic patients showed increased axial diffusivity in the same structures. Uncinate fasciculus DT MRI abnormalities correlated with atrophy in the frontal and temporal lobes. Hippocampal atrophy correlated with reduced WISC scores, whereas putamen atrophy correlated with lower functional independence measure scores. Conclusions The study isolated a distributed fronto-temporal network of structures particularly vulnerable to axonal damage and atrophy that may contribute to cognitive deficits following TBI.	[Molteni, E.; Strazzer, S.; Arrigoni, F.; Beretta, E.; Galbiati, S.] Sci Inst IRCCS Eugenio Medea, Acquired Brain Injury Unit, Lecce, Italy; [Pagani, E.; Boffa, G.; Filippi, M.; Rocca, M. A.] IRCCS San Raffaele Sci Inst, Inst Expt Neurol, Div Neurosci, Neuroimaging Res Unit, Milan, Italy; [Filippi, M.] Univ Vita Salute San Raffaele, Milan, Italy		Rocca, MA (corresponding author), Ist Sci San Raffaele, Neuroimaging Res Unit, Via Olgettina 60, I-20132 Milan, Italy.	rocca.mara@hsr.it	Strazzer, Sandra/AAH-5712-2019; Molteni, Erika/P-4564-2016; ARRIGONI, FILIPPO/G-5828-2011; Beretta, Elena/AAH-5369-2019; Pagani, Elisabetta/X-9219-2019; Filippi, Massimo/K-1755-2018; Galbiati, Sara/AAA-7115-2020; Rocca, Maria Assunta/K-1619-2018	Strazzer, Sandra/0000-0001-8414-6565; Molteni, Erika/0000-0001-7773-8140; ARRIGONI, FILIPPO/0000-0002-5508-1149; Beretta, Elena/0000-0002-8036-7624; Pagani, Elisabetta/0000-0002-1850-1175; Filippi, Massimo/0000-0002-5485-0479; Galbiati, Sara/0000-0001-6810-359X; Rocca, Maria Assunta/0000-0003-2358-4320; BOFFA, GIACOMO/0000-0003-2220-9422			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Aubert-Broche B, 2013, NEUROIMAGE, V82, P393, DOI 10.1016/j.neuroimage.2013.05.065; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Bisecco A, 2015, HUM BRAIN MAPP, V36, P2809, DOI 10.1002/hbm.22809; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dennis EL, 2018, NEUROSCIENTIST, V24, P652, DOI 10.1177/1073858418759489; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Gooijers J, 2016, NEUROREHAB NEURAL RE, V30, P603, DOI 10.1177/1545968315613448; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Konstantinou N, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00029; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Molteni E, 2017, DEV MED CHILD NEUROL, V59, P199, DOI 10.1111/dmcn.13332; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	35	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	SEP	2019	26	9					1183	1190		10.1111/ene.13963			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IN5WZ	WOS:000478748700009	30964589				2022-02-06	
J	Rucker, JC; Buettner-Ennever, JA; Straumann, D; Cohen, B				Rucker, Janet C.; Buettner-Ennever, Jean A.; Straumann, Dominik; Cohen, Bernard			Case Studies in Neuroscience: Instability of the visual near triad in traumatic brain injury-evidence for a putative convergence integrator	JOURNAL OF NEUROPHYSIOLOGY			English	Article						concussion; convergence; near response; pretectum; superior colliculus	MESENCEPHALIC RETICULAR-FORMATION; MONKEY SUPERIOR COLLICULUS; VERGENCE EYE-MOVEMENTS; MEDIAL RECTUS MOTONEURONS; PUPILLARY LIGHT REFLEX; NEURAL-CONTROL; OPTIC TRACT; BINOCULAR COORDINATION; FORMATION PROJECTION; HORIZONTAL SACCADES	Deficits of convergence and accommodation are common following traumatic brain injury, including mild traumatic brain injury, although the mechanism and localization of these deficits have been unclear and supranuclear control of the near-vision response has been incompletely understood. We describe a patient who developed profound instability of the near-vision response with inability to maintain convergence and accommodation following mild traumatic brain injury, who was identified to have a structural lesion on brain MRI in the pulvinar of the caudal thalamus, the pretectum, and the rostral superior colliculus. We discuss the potential relationship between posttraumatic clinical near-vision response deficits and the MRI lesion in this patient. We further propose that the MRI lesion location, specifically the rostral superior colliculus, participates in neural integration for convergence holding, given its proven anatomic connections with the central mesencephalic reticular formation and C-group medial rectus motoneurons in the oculomotor nucleus, which project to extraocular muscle nontwitch fibers specialized for fatigue-resistant, slow, tonic activity such as vergence holding. NEW & NOTEWORTHY Supranuclear control of the near-vision response has been incompletely understood to date. We propose, based on clinical and anatomic evidence, functional pathways for vergence that participate in the generation of the near triad, "slow vergence," and vergence holding.	[Rucker, Janet C.] NYU, Sch Med, Dept Neurol & Ophthalmol, New York, NY USA; [Buettner-Ennever, Jean A.] Ludwig Maximilians Univ Munchen, Dept Anat & Cell Biol 1, Munich, Germany; [Straumann, Dominik] Univ Zurich, Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Straumann, Dominik] Swiss Concuss Ctr, Zurich, Switzerland; [Cohen, Bernard] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Rucker, JC (corresponding author), Dept Neurol, 222 E 41st St,14th Fl, New York, NY 10016 USA.	janet.rucker@nyulangone.org		Rucker, Janet/0000-0002-0397-0999			Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; BAKER RS, 1991, SURV OPHTHALMOL, V35, P245, DOI 10.1016/0039-6257(91)90046-I; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bohlen MO, 2017, J COMP NEUROL, V525, P2000, DOI 10.1002/cne.24187; Bohlen MO, 2016, BRAIN STRUCT FUNCT, V221, P2209, DOI 10.1007/s00429-015-1039-2; Buettner-Ennever JA, 2013, OLZSEWSKI BAXTERS CY; Buttner-Ennever JA, 2006, PROG BRAIN RES, V151, P95, DOI 10.1016/S0079-6123(05)51004-5; Buttner-Ennever JA, 1999, J COMP NEUROL, V413, P55, DOI 10.1002/(SICI)1096-9861(19991011)413:1<55::AID-CNE3>3.0.CO;2-K; ButtnerEnnever JA, 1996, J COMP NEUROL, V366, P348, DOI 10.1002/(SICI)1096-9861(19960304)366:2<348::AID-CNE12>3.0.CO;2-L; Chaturvedi V, 2000, EXP BRAIN RES, V132, P72, DOI 10.1007/s002219900221; Chen BZ, 2000, EXP BRAIN RES, V131, P10, DOI 10.1007/s002219900280; Clarke RJ, 2003, ANAT EMBRYOL, V207, P149, DOI 10.1007/s00429-003-0339-0; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; COHEN B, 1984, EXP BRAIN RES, V57, P167; COHEN B, 1992, ANN NY ACAD SCI, V656, P277; COHEN B, 1986, PROG BRAIN RES, V64, P243; COHEN B, 1985, EXP BRAIN RES, V57, P605; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; COWEY A, 1984, EXP BRAIN RES, V56, P79; Cullen KE, 2011, EUR J NEUROSCI, V33, P2147, DOI 10.1111/j.1460-9568.2011.07692.x; Distler C, 2002, J COMP NEUROL, V444, P144, DOI 10.1002/cne.10127; Duane A, 1922, Trans Am Ophthalmol Soc, V20, P132; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Fleuriet J, 2016, INVEST OPHTH VIS SCI, V57, P3168, DOI 10.1167/iovs.16-19488; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; GAMLIN PDR, 1992, J NEUROPHYSIOL, V67, P64, DOI 10.1152/jn.1992.67.1.64; GAMLIN PDR, 1989, J NEUROPHYSIOL, V62, P70, DOI 10.1152/jn.1989.62.1.70; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Giolli RA, 2006, PROG BRAIN RES, V151, P407, DOI 10.1016/S0079-6123(05)51013-6; Goffart L, 2012, J NEUROSCI, V32, P10627, DOI 10.1523/JNEUROSCI.0696-12.2012; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Hafed ZM, 2008, J NEUROSCI, V28, P8124, DOI 10.1523/JNEUROSCI.1317-08.2008; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Horn AK, 2008, J COMP NEUROL, V507, P1317, DOI 10.1002/cne.21598; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; HUTCHINS B, 1985, J COMP NEUROL, V232, P425, DOI 10.1002/cne.902320402; Jiang H., 1996, SOC NEUROSCIENCE SOC NEUROSCIENCE, V22, P662; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; King WM, 2011, EUR J NEUROSCI, V33, P2139, DOI 10.1111/j.1460-9568.2011.07695.x; King WM, 2000, ANAT REC, V261, P153, DOI 10.1002/1097-0185(20000815)261:4<153::AID-AR4>3.0.CO;2-4; KOWAL L, 1992, AUST NZ J OPHTHALMOL, V20, P35, DOI 10.1111/j.1442-9071.1992.tb00701.x; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; LAWLER KA, 1986, EXP BRAIN RES, V63, P402; LEPORE FE, 1995, ARCH NEUROL-CHICAGO, V52, P924, DOI 10.1001/archneur.1995.00540330106022; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; May PJ, 2018, INVEST OPHTH VIS SCI, V59, P1486, DOI 10.1167/iovs.17-23737; May PJ, 2016, BRAIN STRUCT FUNCT, V221, P4073, DOI 10.1007/s00429-015-1147-z; May PJ, 2008, PROG BRAIN RES, V171, P97, DOI 10.1016/S0079-6123(08)00613-4; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mays LE, 1995, CURR OPIN NEUROBIOL, V5, P763, DOI 10.1016/0959-4388(95)80104-9; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; MAYS LE, 1984, J NEUROPHYSIOL, V52, P743, DOI 10.1152/jn.1984.52.4.743; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; MOSCHOVAKIS AK, 1988, J NEUROPHYSIOL, V60, P263, DOI 10.1152/jn.1988.60.1.263; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; MYERS GA, 1990, OPHTHAL PHYSL OPT, V10, P175, DOI 10.1111/j.1475-1313.1990.tb00972.x; Ohtsuka K, 2002, AM J OPHTHALMOL, V133, P425, DOI 10.1016/S0002-9394(01)01356-3; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; Pong M, 2000, J NEUROPHYSIOL, V84, P964, DOI 10.1152/jn.2000.84.2.964; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P339, DOI 10.1113/jphysiol.1961.sp006812; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P361, DOI 10.1113/jphysiol.1961.sp006813; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Rose SC, 2017, BRAIN INJURY, V31, P260, DOI 10.1080/02699052.2016.1235285; SCHIFF D, 1988, EXP BRAIN RES, V70, P1; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; SCUDDER CA, 1992, J NEUROPHYSIOL, V68, P244, DOI 10.1152/jn.1992.68.1.244; Simpson JI, 1988, NEUROANATOMY OCULOMO, P333; Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1; Stewart CM, 2005, J NEUROPHYSIOL, V94, P2653, DOI 10.1152/jn.00739.2004; Sun WS, 2014, J COMP NEUROL, V522, P3960, DOI 10.1002/cne.23602; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; Sylvestre PA, 2002, J NEUROPHYSIOL, V88, P3452, DOI 10.1152/jn.00331.2002; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Ugolini G, 2006, J COMP NEUROL, V498, P762, DOI 10.1002/cne.21092; Upadhyaya S, 2017, J NEUROPHYSIOL, V117, P1281, DOI 10.1152/jn.00437.2016; Van Horn MR, 2013, J NEUROSCI, V33, P7274, DOI 10.1523/JNEUROSCI.2268-12.2013; Van Stavern GP, 2001, J NEURO-OPHTHALMOL, V21, P112, DOI 10.1097/00041327-200106000-00012; Waitzman DM, 2008, PROG BRAIN RES, V171, P143, DOI 10.1016/S0079-6123(08)00619-5; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018; Wang CA, 2012, J NEUROSCI, V32, P3629, DOI 10.1523/JNEUROSCI.5512-11.2012; Wasicky R, 2004, J COMP NEUROL, V479, P117, DOI 10.1002/cne.20296; Watanabe S, 2001, J VESTIBUL RES-EQUIL, V11, P73; Yakushin SB, 2000, EXP BRAIN RES, V131, P416, DOI 10.1007/s002219900303; Yakushin SB, 2000, EXP BRAIN RES, V131, P433, DOI 10.1007/s002219900302; Zhang HY, 1996, EXP BRAIN RES, V112, P158; ZHANG Y, 1992, J NEUROPHYSIOL, V67, P944, DOI 10.1152/jn.1992.67.4.944; ZHANG Y, 1991, EXP BRAIN RES, V84, P525; Zhou HH, 2016, NEURON, V89, P209, DOI 10.1016/j.neuron.2015.11.034; Zhou L, 2008, EXP BRAIN RES, V189, P485, DOI 10.1007/s00221-008-1444-3; ZUBER BL, 1968, IEEE T SYST SCI CYB, VSSC4, P72, DOI 10.1109/TSSC.1968.300190	96	5	5	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	SEP	2019	122	3					1254	1263		10.1152/jn.00861.2018			10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Physiology	JF5ZY	WOS:000491468500015	31339793	Bronze			2022-02-06	
J	Spitz, G; Mahmooei, BH; Ross, P; McKenzie, D; Ponsford, JL				Spitz, Gershon; Mahmooei, Behrooz Hassani; Ross, Pamela; McKenzie, Dean; Ponsford, Jennie L.			Characterizing Early and Late Return to Work after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						employment; RTW; TBI	EMPLOYMENT; STABILITY; PREDICTION; MODERATE; PRODUCTIVITY; OUTCOMES; COHORT; LIFE	Facilitating successful return to work (RTW) is a key rehabilitation objective following traumatic brain injury (TBI). This study modelled early (within 6 months) and late (7-34 months) RTW by leveraging a large and comprehensive compensation database. The sample comprised 666 participants with TBI, the majority of whom sustained a moderate or severe injury caused by a motor vehicle accident. Early RTW was more likely for individuals who were pre-morbidly employed in a managerial or professional occupation (odds ratio [OR] = 2.1, confidence interval [CI] = 1.29-3.37), and those who experienced shorter post-traumatic amnesia (PTA) (OR = 0.96, CI = 0.94-0.98). RTW was less likely in the late phase for individuals who were older (hazard ratio [HR] = 0.99, CI = 0.98-1.00), experienced longer PTA (HR = 0.98, CI = 0.97-0.99), had an abdominal injury (HR = 0.90, CI = 0.67-1.21) and used more specialist practitioner (HR = 0.99, standard error [SE] = 0.98-1.00) and analgesic services (HR = 0.91, CI = 0.82-1.00). Conversely, RTW in the late phase was more likely for individuals using a greater number of specialist RTW supports (HR = 1.03, CI = 1.01-1.05). Patterns of early service utilization may therefore contribute to prediction of RTW outcome. It is encouraging that RTW was more likely for individuals using vocational supports.	[Spitz, Gershon; Mahmooei, Behrooz Hassani; Ponsford, Jennie L.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Sch Psychol Sci, Clayton, Vic, Australia; Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Spitz, Gershon; Ross, Pamela; McKenzie, Dean; Ponsford, Jennie L.] Epworth HealthCare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Spitz, G (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic 3800, Australia.	Gershon.Spitz@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480			Access Economics , 2009, EC COST SPIN CORD IN; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Collett D., 2015, MODELLING SURVIVAL D; Collie A, 2019, ANN SURG, V269, P972, DOI 10.1097/SLA.0000000000002666; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Finkelstein E., 2006, INCIDENCE EC BURDEN; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kreutzer J S, 1991, Int Disabil Stud, V13, P162; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lemeshow S., 2013, WILEY SERIES PROBABI; Lexell J, 2016, BRAIN INJURY, V30, P969, DOI 10.3109/02699052.2016.1148196; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Odgaard L, 2018, ACTA NEUROL SCAND, V137, P44, DOI 10.1111/ane.12806; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Sander AM, 1997, J HEAD TRAUMA REHAB, V12, P28, DOI 10.1097/00001199-199710000-00004; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; StataCorp, 2017, STATA STAT SOFTWARE; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	36	5	5	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2019	36	17					2533	2540		10.1089/neu.2018.5850			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IW9BT	WOS:000485289000007	30924716				2022-02-06	
J	Sun, S; Zhou, H; Ding, ZZ; Shi, H				Sun, S.; Zhou, H.; Ding, Z-Z; Shi, H.			Risk Factors Associated with the Outcome of Post-Traumatic Hydrocephalus	SCANDINAVIAN JOURNAL OF SURGERY			English	Article						Post-traumatic hydrocephalus; cisterna ambiens; fibrinogen; ventriculoperitoneal shunt; risk factor	NORMAL-PRESSURE HYDROCEPHALUS; DECOMPRESSIVE CRANIECTOMY; INTERHEMISPHERIC HYGROMA; CEREBROSPINAL-FLUID; BRAIN-INJURY	Background and Aim: Post-traumatic hydrocephalus is a common complication that arises after head injury. However, risk factors associated with the outcome of post-traumatic hydrocephalus have seldom been addressed. Therefore, we performed this clinical study to analyze the risk factors affecting the outcome of post-traumatic hydrocephalus in patients with head injuries. Methods: A total of 116 post-traumatic hydrocephalus patients, admitted in our hospital between March 2012 and October 2017 were reviewed. The related factors assessed were age, gender, Glasgow Coma Score on admission, platelet count, plasma fibrinogen levels, D-dimer concentration, subarachnoid hemorrhage, subdural hygroma, cerebral hernia, cisterna ambiens, decompressive craniectomy, cranioplasty, ventriculoperitoneal shunt implantation, intracranial infection, and duration of comatous state. The patient outcomes after 6 months of treatment were evaluated by the Glasgow Outcome Scale. Risk factors for the outcome of post-traumatic hydrocephalus were evaluated by applying logistic regression analysis. Results: Poor outcome was observed in 66.4% of the patients (77/116). Univariate and multivariate analyses revealed that the disappearance of cisterna ambiens, the long duration of comatous state (>2 months), the high levels of plasma fibrinogen, and the ventriculoperitoneal shunt implantation were related to adverse outcomes (p < 0.05). Conclusion: The disappearance of cisterna ambiens, the prolonged duration of comatous state (>2 months), the high plasma fibrinogen levels are the most important factors affecting the outcome of post-traumatic hydrocephalus, and the ventriculoperitoneal shunt implantation is the most critical predictor of the outcome of post-traumatic hydrocephalus.	[Sun, S.; Zhou, H.; Ding, Z-Z] Xuzhou Med Univ, Affiliated Hosp Lianyungang, Dept Neurosurg, Lianyungang, Peoples R China; [Shi, H.] Second Peoples Hosp Lianyungang, Dept Neurosurg, 182 Tongguan Rd North, Lianyungang 222000, Peoples R China		Shi, H (corresponding author), Second Peoples Hosp Lianyungang, Dept Neurosurg, 182 Tongguan Rd North, Lianyungang 222000, Peoples R China.	15949043694@163.com			High Level Talent Project of Jiangsu [2017WSW-166]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The article was funded by the High Level Talent Project of Jiangsu (2017WSW-166).	Botfield H, 2013, BRAIN, V136, P2842, DOI 10.1093/brain/awt203; Brandner S, 2014, J ALZHEIMERS DIS, V41, P1057, DOI 10.3233/JAD-132708; Chen Z, 2014, J REHABIL MED, V46, P876, DOI 10.2340/16501977-1856; Choi I, 2008, J KOREAN NEUROSURG S, V43, P227, DOI 10.3340/jkns.2008.43.5.227; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Denes Z, 2011, INT J REHABIL RES, V34, P222, DOI 10.1097/MRR.0b013e328346e87d; Ding J, 2014, ARQ NEURO-PSIQUIAT, V72, P715, DOI 10.1590/0004-282X20140106; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Huang X, 2014, J CRANIOFAC SURG, V25, P1280, DOI 10.1097/SCS.0000000000000583; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Ki HJ, 2015, J KOREAN NEUROSURG S, V58, P254, DOI 10.3340/jkns.2015.58.3.254; Kim Ho Soo, 2015, Korean J Neurotrauma, V11, P58, DOI 10.13004/kjnt.2015.11.2.58; Linnemann M, 2014, NEUROREHABILITATION, V35, P755, DOI 10.3233/NRE-141160; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Shi SS, 2011, CHIN J TRAUMATOL, V14, P343, DOI 10.3760/cma.j.issn.1008-1275.2011.06.004; Turaj W, 2006, J NEUROL SCI, V246, P13, DOI 10.1016/j.jns.2006.01.020; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Xu H, 2016, TRANSL NEUROSCI, V7, P92, DOI 10.1515/tnsci-2016-0015	20	5	6	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1457-4969	1799-7267		SCAND J SURG	Scand. J. Surg.	SEP	2019	108	3					265	270		10.1177/1457496918812210			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	IW9DB	WOS:000485292400011	30428813				2022-02-06	
J	Venkalesan, UM; Hillary, FG				Venkalesan, Umesh M.; Hillary, Frank G.			Functional Connectivity Within Lateral Posterior Parietal Cortex in Moderate to Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						functional connectivity; graph theory; neuroplasticity; posterior parietal cortex; traumatic brain injury	GRAPH-THEORETICAL ANALYSIS; RESTING-STATE FMRI; INTRAPARIETAL SULCUS; MEMORY PERFORMANCE; ATTENTION DEFICITS; NETWORK DYNAMICS; AGE-DIFFERENCES; SMALL-WORLD; HUBS; DYSFUNCTION	Objective: Functional brain networks converge on areas of heteromodal processing such as lateral posterior parietal cortex (PPC). Traumatic brain injury (TBI) alters global connectivity patterns secondary to both focal and diffuse damage. hut little is known about how it impacts regional environments. We examined local PPC functioning in individuals with moderate-severe TBI and controls during resting-state functional magnetic resonance imaging (rs-fMRI). Method: Eighteen individuals with moderate-severe TBI and 19 healthy controls underwent rs-fMRI and neurocognitive testing. Seed-based analyses characterized remote connectivity of PPC subregions. Voxelwise graph theoretical approaches were used to probe local PPC connectivity and modularity within and between groups, and to examine relationships between local functioning and cognition. Results: Seed-based findings included increased connectivity from left and right hemispheric subregions to right-lateralized default mode and frontoparietal control networks in TBI compared to controls. Graph theoretical analyses revealed increased connection strength within right PPC relative to the contralateral region in TBI. Across groups, right PPC also showed decreased betweenness centrality compared with left PPC. Groups did not differ in the extent of modularity within left or right PPC, but there was less interindividual variability in modular structure within the TBI group. Right PPC modularity significantly predicted individual differences in cognitive performance. Conclusions: Our findings substantiate hyperconnectivity on both local and global levels after TBI and propose a special role for local right hemispheric functioning in supporting cognition independent of neurologic status. Hyperconnectivity does not appear to result from breakdown in local modular organization and may reflect shared responses to neurologic disruption among those with TBI.	[Venkalesan, Umesh M.] VA Boston Healthcare Syst, Translat Res Ctr TB & Stress Disorders, Boston, MA USA; [Venkalesan, Umesh M.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Venkalesan, Umesh M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Hillary, Frank G.] Penn State Hlth Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA USA		Venkalesan, UM (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	VenkateU@einstein.edu	Hillary, Frank/AAN-8622-2021		Social Sciences Research Institute, in University Park, PA, USA; Penn State CTSI Grant from the National Center for Advancing Translational Sciences, National Institutes of Health [UL Tr000127]	This project was supported by the Social Sciences Research Institute, in University Park, PA, USA, and the Penn State CTSI Grant (UL Tr000127) from the National Center for Advancing Translational Sciences, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Alavash M, 2015, NEUROIMAGE, V108, P182, DOI 10.1016/j.neuroimage.2014.12.046; Arsalidou M, 2013, BRAIN BEHAV, V3, P273, DOI 10.1002/brb3.128; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bernier RA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00297; Berryhill ME, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00031; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Chai LR, 2016, CEREB CORTEX, V26, P4148, DOI 10.1093/cercor/bhw238; Chang TY, 2016, J CEREBR BLOOD F MET, V36, P808, DOI 10.1177/0271678X15608390; Chiou KS, 2012, J INT NEUROPSYCH SOC, V18, P379, DOI 10.1017/S1355617711001846; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Duncan ES, 2016, BRAIN CONNECT, V6, P524, DOI 10.1089/brain.2016.0437; Dwyer DB, 2014, J NEUROSCI, V34, P14096, DOI 10.1523/JNEUROSCI.1634-14.2014; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016; Gu S, 2017, NEUROIMAGE, V148, P305, DOI 10.1016/j.neuroimage.2017.01.003; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Hilger K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15795-7; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jaccard P, 1912, NEW PHYTOL, V11, P37, DOI [DOI 10.1111/J.1469-8137.1912.TB05611.X, 10.1111/j.1469-8137.1912.tb05611.x]; Jiang LL, 2016, NEUROSCIENTIST, V22, P486, DOI 10.1177/1073858415595004; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Khan S, 2013, P NATL ACAD SCI USA, V110, P3107, DOI 10.1073/pnas.1214533110; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kuceyeski A, 2016, NEUROIMAGE-CLIN, V11, P635, DOI 10.1016/j.nicl.2016.04.006; Lee S, 2018, BRAIN CONNECT, V8, P288, DOI 10.1089/brain.2017.0499; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mazaika P. K., 2009, 15 ANN M ORG HUM BRA; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Meunier David, 2009, Front Neuroinform, V3, P37, DOI 10.3389/neuro.11.037.2009; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nenadovic V, 2008, J NEUROTRAUM, V25, P615, DOI 10.1089/neu.2007.0474; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Patel KR, 2018, BRAIN STRUCT FUNCT, V223, P2519, DOI 10.1007/s00429-018-1619-z; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; R Development Core Team, 2012, R LANG ENV STAT COMP; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Reitan R, 1985, HALSTEAD REITAN NEUR; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Sato JR, 2016, DEV COGN NEUROS-NETH, V20, P2, DOI 10.1016/j.dcn.2016.05.002; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2017, EXP BRAIN RES, V235, P799, DOI 10.1007/s00221-016-4841-z; Sorensen T.A.A., 1948, BIOL SKAR; Sours C, 2017, J NEUROTRAUM, V34, P1473, DOI 10.1089/neu.2016.4570; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Steward KA, 2018, J HEAD TRAUMA REHAB, V33, pE18, DOI 10.1097/HTR.0000000000000325; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tomasi D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154407; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, IEEE ENG MED BIO, P4274, DOI 10.1109/IEMBS.2010.5626180; Trennerry M. R., 1990, VISUAL SEARCH ATTENT; Uddin LQ, 2010, CEREB CORTEX, V20, P2636, DOI 10.1093/cercor/bhq011; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Verhelst H, 2018, HUM BRAIN MAPP, V39, P2800, DOI 10.1002/hbm.24041; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073	100	5	5	1	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	SEP	2019	33	6					893	910		10.1037/neu0000553			18	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IT0XB	WOS:000482569400012	31192652	Bronze			2022-02-06	
J	Wang, LL; Yang, ZQ; Fang, F; Sun, SH; Wu, XJ; Lu, HX; Lu, XY				Wang, Leilei; Yang, Zhiqian; Fang, Fan; Sun, Shuhong; Wu, Xingjuan; Lu, Haixia; Lu, Xiaoyun			PHBHHx Facilitated the Residence, Survival and Sternness Maintain of Transplanted Neural Stem Cells in Traumatic Brain Injury Rats	BIOMACROMOLECULES			English	Article							BETA-HYDROXYBUTYRATE; ALZHEIMERS; MODEL; 3-HYDROXYBUTYRATE; REGENERATION; EXPRESSION; APOPTOSIS; PROMOTES; RECOVERY; NEURONS	Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) is a polyhydroxyalkanoate (PHA) with broad application prospects in various biomedical fields. Our previous study demonstrated the great biocompatibility of PHBHHx with neural stem cells (NSCs) in vitro. In this study, we went a step further and implanted the NSC-carrying PHBHHx film to in vivo into the lesion region in a rat traumatic brain injury (TBI) model. The in vivo biocompatibility of PHBHHx, as well as the survival, migration and differentiation of the transplanted NSCs were investigated. The results showed that PHBHHx did not induce additional reactive gliosis and supported the in vivo survival and growth of the transplanted stem cells. The transplanted NSCs were able to migrate into the brain tissue and differentiated into both neurons and astrocytes. Moreover, PHBHHx seemed to be able to maintain the sternness of the attached NSCs both in vitro and in vivo. The major monomer of PHBHHx, 3-hydroxybutyrate (3-HB), might contribute to this bioactivity because the addition of low concentrations of 3-HB facilitated the self-renewal of NSCs by shortening the G1 phase, promoted their proliferation, and enhanced the expression of a key regulatory transcription factor which helped to keep the stemness of NSCs. These results highlight the application of PHBHHx as a promising bioactive material for NSC transplantation in the brain and open up a wide space for further studies on functional recovery following the transplantation of NSCs attached to PHBHHx.	[Wang, Leilei; Fang, Fan; Sun, Shuhong; Wu, Xingjuan; Lu, Xiaoyun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China; [Yang, Zhiqian] Guangdong Pharmaceut Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Lu, Haixia] Xi An Jiao Tong Univ, Hlth Sci Ctr, Key Lab Environm & Genes Related Dis, Minist Educ,Inst Neurobiol,Sch Basic Med Sci, Xian 710061, Shaanxi, Peoples R China		Lu, XY (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710049, Shaanxi, Peoples R China.; Lu, HX (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Key Lab Environm & Genes Related Dis, Minist Educ,Inst Neurobiol,Sch Basic Med Sci, Xian 710061, Shaanxi, Peoples R China.	hxl01@mail.xjtu.edu.cn; luxy05@mail.xjtu.edu.cn	Lu, Xiaoyun/AAH-8122-2019	Fan, Fan/0000-0002-6587-0416	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371288, 81571205]	This work was supported by the National Natural Science Foundation of China (No. 81371288, 81571205). The authors are grateful to Prof. Guoqiang Chen from Tsinghua University for providing the PHBHHx material.	ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Beretta S, 2017, CELL TRANSPLANT, V26, P1247, DOI 10.1177/0963689717714107; Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036; Bonnamain V, 2012, FRONT CELL NEUROSCI, V6; Cao Q, 2014, BIOMATERIALS, V35, P8273, DOI 10.1016/j.biomaterials.2014.06.020; Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011; Deng Y, 2002, BIOMATERIALS, V23, P4049, DOI 10.1016/S0142-9612(02)00136-9; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gazalah H, 2016, METHODS MOL BIOL, V1462, P689, DOI 10.1007/978-1-4939-3816-2_38; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Henderson ST, 2008, NEUROTHERAPEUTICS, V5, P470, DOI 10.1016/j.nurt.2008.05.004; Hu EL, 2018, NEUROSCIENCE, V386, P315, DOI 10.1016/j.neuroscience.2018.06.036; Hu EL, 2015, FEBS LETT, V589, P3899, DOI 10.1016/j.febslet.2015.11.001; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kim DY, 2014, CELL MOL LIFE SCI, V71, P4221, DOI 10.1007/s00018-014-1686-0; Li XT, 2008, J BIOMED MATER RES A, V87A, P832, DOI 10.1002/jbm.a.31890; Liu TL, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1416047; Lu HX, 2014, NEUROL RES, V36, P207, DOI 10.1179/1743132813Y.0000000281; Lu Haixia, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P1216; Luo JS, 2017, BIOMATERIALS, V147, P116, DOI 10.1016/j.biomaterials.2017.09.019; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Mariano ED, 2015, WORLD J STEM CELLS, V7, P477, DOI 10.4252/wjsc.v7.i2.477; Nguyen HX, 2017, J NEUROSCI, V37, P9269, DOI 10.1523/JNEUROSCI.2785-16.2017; Pang AL, 2017, CELL TRANSPLANT, V26, P1262, DOI 10.1177/0963689717715168; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025; Sudesh K, 2008, CLEAN-SOIL AIR WATER, V36, P433, DOI 10.1002/clen.200700183; Taupin Philippe, 2006, Recent Pat CNS Drug Discov, V1, P299, DOI 10.2174/157488906778773670; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Tortajada M, 2013, INT MICROBIOL, V16, P1, DOI 10.2436/20.1501.01.175; Vishwakarma SK, 2014, J ADV RES, V5, P277, DOI 10.1016/j.jare.2013.04.005; Wang YW, 2005, BIOMACROMOLECULES, V6, P566, DOI 10.1021/bm049342d; Wang ZG, 2017, EXP THER MED, V13, P3613, DOI 10.3892/etm.2017.4423; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132; Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018; Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5; Zhang JY, 2013, BIOMATERIALS, V34, P7552, DOI 10.1016/j.biomaterials.2013.06.043; Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou J, 2010, BIOMATERIALS, V31, P7512, DOI 10.1016/j.biomaterials.2010.06.044; Zhu Y, 2017, BIOMATERIALS, V147, P133, DOI 10.1016/j.biomaterials.2017.09.018	45	5	6	5	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	SEP	2019	20	9					3294	3302		10.1021/acs.biomac.9b00408			9	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Polymer Science	IW7YX	WOS:000485211000009	31251595				2022-02-06	
J	Ballocco, I; Evangelisti, MA; Deiana, R; Cubeddu, F; Parpaglia, MLP; Serra, G; Carta, G; Manunta, ML				Ballocco, Isabella; Evangelisti, Maria Antonietta; Deiana, Roberta; Cubeddu, Francesca; Parpaglia, Maria Luisa Pinna; Serra, Giovanna; Carta, Giovanni; Manunta, Maria Lucia			A pilot study evaluating the effect of mannitol and hypertonic saline solution in the treatment of increased intracranial pressure in 2 cats and 1 dog naturally affected by traumatic brain injury	JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE			English	Article						brain injury; cerebral edema; hyperosmolar; intracranial hypertension; osmotic	CEREBRAL-BLOOD-FLOW; MANAGEMENT	Objective To evaluate the effects of iso-osmolar doses of 18% mannitol and 3% sodium chloride (NaCl) solutions in decreasing intracranial pressure (ICP) in animals with severe traumatic brain injury (TBI). Design Prospective uncontrolled interventional study. Setting Veterinary university teaching hospital. Animals Two cats and 1 dog with TBI with a modified Glasgow Coma Scale score <= 8 after hemodynamic stabilization, and with brain magnetic resonance imaging changes suggestive of intracranial hypertension. Interventions Animals were surgically instrumented for direct ICP measurement, then randomly treated with iso-osmolar doses of 18% mannitol or 3% NaCl. Direct ICP and cerebral perfusion pressure (CPP) were recorded both before treatment and for 120 minutes following drug administration. Measurements and Main Results Direct ICP and CPP were recorded both before treatment and at 5 additional time points following administration over the subsequent 120 minutes. Case 1 received 3% NaCl without any response to therapy; refractory posttraumatic hypertension was suspected. Case 2 was treated with 3% NaCl; ICP decreased by 40.7% and CPP increased by 15%; however, these effects were transient. Case 3 received 18% mannitol, and ICP decreased by 19% and CPP increased to normal. However, there was a rebound increase in ICP that was higher than pretreatment values, and CPP decreased slightly before it gradually increased to normal values towards the end of the study. Conclusions Both mannitol and hypertonic saline decrease ICP and improve CPP, but the effect observed in this pilot study suggests that there might be differences in the duration of these effects. Appropriately designed studies in a larger and homogeneous population are warranted to further investigate these findings.	[Ballocco, Isabella; Evangelisti, Maria Antonietta; Deiana, Roberta; Cubeddu, Francesca; Parpaglia, Maria Luisa Pinna; Serra, Giovanna; Carta, Giovanni; Manunta, Maria Lucia] Vet Teaching Hosp, Dept Vet Med, Via Vienna SNC, I-07100 Sassari, Italy		Ballocco, I (corresponding author), Vet Teaching Hosp, Dept Vet Med, Via Vienna SNC, I-07100 Sassari, Italy.	iballocco85@gmail.com		CUBEDDU, Francesca/0000-0002-9539-1117; SERRA, GIOVANNA/0000-0002-3340-6301			Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khalili H, 2016, WORLD NEUROSURG, V94, P120, DOI 10.1016/j.wneu.2016.06.122; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Lee K, 1996, NEUROLOGICAL SURG, V1, P491; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; OKEN DE, 1994, RENAL FAILURE, V16, P147, DOI 10.3109/08860229409044856; Platt SR, 2001, J VET INTERN MED, V15, P581, DOI 10.1892/0891-6640(2001)015&lt;0581:TPVOTM&gt;2.3.CO;2; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Wang K, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0006-8; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011	21	5	5	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1479-3261	1476-4431		J VET EMERG CRIT CAR	J. Vet. Emerg. Crit. Care	SEP	2019	29	5					578	584		10.1111/vec.12880		AUG 2019	7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	IY0KB	WOS:000482621200001	31448527				2022-02-06	
J	Pozzi, M; Galbiati, S; Locatelli, F; Carnovale, C; Gentili, M; Radice, S; Strazzer, S; Clementi, E				Pozzi, Marco; Galbiati, Sara; Locatelli, Federica; Carnovale, Carla; Gentili, Marta; Radice, Sonia; Strazzer, Sandra; Clementi, Emilio			Severe acquired brain injury aetiologies, early clinical factors, and rehabilitation outcomes: a retrospective study on pediatric patients in rehabilitation	BRAIN INJURY			English	Article						Brain injury; Pediatrics; rehabilitation; risk factors; outcomes	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; LONG-TERM OUTCOMES; ACUTE ENCEPHALITIS; CHILDREN; ADOLESCENTS; EPIDEMIOLOGY; PREDICTORS; PLASTICITY; MORTALITY; MODERATE	Objective: Studies on pediatric severe acquired brain injury (sABI) outcomes focused mostly on single etiologies, not clarifying the independent role of clinical factors, and scantly explored inter-dependence between variables. We assessed associations of clinical factors at admission with essential outcomes, controlling for inter-dependence and sABI etiology. Methods: We reviewed the clinical records of 280 patients with traumatic and 292 with non-traumatic sABI, discharged from intensive care to pediatric neurological rehabilitation. We analyzed the distribution of clinical factors based on sABI etiology; conducted a factor analysis of variables; built multivariate models evaluating the associations of variables with death, persistent vegetative states, duration of coma, GOS outcome, length of stay. Results: We described the study sample. Factor analysis of inter-dependence between GCS, time before rehabilitation, dysautonomia, device use, produced the indicators "injury severity" and "neurological dysfunction", independent from sABI etiology, age, sex, and admittance GOS. Multivariate analyzes showed that: coma duration, GOS outcome, and length of stay, which may depend on rehabilitation courses, were directly associated with injury severity, neurological dysfunction, and patients' age; death and persistent vegetative states were also associated with etiology. Conclusion: Future studies should analyze larger cohorts and investigate mechanisms linking specific etiologies and patients' age with outcomes.	[Pozzi, Marco; Galbiati, Sara; Locatelli, Federica; Strazzer, Sandra; Clementi, Emilio] Sci Inst IRCCS Eugenio Medea, Acquired Brain Injury Unit, Lecce, Italy; [Carnovale, Carla; Gentili, Marta; Radice, Sonia; Clementi, Emilio] Univ Milan, Luigi Sacco Univ Hosp, Dept Biomed & Clin Sci L Sacco, Unit Clin Pharmacol, Milan, Italy		Strazzer, S (corresponding author), Sci Inst IRCCS Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy.	sandra.strazzer@lanostrafamiglia.it	Galbiati, Sara/AAA-7115-2020; Strazzer, Sandra/AAH-5712-2019; Carnovale, Carla/Z-3073-2019; Pozzi, Marco/Z-2684-2019; FEDERICA, LOCATELLI/AAA-5601-2020	Galbiati, Sara/0000-0001-6810-359X; Strazzer, Sandra/0000-0001-8414-6565; Carnovale, Carla/0000-0002-4107-196X; Pozzi, Marco/0000-0002-3800-5697; FEDERICA, LOCATELLI/0000-0002-8243-5483	Regional Center of Pharmacovigilance of Lombardy; Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA); Italian Ministry of Health (Ricerca Corrente 2019)	This work was supported by the Regional Center of Pharmacovigilance of Lombardy (to EC), the Italian Medicines Agency, Agenzia Italiana del Farmaco (AIFA, to EC) and by the Italian Ministry of Health (Ricerca Corrente 2019, to MP and SS) which is gratefully acknowledged. The funding public institutions had no role in any part of the work.	Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Chan V, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0631-2; Chapman SB, 2003, PEDIATR NEUROL, V29, P34, DOI 10.1016/S0887-8994(03)00012-2; Chi X, 2017, ACTA NEUROL SCAND, V136, P298, DOI 10.1111/ane.12723; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Douglas-Escobar M, 2015, JAMA PEDIATR, V169, P397, DOI 10.1001/jamapediatrics.2014.3269; E Molteni E, 2018, YET END STORY DEV NE, V21, P449, DOI [10.1080/17518423.2017.1360408, DOI 10.1080/17518423.2017.1360408]; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fink Ericka L, 2017, Pediatr Crit Care Med, V18, P330, DOI 10.1097/PCC.0000000000001093; Fowler A, 2010, PEDIATRICS, V126, pE828, DOI 10.1542/peds.2009-3188; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Ganesan V, 2000, DEV MED CHILD NEUROL, V42, P455, DOI 10.1017/S0012162200000852; Gazzellini S, 2012, EUR J PHYS REHAB MED, V48, P423; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Gumer LB, 2014, PEDIATR EMERG CARE, V30, P660, DOI 10.1097/PEC.0000000000000218; Hardcastle N, 2014, PEDIATR ANESTH, V24, P703, DOI 10.1111/pan.12415; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Jambaque I, 2013, HAND CLINIC, V111, P691, DOI 10.1016/B978-0-444-52891-9.00071-3; Jimenez N, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3500; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Kim CT, 2013, J PEDIATR REHAB MED, V6, P11, DOI 10.3233/PRM-130232; Koroknay-Pal P, 2012, STROKE, V43, P2091, DOI 10.1161/STROKEAHA.112.650077; KRIEL RL, 1994, PEDIATR NEUROL, V10, P207, DOI 10.1016/0887-8994(94)90024-8; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Lloyd O, 2015, J HEAD TRAUMA REHAB, V30, P311, DOI 10.1097/HTR.0000000000000113; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Peterson C, 2014, PEDIATRICS, V134, P91, DOI 10.1542/peds.2014-0117; Pozzi M, 2015, J HEAD TRAUMA REHAB, V30, P357, DOI 10.1097/HTR.0000000000000084; Pozzi M, 2014, J NEUROTRAUM, V31, P1897, DOI 10.1089/neu.2014.3540; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao S, 2017, J PEDIATR INFECT DIS, V6, P20, DOI 10.1093/jpids/piv075; Rashid M, 2014, J PEDIATR REHAB MED, V7, P241, DOI 10.3233/PRM-140293; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	47	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2019	33	12					1522	1528		10.1080/02699052.2019.1658128		AUG 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ8NK	WOS:000483560200001	31446793				2022-02-06	
J	Trbovich, AM; Sherry, NK; Henley, J; Emami, K; Kontos, AP				Trbovich, Alicia M.; Sherry, Natalie K.; Henley, Jill; Emami, Kouros; Kontos, Anthony P.			The utility of the Convergence Insufficiency Symptom Survey (CISS) post-concussion	BRAIN INJURY			English	Article						Concussion; mild traumatic brain injury; Convergence Insufficiency Symptom Survey; near point of convergence	RELIABILITY; RECOVERY; PREVALENCE; DYSFUNCTIONS; VALIDITY; CHILDREN	Background: The Convergence Insufficiency Symptom Survey (CISS) is being utilized as an assessment measure following concussion despite minimal research. This study explored the sensitivity and specificity of the CISS in identifying receded near point of convergence (NPC) post-concussion. Methods: Prospective study of 130 patients post-concussion aged 11-25, classified into normal NPC (n = 94) and CI (n = 36) groups (i.e., NPC >5 cm), completed the CISS, VOMS, and PCSS. Sensitivity and specificity identifying receded NPC were explored with published CISS cutoff score (>16). ROC with AUC analysis was conducted to determine an alternate CISS cutoff score to yield optimal sensitivity and specificity in patients with concussion. Results: Utilizing the published cutoff score, the CISS demonstrated adequate sensitivity (.78 [95% CI = .60-.89]) but poor specificity (.35 [95%CI = .26-.46]). ROC curve demonstrated that CISS score was significant (P = .01) in predicting a positive test result (i.e., NPC >5) with AUC of .65 (95%CI .54-.76). An alternative cutoff score (CISS>23) maximized sensitivity (.70) and specificity (.53) for identifying receded NPC. Conclusions: Both the previously published CISS cutoff and our sample-based cutoff score yielded a high rate of false positives for receded NPC. CISS scores post-concussion may help the clinician understand difficulties with visual tasks but is not a suitable diagnostic tool in this patient population.	[Trbovich, Alicia M.; Sherry, Natalie K.; Henley, Jill; Emami, Kouros] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA; [Trbovich, Alicia M.; Sherry, Natalie K.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA		Trbovich, AM (corresponding author), Univ Pittsburgh, Med Ctr, 3200 S Water St, Pittsburgh, PA 15203 USA.	trbovicham@upmc.edu					Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, DOI [10.1097/OPX.0b013e318264cc62, DOI 10.1097/OPX.0B013E318264CC62]; [Anonymous], 2011, IMMEDIATE POSTCONCUS; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bolding Mark S, 2012, Front Psychiatry, V3, P86, DOI 10.3389/fpsyt.2012.00086; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Borsting Eric, 2005, Optometry, V76, P588, DOI 10.1016/j.optm.2005.07.007; Borsting Eric, 2003, Optometry, V74, P25; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Clark TY, 2015, AM J OPHTHALMOL, V160, P905, DOI 10.1016/j.ajo.2015.08.008; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Group CITTS, 2009, OPHTHAL EPIDEMIOL, V15, P24; Horan Lindsay A, 2015, Am Orthopt J, V65, P99, DOI 10.3368/aoj.65.1.99; Horwood AM, 2014, BRIT J OPHTHALMOL, V98, P679, DOI 10.1136/bjophthalmol-2013-304533; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Institute of Neurological Disorders and Stroke, SPORT REL CONC COMM; Pang Y, 2012, CLIN EXP OPTOM, V95, P192, DOI 10.1111/j.1444-0938.2011.00693.x; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Porcar E, 1997, OPTOMETRY VISION SCI, V74, P111, DOI 10.1097/00006324-199702000-00023; Raghuram A, 2019, AM J OPHTHALMOL, V206, P235, DOI 10.1016/j.ajo.2019.04.008; Rouse M, 2009, OPTOMETRY VISION SCI, V86, P357, DOI 10.1097/OPX.0b013e3181989252; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 1996, J Am Optom Assoc, V67, P193; Scheiman MM, 2017, OPTOMETRY VISION SCI, V94, P74, DOI 10.1097/OPX.0000000000000936; Stiebel-Kalish H, 2018, OPHTHALMOLOGY, V125, P924, DOI 10.1016/j.ophtha.2017.11.030; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087	37	5	5	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2019	33	12					1545	1551		10.1080/02699052.2019.1658131		AUG 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ8NK	WOS:000483559200001	31446780				2022-02-06	
J	Cannella, LA; Andrews, AM; Tran, F; Razmpour, R; McGary, H; Collie, C; Tsegaye, T; Maynard, M; Kaufman, MJ; Rawls, SM; Ramirez, SH				Cannella, Lee Anne; Andrews, Allison M.; Tran, Fionya; Razmpour, Roshanak; McGary, Hannah; Collie, Ceryce; Tsegaye, Tarik; Maynard, Marquis; Kaufman, Marc J.; Rawls, Scott M.; Ramirez, Servio H.			Experimental Traumatic Brain Injury during Adolescence Enhances Cocaine Rewarding Efficacy and Dysregulates Dopamine and Neuroimmune Systems in Brain Reward Substrates	JOURNAL OF NEUROTRAUMA			English	Article						addiction; adolescent; behavior; neuroinflammation; traumatic brain injury	CONDITIONED PLACE PREFERENCE; TYROSINE-HYDROXYLASE; NUCLEUS-ACCUMBENS; DOWN-REGULATION; MICROGLIA; IMPACT; RECEPTOR; MODEL; SEX; NEUROINFLAMMATION	Although clinical studies identify traumatic brain injury (TBI) as a risk factor for the development of substance use disorder, much remains unknown about the possible underlying pathogenesis and age-specific effects. Thus, the aim of this study is to test the hypothesis that at an age of ongoing maturation, adolescent TBI alters elements of the reward pathway, resulting in increased sensitivity to the rewarding effects of a subthreshold dose of cocaine that does not induce significant behavioral changes in naive, non-injured mice. Specifically, these results were derived from the combination of the controlled cortical impact model of TBI, performed on either adolescent (6 weeks) or young adult (8 weeks) mice, followed by the cocaine-induced conditioned place preference assay 2 weeks later. Using three-dimensional isosurface rendering and volumetric image analysis, TBI was found to induce neuromorphological changes such as decreased dendritic complexity and reduced spine density in brain regions essential for reward perception and processing of drug-induced euphoria. Further, we demonstrated that these neuronal changes may affect the differential expression of dopamine-associated genes. Our analysis also provided evidence for age-related differences in immune response and the distinct involvement of augmented microglial phagocytic activity in the remodeling of neuronal structures in the adolescent TBI brain. Our studies suggest that TBI during adolescence, a period associated with ongoing maturation of dopaminergic systems, may subsequently enhance the abuse liability of cocaine in adulthood.	[Cannella, Lee Anne; Andrews, Allison M.; Tran, Fionya; Razmpour, Roshanak; McGary, Hannah; Maynard, Marquis; Ramirez, Servio H.] Temple Univ, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Rawls, Scott M.; Ramirez, Servio H.] Temple Univ, Ctr Substance Abuse Res, Philadelphia, PA 19122 USA; [Ramirez, Servio H.] Temple Univ, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA; [Collie, Ceryce; Tsegaye, Tarik] Lincoln Univ, Dept Biol, Philadelphia, PA USA; [Kaufman, Marc J.] Harvard Med Sch, McLean Hosp, McLean Imaging Ctr, Belmont, MA USA		Ramirez, SH (corresponding author), Temple Univ, Sch Med, Dept Pathol & Lab Med, 3500 N Broad St, Philadelphia, PA 19140 USA.	servio@temple.edu		ramirez, servio/0000-0002-4609-5653; Kaufman, Marc/0000-0002-4383-1264	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [P30 DA013429-16, R01DA046833 01, T32 DA007237]; NIH/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS086570-01]; PA-CURE program (Pennsylvania Department of Health)	This work was supported by National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) P30 DA013429-16 (SHR, SMR), R01DA046833 01 (SHR), T32 DA007237 (LAC), NIH/National Institute of Neurological Disorders and Stroke (NINDS), R01 NS086570-01 (SHR), and the PA-CURE program (Pennsylvania Department of Health).	Ashok AH, 2017, JAMA PSYCHIAT, V74, P511, DOI 10.1001/jamapsychiatry.2017.0135; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Chen Yuan-Hao, 2018, Oncotarget, V9, P10016, DOI 10.18632/oncotarget.24245; Chen YH, 2017, NEUROSCIENCE, V348, P180, DOI 10.1016/j.neuroscience.2017.02.001; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Czoty PW, 2007, J ADDICT MED, V1, P33, DOI 10.1097/ADM.0b013e318045c038; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer MA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002374; Hartley CA, 2015, CURR OPIN BEHAV SCI, V5, P108, DOI 10.1016/j.cobeha.2015.09.004; Hicks C, 2017, PSYCHOPHARMACOLOGY, V234, P1671, DOI 10.1007/s00213-017-4568-y; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Ilie G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011824; Jones KA, 2018, BRAIN BEHAV IMMUN, V67, P299, DOI 10.1016/j.bbi.2017.09.006; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kim J, 2017, BRAIN BEHAV IMMUN, V62, P30, DOI 10.1016/j.bbi.2016.08.015; Koob GF, 2013, CURR OPIN NEUROBIOL, V23, P559, DOI 10.1016/j.conb.2013.03.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Y, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3017; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Manitt C, 2011, J NEUROSCI, V31, P8381, DOI 10.1523/JNEUROSCI.0606-11.2011; Marklund N, 2009, NEUROSCIENCE, V163, P540, DOI 10.1016/j.neuroscience.2009.06.042; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Merkel SF, 2017, CELL TRANSPLANT, V26, P1178, DOI 10.1177/0963689717714341; Merkel SF, 2017, NEUROSCI BIOBEHAV R, V77, P209, DOI 10.1016/j.neubiorev.2017.03.015; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Mooney J, 2017, BEHAV PHARMACOL, V28, P405, DOI 10.1097/FBP.0000000000000287; Muelbl MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28062-0; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Naneix F, 2012, J NEUROSCI, V32, P16223, DOI 10.1523/JNEUROSCI.3080-12.2012; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; NICOLAYSEN LC, 1988, BRAIN RES, V456, P317, DOI 10.1016/0006-8993(88)90234-X; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; SCHENK S, 1991, BRAIN RES, V543, P227, DOI 10.1016/0006-8993(91)90032-Q; Spiga S, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00110; Substance Abuse and Mental Health Services Administration, 2014, RES 2013 NAT SURV DR; Tallarida CS, 2015, DRUG ALCOHOL DEPEN, V149, P145, DOI 10.1016/j.drugalcdep.2015.01.035; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tomasevic G, 2012, J NEUROSURG, V116, P1368, DOI 10.3171/2012.2.JNS11888; United Nations Office on Crime and Drugs, 2018, WORLD DRUG REP 2018; Vaughn MG, 2019, PSYCHIAT QUART, V90, P151, DOI 10.1007/s11126-018-9617-0; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Vonder Haar C., 2018, EUR J NEUROSCI; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wake H, 2013, TRENDS NEUROSCI, V36, P209, DOI 10.1016/j.tins.2012.11.007; Walker DM, 2017, J NEUROSCI, V37, P10855, DOI 10.1523/JNEUROSCI.1834-17.2017; Wee S, 2010, PSYCHOPHARMACOLOGY, V210, P121, DOI 10.1007/s00213-010-1825-8; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wynne AM, 2010, BRAIN BEHAV IMMUN, V24, P1190, DOI 10.1016/j.bbi.2010.05.011; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu XP, 2016, BRAIN RES BULL, V124, P214, DOI 10.1016/j.brainresbull.2016.05.010; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zakharova E, 2009, PHARMACOL BIOCHEM BE, V92, P131, DOI 10.1016/j.pbb.2008.11.002; Zakharova E, 2009, BEHAV BRAIN RES, V198, P45, DOI 10.1016/j.bbr.2008.10.019; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	81	5	5	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2020	37	1					27	42		10.1089/neu.2019.6472		AUG 2019	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	KA2YK	WOS:000482736400001	31347447	Green Published			2022-02-06	
J	Nilsson, KJ; Flint, HG; Gao, Y; Kendrick, L; Cutchin, S; Pentecost, R; Pardue, K				Nilsson, Kurt J.; Flint, Hilary G.; Gao, Yong; Kendrick, Leslie; Cutchin, Steve; Pentecost, Ryoko; Pardue, Kristi			Repetitive Head Impacts in Youth Football: Description and Relationship to White Matter Structure	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						youth sports; football; repetitive head impact; diffusion tensor imaging (DTI)	IMAGING DTI FINDINGS; STATES HIGH-SCHOOL; 1ST EXPOSURE; BRAIN; AGE; DIFFUSIVITY; CONCUSSIONS; MAGNITUDE; SPORTS; TBI	Background: Few studies have examined white matter with diffusion tensor imaging in 8- to 12-year-old collision sport (CS) athletes. Hypothesis: Youth CS athletes will demonstrate change in brain fractional anisotropy (FA) after a season of CS compared with an age-matched noncollision sport (NCS) cohort, and the number, magnitude, and location of hits will correlate with changes in the brain determined via FA for CS athletes. Study Design: Prospective cohort study. Methods: Thirty-five 8- to 12-year-old males in a youth tackle football league (CS) and 12 males from local swim teams (NCS) were recruited. Participants underwent brain magnetic resonance imaging with FA before and after the football season. Number, magnitude, and direction of head impacts were recorded for CS participants throughout the season. Results: A total of 1905 hits were recorded in the CS group for the season, 341 (17.9%) collected during 7 games and 1564 (82.1%) observed during 31 practices. No significant interaction between group (CS and NCS) and time (pre- to postseason) was observed (P > 0.05) for FA. Correlation analysis revealed a significantly positive and moderate relationship between increase of left cingulate cortex (CgC) FA from pre- to postseason and the total magnitude of lateral head impacts (r = 0.40; P = 0.03). Conclusion: There was no significant change in FA measurement of white matter integrity in a cohort of 8- to 12-year-old males after a season of youth football, nor was any difference detected in FA between youth football players and an age-matched cohort of swimmers. There was a significant correlation between total magnitude of hits sustained by youth football players and an increase in FA in the left CgC; whether this is adaptive or pathologic remains unknown.	[Nilsson, Kurt J.] St Lukes Sports Med, 1109 West Myrtle,Suite 200, Boise, ID 83702 USA; [Flint, Hilary G.; Kendrick, Leslie; Pentecost, Ryoko] St Lukes Appl Res, Boise, ID USA; [Gao, Yong] Boise State Univ, Dept Kinesiol, Boise, ID 83725 USA; [Kendrick, Leslie] Boise State Univ, Dept Radiol Sci, Boise, ID 83725 USA; [Cutchin, Steve] Boise State Univ, Dept Comp Sci, Boise, ID 83725 USA; [Pardue, Kristi] St Lukes Sport Med Concuss Clin, Boise, ID USA		Nilsson, KJ (corresponding author), St Lukes Sports Med, 1109 West Myrtle,Suite 200, Boise, ID 83702 USA.	knilsson@slhs.org		cutchin, steven/0000-0002-6515-1905			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; [Anonymous], NHANES NAT YOUTH FIT; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Frollo J, POP WARNER ELIMINATE; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; O'Connor KL, 2017, ANN BIOMED ENG, V45, P1985, DOI 10.1007/s10439-017-1843-3; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Roberts RM, 2016, DEV NEUROPSYCHOL, V41, P176, DOI 10.1080/87565641.2016.1186167; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tsushima WT, 2016, APPL NEUROPSYCH-CHIL, V5, P149, DOI 10.1080/21622965.2015.1052813; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	32	5	5	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	NOV	2019	11	6					507	513	1941738119865264	10.1177/1941738119865264		AUG 2019	7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JI0QB	WOS:000483406500001	31433735	Green Published			2022-02-06	
J	Yasmin, A; Pitkanen, A; Jokivarsi, K; Poutiainen, P; Grohn, O; Immonen, R				Yasmin, Amna; Pitkanen, Asla; Jokivarsi, Kimmo; Poutiainen, Pekka; Grohn, Olli; Immonen, Riikka			MRS Reveals Chronic Inflammation in T2w MRI-Negative Perilesional Cortex - A 6-Months Multimodal Imaging Follow-Up Study	FRONTIERS IN NEUROSCIENCE			English	Article						antioxidant; GPC plus PCho; GSH; Ins; neurochemical profile; neuroinflammation; pericontusional zone	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; IN-VIVO; NEUROCHEMICAL PROFILE; RAT-BRAIN; REGIONAL CHANGES; MODEL; GLUTATHIONE; BIOMARKERS; NEUROINFLAMMATION	Sustained inflammation in the injured cortex is a promising therapeutic target for disease-modification after traumatic brain injury (TBI). However, its extent and dynamics of expansion are incompletely understood which challenges the timing and placement of therapeutics to lesioned area. Our aim was to characterize the evolution of chronic inflammation during lesion expansion in lateral fluid-percussion injury (FPI) rat model with focus on the MRI-negative perilesional cortex. T2-weighted MR imaging (T2w MRI) and localized magnetic resonance spectroscopy (MRS) were performed at 1, 3, and 6 months post-injury. End-point histology, including Nissl for neuronal death, GFAP for astrogliosis, and Prussian Blue for iron were used to assess perilesional histopathology. An additional animal cohort was imaged with a positron emission tomography (PET) using translocator protein 18 kDa (TSPO) radiotracer [F-18]-FEPPA. T2w MRI assessed lesion growth and detected chronic inflammation along the lesion border while rest of the ipsilateral cortex was MRI-negative (MRI-). Instead, myo-inositol that is an inflammatory MRS marker for gliosis, glutathione for oxidative stress, and choline for membrane turnover were elevated throughout the 6-months follow-up in the MRI- perilesional cortex (all p < 0.05). MRS markers revealed chronically sustained inflammation across the ipsilateral cortex but did not indicate the upcoming lesion expansion. Instead, the rostral expansion of the cortical lesion was systematically preceded by a hyperintense band in T2w images months earlier. Histologic analysis of the hyperintensity indicated scattered astrocytes, incomplete glial scar, and intracellularly packed and free iron. Yet, the band was negative in [F-18]-FEPPA-PET. [F-18]-FEPPA also showed no cortical TSPO expression within the MRS voxel in MRI- perilesional cortex or anywhere along glial scar when assessed at 2 months post-injury. However, [F-18]-FEPPA showed a robust signal increase, indicating reactive microgliosis in the ipsilateral thalamus at 2 months post-TBI. We present evidence that MRS reveals chronic posttraumatic inflammation in MRI-negative perilesional cortex. The mismatch in MRS, MRI, and PET measures may allow non-invasive endophenotyping of beneficial and detrimental inflammatory processes to aid targeting and timing of anti-inflammatory therapeutics.	[Yasmin, Amna; Pitkanen, Asla; Jokivarsi, Kimmo; Grohn, Olli; Immonen, Riikka] Univ Eastern Finland, AI Vittanen Inst Mol Sci, Kuopio, Finland; [Poutiainen, Pekka] Kuopio Univ Hosp, Ctr Diagnost Imaging, Dept Cyclotron & Radiopharm, Kuopio, Finland		Immonen, R (corresponding author), Univ Eastern Finland, AI Vittanen Inst Mol Sci, Kuopio, Finland.	riikka.immonen@uef.fi		Poutiainen, Pekka/0000-0001-8148-9909	Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science; Epilepsy Research Foundation; European Regional Development FundEuropean Commission [A71429]; Medical Research Council of the Academy of FinlandAcademy of Finland [272249, 273909, 298007]; European UnionEuropean Commission [602102]	This study was supported by the Finnish Cultural Foundation, both Central Fund and North Savo Regional Fund (RI and AY), the Epilepsy Research Foundation (AY), the European Regional Development Fund project A71429 (OG, KJ, and PP), the Medical Research Council of the Academy of Finland [Grants 272249 and 273909 (AP) and Grant 298007 (OG)], and the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602102 (EPITARGET) (AP).	Ali I, 2019, NEUROBIOL DIS, V123, P100, DOI 10.1016/j.nbd.2018.08.006; Amhaoul H, 2014, NEUROSCIENCE, V279, P238, DOI 10.1016/j.neuroscience.2014.08.044; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Beckers L, 2018, MOL IMAGING BIOL, V20, P94, DOI 10.1007/s11307-017-1099-1; BENZI G, 1989, J CEREBR BLOOD F MET, V9, P373, DOI 10.1038/jcbfm.1989.56; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; CDC, 2017, RAT TBI REL EM DEP V; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chiang GC, 2017, AM J NEURORADIOL, V38, P1130, DOI 10.3174/ajnr.A5143; Choi IY, 2011, MULT SCLER J, V17, P289, DOI 10.1177/1352458510384010; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Dadas A, 2019, NEUROBIOL DIS, V123, P20, DOI 10.1016/j.nbd.2018.06.022; Duarte JMN, 2012, NEUROIMAGE, V61, P342, DOI 10.1016/j.neuroimage.2011.12.038; Duffy SL, 2014, ALZHEIMERS DEMENT, V10, P67, DOI 10.1016/j.jalz.2013.01.005; Emir UE, 2011, NMR BIOMED, V24, P888, DOI 10.1002/nbm.1646; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Filibian M, 2012, EPILEPSIA, V53, P1907, DOI 10.1111/j.1528-1167.2012.03685.x; Frigerio F, 2018, BRAIN, V141, P3130, DOI 10.1093/brain/awy247; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; GEREMIA E, 1990, NEUROCHEM RES, V15, P719, DOI 10.1007/BF00973653; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Harris JL, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00202, 10.3389/fnagi.2015.00202]; Harris JL, 2014, NEUROBIOL AGING, V35, P1686, DOI 10.1016/j.neurobiolaging.2014.01.018; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kulak A, 2010, J NEUROCHEM, V115, P1466, DOI 10.1111/j.1471-4159.2010.07051.x; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Lehto LJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3678; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; LEWIS DA, 1986, J COMP NEUROL, V248, P1, DOI 10.1002/cne.902480102; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Liu S, 2014, J HISTOCHEM CYTOCHEM, V62, P767, DOI 10.1369/0022155414546692; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mandal PK, 2015, BIOL PSYCHIAT, V78, P702, DOI 10.1016/j.biopsych.2015.04.005; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Ndode-Ekane XE, 2018, RESTOR NEUROL NEUROS, V36, P485, DOI 10.3233/RNN-170811; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pascente R, 2016, NEUROBIOL DIS, V93, P146, DOI 10.1016/j.nbd.2016.05.001; Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Shutter L, 2006, J HEAD TRAUMA REHAB, V21, P334, DOI 10.1097/00001199-200607000-00005; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tkac I, 2003, MAGN RESON MED, V50, P24, DOI 10.1002/mrm.10497; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tronel C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040802; van Vliet EA, 2017, EPILEPSIA, V58, P315, DOI 10.1111/epi.13621; Vignal N, 2018, MOLECULES, V23, pE1375, DOI [10.3390/molecules23061376, DOI 10.3390/MOLECULES23061376]; Virdee K, 2012, NEUROSCI BIOBEHAV R, V36, P1188, DOI 10.1016/j.neubiorev.2012.01.009; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Wilson AA, 2008, NUCL MED BIOL, V35, P305, DOI 10.1016/j.nucmedbio.2007.12.009; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yoo RE, 2019, EUR RADIOL, V29, P1308, DOI 10.1007/s00330-018-5656-z; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196	80	5	5	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 16	2019	13								863	10.3389/fnins.2019.00863			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IR5CH	WOS:000481450100001	31474824	gold, Green Published			2022-02-06	
J	Shen, IH; Lin, YJ; Chen, CL; Liao, CC				Shen, I-Hsuan; Lin, Ying-Ju; Chen, Chia-Ling; Liao, Cheng-Chih			Neural Correlates of Response Inhibition and Error Processing in Individuals with Mild Traumatic Brain Injury: An Event-Related Potential Study	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						error processing; event-related potential; mild traumatic brain injury; response inhibition; Stop-signal task	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; ERP COMPONENTS; ELECTROPHYSIOLOGICAL MARKERS; CHILDREN; CONFLICT; SYMPTOMS; TBI; PROBABILITY; AWARENESS	Individuals with a mild traumatic brain injury (mTBI) often have executive control deficits; however, the underlying neural mechanisms of such deficits are yet to be clarified. Inhibitory control and cognitive monitoring are two fundamental aspects of executive control processes. This study investigated the executive control of mTBI by using the Stop-signal task. Eighteen adults with mTBI and 18 age-, sex-, and education level-matched controls were recruited. Behavioral performance and event-related potential correlates of response inhibition and error processing were compared between groups. The mTBI group tended to have a lower probability of inhibition and a longer stop signal reaction time. N1 amplitude was greater on successful trials. Also on successful trials, N2 and P3 peaked earlier than on failed trials. The N2 amplitude of the mTBI group tended to be smaller than that of the controls. The control group had larger P3 amplitude on successful trials than on failed trials, whereas the mTBI group exhibited no P3 amplitudes difference between the two trial types. In addition, the mTBI group showed significantly longer error positivity latency than did the controls. These results suggest that inhibitory control and error processing were inefficient in the mTB group even more than three months after injury. Electrophysiological markers of cognitive dysfunction can be used as a sensitive tool for determining executive control after mTBI.	[Shen, I-Hsuan; Lin, Ying-Ju] Chang Gung Univ, Dept Occupat Therapy, Grad Inst Behav Sci, Coll Med, 259 Wen Hwa 1st Rd, Taoyuan 33, Taiwan; [Chen, Chia-Ling] Chang Gung Univ, Grad Inst Early Intervent, Coll Med, Taoyuan, Taiwan; [Shen, I-Hsuan; Chen, Chia-Ling] Chang Gung Mem Hosp, Linkou Branch, Dept Phys Med & Rehabil, Taoyuan, Taiwan; [Liao, Cheng-Chih] Chang Gung Mem Hosp, Dept Neurosurg, Div Neurospine, Linkou Branch, Taoyuan, Taiwan; [Lin, Ying-Ju] Sunshine Social Welf Fdn, Northern Serv Ctr, Taipei, Taiwan; [Liao, Cheng-Chih] Mennonite Christian Hosp, Dept Neurospinal Surg, Hualien, Taiwan		Shen, IH (corresponding author), Chang Gung Univ, Dept Occupat Therapy, Grad Inst Behav Sci, Coll Med, 259 Wen Hwa 1st Rd, Taoyuan 33, Taiwan.	shenih@mail.cgu.edu.tw			Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPD1C0141]	We are grateful to the participants for their enthusiastic participation in this study. The work presented in this article is supported by a research grant from Chang Gung Memorial Hospital, Taiwan, Grant No. CMRPD1C0141. A portion of this article was presented in poster form at the 23rd World Congress of Neurology (WCN 2017), Kyoto, Japan, September 2017.	Bekker EM, 2005, INT J PSYCHOPHYSIOL, V55, P191, DOI 10.1016/j.ijpsycho.2004.07.005; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Conners C. K., 2000, CONNERS CONTINUOUS P; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; Dimoska A, 2003, BIOL PSYCHIAT, V54, P1345, DOI 10.1016/S0006-3223(03)00703-0; Dimoska A, 2006, BRAIN COGNITION, V62, P98, DOI 10.1016/j.bandc.2006.03.011; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Falkenstein M, 2002, J PSYCHOPHYSIOL, V16, P167, DOI 10.1027//0269-8803.16.3.167; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Faul M, 2010, TRAUMATIC BRAIN INJU; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Konrad KN, 2000, BRAIN INJURY, V14, P859; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lachapelle J, 2008, BRAIN INJURY, V22, P265, DOI 10.1080/02699050801938983; Lansbergen MM, 2007, CLIN NEUROPHYSIOL, V118, P2089, DOI 10.1016/j.clinph.2007.06.011; Leblanc N, 2005, DEV NEUROPSYCHOL, V28, P829, DOI 10.1207/s15326942dn2803_5; Logan G.D., 1994, ABILITY INHIBIT THOU; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miltner WHR, 2003, BIOL PSYCHOL, V64, P157, DOI 10.1016/S0301-0511(03)00107-8; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Connell RG, 2009, NEUROPSYCHOLOGIA, V47, P1149, DOI 10.1016/j.neuropsychologia.2009.01.011; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Picton TW, 2007, CEREB CORTEX, V17, P826, DOI 10.1093/cercor/bhk031; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ramautar JR, 2004, BRAIN COGNITION, V56, P234, DOI 10.1016/j.bandc.2004.07.002; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Rieger M, 2002, NEUROPSYCHOLOGIA, V40, P76, DOI 10.1016/S0028-3932(01)00068-9; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Shen IH, 2014, INT J PSYCHOPHYSIOL, V91, P80, DOI 10.1016/j.ijpsycho.2013.11.004; Shen IH, 2011, INT J PSYCHOPHYSIOL, V81, P1, DOI 10.1016/j.ijpsycho.2011.03.015; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; Steer, 1990, MANUAL BECK ANXIETY; Stewart JAL, 1999, BRAIN COGNITION, V41, P411, DOI 10.1006/brcg.1999.1141; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x	61	5	5	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2018.6122		AUG 2019	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IR7EW	WOS:000481604600001	31317830				2022-02-06	
J	Mishra, VR; Sreenivasan, KR; Zhuang, XW; Yang, ZS; Cordes, D; Banks, SJ; Bernick, C				Mishra, Virendra R.; Sreenivasan, Karthik R.; Zhuang, Xiaowei; Yang, Zhengshi; Cordes, Dietmar; Banks, Sarah J.; Bernick, Charles			Understanding white matter structural connectivity differences between cognitively impaired and nonimpaired active professional fighters	HUMAN BRAIN MAPPING			English	Article						cognitive impairment; DTI; graph-theoretical analysis; repeated head impacts; RHI; rich-club analysis	TRAUMATIC BRAIN-INJURY; REPEATED HEAD TRAUMA; WORKING-MEMORY; FIBER TRACKING; DIFFUSION; NETWORKS; TRACTOGRAPHY; CRITERIA; DISEASE; BOXERS	Long-term traumatic brain injury due to repeated head impacts (RHI) has been shown to be a risk factor for neurodegenerative disorders, characterized by a loss in cognitive performance. Establishing the correlation between changes in the white matter (WM) structural connectivity measures and neuropsychological test scores might help to identify the neural correlates of the scores that are used in daily clinical setting to investigate deficits due to repeated head blows. Hence, in this study, we utilized high angular diffusion MRI (dMRI) of 69 cognitively impaired and 70 nonimpaired active professional fighters from the Professional Fighters Brain Health Study, and constructed structural connectomes to understand: (a) whether there is a difference in the topological WM organization between cognitively impaired and nonimpaired active professional fighters, and (b) whether graph-theoretical measures exhibit correlations with neuropsychological scores in these groups. A dMRI derived structural connectome was constructed for every participant using brain regions defined in AAL atlas as nodes, and the product of fiber number and average fractional anisotropy of the tracts connecting the nodes as edges. Our study identified a topological WM reorganization due to RHI in fighters prone to cognitive decline that was correlated with neuropsychological scores. Furthermore, graph-theoretical measures were correlated differentially with neuropsychological scores between groups. We also found differentiated WM connectivity involving regions of hippocampus, precuneus, and insula within our cohort of cognitively impaired fighters suggesting that there is a discernible WM topological reorganization in fighters prone to cognitive decline.	[Mishra, Virendra R.; Sreenivasan, Karthik R.; Zhuang, Xiaowei; Yang, Zhengshi; Cordes, Dietmar; Bernick, Charles] Cleveland Clin Fdn, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Cordes, Dietmar] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Banks, Sarah J.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA		Mishra, VR (corresponding author), Cleveland Clin, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA.	mishrav@ccf.org	Sreenivasan, Karthik/ABA-7605-2020; Mishra, Virendra R./ABE-1942-2020; Yang, Zhengshi/AAM-6739-2021	Sreenivasan, Karthik/0000-0002-6486-302X; Mishra, Virendra R./0000-0002-0452-6400; Cordes, Dietmar/0000-0001-6574-5546	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of HealthGeneral Electric [5P20GM109025]; KMA Young Scientist Award; Peter and Angela Dal Pezzo funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109025] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health, Grant/Award Number: 5P20GM109025; The KMA Young Scientist Award; The Peter and Angela Dal Pezzo funds	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Archer JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194878; Bachmann C, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00528; Banks S. J., 2017, CHRONIC TRAUMATIC EN, P183, DOI [10.1007/978-3-319-56484-5_13, DOI 10.1007/978-3-319-56484-5_13]; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cheng H, 2012, J NEUROSCI METH, V203, P264, DOI 10.1016/j.jneumeth.2011.09.021; Christidi F, 2016, EUR J RADIOL OPEN, V3, P153, DOI 10.1016/j.ejro.2016.06.002; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gooijers J., 2013, NEUROREHAB NEURAL RE, V30, P603; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Huang H, 2015, CEREB CORTEX, V25, P1389, DOI 10.1093/cercor/bht335; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jalili M, 2017, INFORM SCIENCES, V384, P145, DOI 10.1016/j.ins.2016.08.047; Jiang WY, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00179; Johns P., 2014, CLIN NEUROSCI, P27, DOI [10.1016/B978-0-443-10321-6.00003-5, DOI 10.1016/B978-0-443-10321-6.00003-5]; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kaminski M, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00076; Kocevar G, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00478; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Lo CYZ, 2015, P NATL ACAD SCI USA, V112, P9123, DOI 10.1073/pnas.1502052112; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; McDonald S., 1998, HDB NEUROLINGUISTICS, P485, DOI [10.1016/B978-012666055-5/50038-1, DOI 10.1016/B978-012666055-5/50038-1]; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mendez MF, 2017, J ALZHEIMERS DIS, V57, P667, DOI 10.3233/JAD-161002; Meyer ML, 2013, SOC COGN AFFECT NEUR, V8, P446, DOI 10.1093/scan/nss019; Mishra V, 2018, NEUROIMAGE-CLIN, V17, P616, DOI 10.1016/j.nicl.2017.11.013; Mishra V, 2015, MAGN RESON MED, V74, P1768, DOI 10.1002/mrm.25548; Mishra VR, 2017, RADIOLOGY, V285, P555, DOI 10.1148/radiol.2017162403; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Olejarczyk E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188629; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Osaka M, 2007, COGN AFFECT BEHAV NE, V7, P130, DOI 10.3758/CABN.7.2.130; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Philippi CL, 2015, J NEUROSCI, V35, P6068, DOI 10.1523/JNEUROSCI.5010-14.2015; Rae CL, 2012, NEUROIMAGE, V62, P1675, DOI 10.1016/j.neuroimage.2012.06.012; -Ramos CG, 2016, EPILEPSY BEHAV, V64, P329, DOI 10.1016/j.yebeh.2016.02.032; Rangaprakash D, 2018, MAGN RESON MED, V80, P1697, DOI 10.1002/mrm.27146; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Rath JF, 2004, ARCH CLIN NEUROPSYCH, V19, P613, DOI 10.1016/j.acn.2003.08.006; Rocca MA, 2016, BRAIN STRUCT FUNCT, V221, P115, DOI 10.1007/s00429-014-0896-4; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Rubin RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00742; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sala-Llonch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00663; Schinka JA, 2010, AM J GERIAT PSYCHIAT, V18, P684, DOI 10.1097/JGP.0b013e3181e56d5a; Seghier ML, 2018, TRENDS COGN SCI, V22, P517, DOI 10.1016/j.tics.2018.03.003; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Sone D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158728; Song LM, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00561; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2017, J CLIN NEUROPHYSIOL, V34, P300, DOI 10.1097/WNP.0000000000000377; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Wang JH, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fnhum.2015.00386, 10.3389/fnhum.2015.00458]; Wang R., 2007, P INT SOC MAGNETIC R, V3720, P34; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zevin J., 2009, ENCY NEUROSCIENCE, P517, DOI [10.1016/B978-008045046-9.01881-7, DOI 10.1016/B978-008045046-9.01881-7]; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; Zhao TD, 2019, NEUROIMAGE, V185, P699, DOI 10.1016/j.neuroimage.2018.06.047; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548; Zolal A, 2017, J NEUROSURG, V127, P613, DOI 10.3171/2016.8.JNS16363	83	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	DEC 1	2019	40	17					5108	5122		10.1002/hbm.24761		AUG 2019	15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	KW4QR	WOS:000480959300001	31403734	Green Published			2022-02-06	
J	Yamakawa, GR; Weerawardhena, H; Eyolfson, E; Griep, Y; Antle, MC; Mychasiuk, R				Yamakawa, Glenn R.; Weerawardhena, Himanthri; Eyolfson, Eric; Griep, Yannick; Antle, Michael C.; Mychasiuk, Richelle			Investigating the Role of the Hypothalamus in Outcomes to Repetitive Mild Traumatic Brain Injury: Neonatal Monosodium Glutamate Does Not Exacerbate Deficits	NEUROSCIENCE			English	Article						Concussion; Circadian; Behavior; Gene expression; Suprachiasmatic nucleus; Telomere	ELEVATED PLUS-MAZE; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; POSTCONCUSSION SYNDROME; PROFESSIONAL FOOTBALL; CIRCADIAN-RHYTHMS; TELOMERE LENGTH; NEUROPEPTIDE-Y; GROWTH-HORMONE; JUVENILE RATS	Repetitive mild traumatic brain injury (RmTBI) is a prevalent and costly head injury particularly among adolescents. These injuries may result in long-term consequences, especially during this critical period of development. Insomnia and sleeping difficulties are frequently reported following RmTBI and greatly impair recovery. We sought to develop an animal model of exacerbated deficits following RmTBI by disrupting the hypothalamic circadian system. To accomplish this, we conducted RmTBI on adolescent rats that had received neonatal injections of monosodium glutamate (MSG), a known hypothalamic neurotoxin. We then examined behavioral, circadian, and epigenetic changes. MSG treated rats showed lower anxiety-like behaviors and displayed poor short-term working memory. We also showed changes in the morphology of the circadian clock in the suprachiasmatic nucleus (SCN) vasoactive intestinal polypeptide (VIP) immunostaining. VIP optical density in the SCN increased with MSG but decreased with RmTBI. There were changes in the expression of the clock genes and upregulation of the orexin receptors in response to RmTBI. MSG treated rats had longer telomere lengths than controls. Finally, although both MSG and RmTBI alone produced attenuated circadian amplitudes of activity and body temperature, exacerbated deficits were not identified in animals that received MSG and RmTBI. In sum, both MSG and RmTBI can alter behavior, circadian rhythm amplitude, SCN morphology, and gene expression independently, but the effects do not appear to be additive. Specific damage in the hypothalamus and SCN should be considered when patients experience sleeping problems following RmTBI, as this may improve therapeutic strategies. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Yamakawa, Glenn R.; Weerawardhena, Himanthri; Eyolfson, Eric; Griep, Yannick; Antle, Michael C.; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yamakawa, Glenn R.; Mychasiuk, Richelle] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Yamakawa, Glenn R.; Weerawardhena, Himanthri; Eyolfson, Eric; Antle, Michael C.; Mychasiuk, Richelle] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yamakawa, Glenn R.; Weerawardhena, Himanthri; Eyolfson, Eric; Mychasiuk, Richelle] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Griep, Yannick] Stockholm Univ, Stress Res Inst, Div Epidemiol, Stockholm, Sweden		Yamakawa, GR (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	glenn.yamakawa@monash.edu		Yamakawa, Glenn/0000-0003-3079-6532; Eyolfson, Eric/0000-0002-2201-5444	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [PJT-153051]; Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC) [1304881]	This study was supported by Canadian Institutes of Health Research (CIHR) grant number: PJT-153051 and Natural Sciences and Engineering Research Council of Canada (NSERC) grant number: 1304881.	ABE M, 1990, BRAIN RES BULL, V24, P289, DOI 10.1016/0361-9230(90)90218-O; Abrahamson EE, 2001, NEUROREPORT, V12, P435, DOI 10.1097/00001756-200102120-00048; Ali MM, 2000, NEUROSCI LETT, V284, P57, DOI 10.1016/S0304-3940(00)00958-7; Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Arendt DH, 2013, BEHAV NEUROSCI, V127, P86, DOI 10.1037/a0031442; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beane ML, 2002, HORM BEHAV, V41, P33, DOI 10.1006/hbeh.2001.1725; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BLOCH B, 1984, NATURE, V307, P272, DOI 10.1038/307272a0; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Borniger JC, 2018, NEUROSCIENCE, V375, P74, DOI 10.1016/j.neuroscience.2018.01.064; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Butler IJ, 2013, JAMA NEUROL, V70, P636, DOI 10.1001/jamaneurol.2013.2801; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Rojas-Castaneda JC, 2016, INT J EXP PATHOL, V97, P18, DOI 10.1111/iep.12157; CHAMBILLE I, 1993, J COMP NEUROL, V338, P67, DOI 10.1002/cne.903380106; Clark M., 2016, TRANSLATIONAL RES TR; De Boer P, 2018, J PSYCHOPHARMACOL, V32, P668, DOI 10.1177/0269881118773745; Dubovicky M, 1997, PHARMACOL BIOCHEM BE, V56, P565, DOI 10.1016/S0091-3057(96)00427-3; Dyzma M, 2010, SLEEP MED REV, V14, P161, DOI 10.1016/j.smrv.2009.09.001; Elsner VR, 2013, EXP GERONTOL, V48, P136, DOI 10.1016/j.exger.2012.11.011; George D., 2010, SPSS WINDOWS STEP ST, V10th; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Graham YP, 1999, DEV PSYCHOPATHOL, V11, P545, DOI 10.1017/S0954579499002205; Grima NA, 2017, CURR OPIN PULM MED, V23, P493, DOI 10.1097/MCP.0000000000000429; Hashem HE, 2012, J MOL HISTOL, V43, P179, DOI 10.1007/s10735-011-9380-0; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Inutsuka Ayumu, 2013, Front Endocrinol (Lausanne), V4, P18, DOI 10.3389/fendo.2013.00018; Ishikawa K, 1997, BEHAV BRAIN RES, V83, P39, DOI 10.1016/S0166-4328(97)86043-3; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Jurasek JV, 2017, ORVOSI HETILAP, V158, P380, DOI 10.1556/650.2017.30678; Kardesler AC, 2017, TURK J MED SCI, V47, P1002, DOI 10.3906/sag-1511-92; Kiss P, 2007, NEUROTOX RES, V12, P85, DOI 10.1007/BF03033917; Kokubo M, 2018, J PHYSIOL SCI, V68, P663, DOI 10.1007/s12576-017-0580-6; Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7; Li DP, 2016, CELL MOL NEUROBIOL, V36, P1045, DOI 10.1007/s10571-015-0295-2; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; McCormick CM, 2001, PHYSIOL BEHAV, V74, P371, DOI 10.1016/S0031-9384(01)00574-1; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; MILLARD WJ, 1982, ENDOCRINOLOGY, V110, P540, DOI 10.1210/endo-110-2-540; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; MIYABO S, 1985, BRAIN RES, V339, P201, DOI 10.1016/0006-8993(85)90084-8; Mollayeva T, 2016, SLEEP MED, V20, P157, DOI 10.1016/j.sleep.2015.09.008; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Muthen L. K., 2012, MPLUS USERS GUIDE, V5th; Mychasiuk R, 2016, NEUROSCI BIOBEHAV R, V70, P189, DOI 10.1016/j.neubiorev.2016.07.013; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Nofzinger EA, 2005, ARCH GEN PSYCHIAT, V62, P387, DOI 10.1001/archpsyc.62.4.387; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Populin T, 2007, FOOD CHEM, V104, P1712, DOI 10.1016/j.foodchem.2007.03.034; Preacher K.J., 2008, LATENT GROWTH CURVE; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Schallert T, 2002, PHARM CEREBRAL ISCHE; Schoelch C, 2002, AM J PHYSIOL-ENDOC M, V283, pE604, DOI 10.1152/ajpendo.00439.2001; Schwartz JRL, 2008, CURR NEUROPHARMACOL, V6, P367, DOI 10.2174/157015908787386050; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; STEPHAN FK, 1982, PHYSIOL BEHAV, V29, P1153, DOI 10.1016/0031-9384(82)90313-4; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STETSON MH, 1976, SCIENCE, V191, P197, DOI 10.1126/science.942799; Stricker-Krongrad A, 2004, NUTR NEUROSCI, V7, P241, DOI 10.1080/10284150412331281040; TANAKA K, 1978, EXP NEUROL, V62, P191, DOI 10.1016/0014-4886(78)90050-X; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; West S. G., 1991, MULTIPLE REGRESSION; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Wiater MF, 2011, AM J PHYSIOL-REG I, V301, pR1569, DOI 10.1152/ajpregu.00168.2011; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3; Winrow CJ, 2012, NEUROPHARMACOLOGY, V62, P978, DOI 10.1016/j.neuropharm.2011.10.003; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Yan L, 2020, EUR J NEUROSCI, V51, P551, DOI 10.1111/ejn.14172; Zhou YX, 2017, J MAGN RESON IMAGING, V45, P1105, DOI 10.1002/jmri.25413	90	5	6	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 10	2019	413						264	278		10.1016/j.neuroscience.2019.06.022			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IK8SU	WOS:000476866600021	31254543				2022-02-06	
J	Carron, SF; Sun, MJ; Shultz, SR; Rajan, R				Carron, Simone F.; Sun, Mujun; Shultz, Sandy R.; Rajan, Ramesh			Inhibitory neuronal changes following a mixed diffuse-focal model of traumatic brain injury	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						calbindin (); calretinin (); cortex; fluid percussion injury; head trauma; hippocampus (); immunohistochemistry; inhibition; interneurons; neural injury; neuropeptide Y (); somatostatin (); traumatic brain injury	LATERAL FLUID-PERCUSSION; LONG-TERM POTENTIATION; NEUROPEPTIDE-Y; ANIMAL-MODEL; GABAERGIC INTERNEURONS; SYNAPTIC CONNECTIONS; GRANULE CELLS; RAT CAUSES; SOMATOSTATIN; PARVALBUMIN	Traumatic brain injury (TBI) can result in excitation: inhibition imbalance, as well as a range of chronic neurological deficits. However, how TBI affects different interneurons, and how this relates to behavioral abnormalities, remains poorly understood. This study examined the effects of a mixed diffuse-focal model of TBI, the lateral fluid percussion injury (LFPI), on interneurons, 8 weeks post-TBI in rats. Brains were labeled with antibodies against calbindin, parvalbumin, calretinin, neuropeptide Y, and somatostatin, and the number of interneurons were assessed in the cortex and hippocampus following LFPI. LFPI caused a reduction in the numbers of interneurons mediating both perisomatic and dendritic inhibition in the somatosensory cortex. In hippocampus, there were heterogenous changes in the number of interneurons while motor cortex, showed no obvious loss in any of the subsets of interneurons after TBI. In parallel to the investigations of changes in the number of interneurons, we also investigated the long-term behavioral consequences of LFPI. Behaviorally, rats given an LFPI displayed transient reduction in performance in motor tasks and were significantly impaired in reversal learning in the water maze task post-TBI. We also report here progressive neurodegeneration in cortex and hippocampus indicated by Fluoro-Jade C in the different brain areas examined after injury. Our findings suggest differential vulnerability of inhibitory neurons to LFPI in the different brain areas examined after injury. These data will aid in evaluation of new treatments for TBI and help target specific neuronal subtypes as a function of injury time and type.	[Carron, Simone F.; Rajan, Ramesh] Monash Univ, Dept Physiol, Biomed Discovery Inst, Neurosci Discovery Program, Melbourne, Vic, Australia; [Shultz, Sandy R.] Monash Univ, Dept Med & Neurosci, Melbourne, Vic, Australia; [Sun, Mujun; Shultz, Sandy R.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia		Carron, SF (corresponding author), Monash Univ, Dept Physiol, Biomed Discovery Inst, Neurosci Discovery Program, Melbourne, Vic, Australia.	simone.carron@monash.edu		Rajan, Ramesh/0000-0001-9862-0520; carron-peters, simone/0000-0002-6159-0679; Sun, Mujun/0000-0002-9923-9913	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1029311]	National Health and Medical Research Council, Grant/Award Number: APP1029311	Alwis DS, 2013, CLIN EXP PHARMACOL P, V40, P473, DOI 10.1111/1440-1681.12100; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Alwis DS, 2016, J NEUROTRAUM, V33, P1084, DOI 10.1089/neu.2014.3774; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bar-Ilan L., 2013, FRONT NEURAL CIRCUIT, V6, P118; Barinka F, 2010, PHYSIOL RES, V59, P665, DOI 10.33549/physiolres.931930; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2018, NEUROSCIENCE, V388, P152, DOI 10.1016/j.neuroscience.2018.07.020; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; CONDE F, 1994, J COMP NEUROL, V341, P95, DOI 10.1002/cne.903410109; Conti AC, 1998, J NEUROSCI, V18, P5663; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; DEMEULEMEESTER H, 1989, NEUROSCI LETT, V99, P6, DOI 10.1016/0304-3940(89)90255-3; Drexel M, 2012, J NEUROPATH EXP NEUR, V71, P312, DOI 10.1097/NEN.0b013e31824d9882; El Bahh B, 2001, BRAIN RES, V894, P209, DOI 10.1016/S0006-8993(01)02027-3; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; FITZGERALD LW, 1989, BRAIN RES, V505, P246, DOI 10.1016/0006-8993(89)91450-9; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Gonchar Y, 2002, J COMP NEUROL, V443, P1, DOI 10.1002/cne.1425; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HENDRY SHC, 1984, J NEUROSCI, V4, P2497; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARKSTEINER J, 1989, N-S ARCH PHARMACOL, V339, P173; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Noe F, 2008, BRAIN, V131, P1506, DOI 10.1093/brain/awn079; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Ouh In-Ohk, 2013, Lab Anim Res, V29, P156, DOI 10.5625/lar.2013.29.3.156; Parent JM, 1997, J NEUROSCI, V17, P3727; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; ROGERS JH, 1992, BRAIN RES, V587, P147, DOI 10.1016/0006-8993(92)91439-L; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scheyltjens I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8723623; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Toth Z, 1997, J NEUROSCI, V17, P8106; Vezzani A, 2004, NEUROPEPTIDES, V38, P245, DOI 10.1016/j.npep.2004.05.004; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhang W, 2009, J NEUROSCI, V29, P14247, DOI 10.1523/JNEUROSCI.3842-09.2009	81	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	FEB 1	2020	528	2					175	198		10.1002/cne.24746		AUG 2019	24	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	JR6YY	WOS:000481140100001	31343072	Green Published			2022-02-06	
J	Kuan, CY; Lin, YY; Chen, CY; Yang, CC; Chi, CY; Li, CH; Dong, GC; Lin, FH				Kuan, Che-Yung; Lin, Yu-Ying; Chen, Ching-Yun; Yang, Chun-Chen; Chi, Chih-Ying; Li, Chi-Han; Dong, Guo-Chung; Lin, Feng-Huei			The preparation of oxidized methylcellulose crosslinked by adipic acid dihydrazide loaded with vitamin C for traumatic brain injury	JOURNAL OF MATERIALS CHEMISTRY B			English	Article							ASCORBIC-ACID; HYALURONIC-ACID; HYDROGELS; NEUROINFLAMMATION; NEUROPROTECTION; INFLAMMATION; IMPAIRMENT; PREVENTION; DELIVERY; MODEL	Traumatic brain injury (TBI) is defined as the destruction or degeneration of brain cells due to external force. Free radical generation from the damage site is the major factor that causes post-therapeutic failure in TBI patient. In this study, an oxi-methylcellulose-adipic acid dihydrazide (oxi-MC-ADH) hydrogel was prepared as a vitamin C carrier for TBI in emergency that continuously releases vitamin C at the injured site in the brain. The results show that the oxi-MC-ADH hydrogel exhibits adequate gelation time and good biocompatibility in vitro. Vitamin C incorporated in the oxi-MC-ADH hydrogel (oxi-MC-ADH-VC) initially burst released in the first 6 h to serve as a primary treatment and then extendedly released for the secondary treatment. The analysis of gene expression and reactive oxygen species production was done to demonstrate the neuroprotective effects of the hydrogel. In vivo neurological function assays and behavioral tests show a significant improvement in the outcome in rats with TBI 3 weeks after the oxi-MC-ADH-VC hydrogel injection. This study demonstrates that the oxi-MC-ADH-VC hydrogel has a great potential in the management of TBI.	[Kuan, Che-Yung; Lin, Yu-Ying; Chi, Chih-Ying; Li, Chi-Han; Dong, Guo-Chung; Lin, Feng-Huei] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan; [Kuan, Che-Yung; Lin, Yu-Ying; Chen, Ching-Yun; Chi, Chih-Ying; Li, Chi-Han; Dong, Guo-Chung; Lin, Feng-Huei] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan Township 35053, Miaoli County, Taiwan; [Yang, Chun-Chen; Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10087, Taiwan; [Yang, Chun-Chen; Lin, Feng-Huei] Natl Taiwan Univ, Coll Engn, Taipei 10087, Taiwan		Kuan, CY; Dong, GC; Lin, FH (corresponding author), Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan.; Kuan, CY; Dong, GC; Lin, FH (corresponding author), Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Zhunan Township 35053, Miaoli County, Taiwan.; Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med, Taipei 10087, Taiwan.; Lin, FH (corresponding author), Natl Taiwan Univ, Coll Engn, Taipei 10087, Taiwan.	double@ntu.edu.tw; gcdong@nhri.org.tw	Guan, Renee/C-1843-2012; Dong, Guo-Chung/E-3950-2010	Guan, Renee/0000-0002-0070-779X; Dong, Guo-Chung/0000-0003-1159-1718; Chen, Ching-Yun/0000-0001-5218-5121; Kuan, Che-Yung/0000-0002-3349-3556	PhD Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University; National Health Research InstitutesNational Health Research Institutes, JapanNational Health Research Institutes - Taiwan [BN-106-PP-01, BN-108-PP-01]; National Health Research InstitutesNational Health Research Institutes, JapanNational Health Research Institutes - Taiwan	Che-Yung Kuan carried out his thesis research under the auspices of the PhD Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University and National Health Research Institutes. This work was supported by the National Health Research Institutes (grant numbers: BN-106-PP-01 and BN-108-PP-01).	Allahtavakoli M, 2015, BASIC CLIN PHARMACOL, V117, P335, DOI 10.1111/bcpt.12413; Anada RP, 2018, ELECTROPHORESIS, V39, P2308, DOI 10.1002/elps.201700407; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bain MK, 2013, CARBOHYD POLYM, V91, P529, DOI 10.1016/j.carbpol.2012.08.040; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barker-Collo S, 2018, BRAIN INJURY, V32, P1651, DOI 10.1080/02699052.2018.1540797; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen YC, 2013, ACTA BIOMATER, V9, P5181, DOI 10.1016/j.actbio.2012.09.039; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dalia S. A., 2018, INT J CHEM STUD, V6, P2859, DOI DOI 10.22271/chemi; Dasgupta A, 2014, ANTIOXIDANTS IN FOOD, VITAMINS AND SUPPLEMENTS: PREVENTION AND TREATMENT OF DISEASE, P277, DOI 10.1016/B978-0-12-405872-9.00015-X; Dash HH, 2018, KOREAN J ANESTHESIOL, V71, P12, DOI 10.4097/kjae.2018.71.1.12; Ding SY, 2016, NAT REV MATER, V1, DOI [10.1038/natrevmats.2016.71, 10.1038/natrevmats.2016.21]; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Gold GT, 2015, CARBOHYD POLYM, V134, P497, DOI 10.1016/j.carbpol.2015.07.101; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Hanell A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00252; Hu MH, 2017, EUR CELLS MATER, V34, P307, DOI 10.22203/eCM.v034a19; Huang CC, 2014, ADV HEALTHC MATER, V3, P1133, DOI 10.1002/adhm.201300605; Huang J, 2001, P NATL ACAD SCI USA, V98, P11720, DOI 10.1073/pnas.171325998; Khan MK, 2018, J MATER CHEM B, V6, P1640, DOI 10.1039/c7tb02966g; Krawczyk H., 2018, ISSUES INFORM SCI IN, V15, P97; Law N, 2018, J MECH BEHAV BIOMED, V77, P389, DOI 10.1016/j.jmbbm.2017.09.031; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Li L, 2018, J MATER CHEM B, V6, P2474, DOI 10.1039/c8tb00091c; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Manesh BK, 2018, PHYSIOL PHARMACOL, V22, P103; Moor E, 2006, EXP GERONTOL, V41, P303, DOI 10.1016/j.exger.2005.12.006; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Naidu KA, 2003, NUTR J, V2, DOI 10.1186/1475-2891-2-7; Nasatto PL, 2015, POLYMERS-BASEL, V7, P777, DOI 10.3390/polym7050777; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Portugal CC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal2005; Razmkon Ali, 2011, Clin Neurosurg, V58, P133; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Santos LFL, 2008, PHARMACOL BIOCHEM BE, V89, P1, DOI 10.1016/j.pbb.2007.10.007; Sharma A, 2018, THERANOSTICS, V8, P5529, DOI 10.7150/thno.29039; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Sil S, 2016, J MOL NEUROSCI, V60, P421, DOI 10.1007/s12031-016-0817-5; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang K, 2018, J MATER CHEM B, V6, P2982, DOI 10.1039/c7tb03213g; Zhang XY, 2018, INT IMMUNOPHARMACOL, V65, P438, DOI 10.1016/j.intimp.2018.10.020; Zihayat B, 2018, BIOMED ENG-APP BAS C, V30, DOI 10.4015/S1016237218500151	48	5	5	2	17	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2050-750X	2050-7518		J MATER CHEM B	J. Mat. Chem. B	AUG 7	2019	7	29					4499	4508		10.1039/c9tb00816k			10	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	IL8ZT	WOS:000477575700011					2022-02-06	
J	Terpstra, AR; Vasquez, BP; Colella, B; Tartaglia, MC; Tator, CH; Mikulis, D; Davis, KD; Wennberg, R; Green, REA				Terpstra, Alex R.; Vasquez, Brandon P.; Colella, Brenda; Tartaglia, Maria Carmela; Tator, Charles H.; Mikulis, David; Davis, Karen D.; Wennberg, Richard; Green, Robin E. A.			Comprehensive Neuropsychiatric and Cognitive Characterization of Former Professional Football Players: Implications for Neurorehabilitation	FRONTIERS IN NEUROLOGY			English	Article						sports concussion; neuropsychiatric functioning; cognitive dysfunction; executive function; neurorehabilitation	CHRONIC TRAUMATIC ENCEPHALOPATHY; SUSTAINED ATTENTION; RECURRENT CONCUSSION; INTERVIEW MINI; REACTION-TIME; NFL PLAYERS; DEPRESSION; HISTORY; IMPULSIVITY; VARIABILITY	Objectives: To identify novel targets for neurorehabilitation of people with a remote history of multiple concussions by: (1) comprehensively characterizing neuropsychiatric and cognitive functioning in former professional football players, with a focus on executive functions; (2) distinguishing concussion-related findings from pre-morbid/cohort characteristics of professional football players; and, (3) exploring the relationship between executive functions and neuropsychiatric symptoms. Participants: Sixty-one high-functioning former professional football players and 31 age-and sex-matched control participants without history of concussion or participation in contact sports. Design: Between-groups analyses. Main measures: Neuropsychiatric. Personality Assessment Inventory (PAI) clinical scales plus the Aggression treatment consideration scale; the Mini International Neuropsychiatric Interview (MINI). Cognitive. Comprehensive clinical neuropsychological battery assessing domains of verbal and visuospatial attention; speed of processing and memory; current and estimated pre-morbid IQ; and, executive functioning, including two experimental measures that were novel for this population (i.e., response inhibition and inconsistency of responding on a go/no-go task). Results: (1) Compared to control participants, former professional football players scored significantly higher on the PAI Depression, Mania, and Aggression scales, and significantly lower on response inhibition. (2) Relative to controls, former players with > 3 concussions ((x) over bar = 6.1), but not former players with <= 3 concussions ((x) over bar = 2.0), showed (i) significantly higher scores on the PAI Depression scale, (ii) significantly more MINI clinical diagnoses overall, and manic/hypomanic episodes specifically, and (iii) significantly poorer executive function. (3) Mediation analysis revealed that concussion exposure had a significant indirect effect on PAI Depression, Mania, and Aggression via inconsistency of responding on the go/no-go task. Conclusions: Notable impairments to neuropsychiatric functioning and worse performance on a sensitive experimental measure of executive function were observed; these were related to both concussion history and pre-morbid (cohort) factors. Therefore, neuropsychiatric and executive functioning should be carefully assessed in those with a remote history of multiple concussions. Moreover, former players' neuropsychiatric symptoms were associated with inconsistency of responding; this suggests that treatments targeted at response inconsistency could help to mitigate neuropsychiatric dysfunction.	[Terpstra, Alex R.; Vasquez, Brandon P.; Colella, Brenda; Green, Robin E. A.] Toronto Rehabil Inst, Cognit Neurorehabil Sci Lab, Toronto, ON, Canada; [Terpstra, Alex R.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Vasquez, Brandon P.] Baycrest, Neuropsychol & Cognit Hlth, Toronto, ON, Canada; [Colella, Brenda; Tartaglia, Maria Carmela; Tator, Charles H.; Mikulis, David; Davis, Karen D.; Wennberg, Richard; Green, Robin E. A.] Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada; [Tartaglia, Maria Carmela; Wennberg, Richard] Univ Toronto, Univ Hlth Network, Krembil Neurosci Ctr, Div Neurol, Toronto, ON, Canada; [Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Tator, Charles H.; Davis, Karen D.] Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Div Neurosurg, Toronto, ON, Canada; [Mikulis, David] Univ Toronto, Div Neuroradiol, Joint Dept Med Imaging, Toronto Western Hosp, Toronto, ON, Canada; [Davis, Karen D.] Univ Hlth Network, Krembil Res Inst, Div Brain Imaging & Behav, Syst Neurosci, Toronto, ON, Canada; [Davis, Karen D.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Davis, Karen D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Green, Robin E. A.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada		Green, REA (corresponding author), Toronto Rehabil Inst, Cognit Neurorehabil Sci Lab, Toronto, ON, Canada.; Green, REA (corresponding author), Toronto Western Hosp, Canadian Concuss Ctr, Toronto, ON, Canada.; Green, REA (corresponding author), Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada.	robin.green@uhn.ca	Vasquez, Brandon/L-9798-2019		Canadian Concussion Centre from the Toronto General and Western Hospital Foundation, Toronto, ON; Physician Services Incorporated Foundation; Canada Research Chairs programCanada Research Chairs	This work was supported by Canadian Concussion Centre funding from the Toronto General and Western Hospital Foundation, Toronto, ON, a grant from the Physician Services Incorporated Foundation (RG and DM), and the Canada Research Chairs program (RG).	Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Carter L, 2013, BRAIN COGNITION, V82, P35, DOI 10.1016/j.bandc.2013.02.002; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DeBattista Charles, 2005, Expert Rev Neurother, V5, P79, DOI 10.1586/14737175.5.1.79; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dixon T, 2004, PSYCHOL MED, V34, P811, DOI 10.1017/S0033291703001570; Etkin Amit, 2013, Dialogues Clin Neurosci, V15, P419; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gagnon I., 2017, SPORTS CONCUSSIONS C; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Helton WS, 2009, J CLIN EXP NEUROPSYC, V31, P39, DOI 10.1080/13803390801978856; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; HOLM S, 1979, SCAND J STAT, V6, P65; Junge A, 2000, AM J SPORT MED, V28, pS22; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morey, 1991, PERSONALITY ASSESSME; Multani N, 2016, J NEUROL, V263, P1342, DOI 10.1007/s00415-016-8172-6; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; Reck SG, 2011, J EXP CHILD PSYCHOL, V108, P504, DOI 10.1016/j.jecp.2010.07.010; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Smart CM, 2016, J ALZHEIMERS DIS, V52, P757, DOI 10.3233/JAD-150992; SPSS I, 2012, STAT PACK SOC SCI; Strakowski SM, 2009, BIPOLAR DISORD, V11, P41, DOI 10.1111/j.1399-5618.2008.00658.x; Swann AC, 2007, BIPOLAR DISORD, V9, P206, DOI 10.1111/j.1399-5618.2007.00357.x; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Tator CH, 2014, BRIT J SPORT MED, V48, P81, DOI 10.1136/bjsports-2013-093040; Teper R, 2013, CURR DIR PSYCHOL SCI, V22, P449, DOI 10.1177/0963721413495869; Tian YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28028; Till C, 2009, BRAIN INJURY, V23, P655, DOI 10.1080/02699050902970794; Valentine E.R., 1999, MENT HEALTH RELIG CU, V2, P59, DOI [10.1080/13674679908406332, DOI 10.1080/13674679908406332]; Vasquez BP, 2018, NEUROREHAB NEURAL RE, V32, P191, DOI 10.1177/1545968318760727; Vigil-Colet A, 2004, PERS INDIV DIFFER, V37, P1431, DOI 10.1016/j.paid.2004.01.013; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057; Zanesco AP, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00566	64	5	5	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 7	2019	10								712	10.3389/fneur.2019.00712			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IO1PQ	WOS:000479154800001	31447753	Green Published, gold			2022-02-06	
J	Masterson, CJ; Tuttle, J; Maerlender, A				Masterson, Caitlin J.; Tuttle, Julie; Maerlender, Arthur			Confirmatory factor analysis of two computerized neuropsychological test batteries: Immediate post-concussion assessment and cognitive test (ImPACT) and C3 logix	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Factor analysis; structural equation modeling; neuropsychological assessment; computerized neuropsychological testing; concussion	DIGIT MODALITIES TEST; VALIDITY; SYMBOL; SPEED; MEMORY; AGE; CONSTRUCT; DEFICITS; VERSION; FIT	Introduction: Tests of memory and speed of cognitive and motor responses have been the primary foci in sports-related concussion assessment. This study sought to assess the construct validity of neuropsychological tests within C3 Logix. Method: Results of both baseline C3 Logix and the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) computerized tests from 86 Division I collegiate athletes were submitted to a two-factor confirmatory analysis using structural equation modeling. The two factors of Speed and Memory have been confirmed in previous studies of ImPACT. Results: Results confirmed the two-factor model of ImPACT, whereas C3 Logix did not conform to a pure two-factor model. Instead, along with additional error terms, a cross-loading was required between Speed and Memory factors in order to obtain the best model fit (chi(2) = 22.91, p= 0.12, CFI = 0.94, TLI = .90, RMSEA = 0.07 (90% CI [0.00, 0.13], SRMR = .06)): all factor loadings exceeded 0.30. Conclusions: The final model suggested C3 Logix employs three pure indicators of Speed and one indicator of both Speed and Memory. The lack of a pure indicator of Memory in C3 Logix raises a concern about its specificity and ultimately, its sensitivity to a sports-related concussion.	[Masterson, Caitlin J.; Maerlender, Arthur] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA; [Tuttle, Julie] Univ Nebraska, Athlet Med, Lincoln, NE USA		Masterson, CJ (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.	cmasterson864@gmail.com					Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Brown T., 2015, CONFIRMATORY FACTOR, VSecond; Browne MW, 1992, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Charvet LE, 2014, J NEUROL SCI, V341, P79, DOI 10.1016/j.jns.2014.04.006; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Forn C, 2009, NEUROSCI LETT, V456, P11, DOI 10.1016/j.neulet.2009.03.081; Gerrard PB, 2017, ARCH CLIN NEUROPSYCH, V32, P117, DOI 10.1093/arclin/acw097; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Kattiria S. Y., 2018, HORIZONTAL DYNAMIC V; Kenny D.A., 2015, MEASURING MODEL FIT; Kibby M. Y., 2018, CHILD NEUROPSYCHOL, DOI [10.1080/09297049.2018.1556625, DOI 10.1080/09297049.2018.1556625)]; Kline RB., 2016, PRINCIPLES PRACTICE, V4th edn.; Kosinski R.A., 2010, LIT REV REACTION TIM; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lovell M. R, 2004, IMPACT VERSION 2 0 C; Lovell MR, 2007, IMPACT VERSION 6 0 C; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Neurologix Technology Inc, 2015, C3 LOG CONC MAN SYST; Nunnally J., 1994, PSYCHOMETRIC THEORY; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Smith A., 1968, SYMBOL DIGIT MODALIT; Smith A., 1982, SYMBOL DIGITS MODALI; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Valovich McLeod T., 2014, NEW HAMPSH MUSC I MA; Wheaton B., 1977, SOCIOLOGICAL METHODO, V8, P84	42	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	OCT 21	2019	41	9					925	932		10.1080/13803395.2019.1641184		AUG 2019	8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IU5KT	WOS:000478855300001	31379257	Green Published			2022-02-06	
J	Hussein, M; Fathy, W; Nabil, T; Abd Elkareem, R				Hussein, Mona; Fathy, Wael; Nabil, Tamer; Abd Elkareem, Rehab			Postoperative cognitive dysfunction and the possible underlying neurodegenerative effect of anaesthesia	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Anaesthesia; cholecystectomy; PALT; BVRT; S100B	NEURON-SPECIFIC ENOLASE; CORONARY-ARTERY-BYPASS; TRAUMATIC BRAIN-INJURY; GENERAL-ANESTHESIA; ELDERLY-PATIENTS; NEUROBIOCHEMICAL MARKERS; CARDIAC-SURGERY; MAJOR SURGERY; S100B PROTEIN; SERUM	Introduction: There is alarming evidence about the involvement of general anaesthesia in the development of postoperative cognitive dysfunction.Aim: To clarify the impact of general anaesthesia on cognitive function and to study the possible effect of general anaesthesia on serum S100B, the marker of neuronal degeneration.Methods: This is a prospective randomised controlled study carried out on 50 patients undergoing elective laparoscopic cholecystectomy under conventional general anaesthesia. Cognitive assessment for selected patients was done preoperative and 1week postoperative using Paired Associate Learning test (PALT) for assessment of verbal memory and Benton Visual Retention test (BVRT) for assessment of visual memory. Quantitative determination of serum S100B was done for all patients in the basal sample and postoperative sample by applying an enzyme- linked immunoabsorbent assay technique on am automated ELISA platform.Results: Regarding cognitive tests, there was a statistically significant difference between the mean value of preoperative PALT and postoperative PALT (p-value=.012). There was also a statistically significant difference between the mean value of preoperative BVRT and postoperative BVRT (p-value=.011). Regarding S100B, there was a statistically significant difference between preoperative and postoperative serum level (p-value=.002). There was also a statistically significant negative correlation between postoperative S100B serum level and the postoperative scores of both PALT and BVRT.Conclusion: General anaesthesia is incriminated in the development of postoperative verbal and visual memory impairment and in the postoperative increase in serum S100B, the markers of neuronal degeneration.	[Hussein, Mona] Beni Suef Univ, Dept Neurol, Bani Suwayf 62511, Egypt; [Fathy, Wael] Beni Suef Univ, Dept Anaesthesia Intens Care & Pain Management, Bani Suwayf, Egypt; [Nabil, Tamer] Beni Suef Univ, Dept Gen Surg, Bani Suwayf, Egypt; [Abd Elkareem, Rehab] Beni Suef Univ, Dept Clin & Chem Pathol, Bani Suwayf, Egypt		Hussein, M (corresponding author), Beni Suef Univ, Dept Neurol, Bani Suwayf 62511, Egypt.	mona.neuro@yahoo.com	Hussein, Mona/AAA-4587-2020; Fathy, Wael/AAZ-2035-2021	Hussein, Mona/0000-0002-7478-7008			Anwer Hisham M. F., 2006, Middle East Journal of Anesthesiology, V18, P1123; Benton AL, 1974, REVISED VISUAL RETEN; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Blaise G, 2007, ANESTHESIOLOGY ROUND, V6, P1; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Bruggemans EF, 2013, NETH HEART J, V21, P70, DOI 10.1007/s12471-012-0347-x; Bryson GL, 2006, CAN J ANAESTH, V53, P669, DOI 10.1007/BF03021625; Chen Da-qing, 2005, Chin J Traumatol, V8, P245; Chi YL, 2017, EUR REV MED PHARMACO, V21, P1346; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Fodale V, 2010, ANAESTHESIA, V65, P388, DOI 10.1111/j.1365-2044.2010.06244.x; Goto Tomoko, 2010, Masui, V59 Suppl, pS119; He X, 2017, EUR REV MED PHARMACO, V21, P2192; Herrmann M, 2000, STROKE, V31, P645, DOI 10.1161/01.STR.31.3.645; Hopkins RO, 2010, BRAIN INJURY, V24, P1478, DOI 10.3109/02699052.2010.506861; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Ji XL, 2016, INT J CLIN EXP PATHO, V9, P11911; Jildenstal PK, 2014, ANN MED SURG, V3, P100, DOI 10.1016/j.amsu.2014.07.001; Kofke WA, 2004, ANESTH ANALG, V99, P1323, DOI 10.1213/01.ANE.0000135345.03635.6A; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Linstedt U, 2002, ACTA ANAESTH SCAND, V46, P384, DOI 10.1034/j.1399-6576.2002.460409.x; Maldonado JR, 2013, AM J GERIAT PSYCHIAT, V21, P1190, DOI 10.1016/j.jagp.2013.09.005; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Portela LVC, 2002, CLIN CHEM, V48, P950; Rappold T, 2016, BRIT J ANAESTH, V116, P83, DOI 10.1093/bja/aev415; Rasmussen LS, 2003, ACTA ANAESTH SCAND, V47, P260, DOI 10.1034/j.1399-6576.2003.00057.x; Rasmussen LS, 2000, BRIT J ANAESTH, V84, P242, DOI 10.1093/oxfordjournals.bja.a013410; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; SHAW PJ, 1987, STROKE, V18, P700, DOI 10.1161/01.STR.18.4.700; Silva FP, 2016, EUR J ANAESTH, V33, P681, DOI 10.1097/EJA.0000000000000450; Spaan PEJ, 2005, NEUROPSYCHOLOGY, V19, P629, DOI 10.1037/0894-4105.19.5.629; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; van Munster BC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-21; Vatter H, 2011, ACTA NEUROCHIR SUPPL, V110, P177, DOI 10.1007/978-3-7091-0353-1_31; Vlisides P, 2012, CURR PHARM DESIGN, V18, P6232, DOI 10.2174/138161212803832344; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wan YJ, 2010, CRIT CARE MED, V38, P2190, DOI 10.1097/CCM.0b013e3181f17bcb; Wu CL, 2004, REGION ANESTH PAIN M, V29, P257, DOI 10.1016/j.rapm.2003.11.007; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005	45	5	5	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	AUG 3	2019	129	8					729	737		10.1080/00207454.2018.1561451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ5RA	WOS:000475959300001	30590973				2022-02-06	
J	Zhou, Y; Tian, M; Wang, HD; Gao, CC; Zhu, L; Lin, YX; Fang, J; Ding, K				Zhou, Yuan; Tian, Mi; Wang, Han-Dong; Gao, Chao-Chao; Zhu, Lin; Lin, Yi-Xing; Fang, Jiang; Ding, Ke			Activation of the Nrf2-ARE signal pathway after blast induced traumatic brain injury in mice	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Blast induced traumatic brain injury; shock tube; nuclear factor erythroid 2-related factor 2; heme oxygenase-1; NAD(P)H: quinone oxidoreductase-1	PROVIDES NEUROPROTECTION; VETERANS; INFLAMMATION; MODEL	Background: Treatment of blast-induced traumatic brain injury (bTBI) has been hindered. Previous studies have demonstrated that oxidative stress may contribute to the pathophysiological process. The nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) signaling pathway exhibits a protective effect after traumatic brain injury (TBI). This study explored whether the Nrf2-ARE pathway was activated in a modified bTBI mouse model.Method: Mice were randomly divided into six groups: the 6h, 1 d, 3 d, 7 d and 14 d after bTBI groups and a sham group. The protein levels of nuclear Nrf2, heme oxygenase-1 (HO-1) and NAD(P)H: quinone oxidoreductase-1 (NQO1) were detected using western blot, and HO-1 and NQO1 mRNA levels were determined by real-time quantitative polymerase chain reaction. Moreover, HO-1 and Nrf2 were localized using histological staining.Results: The protein level of the Nrf2-ARE pathway in the frontal lobe increased significantly in the 3 d after bTBI. The HO-1 and NQO1 mRNA levels also reached a peak in the frontal lobe 3 d after bTBI. The histological staining demonstrated higher expression of HO-1 in the frontal lobe and hippocampus 3 d after bTBI, when nuclear import of Nrf2 reached a peak in the frontal lobe.Conclusions: bTBI activated the Nrf2-ARE signaling pathway in the brain. The peak activation time in the frontal lobe may be 3 d after injury, and activating the Nrf2 pathway could be a new direction for treatment.	[Zhou, Yuan; Wang, Han-Dong; Gao, Chao-Chao; Zhu, Lin; Lin, Yi-Xing; Fang, Jiang; Ding, Ke] Nanjing Med Univ, Jinling Sch Clin Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Tian, Mi] Nanjing Med Univ, Jinling Sch Clin Med, Jinling Hosp, Dept Anesthesiol, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Med Univ, Jinling Sch Clin Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com	gao, chaochao/AAE-9674-2019		Youth Training Project [16QNP042]; Medical and Health Scientific Research Fund by Nanjing Military Region [ZX28]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672503]	This work was supported by grants from the Youth Training Project (No. 16QNP042), the Medical and Health Scientific Research Fund by Nanjing Military Region (No. ZX28) and the National Natural Science Foundation of China (No. 81672503).	Arun P, 2018, NEUROCHEM INT, V112, P234, DOI 10.1016/j.neuint.2017.07.014; Chavko M, 2009, SHOCK, V32, P325, DOI 10.1097/SHK.0b013e31819c38f1; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Dash PK, 2009, NEUROSCI LETT, V460, P103, DOI 10.1016/j.neulet.2009.04.028; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Dong WW, 2018, TOXICOL APPL PHARM, V346, P28, DOI 10.1016/j.taap.2018.03.020; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kalkstein S, 2017, APPL NEUROPSYCH-ADUL, V24, P92, DOI 10.1080/23279095.2015.1119693; Kawoos U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00219; Kontos AP, 2017, MIL MED, V182, P99, DOI 10.7205/MILMED-D-16-00177; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164237; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Ning J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063741; Rao KVR, 2018, J NEUROTRAUM, V35, P2077, DOI 10.1089/neu.2017.5358; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Ross D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00595; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Song AJ, 2018, NEUROL RES, V40, P139, DOI 10.1080/01616412.2017.1417686; Stokum JA, 2017, BEHAV BRAIN RES, V333, P43, DOI 10.1016/j.bbr.2017.06.038; Wei G, 2017, NEUROIMMUNOMODULAT, V24, P348, DOI 10.1159/000487998; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhou Y, 2018, DRUG DES DEV THER, V12, P4117, DOI 10.2147/DDDT.S179227; Zhou Y, 2018, CHINESE MED J-PEKING, V131, P2447, DOI 10.4103/0366-6999.243558	31	5	6	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	AUG 3	2019	129	8					801	807		10.1080/00207454.2019.1569652			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ5RA	WOS:000475959300010	30648894				2022-02-06	
J	Nordhaug, LH; Linde, M; Follestad, T; Skandsen, ON; Bjarko, VV; Skandsen, T; Vik, A				Nordhaug, Lena H.; Linde, Mattias; Follestad, Turid; Skandsen, Oystein Njolstad; Bjarko, Vera Vik; Skandsen, Toril; Vik, Anne			Change in Headache Suffering and Predictors of Headache after Mild Traumatic Brain Injury: A Population-Based, Controlled, Longitudinal Study with Twelve-Month Follow-Up	JOURNAL OF NEUROTRAUMA			English	Article						epidemiology; headache; mild traumatic brain injury; MTBI; post-traumatic headache; PTH	POST-CONCUSSION SYMPTOMS; NORD-TRONDELAG HEALTH; PREVALENCE; RISK; HOSPITALIZATION; EPIDEMIOLOGY; COMMUNITY; SEVERITY	Headache attributed to traumatic injury to the head (HAIH) is claimed to be the most common sequela following mild traumatic brain injury (MTBI), but epidemiological evidence is scarce. We explored whether patients with MTBI had an increase in headache suffering following injury compared with controls. We also studied predictors of headache. The Trondheim MTBI follow-up study is a population-based, controlled, longitudinal study. We recruited patients exposed to MTBI and controls with minor orthopedic injuries from a trauma center and a municipal outpatient clinic, and community controls from the surrounding population. Information on headache was collected through questionnaires at baseline, and 3 and 12 months post-injury. We used a generalized linear mixed model to investigate the development of headache over time in the three groups, and logistic regression to identify predictors of headache. We included 378 patients exposed to MTBI, 82 trauma controls, and 83 community controls. The MTBI-group had a larger increase in odds of headache from baseline to the first 3 months post-injury than the controls, but not from baseline to 3-12 months post-injury. Predictors for acute HAIH were female sex and pathological imaging findings on computed tomography (CT) or magnetic resonance imaging (MRI). Predictors for persistent HAIH were prior MTBI, being injured under the influence of alcohol, and acute HAIH. Patients who experience HAIH during the first 3 months post-injury have a good chance to improve before 12 months post-injury. Female sex, imaging findings on CT or MRI, prior MTBI, and being injured under the influence of alcohol may predict exacerbation of headache.	[Nordhaug, Lena H.; Linde, Mattias; Skandsen, Oystein Njolstad; Bjarko, Vera Vik; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Post Box 8905, N-7491 Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Bjarko, Vera Vik] Stavanger Univ Hosp, Div Med, Stavanger, Norway		Skandsen, T (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Post Box 8905, N-7491 Trondheim, Norway.	toril.skandsen@ntnu.no			Liaison Committee	The Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology funded the study.	Bakken A., 2012, STORE FORVENTNINGER; Boardman HF, 2005, HEADACHE, V45, P337, DOI 10.1111/j.1526-4610.2005.05071.x; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7; Headache Classification Committee of the International Headache Society (IHS), 2018, CEPHALALGIA, V38, P1, DOI [10.1177/0333102417738202., DOI 10.1177/0333102413485658]; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0774-6; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Linde M, 2011, CEPHALALGIA, V31, P585, DOI 10.1177/0333102410391488; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Nestvold K, 2005, ACTA NEUROL SCAND, V112, P13, DOI 10.1111/j.1600-0404.2005.00344.x; Nestvold K, 2007, NEUROEPIDEMIOLOGY, V29, P113, DOI 10.1159/000109825; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; RASMUSSEN BK, 1993, PAIN, V53, P65, DOI 10.1016/0304-3959(93)90057-V; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Stovner LJ, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	35	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3244	3252		10.1089/neu.2018.6328		AUG 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479858100001	31195890	Green Published, hybrid, Green Submitted			2022-02-06	
J	Snegireva, N; Derman, W; Patricios, J; Welman, KE				Snegireva, Nadja; Derman, Wayne; Patricios, Jon; Welman, Karen E.			Awareness and Perceived Value of Eye Tracking Technology for Concussion Assessment among Sports Medicine Clinicians: A Multinational Study	PHYSICIAN AND SPORTSMEDICINE			English	Article						Sports-related concussion; eye tracking; diagnostics; survey; sports medicine clinicians	FAMILY PHYSICIANS; BRAIN-INJURY; KNOWLEDGE; MANAGEMENT; EPIDEMIOLOGY; ATTITUDES; EDUCATION; COACHES; HEALTH; GAPS	Objective: The awareness of concussion as a serious and frequently occurring sports injury and its management has evolved significantly. One viable objective diagnostic tool is eye tracking technology. The authors hypothesized that while clinicians may be aware that assessing eye movements in concussed athletes can be beneficial, it is possible that, due to the novelty of the eye tracking technology and limited exposure, only a few actually use it in their practice. The study aimed to assess the awareness of eye movement deficits associated with concussion amongst sports medicine clinicians and to determine the utilization and perceptions of the eye tracking technology for concussion diagnosis. Methods: An online 18-question survey was distributed internationally from January until December 2017 and completed by 171 sports medicine clinicians (sport physicians, therapists, general practitioners, neuropsychologists) from 32 countries. Results: Respondents indicated that subjectivity of assessments remained a major limitation of established diagnostic tools. Eye tracking technology, despite its potential to attenuate this limitation, was only used by 12% of respondents. To diagnose concussion, 77% did not use any eye movement assessment tools other than own clinical assessment. With the exception of abnormal pupil light reflex, which was checked by 68%, eye movement deficits were inspected by less than half of the respondents (46.3 +/- 12%). Conclusion: Even among sports medicine clinicians who regularly attend to patients with concussions, there is insufficient awareness that concussion can lead to abnormal eye tracking behavior. Lack of exposure to the sensitive eye tracking equipment may be a limiting factor for using eye movement metrics for concussion diagnostics. Facilitating the awareness of objective methods, like eye tracking technology, may help assure the appropriate continuum of identification and treatment for concussed athletes. Increasing educational opportunities and practical experience of clinicians regarding concussive symptoms and potential innovative technology is strongly advocated.	[Snegireva, Nadja; Welman, Karen E.] Stellenbosch Univ, Movement Lab, Dept Sport Sci, Stellenbosch, South Africa; [Derman, Wayne] Stellenbosch Univ, Inst Sport & Exercise Med, Fac Med & Hlth Sci, Cape Town, South Africa; [Derman, Wayne] Int Olymp Comm IOC Res Ctr, Cape Town, South Africa; [Patricios, Jon] Univ Witwatersrand, Wits Inst Sport & Hlth, Fac Hlth Sci, Johannesburg, South Africa		Snegireva, N (corresponding author), Stellenbosch Univ, Movement Labs, Dept Sport Sci, Private Bag X1, ZA-7602 Matieland, South Africa.	nadja.snegireva@gmail.com	Derman, Wayne/ABD-6557-2020		FIFA Research Scholarship	This manuscript was funded by a FIFA Research Scholarship.	Anderson L, 2009, BRIT J SPORT MED, V43, P1079, DOI 10.1136/bjsm.2008.051086; Baarveld F, 2011, FAM PRACT, V28, P29, DOI 10.1093/fampra/cmq075; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Carroll L J, 2011, CONCUSSION CRISIS AN; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Dijkstra HP, 2014, BRIT J SPORT MED, V48, P523, DOI 10.1136/bjsports-2013-093222; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ekman A, 2006, EUR J EPIDEMIOL, V21, P103, DOI 10.1007/s10654-005-6030-4; Esquivel A, 2013, SPORTS HEALTH, V5, P258, DOI 10.1177/1941738113476850; Ferrara Michael S., 2001, J Athl Train, V36, P145; Gordon KE, 2014, BRAIN INJURY, V28, P311, DOI 10.3109/02699052.2013.862740; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kapoor N, 2004, ARCH PHYS MED REHAB, V85, P1667, DOI 10.1016/j.apmr.2003.12.044; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; KITAGAWA M, 1994, NEUROLOGY, V44, P2285, DOI 10.1212/WNL.44.12.2285; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson RB, 2019, INT J MARKET RES, V61, P534, DOI 10.1177/1470785318805305; Lebrun CM, 2017, BRIT J SPORT MED, V51; Lebrun CM, 2014, BRIT J SPORT MED, V48; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McGrann P., 2012, RCSI STUD MED J, V5, P33; Mele M.L., 2012, COGN PROCESS S, V13; Moreau WJ, 2015, J CHIROPR MED, V14, P169, DOI 10.1016/j.jcm.2015.08.003; Moser RS, 2017, BRIT J SPORT MED, V51; Oculogica, 2019, OC REC FDA MARK AUTH; Patel SS, 2012, J NEUROL SCI, V313, P35, DOI 10.1016/j.jns.2011.09.035; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; RightEye LLC, 2019, RIGHTEYE EYE TRACK S; Salisbury David, 2017, Proc (Bayl Univ Med Cent), V30, P33; Samadani U, 2016, CONCUSSION, V1, P15; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; Snegireva N, 2017, MED SCI SPORT EXER, V49, P545, DOI 10.1249/01.mss.0000518411.52246.0c; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Subramaniam A, 2018, PSYCHIAT RES, V259, P154, DOI 10.1016/j.psychres.2017.10.011; Ting WKC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00137; Tyler CW, 2011, NAT C HELD SMITH KET; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wilcockson TDW, INTELLIGENT DECISI 2, P308; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	51	5	5	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	APR 2	2020	48	2					165	172		10.1080/00913847.2019.1645577		AUG 2019	8	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	LM9OZ	WOS:000480014300001	31322973				2022-02-06	
J	Eagle, SR; Kontos, AP; Mi, Q; Flanagan, SD; Nindl, BC; Beals, K; Connaboy, C				Eagle, Shawn R.; Kontos, Anthony P.; Mi, Qi; Flanagan, Shawn D.; Nindl, Bradley C.; Beals, Kim; Connaboy, Chris			Shared Neuromuscular Performance Traits in Military Personnel with Prior Concussion	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MACHINE LEARNING; MILD TRAUMATIC BRAIN INJURY; DECISION TREE; INJURY RISK	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; LONG-TERM; MUSCULOSKELETAL INJURY; MOTOR; EPIDEMIOLOGY; RISK; RECOVERY; INCREASE	Concussions are common in military personnel and may result in increased risk of musculoskeletal injury. One plausible explanation for this risk could be that neuromotor deficiencies enhance injury risk after a concussion through altered muscular activation/contraction timing. Purpose To compare military personnel with at least one concussion during the past 1 month to 2 yr (CONCUSSED) to military branch-matched, age-matched, and Special Operations Forces group-matched controls (CONTROL) on physiological, musculoskeletal, and biomechanical performance. Methods A total of 48 (24 CONCUSSED, 24 CONTROL) male Air Force and Naval Special Warfare Operators age 19 to 34 yr participated in the study. Participants self-reported demographics/injury history and completed the following assessments: 1) physiological-body composition, anaerobic power and capacity, aerobic capacity and lactate threshold; 2) musculoskeletal-lower extremity isokinetic strength testing, including time to peak torque; and 3) biomechanical-single-leg jump and landing task, including landing kinematics of the hip, knee and ankle. A machine learning decision tree algorithm (C5.0) and one-way ANOVA were used to compare the two groups on these outcomes. Results Despite nonsignificant differences using ANOVA, the C5.0 algorithm revealed CONCUSSED demonstrated quicker time to peak knee flexion angle during the single-leg landing task (<= 0.170 s; CONCUSSED: n = 22 vs CONTROL: n = 14), longer time to peak torque in knee extension isokinetic strength testing (>500 ms; CONCUSSED: n = 18 vs CONTROL: n = 4) and larger knee flexion angle at initial contact (>7.7 degrees; CONCUSSED: n = 18 vs CONTROL: n = 2). Conclusion The findings supported the hypothesis that CONCUSSED military personnel would demonstrate altered neuromuscular control in landing strategies and muscular activation. Future research should assess prospectively neuromuscular changes after a concussion and determine if these changes increase risk of subsequent musculoskeletal injuries.	[Eagle, Shawn R.; Mi, Qi; Flanagan, Shawn D.; Nindl, Bradley C.; Beals, Kim; Connaboy, Chris] Univ Pittsburgh, Warrior Human Performance Res Ctr, Neuromuscular Res Lab, Pittsburgh, PA USA; [Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA		Eagle, SR (corresponding author), 3860 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu	Flanagan, Shawn/AAC-6018-2021; Eagle, Shawn/ABG-1388-2020; Connaboy, Christopher/AAH-4514-2020	Flanagan, Shawn/0000-0002-6531-4567; Eagle, Shawn/0000-0001-6767-1042; Connaboy, Christopher/0000-0002-9031-2192	Air Force Special Operations Command [FA8650-12-2-6271]; Office of Naval ResearchOffice of Naval Research [N00014-11-1-0929]	The results of this study are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation. The results of this study do not constitute endorsement by ACSM. The authors have no conflicts of interest to report. This study was funded by Air Force Special Operations Command (FA8650-12-2-6271) and Office of Naval Research (N00014-11-1-0929). Opinions, interpretations, conclusions, and recommendations are those of the authors and not necessarily endorsed by the Department of Defense, US Navy, US Air Force or Naval Special Warfare. The authors would also like to thank Dr. Meleesa Wohleber, Andrew J. Simonson, Deirdre McFate, Paul Morgan, Darcie Yount, Kate Perlsweig, John Haubenstricker, Chris Beck, and Dr. Matthew Darnell for their work in data collection.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Baker CS, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12252; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Davidson TW, 2016, CLIN NEUROPHYSIOL, V127, P3364, DOI 10.1016/j.clinph.2016.07.012; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2018, BRAIN INJURY, P1; Howes David, 2018, SENSES SENSATIONS CR, P1; Kim AS, 2016, CLIN BIOMECH, V35, P86, DOI 10.1016/j.clinbiomech.2016.04.010; KONONENKO I, 1993, APPL ARTIF INTELL, V7, P317, DOI 10.1080/08839519308949993; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovalekar MT, 2016, MIL MED, V181, P900, DOI 10.7205/MILMED-D-15-00262; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McPherson AL, 2018, AM J SPORTS MED; Medicine ACoS, 2013, ACSMS HLTH REL PHYS; Nindl Bradley C, 2017, J Sci Med Sport, V20 Suppl 4, pS1, DOI 10.1016/j.jsams.2017.10.029; Pandya R., 2015, INT J COMPUT APPL, V117; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Quinlan J.T., 2014, C4 5 PROGRAMS MACHIN; R Core Team, 2013, LANGUAGE ENV STAT CO, DOI DOI 11/44679/INDEX.HTM; Reed N, 2013, BRIT J SPORT MED, V47, pe1; Rodger James A., 2015, Informatics in Medicine Unlocked, V1, P17, DOI 10.1016/j.imu.2016.01.002; Shirali R, 2016, CLASSIFICATION TREES; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; Teschke K, 2000, AM J IND MED, V38, P385, DOI 10.1002/1097-0274(200010)38:4<385::AID-AJIM3>3.3.CO;2-H; Zelic I, 1997, J MED SYST, V21, P429, DOI 10.1023/A:1022880431298	41	5	6	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	AUG	2019	51	8					1619	1625		10.1249/MSS.0000000000001974			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	II7KX	WOS:000475371900007	30845049	Bronze			2022-02-06	
J	Hisle-Gorman, E; Susi, A; Gorman, GH				Hisle-Gorman, Elizabeth; Susi, Apryl; Gorman, Gregory H.			The Impact Of Military Parents' Injuries On The Health And Well-Being Of Their Children	HEALTH AFFAIRS			English	Article							TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; SYMPTOM SEVERITY; ADULT CHILDREN; SUBSTANCE USE; YOUNG-ADULTS; CHRONIC PAIN; ILL PARENTS; UNMET NEEDS; DEPRESSION	Parental injuries and illnesses affect child and family life. We hypothesized that military parental injury would adversely affect children's preventive care, injuries, maltreatment, mental health care, and psychiatric medication prescriptions. Visit and prescription data of 485,002 military-connected children ages 2-16 were tracked for two years before and two years after the injury of a parent in the period 2004-14. Adjusted negative binomial regression compared pre- and post-injury visit and prescription rates. Children with injured parents had decreased rates of preventive care visits and increased rates of visits for injuries, maltreatment, and mental health care, as well as increased psychiatric medication use, following their parent's injury. Across all categories of care, children of parents with posttraumatic stress disorder (PTSD), both alone and with traumatic brain injury, appeared to have more pronounced changes in care patterns. Parental injury and illness are associated with changes in children's health care use, and PTSD in a parent increases the effect.	[Hisle-Gorman, Elizabeth; Susi, Apryl; Gorman, Gregory H.] Uniformed Serv Univ Hlth Sci, Pediat, Bethesda, MD 20814 USA		Hisle-Gorman, E (corresponding author), Uniformed Serv Univ Hlth Sci, Pediat, Bethesda, MD 20814 USA.	elizabeth.hisle-gorman.ctr@usuhs.edu	Hisle-Gorman, Elizabeth/AAC-5820-2019	Susi, Apryl/0000-0003-2580-2563			Agha SS, 2017, EUR CHILD ADOLES PSY, V26, P253, DOI 10.1007/s00787-016-0873-y; Bould H, 2015, INT J EAT DISORDER, V48, P383, DOI 10.1002/eat.22325; Butera-Prinzi F, 2004, BRAIN INJURY, V18, P83, DOI 10.1080/0269905031000118500; Case BG, 2007, ARCH GEN PSYCHIAT, V64, P89, DOI 10.1001/archpsyc.64.1.89; Collishaw S, 2016, LANCET PSYCHIAT, V3, P49, DOI 10.1016/S2215-0366(15)00358-2; Cozza SJ, 2013, CLIN CHILD FAM PSYCH, V16, P311, DOI 10.1007/s10567-013-0141-3; Cozza SJ, 2010, J TRAUMA STRESS, V23, P112, DOI 10.1002/jts.20488; Cross D, 2018, PSYCHOL TRAUMA-US, V10, P327, DOI 10.1037/tra0000264; Eide M, 2010, PEDIATRICS, V126, P22, DOI 10.1542/peds.2009-2704; Frias A, 2015, ACTAS ESP PSIQUIATRI, V43, P221; Garcia-Amador M, 2013, EUR PSYCHIAT, V28, P240, DOI 10.1016/j.eurpsy.2012.03.006; Goodwin RD, 2007, ARCH PEDIAT ADOL MED, V161, P487, DOI 10.1001/archpedi.161.5.487; Gorman GH, 2010, PEDIATRICS, V126, P1058, DOI 10.1542/peds.2009-2856; Guenther E, 2009, J PEDIATR-US, V154, P272, DOI 10.1016/j.jpeds.2008.07.047; Hammerton G, 2015, J AM ACAD CHILD PSY, V54, P385, DOI 10.1016/j.jaac.2015.02.006; Henriksson KM, 2004, SCHIZOPHR RES, V70, P39, DOI 10.1016/j.schres.2003.11.003; Hisle-Gorman E, 2019, PSYCHIAT SERV, V70, P657, DOI 10.1176/appi.ps.201800101; Hisle-Gorman E, 2015, J AM ACAD CHILD PSY, V54, P294, DOI 10.1016/j.jaac.2014.12.017; Holmes AK, 2013, FUTURE CHILD, V23, P143, DOI 10.1353/foc.2013.0017; HORWITZ SM, 1985, MED CARE, V23, P946, DOI 10.1097/00005650-198508000-00002; Huizinga GA, 2005, EUR J CANCER, V41, P288, DOI 10.1016/j.ejca.2004.10.005; Huizinga GA, 2003, CANCER NURS, V26, P195, DOI 10.1097/00002820-200306000-00004; Huizinga GA, 2011, EUR J CANCER, V47, pS239, DOI 10.1016/S0959-8049(11)70170-8; Huizinga GA, 2011, PSYCHO-ONCOLOGY, V20, P730, DOI 10.1002/pon.1779; Jobe-Shields L, 2015, ADDICT BEHAV, V50, P117, DOI 10.1016/j.addbeh.2015.06.019; Joutsenniemi K, 2013, J EPIDEMIOL COMMUN H, V67, P703, DOI 10.1136/jech-2012-201718; Kaasboll J, 2014, J PAIN RES, V7, P483, DOI 10.2147/JPR.S67819; Kaasboll J, 2012, PAIN, V153, P1054, DOI 10.1016/j.pain.2012.02.013; Kieffer-Kristensen R, 2011, NEUROREHABILITATION, V28, P321, DOI 10.3233/NRE-2011-0660; Kieffer-Kristensen R, 2013, NEUROREHABILITATION, V32, P59, DOI 10.3233/NRE-130823; Kieffer-Kristensen R, 2011, BRAIN INJURY, V25, P752, DOI 10.3109/02699052.2011.579933; Kinnunen L, 2018, BRAIN INJURY, V32, P933, DOI 10.1080/02699052.2018.1470331; Krattenmacher T, 2012, J PSYCHOSOM RES, V72, P344, DOI 10.1016/j.jpsychores.2012.01.011; Leen-Feldner EW, 2013, CLIN PSYCHOL REV, V33, P1106, DOI 10.1016/j.cpr.2013.09.001; Leen-Feldner EW, 2011, J ANXIETY DISORD, V25, P169, DOI 10.1016/j.janxdis.2010.08.017; Seco FL, 2015, PSYCHIAT RES, V226, P507, DOI 10.1016/j.psychres.2015.02.010; Lopez-Leon S, 2018, DARU, V26, P5, DOI 10.1007/s40199-018-0204-6; Lyngsoe BK, 2018, BRIT J GEN PRACT, V68, pE97, DOI 10.3399/bjgp18X694565; McDonald FEJ, 2016, PSYCHO-ONCOLOGY, V25, P447, DOI 10.1002/pon.3942; Myhre MC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000740; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; Oh DL, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1037-7; Patterson P, 2017, PSYCHO-ONCOLOGY, V26, P1285, DOI 10.1002/pon.4421; Patwardhan I, 2017, CHILD ABUSE NEGLECT, V70, P92, DOI 10.1016/j.chiabu.2017.06.010; Phelan K, 2007, INJURY PREV, V13, P403, DOI 10.1136/ip.2006.014571; Post RM, 2016, J AFFECT DISORDERS, V191, P180, DOI 10.1016/j.jad.2015.11.038; Potter R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652355; RADKEYARROW M, 1992, J AM ACAD CHILD PSY, V31, P68, DOI 10.1097/00004583-199201000-00011; Redolfi A, 2017, BRAIN INJURY, V31, P1050, DOI 10.1080/02699052.2017.1297486; Rickerby ML, 2017, CHILD ADOL PSYCH CL, V26, P733, DOI 10.1016/j.chc.2017.06.006; Rivara FP, 2014, PEDIATRICS, V134, pE88, DOI 10.1542/peds.2013-3273; Sherman MD, 2016, PSYCHOL SERV, V13, P401, DOI 10.1037/ser0000101; Sills MR, 2007, PEDIATRICS, V119, pE829, DOI 10.1542/peds.2006-2399; Steck B, 2007, EUR CHILD ADOLES PSY, V16, P199, DOI 10.1007/s00787-006-0589-5; Tiar AMV, 2015, BRAIN INJURY, V29, P1005, DOI 10.3109/02699052.2014.976272; Timko C, 2008, PSYCHOL MED, V38, P343, DOI 10.1017/S0033291707002073; Timko C, 2009, J AFFECT DISORDERS, V113, P56, DOI 10.1016/j.jad.2008.04.023; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Visser A, 2005, PSYCHO-ONCOLOGY, V14, P746, DOI 10.1002/pon.902; Visser A, 2004, CANCER TREAT REV, V30, P683, DOI 10.1016/j.ctrv.2004.06.001; Visser A, 2007, ACTA ONCOL, V46, P67, DOI 10.1080/02841860600949560	61	5	5	0	3	PROJECT HOPE	BETHESDA	7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA	0278-2715			HEALTH AFFAIR	Health Aff.	AUG	2019	38	8					1358	1365		10.1377/hlthaff.2019.00276			8	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	IN6IB	WOS:000478780500019	31381386	hybrid			2022-02-06	
J	Howell, DR; Buckley, TA; Berkstresser, B; Wang, F; Meehan, WP				Howell, David R.; Buckley, Thomas A.; Berkstresser, Brant; Wang, Francis; Meehan, William P., III			Identification of Postconcussion Dual-Task Gait Abnormalities Using Normative Reference Values	JOURNAL OF APPLIED BIOMECHANICS			English	Article						locomotion; young adult; mild traumatic brain injury; postural balance	CONCUSSION ASSESSMENT; SPORT CONCUSSION; CONTROL DEFICITS; SYMPTOMS; ADOLESCENTS; RELIABILITY; PERFORMANCE; HISTORY; INJURY; RISK	The purpose of this study was to identify the rate of abnormal single-task and dual-task gait performance following concussion compared to uninjured controls using previously established normative reference values. The authors examined athletes with a concussion (n = 54; mean age = 20.3 [1.1] y, 46% female, tested 2.9 [1.5] d postinjury), and healthy controls were tested during their preseason baseline examination (n = 60; mean age = 18.9 [0.7] y, 37% female). Participants completed an instrumented single-/dual-task gait evaluation. Outcome variables included average walking speed, cadence, and step length. A significantly greater number of those with concussion walked with abnormal dual-task gait speed compared with the control group (56% vs 30%, P = .01). After adjusting for potential confounding variables (age, concussion history, symptom severity, and sleep), concussion was associated with lower dual-task gait speed (beta = -0.150; 95% confidence interval [CI] = -0.252 to -0.047), cadence (beta = -8.179; 95% CI = -14.49 to -1.871), and stride length (beta = -0.109; 95% CI = -0.204 to -0.014). Although group analyses indicated that those with a concussion performed worse on single-task and dual-task gait compared with controls, a higher rate of abnormal gait was detected for the concussion group compared with the control group for dual-task gait speed only. Dual-task gait speed, therefore, may be considered as a measure to compare against normative values to detect postconcussion impairments.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE USA; [Berkstresser, Brant; Wang, Francis] Harvard Univ, Hlth Serv, Cambridge, MA 02138 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.	David.Howell@ucdenver.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01NS100952-01A1]; Eastern Athletic Trainers Association, Inc.; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R 03HD094560-01]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS100952-01A1, 1R41NS103698-01A1, R03NS104371]; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; Office of Naval ResearchOffice of Naval Research [N00014-18-1-2018]; University of MichiganUniversity of Michigan System [W81XWH-14-2-0151]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS104371] Funding Source: NIH RePORTER	This study was funded by research grants from the National Institutes of Health (1R01NS100952-01A1) and Eastern Athletic Trainers Association, Inc. The authors would like to acknowledge Anna Brilliant for her assistance with the collection of data. Dr D.R.H. has received research support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1R 03HD094560-01), the National Institute of Neurological Disorders and Stroke (1R01NS100952-01A1 and 1R41NS103698-01A1), and from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. Dr W.P.M. receives royalties from (1) ABC-CLIO publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in the Young Athlete, and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. Dr T.A.B. has received funding from the National Institute of Neurological Disorders and Stroke (R03NS104371), the Office of Naval Research (N00014-18-1-2018), and as a subcontract from the University of Michigan for participation in the NCAA-DoD Grand Alliance Concussion, Assessment, Research, and Education project (W81XWH-14-2-0151). The remaining authors have conflicts to disclose.	Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Grants L, 2017, INT J SPORTS PHYS TH, V12, P1011, DOI 10.26603/ijspt20171011; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Hanninen T, 2018, J SCI MED SPORT, V21, P794, DOI 10.1016/j.jsams.2017.12.001; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J NEUROTRAUM, V34, P3288, DOI 10.1089/neu.2017.5191; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Manaseer TS, 2020, CLIN J SPORT MED, V30, pS11, DOI 10.1097/JSM.0000000000000537; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Poltavski D, 2017, OPTOMETRY VISION SCI, V94, P742, DOI 10.1097/OPX.0000000000001094; PUBMED ID, MSS, DOI DOI 10.1249/MSS.0B013E318258A9FB; PUBMED ID, MSS, DOI DOI 10.1249/MSS.0B013E318258A9FB; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; WINTER D, 2014, GAIT POSTURE, V96, P82849, DOI DOI 10.1016/0966-6362	36	5	5	0	9	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2019	35	4					290	296		10.1123/jab.2018-0454			7	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IR7SN	WOS:000481641300007	31141425				2022-02-06	
J	McGuire, SA; Ryan, MC; Sherman, PM; Sladky, JH; Rowland, LM; Wijtenburg, SA; Hong, LE; Kochunov, PV				McGuire, Stephen A.; Ryan, Meghann C.; Sherman, Paul M.; Sladky, John H.; Rowland, Laura M.; Wijtenburg, S. Andrea; Hong, L. Elliot; Kochunov, Peter, V			White matter and hypoxic hypobaria in humans	HUMAN BRAIN MAPPING			English	Article						diffusion tensor imaging; FLAIR; hypobaric exposure; magnetic resonance spectroscopy; pseudo continuous arterial spin labeling	ALTITUDE DECOMPRESSION-SICKNESS; TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; PROFESSIONAL SOCCER PLAYERS; SERVICE MEMBERS; GAS EMBOLI; PILOTS; INTEGRITY; MRI; HYPERINTENSITIES	Occupational exposure to hypobaria (low atmospheric pressure) is a risk factor for reduced white matter integrity, increased white matter hyperintensive burden, and decline in cognitive function. We tested the hypothesis that a discrete hypobaric exposure will have a transient impact on cerebral physiology. Cerebral blood flow, fractional anisotropy of water diffusion in cerebral white matter, white matter hyperintensity volume, and concentrations of neurochemicals were measured at baseline and 24 hr and 72 hr postexposure in N = 64 healthy aircrew undergoing standard US Air Force altitude chamber training and compared to N = 60 controls not exposed to hypobaria. We observed that hypobaric exposure led to a significant rise in white matter cerebral blood flow (CBF) 24 hr postexposure that remained elevated, albeit not significantly, at 72 hr. No significant changes were observed in structural measurements or gray matter CBF. Subjects with higher baseline concentrations of neurochemicals associated with neuroprotection and maintenance of normal white matter physiology (glutathione, N-acetylaspartate, glutamate/glutamine) showed proportionally less white matter CBF changes. Our findings suggest that discrete hypobaric exposure may provide a model to study white matter injury associated with occupational hypobaric exposure.	[McGuire, Stephen A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Ryan, Meghann C.; Rowland, Laura M.; Wijtenburg, S. Andrea; Hong, L. Elliot; Kochunov, Peter, V] Univ Maryland, Sch Med, Dept Psychiat, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA; [Sherman, Paul M.; Sladky, John H.] US Air Force, Sch Aerosp Med, 59MDW USAFSAM FHOH, San Antonio, TX USA		McGuire, SA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.; Sladky, JH (corresponding author), 8930 Woodland Pass, Boerne, TX 78006 USA.	dr.stephen.mcguire@gmail.com; john.h.sladky.mil@mail.mil			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32MH067533, R01EB015611, U01MH108148, R01MH096263, R01MH094520]; U.S. Air ForceUnited States Department of Defense [I-11-44, I-11-10]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB015611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH108148, R01MH094520, R01MH096263, R01MH116948, T32MH067533, R01MH112180] Funding Source: NIH RePORTER	NIH, Grant/Award Numbers: T32MH067533, R01EB015611, U01MH108148, R01MH096263, R01MH094520; U.S. Air Force, Grant/Award Numbers: I-11-44, I-11-10	Acheson A, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.615; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Arngrim N, 2016, BRAIN, V139, P723, DOI 10.1093/brain/awv359; Balldin UI, 2004, AVIAT SPACE ENVIR MD, V75, P969; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; DoD, 2011, DOD INSTR 3216 02 32; ERECINSKA M, 1990, PROG NEUROBIOL, V35, P245, DOI 10.1016/0301-0082(90)90013-7; Fayed N, 2006, AM J MED, V119, pe161, DOI DOI 10.1016/J.AMJMED.2005.07.062; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gentry J, 2017, AEROSP MED HUM PERF, V88, P427, DOI 10.3357/AMHP.4691.2017; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hundemer GL, 2012, AVIAT SPACE ENVIR MD, V83, P968, DOI 10.3357/ASEM.3201.2012; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jersey SL, 2011, AVIAT SPACE ENVIR MD, V82, P673, DOI 10.3357/ASEM.2851.2011; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kochunov P, 2010, NEUROIMAGE, V49, P1190, DOI 10.1016/j.neuroimage.2009.09.052; Kochunov P, 2011, HYPERTENSION, V57, P330, DOI 10.1161/HYPERTENSIONAHA.110.162206; Kochunov P, 2010, STROKE, V41, P2137, DOI 10.1161/STROKEAHA.110.590943; Kochunov P, 2009, HUM BRAIN MAPP, V30, P2581, DOI 10.1002/hbm.20689; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lawley JS, 2014, ANN NEUROL, V75, P890, DOI 10.1002/ana.24171; McGuire S, 2013, NEUROLOGY, V81, P729, DOI 10.1212/WNL.0b013e3182a1ab12; McGuire SA, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.759; McGuire SA, 2016, AEROSP MED HUM PERF, V87, P983, DOI 10.3357/AMHP.4585.2016; McGuire SA, 2014, ANN NEUROL, V76, P719, DOI 10.1002/ana.24264; McGuire SA, 2014, NEUROLOGY, V83, P638, DOI 10.1212/WNL.0000000000000694; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P1117, DOI 10.3357/ASEM.3395.2012; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Pilmanis AA, 1996, AVIAT SPACE ENVIR MD, V67, P1092; Pinheiro J, 2008, NLME LINEAR NONLINEA; Rice GM, 2003, AVIAT SPACE ENVIR MD, V74, P56; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soher BJ, 2007, J MAGN RESON, V185, P291, DOI 10.1016/j.jmr.2007.01.005; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Tatel DF, 2016, J NEUROL, V263, P2065, DOI 10.1007/s00415-016-8236-7; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; van Gelderen P, 2008, MAGN RESON MED, V59, P788, DOI 10.1002/mrm.21515; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Wang JJ, 2002, MAGN RESON MED, V48, P242, DOI 10.1002/mrm.10211; Webb JT, 2003, AVIAT SPACE ENVIR MD, V74, P2; Wellcome Trust Centre for Neuroimaging, 2015, STAT PAR MAPP 8 SPM8; Wey HY, 2011, J CEREBR BLOOD F MET, V31, P715, DOI 10.1038/jcbfm.2010.154; Zhang HY, 2012, HIGH ALT MED BIOL, V13, P118, DOI 10.1089/ham.2011.1073	50	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	AUG 1	2019	40	11					3165	3173		10.1002/hbm.24587			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	IF0RQ	WOS:000472785400003	30927318	Bronze, Green Published, Green Accepted			2022-02-06	
J	Saha, P; Gupta, R; Sen, T; Sen, N				Saha, Pampa; Gupta, Rajaneesh; Sen, Tanusree; Sen, Nilkantha			Histone Deacetylase 4 Downregulation Elicits Post-Traumatic Psychiatric Disorders through Impairment of Neurogenesis	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; stem cells; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; OXIDATIVE STRESS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; SYNAPTIC PLASTICITY; CELL-PROLIFERATION; DENTATE GYRUS; QUANTAL SIZE; RAT MODEL	An enduring deficit in neurogenesis largely contributes to the development of severe post-traumatic psychiatric disorders such as anxiety, depression, and memory impairment following traumatic brain injury (TBI); however, the mechanism remains obscure. Here we have shown that an imbalance in the generation of gamma-aminobutyric acid (GABA)ergic and glutamatergic neurons due to aberrant induction of vesicular glutamate transporter 1 (vGlut1)-positive glutamatergic cells is responsible for impaired neuronal differentiation in the hippocampus following TBI. To elucidate the molecular mechanism, we found that TBI activates a transcription factor, Pax3, by increasing its acetylation status, and subsequently induces Ngn2 transcription. This event, in turn, augments the vGlut1-expressing glutamatergic neurons and accumulation of excess glutamate in the hippocampus that can affect neuronal differentiation. In our study the acetylation of Pax3 was increased due to loss of its interaction with a deacetylase, histone deacetylase 4 (HDAC4), which was downregulated after TBI. TBI-induced activation of GSK3 beta was responsible for the degradation of HDAC4. We also showed that overexpression of HDAC4 before TBI reduces Pax3 acetylation by restoring an interaction between HDAC4 and Pax3 in the hippocampus. This event prevents the aberrant induction of vGlut1-positive glutamatergic neurons by decreasing the Ngn2 level and subsequently reinforces the balance between GABAergic and glutamatergic neurons following TBI. Further, we found that overexpression of HDAC4 in the hippocampus improves anxiety, depressive-like behavior, and memory functions following TBI.	[Saha, Pampa; Gupta, Rajaneesh; Sen, Tanusree; Sen, Nilkantha] Univ Pittsburgh, Dept Neurol Surg, Scaife Hall A504,200 Lothrop St, Pittsburgh, PA 15213 USA		Sen, N (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Scaife Hall A504,200 Lothrop St, Pittsburgh, PA 15213 USA.	senn@pitt.edu	Sen, Nilkantha/AAW-9788-2020; Gupta, Rajaneesh/AAD-5893-2019	Gupta, Rajaneesh/0000-0003-0212-6478	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1NS094516, RO1EY025622]; University of PittsburghUniversity of Pittsburgh; Copeland Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY025622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094516] Funding Source: NIH RePORTER	This work was partly supported by the National Institutes of Health (Grants RO1NS094516 and RO1EY025622 to N.S.) and funding from University of Pittsburgh and Copeland Foundation to R.G, T.S, and N.S.	Abrous DN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018952; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Anacker C, 2018, NATURE, V559, P98, DOI 10.1038/s41586-018-0262-4; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Aroniadou-Anderjaska V, 2012, NEUROSCIENCE, V221, P157, DOI 10.1016/j.neuroscience.2012.07.006; Bartlett D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124154; Beckervordersandforth R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018879; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Cernotta N, 2011, MOL BIOL CELL, V22, P278, DOI 10.1091/mbc.E10-07-0616; Cheng BR, 2016, TECHNOL CANCER RES T, V15, P69, DOI 10.7785/tcrt.2012.500447; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Christian KM, 2014, ANNU REV NEUROSCI, V37, P243, DOI 10.1146/annurev-neuro-071013-014134; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Daniels RW, 2011, NEUROBIOL DIS, V41, P415, DOI 10.1016/j.nbd.2010.10.009; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Guida F, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00095; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; Helms AW, 2005, DEVELOPMENT, V132, P2709, DOI 10.1242/dev.01859; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hindley C, 2012, DEVELOPMENT, V139, P1718, DOI 10.1242/dev.077552; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Huang TT, 2012, SEMIN CELL DEV BIOL, V23, P738, DOI 10.1016/j.semcdb.2012.04.003; Ichi S, 2011, MOL BIOL CELL, V22, P503, DOI 10.1091/mbc.E10-06-0541; Imayoshi I, 2014, NEURON, V82, P9, DOI 10.1016/j.neuron.2014.03.018; Jones S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-226; Jouvert P, 2004, J NEUROSCI, V24, P10716, DOI 10.1523/JNEUROSCI.1398-04.2004; Juliandi B, 2015, STEM CELL REP, V5, P996, DOI 10.1016/j.stemcr.2015.10.012; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Kim DS, 2005, BRAIN RES, V1055, P122, DOI 10.1016/j.brainres.2005.06.081; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Koblar SA, 1999, J NEUROSCI RES, V56, P518, DOI 10.1002/(SICI)1097-4547(19990601)56:5<518::AID-JNR7>3.0.CO;2-8; Li J, 1999, DEVELOPMENT, V126, P2495; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Mattar P, 2008, MOL CELL BIOL, V28, P1456, DOI 10.1128/MCB.01510-07; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; MELDRUM BS, 1994, NEUROLOGY, V44, P14; Mielcarek M, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00042; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neuberger EJ, 2017, STEM CELL REP, V9, P972, DOI 10.1016/j.stemcr.2017.07.015; Pariyar R, 2017, PHYTOMEDICINE, V36, P8, DOI 10.1016/j.phymed.2017.09.008; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Petrik D, 2012, NEUROPHARMACOLOGY, V62, P21, DOI 10.1016/j.neuropharm.2011.09.003; Prigatano GP, 2005, ACT NEUR S, V93, P39; Raudensky J, 2007, BRAIN RES, V1135, P129, DOI 10.1016/j.brainres.2006.12.002; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Roybon L, 2010, CEREB CORTEX, V20, P1234, DOI 10.1093/cercor/bhp187; Roybon L, 2009, EUR J NEUROSCI, V29, P232, DOI 10.1111/j.1460-9568.2008.06595.x; Saha P, 2018, NEUROBIOL DIS, V118, P108, DOI 10.1016/j.nbd.2018.07.010; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schaffer DJ, 2010, BRAIN RES, V1362, P32, DOI 10.1016/j.brainres.2010.09.041; Sen T, 2017, J NEUROSCI, V37, P5900, DOI 10.1523/JNEUROSCI.2343-16.2017; Sen T, 2016, NEUROPHARMACOLOGY, V107, P79, DOI 10.1016/j.neuropharm.2016.03.009; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Touret M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-69; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang ZK, 2014, EPIGENOMICS-UK, V6, P139, DOI 10.2217/epi.13.73; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xu L, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00498; Yau SY, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/717958; Yuan TF, 2015, STEM CELL REV REP, V11, P706, DOI 10.1007/s12015-015-9603-y; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310; Zhu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12184-y	98	5	5	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3284	3296		10.1089/neu.2019.6373		AUG 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479853800001	31169064	Green Published			2022-02-06	
J	Tang, B; Zhong, Z; Qiu, Z; Wu, HP; Hu, JY; Ma, JP; Wu, JP				Tang, Bei; Zhong, Ze; Qiu, Zheng; Wu, Hui-Ping; Hu, Jia-Yuan; Ma, Jian-Ping; Wu, Jin-Ping			Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Tumor necrosis factor-like weak inducer of apoptosis; Inflammation; Severity; Prognosis	WEAK INDUCER; MULTIFUNCTIONAL CYTOKINE; RECEPTOR FN14; NEUROINFLAMMATION; INHIBITION; SCORE	Background: Severe traumatic brain injury (sTBI) is characterized by a high mortality. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) participates in inflammation. We determined serum soluble TWEAK (sTWEAK) levels with respect to its prognostic ability. Methods: This was a single-center prospective, observational study that was performed from December 2014 to December 2017. A total of 114 sTBI patients who met the inclusion criteria and 114 randomly selected healthy controls were included in the study. Serum sTWEAK levels were gauged. Patients were followed-up until death or completion of 6 months. Poor outcome was referred to as Glasgow outcome scale score of 1-3. Results: In comparison with controls, patients displayed predominantly higher serum sTWEAK levels. Serum sTWEAK levels were strongly correlated with Glasgow coma scale scores and serum C-reactive protein levels. 32 patients (28.1%) died and 60 patients (52.6%) suffered from a poor outcome. Receiver operating characteristic curve analysis clearly showed that serum sTWEAK levels had substantially high predictive performance for 6-month mortality and poor outcome. Serum sTWEAK emerged as an independent predictor for 6-month mortality, overall survival and poor outcome. Conclusions: Raised serum sTWEAK levels are closely related to increasing inflammatory response, elevated trauma severity and worse clinical outcome after sTBI.	[Tang, Bei; Zhong, Ze; Wu, Hui-Ping; Hu, Jia-Yuan; Ma, Jian-Ping; Wu, Jin-Ping] First Peoples Hosp Jiande City, Dept Crit Care Med, 599 Yanzhou Main Rd, Jiande 311600, Peoples R China; [Qiu, Zheng] First Peoples Hosp Jiande City, Dept Neurosurg, 599 Yanzhou Main Rd, Jiande 311600, Peoples R China		Zhong, Z (corresponding author), First Peoples Hosp Jiande City, Dept Crit Care Med, 599 Yanzhou Main Rd, Jiande 311600, Peoples R China.	jdsytbzz@126.com					Sanz AB, 2011, KIDNEY INT, V80, P708, DOI 10.1038/ki.2011.180; Cabrera-Pastor A, 2019, ACTA PHYSIOL, V226, DOI 10.1111/apha.13270; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Du Q, 2018, CLIN CHIM ACTA, V487, P145, DOI 10.1016/j.cca.2018.09.035; Finneran DJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1412-9; Gogoleva VS, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1089, DOI 10.1134/S0006297918090110; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Huhn K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00084; Icli Abdullah, 2018, Acta Medica (Hradec Kralove), V61, P86, DOI 10.14712/18059694.2018.123; Inta I, 2008, J NEUROL SCI, V275, P117, DOI 10.1016/j.jns.2008.08.005; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jochems D, 2018, CRIT CARE RES PRACT, V2018, DOI 10.1155/2018/3769418; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Liu SY, 2018, J DIABETES INVEST, V9, P1182, DOI 10.1111/jdi.12828; Liu ZC, 2012, INFLAMM RES, V61, P277, DOI 10.1007/s00011-011-0420-8; Luo LF, 2019, CLIN CHIM ACTA, V488, P25, DOI 10.1016/j.cca.2018.10.035; Maarouf A, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1789-3; Mahadewa TGB, 2018, OPEN ACCESS EMERG M, V10, P135, DOI 10.2147/OAEM.S179090; Mustonen E, 2012, ANN MED, V44, P793, DOI 10.3109/07853890.2011.614635; Nayak Raghavendra, 2018, Asian J Neurosurg, V13, P685, DOI 10.4103/ajns.AJNS_232_16; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Ren MY, 2012, MOL BIOL REP, V39, P9971, DOI 10.1007/s11033-012-1867-6; Safavynia SA, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00752; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Shahid S, 2019, EUR J OBSTET GYN R B, V234, P165, DOI 10.1016/j.ejogrb.2019.01.020; van Dijck JT, 2018, J NEUROSURG SCI, V62, P153, DOI 10.23736/S0390-5616.17.04255-2; Wen J, 2015, J AUTOIMMUN, V60, P40, DOI 10.1016/j.jaut.2015.03.005; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Yang DB, 2014, PEPTIDES, V58, P26, DOI 10.1016/j.peptides.2014.05.015; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0; Yepes M, 2007, MOL NEUROBIOL, V35, P255, DOI 10.1007/s12035-007-0024-z; Yepes M, 2007, FRONT BIOSCI-LANDMRK, V12, P2272; Yepes M, 2006, DRUG NEWS PERSPECT, V19, P589, DOI 10.1358/dnp.2006.19.10.1068005; Zhang XH, 2007, J CEREBR BLOOD F MET, V27, P534, DOI 10.1038/sj.jcbfm.9600368	36	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2019	495						227	232		10.1016/j.cca.2019.04.070			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	IL0CR	WOS:000476964200036	31009601				2022-02-06	
J	Wade, SL; Raj, SP; Moscato, EL; Narad, ME				Wade, Shari L.; Raj, Stacey P.; Moscato, Emily L.; Narad, Megan E.			Clinician Perspectives Delivering Telehealth Interventions to Children/Families Impacted by Pediatric Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						clinicians; pediatric traumatic brain injury; telepsychology	PARENTING SKILLS PROGRAM; PROBLEM-SOLVING INTERVENTION; PSYCHIATRIC-DISORDERS; BEHAVIOR PROBLEMS; RANDOMIZED-TRIAL; LONG-TERM; ADOLESCENTS; CHILDREN; OUTCOMES; FEASIBILITY	Purpose: Technological advances have made the delivery of psychological interventions via web-based platforms increasingly feasible. In recent years, there has been growth in the delivery of psychological interventions through web-based modalities, that is, telepsychology. Although there is evidence supporting the usability and feasibility of telepsychology for a range of populations. there is limited literature on clinician perceptions delivering telepsychology, particularly to pediatric rehabilitation populations. In this mixed-methods study, we report on clinician perspectives and experiences delivering telepsychology to children/families impacted by pediatric traumatic brain injury. Method: Seventeen clinicians (psychologists and advanced psychology doctoral students) who delivered telepsychology interventions to children/families impacted by pediatric brain injuries completed surveys and interviews. Results: Overall, clinicians repotted that telepsychology was equivalent to face-to-face treatment in many regards (e.g., therapeutic alliance, weekly progress, child/family engagement. and establishing rapport). Clinicians reported a number of advantages of telepsychology over face-to-face interventions for this pediatric population including greater ease of scheduling, increased understanding of the family and home environments, and less caregiver stigma of behavioral health care. Disadvantages of telepsychology included difficulties reading nonverbal cues. logistical/technological issues, and greater disruptions during sessions. Conclusions: Findings provide an important foundation for future investigations examining the merits of telepsychology versus traditional treatment for both pediatric rehabilitation populations.	[Wade, Shari L.; Moscato, Emily L.; Narad, Megan E.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wade, Shari L.; Moscato, Emily L.] Univ Cincinnati, Dept Psychol, Cincinnati, OH USA; [Raj, Stacey P.] Xavier Univ, Sch Psychol, Cincinnati, OH 45207 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org		Raj, Stacey/0000-0002-3500-4402			Albicini M., 2015, FRESH LOOK ANXIETY D, P199, DOI [10.5772/57353, DOI 10.5772/57353, DOI 10.5772/60426]; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Blaha RZ, 2015, J HEAD TRAUMA REHAB, V30, pE33, DOI 10.1097/HTR.0000000000000059; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Calvert SL, 2005, AM BEHAV SCI, V48, P590, DOI 10.1177/0002764204271508; Creswell J.W., 2013, RES DESIGN QUALITATI; Davis AM, 2013, J PEDIATR PSYCHOL, V38, P932, DOI 10.1093/jpepsy/jst005; Haarbauer-Krupa J, 2018, JAMA PEDIATR, V172, P1078, DOI 10.1001/jamapediatrics.2018.2740; Henderson EM, 2012, J PEDIATR PSYCHOL, V37, P1116, DOI 10.1093/jpepsy/jss085; Hilty DM, 2016, J CHILD ADOL PSYCHOP, V26, P283, DOI 10.1089/cap.2015.0129; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Joint Task Force Dev Telepsycholog, 2013, AM PSYCHOL, V68, P791, DOI 10.1037/a0035001; Karver CL, 2014, ARCH PHYS MED REHAB, V95, P1556, DOI 10.1016/j.apmr.2014.03.030; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lingely-Pottie P, 2006, J TELEMED TELECARE, V12, P396, DOI 10.1258/135763306779378690; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Narad ME, 2015, J DEV BEHAV PEDIATR, V36, P700, DOI 10.1097/DBP.0000000000000208; Nelson EL, 2010, J CLIN PSYCHOL, V66, P490, DOI 10.1002/jclp.20682; Nezu AM, 2006, PROBLEM SOLVING THER; Palermo TM, 2009, PAIN, V146, P205, DOI 10.1016/j.pain.2009.07.034; Raj SP, 2015, J HEAD TRAUMA REHAB, V30, P347, DOI 10.1097/HTR.0000000000000052; Richardson LK, 2009, CLIN PSYCHOL-SCI PR, V16, P323, DOI 10.1111/j.1468-2850.2009.01170.x; Ritterband LM, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1081; Ronzio CR, 2006, AM J ORTHOPSYCHIAT, V76, P37, DOI 10.1037/0002-9432.76.1.37; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Slone NC, 2012, PSYCHOL SERV, V9, P272, DOI 10.1037/a0027607; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Van Allen J, 2011, CHILD ADOL PSYCH CL, V20, P55, DOI 10.1016/j.chc.2010.09.003; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0422; Wade SL, 2017, J AM ACAD CHILD PSY, V56, P930, DOI 10.1016/j.jaac.2017.09.413; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, REHABIL PSYCHOL, V59, P1, DOI 10.1037/a0034911; Wade SL, 2012, HEALTH PSYCHOL, V31, P767, DOI 10.1037/a0028440; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2009, J PEDIATR PSYCHOL, V34, P517, DOI 10.1093/jpepsy/jsn081; Wade SL, 2004, BEHAV RES METH INS C, V36, P261, DOI 10.3758/BF03195572; Zhang Y., 2009, QUALITATIVE ANAL CON	41	5	5	0	8	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2019	64	3					298	306		10.1037/rep0000268			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IE7MX	WOS:000472559200006	30816734				2022-02-06	
J	Wilson, ML; Tenovuo, O; Gissler, M; Saarijarvi, S				Wilson, Michael Lowery; Tenovuo, Olli; Gissler, Mika; Saarijarvi, Simo			Association between parent mental health and paediatric TBI: epidemiological observations from the 1987 Finnish Birth Cohort	INJURY PREVENTION			English	Article						traumatic brain injury; mental health; adolescent; child	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; SEX-DIFFERENCES; CHILDREN; MOTHERS; ADOLESCENTS; PREVALENCE; ILLNESS; IMPACT; CANCER	Background This study examined whether parental mental illness has implications for child risk for traumatic brain injuries (TBI). Method Data on 60 069 Finnish children born in 1987 and their parents were examined for demographic and mental health-related variables in relationship with paediatric TBI. Altogether, 15 variables were derived from the cohort data with ICD-10 F-codes being available for mental health diagnoses for all parents. Bivariate and multivariate analyses were carried out using inpatient and outpatient diagnoses of child TBI. Results Paternal disorders due to psychoactive substance use (F10-F19) was associated with an increased inpatient TBI (OR=1.51; CI=1.07 to 2.14). Mood disorders (F30-F39) were associated with higher rates of outpatient TBI (OR=1.42; CI=1.06 to 1.90). Paternal personality and behavioural disorders (F60-F69) were linked with a twofold increase in risk across both categories of child TBI (OR=2.35; CI=1.41 to 3.90) and (OR=2.29; CI=1.45 to 3.61), respectively. Among the maternal mental health factors associated with child TBI, schizophrenia and other non-mood psychotic disorders (F20-F29) were associated with an increase in inpatient traumatic brain injuries (iTBI) (OR=1.78; 1.22 to 2.59). Mothers having mood disorders (F30-F39) were more likely to have had a child who experienced an iTBI (OR=1.64; CI=1.20 to 2.22). Mothers with personality and behavioural disorders (F60-F69) were also found to have had children with an increased risk for iTBI (OR=2.30; CI=1.14 to 3.65). Conclusion Taken together, these data should call attention to methods and strategies designed to augment and support caregiving environments with modalities that can foster mutually supportive households in cooperation with parents who have been diagnosed with a mental disorder.	[Wilson, Michael Lowery; Saarijarvi, Simo] Turku Univ Hosp, Unit Adolescent Psychiat, Turku, Finland; [Wilson, Michael Lowery; Saarijarvi, Simo] Univ Turku, Dept Adolescent Psychiat, Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, Turku, Finland; [Tenovuo, Olli] Univ Turku, Turku, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Dept Informat Serv, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden		Wilson, ML (corresponding author), Univ Turku, Dept Adolescent Psychiat, Turku Univ Hosp, Unit Adolescent Psychiat,ICT City, Joukahaisenkatu 3-5, Turku 20521, Finland.	michael.l.wilson@utu.fi		Gissler, Mika/0000-0001-8254-7525	Suomen Kulttuurirahasto (Helsinki, Finland)	Author MLW's participation was funded by a grant from Suomen Kulttuurirahasto (Helsinki, Finland). The funding agency had no role in the design of the study or in the interpretation of the results.	Alivandi Vafa M, 2009, REACHING OUT SINGLE; Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; Barkmann C, 2007, PSYCHOSOMATICS, V48, P476, DOI 10.1176/appi.psy.48.6.476; BIJUR PE, 1988, PEDIATRICS, V82, P707; BRONFENBRENNER U, 1979, AM PSYCHOL, V34, P844, DOI 10.1037/0003-066X.34.10.844; Collins NC, 2013, EMERG MED J, V30, P675, DOI 10.1136/emermed-2011-200496; Fisher HL, 2010, PSYCHOL MED, V40, P1967, DOI 10.1017/S0033291710000231; FRIEDMAN SB, 1967, PEDIATRICS, V39, P635; Gonzalez RA, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0885-7; Grenklo TB, 2014, PSYCHO-ONCOLOGY, V23, P989, DOI 10.1002/pon.3515; Haukka J., 2009, NOR EPIDEMIOL, V14, P113; Helakorpi S, 2010, ALCOHOL ALCOHOLISM, V45, P286, DOI 10.1093/alcalc/agq007; Hien D, 2010, CHILD ABUSE NEGLECT, V34, P105, DOI 10.1016/j.chiabu.2009.05.006; Husted JA, 2010, SCHIZOPHR RES, V121, P187, DOI 10.1016/j.schres.2010.05.021; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kaplan LM, 2017, J PEDIATR-US, V184, P186, DOI 10.1016/j.jpeds.2017.01.025; Keenan HT, 2004, AM J PREV MED, V26, P189, DOI 10.1016/j.amepre.2003.10.023; Kimbler DE, 2011, J NEUROSCI NURS, V43, P286, DOI 10.1097/JNN.0b013e31823858a6; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Morch WT, 1997, SCAND J PSYCHOL, V38, P343, DOI 10.1111/1467-9450.00044; Morrongiello BA, 2000, J EXP CHILD PSYCHOL, V76, P89, DOI 10.1006/jecp.2000.2572; Morrongiello BA, 2017, J PEDIATR PSYCHOL, V42, P768, DOI 10.1093/jpepsy/jsw083; Niemela M, 2012, INT J CANCER, V131, P2117, DOI 10.1002/ijc.27466; Olino TM, 2013, J PERS, V81, P119, DOI 10.1111/jopy.12000; Oyserman D, 2000, AM J ORTHOPSYCHIAT, V70, P296, DOI 10.1037/h0087733; Paananen R, 1987, INT J EPIDEMIOL; PARIS J, 1994, COMPR PSYCHIAT, V35, P301, DOI 10.1016/0010-440X(94)90023-X; Rehan W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177252; RIVARA FP, 1982, AM J DIS CHILD, V136, P502, DOI 10.1001/archpedi.1982.03970420026004; ROBSON KM, 1980, BRIT J PSYCHIAT, V136, P347, DOI 10.1192/bjp.136.4.347; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Schrieff L E, 2013, SAMJ, S. Afr. med. j., V103, P616, DOI 10.7196/samj.7137; StataCorp, STAT STAT SOFTW REL; Statistics Finland, 2017, OFFICIAL STATISTICS; Tsoumakas K, 2009, INT NURS REV, V56, P369, DOI 10.1111/j.1466-7657.2009.00720.x; Wickstrom M, 2017, CHILD ABUSE NEGLECT, V65, P124, DOI 10.1016/j.chiabu.2017.01.003; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; Yamaoka Y, 2016, MATERN CHILD HLTH J, V20, P326, DOI 10.1007/s10995-015-1832-9	41	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	AUG	2019	25	4					283	289		10.1136/injuryprev-2017-042624			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IN8GR	WOS:000478919100008	29363588				2022-02-06	
J	Gajewski, BJ; Meinzer, C; Berry, SM; Rockswold, GL; Barsan, WG; Korley, FK; Martin, RH				Gajewski, Byron J.; Meinzer, Caitlyn; Berry, Scott M.; Rockswold, Gaylan L.; Barsan, William G.; Korley, Frederick K.; Martin, Renee' H.			Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials	STATISTICS IN MEDICINE			English	Article						dosing design; Bayesian models; EMAX; hierarchical models; logistic	DESIGN	A primary goal of a phase II dose-ranging trial is to identify a correct dose before moving forward to a phase III confirmatory trial. A correct dose is one that is actually better than control. A popular model in phase II is an independent model that puts no structure on the dose-response relationship. Unfortunately, the independent model does not efficiently use information from related doses. One very successful alternate model improves power using a pre-specified dose-response structure. Past research indicates that EMAX models are broadly successful and therefore attractive for designing dose-response trials. However, there may be instances of slight risk of nonmonotone trends that need to be addressed when planning a clinical trial design. We propose to add hierarchical parameters to the EMAX model. The added layer allows information about the treatment effect in one dose to be "borrowed" when estimating the treatment effect in another dose. This is referred to as the hierarchical EMAX model. Our paper compares three different models (independent, EMAX, and hierarchical EMAX) and two different design strategies. The first design considered is Bayesian with a fixed trial design, and it has a fixed schedule for randomization. The second design is Bayesian but adaptive, and it uses response adaptive randomization. In this article, a randomized trial of patients with severe traumatic brain injury is provided as a motivating example.	[Gajewski, Byron J.; Berry, Scott M.] Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Mail Stop 1026,3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Meinzer, Caitlyn; Martin, Renee' H.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Berry, Scott M.] Berry Consultants LLC, Austin, TX USA; [Rockswold, Gaylan L.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Barsan, William G.; Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA		Gajewski, BJ (corresponding author), Univ Kansas, Med Ctr, Dept Biostat & Data Sci, Mail Stop 1026,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	bgajewski@kumc.edu		Gajewski, Byron/0000-0001-7589-8247	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS095926]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS095926] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke of the National Institutes of Health, Grant/Award Number: U01NS095926	Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488; Bornkamp B, 2009, J STAT SOFTW, V29, P1; Bretz F, 2005, BIOMETRICS, V61, P738, DOI 10.1111/j.1541-0420.2005.00344.x; Gajewski BJ, 2016, PHARM STAT, V15, P396, DOI 10.1002/pst.1755; Gelman A., 2014, BAYESIAN DATA ANAL BAYESIAN DATA ANAL, V3rd; Hjort NL, 2003, J AM STAT ASSOC, V98, P879, DOI 10.1198/016214503000000828; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thomas N, 2014, STAT BIOPHARM RES, V6, P302, DOI 10.1080/19466315.2014.924876; Zaslavsky BG, 2013, BIOMETRICS, V69, P157, DOI 10.1111/j.1541-0420.2012.01806.x	10	5	6	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	JUL 30	2019	38	17					3123	3138		10.1002/sim.8167			16	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	IH1UR	WOS:000474278200002	31070807	Green Accepted, Green Published			2022-02-06	
J	Mantua, J; Ready, RE				Mantua, Janna; Ready, Rebecca E.			Emotion habituation is accelerated in chronic mild traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; concussion; emotion habituation; depression; anxiety	AMYGDALA HABITUATION; DEPRESSION; REACTIVITY; SYMPTOMS; CONCUSSIONS; INVENTORY; DISORDER; EXPOSURE; AROUSAL; EMPATHY	Primary Objective: Risk for mental health disturbances (e.g., depression and anxiety), is elevated following a mild traumatic brain injury (mTBI), even in the chronic stages of injury. In our previous work, we found individuals with chronic mTBI have decreased emotion habituation. The objective of the current study was to test whether reduced habituation is a mechanism underlying increased risk for mental health disturbances following mTBI. Research Design: We used a cross-sectional assessment of emotion habituation in a sample of young adults at least 1 year after an mTBI. Methods and Procedures: We repeatedly showed mTBI and control participants the same set of highly arousing, negative images and positive images. Participants rated each image for arousal and valence. Main Outcomes and Results: Unexpectedly, we found individuals with mTBI habituated faster to emotional images than controls. However, enhanced habituation was not linkd with emotional outcomes. Participants with mTBI did not differ from controls for reactivity, but blunted reactivity in all participants was associated with higher depressive symptoms. Conclusions: Although there are subtle differences in emotion responses in chronic mTBI, the differences were not associated with mental health disturbances. Nevertheless, this difference in emotional processing may increase risk for untested mental health issues.	[Mantua, Janna; Ready, Rebecca E.] Univ Massachusetts, Dept Psychol & Brain Sci, Amherst, MA 01003 USA; [Mantua, Janna] Walter Reed Army Inst Res, Behav Biol Branch, Silver Spring, MD USA		Ready, RE (corresponding author), Univ Massachusetts, Psychol & Brain Sci, Tobin Hall 609,135 Hicks Way, Amherst, MA 01003 USA.	ready@psych.umass.edu					Arntz A, 2007, J BEHAV THER EXP PSY, V38, P345, DOI 10.1016/j.jbtep.2007.10.006; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bylsma LM, 2008, CLIN PSYCHOL REV, V28, P676, DOI 10.1016/j.cpr.2007.10.001; Campbell ML, 2014, COGNITION EMOTION, V28, P46, DOI 10.1080/02699931.2013.799062; Canli T, 2005, NEUROREPORT, V16, P1267, DOI 10.1097/01.wnr.0000174407.09515.cc; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; COMSTOCK GW, 1976, PSYCHOL MED, V6, P551, DOI 10.1017/S0033291700018171; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Gerberding JLBS, 2003, CTR DIS CONTR PREV, P9; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hazlett EA, 2012, BIOL PSYCHIAT, V72, P448, DOI 10.1016/j.biopsych.2012.03.027; Hendler T, 2001, CELL MOL NEUROBIOL, V21, P733, DOI 10.1023/A:1015156222101; Henry LC, 2011, HDB SPORT NEUROPSYCH, V155, P171; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kunzmann U, 2005, PSYCHOL AGING, V20, P47, DOI 10.1037/0882-7974.20.1.47; Kuppens P, 2010, PSYCHOL SCI, V21, P984, DOI 10.1177/0956797610372634; Lang PJ, 1997, PSYCHOLOGY, V77, P1, DOI [10.1016/j.epsr.2006.03.016, DOI 10.1016/J.EPSR.2006.03.016]; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; Levenson RW, 2003, ANN NY ACAD SCI, V1000, P348, DOI 10.1196/annals.1280.016; Leventhal AM, 2007, MOTIV EMOTION, V31, P145, DOI 10.1007/s11031-007-9059-8; Mantua J, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx062; Neumeister A, 2006, NEUROPSYCHOPHARMACOL, V31, pS92; Pace-Schott EF, 2011, NEUROBIOL LEARN MEM, V95, P24, DOI 10.1016/j.nlm.2010.10.006; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Schaefer HS, 2006, BIOL PSYCHIAT, V60, P974, DOI 10.1016/j.biopsych.2006.03.024; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Silver JM, 2005, JAMA-J AM MED ASSOC, P771, DOI [10.1001/jama.293.17.2161-a, DOI 10.1001/JAMA.293.17.2161-A]; Spielberger CD, 1987, ANXIETY, DOI [10.1037/t06496-000, DOI 10.1037/T06496-000]; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Valentine VM, 2002, MIL MED, V167, P9; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Wedig MM, 2005, NEUROSCI LETT, V385, P114, DOI 10.1016/j.neulet.2005.05.039; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039	45	5	5	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP 19	2019	33	11					1467	1475		10.1080/02699052.2019.1646434		JUL 2019	9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IP7SR	WOS:000478136100001	31348684				2022-02-06	
J	DeMatteo, CA; Randall, S; Lin, CYA; Claridge, EA				DeMatteo, Carol A.; Randall, Sarah; Lin, Chia-Yu A.; Claridge, Everett A.			What Comes First: Return to School or Return to Activity for Youth After Concussion? Maybe We Don't Have to Choose	FRONTIERS IN NEUROLOGY			English	Article						children; adolescents; mild traumatic brain injury; concussion management; return to school; return to activity	SPORT-RELATED CONCUSSION; CHILDREN; REST; SYMPTOMS; RECOMMENDATIONS; PLAY; ADOLESCENTS; DEPRESSION; MANAGEMENT; EXERCISE	Objectives: Return to School (RTS) and Return to Activity/Play (RTA) protocols are important in concussion management. Minimal evidence exists as to sequence and whether progression can occur simultaneously. Experts recommend that children/youth fully return to school before beginning RTA protocols. This study investigates recovery trajectories of children/youth while following RTA and RTS protocols simultaneously, with the following objectives: (1) to compare rates and patterns of progression through the stages of both protocols; (2) to evaluate symptom trajectories of youth post-concussion while progressing through stages of RTS and RTA; and (3) to propose a new model for concussion management in youth that involves the integration of Return to Activity and Return to School protocols. Methods: In a 3-year prospective-cohort study of 139 children/youth aged 5-18 years with concussive injury, self-reported symptoms using PCSS and stage of protocols were evaluated every 48 h using electronic surveys until full return to school and activity/sport were attained. Information regarding school accommodation and achievement was collected. Results: Sample mean age is 13 years, 46% male. Youth are returning to school with accommodations significantly quicker than RTA (p = 0.001). Significant negative correlations between total PCSS score and stage of RTS protocol were found at: 1-week (r = -0.376, p < 0.0001; r = -0.317, p = 0.0003), 1-month (r = -0.483, p < 0.0001; r = -0.555, p < 0.0001), and 3-months (r = -0.598, p < 0.0001; r = -0.617, p < 0.0001); indicating lower symptom scores correlated with higher guideline stages. Median full return to school time is 35 days with 21% of youth symptomatic at full return. Median return time to full sport competition is 38 days with 15% still symptomatic. Sixty-four percent of youth reported experiencing school problems during recovery and 30% at symptom resolution, with 31% reporting a drop in their grades during recovery and 18% at study completion. Conclusions: Children/youth return to school faster than they return to play in spite of the self-reported, school-related symptoms they experience while moving through the protocols. Youth can progress simultaneously through the RTS and RTA protocols during stages 1-3. Considering the numbers of youth having school difficulties post-concussion, full contact sport, stage 6, of RTA, should be delayed until full and successful reintegration back to school has been achieved. In light of the huge variability in recovery, determining how to resume participation in activities despite ongoing symptoms is still the challenge for each individual child. There is much to be learned with further research needed in this area.	[DeMatteo, Carol A.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [DeMatteo, Carol A.; Randall, Sarah; Lin, Chia-Yu A.; Claridge, Everett A.] McMaster Univ, CanChild Ctr Disabil Res, Hamilton, ON, Canada; [Lin, Chia-Yu A.] McMaster Univ, Ctr Adv Res Expt & Appl Linguist, ARiEAL, Hamilton, ON, Canada		DeMatteo, CA (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.; DeMatteo, CA (corresponding author), McMaster Univ, CanChild Ctr Disabil Res, Hamilton, ON, Canada.	dematteo@mcmaster.ca			Canadian Institutes of Health Research (CIHR)-Operating GrantCanadian Institutes of Health Research (CIHR) [MOP-133527]	The study was funded by the Canadian Institutes of Health Research (CIHR)-Operating Grant, MOP-133527.	Arbogast KB, 2013, CLIN PEDIATR, V52, P397, DOI 10.1177/0009922813478160; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Berlin AA, 2006, PSYCHOSOM MED, V68, P224, DOI 10.1097/01.psy.0000204628.73273.23; Canadian Pediatric Society, 2006, PAEDIAT CHILD HLTH, V11, P420; CanChild Centre for Childhood Disability Research, 2019, CANCH CONC MAN RET A; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Catholic District School Board, 2016, CONC PROT; Centers for Disease Control and Prevention, 2015, HEADS SCH KNOW YOUR; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; DeMatteo C, 2019, CLIN J SPORT MED; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; DeMatteo C, 2015, DISABIL REHABIL, V37, P1107, DOI 10.3109/09638288.2014.952452; DeMatteo C, 2015, CLIN PEDIATR, V54, P152, DOI 10.1177/0009922814558256; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hachem LD, 2016, CAN J NEUROL SCI, V43, P554, DOI 10.1017/cjn.2016.41; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McFaull S, 2016, Health Promot Chronic Dis Prev Can, V36, P13; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Purcell LK, 2019, BRIT J SPORT MED, V53, P250, DOI 10.1136/bjsports-2017-097853; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Snedden TR, 2019, J PEDIATR-US, V209, P168, DOI 10.1016/j.jpeds.2019.01.041; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	48	5	5	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 23	2019	10								792	10.3389/fneur.2019.00792			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IK7GY	WOS:000476758600002	31396150	Green Published, gold			2022-02-06	
J	Grigorian, A; Nahmias, J; Dolich, M; Barrios, C; Schubl, SD; Sheehan, B; Lekawa, M				Grigorian, Areg; Nahmias, Jeffry; Dolich, Matthew; Barrios, Cristobal, Jr.; Schubl, Sebastian D.; Sheehan, Brian; Lekawa, Michael			Increased risk of head injury in pediatric patients with attention deficit hyperactivity disorder	JOURNAL OF CHILD AND ADOLESCENT PSYCHIATRIC NURSING			English	Article						ADHD; bicycle; collisions; traumatic brain injury	DEFICIT/HYPERACTIVITY DISORDER; TRAUMA; ADHD	Objective The prevalence of attention deficit hyperactivity disorder (ADHD) in the general pediatric population is 7%, whereas the prevalence in trauma is unknown. We hypothesized pediatric patients with ADHD would have a higher risk of involvement in a mechanism of injury (MOI) requiring constant attention to surroundings, such as a bicycle collision. Methods The Pediatric Trauma Quality Improvement Program (2014-2016) was queried for patients with ADHD. Patients, less than 16 years of age, with ADHD were compared to those without ADHD. Results The prevalence of ADHD was 2.5% (2,866). ADHD patients had higher risk for bicycle collision (odds ratio [OR], 1.85; 95% confidence interval [CI], 1.59-2.15; p < .001). ADHD bicyclists were less likely to wear a helmet (9.4% vs. 18.2%, p = .003) and had a higher rate of traumatic brain injury (TBI; 55.6% vs. 39.7%, p < .001), compared to non-ADHD bicyclists. Conclusions Pediatric ADHD patients have a 60% higher risk of being involved in a bicycle collision. ADHD patients that are involved in a bicycle collision are less likely to wear a helmet with a higher rate of TBI. Increased public awareness, education, and supervision may help reduce risk of bicycle collisions and TBI in this population.	[Grigorian, Areg; Nahmias, Jeffry; Dolich, Matthew; Barrios, Cristobal, Jr.; Schubl, Sebastian D.; Sheehan, Brian; Lekawa, Michael] Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, Irvine, CA 92717 USA		Grigorian, A (corresponding author), Univ Calif Irvine, Dept Surg, Div Trauma Burns & Surg Crit Care, Med Ctr, 333 City Blvd West,Ste 1600, Orange, CA 92868 USA.	agrigori@uci.edu	Nahmias, Jeffry/ABA-1850-2020	Nahmias, Jeffry/0000-0003-0094-571X			Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Grummon AH, 2014, HEALTH EDUC RES, V29, P533, DOI 10.1093/her/cyu016; Lara C, 2009, BIOL PSYCHIAT, V65, P46, DOI 10.1016/j.biopsych.2008.10.005; Leblanc John C, 2004, Paediatr Child Health, V9, P315; Miller DJ, 2010, J PSYCHOPATHOL BEHAV, V32, P323, DOI 10.1007/s10862-009-9155-z; Myers S. R., 2016, PEDIATR EMERG CARE, V78, P37; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Perera H, 2009, INT J PEDIATR OTORHI, V73, P1362, DOI 10.1016/j.ijporl.2009.06.011; PLESS IB, 1989, AM J PUBLIC HEALTH, V79, P995, DOI 10.2105/AJPH.79.8.995; PLESS IB, 1995, PEDIATRICS, V95, P219; Schilpzand E. J., 2017, EUROPEAN CHILD ADOLE, V15, P1; Stevens MM, 2002, PEDIATRICS, V109, P490, DOI 10.1542/peds.109.3.490; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Tintinalli J.E., 1992, ADV EMERG NURS J, V14, P74, DOI [10.7326/0003-4819-117-8-703_2, DOI 10.7326/0003-4819-117-8-703_2]; Wozniak J, 1999, J AM ACAD CHILD PSY, V38, P48, DOI 10.1097/00004583-199901000-00019	18	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-6077	1744-6171		J CHILD ADOL PS NURS	J. Child Adolesc. Psychiatry Nurs.	NOV	2019	32	4					171	176		10.1111/jcap.12246		JUL 2019	6	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	JL0WK	WOS:000477421600001	31328370				2022-02-06	
J	da Cruz, WFG; Schoonmaker, JP; de Resende, FD; Siqueira, GR; Rodrigues, LM; Zamudio, GDR; Ladeira, MM				da Cruz, Wendell F. G.; Schoonmaker, Jon P.; de Resende, Flavio D.; Siqueira, Gustavo R.; Rodrigues, Liziana M.; Zamudio, German D. R.; Ladeira, Marcio M.			Effects of maternal protein supplementation and inclusion of rumen-protected fat in the finishing diet on nutrient digestibility and expression of intestinal genes in Nellore steers	ANIMAL SCIENCE JOURNAL			English	Article						amylase activity; calcium salts; fetal programming; maternal protein supplementation	INTRAUTERINE GROWTH-RETARDATION; PANCREATIC EXOCRINE SECRETION; VISCERAL ORGAN MASS; GASTROINTESTINAL-TRACT; FEED-INTAKE; TRANSCRIPTIONAL REGULATION; CHOLESTEROL UPTAKE; DIGESTIVE ENZYMES; LIPID-METABOLISM; ALPHA-AMYLASE	The study aimed to evaluate nutrient digestibility and intestine gene expression in the progeny from cows supplemented during gestation and fed diets with or without rumen-protected fat (RPF) in the feedlot. Forty-eight Nellore steers, averaging 340 kg, were housed in individual pens and allotted in a completely randomized design using a 2 x 2 factorial arrangement (dams nutrition x RPF). Cows' supplementation started after 124 +/- 21 days of gestation. The feedlot lasted 135 days and diets had the inclusion of zero or 6% of RPF. Digestibility was evaluated by total feces collection. Steers were slaughtered using the concussion technique and samples of pancreas and small intestine were collected immediately after the slaughter to analyze alpha-amylase activity, and the expression of SLC5A1, CD36, and CCK and villi morphometry. Feeding RPF increased nutrients digestibility (p < 0.01). There was no effect of maternal nutrition on digestibility and alpha-amylase activity in steers (p > 0.05). Duodenal expression of SLC5A1, CD36, and CCK increased in the progeny from restricted cows. In conclusion, protein restriction during mid to late gestation of dams has long-term effects on small-intestine length and on expression of membrane transporters genes in the duodenum of the progeny. However, maternal nutrition does not affect digestibility in the feedlot.	[da Cruz, Wendell F. G.; Rodrigues, Liziana M.; Zamudio, German D. R.; Ladeira, Marcio M.] Univ Fed Lavras, Dept Anim Sci, BR-37200000 Lavras, MG, Brazil; [Schoonmaker, Jon P.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [de Resende, Flavio D.; Siqueira, Gustavo R.] Agencia Paulista Agronegocio, APTA, Sao Paulo, Brazil		Ladeira, MM (corresponding author), Univ Fed Lavras, Dept Anim Sci, BR-37200000 Lavras, MG, Brazil.	mladeira@dzo.ufla.br	Zamudio, German Dario Ramirez/AAR-5908-2020; Resende, Flavio D/E-5603-2013; Siqueira, Gustavo R/I-9447-2012; Rodrigues, Liziana M/I-5489-2018; Ladeira, Marcio/G-9816-2012	Zamudio, German Dario Ramirez/0000-0002-4843-7653; Resende, Flavio D/0000-0001-6999-9981; Siqueira, Gustavo R/0000-0002-4135-7220; Rodrigues, Liziana M/0000-0003-2467-5865; Ladeira, Marcio/0000-0002-1585-8486	Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado de Minas GeraisFundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia de Ciencia Animal	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Instituto Nacional de Ciencia e Tecnologia de Ciencia Animal	Allen MS, 2000, J DAIRY SCI, V83, P1598, DOI 10.3168/jds.S0022-0302(00)75030-2; [Anonymous], 1990, OFFICIAL METHODS ANA; Arelovich HM, 2008, PROFESSIONAL ANIMAL, V24, P375, DOI DOI 10.15232/S1080-7446(15)30882-2; Bain A, 2016, MEDIA PETERNAK, V39, P180, DOI 10.5398/medpet.2016.39.3.180; Boerman JP, 2015, J DAIRY SCI, V98, P8889, DOI 10.3168/jds.2015-9592; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chavatte-Palmer P, 2018, ANIMAL, V12, pS363, DOI 10.1017/S1751731118001337; Chelikani PK, 2004, J DAIRY RES, V71, P288, DOI 10.1017/S0022029904000299; Chilliard Y, 1998, REPROD NUTR DEV, V38, P131, DOI 10.1051/rnd:19980201; Choi BR, 2000, DOMEST ANIM ENDOCRIN, V19, P159, DOI 10.1016/S0739-7240(00)00075-8; da Silva AG, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0209-x; Oliveira Leonardo Guimarães de, 2015, Acta Sci., Anim. Sci., V37, P181, DOI 10.4025/actascianimsci.v37i2.26446; Moreira Thiago Simas de Oliveira, 2016, Acta Sci., Anim. Sci., V38, P61, DOI 10.4025/actascianimsci.v38i1.27432; Depenbusch BE, 2008, J ANIM SCI, V86, P632, DOI 10.2527/jas.2007-0057; DRACKLEY JK, 1992, J DAIRY SCI, V75, P1517, DOI 10.3168/jds.S0022-0302(92)77908-9; Du M, 2013, J ANIM SCI, V91, P1419, DOI 10.2527/jas.2012-5670; Duarte MS, 2013, LIVEST SCI, V153, P60, DOI 10.1016/j.livsci.2013.01.006; Duarte M. S., 2012, P 8 SIMCORTE BRAZ, P123; Fredin SM, 2014, J DAIRY SCI, V97, P1862, DOI 10.3168/jds.2013-7395; Gibbs James, 1993, P51; Greenwood PL, 2009, ANIM PROD SCI, V49, P468, DOI 10.1071/EA08160; Greenwood PL, 2010, MANAGING THE PRENATAL ENVIRONMENT TO ENHANCE LIVESTOCK PRODUCTIVITY, P3, DOI 10.1007/978-90-481-3135-8_1; Gressley TF, 2011, J ANIM SCI, V89, P1120, DOI 10.2527/jas.2010-3460; Guilloteau P, 2010, NUTR RES REV, V23, P4, DOI 10.1017/S0954422410000077; Hagemeister, 2006, SLOVAK J ANIM SCI, V39, P16; Hall MB, 2009, J AOAC INT, V92, P42; Hansen TVO, 2001, PEPTIDES, V22, P1201, DOI 10.1016/S0196-9781(01)00443-0; HARMON DL, 1993, J DAIRY SCI, V76, P2102, DOI 10.3168/jds.S0022-0302(93)77545-1; Harmon DL, 2004, CAN J ANIM SCI, V84, P309, DOI 10.4141/A03-077; Harvatine KJ, 2006, J DAIRY SCI, V89, P1104, DOI 10.3168/jds.S0022-0302(06)72178-6; HEDIGER MA, 1994, PHYSIOL REV, V74, P993, DOI 10.1152/physrev.1994.74.4.993; Hernandez Joaquin, 2014, ScientificWorldJournal, V2014, P702572, DOI 10.1155/2014/702572; Hiller B, 2012, BRIT J NUTR, V108, P858, DOI 10.1017/S0007114511006179; Howell JA, 2003, J ANIM SCI, V81, P1030; ISO, 2006, 16472 ISO; Ladeira MM, 2012, RECENT PATENTS FOOD, V4, P1; Liao SF, 2010, J ANIM SCI, V88, P306, DOI 10.2527/jas.2009-1992; Lin XueYan, 2017, Advances in Bioscience and Biotechnology, V8, P68, DOI 10.4236/abb.2017.82005; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Meyer AM, 2014, J ANIM SCI, V92, P3855, DOI 10.2527/jas.2014-7646; Meyer AM, 2010, J ANIM SCI, V88, P2410, DOI 10.2527/jas.2009-2220; Meyer AM, 2016, ADV NUTR, V7, P169, DOI 10.3945/an.115.010405; Mir PS, 2006, CAN J ANIM SCI, V86, P159, DOI 10.4141/A05-056; MIR PS, 1987, CAN J ANIM SCI, V67, P83, DOI 10.4141/cjas87-010; Nassir F, 2007, J BIOL CHEM, V282, P19493, DOI 10.1074/jbc.M703330200; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Neel JV, 1999, NUTR REV, V57, pS2, DOI 10.1111/j.1753-4887.1999.tb01782.x; NGIDI ME, 1990, J ANIM SCI, V68, P2555; Nielsen FC, 1996, DNA CELL BIOL, V15, P53, DOI 10.1089/dna.1996.15.53; Niot I, 1997, BIOCHIMIE, V79, P129, DOI 10.1016/S0300-9084(97)81504-0; Oliveira, 2006, RUMINANT NUTR, P287; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinheiro DF, 2013, CLIN SCI, V125, P281, DOI 10.1042/CS20120400; Pluske JR, 1996, ANIM SCI, V62, P145, DOI 10.1017/S1357729800014429; Pluske JR, 1996, BRIT J NUTR, V76, P409, DOI 10.1079/BJN19960046; REIDELBERGER RD, 1994, J NUTR, V124, pS1327, DOI 10.1093/jn/124.suppl_8.1327S; Richards CJ, 2003, J ANIM SCI, V81, P1051; Roche JR, 2008, NUTR RES REV, V21, P207, DOI 10.1017/S0954422408138744; Rodrigues L., 2015, THESIS; Shingfield KJ, 2010, BRIT J NUTR, V104, P56, DOI 10.1017/S0007114510000292; SISSONS JW, 1981, J SCI FOOD AGR, V32, P105, DOI 10.1002/jsfa.2740320202; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; Soto-Navarro SA, 2004, J ANIM SCI, V82, P1788; Swanson KC, 2002, J NUTR, V132, P376; Swanson KC, 2000, J NUTR, V130, P2157, DOI 10.1093/jn/130.9.2157; Trahair JF, 1997, J NUTR, V127, P637, DOI 10.1093/jn/127.4.637; TURGEON OA, 1983, J ANIM SCI, V57, P739, DOI 10.2527/jas1983.573739x; Underwood KR, 2010, MEAT SCI, V86, P588, DOI 10.1016/j.meatsci.2010.04.008; van Schothorst EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-110; Vandoni SL, 2010, ITAL J ANIM SCI, V9, P229, DOI 10.4081/ijas.2010.e44; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Walker JA, 1995, J ANIM SCI, V73, P3766; Wanapat M, 2011, LIVEST SCI, V135, P32, DOI 10.1016/j.livsci.2010.06.006; Wang T, 2005, BIOL NEONATE, V88, P66, DOI 10.1159/000084645; Warner Crystal M., 2015, Journal of Animal Science and Technology, V57, P25, DOI 10.1186/s40781-015-0053-5; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; Wright EM, 2000, ANN NY ACAD SCI, V915, P54; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	80	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1344-3941	1740-0929		ANIM SCI J	Anim. Sci. J.	SEP	2019	90	9					1200	1211		10.1111/asj.13273		JUL 2019	12	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	IU6MF	WOS:000476054500001	31317623				2022-02-06	
J	Champagne, AA; Coverdale, NS; Germuska, M; Bhogal, AA; Cook, DJ				Champagne, Allen A.; Coverdale, Nicole S.; Germuska, Mike; Bhogal, Alex A.; Cook, Douglas J.			Changes in volumetric and metabolic parameters relate to differences in exposure to sub-concussive head impacts	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Brain structure; cerebral blood flow; cerebral metabolism; dual-calibrated fMRI; sub-concussive impacts	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; OXYGEN EXTRACTION FRACTION; CEREBROVASCULAR REACTIVITY; OXIDATIVE-METABOLISM; MODEL; QUANTIFICATION; HYPEROXIA; PERFUSION	Structural and calibrated magnetic resonance imaging data were acquired on 44 collegiate football players prior to the season (PRE), following the first four weeks in-season (PTC) and one month after the last game (POST). Exposure data collected from g-Force accelerometers mounted to the helmet of each player were used to split participants into HIGH (N = 22) and LOW (N = 22) exposure groups, based on the frequency of impacts sustained by each athlete. Significant decreases in grey-matter volume specific to the HIGH group were documented at POST (P = 0.009), compared to baseline. Changes in resting cerebral blood flow (CBF0), corrected for partial volume effects, were observed within the HIGH group, throughout the season (P < 0.0001), suggesting that alterations in perfusion may follow exposure to sub-concussive collisions. Co-localized significant increases in cerebral metabolic rate of oxygen consumption (CMRO2|(0)) mid-season were also documented in the HIGH group, with respect to both PRE- and POST values. No physiological changes were observed in the LOW group. Therefore, cerebral metabolic demand may be elevated in players with greater exposure to head impacts. These results provide novel insight into the effects of sub-concussive collisions on brain structure and cerebrovascular physiology and emphasize the importance of multi-modal imaging for a complete characterization of cerebral health.	[Champagne, Allen A.; Coverdale, Nicole S.; Cook, Douglas J.] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada; [Germuska, Mike] Cardiff Univ, Brain Res Imaging Ctr, Cardiff, S Glam, Wales; [Bhogal, Alex A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Cook, Douglas J.] Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada		Cook, DJ (corresponding author), Queens Univ, Dept Surg, Room 232,18 Stuart St, Kingston, ON K7L 3N6, Canada.	dj.cook@queensu.ca		Germuska, Michael/0000-0003-0580-4350; Bhogal, Alex/0000-0003-3211-1760	Southeastern Ontario Academic Medical Organization (SEAMO); EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/K020404/1] Funding Source: UKRI	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by the Southeastern Ontario Academic Medical Organization (SEAMO).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Adams J, 2007, CLIN J SPORT MED, V17, P304, DOI 10.1097/JSM.0b013e31803202c8; Agel J, 2010, CAN J SURG, V53, P319; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Anand S S, 2009, Med J Armed Forces India, V65, P353, DOI 10.1016/S0377-1237(09)80099-3; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Andersson JLR, 2007, PRACT, P22; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bhogal AA, 2017, J CEREBR BLOOD F MET, V37, P1461, DOI 10.1177/0271678X16656864; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cantu RC, 2011, YB SPORT MED, V2011, P20, DOI [10.1016/j.yspm.2011.01.008, DOI 10.1016/J.YSPM.2011.01.008]; Champagne AA, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101753; Champagne AA, 2019, NEUROIMAGE, V187, P154, DOI 10.1016/j.neuroimage.2017.11.044; Chappell MA, 2011, MAGN RESON MED, V65, P1173, DOI 10.1002/mrm.22641; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Clark MD, 2018, RADIOLOGY, P286; Coles JP, 2006, J CEREBR BLOOD F MET, V26, P48, DOI 10.1038/sj.jcbfm.9600179; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport MG, 2007, INT J EDUC ARTS, V8, P1; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Donahue MJ, 2016, J CEREBR BLOOD F MET, V36, P1767, DOI 10.1177/0271678X15608643; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Germuska M, 2016, NEUROIMAGE, V139, P313, DOI 10.1016/j.neuroimage.2016.06.004; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hoge RD, 2012, NEUROIMAGE, V62, P930, DOI 10.1016/j.neuroimage.2012.02.022; HORVATH I, 1994, J CEREBR BLOOD F MET, V14, P503, DOI 10.1038/jcbfm.1994.62; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Ibaraki M, 2010, J CEREBR BLOOD F MET, V30, P1296, DOI 10.1038/jcbfm.2010.13; Ishii K, 1996, J NUCL MED, V37, P1086; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; Kida I, 2007, J CEREBR BLOOD F MET, V27, P690, DOI 10.1038/sj.jcbfm.9600409; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Lajoie I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174932; Lajoie I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163071; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lin AL, 2008, MAGN RESON MED, V60, P380, DOI 10.1002/mrm.21655; Lu H, 2008, MAGN RESON MED, V60, P380; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Ma Y., 2014, P 22 SCI M INT SOC M, P3099; Ma YH, 2016, MAGN RESON MED, V76, P1905, DOI 10.1002/mrm.26069; Mairbaurl H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00332; Medicine BPGL and BA of S and E, 2013, BRIT J SPORT MED, V47, P259; Merola A, 2018, NEUROIMAGE, V173, P113, DOI 10.1016/j.neuroimage.2018.02.020; Merola A, 2016, NEUROIMAGE, V129, P159, DOI 10.1016/j.neuroimage.2016.01.021; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; Morley WA, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00166; Nelson S, 1966, HEAD INJURY, P444; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; PATTERSON SM, 1995, PSYCHOSOM MED, V57, P592, DOI 10.1097/00006842-199511000-00012; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Poublanc J, 2015, J CEREBR BLOOD F MET, V35, P1746, DOI 10.1038/jcbfm.2015.114; Ring C, 2008, BIOL PSYCHOL, V77, P63, DOI 10.1016/j.biopsycho.2007.09.005; Schmidt JD, 2016, J ATHL TRAINING, V51, P366, DOI 10.4085/1062-6050-51.5.04; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wagner BA, 2011, RATE OXYGEN UTILIZAT, DOI [10.1016/j.freeradbiomed.2011.05.024, DOI 10.1016/J.FREERADBIOMED.2011.05.024.THE]; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Yang YH, 2004, MAGNET RESON MED, V52, P1407, DOI 10.1002/mrm.20302; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.3.CO;2-D; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang X, 2013, MAGN RESON MED, V70, P1082, DOI 10.1002/mrm.24550; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhao MY, 2017, NEUROIMAGE, V162, P384, DOI 10.1016/j.neuroimage.2017.08.072	95	5	5	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2020	40	7					1453	1467	0271678X19862861	10.1177/0271678X19862861		JUL 2019	15	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	NJ3CE	WOS:000479491800001	31307284	Green Accepted, Green Published			2022-02-06	
J	Ramkumar, PN; Navarro, SM; Haeberle, HS; Luu, BC; Jang, A; Frangiamore, SJ; Farrow, LD; Schickendantz, MS; Williams, RJ				Ramkumar, Prem N.; Navarro, Sergio M.; Haeberle, Heather S.; Luu, Bryan C.; Jang, Albert; Frangiamore, Salvatore J.; Farrow, Lutul D.; Schickendantz, Mark S.; Williams, Riley J., III			Concussion in American Versus European Professional Soccer: A Decade-Long Comparative Analysis of Incidence, Return to Play, Performance, and Longevity	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; soccer; incidence; performance; return to play	CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL PLAYERS; HEAD; SYMPTOMS; INJURIES; DEMENTIA; HISTORY; IMPACT; SPORT	Background: The incidence and effect of sports-related concussions (SRCs) within the global sport of professional soccer is poorly described. Purpose: To comparatively examine the effects of SRC on athletes in Major League Soccer (MLS) and the English Premier League (EPL) in terms of incidence, return to play (RTP), performance, and career longevity. Study Design: Cohort study; Level of evidence, 3. Methods: Contracts, transactions, injury reports, and performance statistics from 2008 to 2017 were obtained and cross-referenced across 6 publicly available websites detailing MLS and EPL data, including official league publications. For each league, players who sustained a concussion were compared with the 2008-2017 uninjured player pool. RTP and games missed were analyzed and compared. Career length was analyzed with Kaplan-Meier survival curves. Player performance changes were evaluated before and after concussion. Results: Of the 1784 eligible MLS and 2001 eligible EPL players evaluated over the 10-year period, the incidence of publicly reported concussions per 1000 athlete-exposures was 20.22 and 18.68, respectively (P = .53). The incidence of reported concussions steadily increased in both leagues. MLS players missed a mean 7.3 games after concussion (37.0 days missed); EPL players missed a mean 0.6 games after concussion (10.9 days missed) (P < .0001, P < .0001). Statistical performance in terms of games started, assists, shots on goal, and total shots after concussion was significantly reduced at all nongoalie positions for players in the EPL; however, MLS nongoalie positions with concussion had no significant decreases in these categories. Goalies in both leagues had no significant change in performance or games started. The probability of playing a full season after concussion was not significantly decreased when compared with the uninjured pool in both leagues. Conclusion: This study established the SRC incidence among elite soccer players in 2 international professional leagues and identified major RTP and performance differences between EPL and MLS players. While career longevity was unaffected, the approach to managing concussion as in MLS may better promote player safety and preserve on-field performance.	[Ramkumar, Prem N.; Navarro, Sergio M.; Haeberle, Heather S.; Luu, Bryan C.; Jang, Albert; Frangiamore, Salvatore J.; Farrow, Lutul D.; Schickendantz, Mark S.; Williams, Riley J., III] Cleveland Clin, Dept Orthopaed Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Navarro, Sergio M.] Univ Oxford, Said Business Sch, Oxford, England; [Haeberle, Heather S.; Luu, Bryan C.; Jang, Albert] Baylor Coll Med, Dept Orthopaed Surg, Houston, TX 77030 USA; [Frangiamore, Salvatore J.] Summa Hlth, Dept Orthopaed Surg, Akron, OH USA; [Williams, Riley J., III] Hosp Special Surg, Dept Orthoped Surg, 535 E 70th St, New York, NY 10021 USA		Ramkumar, PN (corresponding author), Cleveland Clin, Dept Orthopaed Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA.	premramkumar@gmail.com	Navarro, Sergio M/K-8923-2019	Navarro, Sergio M/0000-0003-3455-1567; Jang, Albert/0000-0002-0461-6174; Haeberle, Heather/0000-0001-8341-8389; Luu, Bryan/0000-0003-4424-3613			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Associated Press, 2012, ASS PRESS; Beaudouin F, 2019, BRIT J SPORT MED, V53, P948, DOI 10.1136/bjsports-2016-097217; Beghi E, 2019, DO SOCCER PLAYERS HA; Borden S., 2014, NY TIMES; Bunc Gorazd, 2017, Med Arch, V71, P356, DOI 10.5455/medarh.2017.71.356-359; Caccese JB, 2021, CLIN J SPORT MED, V31, P266, DOI 10.1097/JSM.0000000000000709; Cochrane GD, 2017, PHYSICIAN SPORTSMED, V45, P178, DOI 10.1080/00913847.2017.1305875; Delaney JS, 2018, CLIN J SPORT MED, V28, P1, DOI 10.1097/JSM.0000000000000495; Eirale C, 2015, CLIN J SPORT MED, V25, P73, DOI 10.1097/JSM.0000000000000066; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Navarro SM, 2018, J NEUROTRAUM, V35, P2391, DOI 10.1089/neu.2017.5611; Navarro SM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117740847; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Putukian M, 2019, BRIT J SPORT MED, V53, P1332, DOI 10.1136/bjsports-2018-100232; Ramkumar PN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118814238; Redak G., RUGGLES MEDIA; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith P., 2016, SKY SPORTS; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D	31	5	5	1	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2019	47	10					2287	2293	0363546519859542	10.1177/0363546519859542		JUL 2019	7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	IN4QK	WOS:000478698600001	31303010				2022-02-06	
J	De Netto, RK; McKinlay, A				De Netto, Riana K.; McKinlay, Audrey			Impact of childhood traumatic brain injury on educational outcomes and adult standard of living	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; childhood; education; adult outcomes; standard of living	MILD; LIFE; ADOLESCENTS; CHILDREN	Background: There is a limited literature investigating the long-term impact of traumatic brain injury sustained in childhood that compares injury severity with educational attainment, employment, material standard of living, or receipt of government benefits in adulthood. Method: A total of 161 participants who sustained an injury prior to age 18 years, aged between 18 and 30 years, and averaged 13.7 years postinjury. Injuries were mild traumatic brain injury (n = 57), moderate-severe traumatic brain injury (n = 62), and orthopedic injury control group (n = 42). Results: Using a semi-structured interview, with the exception of employment outcomes, adult survivors of childhood traumatic brain injury had poorer outcomes across all domains assessed relative to the other injury control group, with moderate to severe traumatic brain injury having worse outcomes than those with mild traumatic brain injury. Conclusions: Overall, the findings indicate that there is a greater need to consider the long-term impact of traumatic brain injury sustained in childhood, with injury severity impacting several psychosocial domains in adulthood, including education, material standard of living, and benefit recipiency.	[De Netto, Riana K.; McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		McKinlay, Audrey/0000-0001-9846-8514			Access Economics , 2009, EC COST SPIN CORD IN; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Cohen J., 2013, STAT POWER ANAL BEHA; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A., 2017, DISCOVERING STAT USI, V5th; Gladis MM, 1999, J CONSULT CLIN PSYCH, V67, P320, DOI 10.1037/0022-006X.67.3.320; Hendrie D, 1998, AUST J PUBLIC HEALTH, V13, P380; Linden MA, 2018, NEUROREHABILITATION, V42, P311, DOI 10.3233/NRE-172357; Lloyd J, 2015, BRAIN INJURY, V29, P539, DOI 10.3109/02699052.2014.1002003; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schalock RL, 2002, MENT RETARD, V40, P457, DOI 10.1352/0047-6765(2002)040<0457:CMAAOQ>2.0.CO;2; Sirgy MJ, 1998, SOC INDIC RES, V43, P227, DOI 10.1023/A:1006820429653; Tabachnick B.G., 2013, USING MULTIVARIATE S	17	5	5	2	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	AUG 13	2020	42	17			SI		2444	2450		10.1080/09638288.2019.1637948		JUL 2019	7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	NE7PD	WOS:000477192300001	31322433				2022-02-06	
J	La Fountaine, MF; Hill-Lombardi, V; Hohn, AN; Leahy, CL; Testa, AJ				La Fountaine, Michael F.; Hill-Lombardi, Vicci; Hohn, Asante N.; Leahy, Caroline L.; Testa, Anthony J.			Preliminary Evidence for a Window of Increased Vulnerability to Sustain a Concussion in Females: A Brief Report	FRONTIERS IN NEUROLOGY			English	Article						menstrual cycle; luteal phase; concussion; brain injury-traumatic; womens health	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; SEX-DIFFERENCES; HIGH-SCHOOL; NEUROPSYCHOLOGICAL FUNCTION; RECURRENT CONCUSSION; NEUROPROTECTIVE ROLE; ASSOCIATION; SYMPTOMS; TESTOSTERONE	A difference exists between sexes for the incidence of concussion injuries and severity of post-injury outcomes with females having a higher incidence rate (in comparable sports) and experience more robust symptoms than males. The basis for this disparity has remained largely unresolved. Recent findings point to a potential biological mechanism that may be related to the menstrual cycle as an arbiter of post-injury outcomes. What has not been addressed, is whether the phase of menstrual cycle (inferred fluctuations of ovarian hormones) contributes to an increased vulnerability to sustain a concussion injury. This prospective, observational study sought to determine if concussions occurred at different frequencies throughout the phase of the menstrual cycle. Female athletes who sustained a concussion injury were queried three times over the 7-day study (e.g., within 48 h of injury, and 4 and 7 days after injury) to recall the number of days that have elapsed since the beginning of their most recent menstruation. Twenty female athletes enrolled after sustaining a concussion; 18 were eumenorrheic and 2 amenorrheic. Among eumenorrheic participants at the time of injury, 2 were in the follicular phase, 4 were in the early luteal phase and 9 were in the late luteal phase. Two athletes were injured on the first and 1 was injured on the second day of menstruation. The greatest number of concussions were sustained during the late luteal phase and during the first 2 days of menstruation. This 9-day window accounted for 2/3rd of the sustained concussions in our study.	[La Fountaine, Michael F.; Hill-Lombardi, Vicci; Hohn, Asante N.; Leahy, Caroline L.] Seton Hall Univ, Dept Phys Therapy, Sch Hlth & Med Sci, Nutley, NJ 07110 USA; [La Fountaine, Michael F.; Hill-Lombardi, Vicci] Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, Nutley, NJ 07110 USA; [La Fountaine, Michael F.; Hill-Lombardi, Vicci] Seton Hall Univ, Dept Med Sci, Hackensack Meridian Sch Med, Nutley, NJ 07110 USA; [La Fountaine, Michael F.] Seton Hall Univ, Dept Neurol, Hackensack Meridian Sch Med, Nutley, NJ 07110 USA; [Hill-Lombardi, Vicci] Seton Hall Univ, Dept Athlet Training, Sch Hlth & Med Sci, Nutley, NJ USA; [Testa, Anthony J.] Seton Hall Univ, Ctr Sports Med, S Orange, NJ 07079 USA		La Fountaine, MF (corresponding author), Seton Hall Univ, Dept Phys Therapy, Sch Hlth & Med Sci, Nutley, NJ 07110 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Inst Adv Study Rehabil & Sports Sci, Nutley, NJ 07110 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Dept Med Sci, Hackensack Meridian Sch Med, Nutley, NJ 07110 USA.; La Fountaine, MF (corresponding author), Seton Hall Univ, Dept Neurol, Hackensack Meridian Sch Med, Nutley, NJ 07110 USA.	lafounmi@shu.edu			New Jersey Commission for Brain Injury Research Individual Research Grant [CBIR16IRG025]	Data presented in this report was collected in a prospective research investigation supported by the New Jersey Commission for Brain Injury Research Individual Research Grant #CBIR16IRG025. The funding agency had no input on the study design, data analysis, or preparation of the manuscript. Open access publication fees are provided by the budget of the aforementioned grant.	Bialek M, 2004, POL J PHARMACOL, V56, P509; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Correia Sonia C, 2010, Curr Aging Sci, V3, P113; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Dvorak J, 2007, BRIT J SPORT MED, V41, pI44, DOI 10.1136/bjsm.2007.037960; Ellis MJ, 2016, CURR SPORT MED REP, V15, P27, DOI 10.1249/JSR.0000000000000223; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Foley CM, 2012, SPORTS HEALTH, V4, P139, DOI 10.1177/1941738111434275; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hammond J, 2001, J NEUROCHEM, V77, P1319, DOI 10.1046/j.1471-4159.2001.00345.x; Ives JC, 2007, J ATHL TRAINING, V42, P431; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kostyun Regina, 2015, Conn Med, V79, P161; La Fountaine MF, 2019, MED SCI SPORT EXER, V51, P792, DOI 10.1249/MSS.0000000000001833; La Fountaine MF, 2016, J NEUROTRAUM, V33, P904, DOI 10.1089/neu.2015.3968; Little CM, 2009, J COMP NEUROL, V512, P359, DOI 10.1002/cne.21885; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Siddiqui AN, 2016, CNS NEUROSCI THER, V22, P342, DOI 10.1111/cns.12538; Snook ML, 2017, JAMA PEDIATR, V171, P879, DOI 10.1001/jamapediatrics.2017.1140; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spence RD, 2012, FRONT NEUROENDOCRIN, V33, P105, DOI 10.1016/j.yfrne.2011.12.001; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanveer S, 2017, PEDIATR NEUROL, V70, P44, DOI 10.1016/j.pediatrneurol.2017.02.001; Tkachenko N, 2016, PEDIATR NEUROL, V57, P46, DOI 10.1016/j.pediatrneurol.2015.12.019; Undurti A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00072; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	46	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 9	2019	10								691	10.3389/fneur.2019.00691			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH8TK	WOS:000474779000001	31338057	Green Published, gold			2022-02-06	
J	Sorby-Adams, AJ; Leonard, AV; Elms, LE; Marian, OC; Hoving, JW; Yassi, N; Vink, R; Thornton, E; Turner, RJ				Sorby-Adams, Annabel J.; Leonard, Anna, V; Elms, Levi E.; Marian, Oana C.; Hoving, Jan W.; Yassi, Nawaf; Vink, Robert; Thornton, Emma; Turner, Renee J.			Determining the Temporal Profile of Intracranial Pressure Changes Following Transient Stroke in an Ovine Model	FRONTIERS IN NEUROSCIENCE			English	Article						intracranial pressure; cerebral edema; stroke; large animal model; blood-brain barrier	CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; SUBSTANCE-P; BLOOD-FLOW; FUNCTIONAL DEFICITS; ISCHEMIC-STROKE; EDEMA FORMATION; ANIMAL-MODELS; HEAD-INJURY	Background and Purpose: Cerebral edema and elevated intracranial pressure (ICP) are the leading cause of death in the first week following stroke. Despite this, current treatments are limited and fail to address the underlying mechanisms of swelling, highlighting the need for targeted treatments. When screening promising novel agents, it is essential to use clinically relevant large animal models to increase the likelihood of successful clinical translation. As such, we sought to develop a survival model of transient middle cerebral artery occlusion (tMCAO) in the sheep and subsequently characterize the temporal profile of cerebral edema and elevated ICP following stroke in this novel, clinically relevant model. Methods: Merino-sheep (27M; 31F) were anesthetized and subject to 2 h tMCAO with reperfusion or sham surgery. Following surgery, animals were allowed to recover and returned to their home pens. At preselected times points ranging from 1 to 7 days post-stroke, animals were re-anesthetized, ICP measured for 4 h, followed by imaging with MRI to determine cerebral edema, midline shift and infarct volume (FLAIR, T2 and DWI). Animals were subsequently euthanized and their brain removed for immunohistochemical analysis. Serum and cerebrospinal fluid samples were also collected and analyzed for substance P (SP) using ELISA. Results: Intracranial pressure and MRI scans were normal in sham animals. Following stroke, ICP rose gradually over time and by 5 days was significantly (p < 0.0001) elevated above sham levels. Profound cerebral edema was observed as early as 2 days post-stroke and continued to evolve out to 6 days, resulting in significant midline shift which was most prominent at 5 days post-stroke (p < 0.01), in keeping with increasing ICP. Serum SP levels were significantly elevated (p < 0.01) by 7 days post-tMCAO. Conclusion: We have successfully developed a survival model of ovine tMCAO and characterized the temporal profile of ICP. Peak ICP elevation, cerebral edema and midline shift occurred at days 5-6 following stroke, accompanied by an elevation in serum SP. Our findings suggest that novel therapeutic agents screened in this model targeting cerebral edema and elevated ICP would most likely be effective when administered prior to 5 days, or as early as possible following stroke onset.	[Sorby-Adams, Annabel J.; Leonard, Anna, V; Elms, Levi E.; Marian, Oana C.; Thornton, Emma; Turner, Renee J.] Univ Adelaide, Adelaide Ctr Neurosci Res, Adelaide Med Sch, Adelaide, SA, Australia; [Hoving, Jan W.; Yassi, Nawaf] Univ Melbourne, Melbourne Brain Ctr, Dept Med & Neurol, Royal Melbourne Hosp, Melbourne, Vic, Australia; [Hoving, Jan W.] Univ Amsterdam, Dept Radiol, Amsterdam UMC, Amsterdam, Netherlands; [Yassi, Nawaf] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Vink, Robert] Univ South Australia, Div Hlth Sci, Adelaide, SA, Australia		Sorby-Adams, AJ (corresponding author), Univ Adelaide, Adelaide Ctr Neurosci Res, Adelaide Med Sch, Adelaide, SA, Australia.	annabel.sorby-adams@adelaide.edu.au	Hoving, Jan W./ABF-8506-2021	Hoving, Jan W./0000-0003-3310-3973; Sorby-Adams, Annabel/0000-0003-1648-3898; Yassi, Nawaf/0000-0002-0685-0060	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [1082556]; NeuroSurgical Research Foundation (Australia)	This study was supported by funding from the National Health and Medical Research Council (NHMRC; Project Grant 1082556) and the NeuroSurgical Research Foundation (Australia).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Anderson RWG, 2014, J BIOMECH, V47, P2578, DOI 10.1016/j.jbiomech.2014.06.002; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Battey TWK, 2014, STROKE, V45, P3643, DOI 10.1161/STROKEAHA.114.006884; Beard DJ, 2015, J CEREBR BLOOD F MET, V35, P861, DOI 10.1038/jcbfm.2015.2; Simoes ALB, 2018, ANAT REC, V301, P849, DOI 10.1002/ar.23755; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Boulos AS, 2011, J NEUROSURG, V114, P1117, DOI 10.3171/2010.8.JNS09352; Brogan ME, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-014-0327-0; Bruno G, 2003, INT J IMMUNOPATH PH, V16, P67, DOI 10.1177/039463200301600110; Casals JB, 2011, COMPARATIVE MED, V61, P305; Christoforidis GA, 2011, INVEST RADIOL, V46, P34, DOI 10.1097/RLI.0b013e3181f0cbc7; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; D'Ambrosio AL, 2004, METHOD ENZYMOL, V386, P60; Dohmen C, 2007, STROKE, V38, P56, DOI 10.1161/01.STR.0000251642.18522.b6; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Engelhorn T, 2002, STROKE, V33, P617, DOI 10.1161/hs0202.102374; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Furuichi Y, 2007, EXP NEUROL, V204, P138, DOI 10.1016/j.expneurol.2006.10.003; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hewitt A., 2012, SURGERY, V30, P102, DOI [10.1016/j.mpsur.2011.12.004, DOI 10.1016/J.MPSUR.2011.12.004]; Hudetz JA, 2010, J CARDIOTHOR VASC AN, V24, P131, DOI 10.1053/j.jvca.2009.05.008; Huttner HB, 2009, LANCET NEUROL, V8, P949, DOI 10.1016/S1474-4422(09)70224-8; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; Kamoi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102476; Keith M. K., 2007, NATURE, V447, P346, DOI [10.1038/nature05882, DOI 10.1038/NATURE05882]; Kim H, 2015, J CLIN NEUROSCI, V22, P554, DOI 10.1016/j.jocn.2014.08.021; Kuge Y, 2001, J CEREBR BLOOD F MET, V21, P202, DOI 10.1097/00004647-200103000-00003; Lavinio A, 2011, CURR OPIN ANESTHESIO, V24, P117, DOI 10.1097/ACO.0b013e32834458c5; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin HC, 1997, VET SURG, V26, P247, DOI 10.1111/j.1532-950X.1997.tb01494.x; Lorente L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060991; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Mahajan S., 2016, J NEUROANAESTH CRIT, V3, P22; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Morton AJ, 2014, HUM MOL GENET, V23, P3375, DOI 10.1093/hmg/ddu047; Morton AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015752; MURR R, 1993, ANESTH ANALG, V77, P898; Murtha LA, 2015, J CEREBR BLOOD F MET, V35, P2109, DOI 10.1038/jcbfm.2015.209; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; NEHLS DG, 1986, NEUROSURGERY, V18, P388; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Pittenger ST, 2016, SYNAPSE, V70, P336, DOI 10.1002/syn.21907; Platt Simon R, 2014, Exp Transl Stroke Med, V6, P5, DOI 10.1186/2040-7378-6-5; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Qureshi AI, 2004, NEURORADIOLOGY, V46, P988, DOI 10.1007/s00234-004-1180-8; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Reid SJ, 2013, J HUNTINGTONS DIS, V2, P279, DOI 10.3233/JHD-130067; Reinharda M, 2012, PERSPECT MED, V1, P194, DOI DOI 10.1016/J.PERMED.2012.02.028; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Sakoh M, 2000, STROKE, V31, P1958, DOI 10.1161/01.STR.31.8.1958; Sandoz B, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P293; Schifilliti D, 2010, CNS DRUGS, V24, P893, DOI 10.2165/11584760-000000000-00000; Sorby-Adams AJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00681; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Steiner Thorsten, 2001, Curr Treat Options Neurol, V3, P441, DOI 10.1007/s11940-001-0032-7; Suzuki Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/195483; Tagaya M, 1997, STROKE, V28, P1245, DOI 10.1161/01.STR.28.6.1245; Tate AJ, 2006, PHILOS T R SOC B, V361, P2155, DOI 10.1098/rstb.2006.1937; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2012, NEUROSCIENCE, V220, P1, DOI 10.1016/j.neuroscience.2012.06.047; Turner RJ, 2014, NEUROPEPTIDES, V48, P267, DOI 10.1016/j.npep.2014.07.002; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00304; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37; Watanabe H, 2007, J NEUROSCI METH, V160, P109, DOI 10.1016/j.jneumeth.2006.08.016; Wells AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130512; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	77	5	5	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 9	2019	13								587	10.3389/fnins.2019.00587			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IH8YF	WOS:000474792600001	31338013	Green Accepted, Green Published, gold			2022-02-06	
J	Bennett, LL; Arias, JJ; Ford, PJ; Bernick, C; Banks, SJ				Bennett, Lauren L.; Arias, Jalayne J.; Ford, Paul J.; Bernick, Charles; Banks, Sarah J.			Concussion reporting and perceived knowledge of professional fighters	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussion; sports-related concussions; psychological aspects of sport; boxing; martial arts		Objective: For concussions to be effectively managed in sports, they need to be correctly identified and reported. The extent to which professional athletes correctly recognize concussions, and their willingness to report symptoms, is not yet well understood. Given the risk of head injuries leading to concussions across combat sports, insight into professional fighters' knowledge and reporting of concussive symptoms is essential to improve concussion management. Methods: To investigate understanding and reporting patterns of concussions sustained while training or competing, 257 fighters completed a self-report questionnaire assessing self-perception of concussion knowledge, trust of ringside medical providers, and reported number of previous head injuries. Fighting history, including number of knockouts, was obtained from self-report (amateur) and published (professional) records. Results: Significant gaps in fighters' perceived knowledge of concussion symptoms and long-term effects of multiple concussions emerged. Approximately 40% of fighters reported returning to training or competition the same day a head injury was sustained, while 21% of fighters endorsed concealing symptoms of head injury from medical providers and coaches. Conclusions: Confusion surrounding terms used to describe head injuries amongst fighters (e.g., concussions, knockouts), coupled with limited understanding of concussive symptoms and a desire to return to competition, likely contributes to significant underreporting of symptoms.	[Bennett, Lauren L.; Banks, Sarah J.] Cleveland Clin, Neuropsychol Program, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA; [Arias, Jalayne J.] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Ford, Paul J.] Cleveland Clin, Ctr Bioeth, Cleveland, OH 44106 USA; [Bernick, Charles] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Ctr Bioeth, Las Vegas, NV 89106 USA; [Banks, Sarah J.] Univ Calif San Diego, Multidisciplinary Memory Clin, La Jolla, CA 92093 USA		Bennett, LL (corresponding author), Cleveland Clin, Neuropsychol Program, Lou Ruvo Ctr Brain Hlth, 888 W Bonneville Ave, Las Vegas, NV 89106 USA.	BennetL4@ccf.org		Banks, Sarah/0000-0001-7536-2370	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109025] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20 GM109025] Funding Source: Medline		Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; [Anonymous], 2016, US BOX RUL BOOK COMP; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bernick C, 2013, AM J EPIDEMIOL, V178, P280, DOI 10.1093/aje/kws456; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; DESSY A, 2015, NEUROSURG QUART, V25, P423, DOI DOI 10.1097/WNQ.0000000000000085; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Kannan VD, 2014, MED CARE, V52, P336, DOI 10.1097/MLR.0000000000000100; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Sethi N K, 2015, SA J. Sports Med., V27, P3, DOI 10.7196/SAJSM.595; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; UFC, UN RUL OTH MMA REG	21	5	5	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	JUL 3	2019	47	3					295	300		10.1080/00913847.2018.1552481			6	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	IY0MR	WOS:000486087800012	30479188	Green Accepted			2022-02-06	
J	Bianchi, F; Malboubi, M; George, JH; Jerusalem, A; Thompson, MS; Ye, H				Bianchi, Fabio; Malboubi, Majid; George, Julian H.; Jerusalem, Antoine; Thompson, Mark S.; Ye, Hua			Ion current and action potential alterations in peripheral neurons subject to uniaxial strain	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						action potential; Electrophysiology; ion current; peripheral nerve; whole-cell patch clamping	NETWORK ACTIVITY; STRETCH INJURY; VOLTAGE; CHANNELS; TRAUMA; MECHANOSENSITIVITY; TETRODOTOXIN; INACTIVATION; ACTIVATION; ATP	Peripheral nerves, subject to continuous elongation and compression during everyday movement, contain neuron fibers vital for movement and sensation. At supra-physiological strains resulting from trauma, chronic conditions, aberrant limb positioning, or surgery, conduction blocks occur which may result in chronic or temporary loss of function. Previous in vitro stretch models, mainly focused on traumatic brain injury modelling, have demonstrated altered electrophysiological behavior during localized deformation applied by pipette suction. Our aim was to evaluate the changes in voltage-activated ion channel function during uniaxial straining of neurons applied by whole-cell deformation, more physiologically relevant model of peripheral nerve trauma. Here, we quantified experimentally the changes in inwards and outwards ion currents and action potential (AP) firing in dorsal root ganglion-derived neurons subject to uniaxial strains, using a custom-built device allowing simultaneous cell deformation and patch clamp recording. Peak inwards sodium currents and rectifying potassium current magnitudes were found to decrease in cells under stretch, channel reversal potentials were found to be left-shifted, and half-maximum activation potentials right-shifted. The threshold for AP firing was increased in stretched cells, although neurons retained the ability to fire induced APs. Overall, these results point to ion channels being damaged directly and immediately by uniaxial strain, affecting cell electrophysiological activity, and can help develop prevention and treatment strategies for peripheral neuropathies caused by mechanical trauma.	[Bianchi, Fabio; George, Julian H.; Thompson, Mark S.; Ye, Hua] Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford OX3 7DQ, England; [Malboubi, Majid; Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Oxford, England; [Malboubi, Majid] Univ Birmingham, Dept Mech Engn, Birmingham, W Midlands, England		Ye, H (corresponding author), Univ Oxford, Inst Biomed Engn, Dept Engn Sci, Oxford OX3 7DQ, England.	hua.ye@eng.ox.ac.uk	Thompson, Mark/B-9261-2009	Thompson, Mark/0000-0001-8958-0336; Ye, Hua/0000-0001-7613-6041	Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [1514540]; CRMI (China Regenerative Medicine International); FP7 Ideas: European Research Council [306587]; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council, Grant/Award Number: 1514540; CRMI (China Regenerative Medicine International), Grant/Award Number: n/a; FP7 Ideas: European Research Council, Grant/Award Number: 306587	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Bianchi F, 2018, J NEUROSCI METH, V309, P1, DOI 10.1016/j.jneumeth.2018.08.003; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Gurkoff GG, 2012, EPILEPSIA, V53, P53, DOI 10.1111/j.1528-1167.2012.03475.x; Huang LY, 2006, NEUROSCI LETT, V398, P34, DOI 10.1016/j.neulet.2005.12.075; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; KUSANO K, 1993, J NEUROSCI RES, V34, P158, DOI 10.1002/jnr.490340203; Kwong M., LOCALISED MEMB UNPUB; Kwong MT, 2019, COMPUT METHOD APPL M, V346, P1025, DOI 10.1016/j.cma.2018.09.006; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Magou GC, 2015, BRAIN RES, V1624, P525, DOI 10.1016/j.brainres.2015.07.056; Malboubi M, 2011, MICROELECTRON ENG, V88, P2666, DOI 10.1016/j.mee.2011.02.029; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Morris CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118335; Morris CE, 2012, PROG BIOPHYS MOL BIO, V110, P245, DOI 10.1016/j.pbiomolbio.2012.07.003; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Prucha J, 2018, J CELL MOL MED, V22, P1355, DOI 10.1111/jcmm.13423; Qi YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9512; Rickett T, 2011, J MED SYST, V35, P787, DOI 10.1007/s10916-010-9468-1; Schmidt D, 2008, P NATL ACAD SCI USA, V105, P19276, DOI 10.1073/pnas.0810187105; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sontheitner Harald, 2007, V38, P35; TABATABAI M, 1990, CLIN PHYSIOL BIOCH, V8, P289; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Tibbs GR, 2016, TRENDS PHARMACOL SCI, V37, P522, DOI 10.1016/j.tips.2016.05.002; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Wei WC, 2018, CURR BIOL, V28, P3815, DOI 10.1016/j.cub.2018.10.046; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang QY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06215	41	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUL	2019	97	7					744	751		10.1002/jnr.24408			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IK9SP	WOS:000476936600003	30927386	Green Published, hybrid			2022-02-06	
J	Chen, JG; Chen, W; Han, KW; Qi, EB; Chen, RB; Yu, MK; Hou, LJ; Lv, LQ				Chen, Jigang; Chen, Wen; Han, Kaiwei; Qi, Enbo; Chen, Rongbin; Yu, Minkun; Hou, Lijun; Lv, Liquan			Effect of oxidative stress in rostral ventrolateral medulla on sympathetic hyperactivity after traumatic brain injury	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						oxidative stress; rostral ventrolateral medulla; sympathetic hyperactivity; traumatic brain injury	NITRIC-OXIDE SYNTHASE; NERVOUS-SYSTEM; NEURAL MECHANISMS; HYPERTENSION; EPIDEMIOLOGY; TEMPOL; SYMPATHOEXCITATION; OVEREXPRESSION; DYSAUTONOMIA; PRESSURE	Sympathetic hyperactivity occurs in a subgroup of patients after traumatic brain injury (TBI). The rostral ventrolateral medulla (RVLM) is a key region for the activity of sympathetic nervous system. Oxidative stress in the RVLM is proved to be responsible for the increased level of sympathetic activity in animal models of hypertension and heart failure. In this study, we investigated whether oxidative stress in the RVLM contributed to the development of sympathetic hyperactivity after TBI in rats. Model of diffuse axonal injury was induced using Sprague-Dawley rats, and level of mean arterial pressure (MAP) and plasma Norepinephrine (NE) was measured to evaluate the sympathetic activity. For the assessment of oxidative stress, expression of reactive oxygen species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD) in the RVLM was determined. Microinjection of Tempol into the RVLM was performed to determine the effect of oxidative stress on sympathetic hyperactivity. According to the results, TBI led to elevated MAP and plasma NE in rats. It also induced a significantly increased level of ROS, MDA production and decreased level of SOD in the RVLM. The sympathetic activity, ROS, and MDA in the RVLM decreased significantly after microinjection of Tempol. Therefore, the present results suggested that oxidative stress in the RVLM was involved in the development of sympathetic hyperactivity following TBI.	[Chen, Jigang; Chen, Wen; Han, Kaiwei; Qi, Enbo; Chen, Rongbin; Yu, Minkun; Hou, Lijun; Lv, Liquan] Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China		Hou, LJ; Lv, LQ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Neurosurg, Shanghai, Peoples R China.	lijunhoucz@126.com; lvlq1976@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271350]	National Natural Science Foundation of China, Grant/Award Number: 81271350	ASTONJONES G, 1991, PROG BRAIN RES, V88, P501; Baguley IJ, 2008, NEUROCRIT CARE, V8, P293, DOI 10.1007/s12028-007-9021-3; Bonini MG, 2002, CHEM RES TOXICOL, V15, P506, DOI 10.1021/tx015571z; Brooks VL, 2005, CLIN EXP PHARMACOL P, V32, P426, DOI 10.1111/j.1440-1681.2005.04206.x; Carlson SH, 2001, AM J HYPERTENS, V14, p155S, DOI 10.1016/S0895-7061(01)02083-0; Carroll RT, 2000, CHEM RES TOXICOL, V13, P294, DOI 10.1021/tx990159t; CHAN PH, 1995, J NEUROTRAUM, V12, P815, DOI 10.1089/neu.1995.12.815; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hao F, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2158971; Hinson HE, 2012, CURR OPIN CRIT CARE, V18, P139, DOI 10.1097/MCC.0b013e3283513290; Hirooka Y, 2011, AM J PHYSIOL-REG I, V300, pR818, DOI 10.1152/ajpregu.00426.2010; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Huang BS, 2002, HYPERTENSION, V39, P557, DOI 10.1161/hy02t2.103004; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Ito S, 2003, HYPERTENSION, V41, P744, DOI 10.1161/01.HYP.0000052944.54349.7B; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kimura Y, 2005, CIRC RES, V96, P252, DOI 10.1161/01.RES.0000152965.75127.9d; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Kishi T, 2003, HYPERTENSION, V41, P255, DOI 10.1161/01.HYP.0000050649.30821.CB; Koga Y, 2008, HYPERTENS RES, V31, P2075, DOI 10.1291/hypres.31.2075; Konno S, 2012, J HYPERTENS, V30, P1992, DOI 10.1097/HJH.0b013e328357fa98; Kumar A, 2008, NEONATOLOGY, V94, P96, DOI 10.1159/000116633; LAKE CR, 1976, LIFE SCI, V18, P1315, DOI 10.1016/0024-3205(76)90210-1; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Lv LQ, 2011, J TRAUMA, V71, P538, DOI 10.1097/TA.0b013e31820ebee1; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mai J., 2008, RAT BRAIN STEREOTAXI, V3, P6, DOI [10.1016/0165-0270(80)90021-7, DOI 10.1016/0165-0270(80)90021-7]; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; Meyer Kimberly S, 2014, Surg Neurol Int, V5, pS490, DOI 10.4103/2152-7806.144632; Nishihara M, 2012, J HYPERTENS, V30, P97, DOI 10.1097/HJH.0b013e32834e1df4; Ozay R, 2017, WORLD NEUROSURG, V104, P634, DOI 10.1016/j.wneu.2017.04.136; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng J, 2009, CARDIOVASC RES, V84, P283, DOI 10.1093/cvr/cvp202; Peterson JR, 2006, CURR HYPERTENS REP, V8, P232, DOI 10.1007/s11906-006-0056-1; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Yan JQ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00772	53	5	5	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2019	50	2					1972	1980		10.1111/ejn.14374			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IL1HO	WOS:000477050500009	30762917				2022-02-06	
J	Clement, MO				Clement, Mariza O.			Imaging of Brain Trauma	RADIOLOGIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Neurovascular injury; Dissection; Radiology; Brain hemorrhage; Diffuse axonal injury	COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DELAYED INTRACRANIAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; CEREBROVASCULAR INJURY; DIAGNOSIS; HEMATOMA; OUTCOMES; RISK; SIGN	Conventional imaging in the acute setting of brain trauma, relevant pathophysiology of injury, and advanced imaging techniques that may provide value in understanding the immediate management and long-term sequela of traumatic brain injury are reviewed. Key imaging findings that can guide clinical management related to such injuries as concussions, hematomas, dissections, dural atrioventricular fistula, and diffuse axonal injury are discussed. The role and accuracy of computed tomography, dual-energy computed tomography, computed tomography angiography, and magnetic resonance angiography in the acute setting are evaluated. In addition, caveats related to imaging the elderly and pediatric population are addressed.	[Clement, Mariza O.] Boston Univ, Boston Med Ctr, Dept Radiol, 820 Harrison Ave FGH3, Boston, MA 02118 USA		Clement, MO (corresponding author), Boston Univ, Boston Med Ctr, Dept Radiol, 820 Harrison Ave FGH3, Boston, MA 02118 USA.	Mariza.Clement@bmc.org					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Araki T, 2017, NEUROL MED-CHIR, V57, P82, DOI 10.2176/nmc.ra.2016-0191; Balinger KJ, 2015, J SURG RES, V199, P183, DOI 10.1016/j.jss.2015.04.006; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; D'Amato L, 2007, J Neurosurg Sci, V51, P107; Dewan M.C., 2018, J NEUROSURG; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; Ellis JA, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.2.FOCUS1223; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Foreman PM, 2017, J NEUROSURG, V127, P32, DOI 10.3171/2016.7.JNS16849; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Grossman RI, 2003, NEURORADIOLOGY REQUI, P243; Nguyen HS, 2016, INT MED CASE REP J, V9, P15, DOI 10.2147/IMCRJ.S95809; HAN BK, 1989, AM J NEURORADIOL, V10, P1191; Heit JJ, 2017, J STROKE, V19, P11, DOI 10.5853/jos.2016.00563; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Hill JH, 2018, BRAIN INJURY, V32, P735, DOI 10.1080/02699052.2018.1441442; Huisman TAGM, 2009, J NEURORADIOLOGY, V36, P93, DOI 10.1016/j.neurad.2008.06.003; Kanoto M, 2016, NEUROL MED-CHIR, V56, P524, DOI 10.2176/nmc.ra.2015-0294; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Kobata H, 2017, NEUROL MED-CHIR, V57, P410, DOI 10.2176/nmc.oa.2017-0056; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lichenstein R, 2012, ARCH PEDIAT ADOL MED, V166, P725, DOI 10.1001/archpediatrics.2011.1919; Lolli V, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150849; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Malhotra AK, 2007, ANN SURG, V246, P632, DOI 10.1097/SLA.0b013e3181568cab; Mandell DM, 2017, AM J NEURORADIOL, V38, P218, DOI 10.3174/ajnr.A4893; Mann N, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0179-0; Mayo Clinic, CLIN TRIALS; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Nassiri F, 2017, J TRAUMA ACUTE CARE, V83, P725, DOI 10.1097/TA.0000000000001617; Ore CLD, 2018, J NEUROSURG-PEDIATR, V22, P559, DOI 10.3171/2018.5.PEDS18140; Orito K, 2016, STROKE, V47, P958, DOI 10.1161/STROKEAHA.115.011578; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peng WJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4137210; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Selariu E, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-109; Shinoda J, 2017, NEUROL MED-CHIR, V57, P199, DOI 10.2176/nmc.ra.2016-0293; Sun LL, 2017, J ZHEJIANG UNIV-SC B, V18, P733, DOI 10.1631/jzus.B1600499; Swap Clifford, 2016, Perm J, V20, P14, DOI 10.7812/TPP/15-095; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Watanabe Y, 2014, NEURORADIOLOGY, V56, P291, DOI 10.1007/s00234-014-1333-3; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Witiw CD, 2018, CRIT CARE MED, V46, P430, DOI 10.1097/CCM.0000000000002931; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729	56	5	5	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0033-8389	1557-8275		RADIOL CLIN N AM	Radiol. Clin. N. Am.	JUL	2019	57	4					733	+		10.1016/j.rcl.2019.02.008			13	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	IC6NQ	WOS:000471089200006	31076029				2022-02-06	
J	El-Khatib, H; Arbour, C; Sanchez, E; Dumont, M; Duclos, C; Blais, H; Carrier, J; Paquet, J; Gosselin, N				El-Khatib, Hejar; Arbour, Caroline; Sanchez, Erlan; Dumont, Marie; Duclos, Catherine; Blais, Helene; Carrier, Julie; Paquet, Jean; Gosselin, Nadia			Towards a better understanding of increased sleep duration in the chronic phase of moderate to severe traumatic brain injury: an actigraphy study	SLEEP MEDICINE			English	Article						Actigraphy; Sleep quality; Sleepiness; Fatigue; Mood; Medication	COGNITIVE-BEHAVIORAL THERAPY; DAYTIME SLEEPINESS; FATIGUE; INSOMNIA; DISTURBANCES; PAIN; NEED; INDIVIDUALS; DISORDERS; NEURONS	Introduction: Most adults with moderate to severe traumatic brain injury (TBI) report persistent sleep-wake disturbances. Whether these complaints are either associated with abnormal sleep-wake patterns or can be explained by TBI-related characteristics is unclear. The present study aimed at characterising the subjective and objective sleep-wake patterns in TBI adults by taking into consideration the influence of TBI severity, common comorbidities and psychoactive medication. Methods: Overall, 34 adults with moderate-severe TBI (one to four years post-injury) were compared to 34 controls. Sleepiness, fatigue, sleep quality, mood, and pain were assessed with questionnaires. A seven day sleep diary and actigraphy was used to document sleep and wake patterns. Results: Compared to controls, TBI participants reported more sleepiness and fatigue, as well as poorer sleep quality. On actigraphy, they had earlier bedtime and longer time spent in bed, but equivalent sleep efficiency during the nighttime episode compared to controls. TBI participants also took more naps and accumulated more time asleep over the 24 h period than controls. These group differences were accentuated when only TBI adults using psychoactive medication were included. More comorbidities, more severe injuries and longer hospital stay were positively correlated with fatigue, sleepiness and sleep duration. Conclusions: Our results showed that despite complaints regarding sleep and diurnal functioning, TBI survivors have very marginal changes in their objective sleep-wake schedules. Prolonged time spent in bed may reflect an attempt to increase their sleep duration in response to fatigue and sleepiness. TBI adults who use psychoactive medication are those with more evident changes in their sleep-wake schedules. (C) 2018 Elsevier B.V. All rights reserved.	[El-Khatib, Hejar; Arbour, Caroline; Sanchez, Erlan; Dumont, Marie; Duclos, Catherine; Blais, Helene; Carrier, Julie; Paquet, Jean; Gosselin, Nadia] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local E-0330, Montreal, PQ H4J 1C5, Canada; [El-Khatib, Hejar; Carrier, Julie; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Sanchez, Erlan] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Dumont, Marie; Duclos, Catherine] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada		Gosselin, N (corresponding author), Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local E-0330, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca		Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Consortium pour le developpement de la recherche en traumatologie du Quebec [34851]; Fonds de la recherche du Quebec e Sante	This study was supported by research grants to N.G. from the Canadian Institutes of Health Research (#FDN154291 and #MOP115172) and from the Consortium pour le developpement de la recherche en traumatologie du Quebec (#34851). N.G. and J.C. receive salary awards from the Fonds de la recherche du Quebec e Sante. E. S. receives a studentship from the Canadian Institutes of Health Research.	American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S, V3rd; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Boyne K, 2013, SLEEP BREATH, V17, P411, DOI 10.1007/s11325-012-0709-z; Buysse D J, 1989, Psychiatry Res, V28, P193; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kahn M, 2013, INT J PSYCHOPHYSIOL, V89, P218, DOI 10.1016/j.ijpsycho.2013.05.010; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Lavigne G. J., 2011, PRINCIPLES PRACTICE, P1442; Lu W, 2016, NEUROREHABILITATION, V38, P59, DOI 10.3233/NRE-151296; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Mayers AG, 2006, INT J PSYCHIAT CLIN, V10, P2, DOI 10.1080/13651500500328087; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Morin CM, 2012, LANCET, V379, P1129, DOI 10.1016/S0140-6736(11)60750-2; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Ouellet MC, 2004, ARCH PHYS MED REHAB, V85, P1298, DOI 10.1016/j.apmr.2003.11.036; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Suzuki Y, 2017, SLEEP MED, V33, P36, DOI 10.1016/j.sleep.2016.06.033; Theadom A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010453; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wiseman-Hakes C MB, 2016, J SLEEP DISORD THER, V5; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	48	5	5	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	JUL	2019	59						67	75		10.1016/j.sleep.2018.11.012			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ID4SD	WOS:000471665700013	30578112				2022-02-06	
J	Fouche, PF; Smith, K; Jennings, PA; Boyle, M; Bernard, S				Fouche, Pieter Francsois; Smith, Karen; Jennings, Paul Andrew; Boyle, Malcolm; Bernard, Stephen			The association of paramedic rapid sequence intubation and survival in out-of-hospital stroke	EMERGENCY MEDICINE JOURNAL			English	Article						airway; emergency ambulance systems	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CRITICAL-CARE; ADJUSTMENT; MANAGEMENT; SCORES	Introduction Ambulance transport of patients with stroke is common, with rapid sequence intubation (RSI) to secure the airway used regularly. Randomised controlled trial evidence exists to support the use of RSI in traumatic brain injuries (TBIs), but it is not clear whether the RSI evidence from TBI can be applied to the patient with stroke. To this end, we analysed a retrospective stroke dataset to compare survival of patients with RSI compared with patients that did not receive RSI. Methods This study was a retrospective analysis of 10 years of in-hospital and out-of-hospital data for all patients with stroke attended by Ambulance Victoria, in Victoria Australia. Generalised boosted logistic regression was used to predict propensity scores, with initial vital signs, age and demographic variables as well as measures of illness severity and comorbidity included in the prediction model. This analysis employed a 1:1 nearest-neighbour matching which was applied to generate a dataset from which we calculated the OR of survival to hospital discharge of patients receiving RSI versus no-RSI. The sensitivity of these results to unmeasured confounding was assessed with deterministic sensitivity analysis. Results The propensity score-matched cohort showed a decreased survival for RSI in strokes with an OR 0.61 (95% CI 0.45 to 0.82; p=0.001) when compared with no-RSI. A subgroup analysis showed no significant survival difference for ischaemic strokes: OR 0.66 (95% CI 40 to 1.07; p=0.09). The survival for haemorrhagic stroke was OR 0.60 (95% CI 0.41 to 0.90; p=0.01) lesser for RSI. Results were likely robust to unmeasured confounding and missing data. Conclusions Our retrospective analysis shows a decrease in survival when RSI is utilised by paramedics for stroke. Since RSI is commonly used for strokes, controlled trial evidence to support this practice is urgently needed.	[Fouche, Pieter Francsois] Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Frankston, Vic, Australia; [Smith, Karen] Ambulance Victoria, Res & Evaluat, Melbourne, Vic, Australia; [Jennings, Paul Andrew] Ambulance Victoria, Doncaster, Vic, Australia; [Boyle, Malcolm] Griffith Univ, Sch Med, Paramed, Southport, Qld, Australia; [Bernard, Stephen] Ambulance Victoria, Res & Evaluat, Melbourne, Vic, Australia		Fouche, PF (corresponding author), Monash Univ, Dept Community Emergency Hlth & Paramed Practice, Frankston, Vic, Australia.	Pieter.Fouche@monash.edu	Jennings, Paul/AAF-2016-2019	Jennings, Paul/0000-0002-5605-7589; Smith, Karen/0000-0002-9057-0685			Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Fouche PF, 2017, ANN EMERG MED, V70, P449, DOI 10.1016/j.annemergmed.2017.03.026; Fouche PF, 2017, RESUSCITATION, V110, P56, DOI 10.1016/j.resuscitation.2016.10.020; Fouche PF, 2017, PREHOSP EMERG CARE, V21, P700, DOI 10.1080/10903127.2017.1325952; Froehler MT, 2012, NEUROLOGY, V79, pS167, DOI 10.1212/WNL.0b013e31826959c2; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Jeon SB, 2014, J NEUROL NEUROSUR PS, V85, P1301, DOI 10.1136/jnnp-2013-307314; Johnston KC, 2019, LANCET, V393, P963, DOI 10.1016/S0140-6736(19)30276-4; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Kitsios GD, 2015, CRIT CARE MED, V43, P1870, DOI 10.1097/CCM.0000000000001135; Kyriacou DN, 2016, JAMA-J AM MED ASSOC, V316, P1818, DOI 10.1001/jama.2016.16435; Mansour OY, 2015, ALEX J MED, V51, P247, DOI 10.1016/j.ajme.2014.10.002; Meyer PG, 2000, CAN J ANAESTH, V47, P758, DOI 10.1007/BF03019478; Montgomery JM, 2018, AM J POLIT SCI, V62, P760, DOI 10.1111/ajps.12357; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Perkins ZB, 2013, INJURY, V44, P618, DOI 10.1016/j.injury.2012.03.019; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Sjoding MW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0923-8; Takahashi C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00170; Takahashi CE, 2014, NEUROCRIT CARE, V20, P202, DOI 10.1007/s12028-013-9921-3; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Victoria A, 2016, CLIN PRACTICE GUIDEL, P42	24	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2019	36	7					416	+		10.1136/emermed-2019-208613			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IM3LO	WOS:000477894900008	31147349	Green Published			2022-02-06	
J	Gellner, RA; Campolettano, ET; Smith, EP; Rowson, S				Gellner, Ryan A.; Campolettano, Eamon T.; Smith, Eric P.; Rowson, Steven			Are specific players more likely to be involved in high-magnitude head impacts in youth football?	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						youth football; head acceleration; individual intervention; high magnitude; head impacts; trauma	TRAUMATIC BRAIN-INJURY; EXPOSURE; CONCUSSION; RISK; KINEMATICS; LOCATION; SPORTS; RATES	OBJECTIVE Youth football attracts approximately 3.5 million participants every year, but concern has recently arisen about the long-term effects of experiencing repetitive head accelerations from a young age due to participation in football. The objective of this study was to quantify total involvement in high-magnitude impacts among individual players in youth football practices. The authors explored the relationship between the total number of high-magnitude accelerations in which players were involved (experienced either by themselves or by other players) during practices and the number of high-magnitude accelerations players experienced. METHODS A local cohort of 94 youth football players (mean age 11.9 +/- 1.5, mean body mass 50.3 +/- 16.4 kg) from 4 different teams were recruited and outfitted with helmet-mounted accelerometer arrays. The teams were followed for one season each for a total of 128 sessions (practices, games, and scrimmages). All players involved in high-magnitude (greater than 40g) head accelerations were subsequently identified through analysis of practice film. RESULTS Players who experienced more high-magnitude accelerations were more likely to be involved in impacts associated with high-magnitude accelerations in other players. A small subset of 6 players (6%) were collectively involved in 230 (53%) high-magnitude impacts during practice, were involved in but did not experience a high-magnitude acceleration 78 times (21% of the 370 one-sided high-magnitude impacts), and experienced 152 (30%) of the 502 high-magnitude accelerations measured. Quarterbacks/running backs/linebackers were involved in the greatest number of high-magnitude impacts in practice and experienced the greatest number of high-magnitude accelerations. Which team a player was on was an important factor, as one team showed much greater head impact exposure than all others. CONCLUSIONS This study showed that targeting the most impact-prone players for individualized interventions could reduce high-magnitude acceleration exposure for entire teams. These data will help to further quantify elevated head acceleration exposure and enable data-driven interventions that modify exposure for individual players and entire teams.	[Gellner, Ryan A.; Campolettano, Eamon T.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Smith, Eric P.] Virginia Tech, Dept Stat, Blacksburg, VA USA		Rowson, S (corresponding author), Virginia Tech, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410]; Virginia Tech Institute for Critical Technology and Applied Science	The authors would like to thank the National Institute of Neurological Disorders and Stroke of the National Institutes of Health for supporting this work under award number R01NS094410. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would also like to thank the Virginia Tech Institute for Critical Technology and Applied Science for their support. Finally, we are also grateful to the Blacksburg Recreational Football League and Blacksburg Middle School players, parents, coaches, and organizers for their participation and cooperation.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bellamkonda S, 2018, J APPL BIOMECH, V34, P354, DOI 10.1123/jab.2017-0207; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb Bryan R, 2014, Biomed Sci Instrum, V50, P285; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Duma S. M, 2013, EFFECTIVENESS HELMET; Duma SM, 2014, CONCUSSIONS ATHLETIC, P115; Gellner Ryan A, 2018, Biomed Sci Instrum, V54, P39; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Pop Warner Little Scholars, LTD CONT PRACT RUL; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055	44	5	5	1	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2019	24	1					47	53		10.3171/2019.2.PEDS18176			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	IF8HV	WOS:000473331600008	31026823				2022-02-06	
J	Jiang, SY; Smith, K; Gan, RZ				Jiang, Shangyuan; Smith, Kyle; Gan, Rong Z.			Dual-laser measurement and finite element modeling of human tympanic membrane motion under blast exposure	HEARING RESEARCH			English	Article; Proceedings Paper	8th International Symposium on Middle Ear Mechanics in Research and Otology (MEMRO)	JUL 05-09, 2018	Shanghai, PEOPLES R CHINA			Tympanic membrane; Blast exposure; Middle ear; Finite element modeling; Laser Doppler vibrometry	TRAUMATIC BRAIN-INJURY; HUMAN MIDDLE-EAR; SOUND-TRANSMISSION; PRESSURE; DISPLACEMENT; PERFORATIONS; MECHANISMS; FREQUENCY; VIBRATION; RESPONSES	Hearing damage is one of most prevalent injuries in military personnel and civilians exposed to a blast. However, the mechanism of how the blast overpressure interacts with the tympanic membrane (TM) and impairs the peripheral auditory system still remains unclear. A 3D finite element (FE) model of the human ear has been developed to predict the blast overpressure transmission through the ear (Leckness et al., 2018), but the model needs to be further validated in TM response to blast pressure. This paper reports the first-ever approach using two laser Doppler vibrometers (LDVs) to measure the motion of the TM when the ear was exposed to a blast. Five fresh human temporal bones were used in this study with a pressure sensor inserted near the TM to measure the pressure reaching the TM (P1). The temporal bone was mounted in a "head block" and exposed to blast at the overpressure around 35 kPa measured at the entrance of the ear canal (P0). The movements of the TM at the umbo and the "head block" were measured simultaneously by two LDVs and the exact motion of the TM was determined by subtracting the head block motion from the TM data. Results include that the maximum TM velocity was 12.62 +/- 3.63 m/s (mean +/- SD) and the displacement was 0.78 +/- 0.26 mm. The peak-to-peak displacement normalized by the PO pressure was 22.9 +/- 6.6 mu m/kPa. The frequency domain analysis indicated that the spectrum peaks were located at frequencies below 3 kHz. The TM motion was then compared with that calculated from the FE model of the human ear with the measured PO pressure wave applied at the ear canal entrance. The FE model-derived TM displacement under blast overpressure was consistent with the experimental results. This study provides a new methodology to determine the behavior of the middle ear in response to blast overpressure. The experimental data are critical for validating the FE model of the human ear for blast wave transduction and understanding the TM damage induced by blast exposure. (C) 2018 Elsevier B.V. All rights reserved.	[Jiang, Shangyuan; Smith, Kyle; Gan, Rong Z.] Univ Oklahoma, Sch Aerosp & Mech Engn, 865 Asp Ave,Room 200, Norman, OK 73019 USA		Gan, RZ (corresponding author), Univ Oklahoma, Sch Aerosp & Mech Engn, 865 Asp Ave,Room 200, Norman, OK 73019 USA.	rgan@ou.edu			US Department of Defense (DOD)United States Department of Defense [W81XWH-14-1-0228]	This study was supported by the US Department of Defense (DOD) grant W81XWH-14-1-0228.	Aerts JRM, 2010, HEARING RES, V263, P26, DOI 10.1016/j.heares.2009.12.022; Astrom K.J., 2010, FEEDBACK SYSTEMS INT, P241; Breeze J, 2011, J LARYNGOL OTOL, V125, P13, DOI 10.1017/S0022215110002215; Castellini P, 2006, MECH SYST SIGNAL PR, V20, P1265, DOI 10.1016/j.ymssp.2005.11.015; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Cheng J.T., 2017, J ACOUST SOC AM, V141, P3897, DOI [10.1121/1.4988760., DOI 10.1121/1.4988760]; Cheng JT, 2010, HEARING RES, V263, P66, DOI 10.1016/j.heares.2009.12.024; Cho SI, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067618, 10.1371/journal.pone.0081422]; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; de Regloix SB, 2017, J ROY ARMY MED CORPS, V163, P333, DOI 10.1136/jramc-2016-000733; Dougherty AL, 2013, J REHABIL RES DEV, V50, P893, DOI 10.1682/JRRD.2012.02.0024; Engles WG, 2017, ANN BIOMED ENG, V45, P2383, DOI 10.1007/s10439-017-1870-0; Gan RZ, 2007, ANN BIOMED ENG, V35, P2180, DOI 10.1007/s10439-007-9366-y; Gan RZ, 2018, AIP CONF PROC, V1965, DOI 10.1063/1.5038502; Gan RZ, 2018, MIL MED, V183, P245, DOI 10.1093/milmed/usx149; Gan RZ, 2016, HEARING RES, V340, P25, DOI 10.1016/j.heares.2016.01.004; Gan RZ, 2009, J ACOUST SOC AM, V126, P243, DOI 10.1121/1.3129129; Gan TZ, 2004, OTOL NEUROTOL, V25, P423, DOI 10.1097/00129492-200407000-00005; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; GARTH RJN, 1994, J LARYNGOL OTOL, V108, P925, DOI 10.1017/S0022215100128555; GOODE RL, 1994, AM J OTOL, V15, P145; Greene NT, 2018, HEARING RES, V365, P149, DOI 10.1016/j.heares.2018.05.014; Greene NT, 2017, HEARING RES, V348, P16, DOI 10.1016/j.heares.2017.02.002; Hawa T, 2014, J FLUID ENG-T ASME, V136, DOI 10.1115/1.4027141; Keefe DH, 1996, EAR HEARING, V17, P361, DOI 10.1097/00003446-199610000-00002; Kingery C.N., 1964, 1518 BALL RES LAB; Leckness K, 2018, MIL MED, V183, P262, DOI 10.1093/milmed/usx226; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; Peacock J, 2015, JARO-J ASSOC RES OTO, V16, P569, DOI 10.1007/s10162-015-0535-7; Rosowski JJ, 2009, HEARING RES, V253, P83, DOI 10.1016/j.heares.2009.03.010; Rothberg SJ, 2017, OPT LASER ENG, V99, P11, DOI 10.1016/j.optlaseng.2016.10.023; RUAH CB, 1991, ARCH OTOLARYNGOL, V117, P627; Sridhara SK, 2013, OTOLARYNG HEAD NECK, V148, P103, DOI 10.1177/0194599812459326; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Voss SE, 2000, HEARING RES, V150, P43, DOI 10.1016/S0378-5955(00)00177-5; Walter PL, 2004, SOUND VIB, V38, P10; Wang XL, 2016, HEARING RES, V339, P184, DOI 10.1016/j.heares.2016.07.015; Yang C, 2013, I NAVIG SAT DIV INT, P2084; Yeh DD, 2012, WORLD J SURG, V36, P966, DOI 10.1007/s00268-012-1500-9; Zhang XM, 2014, JARO-J ASSOC RES OTO, V15, P867, DOI 10.1007/s10162-014-0482-8; Zhang XM, 2013, HEARING RES, V301, P146, DOI 10.1016/j.heares.2012.12.005	44	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	JUL	2019	378				SI		43	52		10.1016/j.heares.2018.12.003			10	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	IE2VZ	WOS:000472244000006	30630647				2022-02-06	
J	Sabella, SA; Suchan, CS				Sabella, Scott A.; Suchan, Christopher S.			The Contribution of Social Support, Professional Support, and Financial Hardship to Family Caregiver Life Satisfaction After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						family caregivers; financial hardship; professional support; social support; traumatic brain injury	QUALITY-OF-LIFE; REHABILITATION; BURDEN; NEEDS; PREDICTORS; INTERVENTION; INDIVIDUALS; DISTRESS; CHILDREN; OUTCOMES	Objectives: (a) To assess whether 3 changeable environmental variables (social support, professional support, and financial hardship) contribute to explaining differences in well-being of family caregivers after traumatic brain injury (TBI), above and beyond the influence of neurobehavioral functioning. (b) To assess the unique and relative contribution of social support, professional support, and financial hardship to life satisfaction of family caregivers. Participants: Adult family caregivers (n = 136) of individuals who received inpatient rehabilitation following a TBI. Measures: The Social Provisions Scale; Brief Scale of Financial Hardship after Brain Injury; Satisfaction with Life Scale; and adapted scales measuring professional support and neurobehavioral functioning. Design: Cross-sectional study using survey methodology. Results: Social support, professional support, and financial hardship explained a significant amount of variance in life satisfaction after controlling for neurobehavioral functioning (R-2 change = 0.34, considered a large effect size). Social support and financial hardship were significant unique predictors within the model, but professional support was not. Conclusion: Social support and financial hardship are prominent environmental variables that may hold promise for targeted intervention development and testing designed to support family adaptation after TBI.	[Sabella, Scott A.; Suchan, Christopher S.] SUNY Buffalo, Sch & Educ Psychol, Dept Counseling, 419 Baldy Hall, Buffalo, NY 14260 USA		Sabella, SA (corresponding author), SUNY Buffalo, Sch & Educ Psychol, Dept Counseling, 419 Baldy Hall, Buffalo, NY 14260 USA.	sasabell@buffalo.edu					Agency for Healthcare Research andQuality, 2012, DISP HEALTHC QUAL RA; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; [Anonymous], 2013, PLOS ONE; Brunelli AA, 2016, AUST J REHABIL COUNS, V22, P104, DOI 10.1017/jrc.2016.9; Buhl I, 2015, SCAND J OCCUP THER, V22, P181, DOI 10.3109/11038128.2015.1008567; Butterworth P, 2009, SOC SCI MED, V69, P229, DOI 10.1016/j.socscimed.2009.05.008; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Davis K, 2009, J INTELLECT DEV DIS, V34, P153, DOI 10.1080/13668250902874608; Degeneffe CE, 2015, SOC WORK, V60, P19, DOI 10.1093/sw/swu047; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Gall MD, 2007, ED RES; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Heflin CM, 2009, SOC SCI QUART, V90, P1051, DOI 10.1111/j.1540-6237.2009.00645.x; Kitter B, 2015, BRAIN INJURY, V29, P1082, DOI 10.3109/02699052.2015.1018323; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Lee, 2015, FAMILIES REHABILITAT, P153; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; REINHARD SC, 1994, RES NURS HEALTH, V17, P79, DOI 10.1002/nur.4770170203; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Sabella SA, 2018, BRAIN INJURY, V32, P926, DOI 10.1080/02699052.2018.1469168; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Stewart MJ, 1995, INT J NURS STUD, V32, P535, DOI 10.1016/0020-7489(95)00014-9; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tramonti F, 2015, PSYCHOL HEALTH MED, V20, P933, DOI 10.1080/13548506.2015.1009380; Umeasiegbu VI, 2013, AUST J REHABIL COUNS, V19, P155, DOI 10.1017/jrc.2013.18; United States Census Bureau, 2016, QUICKFACTS; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th	47	5	5	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					233	240		10.1097/HTR.0000000000000471			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400012	30829820				2022-02-06	
J	Schneider, KJ				Schneider, Kathryn J.			Concussion part II: Rehabilitation - The need for a multifaceted approach	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Concussion; Treatment; Physiotherapy; Rehabilitation	TRAUMATIC BRAIN-INJURY; PAROXYSMAL POSITIONAL VERTIGO; SPORT-RELATED CONCUSSION; COGNITIVE-BEHAVIORAL PREVENTION; CERVICAL FLEXOR MUSCLES; VESTIBULAR REHABILITATION; POSTCONCUSSION SYNDROME; ACTIVE REHABILITATION; MANUAL THERAPY; HIGH-SCHOOL	Introduction: While most individuals recover in the initial days to weeks following a concussion, in up to 30% of cases symptoms and functional limitations may persist beyond the initial four weeks. There is emerging evidence that multifaceted physiotherapy techniques for individuals who have ongoing symptoms following concussion may be of benefit. Purpose: The purpose of this masterclass article is to summarize the evidence for rehabilitation, describe treatment techniques and multifaceted interventions following concussion.	[Schneider, Kathryn J.] Univ Calgary, Hotchkiss Brain Inst, Fac Kinesiol, Sport Injury Prevent Res Ctr, KNB3300D 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Schneider, Kathryn J.] Univ Calgary, Alberta Childrens Hosp Res Inst, KNB3300D 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada		Schneider, KJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Fac Kinesiol, Sport Injury Prevent Res Ctr, KNB3300D 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.; Schneider, KJ (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, KNB3300D 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca		Schneider, Kathryn/0000-0002-5951-5899			Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Andersen LL, 2008, ARTHRIT RHEUM-ARTHR, V59, P84, DOI 10.1002/art.23256; Avidan Alon Y., 2011, HDB SLEEP MED, V2nd; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Blume HK, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0516-x; Bogdanov S, 2017, BRAIN INJURY, V31, P422, DOI 10.1080/02699052.2017.1282042; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Brown FC, 2002, BEHAV MED, V28, P33, DOI 10.1080/08964280209596396; Ciuffreda KJ, 2017, BRAIN SCI, V7; Clark J, 2017, J ATHL TRAINING, V52, P725, DOI 10.4085/1062-6050-52.4.04; Cluffreda K., 2013, BRAIN INJURY, V27, P41; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Coronado RA, 2012, J ELECTROMYOGR KINES, V22, P752, DOI 10.1016/j.jelekin.2011.12.013; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2018, J HEAD TRAUMA REHABI; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Falla D, 2007, MANUAL THER, V12, P139, DOI 10.1016/j.math.2006.06.003; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Farmer PK, 2015, PHYS THER, V95, P212, DOI 10.2522/ptj.20140073; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gallaway M, 2017, OPTOMETRY VISION SCI, V94, P68, DOI 10.1097/OPX.0000000000000935; Gross A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004249.pub4; Gross AR, 2004, SPINE, V29, P1541, DOI 10.1097/01.BRS.0000131218.35875.ED; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Han BI, 2011, J CLIN NEUROL, V7, P184, DOI 10.3988/jcn.2011.7.4.184; Hecht JS, 2004, J HEAD TRAUMA REHAB, V19, P58, DOI 10.1097/00001199-200401000-00006; Herdman SJ, 2014, VESTIBULAR REHABILIT; Heyer GL, 2016, CEPHALALGIA, V36, P309, DOI 10.1177/0333102415590240; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hillier S, 2007, COCHRANE DB SYST REV, V17; Hilton M, 2002, CLIN OTOLARYNGOL, V27, P440, DOI 10.1046/j.1365-2273.2002.00613.x; Hilton MP, 2014, COCHRANE DB SYST REV, V8; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Imai T, 2017, AURIS NASUS LARYNX, V44, P1, DOI [10.1016/j.an1.2016.03.013, 10.1016/j.anl.2016.03.013]; Perez HI, 2014, MANUAL THER, V19, P215, DOI 10.1016/j.math.2013.12.002; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Jull G, 2008, WHIPLASH HEADACHE NE; Jull G, 2007, J ORTHOP RES, V25, P404, DOI 10.1002/jor.20220; Kay T., 2005, COCHRANE DB SYST REV, V20; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kim D., 2015, J PHYS THER SCI, V27; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lischchynsky J., 2017, BJSM, V51, pe114; Ludvigsson ML, 2015, CLIN J PAIN, V31, P294, DOI 10.1097/AJP.0000000000000123; Ludvigsson ML, 2016, J REHABIL MED, V48, P56, DOI 10.2340/16501977-2041; MacGregor K., 2017, BJSM BR J SEX MED, V51, pE126; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Munoz-Garcia D, 2016, PAIN RES TREAT, V2016, DOI 10.1155/2016/7296032; O'Leary S, 2009, J ORTHOP SPORT PHYS, V39, P324, DOI 10.2519/jospt.2009.2872; Ouchterlony D, 2016, J NEUROSCI NURS, V48, P90, DOI 10.1097/JNN.0000000000000186; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Pavlou M, 2010, J NEUROL PHYS THER, V34, P105, DOI 10.1097/NPT.0b013e3181dde6bf; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Pinder D, 2004, COCHRANE DATABASE SY, V2; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Prokopakis E, 2013, AUDIOL NEURO-OTOL, V18, P83, DOI 10.1159/000343579; Rabey M, 2017, MUSCULOSKEL SCI PRAC, V29, P28, DOI 10.1016/j.msksp.2017.02.010; Reid SA, 2014, ARCH PHYS MED REHAB, V95, P1603, DOI 10.1016/j.apmr.2014.04.009; Reid SA, 2014, PHYS THER, V94, P466, DOI 10.2522/ptj.20120483; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Robinson KE, 2014, J PEDIATR PSYCHOL, V39, P846, DOI 10.1093/jpepsy/jsu031; Scheiman M., 2011, COCHRANE DB SYST REV, V16; Scheiman M, 2011, OPTOMETRY VISION SCI, V88, P1343, DOI 10.1097/OPX.0b013e31822f4d7c; Schneider GM, 2014, ARCH PHYS MED REHAB, V95, P1695, DOI 10.1016/j.apmr.2014.02.026; Schneider GM, 2013, ARCH PHYS MED REHAB, V94, P1628, DOI 10.1016/j.apmr.2013.02.015; Schneider K., 2017, BJSM, V51, pE103; Schneider K, 2009, CLIN J SPORT MED, V19, P265; Schneider K. J., 2017, BJSM BR J SEX MED, V51, pE124; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; SCHNEIDER KJ, 2017, BRIT J SPORT MED, V51; Seeger T., 2014, BRAIN INJ; SHEPARD NT, 1993, ANN OTO RHINOL LARYN, V102, P198, DOI 10.1177/000348949310200306; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; Voogt L, 2015, MANUAL THER, V20, P250, DOI 10.1016/j.math.2014.09.001; Zasler ND, 2015, BRAIN INJURY, V29, P207, DOI 10.3109/02699052.2014.965213; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zonfrillo MR, 2016, J PEDIATR-US, V174, P6, DOI 10.1016/j.jpeds.2016.04.079; Zusman, 2004, PHYS THER REV, V9, P39, DOI 10.1179/108331904225003973	114	5	5	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUL	2019	42						151	161		10.1016/j.msksp.2019.01.006			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	IC2BJ	WOS:000470764100021	30745095				2022-02-06	
J	Vander Werff, KR; Rieger, B				Vander Werff, Kathy R.; Rieger, Brian			Auditory and Cognitive Behavioral Performance Deficits and Symptom Reporting in Postconcussion Syndrome Following Mild Traumatic Brain Injury	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article							IN-NOISE TEST; BLAST-EXPOSED VETERANS; SPONDAIC WORD TEST; METAANALYTIC METHODS; NERVOUS-SYSTEM; NORMAL-HEARING; HEAD; CONCUSSION; TESTS; SEQUELAE	Purpose: This study examined auditory deficits and symptom reporting in individuals with long-term postconcussion symptoms following a single mild traumatic brain injury (mTBI) compared to age-and gender-matched controls without a history of mTBI. Method: Case history interviews, symptom questionnaires, and a battery of central auditory and neuropsychological tests were administered to 2 groups. The mTBI group was a civilian population recruited from a local concussion management program who were seeking rehabilitation for postconcussion-related problems in a postacute period between 3 and 18 months following injury. Symptom validity testing was included to assess the rate of possible insufficient test effort and its influence on scores for all outcome measures. Analyses of group differences in test scores were performed both with and without the participants who showed insufficient test effort. Rates of symptom reporting, correlations among symptoms and behavioral test outcomes, and the relationships between auditory and cognitive test performance were analyzed. Results: The mTBI group reported a high rate of auditory symptoms and general postconcussion symptoms. Performance on neuropsychological tests of cognitive function showed some differences in raw scores between groups, but when effort was considered, there were no significant differences in the rate of abnormal performance between groups. In contrast, there were significant differences in both raw scores and the rate of abnormal performance between groups for some auditory tests when only considering participants with sufficient effort. Auditory symptoms were strongly correlated with other general postconcussion symptoms. Conclusions: Significant auditory symptoms and evidence of long-term central auditory dysfunction were found in a subset of individuals who had chronic postconcussion symptoms after a single mTBI unrelated to blast trauma. The rate of abnormal performance on auditory behavioral tests exceeded the rate of abnormal performance on tests of cognitive function.	[Vander Werff, Kathy R.] Syracuse Univ, Dept Commun Sci & Disorders, Syracuse, NY 13244 USA; [Rieger, Brian] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA		Vander Werff, KR (corresponding author), Syracuse Univ, Dept Commun Sci & Disorders, Syracuse, NY 13244 USA.	kvander@syr.edu		Vander Werff, Kathy/0000-0003-0526-9490	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC010246]	This study was funded by National Institute on Deafness and Other Communication Disorders Grant R03 DC010246, awarded to the first author.	Alberti A, 2001, HEADACHE, V41, P579, DOI 10.1046/j.1526-4610.2001.041006579.x; American National Standards Institute, 2010, S362010 ANSI; [Anonymous], 2015, C TRAUM BRAIN INJ US; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Army Individual Test Battery, 1944, MAN DIR SCOR; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOHNEN N, 1993, ACTA NEUROL BELG, V93, P23; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport ND, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00085; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Department of Veterans Affairs, 2006, SPEECH REC ID MAT DI; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fakhran S, 2014, FUTUR NEUROL, V9, P517, DOI 10.2217/FNL.14.48; Flood GM, 2005, BRAIN INJURY, V19, P1019, DOI 10.1080/02699050500110223; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gallun FJ, 2017, BRAIN INJURY, V31, P1183, DOI 10.1080/02699052.2016.1274781; Gallun FJ, 2016, J REHABIL RES DEV, V53, P705, DOI 10.1682/JRRD.2014.12.0313; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P, 2004, GREENS MED SYMPTOM V; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoover EC, 2017, J AM ACAD AUDIOL, V28, P325, DOI 10.3766/jaaa.16051; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Jury MA, 2001, NEW ZEAL MED J, V114, P286; KATZ J, 1963, ANN OTO RHINOL LARYN, V72, P908, DOI 10.1177/000348946307200405; Katz J, 1991, Ann N Y Acad Sci, V620, P233; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keith, 2009, SCAN 3 TESTS AUDITOR; Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kreuzer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045599; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meehan A, 2016, UNDERSEA HYPERBAR M, V43, P567; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MUELLER H G, 1987, Seminars in Hearing, V8, P267, DOI 10.1055/s-0028-1091377; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Oleksiak M., 2015, J REHABILITATION RES, V49, P995; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reitan R, 1985, HALSTEAD REITAN NEUR; Richman J, 2006, J OCCUP ENVIRON MED, V48, P303, DOI 10.1097/01.jom.0000183482.41957.c3; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Saunders GH, 2018, J AM ACAD AUDIOL, V29, P44, DOI 10.3766/jaaa.16143; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith A., 1982, SYMBOL DIGIT MODALIT; Tillman T.W., 1966, SAMTR6655 USAF SCH A; Tsao JW, 2017, NEUROLOGY, V89, P2010, DOI 10.1212/WNL.0000000000004616; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; VERNON JA, 1994, ARCH OTOLARYNGOL, V120, P547; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Weschler D., 2008, WESCHLER ADULT INTEL; Wilson R H, 1994, J Am Acad Audiol, V5, P269; Wilson RH, 2007, J AM ACAD AUDIOL, V18, P813, DOI 10.3766/jaaa.18.10.2; Wilson RH, 2005, J REHABIL RES DEV, V42, P839, DOI 10.1682/JRRD.2005.01.0009; Wilson RH, 2008, J AM ACAD AUDIOL, V19, P548, DOI 10.3766/jaaa.19.7.4; Woodcock R. W., 2001, WOODCOCKJOHNSON 3 TE; Woodcock RW., 2007, WOODCOCKJOHNSON 3 TE	86	5	5	1	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	JUL	2019	62	7					2501	2518		10.1044/2019_JSLHR-H-18-0281			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	IO1EM	WOS:000479123500031	31260387	Green Published			2022-02-06	
J	Chen, PQ; Li, L; Gao, YF; Xie, ZQ; Zhang, Y; Pan, ZJ; Tu, YX; Wang, H; Han, QQ; Hu, XM; Xin, XM				Chen, Peiqing; Li, Lin; Gao, Yongfeng; Xie, Zhuqing; Zhang, Yin; Pan, Zhoujia; Tu, Yingxin; Wang, Hu; Han, Qiuqin; Hu, Xiamin; Xin, Xiaoming			beta-carotene provides neuro protection after experimental traumatic brain injury via the Nrf2-ARE pathway	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Traumatic brain injury; beta-carotene; oxidative stress; Nrf2-ARC signaling pathway; mouse model	OXIDATIVE STRESS; APOPTOSIS; MELATONIN; MODEL; THERAPY; DISEASE; MICE	We investigate whether beta-carotene, a known natural antioxidant, can reduce oxidative stress induced by traumatic brain injury. In addition, we investigated the underlying mechanism of traumatic brain injury focusing on the NF-E2-related factor (Nrf2) pathway. A controlled cortical impact model was used to mimic traumatic brain injury. Using this model, we evaluated brain edema, lesion volume, neurologic deficits, reactive oxygen species, and the expression of Nrf2-related protein markers. The results of our study demonstrated that cognitive performance and neural functions were improved with beta-carotene administration. In addition, beta-carotene reduced brain edema and reactive oxygen species levels after traumatic brain injury. Nrf2 nuclear accumulation was increased and was accompanied by decreased Keap1 expression. The expression of quinone oxidoreductase 1, a target gene of the Nrf2 signaling pathway was increased. However, lesion volume was not significantly reduced after beta-carotene treatment. Taken together, our data demonstrated that beta-carotene administration was neuroprotective and alleviated oxidative stress by modulating the Nrf2/Keap1-mediated antioxidant pathway in the traumatic brain injury model.	[Chen, Peiqing; Xie, Zhuqing; Zhang, Yin; Pan, Zhoujia; Tu, Yingxin; Wang, Hu; Han, Qiuqin; Hu, Xiamin; Xin, Xiaoming] Shanghai Univ Med & Hlth Sci, Shanghai 201318, Peoples R China; [Li, Lin] Taian City Cent Hosp, Tai An 271000, Shandong, Peoples R China; [Gao, Yongfeng] Shanghai Univ Tradit Chinese Med, Shanghai 201318, Peoples R China; [Xie, Zhuqing; Zhang, Yin] Taishan Med Univ, Sch Pharmaceut Sci, Tai An 271000, Shandong, Peoples R China; [Xin, Xiaoming] Shanghai Univ Med & Hlth Sci, Affiliated Hlth Sch, Shanghai 201318, Peoples R China		Hu, XM; Xin, XM (corresponding author), Shanghai Univ Med & Hlth Sci, Shanghai 201318, Peoples R China.; Xin, XM (corresponding author), Shanghai Univ Med & Hlth Sci, Affiliated Hlth Sch, Shanghai 201318, Peoples R China.	huxm@sumhs.edu.cn; xinxm@sumhs.edu.cn			key special project of collaborative innovation of Shanghai University of Medicine and Health Sciences [E1-0200-18-201001]; Seed fund of Shanghai University of Medicine and Health Sciences [E3-0200-17-201113]; Innovation and entrepreneurship training program for Students majoring in pharmacy of Shanghai University of Medicine and Health Sciences	This work has been supported by grants from key special project of collaborative innovation of Shanghai University of Medicine and Health Sciences (E1-0200-18-201001 to Xiamin Hu); Seed fund of Shanghai University of Medicine and Health Sciences (E3-0200-17-201113 to Xiaoming Xin); Innovation and entrepreneurship training program for Students majoring in pharmacy of Shanghai University of Medicine and Health Sciences.	Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; BITTERMAN N, 1994, J APPL PHYSIOL, V76, P1073, DOI 10.1152/jappl.1994.76.3.1073; Bolduc JA, 2019, FREE RADICAL BIO MED, V132, P73, DOI 10.1016/j.freeradbiomed.2018.08.038; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Eggersdorfer M, 2018, ARCH BIOCHEM BIOPHYS, V652, P18, DOI 10.1016/j.abb.2018.06.001; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fu CJ, 2018, DRUG DES DEV THER, V12, P77, DOI 10.2147/DDDT.S154391; Grodstein F, 2007, ARCH INTERN MED, V167, P2184, DOI 10.1001/archinte.167.20.2184; Hall ED, 2019, NEUROPHARMACOLOGY, V145, P247, DOI 10.1016/j.neuropharm.2018.08.005; Jin W, 2011, INJURY, V42, P714, DOI 10.1016/j.injury.2011.03.009; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kelly ML, 2018, WORLD NEUROSURG, V109, P465, DOI 10.1016/j.wneu.2017.09.155; Lee CT, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0362-8; Li J, 2013, INT J MOL SCI, V14, P24438, DOI 10.3390/ijms141224438; Liu Q, 2018, INT J NEUROSCI, V128, P811, DOI 10.1080/00207454.2018.1424155; McGuire JL, 2019, MOL PSYCHIATR, V24, P995, DOI 10.1038/s41380-018-0239-6; Obulesu M, 2011, NEUROCHEM INT, V59, P535, DOI 10.1016/j.neuint.2011.04.004; Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763; Romanucci M., 2015, OXIDATIVE MED CELLUL, V2015, P1; Shen QH, 2016, WORLDV EVID-BASED NU, V13, P380, DOI 10.1111/wvn.12167; Shi ZH, 2018, MED SCI MONITOR, V24, P1097, DOI 10.12659/MSM.909042; Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Tsai CY, 2013, INT J CARDIOL, V168, P1286, DOI 10.1016/j.ijcard.2012.12.004; Vriend J, 2015, MOL CELL ENDOCRINOL, V401, P213, DOI 10.1016/j.mce.2014.12.013; Xu J., 2013, MATH PROBL ENG, DOI DOI 10.1155/2013/716219; Yusuf M, 2012, INT J NANOMED, V7, P4311, DOI 10.2147/IJN.S34588; Zhang L, 2018, MOL NEUROBIOL, V55, P1773, DOI 10.1007/s12035-017-0456-z; Zhang YT, 2016, TOXICOL LETT, V261, P49, DOI 10.1016/j.toxlet.2016.08.010; Zhao XC, 2015, BRAIN BEHAV IMMUN, V46, P293, DOI 10.1016/j.bbi.2015.02.011; Zhu XZ, 2016, J BIOCHEM MOL TOXIC, V30, P148, DOI 10.1002/jbt.21773	39	5	6	1	2	IMR PRESS	WAN CHAI	RM 19C, LOCKHART CTR, 301-307 LOCKHART RD, WAN CHAI, 00000, HONG KONG	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	JUN 30	2019	18	2					153	161		10.31083/j.jin.2019.02.120			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IJ2AE	WOS:000475699800007	31321956	gold			2022-02-06	
J	Yiannakkaras, C; Konstantinou, N; Constantinidou, F; Pettemeridou, E; Eracleous, E; Papacostas, SS; Seimenis, I				Yiannakkaras, Charalambos; Konstantinou, Nikos; Constantinidou, Fofi; Pettemeridou, Eva; Eracleous, Eleni; Papacostas, Savvas S.; Seimenis, Ioannis			Whole brain and corpus callosum diffusion tensor metrics: How do they correlate with visual and verbal memory performance in chronic traumatic brain injury	JOURNAL OF INTEGRATIVE NEUROSCIENCE			English	Article						Traumatic brain injury; chronic effects; diffusion tensor imaging; white matter; corpus callosum; visual memory; verbal memory	WHITE-MATTER; MICROSTRUCTURAL INTEGRITY; ADDITIONAL EVIDENCE; WORKING-MEMORY; AXONAL INJURY; DYSMYELINATION; REHABILITATION; LESIONS; MRI	This research investigates the chronic effect of moderate to severe traumatic brain injury on brain white matter integrity, as reflected by diffusion tensor imaging metrics, and the assessment of their correlation to neuropsychological response. Thirteen male participants with traumatic brain injury (8.4 years average post-injury time) were compared to a matched group of neurologically healthy controls. None of the traumatic brain injury subjects had received post-acute neurocognitive and/or neuropsychological rehabilitation. Between-group comparison of fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity was performed for the whole brain and corpus callosum. An extensive battery of visual and verbal memory tasks was employed for the comparative assessment of neurocognitive performance. Between-group and within-group performance differences were correlated with fractional anisotropy, mean diffusivity, axial diffusivity, and radial diffusivity of corpus callosum. Significant changes in global fractional anisotropy, mean diffusivity, and radial diffusivity were associated with traumatic brain injury. Visual memory capacity was reduced in traumatic brain injury, and this deficit was correlated to white matter integrity loss at the corpus callosum. Participants with traumatic brain injury underperformed controls in verbal memory as well, but no correlation with corpus callosum diffusion tensor imaging properties was established. Between-group performance difference was correlated with corpus callosum diffusion metrics in several tasks. Significant correlations were found between corpus callosum diffusion tensor imaging metrics and neuropsychological response within the traumatic brain injury group. Changes in whole brain and corpus callosum diffusion tensor metrics inflicted by moderate to severe traumatic brain injury are still evident several years post-injury and relate to neurocognitive impairment, while loss of white matter integrity seems to correlate with episodic and working memory impairment.	[Yiannakkaras, Charalambos; Seimenis, Ioannis] Democritus Univ Thrace, Med Phys Lab, Dept Med, Sch Hlth Sci, Alexandroupolis 68100, Greece; [Konstantinou, Nikos] Cyprus Univ Technol, Dept Rehabil Sci, Fac Hlth Serv, Limassol 3036, Greece; [Constantinidou, Fofi; Pettemeridou, Eva] Univ Cyprus, Ctr Appl Neurosci, CY-1678 Nicosia, Cyprus; [Constantinidou, Fofi; Pettemeridou, Eva] Univ Cyprus, Dept Psychol, CY-1678 Nicosia, Cyprus; [Eracleous, Eleni] Med Diagnost Ctr Ayios Therissos, CY-2033 Nicosia, Cyprus; [Papacostas, Savvas S.] Cyprus Inst Neurol & Genet, Neurol Clin B, CY-1683 Nicosia, Cyprus; [Papacostas, Savvas S.] Cyprus Sch Mol Med, CY-1683 Nicosia, Cyprus		Yiannakkaras, C (corresponding author), Democritus Univ Thrace, Med Phys Lab, Dept Med, Sch Hlth Sci, Alexandroupolis 68100, Greece.	CAN@ucy.ac.cy	Seimenis, Ioannis/AAF-4406-2021	Seimenis, Ioannis/0000-0003-3665-5271; PETTEMERIDOU, EVA/0000-0001-5081-0042; Konstantinou, Nikos/0000-0003-4531-3636	Cyprus Promotion Foundation - Cyprus Government; European Regional Development FundEuropean Commission [NEW INFRASTUCTURE/STRATEGIC/0309/37]	Funding for this project was received from the Cyprus Promotion Foundation through a grant co-funded by the Cyprus Government and the European Regional Development Fund (FC, PI; NEW INFRASTUCTURE/STRATEGIC/0309/37). The authors would like to thank the referral sources and all of our study participants and their families for their participation.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arenth PM, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e318289ede5; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Clasby B, 2018, NEUROREHABILITATION, V42, P345, DOI 10.3233/NRE-172385; Cojen J, 2003, APPL MULTIPLE REGRES; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; Constantinidou F, 2012, CHILD NEUROPSYCHOL, V18, P256, DOI 10.1080/09297049.2011.602013; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Fortin JP, 2017, NEUROIMAGE, V161, P149, DOI 10.1016/j.neuroimage.2017.08.047; Gatto R. G, 2019, BIOL MED; Guan T, 2015, NEURAL REGEN RES, V10, P355, DOI 10.4103/1673-5374.153675; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Hashim E, 2017, FRONT NEUROL, V8, P1; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Jiang S, 2013, NEURAL REGEN RES, V8, P2155, DOI 10.3969/j.issn.1673-5374.2013.23.005; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konstantinou N, 2016, FRONT NEUROL, V7, P7; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwon HG, 2012, NEURAL REGEN RES, V7, P475, DOI 10.3969/j.issn.1673-5374.2012.06.012; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lorenz L, 2015, ISSUE BRIEF MASS HLT, V10, p[1, 1]; Luders E, 2010, J NEUROSCI, V30, P10985, DOI 10.1523/JNEUROSCI.5122-09.2010; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Meyers JE., 1995, REY COMPLEX FIGURE T; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moseley M, 2002, BRAIN COGNITION, V50, P396, DOI 10.1016/S0278-2626(02)00524-9; Pollmann S, 2004, NEUROPSYCHOLOGY, V18, P710, DOI 10.1037/0894-4105.18.4.710; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Voelbel GT, 2012, NEUROREHABILITATION, V31, P281, DOI 10.3233/NRE-2012-0796; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X	48	5	5	1	3	IMR PRESS	WAN CHAI	RM 19C, LOCKHART CTR, 301-307 LOCKHART RD, WAN CHAI, 00000, HONG KONG	0219-6352	1757-448X		J INTEGR NEUROSCI	J. Integr. Neurosci.	JUN 30	2019	18	2					95	105		10.31083/j.jin.2019.02.144			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IJ2AE	WOS:000475699800001	31321950	gold			2022-02-06	
J	Jeon, HM; Lee, WJ; Chung, HS; Yi, YG; Yang, S; Kim, DH; Do, KH				Jeon, Hyun Min; Lee, Won Jae; Chung, Hee Sup; Yi, You Gyoung; Yang, Seoyon; Kim, Dae Hyun; Do, Kyung Hee			Extracorporeal shock wave therapy to treat neurogenic heterotopic ossification in a patient with spinal cord injury: A case report	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Extracorporeal shock wave therapy; Neurogenic heterotopic ossification; Heterotopic ossification; Spinal cord injury	TRAUMATIC BRAIN-INJURY; ESWT	Objective: To evaluate the efficacy and safety of treatment for neurogenic heterotopic ossification (NHO) using extracorporeal shock wave therapy (ESWT) in persons with spinal cord injury (SCI). Design: Single case report. Setting: Department of Physical Medicine and Rehabilitation, Veterans Health Service Medical Center. Participants: A 55-year-old male with cervical SCI, who developed painful NHO around the right hip joint. Interventions: Ultrasound-guided ESWT that used 4,000 shocks at the rate of 3 Hz and the energy flux density between 0.056 and 0.068 mJ/mm(2) was applied to the NHO region a total of 7 times, weekly. Outcome Measures: We assessed the treatment outcomes using a visual analog scale (VAS) score, wheelchair sitting time and size of NHO. Result: After 7 weeks of ESWT treatment, his pain reduced from a VAS score of 7-8 to 3 and his wheelchair sitting time increased. However, there was no significant change of size of NHO. Conclusion: The application of ESWT could be a possible alternative to other treatments for NHO in persons with SCI.	[Jeon, Hyun Min; Lee, Won Jae; Chung, Hee Sup; Yi, You Gyoung; Kim, Dae Hyun; Do, Kyung Hee] Vet Hlth Serv Med Ctr, Dept Phys Med & Rehabil, Seoul, South Korea; [Yang, Seoyon] Ewha Womans Univ, Sch Med, Dept Rehabil Med, Seoul Hosp, Seoul, South Korea		Do, KH (corresponding author), Vet Hlth Serv Med Ctr, Dept Phys Med & Rehabil, Seoul, South Korea.	khdo79@gmail.com	Yi, You Gyoung/Z-6116-2019	Yi, You Gyoung/0000-0003-1791-1831; Yang, Seoyon/0000-0002-7522-1655			Banovac K, 2000, J Spinal Cord Med, V23, P40; Brissot R., 2005, Annales de Readaptation et de Medecine Physique, V48, P581, DOI 10.1016/j.annrmp.2005.04.014; Chang JK, 2009, TOXICOLOGY, V258, P148, DOI 10.1016/j.tox.2009.01.016; Chao ST, 2007, ORTHOPEDICS, V30, P457, DOI 10.3928/01477447-20070601-18; CHAUSSY C, 1980, LANCET, V2, P1265; Choi YM, 2015, ANN REHABIL MED-ARM, V39, P318, DOI 10.5535/arm.2015.39.2.318; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Fu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024342; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Haake M, 2002, ARCH ORTHOP TRAUM SU, V122, P222, DOI 10.1007/s00402-001-0362-7; Maender C, 2010, J SHOULDER ELB SURG, V19, P1269, DOI 10.1016/j.jse.2010.05.029; Mariotto S, 2009, CURR MED CHEM, V16, P2366, DOI 10.2174/092986709788682119; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Reznik JE, 2013, BRAIN INJURY, V27, P242, DOI 10.3109/02699052.2012.729293; Takahashi N, 2003, AUTON NEUROSCI-BASIC, V107, P81, DOI 10.1016/S1566-0702(03)00134-6; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wang FS, 2002, J BONE JOINT SURG BR, V84B, P457, DOI 10.1302/0301-620X.84B3.11609; Wess OJ, 2008, UROL RES, V36, P327, DOI 10.1007/s00240-008-0156-2	21	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	JUL 4	2021	44	4					627	630		10.1080/10790268.2019.1632597		JUN 2019	4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TL0UM	WOS:000473090400001	31242091	Green Published			2022-02-06	
J	Ballout, N; Rochelle, T; Brot, S; Bonnet, ML; Francheteau, M; Prestoz, L; Zibara, K; Gaillard, A				Ballout, Nissrine; Rochelle, Tristan; Brot, Sebastien; Bonnet, Marie-Laure; Francheteau, Maureen; Prestoz, Laetitia; Zibara, Kazem; Gaillard, Afsaneh			Characterization of Inflammation in Delayed Cortical Transplantation	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						motor cortex; cortical lesion; embryonic transplantation; neuroinflammation; delay	TRAUMATIC BRAIN-INJURY; STEM-CELL THERAPY; WHITE-MATTER; ALTERNATIVE ACTIVATION; REACTIVE ASTROCYTES; NEURONS INTEGRATE; GENE-EXPRESSION; NADPH OXIDASE; GLIAL SCAR; IN-VIVO	We previously reported that embryonic motor cortical neurons transplanted 1-week after lesion in the adult mouse motor cortex significantly enhances graft vascularization, survival, and proliferation of grafted cells, the density of projections developed by grafted neurons and improves functional repair and recovery. The purpose of the present study is to understand the extent to which post-traumatic inflammation following cortical lesion could influence the survival of grafted neurons and the development of their projections to target brain regions and conversely how transplanted cells can modulate host inflammation. For this, embryonic motor cortical tissue was grafted either immediately or with a 1-week delay into the lesioned motor cortex of adult mice. Immunohistochemistry (IHC) analysis was performed to determine the density and cell morphology of resident and peripheral infiltrating immune cells. Then, in situ hybridization (ISH) was performed to analyze the distribution and temporal mRNA expression pattern of pro-inflammatory or anti-inflammatory cytokines following cortical lesion. In parallel, we analyzed the protein expression of both M1- and M2-associated markers to study the M1/M2 balance switch. We have shown that 1-week after the lesion, the number of astrocytes, microglia, oligodendrocytes, and CD45+ cells were significantly increased along with characteristics of M2 microglia phenotype. Interestingly, the majority of microglia co-expressed transforming growth factor-beta 1 (TGF-beta 1), an anti-inflammatory cytokine, supporting the hypothesis that microglial activation is also neuroprotective. Our results suggest that the modulation of post-traumatic inflammation 1-week after cortical lesion might be implicated in the improvement of graft vascularization, survival, and density of projections developed by grafted neurons.	[Ballout, Nissrine; Rochelle, Tristan; Brot, Sebastien; Bonnet, Marie-Laure; Francheteau, Maureen; Prestoz, Laetitia; Gaillard, Afsaneh] Univ Poitiers, INSERM, U1084, Lab Neurosci Expt & Clin, Poitiers, France; [Ballout, Nissrine; Zibara, Kazem] Lebanese Univ, Fac Sci 1, Dept Biol, Lab Stem Cells,PRASE,DSST, Beirut, Lebanon; [Bonnet, Marie-Laure] CHU Poitiers, Poitiers, France		Gaillard, A (corresponding author), Univ Poitiers, INSERM, U1084, Lab Neurosci Expt & Clin, Poitiers, France.	afsaneh.gaillard@univ-poitiers.fr	BALLOUT, Nissrine/ABG-2754-2020	BROT, Sebastien/0000-0002-4373-2135; Zibara, Kazem/0000-0002-9887-072X	Institut pour la Recherche sur la Moelle epiniere et l'Encephale; European Union's FEDER funds; region of Nouvelle Aquitaine; INSERM, Poitiers University	This work was funded by grants from the Institut pour la Recherche sur la Moelle epiniere et l'Encephale, the financial participation of the European Union's FEDER funds and the region of Nouvelle Aquitaine, the INSERM, Poitiers University.	Ballout N, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00055; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Demakis GJ, 2010, ARCH CLIN NEUROPSYCH, V25, P191, DOI 10.1093/arclin/acq004; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Dunkerson J, 2014, RESTOR NEUROL NEUROS, V32, P675, DOI 10.3233/RNN-140408; Espuny-Camacho I, 2018, CELL REP, V23, P2732, DOI 10.1016/j.celrep.2018.04.094; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Evrard SM, 2012, J THROMB HAEMOST, V10, P670, DOI 10.1111/j.1538-7836.2012.04644.x; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gaillard A, 1998, ADV ANAT EMBRYOL CEL, V148, P1; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gaillard A, 2007, CELL ADHES MIGR, V1, P161, DOI 10.4161/cam.1.4.5274; Gaillard A, 2009, NEUROBIOL DIS, V35, P477, DOI 10.1016/j.nbd.2009.07.003; Gao HM, 2003, J NEUROSCI, V23, P6181; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gensel JC, 2008, J NEUROSCI, V28, P8385, DOI 10.1523/JNEUROSCI.2533-08.2008; GONZALEZ MF, 1987, J NEUROSCI, V7, P2991; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kiefer R, 1996, AM J PATHOL, V148, P211; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klein A, 2013, CELL TRANSPLANT, V22, P1735, DOI 10.3727/096368912X657918; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lai AY, 2006, CAN J PHYSIOL PHARM, V84, P49, DOI 10.1139/y05-143; Le WD, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00089; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Michelsen KA, 2015, NEURON, V85, P982, DOI 10.1016/j.neuron.2015.02.001; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Peron S, 2017, J NEUROSCI, V37, P1820, DOI 10.1523/JNEUROSCI.2936-16.2017; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; SCHWARTZ JP, 1994, GLIA, V11, P185, DOI 10.1002/glia.440110212; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sochocka M, 2013, CNS NEUROL DISORD-DR, V12, P870, DOI 10.2174/18715273113129990072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thompson LH, 2009, EUR J NEUROSCI, V30, P625, DOI 10.1111/j.1460-9568.2009.06878.x; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vezzani A, 2008, BRAIN BEHAV IMMUN, V22, P797, DOI 10.1016/j.bbi.2008.03.009; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33080; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang ZG, 2017, EXP THER MED, V13, P3613, DOI 10.3892/etm.2017.4423; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	88	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JUN 25	2019	12								160	10.3389/fnmol.2019.00160			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IF6LY	WOS:000473193400001	31293384	Green Published, gold			2022-02-06	
J	Potvin, BM; Aguiar, OMG; Komisar, V; Sidhu, A; Elabd, K; Robinovitch, SN				Potvin, Brigitte M.; Aguiar, Olivia M. G.; Komisar, Vicki; Sidhu, Amerdeep; Elabd, Karam; Robinovitch, Stephen N.			A comparison of the magnitude and duration of linear and rotational head accelerations generated during hand-, elbow- and shoulder-to-head checks delivered by hockey players	JOURNAL OF BIOMECHANICS			English	Article						Biomechanics; Head impact; Upper limb impact; Ice hockey; Traumatic brain injury; Reconstructions; Body-checking; Instrumented dummy	ICE HOCKEY; IMPACT BIOMECHANICS; INJURY; SPORTS; EPIDEMIOLOGY; CONCUSSIONS; MECHANISMS; SYSTEM; MENS	Ice hockey has the highest rates for concussion among team sports in Canada. In elite play, the most common mechanism is impact to the head by an opposing player's upper limb, with shoulder-to-head impacts accounting for twice as many concussions as elbow- and hand-to-head impacts combined. Improved understanding of the biomechanics of head impacts in hockey may inform approaches to prevention. In this study, we measured the magnitude and duration of linear and rotational head accelerations when hockey players (n = 11; aged 21-25) delivered checks "as hard as comfortable" to the head of an instrumented dummy with their shoulder, elbow and hand. There were differences in both peak magnitude and duration of head accelerations across upper limb impact sites, based on repeated-measures ANOVA (p < 0.005). Peak linear head accelerations averaged 1.9-fold greater for hand and 1.3-fold greater for elbow than shoulder (mean values = 20.35, 14.23 and 10.55 g, respectively). Furthermore, peak rotational head accelerations averaged 2.1-fold greater for hand and 1.8-fold greater for elbow than shoulder (1097.9, 944.1 and 523.1 rad/s(2), respectively). However, times to peak linear head acceleration (a measure of the duration of the acceleration impulse) were 2.1-fold longer for shoulder than elbow, and 2.5-fold longer for shoulder than hand (12.26, 5.94 and 4.98 ms, respectively), and there were similar trends in the durations of rotational head acceleration. Our results show that, in body checks to the head delivered by varsity-level hockey players, shoulder-to-head impacts generated longer durations but lower magnitude of peak head acceleration than elbow- and hand-to-head impacts. (C) 2019 Elsevier Ltd. All rights reserved.	[Potvin, Brigitte M.; Aguiar, Olivia M. G.; Komisar, Vicki; Sidhu, Amerdeep; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada; [Elabd, Karam; Robinovitch, Stephen N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada		Robinovitch, SN (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	stever@sfu.ca		Aguiar, Olivia/0000-0001-9131-9049; Robinovitch, Stephen/0000-0003-3881-6227; Komisar, Vicki/0000-0003-3504-1796	Natural Sciences and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/04065]; NSERC Graduate ScholarshipNatural Sciences and Engineering Research Council of Canada (NSERC); NSERC Undergraduate Student Research AwardNatural Sciences and Engineering Research Council of Canada (NSERC)	This research was supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN/04065). O. Aguiar was supported by an NSERC Graduate Scholarship and an NSERC Undergraduate Student Research Award. A. Sidhu was supported by an NSERC Undergraduate Student Research Award. We thank the players, coaches and managers of the men's hockey team of Simon Fraser University for their participation in this research.	Agel J, 2010, CAN J SURG, V53, P319; Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bruschetta M., 2016, BRAIN INJURY, P481; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Delaney JS, 2014, CLIN J SPORT MED, V24, P233, DOI 10.1097/JSM.0000000000000017; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Foster J. K., 1977, 770938 SAE; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; International Ice Hockey Federation (UHF), 2017, SURV PLAYERS; Lafrance X, 2019, MARX ENGELS MARXISM, P1, DOI 10.1007/978-3-319-95657-2_1; Mertz H.J., 1985, SAE T, V94, P97; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2017, J BIOMECH, V61, P183, DOI 10.1016/j.jbiomech.2017.07.013; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Society of Automotive Engineers International, 1995, J2111 SAE; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Virani S., 2017, MED SCI SPORTS EXERC; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	29	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUN 25	2019	91						43	50		10.1016/j.jbiomech.2019.05.002			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	IG5KD	WOS:000473841100006	31153625				2022-02-06	
J	Vikane, E; Froyland, K; Naess, HL; Assmus, J; Skoue, JS				Vikane, Eirik; Froyland, Kaja; Naess, Hanne Langseth; Assmus, Jorg; Skoue, Jan Sture			Predictors for Psychological Distress 2 Months After Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; predictors; psychological distress; anxiety; depression; outcome; treatment	POST-CONCUSSION SYMPTOMS; HEAD-INJURY; HOSPITAL ANXIETY; DEPRESSION SCALE; RISK-FACTORS; QUESTIONNAIRE; GUIDELINES; VALIDITY; PAIN	Objective: To predict psychological distress at 2 months for patients with mild traumatic brain injury. Method: A prospective cohort study of 162 patients with mild traumatic brain injury (MTBI) admitted consecutively to an outpatient clinic at Haukeland University Hospital, Norway. Demographic data were obtained from Statistics Norway and injury characteristics were obtained from the hospital records. Sick leave data from the last year before the injury were obtained from The Norwegian Labor and Welfare Service. Self-report questionnaires were used to obtain history about earlier disease and symptom profiles. The Hospital Anxiety and Depression Scale (HAD) detecting states of depression and anxiety were used as the dependent variable in a stepwise linear regression. Pre-injury factors and injury-related factors were examined as potential predictors for HAD. Results: In the first steps we observed a significant association between HAD at 2 months and education, whiplash associated disorder (WAD), and earlier sick listed with a psychiatric diagnosis. In the final step there was an association only between HAD and self-reported anxiety and WAD. There were no associations between HAD and injury-characteristics like severity at Glasgow Coma Scale or intracranial injury. Conclusion: Patients with low education, earlier psychiatric diagnosis, self-reported earlier anxiety and WAD were more likely to develop a psychological distress after a MTBI. These findings should be taken into consideration when treating patients with MTBI.	[Vikane, Eirik; Froyland, Kaja; Naess, Hanne Langseth; Skoue, Jan Sture] Haukeland Hosp, Dept Phys Med & Rehabil, Bergen, Norway; [Assmus, Jorg] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Skoue, Jan Sture] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway		Vikane, E (corresponding author), Haukeland Hosp, Dept Phys Med & Rehabil, Bergen, Norway.	eirik.vikana@gmail.com			EXTRA funds from the Norwegian Extra Foundation for Health and Rehabilitation	EV was financially supported by EXTRA funds from the Norwegian Extra Foundation for Health and Rehabilitation.	Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Brooks BL, 2019, J NEUROTRAUM, V36, P679, DOI 10.1089/neu.2018.5792; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Craig A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011993; Hellstrom T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00125; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoffer ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146039; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sandborgh M, 2016, PAIN RES MANAG, V2016, DOI 10.1155/2016/8281926; Shafiei E, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.29729; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Singh R, 2019, BRAIN INJURY, V33, P584, DOI 10.1080/02699052.2019.1566837; Snell DL, 2018, BRAIN INJURY, V32, P583, DOI 10.1080/02699052.2018.1432894; Soderlund A, 1999, INT J REHABIL RES, V22, P77; Soderlund A, 2017, PHYSIOTHER THEOR PR, V33, P376, DOI 10.1080/09593985.2017.1307890; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE G, 1974, LANCET, V2, P81; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 2015, INT CLASS DIS ICD; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	5	5	2	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 18	2019	10								639	10.3389/fneur.2019.00639			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ID8KW	WOS:000471934000002	31275230	gold, Green Published			2022-02-06	
J	Kinder, HA; Baker, EW; Wang, SL; Fleischer, CC; Howerth, EW; Duberstein, KJ; Mao, H; Platt, SR; West, FD				Kinder, Holly A.; Baker, Emily W.; Wang, Silun; Fleischer, Candace C.; Howerth, Elizabeth W.; Duberstein, Kylee J.; Mao, Hui; Platt, Simon R.; West, Franklin D.			Traumatic Brain Injury Results in Dynamic Brain Structure Changes Leading to Acute and Chronic Motor Function Deficits in a Pediatric Piglet Model	JOURNAL OF NEUROTRAUMA			English	Article						gait analysis; magnetic resonance imaging; motor function; pig model; traumatic brain injury	MAGNETIC-RESONANCE-SPECTROSCOPY; CONTROLLED CORTICAL IMPACT; WHITE-MATTER; GAIT CHARACTERISTICS; BALANCE ABILITIES; METABOLIC-CHANGES; CORPUS-CALLOSUM; CHILDREN; PATHOPHYSIOLOGY; GROWTH	Traumatic brain injury (TBI) is a leading cause of death and disability in children. Pediatric TBI patients often suffer from crippling cognitive, emotional, and motor function deficits that have negative lifelong effects. The objective of this study was to longitudinally assess TBI pathophysiology using multi-parametric magnetic resonance imaging (MRI), gait analysis, and histological approaches in a pediatric piglet model. TBI was produced by controlled cortical impact in Landrace piglets. MRI data, including from proton magnetic resonance spectroscopy (MRS), were collected 24 hours and 12 weeks post-TBI, and gait analysis was performed at multiple time-points over 12 weeks post-TBI. A subset of animals was sacrificed 24 hours, 1 week, 4 weeks, and 12 weeks post-TBI for histological analysis. MRI results demonstrated that TBI led to a significant brain lesion and midline shift as well as microscopic tissue damage with altered brain diffusivity, decreased white matter integrity, and reduced cerebral blood flow. MRS showed a range of neurochemical changes after TBI. Histological analysis revealed neuronal loss, astrogliosis/astrocytosis, and microglia activation. Further, gait analysis showed transient impairments in cadence, cycle time, % stance, step length, and stride length, as well as long-term impairments in weight distribution after TBI. Taken together, this study illustrates the distinct time course of TBI pathoanatomic and functional responses up to 12 weeks post-TBI in a piglet TBI model. The study of TBI injury and recovery mechanisms, as well as the testing of therapeutics in this translational model, are likely to be more predictive of human responses and clinical outcomes compared to traditional small animal models.	[Kinder, Holly A.; Baker, Emily W.; Howerth, Elizabeth W.; Duberstein, Kylee J.; Platt, Simon R.; West, Franklin D.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Kinder, Holly A.; Baker, Emily W.; Duberstein, Kylee J.; West, Franklin D.] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Howerth, Elizabeth W.] Univ Georgia, Dept Pathol, Athens, GA 30602 USA; [Platt, Simon R.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Wang, Silun; Fleischer, Candace C.; Mao, Hui] Emory Univ, Dept Radiol & Imaging Sci, Atlanta, GA 30322 USA		West, FD (corresponding author), Univ Georgia, Rhodes Ctr Anim & Dairy Sci, Dept Anim & Dairy Sci, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30602 USA.	westf@uga.edu		Kinder, Holly/0000-0001-8310-7265; Fleischer, Candace/0000-0003-3265-2276	University of Georgia Office of the Vice President for Research	We would like to thank Richard Utley and Kelly Parham for their animal assistance; Vivian Lau and Lisa Reno for their surgical expertise and support; and our amazing team of undergraduate researchers that helped us with all aspects of the animal work: Kimberly Straub, Brooke Salehzadeh, Abby Howell, Joette Crews, Aleia Hollands, Kathryn Sellman, Jessica Gladney, Caroline Coleman, Sarah Shaver, Shelley Tau, Jennifer Roveto, Madelaine Wendzik, Kayla Hargrove, Alexandra Ross, and Natalie Bishop. We would like to thank the following for their assistance: Madelaine Wendzik, MRI analysis; Madelaine Wendzik and Elizabeth Waters, gait collection; and Madelaine Wendzik, Mary Kate Mehegan, Sonal Dugar, and Meagan Thomason, histological analysis. We also would like to thank Michael Larche and Samira Yeboah at the Center for Systems Imaging Core at Emory University for their MRI assistance. Financial support was provided by the University of Georgia Office of the Vice President for Research.	Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Baker EW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206481; Baker EW, 2019, J NEUROTRAUM, V36, P61, DOI 10.1089/neu.2017.5551; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Conrad MS, 2015, ANNU REV ANIM BIOSCI, V3, P245, DOI 10.1146/annurev-animal-022114-111049; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Detre JA, 1999, EUR J RADIOL, V30, P115, DOI 10.1016/S0720-048X(99)00050-9; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Drijkoningen D, 2017, J NEUROTRAUM, V34, P1022, DOI 10.1089/neu.2016.4500; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Duberstein KJ, 2014, PHYSIOL BEHAV, V125, P8, DOI 10.1016/j.physbeh.2013.11.004; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Grate LL, 2003, J NEUROSCI METH, V123, P201, DOI 10.1016/S0165-0270(02)00361-8; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Huisman T A G M, 2010, Cancer Imaging, V10 Spec no A, pS163, DOI 10.1102/1470-7330.2010.9023; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; Kawamata T, 2007, PROG BRAIN RES, V161, P235, DOI 10.1016/S0079-6123(06)61016-9; Kim DS, 2015, J KOREAN NEUROSURG S, V58, P131, DOI 10.3340/jkns.2015.58.2.131; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Meijer E, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-37; Mudd AT, 2017, ADV NUTR, V8, P92, DOI 10.3945/an.116.013243; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Sauvigny T, 2016, WORLD NEUROSURG, V88, P519, DOI 10.1016/j.wneu.2015.10.072; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739	70	5	5	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2930	2942		10.1089/neu.2018.6303		JUN 2019	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000472622100001	31084386				2022-02-06	
J	Mannix, R; Zemek, R; Yeates, KO; Arbogast, K; Atabaki, S; Badawy, M; Beauchamp, MH; Beer, D; Bin, S; Burstein, B; Craig, W; Corwin, D; Doan, Q; Ellis, M; Freedman, SB; Gagnon, I; Gravel, J; Leddy, J; Lumba-Brown, A; Master, C; Mayer, AR; Park, G; Penque, M; Rhine, T; Russell, K; Schneider, K; Bell, M; Wisniewski, S				Mannix, Rebekah; Zemek, Roger; Yeates, Keith Owen; Arbogast, Kristy; Atabaki, Shireen; Badawy, Mohammed; Beauchamp, Miriam H.; Beer, Darcy; Bin, Steven; Burstein, Brett; Craig, William; Corwin, Dan; Doan, Quynh; Ellis, Michael; Freedman, Stephen B.; Gagnon, Isabelle; Gravel, Jocelyn; Leddy, John; Lumba-Brown, Angela; Master, Christina; Mayer, Andrew R.; Park, Grace; Penque, Michelle; Rhine, Tara; Russell, Kelly; Schneider, Kathryn; Bell, Michael; Wisniewski, Stephen			Practice Patterns in Pharmacological and Non-Pharmacological Therapies for Children with Mild Traumatic Brain Injury: A Survey of 15 Canadian and United States Centers	JOURNAL OF NEUROTRAUMA			English	Article						concussion; intervention; mild traumatic brain injury	PERSISTENT POSTCONCUSSIVE SYMPTOMS; ACUTE CONCUSSION; PEDIATRIC-PATIENTS; POST-CONCUSSION; MANAGEMENT; PHYSICIANS; KNOWLEDGE; BENEFITS; VISITS	Given the lack of evidence regarding effective pharmacological and non-pharmacological interventions for pediatric mild traumatic brain injury (mTBI) and the resultant lack of treatment recommendations reflected in consensus guidelines, variation in the management of pediatric mTBI is to be expected. We therefore surveyed practitioners across 15 centers in the United States and Canada who care for children with pediatric mTBI to evaluate common-practice variation in the management of pediatric mTBI. The survey, developed by a panel of pediatric mTBI experts, consisted of a 10-item survey instrument regarding providers' perception of common pediatric mTBI symptoms and mTBI interventions. Surveys were distributed electronically to a convenience sample of local experts at each center. Frequencies and percentages (with confidence intervals [CI]) were determined for survey responses. One hundred and seven respondents (71% response rate) included specialists in pediatric Emergency Medicine, Sports Medicine, Neurology, Neurosurgery, Neuropsychology, Neuropsychiatry, Physical and Occupational Therapy, Physiatry/Rehabilitation, and General Pediatrics. Respondents rated headache as the most prevalently reported symptom after pediatric mTBI, followed by cognitive problems, dizziness, and irritability. Of the 65 (61%; [95% CI: 51,70]) respondents able to prescribe medications, non-steroidal anti-inflammatory medications (55%; [95% CI: 42,68]) and acetaminophen (59%; [95% CI: 46,71]) were most commonly recommended. One in five respondents reported prescribing amitriptyline for headache management after pediatric mTBI, whereas topiramate (8%; [95% CI: 3,17]) was less commonly reported. For cognitive problems, methylphenidate (11%; [95% CI: 4,21]) was used more commonly than amantadine (2%; [95% CI: 0,8]). The most common non-pharmacological interventions were rest ("always" or "often" recommended by 83% [95% CI: 63,92] of the 107 respondents), exercise (59%; [95%CI: 49,69]), vestibular therapy (42% [95%CI: 33,53]) and cervical spine exercises (29% [95%CI: 21,39]). Self-reported utilization for common pediatric mTBI interventions varied widely across our Canadian and United States consortium. Future effectiveness studies for pediatric mTBI are urgently needed to advance the evidence-based care.	[Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Zemek, Roger] Univ Ottawa, Dept Pediat, Ottawa, ON, Canada; [Zemek, Roger] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Yeates, Keith Owen] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Alberta Childrens Hosp Res Inst, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Arbogast, Kristy; Corwin, Dan] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med,Div Emergency Med, Sports Med & Performance Ctr,Ctr Injury Res & Pre, Philadelphia, PA 19104 USA; [Master, Christina] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med,Div Orthopaed, Sports Med & Performance Ctr,Ctr Injury Res & Pre, Philadelphia, PA 19104 USA; [Atabaki, Shireen] Childrens Natl Hlth Syst, Div Emergency Med, Washington, DC USA; [Badawy, Mohammed] Univ Texas Southwestern Med Sch, Dept Pediat, Dallas, TX USA; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gravel, Jocelyn] Univ Montreal, Div Emergency Med, Montreal, PQ, Canada; Ste Justine Res Ctr, Montreal, PQ, Canada; [Beer, Darcy] Univ Manitoba, Childrens Hosp Winnipeg, Sect Pediat Emergency Med, Winnipeg, MB, Canada; [Russell, Kelly] Univ Manitoba, Childrens Hosp Winnipeg, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Bin, Steven] UCSF Sch Med, Div Pediat Emergency Med, San Francisco, CA USA; [Burstein, Brett] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Pediat Emergency Med,Dept Pediat, Montreal, PQ, Canada; [Craig, William] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Craig, William] Stollery Childrens Hosp, Edmonton, AB, Canada; [Doan, Quynh] Univ British Columbia, Dept Pediat, Div Emergency Med, Childrens Res Inst, Vancouver, BC, Canada; [Ellis, Michael] Univ Manitoba, Sect Neurosurg, Dept Surg & Pediat, Pan Am Concuss Program, Winnipeg, MB, Canada; [Freedman, Stephen B.] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst,Dept Pediat, Alberta Childrens Hosp,Stephen B Freedman Sect Pe, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Cumming Sch Med, Alberta Childrens Hosp Res Inst,Dept Pediat, Alberta Childrens Hosp,Stephen B Freedman Sect Ga, Calgary, AB, Canada; [Gagnon, Isabelle] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Sch Phys & Occupat Therapy,Trauma Programs, Montreal, PQ, Canada; [Leddy, John] SUNY Buffalo, UBMD Dept Orthopaed & Sports Med, Buffalo, NY USA; [Penque, Michelle] SUNY Buffalo, Pediat Div Emergency Med, Buffalo, NY USA; [Penque, Michelle] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Lumba-Brown, Angela] Stanford Univ, Dept Emergency Med, Concuss & Brain Performance Ctr, Stanford, CA 94305 USA; [Lumba-Brown, Angela] Stanford Univ, Dept Pediat, Concuss & Brain Performance Ctr, Stanford, CA 94305 USA; [Mayer, Andrew R.] Univ New Mexico, Mind Res Network LBERI, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Neurol & Psychiat, Albuquerque, NM 87131 USA; [Park, Grace] Univ New Mexico Hosp, Dept Emergency Med, Albuquerque, NM USA; [Rhine, Tara] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Emergency M, Cincinnati, OH USA; [Bell, Michael] Childrens Natl Med Ctr, Dept Pediat & Crit Care Med, Washington, DC 20010 USA; [Wisniewski, Stephen] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA		Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Doan, Quynh/AAJ-6023-2021; Mannix, Rebekah/AAD-8702-2020; Yeates, Keith/AAJ-4223-2020; Freedman, Stephen/H-9102-2012	Doan, Quynh/0000-0002-8435-7837; Craig, William/0000-0002-4804-194X; Master, Christina/0000-0002-6717-4270; Schneider, Kathryn/0000-0002-5951-5899; Freedman, Stephen/0000-0003-2319-6192; Gagnon, Isabelle/0000-0003-2043-1644; Arbogast, Kristy/0000-0002-1694-4562			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bresee N, 2018, AM J EMERG MED, V36, P2225, DOI 10.1016/j.ajem.2018.04.007; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; Ferrara Michael S., 2001, J Athl Train, V36, P145; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gravel J., 2018, CJEM, V21, P204; Gravel J, 2017, CAN J EMERG MED, V19, P338, DOI 10.1017/cem.2016.369; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Jimenez N., 2017, PEDIATRICS, P139; Kinnaman KA, 2014, PEDIATR EMERG CARE, V30, P458, DOI 10.1097/PEC.0000000000000161; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Lumba-Brown A, 2014, PEDIATR EMERG CARE, V30, P139, DOI 10.1097/PEC.0000000000000084; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2018, J NEUROTRAUM, V35, P1178, DOI 10.1089/neu.2017.5340; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Moser R.S., 2016, REPORT PEDIAT MILD T; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Petrelli T, 2017, PAED CHILD HEALT-CAN, V22, P2, DOI 10.1093/pch/pxw011; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Yeates KO, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017012; Zemek R., 2013, BMJ OPEN, P3; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, JAMA-J AM MED ASSOC, V317, P1375, DOI 10.1001/jama.2017.1327; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	39	5	5	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2886	2894		10.1089/neu.2018.6290		JUN 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000472106400001	31025612				2022-02-06	
J	Martens, KM; Pechacek, KM; Modrak, CG; Milleson, VJ; Zhu, BX; Vonder Haar, C				Martens, Kris M.; Pechacek, Kristen M.; Modrak, Cassandra G.; Milleson, Virginia J.; Zhu, Binxing; Vonder Haar, Cole			Cathodal Transcranial Direct-Current Stimulation Selectively Decreases Impulsivity after Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						attention; continuous performance task; controlled cortical impact; five-choice serial reaction time task; neuromodulation	MAGNETIC STIMULATION; MOTOR; TDCS; NEUROMODULATION; RECOVERY; DISEASE; MEMORY	Traumatic brain injury (TBI) often results in chronic psychiatric-like symptoms. In a condition with few therapeutic options, neuromodulation has emerged as a promising potential treatment avenue for these individuals. The goal of the current study was to determine if transcranial direct-current stimulation (tDCS) could treat deficits of impulsivity and attention in rats. This could then be used as a model to investigate treatment parameters and the mechanism of action underlying therapeutic effects. Rats were trained on a task to measure attention and motor impulsivity (five-choice serial reaction time task), then given a frontal, controlled cortical impact injury. After rats recovered to a new baseline, tDCS (cathodal, 10 min, 800 mu A) was delivered daily prior to testing in a counterbalanced, cross-over design. Treatment with tDCS selectively reduced impulsivity in the TBI group, and the greatest recovery occurred in the rats with the largest deficits. With these data, we have established a rat model for studying the effects of tDCS on psychiatric-like dysfunction. More research is needed to determine the mechanism of action by which tDCS-related gains occur.	[Martens, Kris M.; Pechacek, Kristen M.; Modrak, Cassandra G.; Milleson, Virginia J.; Zhu, Binxing; Vonder Haar, Cole] West Virginia Univ, Dept Psychol, Injury & Recovery Lab, Morgantown, WV 26505 USA; [Martens, Kris M.; Vonder Haar, Cole] West Virginia Univ, Dept Neurosci, Morgantown, WV 26505 USA		Vonder Haar, C (corresponding author), West Virginia Univ, Dept Psychol, POB 6040,53 Campus Dr, Morgantown, WV 26505 USA.	cole.vonderhaar@mail.wvu.edu		Vonder Haar, Cole/0000-0001-7949-2068	National Institute of General Medical Sciences (NIGMS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P20GM109098-04]; West Virginia University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG052375] Funding Source: NIH RePORTER	We thank Gabrielle Portillo, Trinity Shaver, Michelle Frankot, and other members of the Vonder Haar lab for their assistance with performing behavioral and histological analyses. Funding for this project was provided by grants from the National Institute of General Medical Sciences (NIGMS; 5P20GM109098-04) and West Virginia University.	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Chen S.-F., 2018, MOL NEUROBIOL, P1; Clayton E, 2016, BRAIN RES, V1640, P130, DOI 10.1016/j.brainres.2016.01.056; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Dinur-Klein L, 2014, BIOL PSYCHIAT, V76, P742, DOI 10.1016/j.biopsych.2014.05.020; Fasano A, 2012, LANCET NEUROL, V11, P429, DOI 10.1016/S1474-4422(12)70049-2; Gilmore CS, 2018, BRAIN STIMUL, V11, P302, DOI 10.1016/j.brs.2017.11.011; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Jackson MP, 2016, CLIN NEUROPHYSIOL, V127, P3425, DOI 10.1016/j.clinph.2016.08.016; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lu X, 2017, EXP THER MED, V13, P2247, DOI 10.3892/etm.2017.4283; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Ozga JE, 2018, BEHAV PHARMACOL, V29, P617, DOI 10.1097/FBP.0000000000000430; Reeves RR, 2011, J PSYCHOSOC NURS MEN, V49, P42, DOI 10.3928/02793695-20110201-03; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Shaver TK, 2019, BRAIN RES, V1704, P103, DOI 10.1016/j.brainres.2018.10.004; Tanaka T, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00006; Terraneo A, 2016, EUR NEUROPSYCHOPHARM, V26, P37, DOI 10.1016/j.euroneuro.2015.11.011; Treble-Barna A, 2017, J NEUROTRAUM, V34, P1919, DOI 10.1089/neu.2016.4840; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Yoon KJ, 2016, J NEUROL SCI, V362, P314, DOI 10.1016/j.jns.2016.02.005; Yu KP, 2018, ANN REHABIL MED-ARM, V42, P502, DOI 10.5535/arm.2018.42.4.502; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	26	5	5	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2019	36	19					2827	2830		10.1089/neu.2019.6470		JUN 2019	4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JB8IG	WOS:000475151900001	31072218	Green Published, hybrid			2022-02-06	
J	Derry, PJ; Nilewski, LG; Sikkema, WKA; Mendoza, K; Jalilov, A; Berka, V; McHugh, EA; Tsai, AL; Tour, JM; Kent, TA				Derry, Paul J.; Nilewski, Lizanne G.; Sikkema, William K. A.; Mendoza, Kimberly; Jalilov, Almaz; Berka, Vladimir; McHugh, Emily A.; Tsai, Ah-Lim; Tour, James M.; Kent, Thomas A.			Catalytic oxidation and reduction reactions of hydrophilic carbon clusters with NADH and cytochrome C: features of an electron transport nanozyme	NANOSCALE			English	Article							METHYLENE-BLUE; CEREBROVASCULAR DYSFUNCTION; HYDROGEN-PEROXIDE; SUPEROXIDE; GRAPHENE; MITOCHONDRIA; OXYGEN; DRUG; IRON; FUNCTIONALIZATION	Previously, our group reported on the promising efficacy of poly(ethylene glycol)-hydrophilic carbon clusters (PEG-HCCs) to work as broadly active and high capacity antioxidants in brain ischemia and injury models including stroke and traumatic brain injury coupled with hemorrhagic shock. PEG-HCCs are a carbon nanomaterial derived from harsh oxidation of single wall carbon nanotubes and covalently modified with poly(ethylene glycol). They retain no tubular remnants and are composed of a highly oxidized carbon core functionalized with epoxy, peroxyl, quinone, ketone, carboxylate, and hydroxyl groups. HCCs are the redox active carbon core of PEG-HCCs, which have a broad reduction potential range starting at +200 mV and extending to -2 V. Here we describe a new property of these materials: the ability to catalytically transfer electrons between key surrogates and proteins of the mitochondrial electron transport complex in a catalytic fashion consistent with the concept of a nanozyme. The estimated reduction potential of PEG-HCCs is similar to that of ubiquinone and they enabled the catalytic transfer of electrons from low reduction potential species to higher reduction electron transport complex constituents. PEG-HCCs accelerated the reduction of resazurin (a test indicator of mitochondrial viability) and cytochrome c by NADH and ascorbic acid in solution. Kinetic experiments suggested a transient tertiary complex. Electron paramagnetic resonance demonstrated NADH increased the magnitude of PEG-HCCs' intrinsic radical, which then reduced upon subsequent addition of cytochrome c or resazurin. Deconvolution microscopy identified PEG-HCCs in close proximity to mitochondria after brief incubation with cultured SHSY-5Y human neuroblastoma cells. Compared to methylene blue (MB), considered a prototypical small molecule electron transport shuttle, PEG-HCCs were more protective against toxic effects of hydrogen peroxide in vitro and did not demonstrate impaired cell viability as did MB. PEG-HCCs were protective in vitro when cells were exposed to sodium cyanide, a mitochondrial complex IV poison. Because mitochondria are a major source of free radicals in pathology, we suggest that this newly described nanozyme action helps explain their in vivo efficacy in a range of injury models. These findings may also extend their use to mitochondrial disorders.	[Derry, Paul J.; Kent, Thomas A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Derry, Paul J.] Michel E DeBakey VA Med Ctr, Neurol, Houston, TX 77030 USA; [Derry, Paul J.] Michel E DeBakey VA Med Ctr, Ctr Translat Res Inflammatory Dis, Houston, TX 77030 USA; [Nilewski, Lizanne G.; Sikkema, William K. A.; Mendoza, Kimberly; McHugh, Emily A.; Tour, James M.; Kent, Thomas A.] Rice Univ, Dept Chem, 6100 Main St, Houston, TX 77005 USA; [Jalilov, Almaz] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia; [Jalilov, Almaz] King Fahd Univ Petr & Minerals, Ctr Integrat Petr Res, Dhahran 31261, Saudi Arabia; [Berka, Vladimir; Tsai, Ah-Lim] Univ Texas Houston, Sch Med, Hematol, Internal Med, Houston, TX 77030 USA; [Tour, James M.] Rice Univ, NanoCarbon Ctr, 6100 Main St, Houston, TX 77005 USA; [Tour, James M.] Rice Univ, Dept Mat Sci & NanoEngn, 6100 Main St, Houston, TX 77005 USA; [Kent, Thomas A.] Houston Methodist Hosp, Stanley H Appel Dept Neurol, Houston, TX 77030 USA; [Kent, Thomas A.] Inst Acad Med, Houston, TX 77030 USA		Kent, TA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA.; Tour, JM; Kent, TA (corresponding author), Rice Univ, Dept Chem, 6100 Main St, Houston, TX 77005 USA.; Tour, JM (corresponding author), Rice Univ, NanoCarbon Ctr, 6100 Main St, Houston, TX 77005 USA.; Tour, JM (corresponding author), Rice Univ, Dept Mat Sci & NanoEngn, 6100 Main St, Houston, TX 77005 USA.; Kent, TA (corresponding author), Houston Methodist Hosp, Stanley H Appel Dept Neurol, Houston, TX 77030 USA.; Kent, TA (corresponding author), Inst Acad Med, Houston, TX 77030 USA.	tour@rice.edu; tkent@tamhsc.edu	Jalilov, Almaz S/O-3210-2015; Nanozymes, Nanozymes/D-8197-2019	Jalilov, Almaz S/0000-0002-8932-2107; Derry, Paul/0000-0001-6791-8586; Nilewski, Lizanne/0000-0003-0949-9170; Tour, James/0000-0002-8479-9328	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS084290, R01NS094535, DK56338, CA125123]; Robert A. Welch foundationThe Welch Foundation [BE-0048]; National Heart, Lung, and Blood Institute of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007747]; Department of Defense National Defense Science Engineering Graduate (NDSEG) Fellowship; Integrated Microscopy Core at Baylor College of Medicine; CPRIT [RP150578, RP170719]; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094535] Funding Source: NIH RePORTER	Supported by NIH grants R21NS084290 and R01NS094535 (MPIs: TK, JT, and A-LT). TAK was supported by grant number BE-0048 from the Robert A. Welch foundation. PJD was partially supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award number T32HL007747. KM was partially supported by the Department of Defense National Defense Science Engineering Graduate (NDSEG) Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. Imaging for this project was supported by the Integrated Microscopy Core at Baylor College of Medicine with funding from NIH (DK56338, and CA125123), CPRIT (RP150578, RP170719), the Dan L. Duncan Comprehensive Cancer Center, and the John S. Dunn Gulf Coast Consortium for Chemical Genomics.	Arun P, 2005, ANAL BIOCHEM, V339, P282, DOI 10.1016/j.ab.2005.01.015; Ashurst John, 2011, Del Med J, V83, P203; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Beasley DMG, 1998, OCCUP MED-OXFORD, V48, P427, DOI 10.1093/occmed/48.7.427; Berlin JM, 2011, ACS NANO, V5, P6643, DOI 10.1021/nn2021293; Berlin JM, 2010, ACS NANO, V4, P4621, DOI 10.1021/nn100975c; BERNOFSKY C, 1982, J BIOL CHEM, V257, P6809; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Bobadilla AD, 2013, J PHYS CHEM B, V117, P343, DOI 10.1021/jp305302y; Brieger K, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13659; CARLSON BW, 1985, J AM CHEM SOC, V107, P479, DOI 10.1021/ja00288a035; Chen JL, 2016, J PHYS CHEM C, V120, P6225, DOI 10.1021/acs.jpcc.5b10635; Copeland R. A., 2000, ENZYMES PRACTICAL IN, V2nd; Coyle CH, 2006, FREE RADICAL BIO MED, V40, P2206, DOI 10.1016/j.freeradbiomed.2006.02.017; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; eas N. K., 1984, BIOCHIM BIOPHYS ACTA, V767, P108; Eddy NB, 1931, J PHARMACOL EXP THER, V41, P449; Fabian RH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00199; Fedor JG, 2017, P NATL ACAD SCI USA, V114, P12737, DOI 10.1073/pnas.1714074114; FLORENCE TM, 1984, J INORG BIOCHEM, V22, P221, DOI 10.1016/0162-0134(84)85007-2; Frantz MC, 2010, ENVIRON MOL MUTAGEN, V51, P462, DOI 10.1002/em.20554; Hayashi T, 2015, P NATL ACAD SCI USA, V112, P1553, DOI 10.1073/pnas.1419767112; Hebert C. D., 1993, NTP TECHNICAL REPORT; Huq R, 2016, SCI REP-UK, V6, DOI 10.1038/srep33808; Jalilov AS, 2017, ACS NANO, V11, P2024, DOI 10.1021/acsnano.6b08211; Jalilov AS, 2016, ACS APPL MATER INTER, V8, P15086, DOI 10.1021/acsami.6b03502; Judenherc-Haouzi A, 2016, AM J PHYSIOL-REG I, V310, pR1030, DOI 10.1152/ajpregu.00527.2015; Karbowski M, 2014, METHOD ENZYMOL, V547, P57, DOI 10.1016/B978-0-12-801415-8.00004-7; KELNER MJ, 1985, J BIOL CHEM, V260, P5168; Latunde-Dada GO, 2017, BBA-GEN SUBJECTS, V1861, P1893, DOI 10.1016/j.bbagen.2017.05.019; Lee KK, 2014, REDOX BIOL, V2, P599, DOI 10.1016/j.redox.2014.03.003; Lee KK, 2015, HEPATOLOGY, V61, P326, DOI 10.1002/hep.27385; Li X, 2001, ARCH BIOCHEM BIOPHYS, V387, P143, DOI 10.1006/abbi.2000.2245; Luo NN, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14537; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; May JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1390, DOI 10.1152/ajpcell.00512.2003; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Purich DL, 2010, ENZYME KINETICS: CATALYSIS & CONTROL, P1; Qi BP, 2015, NANOSCALE, V7, P5969, DOI 10.1039/c5nr00842e; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Roessler MM, 2018, CHEM SOC REV, V47, P2534, DOI 10.1039/c6cs00565a; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Samuel ELG, 2015, P NATL ACAD SCI USA, V112, P2343, DOI 10.1073/pnas.1417047112; Samuel ELG, 2014, TRENDS BIOTECHNOL, V32, P501, DOI 10.1016/j.tibtech.2014.08.005; SAPPER H, 1982, Z NATURFORSCH C, V37, P942; Segal BH, 2012, FREE RADICAL BIO MED, V53, P72, DOI 10.1016/j.freeradbiomed.2012.04.022; Segel I. H., 1993, ENZYME KINETICS BEHA; Shirman E, 2008, J PHYS CHEM B, V112, P8855, DOI 10.1021/jp8029743; Sun HJ, 2015, ANGEW CHEM INT EDIT, V54, P7176, DOI 10.1002/anie.201500626; Vilanova O, 2016, ACS NANO, V10, P10842, DOI 10.1021/acsnano.6b04858; Visarius TM, 1997, FEBS LETT, V412, P157, DOI 10.1016/S0014-5793(97)00767-9; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wu JJX, 2019, CHEM SOC REV, V48, P1004, DOI 10.1039/c8cs00457a; Zhang C, 2018, SMALL, V14, DOI 10.1002/smll.201703306; Zielonka J, 2003, J PHYS CHEM A, V107, P9860, DOI 10.1021/jp035803y; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	58	5	5	7	70	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2040-3364	2040-3372		NANOSCALE	Nanoscale	JUN 14	2019	11	22					10791	10807		10.1039/c9nr00807a			17	Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	IC1YN	WOS:000470756000021	31134256				2022-02-06	
J	Ren, HH; Lu, H				Ren, Huanhuan; Lu, Hong			Dynamic features of brain edema in rat models of traumatic brain injury	NEUROREPORT			English	Article						brain edema; contusion penumbra; diffusion-weighted imaging; MRI; relative apparent diffusion coefficient	CEREBRAL EDEMA; DIFFUSION MRI; CONTUSION; BARRIER; PERFUSION	We explored the dynamic features of brain edema after traumatic brain injury (TBI) using healthy adult male Wistar rats. After inducing moderate brain injuries in the rats, we divided them randomly among seven groups on the basis of the time elapsed between TBI and examination: 1, 6, 12, 24, 48, 72, and 168 h. All rats were scanned using diffusion-weighted imaging (DWI) to observe tissue changes in the contusion penumbra (CP) after TBI. Immunoglobulin G expression was also detected. At 1 h after TBI, there was an annular light-colored region in the CP where the intercellular space was enlarged, suggesting vasogenic edema. At 6 h, the cells expanded, their nuclei shrank, and the cytoplasm was replaced by vacuoles, indicating intracellular edema. Vasogenic edema and intracellular edema increased 12 h after TBI, but decreased 24 h after TBI, with vasogenic edema increasing 48 h after TBI. By 72 h after TBI, intracellular edema dominated until resolution of all edema by 168 h after TBI. DWI indicated that the relative apparent diffusion coefficient increased markedly at 1 h after TBI, but was reduced at 6 and 12 h after TBI. At 48 h, relative apparent diffusion coefficient increased gradually and then declined at 72 h. In rats, TBI-related changes include dynamic variations in intracellular and vasogenic edema severity. Routine MRI and DWI examinations do not distinguish between the center of trauma and CP; however, the apparent diffusion coefficient diagram can portray variations in CP edema type and degree at different time-points following TBI.	[Ren, Huanhuan; Lu, Hong] Chongqing Seventh Peoples Hosp, Dept Radiol, Chongqing 400054, Peoples R China		Lu, H (corresponding author), Chongqing Seventh Peoples Hosp, Dept Radiol, Chongqing 400054, Peoples R China.	cqlh@sohu.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160181]	This project was supported by the National Natural Science Foundation of China (no. 81160181).	Akiguchi I, 1998, ACTA NEUROPATHOL, V95, P78, DOI 10.1007/s004010050768; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Chen JQ, 2014, ASIAN PAC J TROP MED, V7, P991, DOI 10.1016/S1995-7645(14)60174-7; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gaddam Samson Sujit Kumar, 2015, Handb Clin Neurol, V127, P205, DOI 10.1016/B978-0-444-52892-6.00014-3; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gasparetto EL, 2011, NEUROIMAG CLIN N AM, V21, P115, DOI 10.1016/j.nic.2011.02.003; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Li YH, 2012, NEUROL SCI, V33, P731, DOI 10.1007/s10072-011-0768-0; Maeda T, 2003, ACT NEUR S, V86, P329; Maegele M, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2047981614555142; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Newcombe VFJ, 2013, J CEREBR BLOOD F MET, V33, P855, DOI 10.1038/jcbfm.2013.11; O'Connor CA, 2006, TEMPORAL PROFILE EDE; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Prieto-Valderrey F, 2013, MED INTENSIVA, V37, P375, DOI 10.1016/j.medin.2012.07.002; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1265, DOI 10.1038/sj.jcbfm.9600132; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	37	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUN 12	2019	30	9					605	611		10.1097/WNR.0000000000001213			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC5RR	WOS:000471026400001	30969247	hybrid, Green Published			2022-02-06	
J	Meyer, EJ; Stout, JN; Chung, AW; Grant, PE; Mannix, R; Gagoski, B				Meyer, Erin J.; Stout, Jeffrey N.; Chung, Ai Wern; Grant, P. Ellen; Mannix, Rebekah; Gagoski, Borjan			Longitudinal Changes in Magnetic Resonance Spectroscopy in Pediatric Concussion: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						pediatric; adolescent; mild traumatic brain injury; concussion; magnetic resonance spectroscopy	TRAUMATIC BRAIN-INJURY; POWER ADIABATIC PULSES; ADOLESCENTS; SYMPTOMS; CHILDREN; RECOVERY	Background: Nearly 20% of US adolescents report at least one lifetime concussion. Pathophysiologic models suggest that traumatic biomechanical forces caused by rotational deceleration lead to shear stress, which triggers a neurometabolic cascade beginning with excitotoxicity and leading to significant energy demands and a period of metabolic crisis for the injured brain. Proton magnetic resonance spectroscopy (H-1 MRS) offers a means for non-invasive measurement of neurometabolic changes after concussion. Objective: Describe longitudinal changes in metabolites measured in vivo in the brains of adolescent patients with concussion. Methods: We prospectively recruited 9 patients ages 11 to 20 who presented to a pediatric Emergency Department within 24 h of concussion. Patients underwent MRI scanning within 72 h (acute, n = 8), 2 weeks (subacute, n = 7), and at approximately 1 year (chronic, n = 7). Healthy, age and sex-matched controls were recruited and scanned once (n = 9). H-1 MRS was used to measure N-acetyl-aspartate, choline, creatine, glutamate + glutamine, and myo-inositol concentrations in six regions of interest: left and right frontal white matter, posterior white matter and thalamus. Results: There was a significant increase in total thalamus glutamate+glutamine/choline at the subacute (p = 0.010) and chronic (p = 0.010) time points, and a significant decrease in total white matter myo-inositol/choline (p = 0.030) at the chronic time point as compared to controls. Conclusion: There are no differences in H-1 MRS measurements in the acute concussive period; however, changes in glutamate+glutamine and myo-inositol concentrations detectable by H-1 MRS may develop beyond the acute period.	[Meyer, Erin J.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Stout, Jeffrey N.; Chung, Ai Wern; Grant, P. Ellen; Gagoski, Borjan] Boston Childrens Hosp, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston, MA USA; [Stout, Jeffrey N.; Chung, Ai Wern; Grant, P. Ellen] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Grant, P. Ellen; Gagoski, Borjan] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah] Harvard Med Sch, Dept Emergency Med, Dept Pediat, Boston, MA 02115 USA		Meyer, EJ (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.	erin.meyer@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Chung, Ai Wern/0000-0002-0905-6698	Harvard Catalyst; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL 1TR001102]; Harvard University	This work was conducted with support from Harvard Catalyst. The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	Adalsteinsson E, 1998, MAGNET RESON MED, V39, P889, DOI 10.1002/mrm.1910390606; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Andronesi OC, 2012, RADIOLOGY, V262, P647, DOI 10.1148/radiol.11110277; Andronesi OC, 2012, NMR BIOMED, V25, P195, DOI 10.1002/nbm.1730; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bertholdo D, 2013, NEUROIMAG CLIN N AM, V23, P359, DOI 10.1016/j.nic.2012.10.002; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Chamard E, 2018, BRAIN INJURY, V32, P816, DOI 10.1080/02699052.2018.1463106; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eisenberg M, 2018, CURR OPIN PEDIATR, V30, P344, DOI 10.1097/MOP.0000000000000620; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Friedman SD, 2017, NEUROLOGY, V89, P2151, DOI 10.1212/WNL.0000000000004666; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Sestili P, 2016, AMINO ACIDS, V48, P1897, DOI 10.1007/s00726-015-2161-4; Soares DP, 2009, CLIN RADIOL, V64, P12, DOI 10.1016/j.crad.2008.07.002; Tisdall MD, 2012, MAGN RESON MED, V68, P389, DOI 10.1002/mrm.23228; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	33	5	5	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 7	2019	10								556	10.3389/fneur.2019.00556			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IC8SN	WOS:000471252000001	31231298	gold, Green Published			2022-02-06	
J	Lishchynsky, JT; Putschmann, TD; Toomey, CM; Palacios-Derflingher, L; Yeates, KO; Emery, CA; Schneider, KJ				Lishchynsky, Justin T.; Putschmann, Trevor D.; Toomey, Clodagh M.; Palacios-Derflingher, Luz; Yeates, Keith O.; Emery, Carolyn A.; Schneider, Kathryn J.			The Association Between Moderate and Vigorous Physical Activity and Time to Medical Clearance to Return to Play Following Sport-Related Concussion in Youth Ice Hockey Players	FRONTIERS IN NEUROLOGY			English	Article						concussion; mild traumatic brain injury; ice hockey; youth; activity	4TH INTERNATIONAL-CONFERENCE; TRAUMATIC BRAIN-INJURY; CONSENSUS STATEMENT; REST; CHILDREN; CALIBRATION; ACTIGRAPH; RECOVERY; SYMPTOMS; BENEFITS	Design: Prospective cohort study. Background: The recommendations regarding the optimal amount and type of rest for promoting recovery following concussion are based on expert opinion rather than evidence-based guidelines due to current a lack of high-level studies. There is an evident need for more research into the parameters of rest and activity and its effects on recovery from concussion. Objective: To evaluate the association between the amount of moderate and vigorous physical activity (MVPA) during the first 3 days following concussion diagnosis and time to medical clearance (days) to return to play in youth ice hockey players. Methods: Thirty youth ice hockey players (12-17 years) that were diagnosed with a concussion sustained during ice hockey were recruited to participate. The exposure was the cumulative amount of MVPA (minutes), measured using a waist-worn Actigraph accelerometer. Participants were dichotomized into high (>= 148.5) and low (<148.5) activity groups based on the median of cumulative time spent in MVPA over the first 3 days following injury diagnosis. Results: Participants in both the low and high activity group reported to the clinic at a median time of 4 days post-injury (low activity IQR: 3-5 days; high activity IQR: 3-7 days). The low activity group completed a median time of 110.7 min (IQR: 76.2-131.0 min) in MVPA, whereas the high activity had a median of 217.2 min (IQR 184.2-265.2 min) in MVPA. Kaplan Meier survival curves with Log-rank tests of hypothesis revealed the high activity group took significantly more time to be medically cleared to return to play (p = 0.041) compared to the low activity group. Conclusion: The results from this study suggest that more time in MVPA early in the recovery period may result in a greater time to medical clearance to return to full participation in ice hockey. Future research, using valid measures of activity, are required to better understand the relationship between early activity and recovery following concussion in youth.	[Lishchynsky, Justin T.; Putschmann, Trevor D.; Toomey, Clodagh M.; Palacios-Derflingher, Luz; Emery, Carolyn A.; Schneider, Kathryn J.] Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada; [Toomey, Clodagh M.] Univ Limerick, Sch Allied Hlth, Limerick, Ireland; [Palacios-Derflingher, Luz; Emery, Carolyn A.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Yeates, Keith O.; Emery, Carolyn A.; Schneider, Kathryn J.] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB, Canada; [Yeates, Keith O.; Emery, Carolyn A.; Schneider, Kathryn J.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada; [Yeates, Keith O.] Univ Calgary, Fac Arts, Dept Psychol, Calgary, AB, Canada; [Emery, Carolyn A.] Univ Calgary, Fac Sci, Dept Neurosci, Calgary, AB, Canada		Schneider, KJ (corresponding author), Univ Calgary, Sport Injury Prevent Res Ctr, Fac Kinesiol, Calgary, AB, Canada.; Schneider, KJ (corresponding author), Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB, Canada.; Schneider, KJ (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada.	kjschnei@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Emery, Carolyn/AAI-2761-2020	Schneider, Kathryn/0000-0002-5951-5899	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Foundation (Vi Riddell Pediatric Rehabilitation Research Program); Hotchkiss Brain Institute; International Olympic Committee	We acknowledge funding from the Canadian Institutes of Health Research, the Alberta Children's Hospital Foundation (Vi Riddell Pediatric Rehabilitation Research Program), and Hotchkiss Brain Institute. The Sport Injury Prevention Research Centre at the University of Calgary is one of the International Research Centres for the Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Eastman A, 2015, NEUROREHABILITATION, V37, P235, DOI 10.3233/NRE-151256; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hanggi JM, 2013, J SCI MED SPORT, V16, P40, DOI 10.1016/j.jsams.2012.05.012; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kirkwood MW, 2012, CLIN J SPORT MED, V22, P383, DOI 10.1097/JSM.0b013e31826396fc; Lishchynsky JL, 2016, PHYS COGNITIVE ACTIV; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Romanzini M, 2014, EUR J SPORT SCI, V14, P91, DOI 10.1080/17461391.2012.732614; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; StataCorp, 2013, STATA STAT SOFTW REL; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	32	5	5	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 6	2019	10								588	10.3389/fneur.2019.00588			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IC8RH	WOS:000471248700001	31244754	Green Published, gold			2022-02-06	
J	Chang, T; Li, LH; Yang, YL; Li, M; Qu, Y; Gao, L				Chang, Tao; Li, Lihong; Yang, Yanlong; Li, Min; Qu, Yan; Gao, Li			Transcranial Doppler Ultrasonography for the Management of Severe Traumatic Brain Injury After Decompressive Craniectomy	WORLD NEUROSURGERY			English	Article						Cerebral hemodynamics; Decompressive craniectomy; Intracranial pressure; Transcranial Doppler ultrasonography; Traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SONOGRAPHY; MODERATE	BACKGROUND: Cerebral hemodynamic transformation is a relatively common finding in patients with traumatic brain injury (TBI). Knowledge of cerebral hemodynamic disturbance may assist in predicting the management outcome. Transcranial Doppler ultrasonography (TCD) monitoring of patients with TBI can be used to reveal various pathologic hemodynamic changes. The objective of this study was to compare the clinical outcomes of postoperative routine intracranial pressure (ICP) monitoring versus ICP monitoring combined with TCD monitoring in patients with brain trauma after decompressive craniectomy. METHODS: This was a retrospective study of 30 patients with TBI who underwent ICP combined with TCD monitoring (after 2015) compared with a historical control group of 30 patients who only underwent routine ICP monitoring (in 2013-2014). ICP, partial pressure of carbon dioxide, hemoglobin, and hematocrit values were monitored and recorded on a daily basis for 7 days after operation. Neuroimaging was also performed at admission. Neurologic outcome was assessed at 2 weeks and 6 months after operation using the Glasgow Outcome Score Extended (GOS-E). Unconditional multivariable logistic regression was conducted to analyze the factors for favorable clinical outcome. RESULTS: Two weeks after operation, there were no differences in mortality rate between the 2 groups (P = 0.643). When considering the GOS-E score at 6 months, there were no differences in clinical prognosis between the 2 groups (P = 0.101), but the ICP combined with TCD monitoring group showed a higher frequency of patients with favorable outcome compared with the routine ICP monitoring group (P = 0.043). Unconditional multivariable logistic regression results showed that no factor was independently associated with GOS-E at 6 months. CONCLUSIONS: TCD could be helpful for the serial monitoring of cerebral hemodynamic changes after decompressive craniectomy for TBI, which could be beneficial for neurologic outcome improvement.	[Chang, Tao; Li, Lihong; Yang, Yanlong; Li, Min; Qu, Yan; Gao, Li] Air Force Med Univ, Affiliated Hosp 2, Dept Neurosurg, Xian, Shaanxi, Peoples R China		Gao, L (corresponding author), Air Force Med Univ, Affiliated Hosp 2, Dept Neurosurg, Xian, Shaanxi, Peoples R China.	gaoli089@yeah.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401044]	This study was funded by the National Natural Science Foundation of China (81401044).	Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; Bor-Seng-Shu E, 2004, ARQ NEURO-PSIQUIAT, V62, P715, DOI 10.1590/S0004-282X2004000400028; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; Mahdavi Z, 2015, CRIT CARE NURS CLIN, V27, P213, DOI 10.1016/j.cnc.2015.02.002; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Moon Ji Won, 2017, Korean J Neurotrauma, V13, P1, DOI 10.13004/kjnt.2017.13.1.1; Moreno J A, 2000, Neurosurg Focus, V8, pe8; Pinto SM, 2018, AM J PHYS MED REHAB, V97, P747, DOI 10.1097/PHM.0000000000000961; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Sarkar S, 2007, POSTGRAD MED J, V83, P683, DOI 10.1136/pgmj.2007.058602; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x; Turek Radovan, 2013, Acta Neurochir Suppl, V118, P265, DOI 10.1007/978-3-7091-1434-6_50; Verim S, 2013, TURK KARDIYOL DERN A, V41, P248, DOI 10.5543/tkda.2013.76429; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	21	5	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2019	126						E116	E124		10.1016/j.wneu.2019.02.005			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IA0BU	WOS:000469222400016	30790743	hybrid			2022-02-06	
J	Drost, R; Postma, A; Oudman, E				Drost, Rolinda; Postma, Albert; Oudman, Erik			Cognitive and affective theory of mind in Korsakoff's syndrome	ACTA NEUROPSYCHIATRICA			English	Article						addiction; cognitive function; executive function; neuropsychology; traumatic brain injury	EMOTION RECOGNITION; EXECUTIVE FUNCTIONS; FAUX PAS; DISORDERS; DEFICITS; DISSOCIATION; PSYCHOLOGY; CHILDREN; BRAIN	Objective Korsakoff's syndrome (KS) is a chronic neuropsychiatric disorder characterised by severe anterograde amnesia and executive deficits. Theory of Mind (ToM) is the capacity to represent others' mental states such as their knowledge, thoughts, feelings, beliefs, and intentions in order to explain and predict their behaviour. Surprisingly this topic has received hardly any attention in research on KS, although the severity of behavioural problems in KS suggest possible ToM difficulties. The aim of the present study was therefore to assess whether cognitive and affective ToM are impaired in patients with KS. Methods We examined 21 KS patients and 21 age- and gender-matched healthy controls on three standardised tests that assess cognitive and affective ToM, including the subtests of the mini-Social Cognition and Emotional Assessment battery and a specialised version of the Sally-Anne Test. Results KS patients showed largely impaired cognitive and affective ToM compared to healthy controls, as reflected in large effect sizes on both cognitive and affective ToM tests. Executive deficits explained problems in emotion recognition, but not other ToM aspects. Conclusion KS patients have large impairments in both cognitive and affective aspects of social cognition. Their ability to recognise emotions, take the perspective of others, and understand socially awkward situations is vastly compromised. The impairments in ToM functioning are to a large degree functionally discrepant from executive disorders that are commonly present in KS. This study therefore highlights the importance to properly index ToM functioning in neuropsychological assessments for individuals with a possible KS diagnosis.	[Drost, Rolinda; Postma, Albert; Oudman, Erik] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands; [Drost, Rolinda; Postma, Albert; Oudman, Erik] Slingedael Korsakoff Ctr, Rotterdam, Netherlands		Drost, R (corresponding author), Univ Utrecht, Expt Psychol, Helmholtz Res Inst, Heidelberglaan 1, NL-3584 CS Utrecht, Netherlands.	r.drost@propersona.nl		Oudman, Erik/0000-0002-4441-0365			Aichhorn M, 2006, NEUROIMAGE, V30, P1059, DOI 10.1016/j.neuroimage.2005.10.026; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Arts NJM, 2017, NEUROPSYCH DIS TREAT, V13, P2875, DOI 10.2147/NDT.S130078; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bauminger-Zviely N, 2013, FALSE BELIEF TASK EN, P1249; Bertoux M, 2012, J NEUROL NEUROSUR PS, V83, P411, DOI 10.1136/jnnp-2011-301849; Bodden ME, 2010, PARKINSONISM RELAT D, V16, P466, DOI 10.1016/j.parkreldis.2010.04.014; Brion M, 2017, COGN NEUROPSYCHIATRY, V22, P436, DOI 10.1080/13546805.2017.1373639; Buitelaar JK, 1999, J CHILD PSYCHOL PSYC, V40, P869, DOI 10.1017/S0021963099004321; Cohen J., 2013, STAT POWER ANAL BEHA; Corcoran R, 1999, Cogn Neuropsychiatry, V4, P55, DOI 10.1080/135468099396061; Duits A., 2014, NEUROPSYCHOLOGISCHE, P173; Egger JIM, 2002, ACTA NEUROPSYCHIATR, V14, P231, DOI 10.1034/j.1601-5215.2002.140506.x; Fine C, 2001, BRAIN, V124, P287, DOI 10.1093/brain/124.2.287; Flavell JH, 2000, INT J BEHAV DEV, V24, P15, DOI 10.1080/016502500383421; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gerridzen IJ, 2017, INT J GERIATR PSYCH, V32, P256, DOI 10.1002/gps.4636; Gilboa A, 2010, J INT NEUROPSYCH SOC, V16, P961, DOI 10.1017/S135561771000113X; GOPNIK A, 1988, CHILD DEV, V59, P26, DOI 10.2307/1130386; Hegarty M, 2004, INTELLIGENCE, V32, P175, DOI 10.1016/j.intell.2003.12.001; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hiatt LM, 2004, P INT C COGN MOD ICC; Hurtado-Pomares M, 2018, INT J GERIATR PSYCH, V33, P237, DOI 10.1002/gps.4751; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Kalbe E, 2007, J NEUROPSYCHOL, V1, P27, DOI 10.1348/174866407X180792; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Kopelman MD, 2009, ALCOHOL ALCOHOLISM, V44, P148, DOI 10.1093/alcalc/agn118; Kril JJ, 2012, NEUROPSYCHOL REV, V22, P72, DOI 10.1007/s11065-012-9195-0; Lee SJ, 2009, PSYCHIAT INVEST, V6, P156, DOI 10.4306/pi.2009.6.3.156; Lee TMC, 2010, NEUROPSYCHOLOGIA, V48, P1670, DOI 10.1016/j.neuropsychologia.2010.02.012; Li XM, 2013, INT J PSYCHOL, V48, P715, DOI 10.1080/00207594.2012.673724; Maharasingam M, 2013, J CLIN EXP NEUROPSYC, V35, P501, DOI 10.1080/13803395.2013.795527; Montagne B, 2006, CORTEX, V42, P705, DOI 10.1016/S0010-9452(08)70408-8; Norris G, 2000, NEUROPSYCHOL REHABIL, V10, P33, DOI 10.1080/096020100389282; Oosterman JM, 2011, ACTA NEUROPSYCHIATR, V23, P302, DOI 10.1111/j.1601-5215.2011.00552.x; Oscar-Berman M, 2012, NEUROPSYCHOL REV, V22, P154, DOI 10.1007/s11065-012-9198-x; OscarBerman M, 1997, ALCOHOL HEALTH RES W, V21, P65; Pearson A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00652; Pitel AL, 2012, NEUROLOGY, V78, P1330, DOI 10.1212/WNL.0b013e318251834e; PREMACK D, 1978, SCIENCE, V202, P532, DOI 10.1126/science.705342; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; SQUIRE LR, 1982, J EXP PSYCHOL LEARN, V8, P560, DOI 10.1037/0278-7393.8.6.560; Stuss D. T., 2008, COGNITIVE NEUROREHAB; Tversky B, 2009, COGNITION, V110, P124, DOI 10.1016/j.cognition.2008.10.008; van Loo E.H., 2007, TIJDSCHR NEUROL NEUR, V108, P115; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Yang CQ, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0618-3	54	5	5	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1601-5215			ACTA NEUROPSYCHIATR	Acta Neuropsychiatr.	JUN	2019	31	3					128	134		10.1017/neu.2018.35			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	IC5QU	WOS:000471024000002	30558689	Green Submitted			2022-02-06	
J	Eckersley, CP; Nightingale, RW; Luck, JF; Bass, CR				Eckersley, Christopher P.; Nightingale, Roger W.; Luck, Jason F.; Bass, Cameron R.			The role of cervical muscles in mitigating concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Biomechanical phenomena; Neck muscles; Brain concussion; Muscle strength; Blunt impact	SEGMENT DYNAMIC STABILIZATION; HEAD KINEMATICS; NECK; STRENGTH; RESISTANCE; FOOTBALL; INJURY; BIOMECHANICS; SPINE	Objectives: Increased neck strength has been hypothesized to lower sports related concussion risk, but lacks experimental evidence. The goal is to investigate the role cervical muscle strength plays in blunt impact head kinematics and the biofidelity of common experimental neck conditions. We hypothesize head kinematics do not vary with neck activation due to low short term human head-to-neck coupling; because of the lack of coupling, free-head experimental conditions have higher biofidelity than Hybrid III necks. Methods: Impacts were modeled using the Duke University Head and Neck Model. Four impact types were simulated with six neck conditions at eight impact positions. Peak resultant linear acceleration, peak resultant angular acceleration, Head Injury Criterion, and Head Impact Power compared concussion risk. To determine significance, maximum metric difference between activation states were compared to critical effect sizes (literature derived differences between mild and severe impact metrics). Results: Maximum differences between activation conditions did not exceed critical effect sizes. Kinematic differences from impact location and strength can be ten times cervical muscle activation differences. Hybrid III and free-head linear acceleration metrics were 6 +/- 1.0% lower and 12 +/- 1.5% higher than relaxed condition respectively. Hybrid III and free-head angular acceleration metrics were 12 +/- 4.0% higher and 2 +/- 2.7% lower than relaxed condition respectively. Conclusions: Results from a validated neck model suggest increased cervical muscle force does not influence short term (<50 ms) head kinematics in four athletically relevant scenarios. Impact location and magnitude influence head kinematics more than cervical muscle state. Biofidelic limitations of both Hybrid III and free-head experimental conditions must be considered. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Eckersley, Christopher P.; Nightingale, Roger W.; Luck, Jason F.; Bass, Cameron R.] Duke Univ, Injury Biomech Lab, Dept Biomed Engn, Durham, NC 27706 USA		Eckersley, CP (corresponding author), Duke Univ, Injury Biomech Lab, Dept Biomed Engn, Durham, NC 27706 USA.	cpe4@duke.edu		Eckersley, Christopher/0000-0001-5467-0358			Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Chancey VC, 2007, J BIOMECH, V40, P1953, DOI 10.1016/j.jbiomech.2006.09.007; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Dibb AT, 2014, TRAFFIC INJ PREV, V15, P386, DOI 10.1080/15389588.2013.824568; Dibb AT, 2013, TRAFFIC INJ PREV, V14, pS116, DOI 10.1080/15389588.2013.806795; Dibb Alan T, 2006, Stapp Car Crash J, V50, P567; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Eiband AM, 1959, HUMAN TOLERANCE RAPI; Hendee SP, 1998, J APPL BIOMECH, V14, P390, DOI 10.1123/jab.14.4.390; Jin X, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037399; Liu YK, 1982, DTIC DOCUMENT; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mansell J, 2005, J ATHL TRAINING, V40, P310; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; Mertz H. J, 1996, HEAD INJURY RISK ASS; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mohan P, 2009, SAE TECHNICAL PAPER; Newman JA, 2000, SAE TECHNICAL PAPER; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; REID SE, 1981, AVIAT SPACE ENVIR MD, V52, P78; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	30	5	5	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	JUN	2019	22	6					667	671		10.1016/j.jsams.2019.01.009			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IH7KI	WOS:000474682100009	30745221				2022-02-06	
J	Liu, XY; Zimmermann, LL; Ho, N; Vespa, P; Liao, XL; Hu, X				Liu, Xiuyun; Zimmermann, Lara L.; Ho, Nhi; Vespa, Paul; Liao, Xiaoling; Hu, Xiao			Cerebral Vascular Changes During Acute Intracranial Pressure Drop	NEUROCRITICAL CARE			English	Article						Cerebral autoregulation; Cerebrospinal fluid drainage; Cerebral vascular changes; Intracranial pressure waveform; ICP B-waves	TRAUMATIC BRAIN-INJURY; PERFUSION-PRESSURE; BLOOD-FLOW; COHERENCE ANALYSIS; CEREBROVASCULAR REACTIVITY; TRANSCRANIAL DOPPLER; WAVELET COHERENCE; HEAD-INJURY; AUTOREGULATION; DRAINAGE	ObjectiveThis study applied a new external ventricular catheter, which allows intracranial pressure (ICP) monitoring and cerebral spinal fluid (CSF) drainage simultaneously, to study cerebral vascular responses during acute CSF drainage.MethodsSix patients with 34 external ventricular drain (EVD) opening sessions were retrospectively analyzed. A published algorithm was used to extract morphological features of ICP recordings, and a template-matching algorithm was applied to calculate the likelihood of cerebral vasodilation index (VDI) and cerebral vasoconstriction index (VCI) based on the changes of ICP waveforms during CSF drainage. Power change (P) of ICP B-waves after EVD opening was also calculated. Cerebral autoregulation (CA) was assessed through phase difference between arterial blood pressure (ABP) and ICP using a previously published wavelet-based algorithm.ResultsThe result showed that acute CSF drainage reduced mean ICP (P=0.016) increased VCI (P=0.02) and reduced ICP B-wave power (P=0.016) significantly. VCI reacted to ICP changes negatively when ICP was between 10 and 25mmHg, and VCI remained unchanged when ICP was outside the 10-25mmHg range. VCI negatively (r=-0.44) and VDI positively (r=0.82) correlated with P of ICP B-waves, indicating that stronger vasoconstriction resulted in bigger power drop in ICP B-waves. Better CA prior to EVD opening triggered bigger drop in the power of ICP B-waves (r=-0.612).ConclusionsThis study demonstrates that acute CSF drainage reduces mean ICP, and results in vasoconstriction which can be detected through an index, VCI. Cerebral vessels actively respond to ICP changes or cerebral perfusion pressure (CPP) changes in a certain range; beyond which, the vessels are insensitive to the changes in ICP and CPP.	[Liu, Xiuyun; Ho, Nhi; Hu, Xiao] Univ Calif San Francisco, Dept Physiol Nursing, 2 Koret Way, San Francisco, CA 94143 USA; [Vespa, Paul; Hu, Xiao] Univ Calif Los Angeles, Sch Med, Dept Neurosurg, Los Angeles, CA USA; [Zimmermann, Lara L.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Liao, Xiaoling] Chongqing Univ Sci & Technol, Chongqing Engn Lab Nano Micro Biol Med Detect Tec, Inst Biomed Engn, Chongqing, Peoples R China; [Hu, Xiao] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Hu, Xiao] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA		Liu, XY (corresponding author), Univ Calif San Francisco, Dept Physiol Nursing, 2 Koret Way, San Francisco, CA 94143 USA.	xiuyun.liu@ucsf.edu	Liu, Xiuyun/V-4427-2017	Liu, Xiuyun/0000-0001-9540-4865	UCSF Middle Career Scientist Award; UCSF Institute for Computational Health Sciences; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS076738, NS106905-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS106905] Funding Source: NIH RePORTER	This work was partially supported by the UCSF Middle Career Scientist Award, UCSF Institute for Computational Health Sciences, and National Institutes of Health awards (R01NS076738 and NS106905-01A1).	Addison P.S., 2016, ILLUSTRATED WAVELET, V2nd ed.; Addison PS, 2015, IEEE ENG MED BIO, P5960, DOI 10.1109/EMBC.2015.7319749; [Anonymous], INTEGRA DESIGN VERIF, P49; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Asgari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050795; Asgari S, 2011, PHYSIOL MEAS, V32, P1639, DOI 10.1088/0967-3334/32/10/011; Asgari S, 2011, NEUROCRIT CARE, V15, P55, DOI 10.1007/s12028-010-9463-x; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Chari A, 2017, ACTA NEUROCHIR, V159, P1967, DOI 10.1007/s00701-017-3281-2; Connolly M, 2016, ACTA NEUROCHIR SUPPL, V122, P291, DOI 10.1007/978-3-319-22533-3_58; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Czosnyka Z, 2017, ACTA NEUROCHIR, V159, P1979, DOI 10.1007/s00701-017-3282-1; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; Jeyaseelan AS, 2015, OCEAN ENG, V105, P242, DOI 10.1016/j.oceaneng.2015.06.051; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Keissar K, 2009, PHILOS T R SOC A, V367, P1393, DOI 10.1098/rsta.2008.0273; KEMPLEY ST, 1993, ARCH DIS CHILD-FETAL, V69, P74, DOI 10.1136/adc.69.1_Spec_No.74; Kerr M E, 2001, Neurosurg Focus, V11, pE1; Kerr ME, 2000, J NEUROSURG ANESTH, V12, P324, DOI 10.1097/00008506-200010000-00005; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Kirmani Altaf Rehman, 2015, Surg Neurol Int, V6, P188, DOI 10.4103/2152-7806.172533; Kvandal P, 2013, J CLIN MONIT COMPUT, V27, P375, DOI 10.1007/s10877-013-9484-z; Lane PL, 2000, CAN J SURG, V43, P442; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lemaire JJ, 2002, ACTA NEUROCHIR, V144, P243, DOI 10.1007/s007010200032; Lewis PM, 2008, ACTA NEUROCHIR, V150, P139, DOI 10.1007/s00701-007-1447-z; Liu XN, 2014, J GEOPHYS ENG, V11, DOI 10.1088/1742-2132/11/1/015006; Liu XY, 2018, J PHYSIOL-LONDON, V596, P2797, DOI 10.1113/JP274708; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; Liu XY, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002348; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; PAPO I, 1977, ACTA NEUROCHIR, V39, P187, DOI 10.1007/BF01406729; Peng TY, 2010, IEEE T BIO-MED ENG, V57, P960, DOI 10.1109/TBME.2009.2024265; Physics C, 2014, PRESSURE AUTOREGULAT, V120, P1451; Ps A, 2002, ILLUSTRATED WAVELET; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rangel-Castillo L, 2006, CRIT CARE CLIN, V22, P713, DOI 10.1016/j.ccc.2006.06.003; Rao AR, 2003, J HYDROL, V279, P125, DOI 10.1016/S0022-1694(03)00176-8; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Slazinski T, 2011, AM ASS NEUROSCI NURS, V1, P1, DOI [10.1097/JNN.0b013e318207b65a, DOI 10.1097/JNN.0B013E318207B65A]; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Staykov D, 2017, ANN NEUROL, V81, P93, DOI 10.1002/ana.24834; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Tian FH, 2016, NEUROIMAGE-CLIN, V11, P124, DOI 10.1016/j.nicl.2016.01.020; TRAUNER DA, 1978, ANN NEUROL, V4, P275, DOI 10.1002/ana.410040315; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zweckberger K, 2009, ANAESTHESIST, V58, P392, DOI 10.1007/s00101-009-1522-3	63	5	5	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30	3					635	644		10.1007/s12028-018-0651-4			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HY2EM	WOS:000467930300018	30523541	Green Published, Green Accepted			2022-02-06	
J	Manoel, ALD; van der Jagt, M; Amin-Hanjani, S; Bambakidis, NC; Brophy, GM; Bulsara, K; Claassen, J; Connolly, ES; Hoffer, SA; Hoh, BL; Holloway, RG; Kelly, AG; Mayer, SA; Nakaji, P; Rabinstein, AA; Vajkoczy, P; Vergouwen, MDI; Woo, H; Zipfel, GJ; Suarez, JI; Macdonald, RL; Amin-Hanjani, S; Brown, RD; Derdeyn, CP; Etminan, N; Keller, E; LeRoux, PD; Mayer, S; Morita, A; Rinkel, G; Rufennacht, D; Stienen, MN; Torner, J; Vergouwen, MDI; Wong, GKC; Bijlenga, P; Ko, N; McDougall, CG; Mocco, J; Murayama, Y; Werner, MJH; Mayer, S; Suarez, JI; Damani, R; Broderick, J; Dhar, R; Jauch, EC; Kirkpatrick, PJ; Martin, RH; Mocco, J; Muehlschlegel, S; Mutoh, T; Nyquist, P; Olson, D; Mejia-Mantilla, JH; Amin-Hanjani, S; van der Jagt, M; Bambakidis, NC; Brophy, GM; Bulsara, K; Claassen, J; Connolly, ES; Hoffer, SA; Hoh, BL; Holloway, RG; Kelly, A; Mayer, S; Nakaji, P; Rabinstein, A; Suarez, JI; Vajkoczy, P; Vergouwen, MDI; Woo, H; Zipfel, GJ; Keller, E; Macdonald, RL; Chou, S; Dore, S; Dumont, AS; Gunel, M; Kasuya, H; Roederer, A; Ruigrok, Y; Vespa, PM; Sarrafzadeh-Khorrasani, AS; Derdeyn, CP; Etminan, N; Hackenberg, K; Huston, J; Krings, T; Lanzino, G; Meyers, PM; Rinkel, G; Rufennacht, D; Wintermark, M; Torner, J; Wong, GKC; Broderick, J; Daly, J; Ogilvy, C; Rhoney, DH; Roos, YB; Siddiqui, A; Etminan, N; Rinkel, G; Hackenberg, K; Algra, A; Frosen, J; Hasan, D; Juvela, S; Langer, DJ; Meyers, PM; Morita, A; Salman, RA; Stienen, MN; Vergouwen, MDI; Hanggi, D; Macdonald, RL; Schweizer, T; Visser-Meily, J; Amos, L; Ludet, C; Moy, C; Odenkirchen, J; Ala'i, S; Esterlitz, J; Joseph, K; Sheikh, M				Manoel, Airton Leonardo de Oliveira; van der Jagt, Mathieu; Amin-Hanjani, Sepideh; Bambakidis, Nicholas C.; Brophy, Gretchen M.; Bulsara, Ketan; Claassen, Jan; Connolly, E. Sander; Hoffer, S. Alan; Hoh, Brian L.; Holloway, Robert G.; Kelly, Adam G.; Mayer, Stephan A.; Nakaji, Peter; Rabinstein, Alejandro A.; Vajkoczy, Peter; Vergouwen, Mervyn D. I.; Woo, Henry; Zipfel, Gregory J.; Suarez, Jose I.; Macdonald, R. Loch; Amin-Hanjani, Sepideh; Brown, Robert D., Jr.; Derdeyn, Colin P.; Etminan, Nima; Keller, Emanuela; LeRoux, Peter D.; Mayer, Stephan; Morita, Akio; Rinkel, Gabriel; Rufennacht, Daniel; Stienen, Martin N.; Torner, James; Vergouwen, Mervyn D. I.; Wong, George K. C.; Bijlenga, Philippe; Ko, Nerissa; McDougall, Cameron G.; Mocco, J.; Murayama, Yuuichi; Werner, Marieke J. H.; Mayer, Stephan; Suarez, Jose I.; Damani, Rahul; Broderick, Joseph; Dhar, Raj; Jauch, Edward C.; Kirkpatrick, Peter J.; Martin, Renee H.; Mocco, J.; Muehlschlegel, Susanne; Mutoh, Tatsushi; Nyquist, Paul; Olson, Daiwai; Mejia-Mantilla, Jorge H.; Amin-Hanjani, Sepideh; van der Jagt, Mathieu; Bambakidis, Nicholas C.; Brophy, Gretchen M.; Bulsara, Ketan; Claassen, Jan; Connolly, E. Sander; Hoffer, S. Alan; Hoh, Brian L.; Holloway, Robert G.; Kelly, Adam; Mayer, Stephan; Nakaji, Peter; Rabinstein, Alejandro; Suarez, Jose I.; Vajkoczy, Peter; Vergouwen, Mervyn D. I.; Woo, Henry; Zipfel, Gregory J.; Keller, Emanuela; Macdonald, R. Loch; Chou, Sherry; Dore, Sylvain; Dumont, Aaron S.; Gunel, Murat; Kasuya, Hidetoshi; Roederer, Alexander; Ruigrok, Ynte; Vespa, Paul M.; Sarrafzadeh-Khorrasani, Asita Simone; Derdeyn, Colin P.; Etminan, Nima; Hackenberg, Katharina; Huston, John, III; Krings, Timo; Lanzino, Giuseppe; Meyers, Philip M.; Rinkel, Gabriel; Rufennacht, Daniel; Wintermark, Max; Torner, James; Wong, George K. C.; Broderick, Joseph; Daly, Janis; Ogilvy, Christopher; Rhoney, Denise H.; Roos, Y. B.; Siddiqui, Adnan; Etminan, Nima; Rinkel, Gabriel; Hackenberg, Katharina; Algra, Ale; Frosen, Juhanna; Hasan, David; Juvela, Seppo; Langer, David J.; Meyers, Philip M.; Morita, Akio; Salman, Rustam Al-Shahi; Stienen, Martin N.; Vergouwen, Mervyn D. I.; Hanggi, Daniel; Macdonald, R. Loch; Schweizer, Tom; Visser-Meily, Johanna; Amos, Liz; Ludet, Christophe; Moy, Claudia; Odenkirchen, Joanne; Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza		Unruptured Aneurysms SAH-CDE	Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute TherapiesProposal of a Multidisciplinary Research Group	NEUROCRITICAL CARE			English	Article						Clinical studies; Common Data Elements; Data coding; Data collection; Standardization; Subarachnoid hemorrhage; Aneurysm	MANAGEMENT; BRAIN; TRIAL; DEFINITION; RATIONALE; PRESSURE; ALBUMIN; TBI	IntroductionThe Common Data Elements (CDEs) initiative is a National Institute of Health/National Institute of Neurological Disorders and Stroke (NINDS) effort to standardize naming, definitions, data coding, and data collection for observational studies and clinical trials in major neurological disorders. A working group of experts was established to provide recommendations for Unruptured Aneurysms and Aneurysmal Subarachnoid Hemorrhage (SAH) CDEs.MethodsThis paper summarizes the recommendations of the Hospital Course and Acute Therapies after SAH working group. Consensus recommendations were developed by assessment of previously published CDEs for traumatic brain injury, stroke, and epilepsy. Unruptured aneurysm- and SAH-specific CDEs were also developed. CDEs were categorized into core, supplementalhighly recommended, supplemental and exploratory.ResultsWe identified and developed CDEs for Hospital Course and Acute Therapies after SAH, which included: surgical and procedure interventions; rescue therapy for delayed cerebral ischemia (DCI); neurological complications (i.e. DCI; hydrocephalus; rebleeding; seizures); intensive care unit therapies; prior and concomitant medications; electroencephalography; invasive brain monitoring; medical complications (cardiac dysfunction; pulmonary edema); palliative comfort care and end of life issues; discharge status. The CDEs can be found at the NINDS Web site that provides standardized naming, and definitions for each element, and also case report form templates, based on the CDEs.ConclusionMost of the recommended Hospital Course and Acute Therapies CDEs have been newly developed. Adherence to these recommendations should facilitate data collection and data sharing in SAH research, which could improve the comparison of results across observational studies, clinical trials, and meta-analyses of individual patient data.	[Manoel, Airton Leonardo de Oliveira] Univ Toronto, St Michaels Hosp, Keenan Res Ctr Biomed Sci, Neurosci Res Program, Toronto, ON, Canada; [Manoel, Airton Leonardo de Oliveira] Hosp Paulistano, UnitedHlth Grp Brazil, Dept Crit Care Med, Adult Crit Care Unit, Rua Martiniano de Carvalho 741, BR-01321001 Sao Paulo, SP, Brazil; [van der Jagt, Mathieu] Univ Med Ctr Rotterdam, Erasmus MC, Dept Intens Care Adults, Rotterdam, Netherlands; [Amin-Hanjani, Sepideh] Univ Illinois, Dept Neurosurg, Chicago, IL USA; [Bambakidis, Nicholas C.; Hoffer, S. Alan] Case Western Reserve Univ, UH Cleveland Med Ctr, Dept Neurol Surg, Cleveland, OH 44106 USA; [Brophy, Gretchen M.] Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA USA; [Bulsara, Ketan] Univ Connecticut, Dept Neurosurg, Farmington, CT USA; [Claassen, Jan; Connolly, E. Sander] Columbia Univ, New York, NY USA; [Hoh, Brian L.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Holloway, Robert G.; Kelly, Adam G.] Univ Rochester, Dept Neurol, Rochester, NY USA; [Mayer, Stephan A.] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA; [Nakaji, Peter] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Rabinstein, Alejandro A.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Vajkoczy, Peter] Univ Med, Charite Hosp, Dept Neurosurg, Berlin, Germany; [Vergouwen, Mervyn D. I.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Woo, Henry] Hofstra Northwell Hlth, Zucker Sch Med, Dept Neurosurg & Radiol, New York, NY USA; [Zipfel, Gregory J.] Washington Univ, St Louis, MO 63110 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [LeRoux, Peter D.] Main Line Hlth, Wynnewood, PA USA; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Rufennacht, Daniel] Klin Hirslanden, Zurich, Switzerland; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Torner, James] Univ Iowa, Iowa City, IA USA; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Bijlenga, Philippe] Geneva Univ Hosp, Geneva, Switzerland; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Damani, Rahul] Baylor Coll Med, Houston, TX 77030 USA; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [van der Jagt, Mathieu] Erasmus MC, Rotterdam, Netherlands; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Torner, James] Univ Iowa, Iowa City, IA USA; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Amos, Liz] Natl Lib Med, Natl Informat Ctr Hlth Serv Res & Hlth Care Techn, Bethesda, MD USA; [Ludet, Christophe] Natl Lib Med, Bethesda, MD USA; [Moy, Claudia; Odenkirchen, Joanne] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza] Emmes Corp, Rockville, MD USA		Manoel, ALD (corresponding author), Hosp Paulistano, UnitedHlth Grp Brazil, Dept Crit Care Med, Adult Crit Care Unit, Rua Martiniano de Carvalho 741, BR-01321001 Sao Paulo, SP, Brazil.	airtonleo.manoel@gmail.com	Wong, George Kwok Chu/L-4344-2016; de Oliveira Manoel, Airton Leonardo/C-4724-2018; Dore, Sylvain/AAG-1470-2020; Claassen, Jan/AAA-5451-2020; Olson, DaiWai/I-5932-2019; van der Jagt, Mathieu/G-1905-2017; DAMANI, RAHUL/R-7012-2018	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; Olson, DaiWai/0000-0002-9280-078X; Derdeyn, Colin/0000-0002-5932-2683; van der Jagt, Mathieu/0000-0003-2566-8325; DAMANI, RAHUL/0000-0001-7990-0965; Al-Shahi Salman, Rustam/0000-0002-2108-9222	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN271201200034C]	Logistical support for this project was provided in part through NIH Contract HHSN271201200034C, the Intramural Research Program of the NIH, NLM, The Neurocritical Care Society and the CHI Baylor St Luke's Medical Center in Houston, TX. The development of the NINDS SAH-CDEs was made possible thanks to the great investment of time and effort of WG members and the members of the NINDS CDE Project and NLM CDE project teams participating from 2015 to 2017.	Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Darflinger R, 2016, J NEUROINTERV SURG, V8, P507, DOI 10.1136/neurintsurg-2015-011668; de Oliveira Manoel AL, 2016, NEUROCRIT CARE, V25, P338, DOI 10.1007/s12028-016-0305-3; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Goto Y, 2004, NEUROL SURG TOKYO, V32, P579; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hutchinson P, 2014, NEUROCRIT CARE, V21, P148, DOI 10.1007/s12028-014-0035-3; Loring DW, 2011, EPILEPSIA, V52, P1186, DOI 10.1111/j.1528-1167.2011.03018.x; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Manoel ALD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1193-9; Manoel ALD, 2014, CLEV CLIN J MED, V82, P177, DOI 10.3949/ccjm.82a.14021; McDougall CG, 2012, J NEUROSURG, V116, P135, DOI 10.3171/2011.8.JNS101767; MEES SMD, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Oddo M, 2018, INTENS CARE MED, V44, P1, DOI [10.1007/s00134-017-5005-8, DOI 10.1007/S00134-017-5005-8]; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Sheth SA, 2014, J NEUROSURG, V120, P409, DOI 10.3171/2013.10.JNS13934; Suarez JI, 2012, STROKE, V43, P683, DOI 10.1161/STROKEAHA.111.633958; Suarez JI, 2010, NEUROCRIT CARE, V13, P263, DOI 10.1007/s12028-010-9392-8; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Treggiari MM, 2011, NEUROCRIT CARE, V15, P329, DOI 10.1007/s12028-011-9589-5; van der Jagt M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1309-2; van der Jagt M, 2015, INTENS CARE MED, V41, P1129, DOI 10.1007/s00134-015-3844-8; VANGIJN J, 1985, J NEUROSURG, V63, P355, DOI 10.3171/jns.1985.63.3.0355; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275	34	5	5	1	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30			1			36	45		10.1007/s12028-019-00726-3			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF3IS	WOS:000472974700005	31119687				2022-02-06	
J	Munce, SEP; Jaglal, S; Kastner, M; Nelson, MLA; Salbach, NM; Shepherd, J; Sweet, SN; Wilcock, R; Thoms, C; Bayley, MT				Munce, Sarah E. P.; Jaglal, Susan; Kastner, Monika; Nelson, Michelle L. A.; Salbach, Nancy M.; Shepherd, John; Sweet, Shane N.; Wilcock, Ruth; Thoms, Carla; Bayley, Mark T.			Ontario Brain Injury Association Peer Support Program: a mixed methods protocol for a pilot randomised controlled trial	BMJ OPEN			English	Article							SPINAL-CORD-INJURY; QUALITY-OF-LIFE; SELF-EFFICACY; PARTICIPATION ASSESSMENT; FOLLOW-UP; REHABILITATION; PEOPLE; INTERVENTIONS; INDIVIDUALS; ADULTS	Introduction The objective of this study is to conduct a pilot randomised controlled trial (RCT) of the Ontario Brain Injury Association (OBIA) Peer Support Program. The RCT is designed to evaluate the effectiveness and dose-response of the Peer Support Program in improving participation and mood for people with moderate-to-severe traumatic brain injury compared with a wait-list control group. Methods and analysis The proposed research is a three-phase, mixed methods pilot RCT. Consistent with an integrated knowledge translation approach, the study design has been informed in consultation with the knowledge user (ie, OBIA). It will include an initial qualitative examination of barriers and enablers to the trial implementation (phase 1), a pilot RCT (phase 2) and conclude with a qualitative component (phase 3). A qualitative descriptive approach will be adopted for both qualitative phases of the study (n=20-25) and thematic analysis will be used. The 6 months phase-2 trial will be conducted with 60 participants. These participants will be randomised to one of three groups: a twice a week programme (n=20), a once a week programme (n=20) or the wait-list control group (n=20). The feasibility of participant recruitment and retention, data collection, as well as participant adherence to the OBIA Peer Support Program will be evaluated. The primary outcome measure will be participation, as measured by the Participation Assessment with Recombined Tools-Objective. Other proposed outcomes of interest will include mood, health-related quality of life and self-efficacy. Ethics and dissemination Ethics approval will be obtained from the principal author's institution (University Health Network Research Ethics Board). The results of this study will inform the development of a larger scale RCT and will inform future iterations of the OBIA Peer Support Program including a revised programme curriculum.	[Munce, Sarah E. P.; Salbach, Nancy M.; Bayley, Mark T.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Jaglal, Susan; Salbach, Nancy M.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Jaglal, Susan; Bayley, Mark T.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jaglal, Susan; Salbach, Nancy M.; Shepherd, John] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Kastner, Monika] North York Gen Hosp, Toronto, ON, Canada; [Nelson, Michelle L. A.] Lunenfeld Tanenbaum Res Inst, Bridgepoint Collaboratory, Toronto, ON, Canada; [Sweet, Shane N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Sweet, Shane N.] Ctr Interdisciplinary Res Rehabil Greater Montrea, Toronto, ON, Canada; [Wilcock, Ruth; Thoms, Carla] Ontario Brain Injury Assoc, St Catharines, ON, Canada		Munce, SEP (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.	sarah.munce@uhn.ca		Munce, Sarah/0000-0002-0595-8395; Jaglal, Susan/0000-0002-2930-1443	Ontario Neurotrauma Foundation [2017-ABI-OBIA-1036]	This work was supported by the Ontario Neurotrauma Foundation grant number 2017-ABI-OBIA-1036.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arain M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-67; Bagnall AM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1584-x; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bartone PT, 2017, OMEGA, V1, P30; Bass B.M., 2006, TRANSFORMATIONAL LEA; Beauchamp MR, 2016, DISABIL REHABIL, V38, P1884, DOI 10.3109/09638288.2015.1107773; Bogner J, 2013, J HEAD TRAUMA REHAB, V28, P337, DOI 10.1097/HTR.0b013e31829af969; Boschen K., 2012, ONTARIO BRAIN INJURY; Boschen KA, 2003, INT J REHABIL RES, V26, P157, DOI 10.1097/00004356-200309000-00001; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Creswell J.W., 2003, HDB MIXED METHODS SO, P209; Dale JR, 2012, DIABETIC MED, V29, P1361, DOI 10.1111/j.1464-5491.2012.03749.x; De Vinney DJ, 2000, EFFECTS PEER MENTORI; Deci E, 2002, HDB SELF DETERMINATI; Dennis CL, 2003, INT J NURS STUD, V40, P321, DOI 10.1016/S0020-7489(02)00092-5; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Ford P, 2013, INT J ENV RES PUB HE, V10, P5507, DOI 10.3390/ijerph10115507; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hart T, 2015, REHABIL PSYCHOL, V60, P126, DOI 10.1037/rep0000031; Hoey LM, 2008, PATIENT EDUC COUNS, V70, P315, DOI 10.1016/j.pec.2007.11.016; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Institut national d'excellence en sante et en services sociaux (INESSS)-Ontario Neurotrauma Foundation (ONF), CLIN PRACT GUID REH; Kelly EH, 2007, REHABIL PSYCHOL, V52, P226, DOI 10.1037/0090-5550.52.2.226; Kessler D, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-256; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Ljungberg I, 2011, J CLIN NURS, V20, P351, DOI 10.1111/j.1365-2702.2010.03432.x; Lorig K., 1996, OUTCOME MEASURES HLT; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Morris RPG, 2017, CLIN REHABIL, V31, P1030, DOI 10.1177/0269215516676303; Newby TA, 2015, PSYCHO-ONCOLOGY, V24, P1686, DOI 10.1002/pon.3781; Ontario Brain Injury Association, 2017, ONT BRAIN INJ ASS PE; Patil SJ, 2016, ANN FAM MED, V14, P540, DOI 10.1370/afm.1982; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shaw RB, 2018, REHABIL PSYCHOL, V63, P131, DOI 10.1037/rep0000176; Sherman JE, 2004, REHABIL PSYCHOL, V49, P140, DOI 10.1037/0090-5550.49.2.140; Smith BE, 2018, PILOT FEASIBILITY ST, V4, P24; Sokol R., 2016, AM J PUBLIC HEALTH, V106, P1308, DOI [10.2105/AJPH.2016.303180a, DOI 10.2105/AJPH.2016.303180A]; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Sweet SN, 2018, ARCH PHYS MED REHAB, V99, P468, DOI 10.1016/j.apmr.2017.08.487; TEASDALE G, 1974, LANCET, V2, P81; Veith EM, 2006, REHABIL PSYCHOL, V51, P289, DOI 10.1037/0090-5550.51.4.289; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Webber M, 2005, SOCIAL PERSPECTIVES, P90; Webber M, 2011, J AFFECT DISORDERS, V129, P149, DOI 10.1016/j.jad.2010.08.005; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS24, DOI 10.1016/j.apmr.2013.05.034; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Wobma R, 2016, J REHABIL MED, V48, P837, DOI 10.2340/16501977-2160; Young J M, 1999, Healthc Manage Forum, V12, P51	61	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUN	2019	9	3							e023367	10.1136/bmjopen-2018-023367			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IC7HO	WOS:000471144900057	30904839	Green Published, gold			2022-02-06	
J	Prien, A; Junge, A; Brugger, P; Straumann, D; Feddermann-Demont, N				Prien, Annika; Junge, Astrid; Brugger, Peter; Straumann, Dominik; Feddermann-Demont, Nina			Neurocognitive Performance of 425 Top-Level Football Players: Sport-specific Norm Values and Implications	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Neurocognitive assessment; Computerized cognitive testing; CNS Vital Signs; Concussion; Elite athlete; Soccer	TRAUMATIC BRAIN-INJURY; BASE-LINE; COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL ASSESSMENT; ASSESSMENT TOOLS; CONCUSSION; RELIABILITY; MANAGEMENT; VALIDITY; TESTS	Objective: Concussion diagnosis and management in sports largely relies on neurocognitive testing. In the absence of baseline assessment, only norm values of the general population are available for comparison with scores of concussed athletes. To evaluate whether (elite) sport specific norm values are needed, cognitive performance was compared between top-level football players and the general population. Methods: Cognitive performance of 425 top-level football players was evaluated using the computerized test battery CNS Vital Signs. Players were split into two age groups (15-19 and 20-29 years) and test results were compared with a norm sample (n = 268) by means of age-standardized scores using Cohen's d effect size statistics. Results: The younger age group outperformed the norm sample in all domains, with small to moderate effects on tests of processing speed (d = 0.58, 95% CI = 0.31,0.85), cognitive flexibility (d = 0.27, 95% CI = 0.01,0.53) and psychomotor speed (d = 0.97, 95% CI = 0.69,1.24). In the older age group, no differences were found on four out of six domains; a moderate positive effect was found for psychomotor speed (d = 0.74, 95% CI = 0.54,0.93), a small negative effect for reaction time (d = -0.47, 95% CI = -0.66,-0.28). Relative to the norm, older football players scored lower than younger football players on all test domains. Conclusion: Cognitive performance of elite football players may be different from the general population. It is recommended to use football-specific norm scores for comparison with test results of concussed players, and to choose an adequate control group when investigating effects of contact sport on cognition. Studies with older/retired football players are needed to further analyze potential sport-specific age effects.	[Prien, Annika; Junge, Astrid] MSH Med Sch Hamburg, Dept Prevent Hlth Promot & Sports Med, Hamburg, Germany; [Prien, Annika] Vrije Univ Amsterdam, Med Ctr, Dept Publ & Occupat Hlth, Amsterdam Collaborat Hlth & Safety Sports, Amsterdam, Netherlands; [Junge, Astrid; Feddermann-Demont, Nina] Schulthess Clin, Zurich, Switzerland; [Junge, Astrid; Brugger, Peter; Straumann, Dominik; Feddermann-Demont, Nina] SCC, Zurich, Switzerland; [Brugger, Peter; Straumann, Dominik; Feddermann-Demont, Nina] Univ Zurich, Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Brugger, Peter; Straumann, Dominik; Feddermann-Demont, Nina] Univ Zurich, Univ Hosp Zurich, Clin Neurosci Ctr, Zurich, Switzerland; [Brugger, Peter] Univ Zurich, ZIHP, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland		Prien, A (corresponding author), MSH Med Sch Hamburg, Dept Prevent Hlth Promot & Sports Med, Hamburg, Germany.; Prien, A (corresponding author), MSH Med Sch Hamburg, Kaiserkai 1, D-20457 Hamburg, Germany.	annika.prien@medicalschool-hamburg.de		Junge, Astrid/0000-0002-6815-9793	Federation Internationale de Football Association (FIFA)	This work was supported by the Federation Internationale de Football Association (FIFA).	Alves H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00036; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Baxendale S, 2010, J CLIN EXP NEUROPSYC, V32, P699, DOI 10.1080/13803390903493515; Boyd A., 2015, CNS VITAL SIGNS MANU; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Cole WR, 2018, ARCH CLIN NEUROPSYCH, V33, P102, DOI 10.1093/arclin/acx036; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Oliveira Maira Okada de, 2014, Dement. neuropsychol., V8, P112, DOI 10.1590/S1980-57642014DN82000005; Dickinson MD, 2011, APPL NEUROPSYCHOL, V18, P136, DOI 10.1080/09084282.2010.547785; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Gualtieri C. T., 2015, FRONTIERS, V4, P1; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766; Hinton-Bayre AD, 2015, BRAIN IMPAIR, V16, P80, DOI 10.1017/BrImp.2015.14; Hopkins W.G., 2002, NEW VIEW STAT, V502; Huijgen BCH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144580; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Iverson GL, 2014, APPL NEUROPSYCH-ADUL, V21, P36, DOI 10.1080/09084282.2012.721149; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Kemp S, 2016, BRAIN INJURY, V30, P1068, DOI 10.3109/02699052.2016.1148776; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lanting S. C., 2012, AM REH MED C VANC CA; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; Menezes J., 2015, INDEPENDENT; Meskal I, 2015, J NEURO-ONCOL, V121, P617, DOI 10.1007/s11060-014-1679-8; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Partridge B, 2014, NEUROETHICS-NETH, V7, P63, DOI 10.1007/s12152-013-9182-z; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Rijnen SJM, 2020, ASSESSMENT, V27, P373, DOI 10.1177/1073191117727346; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Trahan LH, 2014, PSYCHOL BULL, V140, P1332, DOI 10.1037/a0037173; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170845; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588	62	5	5	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2019	34	4					575	584		10.1093/arclin/acy056			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	IS9UK	WOS:000482493200014	30165564	Bronze			2022-02-06	
J	Yin, C; Guo, ZD; He, ZZ; Wang, ZY; Sung, XC				Yin, Cheng; Guo, Zong-duo; He, Zong-ze; Wang, Zhen-yu; Sung, Xiao-chuan			Apolipoprotein E Affects In Vitro Axonal Growth and Regeneration via the MAPK Signaling Pathway	CELL TRANSPLANTATION			English	Article						apolipoprotein E; axon; transection; regeneration; MAPK	TRAUMATIC BRAIN-INJURY; PROTEIN-SYNTHESIS; NEURITE OUTGROWTH; APOE; EXPRESSION; CELLS; DEGRADATION; ASSOCIATION; RECOVERY; NEURONS	Following central nervous system injury in mammals, failed axonal regeneration is closely related to dysneuria. Previous studies have shown that the obvious effects of apolipoprotein E (ApoE) on traumatic brain injury (TBI) were associated with an axonal mechanism. However, little information on the actions of ApoE and its isoforms on axonal regeneration following TBI was provided. In our study, the cerebral cortices of ApoE-deficient (ApoE(-/-)) and wild-type (ApoE(+/+)) mice were cultured in vitro, and an axonal transection model was established. Interventions included the conditioned medium of astrocytes, human recombinant ApoE2/3/4 isoforms and inhibitors of the JNK/ERK/p38 pathway. Axonal growth and regeneration were evaluated by measuring the maximum distance and area of the axons. The expression levels of beta-tubulin III, MAP2, ApoE, p-JNK, p-ERK and p-p38 were detected by immunofluorescence and western blotting. The results showed that ApoE mRNA and protein were expressed in intact axons and regenerated axons. Axonal growth and regeneration were attenuated in ApoE(-/-) mice but recovered by exogenous ApoE. Human recombinant ApoE3 positively influenced axonal growth and regeneration; these effects were mediated by the JNK/ERK/p38 pathway. These results suggest ApoE and its isoforms may have influenced axonal growth and regeneration via the MAPK signaling pathway in vitro.	[Yin, Cheng; He, Zong-ze; Wang, Zhen-yu] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Guo, Zong-duo; Sung, Xiao-chuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1st Youyi Rd, Chongqing 400016, Peoples R China		Sung, XC (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 1st Youyi Rd, Chongqing 400016, Peoples R China.	sunxch1445@qq.com		sun, xiao chuan/0000-0001-6992-332X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601031]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was funded by grants from the National Natural Science Foundation of China (No. 81601031, 2017).	Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Comley LH, 2011, HUM MOL GENET, V20, P2406, DOI 10.1093/hmg/ddr147; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Farrar NR, 2009, J NEUROSCI, V29, P14136, DOI 10.1523/JNEUROSCI.2921-09.2009; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Hu JL, 2017, NEURAL REGEN RES, V12, P525, DOI 10.4103/1673-5374.205080; Huang Y, 2015, ZOOKEYS, P25, DOI 10.3897/zookeys.514.9159; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Kay A, 2003, STROKE, V34, P637, DOI 10.1161/01.STR.0000057579.25430.16; Khan IU, 2018, CELL TRANSPLANT, V27, P1140, DOI 10.1177/0963689718779766; Korwek KM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-21; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Li M, 2015, CELL MOL NEUROBIOL, V35, P987, DOI 10.1007/s10571-015-0193-7; Lin JQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1634801; Lorber B, 2009, J NEUROSCI RES, V87, P2645, DOI 10.1002/jnr.22095; Mahley RW, 1996, ANN NY ACAD SCI, V777, P139, DOI 10.1111/j.1749-6632.1996.tb34412.x; Matsuo M., 2010, BIOCHIM BIOPHYS ACTA, V1811, P31; McKay GJ, 2011, AM J EPIDEMIOL, V173, P1357, DOI 10.1093/aje/kwr015; Nathan BP, 2005, BRAIN RES, V1041, P87, DOI 10.1016/j.brainres.2005.02.011; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Okano H, 2011, CORNEA, V30, pS15, DOI 10.1097/ICO.0b013e3182281879; Padgett CR, 2016, J CLIN EXP NEUROPSYC, V38, P551, DOI 10.1080/13803395.2015.1137557; Pocivavsek A, 2009, BIOCHEM BIOPH RES CO, V387, P516, DOI 10.1016/j.bbrc.2009.07.048; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Riemenschneider M, 2002, NEUROBIOL AGING, V23, P205, DOI 10.1016/S0197-4580(01)00272-X; Shi LY, 2018, CELL TRANSPLANT, V27, P1185, DOI 10.1177/0963689718756070; Singh A, 2017, BRAIN INJURY, V31, P1387, DOI 10.1080/02699052.2017.1321781; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Twiss JL, 2006, J NEUROTRAUM, V23, P295, DOI 10.1089/neu.2006.23.295; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wen TC, 2018, CELL TRANSPLANT, V27, P256, DOI 10.1177/0963689717741139; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Yamagishi S, 2005, J BIOL CHEM, V280, P20384, DOI 10.1074/jbc.M501945200; Yin C, 2012, NEUROSCI LETT, V515, P77, DOI 10.1016/j.neulet.2012.03.023; Yoon BC, 2009, RESULTS PROBL CELL D, V48, P269, DOI 10.1007/400_2009_5; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	43	5	5	2	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.	JUN	2019	28	6			SI		691	703		10.1177/0963689718808736			13	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	IO3EU	WOS:000479264200005	30350715	Green Published, gold			2022-02-06	
J	Zhang, Q; Chen, HX; Zhu, C; Chen, FZ; Sun, SH; Liang, N; Zheng, W				Zhang, Qiang; Chen, Hongxing; Zhu, Chao; Chen, Fangzhou; Sun, Suohui; Liang, Nan; Zheng, Wei			Efficacy and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						intrathecal injection; meropenem; vancomycin; severe traumatic brain injury; efficacy; safety	COMMUNITY-ACQUIRED PNEUMONIA; MIDAZOLAM; DEXMEDETOMIDINE; PREVENTION; DRAINAGE; SURGERY	This study investigated the improvement and safety of intrathecal meropenem and vancomycin in the treatment of postoperative intracranial infection in patients with severe traumatic brain injury (STBI). A retrospective analysis was performed on 86 patients with intracranial infections after cranial trauma operation in Tai'an Traditional Chinese Medicine Hospital and Affiliated Hospital of Taishan Medical University from May 2004 to June 2017. The patients were divided into the control group (43 patients) and the experimental group (43 patients) according to the treatment. Patients in the control group were intravenously infused with vancomycin hydrochloride (1.0 g, Q12H) and meropenem (2.0 g, Q8H). After lumbar cistern drainage was performed for the release of cerebrospinal fluid (CSF), patients in the experimental group were slowly given vancomycin 20 mg. After the tube was flushed with 2 ml of 0.9% sodium chloride injection, the patients were slowly given meropenem 20 mg, bid. The clinical efficacy, cure time and treatment cost of patients in the two groups were observed. The adverse reactions and sequelae after 6 months of treatment were recorded. The response rate (RR) of patients in the experimental group was significantly higher than that in the control group (P<0.05). The cure time of patients in the experimental group was significantly lower than that in the control group (P<0.05). The treatment cost of patients in the experimental group was significantly lower than that in the control group (P<0.05). The incidence of adverse reactions of patients, incidence of sequelae of patients in the experimental group was significantly lower than that in the control group (P<0.05). Intrathecal meropenem and vancomycin is more effective than intravenous administration in the treatment of intracranial infection after craniotomy. It can significantly shorten the treatment time and reduce the treatment cost, with better safety.	[Zhang, Qiang] Taian Tradit Chinese Med Hosp, Emergency Dept, Tai An 271000, Shandong, Peoples R China; [Chen, Hongxing] Taishan Med Univ, Affiliated Hosp, Dept ICU, Tai An 271000, Shandong, Peoples R China; [Zhu, Chao; Chen, Fangzhou; Sun, Suohui; Liang, Nan; Zheng, Wei] Taishan Med Univ, Affiliated Hosp, Dept Neurosurg, 366 Taishan Ave, Tai An 271000, Shandong, Peoples R China		Zheng, W (corresponding author), Taishan Med Univ, Affiliated Hosp, Dept Neurosurg, 366 Taishan Ave, Tai An 271000, Shandong, Peoples R China.	vvt26t@163.com					Azeem TMA, 2018, SAUDI J ANAESTH, V12, P190, DOI 10.4103/sja.SJA_303_17; Bao Yun, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P169, DOI 10.3760/cma.j.issn.2095-4352.2016.02.016; Benktander J, 2018, VIRULENCE, V9, P738, DOI 10.1080/21505594.2018.1440171; Blassmann U, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1523-y; Caughlin S, 2018, BBA-GEN SUBJECTS, V1862, P1327, DOI 10.1016/j.bbagen.2018.03.011; Chen K, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2014.09.020; Chen QH, 2017, NEUROCHIRURGIE, V63, P13, DOI 10.1016/j.neuchi.2016.05.002; Cook AM, 2013, NEUROCRIT CARE, V19, P210, DOI 10.1007/s12028-013-9837-y; Dey S, 2018, J ANAESTH CLIN PHARM, V34, P94, DOI 10.4103/joacp.JOACP_297_16; Doder Radoslava, 2010, Med Pregl, V63 Suppl 1, P22; Duan MX, 2015, NEUROL SCI, V36, P625, DOI 10.1007/s10072-014-1956-5; Gaillat J, 2005, EUR J EPIDEMIOL, V20, P643, DOI 10.1007/s10654-005-5868-9; Goldschmidt E, 2016, J NEUROSURG-SPINE, V25, P665, DOI 10.3171/2016.3.SPINE151491; Gupta MK, 2018, INDIAN J CRIT CARE M, V22, P300, DOI 10.4103/ijccm.IJCCM_36_17; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; Huttner HB, 2007, STROKE, V38, P183, DOI 10.1161/01.STR.0000251795.02560.62; Iwasawa T, 2018, INT J ONCOL, V52, P1255, DOI 10.3892/ijo.2018.4266; Kneen R, 2002, ARCH DIS CHILD, V87, P181, DOI 10.1136/adc.87.3.181; Lee K, 2015, INFECT CHEMOTHER, V47, P183, DOI 10.3947/ic.2015.47.3.183; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; Paleti S, 2018, J ANAESTH CLIN PHARM, V34, P23, DOI 10.4103/joacp.JOACP_74_17; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Sasaki N., 2017, ONCOTARGET, V9, P5562, DOI [10.18632/oncotarget.23726, DOI 10.18632/ONCOTARGET.23726]; Wattanathum A, 2003, CHEST, V123, P1512, DOI 10.1378/chest.123.5.1512; Zaki ME, 2009, J INFECT DEV COUNTR, V3, P199	25	5	8	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2019	17	6					4605	4609		10.3892/etm.2019.7503			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IK5CG	WOS:000476602700039	31086592	gold, Green Published, Green Submitted			2022-02-06	
J	Das, M; Tang, XL; Han, JY; Mayilsamy, K; Foran, E; Biswal, MR; Tzekov, R; Mohapatra, SS; Mohapatra, S				Das, Mahasweta; Tang, Xiaolan; Han, Jung Yeon; Mayilsamy, Karthick; Foran, Elspeth; Biswal, Manas R.; Tzekov, Radouil; Mohapatra, Shyam S.; Mohapatra, Subhra			CCL20-CCR6 axis modulated traumatic brain injury-induced visual pathologies	JOURNAL OF NEUROINFLAMMATION			English	Article						rTBI; CCL20; Pioglitazone; CCR6-; -; Retina; RGC	ACTIVATED RECEPTOR-GAMMA; CHEMOKINE LIGAND 20; DELTA T-CELLS; DRY EYE; COGNITIVE IMPAIRMENT; OPTIC-NERVE; INFLAMMATION; PIOGLITAZONE; EXPRESSION; CCR6	BackgroundTraumatic brain injury (TBI) is a major cause of death and disability in the USA and the world; it constitutes 30% of injury-related deaths (Taylor et al., MMWR Surveill Summ 66:1-16, 2017). Contact sports athletes often experience repetitive TBI (rTBI), which exerts a cumulative effect later in life. Visual impairment is a common after-effect of TBI. Previously, we have shown that C-C chemokine 20 (CCL20) plays a critical role in neurodegeneration and inflammation following TBI (Das et al., J Neuroinflammation 8:148, 2011). C-C chemokine receptor 6 (CCR6) is the only receptor that CCL20 interacts with. The objective of the present study was to investigate the role of CCL20-CCR6 axis in mediating rTBI-induced visual dysfunction (TVD).MethodsWild type (WT) or CCR6 knock out (CCR6-/-) mice were subjected to closed head rTBI. Pioglitazone (PG) is a peroxisome proliferator-activated receptor (PPAR) agonist which downregulates CCL20 production. Subsets of WT mice were treated with PG following final rTBI. A subset of mice was also treated with anti-CCL20 antibody to neutralize the CCL20 produced after rTBI. Histopathological assessments were performed to show cerebral pathologies, retinal pathologies, and inflammatory changes induced by rTBI.ResultsrTBI induced cerebral neurodegeneration, retinal degeneration, microgliosis, astrogliosis, and CCL20 expression. CCR6-/- mice showedreduced retinal degeneration, microgliosis, and inflammation. Treatment with CCL20 neutralization antibody or PG showed reduced CCL20 expression along with reduced retinal degeneration and inflammation. rTBI-induced GFAP-positive glial activation in the optic nerve was not affected by knocking out CCR6.ConclusionThe present data indicate that rTBI-induced retinal pathology is mediated at least in part by CCL20 in a CCR6-dependent manner.	[Das, Mahasweta; Tang, Xiaolan; Han, Jung Yeon; Mayilsamy, Karthick; Foran, Elspeth; Tzekov, Radouil; Mohapatra, Shyam S.; Mohapatra, Subhra] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Das, Mahasweta; Tang, Xiaolan; Han, Jung Yeon; Mayilsamy, Karthick; Foran, Elspeth; Mohapatra, Subhra] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Mohapatra, Shyam S.] Univ S Florida, Dept Internal Med, Morsani Coll Med, Tampa, FL USA; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Morsani Coll Med, Tampa, FL USA; [Biswal, Manas R.; Tzekov, Radouil; Mohapatra, Shyam S.] Univ S Florida, Coll Pharm, Grad Programs, Tampa, FL USA; [Tzekov, Radouil] Univ S Florida, Dept Med Engn, Tampa, FL USA; [Tzekov, Radouil] Roskamp Inst, Sarasota, FL USA		Mohapatra, S (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Mohapatra, S (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.	smohapa2@health.usf.edu		Biswal, Manas/0000-0002-9685-2923; Tzekov, Radouil/0000-0002-3662-9818	Veterans Affairs Merit Review grantUS Department of Veterans Affairs [BX002668]; Research Career Scientist Awards [IK6BX004212, IK6 BX003778]; Veterans AffairsUS Department of Veterans Affairs [IK6BX003778, I01BX002668, IK6BX004212] Funding Source: NIH RePORTER	Veterans Affairs Merit Review grant (BX002668) and Research Career Scientist Awards (IK6BX004212) to Dr. Subhra Mohapatra and Research Career Scientist Award (IK6 BX003778) to Shyam S. Mohapatra.	Amanipour RM, 2016, IEEE ENG MED BIO, P1854, DOI 10.1109/EMBC.2016.7591081; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Birnbaum Y, 2011, BASIC RES CARDIOL, V106, P431, DOI 10.1007/s00395-011-0162-3; Chen JJ, 2017, CELL PHYSIOL BIOCHEM, V44, P357, DOI 10.1159/000484907; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Choo J, 2015, J BIOL CHEM, V290, P25609, DOI 10.1074/jbc.M115.673046; Comerford I, 2010, BIOESSAYS, V32, P1067, DOI 10.1002/bies.201000063; Coursey TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078508; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Das M, 2019, REV NEUROSCIENCE, V30, P305, DOI 10.1515/revneuro-2018-0015; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dohlman TH, 2013, INVEST OPHTH VIS SCI, V54, P4081, DOI 10.1167/iovs.12-11216; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Facco M, 2007, J LEUKOCYTE BIOL, V82, P946, DOI 10.1189/jlb.0307133; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Glasgow Coma Scale G, GLASG STRUCT APPR AS; Glatz T, 2010, J HYPERTENS, V28, P1488, DOI 10.1097/HJH.0b013e3283396e4e; Hammerich L, 2014, HEPATOLOGY, V59, P630, DOI 10.1002/hep.26697; Hausser N, 2018, JOVE-J VIS EXP, DOI 10.3791/56044; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hu JZ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0630-7; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Khodeer DM, 2016, CAN J PHYSIOL PHARM, V94, P463, DOI 10.1139/cjpp-2015-0135; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Lee AYS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00194; Lee CJ, 2018, BRIT J OPHTHALMOL, V102, P667, DOI 10.1136/bjophthalmol-2017-310509; Leonardo CC, 2012, TRANSL STROKE RES, V3, P357, DOI 10.1007/s12975-012-0203-8; Li ZJ, 2011, FASEB J, V25, P2659, DOI 10.1096/fj.11-184804; Liston A, 2009, J IMMUNOL, V182, P3121, DOI 10.4049/jimmunol.0713169; LoBue C, 2018, NEUROPSYCHOLOGY, V32, P401, DOI 10.1037/neu0000431; Madeira MH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/673090; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Marin-Teva JL, 2011, NEURON GLIA BIOL, V7, P25, DOI 10.1017/S1740925X12000014; Morse Anne M, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6010015; Nadal-Nicolas FM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0982-7; Nelson RT, 2001, GENOMICS, V73, P28, DOI 10.1006/geno.2001.6482; Paterno R, 2018, J NEUROTRAUM, V35, P2117, DOI 10.1089/neu.2017.5170; Qi WE, 2011, INT J BIOCHEM CELL B, V43, P383, DOI 10.1016/j.biocel.2010.11.008; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rossi S, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7368389; Rutner D, 2006, BRAIN INJURY, V20, P1079, DOI 10.1080/02699050600909904; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Schiffman RM, 2003, OPHTHALMOLOGY, V110, P1412, DOI 10.1016/S0161-6420(03)00462-7; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Sen N, 2017, NEUROCHEM INT, V111, P103, DOI 10.1016/j.neuint.2017.01.019; Singh A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00741-4; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; THANOS S, 1993, INT J DEV NEUROSCI, V11, P671, DOI 10.1016/0736-5748(93)90054-H; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Vallee A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00745; Varona R, 2003, EUR J IMMUNOL, V33, P2937, DOI 10.1002/eji.200324347; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vien L, 2017, OPTOMETRY VISION SCI, V94, P125, DOI 10.1097/OPX.0000000000000899; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Wang X, 2016, J NEUROSCI, V36, P2827, DOI 10.1523/JNEUROSCI.3575-15.2016; Welsh-Bacic D, 2011, NEPHROL DIAL TRANSPL, V26, P1211, DOI 10.1093/ndt/gfq560; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	65	5	5	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAY 31	2019	16								115	10.1186/s12974-019-1499-z			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	IA9OM	WOS:000469886500001	31151410	Green Published, gold			2022-02-06	
J	Kelly, G; Simpson, GK; Brown, S; Kremer, P; Gillett, L				Kelly, Glenn; Simpson, Grahame K.; Brown, Suzanne; Kremer, Peter; Gillett, Lauren			The Overt Behaviour Scale-Self-Report (OBS-SR) for acquired brain injury: exploratory analysis of reliability and validity	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acquired brain injury; traumatic brain injury; brain tumour; challenging behaviour; aggression; insight; self-report; outcome measures	INAPPROPRIATE SEXUAL-BEHAVIOR; COMMUNITY-DWELLING ADULTS; CHALLENGING BEHAVIORS; SIGNIFICANT OTHERS; AWARENESS; PEOPLE; AGGRESSION; PREVALENCE; INDIVIDUALS; INTERVENTIONS	The objectives were to test the properties, via a psychometric study, of the Overt Behaviour Scale-Self-Report (OBS-SR), a version of the OBS-Adult Scale developed to provide a client perspective on challenging behaviours after acquired brain injury. Study sample 1 consisted of 37 patients with primary brain tumour (PBT) and a family-member informant. Sample 2 consisted of 34 clients with other acquired brain injury (mixed brain injury, MBI) and a service-provider informant. Participants completed the OBS-SR (at two time points), and the Awareness Questionnaire (AQ) and Mayo Portland Adaptability Inventory-III (MPAI-III) once; informants completed the OBS-Adult and AQ once only. PBT-informant dyads displayed "good" levels of agreement (ICC2,k = .74; OBS-SR global index). Although MBI-informant dyads displayed no agreement (ICC2,k = .22; OBS-SR global index), the sub-group (17/29) rated by clinicians as having moderate to good levels of awareness displayed "fair" agreement (ICC2,k = .58; OBS-SR global index). Convergent/divergent validity was demonstrated by significant correlations between OBS-SR subscales and MPAI-III subscales with behavioural content (coefficients in the range .36 -.61). Scores had good reliability across one week (ICC2,k = .69). The OBS-SR took approximately 15 minutes to complete. It was concluded that the OBS-SR demonstrated acceptable reliability and validity, providing a useful resource in understanding clients' perspectives about their behaviour.	[Kelly, Glenn] Diverge Consulting, Melbourne, Vic, Australia; [Simpson, Grahame K.; Gillett, Lauren] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia; [Kremer, Peter] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic, Australia		Kelly, G (corresponding author), Psychol Rooms,POB 1227, Barwon Heads, Vic 3227, Australia.	glenn.kelly1@icloud.com	Kremer, Peter/I-8202-2019; Kelly, Glenn/AAA-6894-2021; Simpson, Grahame K/W-1074-2019	Kremer, Peter/0000-0003-2476-1958; Kelly, Glenn/0000-0003-1670-3344; Simpson, Grahame K/0000-0001-8156-9060			Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 2007, BRAIN INJURY, V21, P891, DOI 10.1080/02699050701543560; Alderman N, 2013, BRAIN IMPAIR, V14, P5, DOI 10.1017/BrImp.2013.7; Amtmann D, 2011, ARCH PHYS MED REHAB, V92, pS12, DOI 10.1016/j.apmr.2011.04.025; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Cairns L, 2012, INT J DISABILITY MAN, V7, P35, DOI DOI 10.1017/idm.2012.8; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CICERONE KD, 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Feeney TJ, 2001, J HEAD TRAUMA REHAB, V16, P61, DOI 10.1097/00001199-200102000-00008; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Gagnon J, 2016, BRAIN INJURY, V30, P1019, DOI 10.3109/02699052.2016.1148197; Gagnon J, 2013, BEHAV SCI-BASEL, V3, P72, DOI 10.3390/bs3010072; Gerber GJ, 2015, BRAIN INJURY, V29, P722, DOI 10.3109/02699052.2015.1004745; Grace J, 2001, FRSBE FRONTAL SYSTEM; Gregg N, 2014, SUPPORT CARE CANCER, V22, P2965, DOI 10.1007/s00520-014-2291-3; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; James AIW, 2013, BRAIN INJURY, V27, P1162, DOI 10.3109/02699052.2013.804200; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kelly G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; Kelly G., 2004, BRAIN IMPAIR, V5, DOI [10.1375/brim.5.1.42.35398, DOI 10.1375/brim.5.1.42.35398]; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kelly G, 2011, SEX DISABIL, V29, P313, DOI 10.1007/s11195-011-9213-9; Kelly G, 2008, BRAIN IMPAIR, V9, P293, DOI 10.1375/brim.9.3.293; Knight C, 2008, NEUROPSYCHOL REHABIL, V18, P129, DOI 10.1080/09602010701822381; Lane-Brown AT, 2011, BRAIN IMPAIR, V12, P43, DOI 10.1375/brim.12.1.43; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; Markova IS, 2006, NEUROPSYCHOL REHABIL, V16, P439, DOI 10.1080/09602010500373396; Marosszeky N., 2008, NAT HLTH OUTC C; Marsh NV, 2006, NEUROPSYCHOL REHABIL, V16, P684, DOI 10.1080/09602010500220290; Nott Melissa T, 2014, Top Spinal Cord Inj Rehabil, V20, P225, DOI 10.1310/sci2003-225; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Simpson G. K., 2015, PSYCHOSOCIAL ADV NEU, P41; Simpson GK, 2014, BRAIN IMPAIR, V15, P28, DOI 10.1017/BrImp.2014.7; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Winkler D, 2010, BRAIN IMPAIR, V11, P299, DOI 10.1375/brim.11.3.299; Wood RL, 2001, NEUROBEHAVIOURAL DIS, P1; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Wright KM, 2015, J NEUROSCI NURS, V47, P135, DOI 10.1097/JNN.0000000000000132; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470	59	5	5	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY 28	2019	29	5					704	722		10.1080/09602011.2017.1322523			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HP4NI	WOS:000461652400005	28532322				2022-02-06	
J	Clark, JM; Connor, TA; Post, A; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Connor, Thomas A.; Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.			The influence of impact surface on head kinematics and brain tissue response during impacts with equestrian helmets	SPORTS BIOMECHANICS			English	Article; Early Access						Helmets; certification standards; concussion; injury biomechanics; finite element modelling	DYNAMIC-RESPONSE; DEFORMATION METRICS; INJURY; RECONSTRUCTION; CONCUSSION; FOOTBALL; ACCELERATION; PREDICTORS; THRESHOLD; STRESS	Current equestrian standards employ a drop test to a rigid steel anvil. However, falls in equestrian sports often result in impacts with soft ground. The purpose of this study was to compare head kinematics and brain tissue response associated with surfaces impacted during equestrian accidents and corresponding helmet certification tests. A helmeted Hybrid III headform was dropped freely onto three different anvils (steel, turf and sand) at three impact locations. Peak linear acceleration, rotational acceleration and impact duration of the headform were measured. Resulting accelerations served as input into a three-dimensional finite element head model, which calculated Maximum principal strain (MPS) and von Mises stress (VMS) in the cerebrum. The results indicated that impacts to a steel anvil produced peak head kinematics and brain tissue responses that were two to three times greater than impacts against both turf and sand. Steel impacts were less than half the duration of turf and sand impacts. The observed response magnitudes obtained in this study suggest that equestrian helmet design should be improved, not only for impacts to rigid surfaces but also to compliant surfaces as response magnitudes for impacts to soft surfaces were still within the reported range for concussion in the literature.	[Clark, J. Michio; Connor, Thomas A.; Gilchrist, Michael D.] Univ Coll Dublin Belfield, Coll Engn & Architecture, Sch Mech & Mat Engn, Dublin, Ireland; [Connor, Thomas A.] Charles Owen & Co Ltd, Design Dept, Wrexham, Wales; [Post, Andrew] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada		Gilchrist, MD (corresponding author), Univ Coll Dublin Belfield, Coll Engn & Architecture, Sch Mech & Mat Engn, Dublin, Ireland.; Gilchrist, MD (corresponding author), Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada.	michael.gilchrist@ucd.ie		Connor, Thomas/0000-0002-2093-7162; Post, Andrew/0000-0002-5960-5552	European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie [642662]	This work was supported by the European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie grant agreement No. 642662.	Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; [Anonymous], 2016, 13842016 EN BRIT STA; [Anonymous], 2011, PAS0152011 BRIS STAN; ASTM F1163-15, 2015, F116315 ASTM; Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; Bier G, 2018, BRIT J NEUROSURG, V32, P37, DOI 10.1080/02688697.2017.1409874; BOND GR, 1995, PEDIATRICS, V95, P487; Bourdet N, 2015, IRCOBI C LYON FRANC; Clark JM, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040605; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Forero Rueda M. A., 2010, INJURY, V41, P533, DOI DOI 10.1016/j.injury.2009.05.009; Forero Rueda M. A., 2007, STARSS C LOUGHB UK; Forero Rueda M. A., 2009, THESIS; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Harrison T.I., 1996, P INT IRCOBI C DUBL, P49; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Kendall M., 2016, THESIS; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleiven S., 2001, P INT C BIOM IMP IRC, P161; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Meredith L, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000398; MILLS NJ, 1989, INJURY, V20, P189, DOI 10.1016/0020-1383(89)90108-3; Nahum A, 1977, 770922 SAE; NOCSAE, 2017, STAND TEST METH EQ U; NUSHOLTZ GS, 1984, P 28 STAPP CAR CRASH; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; Ono K., 1980, P 24 STAPP CAR CRASH; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2014, P IRCOBI C BERL GERM, P72; Post A, 2018, INT J CRASHWORTHINES, V23, P278, DOI 10.1080/13588265.2017.1316048; Post A, 2015, ACCIDENT ANAL PREV, V79, P33, DOI 10.1016/j.aap.2015.03.017; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, P I MECH ENG P-J SPO, V228, P276, DOI 10.1177/1754337114527742; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Rueda MAF, 2009, MATER DESIGN, V30, P3405, DOI 10.1016/j.matdes.2009.03.037; Seemann M. R., 1986, 861892 SAE; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Trosseille X, 1992, 922527 SAE; Van Lierde C, 2005, THESIS; Waller AE, 2000, JAMA-J AM MED ASSOC, V283, P1326, DOI 10.1001/jama.283.10.1326; Whitlock MR, 1999, BRIT J SPORT MED, V33, P212, DOI 10.1136/bjsm.33.3.212; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Zhang J, 2006, BIOMED SCI INSTRUM, V43, P24; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, 952714 SAE	62	5	5	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1476-3141	1752-6116		SPORT BIOMECH	Sport. Biomech.												10.1080/14763141.2019.1599062		MAY 2019	14	Engineering, Biomedical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	IA6SZ	WOS:000469689700001	31124751				2022-02-06	
J	Oyesanya, TO; Thompson, N; Arulselvam, K; Seel, RT				Oyesanya, Tolu O.; Thompson, Nicole; Arulselvam, Karthik; Seel, Ronald T.			Technology and TBI: Perspectives of persons with TBI and their family caregivers on technology solutions to address health, wellness, and safety concerns	ASSISTIVE TECHNOLOGY			English	Article; Early Access						assistive technology; family caregiver; health; person; safety; traumatic brain injury; wellness	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INPATIENT REHABILITATION; COMMUNITY; PEOPLE; INDIVIDUALS; TRANSITION; HOME; PARTICIPATION; EXPERIENCES	Assistive technologies that are tailored to individuals' health, wellness, and safety concerns can help people with traumatic brain injury (TBI) and their family caregivers meet their goals. The purpose of this study was to investigate views of technology in the context of managing one's everyday life from the perspectives of persons with TBI and their family caregivers. We conducted 27 in-person, semi-structured interviews with persons with TBI (n = 15) and family caregivers (n = 12) and used conventional content analysis to analyze our data. The major themes that emerged were: 1) views of technology, 2) influence of technology on daily life, 3) desired technology solutions to address health, wellness, and safety concerns, and 4) barriers to adopting technology solutions. To address ongoing concerns, persons with TBI and family caregivers expressed a desire to have a patient portal to share information and communicate with providers, motion sensing devices to provide guidance for mobility, on-demand access to in-home rehabilitation therapy, access to a "social gym" where the persons with TBI could virtually exercise and interact with others, and technologies that help with sleep and facilitate peer support. These findings provide direction for implementation, design, or adaptation of technologies to address the concerns of this population.	[Oyesanya, Tolu O.; Thompson, Nicole; Arulselvam, Karthik; Seel, Ronald T.] Duke Univ, Sch Nursing, Durham, NC USA; [Oyesanya, Tolu O.; Thompson, Nicole; Arulselvam, Karthik; Seel, Ronald T.] Crawford Res Inst, Shepherd Ctr, Atlanta, GA USA; [Oyesanya, Tolu O.; Thompson, Nicole; Arulselvam, Karthik; Seel, Ronald T.] Virginia Commonwealth Univ, Sch Med, Dept Phys Med & Rehabil, Richmond, VA USA		Oyesanya, TO (corresponding author), 307 Trent Dr, Durham, NC 27710 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510	National Institute for Disability, Independent Living, and Rehabilitation Research, Rehabilitation Engineering Research Center [90RE5023-01-00]	This research was supported by the National Institute for Disability, Independent Living, and Rehabilitation Research, Rehabilitation Engineering Research Center (PI, F. DeRuyter) (Grant # 90RE5023-01-00).	Abrahamson V, 2017, DISABIL REHABIL, V39, P1683, DOI 10.1080/09638288.2016.1211755; Antonini TN, 2012, J TELEMED TELECARE, V18, P333, DOI 10.1258/jtt.2012.120404; Bergquist T. F., 2017, BRAIN INJURY PROFESS, V14, P14; Centers for Disease Control and Prevention, 2017, TBI DAT STAT; Charters E, 2015, NEUROPSYCHOL REHABIL, V25, P82, DOI 10.1080/09602011.2014.942672; Chu Y, 2014, DISABIL REHABIL-ASSI, V9, P279, DOI 10.3109/17483107.2013.823631; Cornwell P, 2009, BRAIN IMPAIR, V10, P325, DOI 10.1375/brim.10.3.325; de Joode EA, 2012, BRAIN INJURY, V26, P1257, DOI 10.3109/02699052.2012.667590; Desmond D, 2018, DISABIL REHABIL-ASSI, V13, P437, DOI 10.1080/17483107.2018.1471169; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Dowds MM, 2011, J HEAD TRAUMA REHAB, V26, P339, DOI 10.1097/HTR.0b013e3181f2bf1d; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Fishwick A, 2019, DEV CHANGE, V50, P655, DOI 10.1111/dech.12407; Hauber RP, 2002, J HEAD TRAUMA REHAB, V17, P535, DOI 10.1097/00001199-200212000-00005; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Ismail S, 2016, J EMERG MED, V50, pE177, DOI 10.1016/j.jemermed.2015.10.006; Jamieson M, 2017, NEUROPSYCHOL REHABIL, V27, P919, DOI 10.1080/09602011.2015.1103760; Johnson K. L., 2016, MANUAL TRAUMATIC BRA; Katalinic O, 2013, J TELEMED TELECARE, V19, P418, DOI 10.1177/1357633X13506513; Kin S. M. G., 2016, INT J CHILD HLTH HUM, V9, P351; Kneafsey R, 2004, J CLIN NURS, V13, P601, DOI 10.1111/j.1365-2702.2004.00903.x; Kumar S, 2013, AM J PREV MED, V45, P228, DOI 10.1016/j.amepre.2013.03.017; Kumar S, 2013, COMPUTER, V46, P28, DOI 10.1109/MC.2012.392; Lemoncello R, 2011, DISABIL REHABIL-ASSI, V6, P440, DOI 10.3109/17483107.2010.542571; Levasseur M, 2016, DISABIL REHABIL-ASSI, V11, P636, DOI 10.3109/17483107.2015.1029536; Liddle J, 2014, AUST OCCUP THER J, V61, P215, DOI [10.1111/1440-1630.12153, 10.1111/1440-1630.12119]; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malec JF, 2011, ENCY CLIN NEUROPSYCH, P1526; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Nalder E, 2013, BRAIN INJURY, V27, P1294, DOI 10.3109/02699052.2013.823560; Oyesanya T. O., 2019, J FAMILY NURSING; Oyesanya T, 2017, BRAIN INJURY, V31, P151, DOI 10.1080/02699052.2016.1225987; Picot S. H. A, 2018, HOMO CONNECTUS EINBL, P103; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Powell JM, 2016, J HEAD TRAUMA REHAB, V31, P180, DOI 10.1097/HTR.0000000000000167; Ritchie JB, 2013, QUALITATIVE RES PRAC; Rogers E., 2010, DIFFUSION INNOVATION, V4th; Rosario ER, 2017, BRAIN INJURY, V31, P1340, DOI 10.1080/02699052.2017.1325937; Sander AM, 2009, J HEAD TRAUMA REHAB, V24, P248, DOI 10.1097/HTR.0b013e3181ad593a; Stone K, 2014, REHABIL NURS, V39, P76, DOI 10.1002/rnj.123; Takada K, 2016, BRAIN INJURY, V30, P1590, DOI 10.1080/02699052.2016.1199901; Tanguay AN, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00272; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; Wong D, 2017, DISABIL REHABIL, V39, P2387, DOI 10.1080/09638288.2016.1226434	47	5	5	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1040-0435	1949-3614		ASSIST TECHNOL	Assist. Technol.												10.1080/10400435.2019.1612798		MAY 2019	11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HZ8HR	WOS:000469096000001	31112463				2022-02-06	
J	Servia, L; Jove, M; Sol, J; Pamplona, R; Badia, M; Montserrat, N; Portero-Otin, M; Trujillano, J				Servia, Luis; Jove, Mariona; Sol, Joaquim; Pamplona, Reinald; Badia, Mariona; Montserrat, Neus; Portero-Otin, Manuel; Trujillano, Javier			A prospective pilot study using metabolomics discloses specific fatty acid, catecholamine and tryptophan metabolic pathways as possible predictors for a negative outcome after severe trauma	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Metabolome; Mortality; Traumatic brain injury; Biomarker; Multiple traumatism	CLINICAL-OUTCOMES; CORTISOL-LEVELS; PLASMA; MORTALITY; INJURY; SERUM; BIOMARKERS; HORMONES; OBESITY	BackgroundWe wanted to define metabolomic patterns in plasma to predict a negative outcome in severe trauma patients.MethodsA prospective pilot study was designed to evaluate plasma metabolomic patterns, established by liquid chromatography coupled to mass spectrometry, in patients allocated to an intensive care unit (in the University Hospital Arnau de Vilanova, Lleida, Spain) in the first hours after a severe trauma (n=48). Univariate and multivariate statistics were employed to establish potential predictors of mortality.ResultsPlasma of patients non surviving to trauma (n=5) exhibited a discriminating metabolomic pattern, involving basically metabolites belonging to fatty acid and catecholamine synthesis as well as tryptophan degradation pathways. Thus, concentration of several metabolites exhibited an area under the receiver operating curve (ROC) higher than 0.84, including 3-indolelactic acid, hydroxyisovaleric acid, phenylethanolamine, cortisol, epinephrine and myristic acid. Multivariate binary regression logistic revealed that patients with higher myristic acid concentrations had a non-survival odds ratio of 2.1 (CI 95% 1.1-3.9).ConclusionsSpecific fatty acids, catecholamine synthesis and tryptophan degradation pathways could be implicated in a negative outcome after trauma. The metabolomic study of severe trauma patients could be helpful for biomarker proposal.	[Servia, Luis; Badia, Mariona; Montserrat, Neus; Trujillano, Javier] Univ Hosp Arnau de Vilanova, Crit Care Unit, Lleida 25198, Spain; [Jove, Mariona; Sol, Joaquim; Pamplona, Reinald; Portero-Otin, Manuel] Univ Lleida, Lleida Biomed Res Inst IRBLleida, Dept Expt Med, Lleida 25198, Spain		Trujillano, J (corresponding author), Univ Hosp Arnau de Vilanova, Crit Care Unit, Lleida 25198, Spain.; Portero-Otin, M (corresponding author), Univ Lleida, Lleida Biomed Res Inst IRBLleida, Dept Expt Med, Lleida 25198, Spain.	lserviag@gmail.com; manuel.portero@mex.udl.cat; jtruji@cmb.udl.cat	Trujillano, Javier/A-4325-2010; Badia, Mariona/AAB-5513-2020; Portero-Otin, Manuel/B-7122-2009; Pamplona, Reinald/A-7359-2010; Goixart, Lluis Servia/C-6561-2011; Jove, Mariona/M-9104-2016	Trujillano, Javier/0000-0001-8071-7711; Badia, Mariona/0000-0002-0923-1417; Portero-Otin, Manuel/0000-0002-1823-0299; Pamplona, Reinald/0000-0003-4337-6107; Goixart, Lluis Servia/0000-0001-9513-1465; Sol Cullere, Joaquim/0000-0003-1424-8958; Jove, Mariona/0000-0001-5577-6162	IRBLleida biobank and RETICS BIOBANCOS [RD09/0076/00059]; Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III [PI 17-00134]; Generalitat of Catalonia [2017SGR969]; FEDER FundsEuropean Commission	This work has been partially supported by the IRBLleida biobank and RETICS BIOBANCOS RD09/0076/00059, the Spanish Ministry of Economy and Competitiveness, Institute of Health Carlos III (PI 17-00134) and the Generalitat of Catalonia (2017SGR969). FEDER Funds are also acknowledged: "A way to make Europe". MJ is a professor under the Serra Hunter program (Generalitat de Catalunya).	Ammar NM, 2017, J PHARMACEUT BIOMED, V142, P91, DOI 10.1016/j.jpba.2017.05.001; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900; Cohen MJ, 2010, J TRAUMA, V69, P31, DOI 10.1097/TA.0b013e3181e043fe; D'Alessandro A, 2017, J TRAUMA ACUTE CARE, V83, P491, DOI 10.1097/TA.0000000000001565; Dickens AM, 2018, J NEUROTRAUM, V35, P2673, DOI 10.1089/neu.2017.5272; Ebbesson SOE, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.28055; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Gale SC, 2007, AM SURGEON, V73, P454; Garcia-Simon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140993; GELFAND RA, 1984, J CLIN INVEST, V74, P2238, DOI 10.1172/JCI111650; Gordillo-Escobar E, 2016, MED INTENSIVA, V40, P105, DOI 10.1016/j.medin.2015.11.008; Hagos FT, 2018, CRIT CARE MED, V46, P1471, DOI 10.1097/CCM.0000000000003203; Hardaway RM, 2001, AM J MED SCI, V322, P222, DOI 10.1097/00000441-200110000-00013; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Ikeoka DT, 2011, OBESITY, V19, P715, DOI 10.1038/oby.2010.227; Jayaraman SP, 2018, SHOCK, V50, P5, DOI 10.1097/SHK.0000000000001093; Johansson PI, 2012, J TRAUMA ACUTE CARE, V72, P428, DOI 10.1097/TA.0b013e31821e0f93; Jove M, 2015, NEUROLOGY, V84, P36, DOI 10.1212/WNL.0000000000001093; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Jove M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03346; Kamolz LP, 2003, BURNS, V29, P810, DOI 10.1016/S0305-4179(03)00196-7; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Legrand M, 2013, INTENS CARE MED, V39, P1824, DOI 10.1007/s00134-013-3008-7; Lusczek ER, 2018, INJURY, V49, P2178, DOI 10.1016/j.injury.2018.09.033; Lusczek ER, 2017, J TRAUMA ACUTE CARE, V82, P309, DOI 10.1097/TA.0000000000001277; Mao HL, 2009, J PROTEOME RES, V8, P5423, DOI 10.1021/pr900576y; Miedema MD, 2014, AM J CARDIOL, V114, P843, DOI 10.1016/j.amjcard.2014.06.012; MORITA I, 1990, J CHROMATOGR-BIOMED, V526, P367, DOI 10.1016/S0378-4347(00)82520-7; MOYER ED, 1981, J TRAUMA, V21, P263, DOI 10.1097/00005373-198104000-00002; Naganathar S, 2015, J TRAUMA ACUTE CARE, V79, P71, DOI 10.1097/TA.0000000000000694; NIXON JR, 1978, J TRAUMA, V18, P23, DOI 10.1097/00005373-197801000-00004; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Ottens AK, 2014, J NEUROTRAUM, V31, P782, DOI 10.1089/neu.2013.3116; Pandya U, 2014, AM SURGEON, V80, P1112; Parent BA, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.0853; Cala MP, 2018, J CACHEXIA SARCOPENI, V9, P348, DOI 10.1002/jcsm.12270; Penn AH, 2017, SHOCK, V48, P449, DOI 10.1097/SHK.0000000000000865; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Posti JP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00398; Qi P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38707; Qin X, 2012, AM J PHYSIOL-GASTR L, V303, pG969, DOI 10.1152/ajpgi.00290.2012; Rady MY, 2005, ARCH SURG-CHICAGO, V140, P661, DOI 10.1001/archsurg.140.7.661; Ristagno G, 2013, RESUSCITATION, V84, P1604, DOI 10.1016/j.resuscitation.2013.06.002; Sana Theodore R, 2008, J Biomol Tech, V19, P258; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Servia L, 2019, MED INTENSIVA, V43, P26, DOI 10.1016/j.medin.2017.11.008; SHANNON HE, 1981, J PHARMACOL EXP THER, V217, P379; Speziali G, 2018, J PROTEOMICS, V181, P118, DOI 10.1016/j.jprot.2018.04.008; STONER HB, 1979, CLIN SCI, V56, P563, DOI 10.1042/cs0560563; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Udenwobele DI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00751; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Wang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13997; Witowski N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124467; Wolahan SM, 2019, J NEUROTRAUM, V36, P212, DOI 10.1089/neu.2018.5674; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380	59	5	5	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAY 22	2019	27								56	10.1186/s13049-019-0631-5			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HZ4WR	WOS:000468852600001	31118076	Green Published, gold			2022-02-06	
J	Gallant, C; Good, D				Gallant, Caitlyn; Good, Dawn			Examining the "reading the mind in the eyes test" as an assessment of subtle differences in affective theory of mind after concussion	CLINICAL NEUROPSYCHOLOGIST			English	Article						Theory of mind; Reading the Mind in the Eyes; concussion; head injury	TRAUMATIC BRAIN-INJURY; VENTROMEDIAL PREFRONTAL CORTEX; ASPERGER-SYNDROME; HEAD-INJURY; EMOTION RECOGNITION; SOCIAL COGNITION; DECISION-MAKING; TRANSIENT LOSS; EMPATHY; ADULTS	Objective: This research examined affective theory of mind (ToM) differences between university students with and without a history of concussion using the revised Reading the Mind in the Eyes Test (RMET). Although, previous studies have shown that affective ToM is subserved by the ventromedial prefrontal cortex - a region that is vulnerable in head injury - few have examined whether subtle deficits in affective ToM are evident after concussion. Given the RMET's sensitivity to affective deficits following moderate-to-severe traumatic brain injury, the current study examined its validity following concussion and its correlation with related ToM measures and constructs, such as empathy. Method: Seventy-seven students with and without a history of self-reported concussion completed the RMET, the Interpersonal Reactivity Index, a novel Perspective-Taking Task, and the Questionnaire of Cognitive and Affective Empathy. Indices of spelling/reading capabilities were obtained and baseline electrodermal activation was recorded as an index of arousal. Results: RMET performance did not differ between individuals with and without a prior concussion when controlling for sex and spelling/reading skills and was not correlated with other measures of affective ToM, empathy, and arousal. However, spelling/reading skills were found to be a predictor of RMET performance among both concussion and no-concussion groups. Conclusions: Together, these findings imply that the RMET is not sensitive to ToM impairments after concussion and may be related to language skills among neurotypical students.	[Gallant, Caitlyn; Good, Dawn] Brock Univ, Dept Psychol, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada; [Good, Dawn] Brock Univ, Ctr Neurosci, St Catharines, ON, Canada		Gallant, C (corresponding author), Brock Univ, Dept Psychol, 1812 Sir Isaac Brock Way, St Catharines, ON L2S 3A1, Canada.	cg14xx@brocku.ca		Gallant, Caitlyn/0000-0003-4305-1425	Vanier Canada Graduate Scholarships (Vanier CGS) program; Canadian Institutes of Health Research (CIHR) Frederik Banting and Charles Best Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR); CIHRCanadian Institutes of Health Research (CIHR) Funding Source: Medline	Caitlyn Gallant currently holds a scholarship from the Vanier Canada Graduate Scholarships (Vanier CGS) program and held a scholarship from the Canadian Institutes of Health Research (CIHR) Frederik Banting and Charles Best Canada Graduate Scholarship during the preparation of this research.	Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Ahmed FS, 2011, J AUTISM DEV DISORD, V41, P667, DOI 10.1007/s10803-010-1087-7; Ali F, 2010, PERS INDIV DIFFER, V49, P169, DOI 10.1016/j.paid.2010.03.027; Baker CA, 2014, INTELLIGENCE, V44, P78, DOI 10.1016/j.intell.2014.03.001; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2006, BRAIN COGNITION, V61, P122, DOI 10.1016/j.bandc.2005.12.011; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2009, J HEAD TRAUMA REHAB, V24, P76, DOI 10.1097/HTR.0b013e31819c2190; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bjornsdottir RT, 2016, INT J INTERCULT REL, V52, P39, DOI 10.1016/j.ijintrel.2016.03.003; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Carrillo E, 2001, INT J PSYCHOPHYSIOL, V42, P253, DOI 10.1016/S0167-8760(01)00147-7; Carroll JM, 2006, J AUTISM DEV DISORD, V36, P949, DOI 10.1007/s10803-006-0127-9; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Cook CM, 2010, PERS INDIV DIFFER, V49, P712, DOI 10.1016/j.paid.2010.06.010; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A., 1994, DESCARTES ERROR EMOT; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dodell-Feder D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081279; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Fisher AC, 2015, CLIN NEUROPHYSIOL, V126, P314, DOI 10.1016/j.clinph.2014.05.033; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Gallant C, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1038; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Good D, 2016, EVERYDAY LIVING DEMO; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Hynes CA, 2011, SOC NEUROSCI-UK, V6, P599, DOI 10.1080/17470919.2011.584447; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kalbe E, 2007, J NEUROPSYCHOL, V1, P27, DOI 10.1348/174866407X180792; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kolb B., 2009, FUNDAMENTALS HUMAN N; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Limestone Technologies, 2008, POL PROF SUIT; LYKKEN DT, 1971, PSYCHOPHYSIOLOGY, V8, P656, DOI 10.1111/j.1469-8986.1971.tb00501.x; Maurage P, 2011, ALCOHOL CLIN EXP RES, V35, P1662, DOI 10.1111/j.1530-0277.2011.01512.x; Michaels TM, 2014, PSYCHIAT RES, V220, P803, DOI 10.1016/j.psychres.2014.08.054; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; Moor BG, 2012, SOC COGN AFFECT NEUR, V7, P44, DOI 10.1093/scan/nsr020; Morales D., 2007, BRAIN CONTUSION; Oakley BFM, 2016, J ABNORM PSYCHOL, V125, P818, DOI 10.1037/abn0000182; Owings JT, 1998, ARCH SURG-CHICAGO, V133, P941, DOI 10.1001/archsurg.133.9.941; Pears KC, 2003, SOC DEV, V12, P1, DOI 10.1111/1467-9507.00219; Pubs S., 2013, N AM J PSYCHOL, V15, P121, DOI [DOI 10.3389/FNHUM.2015.00292, DOI 10.3389/fpsyg.2015.01503]; Reniers RLEP, 2011, J PERS ASSESS, V93, P84, DOI 10.1080/00223891.2010.528484; Richell RA, 2003, NEUROPSYCHOLOGIA, V41, P523, DOI 10.1016/S0028-3932(02)00175-6; Rogers G, 2011, BRIT J GEN PRACT, V61, P40, DOI 10.3399/bjgp11X548965; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; San Juan V, 2012, BRIT J DEV PSYCHOL, V30, P105, DOI 10.1111/j.2044-835X.2011.02051.x; Schiffer B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060278; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shamay-Tsoory SG, 2007, SCHIZOPHR RES, V90, P274, DOI 10.1016/j.schres.2006.09.020; Shamay-Tsoory SG, 2010, CORTEX, V46, P668, DOI 10.1016/j.cortex.2009.04.008; SPSS I, 2012, STAT PACK SOC SCI; Stanford AD, 2011, SCHIZOPHR RES, V131, P11, DOI 10.1016/j.schres.2011.06.005; Stone V, 1998, PATIENTS AMYGDALECTO; Stone V.E., 2011, OXFORD HDB SOCIAL NE, P455; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; TEMPLER DI, 1992, PERCEPT MOTOR SKILL, V75, P195, DOI 10.2466/PMS.75.4.195-202; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Voracek M, 2006, PERS INDIV DIFFER, V41, P1481, DOI 10.1016/j.paid.2006.06.009; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	88	5	5	4	19	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2020	34	2					296	317		10.1080/13854046.2019.1612946		MAY 2019	22	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	KG3IM	WOS:000469059300001	31107147				2022-02-06	
J	Smith, AC; Holden, RC; Rasmussen, SM; Hoane, MR; Hylin, MJ				Smith, Aidan C.; Holden, Ryan C.; Rasmussen, Sherry M.; Hoane, Michael R.; Hylin, Michael J.			Effects of nicotinamide on spatial memory and inflammation after juvenile traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Juvenile; Nicotinamide; Traumatic brain injury; Functional recovery; Inflammation	IMPROVES FUNCTIONAL RECOVERY; FOCAL CEREBRAL-ISCHEMIA; CONTROLLED CORTICAL IMPACT; PANCREATIC-ISLETS; HEAD-INJURY; EXPRESSION; CHILDREN; PROTEIN; NEUROPROTECTION; ACTIVATION	Age is a consistent predictor of outcome following traumatic brain injury (TBI). Although children and adolescents have the highest rate of hospitalizations and long-term disabilities, few preclinical studies have attempted to model and treat TBI in this population. Studies using nicotinamide (NAM), a soluble B-group vitamin, in older animals (3-6 months) have shown improved functional recovery in experimental models of TBI. The purpose of this study was two-fold: to examine the preclinical efficacy of NAM at different doses on behavioral outcomes in juvenile rats and examine the microglial response over time. Groups of juvenile rats (PND 28-60) were assigned to sham, NAM (125 mg/kg, 500 mg/kg, or 1000 mg/kg) or saline (1 mL/kg) and received unilateral cortical contusion injuries (CCI) and received injections at 15 min, 24 h, and 72 h after injury. Animals treated with NAM demonstrated no significant behavioral improvements over saline treatments. NAM treatments did however show slowed cortical loss and reduced microglia compared to saline treated animals. In summary, the preclinical efficacy of NAM as a treatment following CCI in juvenile animals differs from that previously documented in older rat models. While NAM treatments did reduce microglial activity and slowed progression of cortical loss, it did not reduce the total cortical volume lost nor did it improve behavioral outcomes. The findings of this study emphasize the need to examine potential treatments for TBI utilizing juvenile populations and may explain why so many treatments have failed in clinical trials.	[Smith, Aidan C.; Holden, Ryan C.; Rasmussen, Sherry M.; Hylin, Michael J.] Southern Illinois Univ, Neurotrauma & Rehabil Lab, Carbondale, IL 62901 USA; [Hoane, Michael R.] Southern Illinois Univ, Restorat Neurosci Lab, Carbondale, IL 62901 USA		Hylin, MJ (corresponding author), Southern Illinois Univ, Neurotrauma & Rehabil Lab, Dept Psychol, Carbondale, IL 62901 USA.	mhylin@siu.edu	Hylin, Michael/U-2878-2019	Hoane, Michael/0000-0001-7779-2657; Hylin, Michael/0000-0002-8600-3047			Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Center for Disease Control and Prevention (CDC), TRAUMATIC BRAIN INJU; Chen CF, 2001, J BIOMED SCI, V8, P446, DOI 10.1007/BF02256606; Chong ZZ, 2004, J CEREBR BLOOD F MET, V24, P728, DOI 10.1097/01.WCB.0000122746.72175.0E; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Coronado V. G., 2002, MMWR-MORBID MORTAL W, P60; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Feng YZ, 2006, BRAIN RES BULL, V69, P117, DOI 10.1016/j.brainresbull.2005.11.011; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Giza C. C., 2006, DEV NEUROSCI, V28; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GOTSCHALL CS, 1995, J NEUROTRAUM, V12, P611, DOI 10.1089/neu.1995.12.611; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2005, J NEUROTRAUM, V22, P1112, DOI 10.1089/neu.2005.22.1112; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Knudsen EI, 2004, J COGNITIVE NEUROSCI, V16, P1412, DOI 10.1162/0898929042304796; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Moberg L, 2003, TRANSPLANTATION, V76, P1285, DOI 10.1097/01.TP.0000098905.86445.0F; Peterson TC, 2015, J NEUROTRAUM, V32, P765, DOI 10.1089/neu.2014.3530; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Reddy S, 2001, HISTOCHEM J, V33, P317, DOI 10.1023/A:1012422821187; Sakakibara Y, 2000, NEUROSCI LETT, V281, P111, DOI 10.1016/S0304-3940(00)00854-5; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WATANABE Y, 1991, J IMMUNOL, V146, P899; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4	48	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 17	2019	364						123	132		10.1016/j.bbr.2019.02.024			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HR4QK	WOS:000463130800013	30771366				2022-02-06	
J	Pastor, P; Curvello, V; Hekierski, H; Armstead, WM				Pastor, Philip; Curvello, Victor; Hekierski, Hugh; Armstead, William M.			Inhaled nitric oxide protects cerebral autoregulation through prevention of impairment of ATP and calcium sensitive K channel mediated cerebrovasodilation after traumatic brain injury	BRAIN RESEARCH			English	Article						Nitric oxide; Traumatic brain injury; Autoregulation; K channels; Endothelin-1	HIPPOCAMPAL NECROSIS; ERK MAPK; HYPOTENSION; DAMAGE; SEX; AGE	Hypotension and low cerebral perfusion pressure are associated with low cerebral blood flow, cerebral ischemia, and poor outcomes after traumatic brain injury (TBI). Cerebral autoregulation is impaired after TBI, contributing to poor outcome. In prior studies, ERK mitogen activated protein kinase (MAPK) and ET-1 had been observed to be upregulated and contribute to impairment of cerebral autoregulation and histopathology after fluid percussion brain injury (FPI). Activation of ATP and Calcium sensitive (Katp and Kca) channels produce cerebrovasodilation and contribute to autoregulation, both impaired after TBI. Upregulation of ERK MAPK and endothelin-1 (ET-1) produces K channel function impairment after CNS injury. Inhaled nitric oxide (iNO) has recently been observed to prevent impairment of cerebral autoregulation and hippocampal CA1 and CA3 neuronal cell necrosis after FPI via block of upregulation of ERK MAPK and ET-1. We presently investigated whether iNO prevented impairment of Katp and Kca-mediated cerebrovasodilation after FPI in pigs equipped with a closed cranial window. Results show that pial artery dilation in response to the Katp agonist cromakalim, the Kca agonist NS1619, PGE2 and the NO releaser sodium nitroprusside (SNP) were blocked by FPI, but such impairment was prevented by iNO administered at 2 h post injury. Protection lasted for at least 1 h after iNO administration was stopped. Using vasodilaton as an index of function, these data indicate that iNO prevents impairment of cerebral autoregulation and limits histopathology after TBI through protection of K channel function via blockade of ERK MAPK and ET-1.	[Pastor, Philip; Curvello, Victor; Hekierski, Hugh; Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	Phillip.Pastor@uphs.upenn.edu; Hugh.Hekierski@uphs.upenn.edu; armsteaw@uphs.upenn.edu			Mallinckrodt Pharmaceuticals	This investigator initiated research was funded by Mallinckrodt Pharmaceuticals.	Armstead W.M., 2014, VASCULAR MECH CNS TR, P269; Armstead WM, 2017, J NEUROSCI RES, V95, P1917, DOI 10.1002/jnr.24063; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2010, BRAIN RES, V1330, P142, DOI 10.1016/j.brainres.2010.03.024; Armstead WM, 2004, CURR PHARM DESIGN, V10, P2185, DOI 10.2174/1381612043384178; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Curvello V., 2018, NEUROCRIT CARE; Curvello V, 2017, BRAIN RES, V1670, P118, DOI 10.1016/j.brainres.2017.06.010; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Hekierski H, 2019, J NEUROTRAUM, V36, P630, DOI 10.1089/neu.2018.5824; Salvucci A, 2000, BRAIN RES, V887, P406, DOI 10.1016/S0006-8993(00)03079-1; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Zhu CL, 2013, TRANSL STROKE RES, V4, P201, DOI 10.1007/s12975-012-0217-2	19	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2019	1711						1	6		10.1016/j.brainres.2019.01.008			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS7ZP	WOS:000464088100001	30629942				2022-02-06	
J	Vassilieva, A; Olsen, MH; Peinkhofer, C; Knudsen, GM; Kondziella, D				Vassilieva, Alexandra; Olsen, Markus Harboe; Peinkhofer, Costanza; Knudsen, Gitte Moos; Kondziella, Daniel			Automated pupillometry to detect command following in neurological patients: a proof-of-concept study	PEERJ			English	Article						Disorders of consciousness; Pupils; Consciousness; Traumatic brain injury; Stroke; Vegetative state; Neurorehabilitation; Coma; Locked-in syndrome; Cognition	LOCKED-IN SYNDROME; BRAIN-INJURY; CONSCIOUSNESS; WITHDRAWAL; DISORDERS; AWARENESS; STATE	Background. Levels of consciousness in patients with acute and chronic brain injury are notoriously underestimated. Paradigms based on electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) may detect covert consciousness in clinically unresponsive patients but are subject to logistical challenges and the need for advanced statistical analysis. Methods. To assess the feasibility of automated pupillometry for the detection of command following, we enrolled 20 healthy volunteers and 48 patients with a wide range of neurological disorders, including seven patients in the intensive care unit (ICU), who were asked to engage in mental arithmetic. Results. Fourteen of 20 (70%) healthy volunteers and 17 of 43 (39.5%) neurological patients, including 1 in the ICU, fulfilled prespecified criteria for command following by showing pupillary dilations during >= 4 of five arithmetic tasks. None of the five sedated and unconscious ICU patients passed this threshold. Conclusions. Automated pupillometry combined with mental arithmetic appears to be a promising paradigm for the detection of covert consciousness in people with brain injury. We plan to build on this study by focusing on non-communicating ICU patients in whom the level of consciousness is unknown. If some of these patients show reproducible pupillary dilation during mental arithmetic, this would suggest that the present paradigm can reveal covert consciousness in unresponsive patients in whom standard investigations have failed to detect signs of consciousness.	[Vassilieva, Alexandra; Peinkhofer, Costanza; Knudsen, Gitte Moos; Kondziella, Daniel] Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark; [Olsen, Markus Harboe] Univ Copenhagen, Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Peinkhofer, Costanza] Univ Trieste, Med Fac, Trieste, Italy; [Knudsen, Gitte Moos; Kondziella, Daniel] Univ Copenhagen, Fac Hlth Sci & Med, Copenhagen, Denmark; [Knudsen, Gitte Moos] Copenhagen Univ Hosp, Rigshosp, Neurobiol Res Unit, Copenhagen, Denmark; [Knudsen, Gitte Moos] Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark; [Kondziella, Daniel] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway		Kondziella, D (corresponding author), Univ Copenhagen, Rigshosp, Dept Neurol, Copenhagen, Denmark.; Kondziella, D (corresponding author), Univ Copenhagen, Fac Hlth Sci & Med, Copenhagen, Denmark.; Kondziella, D (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway.	daniel_kondziella@yahoo.com	Olsen, Markus/AAU-9570-2020; Knudsen, Gitte Moos/C-1368-2013	Olsen, Markus/0000-0003-0981-0723; Kondziella, Daniel/0000-0001-5562-9808; Vassilieva, Alexandra/0000-0002-9476-5850; Knudsen, Gitte Moos/0000-0003-1508-6866			Behrends M, 2019, J CLIN MONIT COMPUT, V33, P317, DOI 10.1007/s10877-018-0147-y; Bodien YG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00688; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Demertzi A, 2011, J NEUROL, V258, P1058, DOI 10.1007/s00415-010-5882-z; Di HB, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-147; Ebitz RB, 2017, J NEUROSCI, V37, P5008, DOI 10.1523/JNEUROSCI.2433-16.2017; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Foroughi CK, 2017, PSYCHOPHYSIOLOGY, V54, P1436, DOI 10.1111/psyp.12896; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Harrison AH, 2017, CONSCIOUS COGN, V48, P104, DOI 10.1016/j.concog.2016.10.006; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; King JR, 2013, NEUROIMAGE, V83, P726, DOI 10.1016/j.neuroimage.2013.07.013; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Larson MD, 2015, ANESTH ANALG, V120, P1242, DOI 10.1213/ANE.0000000000000314; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Loewenfeldt I., 1999, PUPIL ANATOMY PHYSL; Marquart G, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.16; McGarrigle R, 2017, PSYCHOPHYSIOLOGY, V54, P193, DOI 10.1111/psyp.12772; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Neice AE, 2017, ANESTH ANALG, V124, P915, DOI 10.1213/ANE.0000000000001728; Ong CJ, 2016, NEUROCRIT CARE, V25, P258, DOI 10.1007/s12028-016-0275-5; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Quirins M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33202-7; R Core Team, 2017, R LANG ENV STAT COMP; Rohaut B, 2017, BRAIN INJURY, V31, P1398, DOI 10.1080/02699052.2017.1327673; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schnakers C, 2009, NEUROCASE, V15, P271, DOI 10.1080/13554790902724904; Schneider M, 2016, NEUROIMAGE, V139, P189, DOI 10.1016/j.neuroimage.2016.06.011; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Steinhauer SR, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/179542; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Stoll J, 2013, CURR BIOL, V23, pR647, DOI 10.1016/j.cub.2013.06.011; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vanhaudenhuyse A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00671; Weijer C, 2016, BRAIN, V139, P292, DOI 10.1093/brain/awv272	38	5	5	0	3	PEERJ INC	LONDON	341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND	2167-8359			PEERJ	PeerJ	MAY 13	2019	7								e6929	10.7717/peerj.6929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HX8UE	WOS:000467680800008	31139508	Green Submitted, Green Published, gold			2022-02-06	
J	Bernstein, JPK; Calamia, M; Pratt, J; Mullenix, S				Bernstein, John P. K.; Calamia, Matthew; Pratt, Joshua; Mullenix, Shelly			Assessing the effects of concussion using the C3Logix Test Battery: An exploratory study	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Cognition; mild traumatic brain injury; vestibular function test	TRAUMATIC BRAIN-INJURY; DYNAMIC VISUAL-ACUITY; 4TH INTERNATIONAL-CONFERENCE; SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; POSTURAL STABILITY; NEUROPSYCHOLOGICAL IMPACT; CONSENSUS STATEMENT; BALANCE CONTROL; HIGH-SCHOOL	The C3Logix is a computerized concussion assessment tool that measures a wider array of symptoms (i.e., balance and oculomotor functioning) than other computerized batteries. Although the C3Logix has been used increasingly by athletic organizations at all levels of play, its utility within the concussion population has not been extensively examined. The current study aimed to determine whether the C3Logix is sensitive to the effects of concussion. A total of 54 student-athletes enrolled at a large southern university completed the C3Logix at baseline and within days following a suspected concussion (mean = 2.93, SD = 3.14). Dependent-samples t-tests revealed that relative to their baselines, following concussion, athletes both reported significantly greater postconcussive symptoms and performed more poorly on measures of reaction time and computer-measured balance. Decrements in processing speed, visual acuity, and clinician-observed errors on tests of balance also trended toward significance. Results suggest that inclusion of measures of balance and oculomotor functioning in the assessment of concussion may provide additional clinical utility above and beyond domains typically measured by computerized concussion assessments.	[Bernstein, John P. K.; Calamia, Matthew] Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA; [Pratt, Joshua; Mullenix, Shelly] Louisiana State Univ, Dept Athlet, Baton Rouge, LA 70803 USA		Bernstein, JPK (corresponding author), Louisiana State Univ, Dept Psychol, 217 Audubon Hall, Baton Rouge, LA 70803 USA.	jberns3@lsu.edu					Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Borges A, 2017, INT J SPORTS PHYS TH, V12, P381; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burke D, 2017, ASSESSMENT, V24, P885, DOI 10.1177/1073191116633752; Carrick FR, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00414; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Cleveland Clinic, 2015, CLEV CLIN 2015 UNPUB; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Comet Technologies, 2013, C3LOGIX COMPR CONC M; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Fetterly D., 2016, FUNCTIONAL NEUROLOGY, V6, P333; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Herdman SJ, 1998, AM J OTOL, V19, P790; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Leonardis K. E., 2016, FUNCTIONAL NEUROLOGY, V6, P337; Lin HW, 2012, LARYNGOSCOPE, V122, P1858, DOI 10.1002/lary.23376; Longyear M., 2015, FUNCTIONAL NEUROLOGY, V5, P395; Manago MM, 2016, J VESTIBUL RES-EQUIL, V26, P469, DOI 10.3233/VES-160593; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Oliver J, 2015, J EXP NEUROSCI, V9, P67, DOI 10.4137/JEN.S27921; Ozinga SJ, 2015, MOVEMENT DISORD, V30, P1214, DOI 10.1002/mds.26214; Ozinga SJ, 2014, EXP BRAIN RES, V232, P3861, DOI 10.1007/s00221-014-4069-8; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Quai TM, 2005, CLIN REHABIL, V19, P668, DOI 10.1191/0269215505cr857oa; Rao SM, 2017, MULT SCLER J, V23, P1929, DOI 10.1177/1352458516688955; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rine RM, 2003, INT J PEDIATR OTORHI, V67, P1195, DOI 10.1016/j.ijporl.2003.07.004; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Simon M, 2017, DEV NEUROPSYCHOL, V42, P446, DOI 10.1080/87565641.2017.1383994; Su Z., 2017, BRIT J SPORT MED, V51, pA36, DOI [10.1136/bjsports-2016-097270.93, DOI 10.1136/BJSPORTS-2016-097270.93]; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732; Vital D, 2010, ARCH OTOLARYNGOL, V136, P686, DOI 10.1001/archoto.2010.99; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Womble MN, 2016, ARCH CLIN NEUROPSYCH, V31, P305, DOI 10.1093/arclin/acw011	62	5	5	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 4	2019	26	3					275	282		10.1080/23279095.2017.1416471			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HX3CH	WOS:000467268500008	29308917				2022-02-06	
J	Dikmen, S; Machamer, J; Manley, GT; Yuh, EL; Nelson, LD; Temkin, NR; Adeoye, O; Badjatia, N; Boase, K; Bodien, Y; Bullock, MR; Chesnut, R; Corrigan, JD; Crawford, K; Diaz-Arrastia, R; Duhaime, AC; Ellenbogen, R; Feeser, VR; Ferguson, A; Foreman, B; Gardner, R; Gaudette, E; Giacino, J; Goldman, D; Gonzalez, L; Gopinath, S; Gullapalli, R; Hemphill, JC; Hotz, G; Jain, S; Korley, F; Kramer, J; Kreitzer, N; Levin, H; Lindsell, C; Madden, C; Martin, A; McAllister, T; McCrea, M; Merchant, R; Mukherjee, P; Noel, F; Okonkwo, D; Palacios, E; Perl, D; Puccio, A; Rabinowitz, M; Robertson, C; Sander, A; Satris, G; Schnyer, D; Seabury, S; Sherer, M; Stein, M; Taylor, S; Toga, A; Valadka, A; Vassar, M; Vespa, P; Wang, K; Yue, J; Zafonte, R				Dikmen, Sureyya; Machamer, Joan; Manley, Geoffrey T.; Yuh, Esther L.; Nelson, Lindsay D.; Temkin, Nancy R.; Adeoye, Opeolu; Badjatia, Neeraj; Boase, Kim; Bodien, Yelena; Bullock, M. Ross; Chesnut, Randall; Corrigan, John D.; Crawford, Karen; Diaz-Arrastia, Ramon; Duhaime, Ann-Christine; Ellenbogen, Richard; Feeser, V. Ramana; Ferguson, Adam; Foreman, Brandon; Gardner, Raquel; Gaudette, Etienne; Giacino, Joseph; Goldman, Dana; Gonzalez, Luis; Gopinath, Shankar; Gullapalli, Rao; Hemphill, J. Claude; Hotz, Gillian; Jain, Sonia; Korley, Frederick; Kramer, Joel; Kreitzer, Natalie; Levin, Harvey; Lindsell, Chris; Madden, Christopher; Martin, Alastair; McAllister, Thomas; McCrea, Michael; Merchant, Randall; Mukherjee, Pratik; Noel, Florence; Okonkwo, David; Palacios, Eva; Perl, Daniel; Puccio, Ava; Rabinowitz, Miri; Robertson, Claudia; Sander, Angelle; Satris, Gabriella; Schnyer, David; Seabury, Seth; Sherer, Mark; Stein, Murray; Taylor, Sabrina; Toga, Arthur; Valadka, Alex; Vassar, Mary; Vespa, Paul; Wang, Kevin; Yue, John; Zafonte, Ross		TRACK-TBI Investigators	Functional Status Examination versus Glasgow Outcome Scale Extended as Outcome Measures in Traumatic Brain Injuries: How Do They Compare?	JOURNAL OF NEUROTRAUMA			English	Article						outcome assessment; psychosocial outcome; quality of life; traumatic brain injury	CLINICAL-TRIALS; REHABILITATION; HEALTH	Outcome measures are essential components of natural history studies of recovery and treatment effects after traumatic brain injury (TBI). The Glasgow Outcome Scale (GOS) and its revised version, the Glasgow Outcome Scale Extended (GOSE), are well accepted and widely used for both observational and intervention studies, but there are concerns about their psychometric properties and aptness as outcome measures for TBI. The present study compares the Functional Status Examination (FSE) with the GOSE to assess outcome after TBI in a sample of 533 participants with TBI from the Magnesium Sulfate study and the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study by evaluating the sensitivity of each measure to severity of brain injury and recovery of function over time. The results indicate that both measures are strongly correlated with TBI severity. At three months, the correlation strengths between injury severity and each outcome measure do not differ (p = 0.88 for Glasgow Coma Scale [GCS], p = 0.13 for computed tomography [CT] abnormalities) but at six months, the FSE is more strongly related to TBI severity indices than is the GOSE (p = 0.045 for GCS, p = 0.014 for CT abnormalities). In addition, the FSE generally shows significantly more improvement over time than the GOSE (p < 0.001). Detailed, structured administration rules and a wider score range of the FSE likely yields more sensitive and precise assessment of functional level than the GOSE. The FSE may be a valuable alternative to the GOSE for assessing functional outcome after TBI.	[Dikmen, Sureyya; Machamer, Joan; Temkin, Nancy R.] Univ Washington, Dept Rehabil Med, Box 359612,325 Ninth Ave, Seattle, WA 98104 USA; [Dikmen, Sureyya; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [Manley, Geoffrey T.; Yuh, Esther L.] Univ Calif San Francisco, Dept Neurosurg, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Manley, Geoffrey T.; Yuh, Esther L.] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Yuh, Esther L.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Adeoye, Opeolu; Foreman, Brandon; Kreitzer, Natalie] Univ Cincinnati, Cincinnati, OH 45221 USA; [Badjatia, Neeraj; Gullapalli, Rao] Univ Maryland, College Pk, MD 20742 USA; [Boase, Kim; Chesnut, Randall; Ellenbogen, Richard] Univ Washington, Seattle, WA 98104 USA; [Bodien, Yelena] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bullock, M. Ross; Hotz, Gillian] Univ Miami, Coral Gables, FL 33124 USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [Crawford, Karen; Gaudette, Etienne; Goldman, Dana; Seabury, Seth; Toga, Arthur] Univ Southern Calif, Los Angeles, CA 90089 USA; [Diaz-Arrastia, Ramon] Univ Penn, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine] Mass Gen Hosp, Boston, MA USA; [Feeser, V. Ramana; Merchant, Randall; Valadka, Alex] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Ferguson, Adam; Gardner, Raquel; Hemphill, J. Claude; Kramer, Joel; Martin, Alastair; Mukherjee, Pratik; Palacios, Eva; Satris, Gabriella; Taylor, Sabrina; Vassar, Mary; Yue, John] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Giacino, Joseph] Spaulding Rehabilitat Hosp, Boston, MA USA; [Gonzalez, Luis; Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Gopinath, Shankar; Levin, Harvey; Noel, Florence; Robertson, Claudia; Sander, Angelle] Baylor Coll Med, Houston, TX 77030 USA; [Jain, Sonia; Stein, Murray] Univ Calif San Diego, La Jolla, CA 92093 USA; [Korley, Frederick] Univ Michigan, Ann Arbor, MI 48109 USA; [Lindsell, Chris] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Madden, Christopher] UT Southwestern, Dallas, TX USA; [McAllister, Thomas] Indiana Univ, Bloomington, IN 47405 USA; [McCrea, Michael] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Okonkwo, David; Puccio, Ava; Rabinowitz, Miri] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Perl, Daniel] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA; [Schnyer, David] UT Austin, Austin, TX USA; [Vespa, Paul] Univ Calif Los Angeles, Los Angeles, CA USA; [Wang, Kevin] Univ Florida, Gainesville, FL 32611 USA; [Zafonte, Ross] Harvard Med Sch, Boston, MA 02115 USA		Dikmen, S (corresponding author), Univ Washington, Dept Rehabil Med, Box 359612,325 Ninth Ave, Seattle, WA 98104 USA.	dikmen@uw.edu	Goldman, Dana P/E-7667-2013; Badjatia, Neeraj/AAS-4855-2021; Yue, John K/P-1348-2015; Giacino, Joseph/AAF-1952-2021; Hemphill, Claude/AAY-5630-2021; Schnyer, David/ABD-6372-2021	Goldman, Dana P/0000-0001-8498-6396; Yue, John K/0000-0001-9694-7722; Giacino, Joseph/0000-0002-7916-9698; Hemphill, Claude/0000-0003-4019-7525; Schnyer, David/0000-0002-7472-2853; Bodien, Yelena/0000-0003-4858-2903; Ferguson, Adam/0000-0001-7102-1608	 [W81XWH-14-2-0176];  [R01 NS19643];  [U01NS086090]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, R01NS110856] Funding Source: NIH RePORTER	This study was supported by the following grants: W81XWH-14-2-0176, R01 NS19643, U01NS086090. Amy J. Markowitz, JD, provided editorial support.	Choi SC, 2002, J NEUROTRAUM, V19, P17, DOI 10.1089/089771502753460204; CHOI SC, 1977, BIOMETRIKA, V64, P645, DOI 10.1093/biomet/64.3.645; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Glass GV., 1996, STAT METHODS ED PSYC, V3rd ed; JENNETT B, 1975, LANCET, V1, P480; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; Machamer J, 2018, J NEUROTRAUM, V35, P1132, DOI 10.1089/neu.2017.5460; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	17	5	6	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2423	2429		10.1089/neu.2018.6198		MAY 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000466749800001	30827167	Green Published			2022-02-06	
J	Catharine, V; Helena, V; Eva, G; Ellen, D; Karen, C; Guy, V; Karel, D				Catharine, Vander Linden; Helena, Verhelst; Eva, Genbrugge; Ellen, Deschepper; Karen, Caeyenberghs; Guy, Vingerhoets; Karel, Deblaere			Is diffuse axonal injury on susceptibility weighted imaging a biomarker for executive functioning in adolescents with traumatic brain injury?	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Adolescent; Development; Executive function; Pediatric traumatic brain injury; Susceptibility weighted imaging	BEHAVIOR RATING INVENTORY; INDIVIDUAL-DIFFERENCES; PARENT RATINGS; ECHO MRI; CHILDREN; LESIONS; PERFORMANCE; IMPAIRMENT; MATURATION; CHILDHOOD	Traumatic brain injury (TBI) is a heterogeneous disorder in which diffuse axonal injury (DAI) is an important component contributing to executive dysfunction. During adolescence, developing brain networks are especially vulnerable to acceleration-deceleration forces. We aimed to examine the correlation between DAI (number and localization) and executive functioning in adolescents with TBI. We recruited 18 adolescents with a mean age of 15y8m (SD = 1y7m), averaging 2.5 years after sustaining a moderate-to-severe TBI with documented DAI. Susceptibility Weighted Imaging sequence was administered to localize the DAI lesions. The adolescents performed a neurocognitive test-battery, addressing different aspects of executive functioning (working memory, attention, processing speed, planning ability) and their parents completed the Behavior Rating Inventory of Executive Function (BRIEF) - questionnaire. Executive performance of the TBI-group was compared with an age and gender matched control group of typically developing peers. Based on these results we focused on the Stockings of Cambridge test and the BRIEF to correlate with the total number and location of DAI. Results revealed that the anatomical distribution of DAI, especially in the corpus callosum and the deep brain nuclei, may have more implications for executive functioning than the total amount of DAI in adolescents. Results of this study may help guide targeted rehabilitation to redirect the disturbed development of executive function in adolescents with TBI. (C) 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Catharine, Vander Linden] Ghent Univ Hosp, Child Rehabil Ctr K7, Corneel Heymanslaan 10, B-9000 Ghent, Belgium; [Helena, Verhelst; Guy, Vingerhoets] Univ Ghent, Dept Expt Psychol, Fac Psychol & Educ Sci, Henri Dunantlaan 2, B-9000 Ghent, Belgium; [Eva, Genbrugge; Karel, Deblaere] Ghent Univ Hosp, Dept Neuroradiol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium; [Ellen, Deschepper] Univ Ghent, Dept Publ Hlth, Biostat Unit, Corneel Heymanslaan 10, B-9000 Ghent, Belgium; [Karen, Caeyenberghs] Australian Catholic Univ, Mary McKillop Inst Hlth Res, Level 5,215 Spring St, Melbourne, Vic 3000, Australia		Catharine, V (corresponding author), Ghent Univ Hosp, Child Rehabil Ctr K7, Corneel Heymanslaan 10, B-9000 Ghent, Belgium.	catharine.vanderlinden@uzgent.be; helena.verhelst@ugent.be; eva.genbrugge@uzgent.be; ellen.deschepper@ugent.be; karen.caeyenberghs@acu.edu.au; guy.vingerhoets@ugent.be; karel.deblaere@ugent.be		Verhelst, Helena/0000-0002-6861-0249	Special Research Fund (BOF) from Ghent University, Belgium [01N00214]	This research was supported by a grant (#01N00214) from the Special Research Fund (BOF) from Ghent University, Belgium.	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Aoki C, 2017, BRAIN RES, V1654, P85, DOI 10.1016/j.brainres.2016.11.026; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Ardila A, 2008, BRAIN COGNITION, V68, P92, DOI 10.1016/j.bandc.2008.03.003; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Bettcher BM, 2016, NEUROPSYCHOLOGIA, V85, P100, DOI 10.1016/j.neuropsychologia.2016.03.001; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; Buch S, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3551; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Chung SW, 2012, J KOREAN NEUROSURG S, V52, P377, DOI 10.3340/jkns.2012.52.4.377; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Coutinho V, 2017, APPL NEUROPSYCH-CHIL, V6, P255, DOI 10.1080/21622965.2016.1146141; Cropley VL, 2006, BIOL PSYCHIAT, V59, P898, DOI 10.1016/j.biopsych.2006.03.004; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Diamond A, 2014, MINN SYM CHILD PSYCH, V37, P205; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donders J., 2016, CHILD NEUROPSYCHOL, P1; Donolato E, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00663; Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129; Dou Q, 2015, IEEE ENG MED BIO, P7933, DOI 10.1109/EMBC.2015.7320232; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fazlollahi A, 2015, COMPUT MED IMAG GRAP, V46, P269, DOI 10.1016/j.compmedimag.2015.10.001; Foulkes L, 2018, NAT NEUROSCI, V21, P315, DOI 10.1038/s41593-018-0078-4; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friedman NP, 2017, CORTEX, V86, P186, DOI 10.1016/j.cortex.2016.04.023; Greene CM, 2008, BIOL PSYCHOL, V79, P30, DOI 10.1016/j.biopsycho.2007.11.009; Gross AC, 2015, CHILD NEUROPSYCHOL, V21, P531, DOI 10.1080/09297049.2014.911271; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hinton-Bayre A, 2005, PSYCHOL ASSESSMENT, V17, P237, DOI 10.1037/1040-3590.17.2.237; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P663, DOI 10.1016/j.jecp.2010.06.005; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jonsson CA, 2013, J NEUROTRAUM, V30, P76, DOI 10.1089/neu.2012.2592; Kannan Nithya, 2014, Int J Crit Illn Inj Sci, V4, P131, DOI 10.4103/2229-5151.134152; Kostering L, 2015, NEUROPSYCHOLOGIA, V75, P646, DOI 10.1016/j.neuropsychologia.2015.07.017; Kurowski BG, 2013, ARCH PHYS MED REHAB, V94, P543, DOI 10.1016/j.apmr.2012.10.029; Lebel C, 2018, NEUROIMAGE, V182, P207, DOI 10.1016/j.neuroimage.2017.12.097; Lenroot RK, 2009, HUM BRAIN MAPP, V30, P163, DOI 10.1002/hbm.20494; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Li JJ, 2015, J INT NEUROPSYCH SOC, V21, P62, DOI 10.1017/S1355617714001039; Lin Yung-Hsiang, 2013, LASER PHYS LETT, V10, P1; Logue SF, 2014, PHARMACOL BIOCHEM BE, V123, P45, DOI 10.1016/j.pbb.2013.08.007; Luciana M, 2009, DEV NEUROPSYCHOL, V34, P461, DOI 10.1080/87565640902964540; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Maxwell WL, 2012, INT J DEV NEUROSCI, V30, P167, DOI 10.1016/j.ijdevneu.2011.12.008; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Mills KL, 2014, DEV NEUROSCI-BASEL, V36, P147, DOI 10.1159/000362328; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; Monaco EA, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000430738.63491.f3; Moriguchi Y, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00867; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Peters S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02174-z; Piccolo LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162511; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rackley C, 2012, CHILD NEUROPSYCHOL, V18, P512, DOI 10.1080/09297049.2011.628308; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Saito T, 2018, J STROKE CEREBROVASC, V27, P315, DOI 10.1016/j.jstrokecerebrovasdis.2017.09.001; Satterthwaite TD, 2013, J NEUROSCI, V33, P16249, DOI 10.1523/JNEUROSCI.2345-13.2013; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Su E, 2016, DIFFUSE AXONAL INJUR; Syvaoja HJ, 2015, PSYCHOL ASSESSMENT, V27, P698, DOI 10.1037/a0038485; Tamnes CK, 2010, NEUROPSYCHOLOGIA, V48, P2496, DOI 10.1016/j.neuropsychologia.2010.04.024; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Treble-Barna A, 2017, J NEUROTRAUM, V34, P353, DOI 10.1089/neu.2016.4476; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; van Eijck MM, 2018, BRAIN INJURY, V32, P395, DOI 10.1080/02699052.2018.1429018; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Walhovd KB, 2015, CEREB CORTEX, V25, P1835, DOI 10.1093/cercor/bht424; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yuan L, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150129	110	5	5	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	MAY	2019	23	3					525	536		10.1016/j.ejpn.2019.04.003			12	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	IE7XL	WOS:000472588200024	31023628				2022-02-06	
J	Chan, DYC; Tsang, ACO; Li, LF; Cheng, KKF; Tsang, FCP; Taw, BBT; Pu, JKS; Ho, WWS; Lui, WM; Leung, GKK				Chan, David Yuen Chung; Tsang, Anderson Chun On; Li, Lai Fung; Cheng, Kevin King Fai; Tsang, Frederick Chun Pong; Taw, Benedict Beng Teck; Pu, Jenny Kan Suen; Ho, Wilson Wai Shing; Lui, Wai Man; Leung, Gilberto Ka Kit			Improving Survival with Tranexamic Acid in Cerebral Contusions or Traumatic Subarachnoid Hemorrhage: Univariate and Multivariate Analysis of Independent Factors Associated with Lower Mortality	WORLD NEUROSURGERY			English	Article						Cerebral contusion; Subarachnoid hemorrhage; Tranexamic acid; Traumatic brain injury; Traumatic subarachnoid hemorrhage	BRAIN-INJURY; PROGRESSION	BACKGROUND: Fall with head injury is a pervasive challenge, especially in the aging population. Contributing factors for mortality include the development of cerebral contusions and delayed traumatic intracerebral hematoma. Currently, there is no established specific treatment for these conditions. OBJECT: This study aimed to investigate the impact of independent factors on the mortality rate of traumatic brain injury with contusions or traumatic subarachnoid hemorrhage. METHODS: Data were collected from consecutive patients admitted for cerebral contusions or traumatic subarachnoid hemorrhage at an academic trauma center from 2010 to 2016. The primary outcome was the 30-day mortality rate. Independent factors for analysis included patient factors and treatment modalities. Univariate and multivariate analyses were conducted to identify independent factors related to mortality. Secondary outcomes included thromboembolic complication rates associated with the use of tranexamic acid. RESULTS: In total, 651 consecutive patients were identified. For the patient factors, low Glasgow Coma Scale on admission, history of renal impairment, and use of warfarin were identified as independent factors associated with higher mortality from univariate and multivariate analyses. For the treatment modalities, univariate analysis identified tranexamic acid as an independent factor associated with lower mortality (P = 0.021). Thromboembolic events were comparable in patients with or without tranexamic acid. CONCLUSION: Tranexamic acid was identified by univariate analysis as an independent factor associated with lower mortality in cerebral contusions or traumatic subarachnoid hemorrhage. Further prospective studies are needed to validate this finding.	[Chan, David Yuen Chung; Tsang, Anderson Chun On; Li, Lai Fung; Cheng, Kevin King Fai; Tsang, Frederick Chun Pong; Taw, Benedict Beng Teck; Pu, Jenny Kan Suen; Ho, Wilson Wai Shing; Lui, Wai Man; Leung, Gilberto Ka Kit] Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Div Neurosurg,Dept Surg,Pokfulam, Hong Kong, Peoples R China		Leung, GKK (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Queen Mary Hosp, Div Neurosurg,Dept Surg,Pokfulam, Hong Kong, Peoples R China.	gilberto@hku.hk	Leung, Gilberto Ka Kit/C-4337-2009; /E-1487-2011	Leung, Gilberto Ka Kit/0000-0003-3147-3057; /0000-0003-2758-3253; CHAN, David Yuen Chung/0000-0002-9622-3799			Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Choudhry OJ, 2013, NEUROSURGERY, V73, P753, DOI 10.1227/NEU.0000000000000105; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Iorio-Morin C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1358-5; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kageyama H, 2013, J NEUROSURG, V119, P332, DOI 10.3171/2013.3.JNS122162; Kim B, 2018, AM J EMERG MED, V36, P271, DOI 10.1016/j.ajem.2017.08.009; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Mahmood A, 2016, BMJ-BRIT MED J, V354, P4814; Meretoja A, 2014, INT J STROKE, V9, P519, DOI 10.1111/ijs.12132; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Peitzman A, 2000, J TRAUMA, V48, P374; Roberts I, 2011, LANCET, V377; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; Sprigg N, 2018, LANCET, V391, P2107, DOI 10.1016/S0140-6736(18)31033-X; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; J TRAUMA, V48, P367; 2005, NEUROSURGERY, V56, P671, DOI DOI 10.1227/01.NEU.0000156200.76331.7A	29	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2019	125						E665	E670		10.1016/j.wneu.2019.01.145			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW2CX	WOS:000466491700083	30721773				2022-02-06	
J	Cogan, AM; Haines, CE; Devore, MD; Lepore, KM; Ryan, M				Cogan, Alison M.; Haines, Christine E.; Devore, Maria D.; Lepore, Karla M.; Ryan, Margaret			Occupational Challenges in Military Service Members With Chronic Mild Traumatic Brain Injury	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article							SYMPTOMS; COMBAT; IDENTIFICATION; INTERVENTION; THERAPY	OBJECTIVE. The purpose of this study was to identify the needs of military service members with chronic symptoms after mild traumatic brain injury (mTBI) that fall within the scope of occupational therapy practice. METHOD. In this qualitative descriptive study, service members with a history of mTBI (N = 12) participated in semistructured interviews about their injury history, symptoms, daily routines, challenges, and plans. RESULTS. Two main themes were identified: occupational changes and plans for the future. Occupational changes contains six subthemes: (1) rest and sleep, (2) activities of daily living and instrumental activities of daily living, (3) work, (4) social participation, (5) play and leisure, and (6) education. Plans for the future contains three subthemes: (1) supports, (2) barriers, and (3) fears. CONCLUSION. Occupational therapists who work with this population should consider all areas of occupation, especially sleep, during assessment and treatment planning. Some clients may require additional support for preparing for civilian life.	[Cogan, Alison M.] VA Med Ctr, Washington, DC 20422 USA; [Cogan, Alison M.] Univ Southern Calif, Chan Div Occupat Sci & Occupat Therapy, Los Angeles, CA USA; [Haines, Christine E.; Devore, Maria D.] Naval Hosp Camp Pendleton, Oceanside, CA USA; [Lepore, Karla M.] Naval Hosp Camp Pendleton, Clin Serv, Oceanside, CA USA; [Ryan, Margaret] Naval Hosp Camp Pendleton, Clin Invest Program, Oceanside, CA USA		Cogan, AM (corresponding author), VA Med Ctr, Washington, DC 20422 USA.	alisonc79@gmail.com	Cogan, Alison/AAS-3101-2021	Cogan, Alison/0000-0002-6800-1988			American Occupational Therapy Association, 2014, AMERICAN JOURNAL OF, V68, pS1, DOI [10.5014/ajot.2014.682006, DOI 10.5014/AJ0T.2014.682006]; [Anonymous], 2013, DIAGN STAT MAN MENT; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Clark F., 1997, J OCCUP SCI, V4, P86; Classen S, 2014, OTJR-OCCUP PART HEAL, V34, P176, DOI 10.3928/15394492-20141006-01; Classen S, 2014, AM J OCCUP THER, V68, P405, DOI 10.5014/ajot.2014.010041; Davenport ND, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00085; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Dillingham T. R, 1998, REHABILITATION INJUR, V1; Eakman AM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.016519; Erez ABH, 2009, AM J OCCUP THER, V63, P634; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Merriam SB., 2016, QUALITATIVE RES GUID, V4; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Plach HL, 2013, AM J OCCUP THER, V67, P73, DOI 10.5014/ajot.2013.003871; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rogers CM, 2014, AM J OCCUP THER, V68, P395, DOI 10.5014/ajot.2014.011221; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Wilcock A., 1993, J OCCUP SCI, V1, P17; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	30	5	5	0	5	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490	1943-7676		AM J OCCUP THER	Am. J. Occup. Ther.	MAY-JUN	2019	73	3							7303205040	10.5014/ajot.2019.027599			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	HY5HJ	WOS:000468158500003	31120834	Green Published			2022-02-06	
J	Crawford, RJ; Fortin, M; Weber, KA; Smith, A; Elliott, JM				Crawford, Rebecca J.; Fortin, Maryse; Weber, Kenneth A., II; Smith, Andrew; Elliott, James M.			Are Magnetic Resonance Imaging Technologies Crucial to Our Understanding of Spinal Conditions?	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						MRI; muscle; pain; soft tissues; spinal cord; spine	LOW-BACK-PAIN; PARASPINAL MUSCLE MORPHOLOGY; DEGENERATIVE CERVICAL MYELOPATHY; LUMBAR PARAVERTEBRAL MUSCLES; MULTIFIDUS MUSCLE; WHIPLASH INJURY; FATTY INFILTRATION; DISC DEGENERATION; ISSLS PRIZE; CLINICAL SYMPTOMS	Persistent spinal (traumatic and nontraumatic) pain is common and contributes to high societal and personal costs globally. There is an acknowledged urgency for new and interdisciplinary approaches to the condition, and soft tissues, including skeletal muscles, the spinal cord, and the brain, are rightly receiving increased attention as important biological contributors. In reaction to the recent suspicion and questioned value of imaging-based findings, this paper serves to recognize the promise that the technological evolution of imaging techniques, and particularly magnetic resonance imaging, is allowing in characterizing previously less visible morphology. We emphasize the value of quantification and data analysis of several contributors in the biopsychosocial model for understanding spinal pain. Further, we highlight emerging evidence regarding the pathobiology of changes to muscle composition (eg, atrophy, fatty infiltration), as well as advancements in neuroimaging and musculoskeletal imaging techniques (eg, fat-water imaging, functional magnetic resonance imaging, diffusion imaging, magnetization transfer imaging) for these important soft tissues. These noninvasive and objective data sources may complement known prognostic factors of poor recovery, patient self-report, diagnostic tests, and the "-omics" fields. When combined, advanced "big-data" analyses may assist in identifying associations previously not considered. Our clinical commentary is supported by empirical findings that may orient future efforts toward collaborative conversation, hypothesis generation, interdisciplinary research, and translation across a number of health fields. Our emphasis is that magnetic resonance imaging technologies and research are crucial to the advancement of our understanding of the complexities of spinal conditions.	[Crawford, Rebecca J.] Body Urbanist BV, Rotterdam, Netherlands; [Fortin, Maryse] Concordia Univ, PERFORM Ctr, Montreal, PQ, Canada; [Fortin, Maryse] Concordia Univ, Dept Hlth Kinesiol & Appl Physiol, Montreal, PQ, Canada; [Weber, Kenneth A., II] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Syst Neurosci & Pain Lab, Palo Alto, CA 94304 USA; [Smith, Andrew] Regis Univ, Sch Phys Therapy, Denver, CO USA; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Elliott, James M.] Northern Sydney Local Hlth Dist, Royal North Shore Hosp, Kolling Inst Med Res, Level 9,Pacific Highway, St Leonards, NSW 2065, Australia; [Elliott, James M.] Univ Sydney, Fac Hlth Sci, Lidcombe, Australia		Elliott, JM (corresponding author), Northern Sydney Local Hlth Dist, Royal North Shore Hosp, Kolling Inst Med Res, Level 9,Pacific Highway, St Leonards, NSW 2065, Australia.	jim.elliott@sydney.edu.au	; Crawford, Rebecca/F-3120-2017	Smith, Andrew/0000-0001-5020-8094; Weber, Kenneth/0000-0002-0916-9174; Crawford, Rebecca/0000-0001-9153-6684	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD079076, R03HD094577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS104211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA035165] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD094577, R01 HD079076] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [T32 DA035165] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [L30 NS108301, K23 NS104211] Funding Source: Medline		Abbott R, 2018, SPINE J, V18, P717, DOI 10.1016/j.spinee.2017.08.233; Alschuler KN, 2016, REHABIL PSYCHOL, V61, P7, DOI 10.1037/rep0000055; Anderson SE, 2012, RADIOLOGY, V262, P567, DOI 10.1148/radiol.11102115; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bortsov AV, 2014, NEUROMOL MED, V16, P83, DOI 10.1007/s12017-013-8255-9; Bortsov AV, 2013, PAIN, V154, P1419, DOI 10.1016/j.pain.2013.04.037; Bostick GP, 2009, EUR J PAIN, V13, P300, DOI 10.1016/j.ejpain.2008.04.003; Buchbinder R, 2018, LANCET, V391, P2384, DOI 10.1016/S0140-6736(18)30488-4; Burke NN, 2017, J NEUROSCI RES, V95, P1257, DOI 10.1002/jnr.23802; Campbell WW, 1998, MUSCLE NERVE, V21, P1350, DOI 10.1002/(SICI)1097-4598(199810)21:10<1350::AID-MUS21>3.0.CO;2-4; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Chou R, 2012, RADIOL CLIN N AM, V50, P569, DOI 10.1016/j.rcl.2012.04.005; Cloney MB, 2018, SPINE, V43, P675, DOI 10.1097/BRS.0000000000002470; Cohen-Adad J, 2011, NEUROIMAGE, V55, P1024, DOI 10.1016/j.neuroimage.2010.11.089; Conrad BN, 2018, BRAIN, V141, P1650, DOI 10.1093/brain/awy083; Cornwall J, 2011, SPINE, V36, pE1053, DOI 10.1097/BRS.0b013e3181f79629; Crawford RJ, 2016, AM J NEURORADIOL, V37, P742, DOI 10.3174/ajnr.A4596; Crawford RJ, 2017, EUR SPINE J, V26, P3059, DOI 10.1007/s00586-017-5212-6; Crawford RJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-016-1378-z; Crawford RJ, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0080-0; Dahlqvist JR, 2017, MED SCI SPORT EXER, V49, P595, DOI 10.1249/MSS.0000000000001119; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dombrowski ME, 2018, EUR SPINE J, V27, P752, DOI 10.1007/s00586-018-5489-0; Dudli S, 2017, EUR SPINE J, V26, P1362, DOI 10.1007/s00586-017-4955-4; Duewell S, 1996, RADIOLOGY, V199, P780, DOI 10.1148/radiology.199.3.8638005; Ellingson BM, 2015, J NEUROSURG-SPINE, V22, P631, DOI 10.3171/2014.10.SPINE14222; Elliott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021194; Elliott JM, 2018, SPINE J, V18, P1489, DOI 10.1016/j.spinee.2017.06.015; Elliott JM, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2074-y; Elliott JM, 2017, PHYS THER, V97, P145, DOI 10.2522/ptj.20160089; Elliott JM, 2015, SPINE, V40, pE694, DOI 10.1097/BRS.0000000000000891; Elliott JM, 2014, PAIN MED, V15, P1938, DOI 10.1111/pme.12518; Elliott JM, 2013, MANUAL THER, V18, P578, DOI 10.1016/j.math.2013.02.002; Ferrari Robert, 2003, Med Sci Monit, V9, pCR120; Fischer MA, 2013, RADIOLOGY, V266, P555, DOI 10.1148/radiol.12120399; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fortin M, 2015, SCAND J MED SCI SPOR, V25, P880, DOI 10.1111/sms.12301; Fortin M, 2018, MUSCULOSKEL SCI PRAC, V38, P1, DOI 10.1016/j.msksp.2018.07.003; Fortin M, 2017, EUR SPINE J, V26, P2543, DOI 10.1007/s00586-017-5228-y; Fortin M, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0350-y; Fortin M, 2017, SPINE, V42, P232, DOI 10.1097/BRS.0000000000001704; Fortin M, 2014, MED SCI SPORT EXER, V46, P893, DOI 10.1249/MSS.0000000000000179; Fortin M, 2013, PHYS THER, V93, P1540, DOI 10.2522/ptj.20130051; Fortin M, 2013, PHYS THER REHABIL J, V93, P873, DOI 10.2522/ptj.20120457; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goubert D, 2018, SCAND J PAIN, V18, P281, DOI 10.1515/sjpain-2017-0142; Goubert D, 2017, SPINE J, V17, P1285, DOI 10.1016/j.spinee.2017.04.025; Gros C, 2019, NEUROIMAGE, V184, P901, DOI 10.1016/j.neuroimage.2018.09.081; Hancock MJ, 2017, SPINE, V42, P1283, DOI 10.1097/BRS.0000000000002102; Hancock MJ, 2015, SPINE J, V15, P2360, DOI 10.1016/j.spinee.2015.07.007; Hebert JJ, 2014, SPINE, V39, P1417, DOI 10.1097/BRS.0000000000000424; Hebert JJ, DISABIL REHABIL, DOI [10.1080/09638288.2018.1, DOI 10.1080/09638288.2018.1]; Hodges PW, 2015, SPINE, V40, P1057, DOI 10.1097/BRS.0000000000000972; Holly LT, 2009, J NEUROSURG-SPINE, V10, P194, DOI 10.3171/2008.12.SPINE08367; Hopkins BS, 2018, SPINE, V43, pE1204, DOI 10.1097/BRS.0000000000002667; Hori M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23527-8; Ignasiak D, 2018, EUR SPINE J, V27, P2650, DOI 10.1007/s00586-018-5729-3; Ignasiak D, 2018, J BIOMECH, V70, P175, DOI 10.1016/j.jbiomech.2017.11.033; Jamaludin A, 2017, EUR SPINE J, V26, P1374, DOI 10.1007/s00586-017-4956-3; Jensen RK, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1978-x; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Kalin PS, 2018, SKELETAL RADIOL, V47, P1393, DOI 10.1007/s00256-018-2945-1; Karlsson A, 2016, J ORTHOP SPORT PHYS, V46, P886, DOI 10.2519/jospt.2016.6553; Kazemifar S, 2014, J NEUROSCI METH, V227, P35, DOI 10.1016/j.jneumeth.2014.01.033; Kemnitz J, 2017, MAGN RESON MATER PHY, V30, P489, DOI 10.1007/s10334-017-0622-3; Khan AB, 2017, WORLD NEUROSURG, V103, P174, DOI 10.1016/j.wneu.2017.03.097; Kobayashi Yoshitaka, 2009, Spine (Phila Pa 1976), V34, P2431, DOI 10.1097/BRS.0b013e3181b1fb76; Kong J, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-43; Le Cara EC, 2014, ARCH PHYS MED REHAB, V95, P1846, DOI 10.1016/j.apmr.2014.04.019; Linnstaedt SD, 2017, PAIN, V158, P230, DOI 10.1097/j.pain.0000000000000742; Linnstaedt SD, 2016, J ORTHOP SPORT PHYS, V46, P911, DOI 10.2519/jospt.2016.6944; Liu XC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165203; Lloyd D, 2008, SPINE, V33, P1372, DOI 10.1097/BRS.0b013e3181734a8a; Maatta JH, 2015, SPINE J, V15, P1933, DOI 10.1016/j.spinee.2015.06.056; Martin AR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195733; Martucci KT, 2019, ARTHRITIS RHEUMATOL, V71, P441, DOI 10.1002/art.40746; Martucci KT, 2018, ANESTHESIOLOGY, V128, P1241, DOI 10.1097/ALN.0000000000002137; Martucci Katherine T, 2016, Anesthesiol Clin, V34, P255, DOI 10.1016/j.anclin.2016.01.001; Massire A, 2016, NEUROIMAGE, V143, P58, DOI 10.1016/j.neuroimage.2016.08.055; Matsumoto M, 2012, INJURY, V43, P912, DOI 10.1016/j.injury.2012.01.017; McLean SA, 2011, SPINE, V36, pS226, DOI 10.1097/BRS.0b013e3182387fb4; McLean SA, 2011, J PAIN, V12, P101, DOI 10.1016/j.jpain.2010.05.008; Mhuiris AN, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1090-z; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Mok FPS, 2010, SPINE, V35, P1944, DOI 10.1097/BRS.0b013e3181d534f3; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nakashima H, 2015, SPINE, V40, P392, DOI 10.1097/BRS.0000000000000775; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Orgiu S, 2016, J MAGN RESON IMAGING, V43, P601, DOI 10.1002/jmri.25031; Partheni M, 2000, CLIN EXP RHEUMATOL, V18, P67; Perone CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24304-3; Ploumis A, 2011, BRIT J RADIOL, V84, P709, DOI 10.1259/bjr/58136533; Rajasekaran S, 2017, EUR SPINE J, V26, P1384, DOI 10.1007/s00586-017-4972-3; Ranger TA, 2017, SPINE J, V17, P1729, DOI 10.1016/j.spinee.2017.07.002; Reddan MC, 2018, NEUROSCI BULL, V34, P208, DOI 10.1007/s12264-017-0150-1; Reeder SB, 2012, J MAGN RESON IMAGING, V36, P1011, DOI 10.1002/jmri.23741; Resorlu H, 2017, MOD RHEUMATOL, V27, P683, DOI 10.1080/14397595.2016.1245176; Salamon N, 2013, SPINAL CORD, V51, P558, DOI 10.1038/sc.2013.31; Samartzis D, 2015, SPINE J, V15, P1919, DOI 10.1016/j.spinee.2014.09.010; Sasaki T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187765; Schick F, 2016, MAGN RESON MATER PHY, V29, P89, DOI 10.1007/s10334-016-0549-0; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Shahidi B, 2017, J ORTHOP RES, V35, P2700, DOI 10.1002/jor.23597; Shahidi B, 2017, SPINE, V42, P616, DOI 10.1097/BRS.0000000000001848; Sions JM, 2017, ARCH PHYS MED REHAB, V98, P51, DOI 10.1016/j.apmr.2016.07.027; Smith AC., 2015, SPINAL CORD SER CASE, V1, P15024, DOI 10.1038/scsandc.2015.24; Smith AC, 2018, ARCH PHYS MED REHAB, V99, P660, DOI 10.1016/j.apmr.2017.10.002; Storheim K, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1505-5; Suleiman LI, 2018, J CLIN NEUROSCI, V51, P57, DOI 10.1016/j.jocn.2018.02.023; Tetreault L, 2015, NEUROSURGERY, V77, pS51, DOI 10.1227/NEU.0000000000000951; Ulbrich EJ, 2012, J MAGN RESON IMAGING, V36, P1413, DOI 10.1002/jmri.23769; Vachon-Presseau E, 2016, BRAIN, V139, P1958, DOI 10.1093/brain/aww100; Valentin S, 2015, MANUAL THER, V20, P90, DOI 10.1016/j.math.2014.07.007; Valenzuela W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156035; Walton DM, 2018, MUSCULOSKEL SCI PRAC, V36, P17, DOI 10.1016/j.msksp.2018.03.006; Walton DM, 2017, J ORTHOP SPORT PHYS, V47, P462, DOI 10.2519/jospt.2017.7455; Wan Q, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140546; Weber KA, 2016, NEUROIMAGE, V143, P267, DOI 10.1016/j.neuroimage.2016.09.015; Weber KA, 2016, NEUROIMAGE, V125, P233, DOI 10.1016/j.neuroimage.2015.10.014; Wen CY, 2013, SPINE J, V13, P697, DOI 10.1016/j.spinee.2013.02.061; WOLFF SD, 1991, RADIOLOGY, V179, P133, DOI 10.1148/radiology.179.1.2006263; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Xiao YM, 2018, EUR SPINE J, V27, P2442, DOI 10.1007/s00586-018-5704-z; Xiao YM, 2015, INT J COMPUT ASS RAD, V10, P329, DOI 10.1007/s11548-014-1068-y; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Yoo YH, 2015, KOREAN J RADIOL, V16, P1086, DOI 10.3348/kjr.2015.16.5.1086; Young AA, 2009, EXP PHYSIOL, V94, P578, DOI 10.1113/expphysiol.2008.044081; Yu RJ, 2014, NEUROIMAGE-CLIN, V6, P100, DOI 10.1016/j.nicl.2014.08.019; Zehra U, 2018, EUR SPINE J, V27, P2, DOI 10.1007/s00586-017-5292-3; 2013, EUR J PAIN, V17, P1234, DOI DOI 10.1002/J.1532-2149.2012.00265.X; 2011, PAIN, V152, P82, DOI DOI 10.1016/J.PAIN.2010.09.015	136	5	5	0	7	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	MAY	2019	49	5					320	329		10.2519/jospt.2019.8793			10	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	HW3SF	WOS:000466612300005	30913967	Green Accepted			2022-02-06	
J	Fuentes, A; Schoen, C; Kulzer, RR; Long, C; Bushnik, T; Rath, JF				Fuentes, Armando; Schoen, Chelsea; Kulzer, Rebecca R.; Long, Coralynn; Bushnik, Tamara; Rath, Joseph F.			Impact of Racial-Ethnic Minority Status and Systemic Vulnerabilities on Time to Acute TBI Rehabilitation Admission in an Urban Public Hospital Setting	REHABILITATION PSYCHOLOGY			English	Article						health disparities; racial-ethnic minorities; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; OUTCOMES; HEALTH; DISPARITIES; ADULTS; CALL	Purpose/Objective: Racial/ethnic minorities and other vulnerable social groups experience health care disparities. There is a lack of research exploring how time to acute rehabilitation admission is impacted by race/ethnicity and other marginalizing systemic vulnerabilities. The purpose of this study is to investigate whether race/ethnicity and other sociodemographic vulnerabilities impact expediency of acute rehabilitation admission following traumatic brain injury (TBI). Research Method/Design: This study is a secondary analysis of an existing dataset of 111 patients admitted for acute TBI rehabilitation at an urban public hospital. Patient groups were defined by race/ethnicity (People of color or White) and vulnerable group status (high or low vulnerable group membership [VGM]). Results: White patients are admitted to acute TBI rehabilitation significantly faster than people of color. After taking vulnerabilities into account, high VGM people of color experience the most severe injuries and take the longest to receive acute TBI rehabilitation. Despite small differences in injury severity, low VGM people of color take longer to be admitted to acute TBI rehabilitation than White patients. High VGM White patients have less severe injuries yet take longer to be admitted to acute rehabilitation than low VGM White patients. Finally, notable differences exist between White patients and patients of color on rater-based injury severity scales that are discordant with severity as measured by more objective markers. Conclusions/Implications: Overall, findings indicate that sociodemographic factors including race/ethnicity and systemic vulnerabilities impact injury severity and time to acute TBI rehabilitation admission. Impact and Implications Although racial/ethnic minorities experience health care disparities following TBI, research on the combined effects of race/ethnicity with other marginalized identities has been neglected. This study is the first to demonstrate the impact of race/ethnicity and other systematic barriers on time to acute rehabilitation admission following TBI. This study confirms that even in a diverse, metropolitan public hospital, people of color wait longer to receive acute rehabilitation services following TBI. Culturally appropriate educational information regarding brain injury, as well as increased provider awareness of unconscious biases that inform clinical decision making, should underpin policy development and service delivery to ensure that people of color receive acute TBI rehabilitation with the same expediency as White patients.	[Fuentes, Armando; Schoen, Chelsea; Kulzer, Rebecca R.; Long, Coralynn; Rath, Joseph F.] Rusk Rehabil New York Univ Langone Hlth, Dept Psychol, 240 East 38th St,17-33, New York, NY 10016 USA; [Bushnik, Tamara] Rusk Rehabil New York Univ Langone Hlth, Dept Res, New York, NY USA		Fuentes, A (corresponding author), Rusk Rehabil New York Univ Langone Hlth, Dept Psychol, 240 East 38th St,17-33, New York, NY 10016 USA.	afuentes5@fordham.edu	Rath, Joseph F./C-4823-2008	Rath, Joseph F./0000-0003-2933-6299; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Administration for Community Living (ACL), Department of Health and Human Services (HHS) [90DPTB0010, 90ARHF0001]	The authors thank Hilary Bertisch and Michelle Smith for their helpful comments on this article. This work was supported by the following grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), Administration for Community Living (ACL), Department of Health and Human Services (HHS): 90DPTB0010, (Rusk TBI Model System; Tamara Bushnik, Project Director) and 90ARHF0001 (Rusk Advanced Rehabilitation Research Training Postdoctoral Fellowship; Joseph F. Rath, Project Director). The contents of this article do not necessarily represent the policy of NIDILRR, ACL, or HHS, and readers should not assume endorsement by the Federal Government.	Agency for Healthcare Research and Quality, 2016, NAT HEALTHC QUAL DIS; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Ardila A., 2007, INT HDB CROSS CULTUR, P23; Barr D. A., 2014, HLTH DISPARITIES US; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Bushnik T., 2014, TBI REHABILITATION U; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crawley J, 2013, PUBLIC HEALTH, V127, P674, DOI 10.1016/j.puhe.2013.04.006; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Fisher L, 2014, AM PSYCHOL, V69, P355, DOI 10.1037/a0036101; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Grollman EA, 2014, J HEALTH SOC BEHAV, V55, P3, DOI 10.1177/0022146514521215; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kleindorfer DO, 2006, STROKE, V37, P1508, DOI 10.1161/01.STR.0000222933.94460.dd; Kucukboyaci N. E., ARCH PHYS MED REHABI; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; McDermott H., 2014, J INT NEUROPSYCH SOC, V20, ps47; McDermott H, 2014, BRAIN INJURY, V28, P700; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Mindt MR, 2010, CLIN NEUROPSYCHOL, V24, P429, DOI 10.1080/13854040903058960; Mitchell, 2001, AM BECOMING RACIAL T, P371; Nadal KL., 2015, QUAL PSYCHOL, V2, P147, DOI DOI 10.1037/QUP0000026; Nettles R., 2012, MULTIPLE MINORITY ID; Rath J. F., HDB REHABILITATION P; Seng JS, 2012, SOC SCI MED, V75, P2437, DOI 10.1016/j.socscimed.2012.09.023; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Singer B. H., 2001, NEW HORIZON HLTH INT, P100; U. S. Department of Transportation National Highway Traffic Safety Administration, 2009, US DEP TRANSP PUBL	34	5	5	0	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2019	64	2			SI		229	236		10.1037/rep0000260			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	HT2UH	WOS:000464418500014	30688481	Green Accepted, Bronze			2022-02-06	
J	Kanmani, TR; Thimmappur, RM; Birudu, R; Reddy, NK; Raj, P				Kanmani, Thiruchengodu Raju; Thimmappur, Ramappa M.; Birudu, Raju; Reddy, Krishna N.; Raj, Prabhu			Burden and Psychological Distress of Intensive Care Unit Caregivers of Traumatic Brain Injury Patients	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Family burden; ICU caregivers; Psychological distress; Traumatic brain injury	FAMILY-MEMBERS; OF-LIFE; HIGH-RISK; INDIVIDUALS; SUPPORT; HEALTH; IMPACT; NEEDS	Aim: Admission to Intensive Care Unit (ICU) is a stressful event and unforeseen crisis for the caregivers. Burden and psychosocial distress among caregivers in the ICU were unexplored.Therefore,the current study was aimed to assess the caregivers' burden and psychological distress among caregivers of traumatic brain injury (TBI) patients at emergency ICU during hospitalization. Materials and Methods: A total of 60 caregivers recruited by using purposive sampling method with descriptive research design. Consent was obtained. Interview schedule of family for depression, anxiety, stress scale (DAS-21) were administered. The data were analyzed by using SPSS. Descriptive statistics and independent burden t-test were used. Results: Results revealed that male caregivers (75%) and female caregivers (25%) took part in the study. Caregivers' mean age was found to be 35.22 +/- 11.29 years, Most of the TBI survivors admitted in ICU had severe injury (8.30 +/- 3.63). Mean scores showed that caregivers had experienced financial burden (6.28 +/- 2.36), severe depression (12.15 +/- 4.84), and a moderate level of anxiety (12.85 +/- 5.20). Independent t-test showed significant difference in caregiving burden between male and female caregivers at ICU (Male = 18.43 +/- 4.83; Female = 14.29 +/- 4.83;t = 2.16; p <0.035). Overall, caregivers experienced higher family burden and severe psychological distress at ICU. Conclusion:There is an immediate need to assess psychological distress and family burden of caregivers at ICU and provide timely psychosocial intervention.	[Kanmani, Thiruchengodu Raju; Thimmappur, Ramappa M.; Reddy, Krishna N.] Natl Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Bengaluru 2, Karnataka, India; [Birudu, Raju] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, Karnataka, India; [Raj, Prabhu] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bengaluru, Karnataka, India		Kanmani, TR (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Psychiat Social Work, Bengaluru 2, Karnataka, India.	kanmani.raju@gmail.com	RAJ, PROFESSORDES/AAA-1007-2020	RAJ, PROFESSORDES/0000-0002-4050-4778; Birudu, Raju/0000-0002-8104-8692			Agrawal A, 2016, ROMANIAN NEUROSURG, V30, P252; Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Arango-Lasprilla JC, 2010, NEUROREHABILITATION, V27, P83, DOI 10.3233/NRE-2010-0583; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cook D, 2004, CAN J ANAESTH, V51, P266, DOI 10.1007/BF03019109; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Davidson JE, 2007, CRIT CARE MED, V35, P605, DOI 10.1097/01.CCM.0000254067.14607.EB; Deepika A, 2017, NEUROL INDIA, V65, P83, DOI 10.4103/0028-3886.198228; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Gururaj G., 2005, TRAUMATIC BRAIN INJU; Kumar S, 2017, NATL MED J INDIA, V30, P131; Lee LYK, 2003, J CLIN NURS, V12, P490; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; McAdam JL, 2010, CRIT CARE MED, V38, P1078, DOI 10.1097/CCM.0b013e3181cf6d94; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; PAI S, 1981, BRIT J PSYCHIAT, V138, P332, DOI 10.1192/bjp.138.4.332; Price Ann M, 2004, Nurs Crit Care, V9, P134, DOI 10.1111/j.1362-1017.2004.00055.x; Pruthi N, 2012, INDIAN J MED RES, V136, P1039; Raju Birudu, 2016, Int J Crit Illn Inj Sci, V6, P206, DOI 10.4103/2229-5151.195452; Rodriguez AM, 2005, J PSYCHOSOM RES, V58, P447, DOI 10.1016/j.jpsychores.2004.11.011; Tramonti F, 2015, PSYCHOL HEALTH MED, V20, P933, DOI 10.1080/13548506.2015.1009380; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Venkataraman R, 2015, INDIAN J CRIT CARE M, V19, P507, DOI 10.4103/0972-5229.164796	24	5	5	1	5	JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD	NEW DEHLI	4838-24, ANSARI RD, DARYAGANJ, NEW DEHLI, 110 002, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	MAY	2019	23	5					220	223		10.5005/jp-journals-10071-23164			4	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	JM9EG	WOS:000496508800007	31160838	gold, Green Submitted, Green Published			2022-02-06	
J	Kreitzer, NP; Hart, K; Lindsell, CJ; Manley, GT; Dikmen, SS; Ratcliff, JJ; Yue, JK; Adeoye, OM				Kreitzer, Natalie P.; Hart, Kimberly; Lindsell, Christopher J.; Manley, Geoffrey T.; Dikmen, Sureyya S.; Ratcliff, Jonathan J.; Yue, John K.; Adeoye, Opeolu M.			A Comparison of Satisfaction With Life and the Glasgow Outcome Scale-Extended After Traumatic Brain Injury: An Analysis of the TRACK-TBI Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Annual National Meeting of the Society-for-Academic-Emergency-Medicine	MAY 10-13, 2016	New Orleans, LA	Soc Acad Emergency Med		depression; satisfaction with life; TBI outcomes; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURY; MAJOR DEPRESSION; 1ST YEAR; DISABILITY; RELIABILITY; MULTICENTER; MODERATE	Objective: To evaluate the relationship between satisfaction with life (SWL) and functional outcome after traumatic brain injury (TBI). Setting and Participants: The Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot study (TRACK-TBI Pilot) enrolled patients at 3 US Level I trauma centers within 24 hours of TBI. Design: Patients were grouped by outcome measure concordance (good-recovery/good-satisfaction, impaired-recovery/impaired-satisfaction) and discordance (good-recovery/impaired-satisfaction, impaired-recovery/good-satisfaction). Logistic regression was utilized to determine predictors of discordance. Main Measures: Functional outcome: Glasgow Outcome Scale-Extended (GOSE); SWL: Satisfaction with Life Scale (SWLS). Results: Of the 586 enrolled subjects, 298 had completed both outcome measures at 6-month follow-up; the correlation between GOSE and SWLS was 0.380. Patients with impaired-recovery (GOSE < 7)/impaired-satisfaction (SWLS < 20) were more likely to have mild TBI (83% vs 62%, P = .012), baseline depression (42% vs 15%, P < .0001), and 6-month depression (59% vs 21%, P < .0001) when compared with patients with impaired-recovery/good-satisfaction. Patients with good-recovery/impaired-satisfaction were more likely to have baseline depression (31% vs 13%, P < .0001) and 6-month depression (33% vs 6%, P < .0001) compared with good-recovery/good-satisfaction. Conclusion: Correlation between SWL and functional outcome was not strong, and depression may modulate the association. Future research should account for functional, mental health, and patient-centered outcomes when assessing TBI recovery.	[Kreitzer, Natalie P.; Adeoye, Opeolu M.] Univ Cincinnati, Dept Emergency Med, 231 Albert Sabin Way,ML 0769, Cincinnati, OH 45267 USA; [Kreitzer, Natalie P.; Adeoye, Opeolu M.] Univ Cincinnati, Div Neurocrit Care, Cincinnati, OH 45267 USA; [Adeoye, Opeolu M.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA; [Hart, Kimberly; Lindsell, Christopher J.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Manley, Geoffrey T.; Yue, John K.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Emergeng Med, Atlanta, GA 30322 USA; [Ratcliff, Jonathan J.] Emory Univ, Dept Neurol, Div Neurocrit Care, Atlanta, GA 30322 USA		Kreitzer, NP (corresponding author), Univ Cincinnati, Dept Emergency Med, 231 Albert Sabin Way,ML 0769, Cincinnati, OH 45267 USA.	kreitzne@uzmaiLuc.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US DODUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, T32NS047996, RC2NS069409] Funding Source: NIH RePORTER	This work was supported by the following grants: NINDS 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03; US DOD W81XWH-13-1-0441, US DOD W81XWH-14-2-0176 (to G. T. M.)	Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Ansari Ahmed, 2014, Asian J Neurosurg, V9, P182, DOI 10.4103/1793-5482.146597; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jacobsson L, 2013, J REHABIL MED, V45, P1010, DOI 10.2340/16501977-1204; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jones JM, 2011, PSYCHOL HEALTH, V26, P353, DOI 10.1080/08870440903440699; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kraemer HC, 2004, INT J METH PSYCH RES, V13, P141, DOI 10.1002/mpr.170; Machamer J, 2013, J NEUROTRAUM, V30, P1845, DOI 10.1089/neu.2013.2920; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Nelson LD, 2017, J NEUROTRAUM, V34, P3158, DOI 10.1089/neu.2017.5139; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	33	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E10	E17		10.1097/HTR.0000000000000457			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100002	30499935	Green Accepted			2022-02-06	
J	Lee, SY; Finkelstein-Fox, L; Park, CL; Mazure, CM; Huedo-Medina, TB; Hoff, R				Lee, Sharon Y.; Finkelstein-Fox, Lucy; Park, Crystal L.; Mazure, Carolyn M.; Huedo-Medina, Tania B.; Hoff, Rani			Bidirectionality of Pain Interference and PTSD Symptoms in Military Veterans: Does Injury Status Moderate Effects?	PAIN MEDICINE			English	Article						Pain Interference; Posttraumatic Stress Disorder; Injury; Veterans; Mutual Maintenance	POSTTRAUMATIC-STRESS-DISORDER; HEALTH-CARE UTILIZATION; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; DEPLOYMENT; AFGHANISTAN; NEUROTICISM; RISK	Objective. Pain and post-traumatic stress disorder (PTSD) symptoms are strongly correlated in veteran populations. Arguments for which one condition predicts or worsens the other condition have gone in both directions. However, research addressing this issue has been primarily limited to cross-sectional studies rather than examinations of a potential bidirectional relationship between pain interference and PTSD symptoms over time. In addition, no studies have examined deployment injury status as potentially moderating this bidirectional effect in veterans. To address these gaps in the literature, the present longitudinal study examined whether there is a bidirectional relationship between pain interference and PTSD symptoms in a sample of male and female veterans returning from Operation Iraqi Freedom, Operation Enduring Freedom, or Operation New Dawn (N = 729) and whether deployment injury status moderates this relationship. Methods. Participants completed phone interviews regarding pain interference and PTSD symptoms at three time points, each three months apart. Results. Pain interference at Time 1 predicted worse PTSD symptoms at Time 2 for the subset of veterans who sustained injuries during deployment (n = 381) but not for veterans with pain interference who did not sustain injuries (n = 338). From Time 1 to Time 3, elevations in PTSD symptoms were mediated by pain interference for injured veterans; in contrast, PTSD symptoms did not appear to drive changes in pain interference in either group. Conclusions. These results indicate that physical symptom management should be a crucial target of psychological intervention for returning veterans with PTSD symptoms and deployment-related injuries.	[Lee, Sharon Y.; Finkelstein-Fox, Lucy; Park, Crystal L.] Univ Connecticut, Dept Psychol Sci, Storrs, CT USA; [Huedo-Medina, Tania B.] Univ Connecticut, Dept Allied Hlth, Storrs, CT USA; [Mazure, Carolyn M.; Hoff, Rani] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Mazure, Carolyn M.; Hoff, Rani] Womens Hlth Res Yale, New Haven, CT USA; [Hoff, Rani] VA Connecticut Healthcare Syst, VISN1 MIRECC, New Haven, CT USA		Lee, SY (corresponding author), Univ Connecticut, 406 Babbidge Rd,Unit 1020, Storrs, CT 06269 USA.	sharon.y.lee@uconn.edu			Veterans Affairs CSRD [ZDA1]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50DA033945, T32MH06299412]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P50DA033945] Funding Source: NIH RePORTER	This work was supported by the Veterans Affairs CSR&D grant ZDA1 and the National Institutes of Health grants P50DA033945 (SAM) and T32MH06299412.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck JG, 2011, PSYCHOL TRAUMA-US, V3, P101, DOI 10.1037/a0021263; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Breslau N, 2013, PSYCHOL MED, V43, P1697, DOI 10.1017/S0033291712002632; Clapp JD, 2008, PAIN, V138, P301, DOI 10.1016/j.pain.2008.01.001; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goubert L, 2004, PAIN, V107, P234, DOI 10.1016/j.pain.2003.11.005; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jenewein J, 2009, J TRAUMA STRESS, V22, P540, DOI 10.1002/jts.20453; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koch WJ, 2002, B C MED J, V44, P298; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Liedl A, 2010, PSYCHOL MED, V40, P1215, DOI 10.1017/S0033291709991310; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Little T. D., 2013, LONGITUDINAL STRUCTU; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; Nunnally J., 1994, PSYCHOMETRIC THEORY; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Outcalt SD, 2014, PAIN MED, V15, P1872, DOI 10.1111/pme.12045; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Sherman JJ, 2000, CLIN J PAIN, V16, P127, DOI 10.1097/00002508-200006000-00006; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Tate RL, 1998, INTERACTION AND NONLINEAR EFFECTS IN STRUCTURAL EQUATION MODELING, P167; Vaughan CA, 2016, J TRAUMA STRESS, V29, P176, DOI 10.1002/jts.22083; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Weathers F.W., 1993, 9 ANN C ISTSS; West S. G., 1995, STRUCTURAL EQUATION, P56, DOI DOI 10.1037/0008-400X.26.2.210; Zhang XY, 2003, J SPEECH LANG HEAR R, V46, P1340, DOI 10.1044/1092-4388(2003/104)	37	5	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1526-2375	1526-4637		PAIN MED	Pain Med.	MAY	2019	20	5					934	943		10.1093/pm/pny133			10	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anesthesiology; General & Internal Medicine	IO1XP	WOS:000479175500009	30016463	Green Published			2022-02-06	
J	Leonard, JM; Polites, SF; Martin, ND; Glasgow, AE; Habermann, EB; Kaplan, LJ				Leonard, Jennifer M.; Polites, Stephanie F.; Martin, Niels D.; Glasgow, Amy E.; Habermann, Elizabeth B.; Kaplan, Lewis J.			Comfort care in trauma patients without severe head injury: In-hospital complications as a trigger for goals of care discussions	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury; Comfort care; Palliative care; ICU mortality; Hospice; Trauma	PALLIATIVE CARE; LIFE-SUPPORT; WITHDRAWAL; ICU; RESCUE; UNIT	Introduction: Many injured patients or their families make the difficult decision to withdraw life-sustaining therapies (WLST) following severe injury. While this population has been studied in the setting of severe traumatic brain injury (TBI), little is known about patients who undergo WLST without TBI. We sought to describe patients who may benefit from early involvement of end-of-life resources. Methods: Trauma Quality Improvement Program (2013-2014) patients who underwent WLST were identified. WLST patients were compared to those who died with full supportive care (FSC). Patients were excluded for death within 24 h of admission, or head AIS >= 3. Intergroup comparisons were by student's t tests or Wilcoxon rank sum tests; significance for p < 0.05. Results: We identified 3471 total injured patients without major TBI who died > 24 h after admission. Of these death after WLST occurred in 2301 (66% of total). This group had a mean age of 66.8 years; 35.7% were women, and 95.4% sustained blunt injury. WLST patients had a higher ISS (21.6 vs. 12.5, p = 0.001), more in-hospital complications (71.4% vs. 41.6%, p = < 0.0001), and a longer ICU length of stay (8.9 days vs. 7.5 days, p = <0.0001) compared to patients who died with FSC. Conclusion: WLST occurs in two-thirds of injured patients without severe TBI who die in the hospital. Inhospital complications are more frequent in this patient group than those who die with FSC. Early palliative care consultation may improve patient and family satisfaction after acute injury when the timeframe to leverage such services is significantly condensed. (C) 2019 Elsevier Ltd. All rights reserved.	[Martin, Niels D.; Kaplan, Lewis J.] Univ Penn, Perelman Sch Med, Dept Surg, Div Trauma Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Leonard, Jennifer M.; Polites, Stephanie F.; Glasgow, Amy E.; Habermann, Elizabeth B.] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA; [Kaplan, Lewis J.] Corporal Michael J Crescenz VA Med Ctr, Surg Serv, Sect Surg Crit Care, Philadelphia, PA USA		Leonard, JM (corresponding author), Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN 55905 USA.; Kaplan, LJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Surg, Div Trauma Surg Crit Care & Emergency Surg,Surg, 51 N 39thSt,1stFloor Med Off Bldg Suite 120, Philadelphia, PA 19104 USA.	jennifer.leonard@wustl.edu; Lewis.Kaplan@uphs.upenn.edu	Martin, Niels/AAQ-8152-2021	Martin, Niels/0000-0002-2157-0825; Habermann, Elizabeth/0000-0002-1140-003X			Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Goldfarb MJ, 2017, CRIT CARE MED, V45, P1751, DOI 10.1097/CCM.0000000000002624; Haines KL, 2018, AM J HOSP PALLIAT ME, V35, P1081, DOI 10.1177/1049909117753377; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Holena DN, 2016, INJURY, V47, P77, DOI 10.1016/j.injury.2015.10.004; Hornor MA, 2018, J TRAUMA ACUTE CARE, V84, P590, DOI 10.1097/TA.0000000000001775; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Kramer AA, 2013, CRIT CARE MED, V41, P24, DOI 10.1097/CCM.0b013e3182657b8a; Kutcher ME, 2017, J TRAUMA ACUTE CARE, V82, P280, DOI 10.1097/TA.0000000000001312; Lilley EJ, 2016, JAMA SURG, V151, P695, DOI 10.1001/jamasurg.2016.0057; Maung AA, 2015, J TRAUMA ACUTE CARE, V79, P314, DOI 10.1097/TA.0000000000000728; Mosenthal AC, 2012, CRIT CARE MED, V40, P1199, DOI 10.1097/CCM.0b013e31823bc8e7; O'Connell K, 2016, CURR OPIN CRIT CARE, V22, P584, DOI 10.1097/MCC.0000000000000357; O'Mahony Sean, 2005, J Palliat Med, V8, P1033, DOI 10.1089/jpm.2005.8.1033; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Spronk PE, 2009, ANESTH ANALG, V109, P841, DOI 10.1213/ane.0b013e3181acc64a; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; 2017, NEUROCRIT CARE, V27, P154, DOI DOI 10.1007/S12028-017-0427-2	21	5	5	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2019	50	5					1064	1067		10.1016/j.injury.2019.01.024			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HX6UG	WOS:000467538200011	30745124				2022-02-06	
J	Novais, EN; Ferrer, MG; Williams, KA; Bixby, SD				Novais, Eduardo N.; Ferrer, Mariana G.; Williams, Kathryn A.; Bixby, Sarah D.			Acetabular Retroversion and Decreased Posterior Coverage Are Associated With Sports-related Posterior Hip Dislocation in Adolescents	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article; Proceedings Paper	Bernese Hip Symposium	FEB 01-03, 2018	Berne, SWITZERLAND				FEMOROACETABULAR IMPINGEMENT; FEMORAL ANTEVERSION; INSTABILITY; CAM; DEFORMITY; CHILDREN	Background Leverage of the femoral head against the acetabular rim may lead to posterior hip dislocation during sports activities in hips with femoroacetabular impingement (FAI) deformity. Abnormal concavity of the femoral head and neck junction has been well described in association with posterior hip dislocation. However, acetabular morphology variations are not fully understood. Questions/purposes The purpose of this study was to compare the acetabular morphology in terms of acetabular version and coverage of the femoral head in adolescents who sustained a posterior hip dislocation during sports and recreational activities with a control group of patients without a history of hip disease matched by age and sex. Methods In this case-control study, we identified 27 adolescents with posterior hip dislocation sustained during sports or recreational activities who underwent a CT scan of the hips (study group) and matched them to patients without a history of hip disease being evaluated with CT for possible appendicitis (control group). Between 2001 and 2017, we treated 71 adolescents (aged 10-19 years old) for posterior hip dislocations. During the period in question, we obtained CT scans or MR images after closed reduction of a posterior hip dislocation. One patient was excluded because of a diagnosis of Down syndrome. Twenty-one patients who were in motor vehicle-related accidents were also excluded. Twelve patients were excluded because MRI was obtained instead of CT. Finally, three patients with no imaging after reduction and seven patients with inadequate CT reformatting were excluded. Twenty-seven patients (38%) had CT scans of suitable quality for analysis, and these 27 patients constituted the study group. We compared those hips with 27 age-and sex-matched adolescents who had CT scans for appendicitis and who had no history of hip pain or symptoms (control group). One orthopaedic surgeon and one pediatric musculoskeletal radiologist, not invoved in the care of the patients included in the study, measured the lateral center-edge angle, acetabular index, acetabular depth/width ratio, acetabular anteversion angle (10 mm from the dome and at the level of the center of the femoral heads), and the anterior and posterior sector angles in the dislocated hip; the contralateral uninvolved hip of the patients with hip dislocations; and both hips in the matched control patients. Both the study and control groups had 25 (93%) males with a mean age of 13 (+/- 1.7) years. Inter-and intrarater reliability of measurements was assessed with intraclass correlation coefficient (ICC). There was excellent reliability (ICC > 0.90) for the acetabular anteversion angle measured at the center of the femoral head, the acetabular version 10 mm from the dome, and the posterior acetabular sector angle. Results The mean acetabular anteversion angle (+/- SD) was lower in the study group at 10 mm from the acetabular dome (-0.4 degrees +/- 9 degrees versus 4 degrees +/- 4 degrees; mean difference -5 degrees; 95% confidence interval [CI], -9 to -0.3; p = 0.015) and at the center of the femoral heads (10 degrees +/- 5 degrees versus 14 degrees +/- 4 degrees; mean difference -3 degrees; 95% CI, -6 to -0.9; p = 0.003). A higher proportion of acetabula was severely retroverted in the study group (14 of 27 [52%]; 95% CI, 33%-71% versus four of 27 [15%]; 95% CI, 1%-28%; p = 0.006). The mean posterior acetabular sector angle was lower in the study group (82 degrees +/- 8 degrees versus 90 degrees +/- 6 degrees; mean difference -8 degrees; 95% CI, -11 to -4; p < 0.001), whereas no difference was found for the anterior acetabular sector angle (65 degrees +/- 6 degrees versus 65 degrees +/- 7 degrees; mean difference 0.3 degrees; 95% CI, -3 to 4; p = 0.944). There was no difference for the lateral center-edge angle (27 degrees +/- 6 degrees versus 26 degrees +/- 5 degrees; p = 0.299), acetabular index (5 degrees +/- 3 degrees versus 6 +/- 4 degrees; p = 0.761), or acetabular depth/width ration (305 +/- 30 versus 304 +/- 31; p = 0.944) between groups. Acetabular anteversion angle at the center of the femoral heads (11 degrees +/- 4 degrees versus 14 degrees +/- 4 degrees; p = 0.006) and the posterior acetabular sector angle (86 degrees +/- 7 degrees versus 91 degrees +/- 6 degrees; p = 0.007) were lower in the contralateral uninvolved hips compared with control hips. Conclusions Decreased acetabular anteversion angle and posterior acetabular coverage of the femoral head were associated with posterior dislocation of the hip in adolescents with sports-related injury even in the absence of a high-energy mechanism. Further studies are necessary to clarify whether a causative effect exists between acetabular and femoral morphology and the dislocation of the hip in patients with sports-related injuries. Level of Evidence Level III, prognostic study.	[Novais, Eduardo N.; Ferrer, Mariana G.] Boston Childrens Hosp, Dept Orthoped Surg, 300 Longwood Ave, Boston, MA 02115 USA; [Williams, Kathryn A.] Boston Childrens Hosp, Dept Clin Res Ctr, Boston, MA USA; [Bixby, Sarah D.] Boston Childrens Hosp, Dept Radiol, Boston, MA USA		Novais, EN (corresponding author), Boston Childrens Hosp, Dept Orthoped Surg, 300 Longwood Ave, Boston, MA 02115 USA.	Eduardo.Novais@childrens.harvard.edu					Agricola R, 2014, AM J SPORT MED, V42, P798, DOI 10.1177/0363546514524364; ANDA S, 1991, SKELETAL RADIOL, V20, P267, DOI 10.1007/BF02341662; Arpey Nicholas C, 2018, JBJS Case Connect, V8, pe39, DOI 10.2106/JBJS.CC.17.00251; Berkes Marschall B, 2012, Am J Orthop (Belle Mead NJ), V41, P166; Canham CD, 2016, ARTHROSCOPY, V32, P203, DOI 10.1016/j.arthro.2015.07.021; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Crowther JD, 2002, J ORTHOP TRAUMA, V16, P433, DOI 10.1097/00005131-200207000-00013; Fabricant PD, 2013, J BONE JOINT SURG AM, V95A, P230, DOI [10.2106/JBJS.L.00592, 10.2106/JBJS.L.00772]; Fujii M, 2015, CLIN ORTHOP RELAT R, V473, P2056, DOI 10.1007/s11999-014-4084-x; GALBRAITH RT, 1987, J ORTHOP RES, V5, P523, DOI 10.1002/jor.1100050407; Krych AJ, 2012, CLIN ORTHOP RELAT R, V470, P3390, DOI 10.1007/s11999-012-2468-3; Letournel E, 2014, FRACTURE ACETABULUM, P23; Manner HM, 2012, J PEDIATR ORTHOP B, V21, P574, DOI 10.1097/BPB.0b013e328357bf04; Mayer SW, 2016, AM J SPORT MED, V44, P2299, DOI 10.1177/0363546516651119; Mayer SW, 2015, PEDIATR RADIOL, V45, P1355, DOI 10.1007/s00247-015-3317-9; Morris AC, 2017, J PEDIATR ORTHOPED, V37, P435, DOI 10.1097/BPO.0000000000000670; Novais EN, 2018, J BONE JOINT SURG AM, V100, P66, DOI 10.2106/JBJS.17.00377; Novais EN, 2016, J PEDIATR ORTHOPED, V36, P673, DOI 10.1097/BPO.0000000000000527; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; Popejoy D, 2012, J PEDIATR ORTHOPED, V32, P290, DOI 10.1097/BPO.0b013e3182471eb4; Siebenrock KA, 2013, CLIN ORTHOP RELAT R, V471, P1084, DOI 10.1007/s11999-012-2740-6; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V471, P1937, DOI 10.1007/s11999-013-2863-4; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Thanacharoenpanich S, 2018, J PEDIAT ORTHOP; Tonnis D, 1999, J BONE JOINT SURG AM, V81A, P1747; Tonnis D., 1987, CONGENITAL DYSPLASIA; UPADHYAY SS, 1985, J BONE JOINT SURG BR, V67, P232, DOI 10.1302/0301-620X.67B2.3884614; Wiberg G., 1939, ACTA CHIR SCAND S58, P5; World Health Organization. (WHO), ADOLESCENT HEALTH; Wylie JD, 2015, J HIP PRESERV SURG, V2, P303, DOI 10.1093/jhps/hnv036	30	5	5	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAY	2019	477	5					1101	1108		10.1097/CORR.0000000000000514			8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Orthopedics; Surgery	IE8FW	WOS:000472610300030	30272610	Green Published, Bronze			2022-02-06	
J	Ott, C; Bosch, A; Winzer, N; Friedrich, S; Schinzel, R; Tegtmeier, F; Schmieder, RE				Ott, Christian; Bosch, Agnes; Winzer, Nicole; Friedrich, Stephanie; Schinzel, Reinhard; Tegtmeier, Frank; Schmieder, Roland E.			Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY			English	Article						glomerular filtration rate; nitric oxide synthase; renal haemodynamics; renal plasma flow; VAS203	TRAUMATIC BRAIN-INJURY; GLOMERULAR HEMODYNAMICS; INTRARENAL HEMODYNAMICS; SELECTIVE-INHIBITION; ROSUVASTATIN; HYPERTENSION; KIDNEY; PHASE	Aims Reduced nitric oxide (NO) availability may adversely affect renal perfusion and glomerular filtration. The aim of the present study was to characterize in detail the pharmacological effects of VAS203, an inhibitor of NO synthase, on renal haemodynamics in humans. Methods This double-blind, randomized, placebo-controlled, cross-over phase-I-study comprised 18 healthy men. Renal haemodynamics were assessed with constant-infusion input-clearance technique with p-aminohippurate and inulin for renal plasma flow (RPF) and glomerular filtration rate (GFR), respectively. After baseline measurement, a constant infusion of the tetrahydrobiopterin analogue ronopterin (VAS203, total 10 mg/kg body weight) or placebo was administered at random order for 6 hours additionally. After a wash-out phase of 28 days, the second course was applied. In parallel, markers of early kidney injury and renal function were assessed repeatedly up to 48 hours after starting VAS203/placebo-infusion. Results VAS203-infusion resulted in a significant decrease of RPF (P < .0001) and GFR (P < .001) compared to placebo, but magnitude was within the physiological range. RPF and GFR recovered partly 2 hours after end of VAS203-infusion and was normal at beginning of the second infusion period. Compared to placebo, preglomerular resistance (P < .0001), and to lesser extent postglomerular resistance (P < .0001) increased, resulting in a decrease of intraglomerular pressure (P < .01). No treatment related effect on markers of early kidney injury, and on renal function (P for all >.20) have been observed. Conclusions Our phase-I-study in healthy humans indicates that VAS203 (10 mg/kg body weight) reduces renal perfusion and glomerular function within the physiological range mainly due to vasoconstriction at the preglomerular site.	[Ott, Christian; Bosch, Agnes; Winzer, Nicole; Friedrich, Stephanie; Schmieder, Roland E.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, Ulmenweg 18, D-91054 Erlangen, Germany; [Ott, Christian] Paracelsus Med Univ, Dept Nephrol & Hypertens, Nurnberg, Germany; [Schinzel, Reinhard; Tegtmeier, Frank] Vasopharm GmbH, Wurzburg, Germany		Schmieder, RE (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol & Hypertens, Ulmenweg 18, D-91054 Erlangen, Germany.	roland.schmieder@uk-erlangen.de			Vasopharm GmbH	Vasopharm GmbH	Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS272, DOI 10.1111/bph.13877; BROCHNERMORTENSEN J, 1987, SCAND J CLIN LAB INV, V47, P829; Chapman AB, 1997, AM J PHYSIOL-RENAL, V273, pF777, DOI 10.1152/ajprenal.1997.273.5.F777; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Constantin JM, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.05.010; Cruz DN, 2010, INTENS CARE MED, V36, P444, DOI 10.1007/s00134-009-1711-1; Delles C, 2004, NEPHROL DIAL TRANSPL, V19, P1392, DOI 10.1093/ndt/gfh187; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; GOMEZ DM, 1951, J CLIN INVEST, V30, P1143, DOI 10.1172/JCI102534; Guidi E, 2001, AM J HYPERTENS, V14, P121, DOI 10.1016/S0895-7061(00)01238-3; Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Ott C, 2008, ATHEROSCLEROSIS, V196, P704, DOI 10.1016/j.atherosclerosis.2006.12.020; Ott C, 2013, BRIT J CLIN PHARMACO, V75, P129, DOI 10.1111/j.1365-2125.2012.04336.x; Ott C, 2009, J NEPHROL, V22, P675; Pfeiffer S, 1997, BIOCHEM J, V328, P349, DOI 10.1042/bj3280349; Rinecker M, 2003, ACTA NEUROCHIR, V145, P977, DOI 10.1007/s00701-003-0131-1; Schmidt K, 1999, EUR J BIOCHEM, V259, P25, DOI 10.1046/j.1432-1327.1999.00003.x; SCHMIEDER RE, 1994, CLIN NEPHROL, V42, P381; Schmieder RE, 2007, DIABETES CARE, V30, P1351, DOI 10.2337/dc06-1551; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Simon AHR, 1998, NEPHROL DIAL TRANSPL, V13, P2261, DOI 10.1093/ndt/13.9.2261; SMITH HW, 1945, J CLIN INVEST, V24, P388, DOI 10.1172/JCI101618; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Werner ER, 1996, BIOCHEM J, V320, P193, DOI 10.1042/bj3200193	33	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-5251	1365-2125		BRIT J CLIN PHARMACO	Br. J. Clin. Pharmacol.	MAY	2019	85	5					900	907		10.1111/bcp.13870			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HU4JR	WOS:000465241100004	30666700	Bronze, Green Published			2022-02-06	
J	Ownsworth, T; Fleming, J; Doig, E; Shum, DHK; Swan, S				Ownsworth, Tamara; Fleming, Jennifer; Doig, Emmah; Shum, David H. K.; Swan, Sarah			CONCORDANCE BETWEEN THE AWARENESS QUESTIONNAIRE AND SELF-AWARENESS OF DEFICITS INTERVIEW FOR IDENTIFYING IMPAIRED SELF-AWARENESS IN INDIVIDUALS WITH TRAUMATIC BRAIN INJURY IN THE COMMUNITY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; impaired self-awareness; assessment; concordance; sensitivity; specificity	EXECUTIVE FUNCTION; ADJUSTMENT; FEEDBACK	Objective: To investigate concordance between the Awareness Questionnaire (AQ) and Self-Awareness of Deficits Interview (SADI) for identifying impaired self-awareness in the community after traumatic brain injury. Design: A retrospective file audit was conducted to retrieve data on the AQ and SADI for participants with traumatic brain injury involved in previous studies on community-based outcomes. Concordance between the AQ and SADI was examined using receiver operating characteristic curves for different scores on each measure. Participants: A total of 80 individuals with moderateto-severe traumatic brain injury (81% male, mean age 2.25 years, standard deviation (SD) 11.5 years) living in the community. Methods: Participants were administered the AQ and SADI and their significant other completed the AQ and SADI checklist. Results: Consistency of classification of impaired self-awareness between the AQ and SADI was high (i. e. 80-84%) based on scores reflecting good sensitivity and specificity. Corresponding scores on the 2 measures and rates of impaired self-awareness were as follows: SADI > 3 similar to AQ discrepancy > 4 (45-48% with impaired self-awareness); SADI > 4 similar to AQ discrepancy > 9 (26-34% with impaired self-awareness); SADI > 5 similar to AQ discrepancy > 12 (13-26% with impaired self-awareness). Conclusion: The AQ and SADI yielded consistent information regarding the presence of impaired selfawareness in community-based individuals with traumatic brain injury. The choice of measure may depend on how the tool is being used to guide rehabilitation planning.	[Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Ownsworth, Tamara; Shum, David H. K.] Griffith Univ, Menzies Hlth Inst Queensland, Brisbane, Qld, Australia; [Fleming, Jennifer; Doig, Emmah; Swan, Sarah] Univ Queensland, Sch Hlth & Rehabil Sci, St Lucia, Qld, Australia; [Shum, David H. K.] Chinese Acad Sci, Inst Psychol, Neuropsychol & Appl Cognit Neurosci Lab, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Shum, David H. K.] Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Hong Kong, Peoples R China		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Fleming, Jennifer/AAH-5108-2020; Doig, Emmah/AAG-6674-2021; Ownsworth, Tamara/ABB-6961-2021; Shum, David H. K./A-3914-2008	Doig, Emmah/0000-0002-7020-053X; Ownsworth, Tamara/0000-0003-1835-7094; Swan, Sarah/0000-0001-8016-9823; Shum, David H. K./0000-0002-4810-9262	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1083064, APP210347]	Data collection in this study was funded by 2 grants from the National Health and Medical Research Council (APP1083064 & APP210347).	Doig E, 2010, AM J OCCUP THER, V64, P904, DOI 10.5014/ajot.2010.08156; Fleming J, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1758-6; Fleming JM, 1996, BRAIN INJURY, V10, P1; Geytenbeek M, 2017, BRAIN INJURY, V31, P1791, DOI 10.1080/02699052.2017.1346297; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068	13	5	5	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2019	51	5					376	379		10.2340/16501977-2537			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HW7CX	WOS:000466848600007	30805656	gold, Green Published, Green Submitted			2022-02-06	
J	Papacocea, MT; Badarau, IA; Radoi, M; Papacocea, IR				Papacocea, Marius Toma; Badarau, Ioana Anca; Radoi, Mugurel; Papacocea, Ioana Raluca			The Predictive Role of Biochemical Plasma Factors in Patients with Severe Traumatic Brain Injuries	REVISTA DE CHIMIE			English	Article						traumatic brain injury; hyponatremia; glucose	INDEPENDENT PREDICTOR; ANTIOXIDANT ENZYMES; EPIDEMIOLOGY; HYPONATREMIA; METABOLITES; DISORDERS	Traumatic brain injuries (TBI) represent a high impact public health problem due to a high rate of death, long term disability and occurrence especially in young adults. Despite several promising animal studies, several parameters were proposed as biological markers and were assessed for this aim. Our study proposes the study of the early biochemical changes in association to hematological parameters for severe TBI patients prognosis. 43 patients with acute TBI were included in study based on clinical, laboratory and imagistic findings. The severity of the TBI was established by Glasgow Coma Scale GCS 3-8. In all patients were evaluated hematologic parameters (Red blood cell count - RBC, Hematocrit, blood Hemoglobin, White blood cell - WBC, Platelet count and biochemical parameters (glucose, urea, creatinine, electrolytes). Outcome was expressed as Glasgow Outcome Scale (GOS), between 1-5. Values were compared to control group -15 cases. Significant early differences in body temperature, heart rate, and systolic blood pressure were observed in TBI group versus control (p<0.05). After correlation, laboratory findings significantly associated to severe outcome - GOS = 1, 2 - (p<0.05) were plasma Na decrease and significant glucose increase. An early increase of temperature and decrease of Na may predict a severe outcome in patients with acute TBI; association with shifts in heart rate and blood pressure, imposes aggressive treatment measures.	[Papacocea, Marius Toma] Carol Davila Univ Med & Pharm, St Pantelimon Clin Emergency Hosp, Fac Med, Neurosurg Dept, 340-342 Pantelimon Str, Bucharest 021659, Romania; [Badarau, Ioana Anca; Papacocea, Ioana Raluca] Carol Davila Univ Med & Pharm, Fac Med, Discipline Physiol 1, 37 Dionisie Lupu Str, Bucharest 020021, Romania; [Radoi, Mugurel] Carol Davila Univ Med & Pharm, 340-342 Pantelimon Str, Bucharest 021659, Romania; [Radoi, Mugurel] Natl Inst Neurol & Neurovasc Dis, Neurosurg Dept, 10-12 Berceni Str 1, Bucharest 041915, Romania		Papacocea, IR (corresponding author), Carol Davila Univ Med & Pharm, Fac Med, Discipline Physiol 1, 37 Dionisie Lupu Str, Bucharest 020021, Romania.	rpapacocea@gmail.com					Ageu L, 2018, REV CHIM-BUCHAREST, V69, P621; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Ley EJ, 2010, J SURG RES, V163, P142, DOI 10.1016/j.jss.2010.04.046; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mihai LG, 2012, FARMACIA, V60, P49; Miyata K, 2016, J NEUROSURG, V124, P527, DOI 10.3171/2015.3.JNS141895; Nussbaum LA, 2018, REV CHIM-BUCHAREST, V69, P965; Papacocea A, 2010, CHIRURGIA-BUCHAREST, V105, P805; Papacocea T, 2009, CHIRURGIA-BUCHAREST, V104, P99; Papacocea T, 2019, FARMACIA, V67, P140, DOI 10.31925/farmacia.2019.1.19; Papacocea T, 2014, FARMACIA, V62, P1118; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Raftu G, 2019, REV CHIM-BUCHAREST, V70, P228; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Sturdik I, 2014, EUR J INTERN MED, V25, P379, DOI 10.1016/j.ejim.2014.02.002; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Vrinceanu D, 2018, REV ROM MATER, V48, P407; Vrinceanu D, 2018, ROM J LEG MED, V26, P16, DOI 10.4323/rjlm.2018.16; Yokobori S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0137-4; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	26	5	5	0	4	CHIMINFORM DATA S A	BUCHAREST	CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA	0034-7752			REV CHIM-BUCHAREST	Rev. Chim.	MAY	2019	70	5					1754	1757					4	Chemistry, Multidisciplinary; Engineering, Chemical	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Engineering	IB2FZ	WOS:000470086400050					2022-02-06	
J	Petrin, D; Gagolewicz, PJ; Mehder, RH; Bennett, BM; Jin, AY; Andrew, RD				Petrin, Dylan; Gagolewicz, Peter J.; Mehder, Rasha H.; Bennett, Brian M.; Jin, Albert Y.; Andrew, R. David			Spreading depolarization and neuronal damage or survival in mouse neocortical brain slices immediately and 12 hours following middle cerebral artery occlusion	JOURNAL OF NEUROPHYSIOLOGY			English	Article						ATPase; hypothalamus; Na+-K+ pump; neuroprotection; pyramidal; spreading depolarization; spreading depression; stroke; traumatic brain injury; whole cell recording	INTRINSIC OPTICAL SIGNALS; CA1 PYRAMIDAL NEURONS; ANOXIC DEPOLARIZATION; BLOOD-FLOW; GLUTAMATE RELEASE; MEMBRANE-PROPERTIES; FOCAL ISCHEMIA; DEPRESSION; STROKE; NMDA	Whereas many studies have examined the properties of the compromised neocortex in the first several days following ischemia, there is less information regarding the initial 12 h poststroke. In this study we examined live mouse neocortical slices harvested immediately and 12 h after a 30-min middle cerebral artery occlusion (MCAo). We compared nonischemic and ischemic hemispheres with regard to the propensity for tissue swelling and for generating spreading depolarization (SD), as well as evoked synaptic responses and single pyramidal neuron electrophysiological properties. We observed spontaneous SD in 7% of slices on the nonstroked side and 25% in the stroked side following the 30-min MCAo. Spontaneous SD was rare in 12-h recovery slices. The region of the ischemic core and surround in slices was not susceptible to SD induced by oxygen and glucose deprivation. At the neuronal level, neocortical gray matter is surprisingly unaltered in brain slices harvested immediately poststroke. However, by 12 h, the fields of pyramidal and striatal neurons that comprise the infarcted core are electrophysiologically silent because the majority are morphologically devastated. Yet, there remains a subset of diffusely distributed "healthy" pyramidal neurons in the core at 12 h post-MCAo that persist for days poststroke. Their intact electrophysiology and dendritic morphology indicate a surprisingly selective resilience to stroke at the neuronal level. NEW & NOTEWORTHY It is generally accepted that the injured core region of the brain resulting from a focal stroke contains no functioning neurons. Our study shows that some neurons, although surrounded by devastated neighbors, can maintain their structure and electrical activity. This surprising finding raises the possibility of discovering how these neurons are protected to pinpoint new strategies for reducing stroke injury.	[Petrin, Dylan; Gagolewicz, Peter J.; Mehder, Rasha H.; Bennett, Brian M.; Jin, Albert Y.; Andrew, R. David] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada		Andrew, RD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	andrewd@queensu.ca			Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada [G-14-0006260]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN-2017-04624]; King Abdulaziz University of Saudi Arabia; Canadian Institutes of HealthCanadian Institutes of Health Research (CIHR) [PJT 153013]	This work was supported by Heart and Stroke Foundation of Canada Grant G-14-0006260 (to R. David Andrew), Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2017-04624 (R. David Andrew), King Abdulaziz University of Saudi Arabia (to R. H. Mehder), and Canadian Institutes of Health Grant PJT 153013 (to B. M. Bennett).	Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Anderson TR, 2002, J NEUROPHYSIOL, V88, P2713, DOI 10.1152/jn.00321.2002; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Andrew RD, 1996, J NEUROPHYSIOL, V76, P2707, DOI 10.1152/jn.1996.76.4.2707; ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Barber PA, 2004, STROKE, V35, P1720, DOI 10.1161/01.STR.0000129653.22241.d7; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BRANSTON NM, 1977, J NEUROL SCI, V32, P305, DOI 10.1016/0022-510X(77)90014-4; Brisson CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096585; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; FD NeuroTechnologies, 2014, FD RAP GOLG KIT US M, P1; Gao TM, 1999, NEUROSCIENCE, V90, P771, DOI 10.1016/S0306-4522(98)00493-X; Gao TM, 1998, NEUROSCIENCE, V87, P371, DOI 10.1016/S0306-4522(98)00150-X; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; HILLERED L, 1989, J CEREBR BLOOD F MET, V9, P607, DOI 10.1038/jcbfm.1989.87; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Iijima T, 1998, NEUROSCI RES, V32, P201, DOI 10.1016/S0168-0102(98)00090-X; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Jiang MQ, 2017, BRAIN PATHOL, V27, P480, DOI 10.1111/bpa.12425; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; Koroleva VI, 1996, P NATL ACAD SCI USA, V93, P3710, DOI 10.1073/pnas.93.8.3710; LAURITZEN M, 1990, J CEREBR BLOOD F MET, V10, P115, DOI 10.1038/jcbfm.1990.14; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MIES G, 1994, J CEREBR BLOOD F MET, V14, P802, DOI 10.1038/jcbfm.1994.100; Morimoto T, 1996, J CEREBR BLOOD F MET, V16, P92, DOI 10.1097/00004647-199601000-00011; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Obeidat AS, 1998, EUR J NEUROSCI, V10, P3451, DOI 10.1046/j.1460-9568.1998.00358.x; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; OBRENOVITCH TP, 1988, J CEREBR BLOOD F MET, V8, P866, DOI 10.1038/jcbfm.1988.144; PHILLIS JW, 1991, J NEUROCHEM, V56, P644, DOI 10.1111/j.1471-4159.1991.tb08198.x; Polischuk TM, 1996, CAN J PHYSIOL PHARM, V74, P712, DOI 10.1139/cjpp-74-6-712; Satoh M, 1999, BRAIN RES, V822, P142, DOI 10.1016/S0006-8993(99)01141-5; SCIOTTI VM, 1992, J CEREBR BLOOD F MET, V12, P646, DOI 10.1038/jcbfm.1992.89; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; SILVA LR, 1991, J NEUROPHYSIOL, V66, P2034, DOI 10.1152/jn.1991.66.6.2034; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; STRONG AJ, 1983, J CEREBR BLOOD F MET, V3, P86, DOI 10.1038/jcbfm.1983.11; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Sukhotinsky I, 2010, J CEREBR BLOOD F MET, V30, P1168, DOI 10.1038/jcbfm.2009.285; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; Tang YT, 2014, J NEUROPHYSIOL, V112, P2572, DOI 10.1152/jn.00205.2014; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; Zhang WQ, 2010, INT J MOL SCI, V11, P4407, DOI 10.3390/ijms11114407; Zhang XL, 2015, EXP NEUROL, V273, P312, DOI 10.1016/j.expneurol.2015.07.025; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	60	5	5	2	6	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAY	2019	121	5					1650	1663		10.1152/jn.00670.2018			14	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	HU4MP	WOS:000465249500008	30811255	Green Published, Bronze			2022-02-06	
J	Zuckerman, SL; Reynolds, BB; Yengo-Kahn, AM; Kuhn, AW; Chadwell, JT; Goodale, SE; Lafferty, CE; Langford, KT; McKeithan, LJ; Kirby, P; Solomon, GS				Zuckerman, Scott L.; Reynolds, Bryson B.; Yengo-Kahn, Aaron M.; Kuhn, Andrew W.; Chadwell, Jacob T.; Goodale, Sarah E.; Lafferty, Claire E.; Langford, Kyle T.; McKeithan, Lydia J.; Kirby, Paul; Solomon, Gary S.			A football helmet prototype that reduces linear and rotational acceleration with the addition of an outer shell	JOURNAL OF NEUROSURGERY			English	Article						sport-related concussion; American football; engineering; helmet safety; linear acceleration; rotational acceleration; traumatic brain injury	HIGH-SCHOOL FOOTBALL; SPORT-RELATED CONCUSSION; MODEL; MANAGEMENT; SPECTRUM; PLAYERS; DEVICE; RISK	OBJECTIVE Amid the public health controversy surrounding American football, a helmet that can reduce linear and rotational acceleration has the potential to decrease forces transmitted to the brain. The authors hypothesized that a football helmet with an outer shell would reduce both linear and rotational acceleration. The authors' objectives were to 1) determine an optimal material for a shock-absorbing outer shell and 2) examine the ability of an outer shell to reduce linear and/or rotational acceleration. METHODS A laboratory-based investigation was undertaken using an extra-large Riddell Revolution football helmet. Two materials (Dow Corning Dilatant Compound and Sorbothane) were selected for their non-Newtonian properties (changes in viscosity with shear stress) to develop an outer shell. External pads were attached securely to the helmet at 3 locations: the front boss, the side, and the back. The helmet was impacted 5 times per location at 6 m/sec with pneumatic ram testing. Two-sample t-tests were used to evaluate linear/rotational acceleration differences between a helmet with and a helmet without the outer shell. RESULTS Sorbothane was superior to the Dow Corning compound in force reduction and recovered from impact without permanent deformation. Of 5 different grades, 70-duro (a unit of hardness measured with a durometer) Sorbothane was found to have the greatest energy dissipation and stiffness, and it was chosen as the optimal outer-shell material. The helmet prototype with the outer shell reduced linear acceleration by 5.8% (from 75.4g to 71.1g; p < 0.001) and 10.8% (from 89.5g to 79.8g; p = 0.033) at the side and front boss locations, respectively, and reduced rotational acceleration by 49.8% (from 9312.8 rad/sec(2) to 4671.7 rad/sed(2); p < 0.001) at the front boss location. CONCLUSIONS Sorbothane (70 duro) was chosen as the optimal outer-shell material. In the outer-shell prototype helmet, the results demonstrated a 5%-10% reduction in linear acceleration at the side and front boss locations, and a 50% reduction in rotational acceleration at the front boss location. Given the paucity of publicly reported helmet-design literature and the importance of rotational acceleration in head injuries, the substantial reduction seen in rotational acceleration with this outer-shell prototype holds the potential for future helmet-design improvements.	[Zuckerman, Scott L.; Reynolds, Bryson B.; Yengo-Kahn, Aaron M.; Kuhn, Andrew W.; Kirby, Paul; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Yengo-Kahn, Aaron M.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Reynolds, Bryson B.] Vanderbilt Univ, Med Ctr, Dept Radiol, Nashville, TN 37232 USA; [Chadwell, Jacob T.; Goodale, Sarah E.; Lafferty, Claire E.; Langford, Kyle T.; McKeithan, Lydia J.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Yengo-Kahn, Aaron/AAV-7647-2020; Kuhn, Andrew W/AAM-4820-2020	Yengo-Kahn, Aaron/0000-0002-5989-3064; Kuhn, Andrew W/0000-0003-1836-7575; Reynolds, Bryson/0000-0001-9196-1461	NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32 EB001628] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001628] Funding Source: NIH RePORTER		Ahmed A, 2017, COMPUT METHOD BIOMEC, V20, P1464, DOI 10.1080/10255842.2017.1376323; [Anonymous], 2009, EQUISEARCH      0524; Breedlove KM, 2017, J ATHL TRAINING, V52, P802, DOI 10.4085/1062-6050-52.6.01; Bulsara YR, 1998, ENDOD DENT TRAUMATOL, V14, P45; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; CINATS J, 1987, CLIN ORTHOP RELAT R, P281; Collins CL, 2016, AM J SPORT MED, V44, P1382, DOI 10.1177/0363546516629626; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Comstock RD, 2016, SUMMARY REPORT NATL; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; FORBES JA, 2012, NEUROSURG FOCUS, V33; Fowler JN, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029982; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Harman KA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13634; Hayes SG, 2016, MATERIALS AND TECHNO; Hernandez F, 2015, J BIOMECH, V48, P3469, DOI 10.1016/j.jbiomech.2015.05.034; King A. I., 2003, INT RES C BIOM IMP I; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Lange K, 2018, DODLIVE         0204; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; Nakatsuka Austin S, 2014, Hawaii J Med Public Health, V73, P256; Nasir S, 2016, GOMAL J MED SCI, V14, P151; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sarman S, 2015, PHYS CHEM CHEM PHYS, V17, P16615, DOI 10.1039/c5cp02468d; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Zhu W, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4977085; 2017, J ATHL TRAIN, V52, P175	32	5	5	0	7	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2019	130	5					1634	1641		10.3171/2018.1.JNS172733			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW0VW	WOS:000466401100027	29957115	Bronze, Green Accepted			2022-02-06	
J	Romano, F; Bertolini, G; Agostino, D; Straumann, D; Ramat, S; Feddermann-Demont, N				Romano, Fausto; Bertolini, Giovanni; Agostino, Daniel; Straumann, Dominik; Ramat, Stefano; Feddermann-Demont, Nina			Functional Head Impulse Test in Professional Athletes: Sport-Specific Normative Values and Implication for Sport-Related Concussion	FRONTIERS IN NEUROLOGY			English	Article						functional head impulse test; VOR (Vestibulo-Ocular Reflex); sport related concussion; visual acuity (VA); professional athletes; acceleration; normative data; vestibulogram	DYNAMIC VISUAL-ACUITY; TRAUMATIC BRAIN-INJURY; SEMICIRCULAR-CANAL FUNCTION; VESTIBULOOCULAR REFLEX; GAZE STABILIZATION; STIMULATION; PERFORMANCE; SYMPTOMS; DEFICITS; THRUSTS	Dizziness, slow visual tracking, or blurred vision following active head (or body) movements are among the most common symptoms reported following sport-related concussion, often related to concurrent dysfunctions of the vestibular system. In some cases, symptoms persist even if bedside and auxiliary standard vestibular tests are unremarkable. New functional tests have been developed in recent years to objectify neurological alterations that are not captured by standard tests. The functional head impulse test (fHIT) requires the patient to recognize an optotype that is briefly flashed during head rotations with various angular accelerations (2,001-6,000 deg/s(2)) and assesses the proportion if correct answers (pca). 268 active professional athletes (23.70 +/- 5.32y) from six different sports were tested using fHIT. Pca were analyzed both pooling head acceleration in the range of 2,001-6,000 deg/s(2) and computing a single pca value for each 1,000 deg/s(2) bin in the range 2,001-8,000 deg/s(2). No significant difference (p = 0.159) was found between responses to head impulses in the plane of horizontal (pca: 0.977) and vertical semicircular canals (pca: 0.97). The sport practiced had a major effect on the outcome of the fHIT. Handball players achieved a better performance (p < 0.001) than the whole athlete group, irrespective of the direction of head impulses. The pca achieved by athletes practicing snowboard, bob and skeleton were instead significantly below those of the whole athlete group (p < 0.001) but only when vertical head impulses were tested. Overall, pca declined with increasing head acceleration. The decline was particularly evident in the range not included in the standard fHIT exam, i.e., 6,001-8,000 deg/s(2) for horizontal and 5,001-8,000 deg/s(2) for vertical head impulses. When vertical head impulses were tested, athletes practicing snowboard, bob and skeleton (non-ball sports) showed, beside the lower overall pca, also a steeper decline as a function of vertical head acceleration. The findings suggest that: (1) functional VOR testing can help understanding sport-specific VOR requirements; (2) the fHIT is able to detect and objectify subtle, sport-specific changes of functional VOR performance; (3) if sport-specific normative values are used, the fHIT test procedure needs to be optimized, starting from the highest acceleration to minimize the number of head impulses.	[Romano, Fausto; Bertolini, Giovanni; Straumann, Dominik; Feddermann-Demont, Nina] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Romano, Fausto; Bertolini, Giovanni; Straumann, Dominik; Feddermann-Demont, Nina] Univ Hosp Zurich, Clin Neurosci Ctr, Zurich, Switzerland; [Romano, Fausto; Bertolini, Giovanni; Agostino, Daniel; Straumann, Dominik; Feddermann-Demont, Nina] Swiss Concuss Ctr, Zurich, Switzerland; [Ramat, Stefano] Univ Pavia, Dept Comp Elect & Biomed Engn, Pavia, Italy		Bertolini, G (corresponding author), Univ Zurich, Dept Neurol, Zurich, Switzerland.; Bertolini, G (corresponding author), Univ Hosp Zurich, Clin Neurosci Ctr, Zurich, Switzerland.; Bertolini, G (corresponding author), Swiss Concuss Ctr, Zurich, Switzerland.	giovanni.bertolini@swissconcussion.com	Ramat, Stefano/E-6495-2011; Bertolini, Giovanni/W-4117-2019	Ramat, Stefano/0000-0001-5932-186X; Bertolini, Giovanni/0000-0003-2428-9454; Romano, Fausto/0000-0002-6166-7461	Schulthess Foundation (Zurich, Switzerland)	This work was supported by the Schulthess Foundation (Zurich, Switzerland).	Agrawal Y, 2014, OTOL NEUROTOL, V35, P283, DOI 10.1097/MAO.0b013e3182995227; Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Arshad Q, 2017, CLIN NEUROL NEUROSUR, V155, P17, DOI 10.1016/j.clineuro.2017.01.021; BEALS RP, 1971, AMER J OPT ARCH AM A, V48, P585; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; Bohler A, 2010, IEEE ENG MED BIO, P6615, DOI 10.1109/IEMBS.2010.5627138; Brandt, 2003, VERTIGO ITS MULTISEN; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; CARTLIDGE NEF, 1978, SCOT MED J, V23, P103, DOI 10.1177/003693307802300146; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Colagiorgio P, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00165; Corallo G, 2018, J NEUROL, V265, P35, DOI 10.1007/s00415-018-8910-z; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Curthoys IS, 2017, HEARING BALANC COMMU, V15, P113, DOI 10.1080/21695717.2017.1353774; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; de No RL, 1933, ARCH NEURO PSYCHIATR, V30, P245, DOI 10.1001/archneurpsyc.1933.02240140009001; DEMER JL, 1994, AM J OTOL, V15, P340; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; Goebel JA, 2007, OTOL NEUROTOL, V28, P68, DOI 10.1097/01.mao.0000244351.42201.a7; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; Herdman SJ, 1998, AM J OTOL, V19, P790; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGarvie LA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00154; MORRIS GSD, 1977, RES QUART, V48, P480; Peng GCY, 2004, J NEUROPHYSIOL, V91, P1763, DOI 10.1152/jn.00611.2002; Quevedo-Junyent L, 2011, RES Q EXERCISE SPORT, V82, P644, DOI 10.1080/02701367.2011.10599801; Ramat Stefano, 2012, Front Neurol, V3, P39, DOI 10.3389/fneur.2012.00039; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Schmid-Priscoveanu A, 1999, ACTA OTO-LARYNGOL, V119, P750, DOI 10.1080/00016489950180379; Schubert MC, 2006, JARO-J ASSOC RES OTO, V7, P329, DOI 10.1007/s10162-006-0047-6; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shepard NT, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P779; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Uchida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031530; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Versino M, 2014, J VESTIBUL RES-EQUIL, V24, P459, DOI 10.3233/VES-140531; Versino M, 2014, CLIN NEUROPHYSIOL, V125, P1071, DOI 10.1016/j.clinph.2013.09.024; Vital D, 2010, ARCH OTOLARYNGOL, V136, P686, DOI 10.1001/archoto.2010.99; Wallace B, 2016, EYE BRAIN, V8, P153, DOI 10.2147/EB.S82670; Wallace J, 2018, J SPORT HEALTH SCI, V7, P204, DOI 10.1016/j.jshs.2016.11.002; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Wettstein VG, 2016, J VESTIBUL RES-EQUIL, V26, P395, DOI 10.3233/VES-160591; Zar J.H., 2013, BIOSTATISTICAL ANAL BIOSTATISTICAL ANAL; 2013, OTOL NEUROTOL, V34, P1090, DOI DOI 10.1097/MAO.0B013E31827F192E	55	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 30	2019	10								387	10.3389/fneur.2019.00387			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HW2KM	WOS:000466512900001	31130909	Green Accepted, gold, Green Published			2022-02-06	
J	Timaru-Kast, R; Gotthardt, P; Luh, C; Huang, CS; Hummel, R; Schafer, MKE; Thal, SC				Timaru-Kast, Ralph; Gotthardt, Philipp; Luh, Clara; Huang, Changsheng; Hummel, Regina; Schaefer, Michael K. E.; Thal, Serge C.			Angiotensin II Receptor 1 Blockage Limits Brain Damage and Improves Functional Outcome After Brain Injury in Aged Animals Despite Age-Dependent Reduction in AT1 Expression	FRONTIERS IN AGING NEUROSCIENCE			English	Article						angiotensin II receptor type 1; traumatic brain injury; aged; inflammation; candesartan; AT1 inhibition; neutrophil granulocyte; M2 microglia polarization	DOPAMINERGIC DEGENERATION; ALTERNATIVE ACTIVATION; MOUSE MODEL; TYPE-1 RECEPTOR; GENE-EXPRESSION; RHO-KINASE; RT-PCR; SYSTEM; NORMALIZATION; INFLAMMATION	Traumatic brain injury (TBI) is a frequent pathology associated with poor neurological outcome in the aged population. We recently observed accelerated cerebral inflammation in aged mice in response to TBI. Candesartan is a potent specific inhibitor of angiotensin II receptor type 1 (AT1) which limits cerebral inflammation and brain damage in juvenile animals after experimental TBI. In the present study, we show significantly lower posttraumatic AT1 mRNA levels in aged (21 months) compared to young (2 months) mice. Despite low cerebral At1 expression, pharmacologic blockade by treatment with candesartan [daily, beginning 30 min after experimental TBI by controlled cortical impact (CCI)] was highly effective in both young and aged animals and reduced histological brain damage by -20% after 5 days. In young mice, neurological improvement was enhanced by AT1 inhibition 5 days after CCI. In older animals, candesartan treatment reduced functional impairment already on day 3 after TBI and post-traumatic body weight (BW) loss was attenuated. Candesartan reduced microglia activation (-40%) in young and aged animals, and neutrophil infiltration (-40% to 50%) in aged mice, whereas T-cell infiltration was not changed in either age group. In young animals, markers of anti-inflammatory microglia M2a polarization [arginase 1 (Arg1), chitinase3-like 3 (Ym1)] were increased by candesartan at days 1 and 5 after insult. In older mice 5 days after insult, expression of Arg1 was significantly higher independently of the treatment, whereas Ym1 gene expression was further enhanced by AT1 inhibition. Despite age-dependent posttraumatic differences in At1 expression levels, inhibition of AT1 was highly effective in a posttreatment paradigm. Targeting inflammation with candesartan is, therefore, a promising therapeutic strategy to limit secondary brain damage independent of the age.	[Timaru-Kast, Ralph; Gotthardt, Philipp; Luh, Clara; Huang, Changsheng; Hummel, Regina; Schaefer, Michael K. E.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Schaefer, Michael K. E.; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Mol Surg Res, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci, Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany.; Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Mol Surg Res, Mainz, Germany.	serge@thal.de	Thal, Serge/D-6593-2011; Schafer, Michael/AAB-1395-2020; Schaefer, Michael K.E./S-1715-2019; Changsheng, Huang/M-6033-2018	Thal, Serge/0000-0002-1222-8729; Schaefer, Michael K.E./0000-0001-6055-6244; 			Bell-Temin H, 2015, MOL CELL PROTEOMICS, V14, P3173, DOI 10.1074/mcp.M115.053926; Borrajo A, 2014, NEUROPHARMACOLOGY, V85, P1, DOI 10.1016/j.neuropharm.2014.05.021; Borrajo A, 2014, GLIA, V62, P145, DOI 10.1002/glia.22595; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Csiszar A, 2003, FASEB J, V17, P1183, DOI 10.1096/fj.02-1049fje; Culman J, 2002, J HUM HYPERTENS, V16, pS64, DOI 10.1038/sj.jhh.1001442; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Garcia-Bardon A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167209; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hamel E, 2016, CELL MOL NEUROBIOL, V36, P219, DOI 10.1007/s10571-015-0285-4; Hardeland R, 2015, PROG NEUROBIOL, V127, P46, DOI 10.1016/j.pneurobio.2015.02.001; Hazeldine J, 2015, AGEING RES REV, V24, P349, DOI 10.1016/j.arr.2015.10.003; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Ito H, 2001, J HYPERTENS, V19, P591, DOI 10.1097/00004872-200103001-00011; Joseph JP, 2014, NEUROPHARMACOLOGY, V81, P134, DOI 10.1016/j.neuropharm.2014.01.044; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Labandeira-Garcia JL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00129; Labandeira-Garcia JL, 2013, MOVEMENT DISORD, V28, P1337, DOI 10.1002/mds.25614; Labandeira-Garcia JL, 2011, AGING DIS, V2, P257; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenkei Z, 1997, FRONT NEUROENDOCRIN, V18, P383, DOI 10.1006/frne.1997.0155; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Neniskyte U, 2014, FEBS LETT, V588, P2952, DOI 10.1016/j.febslet.2014.05.046; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Ongali B, 2014, NEUROBIOL DIS, V68, P126, DOI 10.1016/j.nbd.2014.04.018; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Rey P, 2007, NEUROBIOL AGING, V28, P555, DOI 10.1016/j.neurobiolaging.2006.02.018; Rodriguez-Perez AI, 2015, GLIA, V63, P466, DOI 10.1002/glia.22765; Rodriguez-Perez AI, 2013, AGE, V35, P1675, DOI 10.1007/s11357-012-9470-2; Saavedra JM, 2004, ANN NY ACAD SCI, V1018, P76, DOI 10.1196/annals.1296.009; Saavedra JM, 2005, CELL MOL NEUROBIOL, V25, P485, DOI 10.1007/s10571-005-4011-5; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Sebastiani A, 2017, J NEUROSCI METH, V276, P73, DOI 10.1016/j.jneumeth.2016.11.012; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Suzuki Y, 2003, INT J BIOCHEM CELL B, V35, P881, DOI 10.1016/S1357-2725(02)00271-6; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2015, J NEUROTRAUM, V32, P1777, DOI 10.1089/neu.2014.3784; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Trigiani LJ, 2018, HYPERTENSION, V72, P1217, DOI 10.1161/HYPERTENSIONAHA.118.11775; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Varin A, 2009, IMMUNOBIOLOGY, V214, P630, DOI 10.1016/j.imbio.2008.11.009; Vega A, 2010, ATHEROSCLEROSIS, V209, P344, DOI 10.1016/j.atherosclerosis.2009.09.067; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Villar-Cheda B, 2014, NEUROBIOL AGING, V35, P1726, DOI 10.1016/j.neurobiolaging.2014.01.017; Villar-Cheda B, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.006; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; 2012, CRIT CARE MED, V40, P935, DOI DOI 10.1097/CCM.0B013E31822F08B9; 2014, NEUROTHERAPEUTICS, V11, P665, DOI DOI 10.1007/S13311-014-0286-X	70	5	6	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	APR 26	2019	11								63	10.3389/fnagi.2019.00063			18	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	HV7PV	WOS:000466173900001	31105549	Green Published, gold			2022-02-06	
J	Witkowski, ED; Gao, Y; Gavsyuk, AF; Maor, I; DeWalt, GJ; Eldred, WD; Mizrahi, A; Davison, IG				Witkowski, Ellen D.; Gao, Yuan; Gavsyuk, Alexander F.; Maor, Ido; DeWalt, Gloria J.; Eldred, William D.; Mizrahi, Adi; Davison, Ian G.			Rapid Changes in Synaptic Strength After Mild Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; piriform cortex; synapse; excitatory-inhibitory balance; neuroinflammation	CEREBRAL VASCULAR INJURY; HEAD-INJURY; PIRIFORM CORTEX; MOUSE MODEL; POSTTRAUMATIC EPILEPSY; HOMEOSTATIC PLASTICITY; TRANSMITTER RELEASE; MICROGLIAL RESPONSE; PERIRHINAL CORTEX; OLFACTORY CORTEX	Traumatic brain injury (TBI) affects millions of Americans annually, but effective treatments remain inadequate due to our poor understanding of how injury impacts neural function. Data are particularly limited for mild, closed-skull TBI, which forms the majority of human cases, and for acute injury phases, when trauma effects and compensatory responses appear highly dynamic. Here we use a mouse model of mild TBI to characterize injury-induced synaptic dysfunction, and examine its progression over the hours to days after trauma. Mild injury consistently caused both locomotor deficits and localized neuroinflammation in piriform and entorhinal cortices, along with reduced olfactory discrimination ability. Using whole-cell recordings to characterize synaptic input onto piriform pyramidal neurons, we found moderate effects on excitatory or inhibitory synaptic function at 48 h after TBI and robust increase in excitatory inputs in slices prepared 1 h after injury. Excitatory increases predominated over inhibitory effects, suggesting that loss of excitatory-inhibitory balance is a common feature of both mild and severe TBI. Our data indicate that mild injury drives rapidly evolving alterations in neural function in the hours following injury, highlighting the need to better characterize the interplay between the primary trauma responses and compensatory effects during this early time period.	[Witkowski, Ellen D.; Gao, Yuan; Gavsyuk, Alexander F.; DeWalt, Gloria J.; Eldred, William D.; Davison, Ian G.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Maor, Ido; Mizrahi, Adi] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Dept Neurobiol, Jerusalem, Israel		Davison, IG (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	idavison@bu.edu			Boston University startup funds	This work was supported by Boston University startup funds.	Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bathellier B, 2009, J NEUROSCI, V29, P12641, DOI 10.1523/JNEUROSCI.1124-09.2009; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Bolding KA, 2018, SCIENCE, V361, P1088, DOI 10.1126/science.aat6904; Bressler S, 2017, HEARING RES, V349, P98, DOI 10.1016/j.heares.2016.10.018; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Candelario-Jalil E, 2001, J APPL TOXICOL, V21, P403, DOI 10.1002/jat.768; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; Chang BS, 2003, NEW ENGL J MED, V349, P1257, DOI 10.1056/NEJMra022308; Chen SY, 2005, BRAIN RES, V1057, P141, DOI 10.1016/j.brainres.2005.07.058; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fleidervish IA, 2001, J NEUROSCI, V21, P4600, DOI 10.1523/JNEUROSCI.21-13-04600.2001; Franks KM, 2011, NEURON, V72, P49, DOI 10.1016/j.neuron.2011.08.020; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024; GALE K, 1988, EPILEPSIA, V29, pS15, DOI 10.1111/j.1528-1157.1988.tb05795.x; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; HALONEN T, 1994, BRAIN RES, V652, P145, DOI 10.1016/0006-8993(94)90328-X; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hansen KR, 2018, J NEUROTRAUM, V35, P1523, DOI 10.1089/neu.2017.5029; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Keck T, 2013, NEURON, V80, P327, DOI 10.1016/j.neuron.2013.08.018; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Large AM, 2018, P NATL ACAD SCI USA, V115, pE8067, DOI 10.1073/pnas.1802428115; Large AM, 2016, P NATL ACAD SCI USA, V113, P2276, DOI 10.1073/pnas.1519295113; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; Levin H., 1987, HEAD INJURY, P442; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lipton P., 1984, BRAIN SLICES; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Maor I., 2019, BIORXIV, DOI [10.1101/273342, DOI 10.1101/273342]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Moyer J., 2002, PATCH CLAMP ANAL ADV, V35; Naylor DE, 2013, NEUROBIOL DIS, V54, P225, DOI 10.1016/j.nbd.2012.12.015; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pereira PMG, 2005, AM J NEURORADIOL, V26, P319; PIREDDA S, 1985, NATURE, V317, P623, DOI 10.1038/317623a0; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Proskynitopoulos Phileas J, 2016, Surg Neurol Int, V7, pS263, DOI 10.4103/2152-7806.181981; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Sheridan DC, 2014, NEUROSCIENCE, V275, P519, DOI 10.1016/j.neuroscience.2014.06.033; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Streit WJ, 2000, TOXICOL PATHOL, V28, P28, DOI 10.1177/019262330002800104; Suzuki N, 2007, CLIN EXP PHARMACOL P, V34, P1064, DOI 10.1111/j.1440-1681.2007.04723.x; Suzuki N, 2011, J NEUROSCI, V31, P2156, DOI 10.1523/JNEUROSCI.5430-10.2011; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; TANG AC, 1994, BRAIN RES, V659, P75, DOI 10.1016/0006-8993(94)90865-6; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tortorella A, 1997, J PHARMACOL EXP THER, V280, P1401; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vismer MS, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00027; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	111	5	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	APR 26	2019	13								166	10.3389/fncel.2019.00166			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV8KV	WOS:000466231100001	31105533	Green Published, gold			2022-02-06	
J	Lucca, LF; Pignolo, L; Leto, E; Ursino, M; Rogano, S; Cerasa, A				Lucca, Lucia Francesca; Pignolo, Loris; Leto, Elio; Ursino, Maria; Rogano, Stefania; Cerasa, Antonio			Paroxysmal Sympathetic Hyperactivity Rate in Vegetative or Minimally Conscious State after Acquired Brain Injury Evaluated by Paroxysmal Sympathetic Hyperactivity Assessment Measure	JOURNAL OF NEUROTRAUMA			English	Article						acquired brain injury; minimally conscious state; paroxysmal sympathetic hyperactivity; rehabilitation; vegetative state; unresponsive wakefulness syndrome	DYSAUTONOMIA; MANAGEMENT	The rate of paroxysmal sympathetic hyperactivity (PSH) was retrospectively assessed using the Paroxysmal Sympathetic Hyperactivity-Assessment Measure (PSH-AM) scale in patients with disorders of consciousness attributed to traumatic and non-traumatic acquired brain injury during the rehabilitation phase. These results were compared with previous studies carried out in the same clinical scenario, in order to verify the prevalence of PSH signs from 1998 to 2014. The entire sample consisted of 140 patients in vegetative state/unresponsive wakefulness syndrome or minimally conscious state admitted to a neurorehabilitation subacute unit from June 2010 to December 2014. PSH-AM revealed the presence of PSH in 16% of traumatic and 12% of non-traumatic younger patients. In the non-traumatic group, the rate was higher in patients with anoxia-hypoxia (37.5%) etiology than those with vascular brain injury (6.7%). A comparison with previous studies revealed a reduction in the number of PSH cases in traumatic patients. This study provides evidence that PSH-AM can be used prospectively to detect the rate of PSH and stratify severity of signs. Further longitudinal analysis is warranted to confirm the prevalence of PSH signs in non-traumatic brain injured patients.	[Lucca, Lucia Francesca; Pignolo, Loris; Leto, Elio; Ursino, Maria; Rogano, Stefania; Cerasa, Antonio] S Anna Inst, Via Siris 11, I-88900 Crotone, Italy; [Lucca, Lucia Francesca; Pignolo, Loris; Leto, Elio; Ursino, Maria; Rogano, Stefania; Cerasa, Antonio] RAN, Via Siris 11, I-88900 Crotone, Italy; [Cerasa, Antonio] CNR, IBFM, Neuroimaging Unit, Catanzaro, Italy		Lucca, LF (corresponding author), S Anna Inst, Via Siris 11, I-88900 Crotone, Italy.; Lucca, LF (corresponding author), RAN, Via Siris 11, I-88900 Crotone, Italy.	l.lucca@istitutosantanna.it	cerasa, antonio/E-8614-2011; Lucca, Lucia Francesca/AAB-8558-2022	cerasa, antonio/0000-0002-8022-4770; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			Baguley IJ, 2007, BRAIN INJURY, V21, P1175, DOI 10.1080/02699050701687375; Baguley IJ, 2007, J NEUROL NEUROSUR PS, V78, P539, DOI 10.1136/jnnp.2006.096388; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baguley IJ, 2009, ARCH PHYS MED REHAB, V90, P580, DOI 10.1016/j.apmr.2008.10.020; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2008, NEUROREHAB NEURAL RE, V22, P570; Bhatnagar S, 2016, BRAIN RES, V1640, P164, DOI 10.1016/j.brainres.2016.01.021; Bower RS, 2010, NEUROCRIT CARE, V13, P233, DOI 10.1007/s12028-010-9381-y; Dolce G, 2021, J NEUROTRAUM, V38, P1441, DOI 10.1089/neu.2008.0536; Fernandez-Ortega JF, 2017, J NEUROTRAUM, V34, P109, DOI 10.1089/neu.2015.4364; Fernandez-Ortega JF, 2006, J TRAUMA, V61, P1129, DOI 10.1097/01.ta.0000197634.83217.80; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Hinson HE, 2015, BRAIN INJURY, V29, P455, DOI 10.3109/02699052.2014.995229; Hoarau X, 2012, BRAIN INJURY, V26, P927, DOI 10.3109/02699052.2012.661913; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kirk KA, 2012, DEV MED CHILD NEUROL, V54, P759, DOI 10.1111/j.1469-8749.2012.04322.x; Krach LE, 1997, J NEUROL REHABIL, V11, P41; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Laxe S, 2013, BRAIN INJURY, V27, P1383, DOI 10.3109/02699052.2013.823648; Lv LQ, 2010, J NEUROTRAUM, V27, P1945, DOI 10.1089/neu.2010.1391; Mathew MJ, 2016, ACTA NEUROCHIR, V158, P2047, DOI 10.1007/s00701-016-2934-x; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Penfield W., 1954, EPILEPSY FUNCTIONAL, P378; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Pignolo L, 2012, J REHABIL MED, V44, P502, DOI 10.2340/16501977-0981; Rabinstein AA, 2007, NEUROL RES, V29, P680, DOI 10.1179/016164107X240071; Samuel S, 2016, J NEUROSCI NURS, V48, P82, DOI 10.1097/JNN.0000000000000207; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104	33	5	9	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2430	2434		10.1089/neu.2018.5963		APR 2019	5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000465473300001	30887860				2022-02-06	
J	Barker-Collo, S; Theadom, A; Starkey, NJ; Kahan, M; Jones, K; Feigin, V				Barker-Collo, Suzanne; Theadom, Alice; Starkey, Nicola J.; Kahan, Michael; Jones, Kelly; Feigin, Valery		BIONIC4you Study Grp	Long-term factor structure of the Rivermead Post-Concussion Symptom Questionnaire in mild traumatic brain injury and normative sample	BRAIN INJURY			English	Article						Post concussion; Factor structure; Rivermead Post Concussion Symptom questionnaire	POSTCONCUSSION-LIKE SYMPTOMS; RATES	Background: Previous studies of the Rivermead Post-Concussive Questionnaire(RPQ)'s factor structure were conducted within 1 year post-injury. Post-concussive symptoms may persist, and are common in the general population, so determining if the factor structure in mild-TBI and controls differ is important. This study examined factor structure of the RPQ in adults 4 years post-mild-TBI and in age-/gender-matched controls. Method: A total of 232 adults 4 years post-mild-TBI and 232 age-/gender-matched controls completed the RPQ. Results: Both samples produced a three-factor solution (57.98% and 56.44% of variance in the RPQ). Factor 1 for both samples included all RPQ items and accounted for the majority of variance explained (42.6% and 40.7%). After mild-TBI factor 2 included dizziness, vomiting/nausea, irritability, and double vision; whilst in controls it involved headache, dizziness, vomiting/nausea, and slowed thinking. Factor 3 for mild-TBI included vomiting/nausea, blurred vision, slowed thinking, and poor memory; while for controls it was restricted to visual symptoms (blurred vision, light sensitivity, double vision). Conclusion: The RPQ factor structure was similar for both groups, although differences were identified in lesser factors. This suggests those with mild-TBI differ minimally from matched controls in the very long term after injury.	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Starkey, Nicola J.] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Kahan, Michael] Waikato Occupat Serv, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Fac Sci, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740	New Zealand Health Research CouncilHealth Research Council of New Zealand	This work was supported by the New Zealand Health Research Council.	Barker-Collo S, 2018, BRAIN INJURY, V32, P453, DOI 10.1080/02699052.2018.1429659; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Thompson C, 2016, BRAIN INJURY, V30, P770; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006	22	5	5	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					618	622		10.1080/02699052.2019.1570339			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200009	30700169				2022-02-06	
J	King, D; Hume, PA; Hardaker, N; Pearce, A; Cummins, C; Clark, T				King, Doug; Hume, Patria A.; Hardaker, Natalie; Pearce, Alan; Cummins, Cloe; Clark, Trevor			Traumatic brain injuries in New Zealand: National Insurance (Accident Compensation Corporation) claims from 2012 to 2016	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Injury costs; Sport; Assault; Falls; Motor vehicle accident	PREVENTION; RECOMMENDATIONS; CONSEQUENCE; MANAGEMENT; COSTS; LEADS	Aim To provide epidemiological data and related costs to the national health insurance scheme for traumatic brain injury (TBI) in New Zealand. Method: A retrospective analytical review utilising detailed descriptive minor and moderate-to-severe epidemiological TBI data obtained from the Accident Compensation Corporation (ACC) for 2012-2016. Injuries were analysed by three levels of increasing severity: moderate, moderate-to-serious (MSC) and severe claims categories. Results: Over the January 2012 to December 2016 period there were 97,955 claims for TBI costing ACC $1,450,643,667 [equivalent to pound$743,417,120]. Falls accounted for nearly half (41.7%, 8262), and over a quarter (39.9%; $67,626,000 [f34,662,176]) of the moderate claims for TBI. Motor vehicle accidents recorded the highest percentage (36.5%), total costs ($610,978,229 [313,170,000]) pound and highest mean cost per-moderate claim per-year ($47,372 +/- $2401 [24,282 +/- 12311) pound for MSC TBI claims. This was similar for severe claims where motor vehicles accidents accounted for 56% of the total serious claims, 65.1% of the costs with a mean cost per-serious claim of $64,913 +/- 4331 [32,759 pound +/- 21861 pound per-year. Conclusion: There were 97,955 TBI injury claims lodged over the duration of the study with 36% (n = 35,304) classified as MSC. The incidence of total TBI in New Zealand was 432 per 100,000 population, and 155 per 100,000 for MSC TBI claims. Despite the growing number of studies reporting on the effects of sports-related TBI, there is a paucity of studies reporting on the longitudinal effects of TBI in falls, assaults and motor vehicle accidents. Further research is warranted into the assessment and management of intimate partner violence and child abuse victims for TBI's.	[King, Doug; Hume, Patria A.; Hardaker, Natalie] Auckland Univ Technol, Fac Hlth & Environm Sci, SPRINZ, Auckland, New Zealand; [King, Doug; Cummins, Cloe] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Hume, Patria A.] Auckland Univ Technol, Fac Hlth & Environm Sci, NISAN, Auckland, New Zealand; [Hardaker, Natalie] Accid Compensat Corp, Wellington, New Zealand; [Pearce, Alan] La Trobe Univ, Dept Rehabil Nutr & Sport, Melbourne, Vic, Australia; [Clark, Trevor] Australian Coll Phys Educ, Dept Sport Performance, Sydney Olympic Pk, NSW, Australia; [Cummins, Cloe] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England		King, D (corresponding author), Hutt Valley Dist Hlth Board, Emergency Dept, Private Bag 31-907, Lower Hutt, New Zealand.	dking@aut.ac.nz	Hume, Patria Anne/P-1084-2017; Hume, Patria/AAN-5514-2021; Cummins, Cloe/AAA-5169-2019; Pearce, Alan J/W-1195-2018	Hume, Patria Anne/0000-0003-1847-8128; Hume, Patria/0000-0003-1847-8128; Cummins, Cloe/0000-0003-1960-8916; Pearce, Alan J/0000-0002-9264-9880; King, Doug/0000-0003-0135-0937; Clark, Dr Trevor/0000-0002-2853-0068			Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Brown  J., 2018, J FORENSIC SCI CRIM, V8, P7; Bryan-Hancock  C., 2010, INJ PREV S1, V16, pA17; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Gianotti S, 2007, J SCI MED SPORT, V10, P436, DOI 10.1016/j.jsams.2006.10.006; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; King D, 2009, NZ J SPORTS MED, V36, P48; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; Lythe M, 1992, NZ J SPORTS MED, V20, P6; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McClure J, 2011, J HEAD TRAUMA REHAB, V26, P392, DOI 10.1097/HTR.0b013e3181f8fd34; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oquendo MA, 2004, AM J PSYCHIAT, V161, P1433, DOI 10.1176/appi.ajp.161.8.1433; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Pozzato I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016222; Rockhill CM, 2010, BRAIN INJURY, V24, P1051, DOI 10.3109/02699052.2010.494586; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Smith  T., 2018, PROF COUNSEL, V8, P1, DOI DOI 10.15241/TJS.8.1.1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Twellaar M, 1996, AM J SPORT MED, V24, P528, DOI 10.1177/036354659602400419; Valera  E., 2016, BRAIN IMAGING BEHAV, DOI [10.1007/x11682-016-9643-1:1-14, DOI 10.1007/X11682-016-9643-1:1-14]	39	5	5	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	APR 15	2019	399						61	68		10.1016/j.jns.2019.01.049			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HU3CK	WOS:000465148900011	30776729				2022-02-06	
J	Schwartz, JA				Schwartz, Joseph A.			A Longitudinal Assessment of Head Injuries as a Source of Acquired Neuropsychological Deficits and the Implications for Criminal Persistence	JUSTICE QUARTERLY			English	Article						Neuropsychological deficits; head injuries; criminal persistence; life course	TRAUMATIC BRAIN-INJURY; THE AMERICAN SOCIETY; ANTISOCIAL-BEHAVIOR; LIFE-COURSE; GENERAL-POPULATION; CONDUCT DISORDER; GANG MEMBERSHIP; EARLY ADULTHOOD; UNITED-STATES; BIRTH COHORT	Few studies have identified factors that may promote criminal persistence. One such influence may be acquired neuropsychological deficits, or subtle changes to brain structure or functioning stemming from detrimental experiences. Head injuries represent one source of acquired neuropsychological deficits that have been linked to increased levels of offending and are differentially concentrated within justice involved populations. Making use of the Pathways to Desistance study (1,336 individuals across 84 months), this study examines the impact of head injuries on criminal persistence. The results of multilevel longitudinal models revealed that within-individual changes in head injury were associated with increases in self-reported offending, and violent offending in particular. A less consistent pattern was observed for arrest and nonviolent offending, indicating that head injury may differentially impact specific forms of criminal persistence. These results provide preliminary evidence suggesting acquired neuropsychological deficits, and head injuries more directly, result in prolonged periods of criminal persistence.	[Schwartz, Joseph A.] Univ Nebraska, Sch Criminol & Criminal Justice, Omaha, NE 68182 USA		Schwartz, JA (corresponding author), Univ Nebraska, Sch Criminol & Criminal Justice, Omaha, NE 68182 USA.	jaschwartz@unomaha.edu			Office of Juvenile Justice and Delinquency Prevention [2007-MU-FX-0002]; National Institute of Justice [2008-IJ-CX-0023]; John D. and Catherine T. MacArthur Foundation; William T. Grant Foundation; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); William Penn Foundation; Center for Disease Control, National Institute on Drug Abuse [R01DA019697]; Pennsylvania Commission on Crime and Delinquency; Arizona Governor's Justice Commission	I would like to thank Kevin Beaver, Jukka Savolainen, and Ben Steiner for their thoughtful comments on previous drafts of this article. I would also like to thank Megan Kurlycheck for her guidance and suggestions, which have strengthened the resulting study considerably. Finally, I would like to thank the three anonymous reviewers for their constructive, and detailed, insights. The project described was supported by funds from the following: Office of Juvenile Justice and Delinquency Prevention (2007-MU-FX-0002), National Institute of Justice (2008-IJ-CX-0023), John D. and Catherine T. MacArthur Foundation, William T. Grant Foundation, Robert Wood Johnson Foundation, William Penn Foundation, Center for Disease Control, National Institute on Drug Abuse (R01DA019697), Pennsylvania Commission on Crime and Delinquency, and the Arizona Governor's Justice Commission. We are grateful for their support. The content of this article, however, is solely the responsibility of the authors and does not necessarily represent the official views of these agencies.	Acock AC, 2005, J MARRIAGE FAM, V67, P1012, DOI 10.1111/j.1741-3737.2005.00191.x; Amemiya J, 2017, DEV PSYCHOPATHOL, V29, P819, DOI 10.1017/S095457941600050X; Beaver KM, 2013, INTELLIGENCE, V41, P277, DOI 10.1016/j.intell.2013.05.001; Beaver KM, 2010, INT J OFFENDER THER, V54, P22, DOI 10.1177/0306624X08325349; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Braga AA, 2014, JUSTICE Q, V31, P633, DOI 10.1080/07418825.2012.673632; Britt CL, 2018, J QUANT CRIMINOL, V34, P591, DOI 10.1007/s10940-017-9346-9; Brown J., 2015, DENVER POST; Bushway SD, 2001, CRIMINOLOGY, V39, P491, DOI 10.1111/j.1745-9125.2001.tb00931.x; Catalano RF, 2004, ANN AM ACAD POLIT SS, V591, P98, DOI 10.1177/0002716203260102; Cauffman E, 2005, CRIMINOLOGY, V43, P133, DOI 10.1111/j.0011-1348.2005.00005.x; Cauffman E, 2000, BEHAV SCI LAW, V18, P741, DOI 10.1002/bsl.416; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cullen FT, 2011, CRIMINOLOGY, V49, P287, DOI 10.1111/j.1745-9125.2011.00224.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; ELLIOTT DS, 1994, CRIMINOLOGY, V32, P1, DOI 10.1111/j.1745-9125.1994.tb01144.x; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Farrington DP, 2003, CRIMINOLOGY, V41, P221, DOI 10.1111/j.1745-9125.2003.tb00987.x; FARRINGTON DP, 1990, ADV CLIN CHILD PSYCH, V13, P283; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Giordano PC, 2002, AM J SOCIOL, V107, P990, DOI 10.1086/343191; Glueck S., 1974, DELINQUENCY CRIME PA; Golden CJ, 1978, STROOP COLOR WORD TE; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; Groff ER, 2015, CRIMINOLOGY, V53, P23, DOI 10.1111/1745-9125.12055; HAWKINS JD, 1992, PSYCHOL BULL, V112, P64, DOI 10.1037/0033-2909.112.1.64; Hawkins JD, 1998, SERIOUS VIOLENT JUVE; Haynie DL, 2008, JUSTICE Q, V25, P595, DOI 10.1080/07418820801907983; HOLLINGSHEAD AB, 1971, SOC FORCES, V49, P563, DOI 10.2307/2576737; HORNEY J, 1995, AM SOCIOL REV, V60, P655, DOI 10.2307/2096316; Hussong AM, 2004, DEV PSYCHOPATHOL, V16, P1029, DOI 10.1017/S095457940404012X; Jackson TL, 2017, J EPIDEMIOL COMMUN H, V71, P800, DOI 10.1136/jech-2016-208582; Knutson KM, 2014, HUM BRAIN MAPP, V35, P943, DOI 10.1002/hbm.22225; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lasher MP, 2017, CRIM JUSTICE BEHAV, V44, P416, DOI 10.1177/0093854816670194; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Laub J.H., 2003, SHARED BEGINNINGS DI; Laub J.H., 1995, CRIME MAKING PATHWAY; Laub JH, 2006, CRIMINOLOGY, V44, P235, DOI 10.1111/j.1745-9125.2006.00048.x; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Loughran TA, 2011, CRIMINOLOGY, V49, P1029, DOI 10.1111/j.1745-9125.2011.00251.x; MARTINSON R, 1974, PUBLIC INTEREST, P22; Maruna S., 2007, J CONTEMP CRIM JUST, V23, P104, DOI DOI 10.1177/1043986206298951; Massoglia M, 2010, AM J SOCIOL, V116, P543, DOI 10.1086/653835; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; McGee TR, 2015, AUST NZ J CRIMINOL, V48, P345, DOI 10.1177/0004865815589828; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moffitt TE, 1996, DEV PSYCHOPATHOL, V8, P399, DOI 10.1017/S0954579400007161; MOFFITT TE, 1994, CRIMINOLOGY, V32, P277, DOI 10.1111/j.1745-9125.1994.tb01155.x; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Monahan KC, 2013, DEV PSYCHOPATHOL, V25, P1093, DOI 10.1017/S0954579413000394; Monahan KC, 2009, DEV PSYCHOL, V45, P1654, DOI 10.1037/a0015862; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Mulvey E.P., 2016, RES PATHWAYS DESISTA; Mulvey Edward P, 2004, Youth Violence Juv Justice, V2, P213, DOI 10.1177/1541204004265864; NAGIN DS, 1995, CRIMINOLOGY, V33, P111, DOI 10.1111/j.1745-9125.1995.tb01173.x; Nolan, 2017, J NEUROL NEUROSUR PS, V4; Osgood DW, 2000, J QUANT CRIMINOL, V16, P21, DOI 10.1023/A:1007521427059; Osgood DW, 2009, HDB QUANTITATIVE CRI; Pardini DA, 2010, J AM ACAD CHILD PSY, V49, P1134, DOI 10.1016/j.jaac.2010.07.010; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Petkovsek MA, 2016, YOUTH VIOLENCE JUV J, V14, P335, DOI 10.1177/1541204015581389; Piquero AR, 2013, CRIME DELINQUENCY, V59, P738, DOI 10.1177/0011128712459491; Polito MZ, 2010, J AM ACAD NURSE PRAC, V22, P504, DOI 10.1111/j.1745-7599.2010.00540.x; Pyrooz DC, 2017, CRIMINOLOGY, V55, P869, DOI 10.1111/1745-9125.12162; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI, VII; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Ray B, 2017, CRIM JUSTICE BEHAV, V44, P472, DOI 10.1177/0093854816686631; Rocque M, 2015, J DEV LIFE-COURSE CR, V1, P350, DOI 10.1007/s40865-015-0018-x; Rocque M, 2015, CRIMINOL CRIM JUSTIC, V15, P340, DOI 10.1177/1748895814547710; Rosenfeld R, 2014, CRIMINOLOGY, V52, P428, DOI 10.1111/1745-9125.12043; Sampson RJ, 2018, CRIMINOLOGY, V56, P269, DOI 10.1111/1745-9125.12171; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Sariaslan A, 2016, JAMA PSYCHIAT, V73, P796, DOI 10.1001/jamapsychiatry.2016.1349; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Schubert Carol A, 2004, Youth Violence Juv Justice, V2, P237, DOI 10.1177/1541204004265875; Schwartz JA, 2019, CURR OPIN PSYCHOL, V27, P67, DOI 10.1016/j.copsyc.2018.09.006; Schwartz JA, 2018, J CRIM JUST, V56, P70, DOI 10.1016/j.jcrimjus.2017.08.004; Schwartz JA, 2017, J RES CRIME DELINQ, V54, P869, DOI 10.1177/0022427817710287; Schwartz JA, 2015, INTELLIGENCE, V51, P109, DOI 10.1016/j.intell.2015.06.001; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Skrondal A., 2012, MULTILEVEL LONGITUDI, V3rd; StataCorp, 2017, STATA STAT SOFTWARE; Steinberg L, 1996, LAW HUMAN BEHAV, V20, P249, DOI 10.1007/BF01499023; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teichner G, 2000, AGGRESS VIOLENT BEH, V5, P509, DOI 10.1016/S1359-1789(98)00035-4; Tremblay RE, 2006, J ABNORM CHILD PSYCH, V34, P481, DOI 10.1007/s10802-006-9038-7; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Walker K, 2013, AGGRESS VIOLENT BEH, V18, P271, DOI 10.1016/j.avb.2012.11.019; Wechsler D., 2011, WECHSLER ABBREVIATED; WEINBERGER DA, 1990, J PERS, V58, P381, DOI 10.1111/j.1467-6494.1990.tb00235.x; White HR, 2015, J DEV LIFE-COURSE CR, V1, P289, DOI 10.1007/s40865-015-0015-0; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wootton B, 1962, SOCIAL SCI SOCIAL PA	107	5	5	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0741-8825	1745-9109		JUSTICE Q	Justice Q.	FEB 23	2021	38	2					196	223		10.1080/07418825.2019.1599044		APR 2019	28	Criminology & Penology	Social Science Citation Index (SSCI)	Criminology & Penology	RF5UW	WOS:000471468600001					2022-02-06	
J	Peltonen, K; Vartiainen, M; Laitala-Leinonen, T; Koskinen, S; Luoto, T; Pertab, J; Hokkanen, L				Peltonen, Kati; Vartiainen, Matti; Laitala-Leinonen, Tiina; Koskinen, Sanna; Luoto, Teemu; Pertab, Jon; Hokkanen, Laura			Adolescent athletes with learning disability display atypical maturational trajectories on concussion baseline testing: Implications based on a Finnish sample	CHILD NEUROPSYCHOLOGY			English	Article						Sport; concussion; learning disability; ImPACT (R); baseline testing	SPORT-RELATED CONCUSSION; SELF-REPORTED CONCUSSIONS; TEST-RETEST RELIABILITY; HIGH-SCHOOL; NEUROPSYCHOLOGICAL PERFORMANCE; PROCESSING SPEED; WORKING-MEMORY; ONLINE VERSION; HOCKEY PLAYERS; UNITED-STATES	Previous research has reported lower cognitive test scores on baseline testing in athletes reporting multiple previous concussions or a history of learning disability (LD). Age also has an important influence on cognitive performance. While these factors have been considered individually in previous studies, the present study is the first to explore the interaction of age, self-reported LD, and history of concussion on baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT (R)) in a nationwide study of adolescent athletes. ImPACT (R) was administered to 1823 Finnish male ice hockey players (aged 12-21 years old) prior to the 2015-2016 or 2016-2017 playing seasons. Linear regressions and simple slopes analyses were used for clarifying the impact of LD and previous concussion history on maturational trajectories. In comparison to typically developing athletes, athletes with LD had lower neurocognitive scores in all composites and differing maturational trajectory in verbal memory and visual motor speed. The number of previous concussions did not impair neurocognitive performance at baseline assessment. Application of standard age-based norms to adolescent athletes with a history of LD has the potential to negatively skew clinical decision-making. Separate reference values for LD athletes are warranted due to their unique developmental cognitive trajectories. The reference values for the Finnish participants in this study are presented.	[Peltonen, Kati; Vartiainen, Matti; Koskinen, Sanna; Hokkanen, Laura] Univ Helsinki, Dept Psychol & Logoped, POB 63, FIN-00014 Helsinki, Finland; [Laitala-Leinonen, Tiina] Univ Turku, Inst Biomed, Turku, Finland; [Luoto, Teemu] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Pertab, Jon] Intermt Healthcare, Neurosci Inst, Murray, UT USA		Peltonen, K (corresponding author), Univ Helsinki, Dept Psychol & Logoped, POB 63, FIN-00014 Helsinki, Finland.	kati.peltonen@helsinki.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284	Ministry of Social Affairs and Health Finland [201510103]; Turku University Foundation	This work was supported by the Ministry of Social Affairs and Health Finland (grant number 201510103) and Turku University Foundation.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bonifacci P, 2008, COGNITION, V107, P999, DOI 10.1016/j.cognition.2007.12.006; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Bull R, 1997, J EXP CHILD PSYCHOL, V65, P1, DOI 10.1006/jecp.1996.2358; Catts HW, 2002, J LEARN DISABIL-US, V35, P509; Collie A, 2003, J INT NEUROPSYCH SOC, V9, P419, DOI 10.1017/S1355617703930074; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Gioa G. A., 2004, BMJ-BRIT MED J, V38, P657; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Hanninen T, 2016, J SCI MED SPORT, V19, P636, DOI 10.1016/j.jsams.2015.08.005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/316575; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maruff P, 2004, BRIT J SPORT MED, V38, P654; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; Moll K, 2016, J LEARN DISABIL-US, V49, P272, DOI 10.1177/0022219414547221; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Rabinowitz AR, 2012, J INT NEUROPSYCH SOC, V18, P139, DOI 10.1017/S1355617711001275; Reynolds E, 2016, APPL NEUROPSYCH-CHIL, V5, P283, DOI 10.1080/21622965.2015.1057637; SCAT3, 2013, BRIT J SPORT MED, V47, P259; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schneider KJ, 2010, BRIT J SPORT MED, V44, P1112, DOI 10.1136/bjsm.2009.071266; SIEGEL LS, 1989, CHILD DEV, V60, P973, DOI 10.1111/j.1467-8624.1989.tb03528.x; SIEGEL LS, 1988, DEV PSYCHOL, V24, P28, DOI 10.1037/0012-1649.24.1.28; Silver CH, 2008, ARCH CLIN NEUROPSYCH, V23, P217, DOI 10.1016/j.acn.2007.09.006; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	55	5	5	0	53	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	APR 3	2019	25	3					336	351		10.1080/09297049.2018.1474865			16	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HJ1VX	WOS:000456954000003	29781392	Green Accepted			2022-02-06	
J	Wahlquist, VE; Glutting, JJ; Kaminski, TW				Wahlquist, Victoria E.; Glutting, Joseph J.; Kaminski, Thomas W.			Examining neurocognitive performance and heading in interscholastic female football players over their playing careers	SCIENCE AND MEDICINE IN FOOTBALL			English	Article						Concussion; heading; reaction time; cognition; soccer	POSTURAL CONTROL; BRAIN-INJURY; SOCCER; SYMPTOMS; ACCELERATION; CONCUSSIONS; BOUT; SEX	The purpose of this study was to examine the effect of purposeful heading in football on measures of cognitive function in a large cohort of female interscholastic football players over the course of their playing career. 217 interscholastic female football players participated in this prospective analysis of football heading over a 4-year timeframe with headers being recorded during sanctioned matches throughout this time. Subjects were categorized into 3 different groups based on their total number of interscholastic career headers: low (< 100), moderate (100-199), and high (200+). Baseline and subsequent post-season neurocognitive performance measures utilizing the Automated Neuropsychological Assessment Metrics (ANAM) software were derived on all players along with a monitoring of concussion-related symptoms. Data were analyzed using a series of two-level growth curves. While there were a few subtle decreases in performance throughout the testing period, no significant differences in test scores occurred during the interscholastic careers of these female football players. While we hypothesized that differences in cognitive performance would degrade over the playing career, especially in the high header group, our results prove otherwise adding to the existing body of evidence recognizing no changes with these variables in other cohorts of football players.	[Wahlquist, Victoria E.; Kaminski, Thomas W.] Univ Delaware, Athlet Training Res Lab, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA; [Glutting, Joseph J.] Univ Delaware, Sch Educ, Newark, DE USA		Kaminski, TW (corresponding author), Univ Delaware, Athlet Training Res Lab, Dept Kinesiol & Appl Physiol, Newark, DE 19716 USA.	kaminski@udel.edu					Associations NF of SHS, 2015 16 HIGH SCH ATH; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Britten N., 2002, TELEGR; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Cohen J., 2013, STAT POWER ANAL BEHA; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699; Green M., 2000, TRANSPORTATION HUMAN, V2, P195, DOI [DOI 10.1207/STHF0203_1, 10.1207/STHF0203_1]; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Jordan SE, 1996, AM J SPORT MED, V24, P205, DOI 10.1177/036354659602400216; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kaminski TW, 2009, J CLIN EXP NEUROPSYC, V31, P689, DOI 10.1080/13803390802484771; Kelso JAS., 2014, HUM MOT BEHAV INTROD; Kerr Z, 2017, J NEUROTRAUM, DOI 10.1089/neu.2017.5319?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Raudenbush SW, 2001, PSYCHOL METHODS, V6, P387, DOI 10.1037//1082-989X.6.4.387; Resch JE, 2018, INT J PSYCHOPHYSIOL, V132, P31, DOI 10.1016/j.ijpsycho.2017.09.011; Rubin TG, 2018, RADIOLOGY, DOI [10.1148/radiol.2018180217?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, DOI 10.1148/RADIOL.2018180217?URL_VER=Z39.88-2003&RFR_ID=ORI:RID:CROSSREF.ORG&RFR_DAT=CR_PUB%3DPUBMED]; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; U.S. Soccer, US SOCC CONC GUID; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	42	5	5	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	2473-3938	2473-4446		SCI MED FOOTBALL	Sci. Med. Football	APR 3	2019	3	2					115	124		10.1080/24733938.2018.1532104			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	OH6DH	WOS:000582678500006					2022-02-06	
J	Chamanzar, A; George, S; Venkatesh, P; Chamanzar, M; Shutter, L; Elmer, J; Grover, P				Chamanzar, Alireza; George, Shilpa; Venkatesh, Praveen; Chamanzar, Maysamreza; Shutter, Lori; Elmer, Jonathan; Grover, Pulkit			An Algorithm for Automated, Noninvasive Detection of Cortical Spreading Depolarizations Based on EEG Simulations	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Cortical spreading depolarization (CSD); electroencephalography (EEG); trauma brain injury (TBI); detection; algorithm	TRAUMATIC BRAIN-INJURY; DEPRESSION; PROPAGATION; HEMORRHAGE; ISCHEMIA; CORTEX	Objective: We present a novel signal processing algorithm for automated, noninvasive detection of cortical spreading depolarizations (CSDs) using electroencephalography (EEG) signals and validate the algorithm on simulated EEG signals. CSDs are waves of neurochemical changes that suppress the neuronal activity as they propagate across the brain's cortical surface. CSDs are believed to mediate secondary brain damage after brain trauma and cerebrovascular diseases like stroke. We address the following two key challenges in detecting CSDs from EEG signals: i) attenuation and loss of high spatial resolution information; and ii) cortical folds, which complicate tracking CSD waves. Methods: Our algorithm detects and tracks "wavefronts" of a CSD wave, and stitch together data across space and time to make a detection. To test our algorithm, we provide different models of CSD waves, including different widths of CSD suppressions and different patterns, and use them to simulate scalp EEG signals using head models of four subjects. Results and conclusion: Our results suggest that low-density EEG grids (40 electrodes) can detect CSD widths of 1.1 cm on average, while higher density EEG grids (340 electrodes) can detect CSD patterns as thin as 0.43 cm (less than minimum widths reported in prior works), among which single-gyrus CSDs are the hardest to detect because of their small suppression area. Significance: The proposed algorithm is a first step toward noninvasive, automated detection of CSDs, which can help in reducing secondary brain damages.	[Chamanzar, Alireza; George, Shilpa; Venkatesh, Praveen; Chamanzar, Maysamreza; Grover, Pulkit] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Shutter, Lori; Elmer, Jonathan] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15260 USA; [Shutter, Lori; Elmer, Jonathan] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA		Chamanzar, A (corresponding author), Carnegie Mellon Univ, Pittsburgh, PA 15213 USA.	achamanz@andrew.cmu.edu	Shutter, Lori A/G-2957-2013; Venkatesh, Praveen/AAZ-4522-2021	Venkatesh, Praveen/0000-0003-0752-1506; George, Shilpa/0000-0002-6756-9627; Shutter, Lori/0000-0002-1390-0628; Grover, Pulkit/0000-0001-7651-7776	Chuck Noll Foundation for Brain Injury Research; CMU CIT Innovation seed funding; CMU BrainHUB award; NIH (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1K23NS097629]; NSF WiFiUS program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS097629] Funding Source: NIH RePORTER	This work was supported in part by the grant from the Chuck Noll Foundation for Brain Injury Research, the CMU CIT Innovation seed funding, NSF WiFiUS program, and a CMU BrainHUB award. The work of J. Elmer was supported by the NIH (NINDS) Grant 1K23NS097629. This work was presented in part at the 12th World Congress on Brain Injury, New Orleans, LA, USA, 2017 [2].	[Anonymous], 2015, MATLAB SIGN PROC TOO; [Anonymous], 2014, MATLAB COMP VIS SYST; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bastany ZJR, 2016, NEUROSCIENCE, V333, P1, DOI 10.1016/j.neuroscience.2016.06.056; Bose T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.23; Chamanzar A., 2018, BIORXIV; Chamanzar A, 2017, BRAIN INJURY, V31, P990; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Gharibans AA, 2017, IEEE T BIO-MED ENG, V64, P807, DOI 10.1109/TBME.2016.2579310; Grover P, 2017, P IEEE, V105, P367, DOI 10.1109/JPROC.2016.2615179; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hofmeijer J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00017; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lucas B.D., 1981, ITERATIVE IMAGE REGI; McEwen JD, 2011, IEEE T SIGNAL PROCES, V59, P5876, DOI 10.1109/TSP.2011.2166394; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Milakara D, 2017, NEUROIMAGE-CLIN, V16, P524, DOI 10.1016/j.nicl.2017.09.005; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oppenheim A. V., 1989, DISCRETE TIME SIGNAL; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Robinson A. K, 2017, SCI REP, V7, P1; Santos E, 2017, J CEREBR BLOOD F MET, V37, P2639, DOI 10.1177/0271678X16689801; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Somjen GG, 2004, IONS BRAIN NORMAL FU; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; TUCKWELL HC, 1981, INT J NEUROSCI, V12, P109, DOI 10.3109/00207458108985795; Tuckwell HC, 2008, AIP CONF PROC, V1028, P46, DOI 10.1063/1.2965101; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Yao W, 2011, B MATH BIOL, V73, P2773, DOI 10.1007/s11538-011-9647-3; Zandt BJ, 2015, REV NEUROSCIENCE, V26, P183, DOI 10.1515/revneuro-2014-0069; Zhou P.-b, 2012, NUMERICAL ANAL ELECT	41	5	5	1	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	APR	2019	66	4					1115	1126		10.1109/TBME.2018.2867112			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HQ4EP	WOS:000462363300021	30176578	Green Accepted, Green Submitted			2022-02-06	
J	Corti, SJ; Pizzimenti, NM; McCarthy, MT; Essad, KM; Kutcher, JS				Corti, Sandro J.; Pizzimenti, Natalie M.; McCarthy, Matthew T.; Essad, Kate M.; Kutcher, Jeffrey S.			Comparing the Acute Presentation of Sport-Related Concussion in the Pediatric and Adult Populations	JOURNAL OF CHILD NEUROLOGY			English	Article						concussions; mild traumatic brain injury; children; adolescent; adults	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; MIGRAINE; MECHANISMS; RECOVERY; DEFICITS; SLEEP	Despite growing research on concussion, there is minimal evidence comparing the acute presentation of concussion between pediatric and adult patients. This cross-sectional study compares injury characteristics, symptoms, and neurologic examination in sport-related concussion based on age. Patients presenting to an outpatient sports neurology clinic for initial assessment of concussion within 7 days of injury were divided into 2 groups, 18 and older (n = 28) and 17 and younger (n = 107). There were no significant differences between pediatric and adult patients in any score of the Sport Concussion Assessment Tool-3rd Edition symptom scale, neurologic examination category, pertinent elements of past medical history, or characteristics of the concussion. The pediatric group had higher average hours of sleep (8.1 +/- 0.3 vs 7.1 +/- 0.58; P = .03) and were less likely to wake refreshed (36.3% vs 65%; P = .02). The initial presentation of concussion within 7 days of injury will likely not differ by age, specifically 18 and older versus 17 and younger.	[Corti, Sandro J.; McCarthy, Matthew T.; Essad, Kate M.; Kutcher, Jeffrey S.] Sports Neurol Clin, Brighton, MI USA; [Pizzimenti, Natalie M.] MORE Fdn, Brighton, MI USA		Corti, SJ (corresponding author), 90 Pinckney Rd, Red Bank, NJ 07701 USA.	sandro.james.corti@gmail.com		Corti, Sandro/0000-0002-0117-7858; McCarthy, Matthew/0000-0001-8543-7225			Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Babl FE, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3258; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2014, NEUROSURGERY, V75, pS24; Gradisar M, 2008, SLEEP BIOL RHYTHMS, V6, P146, DOI 10.1111/j.1479-8425.2008.00353.x; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Hellerstein L F, 1995, J Am Optom Assoc, V66, P634; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hovda D.A., 1996, NEUROTRAUMA, P1459; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2017, ARCH CLIN NEUROPSYCH, V31, P1; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Sekhar MS, 2012, SAUDI PHARM J, V20, P1, DOI 10.1016/j.jsps.2011.07.001; STEWART WF, 1991, AM J EPIDEMIOL, V134, P1111, DOI 10.1093/oxfordjournals.aje.a116014; Thomas RE, 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000095; Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	38	5	5	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	APR	2019	34	5					262	267		10.1177/0883073818825031			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	HP4FI	WOS:000461631400004	30669942				2022-02-06	
J	das Nair, R; Bradshaw, LE; Carpenter, H; Clarke, S; Day, F; Drummond, A; Fitzsimmons, D; Harris, S; Montgomery, AA; Newby, G; Sackley, C; Lincoln, NB				das Nair, Roshan; Bradshaw, Lucy E.; Carpenter, Hannah; Clarke, Sara; Day, Florence; Drummond, Avril; Fitzsimmons, Deborah; Harris, Shaun; Montgomery, Alan A.; Newby, Gavin; Sackley, Catherine; Lincoln, Nadina B.		ReMemBrIn Trial Collaborative	A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrln RCT	HEALTH TECHNOLOGY ASSESSMENT			English	Article							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE REHABILITATION; MULTIPLE-SCLEROSIS; EVERYDAY MEMORY; QUALITATIVE RESEARCH; NEUROLOGICAL DISABILITIES; BEHAVIORAL-THERAPY; QUESTIONNAIRE EBIQ; COST-EFFECTIVENESS; GROUP INTERVENTION	Background: People with traumatic brain injuries (TBIs) commonly report memory impairments. These are persistent, debilitating and reduce quality of life, but patients do not routinely receive memory rehabilitation after discharge from hospital. Objective: To assess the clinical effectiveness and cost-effectiveness of a group memory rehabilitation programme for people with TBI. Design: Multicentre, pragmatic, cluster randomised controlled trial. Qualitative and health economic evaluations were also undertaken. Setting: Community settings in nine sites in England. Participants: Participants were aged 18-69 years, had undergone a TBI > 3 months prior to recruitment, reported memory problems, were able to travel to a site to attend group sessions, could communicate in English and gave informed consent. Randomisation and blinding Clusters of four to six participants were randomised to the memory rehabilitation arm or the usual-care arm on a 1 : 1 ratio. Randomisation was based on a computer-generated pseudo-random code using random permuted blocks of randomly varying size, stratified by study site. Participants and therapists were aware of the treatment allocation whereas outcome assessors were blinded. Interventions: In the memory rehabilitation arm 10 weekly sessions of a manualised memory rehabilitation programme were provided in addition to usual care. Participants were taught restitution strategies to retrain impaired memory functions and compensation strategies to enable them to cope with memory problems. The usual-care arm received usual care only. Main outcome measures: Outcomes were assessed at 6 and 12 months after randomisation. Primary outcome: patient-completed Everyday Memory Questionnaire - patient version (EMQ-p) at 6 months' follow-up. Secondary outcomes: Rivermead Behavioural Memory Test - third edition (RBMT-3), General Health Questionnaire 30-item version, European Brain Injury Questionnaire, Everyday Memory Questionnaire - relative version and individual goal attainment. Costs (based on a UK NHS and Personal Social Services perspective) were collected using a service use questionnaire, with the EuroQol-5 Dimensions, five-level version, used to derive quality-adjusted life-years (QALYs). A Markov model was developed to explore cost-effectiveness at 5 and 10 years, with a 3.5% discount applied. Results: We randomised 328 participants (memory rehabilitation, n = 171; usual care, n = 157), with 129 in the memory rehabilitation arm and 122 in the usual-care arm included in the primary analysis. We found no clinically important difference on the EMQ-p between the two arms at 6 months' follow-up (adjusted difference in mean scores -2.1, 95% confidence interval -6.7 to 2.5; p = 0.37). For secondary outcomes, differences favouring the memory rehabilitation arm were observed at 6 months' follow-up for the RBMT-3 and goal attainment, but remained only for goal attainment at 12 months' follow-up. There were no differences between arms in mood or quality of life. The qualitative results suggested positive experiences of participating in the trial and of attending the groups. Participants reported that memory rehabilitation was not routinely accessible in usual care. The primary health economics outcome at 12 months found memory rehabilitation to be 26.89 pound cheaper than usual care but less effective, with an incremental QALY loss of 0.007. Differences in costs and effects were not statistically significant and non-parametric bootstrapping demonstrated considerable uncertainty in these findings. No safety concerns were raised and no deaths were reported. Limitations: As a pragmatic trial, we had broad inclusion criteria and, therefore, there was considerable heterogeneity within the sample. The study was not powered to perform further subgroup analyses. Participants and therapists could not be blinded to treatment allocation. Conclusion: The group memory rehabilitation delivered in this trial is very unlikely to lead to clinical benefits or to be a cost-effective treatment for people with TBI in the community. Future studies should examine the selection of participants who may benefit most from memory rehabilitation.	[das Nair, Roshan] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England; [das Nair, Roshan] Inst Mental Hlth, Nottingham, England; [das Nair, Roshan] Nottingham Univ Hosp NHS Trust, Dept Clin Psychol & Neuropsychol, Nottingham, England; [Bradshaw, Lucy E.; Day, Florence; Montgomery, Alan A.] Univ Nottingham, Nottingham Clin Trials Unit, Nottingham, England; [Carpenter, Hannah; Clarke, Sara; Lincoln, Nadina B.] Univ Nottingham, Div Rehabil & Ageing, Nottingham, England; [Drummond, Avril] Univ Nottingham, Sch Hlth Sci, Nottingham, England; [Fitzsimmons, Deborah; Harris, Shaun] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Newby, Gavin] Newby Psychol Serv Ltd, Northwich, England; [Sackley, Catherine] Kings Coll London, Div Hlth & Social Care, London, England		das Nair, R (corresponding author), Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England.; das Nair, R (corresponding author), Inst Mental Hlth, Nottingham, England.; das Nair, R (corresponding author), Nottingham Univ Hosp NHS Trust, Dept Clin Psychol & Neuropsychol, Nottingham, England.	roshan.dasnair@nottingham.ac.uk		Drummond, Avril/0000-0003-1220-8354; Harris, Shaun/0000-0001-7724-6621; Montgomery, Alan/0000-0003-0450-1606; sackley, catherine/0000-0002-8580-6622; das Nair, Roshan/0000-0001-8143-7893; Clarke, Sara/0000-0001-5919-4282	National Institute for Health Research (NIHR) Health Technology Assessment programmeNational Institute for Health Research (NIHR)	This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 23, No. 16. See the NIHR Journals Library website for further project information.	Alderwick H, 2015, BETTER VALUE NHS ROL; Archer M., 2013, CRITICAL REALISM ESS; Ashman TA, 2006, MT SINAI J MED, V73, P999; Baldwin SA, 2011, PSYCHOL METHODS, V16, P149, DOI 10.1037/a0023464; Bateman A, 2009, NEUROPSYCHOL REHABIL, V19, P941, DOI 10.1080/09602010903021170; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P290, DOI 10.1097/HTR.0000000000000070; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; BMJ Best Practice, 2016, ASS TRAUM BRAIN INJ; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Bovend'Eerdt TJH, 2011, J REHABIL MED, V43, P46, DOI 10.2340/16501977-0624; Bradshaw LE, 2019, CLIN REHABIL; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; British Psychological Society Division of Clinical Psychology, 2014, DCP POL CLIN SUP; British Psychological Society Division of Neuropsychology, 2005, CLIN NEUR REH SERV A; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Carr SE, 2014, CLIN REHABIL, V28, P552, DOI 10.1177/0269215513512336; Cernich AN, 2010, CURR TREAT OPTION NE, V12, P412, DOI 10.1007/s11940-010-0085-6; Chiaravalloti ND, 2012, J NEUROL, V259, P1337, DOI 10.1007/s00415-011-6353-x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cornish IM, 2000, BRIT J PSYCHOL, V91, P427, DOI 10.1348/000712600161916; Creswell JW, 2002, ED RES PLANNING COND; Curtis L., 2016, UNIT COSTS HLTH SOCI; das Nair R, 2008, THESIS; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2016, CLIN REHABIL, V30, P1156, DOI 10.1177/0269215515616446; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008754.pub3; das Nair R, 2015, NEUROPSYCHOL REHABIL, V25, P479, DOI 10.1080/09602011.2014.971820; das Nair R, 2015, TRIALS, V16, DOI 10.1186/1745-6215-16-6; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; Department of Health, 2010, NEW TRAUM RES; Department of Heath, 2005, RES GOV FRAM HLTH SO; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Elixhauser A, 1999, EPILEPSY RES, V37, P13, DOI 10.1016/S0920-1211(99)00036-4; European Medicines Agency, ICH HARM TRIP GUID G; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Finkelstein E.A., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fletcher AJ, 2017, INT J SOC RES METHOD, V20, P181, DOI 10.1080/13645579.2016.1144401; Frontera WR, 2017, ARCH PHYS MED REHAB, V98, P795, DOI 10.1016/j.apmr.2017.02.001; Fusch PI, 2015, QUAL REP, V20, P1408; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Goldberg RJ, 1988, USERS GUIDE GEN HLTH; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; Harley J. P., 1992, NEUROREHABILITATION, V2, P62; Headway, 2015, ACQ BRAIN INJ NUMB H; Heath C, 1997, QUALITATIVE RES THEO, P183; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hoofien D, 2001, BRAIN INJURY, V15, P189; Humphreys I, 2015, CLIN REHABIL, V29, P30, DOI 10.1177/0269215514537656; Humphreys I, 2013, CLIN REHABIL, V27, P963, DOI 10.1177/0269215513488608; Johnson RB., 2004, EDUC RESEARCHER, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Joint Formulary Committee, 2017, BRIT NATL FORMULARY; Jordan B, 1995, INTERACTION ANAL FDN; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kennedy MRT, 2006, NEUROPSYCHOL REV, V16, P151, DOI 10.1007/s11065-006-9012-8; Klein OA, 2019, NEUROPSYCHOL REHABIL, V29, P491, DOI 10.1080/09602011.2017.1309323; Kurz A, 2009, INT J GERIATR PSYCH, V24, P163, DOI 10.1002/gps.2086; Lincoln K, 2008, AM LIT READ TWENTY-F, P91; Lincoln NB, 2011, MULT SCLER J, V17, P1250, DOI 10.1177/1352458511408753; Mackenzie K, 2014, THESIS; Majid MJ, 2002, COCHRANE DB SYST REV, V2; Marino SE, 2009, EPILEPSY BEHAV, V14, P459, DOI 10.1016/j.yebeh.2008.12.007; Martin KJ, 2016, CLIN REHABIL, V30, P705, DOI 10.1177/0269215515595273; Mason M., 2010, FORUM QUALITATIVE SO, V11, P8, DOI [10.17169/fqs-11.3.1428, DOI 10.17169/FQS-11.3.1428]; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Moles DR, 1999, BRIT J ORAL MAX SURG, V37, P301, DOI 10.1054/bjom.1998.0040; Moss-Morris R, 2013, J CONSULT CLIN PSYCH, V81, P251, DOI 10.1037/a0029132; National Institute for Health and Care Excellence, 2014, QUAL STAT 7 COMM REH; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institutes of Health, 1994, NAT I HLTH NIH GUID; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; O'Brien MC, 2013, NEUROPSYCHOL REHABIL, V23, P321, DOI 10.1080/09602011.2012.753920; O'Cathain A, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-85; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Ptak R, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00057; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rai D, 2012, J EPIDEMIOL COMMUN H, V66, P586, DOI 10.1136/jech.2010.119644; Richardson JTE., 2000, CLIN NEUROPSYCHOLOGI; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Ritchie J, 2003, QUALITATIVE RES PRAC, P219; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Rubin DB, 1987, MULTIPLE IMPUTATION, P258, DOI DOI 10.1002/9780470316696; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Scottish Intercollegiate Guidelines Network, 2013, BRAIN INJ REH AD; Shrier I, 2014, CLIN TRIALS, V11, P28, DOI 10.1177/1740774513504151; Sigmundsdottir L, 2016, NEUROPSYCHOL REHABIL, V26, P673, DOI 10.1080/09602011.2016.1140657; Skeel RL, 2001, REHABILITATION NEURO, P47; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Smale KJ, 2015, CLIN REHABIL, V29, P493, DOI 10.1177/0269215514548733; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Spreij LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00993; Strober Lauren B, 2016, Int J MS Care, V18, P183, DOI 10.7224/1537-2073.2015-028; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Syder D, 1993, SHEFFIELD SCREENING; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; TEASDALE G, 1974, LANCET, V2, P81; Teasdale TW, EBIQ QUESTIONNAIRE; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Turner-Stokes L, 2011, J REHABIL MED, V43, P70, DOI 10.2340/16501977-0656; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Wade D. T., 2005, EFFECTIVENESS REHABI, P31, DOI [10.1093/acprof:oso/9780198526544.003.0004, DOI 10.1093/ACPROF:OSO/9780198526544.003.0004]; Watkins CL, 2007, STROKE, V38, P1004, DOI 10.1161/01.STR.0000258114.28006.d7; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2005, STAT METHODS MED RES, V14, P327, DOI 10.1191/0962280205sm406oa; White IR, 2005, STAT MED, V24, P993, DOI 10.1002/sim.1981; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILLIAMSON J, 1996, ARCHIT DESIGN, P9; Willig C., 2008, INTRO QUALITATIVE RE; Wilson B, 2010, J NEUROL NEUROSUR PS, V81, pE4, DOI 10.1136/jnnp.2010.217554.9; Wilson B., 2008, RIVERMEAD BEHAV MEMO, VThird; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; World Health Organization, 2007, INT CLASS FUNCT DIS; Yates JA, 2017, AGING MENT HEALTH, V21, P313, DOI 10.1080/13607863.2015.1081150; York Health Economics Consortium, 2016, NET MON BEN; 1997, BRAIN INJURY, V11, P543, DOI DOI 10.1080/026990597123250; 2001, AM J PREV MED S, V20, P38, DOI DOI 10.1016/S0749-3797(00)00272-5	145	5	5	4	14	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	APR	2019	23	16					1	+					195	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HV4KJ	WOS:000465954900001	31032782	Green Submitted, Green Published, gold, Green Accepted			2022-02-06	
J	Finan, JD				Finan, John D.			Biomechanical simulation of traumatic brain injury in the rat	CLINICAL BIOMECHANICS			English	Article						Traumatic brain injury; Rat; Biomechanics; Finite element modeling	CONTROLLED CORTICAL IMPACT; FINITE-ELEMENT MODEL; MAGNETIC-RESONANCE ELASTOGRAPHY; DYNAMIC-MECHANICAL PROPERTIES; IN-VIVO; CEREBRAL CONCUSSION; VISCOELASTIC PROPERTIES; ANIMAL-MODEL; TISSUE; INDENTATION	Backgrounds Traumatic brain injury poses an enormous clinical challenge. Rats are the animals most widely used in pre-clinical experiments. Biomechanical simulations of these experiments predict the distribution of mechanical stress and strain across key tissues. It is in theory possible to dramatically increase our understanding of traumatic brain injury pathophysiology by correlating stress and strain with histological and functional injury outcomes. This review summarizes the state of the art in biomechanical simulation of traumatic brain injury in the rat. It also places this body of knowledge in the context of the wider effort to understand traumatic brain injury in rats and in humans. Methods: Peer-reviewed research articles on biomechanical simulation of traumatic brain injury in the rat were reviewed and summarized. Findings: When mathematical models of traumatic brain injury in the rat first emerged, they relied on scant data regarding biomechanical properties. The data on relevant biomechanical properties has increased recently. However, experimental models of traumatic brain injury in the rat have also become less homogeneous. New and modified models have emerged that are biomechanically distinct from traditional models. Interpretation: Important progress in mathematical modeling and measurement of biomechanical properties has led to credible, predictive simulations of traditional, experimental models of traumatic brain injury in the rat, such as controlled cortical impact. However, recent trends such as the increasing popularity of closed head models and blast models create new biomechanical challenges. Investigators studying rat brain biomechanics must continue to innovate to keep pace with these developments.	[Finan, John D.] NorthShore Univ Hlth Syst, Res Inst, 1001 Univ Pl, Evanston, IL 60201 USA		Finan, JD (corresponding author), NorthShore Univ Hlth Syst, Res Inst, 1001 Univ Pl, Evanston, IL 60201 USA.	jfinan@northshore.org		Finan, John/0000-0003-4626-9702	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS098129-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098129] Funding Source: NIH RePORTER	This work was supported in part by funding from the National Institutes of Health (grant number R21NS098129-01).	Alfasi AM, 2013, J NEUROSURG, V119, P1255, DOI 10.3171/2013.7.JNS121973; Antona-Makoshi J, 2015, TRAFFIC INJ PREV, V16, pS91, DOI 10.1080/15389588.2015.1021416; Baumgartner D, 2009, FINITE ELEMENT ANAL, P97; Baumgartner D, 2004, REV EUROPEENNE ELEME, V14, P421; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Chatelin S, 2016, J CEREBR BLOOD F MET, V36, P954, DOI 10.1177/0271678X15606923; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen FQ, 2015, ANN BIOMED ENG, V43, P2903, DOI 10.1007/s10439-015-1350-3; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Clarke EC, 2011, J BIOMECH, V44, P2461, DOI 10.1016/j.jbiomech.2011.06.023; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2011, J NEUROTRAUM, V28, P2277, DOI 10.1089/neu.2010.1603; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Elkin BS, 2010, PHILOS T R SOC A, V368, P585, DOI 10.1098/rsta.2009.0223; FALLENSTEIN GT, 1969, J BIOMECH, V2, P217, DOI 10.1016/0021-9290(69)90079-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Fijalkowski RJ, 2009, STAPP CAR CRASH JO, V53, P193; Finan J. D, 2012, VISCOELASTIC PROPERT, P474; Finan John D, 2016, BMC Res Notes, V9, P160, DOI 10.1186/s13104-016-1968-8; Finan JD, 2014, BIOMECH MODEL MECHAN, V13, P573, DOI 10.1007/s10237-013-0519-7; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Garo A, 2007, BIORHEOLOGY, V44, P51; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gurduian ES, 1944, LANCET, V1, P389; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hetzer S, 2018, J CEREBR BLOOD F MET, V38, P116, DOI 10.1177/0271678X17691530; Holbourn A.H.S, 1943, LANCET, V243, P483; Hua Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/272976; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P1033, DOI 10.1007/s10237-015-0652-6; Kim Bobby, 2014, J Emerg Trauma Shock, V7, P102, DOI 10.4103/0974-2700.130880; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Klatt D, 2015, J MAGN RESON IMAGING, V42, P297, DOI 10.1002/jmri.24806; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Lee E. H., 1960, J APPL MECH, V27, P438, DOI DOI 10.1115/1.3644020; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Mao HJ, 2011, J MECH MED BIOL, V11, P1199, DOI 10.1142/S021951941100423X; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; OMMAYA A K, 1968, Journal of Biomechanics, V1, P127, DOI 10.1016/0021-9290(68)90015-8; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1968, SAE TRANSACTIONS, V76, P172; OMMAYA AK, 1966, SCIENCE, V153, P211, DOI 10.1126/science.153.3732.211; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pierrat B, 2018, J MECH BEHAV BIOMED, V78, P515, DOI 10.1016/j.jmbbm.2017.03.033; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Pong AC, 2016, J BIOMECH, V49, P1751, DOI 10.1016/j.jbiomech.2016.04.005; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Shreiber D. I, 1997, VIVO THRESHOLDS MECH; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stone JL, 2016, J NEUROSURG, V125, P1301, DOI 10.3171/2015.8.JNS142613; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhu Feng, 2010, Stapp Car Crash J, V54, P211; 2016, JAMA NEUROL, V73, P1062, DOI DOI 10.1001/JAMANEUROL.2016.1948; 2011, J BIOMECH, V44, P1158, DOI DOI 10.1016/J.JBIOMECH.2011.01.019; 2017, ACTA BIOMATER, V55, P333, DOI DOI 10.1016/J.ACTBIO.2017.03.037; 1966, J TRAUMA, V6, P600; 1941, BRAIN J NEUROL, V64, P93	118	5	5	3	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	APR	2019	64				SI		114	121		10.1016/j.clinbiomech.2018.01.015			8	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	HY6ON	WOS:000468249700014	29449041	Green Accepted			2022-02-06	
J	Gupte, R; Christian, S; Keselman, P; Habiger, J; Brooks, WM; Harris, JL				Gupte, Raeesa; Christian, Sarah; Keselman, Paul; Habiger, Joshua; Brooks, William M.; Harris, Janna L.			Evaluation of taurine neuroprotection in aged rats with traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Aging; Traumatic brain injury; Therapy; Sensorimotor function; Magnetic resonance imaging; Scientific rigor	CONTROLLED CORTICAL IMPACT; NEUROLOGICAL ORGAN DYSFUNCTION; METABOLIC-CHANGES; AMINO-ACIDS; CONTUSION INJURY; UNITED-STATES; MODEL; RECOVERY; EPIDEMIOLOGY; HIPPOCAMPUS	Despite higher rates of hospitalization and mortality following traumatic brain injury (TBI) in patients over 65years old, older patients remain underrepresented in drug development studies. Worse outcomes in older individuals compared to younger adults could be attributed to exacerbated injury mechanisms including oxidative stress, inflammation, blood-brain barrier disruption, and bioenergetic dysfunction. Accordingly, pleiotropic treatments are attractive candidates for neuroprotection. Taurine, an endogenous amino acid with antioxidant, anti-inflammatory, anti-apoptotic, osmolytic, and neuromodulator effects, is neuroprotective in adult rats with TBI. However, its effects in the aged brain have not been evaluated. We subjected aged male rats to a unilateral controlled cortical impact injury to the sensorimotor cortex, and randomized them into four treatment groups: saline or 25mg/kg, 50mg/kg, or 200mg/kgi.p. taurine. Treatments were administered 20min post-injury and daily for 7days. We assessed sensorimotor function on post-TBI days 1-14 and tissue loss on day 14 using T-2-weighted magnetic resonance imaging. Experimenters were blinded to the treatment group for the duration of the study. We did not observe neuroprotective effects of taurine on functional impairment or tissue loss in aged rats after TBI. These findings in aged rats are in contrast to previous reports of taurine neuroprotection in younger animals. Advanced age is an important variable for drug development studies in TBI, and further research is required to better understand how aging may influence mechanisms of taurine neuroprotection.	[Gupte, Raeesa; Christian, Sarah; Keselman, Paul; Brooks, William M.; Harris, Janna L.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66160 USA; [Gupte, Raeesa; Christian, Sarah; Harris, Janna L.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Habiger, Joshua] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Habiger, Joshua] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Brooks, William M.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA		Harris, JL (corresponding author), Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66160 USA.; Harris, JL (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA.	rgupte@kumc.edu; schristian@kumc.edu; pkeselman@kumc.edu; jhabige@okstate.edu; wbrooks@kumc.edu; jharris2@kumc.edu	Gupte, Raeesa/AAZ-1152-2021; Brooks, William/AAF-8299-2019	Brooks, William/0000-0001-6227-7636; Gupte, Raeesa/0000-0002-3735-8538	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS091920, P30 AG035982]; KUMC Lied Basic Science grant; University of Kansas School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG035982] Funding Source: NIH RePORTER	This study was supported by funding from the National Institutes of Health (R21 NS091920 to Dr. Janna Harris and P30 AG035982 to the University of Kansas Alzheimer's Disease Center) and a KUMC Lied Basic Science grant awarded to Dr. Harris. The Hoglund Brain Imaging Center is supported by Forrest and Sally Hoglund and the University of Kansas School of Medicine. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.T	Aghakhani Kamran, 2015, Acta Med Iran, V53, P652; BANAYSCHWARTZ M, 1989, NEUROCHEM RES, V14, P563, DOI 10.1007/BF00964919; Begley CG, 2013, NATURE, V497, P433, DOI 10.1038/497433a; BENEDETTI MS, 1991, J NEURAL TRANSM-GEN, V86, P191, DOI 10.1007/BF01250705; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Duarte JMN, 2014, NEUROBIOL AGING, V35, P1660, DOI 10.1016/j.neurobiolaging.2014.01.135; DURELLI L, 1983, NEUROLOGY, V33, P599, DOI 10.1212/WNL.33.5.599-a; Idrissi A, 2013, AMINO ACIDS, V45, P735, DOI 10.1007/s00726-013-1544-7; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fiette L, 2011, METHODS MOL BIOL, V691, P39, DOI 10.1007/978-1-60761-849-2_3; Froger N, 2014, PROG RETIN EYE RES, V41, P44, DOI 10.1016/j.preteyeres.2014.03.001; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Gu Y, 2015, NEUROSCIENCE, V291, P331, DOI 10.1016/j.neuroscience.2014.09.073; Gupta RC, 2006, CURR NEUROVASC RES, V3, P225, DOI 10.2174/156720206778018776; Hanell A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00252; Harris JL, 2015, FRONT AGING NEUROSCI, V7, DOI [10.5589/fnagi.2015.00202, 10.3389/fnagi.2015.00202]; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Junyent F, 2009, J NEUROSCI RES, V87, P1500, DOI 10.1002/jnr.21950; Kang YS, 2006, ADV EXP MED BIOL, V583, P291; Kang YS, 2002, J NEUROCHEM, V83, P1188, DOI 10.1046/j.1471-4159.2002.01223.x; Kennard JA, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00009; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kraus JF, 2000, NEUROSURG FOCUS, V8, P1; Kuypers NJ, 2010, J NEUROTRAUM, V27, P1275, DOI 10.1089/neu.2010.1327; Lallemand F, 2004, AMINO ACIDS, V26, P111, DOI 10.1007/s00726-003-0058-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leasure JL, 2010, EXP NEUROL, V226, P58, DOI 10.1016/j.expneurol.2010.08.003; Mitchell JJ, 1998, NEUROBIOL AGING, V19, P259, DOI 10.1016/S0197-4580(98)00058-X; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Oja SS, 2013, EPILEPSY RES, V104, P187, DOI 10.1016/j.eplepsyres.2013.01.010; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pasantes-Morales H, 2002, ARCH MED RES, V33, P237, DOI 10.1016/S0188-4409(02)00353-3; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Peterson TC, 2015, J NEUROTRAUM, V32, P765, DOI 10.1089/neu.2014.3530; Ricci L, 2009, EUR J PHARMACOL, V621, P26, DOI 10.1016/j.ejphar.2009.08.017; Ripps H, 2012, MOL VIS, V18, P2673; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; Shennan DB, 2007, CELL MOL BIOL LETT, V12, P396, DOI 10.2478/s11658-007-0011-4; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Singh K, 2016, NMR BIOMED, V29, P1748, DOI 10.1002/nbm.3627; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Steward O, 2014, NEURON, V84, P572, DOI 10.1016/j.neuron.2014.10.042; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Tan ZJ, 2009, BRAIN RES, V1281, P84, DOI 10.1016/j.brainres.2009.05.042; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; UNDIE AS, 1995, NEUROBIOL AGING, V16, P19, DOI 10.1016/0197-4580(95)80004-B; UNTERBERG A, 1994, ACTA NEUROCHIR, P431; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vitvitsky V, 2011, J BIOL CHEM, V286, P32002, DOI 10.1074/jbc.M111.253344; Wang Q, 2016, AMINO ACIDS, V48, P2169, DOI 10.1007/s00726-016-2244-x; Won SJ, 2006, BRAIN RES, V1123, P237, DOI 10.1016/j.brainres.2006.09.055; Wu JY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S1; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Ye HB, 2013, CAN J NEUROL SCI, V40, P628, DOI 10.1017/S0317167100014840; Zhang XR, 2009, NEUROCHEM INT, V54, P481, DOI 10.1016/j.neuint.2009.02.004; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun DA, 2003, J CRIT CARE, V18, P238, DOI 10.1016/j.jcrc.2003.10.007	72	5	5	2	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	APR	2019	13	2			SI		461	471		10.1007/s11682-018-9865-5			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HV7TJ	WOS:000466183200016	29656312	Green Accepted			2022-02-06	
J	Jenkins, R; Morris, NA; Haac, B; Van Besien, R; Stein, DM; Chang, WT; Schwartzbauer, G; Parikh, G; Badjatia, N				Jenkins, Ryne; Morris, Nicholas A.; Haac, Bryce; Van Besien, Richard; Stein, Deborah M.; Chang, Wan-Tsu; Schwartzbauer, Gary; Parikh, Gunjan; Badjatia, Neeraj			Inpatient Complications Predict Tracheostomy Better than Admission Variables After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Tracheostomy; Traumatic brain injury; Head injury; Outcomes	ACUTE KIDNEY INJURY; RISK-FACTORS; HEAD-INJURY; INTUBATION; SURVIVORS; IMPACT; SCORE; NEED	BackgroundData regarding who will require tracheostomy are lacking which may limit investigations into therapeutic effects of early tracheostomy.MethodsWe performed an observational study of adult traumatic brain injury (TBI) patients requiring intensive care unit (ICU) admission for72h and mechanical ventilation for24h between January 2014 and December 2014 at a level 1 trauma center. Patients who had life-sustaining measures withdrawn were excluded. Multivariable logistic regression analyses were used to assess admission and inpatient factors associated with receiving a tracheostomy and to develop predictive models. Inpatient complications prior to day 7 were used to standardize data collection for patients with and without tracheostomy. Patients who received tracheostomy prior to day 7 were excluded from analysis.ResultsIn total, 209 patients (78% men, mean 48years old, median Glasgow Coma Scale score (GCS) 8) met study criteria with tracheostomy performed in 94 (45%). Admission predictors of tracheostomy included GCS, chest tube, Injury Severity Score, and Marshall score. Inpatient factors associated with tracheostomy included the requirement for an external ventricular drain (EVD), number of operations, inpatient dialysis, aspiration, GCS on day 5, and reintubation. Multiple logistic regression analysis demonstrated that the number of operation room trips (adjusted odds ratio [AOR], 1.75; 95% CI, 1.04-2.97; P=0.036), reintubation (AOR, 8.45; 95% CI, 1.91-37.44; P=.005), and placement of an EVD (AOR, 3.48; 95% CI, 1.27-9.58; P=.016) were independently associated with patients undergoing tracheostomy. Higher GCS on hospital day 5 (AOR, 0.52; 95% CI, 0.40-0.68; P<0.001) was protective against tracheostomy. A model of inpatient variables only had a stronger association with tracheostomy than one with admission variables only (ROC AUC 0.93 vs 0.72, P<0.001) and did not benefit from the addition of admission variables (ROC AUC 0.93 vs 0.92, P=0.78).ConclusionPotentially modifiable inpatient factors have a stronger association with tracheostomy than do admission characteristics. Multicenter studies are needed to validate the results.	[Jenkins, Ryne; Haac, Bryce; Van Besien, Richard; Stein, Deborah M.; Badjatia, Neeraj] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Program Trauma, 22 S Greene St,Gudelsky Bldg,Room G7K18, Baltimore, MD 21201 USA; [Morris, Nicholas A.; Chang, Wan-Tsu; Schwartzbauer, Gary; Parikh, Gunjan; Badjatia, Neeraj] Univ Maryland, Sch Med, Sect Neurocrit Care & Emergency Neurol, Program Trauma,Dept Neurol, Baltimore, MD 21201 USA		Badjatia, N (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Program Trauma, 22 S Greene St,Gudelsky Bldg,Room G7K18, Baltimore, MD 21201 USA.	nbadjatia@umm.edu	Morris, Nicholas/S-7475-2019; Parikh, Gunjan/AAS-1375-2020; Badjatia, Neeraj/AAS-4855-2021	Morris, Nicholas/0000-0002-1270-9805; Parikh, Gunjan/0000-0002-8447-1349; Badjatia, Neeraj/0000-0003-1509-9034; Van Besien, Richard/0000-0002-6967-0657; Stein, Deborah/0000-0003-3683-3963			Ahmadinegad Mehdi, 2011, Tanaffos, V10, P26; Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Baitello André Luciano, 2013, Braz. J. Nephrol., V35, P127, DOI 10.5935/0101-2800.20130021; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baron DM, 2016, WIEN KLIN WOCHENSCHR, V128, P397, DOI 10.1007/s00508-016-1004-y; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Gennarelli TA., 2008, ABBREVIATED INJURY S; Goettler CE, 2006, J TRAUMA, V60, P991, DOI 10.1097/01.ta.0000217270.16860.32; Gurkin MA, 2002, AM SURGEON, V68, P324; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Humble SS, 2016, BRAIN INJURY, V30, P1642, DOI 10.1080/02699052.2016.1199915; Keren O, 2001, BRAIN INJURY, V15, P531, DOI 10.1080/02699050010007371; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lu Q, 2018, WORLD NEUROSURG, V112, pE324, DOI 10.1016/j.wneu.2018.01.043; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Makris Konstantinos, 2016, Clin Biochem Rev, V37, P85; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mehta Y, 2014, INDIAN J CRIT CARE M, V18, P149, DOI 10.4103/0972-5229.128705; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Schauer JM, 2009, J TRAUMA, V66, P220, DOI 10.1097/TA.0b013e31816073e3; Schonenberger S, 2016, NEUROCRIT CARE, V25, P94, DOI 10.1007/s12028-015-0235-5; Schonenberger S, 2016, INT J STROKE, V11, P368, DOI 10.1177/1747493015616638; Shamim MS, 2011, J NEUROSURG, V115, P1007, DOI 10.3171/2011.7.JNS101829; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Szeder V, 2010, NEUROCRIT CARE, V13, P40, DOI 10.1007/s12028-010-9346-1; TEASDALE G, 1974, LANCET, V2, P81; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	34	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2019	30	2					387	393		10.1007/s12028-018-0624-7			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HP0UB	WOS:000461380900022	30334232	Bronze			2022-02-06	
J	Lane, R; Davies, P				Lane, Russell; Davies, Paul			Post traumatic headache (PTH) in a cohort of UK compensation claimants	CEPHALALGIA			English	Article						Head injury; compensation; post-concussion syndrome; migraine	BRAIN-INJURY; POSTTRAUMATIC HEADACHE; SYMPTOM EXPECTATION; PREVALENCE; CANADA	Aim To explore post traumatic headache characteristics and risk factors in compensation claimants by observational retrospective cohort analysis. Case results Medicolegal reports on 116 consecutive compensation claimants aged 41.9 +/- 15.0 years were reviewed 21 +/- 14 months after injury. Eighty eight had suffered head and neck injuries, 21 reported only neck injury and seven had "other injuries". Ninety four percent of the head injuries were "mild". The incidence of post traumatic headache following neck injury did not differ from that following head and neck injury, and none of the "other injuries" cases developed post traumatic headache. We anticipated that all head and neck injury claimants would seek compensation for post traumatic headache, but 25% denied developing headache. Post traumatic headache was very strongly correlated with a past history of primary headache (p < 0.0001) but no other risk factors were identified. Post traumatic headache semiology was consistent with "migraine" or "probable migraine" in 90% of cases. Headache resolved in 30% of claimants between 3 and 24 months after injury but 70% continued to suffer headaches at the time of assessment. Forty one percent of claimants had received no treatment for post traumatic headache in primary care. Conclusions Our data suggest that post traumatic headache is essentially "migraine" provoked by head or neck concussion. It is not clear why so many post traumatic headache sufferers receive poor or inadequate treatment for this condition.	[Lane, Russell] Imperial Coll London, Charing Cross Campus London, London, England; [Davies, Paul] Univ Oxford, Oxford, England		Lane, R (corresponding author), Imperial Coll London, Charing Cross Campus London, London, England.	russell.lane4560@gmail.com					[Anonymous], 2017, HEAD INJURY; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Davies PTG, 2018, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423618000324; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; Headache Classification Committee of the International Headache Society, 2013, CEPHALALGIA, V33, P686; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Lane R.D.P., 2006, MIGRAINE; LEAO AAP, 1945, J NEUROPHYSIOL, V8, P33; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Misic-Pavkov G, 2012, EUR REV MED PHARMACO, V16, P1806; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Riechers Ronald G 2nd, 2015, Handb Clin Neurol, V128, P567, DOI 10.1016/B978-0-444-63521-1.00036-4; Russo A, 2014, NEUROL SCI, V35, pS153, DOI 10.1007/s10072-014-1758-9; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Yilmaz T, 2017, EMERG MED J, V34, P800, DOI 10.1136/emermed-2015-205429	26	5	5	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	APR	2019	39	5					641	647		10.1177/0333102418812091			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU2VB	WOS:000465128700008	30409039				2022-02-06	
J	Lwi, SJ; Barnes, DE; Xia, F; Peltz, C; Hoang, T; Yaffe, K				Lwi, Sandy J.; Barnes, Deborah E.; Xia, Feng; Peltz, Carrie; Hoang, Tina; Yaffe, Kristine			Ten-Year Prevalence of Cognitive Impairment Diagnoses and Associated Medical and Psychiatric Conditions in a National Cohort of Older Female Veterans	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Veterans; dementia; cognitive impairment; prevalence; medical comorbidities; psychiatric comorbidities	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PRIMARY-CARE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; VIETNAM VETERANS; UNITED-STATES; DEMENTIA; GENDER; HEALTH	Objective: Veterans are at risk for dementia because of elevated general risk factors and exposure to military risk factors; however, few studies have focused on female veterans despite their growing numbers. We sought to characterize the 10-year prevalence of cognitive impairment (i.e., mild cognitive impairment and dementia) and associated conditions in older female veterans. Methods: Data were extracted from Veterans Health Administration medical records of 168,111 female veterans aged 65 and older. Cognitive impairment (CI) diagnoses were defined using International Classification of Diseases, Ninth Revision (ICD-9) codes or dementia medication prescriptions. Medical comorbidities and psychiatric conditions were determined using ICD-9 codes occurring within 2 years of CI diagnosis or the last recorded medical encounter for veterans without CI. Results: Ten-year prevalence was 1.8% (3,075) for mild cognitive impairment (MCI) diagnoses and 8.1% (13,653) for dementia diagnoses. Prevalence increased with age (MCI age 65: 1.4%; age 85+: 2.7%; dementia age 65: 2.5%; age 85+: 17.7%); 37.3% had dementia subtype diagnoses, with Alzheimer's disease being the most prevalent (72.7%). 47.7% of veterans with CI had at least one medical comorbidity, whereas 22.5% had at least one psychiatric condition. Conclusion: Few studies have characterized the prevalence of cognitive impairment in female veterans despite the expected increases in CI and impending demographic shifts in the military. The high prevalence of medical and psychiatric conditions in female veterans with CI highlights their healthcare burden and emphasizes the need for further investigations into the prevention, treatment, and care of cognitive impairment in this understudied population.	[Lwi, Sandy J.; Barnes, Deborah E.; Yaffe, Kristine] San Francisco VA Med Ctr, 4150 Clement St,181, San Francisco, CA 94121 USA; [Xia, Feng; Peltz, Carrie; Hoang, Tina] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Barnes, Deborah E.; Yaffe, Kristine] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA		Yaffe, K (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,181, San Francisco, CA 94121 USA.	kristine.yaffe@ucsf.edu			Department of DefenseUnited States Department of Defense [W81XWH-16-1-0507]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155] Funding Source: NIH RePORTER	This research was supported by Department of Defense grant W81XWH-16-1-0507 (principal investigator: Kristine Yaffe, M. D.) and National Institute on Aging grant K24 AG031155 (principal investigator: Kristine Yaffe, M.D.). Kristine Yaffe, M.D., serves on data and safety monitoring boards for Takeda and a National Institute on Aging-sponsored study and is also a member of the Beeson Scientific Advisory Board. All other authors report no disclosures. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, and approval of the manuscript; or decision to submit the manuscript for publication.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Alzheimer's A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI DOI 10.1016/J.JALZ.2017.02.001; Amjad H, 2018, J GEN INTERN MED, V33, P1131, DOI 10.1007/s11606-018-4377-y; Armed Forces Health Surveillance Branch, 2012, SURV CAS DEF; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Baumgart Matthew, 2015, Alzheimers Dement, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Bean-Mayberry B., 2011, WOMEN HEALTH ISS, V21, P84; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DEGAGE SB, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E6231; Department of Veterans Affairs Central Office Geriatrics and Extend Care, 2016, METH PAP PROJ PREV I; Dodd JW, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0116-3; Goldstein KM, 2014, WOMEN HEALTH ISS, V24, P477, DOI 10.1016/j.whi.2014.05.005; GORELICK PB, 1993, ARCH NEUROL-CHICAGO, V50, P714, DOI 10.1001/archneur.1993.00540070034011; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Haskell SG, 2010, J WOMENS HEALTH, V19, P267, DOI 10.1089/jwh.2008.1262; Hebert LE, ALZHEIMER DIS US 201; Herrmann LK, 2018, AM J GERIAT PSYCHIAT, V26, P316, DOI 10.1016/j.jagp.2017.09.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iliffe S, 2009, INT J GERIATR PSYCH, V24, P895, DOI 10.1002/gps.2204; JORDAN BK, 1991, ARCH GEN PSYCHIAT, V48, P207, DOI 10.1001/archpsyc.1991.01810270019002; Langa KM, 2017, JAMA INTERN MED, V177, P51, DOI 10.1001/jamainternmed.2016.6807; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Lobo A, 2000, NEUROLOGY, V54, pS4; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mehta KM, 2017, ALZHEIMERS DEMENT, V13, P72, DOI 10.1016/j.jalz.2016.06.2360; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; National Center of Veterans Analysis and Statistics, 2016, PROF VET 2016; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Panza F, 2015, NAT REV NEUROL, V11; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Pugh MJ, 2016, MIL MED, V181, P476, DOI 10.7205/MILMED-D-15-00035; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Rafferty LA, 2018, PSYCHOL MED, V48, P1400, DOI 10.1017/S0033291717001386; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rissling MB, 2016, GERONTOLOGIST, V56, pS54, DOI 10.1093/geront/gnv668; Scherder E, 2009, PAIN, V145, P276, DOI 10.1016/j.pain.2009.04.007; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Singh B, 2014, JAMA NEUROL, V71, P581, DOI 10.1001/jamaneurol.2014.94; Tamura MK, 2011, CLIN J AM SOC NEPHRO, V6, P248, DOI 10.2215/CJN.02660310; Tanielian T., 2008, INVISIBLE WOUNDS WAR; US Department of Veterans Affairs, 2016, VHA DEM STEER COMM R; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Washington DL, 2015, MED CARE, V53, pS23, DOI 10.1097/MLR.0000000000000312; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61	52	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	APR	2019	27	4					417	425		10.1016/j.jagp.2018.12.015			9	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	HP7WD	WOS:000461900400012	30704839				2022-02-06	
J	Moran, RN; Covassin, T; Elbin, RJ				Moran, Ryan N.; Covassin, Tracey; Elbin, R. J.			Sex Differences on Vestibular and Ocular Motor Assessment in Youth Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; mild traumatic brain injuries; pediatrics	BASE-LINE; CONCUSSION SYMPTOMS; NEUROPSYCHOLOGICAL FUNCTION; POSTURAL STABILITY; PERFORMANCE	Context: The Vestibular/Ocular Motor Screening (VOMS) is a newly developed measure that evaluates vestibular and ocular motor symptom provocation after sport-related concussion. The effects of sex on baseline VOMS scores in youth athletes have not been established. Objective: To examine sex differences on baseline VOMS assessment among youth athletes. Results: No sex differences were demonstrated between male and female youth athletes on individual VOMS items (P range = .07-.98). Female sex was not associated with increased odds for VOMS scores over clinical-cutoff levels (range: odds ratio = 0.64; 95% confidence interval = 0.35, 1.15; P= .13; odds ratio =0.91; 95% confidence interval =0.48, 1.71; P = .77). Conclusions: No sex differences were present on baseline VOMS scores in youth athletes, nor was sex a risk factor for an abnormal VOMS score. These findings highlight the need for continual baseline and postconcussion assessments using multifaceted assessment strategies.	[Moran, Ryan N.] Univ Alabama, 478 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA; [Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA; [Elbin, R. J.] Univ Arkansas, Fayetteville, AR 72701 USA		Moran, RN (corresponding author), Univ Alabama, 478 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA.	rnmoran@ches.ua.edu			Michigan State University College of Education; Michigan State University Graduate School Research Fellowship Award	This study was funded by the Michigan State University College of Education and the Graduate School Research Fellowship Award.	Broglio S, 2004, J ATHL TRAINING, V49, P245; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Ciuffreda KJ, 2011, OPTOMETRY, V82, P61, DOI 10.1016/j.optm.2010.11.011; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Piland SG, 2010, J ATHL TRAINING, V45, P273, DOI 10.4085/1062-6050-45.3.273; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324	18	5	5	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	APR	2019	54	4					445	448		10.4085/1062-6050-220-18			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HY0LT	WOS:000467804100011	31013113	Green Published, gold			2022-02-06	
J	Mortimer, D; Trevena-Peters, J; McKay, A; Ponsford, J				Mortimer, Duncan; Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie			Economic Evaluation of Activities of Daily Living Retraining During Posttraumatic Amnesia for Inpatient Rehabilitation Following Severe Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Activities of daily living; Brain injuries, traumatic; Cost and cost analysis; Rehabilitation	AGITATED BEHAVIOR	Objective: To evaluate the cost-effectiveness of structured activities of daily living (ADL) retraining during posttraumatic amnesia (PTA) plus treatment as usual (TAU) vs TAU alone for inpatient rehabilitation following severe traumatic brain injury (TBI). Design: Trial-based economic evaluation from a health-system perspective. Setting: Inpatient rehabilitation center. Participants: Participants (N=104) admitted to rehabilitation and in PTA for >7 days following severe TBI. Interventions: Structured ADL retraining during PTA plus TAU vs TAU alone. Structured ADL retraining was manualized to minimize the risk of agitation and maximize functional improvement, following principles of errorless and procedural learning and targeting individualized therapy goals. TAU included physiotherapy and/or speech therapy during PTA plus ADL retraining after PTA emergence. Main Outcome Measures: FIM total scores at baseline, PTA emergence, hospital discharge, or final follow-up (2mo postdischarge) where FIM total scores were calculated as the sum of 5 FIM motor self-care items and a FIM meal-preparation item. Results: Structured ADL retraining during PTA significantly increased functional independence at PTA emergence (mean difference: 4.90, SE: 1.4, 95% confidence interval [CI]: 1.5, 8.3) and hospital discharge (mean difference: 5.22, SE: 1.4, 95% CI: 1.8, 8.7). Even in our most pessimistic scenario, structured ADL retraining was cost-saving as compared to TAU (mean:-$7762; 95% CI:-$8105,-$7419). Together, these results imply that structured ADL retraining dominates (less costly but no less effective) TAU when effectiveness is evaluated at PTA emergence and hospital discharge. Conclusions: Structured ADL retraining during PTA yields net cost-savings to the health system and offers a cost-effective means of increasing functional independence at PTA emergence and hospital discharge. (C) 2018 by the American Congress of Rehabilitation Medicine	[Mortimer, Duncan] Monash Univ, Monash Business Sch, Ctr Hlth Econ, Level 2,Bldg 75,Clayton Campus, Melbourne, Vic 3800, Australia; [Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Trevena-Peters, Jessica; McKay, Adam; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia; [McKay, Adam] Epworth HealthCare, Richmond, Vic, Australia		Mortimer, D (corresponding author), Monash Univ, Monash Business Sch, Ctr Hlth Econ, Level 2,Bldg 75,Clayton Campus, Melbourne, Vic 3800, Australia.	duncan.mortimer@monash.edu	McKay, Adam/M-6003-2017	McKay, Adam/0000-0002-0479-7681; Mortimer, Duncan Stuart/0000-0002-7211-6454	Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research [N-13-089]; Epworth Research Institute Grant; William Buckland Foundation Grant	Supported by the Transport Accident Commission, through the Institute for Safety, Compensation and Recovery Research (grant no: N-13-089); a Epworth Research Institute Grant; and a William Buckland Foundation Grant. The supporting institutions did not participate in design or write-up of the study.	Alali AS, 2015, VALUE HEALTH, V18, P721, DOI 10.1016/j.jval.2015.04.012; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; Davidson M, 2014, ENCY QUALITY LIFE WE, P2373; Hauck K, 2011, MED CARE, V49, P1068, DOI 10.1097/MLR.0b013e31822efb09; Jones AM., 2013, APPL HLTH EC; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Skidmore Elizabeth R, 2015, Curr Phys Med Rehabil Rep, V3, P99; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Trevena-Peters J, 2018, J HEAD TRAUMA REHAB, V33, P317, DOI 10.1097/HTR.0000000000000363; Trevena-Peters J, 2018, ARCH PHYS MED REHAB, V99, P329, DOI 10.1016/j.apmr.2017.08.486; van der Naalt J, 2000, BRAIN INJURY, V14, P781	16	5	5	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4					648	655		10.1016/j.apmr.2018.08.184			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FU	WOS:000462951800008	30273549				2022-02-06	
J	Ramazani, J; Hosseini, M				Ramazani, Jamileh; Hosseini, Mohammad			Comparison of Full Outline of Unresponsiveness Score and Glasgow Coma Scale in Medical Intensive Care Unit	ANNALS OF CARDIAC ANAESTHESIA			English	Article						Full outline of unresponsiveness score; Glasgow Coma Scale; Medical Intensive Care Unit; nonsurvivors; survivors	TRAUMATIC BRAIN-INJURY; HEALTH EVALUATION II; INTERRATER RELIABILITY; PREDICTIVE-VALIDITY; ACUTE PHYSIOLOGY; OUTCOMES; GCS; VALIDATION; MORTALITY; CHILDREN	Context: The Glasgow Coma Scale (GCS) is the most commonly used scale, and Full Outline of Unresponsiveness (FOUR) score is new validated coma scale as an alternative to GCS in the evaluation of the level of consciousness. Aim: The aim of the current study was to evaluate FOUR score and GCS ability in predicting the outcomes (Survivors, nonsurvivors) in Medical Intensive Care Unit (MICU). Setting and Design: This was an observational and prospective study of 300 consecutive patients admitted to the MICU during a 14 months' period. Materials and Methods: FOUR score, GCS score, and demographic characteristics of all patients were recorded in the first admission 24 h. Statistical Analysis Used: A receiver operator characteristic (ROC) curve, Hosmer-Lemeshow test, and Logistic regression were used in the statistical analysis (95% confidence interval). Results: Data analysis showed a significant statistical difference in FOUR score and GCS score between survivors and nonsurvivors (P < 0.0001, P < 0.0001; respectively). The discrimination power was good for both FOUR score and GCS (area under ROC curve: 87.3% (standard error [SE]: 2.1%), 82.6% [SE: 2.3%]; respectively). The acceptable calibration was seen just for FOUR score (chi(2) = 8.059, P = 0.428). Conclusions: Both FOUR score and GCS are valuable scales for predicting outcomes in patients are admitted to the MICU; however, the FOUR score showed better discrimination and calibration than GCS, so it is superior to GCS in predicting outcomes in this patients population.	[Ramazani, Jamileh] Islamic Azad Univ, Sch Nursing & Midwifery, Bojnourd Branch, Bojnurd, North Khorasan, Iran; [Hosseini, Mohammad] North Khorasan Univ Med Sci, Sch Nursing & Midwifery, Bojnurd, Iran		Ramazani, J (corresponding author), Islamic Azad Univ, Sch Nursing & Midwifery, Bojnourd Branch, Bojnurd, North Khorasan, Iran.	ramazani182@yahoo.com		Hosseini, Mohammad/0000-0002-5977-1921	Bojnourd Branch, Islamic Azad University	This study has been financially supported by Bojnourd Branch, Islamic Azad University.	Ashkenazi I, 2016, JAMA SURG, V151, P954, DOI 10.1001/jamasurg.2016.1742; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Buyukcam F, 2012, ULUS TRAVMA ACIL CER, V18, P469, DOI 10.5505/tjtes.2012.23169; Cerro L, 2014, REV ESP ANEST REANIM, V61, P125, DOI 10.1016/j.redar.2013.11.014; Cheng K, 2017, J NEUROTRAUM, V34, P1603, DOI 10.1089/neu.2016.4657; Cohen J, 2009, J NEUROSCI NURS, V41, P261, DOI 10.1097/JNN.0b013e3181b2c766; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Gorji MAH, 2014, SAUDI J ANAESTH, V8, P193, DOI 10.4103/1658-354X.130708; Gujjar AR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.06.009; Hosseini M, 2016, SAUDI J ANAESTH, V10, P168, DOI 10.4103/1658-354X.168817; Hosseini M, 2015, SAUDI J ANAESTH, V9, P136, DOI 10.4103/1658-354X.152839; Hosseini S.H., 2017, ANESTH PAIN MED, V7; Johnson VD, 2013, DIMENS CRIT CARE NUR, V32, P180, DOI 10.1097/DCC.0b013e3182998082; Kasprowicz M, 2016, BRIT J NEUROSURG, V30, P211, DOI 10.3109/02688697.2016.1161173; Khajeh A, 2014, IRAN J PEDIATR, V24, P603; Khanal K, 2016, INDIAN J CRIT CARE M, V20, P473, DOI 10.4103/0972-5229.188199; Kochar GS, 2014, J CHILD NEUROL, V29, P1299, DOI 10.1177/0883073813514293; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Momenyan S, 2017, NEUROCRIT CARE, V27, P229, DOI 10.1007/s12028-016-0324-0; Mouri S, 2015, NEUROCRIT CARE, V22, P251, DOI 10.1007/s12028-014-0078-5; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Said Tarek, 2016, Int J Crit Illn Inj Sci, V6, P172, DOI 10.4103/2229-5151.195401; Saika A, 2015, ACTA NEUROCHIR, V157, P1323, DOI 10.1007/s00701-015-2469-6; Sepahvand E, 2016, TURK NEUROSURG, V26, P720, DOI 10.5137/1019-5149.JTN.13536-14.0; Surabenjawong Usapan, 2017, Journal of the Medical Association of Thailand, V100, P960; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yousefzadeh-Chabok S, 2016, ULUS TRAVMA ACIL CER, V22, P328, DOI 10.5505/tjtes.2015.83930; Zeiler FA, 2017, NEUROCRIT CARE, V27, P381, DOI 10.1007/s12028-017-0396-5	30	5	5	1	5	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0971-9784	0974-5181		ANN CARD ANAESTH	Ann. Card. Anaesth.	APR-JUN	2019	22	2					143	148		10.4103/aca.ACA_25_18			6	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	HS9CZ	WOS:000464166700005	30971594	Green Published, gold			2022-02-06	
J	Rockswold, SB; Burton, PC; Chang, A; McNally, N; Grant, A; Rockswold, GL; Low, WC; Eberly, LE; Yacoub, E; Lenglet, C				Rockswold, Sarah B.; Burton, Philip C.; Chang, Amy; McNally, Nova; Grant, Andrea; Rockswold, Gaylan L.; Low, Walter C.; Eberly, Lynn E.; Yacoub, Essa; Lenglet, Christophe			Functional Magnetic Resonance Imaging and Oculomotor Dysfunction in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						functional magnetic resonance imaging; oculomotor dysfunction; post-traumatic visual dysfunction; traumatic brain injury	PREFRONTAL CORTEX; SMOOTH-PURSUIT; FMRI; REHABILITATION; SPECIALIZATION; SOFTWARE; DEFICITS; TBI	Mild traumatic brain injury (mTBI) is a significant cause of disability, especially when symptoms become chronic. This chronicity is often linked to oculomotor dysfunction (OMD). To our knowledge, this is the first prospective study to localize aberrations in brain function between mTBI cohorts, by comparing patients with mTBI with OMD with an mTBI control group without OMD, using task and resting-state functional magnetic resonance imaging (fMRI). Ten subjects with mTBI who had OMD (OMD group) were compared with nine subjects with mTBI who had no findings of OMD (control group). These groups were determined by a developmental optometrist using objective testing for OMD. The (convergence) task fMRI data demonstrated significantly decreased brain activity, measured as decreases in the blood oxygen level dependent (BOLD) signal, in the OMD group compared with the control group in three brain regions: the left posterior lingual gyrus, the bilateral anterior lingual gyrus and cuneus, and the parahippocampal gyrus. When doing a seed-based resting state fMRI analysis in the lingual/parahippocampal region, a large cluster covering the left middle frontal gyrus and the dorsolateral pre-frontal cortex (Brodmann areas 9 and 10), with decreased functional correlation in the OMD group, was identified. Together these observations provide evidence for neural networks of interactions involving the control of eye movement for visual processing, reading comprehension, spatial localization and navigation, and spatial working memory that appear to be decreased in mTBI patients with OMD compared with mTBI patients without OMD. The clinical symptomatology associated with post-traumatic OMD correlates well with these MRI findings.	[Rockswold, Sarah B.; Chang, Amy; McNally, Nova] Hennepin Cty Med Ctr, Dept Phys Med & Rehabil, 701 Pk Ave, Minneapolis, MN 55415 USA; [Rockswold, Sarah B.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Burton, Philip C.; Grant, Andrea; Yacoub, Essa; Lenglet, Christophe] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Rockswold, Gaylan L.; Low, Walter C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Rockswold, Gaylan L.] Hennepin Cty Med Ctr, Dept Surg, Div Neurosurg, Minneapolis, MN 55415 USA; [Eberly, Lynn E.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA		Rockswold, SB (corresponding author), Hennepin Cty Med Ctr, Dept Phys Med & Rehabil, 701 Pk Ave, Minneapolis, MN 55415 USA.	sarah.rockswold@hcmed.org	Yacoub, Essa/AAS-7757-2021; Grant, Andrea/A-1693-2008	Grant, Andrea/0000-0002-1553-596X; Eberly, Lynn/0000-0003-4763-330X	Minnesota Spinal Cord Injury and Traumatic Brain Injury Annual Research Grant Program: Neuroimaging and Neurorehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury Grant [105001]; Minneapolis Medical Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41 EB015894, P30 NS076408]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS076408] Funding Source: NIH RePORTER	This work was supported by the Minnesota Spinal Cord Injury and Traumatic Brain Injury Annual Research Grant Program: Neuroimaging and Neurorehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury Grant Contract No. 105001 as well as the Minneapolis Medical Research Foundation. It was also partly supported by NIH grants P41 EB015894 and P30 NS076408.	Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Antona B, 2008, OPHTHAL PHYSL OPT, V28, P475, DOI 10.1111/j.1475-1313.2008.00583.x; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Borsting Eric, 2005, Optometry, V76, P588, DOI 10.1016/j.optm.2005.07.007; Burgess N, 1996, HIPPOCAMPUS, V6, P749; CDC, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention (CDC), 2010, TRAUMATIC BRAIN INJU; Chang ARS, 2016, NEUROVISION REHABILI; Ciuffreda KJ, 2006, NEUROREHABILITATION, V21, P9; Cooper J, 2010, OPTOMETRIC CLIN PRAC; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DAUM KM, 1983, DOC OPHTHALMOL, V55, P177, DOI 10.1007/BF00140808; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; FRISK V, 1990, NEUROPSYCHOLOGIA, V28, P349, DOI 10.1016/0028-3932(90)90061-R; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Leibowitz Herschel W., 1984, NASA C PUBLICATION, P41; Lieberman S, 1983, J Am Optom Assoc, V54, P631; Lynch JM, 2015, J ATHL TRAINING, V50, P270, DOI 10.4085/1062-6050-49.3.78; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; Mealings M, 2012, BRAIN INJURY, V26, P1165, DOI 10.3109/02699052.2012.672785; NORN MS, 1966, ACTA OPHTHALMOL, V44, P132; O'Driscoll GA, 2000, NEUROREPORT, V11, P1335, DOI 10.1097/00001756-200004270-00037; Olton D S, 1977, Ciba Found Symp, P327; Padula WV, 2017, BRAIN INJURY, V31, P589, DOI 10.1080/02699052.2017.1291991; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Scheiman M., 2014, CLIN MANAGEMENT BINO; Scheiman M, 2011, UNDERSTANDING AND MANAGING VISION DEFICITS: A GUIDE FOR OCCUPATIONAL THERAPISTS, THIRD EDITION, P339; Schraa-Tam CKL, 2009, CLIN PHYSIOL FUNCT I, V29, P245, DOI 10.1111/j.1475-097X.2009.00858.x; Slotnick SD, 2006, NEUROPSYCHOLOGIA, V44, P1560, DOI 10.1016/j.neuropsychologia.2006.01.018; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tyler CW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00173; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zelinsky DG, 2010, PM&R, V2, P852, DOI 10.1016/j.pmrj.2010.06.012; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	47	5	5	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1099	1105		10.1089/neu.2018.5796			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000463235100007	30014758	Green Published			2022-02-06	
J	Rosenfeld, EH; Lau, P; Cunningham, ME; Zhang, W; Russell, RT; Naik-Mathuria, B; Vogel, AM				Rosenfeld, Eric H.; Lau, Patricio; Cunningham, Megan E.; Zhang, Wei; Russell, Robert T.; Naik-Mathuria, Bindi; Vogel, Adam M.			Defining Massive Transfusion in Civilian Pediatric Trauma With Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	13th Annual Meeting of the Academic-Surgical-Congress/Society-of-University-Surgeons/Association-for-Academic-Surgery (AAS)	JAN 30-FEB 01, 2018	Jacksonville, FL	Acad Surg Congress, Soc Univ Surg, Assoc Acad Surg		Pediatric trauma; Traumatic brain injury; massive transfusion; massive transfusion protocol; Hemorrhage control; Mortality	SURVIVAL; CHILDREN; PLASMA; RATIO	Background: The purpose of this study was to identify an optimal definition of massive transfusion in civilian pediatric trauma with severe traumatic brain injury (TBI) Methods: Severely injured children (age <= 18 y) with severe TBI in the Trauma Quality Improvement Program research data sets 2015-2016 that received blood products were identified. Data were analyzed using descriptive statistics, Wilcoxon rank-sum, chi-square, and logistic regression. Continuous variables are presented as median (interquartile range). Massive transfusion thresholds were determined based on receiver operating curves and optimization of sensitivity and specificity Results: Of the 460 included children, the mortality rate was 43%. There were no differences in demographics, heart rate at presentation, or injury severity score between children that lived or died. However, those who died had lower Glasgow coma scores (3 [3, 8] versus 3 [3, 3]; P < 0.01), were more likely to have had a penetrating injury (20% versus 11%; P < 0.01) and were more likely to be hypotensive for age (62% versus 34%; P < 0.01). Total blood products infused were greater in those who died (34 mL/kg/4-h [17, 65] versus 22 [12, 44]; P < 0.01). Sensitivity and specificity for delayed mortality was optimized at 40 mL/kg/4 h, and for the need for a hemorrhage control procedure at 50 mL/kg/4 h. These thresholds predicted delayed mortality (OR 2.12; 95% CI 1.28-3.50; P < 0.01) and the need for hemorrhage control procedures (5.47; 95% CI 2.82- 10.61; P < 0.01) Conclusions: For children with TBI, a massive transfusion threshold of 40 mL/kg/4-h of total administered blood products may be used to identify at-risk patients, improve resource utilization, and guide future research methodology (C) 2018 Elsevier Inc. All rights reserved.	[Rosenfeld, Eric H.; Lau, Patricio; Cunningham, Megan E.; Zhang, Wei; Naik-Mathuria, Bindi; Vogel, Adam M.] Texas Childrens Hosp, Dept Pediat Surg, 6701 Fannin St 1210, Houston, TX 77030 USA; [Rosenfeld, Eric H.; Lau, Patricio; Cunningham, Megan E.; Zhang, Wei; Naik-Mathuria, Bindi; Vogel, Adam M.] Baylor Coll Med, 6701 Fannin St 1210, Houston, TX 77030 USA; [Russell, Robert T.] Childrens Hosp Alabama, Dept Pediat Surg, Birmingham, AL USA		Vogel, AM (corresponding author), Texas Childrens Hosp, Dept Pediat Surg, 6701 Fannin St 1210, Houston, TX 77030 USA.; Vogel, AM (corresponding author), Baylor Coll Med, 6701 Fannin St 1210, Houston, TX 77030 USA.	amvogel@texaschildrens.org	Rosenfeld, Eric H./K-3690-2016	Rosenfeld, Eric H./0000-0003-2455-7711; Cunningham, Megan/0000-0002-1336-1011; Russell, Robert/0000-0002-8531-4249			Avarello JT, 2007, EMERG MED CLIN N AM, V25, P803, DOI 10.1016/j.emc.2007.06.013; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Centers for Disease Control and Prevention, 2017, NCFHS DAT TABL WEIGH; Chidester SJ, 2012, J TRAUMA ACUTE CARE, V73, P1273, DOI 10.1097/TA.0b013e318265d267; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Diab YA, 2013, BRIT J HAEMATOL, V161, P15, DOI 10.1111/bjh.12247; Hendrickson JE, 2012, TRANSFUSION, V52, P1228, DOI 10.1111/j.1537-2995.2011.03458.x; Heron M., 2017, NATL VITAL STAT REPO, V66; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Pathak A, 2005, Neurol India, V53, P178; Rubin D.B., 1987, MULTIPLE IMPUTATION; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Talving P, 2011, J TRAUMA, V71, P1205, DOI 10.1097/TA.0b013e31820d151d; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Zink KA, 2009, AM J SURG, V197, P565, DOI 10.1016/j.amjsurg.2008.12.014	22	5	6	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	APR	2019	236						44	50		10.1016/j.jss.2018.10.053			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	HL1XR	WOS:000458498300007	30694778				2022-02-06	
J	Russell, K; Selci, E; Black, B; Ellis, MJ				Russell, Kelly; Selci, Erin; Black, Brian; Ellis, Michael J.			Health-related quality of life following adolescent sports-related concussion or fracture: a prospective cohort study	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						health-related quality of life; sports-related concussion; fracture; adolescent; patient outcomes; trauma	MILD TRAUMATIC BRAIN; GENERIC CORE SCALES; 1ST YEAR; CHILDREN; RELIABILITY; VALIDITY; INJURY; PEDSQL(TM)-4.0; INVENTORY; SYMPTOMS	OBJECTIVE The longitudinal effects of sports-related concussion (SRC) in adolescents on health-related quality of life (HRQOL) remain poorly understood. Hence, the authors established two objectives of this study: 1) compare HRQOL outcomes among adolescents with an acute SRC or a sports-related extremity fracture (SREF) who were followed up until physician-documented clinical recovery; and 2) identify the clinical variables associated with worse HRQOL among adolescent SRC patients. METHODS The authors conducted a prospective cohort study of adolescents with acute SRC and those with acute SREF who underwent clinical assessment and follow-up at tertiary subspecialty clinics. Longitudinal patient-reported HRQOL was measured at the time of initial assessment and at each follow-up appointment by using the adolescent version (age 13-18 years) of the Pediatric Quality of Life Inventory (PedsQL) Generic Core Scale and Cognitive Functioning Scale. RESULTS A total of 135 patients with SRC (60.0% male; mean age 14.7 years; time from injury to initial assessment 6 days) and 96 patients with SREF (59.4% male; mean age 14.1 years; time from injury to initial assessment 8 days) participated in the study. At the initial assessment, the SRC patients demonstrated significantly worse cognitive HRQOL and clinically meaningful impairments in school and overall HRQOL compared to the SREF patients. Clinical variables associated with a worse HRQOL among SRC patients differed by domain but were significantly affected by the patients' initial symptom burden and the development of delayed physician-documented clinical recovery (> 28 days postinjury). No persistent impairments in HRQOL were observed among SRC patients who were followed up until physician-documented clinical recovery. CONCLUSIONS Adolescent SRC is associated with temporary impairments in HRQOL that have been shown to resolve in patients who are followed up until physician-documented clinical recovery. Future studies are needed to identify the clinicopathological features that are associated with impaired HRQOL and to assess whether the initiation of multi-disciplinary, targeted rehabilitation strategies would lead to an improvement in HRQOL.	[Russell, Kelly; Selci, Erin; Ellis, Michael J.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Black, Brian; Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Black, Brian] Univ Manitoba, Sect Orthopaed Surg, Winnipeg, MB, Canada; [Russell, Kelly; Selci, Erin; Ellis, Michael J.] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Russell, Kelly; Ellis, Michael J.] Canada North Concuss Network, Winnipeg, MB, Canada; [Black, Brian; Ellis, Michael J.] Pan Concuss Program, Winnipeg, MB, Canada		Russell, K (corresponding author), Univ Manitoba, Winnipeg, MB, Canada.	krussell@chrim.ca			Research Manitoba	Dr. Russell received an Establishment Grant from The Manitoba Health Research Council (now Research Manitoba) and this funding was used to support this study; however, the funders played no role in data collection or interpretation of the results.	COSTELLO EJ, 1988, PEDIATRICS, V82, P415; Cusimano MD, 2017, CLIN J SPORT MED, V27, P375, DOI 10.1097/JSM.0000000000000372; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Desai AD, 2014, JAMA PEDIATR, V168, P1114, DOI 10.1001/jamapediatrics.2014.1600; Di Battista A, 2015, BRAIN INJURY, V29, P573, DOI 10.3109/02699052.2014.989905; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2018, J HEAD TRAUMA REHABI; Fineblit S, 2016, J NEUROTRAUM, V33, P1561, DOI 10.1089/neu.2015.4292; Houston MN, 2016, BRAIN INJURY, V30, P891, DOI 10.3109/02699052.2016.1146960; Iadevaia C, 2015, J ATHL TRAINING, V50, P1182, DOI 10.4085/1062-6050-50.11.02; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Pieper P, 2015, J PEDIATR HEALTH CAR, V29, P343, DOI 10.1016/j.pedhc.2015.01.008; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Plourde V, 2018, J INT NEUROPSYCH SOC, V24, P540, DOI 10.1017/S1355617718000061; Purcell L, 2018, BR J SPORTS MED; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-43; Varni JW, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-26; Varni JW, 2007, J PEDIATR PSYCHOL, V32, P1151, DOI 10.1093/jpepsy/jsm008; Varni JW, 2011, QUAL LIFE RES, V20, P913, DOI 10.1007/s11136-010-9823-1; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	41	5	5	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2019	23	4					455	464		10.3171/2018.8.PEDS18356			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	HR1GE	WOS:000462877000007	30660131	Bronze			2022-02-06	
J	Sander, AM; Hanks, RA; Ianni, PA; Boileau, NR; Kratz, AL; Hahn, EA; Tulsky, DS; Carlozzi, NE				Sander, Angelle M.; Hanks, Robin A.; Ianni, Phillip A.; Boileau, Nicholas R.; Kratz, Anna L.; Hahn, Elizabeth A.; Tulsky, David S.; Carlozzi, Noelle E.			Sociocultural Factors Influencing Caregiver Appraisals Following Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; traumatic; Caregivers; Cultural competency; Rehabilitation; Surveys and questionnaires	QUALITY-OF-LIFE; PERCEIVED BURDEN; MENTAL-HEALTH; DISTRESS; VETERANS; BLACK; REHABILITATION; RELIABILITY; PREDICTORS; ADJUSTMENT	Objective: To investigate the association of the sociocultural variables race/ethnicity, education, and poverty level to caregivers' positive and negative appraisals following traumatic brain injury. Design: Survey. Setting: Community. Participants: Caregivers (N=344; 216 white; 69 black; 39 Hispanic) of persons with complicated mild to severe TBI at least 1-year postinjury. Intervention: Not applicable. Main outcome measures: Modified Caregiver Appraisal Scale (M-CAS); Zarit Burden Interview (ZBI). Results: Black caregivers reported lower levels of perceived burden on both the M-CAS and the ZBI. Black and Hispanic caregivers reported more traditional caregiver ideology (caregiving as a responsibility) than did whites. Greater poverty was associated with higher burden on the M-CAS, lower caregiver satisfaction, and less mastery. Higher education was associated with higher burden on the ZBI and with lower caregiver mastery. Conclusions: Treatment professionals should be culturally sensitive to the different perspectives that caregivers may have based on sociocultural factors. Sociocultural factors should be considered in research investigating caregiver outcomes, including appraisals. (C) 2018 by the American Congress of Rehabilitation Medicine	[Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Hanks, Robin A.] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Ianni, Phillip A.; Boileau, Nicholas R.; Kratz, Anna L.; Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE USA		Sander, AM (corresponding author), Baylor Coll Med, Phys Med & Rehabil, TIRR Mem Hermann Res Ctr, 1333 Moursund, Houston, TX 77030 USA.	asander@bcm.edu	Boileau, Nicholas/V-4832-2019	Tulsky, David/0000-0002-4335-4509; Hanks, Robin/0000-0002-3432-4789; Boileau, Nicholas/0000-0002-4056-4404	National Institutes of Health National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health National Institute of Nursing Research (grant no. R01NR013658), and the National Center for Advancing Translational Sciences (grant no. UL1TR000433).	Bachner YG, 2007, AGING MENT HEALTH, V11, P678, DOI 10.1080/13607860701529965; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bulmer, 1979, PRINCIPLES STAT; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS85, DOI 10.1016/j.apmr.2018.05.034; Chronister J, 2016, REHABIL COUNS BULL, V59, P235, DOI 10.1177/0034355215601072; Cohen J, 1969, STAT POWER ANAL BEHA; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; COX C, 1993, AM J ALZHEIMERS CARE, V8, P33; Cox C., 1990, J APPL GERONTOL, V9, P340, DOI [10.1177/073346489000900308, DOI 10.1177/073346489000900308]; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Doser K, 2016, BRAIN INJURY, V30, P334, DOI 10.3109/02699052.2015.1114143; Fisher RA, 1914, BIOMETRIKA, V10, P507; Folkman S., 1984, STRESS; FREEMAN GH, 1951, BIOMETRIKA, V38, P141, DOI 10.1093/biomet/38.1-2.141; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; HINRICHSEN GA, 1992, GERONTOLOGIST, V32, P375, DOI 10.1093/geront/32.3.375; Knight BG, 2000, J GERONTOL B-PSYCHOL, V55, pP142, DOI 10.1093/geronb/55.3.P142; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LAWTON MP, 1992, J GERONTOL, V47, pS156, DOI 10.1093/geronj/47.4.S156; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF., MANUAL MAYO PORTLAND; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Mazlan M, 2016, DISABIL REHABIL, V5, P1; Mbakile-Mahlanza L, 2017, DISABIL REHABIL, V39, P559, DOI 10.3109/09638288.2016.1152605; Meyer OL, 2018, AGING MENT HEALTH, V22, P730, DOI 10.1080/13607863.2017.1317330; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Schnitzer S, 2017, INNOV AGING S1, P447; Sheather SJ, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-09608-7_1; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Stueve A, 1997, AM J ORTHOPSYCHIAT, V67, P199, DOI 10.1037/h0080223; U.S. Department of Health and Human Services, 2016, COMP 2016 ANN UPD HH; United States Census Bureau, 2016, ED ATT US; Wajnberg A, 2016, GERONTOL GERIATR MED, V2; WOOD JB, 1990, J APPL GERONTOL, V0009, P00325, DOI DOI 10.1177/073346489000900307; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	59	5	5	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S58	S64		10.1016/j.apmr.2018.08.193			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900007	30365926	Green Accepted			2022-02-06	
J	Sanz-Garcia, A; Perez-Romero, M; Pastor, J; Sola, RG; Vega-Zelaya, L; Vega, G; Monasterio, F; Torrecilla, C; Pulido, P; Ortega, GJ				Sanz-Garcia, Ancor; Perez-Romero, Miriam; Pastor, Jesus; Sola, Rafael G.; Vega-Zelaya, Lorena; Vega, Gema; Monasterio, Fernando; Torrecilla, Carmen; Pulido, Paloma; Ortega, Guillermo J.			Potential EEG biomarkers of sedation doses in intensive care patients unveiled by using a machine learning approach	JOURNAL OF NEURAL ENGINEERING			English	Article						EEG; ICU; sedation; brain networks; machine learning	DELAYED CEREBRAL-ISCHEMIA; ICU PATIENTS; PHASE SYNCHRONIZATION; PROPOFOL; ANESTHESIA; HEART; INDEX; CLASSIFICATION; CONNECTIVITY; MIDAZOLAM	Objective. Sedation of neurocritically ill patients is one of the most challenging situation in ICUs. Quantitative knowledge on the sedation effect on brain activity in that complex scenario could help to uncover new markers for sedation assessment. Hence, we aim to evaluate the existence of changes of diverse EEG-derived measures in deeply-sedated (BASS-Richmond agitation-sedation scale -4 and -5) neurocritically ill patients, and also whether sedation doses are related with those eventual changes. Approach. We performed an observational prospective cohort study in the intensive care unit of the Hospital de la Princesa. Twenty-six adult patients suffered from traumatic brain injury and subarachnoid hemorrhage were included in the present study. Long-term continuous electroencephalographic (EEG) recordings (2141h) and hourly annotated information were used to determine the relationship between intravenous sedation infusion doses and network and spectral EEG measures. To do that, two different strategies were followed: assessment of the statistical dependence between both variables using the Spearman correlation rank and by performing an automatic classification method based on a machine learning algorithm. Main results. More than 60% of patients presented a correlation greater than 0.5 in at least one of the calculated EEG measures with the sedation dose. The automatic classification method presented an accuracy of 84.3% in discriminating between different sedation doses. In both cases the nodes' degree was the most relevant measurement. Significance. The results presented here provide evidences of brain activity changes during deep sedation linked to sedation doses. Particularly, the capability of network EEG-derived measures in discriminating between different sedation doses could be the framework for the development of accurate methods for sedation levels assessment.	[Pastor, Jesus; Vega-Zelaya, Lorena] Hosp Univ la Princesa, Clin Neurophysiol, Madrid, Spain; [Sola, Rafael G.; Pulido, Paloma] Hosp Univ la Princesa, Neurosurg, Madrid, Spain; [Vega, Gema; Monasterio, Fernando; Torrecilla, Carmen] Hosp Univ la Princesa, Intens Care Unit, Madrid, Spain; [Sanz-Garcia, Ancor; Perez-Romero, Miriam; Pastor, Jesus; Vega-Zelaya, Lorena; Vega, Gema; Monasterio, Fernando; Torrecilla, Carmen; Pulido, Paloma; Ortega, Guillermo J.] Hosp Univ la Princesa, Inst Invest Sanitaria, Madrid, Spain; [Ortega, Guillermo J.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Sanz-Garcia, Ancor] Hosp Univ La Princesa, Fdn Invest Biomed Hosp la Princesa, C Diego de Leon 62, Madrid 28006, Spain		Sanz-Garcia, A (corresponding author), Hosp Univ la Princesa, Inst Invest Sanitaria, Madrid, Spain.; Sanz-Garcia, A (corresponding author), Hosp Univ La Princesa, Fdn Invest Biomed Hosp la Princesa, C Diego de Leon 62, Madrid 28006, Spain.	ancor.sanz@gmail.com	Sanz-Garcia, Ancor/AAL-8043-2021; Vega-Zelaya, Lorena/AAV-5670-2021; Pastor, Jesus/AAH-9238-2020	Sanz-Garcia, Ancor/0000-0002-5024-5108; Pastor, Jesus/0000-0001-6870-8409; Pulido Rivas, Paloma/0000-0002-5933-9274; G. Sola, Rafael/0000-0002-0063-9301	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [PI10/00160]; Fondo Europeo de Desarrollo regional (F E D E R)European CommissionSpanish Government [PI12/02839]; Mutua Madrilena; Ayudante de investigacion fellowship form Comunidad de Madrid	This work was funded by grants from Instituto de Salud Carlos III, through PI10/00160 project and PI12/02839 partially supported by Fondo Europeo de Desarrollo regional (F E D E R) and from Mutua Madrilena. A S-G is the recipient of a postdoctoral fellow from Mutua Madrilena. M P-R is the recipient of an Ayudante de investigacion fellowship form Comunidad de Madrid.	Agarwal R, 1998, ELECTROEN CLIN NEURO, V107, P44, DOI 10.1016/S0013-4694(98)00009-1; Aho AJ, 2009, BRIT J ANAESTH, V102, P227, DOI 10.1093/bja/aen356; Bilgili B, 2017, MINERVA ANESTESIOL, V83, P288, DOI 10.23736/S0375-9393.16.10886-7; Bleasel Martin D., 1994, Palliative Medicine, V8, P231, DOI 10.1177/026921639400800307; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Bradley BD, 2013, CRIT CARE MED, V41, P433, DOI 10.1097/CCM.0b013e31826a47de; Carrasco G, 2000, CRIT CARE, V4, P217, DOI 10.1186/cc697; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Fraser GL, 2007, CRIT CARE MED, V35, P635, DOI 10.1097/01.CCM.0000254072.83323.4E; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; GEPTS E, 1987, ANESTH ANALG, V66, P1256; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Hajat Z, 2017, ANAESTHESIA, V72, P38, DOI 10.1111/anae.13739; Han H, 2014, CANCER INFORM, V13, P145, DOI 10.4137/CIN.S13875; Jackson DL, 2009, CRIT CARE, V13, DOI 10.1186/cc8212; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Johansen JW, 2000, ANESTHESIOLOGY, V93, P1336, DOI 10.1097/00000542-200011000-00029; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Koskinen M, 2001, CLIN NEUROPHYSIOL, V112, P386, DOI 10.1016/S1388-2457(00)00538-1; LESLIE K, 1995, ANESTH ANALG, V81, P1269, DOI 10.1097/00000539-199512000-00025; Liang ZH, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00016; Lobo FA, 2011, CURR OPIN ANESTHESIO, V24, P657, DOI 10.1097/ACO.0b013e32834c7aba; Maksimow A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113616; Mirski MA, 2007, J NEUROL SCI, V261, P16, DOI 10.1016/j.jns.2007.04.028; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Nagaraj SB, 2017, CRIT CARE MED, V45, pE683, DOI 10.1097/CCM.0000000000002364; Nagaraj SB, 2016, CRIT CARE MED, V44, pE782, DOI 10.1097/CCM.0000000000001708; Nagaraj SB, 2018, IEEE T BIO-MED ENG, V65, P2684, DOI 10.1109/TBME.2018.2813265; Ortega GJ, 2008, EPILEPSIA, V49, P269, DOI 10.1111/j.1528-1167.2007.01266.x; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Ranft A, 2016, ANESTHESIOLOGY, V125, P861, DOI 10.1097/ALN.0000000000001322; Rots ML, 2016, NEUROCRIT CARE, V24, P207, DOI 10.1007/s12028-015-0205-y; Roustan JP, 2005, ANESTH ANALG, V101, P1141, DOI 10.1213/01.ane.0000167782.47957.e1; Sackey PV, 2008, CRIT CARE, V12, DOI 10.1186/cc7029; Sanz-Garcia A, 2016, ADV BIOSIGNAL PROCES, DOI [10.5772/63914, DOI 10.5772/63914]; Sanz-Garcia A, 2016, JOVE-J VIS EXP, DOI 10.3791/54746; Sanz-Garcia A, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19020081; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Tallgren M, 2006, ACTA ANAESTH SCAND, V50, P942, DOI 10.1111/j.1399-6576.2006.01094.x; Vega-Zelaya L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140859; VESELIS RA, 1993, ANAESTHESIA, V48, P463, DOI 10.1111/j.1365-2044.1993.tb07063.x; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; Wang K, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00215	44	5	5	1	33	IOP Publishing Ltd	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	APR	2019	16	2							026031	10.1088/1741-2552/ab039f			11	Engineering, Biomedical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	HN0NX	WOS:000459886800002	30703765	Green Published			2022-02-06	
J	Scorza, KA; Cote, W				Scorza, Keith A.; Cote, Wesley			Current Concepts in Concussion: Initial Evaluation and Management	AMERICAN FAMILY PHYSICIAN			English	Article							CT HEAD RULE; TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; CLINICAL-PRACTICE GUIDELINES; PEDIATRIC CONCUSSION; COMPUTED-TOMOGRAPHY; UNITED-STATES; SPORTS; REST	Mild traumatic brain injury, also known as concussion, is common in adults and youth and is a major health concern. Concussion is caused by direct or indirect external trauma to the head resulting in shear stress to brain tissue from rotational or angular forces. Concussion can affect a variety of clinical domains: physical, cognitive, and emotional or behavioral. Signs and symptoms are nonspecific; therefore, a temporal relationship between an appropriate mechanism of injury and symptom onset must be determined. Headache is the most common symptom. Initial evaluation involves eliminating concern for cervical spine injury and more serious traumatic brain injury before diagnosis is established. Tools to aid diagnosis and monitor recovery include symptom checklists, neuropsychological tests, postural stability tests, and sideline assessment tools. If concussion is suspected in an athlete, the athlete should not return to play until medically cleared. Brief cognitive and physical rest are key components of initial management. Initial management also involves patient education and reassurance and symptom management. Individuals recover from concussion differently; therefore, rigid guidelines have been abandoned in favor of an individualized approach. As symptoms resolve, patients may gradually return to activity as tolerated. Those with risk factors, such as more severe symptoms immediately after injury, may require longer recovery periods. There is limited research in the younger population; however, given concern for potential consequences of injury to the developing brain, a more conservative approach to management is warranted. Copyright (C) 2019 American Academy of Family Physicians.	[Scorza, Keith A.; Cote, Wesley] Womack Army Med Ctr, 2817 Reilly Rd, Ft Bragg, NC 28310 USA		Scorza, KA (corresponding author), Womack Army Med Ctr, 2817 Reilly Rd, Ft Bragg, NC 28310 USA.	kascorza@hotmail.com					Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Centers for Disease Control and Prevention, HEADS HLTH CAR PROV; Centers for Disease Control and Prevention, 2015, SPORTS CONC POL LAW; Dessy AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1922; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Farmer O, 2017, SPORTS, V5, DOI 10.3390/sports5040074; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 1999, AM FAM PHYSICIAN, V60, P887; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kerrigan JM, 2017, CHILD NERV SYST, V33, P1669, DOI 10.1007/s00381-017-3537-4; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McAbee GN, 2015, J CHILD NEUROL, V30, P1378, DOI 10.1177/0883073814551794; McCrea MA, 2017, PHYS MED REH CLIN N, V28, P271, DOI 10.1016/j.pmr.2016.12.005; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Sawyer Q, 2016, J ATHL TRAINING, V51, P739, DOI 10.4085/1062-6050-51.12.01; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; U.S. Food and Drug Administration, DE NOV CLASS REQ INF; U.S. Food and Drug Administration, DE NOV CLASS REQ BRA; US Food and Drug Administration, EV AUT CLASS 3 DES B; Zyluk A, 2015, NEUROL NEUROCHIR POL, V49, P52, DOI 10.1016/j.pjnns.2014.12.007	35	5	5	0	9	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	APR 1	2019	99	7					426	434					9	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HS2LD	WOS:000463691200006	30932451				2022-02-06	
J	Sonmez, BM; Temel, E; Iscanli, MD; Yilmaz, F; Guloksuz, U; Parlak, S; Uckun, OM				Sonmez, Bedriye Mude; Temel, Emirhan; Iscanli, Murat Dogan; Yilmaz, Fevzi; Guloksuz, Udur; Parlak, Selcuk; Uckun, Ozhan Merzuk			Is initial optic nerve sheath diameter prognostic of specific head injury in emergency departments?	JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION			English	Article						Neurotrauma; ONSD; Emergency department; Injury type	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; COMPUTED-TOMOGRAPHY; ADULTS; CT	Background: Emergency departments (EDs) are typically the first medical contact for patients with traumatic brain injury (TBI) and early diagnosis and treatment of intracranial pressure (ICP) in patients with neurotrauma primarily falls under the liability of emergency doctors. Monitoring ICP with optic nerve sheath diameter (ONSD) via tools has gained popularity among emergency service doctors. In this study, we aimed to evaluate the predictive value of ONSD for specific head injury on initial cranial tomography. Methods: CT scans of 176 patients with a known intracranial pathology were retrospectively analyzed and compared with normal control CTs of 182 patients presented to ED at the same time interval. The attending radiologist analyzed all initial brain CT scans and randomly sampled control CTs were similarly assessed by the second senior radiologist whom were blind to the patients' medical histories and circumstances of TBI at the time of measurement. ONSD was measured at a distance of 3 mm behind the eyeball, immediately below the sclera. Results: Right ONSD value was significantly higher in patients with herniation and SAH (p = 0.024 and 0.028, respectively). Left ONSD values was at the level of statistical significance and mean ONSD values was significantly higher in patients with SAH (p = 0.05 and 0.026, respectively). Right-left-mean ONSD values were statistically higher in study group with bilateral lesions on brain CT (p < 0.001). ONSD measurements and patient age were higher in patients who died (p < 0.001). Conclusions: ONSD measurement on initial brain CT is lesion dependent and indicates mortality.	[Sonmez, Bedriye Mude; Temel, Emirhan; Iscanli, Murat Dogan; Yilmaz, Fevzi; Guloksuz, Udur; Parlak, Selcuk; Uckun, Ozhan Merzuk] Ankara Numune Training & Res Hosp, Hacettepe Mahallesi Talatpasa Bulvari 44, TR-06100 Ankara, Turkey; [Sonmez, Bedriye Mude; Iscanli, Murat Dogan; Yilmaz, Fevzi; Guloksuz, Udur] Dept Emergency Med, Ankara, Turkey; [Temel, Emirhan; Parlak, Selcuk] Dept Radiol, Ankara, Turkey; [Uckun, Ozhan Merzuk] Dept Neurosurg, Ankara, Turkey		Sonmez, BM (corresponding author), Ankara Numune Training & Res Hosp, Hacettepe Mahallesi Talatpasa Bulvari 44, TR-06100 Ankara, Turkey.	mugesonmez06@yahoo.com	Parlak, Selcuk/AAG-2555-2021; Yilmaz, Fevzi/ABD-2122-2021; yilmaz, fevzi/AAM-2132-2021; yilmaz, Fevzi/ABD-1392-2021	Parlak, Selcuk/0000-0002-3318-7399; yilmaz, fevzi/0000-0002-3675-7457; 			Bekerman I, 2016, AM J EMERG MED, V34, P2336, DOI 10.1016/j.ajem.2016.08.045; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Chandrappa A, 2017, INT J ANAT RADIOL SU, V6, P46; Das SK, 2017, POL J RADIOL, V82, P240, DOI 10.12659/PJR.900196; Dubost C, 2012, J SURG RES, V173, pE43, DOI 10.1016/j.jss.2011.08.027; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Hansen HC, 2011, ACTA OPHTHALMOL, V89, pE528, DOI 10.1111/j.1755-3768.2011.02159.x; Hansen HC, 1996, SURG RADIOL ANAT, V18, P323, DOI 10.1007/BF01627611; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Komut E, 2016, AM J EMERG MED, V34, P963, DOI 10.1016/j.ajem.2016.02.012; Kurve A, 2005, INDIAN J NEUROTRAUM, V2, P47, DOI 10.1016/S0973-0508(05)80011-5; Lee HC, 2018, CLIN NEUROL NEUROSUR, V167, P31, DOI 10.1016/j.clineuro.2018.02.012; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Oh Jiwoong, 2015, Acute and Critical Care, V30, P336; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Sekhon MS, 2014, NEUROCRIT CARE, V21, P245, DOI 10.1007/s12028-014-0003-y; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Vaiman M, 2016, J NEUROTRAUM, V33, P2147, DOI 10.1089/neu.2015.4293; Vaiman M, 2016, J CLIN NEUROSCI, V34, P177, DOI 10.1016/j.jocn.2016.06.008; Vaiman M, 2015, INT J OPHTHALMOL-CHI, V8, P1240, DOI 10.3980/j.issn.2222-3959.2015.06.30; Waheed S, 2018, J PAK MED ASSOC, V68, P268; Yesilaras M, 2017, AM J EMERG MED, V35, P1408, DOI 10.1016/j.ajem.2017.04.022; Zaidi Syed Javed H, 2014, Hawaii J Med Public Health, V73, P251	23	5	5	0	2	NATL MED ASSOC	WASHINGON	1012 10TH ST, N W, WASHINGON, DC 20001 USA	0027-9684	1943-4693		J NATL MED ASSOC	J. Natl. Med. Assoc.	APR	2019	111	2					210	217		10.1016/j.jnma.2018.10.009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HW6YY	WOS:000466837900014	30415927				2022-02-06	
J	Stuart, S; Parrington, L; Martini, D; Popa, B; Fino, PC; King, LA				Stuart, Samuel; Parrington, Lucy; Martini, Douglas; Popa, Bryana; Fino, Peter C.; King, Laurie A.			Validation of a velocity-based algorithm to quantify saccades during walking and turning in mild traumatic brain injury and healthy controls	PHYSIOLOGICAL MEASUREMENT			English	Article						eye-tracking; mild traumatic brain injury; saccades; algorithm; validation	PARKINSONS-DISEASE; EYE-MOVEMENTS; CONCUSSION; TRACKING; PERFORMANCE; FIXATION; GAIT	Objective: Saccadic (fast) eye movements are a routine aspect of neurological examination and are a potential biomarker of mild traumatic brain injury (mTBI). Objective measurement of saccades has become a prominent focus of mTBI research, as eye movements may be a useful assessment tool for deficits in neural structures or processes. However, saccadic measurement within mobile infrared (IR) eye-tracker raw data requires a valid algorithm. The objective of this study was to validate a velocity-based algorithm for saccade detection in IR eye-tracking raw data during walking (straight ahead and while turning) in people with mTBI and healthy controls. Approach: Eye-tracking via a mobile IR Tobii Pro Glasses 2 eye-tracker (100 Hz) was performed in people with mTBI (n = 10) and healthy controls (n = 10). Participants completed two walking tasks: straight walking (walking back and forth for 1 min over a 10 m distance), and walking and turning (turns course included 45 degrees, 90 degrees and 135 degrees turns). Five trials per subject, for one-hundred total trials, were completed. A previously reported velocity-based saccade detection algorithm was adapted and validated by assessing agreement between algorithm saccade detections and the number of correct saccade detections determined from manual video inspection (ground truth reference). Main results: Compared with video inspection, the IR algorithm detected similar to 97% (n = 4888) and similar to 95% (n = 3699) of saccades made by people with mTBI and controls, respectively, with excellent agreement to the ground truth (intra-class correlation coefficient(2,1) = .979 to .999). Significance: This study provides a simple yet highly robust algorithm for the processing of mobile eye-tracker raw data in mTBI and controls. Future studies may consider validating this algorithm with other IR eye-trackers and populations.	[Stuart, Samuel; Parrington, Lucy; Martini, Douglas; Popa, Bryana; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Stuart, Samuel; Parrington, Lucy; Martini, Douglas; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Popa, Bryana] Portland State Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Fino, Peter C.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT USA		Stuart, S (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA.; Stuart, S (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA.	stuarts@ohsu.edu	Stuart, Samuel/I-6449-2019	Stuart, Samuel/0000-0001-6846-9372; Parrington, Lucy/0000-0001-8507-9974; Fino, Peter/0000-0002-8621-3706	Parkinson's Foundation [PF-FBS-1898];  [W81XWH-17-1-0424]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [TL4GM118965, RL5GM118963, UL1GM118964] Funding Source: NIH RePORTER	This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-17-1-0424. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. Samuel Stuart is supported in part by a Postdoctoral Fellowship (Grant No. PF-FBS-1898 from the Parkinson's Foundation).	Andersson R, 2017, BEHAV RES METHODS, V49, P616, DOI 10.3758/s13428-016-0738-9; Andersson R, 2010, J EYE MOVEMENT RES, V3; [Anonymous], 2016, VA DOD CLIN PRACTICE; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; BAHILL AT, 1981, INVEST OPHTH VIS SCI, V21, P116; Baluchi F, 2011, TRENDS NEUROSCI, V34, P210, DOI 10.1016/j.tins.2011.02.003; BOGHEN D, 1974, INVEST OPHTH VISUAL, V13, P619; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Cripps A, 2015, J ATHL ENHANC, V4; Demer JL, 1996, J VESTIBUL RES-EQUIL, V6, P295; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Duchowski A., 2007, EYE TRACKING METHODO; Field A, 2009, DISCOPERING STAT USI; Fino PC, 2018, J NEUROTRAUM, V35, P1167, DOI 10.1089/neu.2017.5231; Franchak JM, 2010, VISION RES, V50, P2766, DOI 10.1016/j.visres.2010.09.024; Fuld PA, 1978, ALZHEIMERS DIS SENIL, V7, P185; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Holmqvist K., 2011, EYE TRACKING COMPREH; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; JUHOLA M, 1991, COMPUT BIOL MED, V21, P43, DOI 10.1016/0010-4825(91)90034-7; Komogortsev OV, 2010, IEEE T BIO-MED ENG, V57, P2635, DOI 10.1109/TBME.2010.2057429; Li D, 2005, IEEE COMP SOC C COMP; Li D., 2006, P 2006 S EYE TRACK R, P95100; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Nystrom M, 2010, BEHAV RES METHODS, V42, P188, DOI 10.3758/BRM.42.1.188; Pearson BC, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.036731; Pedrotti M, 2011, BEHAV RES METHODS, V43, P372, DOI 10.3758/s13428-010-0055-7; Pozzo T., 1990, NORMAL SUBJECTS, V82, P97, DOI DOI 10.1007/BF00230842; Salvucci D.D., 2000, P 2000 S EYE TRACKIN, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Stuart S, 2016, MED ENG PHYS, V38, P308, DOI 10.1016/j.medengphy.2015.12.001; Stuart S, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab02ab; Stuart S, 2018, EUR J NEUROSCI, V47, P769, DOI 10.1111/ejn.13864; Stuart S, 2017, EUR J NEUROSCI, V46, P1703, DOI 10.1111/ejn.13589; Stuart S, 2017, PHYSIOL MEAS, V38, pN16, DOI 10.1088/1361-6579/38/1/N16; Stuart S, 2016, NEUROSCI BIOBEHAV R, V62, P76, DOI 10.1016/j.neubiorev.2016.01.002; Stuart S, 2014, IEEE ENG MED BIO, P5739, DOI 10.1109/EMBC.2014.6944931; Stuart S, 2014, J NEUROSCI METH, V222, P175, DOI 10.1016/j.jneumeth.2013.11.018; Tafaj Enkelejda, 2012, P S EYE TRACK RES AP, P285, DOI DOI 10.1145/2168556.2168617; Tong MH, 2017, J VISION, V17, DOI 10.1167/17.1.28; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Vidal M, 2012, COMPUT COMMUN, V35, P1306, DOI 10.1016/j.comcom.2011.11.002; Weigle C, 2008, PROC SPIE, V6809, DOI 10.1117/12.768424; Woodson J, 2015, US MILITARY HLTH SYS; 2018, PHYSIOL MEAS, V39, DOI DOI 10.1088/1361-6579/AAEF44	52	5	5	0	7	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	APR	2019	40	4							044006	10.1088/1361-6579/ab159d			11	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering; Physiology	HV8XT	WOS:000466268100006	30943463	Green Accepted			2022-02-06	
J	Vaquero, J; Zurita, M; Mucientes, J; Pascual, ML; Fernandez-Mateos, C; Garcia, E; Fernandez-Guinea, S				Vaquero, Jesus; Zurita, Mercedes; Mucientes, Jorge; Pascual, Maria L.; Fernandez-Mateos, Cecilia; Garcia, Estefania; Fernandez-Guinea, Sara			Intrathecal cell therapy with autologous stromal cells increases cerebral glucose metabolism and can offer a new approach to the treatment of Alzheimer's type dementia	CYTOTHERAPY			English	Article						Alzheimer's disease; brain metabolism; cell therapy; dementia	DISEASE; DIAGNOSIS	Background aims: After recent observations that intrathecal administration of autologous bone marrow mesenchymal stromal cells (MSCs) increases cerebral metabolism in patients with severe traumatic brain injury (TBI), we examined this type of cell therapy in Alzheimer's type dementia. Methods: Three patients with clinical diagnosis of Alzheimer's disease received every 3 months 100 million autologous MSCs by intrathecal route, until a total dose of 300 million. Results: During cell therapy the patients showed arrest in neurological deterioration and two of them manifested clear improvement of previous symptoms. A global increase in cerebral glucose metabolism, measured using 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET), was observed after every administration of cell therapy. Conclusions: Our present findings suggest that intrathecal administrations of autologous MSCs can be a new strategy for the treatment of Alzheimer's dementia.	[Vaquero, Jesus; Zurita, Mercedes; Fernandez-Mateos, Cecilia] Autonomous Univ, Puerta Hierro Majadahonda Hosp, Neurosurg Serv, Madrid, Spain; [Mucientes, Jorge] Autonomous Univ, Puerta Hierro Majadahonda Hosp, Nucl Med Serv, Madrid, Spain; [Pascual, Maria L.] Autonomous Univ, Puerta Hierro Majadahonda Hosp, Neurol Serv, Madrid, Spain; [Garcia, Estefania; Fernandez-Guinea, Sara] Univ Complutense Madrid, Fac Psychol, Dept Expt Psychol, Madrid, Spain		Vaquero, J (corresponding author), Hosp Puerta Hierro Majadahonda, Neurosurg Serv, Joaquin Rodrigo 2, Madrid 28222, Spain.	jvaqueroc@telefonica.net					Amemori T, 2015, INT J MOL SCI, V16, P26417, DOI 10.3390/ijms161125961; [Anonymous], 2000, JAMA, V284, P3043; Bae JS, 2013, CURR ALZHEIMER RES, V10, P524; Berti V, 2011, ANN NY ACAD SCI, V1228, P81, DOI 10.1111/j.1749-6632.2011.06015.x; Calsolaro V, 2016, RECENT PATENTS ENDOC, V10, P31, DOI 10.2174/1872214810666160615102809; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Duncan T, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0567-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; International Conference on Harmonisation Expert Working Group ICH, 1996, GUID GOOD CLIN PRACT; Ishii K, 2014, AM J NEURORADIOL, V35, P2030, DOI 10.3174/ajnr.A3695; Jeong Y, 2005, J NUCL MED, V46, P233; Kang JM, 2016, J ALZHEIMERS DIS, V54, P879, DOI 10.3233/JAD-160406; Kim Hee Jin, 2015, Alzheimers Dement (N Y), V1, P95, DOI 10.1016/j.trci.2015.06.007; Mega MS, 2001, NEUROPSY NEUROPSY BE, V14, P63; Oh SH, 2015, CELL TRANSPLANT, V24, P1097, DOI 10.3727/096368914X679237; Parker RI, 2009, BEHAV THER, V40, P357, DOI 10.1016/j.beth.2008.10.006; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Shimada Aiko, 2011, Osaka City Med J, V57, P11; Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Vaquero J, 2017, CYTOTHERAPY, V19, P349, DOI 10.1016/j.jcyt.2016.12.002; Vaquero J, 2017, CYTOTHERAPY, V19, P88, DOI 10.1016/j.jcyt.2016.10.001; Vaquero J, 2016, CYTOTHERAPY, V18, P1025, DOI 10.1016/j.jcyt.2016.05.003; Wechsler D., 1997, WECHSLER MEMORY SCAL; 2013, ARCH CLIN NEUROPSYCH, V28, P763, DOI DOI 10.1093/ARCLIN/ACT064; 2010, J ALZHEIMERS DIS, V22, P1241, DOI DOI 10.3233/JAD-2010-100939	26	5	6	1	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1465-3249	1477-2566		CYTOTHERAPY	Cytotherapy	APR	2019	21	4					428	432		10.1016/j.jcyt.2019.02.009			5	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Hematology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research & Experimental Medicine	HU8SD	WOS:000465559700006	30878382	Green Published, hybrid			2022-02-06	
J	Wallace, J; Covassin, T; Beidler, E				Wallace, Jessica; Covassin, Tracey; Beidler, Erica			Concussion Bingo: Taking an active learning approach to concussion education with vulnerable populations	HEALTH EDUCATION JOURNAL			English	Article						Active learning; concussion education; knowledge transfer; sport-related concussion; USA	REPORTING BEHAVIORS; KNOWLEDGE; SPORTS; URBAN; INFORMATION; EXPERIENCES; ATTITUDES; AMERICAN; SCIENCE; QUALITY	Objective: The ability of athletes in underserved communities to recognise sport-related concussion (SRC) may be complicated by the lack of a qualified professional, such as an athletic trainer, present. An active learning educational activity (Concussion Bingo) was developed to assist in SRC identification. This study examined learning outcomes following the use of this activity by athletes in two US Title I (low socioeconomic status) high schools. Design: Cross-sectional study. Setting: High school sports. Methods: Participants (n = 102 athletes) completed 10-minute SRC knowledge of concussion surveys before and after participating in a Concussion Bingo activity. The 45-question survey assessed SRC knowledge through questions about SRC signs/symptoms, general injury information relating to loss of consciousness, the injured anatomical structure, complications of multiple SRCs and premature return to play. Participants had to mark key SRC terms on a Bingo card as they appeared throughout an SRC presentation including content from published consensus/position statements. Descriptive and parametric statistics were used to analyse the data. Results: Analysis of covariance revealed significant differences between pre- and post-Concussion Bingo scores. Athletes had the greatest knowledge increase of fogginess (n = 30, 29.5%), mood changes (n = 29, 28.5%), nausea (n = 27; 26.5%) and sleep problems (n = 27, 29.5%). On questions pertaining to the injury itself, athletes had the greatest increase on 'you have to be hit in the head to get a concussion' (n = 51, 50%), 'what kind of an injury is a concussion' (n = 31, 40.2%) and a concussion only occurs if you 'black out' (n = 24, 23.4%). Conclusion: Concussion Bingo increased Title I high school athletes' knowledge of SRCs, suggesting that it may be an effective active learning tool for increasing SRC knowledge.	[Wallace, Jessica] Youngstown State Univ, Dept Kinesiol & Sport Sci, Bitonte Coll Hlth & Human Serv, One Univ Plaza, Youngstown, OH 44555 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Beidler, Erica] Duquesne Univ, Dept Athlet Training, Pittsburgh, PA 15219 USA		Wallace, J (corresponding author), Youngstown State Univ, Dept Kinesiol & Sport Sci, Bitonte Coll Hlth & Human Serv, One Univ Plaza, Youngstown, OH 44555 USA.	jwallace02@ysu.edu					Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Barton Straus L, 2018, CONCUSSION SAFETY LA; Bayir E, 2014, J CHEM EDUC, V91, P531, DOI 10.1021/ed4002249; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Centers for Disease Control and Prevention (CDC), 2017, HEADS SPORTS; Donnell Z, 2018, J SAFETY RES, V64, P163, DOI 10.1016/j.jsr.2017.12.001; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Glang AE, 2015, J ADOLESCENT HEALTH, V56, P91, DOI 10.1016/j.jadohealth.2014.08.011; Glanz K., 2008, HLTH BEHAV HLTH ED T; Goldsmith PA, 2003, SOCIOL SPORT J, V20, P147, DOI 10.1123/ssj.20.2.147; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hunt TN., 2015, ATHLETIC TRAIN ED J, V10, P65, DOI [10.4085/100165, DOI 10.4085/100165]; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Leach G.J., 2005, RES STRATEGIES, V20, DOI [DOI 10.1016/J.RESSTR.2006.05.002, 10.1016/j.resstr.2006.05.002]; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Marx RW, 2004, J RES SCI TEACH, V41, P1063, DOI 10.1002/tea.20039; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Purcell GP, 2002, BMJ-BRIT MED J, V324, P557, DOI 10.1136/bmj.324.7337.557; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Taraban R, 2007, J RES SCI TEACH, V44, P960, DOI 10.1002/tea.20183; Trybus J., 2014, GAME BASED LEARNING; USA Football, 2018, CONC REC RESP; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1; Wallace J, 2017, J SCHOOL HEALTH, V87, P665, DOI 10.1111/josh.12543; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; WATSON BC, 1989, J NEGRO EDUC, V58, P309, DOI 10.2307/2295664	33	5	5	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0017-8969	1748-8176		HEALTH EDUC J	Health Educ. J.	APR	2019	78	3					315	327		10.1177/0017896918806935			13	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	HO5QV	WOS:000460983700006					2022-02-06	
J	Liu, W; Yeh, PH; Nathan, DE; Song, CW; Wu, H; Bonavia, GH; Ollinger, J; Riedy, G				Liu, Wei; Yeh, Ping-Hong; Nathan, Dominic E.; Song, Chihwa; Wu, Helena; Bonavia, Grant H.; Ollinger, John; Riedy, Gerard			Assessment of Brain Venous Structure in Military TBI Patients using Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping	JOURNAL OF NEUROTRAUMA			English	Article						quantitative susceptibility maps (QSM); susceptibility weighted images (SWI); traumatic brain injury (TBI); venous structure	INJURY	Brain venous volume above the lateral ventricle in military patients with traumatic brain injury (TBI) was assessed using two segmentation approaches on susceptibility weighted images (SWI) and quantitative susceptibility maps (QSM). This retrospective study included a total of 147 subjects: 14 patients with severe TBI; 38 patients with moderate TBI, 58 patients with mild TBI (28 with blast-related injuries and 30 with non-blast-related injuries), and 37 control subjects without history of TBI. Using the multiscale vessel enhancement filter on SWI images, patients with severe TBI demonstrated significantly higher segmented venous volumes compared with controls. Using a threshold approach on QSM images, TBI patients with different severities all demonstrated increased segmented volumes compared with control subjects: in the whole brain (severe, p = 0.001; moderate, p = 0.008; mild, p = 0.042, compared with controls), in the left hemisphere (severe, p = 0.01; moderate, p = 0.038, compared with controls), in the right hemisphere (severe, p = 0.001; moderate, p = 0.013; mild, p = 0.027, compared with controls). While segmented volumes on SWI appear to overlay directly on the visualized venous structures, the QSM-derived segments also encompass some perivascular and deep white matter areas. This might represent the damage in the perivascular regions associated with iron deposition or astroglial scarring.	[Liu, Wei; Yeh, Ping-Hong; Nathan, Dominic E.; Song, Chihwa; Wu, Helena; Bonavia, Grant H.; Ollinger, John; Riedy, Gerard] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 8901 Wisconsin Ave,Bldg 51,Room 1126, Bethesda, MD 20889 USA; [Liu, Wei; Yeh, Ping-Hong; Nathan, Dominic E.; Wu, Helena] NorthTide Grp LLC, Sterling, VA USA		Riedy, G (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, 8901 Wisconsin Ave,Bldg 51,Room 1126, Bethesda, MD 20889 USA.	gerard.p.riedy.civ@mail.mil			Center for Neuroscience and Regenerative Medicine grant [300606]; United States Army Medical Research and Materiel Command awardU.S. Army Medical Research & Materiel Command (USAMRMC) [13129004]	This research was supported by Center for Neuroscience and Regenerative Medicine grant #300606 and United States Army Medical Research and Materiel Command award #13129004. We'd like to thank Professor Yi Wang from Cornell University for providing the MEDI software. The authors would like to thank the team from the Defense and Veterans Brain Injury Center 15-year Longitudinal TBI Study for recruiting, screening, scheduling, and arranging travel for a portion of the participants in this study.	Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/bfb0056195; Garton T, 2016, STROKE VASC NEUROL, V1, P172, DOI 10.1136/svn-2016-000042; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haacke Em RW., 2013, CEREBRAL BLOOD FLOW, P75; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kou Zhifeng, 2015, Top Magn Reson Imaging, V24, P253, DOI 10.1097/RMR.0000000000000064; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu W., 2017, P INT SOC MAGN RES M; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88	21	5	5	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2213	2221		10.1089/neu.2018.5970		MAR 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000462600800001	30760096				2022-02-06	
J	Wood, TA; Morrison, S; Sosnoff, JJ				Wood, Tyler A.; Morrison, Steven; Sosnoff, Jacob J.			The Role of Neck Musculature in Traumatic Brain Injuries in Older Adults: Implications From Sports Medicine	FRONTIERS IN MEDICINE			English	Article						accidental falls; head movements; neck muscles; older adults; traumatic brain injury	SEGMENT DYNAMIC STABILIZATION; RISK-FACTORS; MUSCLE STRENGTH; HEAD IMPACT; SEX-DIFFERENCES; FREE-FALL; HEALTHY; BIOMECHANICS; CONCUSSION; RESPONSES	Traumatic brain injuries (TBIs) are common and serious injuries to older adults. The majority of TBIs in older adults are sustained when the head impacts the ground or other surface during a fall. While several non-modifiable risk factors have been identified for fall-related TBIs in older adults, there still remains a dearth of knowledge surrounding modifiable risk factors. Thus, this significant knowledge gap warrants an investigation into research across disciplines. The sports medicine literature has examined several modifiable risk factors to prevent a mild form of TBI known as concussion. While this research has identified several risk factors, one particular risk factor may have potential implications to fall-related TBIs in older adults. The sports medicine literature has shown that decreased neck strength and slower neck muscle activation are significant predictors for sports-related concussion. Similarly, older adults experience age-related declines to neck muscle strength and muscle activation. Consequently, these age-related declines to the neck musculature may result in the inability of older adults to control their head during a fall, which results in greater impact forces being transmitted to the brain and increases the risk of TBI. This perspective article assesses the sports medicine literature related to the implications of neck strength and muscle activation in sports-related concussion, discusses age-related declines to neck strength and muscle activation, and highlights the potential impact of the neck musculature on fall-related TBIs in older adults.	[Wood, Tyler A.; Sosnoff, Jacob J.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA; [Morrison, Steven] Old Dominion Univ, Sch Phys Therapy & Athlet Training, Norfolk, VA USA		Sosnoff, JJ (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA.	jsosnoff@illinois.edu		Morrison, Steven/0000-0001-7485-0305			Almosnino S, 2010, J ATHL TRAINING, V45, P453, DOI 10.4085/1062-6050-45.5.453; Alsalaheen B, 2018, J ELECTROMYOGR KINES, V39, P70, DOI 10.1016/j.jelekin.2018.01.011; Andersen JL, 1999, MUSCLE NERVE, V22, P449, DOI 10.1002/(SICI)1097-4598(199904)22:4<449::AID-MUS4>3.0.CO;2-2; AXEN K, 1992, J ORTHOP SPORT PHYS, V16, P275, DOI 10.2519/jospt.1992.16.6.275; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bisdorff AR, 1999, J NEUROL NEUROSUR PS, V66, P447, DOI 10.1136/jnnp.66.4.447; Borde R, 2015, SPORTS MED, V45, P1693, DOI 10.1007/s40279-015-0385-9; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Cadore EL, 2014, AGING DIS, V5, P183, DOI 10.14336/AD.2014.0500183; Caswell SV., 2014, INT J ATHL THER TRAI, V19, P22; Catenaccio E, 2017, PM&R, V9, P884, DOI 10.1016/j.pmrj.2017.01.005; Choi WJ, 2017, CLIN BIOMECH, V49, P28, DOI 10.1016/j.clinbiomech.2017.08.007; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Cornwell Jr R, 2013, CREATING STANDARDIZE; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Eckner JT, 2018, AM J PHYS MED REHAB, V97, P292, DOI 10.1097/PHM.0000000000000843; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Gilchrist I, 2016, CLIN BIOMECH, V37, P44, DOI 10.1016/j.clinbiomech.2016.05.016; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Huelke D. F., 1979, ANATOMY HUMAN CERVIC; Hwang HF, 2015, J HEAD TRAUMA REHAB, V30, pE9, DOI 10.1097/HTR.0000000000000093; Ito Y, 1997, EXP BRAIN RES, V117, P266, DOI 10.1007/s002210050221; Ito Y, 1995, J PHYSIOL-LONDON, V489, P911, DOI 10.1113/jphysiol.1995.sp021103; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; Kanekar N, 2014, EXP BRAIN RES, V232, P1127, DOI 10.1007/s00221-014-3822-3; Krishnamoorthy V, 2015, J TRAUMA NURS, V22, P204, DOI 10.1097/JTN.0000000000000135; Kuramochi R, 2004, NEUROSCI LETT, V366, P206, DOI 10.1016/j.neulet.2004.05.040; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; Lavallee AV, 2013, J BIOMECH, V46, P527, DOI 10.1016/j.jbiomech.2012.09.029; Lisman P., 2012, INT J SPORTS SCI ENG, V6, P131; Mansell J, 2005, J ATHL TRAINING, V40, P310; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meznaric M, 2018, ANN ANAT, V216, P95, DOI 10.1016/j.aanat.2017.12.001; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Murphy MP, 2014, REHABIL NURS, V39, P113, DOI 10.1002/rnj.89; Netter F.H., 2006, ATLAS HUMAN ANATOMY; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Simoneau M, 2008, J BIOMECH, V41, P2097, DOI 10.1016/j.jbiomech.2008.05.002; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257	49	5	5	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		2296-858X		FRONT MED-LAUSANNE	Front. Med.	MAR 27	2019	6								53	10.3389/fmed.2019.00053			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HQ8DP	WOS:000462654500001	31001532	Green Published, gold			2022-02-06	
J	Hays, K; Tefertiller, C; Ketchum, JM; Sevigny, M; O'Dell, DR; Natale, A; Eagye, CB; Harrison-Felix, C				Hays, Kaitlin; Tefertiller, Candace; Ketchum, Jessica M.; Sevigny, Mitch; O'Dell, Denise R.; Natale, Audrey; Eagye, C. B.; Harrison-Felix, Cynthia			Balance in chronic traumatic brain injury: correlations between clinical measures and a self-report measure	BRAIN INJURY			English	Article						Brain injuries; traumatic; balance; outcome assessment; evidence based medicine	EVALUATION SYSTEMS TEST; INTERNAL CONSISTENCY; COMMUNITY BALANCE; MOBILITY SCALE; UNITED-STATES; RELIABILITY; DEFICITS; VALIDITY; GAIT; EPIDEMIOLOGY	Objective: To assess associations among commonly used self-report and clinical measures of balance in chronic TBI. Design: Cross-sectional analysis of balance in a convenience sample of individuals at least one year post TBI. Main Outcome Measures: Activities-Specific Balance Confidence Scale (ABC) (self-reported balance impairment), Community Balance and Mobility Scale (CB&M) (clinical measure validated in TBI), and Balance Evaluation Systems Test (BESTest) (clinical measure not validated in TBI). Methods: Fifty-nine individuals (64% male, mean age 48.2 years) ambulating independently within the home participated in testing. Pearson correlation coefficients were used to quantify the direction and magnitude of the relationships among the three balance impairment measures. Results: A significant positive correlation was noted between the ABC and CB&M (r = 0.42, p = 0.0008), between the ABC and BESTest (r = 0.46, p = 0.0002), and between the CB&M and BESTest (r = 0.86, p < 0.0001). Conclusions: This is the first study we are aware of in the chronic moderate to severe TBI population directly comparing patient's self-reported balance impairment with clinical measures. Positive correlations were found between the self-report measure and both clinical measures. Overall, individuals with chronic TBI tend to self-report less impaired balance than clinical measures indicate. These results provide preliminary evidence to support the need for validation of the BESTest in this population.	[Hays, Kaitlin; Tefertiller, Candace; O'Dell, Denise R.; Natale, Audrey] Craig Hosp, Phys Therapy Dept, 3425 S Clarkson St, Englewood, CO 80113 USA; [Ketchum, Jessica M.; Sevigny, Mitch; Eagye, C. B.; Harrison-Felix, Cynthia] Craig Hosp, Res Dept, Englewood, CO USA; [Ketchum, Jessica M.; Harrison-Felix, Cynthia] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA; [O'Dell, Denise R.] Regis Univ, Sch Phys Therapy, Denver, CO USA; [Harrison-Felix, Cynthia] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA		Hays, K (corresponding author), Craig Hosp, Phys Therapy Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	khays@craighospital.org	Ketchum, Jessica/AAE-8200-2020		Traumatic Brain Injury Model Systems Center grant from the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, Department of Health and Human Services [90DP0034]	This work was supported by the Traumatic Brain Injury Model Systems Center grant from the National Institute on Disability, Independent Living, and Rehabilitation Research, Administration for Community Living, Department of Health and Human Services [90DP0034].	[Anonymous], SAS V 9 4; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Buster TW, 2016, BRAIN INJURY, V30, P1249, DOI 10.1080/02699052.2016.1183822; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Chinsongkram B, 2014, PHYS THER, V94, P1632, DOI 10.2522/ptj.20130558; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Fleming JM, 1996, BRAIN INJURY, V10, P1; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Hoffer ME, 2007, POSTTRAUMATIC BALANC; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Horak FB, 1997, GAIT POSTURE, V6, P76, DOI 10.1016/S0966-6362(97)00018-0; Howe JA, 2006, CLIN REHABIL, V20, P885, DOI 10.1177/0269215506072183; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCulloch KL, 2016, J NEUROL PHYS THER, V40, P269, DOI 10.1097/NPT.0000000000000145; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Padgett PK, 2012, PHYS THER, V92, P1197, DOI 10.2522/ptj.20120056; Pape MM, 2016, J HEAD TRAUMA REHAB, V31, P339, DOI 10.1097/HTR.0000000000000179; Peirone E, 2014, CLIN REHABIL, V28, P329, DOI 10.1177/0269215513501527; Perry SB, 2014, J HEAD TRAUMA REHAB, V29, P117, DOI 10.1097/HTR.0b013e3182864f2f; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; Stapley P, 1998, NEUROREPORT, V9, P395, DOI 10.1097/00001756-199802160-00007; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	36	5	5	4	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					435	441		10.1080/02699052.2019.1565900			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100006	30638404	Green Accepted, Green Published			2022-02-06	
J	Houck, Z; Asken, B; Bauer, R; Clugston, J				Houck, Zac; Asken, Breton; Bauer, Russell; Clugston, James			Predictors of post-concussion symptom severity in a university-based concussion clinic	BRAIN INJURY			English	Article						Concussion; symptom severity; ADHD; risk factors	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIORAL PREVENTION; DEFICIT HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; TEST-PERFORMANCE; HIGH-SCHOOL; SEX-DIFFERENCES; ADULTS; ADHD	Objective: To investigate potential predictors of acute post-concussion symptom severity in a university population. Methods: Data were obtained from the University of Florida Student Health Care Center Concussion Databank. Symptom severity, measured by the Sport Concussion Assessment Tool - third edition Symptom Evaluation (S3SE), was analyzed at 0-3 (n = 99) and 7-14 days (n = 56) post-concussion. Participants were 99 (56 females; age range: 18-30) students from the University of Florida who had been referred to the center's Concussion Clinic. Independent samples t-test and Mann-Whitney U were used to assess group differences in overall and domain-specific symptom severity, respectively. Hierarchical regressions were used to assess predictors of symptom severity at 0-3 and 7-14 days, as well as residual symptom change between time points. Results: Female sex (beta = .293; p = .002) and history of ADHD (beta = .312; p = .001) predicted greater symptom severity at 0-3 days. History of motion sickness predicted lower symptom severity (beta = -.199; p = .033). ADHD (beta = .284; p = .009) and higher 0-3-day physical symptoms (beta = .552; p < .001) predicted greater symptom severity at 7-14 days. ADHD predicted residual symptom severity change between time points (beta = .433; p = .001). Conclusion: ADHD, female sex, and acute physical symptoms (0-3 days) represent risk factors for greater symptom severity in the first two weeks post-concussion among college students.	[Houck, Zac; Asken, Breton; Bauer, Russell] Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA; [Asken, Breton] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA; [Clugston, James] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA		Houck, Z (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, POB 100165, Gainesville, FL 32610 USA.	zhouck@phhp.ufl.edu		Asken, Breton/0000-0001-8419-142X; Clugston, James/0000-0002-2103-1039; Bauer, Russell/0000-0001-6807-2535			Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Anastopoulos AD, 2018, J CLIN CHILD ADOLESC, V47, P236, DOI 10.1080/15374416.2015.1105137; Arnett JJ, 2004, EMEGING ADULTHOOD WI; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; ATTENTION DEFICIT SO, 2011, PEDIATRICS; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Blase SL, 2009, J ATTEN DISORD, V13, P297, DOI 10.1177/1087054709334446; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bruce JM, 2004, NEUROLOGY, V63, P1516; Collings LJ, 2017, BRAIN INJURY, V31, P1479, DOI 10.1080/02699052.2017.1377351; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; CRONBACH LJ, 1970, PSYCHOL BULL, V74, P68, DOI 10.1037/h0029382; Dusselier L, 2005, J AM COLL HEALTH, V54, P15, DOI 10.3200/JACH.54.1.15-24; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis M, 2018, J NEUROSURG-PEDIATR, V21, P401, DOI 10.3171/2017.9.PEDS17392; Gallagher V, 2018, J NEUROTRAUM, V35, P1242, DOI 10.1089/neu.2017.5453; Grissom R.J., 2012, EFFECT SIZES RES UNI, V2; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kamins J, 2018, HEADACHE, V58, P811, DOI 10.1111/head.13312; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lewinsohn PM, 1998, CLIN PSYCHOL REV, V18, P765, DOI 10.1016/S0272-7358(98)00010-5; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nutt DJ, 2007, J PSYCHOPHARMACOL, V21, P10, DOI 10.1177/0269881106073219; Orr D, 2008, J AM COLL HEALTH, V56, P469, DOI 10.3200/JACH.56.5.469-480; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Poysophon P, 2018, SPORTS HEALTH, V10, P317, DOI 10.1177/1941738117751387; Rabiner DL, 2008, J ATTEN DISORD, V11, P689, DOI 10.1177/1087054707305106; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Safren SA, 2004, PSYCHIAT CLIN N AM, V27, P349, DOI 10.1016/S0193-953X(03)00089-3; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Shaw-Zirt Barbara, 2005, J Atten Disord, V8, P109; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Sobanski E, 2006, EUR ARCH PSY CLIN N, V256, P26, DOI 10.1007/s00406-006-1004-4; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; ZIRKEL S, 1992, J PERS SOC PSYCHOL, V62, P506, DOI 10.1037/0022-3514.62.3.506	52	5	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR 21	2019	33	4					480	489		10.1080/02699052.2019.1565897			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HL7QM	WOS:000458936100010	30626213				2022-02-06	
J	Latifi, R; Parsikia, A; Boci, A; Doarn, CR; Merrell, RC				Latifi, Rifat; Parsikia, Afshin; Boci, Arian; Doarn, Charles R.; Merrell, Ronald C.			Increases Access to Care through Telemedicine in Albania: An Analysis of 2,724 Patients	TELEMEDICINE AND E-HEALTH			English	Article						telemedicine; trauma; international health; telehealth	DEVELOPING-COUNTRIES; MEDICAL SYSTEMS; HEALTH	Introduction: The Integrated Telemedicine and e-Health program (ITeHP) of Albania, built by the International Virtual e-Hospital Foundation (IVeH), has improved access to high-quality health care, particularly in high demanding specialty disciplines. We aimed to test the hypothesis that the majority of patients in remote and regional hospitals can be managed using telemedicine and will prevent unnecessary transfers. Methods: A retrospective analysis of prospectively collected data of patients seen between January 2014 and September 2018 was conducted. Patient demographics, type of teleconsultation modality used, and patient disposition were analyzed. The comparison of continuous data was performed with t-test or Mann-Whitney test. The categorical data were tested with chi-squared test and analysis of variance. Results: There were 2,842 patients seen in all the clinical disciplines during the study period. We excluded tele-autism and incomplete data. There were 2,724 records eligible for study. The most frequent consulting clinical programs (82.9%) were teleradiology (39.0%), teleneurotrauma (27.2%), and teletestroke (16.7%). The majority of patients (77.9%) were kept at regional centers and did not require transfer (p < 0.001) to a tertiary center. Of those transferred, 70.3% were male (p < 0.001), of which 81.6% were for transferred due to neurotrauma. Conclusion: The telemedicine program in Albania has improved access to specialized care in a number of specialty clinical disciplines, particularly in potentially life-threatening and time-sensitive conditions such as neurotrauma. Almost 80% of patients did not require transfer to tertiary centers and were kept for further treatment at the regional centers.	[Latifi, Rifat] New York Med Coll, Westchester Med Ctr, Sch Med, Valhalla, NY 10595 USA; [Latifi, Rifat; Parsikia, Afshin; Boci, Arian; Merrell, Ronald C.] Int Virtual E Hosp Fdn, Hope, ID USA; [Boci, Arian] Integrated Telemed & E Hlth Program Albania, Tirana, Albania; [Doarn, Charles R.] Univ Cincinnati, Coll Med, Dept Family & Community Med, Cincinnati, OH USA; [Doarn, Charles R.] Univ Cincinnati, Cincinnati, OH USA		Latifi, R (corresponding author), New York Med Coll, Dept Surg, Sch Med, Westchester Med Ctr, 100 Woods Rd, Valhalla, NY 10595 USA.	rifat.latifi@wmchealth.org		Latifi, Rifat/0000-0003-1091-3682			Alajmi D, 2013, STUD HEALTH TECHNOL, V190, P118, DOI 10.3233/978-1-61499-276-9-118; Bediang G, 2010, Yearb Med Inform, P47; Brauchli K, 2005, STUD HEALTH TECHNOL, V114, P11; Combi C, 2016, APPL CLIN INFORM, V7, P1025, DOI 10.4338/ACI-2016-06-R-0089; Geissbuhler A, 2003, AMIA ANN S P, V2003, P249; Kirigia JM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-137; Lapao LV, 2013, 2013 IST-AFRICA CONFERENCE AND EXHIBITION (IST-AFRICA); Latifi R, 2006, TELEMED J E-HEALTH, V12, P332, DOI 10.1089/tmj.2006.12.332; Latifi R, 2018, WORLD NEUROSURG, V112, pE747, DOI 10.1016/j.wneu.2018.01.146; Latifi R, 2016, TELEMED E-HEALTH, V22, P1024, DOI 10.1089/tmj.2016.0050; Latifi R, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0124-5; Latifi R, 2015, TELEMED E-HEALTH, V21, P503, DOI 10.1089/tmj.2014.0138; Latifi R, 2014, TELEMED E-HEALTH, V20, P1027, DOI 10.1089/tmj.2014.0026; Latifi R, 2014, WORLD J SURG, V38, P1898, DOI 10.1007/s00268-014-2538-7; Latifi Rifat, 2012, Bull Am Coll Surg, V97, P15; Latifi R, 2009, TELEMED J E-HEALTH, V15, P956, DOI 10.1089/tmj.2009.0084; Mars M, 2010, Yearb Med Inform, P87; Mars M, 2012, TELEMED E-HEALTH, V18, P32, DOI 10.1089/tmj.2011.0146; Mattos SD, 2015, B WORLD HEALTH ORGAN, V93, P881, DOI 10.2471/BLT.14.148874; Shiferaw F, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.15638; Skender B, 2017, ALBANIAN J TRAUMA EM, V1, P15; Wootton R, 2001, J TELEMED TELECARE, V7, P3, DOI 10.1258/1357633011937245	22	5	5	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	FEB 1	2020	26	2					164	175		10.1089/tmj.2018.0338		MAR 2019	12	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	KJ7ZL	WOS:000461790800001	30892141				2022-02-06	
J	Lawrence, JB; Haider, MN; Leddy, JJ; Hinds, A; Miecznikowski, JC; Willer, BS				Lawrence, Justine B.; Haider, Mohammad N.; Leddy, John J.; Hinds, Andrea; Miecznikowski, Jeffery C.; Willer, Barry S.			The King-Devick test in an outpatient concussion clinic: Assessing the diagnostic and prognostic value of a vision test in conjunction with exercise testing among acutely concussed adolescents	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						King-Devick test; Concussion; Sport-related concussion; Persistent post-concussion syndrome; Sideline assessment	SPORTS-RELATED CONCUSSION; VISUAL SCREENING TOOL; AMATEUR RUGBY UNION; HIGH-SCHOOL; RELIABILITY; ASSOCIATIONS; COGNITION; RECOVERY; BALANCE; LEAGUE	Objective: This study investigated the diagnostic and prognostic value of the King-Devick (K-D) test in conjunction with treadmill testing in adolescents after sport-related concussion (SRC) in an outpatient concussion management clinic without baseline measures. Design: Prospective cohort. Methods: The K-D test was administered pre- and post-exercise on a graded treadmill test to acutely concussed (AC, < 10 days from injury, n = 46, 15.4 2.1 years) participants for 2 clinic visits (1 week apart) and to matched controls (MC, n = 30, 15.8 1.4 years) for 2 visits (1 week apart). Initial K-D test times were compared between MC and AC. Changes in times from pre- to post- exercise during a treadmill test were compared for MC and AC and from Visit 1 to Visit 2. Smooth pursuits and repetitive saccades were compared with initial visit K-D test performance. Results: Comparison of pre-exercise K-D test times at Visit 1 distinguished MC from AC (46.1 9.2 s vs. 53.7 13.0 s, p =.007). Comparison of pre- and post-exercise K-D test times revealed significant improvements for MC (46.1 9.2 s vs. 43.1 8.5 s, p <.001) and AC who recovered by Visit 2 (Fast Recovery Group [FRG], n = 23, 50.4 10.0 s vs. 47.3 9.8 s, p =.002). No significant difference was seen in pre- and postexercise K-D test times on Visit 1 for AC who took longer than 2 weeks to recover (Slow Recovery Group [SRG], n = 23, 57.0 15.0 s vs. 56.0 16.3 s, p =.478). At Visit 1, AC had more abnormal smooth pursuits than MC (17% vs. 3%, non-significant, p =.064). AC, however, had significantly more abnormal repetitive saccades than MC (37% vs. 3%, p =.001) and AC with abnormal repetitive saccades took significantly longer to complete the Visit 1 pre-exercise K-D test than AC with normal repetitive saccades (58.6 16.0 s vs 50.8 10.2 s, p =.049). Conclusion: The study supports utility of the K-D test as part of outpatient concussion assessment. Lack of improvement in K-D test performance after an exercise test may be an indicator of delayed recovery from SRC.	[Lawrence, Justine B.; Haider, Mohammad N.] SUNY Buffalo, Dept Neurosci, Buffalo, NY 14214 USA; [Haider, Mohammad N.; Leddy, John J.; Hinds, Andrea] SUNY Buffalo, UBMD Dept Orthoped & Sports Med, Buffalo, NY 14214 USA; [Miecznikowski, Jeffery C.] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA; [Willer, Barry S.] SUNY Buffalo, Dept Psychiat, Buffalo, NY 14214 USA		Lawrence, JB (corresponding author), 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	jblawren@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; Ralph and Mary Wilson Foundation; Robert Rich Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094444] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding was also provided by the Ralph and Mary Wilson Foundation and the Robert Rich Family Foundation.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Anderson HD, 2017, BRAIN INJURY, V31, P1813, DOI 10.1080/02699052.2017.1346283; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Bohm A., 2015, NEUROLOGY, V84; Borg G., 1998, BORGS PERCEIVED EXER; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Dhawan P., 2014, NEUROLOGY S, V82; Duenas M., 2014, SURG NEUROL INT, V5; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Harrold GK, 2017, J NEUROL SCI, V379, P312, DOI 10.1016/j.jns.2017.06.038; Hogan CL, 2013, PSYCHOL AGING, V28, P587, DOI 10.1037/a0032634; King AT., 1976, PROPOSED KING DEVICK; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; King-Devick technologies, 2018, I KING DEV TEST ONL; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leigh R John, 2015, NEUROLOGY EYE MOVEME, V90; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lieberman S, 1983, J Am Optom Assoc, V54, P631; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McIntyre L, 2017, J ATHL TRAINING, V52, P1035, DOI 10.4085/1062-6050-52.10.14; Moran R, 2017, J NEUROL SCI, V383, P101, DOI 10.1016/j.jns.2017.10.039; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; Purves D., 2001, NEUROSCIENCE, P361; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Subotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183092; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	48	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	MAR 15	2019	398						91	97		10.1016/j.jns.2018.12.020			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP1CP	WOS:000461403300018	30690413	Green Accepted			2022-02-06	
J	Divito, A; Kerr, K; Wilkerson, C; Shepard, S; Choi, A; Kitagawa, RS				Divito, Anthony; Kerr, Keith; Wilkerson, Christopher; Shepard, Scott; Choi, Alex; Kitagawa, Ryan S.			Use of Anticoagulation Agents After Traumatic Intracranial Hemorrhage	WORLD NEUROSURGERY			English	Article						Anticoagulation; Intracranial hemorrhage; Traumatic brain injury	VENOUS THROMBOEMBOLISM; AMERICAN-COLLEGE; BRAIN-INJURY; 1602 EPISODES; THROMBOSIS; THERAPY; MANAGEMENT; STROKE	OBJECTIVE: Anticoagulant therapy (ACT) after traumatic intracranial hemorrhage may lead to progression of hemorrhage, but in the presence of thromboembolic events, the clinician must decide if the benefits outweigh the risks. Currently, no data exist to guide therapy in the acute setting. METHODS: We retrospectively identified all patients admitted to our institution with traumatic intracranial hemorrhage that received intravenous heparin, full-dose enoxaparin, or warfarin during their initial hospitalization over a 3-year period. We reviewed their demographics, hospital course, clinical indication and timing for initiation of ACT, and complications. RESULTS: A total of 112 patients were identified. The median age and Glasgow Coma Scale score of these patients was 50.5 years and 9.5, respectively. Twenty-two patients required neurosurgical procedures for their presenting injury, including intracranial pressure monitors and/ or open surgeries. Fifty-four patients had deep vein thrombosis or pulmonary embolism prior to initiation, and the remaining 20 patients had preexisting conditions or other indications for initiating ACT. The median time from injury to starting ACT was 8 days. Immediate complications occurred in 6 patients; however, none of these patients required a neurosurgical intervention. Delayed complications included progression of acute to chronic subdural hematoma that required intervention in 2 patients. One patient died from delayed hemorrhage. CONCLUSIONS: For this patient population, the risk of immediate and delayed intracranial hemorrhages from initiating ACT therapy in intracranial injury must be weighed against the morbidity of delaying treatment. Although further studies are needed, our review provides the first rates of complications for this patient population.	[Divito, Anthony; Kerr, Keith; Wilkerson, Christopher; Shepard, Scott; Choi, Alex; Kitagawa, Ryan S.] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA		Kitagawa, RS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA.	Ryan.S.Kitagawa@uth.tmc.edu		Wilkerson, Christopher/0000-0002-5761-1377			Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Brandt MM, 2007, AM J SURG, V193, P383; Byrnes MC, 2012, WORLD J EMERG SURG, V7, DOI 10.1186/1749-7922-7-25; Centers for Disease Control and Prevention (CDC), 2010, NAT HOSP DISCH SURV; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dunn AS, 2003, ARCH INTERN MED, V163, P901, DOI 10.1001/archinte.163.8.901; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Jansen S, 2015, AGE AGEING, V44, P598, DOI 10.1093/ageing/afv017; Kearon C, 2014, BLOOD, V123, P1794, DOI 10.1182/blood-2013-12-512681; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kelly J, 2003, STROKE, V34, P2999, DOI 10.1161/01.STR.0000102561.86835.17; Khaldi A, 2011, J NEUROSURG, V114, P40, DOI 10.3171/2010.8.JNS10332; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Ntaios G, 2013, NEUROLOGY, V80, P1009, DOI 10.1212/WNL.0b013e318287281b; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Romualdi E, 2009, THROMB HAEMOSTASIS, V101, P290, DOI 10.1160/TH08-07-0474; Shackford SR, 2004, ANN SURG, V240, P496; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Wijdicks EFM, 1998, NEUROSURGERY, V42, P769, DOI 10.1097/00006123-199804000-00053	23	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2019	123						E25	E30		10.1016/j.wneu.2018.10.173			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HR2II	WOS:000462958400005	30528524				2022-02-06	
J	Eom, KS; Seo, BR; Rim, BC; Cho, BM; Lee, SK; Jung, HH; Kim, JH; Lee, JH; Kim, JH; Kim, MS; Nam, TK; Song, YJ				Eom, Ki Seong; Seo, Bo-Ra; Rim, Byeong-Cheol; Cho, Byung-Moon; Lee, Sang Koo; Jung, Hyun-Ho; Kim, Jae-Hoon; Lee, Jeong-Ho; Kim, Jong-Hyun; Kim, Min-Su; Nam, Taek-Kyun; Song, Young-Jin		KNTDB Investigators	Epidemiology and Outcomes of Traumatic Brain Injury in Elderly Population : A Multicenter Analysis Using Korean Neuro-Trauma Data Bank System 2010-2014	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Korean Neuro-Trauma Data Bank System; Brain injuries, Traumatic; Elderly; Epidemiology; Mortality	OLDER-ADULTS; MORTALITY; AGE	Objective : Although traumatic brain injury (TBI) occurs in people of all age groups, the elderly population is at a particular risk. The proportion of elderly population in the society is markedly increasing and Korea is one of the most rapidly aging societies. Here, we analyzed the data from 904 patients older over 65 years who were registered in the Korean Neuro-Trauma Data Bank System (KNTDBS). Methods : The Korean Society of Neurotraumatology recorded data from 20 institutions between September 2010 and March 2014. This retrospective study examined the clinical epidemiology, sex difference, outcome epidemiology, sociodemographic variables, and outcomes in the geriatric population related to TBI based on data from the KNTDBS. Results : The study included 540 men and 364 women. The age distributions in the male and female groups were statistically significantly different. The most common cause of trauma was a fall and diagnosis was acute subdural hematoma. The incidence was the highest in men aged 80-84 years and in women aged 75-79 years. The most common time of arrival to hospital after TBI was within 1 hour and 119 rescue team provided first aid earliest to patients with TBI. The mortality rate stratified according to the cause of trauma was significantly different, with mortality rates of 3.77% in fall and 11.65% in traffic accident. The mortality rates according the severity of brain injury, Glasgow Coma Scale score, and treatment were statistically significant. Conclusion : To our knowledge, this study is the first to focus on elderly patients with TBI in Korea and particularly investigate mortality and characteristics related to TBI-related death based on data from the KNTDBS. Although the study has some limitations, our results may be used to obtain useful information to study targeted prevention and more effective treatment options for older TBI patients and establish novel treatment guidelines and health polish for the geriatric population.	[Eom, Ki Seong] Wonkwang Univ Hosp, Dept Neurosurg, 895 Muwang Ro, Iksan 54538, South Korea; [Eom, Ki Seong; KNTDB Investigators] Korean Neurotraumatol Soc, Korea Neurotrauma Data Bank Comm, Seoul, South Korea; [Seo, Bo-Ra] Chonnam Natl Univ Hosp, Gwangju, South Korea; [Rim, Byeong-Cheol] Chungbuk Natl Univ Hosp, Cheongju, South Korea; [Cho, Byung-Moon] Hallym Univ, Kangdong Sacred Heart Hosp, Chunchon, South Korea; [Lee, Sang Koo] Dankook Univ Hosp, Cheonan, South Korea; [Eom, Ki Seong] Wonkwang Univ Hosp, Iksan, South Korea; [Jung, Hyun-Ho] Wonju Severance Christian Hosp, Wonju, South Korea; [Kim, Jae-Hoon] Eulji Univ Hosp, Daejeon, South Korea; [Lee, Jeong-Ho] Daegu Fatima Hosp, Daegu, South Korea; [Kim, Jong-Hyun] Korea Univ, Guro Hosp, Seoul, South Korea; [Kim, Min-Su] Yongnam Univ Hosp, Daegu, South Korea; [Nam, Taek-Kyun] Chung Ang Univ Hosp, Seoul, South Korea; [Song, Young-Jin] Dong A Univ Hosp, Busan, South Korea		Eom, KS (corresponding author), Wonkwang Univ Hosp, Dept Neurosurg, 895 Muwang Ro, Iksan 54538, South Korea.	kseom@wonkwang.ac.kr			Wonkwang University	This work was supported by Wonkwang University in 2017.	Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fu WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175868; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; Korean Statistical Information Service, STAT DAT POP CENS; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Song SY, 2016, J KOREAN NEUROSURG S, V59, P485, DOI 10.3340/jkns.2016.59.5.485; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034	18	5	5	0	1	KOREAN NEUROSURGICAL SOC	SEOUL	BLDG B, #402, 27, CHILPAE-RO, JUNG-GU, SEOUL, 04511, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	MAR	2019	62	2					243	255		10.3340/jkns.2018.0017			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW5GB	WOS:000466716300014	30840980	Green Published, gold, Green Submitted			2022-02-06	
J	Gabbatore, I; Bosco, FM; Makinen, L; Ebeling, H; Hurtig, T; Loukusa, S				Gabbatore, Ilaria; Bosco, Francesca M.; Makinen, Leena; Ebeling, Hanna; Hurtig, Tuula; Loukusa, Soile			Investigating pragmatic abilities in young Finnish adults using the Assessment Battery for Communication	INTERCULTURAL PRAGMATICS			English	Article						pragmatics; cross-cultural; Assessment Battery for Communication; finnish; communicative style	TRAUMATIC BRAIN-INJURY; LANGUAGE DEFICITS; SPEECH ACTS; CHILDREN; IMPAIRMENT; MIND; STRATEGIES; DISORDERS; SCHIZOPHRENIA; ADOLESCENTS	Pragmatic communication refers to the ability to use language and other expressive means, i.e. non-verbal/extralinguistic means such as gestures and facial expressions, in order to convey and interpret meaning in a specific context. Pragmatic abilities are important in everyday life in interpersonal interactions as they affect the way people communicate and behave in social situations. Providing a comprehensive and accurate assessment of pragmatic abilities can be challenging, partially due to the scarcity of valid assessment tools in this area. Culture-related aspects of communication need to be taken into consideration, and the assessment tools need to be specific and sensitive for specific cultural contexts. In this paper, we present the results concerning the administration of the first preliminary translation and adaptation into the Finnish language of the equivalent form A of the Italian Assessment Battery for Communication (ABaCo) to a sample of neurotypical Finnish adults (n = 36); we discuss the results, highlighting cultural features and the consequent adaptation requirements. Data regarding performance on each subscale and on each item of the ABaCo are provided, together with a qualitative analysis of the answers. These data indicate good performance on the majority of the subscales used, thus indicating good properties of the preliminary Finnish version of the ABaCo. Compared to the paralinguistic and context scales, where the participants exhibited good performance, slightly lower scores were obtained on the extralinguistic scale. Such results shed light on a number of differences in the way Finnish people interpret pragmatically challenging communicative situations. The present study represents an interesting starting point for further steps in the specific ABaCo adaptation process, as well as for future studies in terms of cross-cultural investigation.	[Gabbatore, Ilaria; Bosco, Francesca M.] Univ Turin, Dept Psychol, GIPSI Res Grp, Turin, Italy; [Gabbatore, Ilaria; Makinen, Leena; Loukusa, Soile] Univ Oulu, Res Unit Logoped, Oulu, Finland; [Bosco, Francesca M.] Univ Turin, NIT, Turin, Italy; [Ebeling, Hanna; Hurtig, Tuula] Univ Oulu, PEDEGO Res Unit, Child Psychiat, Oulu, Finland; [Ebeling, Hanna; Hurtig, Tuula] Univ Hosp Oulu, Clin Child Psychiat, Oulu, Finland; [Hurtig, Tuula] Univ Oulu, Res Unit Clin Neurosci, Psychiat, Oulu, Finland		Gabbatore, I (corresponding author), Univ Turin, Dept Psychol, GIPSI Res Grp, Turin, Italy.; Gabbatore, I (corresponding author), Univ Oulu, Res Unit Logoped, Oulu, Finland.	ilaria.gabbatore@unito.it; francesca.bosco@unito.it; leena.makinen@oulu.fi; hanna.elina.ebeling@ppshp.fi; tuula.hurtig@oulu.fi; soile.loukusa@oulu.fi	bosco, francesca marina/B-6746-2013; Gabbatore, Ilaria/AAC-1925-2019	bosco, francesca marina/0000-0001-6101-8587; Gabbatore, Ilaria/0000-0002-9724-8066; Loukusa, Soile/0000-0001-6614-4689	Academy of FinlandAcademy of FinlandEuropean Commission; Eudaimonia Institute, Finland	This research was financially supported by the Academy of Finland and by the Eudaimonia Institute, Finland. The authors wish to thank Linda Lonnqvist for her help with data collection and Aija Kotila for her contribution with inter-rater reliability analysis.	Agliati A., 2005, HIDDEN STRUCTURE INT; Agliati A, 2006, BEHAV RES METHODS, V38, P364, DOI 10.3758/BF03192789; Altman D.G., 1990, PRACTICAL STAT MED R; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2016, MINERVA PSICH, V57, P93; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; Arcara G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00070; Aukrust VG, 2004, J CHILD LANG, V31, P177, DOI 10.1017/S0305000903005907; Austin JL., 1962, DO THINGS WORDS, V2; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Bara BG, 2011, INTERCULT PRAGMAT, V8, P443, DOI 10.1515/IPRG.2011.020; Belva BC, 2012, RES DEV DISABIL, V33, P525, DOI 10.1016/j.ridd.2011.10.019; Birdwhistell Ray L., 1970, KINESICS CONTEXT ESS, P65; Bosco FM, 2018, J COMMUN DISORD, V75, P102, DOI 10.1016/j.jcomdis.2018.05.002; Bosco FM, 2004, J PRAGMATICS, V36, P467, DOI 10.1016/S0378-2166(03)00055-9; Bosco FM, 2008, J PRAGMATICS, V40, P583, DOI 10.1016/j.pragma.2007.05.004; Bosco FM, 2017, CORTEX, V94, P73, DOI 10.1016/j.cortex.2017.06.010; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00021; Bosco FM, 2017, APPL PSYCHOLINGUIST, V38, P57, DOI 10.1017/S0142716416000047; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COGN PSYCHOL, V24, P525, DOI 10.1080/20445911.2012.658156; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; BOXER D, 1993, TESOL QUART, V27, P277, DOI 10.2307/3587147; Bryan K., 1995, RIGHT HEMISPHERE LAN, V2nd ed.; Bucciarelli M, 2003, J PRAGMATICS, V35, P207, DOI 10.1016/S0378-2166(02)00099-1; Camarata SM, 1999, MENT RETARD DEV D R, V5, P207, DOI 10.1002/(SICI)1098-2779(1999)5:3<207::AID-MRDD7>3.0.CO;2-O; Champagne-Lavau M, 2009, J NEUROLINGUIST, V22, P413, DOI 10.1016/j.jneuroling.2009.02.002; COHEN AD, 1993, TESOL QUART, V27, P33, DOI 10.2307/3586950; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Cote H., 2004, REEDUCATION ORTHOPHO, V219, P107; CUMMINGS L, 2005, PRAGMATICS MULTIDISC; Darrigrand B, 2011, DISABIL REHABIL, V33, P1169, DOI 10.3109/09638288.2010.524271; Davis B, 2015, J INTERACT RES COM D, V6, P115, DOI 10.1558/jircd.v7i1.26755; Dordevic M, 2016, RES DEV DISABIL, V48, P211, DOI 10.1016/j.ridd.2015.11.001; Fukushima S, 2017, INTERCULT PRAGMAT, V14, P525, DOI 10.1515/ip-2017-0024; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Gibbs Raymond, 2012, INTERPRETING FIGURAT; Golato A, 2003, APPL LINGUIST, V24, P90, DOI 10.1093/applin/24.1.90; Golato A, 2002, J PRAGMATICS, V34, P547, DOI 10.1016/S0378-2166(01)00040-6; Grice P., 1989, STUDIES WAY WORDS; Hatzithomas L, 2011, INT MARKET REV, V28, P57, DOI 10.1108/02651331111107107; House Juliana, 1989, CROSS CULTURAL PRAGM, P54; Huttunen KH, 2013, J PSYCHOLINGUIST RES, V42, P81, DOI 10.1007/s10936-012-9205-7; ISAAC KM, 2002, SPEECH PATHOLOGY CUL; Iverson Jana M, 2008, First Lang, V28, P164, DOI 10.1177/0142723707087736; Joanette Y, 2004, PROTOCOLE MONTREAL E; Jokinen K., 2006, SKY J LINGUISTICS, V19, P291; KENDON A, 1995, J PRAGMATICS, V23, P247, DOI 10.1016/0378-2166(94)00037-F; Kendon A., 2004, SEMANTICS PRAGMATICS, P173; Kendon A., 2004, GESTURE VISIBLE ACTI; Kuntay Aylin, 2014, PRAGMATIC DEV 1 LANG; Kwon Jihyun, 2004, MULTILINGUA, V23, P339, DOI DOI 10.1515/MULT.2004.23.4.339; Lam YG, 2012, RES AUTISM SPECT DIS, V6, P792, DOI 10.1016/j.rasd.2011.08.004; Lehtonen J., 1985, PERSPECTIVES SILENCE, P193; Lehtonen Jussi, 1991, CULTURE COMMUNICATIO, P175; Levinson Stephen., 1983, PRAGMATICS; Lewis R.D., 2006, CULTURES COLLIDE LEA; Linscott RJ, 2005, SCHIZOPHR RES, V75, P225, DOI 10.1016/j.schres.2004.10.007; Loukusa S, 2018, J COMMUN DISORD, V73, P91, DOI 10.1016/j.jcomdis.2018.01.006; Loukusa Soile, 2017, PSYCHOL LANGUAGE COM, V21, P408, DOI DOI 10.1515/PLC-2017-0020; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Matsumura S, 2001, LANG LEARN, V51, P635, DOI 10.1111/0023-8333.00170; Mattila ML, 2011, J AM ACAD CHILD PSY, V50, P583, DOI 10.1016/j.jaac.2011.04.001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Nishimura S., 2008, AINEDIDAKTINEN S, P783; Nouichi Fahima, 2014, REV SCI HUMAINES, V41, P37; Nureddeen FA, 2008, J PRAGMATICS, V40, P279, DOI 10.1016/j.pragma.2007.11.001; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; PAYNE KT, 2002, HUMAN COMMUNICATION; Peterson E, 2014, J POLITENESS RES-LAN, V10, P247, DOI 10.1515/pr-2014-0011; Ryder N, 2003, J PSYCHOLINGUIST RES, V32, P397, DOI 10.1023/A:1024847529077; Sallinen-Kuparinen A., 1991, COMMUN RES REP, V8, P55, DOI [DOI 10.1080/08824099109359876, 10.1080/08824099109359876]; Sallinen-Kuparinen Aino, 1986, STUDIA PHILOLOGICA J, V19; Sanna K, 2009, EUR CHILD ADOLES PSY, V18, P116, DOI 10.1007/s00787-008-0712-x; Schroder U, 2010, J PRAGMATICS, V42, P466, DOI 10.1016/j.pragma.2009.06.014; Searle John R., 1979, EXPRESSION MEANING S; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Sperber D., 1995, RELEVANCE COMMUNICAT; THOMAS J, 1983, APPL LINGUIST, V4, P91, DOI 10.1093/applin/4.2.91; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Vaisanen R, 2014, LOGOP PHONIATR VOCO, V39, P179, DOI 10.3109/14015439.2013.784802; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Xu Z, 2014, J PRAGMATICS, V60, P24, DOI 10.1016/j.pragma.2013.10.009; Zanini S, 2005, NEUROL SCI, V26, P13, DOI 10.1007/s10072-005-0377-x	90	5	5	1	14	DE GRUYTER MOUTON	BERLIN	GENTHINER STRASSE 13, 10785 BERLIN, GERMANY	1612-295X	1613-365X		INTERCULT PRAGMAT	Intercult. Pragmat.	MAR	2019	16	1					27	56		10.1515/ip-2019-0002			30	Linguistics; Language & Linguistics	Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Linguistics	HM2YN	WOS:000459337500002					2022-02-06	
J	Koulaeinejad, N; Haddadi, K; Ehteshami, S; Shafizad, M; Salehifar, E; Emadian, O; Mohammadpour, RA; Ala, S				Koulaeinejad, Neda; Haddadi, Kaveh; Ehteshami, Saeid; Shafizad, Misagh; Salehifar, Ebrahim; Emadian, Omid; Mohammadpour, Reza Ali; Ala, Shahram			Effects of Minocycline on Neurological Outcomes In Patients With Acute Traumatic Brain Injury: A Pilot Study	IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH			English	Article						Neuron-specific enolase (NSE); S100B; Glasgow coma scale (GCS); Glasgow Outcome Scale-Extended (GOS-E); Minocycline; Acute traumatic brain injury	NEURON-SPECIFIC ENOLASE; AMYOTROPHIC-LATERAL-SCLEROSIS; INTRACEREBRAL HEMORRHAGE; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; RANDOMIZED-TRIAL; PROTEIN-LEVELS; CELL-DEATH; SEVERITY; STROKE	Traumatic brain injury (TBI) is a public health problem worldwide. Secondary damage of brain injury begins within a few minutes after the trauma and can last a long time. It can be reversible, unlike primary injury. Therefore, therapeutic intervention can be used. The aims of this study were to assess the effects of minocycline on neurological function and serum S100B protein and neuron-specific enolase (NSE) levels in patients with moderate to severe TBI. Patients with acute onset of TBI and surgical evacuation of hematoma were randomized to receive either minocycline 100 mg orally twice daily or placebo for 7 days. The primary outcomes included changes in level of S100B and NSE at different time points during the trial. Additionally, changes in Glasgow coma scale (GCS) score were evaluated. The Glasgow Outcome Scale-Extended (GOS-E) score at 6 months after injury was assessed in discharge patients. Thirty four patients were randomized into the placebo (n = 20) and treatment (n = 14) groups. There was a marginal statistically significant differences in the normalized value of S100B between groups (p < 0.1). The reduction in serum NSE level from baseline to day 5 was statistically significant (p = 0.01) in minocycline group while it was not significantly decrease in placebo group (p = 0.2). Also, GCS improvement over time within the minocycline group was significant (p = 0.04) while was not significant in placebo group (p = 0.11). The GOS-E scores were not significantly different between minocycline and placebo group. Based on this study, it seems that the use of minocycline may be effective in acute TBI.	[Koulaeinejad, Neda; Salehifar, Ebrahim; Ala, Shahram] Mazandaran Univ Med Sci, Fac Pharm, Dept Clin Pharm, Sari, Iran; [Haddadi, Kaveh; Ehteshami, Saeid; Shafizad, Misagh] Mazandaran Univ Med Sci, Fac Med, Dept Neurosurg, Sari, Iran; [Emadian, Omid] Mazandaran Univ Med Sci, Fac Med, Dept Pathol, Sari, Iran; [Mohammadpour, Reza Ali] Mazandaran Univ Med Sci, Fac Hlth Sci, Dept Biostat, Sari, Iran		Ala, S (corresponding author), Mazandaran Univ Med Sci, Fac Pharm, Dept Clin Pharm, Sari, Iran.	sh204ala@yahoo.com	Koulaeinejad, Neda/AAN-7746-2021; Mohammadpour, Reza Ali/F-4279-2017	Mohammadpour, Reza Ali/0000-0003-2353-5027	Mazandaran University of Medical Sciences	This study was funded by a grant from the vice chancellor for research at Mazandaran University of Medical Sciences and was carried out as a dissertation project of Dr. Neda Koulaeinejad for clinical pharmacy residency. We thank Dr. Abbas Alipour for statistical consultation. We would like to thank Ms Alipour, Mr Mirzaeian, the staff of medical laboratory and particularly the staff of ICU wards of Imam Khomeini Hospital of Mazandaran University of Medical Sciences for their contribution in conducting the trial.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; [Anonymous], 2007, J NEUROTRAUMA, V24; Babadjouni RM, 2017, J NEUROINTERV SURG; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Cao SL, 2018, STROKE, V49, P995, DOI 10.1161/STROKEAHA.117.019860; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Chang JJ, 2017, EUR J NEUROL, V24, P1384, DOI 10.1111/ene.13403; Chapman-Davies Anthony, 2000, Clin Exp Optom, V83, P271; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; El-Maraghi S, 2013, EGYPT J CRIT CARE ME, V1, P25, DOI 10.1016/j.ejccm.2012.12.002; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Guo ZD, 2011, ACTA NEUROCHIR SUPPL, V110, P71, DOI 10.1007/978-3-7091-0353-1_13; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joseph B, 2018, J NEUROSCI RES, V96, P589, DOI 10.1002/jnr.24132; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2014, CRIT CARE MED, V42, P1965, DOI 10.1097/CCM.0000000000000445; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Mehta Samit Satish, 2010, Clin Neurosurg, V57, P134; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Moyer MT, 2018, TRAUMATIC BRAIN INJU, P165; Nakasujja N, 2013, NEUROLOGY, V80, P196, DOI 10.1212/WNL.0b013e31827b9121; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Sacktor N, 2011, NEUROLOGY, V77, P1135, DOI 10.1212/WNL.0b013e31822f0412; Scott G, 2016, EFFECT MINOCYCLINE N; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Srivastava MVP, 2012, NEUROL INDIA, V60, P23, DOI 10.4103/0028-3886.93584; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Uckun OM, 2015, J NEUROSCI RURAL PRA, V6, P27, DOI 10.4103/0976-3147.143186; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wasserman JK, 2007, EXP NEUROL, V207, P227, DOI 10.1016/j.expneurol.2007.06.025; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu JM, 2009, NEUROL RES, V31, P183, DOI 10.1179/174313209X385680; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	58	5	6	3	5	SHAHEED BEHESHTI UNIV, SCH PHARMACY	TEHRAN	NO 10 SHAMS ALLEY, VALI-E ASR ST, TEHRAN, 00000, IRAN	1735-0328	1726-6890		IRAN J PHARM RES	Iran. J. Pharm. Res.	SPR	2019	18	2					1086	1096		10.22037/ijpr.2019.1100677			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HZ6JW	WOS:000468959200050	31531090				2022-02-06	
J	Kurowski, BG; Epstein, JN; Pruitt, DW; Horn, PS; Altaye, M; Wade, SL				Kurowski, Brad G.; Epstein, Jeffery N.; Pruitt, David W.; Horn, Paul S.; Altaye, Mekibib; Wade, Shari L.			Benefits of Methylphenidate for Long-Term Attention Problems After Traumatic Brain Injury in Childhood: A Randomized, Double-Masked, Placebo-Controlled, Dose-Titration, Crossover Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attention problems; clinical trial; medication; pediatrics; traumatic brain injury	PARENT RATING-SCALE; ONCE-A-DAY; DEFICIT/HYPERACTIVITY DISORDER; PSYCHIATRIC-DISORDERS; CHILDREN; ADHD; ADOLESCENTS; SYMPTOMS; INTERVENTIONS; RELIABILITY	Objective: To characterize the benefits and optimal dose of long-acting methylphenidate for management of long-term attention problems after childhood traumatic brain injury (TBI). Design: Phase 2, randomized, double-masked, placebo-controlled, dose-titration, crossover clinical trial. Setting: Outpatient, clinical research. Participants: Twenty-six children aged 6 to 17 years who were at least 6 months post-TBI and met criteria for attention-deficit hyperactivity disorder (ADHD) at the time of enrollment. Outcome Measures: Vanderbilt Rating Scale of attention problems, Pittsburgh Side Effects Rating Scale, and vital signs. Results: Among the 26 participants randomized, 20 completed the trial. The mean ages at injury and enrollment were 6.3 and 11.5 years, respectively. Eight participants had a severe TBI. On an optimal dose of medication, greater reductions were found on the Vanderbilt Parent Rating Scale for the medicated condition than for placebo (P = .022, effect size = 0.59). The mean optimal dose of methylphenidate was 40.5 mg (1.00 mg/kg/day). Preinjury ADHD diagnosis status was not associated with a differential medication response. Methylphenidate was associated with weight loss (similar to 1 kg), increased systolic blood pressure (similar to 3- to 6-point increase), and mild reported changes in appetite. Conclusion: Findings support use of long-acting methylphenidate for management of long-term attention problems after pediatric TBI. Larger trials are warranted of stimulant medications, including comparative effectiveness and combination medication and nonmedication interventions.	[Kurowski, Brad G.; Pruitt, David W.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA; [Epstein, Jeffery N.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Horn, Paul S.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Kurowski, Brad G.; Epstein, Jeffery N.; Pruitt, David W.; Horn, Paul S.; Altaye, Mekibib; Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Kurowski, Brad G.; Pruitt, David W.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA		Kurowski, BG (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Brad.Kurowski@cchmc.org			Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683]; Cincinnati Children's Research Foundation; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001425]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90RT5004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074683] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	This project was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development grant K23HD074683 and, in part, by the Cincinnati Children's Research Foundation, and the National Center for Advancing Translational Sciences of the National Institutes of Health under AwardNumber UL1 TR001425 and the National Institute on Disability, Independent Living, and Rehabilitation Research, formerly known as the National Institute on Disability and Rehabilitation Research (grant number 90RT5004).	Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Backeljauw B, 2014, PM&R, V6, P814, DOI 10.1016/j.pmrj.2014.04.004; Becker SP, 2012, J DEV BEHAV PEDIATR, V33, P221, DOI 10.1097/DBP.0b013e318245615b; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Catroppa C, 2009, DEV NEUROREHABIL, V12, P361, DOI 10.3109/17518420903087335; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; de Kloet AJ, 2012, BRAIN INJURY, V26, P1021, DOI 10.3109/02699052.2012.654592; DuPaul GJ, 2016, PSYCHOL ASSESSMENT, V28, P214, DOI 10.1037/pas0000166; Ekinci O, 2017, BRAIN DEV-JPN, V39, P327, DOI 10.1016/j.braindev.2016.11.005; Faul M, 2010, TRAUMATIC BRAIN INJU; Froehlich TE, 2011, J AM ACAD CHILD PSY, V50, P1129, DOI 10.1016/j.jaac.2011.08.002; Galbiati S, 2009, NEUROPSYCHOLOGY, V23, P40, DOI 10.1037/a0013409; Gayleard JL, 2017, ADHD-ATTEND DEFICIT, V9, P149, DOI 10.1007/s12402-017-0216-y; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Greenhill LL, 1996, J AM ACAD CHILD PSY, V35, P1304, DOI 10.1097/00004583-199610000-00017; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Ho J, 2011, NEUROPSYCHOL REHABIL, V21, P183, DOI 10.1080/09602011.2010.547345; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kim J, 2012, PSYCHOPHARMACOLOGY, V222, P47, DOI 10.1007/s00213-011-2622-8; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lavigne JV, 2012, J DEV BEHAV PEDIATR, V33, P336, DOI 10.1097/DBP.0b013e31824afea1; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Nikles CJ, 2006, PEDIATRICS, V117, P2040, DOI 10.1542/peds.2005-1328; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Pelham WE, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e105; PELHAM WE, 1993, SCHOOL PSYCHOL REV, V22, P199; Rajeh A, 2017, ASIAN J PSYCHIATR, V25, P131, DOI 10.1016/j.ajp.2016.09.005; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Spencer TJ, 2009, J CHILD ADOL PSYCHOP, V19, P501, DOI 10.1089/cap.2008.0152; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thomas-Stonell N, 1994, J HEAD TRAUMA REHAB, V9, P25, DOI DOI 10.1097/00001199-199412000-00005; Van't Hooft I, 2005, BRAIN INJURY, V19, P511, DOI 10.1080/02699050400025224; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 1999, WESCHLER ABBREVIATED; Weisler R., 2010, PRIMARY PSYCHIAT, V17, P44; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; Wolraich ML, 1998, J ABNORM CHILD PSYCH, V26, P141, DOI 10.1023/A:1022673906401; Wolraich ML, 2001, PEDIATRICS, V108, P883, DOI 10.1542/peds.108.4.883; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yoo JH, 2018, BRAIN IMAGING BEHAV, V12, P518, DOI 10.1007/s11682-017-9713-z	61	5	5	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		E1	E12		10.1097/HTR.0000000000000432			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400001	30169436	Green Accepted			2022-02-06	
J	Kyyriainen, J; Bolkvadze, T; Koivisto, H; Lipponen, A; Perez, LO; Ndode-Ekane, XE; Tanila, H; Pitkanen, A				Kyyriainen, Jenni; Bolkvadze, Tamuna; Koivisto, Hennariikka; Lipponen, Anssi; Perez, Laura Oliva; Ndode-Ekane, Xavier Ekolle; Tanila, Heikki; Pitkanen, Asia			Deficiency of urokinase-type plasminogen activator and its receptor affects social behavior and increases seizure susceptibility	EPILEPSY RESEARCH			English	Article						Behavioral analysis; Double knockout; Pentylenetetrazol; Perineuronal nets; Seizure susceptibility; Behavioral analysis; Double knockout; Pentylenetetrazol; Perineuronal nets; Seizure susceptibility	TRAUMATIC BRAIN-INJURY; PERINEURONAL NETS; EXTRACELLULAR-MATRIX; INCREASED EXPRESSION; MOUSE MODEL; EPILEPTOGENESIS; EPILEPSY; DISRUPTION; MICE	Extracellular proteolysis initiated by the binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) regulates the development of inhibitory neuronal circuits in the cerebral cortex and tissue remodeling after epileptogenic brain injury. To study the function of different components of the uPA-uPAR system on behavior and epileptogenesis, and to complement our previous studies on naive and injured mice deficient in the uPA-encoding gene Plau or the uPAR-encoding gene Plaur, we analyzed the behavioral phenotype, seizure susceptibility, and perineuronal nets surrounding parvalbumin-positive inhibitory interneurons in Plau and Plaur (double knockout dKO) mice. In a climbing test, dKO mice showed reduced interest towards the environment as compared with Wt mice (p < 0.01). In a social approach test, however, dKO mice spent more time than Wt mice exploring the compartment containing a stranger mouse than the empty compartment (p < 0.05). Moreover, in a social interaction test, dKO mice exhibited increased contact time (p < 0.01). Compared with Wt mice, the dKO mice also had a longer single contact duration (p < 0.001) with the stranger mouse. In the elevated plus-maze, grooming, and marble burying tests, the anxiety level of dKO mice did not differ from that of Wt mice. Rearing time in an exploratory activity test, and spatial learning and memory in the Morris swim navigation task were also comparable between dKO and Wt mice. In the pentylenetetrazol (PTZ) seizure-susceptibility test, dKO mice had a shorter latency to the first epileptiform spike (p = 0.0001) and a greater total number of spikes (p < 0.001) than Wt mice. The dKO genotype did not affect the number of cortical perineuronal nets. Our findings indicate that Pfau/Plaur-deficiency leads to a more social phenotype toward other mice with diminished interest in the surrounding environment, and increased seizure susceptibility.	[Kyyriainen, Jenni; Bolkvadze, Tamuna; Lipponen, Anssi; Perez, Laura Oliva; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Epilepsy Res Lab, POB 1627, FI-70211 Kuopio, Finland; [Koivisto, Hennariikka; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Neurobiol Memory Lab, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, Virtanen Inst Mol Sci, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632; Lipponen, Anssi/0000-0002-4403-9084	Academy of FinlandAcademy of FinlandEuropean Commission; Instrumentarium Foundation; Epilepsy Foundation; Maire Taponen Foundation	This study was supported by the Academy of Finland, The Instrumentarium Foundation, Epilepsy Foundation, and Maire Taponen Foundation. We thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Bae MH, 2010, EXP NEUROL, V221, P129, DOI 10.1016/j.expneurol.2009.10.011; Bissonette GB, 2014, BEHAV BRAIN RES, V259, P143, DOI 10.1016/j.bbr.2013.10.051; Bolkvadze T, 2016, EPILEPSY BEHAV, V60, P187, DOI 10.1016/j.yebeh.2016.04.038; Bolkvadze T, 2015, EPILEPSY BEHAV, V51, P19, DOI 10.1016/j.yebeh.2015.06.037; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Dityatev A, 2014, PROG BRAIN RES, V214, pXIII, DOI 10.1016/B978-0-444-63486-3.09998-9; Eagleson KL, 2005, J COMP NEUROL, V489, P449, DOI 10.1002/cne.20647; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Farris SD, 2011, J BIOL CHEM, V286, P22665, DOI 10.1074/jbc.M110.202135; Hartig W, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00015; HARTIG W, 1992, NEUROREPORT, V3, P869; Hobohm C, 2005, J NEUROSCI RES, V80, P539, DOI 10.1002/jnr.20459; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Iyer AM, 2010, NEUROSCIENCE, V167, P929, DOI 10.1016/j.neuroscience.2010.02.047; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Katsarou Anna-Maria, 2017, Epilepsia Open, V2, P284, DOI 10.1002/epi4.12062; Kim S. Y, 2017, SCI REP, V7; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Kyyriainen J, 2017, GLIA, V65, P322, DOI 10.1002/glia.23094; Lahtinen L, 2009, NEUROSCIENCE, V163, P316, DOI 10.1016/j.neuroscience.2009.06.019; Lahtinen L, 2006, EUR J NEUROSCI, V24, P1935, DOI 10.1111/j.1460-9568.2006.05062.x; Lahtinen L, 2010, NEUROBIOL DIS, V37, P692, DOI 10.1016/j.nbd.2009.12.008; Levitt P, 2005, EPILEPSIA, V46, P22, DOI 10.1111/j.1528-1167.2005.00305.x; Liu B, 2010, J NEUROSCI RES, V88, P2747, DOI 10.1002/jnr.22419; Madinier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093121; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Nicolas LB, 2006, EUR J PHARMACOL, V547, P106, DOI 10.1016/j.ejphar.2006.07.015; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Paxinos G., 2008, MOUSE BRAIN STEREOTA; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Rantala J, 2015, EPILEPSY BEHAV, V42, P117, DOI 10.1016/j.yebeh.2014.11.001; Sallinen J, 2013, BASIC CLIN PHARMACOL, V113, P239, DOI 10.1111/bcpt.12090; Sato S, 2002, FEBS LETT, V528, P212, DOI 10.1016/S0014-5793(02)03311-2; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Sorg BA, 2016, J NEUROSCI, V36, P11459, DOI 10.1523/JNEUROSCI.2351-16.2016; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Wintergerst ES, 1996, NEUROSCI LETT, V209, P173, DOI 10.1016/0304-3940(96)12643-4	46	5	5	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	MAR	2019	151						67	74		10.1016/j.eplepsyres.2019.02.009			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ0QR	WOS:000462100600008	30836238				2022-02-06	
J	Leeds, DD; D'Lauro, C; Johnson, MAJBR				Leeds, Daniel D.; D'Lauro, Christopher; Johnson, M. A. J. Brian R.			Predictive Power of Head Impact Intensity Measures for Recognition Memory Performance	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			Head impact measures; Principal Component Analysis; Concussion; Memory	TRAUMATIC BRAIN-INJURY; FOOTBALL; CONCUSSION; SOCCER	Subconcussive head injuries are connected to both short-term cognitive changes and long-term neurodegeneration. Further study is required to understand what types of subconcussive impacts might prove detrimental to cognition. We studied cadets at the US Air Force Academy engaged in boxing and physical development, measuring head impact motions during exercise with accelerometers. These head impact measures were compared with post-exercise memory performance. Investigators explored multiple techniques for characterizing the magnitude of head impacts. Boxers received more head impacts and achieved lower performance in post-exercise memory than non-boxers. For several measures of impact motion, impact intensity appeared to set an upper bound on post-exercise memory performance - stronger impacts led to lower expected memory performance. This trend was most significant when impact intensity was measured through a novel technique, applying principal component analysis to boxer motion. Principal component analysis measures also captured more distinct impact information than seven traditional impact measures also tested.	[Leeds, Daniel D.] Fordham Univ, Comp & Informat Sci Dept, John Mulcahy Hall,Room 340,441 East Fordham Rd, Bronx, NY 10458 USA; [D'Lauro, Christopher] US Air Force Acad, Dept Behav Sci & Leadership, 2354 Fairchild Dr,Suite 5L60, Colorado Springs, CO 80840 USA; [Johnson, M. A. J. Brian R.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD USA		Leeds, DD (corresponding author), Fordham Univ, Comp & Informat Sci Dept, John Mulcahy Hall,Room 340,441 East Fordham Rd, Bronx, NY 10458 USA.		Leeds, Daniel/S-2381-2019; D'Lauro, Christopher/X-1518-2019; D'Lauro, Christopher/V-2587-2019	Leeds, Daniel/0000-0001-8039-1088; D'Lauro, Christopher/0000-0003-0894-6602; 	National Collegiate Athletic Association (NCAA) - Department of Defense (DoD) Mind Matters Challenge; Fordham University; Office of the Secretary of Defense for Health Affairs	This research was supported by National Collegiate Athletic Association (NCAA) - Department of Defense (DoD) Mind Matters Challenge grants to CD and BJ. This research was also supported by Fordham University Faculty Research Grant in 2015 to DDL. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	[Anonymous], E PRIM 2 0 PROF; [Anonymous], MATLAB; Bailes JE, 2013, J NEUROSURG, V119, P1233; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bishop CM., 2006, PATTERN RECOGN; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Curran T, 2007, J EXP PSYCHOL LEARN, V33, P2, DOI 10.1037/0278-7393.33.1.2; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Gadd C., 1966, 10 STAPP CAR CRASH C; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; Newman JA, 1986, P INT C BIOM IMP TOK; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Willmott C, 2018, J SCI MED SPORT, V21, P442, DOI 10.1016/j.jsams.2017.09.591; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	28	5	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			206	217		10.1093/milmed/usy415			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100032	30901472	Bronze			2022-02-06	
J	Levy, CE; Miller, DM; Akande, CA; Lok, B; Marsiske, M; Halan, S				Levy, Charles E.; Miller, David M.; Akande, Christiana A.; Lok, Benjamin; Marsiske, Michael; Halan, Shivahankar			V-Mart, a Virtual Reality Grocery Store A Focus Group Study of a Promising Intervention for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Virtual Reality; Veterans; Rehabilitation; Mild TBI	EXPOSURE THERAPY; SYSTEM	Objective This study examined the potential usability, relevance, and acceptability of V-Mart, a virtual reality grocery store as an assessment and intervention tool for veterans with mild traumatic brain injury. Design Six focus groups were conducted for a 2-yr period to assess perceptions from the following three key stakeholders: therapists, veterans with neither mild traumatic brain injury nor posttraumatic stress disorder, and veterans with mild traumatic brain injury with or without posttraumatic stress disorder (mild traumatic brain injury/posttraumatic stress disorder). The System Usability Scale was applied as an objective measure of usability. Transcripts from the six focus groups were subjected to thematic analyses using the constant, comparative method. Results The focus groups indicated that V-Mart was perceived as highly usable, relevant, and acceptable. Early technical problems were resolved satisfactorily. Therapists indicated that they would use an application such as V-Mart if it were available. The veterans with neither mild traumatic brain injury nor posttraumatic stress disorder felt that it was realistic and likely to be useful, as did the veterans with mild traumatic brain injury/posttraumatic stress disorder. The System Usability Scale mean follow-up scores ranged from 71.4 to 86.0, surpassing the threshold for acceptable usability in health care settings. Conclusions Focus group and System Usability Scale data indicate that the V-Mart has great potential as an assessment tool and intervention for veterans with mild traumatic brain injury/posttraumatic stress disorder. Further development and clinical trials are warranted.	[Levy, Charles E.] North Florida South Georgia Vet Hlth Syst, Phys Med & Rehabil Serv, Routing 117,1601 SW Archer Rd, Gainesville, FL 32608 USA; [Levy, Charles E.] North Florida South Georgia Vet Hlth Syst, Ctr Innovat Disabil & Rehabil Res, Gainesville, FL USA; [Levy, Charles E.] Univ Florida, Dept Occupat Therapy, Gainesville, FL USA; [Levy, Charles E.] Univ Florida, Ctr Arts Med, Gainesville, FL USA; [Miller, David M.; Akande, Christiana A.] Univ Florida, Coll Educ, Gainesville, FL USA; [Lok, Benjamin; Halan, Shivahankar] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL USA; [Marsiske, Michael] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA		Levy, CE (corresponding author), North Florida South Georgia Vet Hlth Syst, Phys Med & Rehabil Serv, Routing 117,1601 SW Archer Rd, Gainesville, FL 32608 USA.		Lok, Benjamin/AAW-6501-2021		Congressionally Directed Medical Research Program/Department of Defense, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Health Services Research and Development	This material is based on work supported by the Congressionally Directed Medical Research Program/Department of Defense, Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development and Health Services Research and Development.	Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brooke J., 1996, USABILITY EVALUATION; Difede J, 2002, CYBERPSYCHOL BEHAV, V5, P529, DOI 10.1089/109493102321018169; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Howard E, 1989, Nurse Educ, V14, P38, DOI 10.1097/00006223-198909000-00019; HUBAL RC, 2004, P INT IND TRAIN SIM; Jaycox L. H., 2008, INVISIBLE WOUNDS WAR; Krueger RA, 2000, FOCUS GROUPS PRACTIC, P94; Levy CE, 2015, AM J PHYS MED REHAB, V94, pE31, DOI 10.1097/PHM.0000000000000248; Lewis J. R., 2009, P 1 INT C HUM CTR DE; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Palmer S. R., 2002, PRACTICAL GUIDE FEAT, V1; Reger GM, 2009, TELEMED J E-HEALTH, V15, P101, DOI 10.1089/tmj.2008.0050; Rizzo A, 2010, ANN NY ACAD SCI, V1208, P114, DOI 10.1111/j.1749-6632.2010.05755.x; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rothbaum BO, 2001, J CLIN PSYCHIAT, V62, P617, DOI 10.4088/JCP.v62n0808; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; Wasrden DL, 2005, J NEUROTRAUM, V22, P1178; Watson Institute for International and Public Affairs Brown University ., 2017, COSTS WAR	21	5	5	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2019	98	3					191	198		10.1097/PHM.0000000000001041			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HM4QD	WOS:000459458200007	30801363				2022-02-06	
J	Li, YS; Yang, ZS; Liu, B; Valdez, C; Chavko, M; Cancio, LC				Li, Yansong; Yang, Zhangsheng; Liu, Bin; Valdez, Celina; Chavko, Mikulas; Cancio, Leopoldo C.			Low-Level Primary Blast Induces Neuroinflammation and Neurodegeneration in Rats	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			mild blast injury; neuroinflammation; neurodegeneration; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; NEUTRALIZATION; NEUROTRAUMA; MECHANISMS; EXPRESSION; MODEL; TIME	Objective Mild blast traumatic brain injury is commonly prevalent in modern combat casualty care and has been associated with the development of neurodegenerative conditions. However, whether primary lower level blast overpressure (LBOP) causes neurodegeneration and neuroinflammation remains largely unknown. The aim of our present study was to determine whether LBOP can cause neuroinflammation and neurodegeneration. Methods Anesthetized rats were randomly assigned to LBOP group (70 kPa, n = 5) or sham group (without blast, n = 5). Histopathological and cytokine changes in brain tissue at 5 days post-injury were evaluated by hematoxylin-eosin staining and Bioplex assay, respectively. Results Histopathological assessment revealed neuronal degeneration and increased density of inflammatory cells in frontal and parietal cortex, hippocampus and thalamus in rats exposed to LBOP. LBOP exposure significantly elevated levels of pro-inflammatory cytokines (EPO, IL-1, IL-6, IL-12, IL-18, and TNF-) and chemokines (GRO and RANTES) as well as of an anti-inflammatory cytokine (IL-13) in the frontal cortex. Conclusions This study reveals a role of neuroinflammation in neurodegeneration after mild blast traumatic brain injury. Therapies that target this process might in warfighters might function either by attenuating the development of post-traumatic stress disorder, chronic traumatic encephalopathy and Alzheimer's disease, or by slowing their progression.	[Li, Yansong; Yang, Zhangsheng; Liu, Bin; Valdez, Celina; Cancio, Leopoldo C.] US Army Inst Surg Res, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA; [Chavko, Mikulas] Naval Med Res Ctr, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Li, YS (corresponding author), US Army Inst Surg Res, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.				Defense Medical Research and Development Program [D61_I_10_J6_82]; Office of the Secretary of Defense for Health Affairs	This study was supported by a grant from the Defense Medical Research and Development Program (grant# D61_I_10_J6_82). This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Cernak I., 2015, BRAIN NEUROTRAUMA MO; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kluger Yoram, 2007, Am J Disaster Med, V2, P21; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mellor S G, 1988, Br J Hosp Med, V39, P536; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Xu LY, 2016, EXP NEUROL, V277, P268, DOI 10.1016/j.expneurol.2016.01.010; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	42	5	5	2	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			265	272		10.1093/milmed/usy330			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100039	30901455	Bronze			2022-02-06	
J	Linder, SM; Koop, MM; Ozinga, S; Goldfarb, Z; Alberts, JL				Linder, Susan M.; Koop, Mandy Miller; Ozinga, Sarah; Goldfarb, Zachary; Alberts, Jay L.			A Mobile Device Dual-Task Paradigm for the Assessment of mTBI	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences Systems Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			postural stability; cognitive function; concussion; biomechanics; mild traumatic brain injury	POSTURAL CONTROL; CEREBRAL CONCUSSION; OBSTACLE AVOIDANCE; SERVICE MEMBERS; BALANCE CONTROL; PERFORMANCE; STABILITY; RECOMMENDATIONS; QUANTIFICATION; ATTENTION	Research Objective Dual-task performance, in which individuals complete two or more activities simultaneously, is impaired following mild traumatic brain injury. The aim of this project was to develop a dual-task paradigm that may be conducive to military utilization in evaluating cognitive-motor function in a standardized and scalable manner by leveraging mobile device technology. Methods Fifty healthy young adult civilians (18-24 years) completed four balance stances and a number discrimination task under single- and dual-task conditions. Postural stability was quantified using data gathered from iPad's native accelerometer and gyroscope. Cognitive task difficulty was manipulated by presenting stimuli at 30, 60, or 90 per minute. Performance of cognitive and balance tasks was compared between single- and dual-task trials. Results Cognitive performance from single- to dual-task paradigms showed no significant main effect of balance condition or the interaction of condition by frequency. From single- to dual-task conditions, a significant difference in postural control was revealed in only one stance: tandem with eyes closed, in which a slight improvement in postural stability was observed under dual-task conditions. Conclusion The optimal dual-task paradigm to evaluate cognitive-motor performance with minimal floor and ceiling effects consists of tandem stance with eyes closed while stimuli are presented at a rate of one per second.	[Linder, Susan M.; Koop, Mandy Miller; Ozinga, Sarah; Goldfarb, Zachary; Alberts, Jay L.] Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44106 USA		Linder, SM (corresponding author), Cleveland Clin, Dept Biomed Engn, 9500 Euclid Ave, Cleveland, OH 44106 USA.				U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-14-1-0532]; Office of the Secretary of Defense for Health Affairs	This study was supported by the U.S. Army Medical Research and Material Command: W81XWH-14-1-0532. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Huang CY, 2014, BEHAV BRAIN RES, V274, P95, DOI 10.1016/j.bbr.2014.07.054; Jehu DA, 2015, INT J NEUROSCI, V125, P100, DOI 10.3109/00207454.2014.907573; Kelley AM, 2015, J HEAD TRAUMA REHAB, V30, pE11, DOI 10.1097/HTR.0000000000000060; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; Linder SM, 2018, MED SCI SPORT EXER, V50, P1998, DOI 10.1249/MSS.0000000000001660; Lion A, 2014, INT J NEUROSCI, V124, P558, DOI 10.3109/00207454.2013.864288; Liston MB, 2014, GAIT POSTURE, V39, P198, DOI 10.1016/j.gaitpost.2013.07.004; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; Ozinga SJ, 2017, NEUROREHABILITATION, V41, P211, DOI 10.3233/NRE-171473; Ozinga SJ, 2017, ARCH PHYS MED REHAB, V98, P649, DOI 10.1016/j.apmr.2016.08.479; Ozinga SJ, 2014, EXP BRAIN RES, V232, P3861, DOI 10.1007/s00221-014-4069-8; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Smith LB, 2014, AM J OCCUP THER, V68, P439, DOI 10.5014/ajot.2014.012393; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Weerdesteyn V, 2003, J MOTOR BEHAV, V35, P53, DOI 10.1080/00222890309602121; Weightman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169104; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Worden TA, 2016, EXP BRAIN RES, V234, P387, DOI 10.1007/s00221-015-4461-z; Yu SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170687	35	5	5	1	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			174	180		10.1093/milmed/usy334			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100029	30901418	hybrid			2022-02-06	
J	Neary, JP; Singh, J; Bishop, SA; Dech, RT; Butz, MJA; Len, TK				Neary, J. Patrick; Singh, Jyotpal; Bishop, Scott A.; Dech, Ryan T.; Butz, Matthew J. A.; Len, Trevor K.			An Evidence-Based Objective Study Protocol for Evaluating Cardiovascular and Cerebrovascular Indices Following Concussion: The Neary Protocol	METHODS AND PROTOCOLS			English	Article						concussion; physiological; heart rate variability; cerebral blood flow; oxygenation		Introduction: The prevalence and incidence of sport-related concussion have continued to increase over the past decade, and researchers from various backgrounds strive for evidenced-based clinical assessment and management. When diagnosing and managing a concussion, a battery of tests from several domains (e.g., symptom reporting, neurocognitive, physiology) must be used. In this study, we propose and develop an objective, evidence-based protocol to assess the pathophysiology of the brain by using non-invasive methods. Methods: Contact sport athletes (n = 300) will be assessed at the beginning of the season in a healthy state to establish baseline values, and then prospectively followed if a mild traumatic brain injury (mTBI) occurs on approximately days 1-2, 3-5, 7-10, 21, 30, and subsequently thereafter, depending on the severity of injury. The protocol includes spontaneous measurements at rest, during head postural change, controlled breathing maneuvers for cerebrovascular reactivity, a neurovascular coupling stimuli, and a baroreflex/autoregulation maneuver. Physiological data collection will include cerebral blood flow velocity, cerebral oxygenation, respiratory gases for end-tidal oxygen and carbon dioxide, finger photoplethysmography for blood pressure, seismocardiography for cardiac mechanics, and electrocardiography. Conclusion, Limitations, and Ethics: The protocol will provide an objective, physiological evidence-based approach in an attempt to better diagnose concussion to aid in return-to-play or -learn. Ethics approval has been granted by the University Research Ethics Board.	[Neary, J. Patrick; Singh, Jyotpal; Bishop, Scott A.; Dech, Ryan T.; Butz, Matthew J. A.; Len, Trevor K.] Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK S4S 0A2, Canada		Neary, JP (corresponding author), Univ Regina, Fac Kinesiol & Hlth Studies, Regina, SK S4S 0A2, Canada.	patrick.neary@uregina.ca; jyotpal.singh@uregina.ca; scottbishop170@gmail.com; rdech6@hotmail.com; matthew.butz@usask.ca; trevor.len@uregina.ca			Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Saskatchewan Health Research Foundation (SHRF); Heart & Stroke Foundation of Canada (HSF Student Award)	Funding for this research was acquired from grants from the Canadian Institutes for Health Research (CIHR), Saskatchewan Health Research Foundation (SHRF), and the Heart & Stroke Foundation of Canada (HSF Student Award for TKL).	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alberts JL., 2015, KINESIOL REV, V4, P39, DOI [10.1123/kr.2014-0080, DOI 10.1123/KR.2014-0080]; Bailey DM, 2013, STROKE, V44, P3235, DOI 10.1161/STROKEAHA.113.002589; Bishop S.A., 2015, CURR RES CONCUSSION, V2, P49; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P573, DOI 10.1111/cpf.12447; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Busse E.F.G., 2011, OPEN SPORTS MED J, V5, P26, DOI [10.2174/1874387001105010026, DOI 10.2174/1874387001105010026]; Camm AJ, 1996, CIRCULATION, V93, P1043; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Di Battista AP, 2018, J NEUROIMMUNOL, V319, P1, DOI 10.1016/j.jneuroim.2018.03.002; Ellis M.J., 2014, CURR RES CONCUSSION, V1, P33; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guzik P, 2007, J PHYSIOL SCI, V57, P63, DOI 10.2170/physiolsci.RP005506; Guzik P, 2018, INT J CARDIOL, V258, P154, DOI 10.1016/j.ijcard.2018.01.056; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Howell David R, 2018, Concussion, V3, pCNC54, DOI 10.2217/cnc-2017-0014; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; La Fountaine MF, 2019, MED SCI SPORT EXER, V51, P792, DOI 10.1249/MSS.0000000000001833; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Loncar G, 2011, AGING MALE, V14, P59, DOI 10.3109/13685538.2010.511326; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Piskorski J, 2007, PHYSIOL MEAS, V28, P287, DOI 10.1088/0967-3334/28/3/005; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Shin H, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-016-0302-y; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Smirl JD, 2015, J APPL PHYSIOL, V119, P487, DOI 10.1152/japplphysiol.00264.2015; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Truijen J, 2018, EUR J NEUROL, V25, P1365, DOI 10.1111/ene.13737; van Donkelaar, 2017, BRIT J SPORT MED, V51, pA38, DOI [10.1136/bjsports-2016-097270.97, DOI 10.1136/BJSPORTS-2016-097270.97, 10.1136/bjsports-2016-097270.96, DOI 10.1136/BJSPORTS-2016-097270.96]; Vogt E, 2012, CLIN PHYSIOL FUNCT I, V32, P415, DOI 10.1111/j.1475-097X.2012.01150.x; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wright AD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00196; Wszedybyl-Winklewska M, 2012, ACTA NEUROBIOL EXP, V72, P80; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	50	5	5	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2409-9279		METHOD PROTOCOL	Methods Protoc.	MAR	2019	2	1							23	10.3390/mps2010023			11	Biochemical Research Methods	Emerging Sources Citation Index (ESCI)	Biochemistry & Molecular Biology	VK4MD	WOS:000698974900023	31164604	Green Published, gold			2022-02-06	
J	Onyemaechi, NOC; Urube, SU; Ekenze, SO				Onyemaechi, Ndubuisi O. C.; Urube, Sunday U.; Ekenze, Sebastian O.			Pattern of surgical emergencies in a Nigerian tertiary hospital	AFRICAN HEALTH SCIENCES			English	Article						Surgical emergencies; Pattern; tertiary hospital; Nigeria	HEALTH; BURDEN; SURGERY	Background: Surgical emergencies account for a major part of the surgeon's workload. Evaluation of pattern of surgical emergencies will assist in developing concrete proposals for improved care. The aim was to assess the pattern of surgical emergencies in our center. Methods: We undertook one-year prospective study of all the emergency surgical admissions at Federal Medical Centre Makurdi from January to December 2011. Results: There were 575 surgical emergencies which constituted 56.8% of surgical admission, and 27.2% of all emergency hospital admissions. The commonest trauma cases were soft tissue injuries (30.3%), while the commonest non-trauma case was acute abdomen (41.6%). The mean age of the patients was 33.7 +/- 17.2 years. Multiple injuries and traumatic brain injuries requiring intensive care monitoring, and malignancies were associated with higher mortality rates (p = 0.001). The 1-year mortality rate was 7.8% and the preventable death rate (PDR) for the trauma-related emergencies was 71.4%. Conclusion: There is a wide spectrum of surgical emergencies in our setting with trauma accounting for a substantial proportion of cases. Improved trauma care, neurosurgical services and intensive care facilities may improve the outcome of surgical emergencies in our environment.	[Onyemaechi, Ndubuisi O. C.; Ekenze, Sebastian O.] Univ Nigeria, Coll Med, Dept Surg, Ituku Ozalla, Enugu, Nigeria; [Urube, Sunday U.] Fed Med Ctr, Dept Surg, Makurdi, Benue State, Nigeria		Onyemaechi, NOC (corresponding author), Univ Nigeria, Coll Med, Dept Surg, Ituku Ozalla, Enugu, Nigeria.	ndubuisi.onyemaechi@unn.edu.ng; urubesu2@yahoo.com; sebastian.ekenze@unn.edu.ng	ONYEMAECHI, NDUBUISI/AAO-7745-2021; Ekenze, Sebastian/ABC-2002-2021	Ekenze, Sebastian/0000-0002-7240-3453	FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW010463] Funding Source: NIH RePORTER; FIC NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43 TW010463] Funding Source: Medline		Agbo PS, 2014, INT RES J BASIC CLIN, V2, P46; Ahmed A, 2009, West Afr J Med, V28, P106; Ahmed M, 1999, TROP MED INT HEALTH, V4, P846, DOI 10.1046/j.1365-3156.1999.00490.x; Armon K, 2001, ARCH DIS CHILD, V84, P390, DOI 10.1136/adc.84.5.390; Bain IM, 1996, BRIT J SURG, V83, P1248, DOI 10.1046/j.1365-2168.1996.02344.x; Campbell WB, 2002, ANN ROY COLL SURG, V84, P273, DOI 10.1308/003588402320439739; Capewell S, 1996, BRIT MED J, V312, P991; Chianakwana GU, 2005, WORLD J SURG, V29, P804, DOI 10.1007/s00268-005-7670-y; Dada AA, 2010, NIGERIAN MED J, V51, P167; DAVIES MG, 1991, IRISH J MED SCI, V160, P303, DOI 10.1007/BF02957857; Ekere A U, 2005, Niger J Clin Pract, V8, P14; Farmer PE, 2008, WORLD J SURG, V32, P533, DOI 10.1007/s00268-008-9525-9; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gale SC, 2014, J TRAUMA ACUTE CARE, V77, P202, DOI 10.1097/TA.0000000000000362; Ibrahim NA, 2015, ANN MED SURG, V4, P325, DOI 10.1016/j.amsu.2015.09.004; Karim MZ, 2009, ORION MED J, V33, P650; Komolafe, 2006, E CENT AFR J SURG, V12, P63; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Mai-Phan TA, 2008, WORLD J EMERG SURG, V3, DOI 10.1186/1749-7922-3-19; Masiira-Mukasa N, 2002, East Afr Med J, V79, P373; Mofikoya B.O., 2010, EUR J SCI RES, V43, P265; Onyemaechi NOC, 2016, ANN MED HEALTH SCI R, V6, P199, DOI 10.4103/amhsr.amhsr_452_15; Onyemaechi N. O. C, 2012, NIG J ORTHO TRAUMA, V11, P79; Solagberu B A, 2003, West Afr J Med, V22, P177; Solagberu B A, 2003, Niger Postgrad Med J, V10, P140; Stewart B, 2014, BRIT J SURG, V101, pE9, DOI 10.1002/bjs.9329; Taye BW, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-2; Verma A, 2016, INT J CONT MED RES, V3, P648	28	5	5	0	1	MAKERERE UNIV, FAC MED	KAMPALA	PO BOX 7072, KAMPALA, 00000, UGANDA	1680-6905	1729-0503		AFR HEALTH SCI	Afr. Health Sci.	MAR	2019	19	1					1768	1777		10.4314/ahs.v19i1.53			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HU7NQ	WOS:000465469000053	31149007	Green Submitted, gold, Green Published			2022-02-06	
J	Ownsworth, T; Gooding, K; Beadle, E				Ownsworth, Tamara; Gooding, Kynan; Beadle, Elizabeth			Self-focused processing after severe traumatic brain injury: Relationship to neurocognitive functioning and mood symptoms	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						traumatic brain injury; neurocognitive function; self-focused processing; mood symptoms	COGNITIVE-BEHAVIORAL THERAPY; ANXIETY STRESS SCALES; PSYCHIATRIC-DISORDERS; DEPRESSION; RUMINATION; ADJUSTMENT; AWARENESS; REHABILITATION; DEFICITS; PEOPLE	Objective To investigate the impact of neurocognitive functioning on the self-focused processing styles of rumination and reflection, and the relationship to mood symptoms after severe traumatic brain injury (TBI). Design A cross-sectional design with a between-group component comparing self-focused processing styles and mood symptoms of adults with TBI and age- and gender-matched controls. Method Fifty-two participants with severe TBI (75% male, M age = 36.56, SD = 12.39) completed cognitive tests of attention, memory, executive functioning and the Awareness Questionnaire, Reflection and Rumination Questionnaire (RRQ), and Depression, Anxiety, and Stress Scales (DASS - 21). Fifty age- and gender-matched controls completed the RRQ and DASS-21. Results TBI participants reported significantly greater mood symptoms than controls (p < .05); however, levels of rumination and reflection did not significantly differ. TBI participants high on both reflection and rumination had significantly greater mood symptoms than those with high reflection and low rumination (p < .001). Higher levels of rumination and reflection were associated with better working memory and immediate and delayed verbal memory (r = .36-.43, p < .01). Higher levels of rumination were also associated with greater verbal fluency, self-awareness, and mood symptoms (r = .36-.70, p < .01). Conclusions Individuals with better memory functioning may be more likely to engage in self-focused processing after severe TBI. Reflection without ruminative tendencies is more adaptive for mental health than reflection with rumination.	[Ownsworth, Tamara; Gooding, Kynan; Beadle, Elizabeth] Griffith Univ, Menzies Hlth Inst Queensland, Sch Appl Psychol, Nathan, Qld, Australia		Ownsworth, T (corresponding author), Griffith Univ, Sch Appl Psychol, Mt Gravatt Campus, Mt Gravatt, Qld 4122, Australia.	t.ownsworth@griffith.edu.au	Ownsworth, Tamara/ABB-6961-2021	Ownsworth, Tamara/0000-0003-1835-7094	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1043677]	This research was partially funded by a National Health and Medical Research Council Project Grant (APP1043677).	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Army U S, 1944, ARM IND TEST BATT MA; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Beadle EJ, 2018, J HEAD TRAUMA REHAB, V33, pE42, DOI 10.1097/HTR.0000000000000360; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brindley R, 2011, MEMORY, V19, P745, DOI 10.1080/09658211.2010.493893; Campbell-Sills L., 2007, HDB EMOTION REGULATI, P542; Cohen J., 1988, STAT POWER ANAL SOCI, V2nd; Culley C, 2010, NEUROPSYCHOL REHABIL, V20, P103, DOI 10.1080/09602010902906926; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Dewar BK, 2007, NEUROPSYCHOL REHABIL, V17, P602, DOI 10.1080/09602010601051610; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fawcett JM, 2015, J BEHAV THER EXP PSY, V47, P1, DOI 10.1016/j.jbtep.2014.10.009; Gomez R, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01320; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gracey F., 2015, NEURODISABILITY PSYC, V3, P154; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hamsher K., 1989, MULTILINGUAL APHASIA; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Joormann J, 2006, BEHAV THER, V37, P269, DOI 10.1016/j.beth.2006.01.002; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Koponen S, 2006, PSYCHIAT RES-NEUROIM, V146, P263, DOI 10.1016/j.pscychresns.2005.05.015; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S., 2004, DEPRESSIVE RUMINATIO, P206; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Ownsworth T., 2014, SELF IDENTITY BRAIN; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth T, 2017, NEUROPSYCHOLOGICAL REHABILITATION: THE INTERNATIONAL HANDBOOK, P313; Ownsworth T, 2017, NEUROREHAB NEURAL RE, V31, P1072, DOI 10.1177/1545968317740635; Ownsworth T, 2011, J INT NEUROPSYCH SOC, V17, P112, DOI 10.1017/S1355617710001311; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Papageorgiou C, 2001, COGN BEHAV PRACT, V8, P160, DOI 10.1016/S1077-7229(01)80021-3; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Sherer M, 2004, AWARENESS QUESTIONNA; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss D. T., 2007, HUMAN FRONTAL LOBES, V2, P292; Takano K, 2009, BEHAV RES THER, V47, P260, DOI 10.1016/j.brat.2008.12.008; Teasdale JD, 2004, PERS INDIV DIFFER, V36, P1933, DOI 10.1016/j.paid.2003.08.022; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Wallace CA, 2000, BRAIN INJURY, V14, P549; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	54	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0144-6657	2044-8260		BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	MAR	2019	58	1					35	50		10.1111/bjc.12185			16	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HK8YR	WOS:000458276300003	29808542				2022-02-06	
J	Panwar, N; Purohit, D; Sinha, VD; Joshi, M				Panwar, Naresh; Purohit, Devendra; Sinha, Virendra Deo; Joshi, Mrinal			Evaluation of extent and pattern of neurocognitive functions in mild and moderate traumatic brain injury patients by using Montreal Cognitive Assessment (MoCA) score as a screening tool: An observational study from India	ASIAN JOURNAL OF PSYCHIATRY			English	Article						Montreal Cognitive Assessment (MoCA); TBI (Traumatic brain injury); Cognitive impairment; Mild to moderate level	VALIDATION; VALIDITY; VERSION; NEUROPSYCHOLOGY; RELIABILITY; IMPAIRMENT; CONCUSSION; DEFICITS; BURDEN; STATE	Introduction: Cognitive impairment is one of the most important culprit influencing the long-term neurological outcome commonlyobserved in TBI survivors. Aims: To examine the performance of patients with Mild and Moderate traumatic brain injury (TBI) on the Montreal Cognitive Assessment (MoCA) using as a screening tool. Results: Total 228 (127 Mild TBI & 101 Moderate TBI) patients were recruited in this study. Results showed that patients with moderate TBI had lower score on the MoCA as compared to patients with mild TBI (p Value = 0.031). This difference was observed statistically significant among mild and moderate TBI for the cube copy (p = 0.039) and clock (p = 0.017) i.e. visuospatial/executive function, Digit span test (p value = 0.040) i.e. concentration and recall memory (p = 0.04). MoCA Score were higher for patients with higher GCS score at admission. Education status was also correlated with MoCA scores; those patients with higher level of education had significant association with higher MoCA scores (p value = 0.012). This study showed that age and gender were insignificant variables to determine cognitive function. Conclusion: Assessment of cognitive impairment should be considered as a mandatory protocol while evaluating post TBI patients, even in cases of mild TBI. Visuospatial/Executive function, memory and attention are the most commonly impaired cognitive functions in patients of TBI, and these are the main domain of cognition which differentiates mild impairment from moderate impairment. This information enables us and provides insight to our experience to predict the burdens of problem and plan to develop post TBI dedicated rehabilitating programme.	[Panwar, Naresh; Purohit, Devendra; Sinha, Virendra Deo; Joshi, Mrinal] SMS Med Coll & Hosp, Dept Neurosurg, Dept Phys Med & Rehabil RRC, Jaipur, Rajasthan, India		Purohit, D (corresponding author), SMS Med Coll & Hosp, Dept Neurosurg, Jaipur, Rajasthan, India.	devendrapurohit@rediffmail.com					Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blankenship M, 1988, COGNITIVE REHABILITA, V6, P40; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; de Guise E, 2014, APPL NEUROPSYCH-ADUL, V21, P128, DOI 10.1080/09084282.2013.778260; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Freitas S, 2012, ARCH CLIN NEUROPSYCH, V27, P165, DOI 10.1093/arclin/acr116; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Goleburn G, 2001, J CLIN GEROPSYCHOL, V7, P161, DOI DOI 10.1023/A:1011335027445; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kemp S, 2005, BRAIN INJURY, V19, P1269, DOI 10.1080/02699050500309353; Krishnan S, 2015, NEUROL INDIA, V63, P63, DOI 10.4103/0028-3886.152637; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Lezak M. D, 2012, NEUROPSYCHOLOGICAL A, P158; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Nasreddine ZS, 2016, CAN J NEUROL SCI, V43, P665, DOI 10.1017/cjn.2016.273; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Rahman TTA, 2009, GERIATR GERONTOL INT, V9, P54, DOI 10.1111/j.1447-0594.2008.00509.x; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Rossetti HC, 2011, NEUROLOGY, V77, P1272, DOI 10.1212/WNL.0b013e318230208a; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; TEASDALE G, 1974, LANCET, V2, P81; Thissen A J A M, 2010, Tijdschr Gerontol Geriatr, V41, P231, DOI 10.1007/s12439-010-0218-0; Tsai CF, 2012, INT PSYCHOGERIATR, V24, P651, DOI 10.1017/S1041610211002298; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Wong A, 2009, DEMENT GERIATR COGN, V28, P81, DOI 10.1159/000232589; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Zhang H, 2016, CHIN J TRAUMATOL, V19, P271, DOI 10.1016/j.cjtee.2015.03.007	44	5	5	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1876-2018	1876-2026		ASIAN J PSYCHIATR	Asian J. Psychiatr.	MAR	2019	41						60	65		10.1016/j.ajp.2018.08.007			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	HR5TY	WOS:000463211000013	30396805				2022-02-06	
J	Rigon, A; Duff, MC; Beadle, J				Rigon, Arianna; Duff, Melissa C.; Beadle, Janelle			Lonely But Not Alone: Neuroticism Mediates the Relationship Between Social Network Size and Loneliness in Individuals With Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Personality; Social isolation; Aloneness; Mediator; Social network	DIFFERENCE VARIABLES; ADULTS; ABILITY; PARTICIPATION; COMMUNICATION; RECOGNITION; RELIABILITY; IMPAIRMENT; PREDICTORS; DEPRESSION	Objectives: Although individuals with traumatic brain injury (TBI) often report higher levels of social isolation, little is known about the factors influencing their self-perception of loneliness. The aim of the current study was to investigate the relationship between loneliness, social network size, and personality variables (neuroticism and extraversion) after TBI, and in particular whether specific personality variables mediate the relationship between social network size and perception of loneliness. Methods: Here, we assessed self-reported loneliness, personality variables, and social network size of 24 individuals with moderate-to-severe TBI and 41 healthy comparison participants. We then carried out a mediation analysis to examine whether personality variables mediated the relationship between loneliness and social network size. Results: Our results indicate that individuals with TBI reported higher levels of loneliness and neuroticism, but there was no group difference in social network size or extraversion. The mediation analysis revealed that the association between social network size and loneliness was mediated by neuroticism, but not by extraversion. Conclusions: Our findings show that neuroticism is an intervening variable in the relationship between social network size and self-perception of loneliness in individuals with moderate-to-severe TBI, and presents a new possible target for clinicians and rehabilitators seeking to address reports of loneliness and social isolation in TBI. (JINS 2019, 25, 266-274)	[Rigon, Arianna; Duff, Melissa C.] Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA; [Beadle, Janelle] Univ Nebraska, Dept Gerontol, Omaha, NE 68182 USA		Rigon, A (corresponding author), Vanderbilt Univ, Med Ctr, Dept Hearing & Speech Sci, Nashville, TN 37232 USA.	arianna.rigon@vanderbilt.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54 GM115458] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM115458] Funding Source: NIH RePORTER		Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Armstrong L, 2016, BEHAV THER, V47, P287, DOI 10.1016/j.beth.2015.12.005; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Cornwell B, 2014, J GERONTOL B-PSYCHOL, V69, pS75, DOI 10.1093/geronb/gbu037; Cornwell B, 2009, J GERONTOL B-PSYCHOL, V64, pI47, DOI 10.1093/geronb/gbp042; Davidson PSR, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00531; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; Douglas JM, 2016, J SPEECH LANG HEAR R, V59, P511, DOI 10.1044/2015_JSLHR-L-15-0025; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Hagger BF, 2019, NEUROPSYCHOL REHABIL, V29, P1129, DOI 10.1080/09602011.2017.1375416; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hayes A.F., 2012, PROCESS VERSATILE CO; Hedman E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113871; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kotwal AA, 2016, J GEN INTERN MED, V31, P854, DOI 10.1007/s11606-016-3696-0; LEVIN I, 1986, J PERS, V54, P717, DOI 10.1111/j.1467-6494.1986.tb00422.x; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; McCrae R.R., 2010, NEO INVENTORIES NEO; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Pressman SD, 2005, HEALTH PSYCHOL, V24, P297, DOI 10.1037/0278-6133.24.3.297; Rauch RJ, 2001, NEUROREHABILITATION, V16, P1; Rigon A, 2018, J CLIN EXP NEUROPSYC, V40, P805, DOI 10.1080/13803395.2018.1437120; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SAKLOFSKE DH, 1989, PERS INDIV DIFFER, V10, P467, DOI 10.1016/0191-8869(89)90011-1; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; STOKES JP, 1985, J PERS SOC PSYCHOL, V48, P981, DOI 10.1037/0022-3514.48.4.981; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104	48	5	5	3	20	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2019	25	3					285	292		10.1017/S1355617718001108			8	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HO8ML	WOS:000461206600005	30567616				2022-02-06	
J	Munawar, K; Khan, MT; Hussain, SW; Qadeer, A; Shad, ZS; Bano, S; Abdullah, A				Munawar, Kamran; Khan, Muhammad Tariq; Hussain, Syed Waqar; Qadeer, Aayesha; Shad, Zahid Siddique; Bano, Sheher; Abdullah, Azmat			Optic Nerve Sheath Diameter Correlation with Elevated Intracranial Pressure Determined via Ultrasound	CUREUS			English	Article						onsd; icu; tbi; icp	COMPUTED-TOMOGRAPHY	Background The early detection of elevated intracranial pressure (ICP) can not only prevent mortality but also aid in more aggressive management. Brain computed tomography (CT) is a mainstay modality in detecting elevated ICP, but the feasibility of using brain CTs to detect elevated ICP in critically ill patients is limited, especially for patients who require high levels of inotropic support. The optic nerve sheath is a direct extension of the brain meninges. Therefore, the elevation of ICP is directly transmitted to the sheath. Measuring the optic nerve sheath diameter (ONSD) through ultrasound (US) is a bedside, noninvasive means to detect elevated ICP. The goal of this study was to assess the correlation of ONSD with elevated ICP as measured via US in an intensive care unit (ICU). Methods We conducted a six-month prospective, single-center, observational study of mass effect stroke patients aged 18 to 65 years who had a traumatic brain injury (TBI) and were admitted to the ICU. Patients with chronic hydrocephalus, extensive local orbit trauma, a pre-existing ocular disease affecting the optic nerve and/or orbital cavity, hyperthyroidism with exophthalmos, and facial trauma affecting the orbits and/or eyeballs were excluded. We measured the ONSD at the entry of optic nerve into the globe using two-dimensional (2D) US. Results One hundred patients were included in the study. Forty-nine patients had diffuse cerebral edema detected on CT scan correlating with increased ONSD notable via bedside US. The mean ONSD related to CT-detectable elevated ICP was 0.61 cm. The sensitivity for the ONSD cut-off value of >= 5.8 mm was 94% (95% confidence interval [CI], 84.05% to 98.79%), and the specificity was 96.08% (95% CI, 86.7% to 99.52%).The positive predictive value was 92.08% (95% CI, 86.28% to 98.96%), and the negative predictive value was 94.23% (95% CI, 84.47% to 98.00%). Conclusion The greatest accuracy in ONSD was found with a cut-off of >0.58 cm in patients with positive CT brain findings. Therefore, US can be used as an initial screening test when physicians suspect a patient has elevated ICP.	[Munawar, Kamran] Shifa Coll Med, Internal Med, Islamabad, Pakistan; [Khan, Muhammad Tariq] Shifa Int Hosp, Pulmonol, Islamabad, Pakistan; [Hussain, Syed Waqar] Khan Res Labs Hosp, Internal Med, Islamabad, Pakistan; [Qadeer, Aayesha] Shifa Int Hosp, Crit Care, Islamabad, Pakistan; [Shad, Zahid Siddique; Abdullah, Azmat] Shifa Int Hosp, Internal Med, Islamabad, Pakistan; [Bano, Sheher] Shifa Int Hosp, Crit Care Med, Islamabad, Pakistan		Munawar, K (corresponding author), Shifa Coll Med, Internal Med, Islamabad, Pakistan.	dr.kam18@gmail.com					Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; GANGEMI M, 1987, NEUROCHIRURGIA, V30, P53; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Hassen GW, 2015, J EMERG MED, V48, P450, DOI 10.1016/j.jemermed.2014.09.060; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Karakitsos D, 2006, TRANSPL P, V38, P3700, DOI 10.1016/j.transproceed.2006.10.185; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Major R, 2011, EMERG MED J, V28, P679, DOI 10.1136/emj.2009.087353; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; Ohle R, 2015, J ULTRAS MED, V34, P1285, DOI 10.7863/ultra.34.7.1285; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Shen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168901; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Zewdie A, 2016, AFR J EMERG MED, V6, pE1, DOI 10.1016/j.afjem.2016.06.002	15	5	6	0	0	CUREUS INC	PALO ALTO	PO BOX 61002, PALO ALTO, CA 94306 USA		2168-8184		CUREUS	Cureus	FEB 27	2019	11	2							e4145	10.7759/cureus.4145			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HQ0AT	WOS:000462055300003	31058028	Green Submitted, Green Published, gold			2022-02-06	
J	Samadi-Dooki, A; Voyiadjis, GZ				Samadi-Dooki, Aref; Voyiadjis, George Z.			A fully nonlinear viscohyperelastic model for the brain tissue applicable to dynamic rates	JOURNAL OF BIOMECHANICS			English	Article						Brain biomechanics; Traumatic brain injury; Impact loading condition; Viscohyperelastic model; Nonlinear mechanical behavior	MECHANICAL-PROPERTIES; STRAIN; COMPRESSION; TENSION	Understanding the mechanical response of the brain to external loadings is of critical importance in investigating the pathological conditions of this tissue during injurious conditions. Such injurious loadings may occur at high rates, for example among others, during road traffic or sport accidents, falls, or due to explosions. Hence, investigating the injury mechanism and design of protective devices for the brain requires constitutive modeling of this tissue at such rates. Accordingly, this paper is aimed at critically investigating the physical background for viscohyperelastic modeling of the brain tissue with scrutinizing the elastic fields pertinent to large, time dependent deformations, and developing a fully nonlinear multimode Maxwell model that can mathematically explain such deformations. The proposed model can be calibrated using the simple monotonic uniaxial deformation of the sample extracted from the tissue, and does not require additional information from relaxation or creep experiments. The performance of the proposed model is examined using the experimental results of two different studies, which reveals a desirable agreement. The usefulness, limitations, and future developments of the proposed model are discussed in this paper. (C) 2019 Elsevier Ltd. All rights reserved.	[Samadi-Dooki, Aref; Voyiadjis, George Z.] Louisiana State Univ, Dept Civil & Environm Engn, Computat Solid Mech Lab, Baton Rouge, LA 70803 USA		Voyiadjis, GZ (corresponding author), Louisiana State Univ, Dept Civil & Environm Engn, Computat Solid Mech Lab, Baton Rouge, LA 70803 USA.	asamad3@lsu.edu; voyiadjis@eng.lsu.edu		Samadi-Dooki, Aref/0000-0001-5927-9016			Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Attard MM, 2004, INT J SOLIDS STRUCT, V41, P5327, DOI 10.1016/j.ijsolstr.2004.03.016; Attard MM, 2003, INT J SOLIDS STRUCT, V40, P4353, DOI 10.1016/S0020-7683(03)00217-8; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Faul M, 2010, TRAUMATIC BRAIN INJU; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; HILL R, 1968, J MECH PHYS SOLIDS, V16, P229, DOI 10.1016/0022-5096(68)90031-8; Holzapfel AG, 2000, NONLINEAR SOLID MECH; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; Mihai LA, 2017, J MECH PHYS SOLIDS, V106, P60, DOI 10.1016/j.jmps.2017.05.015; Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Moerman KM, 2016, J MECH BEHAV BIOMED, V56, P218, DOI 10.1016/j.jmbbm.2015.11.027; Moran R, 2014, J BIOMECH, V47, P3762, DOI 10.1016/j.jbiomech.2014.09.030; Ogden R.W., 1997, NONLINEAR ELASTIC DE; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Samadi-Dooki A, 2018, J MECH BEHAV BIOMED, V77, P24, DOI 10.1016/j.jmbbm.2017.08.037; Samadi-Dooki A, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036486; Seth B.R., 1961, 248 MRC U WISC US AR, P1; Tamura A, 2007, J BIOMECH SCI ENG, V2, P115, DOI [10.1299/jbse.2.115, DOI 10.1299/JBSE.2.115]; Truesdell C., 2004, NONLINEAR FIELD THEO; Voyiadjis GZ, 2018, J MECH BEHAV BIOMED, V83, P63, DOI 10.1016/j.jmbbm.2018.04.011	32	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	FEB 14	2019	84						211	217		10.1016/j.jbiomech.2019.01.007			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	HL4QR	WOS:000458708700028	30678890				2022-02-06	
J	Rosenberg, H; McDonald, S; Rosenberg, J; Westbrook, RF				Rosenberg, Hannah; McDonald, Skye; Rosenberg, Jacob; Westbrook, Reginald Frederick			Measuring emotion perception following traumatic brain injury: The Complex Audio Visual Emotion Assessment Task (CAVEAT)	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; emotion recognition; complex emotions; psychometric qualities; validity; reliability	TORONTO-ALEXITHYMIA-SCALE; ASSESSING SOCIAL-PERCEPTION; FACIAL AFFECT RECOGNITION; EXPRESSIONS; DEFICITS; RELIABILITY; VALIDITY; EMPATHY; ADULTS; IDENTIFICATION	Introduction: While emotion recognition difficulties in moderate-severe TBI are well established, the standard measures of emotion recognition significantly limit the conclusions which can be drawn regarding real-life deficits. Two studies report on the development of CAVEAT, a new measure of emotion recognition that attempts to overcome these limitations. Method: These studies were designed to establish CAVEAT's psychometric properties by examining performance of a TBI group and matched controls in order to provide estimates of its reliability and validity (study 1), and to compare performance of the TBI and control groups on a subgroup of emotions from the CAVEAT that represented the six basic emotions used in conventional emotion research (study 2). Thirty-two participants with TBI and 32 matched controls (study 1) and 16 participants with TBI and 12 matched controls (study 2) participated in this study. Results: CAVEAT demonstrated high construct validity and internal consistency. Performance on the subgroup of "basic" six emotions was largely similar to the rates reported in the literature. Conclusions: These findings provided some evidence for the psychometric properties of CAVEAT, indicating that it can be used as a clinical test for assessing emotion recognition in people with moderate-severe TBI.	[Rosenberg, Hannah; McDonald, Skye; Rosenberg, Jacob; Westbrook, Reginald Frederick] Univ New South Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia		Rosenberg, H (corresponding author), Univ New South Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia.	hannah.rosenberg@unsw.edu.au	; McDonald, Skye/G-4118-2014	Westbrook, Fred/0000-0002-6880-9274; McDonald, Skye/0000-0003-0723-6094			Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BASSILI JN, 1978, J EXP PSYCHOL HUMAN, V4, P373, DOI 10.1037/0096-1523.4.3.373; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Bornhofen C., 2010, READING SMILES OTHER; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Burgess P.W., 1997, HAYLING BRIXTON TEST; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Ekman P., 1999, HDB COGNITION EMOTIO, P45, DOI 10.1002/0470013494.ch3; Ekman P., 1976, PICTURES FACIAL AFFE; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Grattan L. M., 2002, REHABILITATION NEURO, Vxiv; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; Matsumoto D., 1988, JAPANESE CAUCASIAN F; MAZURSKI EJ, 1993, AUST J PSYCHOL, V45, P41, DOI 10.1080/00049539308259117; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S., 2003, BRAIN IMPAIR, V4, P36, DOI [10.1375/brim.4.1.36.27032, DOI 10.1375/BRIM.4.1.36.27032, DOI 10.1375/brim.4.1.36.27032]; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2011, BRAIN IMPAIR, V12, P165; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; Mehrabian A, 1997, AGGRESSIVE BEHAV, V23, P433, DOI 10.1002/(SICI)1098-2337(1997)23:6<433::AID-AB3>3.0.CO;2-H; Mehrabian A., 2000, MANUAL BALANCED EMOT; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; ORTONY A, 1990, PSYCHOL REV, V97, P315, DOI 10.1037/0033-295X.97.3.315; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Reitan RM, 1992, TRAIL MAKING TEST; Rosenberg H., 2015, THESIS; Rosenberg H, 2018, J NEUROPSYCHOL, V12, P145, DOI 10.1111/jnp.12109; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; RUSSELL JA, 1993, MOTIV EMOTION, V17, P41, DOI 10.1007/BF00995206; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Taylor GJ, 2003, J PSYCHOSOM RES, V55, P277, DOI 10.1016/S0022-3999(02)00601-3; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tottenham N, 2002, J COGNITIVE NEUROSCI, P74; Urbina S, 1997, PSYCHOL TESTING; Watson T. L., 2002, J VISION, V2, P592, DOI [10.1167/2.7.592, DOI 10.1167/2.7.592]; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	64	5	5	0	14	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2019	29	2					232	250		10.1080/09602011.2016.1273118			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HE7RF	WOS:000453636700004	28030989				2022-02-06	
J	Chen, B; Tjahja, J; Malla, S; Liebman, C; Cho, M				Chen, Bo; Tjahja, Jessica; Malla, Sameep; Liebman, Caleb; Cho, Michael			Astrocyte Viability and Functionality in Spatially Confined Microcavitation Zone	ACS APPLIED MATERIALS & INTERFACES			English	Article						blast-induced traumatic brain injury (bTBI); microcavitation; astrocytes; microfabrication; calcium dynamics; poloxamer P188	TRAUMATIC BRAIN-INJURY; CALCIUM HOMEOSTASIS; POLOXAMER 188; EXPOSURE	Blast-induced traumatic brain injury (bTBI) can result in cell/tissue damage and lead to clinical and neuropsychiatric symptoms. Shock waves from a blast propagate through the brain and initiate cascades of mechanical and physiological events that can adversely affect the brain function. Although studies using animal models and brain slices have shown macroscale changes in the brain tissue in response to blast, systematic elucidation of coupling mechanisms is currently lacking. One mechanism that has been postulated and demonstrated repeatedly is the blast induced generation and subsequent collapse of micron-size bubbles (i.e., microcavitation). Using a custom-designed exposure system, we have previously reported that upon collapsing of microbubbles, astrocytes exhibited changes in the cell viability, cellular biomechanics, production of reactive oxygen species, and activation of apoptotic signaling pathways. In this paper, we have applied microfabrication techniques and seeded astrocytes in a spatially controlled manner to determine the extent of cell damage from the site of the collapse of microbubbles. Such a novel experimental design is proven to facilitate our effort to examine the altered cell viability and functionality by monitoring the transient calcium spiking activity in real-time. We now report that the effect of microcavitation depends on the distance from which cells are seeded, and the cell functionality assessed by calcium dynamics is significantly diminished in the cells located within similar to 800 mu m of the collapsing microbubbles. Both calcium influx across the cell membrane via N-type calcium channels and intracellular calcium store are altered in response to microcavitation. Finally, the FDA-approved poloxamer 188 (P188) was used to reconstitute the compromised cell membrane and restore the cell's reparative capability. This finding may lead to a feasible treatment for partially mitigating the tissue damage associated with bTBI.	[Chen, Bo; Tjahja, Jessica; Malla, Sameep; Liebman, Caleb; Cho, Michael] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA		Cho, M (corresponding author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.	michael.cho@uta.edu		Cho, Myoung Rae/0000-0002-8191-8045	Office of Naval ResearchOffice of Naval Research [N00014-16-1-2140]	This work was supported by a grant (N00014-16-1-2140) from the Office of Naval Research.	AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; Asher RA, 2000, J NEUROSCI, V20, P2427; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Collins JM, 2007, BBA-BIOMEMBRANES, V1768, P1238, DOI 10.1016/j.bbamem.2007.01.012; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kanagaraj J, 2018, ANN BIOMED ENG, V46, P354, DOI 10.1007/s10439-017-1953-y; Kang D, 2014, IEEE T PLASMA SCI, V42, P3231, DOI 10.1109/TPS.2014.2339171; Kosaka T, 2009, J CARDIOL, V54, P262, DOI 10.1016/j.jjcc.2009.05.012; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Lohse D, 2003, PHYS TODAY, V56, P36, DOI 10.1063/1.1564347; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Marks Jeremy D., 2001, FASEB Journal, V15, P1107; Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4; Mazzanti M, 2003, GLIA, V41, P128, DOI 10.1002/glia.10135; Moloughney Joseph G, 2012, Recent Pat Biotechnol, V6, P200; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nattel S, 2014, CARDIOVASC RES, V104, P1, DOI 10.1093/cvr/cvu197; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; Pringle AK, 1996, STROKE, V27, P2124, DOI 10.1161/01.STR.27.11.2124; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P273; Ravin R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25713; Rusakov DA, 2015, NAT REV NEUROSCI, V16, P226, DOI 10.1038/nrn3878; Sakuragi S, 2017, BIOCHEM BIOPH RES CO, V486, P879, DOI 10.1016/j.bbrc.2017.03.096; Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje; Singh AV, 2015, SCI REP-UK, V5, DOI 10.1038/srep07847; Singh AV, 2018, J BIOMED MATER RES B, V106, P1369, DOI 10.1002/jbm.b.33922; Singh AV, 2013, J BIOMED MATER RES A, V101, P3019, DOI 10.1002/jbm.a.34586; Small DH, 2009, NEUROCHEM RES, V34, P1824, DOI 10.1007/s11064-009-9960-5; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sun S, 2015, J NEUROTRAUM, V32, P1441, DOI 10.1089/neu.2014.3699; Treinys R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102357; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wu GH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028101; Yang E., 2018, BIOMED RES INT, V2018, P1; Young SZ, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00008; Zhang YL, 2018, J NEUROTRAUM, V35, P661, DOI 10.1089/neu.2017.5284	52	5	6	0	11	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244	1944-8252		ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	FEB 6	2019	11	5					4889	4899		10.1021/acsami.8b21410			11	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	HK9YD	WOS:000458347900020	30638362				2022-02-06	
J	Hu, SK; Wu, G; Zheng, JJ; Liu, XW; Zhang, Y				Hu, Shukun; Wu, Gang; Zheng, Jiajun; Liu, Xunwei; Zhang, Yi			Astrocytic thrombin-evoked VEGF release is dependent on p44/42 MAPKs and PAR1	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						ICH; Thrombin; Astrocyte; VEGF; PAR-1; MAPKs	ENDOTHELIAL GROWTH-FACTOR; BRAIN-INJURY; UP-REGULATION; ANGIOGENESIS; ACTIVATION; AUTOPHAGY; MECHANISM; CELLS	Intracerebral haemorrhage (ICH) often causes severe neurological deficits in survived patients, although its underlying mechanisms remain elusive. A common feature of ICH is the accumulation of thrombin around the lesion site. Previous studies showed that thrombin promotes VEGF release and angiogenesis at a late stage post ICH [1]. In current study, we explored the source for thrombin-induced VEGF release by adding thrombin or its receptor agonist peptide to the neuronal or astrocytic primarily cultures. We identified that astrocytes specifically respond to thrombin by up-regulating and releasing VEGF. Furthermore, such release is dependent on p44/42 MAPKs and PAR1, a thrombin specific receptor. Our study therefore helps clarifying the underlying mechanisms of thrombin-induced VEGF release in ICH, which will further provide novel insights into the designing principles for treating ICH and traumatic brain injuries. (C) 2018 Published by Elsevier Inc.	[Hu, Shukun; Wu, Gang; Zheng, Jiajun; Zhang, Yi] Fudan Univ, Affiliated Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai 200042, Peoples R China; [Liu, Xunwei] Wuxi Childrens Hosp, Dept Nephrol & Rheumatol, Wuxi 214023, Peoples R China		Zhang, Y (corresponding author), Fudan Univ, Affiliated Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Middle Rd, Shanghai 200042, Peoples R China.	zhangyi3@huashan.org.cn			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81501007, 81272374]	This study is supported by National Natural Science Foundation of China (NSFC): 81501007, 81272374.	Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Chaitanya GV, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-162; Chen B, 2012, J NEUROSCI, V32, P7622, DOI 10.1523/JNEUROSCI.0369-12.2012; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Hu SK, 2016, NEUROSCI LETT, V630, P53, DOI 10.1016/j.neulet.2016.07.023; Hu SK, 2011, BRAIN RES, V1424, P60, DOI 10.1016/j.brainres.2011.09.062; Hua Y, 2009, STROKE, V40, pS88, DOI 10.1161/STROKEAHA.108.533281; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Maragoudakis ME, 2002, BIOCHEM SOC T, V30, P173, DOI 10.1042/BST0300173; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Salhia B, 2000, BRAIN RES, V883, P87, DOI 10.1016/S0006-8993(00)02825-0; Tsopanoglou NE, 1999, J BIOL CHEM, V274, P23969, DOI 10.1074/jbc.274.34.23969; Tsopanoglou NE, 2007, SEMIN THROMB HEMOST, V33, P680, DOI 10.1055/s-2007-991535; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Wang H, 2002, AM J PHYSIOL-CELL PH, V283, pC1351, DOI 10.1152/ajpcell.00001.2002; Wang JH, 2012, STROKE, V43, P2476, DOI 10.1161/STROKEAHA.112.661819; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2001, BRAIN RES, V895, P153, DOI 10.1016/S0006-8993(01)02064-9; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xu Y, 2009, NEUROL RES, V31, P759, DOI 10.1179/174313209X385699; Yamahata H, 2002, INT J ONCOL, V20, P921	23	5	5	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 5	2019	509	2					585	589		10.1016/j.bbrc.2018.12.168			5	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	HK6MM	WOS:000458094800039	30606478				2022-02-06	
J	Vaudreuil, R; Bronson, H; Bradt, J				Vaudreuil, Rebecca; Bronson, Hannah; Bradt, Joke			Bridging the Clinic to Community: Music Performance as Social Transformation for Military Service Members	FRONTIERS IN PSYCHOLOGY			English	Article						performance; music; music therapy; social transformation; military service members; traumatic barin injury; post traumatic stress disorder		The use of music performance in music therapy with military service members is discussed as a vehicle for social transformation and reintegration. The use of performance in music therapy is not without controversy primarily because therapy is considered a process, not a product, and confidentiality and privacy are essential components of therapy. However, others have argued that public performances can validate therapeutic changes in clients, give voice to their experiences, raise awareness of social issues within their communities, transform perceptions of injury, or illness in audience members, and may result in the clients gaining support and validation from their communities. We discuss the potential of music performances to contribute to individual development, reinforce rehabilitation, enhance function, and facilitate change at the community level to support reintegration of military service members. We illustrate this through two brief case reports of service members who received music therapy as part of their treatment for post-traumatic stress disorder, traumatic brain injury, and other psychological health concerns at the National Intrepid Center of Excellence, a Directorate of the Walter Reed National Military Medical Center, Bethesda, MD, United States. The service members wrote, learned, and refined songs over multiple music therapy sessions and created song introductions to share with audiences the meanings and benefits gained from integrating performance in music therapy. The case reports also include excerpts of interviews conducted with these service members several months after treatment about their experiences of performing and the perceived impact of their performances on the audience and greater community.	[Vaudreuil, Rebecca; Bronson, Hannah] Natl Endowment Arts, Washington, DC 20506 USA; [Vaudreuil, Rebecca] Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA; [Bradt, Joke] Drexel Univ, Dept Creat Arts Therapies, Philadelphia, PA 19104 USA		Vaudreuil, R (corresponding author), Natl Endowment Arts, Washington, DC 20506 USA.; Vaudreuil, R (corresponding author), Natl Intrepid Ctr Excellence, Bethesda, MD 20889 USA.	rebecca_vaudreuil@mail.harvard.edu	bradt, joke/C-5930-2014	bradt, joke/0000-0001-7313-9829	National Endowment for the Arts, Creative Forces: NEA Military Healing Arts Network	This work was supported by the National Endowment for the Arts, Creative Forces: NEA Military Healing Arts Network.	American Music Therapy Association [AMTA], 1998, WHAT IS MUS THER; Ansdell G., 2010, MUSIC HELPS COMMUNIT, P161; Ansdell G, 2005, BEING WHO YOU ARENT, DOI [10.15845/voices.v5i3.229, DOI 10.15845/VOICES.V5I3.229]; Baker FA, 2013, ART PSYCHOTHER, V40, P20, DOI 10.1016/j.aip.2012.09.004; Band Dave Matthews, 2012, MERCY AWAY WORLD; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Bronson H, 2018, MUSIC THER PERSPECT, V36, P195, DOI 10.1093/mtp/miy006; Bruscia K.E., 2014, DEFINING MUSIC THERA; Day T, 2009, BRIT J MUSIC THER, V23, P19, DOI 10.1177/135945750902300103; Joy Resounding, SEMP SOUND MUS THER; KXTV, 2018, MUS THER HELP CAMP P; National Endowments for the Arts, CREAT FORC NEA MIL H; O'Grady L., 2009, THESIS LONDON; O'Grady L, 2015, NORD J MUSIC THER, V24, P123, DOI 10.1080/08098131.2013.877518; Pease JL, 2016, SOC WORK, V61, P83, DOI 10.1093/sw/swv050; Public Broadcasting Service, 2017, NAT MEM DAY CONC; Ruud E., 2004, DEBATING WINDS CHANG; Soshensky R, 2011, MUSIC THER PERSPECT, V29, P23, DOI 10.1093/mtp/29.1.23; Stige B., 2012, INVITATION COMMUNITY; Turry A, 2005, VOICES WORLD FORUM M, V5, DOI [10.15845/voices.v5i1.208, DOI 10.15845/VOICES.V5I1.208]; Vaudreuil R, 2019, DISABIL REHABIL, V41, P2333, DOI 10.1080/09638288.2018.1462412; Yotis L, 2017, ART PSYCHOTHER, V55, P80, DOI 10.1016/j.aip.2017.04.009	22	5	5	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	FEB 5	2019	10								119	10.3389/fpsyg.2019.00119			6	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	HK3UG	WOS:000457843300001	30804832	Green Published, gold			2022-02-06	
J	Abdallah, YEH; Beveridge, J; Chan, M; Deeb, T; Mowafi, H; Al-Nuaimi, S; Easa, AS; Saqqur, M				Abdallah, Yasmeen El Hajj; Beveridge, Julie; Chan, Ming; Deeb, Taha; Mowafi, Hani; Al-Nuaimi, Saleem; Easa, Abdulkader Saed; Saqqur, Maher		Union Med Care Relief Org	Devastating neurologic injuries in the Syrian war	NEUROLOGY-CLINICAL PRACTICE			English	Article								Background Since 2011, hundreds of thousands of Syrians have been displaced and injured due to the ongoing Syrian civil war. In this study, we report the prevalence of neurologic injuries in a major rehabilitation center on the Turkish-Syrian border where death and injury tolls continue to rise. Method Based on several on-site visits from 2013 to 2016, medical practitioners collected data from patients in the major rehabilitation center on the border of Turkey and Syria. The clinical data, which included the type and cause of injury, laterality, paralysis, areas injured, and treatment offered, were analyzed. Results A total of 230 patients were identified as having sustained a neurologic injury, 221/230 (96.1%) male and 9/230 (3.91%) female, ranging from ages 2-52 years. A total of 305 total injuries were documented over the course of a 4-year analysis due to several patients having multiple injuries. Gunshot wounds were the dominant mechanism of injury in 125/230 (54.3%) patients. Patients more frequently sustained single injuries 152/230 (66.1%) than multiple injuries 78/230 (33.9%). Peripheral nerve injuries were the most prevalent injuries, at 92.5% of all neurologic injuries (282/305), specifically injury to the radial nerve, at 19.1% (54/282) of peripheral injuries. Patients with spinal cord injuries made up 20/230 (8.7%) of all patients, with thoracic spine injuries composing 50% (10/20). Traumatic brain injuries were the least prevalent, 3/230 (1.3%), with an equal distribution of subtypes. Conclusion This study and critical analysis of the devastation in Syria suggests the desperate need for emergency aid.	[Abdallah, Yasmeen El Hajj] Univ Alberta, Dept Med, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada; [Beveridge, Julie] Univ Alberta, Dept Med, Div Surg, Edmonton, AB, Canada; [Chan, Ming] Univ Alberta, Dept Med, Div Phys Med & Rehabil, Edmonton, AB, Canada; [Al-Nuaimi, Saleem] Univ Alberta, Dept Med, Div Psychiat, Edmonton, AB, Canada; [Easa, Abdulkader Saed] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada; [Deeb, Taha] AdamPhysio & Sports Clin Ltd, Anat Acupuncture, Edmonton, AB, Canada; [Mowafi, Hani] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Saqqur, Maher] Hamad Gen Hosp, Neurosci Inst, Doha, Qatar		Saqqur, M (corresponding author), Hamad Gen Hosp, Neurosci Inst, Doha, Qatar.	msaqqur@ualberta.ca	Mowafi, Hani O/P-1380-2014	Mowafi, Hani O/0000-0001-6225-8048; chan, ming/0000-0002-6904-1420			Al-Nuaimi S, 2018, COMPR PSYCHIAT, V80, P34, DOI 10.1016/j.comppsych.2017.08.002; [Anonymous], 2015, SYR CONFR FRAGM IMP, P67; Birch R, 2012, J BONE JOINT SURG BR, V94B, P523, DOI 10.1302/0301-620X.94B4.28483; Daroff RB, 1999, J NEUROL SCI, V170, P131, DOI 10.1016/S0022-510X(99)00224-5; Freedman BA, 2014, ARCH ORTHOP TRAUM SU, V134, P1353, DOI 10.1007/s00402-014-2066-9; Hartmann JE, 2006, J NEUROL SCI, V241, P83, DOI 10.1016/j.jns.2005.11.002; Kherallah Mazen, 2012, Avicenna J Med, V2, P51; Mowafi H, 2016, JAMA SURG, V151, P815, DOI 10.1001/jamasurg.2016.1297; Schoenfeld AJ, 2012, SPINE J, V12, P771, DOI 10.1016/j.spinee.2010.05.004; UNHCR, 2018, SIT SYR REG REF RESP; WHO, 2017, ANN REP 2017	11	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	FEB	2019	9	1					9	15		10.1212/CPJ.0000000000000556			7	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	IF5HL	WOS:000473111800012	30859002	Green Published			2022-02-06	
J	Bomyea, J; Flashman, LA; Zafonte, R; Andaluz, N; Coimbra, R; George, MS; Grant, GA; Marx, CE; McAllister, TW; Shutter, L; Lang, AJ; Stein, MB				Bomyea, Jessica; Flashman, Laura A.; Zafonte, Ross; Andaluz, Norberto; Coimbra, Raul; George, Mark S.; Grant, Gerald A.; Marx, Christine E.; McAllister, Thomas W.; Shutter, Lori; Lang, Ariel J.; Stein, Murray B.			Associations between neuropsychiatric and health status outcomes in individuals with probable mTBI	PSYCHIATRY RESEARCH			English	Article						Traumatic brain injury; Disability; Functioning; Quality of life; Neuropsychology; Memory; Posttraumatic stress disorder	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYMPTOMS; IRAQI FREEDOM VETERANS; PERFORMANCE VALIDITY; POSTCONCUSSION SYMPTOMS; BLAST EXPOSURE; HEAD-INJURY; SELF-REPORT	Mild traumatic brain injury (mTBI) is a common occurrence, and may impact distal outcomes in a subgroup of individuals. Improved characterization of health outcomes and identification of factors associated with poor outcomes is needed to better understand the impact of mTBI, particularly in those with co-occurring posttraumatic stress disorder (PTSD). Participants in a data repository of the Injury and Traumatic Stress (INTRuST) Clinical Consortium (n = 625) completed functional disability [FD] and health-related quality of life [HRQOL] questionnaires, and a subset completed a neuropsychological assessment. FD and HRQOL were compared among participants with probable mTBI (mTBI), probable mTBI with PTSD (mTBI/PTSD), and health comparison participants (HC). Associations between symptoms, neuropsychological performance, and health outcomes were examined in those with probable mTBI with and without PTSD (n = 316). Individuals in the mTBI/PTSD group endorsed poorer health outcomes than those in the mTBI group, who endorsed poorer outcomes than those in the HC group. Individuals in either mTBI group performed worse than those in the HC on verbal learning and memory and psychomotor speed. Health outcomes were correlated with mental health and postconcussive symptoms, as well as neuropsychological variables. mTBI may adversely impact self-reported health, with the greatest effect observed in individuals with co-occurring mTBI/PTSD.	[Bomyea, Jessica; Lang, Ariel J.] VA San Diego Healthcare Syst Ctr Excellence Stres, La Jolla, CA USA; [Bomyea, Jessica; Lang, Ariel J.; Stein, Murray B.] Univ Calif San Diego, San Diego Dept Psychiat, 9500 Gilman Dr MC 0855, La Jolla, CA 92037 USA; [Flashman, Laura A.] Dartmouth Hitchcock Med Ctr, Dartmouth Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Zafonte, Ross] Harvard Med Sch, Massachusetts Gen Hosp, Brigham & Womens Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Andaluz, Norberto] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [George, Mark S.] Ralph H Johnson VA Med Ctr, Psychiat Div, Charleston, SC USA; [George, Mark S.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA; [Grant, Gerald A.] Stanford Univ, Med Ctr, Dept Neurol & Neurosci, Stanford, CA 94305 USA; [Marx, Christine E.] Durham VA Med Ctr, Durham, NC USA; [Marx, Christine E.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Bomyea, Jessica; Flashman, Laura A.; Zafonte, Ross; George, Mark S.; Grant, Gerald A.; Marx, Christine E.; McAllister, Thomas W.; Shutter, Lori; Lang, Ariel J.; Stein, Murray B.] Univ Pittsburgh, Dept Crit Care Med Neurol & Neurosurg, Pittsburgh, PA USA; [Stein, Murray B.] Univ Calif San Diego, San Diego Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Coimbra, Raul] Riverside Univ Hlth Syst, Riverside, CA USA		Bomyea, J (corresponding author), Univ Calif San Diego, San Diego Dept Psychiat, 9500 Gilman Dr MC 0855, La Jolla, CA 92037 USA.	jbomyea@ucsd.edu	Coimbra, Raul/AAP-3019-2020; Shutter, Lori A/G-2957-2013	Coimbra, Raul/0000-0002-3759-6851; George, Mark/0000-0003-1767-1815; Shutter, Lori/0000-0002-1390-0628	CDRP award [W81XWH-08-2-0159]; VA Office of Academic Affairs [CX001600-01A1]; VA CSRD [CX001600-01A1]	This work was supported by the CDRP award W81XWH-08-2-0159 (Stein et al) and the VA Office of Academic Affairs and CSR&D (J. Bomyea CX001600-01A1). Thank you to Charles Kim for his assistance with the preparation of this manuscript.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Andreou C, 2013, CURR OPIN PSYCHIATR, V26, P54, DOI 10.1097/YCO.0b013e32835a2acf; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benedict R.H., 1997, BRIEF BISUOSPATIAL M; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brissos S, 2008, CAN J PSYCHIAT, V53, P517, DOI 10.1177/070674370805300806; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Costa SL, 2016, MULT SCLER; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Derogatis L.R, 2001, BRIEF SYMPTOM INVENT, V18; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Disner SG, 2017, CLIN PSYCHOL SCI, V5, P650, DOI 10.1177/2167702617703436; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Faul M, 2010, TRAUMATIC BRAIN INJU; Freeman T, 2008, PSYCHIAT RES, V158, P374, DOI 10.1016/j.psychres.2007.04.002; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Frueh BC, 2000, CLIN PSYCHOL REV, V20, P853, DOI 10.1016/S0272-7358(99)00015-X; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lau KM, 2016, BRAIN INJURY, V30, P287, DOI 10.3109/02699052.2015.1089601; Maguen S, 2009, MIL MED, V174, P779, DOI 10.7205/MILMED-D-03-2808; Martindale SL, 2016, REHABIL PSYCHOL, V61, P231, DOI 10.1037/rep0000076; Marx BP, 2008, AM J PUBLIC HEALTH, V98, P773, DOI 10.2105/AJPH.2007.133223; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meneses RF, 2009, SEIZURE-EUR J EPILEP, V18, P313, DOI 10.1016/j.seizure.2008.11.010; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; O'Neil ME, 2017, J CLIN EXP NEUROPSYC, V39, P449, DOI 10.1080/13803395.2016.1232699; Ojeda N, 2012, ACTAS ESP PSIQUIATRI, V40, P10; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schmidt M., 1996, REY AUDITORY VERBAL; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seidl JNT, 2015, REHABIL PSYCHOL, V60, P335, DOI 10.1037/rep0000064; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tolin DF, 2010, PSYCHOL ASSESSMENT, V22, P729, DOI 10.1037/a0020973; Vasterling J. J., 2017, J INT NEUROPSYCHOL S, V1; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Ware J.E., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers FW, 1993, ANN M INT SOC TRAUMA; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whitney KA, 2015, ARCH CLIN NEUROPSYCH, V30, P130, DOI 10.1093/arclin/acu094; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wolfson, 1993, HALSTEAD REITAN NEUR	84	5	5	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	FEB	2019	272						531	539		10.1016/j.psychres.2018.12.021			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	HO5UW	WOS:000460994400077	30616120	Green Submitted			2022-02-06	
J	Goldberg, LD; McDonald, SD; Perrin, PB				Goldberg, Lisa D.; McDonald, Scott D.; Perrin, Paul B.			Predicting Trajectories of Posttraumatic Growth Following Acquired Physical Disability	REHABILITATION PSYCHOLOGY			English	Article						acquired physical disability; posttraumatic growth; resilience	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; COPING STRATEGIES; COGNITIVE APPRAISALS; NATIONAL-HEALTH; VETERANS; STRESS; INTERVENTIONS; RELIABILITY; RESILIENCE	Purpose/Objective: This study examined predictors of trajectories of posttraumatic growth (PTG) among individuals with acquired physical disability across the first year after discharge from acute rehabilitation. Research Method/Design: Data were collected from participants (64 veterans with spinal cord injury and dysfunction, and 19 with brain injury) on various demographic and injury characteristics, appraisals of injury, and coping styles at baseline, as well as PTG at baseline and 1-, 3-, 6-, and 12-month follow-ups. Results: Comparison of initial curvature models suggested that a cubic, or S-shaped, trend best fit the trajectory of PTG over time. Three hierarchical linear models (HLMs) were run to examine whether demographic and injury characteristics, appraisals of injury, and coping styles predicted height of PTG over time, and a final HLM examined whether any significant effects in the first HLMs interacted with time effects in the prediction of participants' PTG trajectories. Individuals with lower estimated premorbid IQ, older age, greater use of challenge appraisals, and greater use of reframing and religious coping experienced higher levels of PTG over the first year after discharge from rehabilitation. None of these predictors interacted with time effects in predicting participants' PTG trajectories. Conclusions/Implications: These findings point to ways in which clinical researchers can better understand PTG following acquired physical disability and investigate the honing of psychological interventions to more precisely target specific modifiable predictors of PTG. Impact and Implications Many individuals with acquired physical disability experience positive outcomes after acute rehabilitation and may even show signs of posttraumatic growth. Individuals with lower estimated premorbid IQ, older age, greater use of challenge appraisals, and greater use of reframing and religious coping tend to have higher posttraumatic growth over the first year after discharge from rehabilitation. The identification of predictors of posttraumatic growth after physical disability is a critical area for clinical research, as modifiable factors may be ripe targets for intervention studies.	[Goldberg, Lisa D.; Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, POB 842018, Richmond, VA 23284 USA; [McDonald, Scott D.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA		Perrin, PB (corresponding author), Virginia Commonwealth Univ, Dept Psychol, POB 842018, Richmond, VA 23284 USA.	pperrin@vcu.edu			VA Career Development Award-2 [1IK2RX000703-01]	This study was supported by a VA Career Development Award-2 (1IK2RX000703-01; PI: Scott D. McDonald).	Adriaansen JJE, 2013, DISABIL REHABIL, V35, P1104, DOI 10.3109/09638288.2012.712196; Armeli S, 2001, J SOC CLIN PSYCHOL, V20, P366, DOI 10.1521/jscp.20.3.366.22304; Cann A, 2010, ANXIETY STRESS COPIN, V23, P127, DOI 10.1080/10615800903094273; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CHESNEY MA, 1994, PSYCHIAT CLIN N AM, V17, P163; Chun S, 2008, QUAL HEALTH RES, V18, P877, DOI 10.1177/1049732308318028; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Danhauer SC, 2015, ANN BEHAV MED, V49, P650, DOI 10.1007/s12160-015-9696-1; de Ridder D, 2001, CLIN PSYCHOL REV, V21, P205, DOI 10.1016/S0272-7358(99)00046-X; Dean RE, 2009, REHABIL PSYCHOL, V54, P222, DOI 10.1037/a0015581; Defense and Veterans Brain Injury Center, DOD WORLDWIDE NUMBER; Department of Veterans Affairs, 2011, SPIN CORD INJ DIS SC; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; Ferguson E, 1999, BRIT J HEALTH PSYCH, V4, P97, DOI 10.1348/135910799168506; Findley PA, 2011, DISABIL REHABIL, V33, P1608, DOI 10.3109/09638288.2010.540294; Finset A, 2000, BRAIN INJURY, V14, P887; Gross JJ, 1997, PSYCHOL AGING, V12, P590, DOI 10.1037/0882-7974.12.4.590; Guarino, 2017, APPL MULTIVARIATE RE; Hagen C, 1972, RANCHO AMIGOS LEVELS; IBM Corp, 2015, IBM SPSS STAT WIND V; January AM, 2015, DEV MED CHILD NEUROL, V57, P1143, DOI 10.1111/dmcn.12820; Kalpakjian CZ, 2014, J SPINAL CORD MED, V37, P218, DOI 10.1179/2045772313Y.0000000169; Kennedy P, 2003, BRIT J CLIN PSYCHOL, V42, P41, DOI 10.1348/014466503762842002; Kennedy P, 2010, SPINAL CORD, V48, P762, DOI 10.1038/sc.2010.20; Kennedy P, 2016, REHABIL PSYCHOL, V61, P92, DOI 10.1037/rep0000066; King C, 1999, BRIT J CLIN PSYCHOL, V38, P5, DOI 10.1348/014466599162629; Lazarus RS, 1984, STRESS APPRAISAL AND; Lechner SC, 2004, PSYCHOL INQ, V15, P35; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; Moore SA, 2010, PSYCHOL TRAUMA-US, V2, P93, DOI 10.1037/a0018975; Psychological Corporation, 2001, WTAR WECHSL TEST AD; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Strauss E., 2006, A COMPENDIUM OF NEUR; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Teixeira RJ, 2013, J PSYCHOSOC ONCOL, V31, P235, DOI 10.1080/07347332.2013.778932; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Tsai J, 2015, PSYCHOL MED, V45, P165, DOI 10.1017/S0033291714001202; Tsai J, 2016, DEPRESS ANXIETY, V33, P9, DOI 10.1002/da.22371; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Yeung NCY, 2016, PSYCHOL TRAUMA-US, V8, P284, DOI 10.1037/tra0000091; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	46	5	5	1	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2019	64	1					37	49		10.1037/rep0000247			13	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	HK5TA	WOS:000458029100004	30382715	Bronze			2022-02-06	
J	Gouttebarge, V; Andersen, TE; Cowie, C; Goedhart, E; Jorstad, H; Kemp, S; Konigs, M; Maas, M; Orhant, E; Rantanen, J; Salo, J; Serratosa, L; Stokes, K; Tol, JL; Verhagen, E; Weber, A; Kerkhoffs, G				Gouttebarge, Vincent; Andersen, Thor Einar; Cowie, Charlotte; Goedhart, Edwin; Jorstad, Harald; Kemp, Simon; Konigs, Marsh; Maas, Mario; Orhant, Emmanuel; Rantanen, Jussi; Salo, Jari; Serratosa, Luis; Stokes, Keith; Tol, Johannes L.; Verhagen, Evert; Weber, Alexis; Kerkhoffs, Gino			Monitoring the health of transitioning professional footballers: protocol of an observational prospective cohort study	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article							COMMON MENTAL-DISORDERS; COGNITIVE IMPAIRMENT; SOCCER PLAYERS; RISK-FACTORS; LOWER-LIMB; OSTEOARTHRITIS; PREVALENCE; SYMPTOMS; VALIDITY; BRAIN	Introduction Transitioning out of professional football is a challenging time in most players' lives. During these preretirement and postretirement years, professional footballers may struggle with their mental, musculoskeletal, neurocognitive and cardiovascular health. Currently, longitudinal data about these health conditions are lacking. This article presents the design of a prospective cohort study with the primary aim of gathering epidemiological evidence about the onset and course of mental, musculoskeletal, neurocognitive and cardiovascular health conditions in professional footballers during their preretirement and postretirement years and evaluating the associations between risk indicators and the health conditions under study in these players. Methods and analysis An observational prospective cohort study with repeated measurements over a follow-up period of 10 years will be conducted among at least 200 professional footballers (male; 27 (+/- 1) years old). Mental health will be explored by assessing symptoms of distress, anxiety, depression, sleep disturbance, alcohol misuse, drug misuse and disordered eating. Musculoskeletal health will be explored by assessing severe joint injury and related surgery, clinical and radiological osteoarthritis, and joint function (hips, knees and ankles). Neurocognitive health will be explored by assessing the concussion, brain structure and functioning, and neurocognitive functioning. Cardiovascular health will be explored by assessing blood pressure, lipid profile and ECG abnormalities. Ethics and dissemination Ethical approval for the study was provided by the Medical Ethics Review Committee of the Amsterdam University Medical Centers. The results of the study will be submitted to peer-reviewed journals, will be presented at scientific conferences and will be released in the media (postpublication).	[Gouttebarge, Vincent; Tol, Johannes L.; Kerkhoffs, Gino] Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Orthopaed Surg, Meibergdreef 9, Amsterdam, Netherlands; [Gouttebarge, Vincent] FIFPRO Football Players Worldwide, Hoofddorp, Netherlands; [Gouttebarge, Vincent; Jorstad, Harald; Maas, Mario; Tol, Johannes L.; Kerkhoffs, Gino] Amsterdam Movement Sci, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands; [Gouttebarge, Vincent; Jorstad, Harald; Maas, Mario; Tol, Johannes L.; Verhagen, Evert; Kerkhoffs, Gino] Amsterdam UMC, IOC Res Ctr Excellence, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Amsterdam, Netherlands; [Gouttebarge, Vincent; Verhagen, Evert] Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Andersen, Thor Einar] Norwegian Sch Sport Sci, Oslo Sports Trauma Res Ctr, Dept Sports Med, Oslo, Norway; [Andersen, Thor Einar] Football Assoc Norway, Norwegian FA Med Ctr, Oslo, Norway; [Cowie, Charlotte] Football Assoc, Natl Football Ctr, St Georges Pk, Needwood, England; [Goedhart, Edwin; Konigs, Marsh] Royal Netherlands Football Assoc KNVB, FIFA Med Ctr Excellence, Zeist, Netherlands; [Jorstad, Harald] Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Cardiol, Meibergdreef 9, Amsterdam, Netherlands; [Kemp, Simon; Stokes, Keith] Rugby Football Union, Twickenham, England; [Konigs, Marsh] Univ Amsterdam, Amsterdam UMC, Emma Childrens Hosp, Emma Neurosci Grp, Amsterdam, Netherlands; [Maas, Mario] Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Musculoskeletal Radiol, Meibergdreef 9, Amsterdam, Netherlands; [Orhant, Emmanuel] French Football Federat FFF, Clairefontaine Med Ctr, FIFA Med Ctr Excellence, Clairefontaine, France; [Rantanen, Jussi] Mehilainen NEO Hosp, Orthopaed & Sports Clin, Turku, Finland; [Salo, Jari] Sports Hosp Mehilainen, Helsinki, Finland; [Serratosa, Luis] Ripoll & Prado Sport Clin, FIFA Med Ctr Excellence, Madrid, Spain; [Serratosa, Luis] Hosp Univ Quironsalud, Madrid, Spain; [Stokes, Keith] Univ Bath, Dept Hlth, Bath, Avon, England; [Stokes, Keith] Univ Bath, Ctr Sport Exercise & Osteoarthrit Res Versus Arth, Bath, Avon, England; [Verhagen, Evert] Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Publ & Occupat Hlth, Boelelaan 1117, Amsterdam, Netherlands; [Weber, Alexis] Federat Int Football Assoc FIFA, Zurich, Netherlands		Gouttebarge, V (corresponding author), Univ Amsterdam, Amsterdam UMC, Amsterdam Movement Sci, Dept Orthopaed Surg, Meibergdreef 9, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), FIFPRO Football Players Worldwide, Hoofddorp, Netherlands.; Gouttebarge, V (corresponding author), Amsterdam Movement Sci, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), Amsterdam UMC, IOC Res Ctr Excellence, Amsterdam Collaborat Hlth & Safety Sports ACHSS, Amsterdam, Netherlands.; Gouttebarge, V (corresponding author), Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa.	v.gouttebarge@amsterdamumc.nl	Serratosa, Luis/ABH-1910-2020; Verhagen, Evert/A-1502-2013; Stokes, Keith/C-2605-2009	Verhagen, Evert/0000-0001-9227-8234; Stokes, Keith/0000-0002-5049-2838; Kemp, Simon/0000-0002-3250-2713; Jorstad, Harald/0000-0003-3617-3256; Andersen, Thor Einar/0000-0003-4172-4518; orhant, emmanuel/0000-0002-0548-3940	Drake Foundation located in London (UK); Mehilainen NEO Hospital located in Turku (Finland); Sports Hospital Mehilainen located in Helsinki (Finland); Nea International bv. located in Maastricht (the Netherlands)Netherlands Government	The Drake Football Study received seed funding from the Drake Foundation located in London (UK) and financial support from Mehilainen NEO Hospital located in Turku (Finland), from Sports Hospital Mehilainen located in Helsinki (Finland) and from Nea International bv. located in Maastricht (the Netherlands).	Aagaard P, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010401; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; [Anonymous], 2000, WHO TECHN REP SER; Arnold R, 2012, J SPORT EXERCISE PSY, V34, P397, DOI 10.1123/jsep.34.3.397; Bender AM, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0140-5; Brown R L, 1995, Wis Med J, V94, P135; Campbell B, 2017, CLIN GUIDELINES CONS; Chang AY, 2009, AM J CARDIOL, V104, P805, DOI 10.1016/j.amjcard.2009.05.008; Chow MSM, 2017, WORLD J RADIOL, V9, P5, DOI 10.4329/wjr.v9.i1.5; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Drezner JA, 2017, BRIT J SPORT MED, V51, P704, DOI 10.1136/bjsports-2016-097331; Dyson V, 1998, J ADDICT DIS, V17, P57, DOI 10.1300/J069v17n02_05; Fernandes GS, 2018, BRIT J SPORT MED, V52, P678, DOI 10.1136/bjsports-2017-097503; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Gouttebarge V, 2018, INJ EPIDEMIOL, V5; Gouttebarge V, INT OLYMPIC COMMITTE; Gouttebarge V., 2019, 18 BIEEN C S AFR SPO; Gouttebarge V, 2019, BRIT J SPORT MED, V53, P700, DOI 10.1136/bjsports-2019-100671; Gouttebarge V, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2018-000466; Gouttebarge V, 2018, PHYSICIAN SPORTSMED, V46, P471, DOI 10.1080/00913847.2018.1451718; Gouttebarge V, 2016, J SPORT MED PHYS FIT, V56, P648; Gouttebarge V, 2015, J SPORT SCI MED, V14, P811; Gouttebarge V, 2015, RHEUMATOL INT, V35, P405, DOI 10.1007/s00296-014-3093-0; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Huan T, 2018, J ALZHEIMERS DIS, V65, P1401, DOI 10.3233/JAD-180711; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Iverson GL, 2011, J AFFECT DISORDERS, V132, P360, DOI 10.1016/j.jad.2011.03.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johanson NA, 2004, J BONE JOINT SURG AM, V86A, P902, DOI 10.2106/00004623-200405000-00003; Johansson JK, 2016, SCAND J MED SCI SPOR, V26, P535, DOI 10.1111/sms.12474; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kilic O, 2018, KNEE SURG SPORT TR A, V26, P946, DOI 10.1007/s00167-017-4644-1; Kokkonen HT, 2014, J ORTHOP RES, V32, P403, DOI 10.1002/jor.22521; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P2059, DOI 10.1016/j.joca.2015.08.008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuijt MTK, 2012, J SCI MED SPORT, V15, P480, DOI 10.1016/j.jsams.2012.02.008; Lee B, 2019, J HEAD TRAUMA REHABI; Lemez S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0024-x; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Lohkamp M, 2017, SCAND J MED SCI SPOR, V27, P1038, DOI 10.1111/sms.12846; Lwanga SK, 1991, PRACTICAL MANUAL; Lyman S, 2016, CLIN ORTHOP RELAT R, V474, P1461, DOI 10.1007/s11999-016-4719-1; Lyman S, 2016, CLIN ORTHOP RELAT R, V474, P1472, DOI 10.1007/s11999-016-4718-2; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Martinsen M, 2014, MED SCI SPORT EXER, V46, P1666, DOI 10.1249/MSS.0000000000000276; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Merghani A, 2017, CIRCULATION, V136, P126, DOI 10.1161/CIRCULATIONAHA.116.026964; Meskal I, 2015, J NEURO-ONCOL, V121, P617, DOI 10.1007/s11060-014-1679-8; Morris R, 2015, J APPL SPORT PSYCHOL, V27, P216, DOI 10.1080/10413200.2014.980015; National Clinical Guideline Centre (UK), 2014, OST CAR MAN AD OST CAR MAN AD; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Ornetti P, 2009, OSTEOARTHR CARTILAGE, V17, P1604, DOI 10.1016/j.joca.2009.06.007; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Prien A, 2019, ARCH CLIN NEUROPSYCH, V34, P575, DOI 10.1093/arclin/acy056; Rice SM, 2019, INT J SPORT EXERC PS; Rice SM, 2019, BMJ OPEN SPORT EXERC; Rogers SD, 2017, SPORTS MED, V47, P1893, DOI 10.1007/s40279-017-0686-2; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Samuels C, 2016, BRIT J SPORT MED, V50, P418, DOI 10.1136/bjsports-2014-094332; Schuring N, 2017, KNEE SURG SPORT TR A, V25, P3179, DOI 10.1007/s00167-016-4255-2; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Teague S, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0586-7; Tucker AM, 2009, JAMA-J AM MED ASSOC, V301, P2111, DOI 10.1001/jama.2009.716; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Venalainen MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37538; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Woodward M., 2014, EPIDEMIOLOGY STUDY D; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wylleman P, 2004, PSYCHOL SPORT EXERC, V5, P7, DOI 10.1016/S1469-0292(02)00049-3; Yu M, 2017, SUBST USE MISUSE, V52, P303, DOI 10.1080/10826084.2016.1225763	83	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	FEB	2019	5	1							e000680	10.1136/bmjsem-2019-000680			10	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	PC2AQ	WOS:000596810500119	31908839	Green Published, gold			2022-02-06	
J	Knollman-Porter, K; Constantinidou, F; Beardslee, J; Dailey, S				Knollman-Porter, Kelly; Constantinidou, Fofi; Beardslee, Jennifer; Dailey, Stephen			Multidisciplinary Management of Collegiate Sports-Related Concussions	SEMINARS IN SPEECH AND LANGUAGE			English	Article						concussion; cognition; symptoms; multidisciplinary	HIGH-SCHOOL; BASE-LINE; NEUROCOGNITIVE PERFORMANCE; CONSTRUCT-VALIDITY; SYMPTOMS; IMPACT; STATEMENT; RECOVERY; SPECIFICITY; SENSITIVITY	Purpose Collegiate varsity athletes are at risk for sustaining a sports-related concussion, which can negatively impact performance during academic, social, work, and athletic endeavors. Because of the complex nature of concussions and high rates of underreporting by athletes, concussion education, identification, and postinjury care require a collaborative, multidisciplinary approach. Therefore, the purpose of this paper is to describe the specific responsibilities of the team members along with the established pre- and postconcussion procedures of one of the oldest university-based multidisciplinary concussion management programs that is coordinated by speech-language pathology. Method The authors provide a theoretical review of current best practices for the multidisciplinary team along with a discussion of baseline and postconcussion neurocognitive assessment and management procedures directly involving speech-language pathology. Included is a case example illustrating the postinjury procedures utilized by the team. Conclusion Management of the complex sequelae of sports-related concussion for the varsity collegiate athlete necessitates implementation of a multidisciplinary, collaborative approach. Speech-language pathologists' training in the assessment and treatment of brain injury provides the team with an objective perspective in the evaluation and postinjury management of the injured student athlete. While our understanding of concussions has improved greatly over the past two decades, researchers and clinicians on the front lines of care recognize that continued voids exist in our knowledge, with the need to continually explore new methods to identify and manage the complex immediate and potentially long-term ramifications of concussion.	[Knollman-Porter, Kelly] Miami Univ, Dept Speech Pathol & Audiol, 2 Bachelor Hall, Oxford, OH 45056 USA; [Constantinidou, Fofi] Univ Cyprus, Dept Psychol, Nicosia, Cyprus; [Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, Nicosia, Cyprus; [Beardslee, Jennifer; Dailey, Stephen] Miami Univ, Sports Med, Oxford, OH 45056 USA		Knollman-Porter, K (corresponding author), Miami Univ, Dept Speech Pathol & Audiol, 2 Bachelor Hall, Oxford, OH 45056 USA.	knollmkk@miamioh.edu					[Anonymous], 2013, MED SCI SPORT EXER, V45, P1618, DOI 10.1249/MSS.0b013e31829ba437; [Anonymous], CONC DIAGN MAN BEST; [Anonymous], BAL ERR SCOR SYST; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benton A., 1978, MULTILINGUAL APHASIA; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Chertok GJ, 2013, INT J ATHL THER TRAI, V18, P7, DOI 10.1123/ijatt.18.3.7; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2004, STUD NEUROPSYCHOL DE, P111; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Cripps AE, 2015, INT J ATHL THER TRAI, V20, P46, DOI 10.1123/ijatt.2014-0051; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Davies SC, 2015, J CLIN SPORT PSYCHOL, V9, P101, DOI 10.1123/jcsp.2014-0037; Devick S., 2010, KING DEVICK TEST; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2011, PHYS MED REH CLIN N, V22, P603, DOI 10.1016/j.pmr.2011.08.003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Klove, 1963, LAF INSTR GROOV PEGB; Knollman-Porter K, 2018, AM J SPEECH-LANG PAT, V27, P778, DOI 10.1044/2018_AJSLP-17-0108; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Seifert T, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0513-0; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	57	5	5	0	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0734-0478	1098-9056		SEMIN SPEECH LANG	Semin. Speech Lang.	FEB	2019	40	1					3	12		10.1055/s-0038-1676363			10	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HG5OT	WOS:000455027900002	30616290				2022-02-06	
J	Kriz, PK; Staffa, SJ; Zurakowski, D; MacAskill, M; Kirchberg, T; Robert, K; Baird, J; Lockhart, G				Kriz, Peter K.; Staffa, Steven J.; Zurakowski, David; MacAskill, Matthew; Kirchberg, Tyler; Robert, Kyle; Baird, Janette; Lockhart, Greg			Effect of Penalty Minute Rule Change on Injuries and Game Disqualification Penalties in High School Ice Hockey	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						ice hockey; rule change; fair play; body checking; injury prevention	SUMMIT	Background: Recent efforts have focused on eliminating dangerous hits in ice hockey. Fair play rule changes have successfully reduced injury risk but have not been widely implemented. Purpose: To determine the effect of a penalty infraction minutes (PIM) rule change in high school boys' ice hockey on injuries and game disqualification penalties. Study Design: Cohort study; Level of evidence, 3. Methods: Injury data were collected from 2 Rhode Island hospital systems and game/penalty data through the Rhode Island Hockey Coaches Association website. Participants included high school boys' hockey varsity players aged 13 to 19 years presenting to 5 emergency departments for hockey injuries during 6 seasons (December 2012-April 2018). Rule change for the 2015-2016 season implemented varying suspensions for players accumulating >= 50 PIM and >= 70 PIM during regular season and playoffs. Injuries were classified as body checking or non-body checking related, and injury rates pre- versus post-rule change were compared via the Cochran-Mantel-Haenszel chi-square test with the odds ratio (OR) to measure risk reduction. Results: During the study period, 1762 boys' high school varsity hockey games were played. Of 134 game-related injuries, 82 (61.2%) were attributable to body checking. The PIM rule change was associated with a significant reduction in all injuries (OR, 0.55; 95% CI, 0.35-0.86; P = .008), concussion/closed head injury (OR, 0.44; 95% CI, 0.23-0.85; P = .012), and combined subgroups of concussion/closed head injury and upper body injury (OR, 0.50; 95% CI, 0.31-0.80; P = .003). Game disqualification penalties per season were not significantly reduced following the rule change, occurring in 5.2% of games before the rule change and 4.4% of games after (OR, 0.84; 95% CI, 0.54-1.31; P = .440). Conclusion: Implementation of a statewide PIM restriction rule change effectively reduced the mean number of game-related injuries per season among high school boys' hockey varsity players.	[Kriz, Peter K.; Staffa, Steven J.; Zurakowski, David; MacAskill, Matthew; Kirchberg, Tyler; Robert, Kyle; Baird, Janette; Lockhart, Greg] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Providence, RI 02905 USA; [Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Warren Alpert Med Sch,Dept Orthoped,Div Sports Me, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Kriz, Peter K.] Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Warren Alpert Med Sch,Dept Pediat,Div Sports Med, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Staffa, Steven J.; Zurakowski, David] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [MacAskill, Matthew] Univ New England, Kent Hosp, Coll Osteopath Med, Dept Emergency Med, Warwick, RI USA; [Kirchberg, Tyler] Brown Univ, Providence, RI 02905 USA; [Robert, Kyle] Boston Univ, Boston, MA 02215 USA; [Baird, Janette; Lockhart, Greg] Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Warren Alpert Med Sch,Dept Emergency Med, Providence, RI 02905 USA		Kriz, PK (corresponding author), Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Warren Alpert Med Sch,Dept Orthoped,Div Sports Me, 2 Dudley St,Suite 200, Providence, RI 02905 USA.; Kriz, PK (corresponding author), Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Warren Alpert Med Sch,Dept Pediat,Div Sports Med, 2 Dudley St,Suite 200, Providence, RI 02905 USA.	peter_kriz@brown.edu					Allen K, 2016, HOCKEY ROUGH STUFF J; BLYTH CR, 1986, J AM STAT ASSOC, V81, P843, DOI 10.2307/2289018; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU; King B, 2015, STREET SMITHS SPORTS; Mishra D, 2015, SAFETY RULE CHANGES; Muir A, 2016, AHL ANNOUNCES CRACKD; National Federation of State High School Associations, PART STAT; National Federation of State High School Associations, 2014, PEN BOARD CHECK BEHI; Pond D, 2018, CHANGING DANGEROUS P; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Smith AM., 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2015-000074, DOI 10.1136/BMJSEM-2015-000074]; Smith AM, 2015, CLIN J SPORT MED, V25, P78, DOI 10.1097/JSM.0000000000000195; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Yard EE, 2006, J ATHL TRAINING, V41, P441	14	5	5	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	FEB	2019	47	2					438	443		10.1177/0363546518815886			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	HK1CD	WOS:000457641400026	30571140				2022-02-06	
J	Lawrence, LM; Cottrill, A; Valluri, A; Marenzi, G; Denning, KL; Valluri, J; Claudio, PP; Day, JB				Lawrence, Logan M.; Cottrill, Andrew; Valluri, Amrita; Marenzi, Gaetano; Denning, Krista L.; Valluri, Jagan; Claudio, Pier Paolo; Day, James B.			Minimally Manipulative Method for the Expansion of Human Bone Marrow Mesenchymal Stem Cells to Treat Osseous Defects	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						bone marrow mesenchymal stem cells; autologous transplant; regenerative medicine; fracture healing; bone defects; traumatic injuries		Lack of standardization of clinically compliant culture protocols of mesenchymal stem cells for re-implantation in humans have hindered clinical progress in the field of tissue regeneration to repair maxillofacial and orthopedic defects. The goal of this study was to establish a clinically relevant osteogenic protocol for collection and expansion of autologous stem cells to be used at Marshall University for re-implantation and repair of maxillofacial and orthopedic conditions. Human bone marrow (hBM) samples were collected from patients undergoing intramedullary nail fixation for closed femoral fractures. hBM mesenchymal cells were expanded by growing them first in Petri dishes for two weeks, followed by a week of culture using Perfecta 3D Hanging Drop Plates((R)). Various scaffold materials were tested and analyzed for cellular integration, vitality, and differentiation capacity of harvested hBM-MSCs including: 60/40 blend of hydroxyapatite biomatrix; Acellular bone composite discs; Allowash((R)), cancellous bone cubes; PLGA (poly lactic-co-glycolic acid); and Woven chitin derived fiber. We found that the 3D spheroid culture allowed production of hBM mesenchymal cells that retained osteoblast differentiation capacity over a monolayer culture of hBM-MSCs without the need to use chemical or hormonal modulation. We also observed that hydroxyapatite and Allowash cancellous bone scaffolds allowed better cell integration and viability properties as compared to other materials tested in this study. In conclusion, the multimodal culture methodology we developed creates actively differentiating stem-cell spheroids that can then be readily utilized in clinical practices to improve the regeneration of tissues of the head and the body.	[Lawrence, Logan M.; Denning, Krista L.] Marshall Univ, Joan C Edwards Sch Med, Dept Pathol, Cabell Huntington Hosp Lab, Huntington, WV 25705 USA; [Cottrill, Andrew; Valluri, Amrita; Valluri, Jagan] Marshall Univ, Dept Biol Sci, Huntington, WV 25705 USA; [Marenzi, Gaetano] Univ Naples Federico II, Dept Neurosci Reprod & Odontostomatol Sci, I-80131 Naples, Italy; [Claudio, Pier Paolo] Univ Mississippi, Natl Ctr Nat Prod Res, Dept BioMol Sci, Jackson, MS 39216 USA; [Day, James B.] Marshall Univ, Dept Orthopaed Surg, Joan C Edwards Sch Med, Huntington, WV 25705 USA		Claudio, PP (corresponding author), Univ Mississippi, Natl Ctr Nat Prod Res, Dept BioMol Sci, Jackson, MS 39216 USA.; Day, JB (corresponding author), Marshall Univ, Dept Orthopaed Surg, Joan C Edwards Sch Med, Huntington, WV 25705 USA.	loganlawrence38@gmail.com; cottrill40@live.marshall.edu; valluri3@live.marshall.edu; gaetano.marenzi@gmail.com; haught5@marshall.edu; valluri@marshall.edu; pclaudio@olemiss.edu; day62@marshall.edu	Claudio, Pier Paolo/AAW-7282-2021	Claudio, Pier Paolo/0000-0001-7790-1622	Marshall University translational research grant	The present studies were partially funded by a Marshall University translational research grant (to PPC).	Alm JJ, 2012, TISSUE ENG PART C-ME, V18, P658, DOI [10.1089/ten.TEC.2011.0675, 10.1089/ten.tec.2011.0675]; Assem Mostafa, 2018, Open Access Maced J Med Sci, V6, P254, DOI 10.3889/oamjms.2018.076; Baghaei Kaveh, 2017, Gastroenterol Hepatol Bed Bench, V10, P208; Beeravolu N, 2017, JOVE-J VIS EXP, DOI 10.3791/55224; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Cesarz Z, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/9176357; Choi W, 2017, CLIN TRANSL MED, V6, DOI 10.1186/s40169-017-0168-z; Langhans MT, 2016, CURR STEM CELL RES T, V11, P453, DOI 10.2174/1574888X10666151001115248; Lu HX, 2012, CELLS TISSUES ORGANS, V196, P48, DOI 10.1159/000330794; Mills LA, 2017, ACTA ORTHOP, V88, P434, DOI 10.1080/17453674.2017.1321351; Ren JQ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1400-3; Rohban R, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/5173732; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; Santos JM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0082-5; Schultz MB, 2016, DEVELOPMENT, V143, P3, DOI 10.1242/dev.130633; Wong TM, 2014, SCI WORLD J, DOI 10.1155/2014/710302; Zhang XY, 2015, CELL BIOCHEM BIOPHYS, V72, P777, DOI 10.1007/s12013-015-0531-x; Zhou Y, 2017, J CELL MOL MED, V21, P1073, DOI 10.1111/jcmm.12946	18	5	5	0	8	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	FEB 1	2019	20	3							612	10.3390/ijms20030612			14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HQ4WR	WOS:000462412500156	30708975	Green Submitted, Green Published, gold			2022-02-06	
J	Miao, XL; Liang, AR				Miao, Xinglu; Liang, Anran			RETRACTED: Knockdown of long noncoding RNA GAS5 attenuates H2O2-induced damage in retinal ganglion cells through upregulating miR-124: Potential role in traumatic brain injury (Retracted article. See vol. 122, 2021)	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article; Retracted Publication						GAS5; JAK; STAT3 pathway; JNK pathway; miR-124; oxidation stress; traumatic brain injury	DOWN-REGULATION; OXIDATIVE STRESS; PARKINSONS-DISEASE; PROSTATE-CANCER; EXPRESSION; APOPTOSIS; PROLIFERATION; PROGRESSION; ACTIVATION; MECHANISMS	BackgroundOptic nerve injury is one of the most common and serious complications in traumatic brain injury (TBI). Alleviating degree of optic nerve injury is important to cure of TBI. This study explored the role of long noncoding RNA (lncRNA) GAS5 in mice retinal ganglion cells (RGCs) suffered to H2O (2) injury. MethodsPrimary RGC (PRGCs) were treated with H2O (2) to simulate an in vitro oxidation stress model. LncRNA GAS5 and miR-124 expressions were knocked down by cell transfection with short-hairpin RNA against GAS5 and miR-124 inhibitor, and the transfection efficiency was determined by qRT-PCR. Cell viability, apoptotic cell rate, and production of reactive oxygen species (ROS) was analyzed by CCK-8 assay, PI/FITC-Annexin V method, and DCFH-DA fluorometric assay. Cell apoptosis-associated proteins as well as activations of JAK/STAT3 signaling and JNK signaling were analyzed by Western blot. ResultsH(2)O (2) treatment-induced cell injury was inhibited by lncRNA GAS5 silence. Specifically, knockdown of GAS5 improved viability of primary PRGCs, inhibited apoptosis, decreased ROS expression, increased antiapoptosis proteins' expressions, and decreased proapoptosis proteins' expressions. It was also found that miR-124 inhibitor treatment impaired the cell protective effect of GAS5 silence, indicating low level of GAS5 protected PRGCs via upregulating miR-124. GAS5 silence might exert cytoprotection effect via activating JAK/STAT3 signaling pathway and inhibiting activation of JNK signaling pathway. ConclusionKnocking down lncRNA GAS5 alleviated H2O (2)-induced injury in PRGCs via upregulation of miR-124, which might dependent on activation of JAK/STAT3 signaling pathway and inhibition of JNK signaling pathway.	[Miao, Xinglu] Jining 1 Peoples Hosp, Dept Neurosurg, Jining, Shandong, Peoples R China; [Liang, Anran] Jining 1 Peoples Hosp, Dept Ophthalmol, 6 Jiankang Rd, Jining 272011, Shandong, Peoples R China		Liang, AR (corresponding author), Jining 1 Peoples Hosp, Dept Ophthalmol, 6 Jiankang Rd, Jining 272011, Shandong, Peoples R China.	anranliang0040@sohu.com					Alas S, 2001, CANCER RES, V61, P5137; ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; Bian DH, 2017, AM J TRANSL RES, V9, P1509; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; Doeppner TR, 2013, ACTA NEUROPATHOL, V126, P251, DOI 10.1007/s00401-013-1142-5; Dolcet X, 2001, MOL CELL NEUROSCI, V18, P619, DOI 10.1006/mcne.2001.1058; Dun Y, 2006, CELL TISSUE RES, V324, P189, DOI 10.1007/s00441-005-0116-x; Dun Y, 2007, INVEST OPHTH VIS SCI, V48, P4785, DOI 10.1167/iovs.07-0343; Fernandes KA, 2012, NEUROBIOL DIS, V46, P393, DOI 10.1016/j.nbd.2012.02.003; Gao ZQ, 2018, BIOMED PHARMACOTHER, V97, P809, DOI 10.1016/j.biopha.2017.10.157; Howell JC, 2013, MOL VIS, V19, P544; Ji JZ, 2004, EUR J NEUROSCI, V19, P265, DOI 10.1111/j.0953-816X.2003.03107.x; Kanagaraj N, 2014, NEUROSCIENCE, V272, P167, DOI 10.1016/j.neuroscience.2014.04.039; Li XH, 2014, BIOCHEM BIOPH RES CO, V450, P148, DOI 10.1016/j.bbrc.2014.05.085; Lin WJ, 2014, AUTOPHAGY, V10, P1692, DOI 10.4161/auto.36076; Liu Q, 2007, INVEST OPHTH VIS SCI, V48, P4580, DOI 10.1167/iovs.07-0170; Lu XX, 2013, CELL TISSUE RES, V354, P891, DOI 10.1007/s00441-013-1711-x; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Shi XF, 2015, MOL CARCINOGEN, V54, pE1, DOI 10.1002/mc.22120; Simon GJB, 2006, J NEUROTRAUM, V23, P1072, DOI 10.1089/neu.2006.23.1072; Wang HQ, 2016, BRAIN PATHOL, V26, P167, DOI 10.1111/bpa.12267; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang P, 2014, ONCOGENE, V33, P514, DOI 10.1038/onc.2012.598; Wen QR, 2017, INT J GYNECOL CANCER, V27, P1096, DOI 10.1097/IGC.0000000000001028; Xue D, 2016, TUMOR BIOL, V37, P16187, DOI 10.1007/s13277-016-5429-8; Yang WW, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317711315; Zhang XZ, 2017, MOL MED REP, V16, P5363, DOI 10.3892/mmr.2017.7243; Zhao XH, 2017, BBA-MOL CELL RES, V1864, P1605, DOI 10.1016/j.bbamcr.2017.06.020	33	5	6	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	FEB	2019	120	2					2313	2322		10.1002/jcb.27560			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HL6CW	WOS:000458822400117	30450834				2022-02-06	
J	Niu, YY; Zhou, HB; Liu, YC; Wang, YF; Xie, JD; Feng, C; An, N				Niu, Yingying; Zhou, Hongbo; Liu, Yancui; Wang, Yunfeng; Xie, Jinding; Feng, Chong; An, Ning			miR-16 regulates proliferation and apoptosis of pituitary adenoma cells by inhibiting HMGA2	ONCOLOGY LETTERS			English	Article						microRNA-16; high mobility group A2; pituitary adenoma; proliferation; apoptosis	DOWN-REGULATION; GENE-EXPRESSION; OVEREXPRESSION; METASTASIS; SUPPRESSES; PREDICTION; INVASION	Previous studies have revealed that elevated expression of high mobility group A2 (HMGA2) is closely associated with the occurrence of pituitary adenomas (PAs). The expression of microRNA (miR)-16 is deregulated in PA tissues. Bioinformatics analysis has demonstrated that there is a complementary region between seed region of miR-16 and 3-untranslated region (3-UTR) of HMGA2 gene. In the present study, it was investigated whether miR-16 may regulate the expression of HMGA2 and whether it is involved in the pathogenesis of PAs. A total of 52 patients with PAs were recruited. Normal brain tissues obtained from 12 patients with traumatic brain injury were used as controls. The association between miR-16 and HMGA2 was validated using dual-luciferase reporter gene assay. HP75 cells were cultured in vitro and divided into the following groups: miR control, miR-16 mimic, small interfering RNA (si)-negative control, si-HMGA2 and miR-16 mimic+si-HMGA2 groups. The expression of miR-16 and HMGA2 in HP75 cells was determined using qRT-PCR and western blot. Cell proliferation was detected using the Cell Counting Kit-8 assay and apoptosis was detected using the TdT-UTP nick end labeling assay. Compared with normal pituitary tissues, the expression of miR-16 in PA tissues was significantly decreased, while the mRNA and protein levels of HMGA2 were significantly increased. miR-16 targeted the 3-UTR of HMGA2 gene and regulated the expression of HMGA2. Transfection with siRNAs targeting HMGA2 and/or miR-16 mimics inhibited the expression of HMGA2 and the proliferative ability of HP75 cells, whereas it increased apoptosis of HP75 cells. The downregulation of miR-16 and upregulation of HMGA2 were involved in the pathogenesis of PAs. Thus, it is hypothesized that miR-16 inhibited the proliferation and promoted apoptosis of HP75 cells by inhibiting HMGA2 expression.	[Niu, Yingying] Mudanjiang Med Univ, Sch Publ Hlth, Dept Labor & Environm Hyg, Mudanjiang 157000, Heilongjiang, Peoples R China; [Zhou, Hongbo] Mudanjiang Med Univ, Hongqi Hosp, Dept Oncol, Mudanjiang 157000, Heilongjiang, Peoples R China; [Liu, Yancui] Mudanjiang Med Univ, Dept Anat, Mudanjiang 157000, Heilongjiang, Peoples R China; [Wang, Yunfeng] Mudanjiang Ctr Dis Control & Prevent, Dept Infect Dis Prevent & Control, Mudanjiang 157021, Heilongjiang, Peoples R China; [Xie, Jinding] MuDanJiang Med Univ, Mudanjiang Forestry Hosp, Dept Orthoped, Mudanjiang 157000, Heilongjiang, Peoples R China; [Feng, Chong] MuDanJiang Med Univ, Hongqi Hosp, Dept Med Imaging, Mudanjiang 157000, Heilongjiang, Peoples R China; [An, Ning] MuDanJiang Med Univ, Hongqi Hosp, Dept Neurol, 1 Taiping Rd, Mudanjiang 157000, Heilongjiang, Peoples R China		An, N (corresponding author), MuDanJiang Med Univ, Hongqi Hosp, Dept Neurol, 1 Taiping Rd, Mudanjiang 157000, Heilongjiang, Peoples R China.	ningan170202@sina.com			Scientific Research Project of Heilongjiang Provincial Health Department [2012-290]; Science and Technology Research Project of Mudanjiang Medical University [ZS201523, ZS201526]; Key Laboratory of Mudanjiang Center for Disease Control and Prevention	The present study was supported by the Scientific Research Project of Heilongjiang Provincial Health Department (grant no. 2012-290), the Science and Technology Research Project of Mudanjiang Medical University (grant nos. ZS201523 and ZS201526) and the Key Laboratory of Mudanjiang Center for Disease Control and Prevention.	Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Borrmann L, 2003, NUCLEIC ACIDS RES, V31, P6841, DOI 10.1093/nar/gkg884; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Cai JY, 2016, TUMOR BIOL, V37, P699, DOI 10.1007/s13277-015-3853-9; D'Angelo D, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00039; D'Angelo D, 2012, J CLIN ENDOCR METAB, V97, pE1128, DOI 10.1210/jc.2011-3482; De Martino I, 2009, CANCER RES, V69, P1844, DOI 10.1158/0008-5472.CAN-08-4133; Esposito F, 2015, CELL CYCLE, V14, P1471, DOI 10.1080/15384101.2015.1021520; Fan CN, 2016, ONCOTARGET, V7, P21825, DOI 10.18632/oncotarget.7989; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Gao XT, 2017, THORAC CANCER, V8, P501, DOI 10.1111/1759-7714.12476; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Leone V, 2014, MOL CELL ENDOCRINOL, V390, P1, DOI 10.1016/j.mce.2014.03.002; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu W, 2015, FEBS LETT, V589, P3148, DOI 10.1016/j.febslet.2015.08.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oruckaptan HH, 2000, SURG NEUROL, V53, P211, DOI 10.1016/S0090-3019(00)00171-3; Shi Z, 2016, J BIOSCIENCES, V41, P229, DOI 10.1007/s12038-016-9603-3; Siahmansouri H, 2016, J PHARM PHARMACOL, V68, P1119, DOI 10.1111/jphp.12593; Wang RJ, 2015, CANCER LETT, V356, P568, DOI 10.1016/j.canlet.2014.10.003; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wu JJ, 2016, CANCER LETT, V376, P284, DOI 10.1016/j.canlet.2016.04.005; Zhao XP, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0777-0; Zhuo HC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028173; Zou QY, 2016, ARCH BIOCHEM BIOPHYS, V610, P25, DOI 10.1016/j.abb.2016.09.007	26	5	6	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	FEB	2019	17	2					2491	2497		10.3892/ol.2018.9872			7	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	HM5YS	WOS:000459551800136	30719118	Green Published, gold			2022-02-06	
J	Parent, M; Li, Y; Santhakumar, V; Hyder, F; Sanganahalli, BG; Kannurpatti, SS				Parent, Maxime; Li, Ying; Santhakumar, Vijayalakshmi; Hyder, Fahmeed; Sanganahalli, Basavaraju G.; Kannurpatti, Sridhar S.			Alterations of Parenchymal Microstructure, Neuronal Connectivity, and Cerebrovascular Resistance at Adolescence after Mild-to-Moderate Traumatic Brain Injury in Early Development	JOURNAL OF NEUROTRAUMA			English	Article						adolescence; cerebrovascular; connectivity; fMRI; traumatic brain injury	STATE FUNCTIONAL CONNECTIVITY; METHYL-D-ASPARTATE; DEFAULT NETWORK; RAT; NEUROTOXICITY; CONSEQUENCES; EXCITABILITY; PREDICTION; SEIZURES; HUMANS	Traumatic brain injury (TBI) is a leading cause of morbidity in children. To investigate outcome of early developmental TBI during adolescence, a rat model of fluid percussion injury was developed, where previous work reported deficits in sensorimotor behavior and cortical blood flow at adolescence.(1) Based on the nonlocalized outcome, we hypothesized that multiple neurophysiological components of brain function, namely neuronal connectivity, synapse/axonal microstructural integrity, and neurovascular function, are altered and magnetic resonance imaging (MRI) methods could be used to determine regional alterations. Adolescent outcomes of developmental TBI were studied 2 months after injury, using functional MRI (fMRI) and diffusion tensor imaging (DTI). fMRI-based resting-state functional connectivity (RSFC), representing neural connectivity, was significantly altered between sham and TBI. RSFC strength decreased in the cortex, hippocampus, and thalamus, accompanied by decrease in spatial extent of their corresponding RSFC networks and interhemispheric asymmetry. Cerebrovascular reactivity to arterial CO2 changes diminished after TBI across both hemispheres, with a more pronounced decrease in the ipsilateral hippocampus, thalamus, and motor cortex. DTI measures of fractional anisotropy and apparent diffusion coefficient, reporting on axonal and microstructural integrity of the brain, indicated similar interhemispheric asymmetry, with highest change in the ipsilateral hippocampus and regions adjoining the ipsilateral thalamus, hypothalamus, and amygdala. TBI-induced corpus callosal microstructural alterations indicated measurable changes in interhemispheric structural connectivity. Hippocampus, thalamus, and select cortical regions were most consistently affected in multiple imaging markers. The multi-modal MRI results demonstrate cortical and subcortical alterations in neural connectivity, cerebrovascular resistance, and parenchymal microstructure in the adolescent brain, indicating the highly diffuse and persistent nature of the lateral fluid percussion TBI early in development.	[Parent, Maxime; Hyder, Fahmeed; Sanganahalli, Basavaraju G.] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA; [Li, Ying; Santhakumar, Vijayalakshmi] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Univ Calif Riverside, Dept Mol Cell & Syst Neurosci, Riverside, CA 92521 USA; [Hyder, Fahmeed] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Kannurpatti, Sridhar S.] Rutgers Biomed & Hlth Sci New Jersey Med Sch, Dept Radiol, Newark, NJ USA		Kannurpatti, SS (corresponding author), Rutgers New Jersey Med Sch, Dept Radiol, ADMC 5,Room 575,30 Bergen St, Newark, NJ 07103 USA.	kannursr@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019; Sanganahalli, Basavaraju G/C-3296-2008	Santhakumar, Viji/0000-0001-6278-4187; Sanganahalli, Basavaraju G/0000-0002-0851-6621	New Jersey Commission for Brain Injury research [CBIR12PIL028, CBIR15IRG010, R01 NS097750, R01 MH-067528, P30 NS-052519]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH067528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097750, P30NS052519, R01NS069861] Funding Source: NIH RePORTER	Funding from the New Jersey Commission for Brain Injury research CBIR12PIL028 (S.K.), CBIR15IRG010 (S.K.), R01 NS097750 (V.S.), R01 MH-067528 (F.H.), and P30 NS-052519 (F.H.) are acknowledged.	Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal Bharat B., 2009, V489, P255, DOI 10.1007/978-1-59745-543-5_12; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chahboune H, 2009, NEUROIMAGE, V47, P459, DOI 10.1016/j.neuroimage.2009.04.060; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen HCI, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3339/fnsys.2016.00100, 10.3389/fnsys.2016.00100]; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; Dona O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169647; Duong T, 2015, J NEUROTRAUM, V32, pA138; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hyder F., 2010, 2 BIENN INT C REST S; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kaneko G, 2017, BIOL PSYCHIAT, V81, P503, DOI 10.1016/j.biopsych.2016.05.019; Kannurpatti SS, 2015, NMR BIOMED, V28, P1579, DOI 10.1002/nbm.3421; Kannurpatti SS, 2011, HUM BRAIN MAPP, V32, P1125, DOI 10.1002/hbm.21097; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kharatishvili I, 2005, J NEUROTRAUM, V22, P1208; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lima FPS, 2011, NEUROL SCI, V32, P633, DOI 10.1007/s10072-011-0604-6; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; MCDONALD JW, 1988, ANN NEUROL, V24, P337; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P465, DOI 10.1016/B978-012088554-1/50039-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ragan DK, 2013, J CEREBR BLOOD F MET, V33, P48, DOI 10.1038/jcbfm.2012.130; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Shen Q, 2016, METHODS MOL BIOL, V1462, P645, DOI 10.1007/978-1-4939-3816-2_35; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Stephens JA, 2017, J NEUROTRAUM, V34, P3117, DOI 10.1089/neu.2017.5081; Watts L, 2015, J NEUROTRAUM, V32, pA48; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	59	5	6	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					601	608		10.1089/neu.2018.5741			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000459448300010	29855211	Green Published			2022-02-06	
J	Petkus, V; Preiksaitis, A; Krakauskaite, S; Bartusis, L; Chomskis, R; Hamarat, Y; Zubaviciute, E; Vosylius, S; Rocka, S; Ragauskas, A				Petkus, Vytautas; Preiksaitis, Aidanas; Krakauskaite, Solventa; Bartusis, Laimonas; Chomskis, Romanas; Hamarat, Yasin; Zubaviciute, Erika; Vosylius, Saulius; Rocka, Saulius; Ragauskas, Arminas			Non-invasive Cerebrovascular Autoregulation Assessment Using the Volumetric Reactivity Index: Prospective Study	NEUROCRITICAL CARE			English	Article						Cerebrovascular autoregulation; Pressure reactivity index; Non-invasive monitoring; Ultrasonic time-of-flight measurement method; Traumatic brain injury patients	CEREBRAL PERFUSION-PRESSURE; NEAR-INFRARED SPECTROSCOPY; TRANSCRANIAL DOPPLER; ASSOCIATION; VALIDATION; LIMIT	BackgroundThis prospective study of an innovative non-invasive ultrasonic cerebrovascular autoregulation (CA) monitoring method is based on real-time measurements of intracranial blood volume (IBV) reactions following changes in arterial blood pressure. In this study, we aimed to determine the clinical applicability of a non-invasive CA monitoring method by performing a prospective comparative clinical study of simultaneous invasive and non-invasive CA monitoring on intensive care patients.MethodsCA was monitored in 61 patients with severe traumatic brain injuries invasively by calculating the pressure reactivity index (PRx) and non-invasively by calculating the volumetric reactivity index (VRx) simultaneously. The PRx was calculated as a moving correlation coefficient between intracranial pressure and arterial blood pressure slow waves. The VRx was calculated as a moving correlation coefficient between arterial blood pressure and non-invasively-measured IBV slow waves.ResultsA linear regression between VRx and PRx averaged per patients' monitoring session showed a significant correlation (r=0.843, p<0.001; 95% confidence interval 0.751 - 0.903). The standard deviation of the difference between VRx and PRx was 0.192; bias was -0.065.ConclusionsThis prospective clinical study of the non-invasive ultrasonic volumetric reactivity index VRx monitoring, based on ultrasonic time-of-flight measurements of IBV dynamics, showed significant coincidence of non-invasive VRx index with invasive PRx index. The ultrasonic time-of-flight method reflects blood volume changes inside the acoustic path, which crosses both hemispheres of the brain. This method does not reflect locally and invasively-recorded intracranial pressure slow waves, but the autoregulatory reactions of both hemispheres of the brain. Therefore, VRx can be used as a non-invasive cerebrovascular autoregulation index in the same way as PRx and can also provide information about the CA status encompassing all intracranial hemodynamics.	[Petkus, Vytautas; Preiksaitis, Aidanas; Krakauskaite, Solventa; Bartusis, Laimonas; Chomskis, Romanas; Hamarat, Yasin; Ragauskas, Arminas] Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania; [Preiksaitis, Aidanas] Lithuanian Univ Hlth Sci, Dept Neurol, Med Acad, Kaunas, Lithuania; [Preiksaitis, Aidanas; Zubaviciute, Erika; Vosylius, Saulius; Rocka, Saulius] Vilnius Univ, Clin Neurol & Neurosurg, Fac Med, Vilnius, Lithuania; [Preiksaitis, Aidanas; Zubaviciute, Erika; Vosylius, Saulius; Rocka, Saulius] Republ Vilnius Univ Hosp, Dept Neurosurg, Vilnius, Lithuania		Petkus, V (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania.	vytautas.petkus@ktu.lt	Hamarat, Yasin/H-9886-2018	Hamarat, Yasin/0000-0002-1343-5068; Petkus, Vytautas/0000-0002-8964-0738	Research Council of LithuaniaResearch Council of Lithuania (LMTLT) [MIP-087/2015]; European Commission FP7-HEALTHEuropean Commission [602150]	This research was supported by the Research Council of Lithuania (Grant No. MIP-087/2015) and European Commission FP7-HEALTH (Grant No. 602150).	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2005, ACT NEUR S, V95, P25; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; CHILLON JM, 2002, CEREBRAL BLOOD FLOW, P395; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Fantini S, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031411; Highton D, 2015, ANESTH ANALG, V121, P198, DOI 10.1213/ANE.0000000000000790; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; Horsfield MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062588; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lang EW., 2005, ANAESTH AUSTRALAS, P161; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Lavinio A, 2008, ACTA NEUROCHIR SUPPL, V102, P3, DOI 10.1007/978-3-211-85578-2_1; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Petkus V, 2014, ELEKTRON ELEKTROTECH, V20, P24, DOI 10.5755/j01.eee.20.8.5464; Petkus V, 2002, ULTRASONICS, V40, P829, DOI 10.1016/S0041-624X(02)00216-0; Petkus V, 2017, J CRIT CARE, V41, P49, DOI 10.1016/j.jcrc.2017.04.029; Petkus V, 2014, COMP MED SY, P427, DOI 10.1109/CBMS.2014.44; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Qiu WS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-112; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; Rasulo FA, 2012, J NEUROSURG ANESTH, V24, P3, DOI 10.1097/ANA.0b013e318224030a; Rivera-Lara L, 2017, NEUROCRIT CARE, V27, P362, DOI 10.1007/s12028-017-0421-8; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Scheeren TWL, 2017, J CLIN MONIT COMPUT, V31, P241, DOI 10.1007/s10877-017-9980-7; Schmidt B, 2016, J CLIN MONIT COMPUT, V30, P367, DOI 10.1007/s10877-015-9726-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri G.E., 2010, J OPEN NEUROSURGERY, V3, P6; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	42	5	5	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					42	50		10.1007/s12028-018-0569-x			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700006	29951960				2022-02-06	
J	Rastogi, N; Khurana, S; Veeraraghavan, B; Inbanathan, FY; Sekar, SKR; Gupta, D; Goyal, K; Bindra, A; Sokhal, N; Panda, A; Malhotra, R; Mathur, P				Rastogi, Neha; Khurana, Surbhi; Veeraraghavan, Balaji; Inbanathan, Francis Yesurajan; Sekar, Suresh Kumar Rajamani; Gupta, Deepak; Goyal, Keshav; Bindra, Ashish; Sokhal, Navdeep; Panda, Ashutosh; Malhotra, Rajesh; Mathur, Purva			Epidemiological investigation and successful management of a Burkholderia cepacia outbreak in a neurotrauma intensive care unit	INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES			English	Article						Burkholderia cepacia; Outbreak; Neurotrauma unit; MLST typing; Novel ST type	COMPLEX BACTEREMIA; CYSTIC-FIBROSIS; INFECTIONS; COLONIZATION; CHILDREN	Objective: The detailed epidemiological and molecular characterization of an outbreak of Burkholderia cepacia at a neurotrauma intensive care unit of a level 1 trauma centre is described. The stringent infection control interventions taken to successfully curb this outbreak are emphasized. Methods: The clinical and microbiological data for those patients who had more than one blood culture that grew B. cepacia were reviewed. Bacterial identification and antimicrobial susceptibility testing was done using automated Vitek 2 systems. Prospective surveillance, environmental sampling, and multilocus sequence typing (MLST) were performed for extensive source tracking. Intensive infection control measures were taken to further control the hospital spread. Results: Out of a total 48 patients with B. cepacia bacteraemia, 15 (31%) had central line-associated blood stream infections. Two hundred and thirty-one environmental samples were collected and screened, and only two water samples grew B. cepacia with similar phenotypic characteristics. The clinical strains characterized by MLST typing were clonal. However, isolates from the water represented a novel strain type (ST-1289). Intensive terminal cleaning, disinfection of the water supply, and the augmentation of infection control activities were done to curb the outbreak. A subsequent reduction in bacteraemia cases was observed. Conclusion: Early diagnosis and appropriate therapy, along with the rigorous implementation of essential hospital infection control practices is required for successful containment of this pathogen and to curb such an outbreak. (c) 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Rastogi, Neha] All India Inst Med Sci, Dept Microbiol & Med, New Delhi, India; [Khurana, Surbhi; Mathur, Purva] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, New Delhi 110029, India; [Veeraraghavan, Balaji; Inbanathan, Francis Yesurajan; Sekar, Suresh Kumar Rajamani] CMC, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [Gupta, Deepak] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi, India; [Goyal, Keshav; Bindra, Ashish; Sokhal, Navdeep] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neuroanaesthesiol, New Delhi, India; [Panda, Ashutosh] All India Inst Med Sci, Dept Microbiol, New Delhi, India; [Malhotra, Rajesh] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Orthopaed, New Delhi, India		Mathur, P (corresponding author), All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Lab Med, New Delhi 110029, India.	neha.rstg@gmail.com; surbhikhurana.11@gmail.com; vbalaji@cmcvellore.ac.in; francisyesurajansci@gmail.com; suresh874u@gmail.com; drdeepakgupta@gmail.com; keshavgoyal@yahoo.co.in; dr_ashi2208@yahoo.com; drnavdeep_kumar@yahoo.com; ashutoshpanda2086@gmail.com; rmalhotra62@hotmail.com; purvamathur@yahoo.co.in	Panda, Ashutosh/AAK-7851-2020				Argyres MI, 2010, NEW ENGL J MED, V363, P1483, DOI 10.1056/NEJMc1006641; Bittar F, 2010, CLIN MICROBIOL INFEC, V16, P809, DOI 10.1111/j.1469-0691.2010.03236.x; Boszczowski I, 2014, REV INST MED TROP SP, V56, P71, DOI 10.1590/S0036-46652014000100011; Bressler AM, 2007, INFECT CONT HOSP EP, V28, P951, DOI 10.1086/519177; CDC, 2017, CDC NHSN SURV DEF SP, P17; de Oliveira JM, 2010, NEW ENGL J MED, V363, P3; De Smet B, 2013, CLIN MICROBIOL INFEC, V19, P832, DOI 10.1111/1469-0691.12047; Dizbay M, 2009, J INFECT DEV COUNTR, V3, P273; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gautam V, 2011, INDIAN J MED MICROBI, V29, P4, DOI 10.4103/0255-0857.76516; Gautam V, 2016, SCI REP-UK, V6, DOI 10.1038/srep35769; Gomes-Filho IS, 2010, J ORAL MICROBIOL, V2; Guo LP, 2017, AM J INFECT CONTROL, V45, P660, DOI 10.1016/j.ajic.2017.01.024; Institute CaLS, 2015, M100S25 CLSI I CALS, P240; Jolley K., 2010, BURKHOLDERIA CEPACIA; Kim KY, 2016, YONSEI MED J, V57, P97, DOI 10.3349/ymj.2016.57.1.97; Kuzumoto K, 2011, EUR J MED RES, V16, P537, DOI 10.1186/2047-783X-16-12-537; Lee JKF, 2008, J PAEDIATR CHILD H, V44, P62, DOI 10.1111/j.1440-1754.2007.01173.x; Lucero CA, 2011, AM J INFECT CONTROL, V39, P775, DOI 10.1016/j.ajic.2010.12.005; Machado GE, 2014, J CLIN MICROBIOL, V52, P2881, DOI 10.1128/JCM.00688-14; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mali S, 2017, INDIAN J MED MICROBI, V35, P216, DOI 10.4103/ijmm.IJMM_16_258; Mangram A, 1996, INFECT CONT HOSP EP, V17, P718; Martins IS, 2010, INFECT CONT HOSP EP, V31, P516, DOI 10.1086/651667; Mathur P, 2015, INDIAN J MED MICROBI, V33, P51, DOI 10.4103/0255-0857.148378; Memish ZA, 2009, AM J INFECT CONTROL, V37, P431, DOI 10.1016/j.ajic.2006.10.002; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; Sails AD, 2003, J CLIN MICROBIOL, V41, P4733, DOI 10.1128/JCM.41.10.4733-4739.2003; Singhal T, 2015, INDIAN J MED MICROBI, V33, P117, DOI 10.4103/0255-0857.148405; Sousa SA, 2011, INT J MICROBIOL, V2011; Sousa SA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010043; Tseng SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104986; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Wang LJ, 2015, INT J INFECT DIS, V33, P71, DOI 10.1016/j.ijid.2014.12.046; Wiener-Well Y, 2014, AM J INFECT CONTROL, V42, P580, DOI 10.1016/j.ajic.2013.12.015; Zurita J, 2014, INT J INFECT DIS, V29, P96, DOI 10.1016/j.ijid.2014.07.016	37	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1201-9712	1878-3511		INT J INFECT DIS	Int. J. Infect. Dis.	FEB	2019	79						4	11		10.1016/j.ijid.2018.10.008			8	Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases	HJ4EV	WOS:000457127700002	30342249	gold			2022-02-06	
J	Resch, C; Anderson, VA; Beauchamp, MH; Crossley, L; Hearps, SJC; van Heugten, CM; Hurks, PPM; Ryan, NP; Catroppa, C				Resch, Christine; Anderson, Vicki A.; Beauchamp, Miriam H.; Crossley, Louise; Hearps, Stephen J. C.; van Heugten, Caroline M.; Hurks, Petra P. M.; Ryan, Nicholas P.; Catroppa, Cathy			Age-dependent differences in the impact of paediatric traumatic brain injury on executive functions: A prospective study using susceptibility-weighted imaging	NEUROPSYCHOLOGIA			English	Article						Traumatic brain injury; Executive functions; Sensitive periods; Magnetic resonance imaging	WORKING-MEMORY; CHILDHOOD; CHILDREN; PLASTICITY; RECOVERY; DEFICITS; LESIONS; VULNERABILITY; ADOLESCENCE; PREDICTORS	Childhood and adolescence represent sensitive developmental periods for brain networks implicated in a range of complex skills, including executive functions (EF; inhibitory control, working memory, and cognitive flexibility). As a consequence, these skills may be particularly vulnerable to injuries sustained during these sensitive developmental periods. The present study investigated 1) whether age at injury differentially affects EF 6 months and 2 years after TBI in children aged 5-15 years, and 2) whether the association between brain lesions and EF depend on age at injury. Children with TBI (n = 105) were categorized into four age-at-injury groups based on previous studies and proposed timing of cerebral maturational spurts: early childhood (5-6 years, n = 14), middle childhood (7-9 years, n = 24), late childhood (10-12 years, n = 52), and adolescence (13-15 years, n = 15). EF were assessed with performance-based tasks and a parent-report of everyday EF. TBI patients' EF scores 6 months and 2 years post-injury were compared to those of typically developing (TD) controls (n = 42). Brain lesions were identified using susceptibility weighted imaging (SWI). Results indicated that inhibitory control performance 2 years post-injury was differentially affected by the impact of TBI depending on age at injury. Follow-up analyses did not reveal significant differences within the age groups, preventing drawing strong conclusions regarding the contribution of age at injury to EF outcome after TBI. Tentatively, large effect sizes suggest that vulnerability is most apparent in early childhood and adolescence. Everyday inhibitory control behaviour was worse for children with TBI than TD children across childhood and adolescence at the 2-year assessment. There was no evidence for impairment in working memory or cognitive flexibility after TBI at the group level. Given small group sizes, findings from analyses into correlations between EF and SWI lesions should be interpreted with caution. Extent, number and volume of brain lesions correlated with adolescent everyday EF behaviour 6 months post-injury. Taken together, the results emphasize the need for long-term follow-up after paediatric TBI during sensitive developmental periods given negative outcomes 2-year post injury. Inhibitory control seems to be particular vulnerable to the impact of TBI. Findings of associations between EF and SWI lesions need to be replicated with larger samples.	[Resch, Christine; van Heugten, Caroline M.; Hurks, Petra P. M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharrnacol, POB 616, NL-6200 MD Maastricht, Netherlands; [Resch, Christine; Anderson, Vicki A.; Crossley, Louise; Hearps, Stephen J. C.; Ryan, Nicholas P.; Catroppa, Cathy] Royal Childrens Hosp, Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia; [Anderson, Vicki A.; Catroppa, Cathy] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Anderson, Vicki A.; Catroppa, Cathy] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Pavillon Marie Victorin, Montreal, PQ H3C 317, Canada; [Beauchamp, Miriam H.] Ste Justine Res Ctr, Montreal, PQ, Canada; [van Heugten, Caroline M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Fac Hlth Med & Life Sci, Med Ctr, POB 616, NL-6200 MD Maastricht, Netherlands; [Ryan, Nicholas P.] Deakin Univ, Cognit Neurosci Unit, Sch Psychol, Geelong, Vic, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, 50 Flemington Rd, Melbourne, Vic 3052, Australia.	christine.resch@maastrichtuniversity.nl; vicki.anderson@mcri.edu.au; miriam.beauchamp@umontreal.ca; louise.crossley@mcri.edu.au; stephen.hearps@mcri.edu.au; c.vanheugten@maastrichtuniversity.nl; p.m.hurks@maastrichtuniversity.nl; nicholas.ryan@mcri.edu.au; cathy.catroppa@mcri.edu.au	Cronk, Lee/V-1918-2019; Hearps, Stephen/L-6853-2016; Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Resch, Christine/0000-0003-2797-6137; Ryan, Nicholas/0000-0002-0878-8889; Hearps, Stephen/0000-0003-2984-1172	Victorian Neurotrauma Initiative; Victorian Government Operational Infrastructure Scheme	This research was supported by the Victorian Neurotrauma Initiative and the Victorian Government Operational Infrastructure Scheme (No. CO6E1). The funding bodies did not play a role in the design of the study, collection, analysis and interpretation of the data, or writing of the manuscript.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V., 2009, J PEDIATR PSYCHOL; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T., 2009, NEUROCOGNITIVE OUTCO; Bayliss DM, 2005, DEV PSYCHOL, V41, P579, DOI 10.1037/0012-1649.41.4.579; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Blakemore SJ, 2012, NAT NEUROSCI, V15, P1184, DOI 10.1038/nn.3177; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Borella E, 2010, J LEARN DISABIL-US, V43, P541, DOI 10.1177/0022219410371676; Botchway EN, 2019, J NEUROTRAUM, V36, P669, DOI 10.1089/neu.2018.5743; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; *CO MED SOC, 1991, REP SPORTS MED COMM; Coffey CE, 1991, PSYCHOPATHOL BRAIN, P243; Cohen J., 2013, STAT POWER ANAL BEHA; Cohen Jacob, 2013, APPL MULTIPLE REGRES; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gioia GA IP, 2000, BEHAV RATING INVENTO; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Huizinga M, 2006, NEUROPSYCHOLOGIA, V44, P2017, DOI 10.1016/j.neuropsychologia.2006.01.010; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kolb B, 2004, BRAIN COGNITION, V55, P104, DOI 10.1016/s0278-2626(03)00278-1; Krasny-Pacini A, 2017, ANN PHYS REHABIL MED, V60, P74, DOI 10.1016/j.rehab.2016.06.001; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Manly T., 1994, TEST EVERYDAY ATTENT; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Nowrangi MA, 2014, J NEUROPSYCH CLIN N, V26, P114, DOI 10.1176/appi.neuropsych.12070176; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Rest J. R., 2009, DEV REV, V29, P180; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; van Heugten C., 2000, BRAIN INJURY, V20, P895; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D, 2003, WECHSLER INTELLIGENC; Woodward H, 1999, J HEAD TRAUMA REHAB, V14, P351, DOI 10.1097/00001199-199908000-00004; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	75	5	5	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	FEB	2019	124						236	245		10.1016/j.neuropsychologia.2018.12.004			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	HO5XQ	WOS:000461003000025	30528585	Green Published			2022-02-06	
J	Rugg, A				Rugg, Adam			Civilizing the Child: Violence, Masculinity, and Race in Media Narratives of James Harrison	COMMUNICATION & SPORT			English	Article						football; masculinity; race; violence; concussions	FOOTBALL	This article critically examines the media coverage surrounding National Football League (NFL) player James Harrison in 2010 and 2011. In 2009, medical research linking hits to the head and the Alzheimer's-like condition known as chronic traumatic encephalopathy prompted the league to institute rule changes to limit violent tackles. Harrison was repeatedly punished by the league office and criticized by sports media outlets for his violent tackles and recalcitrant attitude. Guiding both the discipline and media coverage of Harrison are narratives rooted in a neoliberal logic situating the existence of and responsibility for football violence within the individual decisions of football players. Intensifying these narratives is the NFL and its media partners' invocation of discourses of Black criminality to construct the most damaging moments of football violence as unsanctioned acts that operate "outside the game." This invocation serves to place the authority over the judgment and legitimation of football violence within the White corporate morality of the league's offices and its media partners, allowing them to preserve the sport's central place in producing and maintaining dominant American masculinities through football violence while casting off the responsibility for the consequences of that violence to the footballing bodies that administer and receive it.	[Rugg, Adam] Fairfield Univ, Dept Commun, Fairfield, CT 06824 USA		Rugg, A (corresponding author), Fairfield Univ, Dept Commun, Fairfield, CT 06824 USA.	arugg@fairfield.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Anderson LC, 2018, COMMUN SPORT, V6, P263, DOI 10.1177/2167479517713152; ANDREWS VL, 1996, J AFRICAN AM MEN, V2, P33, DOI DOI 10.1007/BF02733939; [Anonymous], 2016, US TODAY; Belson K., 2017, NY TIMES; Benson P, 2017, J SPORT SOC ISSUES, V41, P307, DOI 10.1177/0193723517707699; BIRRELL S, 2000, READING SPORT CRITIC; Bloom E., 2010, ORANGE COUNTRY  1022; Borges R., 2011, BOSTON HERALD; Brinson W., 2011, CBS SPORTS      0713; Brooks M., 2011, EARLY LEAD      0713; Broussard C., 2014, ESPN; Burton N., 2011, THE ROOT; Butterworth M.L., 2009, COMMUNICATION CULTUR, V2, P411, DOI [10.1111/j.1753-9137.2009.01046.x, DOI 10.1111/J.1753-9137.2009.01046.X]; Butterworth ML, 2012, COMMUN CRIT-CULT STU, V9, P241, DOI 10.1080/14791420.2012.675438; Byrne K. J., 2011, SPORTS ILLUSTRATED; Chase C., 2010, YAHOO SPORTS    1020; Cunningham PL, 2009, J SPORT SOC ISSUES, V33, P39, DOI 10.1177/0193723508328630; Daly D., 2011, WASHINGTON TIMES; Davis L. R., 2002, MEDIASPORT, P154; Davis N., 2011, US TODAY; Dohrmann G., 2016, HUFFINGTON POST; Enck-Wanzer S.M., 2009, COMMUNICATION CRITIC, V6, P1, DOI [https://doi.org/10.1080/14791420802632087, DOI 10.1080/14791420802632087]; Florio M., 2010, PROFOOTBALL TAL 1103; Florio M., 2010, PROFOOTBALL TAL 1202; Florio M., 2011, PROFOOTBALL TAL 0715; Florio M., 2010, PROFOOTBALL TAL 1019; Florio M., 2010, PROFOOTBALL TAL 1028; Florio M., 2010, PROFOOTBALL TAL 1101; Fox A., 2011, ESPN; Freeman M., 2011, CBS SPORTS      0713; Furness Z, 2016, POP COMMUN, V14, P49, DOI 10.1080/15405702.2015.1084628; Granderson L., 2011, ESPN; Hall S., 1997, SPECTACLE OTHER, P223; HOWE P. D., 2004, SPORT PROFESSIONALIS; Jackson Z., 2011, FOX SPORTS OHIO 0713; Jhally Sut, 1984, CRIT SOCIOL, V12, P41; Johnson VE, 2016, POP COMMUN, V14, P12, DOI 10.1080/15405702.2015.1084622; Jones R., 2015, CNN; King C. Richard, 2001, CHEERS RACE SPECTACL; King P., 2010, SPORTS ILLUSTRATED; Lapchick R., 2015, 2015 RACIAL GENDER R; Lapchick RE, 2000, SOCIETY, V37, P14, DOI 10.1007/BF02686168; Lapchick Richard, 2015, 2014 ASS PRESS SPORT; Leonard DJ, 2010, J SPORT SOC ISSUES, V34, P252, DOI 10.1177/0193723510367781; Lopresti Mike, 2011, US TODAY; Marcus MB, 2017, CBS NEWS; Mastro DE, 2011, J BROADCAST ELECTRON, V55, P526, DOI 10.1080/08838151.2011.620664; McChesney Robert W., 1989, MEDIA SPORTS SOC, P49; Merrill E., 2009, ESPN; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montez de Oca J., 2013, DISCIPLINE INDULGENC; Montez de Oca J., 2016, CHILDS PLAY SPORT KI, P167; Morrison DR, 2017, ROUTL RES SPORT CULT, P156; Mutua, 2006, PROGR BLACK MASCULIN, P73; NFL Network, 2011, NFL             0714; Oates T., 2007, COMMUNICATION CRITIC, V4, P74, DOI [10.1080/14791420601138351, DOI 10.1080/14791420601138351]; Oates T.P., 2017, FOOTBALL MANLINESS U; Oates TP, 2009, SOCIOL SPORT J, V26, P31, DOI 10.1123/ssj.26.1.31; Omalu B., 2015, NY TIMES; Oriard M, 2014, INT J HIST SPORT, V31, P120, DOI 10.1080/09523367.2013.842557; Owens S. J., 2011, ORLANDO SENTINEL; Primm E, 2007, J AM CULTURE, V30, P222, DOI 10.1111/j.1542-734X.2007.00511.x; Pro Football Talk, 2010, PROFOOTBALL TAL 1017; Rada JA, 2005, J BROADCAST ELECTRON, V49, P65, DOI 10.1207/s15506878jobem4901_5; Rosenberg M., 2012, SPORTS ILLUSTRATED; Rosenthal G., 2010, PROFOOTBALL TAL 1022; Rugg A, 2016, POP COMMUN, V14, P21, DOI 10.1080/15405702.2015.1084625; Sabo Donald F., 1990, SPORT MEN GENDER ORD; Serby S., 2010, NEW YORK POST; Silver M., 2011, GQ              0201; Smith M. D., 2012, PROFOOTBALL TAL 0503; Smith M. D., 2011, PROFOOTBALL TAL 0713; Smith M. D., 2012, PROFOOTBALL TAL 0508; Solotaroff P., 2011, MENS J          0713; Sparkes Andrew, 2002, MEN MASC, V4, P258, DOI DOI 10.1177/1097184X02004003003; The Rap Sheet, 2011, THE RAP SHEET; Trotter J., 2010, SPORTS ILLUSTRATED; TRUJILLO N, 1995, SOCIOL SPORT J, V12, P403, DOI 10.1123/ssj.12.4.403; Van Sterkenburg J, 2010, MEDIA CULT SOC, V32, P819, DOI 10.1177/0163443710373955; Wilking C., 2015, OUT BOUNDS NFLS INTE	82	5	5	1	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	FEB	2019	7	1					46	63		10.1177/2167479517745299			18	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	HH6HQ	WOS:000455831100003					2022-02-06	
J	van der Walt, K; Tyson, A; Kennedy, E				van der Walt, Karla; Tyson, Amy; Kennedy, Ewan			How often is neck and vestibulo-ocular physiotherapy treatment recommended in people with persistent post-concussion symptoms? A retrospective analysis	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; CERVICAL-SPINE; DIZZINESS; REHABILITATION; MANAGEMENT; DISORDERS	Background: Persistent post-concussion symptoms (PPCS) are complex, and typically involve multidisciplinary assessment and management. The neck and vestibulo-ocular systems are recognised as potential contributors to PPCS, yet it is not clear how often treatment for these systems is warranted. Objectives: To explore how often neck and vestibulo-ocular treatment is received or recommended in people with PPCS. Design: Retrospective chart review. Method: De-identified clinical service data for the calendar year of 2017 were extracted from a single concussion service provider in Dunedin, New Zealand. A summary of the individual assessments and treatments received were extracted and used to determine how often cases were considered to require physician or neuropsychological assessment; and how often cases received or were recommended neck and/or vestibulo-ocular physiotherapy treatment. Results/findings: 147 cases were included in this study. Physician assessment was considered required in 25 cases (17%), and neuropsychological assessment in 90 cases (61%). For physiotherapy, neck treatment was received or recommended in 80 cases (54%), and vestibulo-ocular treatment in 106 cases (72%). Notably, this included 59 cases (40%) where both neck and vestibulo-ocular treatment were received or recommended. Conclusions: The high proportion of cases receiving or recommended neck and vestibulo-ocular treatment strongly suggests both these systems often contribute to PPCS, often in overlap. While based on retrospective data, these findings highlight the value of routine neck and vestibulo-ocular examination in the assessment and management of PPCS. Further prospective study would be beneficial to explore these proportions in more detail and in other regions.	[van der Walt, Karla; Kennedy, Ewan] Univ Otago, Sch Physiotherapy, Dunedin, New Zealand; [Tyson, Amy] APM Workcare Ltd, Whangaparaoa, New Zealand		Kennedy, E (corresponding author), Univ Otago, Sch Physiotherapy, Dunedin, New Zealand.	ewan.kennedy@otago.ac.nz	Kennedy, Ewan/Q-5803-2019	Kennedy, Ewan/0000-0002-7341-5309			Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Elkin BS, 2016, J ORTHOP SPORT PHYS, V46, P874, DOI 10.2519/jospt.2016.7049; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Matuszak J. M., 2016, SPORTS HLTH; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pabian PS, 2017, PHYS THER SPORT, V23, P123, DOI 10.1016/j.ptsp.2016.09.006; Park K, 2018, J SPORT REHABIL, V27, P485, DOI 10.1123/jsr.2016-0222; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Reneker JC, 2015, BRIT J SPORT MED, V49, P491, DOI 10.1136/bjsports-2014-093634; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006	24	5	5	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	FEB	2019	39						130	135		10.1016/j.msksp.2018.12.004			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	HI6NV	WOS:000456572900021	30583251				2022-02-06	
J	Wu, JZ; Pan, CS; Wimer, BM				Wu, John Z.; Pan, Christopher S.; Wimer, Bryan M.			Evaluation of the shock absorption performance of construction helmets under repeated top impacts	ENGINEERING FAILURE ANALYSIS			English	Article						Construction helmet; Experiment; Shock absorption; Top strike; Repeated impacts	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY	It is accepted in industries that an industrial helmet should be disposed of when it is subjected to a significant impact. There is no scientific evidence that supports this well-accepted belief. The current study was intended to evaluate the shock absorption performance of industrial helmets under repeated impacts. Common industrial or construction helmets are categorized as Type I according to ANSI Z89.1 and they are designed to mainly protect top impacts. A representative basic Type I construction helmet model was selected in the study. Helmets were repeatedly impacted ten times using a commercial drop tower tester with an impactor (mass 3.6 kg) at different drop heights from 0.30 to 2.03 m. A total of 80 impact trials were performed in the study. The relationships of the transmitted force with the drop height and with impact number were analyzed. A new parameter - the endurance limit - was proposed to evaluate the shock absorption performance of a helmet. The helmets were observed to experience cumulative structural damage with increasing impact number, resulting in a degrading shock absorption performance, when being impacted repeatedly with magnitudes greater than the endurance limit. Repeated impacts with magnitudes smaller than the endurance limit did not cause measurable cumulative structural damage to the helmets in our study.	[Wu, John Z.; Pan, Christopher S.; Wimer, Bryan M.] Natl Inst Occupat Safety & Hlth, Morgantown, WV 26505 USA		Pan, CS (corresponding author), NIOSH, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	cpan@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		[Anonymous], 2018, COLUMBIA SAFETY HELM; ANSI, 2014, 891 ANSIISEA; ASTM, 2013, F116304A ASTM; BS, 2012, 140522012A1 BS EN; BS, 2012, 3972012A1 BS EN; Bullard, 2018, HEAD PROT SHOULD REP; Chang VC, 2015, AM J IND MED, V58, P353, DOI 10.1002/ajim.22418; Cournoyer J, 2016, J ATHL TRAINING, V51, P258, DOI 10.4085/1062-6050-51.4.08; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kim SC, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111063; Konda S, 2015, INJURY PREV, V21, P115, DOI 10.1136/injuryprev-2014-041323; Lam T., 2010, SAE WORLD C EXHIBITI; Mattacola C., 2017, BRIT J SPORT MED, V51, P65; MSA, 2018, GARD SAF HELM; OSHA, 2012, 19261001910135 OSHA; Paci M, 2017, CAN J NEUROL SCI, V44, P518, DOI 10.1017/cjn.2017.43; Pearsall D., 2005, JOINT C 12 ISB 29 AS, P696; Sears JM, 2013, J OCCUP ENVIRON MED, V55, P507, DOI 10.1097/JOM.0b013e31827ee018; Swaren M, 2013, SPORTS TECH, V6, P43; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tiesman HM, 2011, AM J PREV MED, V41, P61, DOI 10.1016/j.amepre.2011.03.007; Tomioka R., 2009, J JPN SOC SPORTS IND, V19, P105; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Wu J. Z., 2018, P 42 ANN M AM S3C	25	5	5	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1350-6307	1873-1961		ENG FAIL ANAL	Eng. Fail. Anal.	FEB	2019	96						330	339		10.1016/j.engfailanal.2018.10.015			10	Engineering, Mechanical; Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	HH6OB	WOS:000455849800028	31555053	Green Accepted			2022-02-06	
J	Lateef, S; Holman, A; Carpenter, J; James, J				Lateef, Shan; Holman, Aubrie; Carpenter, Jessica; James, Jennifer			Can Therapeutic Hypothermia Diminish the Impact of Traumatic Brain Injury in Drosophila melanogaster?	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Recurrent TBI; hypothermia; concussion; Drosophila melanogaster	ENCEPHALOPATHY; TAUOPATHY; GENETICS	BACKGROUND/MAIN OBJECTIVES: No effective strategy exists to treat the well-recognized, devastating impact of traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE), which is the brain degeneration likely caused by repeated head trauma. The goals of this project were (1) to study the effects of single and recurrent TBI (rTBI) on Drosophila melanogaster's (a) life span, (b) response to sedatives, and (c) behavioral responses to light and gravity and (2) to determine whether therapeutic hypothermia can mitigate the deleterious effects of TBI. METHODS: Five experimental groups were created: (1) control, (2) single TBI or concussion; (3) concussion + hypothermia, (4) rTBI, and (5) rTBI + hypothermia. A "high-impact trauma" (HIT) device was built, which used a spring-based mechanism to propel flies against the wall of a vial, causing mechanical damage to the brain. Hypothermia groups were cooled to 15 degrees C for 3 minutes. Group differences were analyzed with chi-square tests for the categorical variables and with ANOVA tests for the continuous variables. RESULTS: Survival curve analysis showed that rTBI can decrease Drosophila lifespan and hypothermia diminished this impact. Average sedation time for control vs concussion vs concussion + hypothermia was 78 vs 52 vs 61 seconds (P<.0001). Similarly, rTBI vs rTBI/hypothermia groups took 43 vs 59 seconds (P<.0001). Concussed flies preferred dark environments compared with control flies (risk ratio 3.3, P<.01) while flies who were concussed and cooled had a risk ratio of 2.7 (P<.01). Flies with rTBI were almost 4 times likely to prefer the dark environment but only 3 times as likely if they were cooled, compared with controls. Geotaxis was significantly affected by rTBI only and yet less so if rTBI flies were cooled. CONCLUSIONS: Hypot hermia successfully mitigated many deleterious effects of single TBI and rTBI in Drosophila and may represent a promising breakthrough in the treatment of human TBI.	[Lateef, Shan; Holman, Aubrie; James, Jennifer] Thomas Jefferson High Sch Sci & Technol, Jefferson Underclassman Multidisciplinary Lab JUM, Alexandria, VA USA; [Carpenter, Jessica] George Washington Univ, Childrens Natl Hlth Syst, Washington, DC USA; [Carpenter, Jessica] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA		Lateef, S (corresponding author), Thomas Jefferson High Sch Sci & Technol, Jefferson Underclassman Multidisciplinary Lab JUM, 13001 Chaddsford Terrace, Manassas, VA 20112 USA.	shanrlateef@gmail.com					Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Baxter SL, 2014, DIS MODEL MECH, V7, P1005, DOI 10.1242/dmm.013987; Bushey D, 2011, INT REV NEUROBIOL, V99, P213, DOI 10.1016/B978-0-12-387003-2.00009-4; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kahsai L, 2011, INT REV NEUROBIOL, V99, P139, DOI 10.1016/B978-0-12-387003-2.00006-9; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lessing D, 2009, NAT REV GENET, V10, P359, DOI 10.1038/nrg2563; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mrozek S, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/989487; Neckameyer W, 2016, METHODS MOL BIOL, V1478; Rodriguez EC, 2012, J EXP BIOL, V215, P4157, DOI 10.1242/jeb.074468; Shaefi Shahzad, 2016, Surg Neurol Int, V7, P103, DOI 10.4103/2152-7806.194816; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X	23	5	5	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	JAN 21	2019	13								1179069518824852	10.1177/1179069518824852			8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HM6BJ	WOS:000459558700001	30733630	Green Published, gold			2022-02-06	
J	Phillips, JK; Sherman, SA; Cotton, KY; Heddleston, JM; Taylor, AB; Finan, JD				Phillips, Jack K.; Sherman, Sydney A.; Cotton, Kristen Y.; Heddleston, John M.; Taylor, Aaron B.; Finan, John D.			Characterization of neurite dystrophy after trauma by high speed structured illumination microscopy and lattice light sheet microscopy	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Structured illumination microscopy; Lattice light sheet microscopy; Dystrophy; Traumatic brain injury; Human induced pluripotent stem cell derived neurons	AXONAL INJURY; ACTIN; CELLS; TRANSPORT; MODELS	Background: Unbiased screening studies have repeatedly identified actin-related proteins as one of the families of proteins most influenced by neurotrauma. Nevertheless, the status quo model of cytoskeletal reorganization after neurotrauma excludes actin and incorporates only changes in microtubules and intermediate filaments. Actin is excluded in part because it is difficult to image with conventional techniques. However, recent innovations in fluorescent microscopy provide an opportunity to image the actin cytoskeleton at super-resolution resolution in living cells. This study applied these innovations to an in vitro model of neurotrauma. New method: New methods are introduced for traumatizing neurons before imaging them with high speed structured illumination microscopy or lattice light sheet microscopy. Also, methods for analyzing structured illumination microscopy images to quantify post-traumatic neurite dystrophy are presented. Results: Human induced pluripotent stem cell-derived neurons exhibited actin organization typical of immature neurons. Neurite dystrophy increased after trauma but was not influenced by jasplakinolide treatment. The Factin content of dystrophies varied greatly from one dystrophy to another. Comparison with existing methods: In contrast to fixation dependent methods, these methods capture the evolution of the actin cytoskeleton over time in a living cell. In contrast to prior methods based on counting dystrophies, this quantification scheme parameterizes the severity of a given dystrophy as it evolves from a local swelling to an almost-perfect spheroid that threatens to transect the neurite. Conclusions: These methods can be used to investigate genetic factors and therapeutic interventions that modulate the course of neurite dystrophy after trauma.	[Phillips, Jack K.; Sherman, Sydney A.; Cotton, Kristen Y.; Finan, John D.] NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA; [Heddleston, John M.; Taylor, Aaron B.] Janelia Res Campus, Howard Hughes Med Inst, Adv Imaging Ctr, Ashburn, VA USA; [Sherman, Sydney A.] Midwestern Univ, Chicago Coll Osteopath Med, Downers Grove, IL 60515 USA; [Cotton, Kristen Y.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Taylor, Aaron B.] Univ Michigan, Sch Med, Biomed Res Microscopy Core, Ann Arbor, MI USA		Finan, JD (corresponding author), NorthShore Univ HealthSyst, Dept Neurosurg, Evanston, IL 60201 USA.	jfinan@northshore.org		Finan, John/0000-0003-4626-9702; Phillips, Jack/0000-0002-5362-8833	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS098129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098129] Funding Source: NIH RePORTER	This work was funded in part by the National Institutes of Health (R21NS098129).	Bar-Kochba E, 2015, EXP MECH, V55, P261, DOI 10.1007/s11340-014-9874-2; Bar-Ziv R, 1999, P NATL ACAD SCI USA, V96, P10140, DOI 10.1073/pnas.96.18.10140; Beevers JE, 2013, BIOCHEM SOC T, V41, P1503, DOI 10.1042/BST20130194; BROCHARD F, 1975, J PHYS-PARIS, V36, P1035, DOI 10.1051/jphys:0197500360110103500; Budde MD, 2010, P NATL ACAD SCI USA, V107, P14472, DOI 10.1073/pnas.1004841107; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chu FY, 2017, P NATL ACAD SCI USA, V114, P10338, DOI 10.1073/pnas.1702226114; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Gallo G, 2004, EXP NEUROL, V189, P112, DOI 10.1016/j.expneurol.2004.05.019; Ganguly A, 2015, J CELL BIOL, V210, P401, DOI 10.1083/jcb.201506110; Garland P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047552; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Huang XS, 2018, NAT BIOTECHNOL, V36, P451, DOI 10.1038/nbt.4115; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kim HS, 2014, STEM CELLS DEV, V23, P2673, DOI 10.1089/scd.2014.0167; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Maglione M, 2013, NAT NEUROSCI, V16, P790, DOI 10.1038/nn.3403; Markin VS, 1999, BIOPHYS J, V76, P2852, DOI 10.1016/S0006-3495(99)77439-4; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Nakamura H, 2015, J PHARMACOL SCI, V128, P170, DOI 10.1016/j.jphs.2015.06.006; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Phillips J. K., 2018, J VIS EXP; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Qu Y, 2017, MOL BIOL CELL, V28, P296, DOI 10.1091/mbc.E16-10-0727; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Smith DH, 1999, J NEUROSCI, V19, P4263; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Unsain N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21232-0; Vera E, 2016, CELL REP, V17, P1184, DOI 10.1016/j.celrep.2016.09.062; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Zhong GS, 2014, ELIFE, V3, DOI 10.7554/eLife.04581	47	5	6	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	JAN 15	2019	312						154	161		10.1016/j.jneumeth.2018.12.005			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HI1QU	WOS:000456220900018	30529411	Green Accepted			2022-02-06	
J	Silveira, GD; Ishimura, ME; Teixeira, D; Galindo, LT; Sardinha, AA; Porcionatto, M; Longo-Maugeri, IM				Silveira, Gabriela da Paz; Ishimura, Mayari Eika; Teixeira, Daniela; Galindo, Layla Tesla; Sardinha, Agnes Araujo; Porcionatto, Marimelia; Longo-Maugeri, Ieda Maria			Improvement of Mesenchymal Stem Cell Immunomodulatory Properties by Heat-Killed Propionibacterium acnes via TLR2	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						Propionibacterium acnes; mesenchymal stem cell; immunomodulation; toll-like receptor 2; traumatic brain injury	PURIFIED SOLUBLE POLYSACCHARIDE; TRAUMATIC BRAIN-INJURY; BONE-MARROW; GROWTH-FACTOR; CORYNEBACTERIUM-PARVUM; HUMAN KERATINOCYTES; CYTOKINE PRODUCTION; P-ACNES; EXPRESSION; MICE	Mesenchymal stem cells (MSCs) are an essential tool for regenerative medicine, which aims to develop new technologies to improve their effects to obtain useful transplantation results. MSC immunomodulatory role has been just demonstrated; however, how they react when they are stimulated by an adjuvant is poorly understood. Our group showed the adjuvant effect of killed Propionibacterium acnes (P. acnes) on hematopoietic stem cells. As these cells share the same MSCs bone marrow (BM) site and interact with each other, here we evaluated the P. acnes and its soluble polysaccharide (PS) effect on MSCs and their immunomodulatory role in a murine model of traumatic brain injury (TBI). The bacteria increased the absolute number of MSCs, including MSC subpopulations, and maintained MSC plasticity. P. acnes and PS enhanced MSC proliferation and improved their immunomodulatory effect. P. acnes-MSC and PS-MSC transplantation increased anti-inflammatory cytokine expression and diminished pro-inflammatory cytokine expression after injury. This effect seemed to be mediated via TLR2 since P. acnes-KOTLR2-MSC transplantation decreased TGF-beta and IL-10 expression. Increasing in neural stem cells and neuroblasts after PS-MSC transplantation was also observed. The adjuvant effect of P. acnes is an alternative means of expanding MSCs and important to identify their subpopulations to know better their role under exogenous stimuli including inflammation resolution in an experimental model.	[Silveira, Gabriela da Paz; Ishimura, Mayari Eika; Teixeira, Daniela; Longo-Maugeri, Ieda Maria] Univ Fed Sao Paulo, Paulista Sch Med, Dept Microbiol Immunol & Parasitol, Div Immunol, Sao Paulo, Brazil; [Galindo, Layla Tesla; Sardinha, Agnes Araujo; Porcionatto, Marimelia] Univ Fed Sao Paulo, Paulista Sch Med, Dept Biochem, Div Mol Biol, Sao Paulo, Brazil		Longo-Maugeri, IM (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Dept Microbiol Immunol & Parasitol, Div Immunol, Sao Paulo, Brazil.	imaugeri@unifesp.br	Teixeira, Daniela/A-6600-2019; Araujo Sardinha Pinto, Agnes/ABB-4851-2021; Longo-Maugeri, Ieda M/B-9764-2012; Porcionatto, Marimelia/C-3322-2012	Teixeira, Daniela/0000-0001-7092-2009; Araujo Sardinha Pinto, Agnes/0000-0002-5895-7353; Longo-Maugeri, Ieda M/0000-0003-4184-8414; Porcionatto, Marimelia/0000-0001-6287-916X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/25307-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2014/25307-4), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ananias RZ, 2007, SCAND J IMMUNOL, V65, P538, DOI 10.1111/j.1365-3083.2007.01939.x; Anderson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076979; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braga EG, 2003, IMMUNOL LETT, V88, P163, DOI 10.1016/S0165-2478(03)00079-8; BRENER Z, 1976, J PARASITOL, V62, P645, DOI 10.2307/3279437; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campioni D, 2009, CYTOM PART B-CLIN CY, V76B, P225, DOI 10.1002/cyto.b.20461; Chen XT, 2016, STEM CELLS DEV, V25, P337, DOI 10.1089/scd.2015.0227; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; FISHER B, 1990, CANCER-AM CANCER SOC, V66, P220, DOI 10.1002/1097-0142(19900715)66:2<220::AID-CNCR2820660205>3.0.CO;2-6; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gambero M, 2016, IMMUNOBIOLOGY, V221, P1001, DOI 10.1016/j.imbio.2016.03.003; Gao JL, 2016, CELL TRANSPLANT, V25, P1863, DOI 10.3727/096368916X691150; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; GREEN S, 1977, J NATL CANCER I, V59, P1519, DOI 10.1093/jnci/59.5.1519; HALPERN BN, 1964, J RETICULOENDOTH SOC, V1, P77; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Ichiyasu H, 1999, J LEUKOCYTE BIOL, V65, P482, DOI 10.1002/jlb.65.4.482; Ishimura D, 2008, TOHOKU J EXP MED, V216, P149, DOI 10.1620/tjem.216.149; Kalis C, 2005, J IMMUNOL, V174, P4295, DOI 10.4049/jimmunol.174.7.4295; Kaneko N, 2009, NEUROSCI RES, V63, P155, DOI 10.1016/j.neures.2008.12.001; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kim HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014041; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; KLIGMAN AM, 1976, J INVEST DERMATOL, V67, P160, DOI 10.1111/1523-1747.ep12513007; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Leyden JJ, 1998, DERMATOLOGY, V196, P55, DOI 10.1159/000017868; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Liu Nan, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P498; Ma MM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-117; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; MASUHARA M, 1995, J GASTROENTEROL, V30, P48, DOI 10.1007/BF01211374; Matsui K, 1997, J IMMUNOL, V159, P97; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mussalem JS, 2006, MICROBIOL IMMUNOL, V50, P253, DOI 10.1111/j.1348-0421.2006.tb03791.x; Mussalem JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033955; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nam SC, 2007, J COMP NEUROL, V505, P190, DOI 10.1002/cne.21473; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; NUSSENZWEIG RS, 1967, EXP PARASITOL, V21, P224, DOI 10.1016/0014-4894(67)90084-7; PALMER JOHN W., 1940, SCIENCE, V92, P155, DOI 10.1126/science.92.2381.155; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Raicevic G, 2011, CELL IMMUNOL, V270, P207, DOI 10.1016/j.cellimm.2011.05.010; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Ruhl T, 2018, EXP CELL RES, V370, P653, DOI 10.1016/j.yexcr.2018.07.030; Sempere JM, 2014, CLIN EXP IMMUNOL, V176, P255, DOI 10.1111/cei.12270; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; SMITH SR, 1993, J LEUKOCYTE BIOL, V54, P23, DOI 10.1002/jlb.54.1.23; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Squaiella CC, 2008, IMMUNOL LETT, V121, P157, DOI 10.1016/j.imlet.2008.10.005; Squaiella CC, 2006, IMMUNOBIOLOGY, V211, P105, DOI 10.1016/j.imbio.2005.10.013; Squaiella-Baptistao CC, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/132083; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Teixeira Kirte M., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P359, DOI 10.1590/S0036-46651996000500007; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Wang XY, 2015, NEUROCHEM RES, V40, P1671, DOI 10.1007/s11064-015-1634-x; WEBSTER GF, 1990, INT J DERMATOL, V29, P313, DOI 10.1111/j.1365-4362.1990.tb04749.x; Xiong XX, 2011, STROKE, V42, P2026, DOI 10.1161/STROKEAHA.110.593772; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Yoneyama H, 2001, J EXP MED, V193, P35, DOI 10.1084/jem.193.1.35; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y	77	5	5	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JAN 10	2019	11								489	10.3389/fnmol.2018.00489			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HH0OJ	WOS:000455416800002	30687005	Green Published, gold			2022-02-06	
J	Fraser, S; Wright, AD; van Donkelaar, P; Smirl, JD				Fraser, Sarah; Wright, Alexander D.; van Donkelaar, Paul; Smirl, Jonathan D.			Cross-sectional comparison of spiral versus block integrated curriculums in preparing medical students to diagnose and manage concussions	BMC MEDICAL EDUCATION			English	Article						Medical education; Curriculum design; Spiral curriculum; Integrated; Concussion	EDUCATION; WORK	BackgroundAn integrated curriculum is designed to be repetitive yet progressive and the concept has rapidly established itself within medical education. National organizations have recommended a shift to a spiral curriculum design, which uses both vertical and horizontal integration. This study examined differences between the recently implemented integrated spiral (class of 2019) and conventional block (classes of 2016-2018) MD curricula at the University of British Columbia (UBC) with respect to knowledge of concussion.MethodsCross-sectional online survey (FluidSurveys: Fluidware, Ottawa, ON), distributed via email to UBC medical students during the 2015-2016 academic year. Questions focused on demographic data, knowledge of concussion definition, and management considerations. Differences in responses across the two groups were assessed using chi-square tests. Ordinal Likert-scale data were analyzed using Mann-Whitney U-Tests. Statistical significance was determined a priori at p<0.05.ResultsOne hundred forty eight medical students (57% female) responded with 78 students in the spiral curriculum and 70 students the block curriculum. Important differences between responses from spiral versus block curricula students included: formal exposure to concussion-related educational material (10.8h spiral vs. 3.95h block), understanding concussions can occur without direct head impacts (90% spiral vs. 70% block, X-1,148(2)=9.41, p=0.002) and identifying long-term consequences (dementia: 90% spiral vs. 66% block, X-1,148(2)=12.57, p<0.0001; second impact syndrome: 80% spiral vs. 57% block, X-1,148(2)=8.60, p=0.003; Parkinsonism: 47% spiral vs. 17% block, X-1,148(2)=14.87, p<0.001). Block students identified the need for a full neurological exam (X-1,148(2)=17.63, p<0.001) and had greater clinical exposure to acute concussion (47% block vs. 14% spiral, X-1,148(2)=19.27, p<0.001) and post-concussion syndrome (37% block vs. 19% spiral, X-1,148(2)=5.91, p=0.015).ConclusionsThe findings from this preliminary study suggest the spiral curriculum design, which emphasizes and revisits clinical competencies, promotes a strong understanding and retention of knowledge in highly prevalent clinical conditions such as concussion.	[Fraser, Sarah; Wright, Alexander D.] Univ British Columbia Okanagan, Reichwald Hlth Sci Ctr, Southern Med Program, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Fac Med, Expt Med Program, Vancouver, BC, Canada; [Wright, Alexander D.; van Donkelaar, Paul; Smirl, Jonathan D.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, ART 180,3333 Univ Way, Kelowna, BC V1V 1V7, Canada		Fraser, S (corresponding author), Univ British Columbia Okanagan, Reichwald Hlth Sci Ctr, Southern Med Program, Kelowna, BC, Canada.	sarah.fraser@alumni.ubc.ca		Smirl, Jonathan/0000-0003-1054-0038			ALBANESE MA, 1993, ACAD MED, V68, P615; ARMSTRONG JS, 1977, J MARKETING RES, V14, P396, DOI 10.2307/3150783; Barrows HS, 1998, APPROACH MED ED, P1; Bates J, 2010, DEANS TASK FORCE MD; Boggild M, 2012, CAN J NEUROL SCI, V39, P361, DOI 10.1017/S0317167100013524; Brauer DG, 2015, MED TEACH, V37, P312, DOI 10.3109/0142159X.2014.970998; Burke MJ, 2012, CAN J NEUROL SCI, V39, P763, DOI 10.1017/S0317167100015584; Colliver JA, 2000, ACAD MED, V75, P259, DOI 10.1097/00001888-200003000-00017; Corbett EC, 2006, AAMC PROJECT CLIN ED; Davis MH, 2003, MED TEACH, V25, P596, DOI 10.1080/0142159032000144383; Donaworth MA, 2016, PHYSICIAN SPORTSMED, V44, P1, DOI 10.1080/00913847.2016.1135039; Ellaway R, 2013, MED TEACH, V35, P989, DOI 10.3109/0142159X.2013.818110; General Medical Council (GMC), 2010, UPD STAND CURR ASS S; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Harden RM, 1999, MED TEACH, V21, P141, DOI 10.1080/01421599979752; Kirschner PA, 2006, EDUC PSYCHOL-US, V41, P75, DOI 10.1207/s15326985ep4102_1; LCME, 2016, FUNCT STRUCT MED SCH; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miller LE, 1983, J EXT, V21, P45; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sherman SW, 1976, MULTIPLE CHOICE TEST, P29; The Association of Faculties of Medicine of Canada, 2015, FMEC MD 2015 FUT MED; VERNON DTA, 1993, ACAD MED, V68, P550, DOI 10.1097/00001888-199307000-00015; Walker A, 2009, INTERDISCIP J PROBL-, V3, P12, DOI 10.7771/1541-5015.1061; Wijnen-Meijer M, 2009, MED TEACH, V31, pE528, DOI 10.3109/01421590902842417; Wood DF, 2003, BMJ-BRIT MED J, V326, P328, DOI 10.1136/bmj.326.7384.328	26	5	5	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6920			BMC MED EDUC	BMC Med. Educ.	JAN 9	2019	19								17	10.1186/s12909-018-1439-0			8	Education & Educational Research; Education, Scientific Disciplines	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research	HG9SO	WOS:000455349800003	30626361	Green Published, gold			2022-02-06	
J	Meth, MZ; Bernstein, JPK; Calamia, M; Tranel, D				Meth, Molly Z.; Bernstein, John P. K.; Calamia, Matthew; Tranel, Daniel			What types of recommendations are we giving patients? A survey of clinical neuropsychologists	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuropsychological assessment; neuropsychology survey; feedback	TRAUMATIC BRAIN-INJURY; SURVEY PROFESSIONAL PRACTICES; COMPENSATORY STRATEGIES; COGNITIVE REHABILITATION; PSYCHOLOGICAL-ASSESSMENT; NATIONAL-SURVEY; TEST FEEDBACK; SUBSTANCE USE; SATISFACTION; PREVALENCE	Objective: To identify types of recommendations that neuropsychologists most frequently give to patients, and determine which specific recommendations are most and least consistently given to patients across and within different diagnostic populations. Method: A total of 309 clinical neuropsychologists completed a survey evaluating the frequency with which they made particular types of recommendations (e.g. driving, employment and education, health and rehabilitation referrals) to patients with various disorders (e.g. traumatic brain injury, dementia). Results: Recommendations in some categories were common across diagnoses (e.g. recommendations related to health). Neuropsychologists reported being more likely to give patients with dementia (relative to other clinical populations) recommendations related to educational resources, supervision and independence, and driving. Patients with a TBI diagnosis were more likely to be given recommendations related to employment and education, health and rehabilitation referrals, and mental health and substance use. Patients with a psychiatric diagnosis were more likely to be given recommendations related to mental health and substance use. Irrespective of diagnosis, neuropsychologists reported being most likely to give recommendations that could be implemented by the patient or caregiver without assistance from outside sources. Neuropsychologists varied in their use of recommendations to seek evaluations and treatment from health and rehabilitation referrals and in providing recommendations related to driving. Conclusions: Recommendations provided within diagnostic groups are consistent with the etiology and prognosis of those conditions. Recommendations for the use of compensatory strategies to address cognitive deficits and recommendations to improve health were endorsed by the vast majority of neuropsychologists across diagnoses.	[Meth, Molly Z.; Tranel, Daniel] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA; [Meth, Molly Z.] Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA; [Meth, Molly Z.] Vet Affairs Med Ctr, Providence, RI 02908 USA; [Bernstein, John P. K.; Calamia, Matthew] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA; [Tranel, Daniel] Univ Iowa, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA		Meth, MZ (corresponding author), Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA 52242 USA.; Meth, MZ (corresponding author), Brown Univ, Dept Psychiat & Human Behav, Warren Alpert Med Sch, Providence, RI 02912 USA.; Meth, MZ (corresponding author), Vet Affairs Med Ctr, Providence, RI 02908 USA.	Molly.Meth2@va.gov		Calamia, Matthew/0000-0002-7252-7181; Tranel, Daniel/0000-0002-1338-1389	Graduate and Professional Student Government Research Grant; State of Iowa Fraternal Order of Eagle Research Grant	This study was supported by a Graduate and Professional Student Government Research Grant and a State of Iowa Fraternal Order of Eagle Research Grant.	Andersen Christian K, 2004, Health Qual Life Outcomes, V2, P52, DOI 10.1186/1477-7525-2-52; Baker R., 2016, EVALUATING SURVEY QU; BENNETTLEVY J, 1994, CLIN NEUROPSYCHOL, V8, P219, DOI 10.1080/13854049408401559; Borkosky B, 2014, PSYCHOL INJ LAW, V7, P264, DOI 10.1007/s12207-014-9199-6; Bortnik KE, 2013, J CLIN EXP NEUROPSYC, V35, P857, DOI 10.1080/13803395.2013.826182; Bouazzaoui B, 2010, ACTA PSYCHOL, V135, P59, DOI 10.1016/j.actpsy.2010.05.007; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Curry KT, 2010, J PERS ASSESS, V92, P327, DOI 10.1080/00223891.2010.482006; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Donofrio N, 1999, ARCH CLIN NEUROPSYCH, V14, P721, DOI 10.1016/S0887-6177(99)80199-1; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fallows RR, 2013, ARCH CLIN NEUROPSYCH, V28, P180, DOI 10.1093/arclin/acs142; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Grabowski DC, 2004, JAMA-J AM MED ASSOC, V291, P2840, DOI 10.1001/jama.291.23.2840; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; GUADAGNOLI E, 1988, PSYCHOL BULL, V103, P265, DOI 10.1037/0033-2909.103.2.265; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Johnstone B., 2002, REHABILITATION NEURO; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lings S, 2001, NEUROLOGY, V57, P435, DOI 10.1212/WNL.57.3.435; LOEWEN ER, 1990, EXP AGING RES, V16, P43, DOI 10.1080/03610739008253873; Man-Son-Hing M, 2007, J AM GERIATR SOC, V55, P878, DOI 10.1111/j.1532-5415.2007.01177.x; Mason D. J., 2001, THE MEMORY WORKBOOK; Meth Molly, 2016, Appl Neuropsychol Adult, V23, P21, DOI 10.1080/23279095.2014.996881; Mueser KT, 2000, SCHIZOPHRENIA BULL, V26, P179, DOI 10.1093/oxfordjournals.schbul.a033438; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Postal K., 2017, CLIN NEUROPSYCHOL, P1; Postal KS, 2013, FEEDBACK STICKS ART; Poston JM, 2010, PSYCHOL ASSESSMENT, V22, P203, DOI 10.1037/a0018679; Pritchard AE, 2014, CLIN NEUROPSYCHOL, V28, P26, DOI 10.1080/13854046.2013.863978; Quaney BM, 2009, NEUROREHAB NEURAL RE, V23, P879, DOI 10.1177/1545968309338193; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabin LA, 2008, APPL NEUROPSYCHOL, V15, P264, DOI 10.1080/09084280802325090; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; ROSS HE, 1988, ARCH GEN PSYCHIAT, V45, P1023; Ruff RM, 2003, ARCH CLIN NEUROPSYCH, V18, P847, DOI 10.1016/j.acn.2003.07.002; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sitzer DI, 2006, ACTA PSYCHIAT SCAND, V114, P75, DOI 10.1111/j.1600-0447.2006.00789.x; Smith SR, 2007, ASSESSMENT, V14, P310, DOI 10.1177/1073191107302842; Stathopoulou G, 2006, CLIN PSYCHOL-SCI PR, V13, P179, DOI 10.1111/j.1468-2850.2006.00021.x; Sullivan M.J., 1990, CAN J REHABIL, V4, P99, DOI 10.1097/JNN.0000000000000314; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; SWEET JJ, 1990, CLIN NEUROPSYCHOL, V4, P101, DOI DOI 10.1080/13854049008401504; Temple RO, 2006, ARCH CLIN NEUROPSYCH, V21, P371, DOI 10.1016/j.acn.2006.05.002; Trombly CA, 2002, AM J OCCUP THER, V56, P489, DOI 10.5014/ajot.56.5.489; VanKirk KK, 2013, CLIN NEUROPSYCHOL, V27, P750, DOI 10.1080/13854046.2013.783122; Westervelt HJ, 2007, CLIN NEUROPSYCHOL, V21, P263, DOI 10.1080/13854040500519745; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; [No title captured]; [No title captured]	64	5	5	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JAN 2	2019	33	1					57	74		10.1080/13854046.2018.1456564			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HK9OC	WOS:000458320100004	29600743				2022-02-06	
J	Avallone, KM; Smith, ER; Ma, S; Gargan, S; Porter, KE; Authier, CC; Martis, B; Liberzon, I; Rauch, SAM				Avallone, Kimberly M.; Smith, Erin R.; Ma, Sean; Gargan, Sean; Porter, Katherine E.; Authier, Caitlin C.; Martis, Brian; Liberzon, Israel; Rauch, Sheila A. M.			PTSD as a Mediator in the Relationship Between Post-Concussive Symptoms and Pain Among OEF/OIF/OND Veterans	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; SEEKING TREATMENT; DEPLOYMENT; AFGHANISTAN; DIAGNOSES; IMPACT; IRAQ; TBI	Introduction: Traumatic brain injury (TBI), pain, and post-traumatic stress disorder (PTSD) commonly co-occur in Veteran populations, particularly among Veterans returning from the recent conflicts in Iraq and Afghanistan. Extant research indicates that both TBI and PTSD can negatively impact pain broadly; however, less is known about how these variables impact one another. The current study examines the impact of self-reported post-concussive symptoms on both pain severity and pain interference among Veterans with PTSD who screened positive for a possible TBI, and subsequently, evaluates the potential mediating role of PTSD in these relationships. Materials and Methods: Participants were 126 combat Veterans that served in Operation Enduring Freedom, Operation Iraqi Freedom, or Operation New Dawn who were being evaluated for participation in a multisite treatment outcomes study. As part of an initial evaluation for inclusion in the study, participants completed several self-report measures and interviews, including the Brief Traumatic Brain Injury Screen, Neurobehavioral Symptom Inventory, Brief Pain Inventory, and the Clinician Administered PTSD Scale, which were utilized in these analyses. Results: For pain severity, greater post-concussive symptoms significantly predicted increased pain severity with a significant indirect effect of post-concussive symptoms on pain severity through PTSD (indirect effect = 0.03; 95% confidence interval = 0.0094-0.0526). Similar results were found for pain interference (indirect effect = 0.03; 95% confidence interval = 0.0075-0.0471). Conclusions: These findings replicate and extend previous findings regarding the relationship between TBI, pain, and PTSD. Self-reported post-concussive symptoms negatively impact both pain severity and pain interference among Veterans with probable TBI, and PTSD serves as a mediator in these relationships. Clinically, these results highlight the importance of fully assessing for PTSD symptoms in Veterans with a history of TBI presenting with pain. Further, it is possible that providing effective PTSD treatment to reduce PTSD severity may provide some benefit in reducing post-concussive and pain symptoms.	[Avallone, Kimberly M.; Smith, Erin R.; Porter, Katherine E.; Martis, Brian; Liberzon, Israel] VA Ann Arbor Healthcare Syst, Mental Hlth Serv, 2215 Fuller Rd, Ann Arbor, MI 48105 USA; [Avallone, Kimberly M.; Smith, Erin R.; Ma, Sean; Gargan, Sean; Porter, Katherine E.; Authier, Caitlin C.; Martis, Brian; Liberzon, Israel] Univ Michigan, Dept Psychiat, 500S State St, Ann Arbor, MI 48109 USA; [Rauch, Sheila A. M.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1648 Pierce Dr NE, Atlanta, GA 30307 USA; [Rauch, Sheila A. M.] Atlanta VA Med Ctr, Mental Hlth Serv Line, 1670 Clairmont Rd, Decatur, GA 30033 USA		Avallone, KM (corresponding author), VA Ann Arbor Healthcare Syst, Mental Hlth Serv, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.; Avallone, KM (corresponding author), Univ Michigan, Dept Psychiat, 500S State St, Ann Arbor, MI 48109 USA.				United States Army Medical Research and Materiel Command (MRMC) [W81XWH-11-1-0073]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; VA Ann Arbor Healthcare System; VA San Diego Healthcare SystemUS Department of Veterans Affairs; Ralph H. Johnson VA Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240] Funding Source: NIH RePORTER	This work was supported by the United States Army Medical Research and Materiel Command (MRMC; Grant #W81XWH-11-1-0073); the National Center for Advancing Translational Sciences of the National Institutes of Health (Grant #UL1TR000433). This material is the result of work supported with resources and the use of facilities at the VA Ann Arbor Healthcare System, Ralph H. Johnson VA Medical Center, and VA San Diego Healthcare System.	Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brennstuhl MJ, 2015, PERSPECT PSYCHIATR C, V51, P295, DOI 10.1111/ppc.12093; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cleeland CS., 2009, BRIEF PAIN INVENTORY; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; Mendoza T, 2006, EUR J PAIN, V10, P353, DOI 10.1016/j.ejpain.2005.06.002; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Morasco BJ, 2013, PAIN, V154, P609, DOI 10.1016/j.pain.2013.01.001; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Outcalt SD, 2014, J REHABIL RES DEV, V51, P559, DOI 10.1682/JRRD.2013.06.0134; Porter KE, 2013, PAIN MED, V14, P1797, DOI 10.1111/pme.12260; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rauch SAM, 2018, CONTEMP CLIN TRIALS, V64, P128, DOI 10.1016/j.cct.2017.10.013; Rauch SAM, 2010, J AFFECT DISORDERS, V121, P165, DOI 10.1016/j.jad.2009.05.026; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Veterans Health Administration, 2005, VAL REP PROINS C PEP, V1172	35	5	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JAN-FEB	2019	184	1-2					E118	E123		10.1093/milmed/usy225			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HJ1JU	WOS:000456919100009	30215758	Green Published, hybrid			2022-02-06	
J	Balsamo, LM; Mitchell, HR; Ross, W; Metayer, C; Hardy, KK; Kadan-Lottick, NS				Balsamo, Lyn M.; Mitchell, Hannah-Rose; Ross, Wilhelmenia; Metayer, Catherine; Hardy, Kristina K.; Kadan-Lottick, Nina S.			Monitoring neurocognitive functioning in childhood cancer survivors: evaluation of CogState computerized assessment and the Behavior Rating Inventory of Executive Function (BRIEF)	BMC PSYCHOLOGY			English	Article						Late effects; Neurocognitive; Neuropsychological evaluation; Computerized assessment; Survivorship	ACUTE LYMPHOBLASTIC-LEUKEMIA; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; COGNITIVE IMPAIRMENT; ECOLOGICAL VALIDITY; CHILDREN; PARENT; CHEMOTHERAPY; PERFORMANCE; SERVICES	Background: Many childhood cancer survivors develop neurocognitive impairment, negatively affecting education and psychosocial functioning. Recommended comprehensive neuropsychological testing can be time- and cost- intensive for both institutions and patients and their families. It is important to find quick and easily administered surveillance measures to identify those in need of evaluation. Methods: We evaluated, individually and in combination, the sensitivity and specificity of the 1) Behavior Rating Inventory of Executive Functioning-Metacognition Index (BRIEF-MCI), and 2) CogState Composite Index (computerized assessment of cognition) in identifying below grade-level performance on state-administered tests of reading and mathematics among childhood cancer survivors. Results: The 45 participants (39% female) were a mean age of 7.1 +/- 4.4years at diagnosis, 14.0 +/- 3.0 at evaluation, with a history of leukemia (58%), lymphoma (9%), central nervous system tumors (20%), and other tumors (13%). Impairment on the BRIEF-MCI was associated with low sensitivity (26% reading, 41% mathematics) but stronger specificity (88% reading, 96% mathematics). We found similar associations for the CogState Composite Index with sensitivity of 26% for reading and 29% for mathematics and specificity of 92% for both reading and mathematics. Combining the two measures did not improve sensitivity appreciably (47% reading, 59% mathematics) while reducing specificity (84% reading, 88% mathematics). Conclusions: While individuals identified from the BRIEF-MCI or CogState Composite would likely benefit from a full neuropsychological evaluation given the strong specificity, use of these measures as screening tools is limited. With poor sensitivity, they do not identify many patients with academic difficulties and in need of a full neuropsychological evaluation. Continued effort is required to find screening measures that have both strong sensitivity and specificity.	[Balsamo, Lyn M.; Ross, Wilhelmenia; Kadan-Lottick, Nina S.] Yale Univ, Sch Med, 15 POB 208064,16 333 Cedar St,LMP 2073, New Haven, CT 06520 USA; [Mitchell, Hannah-Rose] Univ Miami, Coral Gables, FL 33124 USA; [Metayer, Catherine] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Hardy, Kristina K.] Childrens Natl Med Ctr, Ctr Neurosci & Behav Med, Neuropsychol Div, Washington, DC 20010 USA; [Hardy, Kristina K.] George Washington Univ, Sch Med, Dept Psychiat & Behav Sci, Washington, DC USA; [Kadan-Lottick, Nina S.] Yale Canc Ctr, New Haven, CT USA		Balsamo, LM (corresponding author), Yale Univ, Sch Med, 15 POB 208064,16 333 Cedar St,LMP 2073, New Haven, CT 06520 USA.	lyn.balsamo@yale.edu		Metayer, Catherine/0000-0003-3467-4145; Kadan-Lottick, Nina/0000-0002-6857-396X; Balsamo, Lyn/0000-0003-3703-2623	St. Baldrick's foundation	This research was supported by a Scholars Award from the St. Baldrick's foundation to NKL. CogState software was provided to the investigators without cost for use in the study. However, CogState had no role in the design, conduct, or analysis of the study.	Anderson FS, 2009, PEDIATR BLOOD CANCER, V52, P159, DOI 10.1002/pbc.21700; Basco MR, 2000, AM J PSYCHIAT, V157, P1599, DOI 10.1176/appi.ajp.157.10.1599; Borges A, 2017, INT J SPORTS PHYS TH, V12, P381; Bull KS, 2015, NEURO-ONCOLOGY, V17, P1628, DOI 10.1093/neuonc/nov129; Butler RW, 2006, MENT RETARD DEV D R, V12, P184, DOI 10.1002/mrdd.20110; Campbell LK, 2007, PEDIATR BLOOD CANCER, V49, P65, DOI 10.1002/pbc.20860; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Farnsworth JL, 2017, J ATHL TRAINING, V52, P826, DOI 10.4085/1062-6050-52.6.03; Feig SA, 2009, PEDIATRICS, V123, P906, DOI 10.1542/peds.2008-3688; Frias A, 2017, BIPOLAR DISORD, V19, P273, DOI 10.1111/bdi.12510; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Group UKCsCSGLE, 2005, THER BAS LONG TERM F; Hardy KKWN, 2014, 2014 AM AC PED C EXH; Hardy KK, 2017, J PEDIATR PSYCHOL, V42, P815, DOI 10.1093/jpepsy/jsx060; Hardy KK, 2015, NEURO-ONCOL PRACT, V2, P32, DOI 10.1093/nop/npu026; Harshman LA, 2012, J PEDIATR PSYCHOL, V37, P458, DOI 10.1093/jpepsy/jsr119; Hayes J., 2010, CONNECTICUT MASTERY; Howarth RA, 2013, J INT NEUROPSYCH SOC, V19, P380, DOI 10.1017/S1355617712001567; Howell DHT., 2011, PAN CANADIAN PRACTIC; Jameson JP, 2007, CLIN PSYCHOL-SCI PR, V14, P283, DOI 10.1111/j.1468-2850.2007.00089.x; Kadan-Lottick NS, 2010, JNCI-J NATL CANCER I, V102, P881, DOI 10.1093/jnci/djq156; Kral TVE, 2012, J DEV BEHAV PEDIATR, V33, P9, DOI 10.1097/DBP.0b013e31823f2f35; Krull KR, 2008, J CLIN ONCOL, V26, P4138, DOI 10.1200/JCO.2008.16.8864; Lai JS, 2014, QUAL LIFE RES, V23, P1049, DOI 10.1007/s11136-013-0548-9; Lang S, 2017, WORLD NEUROSURG, V99, P448, DOI 10.1016/j.wneu.2016.12.061; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matsos A, 2017, CANCER TREAT REV, V61, P6, DOI 10.1016/j.ctrv.2017.09.010; Mayes SD, 2009, LEARN INDIVID DIFFER, V19, P238, DOI 10.1016/j.lindif.2008.09.001; Mitby PA, 2003, CANCER-AM CANCER SOC, V97, P1115, DOI 10.1002/cncr.11117; Mollica CM, 2005, CHILD NEUROPSYCHOL, V11, P303, DOI 10.1080/092970490911306; Nathan PC, 2007, ARCH PEDIAT ADOL MED, V161, P798, DOI 10.1001/archpedi.161.8.798; O'Leary TE, 2007, QUAL LIFE RES, V16, P1211, DOI 10.1007/s11136-007-9231-3; Olson K, 2013, APPL NEUROPSYCH-CHIL, V2, P17, DOI 10.1080/21622965.2012.686330; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Tabor E., 2009, REGULATORY FOCUS, V14, P16; Viola A, 2017, J PEDIAT HEMATOL ONC, V39, P174, DOI 10.1097/MPH.0000000000000761; Vitali M, 2017, CRIT REV ONCOL HEMAT, V118, P7, DOI 10.1016/j.critrevonc.2017.08.001; Wallace WHB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1190; Walsh KS, 2016, PEDIATR BLOOD CANCER, V63, P191, DOI 10.1002/pbc.25759; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wild K, 2008, ALZHEIMERS DEMENT, V4, P428, DOI 10.1016/j.jalz.2008.07.003; Willard VW, 2016, PSYCHOL ASSESSMENT, V28, P1110, DOI 10.1037/pas0000265; Winick N, 2011, CURR OPIN PEDIATR, V23, P27, DOI 10.1097/MOP.0b013e32834255e9; Yamashita Y, 2011, BRAIN DEV-JPN, V33, P260, DOI 10.1016/j.braindev.2010.09.005	47	5	5	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND		2050-7283		BMC PSYCHOL	BMC Psychol.		2019	7	1							26	10.1186/s40359-019-0302-3			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	VK4NZ	WOS:000700859900026	31046815	gold, Green Published			2022-02-06	
J	Bertisch, H; Satris, G; Temkin, N; Barber, J; Manley, GT; Adeoye, OM; Badjatia, N; Boase, KD; Bodien-Guller, Y; Bullock, MR; Chesnut, RM; Corrigan, JD; Crawford, KL; Diaz-Arrastia, R; Dikmen, SS; Duhaime, AC; Ellenbogen, RG; Ezekiel, F; Feeser, VR; Gaudette, E; Giacino, JT; Goldman, DP; Gonzales, L; Gopinath, SP; Gullapalli, RP; Hemphill, JC; Hotz, GA; Kramer, JH; Levin, H; Lindsell, CJ; Machamer, J; Madden, C; Markowitz, AJ; Martin, A; Mathern, BE; McAllister, TW; McCrea, MA; Merchant, RE; Noel, F; Perl, DP; Puccio, AM; Rabinowitz, M; Robertson, CS; Rosand, J; Sander, AM; Schnyer, DM; Seabury, SA; Sergot, P; Sherer, M; Stein, DM; Stein, MB; Taylor, SR; Toga, AW; Turtzo, LC; Vespa, PM; Wang, KK; Yue, JK; Zafonte, R; Zhang, ZQ				Bertisch, Hilary; Satris, Gigi; Temkin, Nancy; Barber, Jason; Manley, Geoffrey T.; Adeoye, Opeolu M.; Badjatia, Neeraj; Boase, Kimberly D.; Bodien-Guller, Yelena; Bullock, Malcolm R.; Chesnut, Randall M.; Corrigan, John D.; Crawford, Karen L.; Diaz-Arrastia, Ramon; Dikmen, Sureyya S.; Duhaime, Ann-Christine; Ellenbogen, Richard G.; Ezekiel, Frank; Feeser, Venkata R.; Gaudette, Etienne; Giacino, Joseph T.; Goldman, Dana P.; Gonzales, Luis; Gopinath, Shankar P.; Gullapalli, Rao P.; Hemphill, Jesse C.; Hotz, Gillian A.; Kramer, Joel H.; Levin, Harvey; Lindsell, Christopher J.; Machamer, Joan; Madden, Christopher; Markowitz, Amy J.; Martin, Alastair; Mathern, Bruce E.; McAllister, Thomas W.; McCrea, Michael A.; Merchant, Randall E.; Noel, Florence; Perl, Daniel P.; Puccio, Ava M.; Rabinowitz, Miri; Robertson, Claudia S.; Rosand, Jonathan; Sander, Angelle M.; Schnyer, David M.; Seabury, Seth A.; Sergot, Paulina; Sherer, Mark; Stein, Deborah M.; Stein, Murray B.; Taylor, Sabrina R.; Toga, Arthur W.; Turtzo, L. Christine; Vespa, Paul M.; Wang, Kevin K.; Yue, John K.; Zafonte, Ross; Zhang, Zhiqun		Transforming Res Clinical Knowledg	Rehabilitation Trajectories and Outcomes in Individuals With Mild Traumatic Brain Injury and Psychiatric Histories: A TRACK-TBI Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive; mild traumatic brain injury (mTBI); outcome; psychiatric; rehabilitation; return to work; social	RETURN-TO-WORK; STRESS-DISORDER; YOUNG-ADULTS; INTEGRATION; CONCUSSION; RECOMMENDATIONS; PREDICTORS; COGNITION; PROGRAM; TRIAL	Objective: To determine differences in rehabilitation trajectories and return to work (RTW) and social outcomes in individuals with mild traumatic brain injury (mTBI) with and without significant psychiatric histories at index hospitalization. Setting: Three level 1 trauma centers participating in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) consortium. Participants: A total of 305 individuals with index mTBI enrolled in the TRACK-TBI pilot project. Design: Secondary analysis of data from the TRACK-TBI pilot study. Main Measures: Chart review and patient/family interview at emergency department (ED) admission, ED clinical data, ED discharge plan, functional interview data at 3- and 6-month outcomes, Trail Making Tests, the Wechsler Adult Intelligence Scale, Fourth Edition, Processing Speed Index, the California Verbal Learning Test, Second Edition, and the Craig Handicap Assessment and Reporting Technique. Results: Controlling for neurological history and CT lesion at ED admission, participants with and without psychiatric histories did not differ in terms of treatment, return to work, or reported social function. Individuals with psychiatric histories demonstrated lower processing speed and reported reduced satisfaction with occupational function at outcome. Conclusions: Individuals with mTBI and psychiatric histories may require specialized rehabilitation planning to address increased risk for cognitive difficulties and occupational dissatisfaction at outcome. CT lesion may independently influence outcomes.	[Bertisch, Hilary] NYU, Sch Med, 550 1St Ave, New York, NY USA; [Satris, Gigi] Univ Calif San Francisco, Zuckerberg San Francisco Gen & Trauma Ctr, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Barber, Jason] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Adeoye, Opeolu M.] Univ Cincinnati, Cincinnati, OH 45221 USA; [Badjatia, Neeraj; Gullapalli, Rao P.] Univ Maryland, Baltimore, MD 21201 USA; [Boase, Kimberly D.; Chesnut, Randall M.; Dikmen, Sureyya S.; Ellenbogen, Richard G.; Machamer, Joan] Univ Washington, Seattle, WA 98195 USA; [Bodien-Guller, Yelena; Giacino, Joseph T.; Zafonte, Ross] Harvard Spaulding Rehabil Hosp, Charlestown, MA USA; [Bullock, Malcolm R.; Hotz, Gillian A.] Univ Miami, Coral Gables, FL 33124 USA; [Corrigan, John D.] Ohio State Univ, Columbus, OH 43210 USA; [Crawford, Karen L.; Gaudette, Etienne; Goldman, Dana P.; Seabury, Seth A.; Toga, Arthur W.] Univ Southern Calif, Los Angeles, CA 90089 USA; [Diaz-Arrastia, Ramon] Univ Penn, Philadelphia, PA 19104 USA; [Duhaime, Ann-Christine; Rosand, Jonathan] Harvard Massachusetts Gen Hosp, Charlestown, MA USA; [Ezekiel, Frank; Hemphill, Jesse C.; Kramer, Joel H.; Markowitz, Amy J.; Martin, Alastair; Taylor, Sabrina R.; Yue, John K.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Feeser, Venkata R.; Mathern, Bruce E.; Merchant, Randall E.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Gonzales, Luis; Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Gopinath, Shankar P.; Levin, Harvey; Noel, Florence; Robertson, Claudia S.; Sander, Angelle M.; Sergot, Paulina] Baylor Coll Med, Houston, TX 77030 USA; [Lindsell, Christopher J.] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Madden, Christopher] UT Southwestern, Dallas, TX USA; [McAllister, Thomas W.] Indiana Univ, Bloomington, IN 47405 USA; [McCrea, Michael A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Perl, Daniel P.; Turtzo, L. Christine] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Puccio, Ava M.; Rabinowitz, Miri] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Schnyer, David M.] UT Austin, Austin, TX USA; [Stein, Deborah M.] Univ Maryland, College Pk, MD 20742 USA; [Stein, Murray B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Vespa, Paul M.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Wang, Kevin K.; Zhang, Zhiqun] Univ Florida, Gainesville, FL 32611 USA		Bertisch, H (corresponding author), NYU, Ambulatory Care Ctr, Langone Med Ctr, Rusk Rehabil, 240 East 38th St,17th Floor, New York, NY 10016 USA.	hilary.bertisch@nyumc.org	Corrigan, John D./E-2921-2011; Hemphill, Claude/AAY-5630-2021; Yue, John K/P-1348-2015; Schnyer, David/ABD-6372-2021; Badjatia, Neeraj/AAS-4855-2021; Goldman, Dana P/E-7667-2013; Giacino, Joseph/AAF-1952-2021	Hemphill, Claude/0000-0003-4019-7525; Yue, John K/0000-0001-9694-7722; Schnyer, David/0000-0002-7472-2853; Goldman, Dana P/0000-0001-8498-6396; Giacino, Joseph/0000-0002-7916-9698			Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cole W. R., 2016, TRANSLATIONAL RES TR; Culpepper Larry, 2015, J Clin Psychiatry, V76, pe901, DOI 10.4088/JCP.13086tx4c; Curran C, 2015, BRAIN INJURY, V29, P25, DOI 10.3109/02699052.2014.948067; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Ditchman N, 2016, BRAIN INJURY, V30, P1581, DOI 10.1080/02699052.2016.1199900; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Ebaid D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00062; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Foy CML, 2014, J OCCUP REHABIL, V24, P533, DOI 10.1007/s10926-013-9488-z; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Garrelfs SF, 2015, BRAIN INJURY, V29, P550, DOI 10.3109/02699052.2014.995227; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Leute PJF, 2015, EUR J TRAUMA EMERG S, V41, P299, DOI 10.1007/s00068-014-0429-0; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Mellick D, 2016, CRAIG HANDICAP ASSES; Migliorini C, 2016, BRAIN INJURY, V30, P1201, DOI 10.1080/02699052.2016.1175666; Moran B, 2015, SOUTH MED J, V108, P553, DOI 10.14423/SMJ.0000000000000340; Oldenburg C, 2015, BRAIN INJURY, V30, P1; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Pineau H, 2015, BEHAV SCI-BASEL, V5, P43, DOI 10.3390/bs5010043; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Powell JM, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020909; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Radomski MV, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.020776; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Studerus-Germann AM, 2017, INT J NEUROSCI, V127, P900, DOI 10.1080/00207454.2017.1278589; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trexler LE, 2016, ARCH PHYS MED REHAB, V97, P204, DOI 10.1016/j.apmr.2015.09.016; Unoka Z, 2016, CLIN PSYCHOL REV, V44, P1, DOI 10.1016/j.cpr.2015.11.009; Vance DE, 2013, J NEUROSCI NURS, V45, P77, DOI 10.1097/JNN.0b013e3182829038; Vikane E, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/8026414; Wechsler D., 2008, WECHSLER ADULT INTEL; Wheeler S, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.115.020677; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuen KM, 2016, APPL NEUROPSYCH-ADUL, V23, P322, DOI 10.1080/23279095.2015.1057638; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zakzanis KK, 2017, APPL NEUROPSYCH-ADUL, V24, P559, DOI 10.1080/23279095.2016.1225216	58	5	5	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		36	44		10.1097/HTR.0000000000000399			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600010	29863617				2022-02-06	
J	Borner, U; Anschuetz, L; Kaiser, N; Rieke, A; Dubach, P; Caversaccio, M				Borner, Urs; Anschuetz, Lukas; Kaiser, Nadine; Rieke, Alexander; Dubach, Patrick; Caversaccio, Marco			Blunt nasal trauma in children: a frequent diagnostic challenge	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Pediatric nose trauma; Complications; Outcome; Treatment; Nasal fracture; Closed reposition	PEDIATRIC FACIAL FRACTURES; SEPTAL ABSCESS; CLOSED REDUCTION; ADOLESCENTS; MANAGEMENT; INJURIES; HEAD; CT	ObjectiveThe clinical challenge in blunt nasal trauma in children, is to identify cases requiring specialized care among frequently encountered banalities, whilst trying to minimize the exposure to diagnostic procedures. We aim to evaluate the related diagnostic and therapeutic pathways and its outcome during follow-up.MethodsThis retrospective cohort study includes children up to 16 years presenting at the emergency department with blunt nasal trauma of our tertiary reference center.ResultsThe incidence of blunt nasal injuries was estimated 1750 cases in 7 years. A total of 459 consecutive cases with suspected complications were enrolled. Univariate comparison between age groups revealed a statistically significant diminution of downfall related injuries with growing up, whereas blows (including violence) significantly increased with age (p<0.001 each). The logistic regression model identified male sex as an independent risk factor for soft tissue lesions (OR 1.699, p=0.017) and for frontobasal fractures (OR 2.415, p=0.050). Age was not identified to play a significant role regarding localization of injuries. Delayed septorhinoplasties became necessary in 2 cases only (0.4%). The logistic regression model identified nasal bone fracture (OR17.038, p<0.001) and mandibular fracture (OR 4.753, p=0.004) as independent risk factor for a surgical intervention.ConclusionsBlunt trauma to the nose is frequent in children. Trauma mechanisms differ significantly between age groups, whereas localization and concomitant injuries do not. Male sex was identified as an independent risk factor for soft tissue lesions and frontobasal fractures. In our experience, initial triage by the pediatric department with consecutive involvement of the ENT specialists in case of suspected complications is safe and effective and may help to reduce unnecessary diagnostic procedures/irradiation to the young patients.	[Borner, Urs; Anschuetz, Lukas; Dubach, Patrick; Caversaccio, Marco] Univ Hosp, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland; [Borner, Urs; Anschuetz, Lukas; Dubach, Patrick; Caversaccio, Marco] Univ Bern, Bern, Switzerland; [Kaiser, Nadine] Univ Bern, Bern Univ Hosp, Inselspital, Dept Pediat Surg, Bern, Switzerland; [Rieke, Alexander] Kantonsspital Graubuenden, Dept Radiol, Chur, Switzerland; [Dubach, Patrick] Burgerspital, Dept Otorhinolaryngol Head & Neck Surg, Solothurn, Switzerland		Anschuetz, L (corresponding author), Univ Hosp, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland.; Anschuetz, L (corresponding author), Univ Bern, Bern, Switzerland.	anschuetz.lukas@gmail.com	Anschuetz, Lukas/X-3595-2019	Anschuetz, Lukas/0000-0001-6927-0664			Alcala-Galiano A, 2008, RADIOGRAPHICS, V28, P441, DOI 10.1148/rg.282075060; Allareddy V, 2014, J ORAL MAXIL SURG, V72, P1756, DOI 10.1016/j.joms.2014.03.015; Alvarez H, 2000, Auris Nasus Larynx, V27, P339, DOI 10.1016/S0385-8146(00)00071-7; AMBRUS PS, 1981, LARYNGOSCOPE, V91, P575, DOI 10.1288/00005537-198104000-00010; Bede SYH, 2016, J CRANIOFAC SURG, V27, pE271, DOI 10.1097/SCS.0000000000002502; Belechri M, 2001, EUR J EPIDEMIOL, V17, P1005, DOI 10.1023/A:1020078522493; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brussoni M, 2012, INT J ENV RES PUB HE, V9, P3134, DOI 10.3390/ijerph9093134; Cai Y, 2017, J EMERG MED, V52, pE129, DOI 10.1016/j.jemermed.2016.10.049; Chen JX, 2014, OTOLARYNG HEAD NECK, V151, P554, DOI 10.1177/0194599814542588; Dispenza C, 2004, INT J PEDIATR OTORHI, V68, P1417, DOI 10.1016/j.ijporl.2004.05.014; Dispenza F, 2009, AURIS NASUS LARYNX, V36, P665, DOI 10.1016/j.anl.2009.02.005; Dubach P, 2008, RHINOLOGY, V46, P342; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Gurkov R, 2008, AM J RHINOL, V22, P613, DOI 10.2500/ajr.2008.22.3239; Hoppe IC, 2014, J CRANIO MAXILL SURG, V42, P1408, DOI 10.1016/j.jcms.2014.04.002; IIZUKA T, 1995, ARCH OTOLARYNGOL, V121, P1366; Lim H, 2017, J CRANIOFAC SURG, V28, P1649, DOI 10.1097/SCS.0000000000003602; Liu C, 2015, INT J PEDIATR OTORHI, V79, P2238, DOI 10.1016/j.ijporl.2015.10.011; Nishioka H, 2018, J PLAST RECONSTR AES, V71, P85, DOI 10.1016/j.bjps.2017.08.022; Oikarinen H, 2009, EUR RADIOL, V19, P1161, DOI 10.1007/s00330-008-1256-7; Ridder Gerd Jurgen, 2002, Ear Nose Throat J, V81, P49; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Soleimani T, 2015, J CRANIO MAXILL SURG, V43, P1979, DOI 10.1016/j.jcms.2015.10.008; Tamada I, 2017, J CRANIOFAC SURG, V28, P84, DOI 10.1097/SCS.0000000000003217; Tien DA, 2016, INT J PEDIATR OTORHI, V91, P27, DOI 10.1016/j.ijporl.2016.10.007; Vyas RM, 2008, J CRANIOFAC SURG, V19, P339, DOI 10.1097/SCS.0b013e31814fb5e3; Wymann NME, 2008, J ORAL MAXIL SURG, V66, P58, DOI 10.1016/j.joms.2007.04.023	28	5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	JAN	2019	276	1					85	91		10.1007/s00405-018-5183-1			7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	HI1JL	WOS:000456201500012	30382396				2022-02-06	
J	Buckley, TA; Oldham, JR; Watson, DJ; Murray, NG; Munkasy, BA; Evans, KM				Buckley, Thomas A.; Oldham, Jessie R.; Watson, Daniel J.; Murray, Nicholas G.; Munkasy, Barry A.; Evans, Kelsey M.			Repetitive Head Impacts in Football Do Not Impair Dynamic Postural Control	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						CONCUSSION; SUBCONCUSSIVE IMPACTS; BALANCE; BIOMECHANICS	GAITRITE(R) WALKWAY SYSTEM; CONTROL DEFICITS; CONCUSSION; GAIT; INJURY; ADJUSTMENTS; PARAMETERS; PLAYERS; COHORT; SEASON	Purpose The purpose of this study was to assess the effect of repetitive head impacts experienced by football players compared to noncontact athletes on dynamic postural control during both single-task (ST) and dual-task (DT) conditions. Methods Thirty-four football players wearing accelerometer instrumented helmets and 13 cheerleaders performed a dynamic postural control battery, consisting of ST and DT gait initiation, gait, and gait termination, both prior to and following the football season. A 2 (group) x 2 (time) repeated measures ANOVA compared performance across 32 dynamic postural outcomes. A linear regression was performed on postural control change scores with common head impact kinematics serving as the independent variables. Results The football players experienced a mean of 538.1 409.1 head impacts in the season with a mean linear acceleration of 27.8g +/- 3.2g. There were no significant interactions for any of the ST or DT dynamic postural control tasks. There was a significant relationship between head impact kinematics and the lateral center of pressure displacement during the anticipatory postural adjustment phase (r(2) = 0.26, P = 0.010) and transitional phase (r(2) = 0.511, P = 0.042) during ST gait initiation. For both measures, the number of impacts exceeding 98g was the only significant predictor of decreased center of pressure displacement. Conclusions A single competitive football season did not adversely affect dynamic postural control when comparing football players to cheerleaders who do not experience repetitive head impacts. Furthermore, there were limited relationships with head impact kinematics suggesting that a single season of football does not adversely affect most outcome measures of instrumented dynamic postural control. These findings are consistent with most studies which fail to identify clinical differences related to repetitive head impacts.	[Buckley, Thomas A.; Oldham, Jessie R.; Watson, Daniel J.] Univ Delaware, Dept Kinesiol & Appl Physiol, 100 Discovery Blvd, Newark, DE 19716 USA; [Buckley, Thomas A.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA; [Watson, Daniel J.] Univ Delaware, Dept Intercollegiate Athlet, Newark, DE 19716 USA; [Murray, Nicholas G.] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Munkasy, Barry A.] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA USA; [Evans, Kelsey M.] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 100 Discovery Blvd, Newark, DE 19716 USA.; Buckley, TA (corresponding author), Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE 19716 USA.	TBuckley@udel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150	National Institute of Health/Neurological Disorders and Stroke [1R15NS070744]	This study was funded, in part, by a grant from the National Institute of Health/Neurological Disorders and Stroke (1R15NS070744). The funding agency had no role in the development of this manuscript or the decision to submit to Medicine and Science in Sports and Exercise.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bazarian J. J, 2014, PLOS ONE, V9; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Buckley TA, 2017, ARCH PHYS MED REHAB, V98, P1962, DOI 10.1016/j.apmr.2017.05.002; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Chang WH, 2010, GAIT POSTURE, V32, P487, DOI 10.1016/j.gaitpost.2010.07.007; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moon Y, 2016, HUM MOVEMENT SCI, V47, P197, DOI 10.1016/j.humov.2016.03.010; Murray NG, 2017, INT J PSYCHOPHYSIOL, V3, P30576; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schmidt JD, 2018, CLIN J SPORT MED, V28, P106, DOI 10.1097/JSM.0000000000000437; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Shumway-Cook A, 2012, MOTOR CONTROL TRANSL; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Vallabhajosula S, 2013, GAIT POSTURE, V37, P280, DOI 10.1016/j.gaitpost.2012.07.018; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005	43	5	6	3	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JAN	2019	51	1					132	140		10.1249/MSS.0000000000001761			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HI3XB	WOS:000456383700017	30138221	Green Accepted, Bronze			2022-02-06	
J	Cetin, A; Deveci, E				Cetin, A.; Deveci, E.			Evaluation of PECAM-1 and p38 MAPK expressions in cerebellum tissue of rats treated with caffeic acid phenethyl ester: a biochemical and immunohistochemical study	FOLIA MORPHOLOGICA			English	Article						traumatic brain injury; cerebellum; PECAM-1; p38 MAPK; rat	CELL-ADHESION MOLECULE-1; ACTIVATED PROTEIN-KINASES; TRAUMATIC BRAIN-INJURY; INFLAMMATORY RESPONSE; REPERFUSION INJURY; ENDOTHELIAL-CELLS; MITOGEN; ISCHEMIA; APOPTOSIS; REGION	Background: This study aimed to investigate the antioxidative and anti-inflammatory effects of caffeic acid phenethyl ester (CAPE) on damage caused to cerebellum tissue by diffuse traumatic head trauma via biochemical, histopathologic, and immuno-histochemical methods. Materials and methods: Male Sprague-Dawley (300-350 g) rats were subjected to traumatic brain injury with a weight-drop device (300 g/1 m weight-height impact). Twenty-four adult rats were randomly divided into three equal groups of 8, including a control group, traumatic brain injury (TBI) group, and TBI + CAPE treatment group (10 mu moL/kg/i.p.). Cerebellum tissue samples taken from anterior lobe from all rats were taken 7 days after traumatic injury and were subjected to biochemical and histopathological analysis, as well as immunohistochemical analysis for platelet endothelial cell adhesion molecule-1 (PECAM-1) and phosphate 38-mitogen-activated protein kinase (p38 MAPK). Results: In the TBI group, the granular layer had dilatation and haemorrhage in the capillary vessels and inflammatory cell infiltration around the periphery of the blood vessels. In the TBI + CAPE group, the small capillaries in the white matter were slightly dilated, there were no inflammatory cells, and dense chromatin/granular cells were observed in the granular layer. Also in the TBI + CAPE group, the Purkinje cells of the ganglion cell layer had ovoid nuclei, were chromatin-rich, and their extensions protruded to the molecular layer. CAPE is thought to regulate inflammation, cell damage, and angiogenetic development by affecting the PECAM-1 and p38 MAPK proteins. Conclusions: These proteins are key modulators of endothelial integrity and neuroinflammation in vessels in response to endothelial damage as well as of the proinflammatory response in the cerebellum in response to traumatic damage.	[Cetin, A.] Univ Hlth Sci, Gazi Yasagil Educ & Res Hosp, Dept Neurosurg, Diyarbakir, Turkey; [Deveci, E.] Dicle Univ, Fac Med, Dept Histol & Embryol, TR-21280 Diyarbakir, Turkey		Deveci, E (corresponding author), Dicle Univ, Fac Med, Dept Histol & Embryol, TR-21280 Diyarbakir, Turkey.	devecie32@hotmail.com		Cetin, Abdurrahman/0000-0002-5246-7652			Aebi H.E., 1983, CATALASE, VIII, P273; Arumugam S, 2018, J CELL PHYSIOL, V233, P3244, DOI 10.1002/jcp.26167; Ayla S, 2018, ACTA HISTOCHEM, V120, P117, DOI 10.1016/j.acthis.2018.01.001; Barateiro A, 2016, MOL NEUROBIOL, V53, P3976, DOI 10.1007/s12035-015-9336-6; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Chen J, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005648; Chen ZM, 2009, ARTERIOSCL THROM VAS, V29, P1067, DOI 10.1161/ATVBAHA.109.186692; Choi JH, 2015, EXP EYE RES, V134, P53, DOI 10.1016/j.exer.2015.03.014; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Deddens LH, 2013, CONTRAST MEDIA MOL I, V8, P393, DOI 10.1002/cmmi.1536; Demeule M, 2001, BIOCHEM BIOPH RES CO, V281, P827, DOI 10.1006/bbrc.2001.4312; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Duan SS, 2015, INT J NEUROSCI, V125, P625, DOI 10.3109/00207454.2014.956101; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Greenwood J, 2002, VASC PHARMACOL, V38, P315, DOI 10.1016/S1537-1891(02)00199-4; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Hu M, 2018, J ENDOCRINOL, V237, P123, DOI 10.1530/JOE-18-0086; Huang CF, 2018, MOL CARCINOGEN, V57, P1300, DOI 10.1002/mc.22844; Hwang IK, 2005, BRAIN RES, V1048, P251, DOI 10.1016/j.brainres.2005.04.049; Kaminska B, 2009, ANAT REC, V292, P1902, DOI 10.1002/ar.21047; Kaur C, 2014, BRAIN STRUCT FUNCT, V219, P151, DOI 10.1007/s00429-012-0491-5; Kerman M, 2012, J MOL HISTOL, V43, P49, DOI 10.1007/s10735-011-9376-9; Kyosseva SV, 2004, INT REV NEUROBIOL, V59, P201; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lertkiatmongkol P, 2016, CURR OPIN HEMATOL, V23, P253, DOI 10.1097/MOH.0000000000000239; Mandyam CD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7100131; Mao LM, 2016, MOL NEUROBIOL, V53, P6309, DOI 10.1007/s12035-015-9535-1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Murohara T, 1996, J IMMUNOL, V156, P3550; Pabon MM, 2016, CNS NEUROSCI THER, V22, P200, DOI 10.1111/cns.12485; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Rose BA, 2017, J BIOL CHEM, V292, P12787, DOI 10.1074/jbc.M117.784553; ROSENBLUM WI, 1994, AM J PATHOL, V145, P33; Roy AR, 2018, METHODS MOL BIOL, V1752, P11, DOI 10.1007/978-1-4939-7714-7_2; Rubinfeld Hadara, 2004, Methods Mol Biol, V250, P1; Sahu V, 2019, CANCER RES TREAT, V51, P313, DOI 10.4143/crt.2018.105; Sari E, 2016, AESTHET SURG J, V36, pNP58, DOI 10.1093/asj/sjv119; Seo TB, 2010, NEUROSCI LETT, V481, P178, DOI 10.1016/j.neulet.2010.06.087; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Sun L, 2018, KIDNEY BLOOD PRESS R, V43, P820, DOI 10.1159/000490136; SUN Y, 1988, CLIN CHEM, V34, P497; Tan J, 2013, J HEART LUNG TRANSPL, V32, P823, DOI 10.1016/j.healun.2013.05.005; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Nguyen V, 2018, CEREBELLUM, V17, P213, DOI 10.1007/s12311-017-0895-0; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Wolters TLC, 2017, J MOL ENDOCRINOL, V59, P129, DOI 10.1530/JME-17-0062; Wu N, 2013, INT J ONCOL, V42, P419, DOI 10.3892/ijo.2012.1729; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiao HL, 2018, MOL MED REP, V17, P4221, DOI [10.3892/mmr.2018.8426, 10.3892/mmr.2018.8527]; XIE Y, 1993, P NATL ACAD SCI USA, V90, P5569, DOI 10.1073/pnas.90.12.5569; Yang GM, 2013, J TRAUMA ACUTE CARE, V74, P1033, DOI 10.1097/TA.0b013e31828586a2; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Zhang JH, 2018, INT J MOL MED, V41, P25, DOI 10.3892/ijmm.2017.3204; Zhang XK, 2018, ONCOL LETT, V15, P9868, DOI 10.3892/ol.2018.8541; Zhang YY, 2018, CANCER LETT, V429, P29, DOI 10.1016/j.canlet.2018.05.004; Zhu JH, 2018, ONCOL LETT, V15, P8761, DOI 10.3892/ol.2018.8363	65	5	5	1	4	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	0015-5659	1644-3284		FOLIA MORPHOL	Folia Morphol.		2019	78	2					221	229	PMID 30543083	10.5603/FM.a2018.0085			9	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	IA8VC	WOS:000469835600001	30543083	gold			2022-02-06	
J	Chang, PP; Tian, YZ; Williams, AM; Bhatti, UF; Li, BL; Li, YQ; Alam, HB				Chang, Panpan; Tian, Yuzi; Williams, Aaron M.; Bhatti, Umar F.; Li, Baoling; Li, Yongqing; Alam, Hasan B.			Inhibition of Histone Deacetylase 6 Protects Hippocampal Cells Against Mitochondria-mediated Apoptosis in a Model of Severe Oxygen-glucose Deprivation	CURRENT MOLECULAR MEDICINE			English	Article						Histone deacetylase 6; oxygen-glucose deprivation; neurons; mitochondria membrane potential; apoptosis; HT22 cells	PLASMA-MEMBRANE DEPOLARIZATION; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; SH-SY5Y CELLS; BRAIN-INJURY; IN-VIVO; KINASE; HDAC6; SURVIVAL; PATHWAY	Background: Histone deacetylase (HDAC) 6 inhibitors have demonstrated significant protective effects in traumatic injuries. However, their roles in neuroprotection and underlying mechanisms are poorly understood. This study sought to investigate the neuroprotective effects of Tubastatin A (Tub-A), an HDAC6 inhibitor, during oxygen-glucose deprivation (OGD) in HT22 hippocampal cells. Methods: HT22 hippocampal cells were exposed to OGD. Cell viability and cytotoxicity were assessed by cell counting kit-8 (CCK-8) and lactate dehydrogenase (LDH) release assay. Cellular apoptosis was assessed by Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Mitochondria membrane potential was detected using JC-1 dye. Expressions of acetylated alpha-tubulin, alpha-tubulin, cytochrome c, VDAC, Bax, Bcl-2, cleaved caspase 3, phosphorylated Akt, Akt, phosphorylated GSK3 and GSK3 beta were analyzed by Western blot analysis. Results: Tub-A induced acetylation of alpha-tubulin, demonstrating appropriate efficacy. Tub-A significantly increased cell viability and attenuated LDH release after exposure to OGD. Furthermore, Tub-A treatment blunted the increase in TUNEL-positive cells following OGD and preserved the mitochondrial membrane potential. Tub-A also attenuated the release of cytochrome c from the mitochondria into the cytoplasm and suppressed the ratio of Bax/Bcl-2 and cleaved caspase 3. This was mediated, in part, by the increased phosphorylation of Akt and GSK3 beta signaling pathways. Conclusion: HDAC 6 inhibition, using Tub-A, protects against OGD-induced injury in HT22 cells by modulating Akt/GSK3 beta signaling and inhibiting mitochondria-mediated apoptosis.	[Chang, Panpan] Peking Univ, Trauma Med Ctr, Peoples Hosp, Beijing, Peoples R China; [Chang, Panpan; Tian, Yuzi; Williams, Aaron M.; Bhatti, Umar F.; Li, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Tian, Yuzi] Cent S Univ, Xiangya Hosp, Dept Rheumatol, Changsha, Hunan, Peoples R China		Li, YQ; Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	yqli@umich.edu; alamh@umich.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM084127]	This study was funded by NIH RO1 GM084127 (HBA).	Bortner CD, 2001, J BIOL CHEM, V276, P4304, DOI 10.1074/jbc.M005171200; Chang PP, 2018, J TRAUMA ACUTE CARE, V84, P795, DOI 10.1097/TA.0000000000001824; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Chuang DM, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00015; Darshit BS, 2016, MOL NEUROBIOL, V53, P6716, DOI 10.1007/s12035-015-9598-z; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Gold WA, 2015, J MOL MED, V93, P63, DOI 10.1007/s00109-014-1202-x; Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Hetman M, 2000, J NEUROSCI, V20, P2567; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jiang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152371; Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385; Jordan Joaquin, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P98; Kaliszczak M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.180; Kichev A, 2014, J BIOL CHEM, V289, P9430, DOI 10.1074/jbc.M113.512350; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Li Z, 2012, CELL MOL NEUROBIOL, V32, P381, DOI 10.1007/s10571-011-9766-2; Li ZY, 2016, NEUROCHEM INT, V99, P239, DOI 10.1016/j.neuint.2016.08.004; Liang JM, 2013, MOLECULES, V18, P12777, DOI 10.3390/molecules181012777; Liu L, 2017, CHEM-BIOL INTERACT, V262, P1, DOI 10.1016/j.cbi.2016.12.001; Malagelada C, 2005, NEUROBIOL DIS, V20, P27, DOI 10.1016/j.nbd.2005.01.028; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Park JH, 2014, NEUROCHEM RES, V39, P1300, DOI 10.1007/s11064-014-1312-4; Prentice H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964518; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Shi YF, 2017, AM J PHYSIOL-RENAL, V312, pF502, DOI 10.1152/ajprenal.00546.2016; Simoes-Pires C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-7; Tang JH, 2018, CLIN SCI, V132, P339, DOI 10.1042/CS20171417; Uchiyama T, 2004, CIRCULATION, V109, P3042, DOI 10.1161/01.CIR.0000130647.29030.90; Wang ZF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19626; Wu CX, 2013, NEUROSCI LETT, V546, P57, DOI 10.1016/j.neulet.2013.04.060; Yin W, 2009, BIOCHEM PHARMACOL, V78, P191, DOI 10.1016/j.bcp.2009.03.025; Zhang J, 2018, BBA-MOL CELL RES, V1865, P172, DOI 10.1016/j.bbamcr.2017.10.007; Zhang L, 2014, J ALZHEIMERS DIS, V41, P1193, DOI 10.3233/JAD-140066; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhao T, 2014, SURGERY, V156, P235, DOI 10.1016/j.surg.2014.03.033; Zhou CF, 2011, NEUROCHEM INT, V59, P749, DOI 10.1016/j.neuint.2011.08.008	52	5	5	2	9	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1566-5240	1875-5666		CURR MOL MED	Curr. Mol. Med.		2019	19	9					673	682		10.2174/1566524019666190724102755			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	JD1JX	WOS:000489732100004	31339071				2022-02-06	
J	Cuff, SC; Coxe, K; Young, JA; Li, HM; Yi, HG; Yang, JZ				Cuff, Steven C.; Coxe, Kathryn; Young, Julie A.; Li, Hongmei; Yi, Honggang; Yang, Jingzhen			Concussion clinic presentation and symptom duration for pediatric sports-related concussions following Ohio concussion law	RESEARCH IN SPORTS MEDICINE			English	Article						Concussion; law; pediatric; symptom duration	TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT VISITS; POSTCONCUSSIVE SYMPTOMS; DIAGNOSIS; CHILDREN; ENCEPHALOPATHY; MANAGEMENT; STATEMENT; IMPACT; LIFE	In 2013, Ohio enacted a law to mitigate consequences of pediatric sports-related concussions. This study aimed to describe changes in clinic visits and symptom duration for pediatric sports-related concussions before and after this law. 3,133 new visits by 2,861 unique patients (10-18years) presenting between April 2012 and April 2015 for sports-related concussions within 30days of injury were included. There were 937 (29.9%), 1,132 (36.1%) and 1,064 (34.0%) concussion visits for pre-law, immediate-post law, and post-law periods, respectively. A greater proportion of concussion visits was observed among females from pre-law to post-law (P<0.0001). No differences were observed across the three periods in symptom scores at injury (P=0.5028) or at first clinic visit (P=0.5686). However, patients presented to concussion clinics significantly earlier (17.6 vs. 22.8 days, P<0.0001) and had quicker recovery (26.5 vs. 40.6days, P<0.0001) post-law than pre-law.	[Cuff, Steven C.; Young, Julie A.] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH USA; [Coxe, Kathryn; Li, Hongmei; Yi, Honggang; Yang, Jingzhen] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, Columbus, OH USA; [Li, Hongmei] Soochow Univ, Med Coll, Dept Epidemiol & Biostat, Sch Publ Hlth, Suzhou, Jiangsu, Peoples R China; [Yi, Honggang] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing, Jiangsu, Peoples R China; [Cuff, Steven C.; Yang, Jingzhen] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA		Cuff, SC (corresponding author), 584 Cty Line Rd W, Westerville, OH 43082 USA.	Steven.Cuff@nationwidechildrens.org	Coxe, Kathryn/AAJ-8041-2021	Coxe, Kathryn/0000-0002-7813-1081			Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blumenfeld RS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00098; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hanson HR, 2013, PEDIATRICS, V132, pE859, DOI 10.1542/peds.2013-1704; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Mackenzie B, 2015, PEDIATR EMERG CARE, V31, P25, DOI 10.1097/PEC.0000000000000325; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miyashita TL, 2016, SPORTS HEALTH, V8, P359, DOI 10.1177/1941738116651856; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Trojian Thomas, 2015, Inj Epidemiol, V2, P2; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	29	5	5	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2019	27	1					11	20		10.1080/15438627.2018.1502186			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HP6MW	WOS:000461799900002	30027763				2022-02-06	
J	Daugherty, JC; Maranon-Murcia, M; Hidalgo-Ruzzante, N; Bueso-Izquierdo, N; Jimenez-Gonzalez, P; Gomez-Medialdea, P; Perez-Garcia, M				Daugherty, Julia C.; Maranon-Murcia, Mar; Hidalgo-Ruzzante, Natalia; Bueso-Izquierdo, Natalia; Jimenez-Gonzalez, Pilar; Gomez-Medialdea, Pilar; Perez-Garcia, Miguel			Severity of neurocognitive impairment in women who have experienced intimate partner violence in Spain	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Intimate partner violence; neuropsychological impairment; women; physical abuse; psychological abuse	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; CONSEQUENCES; VICTIMS; OUTCOMES; SAMPLE	This study examines neuropsychological impairment in women who have experienced intimate partner violence using DSM 5 criteria for mild and severe cognitive impairment. A total of 108 females in Spain were included in one of three groups: psychological abuse (n =24), physical and psychological abuse (n =45), and no-abuse (n =39). There were differences between the control and IPV groups in attention and executive functioning. Furthermore, approximately 25% of women experiencing IPV suffer mild neuropsychological alterations and 5% severe, mostly in memory and executive function domains. This evidence supports the growth in research that suggests psychological violence on its own to be as strongly related to poor health outcomes as physical violence in intimate partner relationships.	[Daugherty, Julia C.; Hidalgo-Ruzzante, Natalia; Bueso-Izquierdo, Natalia; Perez-Garcia, Miguel] Univ Granada CIMCYC UGR, Brain Mind & Behav Res Ctr, Granada, Spain; [Daugherty, Julia C.; Maranon-Murcia, Mar; Bueso-Izquierdo, Natalia; Perez-Garcia, Miguel] Univ Granada UGR, Sch Psychol, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Hidalgo-Ruzzante, Natalia] Univ Granada UGR, Dept Dev & Educ Psychol, Sch Educ, Granada, Spain; [Jimenez-Gonzalez, Pilar; Gomez-Medialdea, Pilar] Asociac Mujeres Apoyo & Def Victimas Malos Tratos, Nongovt Org ACTIVA, Granada, Spain		Hidalgo-Ruzzante, N (corresponding author), Univ Granada CIMCYC UGR, Brain Mind & Behav Res Ctr, Granada, Spain.; Hidalgo-Ruzzante, N (corresponding author), Univ Granada UGR, Dept Dev & Educ Psychol, Sch Educ, Granada, Spain.	nhidalgo@ugr.es	Daugherty, Julia C./Q-8716-2017; Garcia, Miguel Perez/F-9630-2010; Hidalgo-Ruzzante, Natalia/F-1108-2016	Daugherty, Julia C./0000-0002-1221-4394; Garcia, Miguel Perez/0000-0003-4775-7556; Hidalgo-Ruzzante, Natalia/0000-0002-9952-9478; Bueso Izquierdo, Natalia/0000-0002-2469-8867	Caixa Fundacion [CiCInfGenSolcPag31]	This work was supported by Caixa Fundacion who provides financial support to Social Institutions (CiCInfGenSolcPag31).	APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Benedet Alvarez MJ, 1998, TEST APRENDIZAJE VER; Black M. C., 2011, AM J LIFESTYLE MED, V25, P455; Brewin CR, 2007, J ABNORM PSYCHOL, V116, P448, DOI 10.1037/0021-843X.116.3.448; Brickenkamp R, 2002, D2 TEST DE ATENCION; Burgess P, 1996, BEHAV ASSESSMENT DYS; Butchart A, 2014, GLOBAL STATUS REPORT; Delis D.C., 1987, CVLT CALIFORNIA VERB; Delis DC., 2001, DELIS KAPLAN EXECUTI; Echeburua E., 1994, MANUAL VIOLENCIA FAM, P28; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Faugno D, 2013, ADV EMERG NURS J, V35, P314, DOI 10.1097/TME.0b013e3182aa05d3; Fernandez-Gonzalez L, 2017, PSYCHOSOC INTERV, V26, P9, DOI 10.1016/j.psi.2016.10.001; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; GERSON A, 1974, PERCEPT MOTOR SKILL, V39, P95, DOI 10.2466/pms.1974.39.1.95; Heaton RK, 1991, COMPREHENSIVE NORMS; Hooper H. E., 1948, THESIS; Hooper HE., 1983, HOOPER VISUAL ORG TE; Kaufman N. L., 1997, K BIT TEST BREVE INT; Krebs C, 2011, J FAM VIOLENCE, V26, P487, DOI 10.1007/s10896-011-9383-3; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lejuez CW, 2003, EXP CLIN PSYCHOPHARM, V11, P26, DOI 10.1037/1064-1297.11.1.26; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loinaz I, 2012, PSICOTHEMA, V24, P142; Torices MIM, 2018, J FORENSIC PSYCHI PS, V29, P86, DOI 10.1080/14789949.2017.1339106; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Ministry of Health Social Services and Equality (Ministerio de Sanidad Servicios Sociales y Igualdad), 2015, MACR VIOL MUJ 2015; Nathanson AM, 2012, PARTN ABUSE, V3, P59, DOI 10.1891/1946-6560.3.1.59; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; REY A, 1997, TEST COPIA REPRODUCC; Ruiz-Perez I, 2005, PSYCHOSOM MED, V67, P791, DOI 10.1097/01.psy.0000181269.11979.cd; Saddki N, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-268; Schmitz F, 2020, ASSESSMENT, V27, P232, DOI 10.1177/1073191117750470; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sedo MA, 2007, FDT TEST CINCO DIGIT; Strack S., 2010, CORSINI ENCY PSYCHOL, P1; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Symes L, 2014, J CLIN NURS, V23, P2909, DOI 10.1111/jocn.12542; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vives-Cases C, 2011, J PUBLIC HEALTH-UK, V33, P15, DOI 10.1093/pubmed/fdq101; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wolstenholme N, 2010, PROG NEUROL PSYCHIAT, V14, P8, DOI 10.1002/pnp.166; Wong JYH, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-6; Wong JYH, 2014, TRAUMA VIOLENCE ABUS, V15, P22, DOI 10.1177/1524838013496333; World Health Organization, 2016, VIOLENCE AGAINST WOM; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Xu SH, 2013, SOC BEHAV PERSONAL, V41, P477, DOI 10.2224/sbp.2013.41.3.477	51	5	5	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.		2019	30	2					322	340		10.1080/14789949.2018.1546886			19	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	HP5AN	WOS:000461688300009					2022-02-06	
J	Elbogen, EB; Dennis, PA; Van Voorhees, EE; Blakey, SM; Johnson, JL; Johnson, SC; Wagner, HR; Hamer, RM; Beckham, JC; Manly, T; Belger, A				Elbogen, Eric B.; Dennis, Paul A.; Van Voorhees, Elizabeth E.; Blakey, Shannon M.; Johnson, Jacqueline L.; Johnson, Sally C.; Wagner, H. Ryan; Hamer, Robert M.; Beckham, Jean C.; Manly, Tom; Belger, Aysenil			Cognitive Rehabilitation With Mobile Technology and Social Support for Veterans With TBI and PTSD: A Randomized Clinical Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive rehabilitation; emotion regulation; executive function; mobile technology; posttraumatic stress disorder; social support; traumatic brain injury; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; EXECUTIVE FUNCTIONS; OEF/OIF VETERANS; WORKING-MEMORY; METAANALYSIS; ANGER; IRAQ; AFGHANISTAN; PERFORMANCE	Objective: To investigate effects of cognitive rehabilitation with mobile technology and social support on veterans with traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). Participants: There were 112 dyads, comprised by a veteran and a family member or friend (224 participants in total). Design: Dyads were randomized to the following: (1) a novel intervention, Cognitive Applications for Life Management (CALM), involving goal management training plus mobile devices for cueing and training attentional control; or (2) Brain Health Training, involving psychoeducation plus mobile devices to train visual memory. Main Measures: Executive dysfunction (disinhibition, impulsivity) and emotional dysregulation (anger, maladaptive interpersonal behaviors) collected prior to randomization and following intervention completion at 6 months. Results: The clinical trial yielded negative findings regarding executive dysfunction but positive findings on measures of emotion dysregulation. Veterans randomized to CALM reported a 25% decrease in anger over 6 months compared with 8% reduction in the control (B = -5.27, P = .008). Family/friends reported that veterans randomized to CALM engaged in 26% fewer maladaptive interpersonal behaviors (eg, aggression) over 6 months compared with 6% reduction in the control (B = -2.08, P = .016). An unanticipated result was clinically meaningful change in reduced PTSD symptoms among veterans randomized to CALM (P < .001). Conclusion: This preliminary study demonstrated effectiveness of CALM for reducing emotional dysregulation in veterans with TBI and PTSD.	[Elbogen, Eric B.; Dennis, Paul A.; Van Voorhees, Elizabeth E.; Wagner, H. Ryan; Beckham, Jean C.] Vet Affairs VA MidAtlantic Mental Illness Res Edu, Durham, NC USA; [Elbogen, Eric B.; Dennis, Paul A.; Van Voorhees, Elizabeth E.; Wagner, H. Ryan; Beckham, Jean C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Blakey, Shannon M.] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC 27515 USA; [Johnson, Sally C.; Hamer, Robert M.; Belger, Aysenil] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Johnson, Jacqueline L.] Rho Inc, Chapel Hill, NC USA; [Manly, Tom] Univ Cambridge, Dept Neurosci, Cambridge, England		Elbogen, EB (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27705 USA.	eric.elbogen@duke.edu		Blakey, Shannon/0000-0002-9291-3688	Department of DefenseUnited States Department of Defense [W81XWH1110796]; Foundation of Hope [5100678]; Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC); Rehabilitation Research Career Development Award [1IK2RX001298-01A2]; Clinical Sciences Research and Development Senior Research Career Scientist Award from the US Department of Veterans AffairsUS Department of Veterans Affairs [IK6CX001494]; Veterans AffairsUS Department of Veterans Affairs [IK2RX001298, IK6BX003777] Funding Source: NIH RePORTER; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_00005/10, MC_U105559837] Funding Source: UKRI	The authors extend their sincere thanks to the participants who volunteered for this study. The authors also thank their research staff Carolyn Bellion, Alana Campbell, Erin Clevenger, Michelle Cueva, Chelsea Greenburg, Virginia Newton, Mariko Weber, and James Wolfe for coordinating data collection and intervention facilitation throughout the study. Preparation of the manuscript was supported by the Department of Defense (W81XWH1110796), the Foundation of Hope (Project #5100678), the Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), and a Rehabilitation Research Career Development Award #1IK2RX001298-01A2 (E.E.V.) and a Clinical Sciences Research and Development Senior Research Career Scientist Award #IK6CX001494 (J.C.B.) from the US Department of Veterans Affairs.	Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Elbogen EB, 2008, J TRAUMA STRESS, V21, P113, DOI 10.1002/jts.20283; Elbogen Eric B, 2012, J Clin Psychiatry, V73, pe767, DOI 10.4088/JCP.11m07593; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Forbes D, 2004, J TRAUMA STRESS, V17, P249, DOI 10.1023/B:JOTS.0000029268.22161.bd; Forbes D, 2008, J TRAUMA STRESS, V21, P142, DOI 10.1002/jts.20315; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Hart T, 2017, BRAIN INJURY, V31, P297, DOI 10.1080/02699052.2016.1251612; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Lanius RA, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.27313; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lunney CA, 2007, J TRAUMA STRESS, V20, P955, DOI 10.1002/jts.20269; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Shea MT, 2013, BEHAV RES THER, V51, P607, DOI 10.1016/j.brat.2013.05.013; Sippel LM, 2016, PSYCHIAT RES, V243, P421, DOI 10.1016/j.psychres.2016.06.040; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steinhubl SR, 2013, JAMA-J AM MED ASSOC, V310, P2395, DOI 10.1001/jama.2013.281078; Tornas S, 2016, J INT NEUROPSYCH SOC, V22, P436, DOI 10.1017/S1355617715001344; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Tsuchida A, 2009, J COGNITIVE NEUROSCI, V21, P2263, DOI 10.1162/jocn.2008.21172; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Woon FL, 2017, COGN NEUROPSYCHIATRY, V22, P1, DOI 10.1080/13546805.2016.1255603	40	5	5	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		1	10		10.1097/HTR.0000000000000435			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600002	30169439	Bronze, Green Accepted, Green Submitted			2022-02-06	
J	Erbil, G; Sacik, U; Yilmaz, F; Kisaoglu, H; Erbayraktar, Z; Pekcetin, C; Ozogul, C				Erbil, G.; Sacik, U.; Yilmaz, F.; Kisaoglu, H.; Erbayraktar, Z.; Pekcetin, C.; Ozogul, C.			The effect of ferulic acid on experimental traumatic brain damage in rats	BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY			English	Article						ferulic acid; head trauma; hippocampus; prefrontal cortex	ALPHA-LIPOIC ACID; INJURY	AIM: Traumatic brain injury is an important social health problem due to the fact that young adults are more likely to be affected, and advanced functional limitations are observed in survivors. In this study, we aimed to investigate the protective effect of ferulic acid in an experimental trauma model. MATERIAL AND METHODS: This study was performed in March 2016 at Dokuz Eylul University Experimental Animal Laboratory. Subjects were randomly divided into 4 groups Control, Ethyl Alcohol, Trauma, Trauma/Ferulic Acid groups. For histological findings, Cresyl violet; for immunohistochemical analysis, TUNEL and Active Caspase-3 staining were used. For biochemical analysis, Superoxide dismutase, Malondialdehyde, and Glutathione values were examined. RESULTS: The application of ferulic acid has been shown to primarily reduce neuronal apoptosis, the levels of free radicals, and to effect oxidant/antioxidant balance positively by increasing the levels of antioxidants, such as Superoxide dismutase and Glutathione that are developed due to brain damage. Our study group has shown that ferulic acid decreased nerve tissue pathologies after generated brain trauma compared to injury groups. CONCLUSION: Addition of ferulic acid to the traditional head trauma treatment has the strength, and ability to increase the rate, and percentage of healing	[Erbil, G.; Sacik, U.; Yilmaz, F.; Kisaoglu, H.; Pekcetin, C.] Dokuz Eylul Univ, Fac Med, Dept Histol & Embryol, TR-35340 Izmir, Turkey; [Erbayraktar, Z.] Dokuz Eylul Univ, Fac Med, Dept Biochem, Izmir, Turkey; [Ozogul, C.] Univ Kyrenia, Fac Med, Dept Histol & Embryol, Kyrenia, Northern Cyprus, Turkey		Yilmaz, F (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Histol & Embryol, TR-35340 Izmir, Turkey.	drfilizyilmaz@gmail.com	yilmaz, filiz/ABG-5860-2021; erbil, guven/ABB-6661-2021	yilmaz, filiz/0000-0003-0505-3905; 			Davis A E, 2000, Crit Care Nurs Q, V23, P1; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Girotti AW, 1998, J LIPID RES, V39, P1529; Koh PO, 2013, NEUROSCI LETT, V555, P7, DOI 10.1016/j.neulet.2013.09.001; Krbila S, 2013, BRATISL MED J, V114, P696, DOI 10.4149/BLL_2013_147; Mancuso C, 2014, FOOD CHEM TOXICOL, V65, P185, DOI 10.1016/j.fct.2013.12.024; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Ojha S, 2015, DRUG DES DEV THER, V9, P5499, DOI 10.2147/DDDT.S90616; Ozbal S, 2015, BIOTECH HISTOCHEM, V90, P206, DOI 10.3109/10520295.2014.977950; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saba M, 1997, J UROLOGY, V157, P1149, DOI 10.1016/S0022-5347(01)65158-9; SANDEL ME, 1998, ARCH PHYS MED REHA S, V79, pS; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sivak S, 2016, BRATISL MED J, V117, P22, DOI 10.4149/BLL_2016_005; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Sung JH, 2014, NEUROSCI LETT, V566, P88, DOI 10.1016/j.neulet.2014.02.040; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Tugyan K, 2013, NEUROSCI LETT, V533, P28, DOI 10.1016/j.neulet.2012.10.004; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Vural M, 2012, MED J BAKIRKOY, V8, P53, DOI 10.5350/BTDMJB201208201; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; WHYTE J, 1998, REHABILITATION MED P, P1191; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263; Zhao ZH, 2004, J NUTR, V134, P3083, DOI 10.1093/jn/134.11.3083	27	5	5	1	3	COMENIUS UNIV	BRATISLAVA I	SCH MEDICINE, SPITALSKA 24, BRATISLAVA I, SK-813 72, SLOVAKIA	0006-9248	1336-0345		BRATISL MED J	Bratisl. Med. J.		2019	120	5					372	379		10.4149/BLL_2019_061			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HZ0KJ	WOS:000468529200009	31113201	gold			2022-02-06	
J	Hubbard, R; Stringer, G; Peterson, K; Carneiro, MRFV; Finnoff, JT; Savica, R				Hubbard, Ryan; Stringer, Gene; Peterson, Ken; Carneiro, Mario Roberto Filho Vaz; Finnoff, Jonathan T.; Savica, Rodolfo			The King-Devick test in mixed martial arts: the immediate consequences of knock-outs, technical knock-outs, and chokes on brain functions	BRAIN INJURY			English	Article						Concussion; brain injury; King-Devick; mixed martial arts	VISUAL SCREENING TOOL; AMATEUR RUGBY UNION; BLOOD-FLOW; CONCUSSION; SPORT; ZURICH; LEAGUE	The aim of this prospective cohort study was to determine the effect of an event,' defined as a knock-out (KO), technical knock-out (TKO), choke, or submission, on King-Devick (K-D) test times in mixed martial arts (MMA) athletes. MMA athletes (28.3 +/- 6.6 years, n = 92) underwent K-D testing prior to and following a workout or match. Comparison of baseline and post-workout/match K-D times to assess any significant change. K-D tests worsened (longer) in a majority of athletes following an event' (N = 21) (49.6 +/- 7.8 s vs 46.6 +/- 7.8 s, p = 0.0156, Wilcoxon signed-rank test). K-D tests improved (shorter) following a standard workout or match in which no event' occurred in a majority of cases (n = 69) (44.2 +/- 7.2 s vs 49.2 +/- 10.9 s, p = <0.0001, Wilcoxon signed-rank test). Longer duration (worsening) of post-match K-D tests occurred in most athletes sustaining an event'; K-D tests shortened (improved) in a majority of athletes not sustaining an event'. Our study suggests MMA athletes suffering an event' may have sustained a brain injury similar to a concussion.	[Hubbard, Ryan] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Stringer, Gene; Peterson, Ken] Minnesota Combat Sports Commiss, St Paul, MN USA; [Carneiro, Mario Roberto Filho Vaz] Mario Roberto Jiu Jitsu Acad, Rochester, MN USA; [Finnoff, Jonathan T.] Mayo Clin, Sports Med Ctr, Dept Phys Med, Minneapolis, MN USA; [Finnoff, Jonathan T.] Mayo Clin, Sports Med Ctr, Dept Rehabil, Minneapolis, MN USA; [Savica, Rodolfo] Mayo Clin, Dept Neurol & Hlth Sci Res, Rochester, MN USA		Savica, R (corresponding author), Dept Neurol, 8W Gonda Bldg,200 1st ST SW, Rochester, MN 55905 USA.	savica.rodolfo@mayo.edu			Mayo Clinic Institutional Funds	Research was supported by Mayo Clinic Institutional Funds. Preliminary research was presented at the American Academy of Neurology 2016 Sports Concussion Conference Annual Assembly in Chicago, IL, USA. This research has not been previously published or submitted for publication. No authors involved in this study have any financial interests to disclose.	Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DENK W, 1990, Z RECHTSMED, V103, P369, DOI 10.1007/BF01263042; DHAWAN P, 2014, NEUROLOGY S, V10, pS11, DOI DOI 10.1212/WNL.0000000000000513; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Heitger M., 2008, C P IEEE ENG MED BIO; Holmes B, 2009, HADAKAJIME AIR BLOOD; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marinides Zoe, 2015, Neurol Clin Pract, V5, P25, DOI 10.1212/CPJ.0000000000000060; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Pusateri ME, 2018, CURR SPORT MED REP, V17, P26, DOI 10.1249/JSR.0000000000000444; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Raynowska J., 2015, ANN SPORTS MED RES, V2, P1051; Spradley B, 2014, SPORT J; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thoma RJ, 2015, BRAIN INJURY, V29, P633, DOI 10.3109/02699052.2014.999352; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07	31	5	5	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					349	354		10.1080/02699052.2018.1553068			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400010	30507317				2022-02-06	
J	Li, ZG; Yang, HF; Wang, GL; Han, XQ; Zhang, SP				Li, Zhigang; Yang, Haifeng; Wang, Guangliang; Han, Xiaoqiang; Zhang, Shaopeng			Compressive properties and constitutive modeling of different regions of 8-week-old pediatric porcine brain under large strain and wide strain rates	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Traumatic brain injury (TBI); Pediatric porcine brain; Compressive material properties; Brain region; Strain rate; Constitutive modeling	MECHANICAL CHARACTERIZATION; HEAD IMPACT; TISSUE; BEHAVIOR; INJURY; SHEAR; VALIDATION; CHILD; STEM	Porcine head is often used as a human surrogate in traumatic head injury research. Extensive research on mechanical properties of adult human/porcine brain tissues has been performed previously; however, very limited data is available for children, which is particular important for modeling the pediatric traumatic brain injury (TBI). In this study, uniaxial compression tests at strain rates of 0.01/s, 1/s and 50/s up to 50% strain were performed for the corona radiata, corpus callosum, thalamus, cortex, cerebellum and brainstem of 8-week-old piglets. No significant difference in tissue strength was found among the cerebrum regions of cortex, thalamus, corona radiata and corpus callosum. The average stress of cerebellum was approximate 21% and 15% higher than that of cerebrum at a strain of 0.25 and 0.5, respectively, but it did not reach statistical significant level than most of the cerebrum regions. Brainstem was the stiffest among these 6 regions, and it was significant stiffer than most regions of cerebrum, with average stress of about 28% and 40% higher at a strain of 0.25 and 0.5, respectively. The strengths of all these three regions showed significant strain-rate dependent characteristics, with the strain rate increasing from 0.01/s to 50/s, the average stress of cerebrum, cerebellum and brainstem increased to approximate 4.6, 6.3 and 6.3 times, respectively at a strain of 0.25; and increased to approximate 1.9, 2.6, and 2.5 times, respectively at a strain of 0.5. One-term Ogden model was used to fit the experimental data to obtain the material parameters and numerical simulation was performed on the compression of cerebrum specimen. Results show that the constitutive model and the calibrated parameters can well represent the compressive behavior of the brain tissue at different strain rates. The results of this study are useful for developing biofidelic pediatric brain FE models and further predict the brain injuries under impact conditions.	[Li, Zhigang; Yang, Haifeng; Wang, Guangliang; Han, Xiaoqiang; Zhang, Shaopeng] Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing 100044, Peoples R China		Li, ZG (corresponding author), Beijing Jiaotong Univ, Sch Mech Elect & Control Engn, Beijing 100044, Peoples R China.	zgli@bjtu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51505024]; Fundamental Research Funds for the Central Universities, ChinaFundamental Research Funds for the Central Universities [2017JBM041]	This study was supported by the National Natural Science Foundation of China (Grant No. 51505024) and the Fundamental Research Funds for the Central Universities, China (Grant No. 2017JBM041). The authors would thank Guoyang Li from Tsinghua University and Xiaoming Wang from TA Instruments for their assistances in compression test. The authors also would like to express their appreciation to Dr. Xin Jin from Wayne State University for the design of cutting tools and some valuable discussions.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Bilston LE, 2001, BIORHEOLOGY, V38, P335; CDC, 2006, CHILD PASS SAF FACT; Chatelin S, 2012, J MECH BEHAV BIOMED, V6, P166, DOI 10.1016/j.jmbbm.2011.09.013; Coats B, 2007, STAPP CAR CRASH JO, V51, P1; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Elkin B S, 2010, J BIOMECHANICAL ENG, V132, P1; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Fan H., 2014, P WSU 75 ANN S INJ B; Franklyn Melanie, 2007, Critical Reviews in Biomedical Engineering, V35, P197; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Hrapko M, 2006, BIORHEOLOGY, V43, P623; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Li K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123506; Li ZG, 2016, J MECH BEHAV BIOMED, V60, P557, DOI 10.1016/j.jmbbm.2016.03.021; Li ZG, 2013, COMPUT METH PROG BIO, V112, P309, DOI 10.1016/j.cmpb.2013.05.008; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Mao HJ, 2013, COMPUT METHOD BIOMEC, V16, P271, DOI 10.1080/10255842.2011.617005; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Nicolle S., 2004, SAE TECHNICAL PAPER; Ogden R.W., 1997, NONLINEAR ELASTIC DE; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Prange M., 2000, SAE TECHNICAL PAPER; Prange M.T., 2002, THESIS; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Roth S, 2007, INT J LEGAL MED, V121, P223, DOI 10.1007/s00414-006-0129-3; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; [阮世捷 Ruan Shijie], 2012, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V31, P502; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Takhounts EG, 2003, SAE TECHNICAL PAPER; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Tsai WC, 2004, J CLIN NEUROSCI, V11, P126, DOI 10.1016/S0967-5868(03)00156-5; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Viano D, 1997, ACCIDENT ANAL PREV, V29, P811, DOI 10.1016/S0001-4575(97)00050-X; Zhao H, 2016, MED SCI MONIT BASIC, V22, P6, DOI 10.12659/MSMBR.896368	40	5	5	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2019	89						122	131		10.1016/j.jmbbm.2018.09.010			10	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GZ1JT	WOS:000449125100015	30268868				2022-02-06	
S	Lopez-Vales, R; David, S		Trostchansky, A; Rubbo, H		Lopez-Vales, Ruben; David, Samuel			Bioactive Lipids in Inflammation After Central Nervous System Injury	BIOACTIVE LIPIDS IN HEALTH AND DISEASE	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Eicosanoids; Inflammation; Resolution; Specialized pro-resolving mediators; Neurotrauma	SPINAL-CORD-INJURY; PROSTAGLANDIN-D SYNTHASE; PHOSPHOLIPASE A(2) SUPERFAMILY; PRO-RESOLVING MEDIATORS; PGE(2) EP2 RECEPTOR; LEUKOTRIENE B-4; DP1 RECEPTOR; BRAIN-INJURY; EMERGING ROLES; MICE DEFICIENT	Despite the progress made over the last decades to understand the mechanisms underlying tissue damage and neurological deficits after neurotrauma, there are currently no effective treatments in the clinic. It is well accepted that the inflammatory response in the CNS after injury exacerbates tissue loss and functional impairments. Unfortunately, the use of potent anti-inflammatory drugs, such as methylprednisolone, fails to promote therapeutic recovery and also gives rise to several undesirable side effects related to immunosuppression. The injury-induced inflammatory response is complex, and understanding the mechanisms that regulate this inflammation is therefore crucial in the quest to develop effective treatments. Bioactive lipids have emerged as potent molecules in controlling the initiation, coordination, and resolution of inflammation and in promoting tissue repair and recovery of homeostasis. These bioactive lipids are produced by cells involved in the inflammatory response, and their defective synthesis leads to persistent chronic inflammation, tissue damage, and fibrosis. The present chapter discusses recent evidence for the role of some of these bioactive lipids, in particular, eicosanoid and pro-resolving lipid mediators, in the regulation of inflammation after neurotrauma and highlights the therapeutic potential of some of these lipids in enhancing neurological outcomes after CNS injuries.	[Lopez-Vales, Ruben] Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Biol Cellular Fisiol & Immunol, Inst Neurociencies, Barcelona, Catalonia, Spain; [David, Samuel] McGill Univ, Ctr Hlth, Res Inst, Ctr Res Neurosci, Montreal, PQ, Canada		Lopez-Vales, R (corresponding author), Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Dept Biol Cellular Fisiol & Immunol, Inst Neurociencies, Barcelona, Catalonia, Spain.	ruben.lopez@uab.cat	Lopez-Vales, Ruben/E-2150-2011	Lopez-Vales, Ruben/0000-0001-7615-9550			Ahmad AS, 2010, AGE, V32, P271, DOI 10.1007/s11357-010-9135-y; Ahmad AS, 2005, BRAIN RES, V1066, P71, DOI 10.1016/j.brainres.2005.10.068; Ahmad AS, 2006, TOXICOL SCI, V89, P265, DOI 10.1093/toxsci/kfj022; Ahmad M, 2006, EUR J NEUROSCI, V23, P35, DOI 10.1111/j.1460-9568.2005.04540.x; Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Andreasson K, 2010, PROSTAG OTH LIPID M, V91, P104, DOI 10.1016/j.prostaglandins.2009.04.003; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Bilak M, 2004, ANN NEUROL, V56, P240, DOI 10.1002/ana.20179; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Caughey GE, 1997, J IMMUNOL, V158, P351; Chen XG, 2018, DRUG DES DEV THER, V12, P2389, DOI 10.2147/DDDT.S154814; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Dalli J, 2018, CURR OPIN IMMUNOL, V50, P48, DOI 10.1016/j.coi.2017.10.007; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; David S, 2018, J NEUROIMMUNOL, V321, P97, DOI 10.1016/j.jneuroim.2018.06.003; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; David S, 2012, CELL TISSUE RES, V349, P249, DOI 10.1007/s00441-012-1430-8; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; Dunn HC, 2015, J ALZHEIMERS DIS, V43, P893, DOI 10.3233/JAD-141335; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Frisen J, 2016, ANNU REV CELL DEV BI, V32, P127, DOI 10.1146/annurev-cellbio-111315-124953; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Greenhalgh AD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005264; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Gu JQ, 2018, LAB INVEST, V98, P715, DOI 10.1038/s41374-018-0031-x; Hapak SM, 2018, TRENDS MOL MED, V24, P615, DOI 10.1016/j.molmed.2018.05.007; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hayaishi O, 2002, NEUROSCIENTIST, V8, P12, DOI 10.1177/107385840200800105; Hilton BJ, 2017, NEUROSCI LETT, V652, P3, DOI 10.1016/j.neulet.2016.12.004; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Ikeda-Matsuo Y, 2006, P NATL ACAD SCI USA, V103, P11790, DOI 10.1073/pnas.0604400103; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; Kalyvas A, 2009, BRAIN, V132, P1221, DOI 10.1093/brain/awp002; Kanaoka Y, 2000, EUR J BIOCHEM, V267, P3315, DOI 10.1046/j.1432-1327.2000.01362.x; Kantarci A, 2018, EXP NEUROL, V300, P111, DOI 10.1016/j.expneurol.2017.11.005; Kasikara C, 2018, J CLIN INVEST, V128, P2713, DOI 10.1172/JCI97950; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; KEMPSKI O, 1987, STROKE, V18, P111, DOI 10.1161/01.STR.18.1.111; Kerr BJ, 2008, GLIA, V56, P436, DOI 10.1002/glia.20630; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Liang XB, 2005, J NEUROSCI, V25, P10180, DOI 10.1523/JNEUROSCI.3591-05.2005; Liang XB, 2008, ANN NEUROL, V64, P304, DOI 10.1002/ana.21437; Lim SN, 2013, NEUROBIOL DIS, V51, P104, DOI 10.1016/j.nbd.2012.10.021; Lim SN, 2010, PROSTAG LEUKOTR ESS, V83, P193, DOI 10.1016/j.plefa.2010.08.003; Liu D, 2005, ANN NEUROL, V57, P758, DOI 10.1002/ana.20461; Liu M, 2009, NEUROSCIENCE, V163, P296, DOI 10.1016/j.neuroscience.2009.06.027; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Lopez-Vales R, 2008, BRAIN, V131, P2620, DOI 10.1093/brain/awn188; Lopez-Vales R, 2011, FASEB J, V25, P4240, DOI 10.1096/fj.11-183186; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; McCullough L, 2004, J NEUROSCI, V24, P257, DOI 10.1523/JNEUROSCI.4485-03.2004; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Mohri I, 2007, J NEUROPATH EXP NEUR, V66, P469, DOI 10.1097/01.jnen.0000240472.43038.27; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; Pereira MP, 2006, J CEREBR BLOOD F MET, V26, P218, DOI 10.1038/sj.jcbfm.9600182; Redensek A, 2011, GLIA, V59, P603, DOI 10.1002/glia.21128; Resnick D K, 2001, Spine J, V1, P432, DOI 10.1016/S1529-9430(01)00130-9; Rocha PN, 2003, SPRINGER SEMIN IMMUN, V25, P215, DOI 10.1007/s00281-003-0132-4; Saleem S, 2007, EUR J NEUROSCI, V26, P73, DOI 10.1111/j.1460-9568.2007.05627.x; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sobrado M, 2009, J NEUROSCI, V29, P3875, DOI 10.1523/JNEUROSCI.5529-08.2009; Tabuchi S, 2003, ACT NEUR S, V86, P169; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tager AM, 2003, PROSTAG LEUKOTR ESS, V69, P123, DOI 10.1016/S0952-3278(03)00073-5; Takadera T, 2002, NEUROSCI LETT, V317, P61, DOI 10.1016/S0304-3940(01)02449-1; Thura M, 2009, EXP NEUROL, V219, P481, DOI 10.1016/j.expneurol.2009.06.019; Titsworth WL, 2009, GLIA, V57, P1521, DOI 10.1002/glia.20867; Urade Y, 1985, Adv Prostaglandin Thromboxane Leukot Res, V15, P549; Vasquez Alexis M., 2018, Advances in Biological Regulation, V67, P212, DOI 10.1016/j.jbior.2017.10.009; Wang X., 2015, ALZHEIMERS DEMENT, V11, pe41; WONG A, 1991, BIOCHEMISTRY-US, V30, P9346, DOI 10.1021/bi00102a030; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Zarruk JG, 2018, EXP NEUROL, V301, P120, DOI 10.1016/j.expneurol.2017.08.011	100	5	5	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0065-2598	2214-8019	978-3-030-11488-6; 978-3-030-11487-9	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2019	1127						181	194		10.1007/978-3-030-11488-6_12	10.1007/978-3-030-11488-6		14	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine	BM9TZ	WOS:000471743300013	31140179				2022-02-06	
J	Lu, LH; Reid, MW; Cooper, DB; Kennedy, JE				Lu, Lisa H.; Reid, Matthew W.; Cooper, Douglas B.; Kennedy, Jan E.			Sleep problems contribute to post-concussive symptoms in service members with a history of mild traumatic brain injury without posttraumatic stress disorder or major depressive disorder	NEUROREHABILITATION			English	Article						Concussion; sports; combat; blast; insomnia; sleep apnea; psychiatry; primary care; stress; dysthymia	PTSD; VETERANS; DISTURBANCES; PREVALENCE; TBI; POSTCONCUSSION; POLYTRAUMA; MILITARY; SEQUELAE	BACKGROUND: Many with a history of mild traumatic brain injury (TBI) experience sleep problems, which are also common symptoms of stress-related and mood disorders. OBJECTIVE: To determine if sleep problems contributed unique variance to post-concussive symptoms above and beyond symptoms of posttraumatic stress disorder/major depressive disorder (PTSD/MDD) after mild TBI. METHODS: 313 active duty service members with a history of mild TBI completed sleep, PTSD, and mood symptom questionnaires, which were used to determine contributions to the Neurobehavioral Symptom Inventory. RESULTS: 59% of the variance in post-concussive symptoms were due to PTSD symptom severity while depressive symptoms and sleep problems contributed an additional 1% each. This pattern differed between those with and without clinical diagnosis of PTSD/MDD. For those with PTSD/MDD, PTSD and depression symptoms but not sleep contributed to post-concussive symptoms. For those without PTSD/MDD, PTSD symptoms and sleep contributed specifically to somatosensory post-concussive symptoms. Daytime dysfunction and sleep disturbances were associated with post-concussive symptoms after PTSD and depression symptoms were controlled. CONCLUSIONS: PTSD symptom severity explained the most variance for post-concussive symptoms among service members with a history of mild TBI, while depression symptoms, daytime dysfunction, and sleep disturbances independently contributed small amounts of variance.	[Lu, Lisa H.; Reid, Matthew W.; Kennedy, Jan E.] Brooke Army Med Ctr, Def & Vet Brain Injury Ctr, Jbsa Ft Sam Houston, TX USA; [Lu, Lisa H.; Reid, Matthew W.; Cooper, Douglas B.; Kennedy, Jan E.] Gen Dynam Informat Technol, San Antonio, TX USA; [Cooper, Douglas B.] South Texas Vet Hlth Care Syst, Def & Vet Brain Injury Ctr, San Antonio, TX USA		Lu, LH (corresponding author), Brooke Army Med Ctr, Gen Dynam Hlth Solut, Neurol Serv DVBIC, Def & Vet Brain Injury Ctr DVBIC, 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 USA.	lisa.h.lu.ctr@mail.mil	Reid, Matthew/AAO-8870-2020		Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs [W91YTZ-13-C-0015]	Funding for all authors were received from the Defense and Veterans Brain Injury Center (W91YTZ-13-C-0015 25Mar2019).	ADAM K, 1983, CLIN SCI, V65, P561, DOI 10.1042/cs0650561; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; DeGutis J, 2018, BEHAV SLEEP MED, V16, P38, DOI 10.1080/15402002.2016.1173550; Department of Veterans Affairs, 2019, VA DOD CLIN PRACT GU; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holcomb EM, 2016, J HEAD TRAUMA REHAB, V31, P108, DOI 10.1097/HTR.0000000000000206; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King PR, 2017, J PSYCHOSOM RES, V96, P60, DOI 10.1016/j.jpsychores.2017.03.012; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lind MJ, 2017, J CLIN SLEEP MED, V13, P291, DOI 10.5664/jcsm.6466; Martindale SL, 2017, NEUROPSYCHOLOGY, V31, P93, DOI 10.1037/neu0000312; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Norris FH, 2003, ASSESSING PSYCHOL TR, Vsecond, P63; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2016, J NEUROTRAUM, V33, P2125, DOI 10.1089/neu.2015.4320; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P426, DOI 10.1080/23279095.2016.1172229; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F.W., 1993, 9 ANN C ISTSS; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003	37	5	5	1	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2019	44	4					511	521		10.3233/NRE-192702			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IK4NR	WOS:000476564100005	31256090	Green Published, hybrid			2022-02-06	
J	Naguy, A; Al-Enezi, N				Naguy, Ahmed; Al-Enezi, Najah			Lamotrigine Uses in Psychiatric Practice	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						lamotrigine; psychiatric uses	OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN REUPTAKE INHIBITORS; BORDERLINE PERSONALITY-DISORDER; LITHIUM MAINTENANCE TREATMENT; CONTROLLED 18-MONTH TRIAL; DOUBLE-BLIND; BIPOLAR DISORDER; DEPERSONALIZATION DISORDER; RESISTANT SCHIZOPHRENIA; MOOD DISORDERS	Background: Lamotrigine (LAM), an antiepileptic, with panoply of indications and uses in neurology, is FDA approved, in psychiatry, for bipolar prophylaxis. Apart from this indication, trend of its use in psychiatry is on the rise addressing a multitude of disorders. Study Question: LAM remains one of only few psychotropic drugs with antiglutamate activity. This might render LAM a potential therapeutic option in treatment-resistant major psychiatric disorders. We reviewed LAM pharmacology and its diverse indications while examining the extant evidence. Methods: EMBASE, Ovid MEDLINE, PubMed, Scopus, Web of Science, and Cochrane Database of Systemic Reviews were searched for all relevant studies up to date of June 2016. Results: Sound evidence supports use of LAM for acute bipolar depression and prophylaxis, treatment-resistant schizophrenia, treatment-resistant obsessive-compulsive disorder, posttraumatic stress disorder, depersonalization disorder, and affective dysregulation and behavioral dyscontrol domains of borderline personality disorder. Less compelling evidence is present for use in behavioral and psychological symptoms of dementia and neuropsychiatric sequelae of traumatic brain injury. No evidence supports use in autism spectrum disorder or acute unipolar depression. Conclusions: LAM is an important addition to the psychopharmacological armamentarium. Level of evidence supporting the use of LAM in off-label indications is highly variable, and hence, sound clinical judgment is necessary for its proper use and placement in real-life psychiatric practice and psychopharmacotherapy algorithms.	[Naguy, Ahmed] KCMH, Al Manara CAP Ctr, Shuwaikh, Kuwait; [Al-Enezi, Najah] KCMH, Emergency Psychiat Dept, Shuwaikh, Kuwait		Naguy, A (corresponding author), KCMH, Al Manara CAP Ctr, Jamal Abdul Nassir St, Safat 13041, Kuwait.	ahmednagy@hotmail.co.uk	Naguy, Ahmed/I-9879-2016	Naguy, Ahmed/0000-0002-6465-456X			Aliyev NA, 2011, J CLIN PSYCHOPHARM, V31, P61, DOI 10.1097/JCP.0b013e31820428e1; Arrojo- Romero M, 2013, CASE REP PSYCHIAT, V2013; Aulakh JS, 2005, J GERIATR PSYCH NEUR, V18, P8, DOI 10.1177/0891988704271762; Barbosa L, 2003, J CLIN PSYCHIAT, V64, P403, DOI 10.4088/JCP.v64n0407; Belsito KM, 2001, J AUTISM DEV DISORD, V31, P175, DOI 10.1023/A:1010799115457; Besag FMC, 1998, J INTELL DISABIL RES, V42, P50; Besag FMC, 2000, CNS DRUGS, V13, P21, DOI 10.2165/00023210-200013010-00003; Bowden CL, 2003, ARCH GEN PSYCHIAT, V60, P392, DOI 10.1001/archpsyc.60.4.392; Bruno A, 2012, J PSYCHOPHARMACOL, V26, P1456, DOI 10.1177/0269881111431751; Calabrese JR, 2003, J CLIN PSYCHIAT, V64, P1013, DOI 10.4088/JCP.v64n0906; Calabrese JR, 2002, J CLIN PSYCHIAT, V63, P1012, DOI 10.4088/JCP.v63n1110; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Devarajan S, 2000, AM J PSYCHIAT, V157, P1178, DOI 10.1176/appi.ajp.157.7.1178; Erfurth A, 1998, NEUROPSYCHOBIOLOGY, V38, P204, DOI 10.1159/000026540; Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; Hermle L, 2012, THER ADV PSYCHOPHARM, V2, P199, DOI 10.1177/2045125312451270; Hertzberg MA, 1999, BIOL PSYCHIAT, V45, P1226, DOI 10.1016/S0006-3223(99)00011-6; Kanner Andres M, 2004, Epilepsy Curr, V4, P206, DOI 10.1111/j.1535-7597.2004.04515.x; Kato K, 2012, CLIN NEUROPSYCHOPHAR, V3, P15; Khalkhali Mohammadrasoul, 2016, Iran J Psychiatry, V11, P104; Kozaric-Kovacic D, 2013, CLIN NEUROPHARMACOL, V36, P94, DOI 10.1097/WNF.0b013e318288a7d3; Kubagawa Tetsuji, 2015, No To Hattatsu, V47, P289; Kumandas S, 2001, BRAIN DEV-JPN, V23, P240, DOI 10.1016/S0387-7604(01)00191-7; Kumar TCR, 2000, AUST NZ J PSYCHIAT, V34, P527, DOI 10.1080/j.1440-1614.2000.0751c.x; Leiberich P, 2008, J PSYCHOPHARMACOL, V22, P805, DOI 10.1177/0269881107084004; Lieb K, 2010, BRIT J PSYCHIAT, V196, P4, DOI 10.1192/bjp.bp.108.062984; Moore JL, 2012, EXPERT OPIN PHARMACO, V13, P1213, DOI 10.1517/14656566.2012.665875; Naguy A, 2016, J CHILD ADOL PSYCHOP, V26, P769, DOI 10.1089/cap.2015.0083; Nolen WA, 2000, ACTA NEUROPSYCHIATR, V12, P122, DOI 10.1017/S0924270800035572; Ohnuma T, 2013, ASIA-PAC PSYCHIAT, V5, P336, DOI 10.1111/j.1758-5872.2012.00225.x; Oncu B, 2014, J PSYCHOPHARMACOL, V28, P282, DOI 10.1177/0269881113493365; Pachet A, 2003, BRAIN INJURY, V17, P715, DOI 10.1080/0269905031000110445; Pallanti S, 2014, EUR NEUROPSYCHOPHARM, V24, P375, DOI 10.1016/j.euroneuro.2013.12.003; PECK AW, 1991, EPILEPSIA, V32, pS9, DOI 10.1111/j.1528-1157.1991.tb05883.x; Premkumar TS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005962; Preston GA, 2004, J AFFECT DISORDERS, V79, P297, DOI 10.1016/S0165-0327(02)00358-0; Rubio G, 2006, BIPOLAR DISORD, V8, P289, DOI 10.1111/j.1399-5618.2006.00292.x; Showalter PEC, 2000, BRAIN INJURY, V14, P997; Sierra M, 2003, J PSYCHOPHARMACOL, V17, P103, DOI 10.1177/0269881103017001712; Sierra M, 2006, CLIN NEUROPHARMACOL, V29, P253, DOI 10.1097/01.WNF.0000228368.17970.DA; Simms KM, 2012, NEUROLOGY, V78, P921, DOI 10.1212/WNL.0b013e31824c4634; Subodh NB, 2011, PRIM CARE COMPANION, V13; Suzuki H, 2015, PSYCHOGERIATRICS, V15, P32, DOI 10.1111/psyg.12085; Tiihonen J, 2009, SCHIZOPHR RES, V109, P10, DOI 10.1016/j.schres.2009.01.002; Tritt K, 2005, J PSYCHOPHARMACOL, V19, P287, DOI 10.1177/0269881105051540; ULDALL P, 1993, NEUROPEDIATRICS, V24, P339, DOI 10.1055/s-2008-1071568; UVEBRANT P, 1994, NEUROPEDIATRICS, V25, P284, DOI 10.1055/s-2008-1073041; Uzun O, 2010, J PSYCHOPHARMACOL, V24, P425, DOI 10.1177/0269881108098809; Werz Mary Ann, 2008, Ther Clin Risk Manag, V4, P1035; Zoccali R, 2007, SCHIZOPHR RES, V93, P109, DOI 10.1016/j.schres.2007.02.009	51	5	6	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	JAN-FEB	2019	26	1					E96	E102		10.1097/MJT.0000000000000535			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	HX9RO	WOS:000467746200014	30601211				2022-02-06	
J	Ndung'u, A; Sun, J; Musau, J; Ndirangu, E				Ndung'u, Anthony; Sun, Jared; Musau, Joan; Ndirangu, Eunice			Patterns and outcomes of paediatric trauma at a tertiary teaching hospital in Kenya	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Medical specialty; Clinical finding; Human activity in medical context	MIDDLE-INCOME COUNTRIES; CARE; INJURY	Introduction: Trauma continues to be a major cause of morbidity and mortality especially in the paediatric population of low- and middle-income countries such as Kenya. The aim of this study was to establish the profile and outcomes of admitted paediatric trauma cases at the Aga Khan University Hospital, Nairobi. Methods: This retrospective, descriptive study involved a 12-month chart review (January 2016-December 2016). A total of 218 records were identified of which 144 were reviewed. Results: Most injuries were amongst boys (65.3%) and the very young (mean age 6), occurred in private residences (42.4% homes, 25.7% residential institutions), were typically caused by falls (56.3%) or penetrating trauma (13.2%), mostly resulted in extremity fractures (45.8% closed, 4.9% open) and burn or head injuries (in infants and small children), and got very little or no pre-hospital care (51.4% no care). Additionally, children with burns, brain injuries, or poly-trauma had the longest hospital stays and highest rates of mortality. A more detailed description of the patterns and outcomes seen are included in the study. Discussion: Paediatric injuries remain a major public health problem and contribute a substantial proportion of all paediatric surgical admissions at the Aga Khan University Hospital in Nairobi. Based on the patterns and outcomes seen in this study, we therefore recommend for Nairobi (and possibly Kenya) to establish greater supervision and safety measures for children; targeting safety interventions at all children but particularly at boys, the very young, at home and in residential buildings; building pre-hospital emergency care that can accommodate children; and equipping paediatric trauma hospitals to especially handle bony fractures, burns, head injuries, and poly-traumas. A bespoke trauma registry would benefit the hospital, and likely the country as a whole.	[Ndung'u, Anthony] Aga Khan Univ Hosp, 3rd Parklands Ave,Limuru Rd,POB 30270-00100, Nairobi, Kenya; [Sun, Jared] Harbor UCLA, Dept Emergency Med, 1000 W Carson St,Bldg D-9 Box 21, Torrance, CA 90509 USA; [Musau, Joan; Ndirangu, Eunice] Aga Khan Univ, Sch Nursing & Midwifery, Sunny Plaza,Wangapala Rd,Off 4th Parklands Ave, Nairobi, Kenya		Ndung'u, A (corresponding author), Aga Khan Univ Hosp, 3rd Parklands Ave,Limuru Rd,POB 30270-00100, Nairobi, Kenya.	tonyndungu90@gmail.com		Ndirangu-Mugo, Eunice Wambui/0000-0001-8594-0808			Abdur-Rahman LO, 2012, SEM PED SURG; Ageing WHO Unit LC., 2008, WHO GLOB REP FALLP; Bhatti Khalid M, 2016, Sultan Qaboos Univ Med J, V16, pe210, DOI 10.18295/squmj.2016.16.02.012; Botchey IM, 2017, SURGERY; Chokotho L, 2014, INJURY, V45, P2065, DOI 10.1016/j.injury.2014.10.001; Elachi Itodo C, 2015, Int J Crit Illn Inj Sci, V5, P99, DOI 10.4103/2229-5151.158404; Jalalvandi Fereshteh, 2015, Glob J Health Sci, V8, P139, DOI 10.5539/gjhs.v8n6p139; Kiragu AW, 2017, J PEDIATR INTENSIVE, V6, P52, DOI 10.1055/s-0036-1584676; Kundal Vijay Kumar, 2017, J Indian Assoc Pediatr Surg, V22, P33, DOI 10.4103/0971-9261.194618; Naidoo N, 2015, SAMJ S AFR MED J, V105, P823, DOI [10.7196/SAMJnew.8090, 10.7196/SAMJNEW.8090]; Oboirien Muhammad, 2013, Afr J Paediatr Surg, V10, P172, DOI 10.4103/0189-6725.115047; Odetola FO, 2015, INT J INJ CONTROL SA, V22, P260, DOI 10.1080/17457300.2014.925937; Osifo OD, 2012, INJURY, V43, P1861, DOI 10.1016/j.injury.2011.07.016; Simon Raymond, 2013, J Trauma Manag Outcomes, V7, P10, DOI 10.1186/1752-2897-7-10; Tracy ET, 2013, J PEDIATR SURG, V48, P1384, DOI 10.1016/j.jpedsurg.2013.03.041; W. H. O. Unit LC, 2007, WHO GLOB REP FALLP; Wesson HKH, 2015, QUAL HEALTH RES, V25, P589, DOI 10.1177/1049732314562890; Wesson HKH, 2014, HEALTH POLICY PLANN, V29, P795, DOI 10.1093/heapol/czt064; WHO, 2004, MORT BURD DIS EST WH; WHO/UNICEF, 2005, CHILD AD INJ PREV GL	20	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.		2019	9			S	SI		S47	S51		10.1016/j.afjem.2018.12.004			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HO8FY	WOS:000461186500010	30976501	Green Published, gold			2022-02-06	
J	Olczak, M; Poniatowski, L; Kwiatkowska, M; Samojlowicz, D; Tarka, S; Wierzba-Bobrowicz, T				Olczak, Mieszko; Poniatowski, Lukasz; Kwiatkowska, Magdalena; Samojlowicz, Dorota; Tarka, Sylwia; Wierzba-Bobrowicz, Teresa			Immunolocalization of dynein, dynactin, and kinesin in the cerebral tissue as a possible supplemental diagnostic tool for traumatic brain injury in postmortem examination	FOLIA NEUROPATHOLOGICA			English	Article						dynein; dynactin; kinesin; axon pathology; traumatic brain injury	DIFFUSE AXONAL INJURY; CYTOPLASMIC DYNEIN; HEAD-INJURY; NEURODEGENERATIVE DISEASES; BETA-APP; PATHOPHYSIOLOGY; DAMAGE; MICROENVIRONMENT; NEUROPATHOLOGY; EPIDEMIOLOGY	Traumatic brain injury (TBI) is characterized by various micro- and macrostructural neuropathological changes which can be identified in the light microscope examination. The most common pathophenotype of TBI visualized in postmortem neuropathological assessment includes neuron injury with involvement of all of its structural regions followed by its progressive degeneration defined as traumatic axonal injury (TAI). This is directly related with disruption of the axolemmal cytoskeletal network architecture resulting in breakdown, dissolution and accumulation of a number of neuronal proteins. Regarding the availability and progress in the development of specific antibodies against neuronal proteins, their usage is restricted due to low specificity for injured axons in the pathomechanism of TBI followed by TAI. Taking this into account with relation to expanding the role of axonal cytoskeleton and its based biomarkers we have presented a study documenting neuropathological features concerning the expression of dynein (DNAH9), dynactin (DCTN1) and kinesin (KIF5B) in the brain specimens obtained during forensic autopsies from TBI victims. The study was carried out using cases (n = 21) of severe head injury suspected to be the cause of death and control cases (n = 17) of sudden death in the mechanism of cardiopulmonary failure along with a positive control case which died after suicidal gunshot injury. In our study, we documented that DNAH9, DCTN1, and KIF5B staining should be considered as a supplemental diagnostic tool for TBI in postmortem neuropathological examination and forensic autopsy. This additional motor protein immunohistochemical staining procedure could be useful in the evaluation of lesions that may remain undiagnosed during a routine examination and aid in more accurate identification of TBI followed by TAI.	[Olczak, Mieszko; Kwiatkowska, Magdalena; Samojlowicz, Dorota; Tarka, Sylwia] Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland; [Poniatowski, Lukasz] Med Univ Warsaw, Ctr Preclin Res & Technol CePT, Dept Expt & Clin Pharmacol, Warsaw, Poland; [Poniatowski, Lukasz] Maria Sklodowska Curie Mem Canc Ctr, Dept Neurosurg, Warsaw, Poland; [Poniatowski, Lukasz] Inst Oncol, Warsaw, Poland; [Tarka, Sylwia; Wierzba-Bobrowicz, Teresa] Inst Psychiat & Neurol, Dept Neuropathol, Warsaw, Poland		Olczak, M (corresponding author), Med Univ Warsaw, Dept Forens Med, 1 Oczki St, PL-02007 Warsaw, Poland.	mieszkothe1st@hotmail.com	Poniatowski, Lukasz A./AAF-6980-2019	Poniatowski, Lukasz A./0000-0003-4202-7984; Wierzba-Bobrowicz, Teresa/0000-0003-2518-8321	Medical University of Warsaw [1MB/PM11/14]; European Union (EU) - the European Regional Development Fund (ERDF) within the "Infrastructure and Environment'' operational program for years 2007-2013	This study was supported by internal grant 1MB/PM11/14 conducted in the years 2014-2015 from the Medical University of Warsaw. The project was implemented using the infrastructure financed by the European Union (EU) - the European Regional Development Fund (ERDF) within the "Infrastructure and Environment'' operational program for years 2007-2013. No additional external funding and support was received for this study.	ABDELBASSET E, 1995, J NEUROSCI RES, V41, P222, DOI 10.1002/jnr.490410210; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Amunts K, 2015, NEURON, V88, P1086, DOI 10.1016/j.neuron.2015.12.001; Araque A, 2010, PHILOS T R SOC B, V365, P2375, DOI 10.1098/rstb.2009.0313; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cho C, 2012, BBA-MOL CELL RES, V1823, P182, DOI 10.1016/j.bbamcr.2011.10.009; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jessen KR, 2004, INT J BIOCHEM CELL B, V36, P1861, DOI 10.1016/j.biocel.2004.02.023; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Olczak M, 2018, FOLIA NEUROPATHOL, V56, P97, DOI 10.5114/fn.2018.76613; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Roth S, 2014, METHOD ENZYMOL, V540, P205, DOI 10.1016/B978-0-12-397924-7.00012-1; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Zhao ZL, 2017, PROTEIN CELL, V8, P801, DOI 10.1007/s13238-017-0414-6	73	5	5	1	2	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1641-4640	1509-572X		FOLIA NEUROPATHOL	Folia Neuropathol.		2019	57	1					51	62		10.5114/fn.2019.83831			12	Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HR2SX	WOS:000462988400007	31038188	gold			2022-02-06	
J	Pelaez, CA; Spilman, SK; Bell, CT; Eastman, DK; Sidwell, RA				Pelaez, Carlos A.; Spilman, Sarah K.; Bell, Christopher T.; Eastman, Darla K.; Sidwell, Richard A.			Not all head injured patients on antiplatelet drugs need platelets: Integrating platelet reactivity testing into platelet transfusion guidelines	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Platelet transfusion; Intracranial hemorrhage; Anticoagulation reversal; Antiplatelet reversal; Platelet reactivity testing	INTRACRANIAL HEMORRHAGE; EMERGENCY REVERSAL; IMPROVE OUTCOMES; BRAIN-INJURY; PROGRESSION; ASPIRIN; AGENTS; DESMOPRESSIN; METAANALYSIS; DYSFUNCTION	Introduction: Antiplatelet medication use continues to rise in an aging population, and these agents can have a deleterious effect for patients with traumatic intracranial hemorrhage (tICH). The purpose of the current investigation is to assess the safety and efficacy of using platelet reactivity testing (PRT) to direct platelet transfusion for tICH patients. Patients and Methods: A Level I trauma center adopted a targeted platelet transfusion guideline using PRT to determine whether platelets were inhibited by an antiplatelet medication (aspirin or P2Y12 inhibitors). Non-inhibited patients were monitored without platelet transfusion, regardless of severity of the head injury. The guideline was analyzed retrospectively to evaluate patient outcomes during the study period (June 2014-December 2016). All patients sustained blunt tICH and received a PRT for known or suspected antiplatelet medication use. Differences were assessed with Kruskal-Wallis and Fisher's Exact tests. Results: 166 patients met study inclusion criteria. PRT results indicated that 48 patients (29%) were not inhibited by an antiplatelet medication, and 92% of those patients (n = 44) were spared platelet transfusion. Seven percent (n = 11) of all patients had a clinically significant progression of the head bleed, but this did not differ by inhibition or transfusion status. Implementation of this guideline reduced platelet transfusions by an estimated 30-50% and associated healthcare costs by 42%. Conclusions: A targeted platelet transfusion guideline using PRT reduced platelet usage for patients with tICH. If appropriately tested, results suggest that not all tICH patients taking or suspected of taking antiplatelet drugs need platelet transfusion. Platelet reactivity testing can significantly reduce healthcare costs and resource usage. (C) 2018 Elsevier Ltd. All rights reserved.	[Pelaez, Carlos A.; Sidwell, Richard A.] Iowa Clin, Trauma Surg, Des Moines, IA USA; [Pelaez, Carlos A.; Spilman, Sarah K.; Sidwell, Richard A.] UnityPoint Hlth, Trauma Serv, 1200 Pleast St, Des Moines, IA 50309 USA; [Pelaez, Carlos A.; Bell, Christopher T.; Sidwell, Richard A.] Iowa Methodist Med Ctr, Gen Surg Residency Program, Des Moines, IA USA; [Eastman, Darla K.] Drake Univ, Coll Pharm & Hlth Sci, Des Moines, IA USA		Spilman, SK (corresponding author), UnityPoint Hlth, Trauma Serv, 1200 Pleast St, Des Moines, IA 50309 USA.	sarah.spilman@unitypoint.org		Spilman, Sarah/0000-0001-6890-2332			Accriva diagnostics, 2016, VERIFYNOW REF GUID; Accriva diagnostics, 2015, VERIFYNOW SYST REF G; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Basha J, 2005, INTERNET J EMERG INT, P9; Beshay JE, 2010, J NEUROSURG, V112, P307, DOI 10.3171/2009.7.JNS0982; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Desborough MJR, 2017, J THROMB HAEMOST, V15, P263, DOI 10.1111/jth.13576; Downey DM, 2009, AM SURGEON, V75, P1100; Ferraris VA, 2012, ANN THORAC SURG, V94, P1761, DOI 10.1016/j.athoracsur.2012.07.086; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Gordon JL, 2013, J TRAUMA ACUTE CARE, V75, P475, DOI 10.1097/TA.0b013e3182a07391; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; James RF, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1328; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Li XW, 2013, J NEUROSURG, V118, P94, DOI 10.3171/2012.9.JNS112286; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schochl H, 2013, J TRAUMA ACUTE CARE, V74, P1587, DOI 10.1097/TA.0b013e31828c3171; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Toner RW, 2011, APPL HEALTH ECON HEA, V9, P29, DOI 10.2165/11530740-000000000-00000; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yeung LYY, 2016, TRAUMA SURG ACUTE CA, V1, P1; Zbrozek A, 2015, CLIN THER, V37, P1966, DOI 10.1016/j.clinthera.2015.06.007	33	5	5	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2019	50	1					73	78		10.1016/j.injury.2018.08.020			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	HG1LR	WOS:000454717700014	30170785				2022-02-06	
J	Ralston, B; Rable, J; Larson, T; Handmaker, H; Lifshitz, J				Ralston, Bridget; Rable, Jill; Larson, Todd; Handmaker, Hirsch; Lifshitz, Jonathan			Forensic Nursing Examination to Screen for Traumatic Brain Injury following Intimate Partner Violence	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Community violence; family/domestic violence; intimate partner violence; physical abuse; trauma; victim; assessment/evaluation; intervention	CONCUSSION; OUTCOMES; WOMEN	Intimate partner violence (IPV) causes harm to an estimated 42 million victims each year. Routine forensic examination excludes specific evaluation of traumatic brain injury (TBI), thereby missing an opportunity to diagnose and offer treatment. This quality assurance/quality improvement project was designed to determine whether TBI signs and symptoms are detected in IPV patients using existing forensic nurse examination protocols. TBI signs and symptoms were cataloged from medical records to infer the incidence of TBI and inform an expansion of the nursing exam. Retrospective review of 19 cases collected over 31 days in June and July 2017 identified a predominance of young (average age 32.3), female (89.5%) patients with obstetric history (76.5% with one or more pregnancy), presenting with symptoms including lightheadedness/dizziness (84.2%), headache (78.9%), difficulty breathing (78.9%), and throat pain (68.4%). Subjective mechanism of injury included strangulation (100%), blow to the head with the perpetrator's hand (52.6%), and fall to the ground (36.8%). TBI was not diagnosed during the exam, but recorded signs and symptoms indicated patterns consistent with brain injury. As a result of these findings, our team proposes an expansion of the exam to include near point of convergence, balance, and hand-eye coordination testing to ensure detection of TBI signs in IPV victims. By detecting TBI signs early, community efforts can guide patients towards recovery, appropriate treatment options and successful return to society.	[Ralston, Bridget; Handmaker, Hirsch; Lifshitz, Jonathan] Univ Arizona, Coll Med, 325 ABC 1 Bldg,425 North Fifth St, Phoenix, AZ 85004 USA; [Rable, Jill; Larson, Todd] HonorHealth, Mesa Family Advocacy Ctr, Mesa, AZ USA; [Handmaker, Hirsch; Lifshitz, Jonathan] CACTIS Fdn, Scottsdale, AZ USA; [Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lifshitz, Jonathan] Phoenix VA Healthcare Syst, Phoenix, AZ USA		Lifshitz, J (corresponding author), Univ Arizona, Coll Med, 325 ABC 1 Bldg,425 North Fifth St, Phoenix, AZ 85004 USA.	JLifshitz@email.arizona.edu		Ralston, Bridget/0000-0001-5469-6267	Hickey Family Foundation	This work was supported by the Hickey Family Foundation.	Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Black M C., 2011, NATL INTIMATE PARTNE; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goble DJ, 2016, INT J SPORTS PHYS TH, V11, P149; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hunnicutt G, 2017, J FAM VIOLENCE, V32, P471, DOI 10.1007/s10896-016-9854-7; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Tjaden P., 2000, 181867 NCJ, P1, DOI DOI 10.1037/E300342003-001; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wilbur L, 2001, J EMERG MED, V21, P297, DOI 10.1016/S0736-4679(01)00398-5; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Zieman G, 2017, J NEUROTRAUM, V34, P876, DOI 10.1089/neu.2016.4579; ZUPAN MF, 2006, OPTOMETRY TODAY, V1, P43	23	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		732	743		10.1080/10926771.2019.1637988			12	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700006					2022-02-06	
S	Shandra, O; Robel, S		DiBenedetto, B		Shandra, Oleksii; Robel, Stefanie			Imaging and Manipulating Astrocyte Function In Vivo in the Context of CNS Injury	ASTROCYTES: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Astrocytes; Astrogliosis; In vivo imaging; Multiphoton; Two-photon; Microscopy; Traumatic brain injury; Calcium	NEURONS	Astrocytes are glial cells carrying out complex homeostatic functions in the healthy and diseased central nervous system (CNS). It has so far been impossible to reliably culture adult astrocytes and the results of studies on astrocytes outside of their normal environment are challenging to interpret. Consequently, most culture studies use astrocytes isolated from postnatal rodents. Yet cultured astrocytes do not display their complex three-dimensional in vivo morphology, and transcriptomes of cultured astrocytes vary significantly from those of acutely isolated astrocytes (Cahoy et al., J Neurosci 28:264-278, 2008). Astrocyte isolation for culture experiments, and the cutting of acute brain slices, induces astrocyte reactivity similar to a severe acute injury. In response to CNS injury, such as moderate or severe focal traumatic brain injury (TBI), astrocytes can change in cell number, physiological state, gene and protein expression, secretome, and morphology, in a process termed reactive astrogliosis. This makes the use of methods that inherently induce astrogliosis (e.g., dissociation of brain tissue for culture or sectioning of brains for acute brain slices) challenging, especially when conditions are studied that present with changes in astrocyte function that are milder and/or of a different nature. In this methods chapter, we will describe a technical approach that allows one to study astrocytes in the intact brain using two-photon in vivo imaging. We will use mild TBI as an example of how to use this approach to compare astrocyte function in the same animal before and after an injury. Here we describe the use of a noninvasive label-free method (Choi et al., J Biomed Opt 16:075003, 2011) to increase astrocyte Ca2+ using optical femtosecond pulsed laser activation. We will provide systematic instruction of the surgical technique, which when done properly, allows in vivo astrocyte imaging in the same experimental animal before the injury as well as over the course of days, weeks, and even months after injury. We will also elaborate on challenges in astrocytic Ca2+ imaging and how different image acquisition settings can affect the readout of astrocyte Ca2+ oscillations.	[Shandra, Oleksii; Robel, Stefanie] Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA; [Robel, Stefanie] Virginia Tech, Sch Neurosci, Blacksburg, VA USA; [Robel, Stefanie] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA		Shandra, O (corresponding author), Virginia Tech, Caril Res Inst, Roanoke, VA 24016 USA.		Shandra, Oleksii/AAD-2622-2020	Shandra, Oleksii/0000-0003-4447-3312; Robel, Stefanie/0000-0001-6716-3670	National Institute of Neurological Disorders and Stroke at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105807]	This work was supported by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (grant number R01NS105807).	[Anonymous], 2018, LAB ANIMAL RES COMPO; Bazargani N, 2016, NAT NEUROSCI, V19, P182, DOI 10.1038/nn.4201; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Choi M, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600774; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Kimbrough IF, 2015, BRAIN, V138, P3716, DOI 10.1093/brain/awv327; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Shen ZM, 2012, NAT METHODS, V9, P273, DOI [10.1038/NMETH.1857, 10.1038/nmeth.1857]; Shih Andy Y, 2012, J Vis Exp, DOI 10.3791/3742; Shimizu S, 2004, LAB MOUSE, P527, DOI DOI 10.1016/B978-012336425-8/50085-6; Smith NA, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aal2039; Stobart JL, 2018, NEURON, V98, P726, DOI 10.1016/j.neuron.2018.03.050; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; Watkins S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5196; Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155	17	5	5	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-9068-9; 978-1-4939-9067-2	METHODS MOL BIOL	Methods Mol. Biol.		2019	1938						233	246		10.1007/978-1-4939-9068-9_16	10.1007/978-1-4939-9068-9		14	Cell Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Cell Biology; Neurosciences & Neurology	BQ8MJ	WOS:000620741300015	30617984				2022-02-06	
J	Silverberg, ND				Silverberg, Noah D.			Behavioral treatment for post-traumatic headache after mild traumatic brain injury: Rationale and case series	NEUROREHABILITATION			English	Article						Brain concussion; post-traumatic headache; behavior therapy	RECURRENT HEADACHE; QUESTIONNAIRE; TRIGGERS; FEAR; SENSITIVITY; COGNIPHOBIA; PREVALENCE; SYMPTOMS; IMPACT; PHQ-9	BACKGROUND: Headache is among the most common persistent symptoms after mild traumatic brain injury (mTBI). Currently available treatments have limited efficacy. OBJECTIVE: To present a rationale for a novel behavioral treatment approach and a supporting case series with a multiple baseline design. METHOD: Pervasive avoidance of common headache triggers may be maladaptive, promoting sensitization and restricting life participation. Graded exposure to triggers that are prone to sensitization (e.g., stress, light flicker, loud noise) may represent an alternative behavioral approach to treating chronic headaches after mTBI. The present study reports on a series of physician-referred patients (N= 4, aged 28-48, enrolled at 9-19 months post-injury) with persistent headache attributed to mTBI. They participated in an 8-session manualized treatment with a registered psychologist. Patients completed a daily headache diary before, during, and after treatment, as well as pre- and post-treatment assessments with a battery of questionnaires. RESULTS: All patients finished treatment and no adverse events were reported. Improvement was variable across measures of headache frequency/intensity, headache trigger avoidance, post-concussion symptoms, disability, and patient global impression of change. CONCLUSION: Future directions for behavioral management of headache triggers as a potential treatment for chronic post-traumatic headaches after mTBI are discussed.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca					Andrasik F, 2005, HEADACHE, V45, P429, DOI 10.1111/j.1526-4610.2005.05094.x; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Castien RF, 2012, CEPHALALGIA, V32, P710, DOI 10.1177/0333102412449933; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fraser F, 2017, CURR PAIN HEADACHE R, V21, DOI 10.1007/s11916-017-0624-x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kubik SU, 2017, HEADACHE, V57, P236, DOI 10.1111/head.12940; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Martin PR, 2014, BEHAV RES THER, V61, P1, DOI 10.1016/j.brat.2014.07.002; Martin PR, 2010, CURR PAIN HEADACHE R, V14, P221, DOI 10.1007/s11916-010-0112-z; Martin PR, 2009, CLIN PSYCHOL REV, V29, P483, DOI 10.1016/j.cpr.2009.05.002; Martin PR, 2000, PSYCHOL HEALTH, V15, P801, DOI 10.1080/08870440008405582; McMillan D, 2010, J AFFECT DISORDERS, V127, P122, DOI 10.1016/j.jad.2010.04.030; Norton PJ, 2004, PAIN, V111, P218, DOI 10.1016/j.pain.2004.06.018; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM; Pellegrino A. B. W, 2017, CEPHALALGIA, DOI [10.1177/033310241772753, DOI 10.1177/033310241772753]; Penzien D. B, 2005, HEADACHE, DOI [10.1111/j.1526-4610.2005.4502004.x, DOI 10.1111/J.1526-4610.2005.4502004.X]; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silverberg N. D, 2018, J NEUROTRAUMA; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2017, J NEUROTRAUMA; Steiner TJ, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-3; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Veterans Affairs/Department of Defense, 2016, MAN CONC MILD TRAUM; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Zeeberg P, 2005, CEPHALALGIA, V25, P1159, DOI 10.1111/j.1468-2982.2005.00980.x	42	5	5	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2019	44	4					523	530		10.3233/NRE-192708			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IK4NR	WOS:000476564100006	31256091				2022-02-06	
J	Tseng, WS; Chien, WC; Chung, CH; Chou, YC; Tzeng, NS				Tseng, Wei-Shih; Chien, Wu-Chien; Chung, Chi-Hsiang; Chou, Yu-Ching; Tzeng, Nian-Sheng			RISK OF SLEEP DISORDERS IN PATIENTS WITH DECOMPRESSION SICKNESS: A NATIONWIDE, POPULATION-BASED STUDY IN TAIWAN	PSYCHIATRIA DANUBINA			English	Article						decompression sickness; psychiatric disorders; sleep disorders; National Health Insurance Research Database; Cohort study	TRAUMATIC BRAIN-INJURY; HYPERBARIC-OXYGEN THERAPY; POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; PROFESSIONAL DIVERS; BIPOLAR DISORDER; YOUNG-ADULTS; SHIFT WORK; SCUBA	Background: Decompression sickness (DCS) primarily manifests musculoskeletal pain, cutaneous manifestations, lymphatic symptoms, and neurological symptoms. DCS might affect the central nervous system and induce the stress in the patients, but few studies about the psychiatric morbidity after DCS have been conducted. This study aimed to investigate the association between DCS and the risk of developing psychiatric disorders. Subjects and methods: This study was a population-based, matched-cohort design. A total of 738 enrolled patients, with 123 study subjects who had suffered from DCS, and 615 controls matched for sex and age, from the Longitudinal Health Insurance Databank from 2000-2010 in Taiwan, and selected from the National Health Insurance Research Database. After adjusting for the confounding factors, Cox proportional hazards analysis was used to compare the risk of developing psychiatric disorders during the 10 years of follow-up period. Results: Of the study subjects, 10 (8.13%) developed psychiatric disorders when compared to 35 (5.69%) in the control group. The study subjects were more likely to develop psychiatric disorders (crude hazard ratio [HR]: 2.79 (95% CI=1.37-5.69, P<0.01). After adjusting for sex, age, monthly income, urbanization level, geographic region, and comorbidities, the adjusted HR was 3.83 (95% CI=1.60-9.16, P<0.01). Sleep disorders was associated with DCS with the adjusted HR as 5.74 (95% CI= 1.04-31.56, P<0.01). Hyperbaric oxygenation therapy was not associated with a lower risk of psychiatric disorders. Conclusions: Patients who suffered from DCS have a 3.8-fold risk of developing psychiatric disorders, and a 5.7-fold risk of sleep disorders. This finding is a reminder for the clinicians that a regular psychiatric follow-up might well be needed for these patients.	[Tseng, Wei-Shih] Armed Force Kaohsiung Gen Hosp, Dept Diving & Hyperbar Med, Zuoying Branch, Kaohsiung, Taiwan; [Tseng, Wei-Shih] Natl Def Med Ctr, Triserv Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang; Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Triserv Gen Hosp, Sch Med, Dept Psychiat, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan		Tzeng, NS (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Joint Program Geriatr Psychiat & Psychosomat Med, Dept Psychiat, 325 Chung Gung Rd,Sec 2, Nei Hu Dist 114, Tapei, Taiwan.	pierrens@mail.ndmctsgh.edu.tw	Tzeng, Nian-Sheng/AAU-4945-2021; Chung, Chi-Hsiang/AAY-3386-2021		Medical Affairs Bureau, Ministry of Defense of Taiwan [MAB-107-084]; Tri-Service General Hospital Research Foundation [TSGH-C105-130, TSGH-C106-002, TSGH-C106-106, TSGH-C107-004]	This study was funded by the Medical Affairs Bureau, Ministry of Defense of Taiwan (MAB-107-084) and the Tri-Service General Hospital Research Foundation (TSGH-C105-130, TSGH-C106-002, TSGH-C106-106, and TSGH-C107-004).	Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Auten JD, 2010, AVIAT SPACE ENVIR MD, V81, P427, DOI 10.3357/ASEM.2406.2010; Bast-Pettersen R, 1999, AVIAT SPACE ENVIR MD, V70, P51; Bast-Pettersen R, 2015, INT ARCH OCC ENV HEA, V88, P669, DOI 10.1007/s00420-014-0991-0; Bonnet A, 2003, ENCEPHALE, V29, P488; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Boussuges A, 1996, UNDERSEA HYPERBAR M, V23, P151; CALDER I, 1992, OCCUP MED-OXFORD, V42, P213, DOI 10.1093/occmed/42.4.213; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chen MH, 2014, SCHIZOPHR RES, V159, P171, DOI 10.1016/j.schres.2014.07.029; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chen YH, 2017, PSYCHOSOM MED, V79, P664, DOI 10.1097/PSY.0000000000000463; Cheng P, 2017, J BIOL RHYTHM, V32, P143, DOI 10.1177/0748730417699309; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Chien WuChien, 2017, Journal of Medical Sciences, V37, P137, DOI 10.4103/jmedsci.jmedsci_94_16; Chiu HY, 2015, EUR NEUROPSYCHOPHARM, V25, P2271, DOI 10.1016/j.euroneuro.2015.09.011; Cianci P, 2006, AVIAT SPACE ENVIR MD, V77, P1003; Connolly DM, 2015, AEROSP MED HUM PERF, V86, P928, DOI 10.3357/AMHP.4392.2015; Cordes P, 2000, NEUROLOGY, V55, P1743, DOI 10.1212/WNL.55.11.1743; CURLEY MD, 1988, UNDERSEA BIOMED RES, V15, P39; EDMONDS C, 1985, UNDERSEA BIOMED RES, V12, P321; Edmonds C., 2015, DIVING SUBAQUATIC ME, V5th Edition; Eve DJ, 2016, NEUROPSYCH DIS TREAT, V12, P2689, DOI 10.2147/NDT.S110126; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Francis T.J.R., 2003, BENNETT ELLIOTTS PHY, V5th; Gamedze L, 2014, DAY LIFE OFFSHORE 1; Germonpre P, 2016, B-ENT, V12, P87; Gronning M, 2005, UNDERSEA HYPERBAR M, V32, P397; Hadanny A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023387; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harding S, 2008, DIVING HYPERB MED, V38, P134; Hemelryck W, 2014, SCAND J MED SCI SPOR, V24, P928, DOI 10.1111/sms.12100; Hitchen P, 2013, LIFE PRESSURE DAY LI; Hopkins RO, 2001, UNDERSEA HYPERBAR M, V28, P145; Howle LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172665; Huang MF, 2018, PSYCHIAT RES, V261, P517, DOI 10.1016/j.psychres.2017.12.061; Huchim-Lara O, 2017, UNDERSEA HYPERBAR M, V44, P149; Hunt JC, 1996, J CLIN PSYCHOL MED S, V3, P253, DOI 10.1007/BF01993911; Irgens A, 2007, OCCUP MED-OXFORD, V57, P349, DOI 10.1093/occmed/kqm032; Jain K. K., 2016, TXB HYPERBARIC MED; JAIN KK, 1994, ACTA NEUROL SCAND, V90, P45; Javidi H, 2012, INT J OCCUP ENV MED, V3, P2; Kohshi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105006; Lukaschek K, 2013, SOC PSYCH PSYCH EPID, V48, P525, DOI 10.1007/s00127-012-0585-7; MCQUEEN D, 1994, BRIT J SPORT MED, V28, P101, DOI 10.1136/bjsm.28.2.101; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; MORGAN WP, 1995, SPORTS MED, V20, P398, DOI 10.2165/00007256-199520060-00005; Nicolas M, 2000, PSYCHOL REP, V86, P119, DOI 10.2466/PR0.86.1.119-126; PARK YS, 1983, UNDERSEA BIOMED RES, V10, P203; Pourhashemi SF, 2016, ASIAN J SPORTS MED, V7, DOI DOI 10.5812/ASJSM.3863327826405; Ridgway L, 2006, CLIN NEUROPSYCHOL, V20, P160, DOI 10.1080/13854040590947407; RiosTejada F, 1997, AVIAT SPACE ENVIR MD, V68, P1025; Ross JAS, 2007, OCCUP MED-OXFORD, V57, P254, DOI 10.1093/occmed/kqm005; ROZSAHEGYI I, 1966, IND MED SURG, V35, P101; SHEFFIELD PJ, 1976, AVIAT SPACE ENVIR MD, V47, P759; Shen CC, 2016, J RHEUMATOL, V43, P625, DOI 10.3899/jrheum.150388; Shen CC, 2016, J PSYCHOSOM OBST GYN, V37, P6, DOI 10.3109/0167482X.2015.1124852; Shen CC, 2015, J RHEUMATOL, V42, P1203, DOI 10.3899/jrheum.141361; Slosman DO, 2004, BRIT J SPORT MED, V38, P108, DOI 10.1136/bjsm.2002.003434; Strauss MB, 2017, UNDERSEA HYPERBAR M, V44, P45; Sutherland A, 1993, SPUMS J, V23, P7; Taylor CL, 2006, SCAND J WORK ENV HEA, V32, P310, DOI 10.5271/sjweh.1015; Tetzlaff K, 1999, EUR NEUROL, V42, P194, DOI 10.1159/000008106; Trevett A, 2010, J PSYCHOSOM RES, V68, P263, DOI 10.1016/j.jpsychores.2009.05.005; Tsai MC, 2014, J PEDIATR-US, V164, P136, DOI 10.1016/j.jpeds.2013.08.042; Tzeng NS, 2017, J NEUROL SCI, V381, P88, DOI 10.1016/j.jns.2017.08.022; VAERNES RJ, 1989, UNDERSEA BIOMED RES, V16, P233; Van Wijk CH, 2017, DIVING HYPERB MED, V47, P248, DOI 10.28920/dhm47.4.248-252; Vgontzas AN, 2003, J CLIN ENDOCR METAB, V88, P2087, DOI 10.1210/jc.2002-021176; Wang J, 2002, UNDERSEA HYPERBAR M, V29, P242; WILLIAMSON AM, 1987, BRIT J IND MED, V44, P459; WIRJOSEMITO SA, 1989, AVIAT SPACE ENVIR MD, V60, P256; Wu CH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8030676	73	5	5	0	1	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-5053			PSYCHIAT DANUB	Psychiatr. Danub.		2019	31	2					172	181		10.24869/psyd.2019.172			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	IH1LT	WOS:000474253000006	31291221	gold, Green Submitted			2022-02-06	
J	Tuxworth, RI; Taylor, MJ; Anduaga, AM; Hussien-Ali, A; Chatzimatthaiou, S; Longland, J; Thompson, AM; Almutiri, S; Alifragis, P; Kyriacou, CP; Kysela, B; Ahmed, Z				Tuxworth, Richard, I; Taylor, Matthew J.; Anduaga, Ane Martin; Hussien-Ali, Alaa; Chatzimatthaiou, Sotiroula; Longland, Joanne; Thompson, Adam M.; Almutiri, Sharif; Alifragis, Pavlos; Kyriacou, Charalambos P.; Kysela, Boris; Ahmed, Zubair			Attenuating the DNA damage response to double-strand breaks restores function in models of CNS neurodegeneration	BRAIN COMMUNICATIONS			English	Article						DNA damage; neurodegeneration; neuroprotection; CNS trauma; spinal cord injury	SPINAL-CORD-INJURY; DORSAL-ROOT GANGLION; CELL-CYCLE; AXON REGENERATION; OPTIC-NERVE; GENOMIC INSTABILITY; CONTUSION MODEL; SMALL-MOLECULE; EXPRESSION; NEURONS	DNA double-strand breaks are a feature of many acute and long-term neurological disorders, including neurodegeneration, following neurotrauma and after stroke. Persistent activation of the DNA damage response in response to double-strand breaks contributes to neural dysfunction and pathology as it can force post-mitotic neurons to re-enter the cell cycle leading to senescence or apoptosis. Mature, non-dividing neurons may tolerate low levels of DNA damage, in which case muting the DNA damage response might be neuroprotective. Here, we show that attenuating the DNA damage response by targeting the meiotic recombination 11, Rad50, Nijmegen breakage syndrome 1 complex, which is involved in double-strand break recognition, is neuroprotective in three neurodegeneration models in Drosophila and prevents A beta(1-42)-induced loss of synapses in embryonic hippocampal neurons. Attenuating the DNA damage response after optic nerve injury is also neuroprotective to retinal ganglion cells and promotes dramatic regeneration of their neurites both in vitro and in vivo. Dorsal root ganglion neurons similarly regenerate when the DNA damage response is targeted in vitro and in vivo and this strategy also induces significant restoration of lost function after spinal cord injury. We conclude that muting the DNA damage response in the nervous system is neuroprotective in multiple neurological disorders. Our results point to new therapies to maintain or repair the nervous system.	[Tuxworth, Richard, I; Taylor, Matthew J.; Chatzimatthaiou, Sotiroula; Kysela, Boris] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Anduaga, Ane Martin; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet & Genome Biol, Leicester LE1 7RH, Leics, England; [Hussien-Ali, Alaa; Alifragis, Pavlos] Royal Holloway Univ London, Ctr Biomed Sci, Ctr Gene & Cell Therapy, Sch Biol Sci, Surrey TW20 0EX, England; [Longland, Joanne; Thompson, Adam M.; Almutiri, Sharif; Ahmed, Zubair] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol, Room 386 Robert Aitken Inst Clin Res, Birmingham B15 2TT, W Midlands, England; [Almutiri, Sharif] Shaqra Univ, Appl Med Sci Coll, Riyadh, Saudi Arabia; [Kysela, Boris] Aston Univ, Aston Med Sch, Aston Med Res Inst, Birmingham B4 7ET, W Midlands, England; [Anduaga, Ane Martin] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02453 USA		Tuxworth, RI; Kysela, B (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England.; Ahmed, Z (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Neurosci & Ophthalmol, Room 386 Robert Aitken Inst Clin Res, Birmingham B15 2TT, W Midlands, England.; Kysela, B (corresponding author), Aston Univ, Aston Med Sch, Aston Med Res Inst, Birmingham B4 7ET, W Midlands, England.	r.i.tuxworth@bham.ac.uk; b.kysela@aston.ac.uk; z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021	Taylor, Matthew/0000-0003-3055-4453; Tuxworth, Richard/0000-0001-5697-6254; Martin Anduaga, Ane/0000-0003-2447-2195; Chatzimatthaiou, Sotiroula/0000-0003-4418-7965	UK Biotechnology and Biological Sciences Research Council New Investigator awardUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N008472/1]; Marie-Curie ITN grant INsecTIME [PITN-GA-2012-316790]; Saudi Education Ministry PhD Studentship; University of Birmingham Bryant Bequest PhD Studentship; UK Medical Research Council Confidence in Concept awardUK Research & Innovation (UKRI)Medical Research Council UK (MRC); BBSRCUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC) [BB/N008472/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0900034] Funding Source: UKRI	This work was supported by a UK Biotechnology and Biological Sciences Research Council New Investigator award BB/N008472/1 (R.I.T.), AMA was supported by Marie-Curie ITN grant INsecTIME PITN-GA-2012-316790 (C.P.K), Saudi Education Ministry PhD Studentship (S.A. and Z.A.), University of Birmingham Bryant Bequest PhD Studentship (A.M.T. and Z.A.) and a UK Medical Research Council Confidence in Concept award (B.K).	Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P509, DOI 10.1016/j.mcn.2004.11.002; Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Ahmed Z, 2006, BRAIN, V129, P1517, DOI 10.1093/brain/awl080; Ahmed Z, 2014, NEUROBIOL DIS, V64, P163, DOI 10.1016/j.nbd.2013.12.008; Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024; Almutiri S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29124-z; Bartkova J, 2008, MOL ONCOL, V2, P296, DOI 10.1016/j.molonc.2008.09.007; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Bilgen M, 2007, MAGN RESON IMAGING, V25, P657, DOI 10.1016/j.mri.2006.10.009; Bottros MM, 2014, J PAIN RES, V7, P615, DOI 10.2147/JPR.S37591; Brechtel K, 2006, SPINAL CORD, V44, P605, DOI 10.1038/sj.sc.3101894; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Damiola F, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3669; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Dupre A, 2008, NAT CHEM BIOL, V4, P119, DOI 10.1038/nchembio.63; Fagoe ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150141; Farrukh F, 2019, MOL NEUROBIOL, V56, P6807, DOI 10.1007/s12035-019-1555-9; Faville R, 2015, SCI REP-UK, V5, DOI 10.1038/srep08454; Fielder E, 2017, J ALZHEIMERS DIS, V60, pS107, DOI 10.3233/JAD-161221; Garner KM, 2009, NAT CHEM BIOL, V5, P129, DOI 10.1038/nchembio0309-129; Gillingwater TH, 2013, NEUROPATH APPL NEURO, V39, P320, DOI 10.1111/nan.12014; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Hains BC, 2004, EXP NEUROL, V188, P365, DOI 10.1016/j.expneurol.2004.04.001; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hayashi T, 1998, STROKE, V29, P1007, DOI 10.1161/01.STR.29.5.1007; He M, 2012, BREAST CANCER RES TR, V133, P111, DOI 10.1007/s10549-011-1700-2; He N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.437; Herrup K, 2004, J NEUROSCI, V24, P9232, DOI 10.1523/JNEUROSCI.3347-04.2004; Hosoya N, 2014, CANCER SCI, V105, P370, DOI 10.1111/cas.12366; Jacques SJ, 2012, MOL CELL NEUROSCI, V49, P464, DOI 10.1016/j.mcn.2012.03.002; Katchanov J, 2001, J NEUROSCI, V21, P5045, DOI 10.1523/JNEUROSCI.21-14-05045.2001; Kerr F, 2011, NEUROBIOL AGING, V32, P1977, DOI 10.1016/j.neurobiolaging.2009.10.015; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Kruman II, 2008, FRONT BIOSCI-LANDMRK, V13, P2504, DOI 10.2741/2862; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Kuusisto KM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2832; Kwon BK, 2002, SPINE, V27, P1504, DOI 10.1097/00007632-200207150-00005; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; LEVINE JD, 2002, BMC NEUROSCI, V0003; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Long DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106068; Love S, 2003, NEUROSCI LETT, V353, P29, DOI 10.1016/j.neulet.2003.09.004; Lu XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010523; Marsh J, 2017, NEUROBIOL DIS, V106, P63, DOI 10.1016/j.nbd.2017.06.011; McShea A, 1997, AM J PATHOL, V150, P1933; Merlo D, 2016, CURR ALZHEIMER RES, V13, P1208, DOI 10.2174/1567205013666160401114915; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Milanese C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0848-7; Mladenov E, 2016, SEMIN CANCER BIOL, V37-38, P51, DOI 10.1016/j.semcancer.2016.03.003; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Pernet V, 2013, NEUROBIOL DIS, V51, P202, DOI 10.1016/j.nbd.2012.11.011; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Romero E, 2008, NEURON, V57, P27, DOI 10.1016/j.neuron.2007.11.025; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Russell CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043201; Saeed Y, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0745-y; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Simpson JE, 2015, NEUROPATH APPL NEURO, V41, P483, DOI 10.1111/nan.12202; Speretta E, 2012, J BIOL CHEM, V287, P20748, DOI 10.1074/jbc.M112.350124; Stivers JT, 2008, NAT CHEM BIOL, V4, P86, DOI 10.1038/nchembio0208-86; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Surey S, 2014, NEUROSCIENCE, V275, P62, DOI 10.1016/j.neuroscience.2014.06.003; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Taylor MJ, 2019, J NEUROGENET, V33, P190, DOI 10.1080/01677063.2019.1634065; Thomas CN, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.32; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Vigneswara V, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.44; Vigneswara V, 2013, PLOS ONE, V8; Vigneswara V, 2014, BRAIN, V137, P1656, DOI 10.1093/brain/awu037; Wei Z, 2016, CHINESE MED J-PEKING, V129, P1835, DOI 10.4103/0366-6999.186646; Wen Y, 2004, J BIOL CHEM, V279, P22684, DOI 10.1074/jbc.M311768200; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.341; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701	89	5	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2019	1	1							05	10.1093/braincomms/fcz005			21	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3RF	WOS:000574927100005	32954257	Green Submitted, Green Published, Green Accepted, gold			2022-02-06	
J	van Markus-Doornbosch, F; Peeters, E; van der Pas, S; Vlieland, TV; Meesters, J				van Markus-Doornbosch, F.; Peeters, E.; van der Pas, S.; Vlieland, T. Vliet; Meesters, J.			Physical activity after mild traumatic brain injury: What are the relationships with fatigue and sleep quality?	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Brain injuries; Adolescent; Fatigue; Sleep; Physical activity; Pediatric	CHILDREN; ADOLESCENTS; SYMPTOMS; PARTICIPATION; IMPACT; ADULTS; INDEX; DISTURBANCES; PERFORMANCE; CONCUSSION	Objectives: To determine self-reported physical activity (PA) levels and relationships with fatigue and sleep quality in adolescents and young adults after mild traumatic brain injury (mTBI). Setting: Follow-up 6-18 months after visiting the emergency department of one of 2 general hospitals. Participants: Forty-nine adolescents and young adults aged 12-25 years (mean 18.4 years), 22 (45%) male with mTBI. Design: Cross-sectional survey study. Main outcome measures: The Activity Questionnaire for Adults and Adolescents (AQuAA), with results dichotomized into meeting or not meeting Dutch Health Enhancing PA recommendations (D-HEPA), the Checklist Individual Strength (CIS, 4 subscores) and the Pittsburgh Sleep Quality Index (PSQI, total score) were administered. Results: Twenty-five participants (51%) did not meet the D-HEPA recommendations. After adjusting for sex, BMI and age, not meeting the recommendations was associated with a higher CIS Total Score (OR 1.04 95%CI 1.01, 1.07) but not with PSQI Total Score (OR 0.99, 95% CI 0.80, 1.21). Conclusions: In adolescents and young adults with mTBI the level of reported PA is associated with fatigue but not with sleep quality. It remains to be established whether interventions aiming to promote PA should primarily be focused on PA or fatigue or both. (C) 2018 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[van Markus-Doornbosch, F.; Vlieland, T. Vliet; Meesters, J.] Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands; [van Markus-Doornbosch, F.; Vlieland, T. Vliet; Meesters, J.] Leiden Univ, Med Ctr, Dept Orthopaed Rehabil & Phys Therapy, Leiden, Netherlands; [Peeters, E.] Juliana Childrens Hosp, Haga Teaching Hosp, The Hague, Netherlands; [van der Pas, S.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Med Stat, Leiden, Netherlands; [Vlieland, T. Vliet] Rijnlands Rehabil Ctr, Leiden, Netherlands		van Markus-Doornbosch, F (corresponding author), Sophia Rehabil, Vrederustlaan 180, NL-2543 SW The Hague, Netherlands.	f.vanmarkus@sophiarevalidatie.nl	Vlieland, Thea Vliet/AAJ-8119-2020	Vlieland, Thea Vliet/0000-0001-6322-3859; van der Pas, Stephanie/0000-0002-2448-5378			AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; [Anonymous], 2010, GLOB REC PHYS ACT HL; [Anonymous], 2013, TNO MON PHYS ACT HLT; Balemans ACJ, 2015, PHYS THER, V95, P996, DOI 10.2522/ptj.20140270; Baque E, 2017, BRAIN INJURY, V31, P667, DOI 10.1080/02699052.2017.1291990; Baque E, 2017, CLIN REHABIL, V31, P722, DOI 10.1177/0269215516651980; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Berger Ivona, 2017, Glob Pediatr Health, V4, p2333794X17745973, DOI 10.1177/2333794X17745973; Braam KI, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008796.pub3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cancelliere C, 2014, ARCH PHYS MED REHAB, V95, P5210; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Crichton A, 2018, J HEAD TRAUMA REHAB, V33, P200, DOI 10.1097/HTR.0000000000000330; Crichton AJ, 2017, J HEAD TRAUMA REHAB, V32, P107, DOI 10.1097/HTR.0000000000000248; de Kloet AJ, 2013, BRAIN INJURY, V27, P843, DOI 10.3109/02699052.2013.775496; de Kloet AJ, 2015, J DEV BEHAV PEDIATR, V36, P342, DOI 10.1097/DBP.0000000000000169; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hassett L, 2015, J HEAD TRAUMA REHAB, V30, pE55, DOI 10.1097/HTR.0000000000000047; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; IBM, 2015, SPSS STAT WIND VERS; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Maher C, 2015, DEV MED CHILD NEUROL, V57, P742, DOI 10.1111/dmcn.12736; McCrory P, 2017, BRIT J SPORT MED, V51, P1; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Necajauskaite Olga, 2005, Medicina (Kaunas), V41, P457; Ooijendijk W, 2007, TREND REPORT PHYS AC; Orsey AD, 2013, PEDIATR BLOOD CANCER, V60, P1908, DOI 10.1002/pbc.24641; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Saunders TJ, 2016, APPL PHYSIOL NUTR ME, V41, pS283, DOI 10.1139/apnm-2015-0626; Sawyer Q, 2016, J ATHL TRAINING, V51, P739, DOI 10.4085/1062-6050-51.12.01; Soric M, 2015, ANN HUM BIOL, V42, P31, DOI 10.3109/03014460.2014.928367; Starkey NJ, 2018, BRAIN INJURY, V32, P617, DOI 10.1080/02699052.2018.1439533; Stiggelbout M., 2000, TIJDSCHR SOC GEZONDH, V78, P180; TEASDALE G, 1974, LANCET, V2, P81; ter Wolbeek M, 2006, PEDIATRICS, V117, pE1078, DOI 10.1542/peds.2005-2575; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; van Buuren S, 2004, Ned Tijdschr Geneeskd, V148, P1967; van Markus-Doornbosch F, 2017, EUR J PHYS REHAB MED, V53, P900, DOI 10.23736/S1973-9087.17.04517-8; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO, 2017, WORLD DAT BOD MASS I; Yeh EA, 2015, MULT SCLER J, V21, P1618, DOI 10.1177/1352458515606526	57	5	5	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	JAN	2019	23	1					53	60		10.1016/j.ejpn.2018.11.002			8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	HK1IJ	WOS:000457658200009	30522904	Green Published, Bronze			2022-02-06	
J	Wang, J; Mahajan, HP; Toto, PE; McCue, MP; Ding, D				Wang, Jing; Mahajan, Harshal P.; Toto, Pamela E.; McCue, Michael P.; Ding, Dan			The feasibility of an automatic prompting system in assisting people with traumatic brain injury in cooking tasks	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						Assistive technology for cognition; context-based prompts; multi-step tasks	MONTREAL COGNITIVE ASSESSMENT; REHABILITATION; TECHNOLOGY	Purpose: Individuals with traumatic brain injury (TBI) often experience difficulties in performing kitchen-related sequencing tasks due to cognitive deficits. The primary aim of this study is to examine the feasibility of a context-aware automatic prompting system in assisting individuals with TBI in multi-step cooking tasks. Method: Sixteen individuals with TBI participated in the study. A randomized cross-over design was used to compare the automatic prompting method with a conventional user-controlled method through a tablet device. Participant performance under each prompting method was assessed using the Performance Assessment of Self-Care Skills in terms of independence, safety, and adequacy. Subjective workload and qualitative feedback were also collected. Results: The automatic method, when compared with the user-controlled method, significantly decreased the amount of external assistance required by participants, received higher ratings in user perceived ease-of-use, and was considered less stressful for participants. However, the user-controlled method showed strengths in offering participants more flexibility in terms of controlling on the timing of prompts. Conclusions: The results provided insight into the potential benefits and user perceptions of a context-aware prompting system. The information could contribute to the future development of advanced prompting technology for people with cognitive impairments in completing sequential tasks.	[Wang, Jing; Mahajan, Harshal P.; McCue, Michael P.; Ding, Dan] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA; [Wang, Jing; Mahajan, Harshal P.; Ding, Dan] Human Engn Res Labs, Pittsburgh, PA USA; [Toto, Pamela E.] Univ Pittsburgh, Dept Occupat Therapy, Sch Hlth & Rehabil Sci, 6425 Penn Ave,Suite 400, Pittsburgh, PA 15206 USA		Ding, D (corresponding author), Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Rehabil Sci & Technol, Pittsburgh, PA 15260 USA.	dad5@pitt.edu			National Science Foundation, Quality of Life Technology Engineering Research CenterNational Science Foundation (NSF) [EEC 0540865]	This research was funded through the National Science Foundation, Quality of Life Technology Engineering Research Center (grant #EEC 0540865). No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit on the authors or on any organization with which the authors are associated.	AbleLink Technologies, 2014, VIS ASS; [Anonymous], 2012, VIS IMP PRO; Davies DK, 2003, RES PRACT PERS SEV D, V28, P182, DOI 10.2511/rpsd.28.4.182; de Guise E, 2013, BRAIN INJURY, V27, P1428, DOI 10.3109/02699052.2013.835867; Harshal P, 2013, RESNA ANN C 2013 SEA; HART S G, 1988, P139; Hart SG., 2006, P HUM FACT ERG SOC A, V50, P904, DOI DOI 10.1177/154193120605000909; Holm MB, 2008, ASSESSMENTS OCCUPATI, P101; Inc. M, 2014, KIN OFF WEBS; Inc. S, 2014, INSTEON HOM AUT; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; McCue M, 2008, TELEMED E HLTH, V14, P58; Mihailidis A, 2001, ASSIST TECHNOL, V13, P23, DOI 10.1080/10400435.2001.10132031; Mihailidis A., 2002, GERONTECHNOLOGY, V2, P173, DOI [10.4017/gt.2002.02.02.002.00, DOI 10.4017/GT.2002.02.02.002.00]; Mihailidis Alex, 2008, BMC Geriatr, V8, P28, DOI 10.1186/1471-2318-8-28; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; O'Neill B, 2010, NEUROPSYCHOL REHABIL, V20, P509, DOI 10.1080/09602010903519652; Peters C, 2014, ACM T ACCESS COMPUT, V5, DOI 10.1145/2579700; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Research IB, 2012, 2012 BRULT ECM 1240; Roalf DR, 2013, ALZHEIMERS DEMENT, V9, P529, DOI 10.1016/j.jalz.2012.10.001; Sauro J, 2011, MEASURING USEFULNESS; Tsui KM, 2010, QOLT INT S INT SYST; Wang Jianping, 2014, COMP 2 PROMPTING MET, P83; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746	26	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2019	14	8					817	825		10.1080/17483107.2018.1499144			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	KE0SQ	WOS:000508271700014	30318931				2022-02-06	
J	Yau, RK; Dennis, SG; Boden, BP; Cantu, RC; Lord, JA; Kucera, KL				Yau, Rebecca K.; Dennis, Savannah G.; Boden, Barry P.; Cantu, Robert C.; Lord, James A., III; Kucera, Kristen L.			Catastrophic High School and Collegiate Cheerleading Injuries in the United States: An Examination of the 2006-2007 Basket Toss Rule Change	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						injury prevention; epidemiology; head injuries/concussion; cervical spine; cheerleading	NORTH-CAROLINA; RISK-FACTORS; EPIDEMIOLOGY; FREQUENCY	Background: Cheerleading is a specialized athletic activity that can lead to catastrophic injuries. Cheerleading rules are in place to maximize safety of participants. The purpose of this study was to describe catastrophic cheerleading injuries among high school and collegiate-level participants in the United States and to explore whether the 2006-2007 basket toss rule change was effective at reducing the number of catastrophic injuries. Hypothesis: The 2006-2007 basket toss rule change contributed to a reduction in the number of catastrophic injuries among high school and collegiate cheerleaders. Study Design: Case series. Level of Evidence: Level 4. Methods: Data on catastrophic cheerleading injuries were collected by the National Center for Catastrophic Sport Injury Research from July 2002 to June 2017. Information collected included cheerleader, event, and injury characteristics. The impact of the 2006-2007 rule change banning the basket toss on any hard surfaces was assessed by comparing injury rates and 95% CIs before and after the rule change. Results: There were 54 catastrophic cheerleading injuries, or 3.6 injuries per year. From July 2002 through June 2017, the injury rate was 2.12 per 1,000,000 cheerleaders (95% CI, 1.56-2.69). Most cheerleaders sustained serious injuries (n = 27; 50%) during practice (n = 37; 69%) to the head (n = 28; 52%) and cervical spine (n = 17; 32%). From July 2002 through June 2017, basket tosses were the stunt that accounted for the highest proportion of injuries (n = 19; 35%). The basket toss injury rate decreased from 1.55 to 0.40 per 1,000,000 cheerleaders among both high school and collegiate cheerleaders after the rule change. Conclusion: Catastrophic injury rates in cheerleading decreased dramatically after the 2006-2007 rule change banning basket tosses from being performed on any hard surfaces. In particular, there was a nearly 4-fold reduction in the rate of catastrophic basket toss injuries.	[Yau, Rebecca K.] Prevent Res Ctr, 2150 Shattuck Ave,Suite 601, Berkeley, CA 94704 USA; [Yau, Rebecca K.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Dennis, Savannah G.; Kucera, Kristen L.] Univ N Carolina, Natl Ctr Catastroph Sport Injury Res, Chapel Hill, NC USA; [Boden, Barry P.] Orthopaed Ctr, Rockville, MD USA; [Cantu, Robert C.] Emerson Hosp, Concord, MA USA; [Cantu, Robert C.] Boston Univ, Boston, MA 02215 USA; [Lord, James A., III] USA Cheer, Memphis, TN USA; [Kucera, Kristen L.] Univ N Carolina, Dept Exercise & Sports Sci, Chapel Hill, NC USA		Yau, RK (corresponding author), Prevent Res Ctr, 2150 Shattuck Ave,Suite 601, Berkeley, CA 94704 USA.	ryau@prev.org			National Institute on Alcohol Abuse and Alcoholism of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA014125]; American Football Coaches Association; National Athletic Trainers' Association; National Collegiate Athletic Association; National Federation of State High School Associations; National Operating Committee on Standards for Athletic Equipment; American Medical Society for Sports Medicine; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA014125] Funding Source: NIH RePORTER	Rebecca K. Yau, PhD, was supported by grant number T32AA014125 from the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health. The National Center for Catastrophic Sport Injury Research is funded by the following organizations: the American Football Coaches Association, the National Athletic Trainers' Association, the National Collegiate Athletic Association, the National Federation of State High School Associations, the National Operating Committee on Standards for Athletic Equipment, and the American Medical Society for Sports Medicine.	American Association of Cheerleading Coaches and Administrators, 2015 6 AACCA SCH CHE; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; FLYNN L, 1996, NY TIMES; Jacobson BH, 2005, BRIT J SPORT MED, V39, P237, DOI 10.1136/bjsm.2004.014605; Jacobson BH, 2004, J ORTHOP SPORT PHYS, V34, P261, DOI 10.2519/jospt.2004.34.5.261; Kucera KL, 2016, CATASTROPHIC SPORTS; Kucera KL, 2017, CATASTROPHIC SPORTS; LaBella CR, 2012, PEDIATRICS, V130, P966, DOI 10.1542/peds.2012-2480; Lewis PH., 1996, NY TIMES, pD7; Mueller FO, 2012, CATASTROPHIC SPORTS; Mueller FO, 2009, J ATHL TRAINING, V44, P565, DOI 10.4085/1062-6050-44.6.565; Naiyer N, 2017, CLIN PEDIATR, V56, P985, DOI 10.1177/0009922817702938; National Federation of State High School Associations, PART STAT; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Schulz MR, 2004, AM J SPORT MED, V32, P396, DOI 10.1177/0363546503261715; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Sports Market Analytics, MARK RES DEM	17	5	5	2	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2019	11	1					32	39		10.1177/1941738118807122			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HF3KQ	WOS:000454134300004	30354940	Green Published, Bronze			2022-02-06	
J	Kramer, TJ; Sakas, W; Jussen, D; Krenzlin, H; Kempski, O; Alessandri, B				Kraemer, Tobias J.; Sakas, Wasim; Jussen, Daniel; Krenzlin, Harald; Kempski, Oliver; Alessandri, Beat			Thrombin contributes to the injury development and neurological deficit after acute subdural hemorrhage in rats only in collaboration with additional blood-derived factors	BMC NEUROSCIENCE			English	Article						Acute subdural hemorrhage; Thrombin; Neurotoxicity; Argatroban; PAR1; SCH79797	ACTIVATED RECEPTOR 1; TRAUMATIC BRAIN-INJURY; CEREBRAL ISCHEMIA/REPERFUSION INJURY; HEPARIN-INDUCED THROMBOCYTOPENIA; DELAYED ARGATROBAN TREATMENT; INTRACEREBRAL HEMORRHAGE; SERINE PROTEASES; IN-VIVO; HEMATOMA; DAMAGE	BackgroundAcute subdural hemorrhage (ASDH) is a severe consequence of traumatic brain injury. The occurrence of subdural blood increases the lethality of these patients independent of the amount of blood or elevated intracranial pressure. Thrombin is one of the potential harmful blood components. Possible harmful effects of thrombin are mediated via the Protease-activated-receptor-1 (PAR1) and thus, translating the acute Thrombin release after ASDH into cell loss. The objectives of the present study were twofold, namely to examine (1) the impact of direct thrombin inhibition in the acute phase after hemorrhage on the long-term histological and functional deficits and (2) the early inhibition of PAR1 activation by thrombin with the selective antagonist SCH79797 on lesion volume at 14days after ASDH. The effects of thrombin on the lesion size were investigated in two separate experiments via (1) direct thrombin inhibition in the subdural infused blood (Argatroban 600 mu g) as well as by (2) intraventricular injection ofthe PAR-1 antagonistSCH79797 (1 mu g or 5 mu g). Lesion volume and behavior deficits using a neurological deficit score and a motor function test (beam balance test) were analyzed as outcome parameters at 14days after injury.Results59 Male Sprague-Dawley rats received a subdural infusion of 300 mu l autologous blood or sham operation. Lesion volume at 14days after ASDH tended to be smaller in the Argatroban-treated group when compared to the vehicle group (8.11.1 vs. 10.1 +/- 2.3mm(2), n.s.). Motor deficits in the beam balance test were not significantly less severe in the Argatroban-treated group. Animals treated with SCH79797 also showed a trend towards dose-dependent decreased lesion volume in comparison to the vehicle-treated group (1g: 4.3 +/- 0.7mm(3); 5g: 3.8 +/- 1.1mm(3); vehicle: 6.5 +/- 2.0mm(3), n.s).Conclusions Thrombin inhibition in the subdural blood and local cerebral blockade of PAR-1 cause a tendency towards reduced lesion volume or functional recovery. All results show a trend in favor of the acute treatment on the outcome parameters. Our results suggests that thrombin could be an important blood-derived factor during acute subdural hemorrhage that translates its deleterious effects in concert with other blood-induced factors.	[Kraemer, Tobias J.; Sakas, Wasim; Jussen, Daniel; Krenzlin, Harald; Kempski, Oliver; Alessandri, Beat] Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany; [Jussen, Daniel] HELIOS Dr Horst Schmidt Kliniken, Dept Neurosurg, Wiesbaden, Germany; [Krenzlin, Harald] Johannes Gutenberg Univ Mainz, Dept Neurosurg, Univ Med Ctr, Mainz, Germany		Kramer, TJ (corresponding author), Johannes Gutenberg Univ Mainz, Inst Neurosurg Pathophysiol, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.	kraemertobi@web.de	Krenzlin, Harald/AAS-7602-2020; Krenzlin, Harald/AAM-5444-2020	Kramer, Tobias/0000-0001-6900-3486			Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; Almonte AG, 2011, BRAIN RES, V1407, P107, DOI 10.1016/j.brainres.2011.06.042; Baechli H, 2010, J CEREBR BLOOD F MET, V30, P576, DOI 10.1038/jcbfm.2009.230; Baxter MG, 2009, ANESTHESIOLOGY, V111, P209, DOI 10.1097/ALN.0b013e3181a8617e; Ben Shimon M, 2017, PLOS ONE, V12; Chandrasekharan UM, 2010, ARTERIOSCL THROM VAS, V30, P1983, DOI 10.1161/ATVBAHA.110.212399; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Citron BA, 2000, J NEUROTRAUM, V17, P1191, DOI 10.1089/neu.2000.17.1191; Citron BA, 2016, BRAIN RES, V1643, P10, DOI 10.1016/j.brainres.2016.04.071; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Covic L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082237; Cui QL, 2007, J NEUROCHEM, V100, P1480, DOI 10.1111/j.1471-4159.2006.04329.x; De Luca C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102128; DUHAIME AC, 1994, J NEUROTRAUM, V11, P669, DOI 10.1089/neu.1994.11.669; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; Fujimoto S, 2006, NEUROBIOL DIS, V22, P130, DOI 10.1016/j.nbd.2005.10.008; Gao F, 2014, J CEREBR BLOOD F MET, V34, P489, DOI 10.1038/jcbfm.2013.225; Gong Y, 2008, ACTA NEUROCHIR SUPPL, V105, P47; GRABHAM P, 1995, J NEUROCHEM, V64, P583; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hamill CE, 2009, EXP NEUROL, V217, P136, DOI 10.1016/j.expneurol.2009.01.023; Henrich-Noack P, 2006, BRAIN RES, V1070, P232, DOI 10.1016/j.brainres.2005.10.100; Isaev D, 2015, NEUROBIOL DIS, V78, P68, DOI 10.1016/j.nbd.2015.03.026; Itsekson-Hayosh Z, 2016, J NEUROTRAUM, V33, P1848, DOI 10.1089/neu.2015.4146; Itzekson Z, 2014, J MOL NEUROSCI, V53, P87, DOI 10.1007/s12031-013-0200-8; JENKINS A, 1990, British Journal of Neurosurgery, V4, P45, DOI 10.3109/02688699009000681; Junge CE, 2003, P NATL ACAD SCI USA, V100, P13019, DOI 10.1073/pnas.2235594100; Jussen D, 2008, CRIT CARE MED, V36, P543, DOI 10.1097/01.CCM.0B013E3181620A0F; Jussen D, 2017, J NEUROTRAUM, V34, P906, DOI 10.1089/neu.2016.4464; Kameda K, 2012, BRIT J PHARMACOL, V165, P106, DOI 10.1111/j.1476-5381.2011.01485.x; Karabiyikoglu M, 2005, NEUROSURGERY, V57, P565, DOI 10.1227/01.NEU.0000170435.47739.AE; Keep RF, 2005, STROKE, V36, P1594, DOI 10.1161/01.STR.0000170701.41507.e1; Kitaoka T, 2003, ACT NEUR S, V86, P457; Kitaoka T, 2002, STROKE, V33, P3012, DOI 10.1161/01.STR.0000037673.17260.1B; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lee D, 2005, GLIA, V51, P98, DOI 10.1002/glia.20190; Lewis BE, 1997, SEMIN THROMB HEMOST, V23, P197, DOI 10.1055/s-2007-996091; Li YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38247; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Maggio N, 2013, EXP NEUROL, V247, P595, DOI 10.1016/j.expneurol.2013.02.011; Manaenko A, 2013, NEUROBIOL DIS, V50, P13, DOI 10.1016/j.nbd.2012.09.004; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Morihara R, 2017, J NEUROSCI RES, V95, P1818, DOI 10.1002/jnr.24013; Nedelmann M, 2007, BRAIN RES, V1130, P188, DOI 10.1016/j.brainres.2006.10.087; Radulovic M, 2016, NEUROBIOL DIS, V93, P226, DOI 10.1016/j.nbd.2016.04.010; Rajput PS, 2014, NEUROSCIENCE, V281, P229, DOI 10.1016/j.neuroscience.2014.09.038; Ramos-Mandujano G, 2007, GLIA, V55, P917, DOI 10.1002/glia.20513; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.3.CO;2-4; Smirnova IV, 2001, J NEUROBIOL, V48, P87, DOI 10.1002/neu.1044; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Sugawara T, 2009, STROKE, V40, P1530, DOI 10.1161/STROKEAHA.108.531699; Sweeney AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43606; Tardy-Poncet B, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1109-0; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Thevenet J, 2009, J NEUROCHEM, V111, P828, DOI 10.1111/j.1471-4159.2009.06369.x; Timaru-Kast R, 2008, J NEUROTRAUM, V25, P1107, DOI 10.1089/neu.2008.0517; VanLandingham JW, 2008, J CEREBR BLOOD F MET, V28, P1786, DOI 10.1038/jcbfm.2008.73; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Walker CPR, 2002, BRIT J ANAESTH, V88, P848, DOI 10.1093/bja/88.6.848; Wang JH, 2012, STROKE, V43, P2476, DOI 10.1161/STROKEAHA.112.661819; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Yan JH, 2013, STROKE, V44, P1410, DOI 10.1161/STROKEAHA.113.678474; Yang JN, 2017, NEURAL REGEN RES, V12, P242, DOI 10.4103/1673-5374.199011; Yang Y, 2014, NEUROSCI LETT, V568, P44, DOI 10.1016/j.neulet.2014.03.037; Zhou ZH, 2011, BRAIN RES BULL, V86, P235, DOI 10.1016/j.brainresbull.2011.07.012; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	70	5	6	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	DEC 27	2018	19								81	10.1186/s12868-018-0481-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF9QF	WOS:000454576100001	30591020	Green Published, gold			2022-02-06	
J	Ojo, JO; Crynen, G; Reed, JM; Ajoy, R; Vallabhaneni, P; Algamal, M; Leary, P; Rafi, NG; Mouzon, B; Mullan, M; Crawford, F				Ojo, Joseph O.; Crynen, Gogce; Reed, Jon M.; Ajoy, Rosa; Vallabhaneni, Prashanthi; Algamal, Moustafa; Leary, Paige; Rafi, Naomi G.; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona			Unbiased Proteomic Approach Identifies Unique and Coincidental Plasma Biomarkers in Repetitive mTBI and AD Pathogenesis	FRONTIERS IN AGING NEUROSCIENCE			English	Article						mild-TBI; Alzheimer's disease; hTau; PS1/APP; plasma biomarker; proteomics	TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; AMYLOID-PRECURSOR-PROTEIN; ALZHEIMER-LIKE PATHOLOGY; GENOME-WIDE ASSOCIATION; NEURON-SPECIFIC-ENOLASE; TIME-DEPENDENT CHANGES; CLUSTERIN CONCENTRATION; SERUM CONCENTRATIONS	The relationship between repetitive mild traumatic brain injury (r-mTBI) and Alzheimer's disease (AD) is well-recognized. However, the precise nature of how r-mTBI leads to or precipitates AD pathogenesis is currently not understood. Plasma biomarkers potentially provide non-invasive tools for detecting neurological changes in the brain, and can reveal overlaps between long-term consequences of r-mTBI and AD. In this study we address this by generating time-dependent molecular profiles of response to r-mTBI and AD pathogenesis in mouse models using unbiased proteomic analyses. To model AD, we used the well-validated hTau and PSAPP(APP/PS1) mouse models that develop age-related tau and amyloid pathological features, respectively, and our well-established model of r-mTBI in C57BL/6 mice. Plasma were collected at different ages (3, 9, and 15 months-old for hTau and PSAPP mice), encompassing pre-, peri-and post-"onset" of the cognitive and neuropathological phenotypes, or at different timepoints after r-mTBI (24 h, 3, 6, 9, and 12 months post-injury). Liquid chromatography/mass spectrometry (LC-MS) approaches coupled with Tandem Mass Tag labeling technology were applied to develop molecular profiles of protein species that were significantly differentially expressed as a consequence of mTBI or AD. Mixed model ANOVA after Benjamini-Hochberg correction, and a stringent cut-off identified 31 proteins significantly changing in r-mTBI groups over time and, when compared with changes over time in sham mice, 13 of these were unique to the injured mice. The canonical pathways predicted to be modulated by these changes were LXR/RXR activation, production of nitric oxide and reactive oxygen species and complement systems. We identified 18 proteins significantly changing in PSAPP mice and 19 proteins in hTau mice compared to their wild-type littermates with aging. Six proteins were found to be significantly regulated in all three models, i.e., r-mTBI, hTau, and PSAPP mice compared to their controls. The top canonical pathways coincidently changing in all three models were LXR/RXR activation, and production of nitric oxide and reactive oxygen species. This work suggests potential biomarkers for TBI and AD pathogenesis and for the overlap between these two, and warrant targeted investigation in human populations.	[Ojo, Joseph O.; Crynen, Gogce; Reed, Jon M.; Ajoy, Rosa; Vallabhaneni, Prashanthi; Algamal, Moustafa; Leary, Paige; Rafi, Naomi G.; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Expt Neuropathol & Prote Lab, Sarasota, FL 34243 USA; [Ojo, Joseph O.; Mouzon, Benoit; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Ojo, Joseph O.; Crynen, Gogce; Algamal, Moustafa; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Open Univ, Life Hlth & Chem Sci, Milton Keynes, Bucks, England; [Reed, Jon M.] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA		Ojo, JO (corresponding author), Roskamp Inst, Expt Neuropathol & Prote Lab, Sarasota, FL 34243 USA.; Ojo, JO (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Ojo, JO (corresponding author), Open Univ, Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	jojo@roskampinstitute.org		Algamal, Moustafa/0000-0002-6215-0122	CDMRPUnited States Department of Defense [DOD/W81XWH-13-1-0253]; Roskamp Foundation	This project was supported by the CDMRP award to Fiona Crawford DOD/W81XWH-13-1-0253 and by the Roskamp Foundation. The content presented do not express the views of the Department of Defense or Veteran Affairs or the United States Government.	Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arendash GW, 2001, BRAIN RES, V891, P42, DOI 10.1016/S0006-8993(00)03186-3; Ashton Nicholas J, 1800, Alzheimers Dement (Amst), V1, P48, DOI 10.1016/j.dadm.2014.11.005; Baird AL, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00236; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Burnham SC, 2014, MOL PSYCHIATR, V19, P519, DOI 10.1038/mp.2013.40; Chase Alex, 2014, Nat Rev Neurol, V10, P240, DOI 10.1038/nrneurol.2014.65; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Csaszar A, 1997, NEUROSCI LETT, V230, P151, DOI 10.1016/S0304-3940(97)00500-4; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Du Y, 2000, NEUROLOGY, V55, P480, DOI 10.1212/WNL.55.4.480; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fu Q, 2005, PROTEOMICS, V5, P2656, DOI 10.1002/pmic.200402048; Fu Qin, 2007, Methods Mol Biol, V357, P365; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N; Guan FL, 2012, MOL BIOL REP, V39, P6661, DOI 10.1007/s11033-012-1472-8; Gupta VB, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt185; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hye A, 2006, BRAIN, V129, P3042, DOI 10.1093/brain/awl279; Hye A, 2014, ALZHEIMERS DEMENT, V10, P799, DOI 10.1016/j.jalz.2014.05.1749; Jeromin A, 2017, ADV NEUROBIOL, V15, P491, DOI 10.1007/978-3-319-57193-5_20; Jongbloed W, 2015, J ALZHEIMERS DIS, V46, P1103, DOI 10.3233/JAD-150036; Kamboh MI, 2006, NEUROBIOL AGING, V27, P1435, DOI 10.1016/j.neurobiolaging.2005.07.015; KAMBOH MI, 1995, NAT GENET, V10, P486, DOI 10.1038/ng0895-486; Kiddle SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044260; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kovacs DM, 2000, EXP GERONTOL, V35, P473, DOI 10.1016/S0531-5565(00)00113-3; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Leung R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064971; Lleo A, 2015, NAT REV NEUROL, V11, P41, DOI 10.1038/nrneurol.2014.232; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Mondello S., 2017, J NEUROTRAUM, V34, P3134; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Mouzon B, 2018, BRAIN INJURY, V32, P1285, DOI 10.1080/02699052.2018.1486457; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Ohrt-Nissen S, 2011, EMERG MED J, V28, P941, DOI 10.1136/emj.2010.091363; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Papa L., 2015, BRAIN NEUROTRAUMA MO; Papa L., 2011, NEUROCRIT CARE, V1, pS172; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Reed J., 2014, 62 AM SOC MASS SPECT; Reed J., 2013, 61 AM SOC MASS SPECT; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Sandler SJI, 2010, CHILD NERV SYST, V26, P205, DOI 10.1007/s00381-009-1009-1; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Sousa JC, 2007, NEUROBIOL AGING, V28, P713, DOI 10.1016/j.neurobiolaging.2006.03.015; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Tenovuo O., 2016, J NEUROTRAUM, V33, DOI [10.1089/neu.2016.4442, DOI 10.1089/NEU.2016.4442]; Thambisetty M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028527; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Thambisetty M, 2010, J ALZHEIMERS DIS, V22, P1099, DOI 10.3233/JAD-2010-101350; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tyagi Ethika, 2013, Int J Alzheimers Dis, V2013, P606083, DOI 10.1155/2013/606083; Vasan RS, 2006, CIRCULATION, V113, P2335, DOI 10.1161/CIRCULATIONAHA.104.482570; Velayudhan L, 2012, J ALZHEIMERS DIS, V28, P369, DOI 10.3233/JAD-2011-110611; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wildsmith KR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-22; Yang MH, 2012, J PROTEOMICS, V75, P3617, DOI 10.1016/j.jprot.2012.04.017; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Yong E, 2014, NATURE, V511, P524, DOI 10.1038/511524a; Zabel M, 2012, J ALZHEIMERS DIS, V30, P311, DOI 10.3233/JAD-2012-112012; Zakirova Z, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201600190; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	111	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	DEC 18	2018	10								405	10.3389/fnagi.2018.00405			20	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	HE8AR	WOS:000453665600001	30618712	gold, Green Published, Green Accepted			2022-02-06	
